PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beniaminov, AD; Dezhenkova, LG; Mamaeva, OK; Shchyolkina, AK; Tevyashova, AN; Kaluzhny, DN; Shtil, AA				Beniaminov, Artemy D.; Dezhenkova, Lyubov G.; Mamaeva, Olga K.; Shchyolkina, Anna K.; Tevyashova, Anna N.; Kaluzhny, Dmitry N.; Shtil, Alexander A.			Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative	PLOS ONE			English	Article							SPECIFICITY; LIGANDS; COMPLEX	The current model of binding of the antitumor antibiotic olivomycin A (1) to GC-rich DNA regions presumes that coordination of the magnesium divalent cation with drug dimers is necessary for binding of 1 into the minor groove of the DNA duplex. Previously we have synthesized the derivatives of 1 termed 'short acid' (2) and its N,N-dimethylaminoethylamide (3). The latter compound demonstrated an improved tolerance in vivo compared to 1 and good therapeutic potency in animal models. We herein report that compound 3 is able to form stable complexes with DNA in the absence of Mg2+, in striking contrast to 1 whose binding to the DNA absolutely requires Mg2+. The mode of binding of 3 to DNA is similar in the presence or absence of Mg2+ as determined by circular dichroism. The affinity to DNA of 3 in Mg2+-free solution was similar to that of 1 or 3 in the presence of Mg2+ at low ionic strength. Non-electrostatic contributions to total free energy of binding of 1 and 3 to DNA were comparable for Mg2+-free complexes. Our data strongly suggest that electrostatic interaction of the positively charged 3 can compensate for the absence of divalent ions in complexes with DNA. This new property of the olivomycin A derivative expands the mechanistic knowledge of the modes of interaction with DNA of small molecular weight drug candidates.	[Beniaminov, Artemy D.; Mamaeva, Olga K.; Shchyolkina, Anna K.; Kaluzhny, Dmitry N.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Dezhenkova, Lyubov G.; Tevyashova, Anna N.] Gause Inst New Antibiot, Moscow, Russia; [Tevyashova, Anna N.] Mendeleev Univ Chem Technol, 9 Miusskaya Sq, Moscow, Russia; [Shtil, Alexander A.] NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia; [Shtil, Alexander A.] ITMO Univ, St Petersburg, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Gause Institute of New Antibiotics; Mendeleev University of Chemical Technology of Russia; ITMO University	Kaluzhny, DN (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	uzhny@mail.ru; shtilaa@yahoo.com	Kaluzhny, Dmitry N/G-7256-2014; Tevyashova, Anna/A-8293-2014; Shchyolkina, Anna/AAB-8268-2021; Beniaminov, Artemy D/G-7435-2014	Beniaminov, Artemy D/0000-0002-9076-5386; Kaluzhny, Dmitry/0000-0001-7090-3334	Pharma program [14.N08.12.0058]; Russian Science Foundation [16-14-10396]	Pharma program; Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by Pharma-2020 program (state contract 14.N08.12.0058 with the Ministry of Education and Science of the Russian Federation) to AT. Part of this work was funded by the Russian Science Foundation (project 16-14-10396) to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brikenshtein V Kh, 1984, Mol Biol (Mosk), V18, P1606; Chaires JB, 1996, BIOCHEMISTRY-US, V35, P2047, DOI 10.1021/bi952812r; CHEN KX, 1989, FEBS LETT, V245, P145, DOI 10.1016/0014-5793(89)80209-1; FOX KR, 1985, NUCLEIC ACIDS RES, V13, P8695, DOI 10.1093/nar/13.24.8695; GAO XL, 1992, J MOL BIOL, V223, P259, DOI 10.1016/0022-2836(92)90730-8; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043792; Kaluzhny DN, 2009, CHEMMEDCHEM, V4, P1641, DOI 10.1002/cmdc.200900227; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; PITINA L R, 1982, Pharmaceutical Chemistry Journal (English Translation of Khimiko-Farmatsevticheskii Zhurnal), V16, P327, DOI 10.1007/BF00762046; Tevyashova AN, 2011, BIOORGAN MED CHEM, V19, P7387, DOI 10.1016/j.bmc.2011.10.055; Tevyashova AN, 2009, BIOORGAN MED CHEM, V17, P4961, DOI 10.1016/j.bmc.2009.05.076; Yang TP, 2010, CHEM-BIOL INTERACT, V183, P181, DOI 10.1016/j.cbi.2009.09.018	13	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191923	10.1371/journal.pone.0191923	http://dx.doi.org/10.1371/journal.pone.0191923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420558	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900029
J	Jaudan, A; Sharma, S; Abd Malek, SN; Dixit, A				Jaudan, Alka; Sharma, Sapna; Abd Malek, Sri Nurestri; Dixit, Aparna			Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action	PLOS ONE			English	Article							OXIDATIVE STRESS; CYTOCHROME-C; QUERCETIN; CYCLE; RESVERATROL; PHYTOCHEMICALS; PROLIFERATION; GENERATION; FLAVONOIDS; TOXICITY	Pinostrobin (P-N) is a naturally occurring dietary bioflavonoid, found in various medicinal herbs/plants. Though anti-cancer potential of many such similar constituents has been demonstrated, critical biochemical targets and exact mechanism for their apoptosis-inducing actions have not been fully elucidated. The present study was aimed to investigate if P-N induced apoptosis in cervical cancer cells (HeLa) of human origin. It is demonstrated that P-N at increasing dose effectivity reduced the cell viability as well as GSH and NO2- levels. Condensed nuclei with fragmented chromatin and changes in mitochondrial matrix morphology clearly indicated the role of mitochondria in P-N induced apoptosis. A marked reduction in mitochondrial membrane potential and increased ROS production after P-N treatment showed involvement of free radicals, which in turn further augment ROS levels. P-N treatment resulted in DNA damage, which could have been triggered by an increase in ROS levels. Decrease in apoptotic cells in the presence of caspase 3 inhibitor in P-N-treated cells suggested that PN induced apoptosis via caspase dependent pathways. Additionally, a significant increase in the expression of proteins of extrinsic (TRAIL R1/DR4, TRAIL R2/DR5, TNF RI/TNFRSF1A, FADD, Fas/TNFRSF6) and intrinsic pathway (Bad, Bax, HTRA2/Omi, SMAC/Diablo, cytochrome C, Pro-Caspase-3, Cleaved Caspase-3) was observed in the cells exposed to P-N. Taken together, these observations suggest that P-N efficiently induces apoptosis through ROS mediated extrinsic and intrinsic dependent signaling pathways, as well as ROS mediated mitochondrial damage in HeLa cells.	[Jaudan, Alka; Sharma, Sapna; Dixit, Aparna] Jawaharlal Nehru Univ, Sch Biotechnol, Gene Regulat Lab, New Delhi, India; [Abd Malek, Sri Nurestri] Univ Malaya, Fac Sci, Kuala Lumpur, Malaysia	Jawaharlal Nehru University, New Delhi; Universiti Malaya	Dixit, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Gene Regulat Lab, New Delhi, India.	adixit7@gmail.com	Malek, Sri Nurestri/W-8556-2019; Malek, Sri Nurestri Abd/B-9834-2010	Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559	Jawaharlal Nehru University, New Delhi, India; Department of Science and Technology, New Delhi, India [SR/PURSE/Phase2/11(C)]; Department of Biotechnology, Ministry of Science and Technology, India	Jawaharlal Nehru University, New Delhi, India; Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Department of Biotechnology, Ministry of Science and Technology, India	The Jawaharlal Nehru University, New Delhi, India is acknowledged for providing financial support. The Department of Science and Technology, New Delhi, India is acknowledged for PURSE grant [SR/PURSE/Phase2/11(C) 2015] to the Jawaharlal Nehru University, New Delhi, India. The Department of Biotechnology, Ministry of Science and Technology, India is acknowledged for providing research fellowship to AJ. Advanced Instrumentation Research Facility (AIRF), Jawaharlal Nehru University, New Delhi is acknowledged for providing the TEM, FACS, Confocal and Live Cell Imaging Facilities.	Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; Altinoz MA, 2007, CELL BIOL INT, V31, P473, DOI 10.1016/j.cellbi.2006.11.013; Ariffin SHZ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-6; Ashidi JS, 2010, J ETHNOPHARMACOL, V128, P501, DOI 10.1016/j.jep.2010.01.009; Beevi SS, 2007, CLIN CHIM ACTA, V375, P119, DOI 10.1016/j.cca.2006.06.028; Bhamarapravati S, 2003, P 3 WORLD C MED AR P, P521; Bi L, 2016, INTEGR CANCER THER, V15, P226, DOI 10.1177/1534735416637424; Bishayee K, 2013, CELL PROLIFERAT, V46, P153, DOI 10.1111/cpr.12017; Cao XD, 2012, NAT PROD RES, V26, P2089, DOI 10.1080/14786419.2011.628174; Chua A.J.S., 2012, CURRENT MICROSCOPY C, P763; Del Follo-Martinez A, 2013, NUTR CANCER, V65, P494, DOI 10.1080/01635581.2012.725194; El Hady FA., 2013, INT J PHARM SCI REV, V21, P338; EVANS VG, 1993, CELL BIOL INT, V17, P461, DOI 10.1006/cbir.1993.1087; Foppoli C., 2014, CANCER CYTOPATHOL, P51, DOI [10.1016/B978-0-12-405205-5.00006-4, DOI 10.1016/B978-0-12-405205-5.00006-4]; Gokbulut AA, 2013, HEMATOLOGY, V18, P144, DOI 10.1179/1607845412Y.0000000042; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haddad AQ, 2006, PROSTATE CANCER P D, V9, P68, DOI 10.1038/sj.pcan.4500845; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Hunter P, 2014, EMBO REP, V15, P485, DOI 10.1002/embr.201438780; Jadaun A, 2017, J PHOTOCH PHOTOBIO B, V167, P299, DOI 10.1016/j.jphotobiol.2017.01.010; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim SJ, 2012, MOL MED REP, V6, P1443, DOI 10.3892/mmr.2012.1085; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Li JM, 2015, BANGL J PHARMACOL, V10, P820, DOI 10.3329/bjp.v10i4.23039; Li XX, 2015, MOL MED REP, V11, P3746, DOI 10.3892/mmr.2015.3224; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Maciejczyk A, 2013, GINEKOL POL, V84, P590; Mahyar-Roemer M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-27; Meydani M, 2017, FUNCT FOOD SCI TECHN, P125; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Nicholson RA, 2010, FITOTERAPIA, V81, P826, DOI 10.1016/j.fitote.2010.05.005; Padma VV, 2007, BASIC CLIN PHARMACOL, V100, P302, DOI 10.1111/j.1742-7843.2007.00046.x; Pal D, 2011, J ADV PHARM TECHNOL, V2, P207, DOI 10.4103/2231-4040.90874; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Raja SB, 2017, FOOD CHEM TOXICOL, V106, P92, DOI 10.1016/j.fct.2017.05.006; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Riley JS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.213; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Sayre CL, 2015, J PHARM PHARM SCI, V18, P368, DOI 10.18433/J3BK5T; Sayre CL, 2013, J PHARM PHARM SCI, V16, P272, DOI 10.18433/J3X01Q; Takeara R, 2003, PHYTOMEDICINE, V10, P490, DOI 10.1078/094471103322331430; Tatiraju DV., 2013, J PHARMACOGN PHYTOCH, V2, P55; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281, DOI 10.2174/187152012803833026; WHO, 2016, HUMAN PAPILLOMAVIRUS, DOI 10.12968/indn.2020.2.20; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu N, 2011, PHYTOMEDICINE, V18, P110, DOI 10.1016/j.phymed.2010.07.001; Xiao XY, 2011, CANCER LETT, V302, P69, DOI 10.1016/j.canlet.2010.12.016; Xu WL, 2017, MOLECULES, V22, DOI 10.3390/molecules22081299; Yong WK, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/921306; Zhang X, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05014	59	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191523	10.1371/journal.pone.0191523	http://dx.doi.org/10.1371/journal.pone.0191523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420562	gold, Green Submitted, Green Published			2022-12-27	WOS:000424517900016
J	Mamulwar, M; Godbole, S; Bembalkar, S; Kamble, P; Dulhani, N; Yadav, R; Kadu, C; Kumar, P; Lalikar, S; Acharya, S; Gangakhedkar, R; Risbud, A; Venkatesh, S				Mamulwar, Megha; Godbole, Sheela; Bembalkar, Shilpa; Kamble, Pranil; Dulhani, Nisha; Yadav, Rajesh; Kadu, Chitra; Kumar, Pradeep; Lalikar, Shivraj; Acharya, Shrikala; Gangakhedkar, Raman; Risbud, Arun; Venkatesh, Srinivas			Differing HIV vulnerability among female sex workers in a high HIV burden Indian state	PLOS ONE			English	Article							PREVENTION; HIV/AIDS; INTERVENTION; MICROFINANCE	Introduction The HIV sentinel surveillance [HSS] conducted in 2010-11 among female sex workers [FSW] in the state of Maharashtra, India provided an opportunity to assess characteristics of different types of FSWs and their HIV risk. It is important for India's National AIDS Control Program, to understand the differences in vulnerability among these FSW, in order to define more specific and effective risk reduction intervention strategies. Therefore, we analyzed data from HSS with the objective of understanding the HIV vulnerability among different types of FSW in Maharashtra. Material and methods Cross sectional data collected as a part of HSS among FSWs in year 2010-11 from 21 sentinel sites in the state of Maharashtra were analyzed to understand the vulnerability and characteristics of different types of female sex workers based on their place of solicitation using multinomial logistic regression. Results While the HIV prevalence was 6.6% among all FSWs, it was 9.9% among brothel based [BB], 9% among street based [SB] and 3.1% and 3.7% among home based [HB], and bar based [Bar-B] sex workers respectively. SB FSWs were least likely to be located in HIV low burden districts [ANC] [ARRR: 0.61[95% CI: 0.49, 0.77]], but were 6 times more likely to be recently [<1 year] involved in sex work [ARRR: 6.15 [95% CI: 3.15, 12.0]]. The number of clients of SB FSWs in the preceding week were lower than 11% [ARRR: 0.89 [95% CI: 0.87, 0.90]] as compared to the BB FSWs denoting lesser client load. The duration since last paid sex was shorter [ARRR: 0.94[95% CI: 0.91, 0.96]] as compared to the BB FSWs. Conclusion Street based FSWs have emerged as one of the most vulnerable types of FSW with a high HIV prevalence similar to BB FSWs. Our study reveals that they have more frequent sex acts despite lower client loads, and are more likely to be located in districts highly affected by HIV (ANC prevalence >1%). We identify them as a group to be focused on for prevention interventions and it is likely that they would be easily amenable to novel interventions due to their higher literacy rate as compared to other typologies.	[Mamulwar, Megha; Godbole, Sheela; Bembalkar, Shilpa; Kamble, Pranil; Dulhani, Nisha; Yadav, Rajesh; Kadu, Chitra; Gangakhedkar, Raman; Risbud, Arun] Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India; [Kumar, Pradeep] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, SIMU, New Delhi, India; [Lalikar, Shivraj] Maharashtra State AIDS Control Soc, STI, Monitoring & Evaluat, Bombay, Maharashtra, India; [Acharya, Shrikala] Mumbai Dist AIDS Control Soc, Bombay, Maharashtra, India; [Venkatesh, Srinivas] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Kamble, Pranil] GOI, DGHS, Natl Ctr Dis Control, Delhi, India; [Dulhani, Nisha] Evalueserve, Gurgaon, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); National Centre for Disease Control (NCDC)	Godbole, S (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India.	sgodbole@nariindia.org	Godbole, Sheela/ABG-4942-2020	Acharya, Shrikala/0000-0001-8968-4258; Godbole, Sheela/0000-0001-6537-9064; Kumar, Pradeep/0000-0002-7638-1263	National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India	National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India	The HSS 2010-11 round conducted for HRG was funded by National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare Government of India. The HIV Sentinel surveillance is a national activity conducted by NACO and the overall design of the surveillance is attributable to them. The data analysis plan and manuscript development was led by the first and corresponding and other authors from NARI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avert NACO USAID MSACS M, 2009, BEH SURV SURV MAH; Bannakkopa RM, 2008, AIDS, P22; Brahme R, 2006, J ACQ IMMUN DEF SYND, P41; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dandona Rakhi, 2006, BMC Int Health Hum Rights, V6, P5, DOI 10.1186/1472-698X-6-5; Dworkin SL, 2009, AIDS BEHAV, V13, P462, DOI 10.1007/s10461-009-9532-3; Godbole S, 2017, 9 IAS C HIV SCI IAS; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gurung A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S10; Khot S., 2010, NEEDS ASSESSMENT BAR; Kumar GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-65; Kumar R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-549; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, MIN HLTH FAM WELF G; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2015, INT BIOL BEH SURV IB; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2012, HIV SENT SURV 2010 1; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2010, HIV SENT SURV 2010 O; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, 2007, TARG INT NACP 3 OP G; National AIDS Control Organisation Ministry of Health and Family Welfare G of I, HIV SENT SURV NAT RE; National AIDS Control Organisation & National Institute of Medical Statistics Ministry of Health and Family Welfare IG of I, 2015, TECHNICAL REPORT; Nirgude Abhay, 2011, Indian J Community Med, V36, P31, DOI 10.4103/0970-0218.80790; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Ranebennur V, 2014, HIV AIDS-RES PALLIAT, V6, P9, DOI 10.2147/HIV.S54062; Thappa D. M., 2007, Indian Journal of Sexually Transmitted Diseases, V28, P69; Trust IHA, 2010, HIV AIDS SIT RESP MA; Tsai Laura Cordisco, 2011, Open Womens Health J, V5, P26; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Witte SS, 2015, AM J PUBLIC HEALTH, V105, pE95, DOI 10.2105/AJPH.2014.302291	30	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192130	10.1371/journal.pone.0192130	http://dx.doi.org/10.1371/journal.pone.0192130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420577	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900041
J	Essa, K; Sabouri, A; Butt, H; Basuny, FH; Ghazy, M; El-Sayed, MA				Essa, Khamis; Sabouri, Aydin; Butt, Haider; Basuny, Fawzia Hamed; Ghazy, Mootaz; El-Sayed, Mahmoud Ahmed			Laser additive manufacturing of 3D meshes for optical applications	PLOS ONE			English	Article							LATTICE STRUCTURES; OPTIMIZATION; BEHAVIOR	Selective laser melting (SLM) is a widely used additive manufacturing process that can be used for printing of intricate three dimensional (3D) metallic structures. Here we demonstrate the fabrication of titanium alloy Ti-6Al-4V alloy based 3D meshes with nodally-connected diamond like unit cells, with lattice spacing varying from 400 to 1000 microns. A Concept Laser M2 system equipped with laser that has a wavelength of 1075 nm, a constant beam spot size of 50 mu m and maximum power of 400W was used to manufacture the 3D meshes. These meshes act as optical shutters/directional transmitters and display interesting optical properties. A detailed optical characterisation was carried out and it was found that these structures can be optimised to act as scalable rotational shutters with high efficiencies and as angle selective transmission screens for protection against unwanted and dangerous radiations. The efficiency of fabricated lattice structures can be increased by enlarging the meshing size.	[Essa, Khamis; Sabouri, Aydin; Butt, Haider] Univ Birmingham, Sch Mech Engn, Birmingham, W Midlands, England; [Basuny, Fawzia Hamed] Arab Acad Sci & Technol & Maritime Transport, Indstry Serv Complex, Alexandria, Egypt; [Ghazy, Mootaz; El-Sayed, Mahmoud Ahmed] Arab Acad Sci & Technol & Maritime Transport, Dept Ind & Management Engn, Alexandria, Egypt	University of Birmingham; Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport; Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	El-Sayed, MA (corresponding author), Arab Acad Sci & Technol & Maritime Transport, Dept Ind & Management Engn, Alexandria, Egypt.	m_elsayed@aast.edu	El-Sayed, Mahmoud Ahmed/Q-7425-2016; Essa, Khamis/AAF-8072-2020; Butt, Haider/AAK-4361-2021	El-Sayed, Mahmoud Ahmed/0000-0003-3086-0872; Essa, Khamis/0000-0001-6090-0869; Butt, Haider/0000-0003-2434-9525				Ahmed R, 2016, OPT COMMUN, V370, P183, DOI 10.1016/j.optcom.2016.03.015; [Anonymous], 2012, ISRN MECH ENG; CRANDALL KA, 1994, APPL PHYS LETT, V65, P118, DOI 10.1063/1.113053; Dadbakhsh LHS, 2009, CHINESE J LASERS, V12; Essa K, 2016, INT J ADV MANUF TECH, P1; Fatemi SA, 2017, VIRTUAL PHYS PROTOTY, V12, P133, DOI 10.1080/17452759.2017.1293274; Gu DD, 2012, INT MATER REV, V57, P133, DOI 10.1179/1743280411Y.0000000014; Hassanin H, 2016, ADV ENG MATER, V18, P1544, DOI 10.1002/adem.201600172; Liu YJ, 2017, ACTA MATER, V126, P58, DOI 10.1016/j.actamat.2016.12.052; Ma J, 2015, DISPLAYS, V37, P2, DOI 10.1016/j.displa.2014.10.003; Morris SM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818679; Nicoletta FP, 1999, APPL PHYS LETT, V74, P3945, DOI 10.1063/1.124232; Qiu CL, 2015, MAT SCI ENG A-STRUCT, V628, P188, DOI 10.1016/j.msea.2015.01.031; Read N, 2015, MATER DESIGN, V65, P417, DOI 10.1016/j.matdes.2014.09.044; Sabouri A, 2017, ENERG FUEL, V31, P2524, DOI 10.1021/acs.energyfuels.6b02850; Sing SL, 2018, ROBOT CIM-INT MANUF, V49, P170, DOI 10.1016/j.rcim.2017.06.006; Sun JF, 2013, OPT LASER TECHNOL, V49, P118, DOI 10.1016/j.optlastec.2012.12.002; Zhao R, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4834095	18	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192389	10.1371/journal.pone.0192389	http://dx.doi.org/10.1371/journal.pone.0192389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414982	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300073
J	Coppens, V; Leuckx, G; Heremans, Y; Staels, W; Verdonck, Y; Baeyens, L; De Leu, N; Heimberg, H				Coppens, Violette; Leuckx, Gunter; Heremans, Yves; Staels, Willem; Verdonck, Yannick; Baeyens, Luc; De Leu, Nico; Heimberg, Harry			Semi-automated digital measurement as the method of choice for beta cell mass analysis	PLOS ONE			English	Article							IMAGE-ANALYSIS; SOFTWARE	Pancreas injury by partial duct ligation (PDL) activates beta cell differentiation and proliferation in adult mouse pancreas but remains controversial regarding the anticipated increase in beta cell volume. Several reports unable to show beta cell volume augmentation in PDL pancreas used automated digital image analysis software. We hypothesized that fully automatic beta cell morphometry without manual micrograph artifact remediation introduces bias and therefore might be responsible for reported discrepancies and controversy. However, our present results prove that standard digital image processing with automatic thresholding is sufficiently robust albeit less sensitive and less adequate to demonstrate a significant increase in beta cell volume in PDL versus Sham-operated pancreas. We therefore conclude that other confounding factors such as quality of surgery, selection of samples based on relative abundance of the transcription factor Neurogenin 3 (Ngn3) and tissue processing give rise to inter-laboratory inconsistencies in beta cell volume quantification in PDL pancreas.	[Coppens, Violette; Leuckx, Gunter; Heremans, Yves; Staels, Willem; Verdonck, Yannick; Baeyens, Luc; De Leu, Nico; Heimberg, Harry] Vrije Univ Brussel, Beta Cell Neogenesis, Brussels, Belgium; [Coppens, Violette] Univ Antwerp, Fac Med & Hlth Sci, Collaborat Antwerp Psychiat Res Inst, Campus Drie Eiken, Antwerp, Belgium; [Coppens, Violette] Univ Dept Psychiat, Campus Duffel, Duffel, Belgium; [Staels, Willem] Univ Ghent, Div Pediat Endocrinol, Dept Pediat, Hosp & Dept Pediat & Genet, Ghent, Belgium; [De Leu, Nico] Univ Ziekenhuis Brussel, Dept Endocrinol, Brussels, Belgium; [De Leu, Nico] Algemeen Stedelijk Ziekenhuis Aalst, Dept Endocrinol, Aalst, Belgium	Vrije Universiteit Brussel; University of Antwerp; Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels	Heimberg, H (corresponding author), Vrije Univ Brussel, Beta Cell Neogenesis, Brussels, Belgium.	Harry.Heimberg@vub.ac.be	Staels, Willem/I-4985-2013; Coppens, Violette/AAH-6649-2020	Staels, Willem/0000-0001-8259-3329; Coppens, Violette/0000-0001-6247-551X; Heimberg, Harry/0000-0003-1954-7375; De Leu, Nico/0000-0002-0542-5708	Instituut voor Innovatie door Wetenschap en Technologie (IWT) [91113]; Research Council, Vrije Universiteit Brussel [SRP35, P7/07]; Fund for Scientific Research Flanders (FWO) [G024512N]; FWO-Odysseus [GOF9116N]; DON Foundation; European Research Council [ERC DLV-677555]	Instituut voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Council, Vrije Universiteit Brussel; Fund for Scientific Research Flanders (FWO)(FWO); FWO-Odysseus; DON Foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Instituut voor Innovatie door Wetenschap en Technologie (IWT) (project nr: 91113; URL: http://www.iwt.be/) provided a PhD scholarship for the first author (VC); Research Council, Vrije Universiteit Brussel (Strategic Research Project SRP35) to HH" "Belgian Science Policy (Interuniversity Attraction Pole phase VI, project P7/07 to HH; Fund for Scientific Research Flanders (FWO) (Research Grant G024512N) to HH; FWO-Odysseus GOF9116N) to LB; DON Foundation (www.scion.nI) to HH and the European Research Council (ERC DLV-677555) to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; De Groef S, 2015, JOVE-J VIS EXP, DOI 10.3791/52765; de Jonge GJ, 2011, INT J CARDIOVAS IMAG, V27, P787, DOI 10.1007/s10554-010-9727-8; HALLY AD, 1964, Q J MICROSC SCI, V105, P503; Inuwa IM, 2005, INT J DIABETES METAB, V13; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Marks Peter C, 2013, Open Med Imaging J, V7, P19; McGrath JC, 2015, BRIT J PHARMACOL, V172, P2427, DOI 10.1111/bph.12956; Molinari F, 2012, INT ANGIOL, V31, P42; Olerud J, 2009, DIABETOLOGIA, V52, P2594, DOI 10.1007/s00125-009-1544-z; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Picut CA, 2008, TOXICOL PATHOL, V36, P674, DOI 10.1177/0192623308317428; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041976; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191249	10.1371/journal.pone.0191249	http://dx.doi.org/10.1371/journal.pone.0191249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408875	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800013
J	Kim, HJ; Min, JY; Min, KB; Lee, TJ; Yoo, S				Kim, Hye-Jin; Min, Jin-Young; Min, Kyoung-Bok; Lee, Tae-Jin; Yoo, Seunghyun			Relationship among family environment, self-control, friendship quality, and adolescents' smartphone addiction in South Korea: Findings from nationwide data	PLOS ONE			English	Article							BEHAVIOR; CHILDREN; SATISFACTION; DELINQUENCY; DYSFUNCTION; TEENAGERS; DYNAMICS; EXPOSURE; STUDENTS; VIOLENCE	Background Many studies have examined the negative impact on smartphone addiction in adolescents. Recent concerns have focused on predictors of smartphone addiction. This study aimed to investigate the association of adolescents' smartphone addiction with family environment (specifically, domestic violence and parental addiction). We further investigated whether self-control and friendship quality, as predictors of smartphone addiction, may reduce the observed risk. Methods We used the 2013 national survey on internet usage and utilization data from the National Information Agency of Korea. Information on exposure and covariates included self-reported experience of domestic violence and parental addiction, sociodemographic variables, and other variables potentially related to smartphone addiction. Smartphone addiction was estimated using a smartphone addiction proneness scale, a standardized measure developed by national institutions in Korea. Results Adolescents who had experienced domestic violence (OR = 1.74; 95% CI: 1.23 +/- 2.45) and parental addiction (OR = 2.01; 95% CI: 1.24 +/- 3.27) were found to be at an increased risk for smartphone addiction after controlling for all potential variables. Furthermore, on classifying adolescents according to their level of self-control and friendship quality the association between domestic violence and parental addiction, and smartphone addiction was found to be significant in the group with adolescents with lower levels of self-control (OR = 2.87; 95% CI: 1.68 +/- 4.90 and OR = 1.95; 95% CI: 1.34 +/- 2.83) and friendship quality (OR = 2.33; 95% CI: 1.41 +/- 3.85 and OR = 1.83; 95% CI: 1.26 +/- 2.64). Conclusion Our findings suggest that family dysfunction was significantly associated with smartphone addiction. We also observed that self-control and friendship quality act as protective factors against adolescents' smartphone addiction.	[Kim, Hye-Jin; Min, Kyoung-Bok] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Min, Jin-Young] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lee, Tae-Jin; Yoo, Seunghyun] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Min, KB (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	minkb@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2015R1D1A1A01059048]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This study was supported by Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (grant 2015R1D1A1A01059048) to KM.	Bae SM, 2015, SCHOOL PSYCHOL INT, V36, P513, DOI 10.1177/0143034315604017; BURTON D, 1994, J TRAUMA STRESS, V7, P83, DOI 10.1002/jts.2490070109; Cao Yuping, 2016, J Child Adolesc Trauma, V9, P127; Cohen DA, 1997, J DRUG EDUC, V27, P199, DOI 10.2190/QPQQ-6Q1G-UF7D-5UTJ; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Darcin AE, 2016, BEHAV INFORM TECHNOL, V35, P520, DOI 10.1080/0144929X.2016.1158319; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Deutsch C, 1982, SERVICES CHILDREN AL, P147; Dong-il Kim, 2008, [Korea Journal of Counseling, 상담학연구], V9, P1703; Edleson JL, 1999, J INTERPERS VIOLENCE, V14, P839, DOI 10.1177/088626099014008004; Ericsson S, 2016, TELEWORK EXPERIENCES; Eum Y, 2016, TEENAGERS ADDICTION; Finkenauer C, 2005, INT J BEHAV DEV, V29, P58, DOI 10.1080/01650250444000333; Gottfredson M.R., 1990, GEN THEORY CRIME; Granitz NA, 1996, NA ADV CONSUMER RES, V23; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; Holt TJ, 2012, AM J CRIM JUSTICE, V37, P378, DOI 10.1007/s12103-011-9117-3; 박지영, 2012, Korean Journal of Clinical Psychology, V31, P151; Hong J, 2002, J KOREAN HOME MANAGE, V20, P125; Hye Hwang Kyung, 2012, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V12, P365, DOI 10.5392/JKCA.2012.12.10.365; Inal EE, 2015, MUSCLE NERVE, V52, P183, DOI 10.1002/mus.24695; Jeong SH, 2016, COMPUT HUM BEHAV, V54, P10, DOI 10.1016/j.chb.2015.07.035; Johnson SB, 2012, STRESS BRAIN EXPERIE; JONES DC, 1991, J SOC PERS RELAT, V8, P167, DOI 10.1177/0265407591082002; Jung J, 2014, MOB MEDIA COMMUN, V2, P352, DOI 10.1177/2050157914542172; Kee IK, 2016, J PHYS THER SCI, V28, P339, DOI 10.1589/jpts.28.339; Kim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097920; Kim H. S., 1997, J KOREAN ACAD CHILD, V8, P57; Kim HS, 2008, CHILD PSYCHIAT HUM D, V39, P439, DOI 10.1007/s10578-008-0099-4; Kim H, 2013, J EXERC REHABIL, V9, P500, DOI 10.12965/jer.130080; Kim K, 2013, PEDIATR INT, V55, P703, DOI 10.1111/ped.12171; KNUTSON JF, 1995, ANNU REV PSYCHOL, V46, P401, DOI 10.1146/annurev.ps.46.020195.002153; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; LEBLANC M, 1992, PSYCHIATRY, V55, P336; Mannikko N, 2015, J BEHAV ADDICT, V4, P281, DOI 10.1556/2006.4.2015.040; MARQUIS P, 1992, PSYCHOL REP, V71, P468, DOI 10.2466/PR0.71.6.468-470; Meldrum RC, 2013, J CRIM JUST, V41, P24, DOI 10.1016/j.jcrimjus.2012.10.003; Mesch G, 2006, INFORM SOC, V22, P137, DOI 10.1080/01972240600677805; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Osofsky JD, 1999, FUTURE CHILD, V9, P33, DOI 10.2307/1602780; Park SK, 2008, ADOLESCENCE, V43, P895; Pearson C, 2016, GAMING TECHNOLOGY AD, V2, P212; Peterson G. W., 2005, HDB ADOLESCENT BEHAV, P27, DOI DOI 10.1007/0-387-23846-8_3; Reisig MD, 2011, DEVIANT BEHAV, V32, P589, DOI 10.1080/01639621003800505; Rosen LD, 2014, COMPUT HUM BEHAV, V35, P364, DOI 10.1016/j.chb.2014.01.036; RUBIOSTIPEC M, 1991, J STUD ALCOHOL, V52, P78, DOI 10.15288/jsa.1991.52.78; Simons-Morton BG, 2004, HEALTH EDUC RES, V19, P561, DOI 10.1093/her/cyg071; Steinberg L, 2000, NATL I JUSTICE J, P31; Toda M., 2015, Open Journal of Preventive Medicine, V5, P456, DOI 10.4236/ojpm.2015.512051; Wolak J, 2007, PEDIATRICS, V119, P247, DOI 10.1542/peds.2006-1891; 류명운, 2015, [Journal of Internet Computing and Services, 인터넷정보학회논문지], V16, P95, DOI 10.7472/jksii.2015.16.3.95; Yun I, 2016, INT J OFFENDER THER, V60, P1185, DOI 10.1177/0306624X15574683; 백혜원, 2014, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V53, P320, DOI 10.4306/jknpa.2014.53.5.320; 이지인, 2014, Journal of Acupuncture Research, V31, P99; 김병년, 2013, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V13, P208, DOI 10.5392/JKCA.2013.13.04.208	55	80	83	11	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190896	10.1371/journal.pone.0190896	http://dx.doi.org/10.1371/journal.pone.0190896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401496	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400007
J	Tang, XH; Li, YZ; Ao, JY; Ding, L; Liu, Y; Yuan, Y; Wang, ZF; Wang, GL				Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Liu, Yang; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin			Role of alpha 7nAChR-NMDAR in sevoflurane-induced memory deficits in the developing rat hippocampus	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LONG-TERM DEPRESSION; NMDA-RECEPTOR; GENERAL-ANESTHESIA; NEONATAL EXPOSURE; DENDRITIC SPINES; AMYLOID-BETA; MICE; PROTEIN; EXPRESSION	Detrimental effects of volatile anaesthetics, including sevoflurane, on the structure and function of the developing brain have been reported. The internalization of N-methyl-D-aspartate receptors (NMDARs) contributes to anaesthetic neurotoxicity. Both nicotinic acetylcholine receptors (nAChRs) and NMDAR play a critical role in the development of the nervous system. Moreover, nAChR can interact with NMDAR, and previous studies have demonstrated modulation of NMDAR by nAChR. In our study, we used an alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) agonist and alpha 7nAChR antagonist to explore the role of alpha 7nAChR and NMDAR in sevoflurane-induced long-term effects on memory and dendritic spine both in vivo and in vitro. The results revealed that the activation of alpha 7nAChR attenuated the development of sevoflurane-induced memory deficit and dendritic spine changes, which might be by regulating NR2B-containing NMDAR trafficking from the intracellular pool to the cell surface pool in the hippocampus. Moreover, we demonstrated that alpha 7nAChR could regulate NR2B-containing NMDAR via Src-family tyrosine kinase (SFK). Thus, our current study indicates that the trafficking of NR2B-containing NMDAR is regulated by alpha 7nAChR via SFK in neonatal rat hippocampus, which may be secondary to sevoflurane-induced cognitive deficits in the developing hippocampus.	[Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin] Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China; [Liu, Yang] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, GL (corresponding author), Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China.; Wang, GL (corresponding author), Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China.	wangguolinemail@126.com			National Natural Science Foundation of China [NSFC 81300960, 81371245, 81400908]; Key Projects in the Tianjin Science & Technology Pillar Program [12ZCZDSY03000]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC12800]; Scientific Grant from Tianjin Health Bureau [2013KZ124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program; Tianjin Research Program of Application Foundation and Advanced Technology; Scientific Grant from Tianjin Health Bureau	Our study is supported by National Natural Science Foundation of China(NSFC 81300960, 81371245, and 81400908), Key Projects in the Tianjin Science & Technology Pillar Program (12ZCZDSY03000), Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC12800), Scientific Grant from Tianjin Health Bureau (2013KZ124). The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dong Y, 2013, CURR MOL MED, V13, P488; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, TOXICOL LETT, V101, P1, DOI 10.1016/S0378-4274(98)00158-1; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Han XD, 2015, MOL MED REP, V11, P226, DOI 10.3892/mmr.2014.2751; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Kim DH, 2007, J PHARMACOL SCI, V105, P82, DOI 10.1254/jphs.FP0061565; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Lee S, 2008, BIOCHEM BIOPH RES CO, V377, P930, DOI 10.1016/j.bbrc.2008.10.082; LERMAN J, 1994, ANESTHESIOLOGY, V80, P814, DOI 10.1097/00000542-199404000-00014; Li SP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-58; Li SP, 2012, J EXP MED, V209, P2141, DOI 10.1084/jem.20121270; Lin CS, 2009, NEUROSCIENCE, V158, P1326, DOI 10.1016/j.neuroscience.2008.11.007; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Morley BJ, 2013, NEUROSCIENCE, V233, P54, DOI 10.1016/j.neuroscience.2012.12.025; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Rada EM, 2003, ANESTH ANALG, V96, P108, DOI 10.1097/00000539-200301000-00023; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; Roberts M, 2002, BEHAV NEUROSCI, V116, P1059, DOI 10.1037//0735-7044.116.6.1059; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Shen L, 2016, ACTA PHARMACOL SIN, V37, P312, DOI 10.1038/aps.2015.106; Shen XF, 2013, NEUROTOXICOLOGY, V39, P45, DOI 10.1016/j.neuro.2013.08.007; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takaenoki Y, 2014, ANESTHESIOLOGY, V120, P403, DOI 10.1097/ALN.0000435846.28299.e7; Wang WY, 2016, MOL NEUROBIOL, V53, P216, DOI 10.1007/s12035-014-9005-1; Yamazaki Y, 2006, EUR J NEUROSCI, V23, P1819, DOI 10.1111/j.1460-9568.2006.04714.x; Yang Y, 2013, P NATL ACAD SCI USA, V110, P12078, DOI 10.1073/pnas.1307849110; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhang HL, 2016, J PROTEOMICS, V131, P113, DOI 10.1016/j.jprot.2015.10.018; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192498	10.1371/journal.pone.0192498	http://dx.doi.org/10.1371/journal.pone.0192498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401517	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400063
J	Li, L; Liao, ZB; Yang, Y; Lv, L; Cao, YY; Zhu, ZY				Li, Ling; Liao, ZeBin; Yang, Yu; Lv, Lei; Cao, YingYing; Zhu, ZhenYu			Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEIN; EXTRACTION; EXPRESSION; TREHALOSE; GLYCEROL; STRESS; YEAST	Candida albicans, one of the most common fungal pathogens, is responsible for several yeast infections in human hosts, being resistant to classically used antifungal drugs, such as azole drugs. Multifactorial and multistep alterations are involved in the azole resistance in Candida albicans. In this study, a FCZ-resistant C. albicans strain was obtained by serial cultures of a FCZ-susceptible C. albicans strain in incrementally increasing concentrations of FCZ. We performed an integrated profile of different classes of molecules related to azole resistance in C. albicans by combining several mass-spectrometry based methodologies. The comparative metabolomic study was performed with the sensitive and resistant strains of C. albicans to identify metabolites altered during the development of resistance to fluconazole, while the intervention strains and non-intervention strains of C. albicans to identify metabolites altered involved in cross-resistant to azole drugs. Our analysis of the different metabolites identified molecules mainly involved in metabolic processes such as amino acid metabolism, tricarboxylic acid cycle and phospholipid metabolism. We also compared the phospholipid composition of each group, revealing that the relative content of phospholipids significantly changed during the development of resistance to azole drugs. According with these results, we hypothesized that the metabolism shift might contribute to azole drugs resistance in C. albicans from multifactorial alterations. Our result paves the way to understand processes underlying the resistance to azole drugs in C. albicans, providing the basis for developing new antifungal drugs.	[Li, Ling; Yang, Yu; Cao, YingYing; Zhu, ZhenYu] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Liao, ZeBin] Second Mil Med Univ, Fac Naval Med, Dept Radiat Med, Shanghai, Peoples R China; [Lv, Lei] Shanghai Eastern Hepatobiliary Surg Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Cao, YY; Zhu, ZY (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	caoyingying608@163.com; zzyzyfzhu@126.com	Liao, Zebin/AAC-8303-2022		National Nature Science Foundation of China [81273474, 81671991]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two National Nature Science Foundation of China (81273474 and 81671991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor William A. Fonzi for kindly providing the C. albicans strains SC5314. This work was financially supported by two National Nature Science Foundation of China (81273474 and 81671991). In addition, the authors would like to thank the referees and editor for their useful comments and suggestions, which have helped us to improve our manuscript.	Bari VK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09685; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bona E, 2016, J APPL MICROBIOL, V121, P1530, DOI 10.1111/jam.13282; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Chauhan N, 2015, MITOCHONDRION, V22, P60, DOI 10.1016/j.mito.2015.03.003; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Flis VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135084; Fuentes M, 2014, REV CHIL INFECTOL, V31, P511, DOI 10.4067/S0716-10182014000500001; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Hounoum BM, 2015, ANAL BIOANAL CHEM, V407, P8861, DOI 10.1007/s00216-015-9047-x; Howe AG, 2001, BBA-MOL CELL BIOL L, V1534, P65, DOI 10.1016/S1388-1981(01)00181-0; Ito T, 2013, J BACTERIOL, V195, P5439, DOI 10.1128/JB.00593-13; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Li LL, 2009, BIOCHEM BIOPH RES CO, V387, P778, DOI 10.1016/j.bbrc.2009.07.113; Liebeke M, 2014, INT J MED MICROBIOL, V304, P222, DOI 10.1016/j.ijmm.2013.11.017; Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P587, DOI 10.1016/j.bbabio.2015.03.007; Luo LL, 2011, CHEMOTHERAPY, V57, P77, DOI 10.1159/000323620; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Min J, 2001, BBA-MOL CELL BIOL L, V1531, P77, DOI 10.1016/S1388-1981(01)00088-9; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Peetla C, 2013, ADV DRUG DELIVER REV, V65, P1686, DOI 10.1016/j.addr.2013.09.004; Pokorna L, 2016, BBA-BIOENERGETICS, V1857, P34, DOI 10.1016/j.bbabio.2015.10.004; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sanchez-Fresneda R, 2013, BIOCHEM BIOPH RES CO, V430, P1334, DOI 10.1016/j.bbrc.2012.10.118; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sharma S, 2014, ANTIMICROB AGENTS CH, V58, P2409, DOI 10.1128/AAC.02130-13; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0044931, 10.1371/journal.pone.0039812]; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Tagliaferri E, 2015, EXPERT REV ANTI-INFE, V13, P685, DOI 10.1586/14787210.2015.1029916; Teoh ST, 2016, J BIOSCI BIOENG, V122, P168, DOI 10.1016/j.jbiosc.2016.01.007; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; VanEldere J, 1996, J CLIN MICROBIOL, V34, P842, DOI 10.1128/JCM.34.4.842-847.1996; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Zhang L, 2015, J BACTERIOL, V197, P431, DOI 10.1128/JB.02282-14	39	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192328	10.1371/journal.pone.0192328	http://dx.doi.org/10.1371/journal.pone.0192328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394282	Green Submitted, gold, Green Published			2022-12-27	WOS:000424060400035
J	Srinivasan, L; Kilpatrick, L; Shah, SS; Abbasi, S; Harris, MC				Srinivasan, Lakshmi; Kilpatrick, Laurie; Shah, Samir S.; Abbasi, Soraya; Harris, Mary C.			Elevations of novel cytokines in bacterial meningitis in infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; CEREBROSPINAL-FLUID PARAMETERS; NEONATAL MENINGITIS; LUMBAR PUNCTURE; SEPSIS; INFLAMMATION; INFECTION; IL-23; EXPRESSION; CELLS	Background Bacterial meningitis is challenging to diagnose in infants, especially in the common setting of antibiotic pre-treatment, which diminishes yield of cerebrospinal fluid (CSF) cultures. Prior studies of diagnostic markers have not demonstrated sufficient accuracy. Interleukin-23 (IL-23), interleukin-18 (IL-18) and soluble receptor for advanced glycation end products (sRAGE) possess biologic plausibility, and may be useful as diagnostic markers in bacterial meningitis. Methods In a prospective cohort study, we measured IL-23, IL-18 and sRAGE levels in CSF. We compared differences between infected and non-infected infants, and conducted receiver operating characteristic (ROC) analyses to identify individual markers and combinations of markers with the best diagnostic accuracy. Results 189 infants <6 months, including 8 with bacterial meningitis, 30 without meningitis, and 151 with indeterminate diagnosis (due to antibiotic pretreatment) were included. CSF IL-23, IL-18 and sRAGE levels were significantly elevated in infants with culture proven meningitis. Among individual markers, IL-23 possessed the greatest accuracy for diagnosis of bacterial meningitis (area under the curve (AUC) 0.9698). The combination of all three markers had an AUC of 1. Conclusions IL-23, alone and in combination with IL-18 and sRAGE, identified bacterial meningitis with excellent accuracy. Following validation, these markers could aid clinicians in diagnosis of bacterial meningitis and decision-making regarding prolongation of antibiotic therapy.	[Srinivasan, Lakshmi; Harris, Mary C.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Srinivasan, Lakshmi; Harris, Mary C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kilpatrick, Laurie] Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, Cincinnati, OH 45229 USA; [Shah, Samir S.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Abbasi, Soraya] Penn Hosp, Div Newborn Pediat, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine	Srinivasan, L (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; Srinivasan, L (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	srinivasanl@email.chop.edu		Harris, Mary Catherine/0000-0001-6287-0026	Foerderer Murray Award (The Children's Hospital of Philadelphia); University Research Foundation grant (University of Pennsylvania); National Center for Research Resources [UL1-RR-024134]; Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania; Children's Hospital of Philadelphia	Foerderer Murray Award (The Children's Hospital of Philadelphia); University Research Foundation grant (University of Pennsylvania); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania; Children's Hospital of Philadelphia	This study was supported by the Foerderer Murray Award (The Childrens Hospital of Philadelphia) and the University Research Foundation grant (University of Pennsylvania). The project described was supported by grant number UL1-RR-024134 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.; We would like to thank Caitlin La Russa, Kaitilin Mahoney, Lavanya Madhusudan, Sharon Zirin, Linda Corcoran and Toni Mancini for their help with subject enrollment and data collection. We would also like to acknowledge the Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania and the Childrens Hospital of Philadelphia for providing support with sample collection and storage for this study. A special thanks to Dr. Ting Zhang for her assistance in performance of ELISA testing of the biomarkers.	Baker MD, 1999, ARCH PEDIAT ADOL MED, V153, P508; BAKER MD, 1990, PEDIATRICS, V85, P1040; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Comim CM, 2009, CURR NEUROVASC RES, V6, P194, DOI 10.2174/156720209788970045; Endo Shigeatsu, 2000, Journal of Medicine (Westbury), V31, P15; FRANCO SM, 1992, AM J DIS CHILD, V146, P567, DOI 10.1001/archpedi.1992.02160170047014; Garges HP, 2006, PEDIATRICS, V117, P1094, DOI 10.1542/peds.2005-1132; Garofalo RP, 2004, J MED VIROL, V73, P289, DOI 10.1002/jmv.20089; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Heath PT, 2003, ARCH DIS CHILD-FETAL, V88, P173; Hofer S, 2016, J SURG RES, V202, P315, DOI 10.1016/j.jss.2016.01.019; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; HRISTEVA L, 1993, ARCH DIS CHILD-FETAL, V69, P14, DOI 10.1136/adc.69.1_Spec_No.14; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Schwalm MT, 2014, MOL NEUROBIOL, V49, P380, DOI 10.1007/s12035-013-8526-3; Smith PB, 2008, AM J PERINAT, V25, P421, DOI 10.1055/s-0028-1083839; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Srinivasan L, 2016, PEDIATR RES, V80, P566, DOI 10.1038/pr.2016.117; Srinivasan L, 2013, PEDIATR INFECT DIS J, V32, P1150, DOI 10.1097/INF.0b013e31829862b7; Srinivasan L, 2012, SEMIN PERINATOL, V36, P445, DOI 10.1053/j.semperi.2012.06.007; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2004, PEDIATRICS, V113, P1181, DOI 10.1542/peds.113.5.1181; Sugitharini V, 2013, INFLAMM RES, V62, P1025, DOI 10.1007/s00011-013-0661-9; Wei TT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003079; WISWELL TE, 1995, PEDIATRICS, V95, P803; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; Ye Q, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003222	40	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0181449	10.1371/journal.pone.0181449	http://dx.doi.org/10.1371/journal.pone.0181449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394248	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400001
J	Noden, BH; Martin, J; Carrillo, Y; Talley, JL; Ochoa-Corona, FM				Noden, Bruce H.; Martin, Jaclyn; Carrillo, Yisel; Talley, Justin L.; Ochoa-Corona, Francisco M.			Development of a loop-mediated isothermal amplification (LAMP) assay for rapid screening of ticks and fleas for spotted fever group rickettsia	PLOS ONE			English	Article							SENSITIVE DETECTION; FIELD-EVALUATION; DIAGNOSIS; TYPHUS; SPECIMENS; NORTH; STATE; AREA; DNA	Background The importance of tick and flea-borne rickettsia infections is increasingly recognized worldwide. While increased focus has shifted in recent years to the development of point-of-care diagnostics for various vector-borne diseases in humans and animals, little research effort has been devoted to their integration into vector surveillance and control programs, particularly in resource-challenged countries. One technology which may be helpful for large scale vector surveillance initiatives is loop-mediated isothermal amplification (LAMP). The aim of this study was to develop a LAMP assay to detect spotted fever group (SFG) rickettsia DNA from field-collected ticks and fleas and compare with published end-point PCR results. Methodology/Principal findings A Spotted Fever Group rickettsia-specific loop-mediated isothermal amplification (SFGRLAMP) assay was developed using primers based on a region of the R. rickettsii 17kDa protein gene. The sensitivity, specificity, and reproducibility of the assay were evaluated. The assay was then compared with the results of end-point PCR assays for pooled tick and flea samples obtained from field-based surveillance studies. The sensitivity of the SFGR-LAMP assay was 0.00001 ng/mu l (25 mu l volume) which was 10 times more sensitive than the 17kDa protein gene end-point PCR used as the reference method. The assay only recognized gDNA from SFG and transitional group (TRG) rickettsia species tested but did not detect gDNA from typhus group (TG) rickettsia species or closely or distantly related bacterial species. The SFGRLAMP assay detected the same positives from a set of pooled tick and flea samples detected by end-point PCR in addition to two pooled flea samples not detected by end-point PCR. Conclusions/significance To our knowledge, this is the first study to develop a functional LAMP assay to initially screen for SFG and TRG rickettsia pathogens in field-collected ticks and fleas. With a high sensitivity and specificity, the results indicate the potential use as a field-based surveillance tool for tick and flea-borne rickettsial pathogens in resource-challenged countries.	[Noden, Bruce H.; Martin, Jaclyn; Carrillo, Yisel; Talley, Justin L.; Ochoa-Corona, Francisco M.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Noden, BH (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	bruce.noden@okstate.edu		Noden, Bruce/0000-0002-0096-370X; Ochoa-Corona, Francisco/0000-0002-4112-8209	NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station [OKL-02909]	NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station	Funding for this project was provided by NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station (OKL-02909) to BHN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Beier-Sexton M, 2015, PRACTICAL HDB MICROB, P54; Brown Lisa D, 2016, Curr Trop Med Rep, V3, P27; Chikeka I, 2015, CLIN MICROBIOL INFEC, V21, P404, DOI 10.1016/j.cmi.2015.04.022; Cunningham LJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004441; Dittrich S, 2014, J CLIN MICROBIOL, V52, P832, DOI 10.1128/JCM.02786-13; Gillespie JJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008050; Gomes J, 2017, MOL CELL PROBE, V31, P61, DOI 10.1016/j.mcp.2016.12.006; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Karpathy SE, 2016, INT J SYST EVOL MICR, V66, P5236, DOI 10.1099/ijsem.0.001502; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Laohasinnarong D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1112-y; Lucchi NW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151437; Luce-Fedrow A, 2015, FUTURE MICROBIOL, V10, P537, DOI [10.2217/fmb.14.141, 10.2217/FMB.14.141]; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Martin A.N., 2016, CORRECTIVE CHURCH DI; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Noden BH, 2017, J MED ENTOMOL, V54, P1093, DOI 10.1093/jme/tjx069; Noden BH, 2017, TICKS TICK-BORNE DIS, V8, P119, DOI 10.1016/j.ttbdis.2016.10.007; Noden BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108674; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nzelu CO, 2014, ACTA TROP, V132, P1, DOI 10.1016/j.actatropica.2013.12.016; Pan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002231; Pan L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-254; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Paris DH, 2016, CURR OPIN INFECT DIS, V29, P433, DOI 10.1097/QCO.0000000000000298; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Richards AL, 2012, FEMS IMMUNOL MED MIC, V64, P107, DOI 10.1111/j.1574-695X.2011.00875.x; Salazar J. L., 2015, THESIS; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962; Yang J, 2013, TRANSBOUND EMERG DIS, V60, P238, DOI 10.1111/j.1865-1682.2012.01335.x; Yang YM, 2016, VET PARASITOL, V219, P71, DOI 10.1016/j.vetpar.2016.02.004	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192331	10.1371/journal.pone.0192331	http://dx.doi.org/10.1371/journal.pone.0192331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390021	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400088
J	Pena, CS; Costa, MA; Oliveira, RPB				Pena, Carolina Silva; Costa, Marcelo Azevedo; Braga Oliveira, Rivert Paulo			A new item response theory model to adjust data allowing examinee choice	PLOS ONE			English	Article							MOTIVATION; PARAMETERS; SCORES	In a typical questionnaire testing situation, examinees are not allowed to choose which items they answer because of a technical issue in obtaining satisfactory statistical estimates of examinee ability and item difficulty. This paper introduces a new item response theory (IRT) model that incorporates information from a novel representation of questionnaire data using network analysis. Three scenarios in which examinees select a subset of items were simulated. In the first scenario, the assumptions required to apply the standard Rasch model are met, thus establishing a reference for parameter accuracy. The second and third scenarios include five increasing levels of violating those assumptions. The results show substantial improvements over the standard model in item parameter recovery. Furthermore, the accuracy was closer to the reference in almost every evaluated scenario. To the best of our knowledge, this is the first proposal to obtain satisfactory IRT statistical estimates in the last two scenarios.	[Pena, Carolina Silva; Costa, Marcelo Azevedo] Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil; [Pena, Carolina Silva] Univ Fed Minas Gerais, Proreitoria Grad, Belo Horizonte, MG, Brazil; [Braga Oliveira, Rivert Paulo] Univ Fed Ouro Preto, Dept Stat, Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto	Pena, CS (corresponding author), Univ Fed Minas Gerais, Dept Prod Engn, Belo Horizonte, MG, Brazil.; Pena, CS (corresponding author), Univ Fed Minas Gerais, Proreitoria Grad, Belo Horizonte, MG, Brazil.	carolinasend@gmail.com	Oliveira, Rivert Paulo Braga/AAS-5119-2021	Oliveira, Rivert Paulo Braga/0000-0002-3868-9099; Costa, Marcelo/0000-0002-2330-5056				ALBERT JH, 1992, J EDUC STAT, V17, P251, DOI 10.3102/10769986017003251; [Anonymous], 2010, CUST PRET IT EN POD; [Anonymous], 2009, NETWORK SCI THEORY A; BALDWIN TT, 1991, PERS PSYCHOL, V44, P51, DOI 10.1111/j.1744-6570.1991.tb00690.x; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; BOCK RD, 1972, PSYCHOMETRIKA, V37, P29; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Borges P., 2011, PROVAS PRETESTE ENEM; Bradlow ET, 1998, J EDUC BEHAV STAT, V23, P236, DOI 10.2307/1165246; Brigham T.A., 1979, CHOICE PERCEIVED CON; Cankar G., 2010, METODOLOSKI ZVEZKI, V2, P151; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Chi M.T., 1978, CHILDRENS THINKING W, P75; Chi M. T. H., 1982, ADV PSYCHOL HUMAN IN, P7; Cordova DI, 1996, J EDUC PSYCHOL, V88, P715, DOI 10.1037/0022-0663.88.4.715; Curtis S. M., 2010, J STAT SOFTWARE CODE, V36, P1, DOI DOI 10.18637/JSS.V036.C01; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; FITZPATRICK AR, 1995, J EDUC MEAS, V32, P243, DOI 10.1111/j.1745-3984.1995.tb00465.x; Fox J., 2019, R POPULATION, V150, P200; Fox JP, 2010, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-0742-4; GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; Jennings M., 1999, LANG TEST, V16, P426, DOI [DOI 10.1177/026553229901600402, 10.1177/026553229901600402]; Kieftenbeld V, 2012, APPL PSYCH MEAS, V36, P399, DOI 10.1177/0146621612446170; Linn RL, 1998, 485 CSE U CAL; Little R. J. A., 1987, STAT ANAL MISSING DA; Liu CW, 2017, BRIT J MATH STAT PSY, V70, P499, DOI 10.1111/bmsp.12097; Lu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106747; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Patz RJ, 1999, J EDUC BEHAV STAT, V24, P342, DOI 10.3102/10769986024004342; Pena CS, 2016, THESIS; Plummer M., 2003, P 3 INT WORKSH DISTR; Powers DE, 2000, APPL MEAN EDUC, V12, P257; Rasch G., 1960, PROBABILISTIC MODELS; ROCKLIN TR, 1995, J EDUC PSYCHOL, V87, P103, DOI 10.1037/0022-0663.87.1.103; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Siegler RS, 1997, J EXP PSYCHOL GEN, V126, P71, DOI 10.1037/0096-3445.126.1.71; Smeeth L., 2014, INT J EPIDEMIOLOGY; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Team RC., 2013, R LANG ENV STAT COMP; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; van der Aalst W, 2014, IEEE INT ENTERP DIST, P1, DOI 10.1109/EDOC.2014.11; WAINER H, 1994, J EDUC MEAS, V31, P183, DOI 10.1111/j.1745-3984.1994.tb00442.x; Wang WC, 2012, J EDUC MEAS, V49, P419, DOI 10.1111/j.1745-3984.2012.00184.x; WANG XB, 1995, APPL MEAS EDUC, V8, P211, DOI 10.1207/s15324818ame0803_2	48	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191600	10.1371/journal.pone.0191600	http://dx.doi.org/10.1371/journal.pone.0191600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389996	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400024
J	Meisel, JD; Sarmiento, OL; Olaya, C; Lemoine, PD; Valdivia, JA; Zarama, R				Meisel, Jose D.; Sarmiento, Olga L.; Olaya, Camilo; Lemoine, Pablo D.; Valdivia, Juan A.; Zarama, Roberto			Towards a novel model for studying the nutritional stage dynamics of the Colombian population by age and socioeconomic status	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; OBESITY; SYSTEM; HEALTH; CHILDREN; SCIENCE; TRENDS; DIET	Low-and middle-income countries (LMICs) are experiencing a nutritional transition in which the burden of obesity tends to shift towards the lower-socioeconomic status (SES) group. We propose a system dynamics (SD) model for assessing the nutritional stage dynamics of the Colombian urban population by age and SES projected to 2030. This SD model captures the ageing population according to body mass index (BMI) categories and SES. In this model, the transference rates (TRs) between BMI categories by age and SES are estimated using a heuristic based on data obtained from national surveys. The simulation results show that the Colombian population, particularly those aged 20 to 39 years with a lower SES, is moving towards the overweight and obese categories. The TRs for overweight and obese categories in the lower SES group (the mean TR from not overweight to overweight = 0.0215 (per year) and mean TR from overweight to obese = 0.0098 (per year)) are increasing more rapidly than the those in the middle (the mean TR from not overweight to overweight = 0.0162 (per year) and mean TR from overweight to obese = 0.0065 (per year)) and higher SES groups (the mean TR from not overweight to overweight = 0.0166 and mean TR from overweight to obese = 0.0054 (per year)). Additionally, from 2005 to 2010, individuals aged 20 to 39 years had the highest TRs towards the overweight and obese categories (from 0.026 to 0.036 per year and from 0.0064 to 0.012 per year, respectively). The TRs also indicated that children aged 0 to 14 years are moving from the obese to overweight and from the overweight to not overweight categories. These TRs show that the Colombian population is experiencing an SES-related nutritional transition that is affecting the lower SES population. The proposed model could be implemented to assess the nutritional transitions experienced in other LMICs.	[Meisel, Jose D.; Olaya, Camilo; Lemoine, Pablo D.; Zarama, Roberto] Univ Los Andes, Fac Engn, Dept Ind Engn, Bogota, Colombia; [Meisel, Jose D.] Univ Ibague, Fac Ingn, Ibague, Colombia; [Meisel, Jose D.; Sarmiento, Olga L.; Olaya, Camilo; Lemoine, Pablo D.; Valdivia, Juan A.; Zarama, Roberto] CeiBA Complex Syst Res Ctr, Bogota, Colombia; [Sarmiento, Olga L.] Univ Los Andes, Sch Med, Dept Publ Hlth, Bogota, Colombia; [Lemoine, Pablo D.] Ctr Nacl Consultoria, Bogota, Colombia; [Valdivia, Juan A.] Univ Chile, Fac Ciencias, Dept Fis, Santiago, Chile; [Valdivia, Juan A.] CEDENNA, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile	Universidad de los Andes (Colombia); CEIBA; Universidad de los Andes (Colombia); Universidad de Chile	Meisel, JD (corresponding author), Univ Los Andes, Fac Engn, Dept Ind Engn, Bogota, Colombia.; Meisel, JD (corresponding author), Univ Ibague, Fac Ingn, Ibague, Colombia.; Meisel, JD (corresponding author), CeiBA Complex Syst Res Ctr, Bogota, Colombia.	jd.meisel28@uniandes.edu.co	Sarmiento, Olga L/AAS-4165-2020; Zarama, Roberto/E-3101-2010; Valdivia, Juan Alejandro/A-3631-2008; Olaya, Camilo/Y-2350-2019; Meisel, Jose/AAV-8857-2021; Meisel, Jose David/K-8040-2019; Meisel, Jose David/K-7895-2019	Sarmiento, Olga L/0000-0002-9190-3568; Zarama, Roberto/0000-0002-5018-9783; Valdivia, Juan Alejandro/0000-0003-3381-9904; Meisel, Jose/0000-0002-1032-0900; Olaya, Camilo/0000-0002-2126-7498	Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA; Universidad de Ibague; Colciencias; Fundacion CeiBA; "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias [511-2010, 567-2012]; Fondecyt [1150718]; Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA); Colciencias [750-2013]; Research office at the Universidad de los Andes; Universidad de Ibague [16-414-INT]	Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA; Universidad de Ibague; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fundacion CeiBA; "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Research office at the Universidad de los Andes; Universidad de Ibague	This work was funded by the Fundacion Centro de Estudios Interdisciplinarios Basicos y Aplicados - Fundacion CEIBA, Universidad de Ibague, and Colciencias. Fundacion CeiBA funded the doctoral students, Universidad de Ibague funded the publication of the article, and the "Programa nacional de formacion doctoral Francisco Jose de Caldas" from Colciencias", (Convocatorias 511-2010 and 567-2012) funded the work of JDM and PDL. JAV thanks Fondecyt grant 1150718 and the support of Centro para el Desarrollo de la Nanociencias y la Nanotecnologia (CEDENNA). OLS, JDM, and PDL received funding from Colciencias grant 750-2013. OLS received funding from the Research office at the Universidad de los Andes. JDM thanks the Universidad de Ibague (project 16-414-INT) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid TK, 2003, MED SCI SPORT EXER, V35, P400, DOI 10.1249/01.MSS.0000053659.32126.2D; Abdel-Hamid TK, 2009, THINKING CIRCLES OBE; Abidin NZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114135; [Anonymous], ENC NAC DEM SAL 2010; [Anonymous], 2005, DEM HLTH SURV PROGR; [Anonymous], 2010, DEM HLTH SURV PROGR; [Anonymous], 2013, GLOB BURD DIS GEN EV; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Dangerfield BC, 2010, P INT SYST DYN C KOR; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Departamento Administrativo Nacional de Estadistica, EST VIT; Departamento Administrativo Nacional de Estadistica, SER DE POBL; Departamento Administrativo Nacional de Estadisticas (Dane), 2011, PROYECC POBL; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Fallah-Fini S, 2014, AM J PUBLIC HEALTH, V104, P1230, DOI 10.2105/AJPH.2014.301882; Fotso JC, 2005, SOC INDIC RES, V72, P189, DOI 10.1007/s11205-004-5579-8; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gonzalez SA, 2014, J PHYS ACT HEALTH, V11, pS33, DOI 10.1123/jpah.2014-0170; Hammond RA, 2009, PREV CHRONIC DIS, V6; Homer J., 2006, OBESITY POPULATION D; HUANG TT, 2009, PREV CHRONIC DIS, V6; Instituto Nacional de Salud Pblica, 2020, CURS AV IN NOM 051 E; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Karanfil O., 2009, SYSTEM DYNAMICS MODE; Karanfil O, 2011, MULTISCALE PARADIGM; Lemoine PD, 2016, PREV MED, V88, P39, DOI 10.1016/j.ypmed.2016.03.015; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Meisel JD, 2016, KYBERNETES, V45, P554, DOI 10.1108/K-01-2015-0010; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Profamilia, 2005, ENC NAC DEM SALUD 20; Rahmandad Hazhir, 2012, Social Computing, Behavioral-Cultural Modeling and Prediction. Proceedings of the 5th International Conference, SBP 2012, P306, DOI 10.1007/978-3-642-29047-3_37; Rutstein S. O., 2004, DHS COMP REPORTS; Sabounchi NS, 2014, AM J PUBLIC HEALTH, V104, P1240, DOI 10.2105/AJPH.2014.301898; Sterman J., 2010, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stunkard A. J., 2000, Obesity and poverty: a new public health challenge., P23; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vandenbroeck P, 2007, FORESIGHT TACKLING O; World Data Bank, WORLD DEV IND; World Health Organization, 2013, PROJ MORT CAUS DEATH; World Health Organization, 2006, WHO CHILD GROWTH STA	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191929	10.1371/journal.pone.0191929	http://dx.doi.org/10.1371/journal.pone.0191929			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420563	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900030
J	Sinnathamby, G; Henderson, G; Umair, S; Janssen, P; Bland, R; Simpson, H				Sinnathamby, Gajenathirin; Henderson, Gemma; Umair, Saleh; Janssen, Peter; Bland, Ross; Simpson, Heather			The bacterial community associated with the sheep gastrointestinal nematode parasite Haemonchus contortus	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MELOIDOGYNE-INCOGNITA; MARINE NEMATODES; LECTIN-BINDING; SURFACE-COAT; DIVERSITY; XENORHABDUS; POPULATION; WOLBACHIA; SYMBIONTS	Culture-independent methods were used to study the microbiota of adult worms, third-stage larvae and eggs, both in faeces and laid in vitro, of Haemonchus contortus, a nematode parasite of the abomasa of ruminants which is a major cause of production losses and ill-health. Bacteria were identified in eggs, the female reproductive tract and the gut of adult and third-stage larvae (L3). PCR amplification of 16S rRNA sequences, denaturing gradient gel electrophoresis (DGGE) and clone libraries were used to compare the composition of the microbial communities of the different life-cycle stages of the parasites, as well as parasites and their natural environments. The microbiomes of adult worms and L3 were different from those in the abomasum or faeces respectively. The H. contortus microbiota was mainly comprised of members of the phyla Proteobacteria, Firmicutes and Bacteroidetes. Bacteria were localised in the gut, inside eggs and within the uterus of adult female worms using the universal FISH Eub338 probe, which targets most bacteria, and were also seen in these tissues by light and transmission electron microscopy. Streptococcus/Lactococcus sp. were identified within the distal uterus with the probe Strc493. Sequences from the genera Weissella and Leuconostoc were found in all life-cycle stages, except eggs collected from faeces, in which most sequences belonged to Clostridium sp. Bacteria affiliated with Weissella/Leuconostoc were identified in both PCR-DGGE short sequences and clone libraries of nearly full length 16S rRNA bacterial sequences in all life-cycle stages and subsequently visualised in eggs by fluorescent in situ hybridisation (FISH) with group-specific probes. This strongly suggests they are vertically transmitted endosymbionts. As this study was carried out on a parasite strain which has been maintained in the laboratory, other field isolates will need to be examined to establish whether these bacteria are more widely dispersed and have potential as targets to control H. contortus infections.	[Sinnathamby, Gajenathirin; Simpson, Heather] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Henderson, Gemma; Umair, Saleh; Janssen, Peter; Bland, Ross] AgResearch Ltd, Palmerston North, New Zealand	Massey University; AgResearch - New Zealand	Simpson, H (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	H.V.Simpson@massey.ac.nz		Henderson, Gemma/0000-0002-8258-2811	Meat and Wool New Zealand [96MU 25/1.1]; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	Meat and Wool New Zealand; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	This work was supported by Meat and Wool New Zealand (96MU 25/1.1 Development of alternative methods of parasite control) H.V. Simpson; Massey University Research Fund, H.V. Simpson; C. Alma Baker Trust, H.V. Simpson; E. & C. Thoms Bequest, H.V. Simpson.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; Albers A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atibalentja N, 2008, SYMBIOSIS, V46, P87; BADLEY JE, 1987, PARASITE IMMUNOL, V9, P133, DOI 10.1111/j.1365-3024.1987.tb00494.x; Baquiran JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067425; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bjorkroth KJ, 2002, INT J SYST EVOL MICR, V52, P141, DOI 10.1099/00207713-52-1-141; BOEMARE NE, 1988, J GEN MICROBIOL, V134, P751; Brunsdon RV, 1988, NZ J ZOOL, V15, P328; Bulgheresi S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw007; Burnell AM, 2000, NEMATOLOGY, V2, P31, DOI 10.1163/156854100508872; Cao Y, 2015, J BASIC MICROB, V55, P950, DOI 10.1002/jobm.201400816; Casiraghi M, 2002, INT J PARASITOL, V32, P1457, DOI 10.1016/S0020-7519(02)00158-3; Coomans A, 2000, NEMATOLOGY, V2, P443, DOI 10.1163/156854100509303; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; De Barbieri I, 2015, LIVEST SCI, V178, P119, DOI 10.1016/j.livsci.2015.05.023; De Mendoza MEL, 2000, PARASITOLOGY, V120, P203, DOI 10.1017/S0031182099005326; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3, DOI DOI 10.1016/B978-0-12-341280-5.50007-0; Fusco V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00155; Ghafouri S, 2007, NEMATOLOGY, V9, P87, DOI 10.1163/156854107779969718; Gibson KE, 2005, ENVIRON MICROBIOL, V7, P203, DOI 10.1111/j.1462-2920.2004.00683.x; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gottlieb Y, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-133; Greiman SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098453; Greiman SE, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-303; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hillrichs K, 2012, PARASITOL RES, V110, P449, DOI 10.1007/s00436-011-2511-4; Hoang KL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01444; Hoerauf A., 2007, Wolbachia: a bug's life in another bug, P31, DOI 10.1159/000104231; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Kamboj K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01204; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kersters K, 2001, PROTEOBACTERIA ENCY, P1; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Lacharme-Lora L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S17; Ladygina N, 2009, FEMS MICROBIOL ECOL, V69, P53, DOI 10.1111/j.1574-6941.2009.00687.x; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17128; Lefoulon E, 2016, PEERJ, V4, DOI 10.7717/peerj.1840; Leng J, 2011, CHINA MOL BIOL REP, V39, P1181; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Marchetti M, 2014, MOL PLANT MICROBE IN, V27, P956, DOI 10.1094/MPMI-03-14-0083-R; Marchetti M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000280; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Muyzer G, 1996, MOL MICROBIAL ECOLOG, P1; Niu QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20178; Nussbaumer AD, 2004, AQUAT MICROB ECOL, V34, P239, DOI 10.3354/ame034239; OTT JA, 1991, MAR ECOL-P S Z N I, V12, P261, DOI 10.1111/j.1439-0485.1991.tb00258.x; PAGE AP, 1992, PARASITOLOGY, V105, P285, DOI 10.1017/S0031182000074217; POLITZ SM, 1992, PARASITOL TODAY, V8, P6, DOI 10.1016/0169-4758(92)90302-I; POLZ MF, 1992, MICROBIAL ECOL, V24, P313, DOI 10.1007/BF00167789; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; PRICHARD RK, 1980, AUST VET J, V56, P239, DOI 10.1111/j.1751-0813.1980.tb15983.x; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rothmann W, 2016, THESIS; Sacket D, ASSESSING EC COST EN, P1; SILVERMAN PH, 1959, PARASITOLOGY, V49, P23, DOI 10.1017/S0031182000026688; Simcock DC, 1999, INT J PARASITOL, V29, P1053, DOI 10.1016/S0020-7519(99)00065-X; Simpson HV, 1999, NEW ZEAL VET J, V47, P20, DOI 10.1080/00480169.1999.36102; SMITH HV, 1981, MOL BIOCHEM PARASIT, V4, P183, DOI 10.1016/0166-6851(81)90017-7; SPIEGEL Y, 1995, J NEMATOL, V27, P127; Stoll Norman R., 1943, JOUR PARASITOL, V29, P407, DOI 10.2307/3272850; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Urquhart GM, VET PARASITOLOGY, V2; Vandekerckhove TTM, 2000, INT J SYST EVOL MICR, V50, P2197, DOI 10.1099/00207713-50-6-2197; Vlassoff A, 2001, NEW ZEAL VET J, V49, P213, DOI 10.1080/00480169.2001.36235; Wang JX, 1996, FUND APPL NEMATOL, V19, P363; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	88	18	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192164	10.1371/journal.pone.0192164	http://dx.doi.org/10.1371/journal.pone.0192164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420571	gold, Green Submitted, Green Published			2022-12-27	WOS:000424517900044
J	Uy, EJB; Bautista, DC; Xin, XH; Cheung, YB; Thio, ST; Thumboo, J				Uy, Elenore Judy B.; Bautista, Dianne Carrol; Xin, Xiaohui; Cheung, Yin Bun; Thio, Szu-Tien; Thumboo, Julian			Using best-worst scaling choice experiments to elicit the most important domains of health for health-related quality of life in Singapore	PLOS ONE			English	Article							SF-36; WHOQOL; PREFERENCES; ADAPTATION; VALIDATION; INSTRUMENT; VALIDITY; EUROQOL; MODELS	Health-related quality of life (HRQOL) instruments are sometimes used without explicit understanding of which HRQOL domains are important to a given population. In this study, we sought to elicit an importance hierarchy among 27 HRQOL domains (derived from the general population) via a best-worst scaling survey of the population in Singapore, and to determine whether these domains were consistently valued across gender, age, ethnicity, and presence of chronic illnesses. We conducted a community-based study that sampled participants with quotas for gender, ethnicity, age, presence of chronic illness, and interview language. For the best-worst scaling exercise, we constructed comparison sets according to a balanced incomplete block design resulting in 13 sets of questions, each with nine choice tasks. Each task involved three HRQOL domains from which participants identified the most and least important domain. We performed a standard analysis of best-worst object scaling design (Case 1) using simple summary statistics; 603 residents participated in the survey. The three most important domains of health were: "the ability to take care of self without help from others" (best-worst score (BWS): 636), "healing and resistance to illness" (BWS: 461), and "having good relationships with family, friends, and others" (BWS: 373). The 10 top-ranked domains included physical, mental, and social health. The three least important domains were: "having a satisfying sex life" (BWS: -803), having normal physical appearance" (BWS: -461), and "interacting with others (talking, shared activities, etc.)" (BWS: -444). Generally, top-ranked domains were consistently valued across gender, age, ethnicity, and presence of chronic illness. We conclude that the 10 top-ranked domains reflect physical, mental, and social dimensions of well-being suggesting that the sampled population's views on health are consistent with the World Health Organization's definition of health, "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity".	[Uy, Elenore Judy B.; Thio, Szu-Tien; Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Bautista, Dianne Carrol] Singapore Clin Res Inst, Singapore, Singapore; [Bautista, Dianne Carrol; Cheung, Yin Bun] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Xin, Xiaohui] Singapore Gen Hosp, Acad Clin Programme Med, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Cheung, Yin Bun] Tampere Univ Hosp, Tampere, Finland; [Thumboo, Julian] Duke NUS Med Sch, Acad & Fac Affairs, Off Clin, Singapore, Singapore; [Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	Singapore General Hospital; Singapore Clinical Research Institute; National University of Singapore; Singapore General Hospital; Tampere University; Tampere University; Tampere University Hospital; National University of Singapore; National University of Singapore	Thumboo, J (corresponding author), Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.; Thumboo, J (corresponding author), Duke NUS Med Sch, Acad & Fac Affairs, Off Clin, Singapore, Singapore.; Thumboo, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.	julian.thumboo@singhealth.com.sg	Uy, EJ/O-1245-2019	Uy, EJ/0000-0003-1062-8638	Singapore Ministry of Health's National Medical Research Council under its Health Services Research Grant [HSRG/0034/2013]; HSR [HSRG/0034/2013]	Singapore Ministry of Health's National Medical Research Council under its Health Services Research Grant; HSR	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its Health Services Research Grant (HSRG/0034/2013), URL of funder's website: www.nmrc.gov.sg, HSR Grant Number: HSRG/0034/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AN, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.1; ALLISON PD, 1994, SOCIOL METHODOL, V24, P199, DOI 10.2307/270983; [Anonymous], 2010, SING BURD DIS STUD 2; Auger P, 2007, J BUS ETHICS, V70, P299, DOI 10.1007/s10551-006-9112-7; BOWLING A, 1995, SOC SCI MED, V41, P1447, DOI 10.1016/0277-9536(95)00113-L; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chung WS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-630; Cohen E, 2009, INT J WINE BUS RES, V21, P8, DOI 10.1108/17511060910948008; Department of Statistics, 2014, POP TRENDS 2014; Department of Statistics Singapore, 2014, POP TRENDS 2014; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Flynn TN, 2010, EXPERT REV PHARM OUT, V10, P259, DOI [10.1586/erp.10.29, 10.1586/ERP.10.29]; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Gothwal VK, 2013, QUAL LIFE RES, V22, P839, DOI 10.1007/s11136-012-0195-6; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hauber AB, 2014, QUAL LIFE RES, V23, P1813, DOI 10.1007/s11136-013-0620-5; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Inoguchi T., ASIABAROMETER SURVEY; Khare M., 1981, BIOMETR J, V23, P121, DOI 10.1002/bimj.4710230203; Kuo Chun-Hua, 2004, J Nurs Res, V12, P21; Lee JA, 2008, J PERS ASSESS, V90, P335, DOI 10.1080/00223890802107925; Leung Kwok-fai, 2005, Health Qual Life Outcomes, V3, P26, DOI 10.1186/1477-7525-3-26; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Louviere J, 2013, INT J RES MARK, V30, P292, DOI 10.1016/j.ijresmar.2012.10.002; Louviere JJ, 2010, PATIENT, V3, P275, DOI 10.2165/11539660-000000000-00000; Marley AAJ, 2005, J MATH PSYCHOL, V49, P464, DOI 10.1016/j.jmp.2005.05.003; Marley AAJ, 2012, HANDB CHOICE MODEL E; Molzahn AE, 2011, AGE AGEING, V40, P192, DOI 10.1093/ageing/afq156; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; Saxena S, 2001, QUAL LIFE RES, V10, P711, DOI 10.1023/A:1013867826835; Tambyah SK, 2010, WELLBEING SINGAPOREA, P30; Tan S.J., 2004, UNDERSTANDING SINGAP; Tarumi K, 1999, Environ Health Prev Med, V4, P39, DOI 10.1007/BF02931249; Thumboo J, 2001, QUAL LIFE RES, V10, P175, DOI 10.1023/A:1016701514299; Thumboo J, DEV COMPREHENS UNPUB; Tseng Hsu-Min, 2003, Health Qual Life Outcomes, V1, P72, DOI 10.1186/1477-7525-1-72; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeh CH, 2001, NURS SCI QUART, V14, P141, DOI 10.1177/08943180122108337; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0189687	10.1371/journal.pone.0189687	http://dx.doi.org/10.1371/journal.pone.0189687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420564	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900004
J	Forson, AO; Arthur, I; Ayeh-Kumi, PF				Forson, Akua Obeng; Arthur, Isaac; Ayeh-Kumi, Patrick F.			The role of family size, employment and education of parents in the prevalence of intestinal parasitic infections in school children in Accra	PLOS ONE			English	Article							RISK-FACTORS; KNOWLEDGE	Introduction Intestinal parasitic infections (IPIs) in school children are a public health problem in most developing countries. Methods and principal findings A cross sectional survey was conducted from May to July 2016 with school children living in overcrowded urban slums in Accra, Ghana. A simple random sample of 300 children aged 2-9 years was collected. The study used structured pre-tested questionnaire and stool tests to obtain information on epidemiological, sanitation habits, employment and education status of parents and children. Data were analysed using appropriate descriptive, univariate and multivariable logistic tools of analyses. The mean age of participants was 6.9 years and 49% were males and 51.3% were females. Giardia lamblia was found in males (10.95%) and females (7.79%). Very low prevalences for Schistosoma mansoni, Ascaris lumbricoides, Taenia species, and Entamoeba coli were detected. Whilst children from mothers (62.2%) and fathers (55.6%) with no education were often infected, a few children from fathers (22.2%) and mothers (6.7%) with no jobs were infected. Most of the infected children's (93.7%) parents did not have any knowledge of IPIs. The educational and employment status of the mothers [p = 1.0 and p = 0.422] was not significant, however, the family size was a predisposing factor (p = 0.031) for parasitic infections. Conclusions Intestinal parasites were prevalent in children from overcrowded families and with no knowledge of IPIs. Educative programmes on IPIs, improving hygiene, and application of supportive programmes to elevate socioeconomic conditions may help reduce the burden of intestinal parasite carriage in children.	[Forson, Akua Obeng; Arthur, Isaac; Ayeh-Kumi, Patrick F.] Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana; [Ayeh-Kumi, Patrick F.] Univ Ghana, Dept Med Microbiol, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana	University of Ghana; University of Ghana	Forson, AO (corresponding author), Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana.	obeng.akua@yahoo.com		Forson, akua obeng/0000-0002-6398-3118; Ayeh-Kumi, Patrick Ferdinand/0000-0001-8764-4463	University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project; Carnegie Corporation of New York at a Writing workshop; Carnegie Corporation of New York	University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project; Carnegie Corporation of New York at a Writing workshop; Carnegie Corporation of New York	No specific grant from any funding agency in the public, commercial, or not for-profit sectors was received for the project work. However, the writing of this research paper was supported by the University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project with funding from the Carnegie Corporation of New York at a Writing workshop.; The authors would like to express their gratitude to all staff of Ghana Education Service, the various communities, teachers, parents and pupils for their cooperation and support during the various aspects of the study. The research paper was also supported by the University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project with funding from the Carnegie Corporation of New York.	Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Ahmed A, 2010, ASIAN PAC J TROP MED, P92; Ahmed Akbar K, 2003, J Ayub Med Coll Abbottabad, V15, P28; Alamir M., 2013, Health, V5, P1697, DOI 10.4236/health.2013.510228; Amuta EU, 2010, ASIAN PAC J TROP MED, V3, P993, DOI 10.1016/S1995-7645(11)60016-3; Anim-Baidoo I, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.217.8012; [Anonymous], [No title captured]; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brannan M, 2012, VOLUNTEER PARTNERSHI; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; CDC, 2006, LAB ID PAR PUBL HTLH; Cheesbrough M, 2005, DISTRICT LAB PRACTIC; Contreras CF, 1993, ASIAN PARASITE CONTR, VV, P335; Curtale F, 1998, HEALTH POLICY PLANN, V13, P423, DOI 10.1093/heapol/13.4.423; Erismann S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1835-4; Gelaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-304; Ghana Statistical Service, 2010, DISTR AN REP; Hailegebriel T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2466-x; Maia MMM, 2009, ANN TROP MED PARASIT, V103, P583, DOI 10.1179/000349809X12459740922417; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Modern Ghana, 2002, UNTOLD STORY SODOM G; Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Payapvipapong P., 1993, ASIAN PARASITE CONTR, VV, P318; Quihui L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-225; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Shakya B, 2012, J Nepal Health Res Counc, V10, P20; Wamani H., 2004, INT, V3, P9, DOI [10.1186/1475-9276-3-9, DOI 10.1186/1475-9276-3-9]; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x	32	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192303	10.1371/journal.pone.0192303	http://dx.doi.org/10.1371/journal.pone.0192303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415040	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300070
J	Hersh, DS; Anastasiadis, P; Mohammadabadi, A; Nguyen, BA; Guo, SJ; Winkles, JA; Kim, AJ; Gullapalli, R; Keller, A; Frenkel, V; Woodworth, GF				Hersh, David S.; Anastasiadis, Pavlos; Mohammadabadi, Ali; Nguyen, Ben A.; Guo, Sijia; Winkles, Jeffrey A.; Kim, Anthony J.; Gullapalli, Rao; Keller, Asaf; Frenkel, Victor; Woodworth, Graeme F.			MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain	PLOS ONE			English	Article							EXTRACELLULAR-SPACE; IN-VIVO; NONTHERMAL ABLATION; BARRIER DISRUPTION; CONTRAST AGENT; DRUG-DELIVERY; TUMOR-MODEL; BLOOD; DIFFUSION; THROMBOLYSIS	Generating spatially controlled, non-destructive changes in the interstitial spaces of the brain has a host of potential clinical applications, including enhancing the delivery of therapeutics, modulating biological features within the tissue microenvironment, altering fluid and pressure dynamics, and increasing the clearance of toxins, such as plaques found in Alzheimer's disease. Recently we demonstrated that ultrasound can non-destructively enlarge the interstitial spaces of the brain ex vivo. The goal of the current study was to determine whether these effects could be reproduced in the living brain using non-invasive, transcranial MRI-guided focused ultrasound (MRgFUS). The left striatum of healthy rats was treated using MRgFUS. Computer simulations facilitated treatment planning, and targeting was validated using MRI acoustic radiation force impulse imaging. Following MRgFUS treatments, Evans blue dye or nanoparticle probes were infused to assess changes in the interstitial space. In MRgFUS-treated animals, enhanced dispersion was observed compared to controls for 70 nm (12.8 +/- 0.9 mm(3) vs. 10.6 +/- 1.0 mm(3), p = 0.01), 200 nm (10.9 +/- 1.4 mm(3) vs. 7.4 +/- 0.7 mm(3), p = 0.01) and 700 nm (7.5 +/- 0.4 mm(3) vs. 5.4 +/- 1.2 mm(3), p = 0.02) nanoparticles, indicating enlargement of the interstitial spaces. No evidence of significant histological or electrophysiological injury was identified. These findings suggest that transcranial ultrasound can safely and effectively modulate the brain interstitium and increase the dispersion of large therapeutic entities such as particulate drug carriers or modified viruses. This has the potential to expand the therapeutic uses of MRgFUS.	[Hersh, David S.; Kim, Anthony J.; Woodworth, Graeme F.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Anastasiadis, Pavlos; Mohammadabadi, Ali; Nguyen, Ben A.; Guo, Sijia; Gullapalli, Rao; Frenkel, Victor] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.; Kim, Anthony J.; Frenkel, Victor; Woodworth, Graeme F.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Kim, Anthony J.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Keller, Asaf] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Frenkel, V (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.; Frenkel, V; Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	VFrenkel@som.umaryland.edu; GWoodworth@som.umaryland.edu	Mohammadabadi, Ali/U-7127-2019; Anastasiadis, Pavlos/B-3685-2011	Anastasiadis, Pavlos/0000-0002-0230-7925; Mohammadabadi, Ali/0000-0002-9124-3942; Hersh, David/0000-0003-1177-2201	Focused Ultrasound Foundation; National Institutes of Health [K08NS09043]; National Science Foundation [NSF EAGER 1557922]; NATIONAL CANCER INSTITUTE [T32CA154274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS090430] Funding Source: NIH RePORTER	Focused Ultrasound Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Focused Ultrasound Foundation, the National Institutes of Health (K08NS09043 (G.F.W.)) and the National Science Foundation (NSF EAGER 1557922 (V.F., A.J.K., and G.F.W)). There was no additional external funding received for this study.	Abi-Jaoudeh N, 2012, J VASC INTERV RADIOL, V23, P953, DOI 10.1016/j.jvir.2012.04.001; Arvanitis CD, 2015, IEEE T MED IMAGING, V34, P1270, DOI 10.1109/TMI.2014.2383835; Arvanitis CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045783; Aryal M, 2015, J CONTROL RELEASE, V204, P60, DOI 10.1016/j.jconrel.2015.02.033; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Doinikov AA, 2014, IEEE T ULTRASON FERR, V61, P1470, DOI 10.1109/TUFFC.2014.3061; Elias WJ, 2016, NEW ENGL J MED, V375, P730, DOI 10.1056/NEJMoa1600159; Fishman PS, 2017, NEUROTHERAPEUTICS, V14, P393, DOI 10.1007/s13311-017-0515-1; Foley CP, 2012, ANN BIOMED ENG, V40, P292, DOI 10.1007/s10439-011-0440-0; Frenkel V, 2006, ACAD RADIOL, V13, P469, DOI 10.1016/j.acra.2005.08.024; Frenkel V, 2006, RADIOLOGY, V239, P86, DOI 10.1148/radiol.2391042181; Frenkel V, 2001, ULTRASONICS, V39, P153, DOI 10.1016/S0041-624X(00)00064-0; Hancock HA, 2009, ULTRASOUND MED BIOL, V35, P1722, DOI 10.1016/j.ultrasmedbio.2009.04.020; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Hersh DS, 2016, BRAIN RES, V1646, P543, DOI 10.1016/j.brainres.2016.06.040; Hertzberg Y, 2010, MED PHYS, V37, P2934, DOI 10.1118/1.3395553; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jones G, 2010, IEEE T BIO-MED ENG, V57, P33, DOI 10.1109/TBME.2009.2028316; Kaye EA, 2011, MAGN RESON MED, V65, P738, DOI 10.1002/mrm.22662; Kobus T, 2016, ULTRASOUND MED BIOL, V42, P481, DOI 10.1016/j.ultrasmedbio.2015.10.009; Kovacs ZI, 2017, P NATL ACAD SCI USA, V114, pE75, DOI 10.1073/pnas.1614777114; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kuroda K., 2017, J MAGN RESON IMAGING; Kyrtsos CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139574; Lewis GK, 2012, J NEUROSURG, V117, P1128, DOI 10.3171/2012.7.JNS11144; Liu Y, 2010, AAPS PHARMSCITECH, V11, P1005, DOI 10.1208/s12249-010-9458-0; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139667; Lizzi FL, 2003, ULTRASOUND MED BIOL, V29, P1593, DOI 10.1016/S0301-5629(03)01052-4; Mano Y., 2015, J NEUROSURG, P1; Mano Y, 2016, J NEUROSURG, V124, P1490, DOI 10.3171/2015.3.JNS142152; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; McDannold N, 2013, J NEUROSURG, V119, P1208, DOI 10.3171/2013.8.JNS122387; McDannold N, 2016, J NEUROSURG, V125, P1539, DOI 10.3171/2015.10.JNS151525; NANCE EA, 2012, SCI TRANSL MED, V4; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; O'Neill BE, 2009, ULTRASOUND MED BIOL, V35, P416, DOI 10.1016/j.ultrasmedbio.2008.09.021; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P1930, DOI 10.1016/j.ultrasmedbio.2011.08.001; Olbricht W, 2013, J ACOUST SOC AM, V134, P1569, DOI 10.1121/1.4812879; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmeri ML, 2004, IEEE T ULTRASON FERR, V51, P551, DOI 10.1109/TUFFC.2004.1320828; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Schneider CS, 2015, BIOMATERIALS, V42, P42, DOI 10.1016/j.biomaterials.2014.11.054; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stone MJ, 2007, THROMB RES, V121, P193, DOI 10.1016/j.thromres.2007.03.023; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Vargova L, 2008, PHYSIOL RES, V57, pS89, DOI 10.33549/physiolres.931603; Wang ST, 2017, J CEREBR BLOOD F MET, V37, P706, DOI 10.1177/0271678X16637881; Wang S, 2012, J CONTROL RELEASE, V162, P218, DOI 10.1016/j.jconrel.2012.06.025; Wolak DJ, 2013, MOL PHARMACEUT, V10, P1492, DOI 10.1021/mp300495e; Ziadloo A, 2013, J ACOUST SOC AM, V133, P1827, DOI 10.1121/1.4789390; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	61	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192240	10.1371/journal.pone.0192240	http://dx.doi.org/10.1371/journal.pone.0192240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415084	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300062
J	Qiao, S; Zhang, Y; Li, XM; Menon, JA				Qiao, Shan; Zhang, Yao; Li, Xiaoming; Menon, J. Anitha			Facilitators and barriers for HIV-testing in Zambia: A systematic review of multi-level factors	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; INTIMATE PARTNER VIOLENCE; CLUSTER-RANDOMIZED-TRIAL; ACCEPTANCE; ACCEPTABILITY; PREDICTORS; NDOLA; PREVENTION; FAMILIES; SERVICES	It was estimated that 1.2 million people live with HIV/AIDS in Zambia by 2015. Zambia has developed and implemented diverse programs to reduce the prevalence in the country. HIV-testing is a critical step in HIV treatment and prevention, especially among all the key populations. However, there is no systematic review so far to demonstrate the trend of HIV-testing studies in Zambia since 1990s or synthesis the key factors that associated with HIV-testing practices in the country. Therefore, this study conducted a systematic review to search all English literature published prior to November 2016 in six electronic databases and retrieved 32 articles that meet our inclusion criteria. The results indicated that higher education was a common facilitator of HIV testing, while misconception of HIV testing and the fear of negative consequences were the major barriers for using the testing services. Other factors, such as demographic characteristics, marital dynamics, partner relationship, and relationship with the health care services, also greatly affects the participants' decision making. The findings indicated that 1) individualized strategies and comprehensive services are needed for diverse key population; 2) capacity building for healthcare providers is critical for effectively implementing the task-shifting strategy; 3) HIV testing services need to adapt to the social context of Zambia where HIV-related stigma and discrimination is still persistent and overwhelming; and 4) family-based education and intervention should involving improving gender equity.	[Qiao, Shan; Li, Xiaoming] Univ South Carolina, Dept Hlth Promot Educ & Behav, South Carolina SmartState Ctr Healthcare Qual CHQ, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Zhang, Yao] Kent State Univ, Sch Informat, Kent, OH 44242 USA; [Menon, J. Anitha] Univ Zambia, Dept Psychol, Cent Adm Block Great East Rd Campus, Lusaka, Zambia	University of South Carolina System; University of South Carolina Columbia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Zambia	Zhang, Y (corresponding author), Kent State Univ, Sch Informat, Kent, OH 44242 USA.	yzhan110@kent.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Menon, J. Anitha/0000-0002-7388-7509	National Institution of Child and Human Development Grant [R01HD074221]; National Institute of Allergy and Infectious Diseases Grant [1R21AI122919 - 01A1]	National Institution of Child and Human Development Grant; National Institute of Allergy and Infectious Diseases Grant	The study was supported by the National Institution of Child and Human Development Grant #R01HD074221 (https://www.nichd.nih.gov/Pages/index.aspx) to XL and the National Institute of Allergy and Infectious Diseases Grant 1R21AI122919 - 01A1 to SQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the National Institution of Child and Human Development Grant #R01HD074221 and National Institute of Allergy and Infectious Diseases Grant 1R21AI122919 - 01A1. The authors also want to thank Christine Beyer and Joanne Zwemer for assistance with the manuscript preparation.	Aggleton P, 2012, AIDS, V26, P1215, DOI 10.1097/QAD.0b013e3283536bc5; Allen S., 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Banda J., 2013, MED J ZAMBIA, V40, P55; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Bourne C, 2011, SEX TRANSM INFECT, V87, P229, DOI 10.1136/sti.2010.048397; Brennan AT, 2014, J MIDWIFERY WOM HEAL, V59, P198, DOI 10.1111/jmwh.12038; Chi BH, 2004, INT J STD AIDS, V15, P685, DOI 10.1258/0956462041944295; Conserve DF, 2016, J TELEMED TELECARE; Czaicki NL, 2014, JAIDS-J ACQ IMM DEF, V66, pE1, DOI 10.1097/QAI.0000000000000076; de Tolly K, 2012, TELEMED E-HEALTH, V18, P18, DOI 10.1089/tmj.2011.0058; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Denison JA, 2008, AIDS CARE, V20, P101, DOI 10.1080/09540120701427498; Denison JA, 2014, VULNERABLE CHILD YOU, V9, P132, DOI 10.1080/17450128.2013.808781; Detsis M, 2017, CURR PHARM DESIGN, V23, P2568, DOI 10.2174/1381612823666170329125820; Frank E, 2009, AJAR-AFR J AIDS RES, V8, P515, DOI 10.2989/AJAR.2009.8.4.15.1052; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Fylkesnes K, 1999, AIDS, V13, P2469, DOI 10.1097/00002030-199912030-00019; Fylkesnes K, 2013, SOC SCI MED, V86, P9, DOI 10.1016/j.socscimed.2013.02.036; Gari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071922; Gari S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-198; Hensen B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2259-3; Hensen B, 2015, AIDS BEHAV, V19, P492, DOI 10.1007/s10461-014-0866-0; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Jurgensen M, 2013, SOC SCI MED, V97, P210, DOI 10.1016/j.socscimed.2013.07.033; Jurgensen M, 2013, SOC SCI MED, V81, P18, DOI 10.1016/j.socscimed.2013.01.011; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kapata N, 2012, TROP MED INT HEALTH, V17, P760, DOI 10.1111/j.1365-3156.2012.02981.x; Kelley AL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3424-z; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Levey IR, 2014, HEALTH POLICY PLANN, V29, pI30, DOI 10.1093/heapol/czt036; Maggard KR, 2015, B WORLD HEALTH ORGAN, V93, P93, DOI 10.2471/BLT.14.135285; Megazzini KM, 2009, JAIDS-J ACQ IMM DEF, V52, P273, DOI 10.1097/QAI.0b013e3181ab6e7c; Merten S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155510; Ministry of Health National HIV/AIDS/STI/TB Council, 2007, NAT HIV RAP TEST TRA; Musheke M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3396-z; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Mwangala S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146700; Mwangala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143075; Nelson KA, 2016, INT J STD AIDS, V27, P832, DOI 10.1177/0956462415596299; Odeny TA, 2014, AIDS, V28, P2307, DOI 10.1097/QAD.0000000000000409; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; Sikasote J, 2011, SEX TRANSM INFECT, V87, P433, DOI 10.1136/sti.2010.047738; Singh K, 2013, AIDS CARE, V25, P1452, DOI 10.1080/09540121.2013.774311; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; Thierman S, 2006, AM J MED SCI, V332, P13, DOI 10.1097/00000441-200607000-00003; WALL K, 2012, RETROVIROLOGY S2, V9, DOI DOI 10.1186/1742-4690-9-S2-P210; Wang PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141455; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Zachary D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-183; Zambia National AIDS Counsil, 2015, ZAMB COUNTR REP MON; Zhang Y, 2017, INT J INFORM MANAGE, V37, P75, DOI 10.1016/j.ijinfomgt.2016.11.003; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919; Zulu K, 2006, AIDS, P13	54	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192327	10.1371/journal.pone.0192327	http://dx.doi.org/10.1371/journal.pone.0192327			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415004	Green Published, gold			2022-12-27	WOS:000424325300071
J	Freedman, SA; Mashiach, RT				Freedman, Sara A.; Mashiach, Rivka Tuval			Shared trauma reality in war: Mental health therapists' experience	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BURNOUT; EXPOSURE; NURSES; IMPACT; PTSD	Introduction Shared traumatic reality occurs when therapists are doubly exposed to a traumatic event, both through their clients' experience, along with their own direct exposure. Studies have shown that a shared traumatic reality can lead to both positive and negative outcomes for therapists. Most studies have examined these reactions sometime after the end of the traumatic event, and less is known about reactions that occur during a traumatic event. In addition, most studies have assumed, rather than examined, indirect exposure. In this study, we extend this literature by examining direct and indirect exposure of therapists during a war situation, and their psychological reactions. Method Over a period of two months in 2014, 70% of the Israeli population was exposed to rocket fire. Geographical areas differed in terms of amount of exposure, and its potential danger. 151 therapists living throughout Israel were assessed via an Internet based survey in the middle of the war, and were assessed for the effects on their professional and personal lives, degree of burnout, ways of coping and symptoms levels of PTSD and psychological distress. Results These indicate that significant differences in direct exposure occurred depending on place of residence. PTSD levels were related to higher direct exposure, as well as prior trauma exposure, but not to indirect exposure. Indirect exposure, as measured by increased workload, was related to increased distress and emotional exhaustion. Discussion These data shed light on the effects of direct and indirect exposure to a shared traumatic experience of war amongst therapists. The data support previous studies showing a greater effect of direct exposure on PTSD. Since indirect exposure appears to negatively impact burnout and psychological distress, rather than PTSD, this study shows that symptoms other than PTSD should be the result of in a shared traumatic reality.	[Freedman, Sara A.] Bar Ilan Univ, Sch Social Work, Ramat Gan, Israel; [Mashiach, Rivka Tuval] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Freedman, SA (corresponding author), Bar Ilan Univ, Sch Social Work, Ramat Gan, Israel.	sara.freedman@biu.ac.il		Freedman, Sara/0000-0001-8733-0202				[Anonymous], 2014, TRAUMATOLOGY; Association AP, 2013, AM J PSYCHIAT; Baum N., 2014, PROFESSIONALS DOUBLE, P2113; Baum N, 2010, PSYCHOTHERAPY, V47, P249, DOI 10.1037/a0019784; Canfield J, 2005, SMITH COLL STUD SOC, V75, P81, DOI 10.1300/J497v75n02_06; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cohen E, 2014, CLIN SOC WORK J; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Dekel R, 2010, BRIT J SOC WORK, V40, P1927, DOI 10.1093/bjsw/bcp137; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Eidelson RJ, 2003, PROF PSYCHOL-RES PR, V34, P144, DOI 10.1037/0735-7028.34.2.144; FARHOOD L, 1993, SOC SCI MED, V36, P1555, DOI 10.1016/0277-9536(93)90344-4; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finklestein M, 2015, HEALTH SOC WORK, V40, pE25, DOI 10.1093/hsw/hlv026; Gaza OIR, 2014, 2014 GAZ CONFL FACT; Helpman L, 2015, J ANXIETY DISORD, V35, P27, DOI 10.1016/j.janxdis.2015.08.001; Lev-Wiesel R, 2009, BRIT J SOC WORK, V39, P1154, DOI 10.1093/bjsw/bcn021; Maslach C., 1997, EVALUATING STRESS BO, P191; May CL, 2016, PSYCHOL TRAUMA-US, V8, P233, DOI 10.1037/tra0000077; McManus IC, 2002, LANCET, V359, P2089, DOI 10.1016/S0140-6736(02)08915-8; McTiernan K, 2015, J PSYCHIATR MENT HLT, V22, P208, DOI 10.1111/jpm.12170; Mewton L, 2015, PSYCHOL ASSESS; Orsillo, 2002, BEHAV THERAPIST, V25, P36, DOI [https://doi.org/10.1037/a0019784, DOI 10.1037/A0019784]; Pitts BL, 2013, MIL PSYCHOL, V25, P537, DOI 10.1037/mil0000025; Schaal S, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.24981; Schmideberg M, 1942, INT J PSYCHOANAL, V23, P146; Seeley Karen M., 2008, THERAPY TERROR 9 11; Shalev AY, 2004, J CLIN PSYCHIAT, V65, P4; Shamai M, 2009, QUAL HEALTH RES, V19, P42, DOI 10.1177/1049732308327350; Tosone C, 2015, BRIT J SOC WORK, V45, P1313, DOI 10.1093/bjsw/bct194; Tosone C, 2012, CLIN SOC WORK J, V40, P231, DOI 10.1007/s10615-012-0395-0; Weathers FW, 2013, LIFE EVENTS CHECKLIS	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191949	10.1371/journal.pone.0191949	http://dx.doi.org/10.1371/journal.pone.0191949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408879	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800033
J	Martinez, SA; Beebe, LA; Thompson, DM; Wagener, TL; Terrell, DR; Campbell, JE				Martinez, Sydney A.; Beebe, Laura A.; Thompson, David M.; Wagener, Theodore L.; Terrell, Deirdra R.; Campbell, Janis E.			A structural equation modeling approach to understanding pathways that connect socioeconomic status and smoking	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; SLEEP DISTURBANCE; CIGARETTE-SMOKING; SOCIAL COHESION; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL FACTORS; HEALTH DISPARITIES; FINANCIAL STRESS; NATIONAL-HEALTH; UNITED-STATES	The inverse association between socioeconomic status and smoking is well established, yet the mechanisms that drive this relationship are unclear. We developed and tested four theoretical models of the pathways that link socioeconomic status to current smoking prevalence using a structural equation modeling (SEM) approach. Using data from the 2013 National Health Interview Survey, we selected four indicator variables (poverty ratio, personal earnings, educational attainment, and employment status) that we hypothesize underlie a latent variable, socioeconomic status. We measured direct, indirect, and total effects of socioeconomic status on smoking on four pathways through four latent variables representing social cohesion, financial strain, sleep disturbance, and psychological distress. Results of the model indicated that the probability of being a smoker decreased by 26% of a standard deviation for every one standard deviation increase in socioeconomic status. The direct effects of socioeconomic status on smoking accounted for the majority of the total effects, but the overall model also included significant indirect effects. Of the four mediators, sleep disturbance and psychological distress had the largest total effects on current smoking. We explored the use of structural equation modeling in epidemiology to quantify effects of socioeconomic status on smoking through four social and psychological factors to identify potential targets for interventions. A better understanding of the complex relationship between socioeconomic status and smoking is critical as we continue to reduce the burden of tobacco and eliminate health disparities related to smoking.	[Martinez, Sydney A.; Beebe, Laura A.; Thompson, David M.; Terrell, Deirdra R.; Campbell, Janis E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [Wagener, Theodore L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Martinez, SA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA.	Sydney-martinez@ouhsc.edu			NCI NIH HHS [P30 CA225520] Funding Source: Medline; NHLBI NIH HHS [K01 HL135466] Funding Source: Medline; NIGMS NIH HHS [U54 GM104938] Funding Source: Medline; NIMHD NIH HHS [R25 MD011564] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL135466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD011564] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Adler N, 1999, NEW YORK ACAD, P3; Adler NE, 2003, CURR DIR PSYCHOL SCI, V12, P119, DOI 10.1111/1467-8721.01245; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Agaku I, 2014, MMWR-MORBID MORTAL W, V63, P2005; Alcala HE, 2016, ADDICT BEHAV, V53, P201, DOI 10.1016/j.addbeh.2015.10.022; Alison PD, 2015, INTRO STRUCTURAL EQU; Amorim Leila Denise Alves Ferreira, 2010, Cad. Saúde Pública, V26, P2251, DOI 10.1590/S0102-311X2010001200004; [Anonymous], 2014, HLTH CONSEQUENCES SM; [Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P1232; Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Businelle MS, 2013, ANN BEHAV MED, V45, P180, DOI 10.1007/s12160-012-9434-x; Businelle MS, 2010, HEALTH PSYCHOL, V29, P262, DOI 10.1037/a0019285; Cruz, 2010, ESC NAC SAUDE PUBLIC, V26, P2251; De Vogli R, 2005, TOB CONTROL, V14, P389, DOI 10.1136/tc.2004.010611; Dube SR, 2009, INT J PUBLIC HEALTH, V54, P68, DOI 10.1007/s00038-009-0009-y; Escobedo LG, 1996, AM J PUBLIC HEALTH, V86, P231, DOI 10.2105/AJPH.86.2.231; Fagan P, 2007, ADDICTION, V102, P5, DOI 10.1111/j.1360-0443.2007.01952.x; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Fucito LM, 2014, J SMOK CESS, V9, P31, DOI 10.1017/jsc.2013.19; Garrett BE, 2015, NICOTINE TOB RES, V17, P892, DOI 10.1093/ntr/ntu266; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; Hall M, 2008, BIOL PSYCHOL, V77, P217, DOI 10.1016/j.biopsycho.2007.10.012; Hamilton NA, 2007, SOC INDIC RES, V82, P147, DOI 10.1007/s11205-006-9030-1; Harwood GA, 2007, PUBLIC HEALTH NURS, V24, P361, DOI 10.1111/j.1525-1446.2007.00645.x; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Honjo K, 2006, SOC SCI MED, V62, P317, DOI 10.1016/j.socscimed.2005.06.011; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Kendzor DE, 2009, J BEHAV MED, V32, P545, DOI 10.1007/s10865-009-9226-3; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kline R.B., 2011, PRINCIPLES PRACTICE; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Lawrence D., 2005, BMC PUBLIC HEALTH, V11, P256, DOI DOI 10.1186/1471-2458-11-256; Lawrence D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-462; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Manfredi C, 2007, HEALTH EDUC RES, V22, P747, DOI 10.1093/her/cyl155; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Mezick EJ, 2008, PSYCHOSOM MED, V70, P410, DOI 10.1097/PSY.0b013e31816fdf21; Moolchan ET, 2007, ADDICTION, V102, P30, DOI 10.1111/j.1360-0443.2007.01953.x; Moore PJ, 2002, PSYCHOSOM MED, V64, P337, DOI 10.1097/00006842-200203000-00018; Muthen B, 1987, STRUCTURAL EQUATION, P52; Muthen L.K., 2010, MPLUS USERS GUIDE; National Health Interview Survey, 2013, 2013 NHIS QUEST SAMP; Okun ML, 2011, ADDICT BEHAV, V36, P861, DOI 10.1016/j.addbeh.2011.03.001; Parsons V, 2014, DATA, P2; Patel NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-475; Patterson JM, 2004, J EPIDEMIOL COMMUN H, V58, P692, DOI 10.1136/jech.2003.009167; PHILLIPS BA, 1995, ARCH INTERN MED, V155, P734, DOI 10.1001/archinte.155.7.734; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Reitzel LR, 2013, ANN BEHAV MED, V45, P249, DOI 10.1007/s12160-012-9438-6; Report MW, 2013, VIT SIGNS CURR CIG S, V62, P2009; Rios R, 2012, ANN BEHAV MED, V43, P50, DOI 10.1007/s12160-011-9306-9; RTI International, 2012, SUDAAN LANG MAN, V1; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SAS Instititute Inc, 2013, SAS STAT 9 4 HELP DO; Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Siahpush M, 2006, ADDICTION, V101, P121, DOI 10.1111/j.1360-0443.2005.01292.x; Siahpush M, 2009, ADDICTION, V104, P1382, DOI 10.1111/j.1360-0443.2009.02599.x; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; States U, 2015, SERIOUS PSYCHOL DIST, V2009, P13; Statistics D of HI Statistics NC for H, 2014, MULT IMP FAM INC PER; Statistics NC for H, 2013, NAT HLTH INT SURV; Statistics NC for H, 2013, SURV DESCR; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Taylor DJ, 2007, BEHAV THER, V38, P49, DOI 10.1016/j.beth.2006.04.002; Tomar SL, 2003, AM J MED SCI, V326, P248, DOI 10.1097/00000441-200310000-00019; Tu YK, 2009, INT J EPIDEMIOL, V38, P549, DOI 10.1093/ije/dyn346; Van Cauter E, 1999, ANN NY ACAD SCI, V896, P254, DOI 10.1111/j.1749-6632.1999.tb08120.x; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Zhou XL, 2009, ADDICT BEHAV, V34, P365, DOI 10.1016/j.addbeh.2008.11.013; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	80	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192451	10.1371/journal.pone.0192451	http://dx.doi.org/10.1371/journal.pone.0192451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408939	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800067
J	Im, SH; Cho, JY; Dubinsky, JM; Varma, S				Im, Soo-hyun; Cho, Joo-Yun; Dubinsky, Janet M.; Varma, Sashank			Taking an educational psychology course improves neuroscience literacy but does not reduce belief in neuromyths	PLOS ONE			English	Article							SEDUCTIVE ALLURE; BRAIN IMAGES; TEACHERS; DISCIPLINE; CHALLENGES; EDUCATORS; THINKING; BLIND; MIND	Educators are increasingly interested in applying neuroscience findings to improve educational practice. However, their understanding of the brain often lags behind their enthusiasm for the brain. We propose that educational psychology can serve as a bridge between basic research in neuroscience and psychology on one hand and educational practice on the other. We evaluated whether taking an educational psychology course is associated with increased neuroscience literacy and reduced belief in neuromyths in a sample of South Korean pre-service teachers. The results showed that taking an educational psychology course was associated with the increased neuroscience literacy, but there was no impact on belief in neuromyths. We consider the implications of these and other findings of the study for redesigning educational psychology courses and textbooks for improving neuroscience literacy.	[Im, Soo-hyun; Varma, Sashank] Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA; [Cho, Joo-Yun] Seoul Natl Univ Educ, Dept Elementary Educ, Seoul, South Korea; [Dubinsky, Janet M.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Im, SH (corresponding author), Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA.	imxxx045@umn.edu						Ainslie Philip N, 2014, F1000Prime Rep, V6, P14, DOI 10.12703/P6-14; Ansari D, 2006, TRENDS COGN SCI, V10, P146, DOI 10.1016/j.tics.2006.02.007; Beck DM, 2010, PERSPECT PSYCHOL SCI, V5, P762, DOI 10.1177/1745691610388779; Bensley DA, 2015, TEACH PSYCHOL, V42, P282, DOI 10.1177/0098628315603059; BROWN LT, 1983, TEACH PSYCHOL, V10, P207, DOI 10.1207/s15328023top1004_4; Bruer J. T., 2016, ED NEUROSCIENCE, V1, P1, DOI DOI 10.1177/2377616115618036; Bruer J. T., 1997, ED RES, V26, P4, DOI DOI 10.3102/0013189X026008004; Coffield F., 2004, LEARNING STYLES PEDA; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; Dubinsky JM, 2013, EDUC RESEARCHER, V42, P317, DOI 10.3102/0013189X13499403; Eggen P, 2009, ED PSYCHOL WINDOWS C; Ferrero M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00496; Fischer KW, 2010, MIND BRAIN EDUC, V4, P68, DOI 10.1111/j.1751-228X.2010.01086.x; Fischer KW, 2007, MIND BRAIN EDUC, V1, P1, DOI 10.1111/j.1751-228X.2007.00006.x; Gardner H, 1983, FRAMES MIND THEORY M; GAZZANIGA MS, 1967, BRAIN, V90, P131, DOI 10.1093/brain/90.1.131; Geake J, 2008, EDUC RES-UK, V50, P123, DOI 10.1080/00131880802082518; Genetic Science Learning Center, LEARN GEN; Gleichgerrcht E, 2015, MIND BRAIN EDUC, V9, P170, DOI 10.1111/mbe.12086; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; Hall J, 2005, NEUROSCIENCE ED REV; Hellige JB, 2000, BRAIN COGNITION, V42, P7, DOI 10.1006/brcg.1999.1146; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Howard-Jones P, 2007, NEUROSCIENCE ED ISSU; Howard-Jones P.A., 2009, NEUROSCIENCE LITERAC; Howard-Jones PA, 2016, PSYCHOL REV, V123, P620, DOI 10.1037/rev0000036; Howard-Jones PA, 2014, NAT REV NEUROSCI, V15, P817, DOI 10.1038/nrn3817; Hoy AW, 2000, EDUC PSYCHOL-US, V35, P257, DOI 10.1207/S15326985EP3504_04; Im SH, 2017, BRIT J EDUC PSYCHOL, V87, P518, DOI 10.1111/bjep.12162; Just Marcel Adam, 2007, Cogn Affect Behav Neurosci, V7, P153; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Labriole M, 2010, PROMOTING BRAIN SCI; LEHMAN DR, 1988, AM PSYCHOL, V43, P431, DOI 10.1037/0003-066X.43.6.431; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lohse-Bossenz H, 2013, EUR J PSYCHOL EDUC, V28, P1543, DOI 10.1007/s10212-013-0181-6; Macdonald K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01314; MacNabb C., BRAINU NEUROSCIENCE; Marcus G., 2012, NEW YORKER; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; NISBETT RE, 1987, SCIENCE, V238, P625, DOI 10.1126/science.3672116; Organisation for Economic Co-operation and Development, 2002, UND BRAIN NEW LEARN; Organization for Economic Cooperation and Development, 2003, PISA 2003 ASS FRAM M; Papadatou-Pastou M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00804; Park Soowon, 2016, [Korean Journal of Teacher Education, 교원교육], V32, P185; Patrick H, 2011, EDUC PSYCHOL-US, V46, P71, DOI 10.1080/00461520.2011.538648; Petitto LA, 2004, MONOGRAPH MIND BRAIN; Pickering SJ, 2007, MIND BRAIN EDUC, V1, P109, DOI 10.1111/j.1751-228X.2007.00011.x; Puckett M., 1999, CHILDHOOD EDUC, V76, P8, DOI [10.1080/00094056.1999.10522062, DOI 10.1080/00094056.1999.10522062]; Schuftz N, 2009, NEW SCI, V203, P8, DOI 10.1016/S0262-4079(09)62446-5; Simons DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022757; Sylvan LJ, 2010, MIND BRAIN EDUC, V4, P1, DOI 10.1111/j.1751-228X.2009.01077.x; Szucs D, 2007, MIND BRAIN EDUC, V1, P114, DOI 10.1111/j.1751-228X.2007.00012.x; Tardif E, 2015, MIND BRAIN EDUC, V9, P50, DOI 10.1111/mbe.12070; Tokuhama-Espinosa T., 2010, NEW SCI TEACHING LEA; van der Meulen A, 2015, BRIT J EDUC STUD, V63, P229, DOI 10.1080/00071005.2015.1036836; Varma S, 2008, EDUC RESEARCHER, V37, P140, DOI 10.3102/0013189X08317687; Wardlaw JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025829; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20.3.470; Willingham D.T, 2006, AM ED            SPR, P30; Zardetto-Smith AM, 2002, NEUROSCIENTIST, V8, P396, DOI 10.1177/107385802236965	61	33	35	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192163	10.1371/journal.pone.0192163	http://dx.doi.org/10.1371/journal.pone.0192163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401508	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400039
J	Coulibaly, A; Haas, A; Steinmann, S; Jakobs, A; Schmidt, TJ; Klempnauer, KH				Coulibaly, Anna; Haas, Astrid; Steinmann, Simone; Jakobs, Anke; Schmidt, Thomas J.; Klempnauer, Karl-Heinz			The natural anti-tumor compound Celastrol targets a Myb-C/EBP beta-p300 transcriptional module implicated in myeloid gene expression	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; C/EBP-BETA; SYNERGISTIC ACTIVATION; SESQUITERPENE LACTONE; SUPER-ENHANCERS; CELL IDENTITY; V-MYB; NF-M; LEUKEMIA; PHOSPHORYLATION	Myb is a key regulator of hematopoietic progenitor cell proliferation and differentiation and has emerged as a potential target for the treatment of acute leukemia. Using a myeloid cell line with a stably integrated Myb-inducible reporter gene as a screening tool we have previously identified Celastrol, a natural compound with anti-tumor activity, as a potent Myb inhibitor that disrupts the interaction of Myb with the co-activator p300. We showed that Celastrol inhibits the proliferation of acute myeloid leukemia (AML) cells and prolongs the survival of mice in an in vivo model of AML, demonstrating that targeting Myb with a small-molecule inhibitor is feasible and might have potential as a therapeutic approach against AML. Recently we became aware that the reporter system used for Myb inhibitor screening also responds to inhibition of C/EBP beta, a transcription factor known to cooperate with Myb in myeloid cells. By re-investigating the inhibitory potential of Celastrol we have found that Celastrol also strongly inhibits the activity of C/EBP beta by disrupting its interaction with the Taz2 domain of p300. Together with previous studies our work reveals that Celastrol independently targets Myb and C/EBP beta by disrupting the interaction of both transcription factors with p300. Myb, C/EBP beta and p300 cooperate in myeloid-specific gene expression and, as shown recently, are associated with so-called super-enhancers in AML cells that have been implicated in the maintenance of the leukemia. We hypothesize that the ability of Celastrol to disrupt the activity of a transcriptional Myb-C/EBP beta-p300 module might explain its promising anti-leukemic activity.	[Coulibaly, Anna; Haas, Astrid; Steinmann, Simone; Jakobs, Anke; Klempnauer, Karl-Heinz] Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany; [Schmidt, Thomas J.] Westfal Wilhelms Univ, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Coulibaly, Anna] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Klin Anasthesiol & Operat Intens Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany	University of Munster; University of Munster; Ruprecht Karls University Heidelberg	Klempnauer, KH (corresponding author), Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany.	klempna@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705; Coulibaly, Anna/0000-0001-5746-4496; Klempnauer, Karl-Heinz/0000-0002-5239-7690	Deutsche Krebshilfe [109269]; Deutsche Forschungsgemeinschaft [KL461/17-1]; Open Access Publication Fund of the University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster	This work was supported by the Deutsche Krebshilfe (www.krebshilfe.de), grant number 109269, Deutsche Forschungsgemeinschaft (www.dfg.de), grant number KL461/17-1, and the Open Access Publication Fund of the University of Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Morante D, 2015, ONCOTARGET, V6, P4369, DOI 10.18632/oncotarget.2976; Bhaumik P, 2014, ACTA CRYSTALLOGR D, V70, P1914, DOI 10.1107/S1399004714009262; Bujnicki T, 2012, LEUKEMIA, V26, P615, DOI 10.1038/leu.2011.275; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Falkenberg KD, 2017, BBA-MOL CELL RES, V1864, P1349, DOI 10.1016/j.bbamcr.2017.05.003; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jakobs A, 2016, LEUKEMIA, V30, P1612, DOI 10.1038/leu.2016.16; Jakobs A, 2016, J BIOL CHEM, V291, P26098, DOI 10.1074/jbc.M116.748129; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Regalo G, 2016, J MOL MED, V94, P1385, DOI 10.1007/s00109-016-1447-7; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Steinmann S, 2013, J BIOL CHEM, V288, P22257, DOI 10.1074/jbc.M113.487769; Uttarkar S, 2016, MOL CANCER THER, V15, P2905, DOI 10.1158/1535-7163.MCT-16-0185; Uttarkar S, 2016, BLOOD, V127, P1173, DOI 10.1182/blood-2015-09-668632; Uttarkar S, 2015, MOL CANCER THER, V14, P1276, DOI 10.1158/1535-7163.MCT-14-0662; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	49	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0190934	10.1371/journal.pone.0190934	http://dx.doi.org/10.1371/journal.pone.0190934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394256	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400007
J	Cohen, AD; Nencka, AS; Wang, Y				Cohen, Alexander D.; Nencka, Andrew S.; Wang, Yang			Multiband multi-echo simultaneous ASL/BOLD for task-induced functional MRI	PLOS ONE			English	Article							BOLD-CONTRAST SENSITIVITY; CEREBRAL-BLOOD-FLOW; FMRI TIME-SERIES; DIFFERENTIATING BOLD; BRAIN; EPI; PERFUSION; CONNECTIVITY; SIGNAL; VISUALIZATION	Typical simultaneous blood oxygenation-level dependent (BOLD) and arterial spin labeling (ASL) sequences acquire two echoes, one perfusion-sensitive and one BOLD-sensitive. However, for ASL, spatial resolution and brain coverage are limited due to the T1 decay of the labeled blood. This study applies a sequence combining a multiband acquisition with four echoes for simultaneous BOLD and pseudo-continuous ASL (pCASL) echo planar imaging (MBME ASL/BOLD) for block-design task-fMRI. A multiband acceleration of four was employed to increase brain coverage and reduce slice-timing effects on the ASL signal. Multi-echo independent component analysis (MEICA) was implemented to automatically denoise the BOLD signal by regressing non-BOLD components. This technique led to increased temporal signal-to-noise ratio (tSNR) and BOLD sensitivity. The MEICA technique was also modified to denoise the ASL signal by regressing artifact and BOLD signals from the first echo time-series. The MBME ASL/BOLD sequence was applied to a finger-tapping task functional MRI (fMRI) experiment. Signal characteristics and activation were evaluated using single echo BOLD, combined ME BOLD, combined ME BOLD after MEICA denoising, perfusion-weighted (PW), and perfusion-weighted after MEICA denoising time-series. The PW data was extracted using both surround subtraction and high-pass filtering followed by demodulation. In addition, the CBF/BOLD response ratio and CBF/BOLD coupling were analyzed. Results showed that the MEICA denoising procedure significantly improved the BOLD signal, leading to increased BOLD sensitivity, tSNR, and activation statistics compared to conventional single echo BOLD data. At the same time, the denoised PW data showed increased tSNR and activation statistics compared to the non-denoised PW data. CBF/BOLD coupling was also increased using the denoised ASL and BOLD data. Our preliminary data suggest that the MBME ASL/BOLD sequence can be employed to collect whole-brain task-fMRI with improved data quality for both BOLD and PW time series, thus improving the results of block-design task fMRI.	[Cohen, Alexander D.; Nencka, Andrew S.; Wang, Yang] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cohen, AD; Wang, Y (corresponding author), Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	acohen@mcw.edu; yangwang@mcw.edu			Daniel M. Soref Charitable Trust Grant	Daniel M. Soref Charitable Trust Grant	This work was supported by a Daniel M. Soref Charitable Trust Grant (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Bangen KJ, 2009, NEUROBIOL AGING, V30, P1276, DOI 10.1016/j.neurobiolaging.2007.11.012; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Cohen AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169253; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; Evans JW, 2015, NEUROIMAGE, V105, P189, DOI 10.1016/j.neuroimage.2014.10.051; Faraco CC, 2015, MAGN RESON MED, V73, P1579, DOI 10.1002/mrm.25268; Feinberg DA, 2013, MAGN RESON MED, V70, P1500, DOI 10.1002/mrm.24994; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Ghariq E, 2014, NEUROIMAGE, V103, P316, DOI 10.1016/j.neuroimage.2014.09.051; Gonzalez-At JB, 2000, MAGNET RESON MED, V43, P739, DOI 10.1002/(SICI)1522-2594(200005)43:5<739::AID-MRM17>3.0.CO;2-2; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Kundu P, 2015, BRAIN IMAGING BEHAV, V9, P56, DOI 10.1007/s11682-014-9346-4; Kundu P, 2014, NEUROIMAGE, V102, P861, DOI 10.1016/j.neuroimage.2014.07.025; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Liu TT, 2005, NEUROIMAGE, V24, P207, DOI 10.1016/j.neuroimage.2004.09.047; Lowe MJ, 2000, J CEREBR BLOOD F MET, V20, P1331, DOI 10.1097/00004647-200009000-00008; Lu HZ, 2006, MAGN RESON MED, V56, P546, DOI 10.1002/mrm.20976; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Poser BA, 2009, NEUROIMAGE, V45, P1162, DOI 10.1016/j.neuroimage.2009.01.007; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Posse S, 2012, NEUROIMAGE, V62, P665, DOI 10.1016/j.neuroimage.2011.10.057; Restom K, 2007, NEUROIMAGE, V37, P430, DOI 10.1016/j.neuroimage.2007.05.024; Schmithorst VJ, 2014, J MAGN RESON IMAGING, V39, P1104, DOI 10.1002/jmri.24273; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Suchandrima Banerjee AT, 2012, ROBUST CALIBRATION S; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Wang Y, 2015, NEUROIMAGE, V113, P279, DOI 10.1016/j.neuroimage.2015.03.060; Whittaker JR, 2016, NEUROIMAGE, V125, P198, DOI 10.1016/j.neuroimage.2015.10.023; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Zhu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065884	49	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190427	10.1371/journal.pone.0190427	http://dx.doi.org/10.1371/journal.pone.0190427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389985	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400005
J	Tang, JC; Cheng, RM; Shi, ZM; Xu, GX; Liu, SR; Centritto, M				Tang, Jingchao; Cheng, Ruimei; Shi, Zuomin; Xu, Gexi; Liu, Shirong; Centritto, Mauro			Fagaceae tree species allocate higher fraction of nitrogen to photosynthetic apparatus than Leguminosae in Jianfengling tropical montane rain forest, China	PLOS ONE			English	Article							MESOPHYLL DIFFUSION CONDUCTANCE; CO2 TRANSFER CONDUCTANCE; WATER-USE EFFICIENCY; CELL-WALLS; INTERNAL CONDUCTANCE; TEMPERATURE RESPONSE; LEAF; LEAVES; LIGHT; EVERGREEN	Variation in photosynthetic-nitrogen use efficiency (PNUE) is generally affected by several factors such as leaf nitrogen allocation and leaf diffusional conductances to CO2, although it is still unclear which factors significantly affect PNUE in tropical montane rain forest trees. In this study, comparison of PNUE, photosynthetic capacity, leaf nitrogen allocation, and diffusional conductances to CO2 between five Fagaceae tree species and five Leguminosae tree species were analyzed in Jianfengling tropical montane rain forest, Hainan Island, China. The result showed that PNUE of Fagaceae was significantly higher than that of Leguminosae (+35.5%), attributed to lower leaf nitrogen content per area (N-area, -29.4%). The difference in nitrogen allocation was the main biochemical factor that influenced interspecific variation in PNUE of these tree species. Fagaceae species allocated a higher fraction of leaf nitrogen to the photosynthetic apparatus (P-P, +43.8%), especially to Rubisco (P-R, +50.0%) and bioenergetics (P-B +33.3%) in comparison with Leguminosae species. Leaf mass per area (LMA) of Leguminosae species was lower than that of Fagaceae species (-15.4%). While there was no significant difference shown for mesophyll conductance (g(m)), Fagaceae tree species may have greater chloroplast to total leaf surface area ratios and that offset the action of thicker cell walls on g(m). Furthermore, weak negative relationship between nitrogen allocation in cell walls and in Rubisco was found for Castanopsis hystrix, Cyclobalanopsis phanera and Cy. patelliformis, which might imply that nitrogen in the leaves was insufficient for both Rubisco and cell walls. In summary, our study concluded that higher PNUE might contribute to the dominance of most Fagaceae tree species in Jianfengling tropical montane rain forest.	[Tang, Jingchao; Cheng, Ruimei; Shi, Zuomin; Xu, Gexi; Liu, Shirong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm Sci, Beijing, Peoples R China; [Cheng, Ruimei; Shi, Zuomin] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Shi, Zuomin; Centritto, Mauro] Natl Res Council Italy Sesto, Tree & Timber Inst, Fiorentino, Italy	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Nanjing Forestry University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR)	Shi, ZM (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm Sci, Beijing, Peoples R China.; Shi, ZM (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Shi, ZM (corresponding author), Natl Res Council Italy Sesto, Tree & Timber Inst, Fiorentino, Italy.	shizm@caf.ac.cn			National Natural Science Foundation of China (Ministry of National Science and Technology, China) [31290223, 31570240]	National Natural Science Foundation of China (Ministry of National Science and Technology, China)	This research was supported by projects of the National Natural Science Foundation of China, http://www.nsfc.gov.cn/ (funder: Ministry of National Science and Technology, China, no. 31290223 and 31570240, received by ZS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bahar N. H. A., 2016, NEW PHYTOL; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Bloomfield KJ, 2014, FUNCT PLANT BIOL, V41, P820, DOI 10.1071/FP13278; Broeckx LS, 2014, TREE PHYSIOL, V34, P701, DOI 10.1093/treephys/tpu057; Buckley TN, 2014, PHOTOSYNTH RES, V119, P77, DOI 10.1007/s11120-013-9825-2; Burns AE, 2002, OECOLOGIA, V133, P288, DOI 10.1007/s00442-002-1055-9; Chen LH, 2014, TREES-STRUCT FUNCT, V28, P793, DOI 10.1007/s00468-014-0992-3; Dusenge ME, 2015, OECOLOGIA, V177, P1183, DOI 10.1007/s00442-015-3260-3; Ethier GJ, 2006, PLANT CELL ENVIRON, V29, P2168, DOI 10.1111/j.1365-3040.2006.01590.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fang JY, 2004, BIODIVERSITY SCI, V12, P29, DOI DOI 10.3321/J.ISSN:1005-0094.2004.01.005; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feng Qiu-Hong, 2013, Chinese Journal of Plant Ecology, V37, P591, DOI 10.3724/SP.J.1258.2013.00061; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Feng YL, 2007, ACTA OECOL, V31, P40, DOI 10.1016/j.actao.2006.03.009; Field C. H., 1986, EC FORM FUNCTION, P25; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Gu LH, 2010, PLANT CELL ENVIRON, V33, P1852, DOI 10.1111/j.1365-3040.2010.02192.x; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Harrison MT, 2009, PLANT CELL ENVIRON, V32, P259, DOI 10.1111/j.1365-3040.2008.01918.x; Hassiotou F, 2009, J EXP BOT, V60, P2303, DOI 10.1093/jxb/erp021; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Hikosaka K, 2010, PLANT BIOTECHNOL, V27, P223, DOI 10.5511/plantbiotechnology.27.223; Hikosaka K, 2009, OECOLOGIA, V160, P443, DOI 10.1007/s00442-009-1315-z; Imanishi L, 2011, MOL PLANT MICROBE IN, V24, P1317, DOI 10.1094/MPMI-03-11-0078; Jang YX, 1991, TROPICAL FOREST ECOS, P47; Peguero-Pina JJ, 2012, PLANT CELL ENVIRON, V35, P2121, DOI 10.1111/j.1365-3040.2012.02540.x; Jin SH, 2011, TREE PHYSIOL, V31, P1142, DOI 10.1093/treephys/tpr095; Kositsup B, 2009, TREES-STRUCT FUNCT, V23, P357, DOI 10.1007/s00468-008-0284-x; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057130; Li Y, 2009, J EXP BOT, V60, P2351, DOI 10.1093/jxb/erp127; LORETO F, 1994, PHOTOSYNTH RES, V41, P397, DOI 10.1007/BF02183042; Loreto F, 2009, J EXP BOT, V60, P2283, DOI 10.1093/jxb/erp112; Loustau D, 1999, TREE PHYSIOL, V19, P707; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Momayyezi M, 2017, J PLANT PHYSIOL, V213, P122, DOI 10.1016/j.jplph.2017.03.006; Moon M, 2015, J KOREAN SOC APPL BI, V58, P511, DOI 10.1007/s13765-015-0074-2; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Niinemets U, 2005, PLANT CELL ENVIRON, V28, P1552, DOI 10.1111/j.1365-3040.2005.01392.x; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Niinemets U, 2009, J EXP BOT, V60, P2433, DOI 10.1093/jxb/erp045; Novriyanti E, 2012, PHOTOSYNTHETICA, V50, P273, DOI 10.1007/s11099-012-0033-7; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Pegueropina JJ, 2017, NEW PHYTOL; Piel C, 2002, J EXP BOT, V53, P2423, DOI 10.1093/jxb/erf095; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Qing H, 2012, BIOL INVASIONS, V14, P2039, DOI 10.1007/s10530-012-0210-4; Raim O, 2012, PLANT BIOLOGY, V14, P306, DOI 10.1111/j.1438-8677.2011.00503.x; Robinson DE, 2001, CAN J FOREST RES, V31, P2014, DOI 10.1139/cjfr-31-11-2014; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Scafaro AP, 2011, PLANT CELL ENVIRON, V34, P1999, DOI 10.1111/j.1365-3040.2011.02398.x; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shi ZM, 2006, PHYSIOL PLANTARUM, V128, P722, DOI 10.1111/j.1399-3054.2006.00805.x; Sorrentino G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148554; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Tenhaken R., 2015, FRONT PLANT SCI, DOI [10.1105/tpc.16.00891, DOI 10.3389/FPLS.2014.00771, 10.3389/fpls.2014.00771.eCollection2014]; Terashima I, 2005, ANN BOT-LONDON, V95, P507, DOI 10.1093/aob/mci049; Tosens T, 2012, PLANT CELL ENVIRON, V35, P839, DOI 10.1111/j.1365-3040.2011.02457.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Warren CR, 2008, J EXP BOT, V59, P1475, DOI 10.1093/jxb/erm245; Warren CR, 2004, TRENDS PLANT SCI, V9, P270, DOI 10.1016/j.tplants.2004.04.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu G, 2013, PHOTOSYNTHETICA, V51, P438, DOI 10.1007/s11099-013-0043-0; Xu H, 2015, J ECOL, V103, P1325, DOI 10.1111/1365-2745.12442; Xu Han, 2015, Biodiversity Science, V23, P192, DOI 10.17520/biods.2014157; Yamori W, 2010, PLANT CELL ENVIRON, V33, P332, DOI 10.1111/j.1365-3040.2009.02067.x; Zhang LL, 2016, BIOL INVASIONS, V18, P1391, DOI 10.1007/s10530-016-1089-2; [周璋 ZHOU Zhang], 2009, [生态学报, Acta Ecologica Sinica], V29, P1112; Zhou Zhang, 2009, Shengtaixue Zazhi, V28, P1006; Zhu JT, 2012, AUST J BOT, V60, P61, DOI 10.1071/BT11181	76	4	7	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192040	10.1371/journal.pone.0192040	http://dx.doi.org/10.1371/journal.pone.0192040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390007	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400056
J	Wang, Y; Liu, ZZ; Han, Y; Xu, JP; Huang, W; Li, ZS				Wang, Ying; Liu, Zhenzhen; Han, Yi; Xu, Jiping; Huang, Wen; Li, Zhaoshen			Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; WEIGHT-LOSS; ENERGY-EXPENDITURE; BODY-COMPOSITION; FOOD-INTAKE; CANCER; FAT; THERMOGENESIS; MUSCLE; DIET	Medium Chain Triglycerides (MCT) is a dietary supplement and usually used along with medications for treating food absorption disorders including diarrhea, steatorrhea and liver disease. It has been shown that MCT plays a role in lowering weight, and decreasing metabolic syndrome, abdominal obesity and inflammation. However, it is still unknown whether MCT enhances exercise endurance. Here, we demonstrated that MCT containing diet improves high temperature induced exercise performance impairment. We found that MCT up-regulates the expression and protein levels of genes involved in mitochondrial biogenesis and metabolism. Further investigation demonstrated that the increased mitochondrial biogenesis and metabolism is mediated through the activation of Akt and AMPK signaling pathways and inhibition of TGF-beta signaling pathway. Collectively, our findings indicate a beneficial effect of dietary MCT in exercise performance through the increase of mitochondrial biogenesis and metabolism.	[Wang, Ying; Liu, Zhenzhen; Han, Yi; Xu, Jiping; Huang, Wen; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Huang, W (corresponding author), Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China.	huangsh666@163.com						Abe S, 2016, J NUTR, V146, P1017, DOI 10.3945/jn.115.228965; BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678; BRAY GA, 1980, INT J OBESITY, V4, P27; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Clegg ME, 2013, EUR J NUTR, V52, P1579, DOI 10.1007/s00394-012-0463-9; Clegg ME, 2010, INT J FOOD SCI NUTR, V61, P653, DOI 10.3109/09637481003702114; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DERYNCK R, 1987, CANCER RES, V47, P707; DICKSON RB, 1987, P NATL ACAD SCI USA, V84, P837, DOI 10.1073/pnas.84.3.837; Goedecke JH, 1999, INT J SPORT NUTR, V9, P35, DOI 10.1123/ijsn.9.1.35; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001; Costa ACR, 2012, NUTR HOSP, V27, P103, DOI [10.1590/S0212-16112012000100011, 10.3305/nh.2012.27.1.5369]; ROTHWELL NJ, 1987, METABOLISM, V36, P128, DOI 10.1016/0026-0495(87)90005-9; Saifudeen I, 2017, J CARD FAIL, V23, P240, DOI 10.1016/j.cardfail.2016.08.001; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sohn EJ, 2012, CELL MOL BIOL NOIS S, V58; St-Onge MP, 2014, EUR J CLIN NUTR, V68, P1134, DOI 10.1038/ejcn.2014.145; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; St-Onge MP, 2002, J NUTR, V132, P329; Van Wymelbeke V, 1998, AM J CLIN NUTR, V68, P226, DOI 10.1093/ajcn/68.2.226; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Zhao JX, 2015, LIFE SCI, V141, P74, DOI 10.1016/j.lfs.2015.09.001	35	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191182	10.1371/journal.pone.0191182	http://dx.doi.org/10.1371/journal.pone.0191182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420554	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900012
J	Wendel, U; Persson, N; Risinger, C; Bengtsson, E; Nodin, B; Danielsson, L; Welinder, C; Fredrikson, GN; Jansson, B; Blixt, O				Wendel, Ulrika; Persson, Nina; Risinger, Christian; Bengtsson, Eva; Nodin, Bjorn; Danielsson, Lena; Welinder, Charlotte; Fredrikson, Gunilla Nordin; Jansson, Bo; Blixt, Ola			A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACCUMULATION; PROTEINS; N-EPSILON-(CARBOXYMETHYL)LYSINE; GLYCOXIDATION; PROGRESSION; RECEPTOR; PLASMA	Advanced glycation end products are formed by non-enzymatic reactions between proteins and carbohydrates, causing irreversible lysine and arginine alterations that severely affect protein structure and function. The resulting modifications induce inflammation by binding to scavenger receptors. An increase in advanced glycation end products is observed in a number of diseases e.g. atherosclerosis and cancer. Since advanced glycation end products also are present in healthy individuals, their detection and quantification are of great importance for usage as potential biomarkers. Current methods for advanced glycation end product detection are though limited and solely measure total glycation. This study describes a new epitope-mapped single chain variable fragment, D1-B2, against carboxymethyllysine, produced from a phage library that was constructed from mouse immunizations. The phage library was selected against advanced glycation end product targets using a phage display platform. Characterization of its binding pattern was performed using large synthetic glycated peptide and protein libraries displayed on microarray slides. D1-B2 showed a preference for an aspartic acid, three positions N-terminally from a carboxymethyllysine residue and also bound to a broad collection of glycated proteins. Positive immunohistochemical staining of mouse atherosclerotic plaques and of a tissue microarray of human pancreatic tumors confirmed the usability of the new scFv for advanced glycation end product detection in tissues. This study demonstrates a promising methodology for high-throughput generation of epitope-mapped monoclonal antibodies against AGE.	[Wendel, Ulrika; Persson, Nina; Risinger, Christian; Blixt, Ola] Univ Copenhagen, Fac Sci, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark; [Bengtsson, Eva; Fredrikson, Gunilla Nordin] Malmo Lund Univ, Scania Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Nodin, Bjorn; Welinder, Charlotte; Jansson, Bo] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Danielsson, Lena] Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, Lund, Sweden; [Welinder, Charlotte] Lund Univ, Biomed Ctr D13, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Lund, Sweden	University of Copenhagen; Lund University; Lund University; Lund University; Lund University	Blixt, O (corresponding author), Univ Copenhagen, Fac Sci, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark.	olablixt@chem.ku.dk	Bengtsson, Eva/AAA-1968-2019; Bengtsson, Eva/AGH-2754-2022; Welinder, Charlotte/G-1144-2014	Bengtsson, Eva/0000-0001-7075-1772; Welinder, Charlotte/0000-0001-9626-0576; Blixt, Ola/0000-0003-4143-6276	Danish Research Council [4005-00285]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Research Council (https://dff.dk/en/application), grant nr. 4005-00285, received by OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf JM, 2017, BIOCHEMISTRY-MOSCOW+, V82, P579, DOI 10.1134/S0006297917050066; Awasthi S, 2016, SPECTROCHIM ACTA A, V163, P60, DOI 10.1016/j.saa.2016.03.023; Bandholtz L, 2005, ARTERIOSCL THROM VAS, V25, P2151; Bennmann D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112115; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2013, METHODS MOL BIOL, V1047, P201, DOI 10.1007/978-1-62703-544-6_14; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527; CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x; Chiavarina B, 2014, ONCOTARGET, V5, P5472, DOI 10.18632/oncotarget.2121; de Groot L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3538; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; Engelbertsen D, 2015, J IMMUNOL, V195, P3020, DOI 10.4049/jimmunol.1402869; Foster D, 2014, CANCER EPIDEM BIOMAR, V23, P2186, DOI 10.1158/1055-9965.EPI-14-0564; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Imanaga Y, 2000, ATHEROSCLEROSIS, V150, P343, DOI 10.1016/S0021-9150(99)00396-2; Kolbus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033932; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; KUME S, 1995, AM J PATHOL, V147, P654; Lindner Peter, 2001, P637; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; Mohd J, 2015, INT UNION BIOCH MOL, V67, P897; Nagai R, 2007, BBA-MOL BASIS DIS, V1772, P1192, DOI 10.1016/j.bbadis.2007.09.001; Nagai R, 2016, GLYCOCONJUGATE J, V33, P545, DOI 10.1007/s10719-016-9708-9; Paradela-Dobarro B, 2016, J MOL ENDOCRINOL, V56, P23, DOI 10.1530/JME-15-0031; Persson N, 2017, GLYCOBIOLOGY, P1; Persson N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168761; Rockefeller T., 1977, J BIOL CHEM, V252, P2992; Sakata N, 2001, CARDIOVASC RES, V49, P466, DOI 10.1016/S0008-6363(00)00262-5; Schaefer JV, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P21, DOI 10.1007/978-3-642-01144-3_3; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Shahsavarian MA, 2014, J IMMUNOL METHODS, V407, P26, DOI 10.1016/j.jim.2014.03.015; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sorensen KK, 2017, ACS INFECT DIS, P1; Takino JI, 2010, J ONCOL, V2010, DOI 10.1155/2010/739852; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Van Heijst JWJ, 2005, ANN NY ACAD SCI, V1043, P725, DOI 10.1196/annals.1333.084; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; YAN SD, 1994, J BIOL CHEM, V269, P9889; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191872	10.1371/journal.pone.0191872	http://dx.doi.org/10.1371/journal.pone.0191872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420566	gold, Green Published			2022-12-27	WOS:000424517900028
J	den Boer, JCL; van Dijk, W; Horn, V; Hescot, P; Bruers, JJM				den Boer, Joost C. L.; van Dijk, Ward; Horn, Virginie; Hescot, Patrick; Bruers, Josef J. M.			Collecting standardised oral health data via mobile application: A proof of concept study in the Netherlands	PLOS ONE			English	Article							GLOBAL BURDEN; QUALITY; LIFE; PROVISION; SERVICES; FUTURE; CARIES; IMPACT	FDI World Dental Federation, founded as Fe A de A ration Dentaire Internationale, has taken the initiative to develop the Oral Health Observatory, a mobile application to conduct oral health surveys worldwide. The aim is to collect reliable standardized international data on oral health and oral health care via a network of dentists. A proof of concept study project was set up in the Netherlands to test the methodology and to validate the approach. Data about caries, gingivitis, oral self-care and oral health related quality of life were analysed and compared to datasets validated in other studies. The Android app embeds three questionnaires addressing oral health history, status and patient behaviour. One questionnaire was completed by the patient and two by the dentist. The proof of concept study involved two phases: in the first phase, five dentists, regular participants in KNMT-surveys, evaluated the usability of the app; after the first phase, the app was adjusted for a second phase. For this phase an extra 15 dentists were recruited from a group of 20 other dentists: five of them declined to participate. Attention was paid to ensuring there was a proportional representation of gender, age and region. In the second phase the five first and 15 new participants collected data on up to a maximum of 38 patients. Data from this 653 patients correspond with results from previously published surveys on the prevalence of caries and gingivitis in the Netherlands. Hence demonstrating an association between caries and gingivitis with oral self-care, problems eating and experiencing oral pain. This proof of concept study shows that the app makes it possible to collect reliable information on oral health in a short period of time. Both dentists and patients evaluated the methodology as user-friendly. Altogether, the results of this proof of concept study are promising.	[den Boer, Joost C. L.; Bruers, Josef J. M.] Royal Dutch Dent Assoc KNMT, Res & Informat Dept, Utrecht, Netherlands; [van Dijk, Ward; Horn, Virginie; Hescot, Patrick] FDI World Dent Federat, Geneva, Switzerland; [Bruers, Josef J. M.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Bruers, Josef J. M.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	den Boer, JCL (corresponding author), Royal Dutch Dent Assoc KNMT, Res & Informat Dept, Utrecht, Netherlands.	j.den.boer@knmt.nl	Boer, Joost Den/AAW-8088-2020	Boer, Joost Den/0000-0002-6330-4445	FDI World Dental Federation; Royal Dutch Dental Association	FDI World Dental Federation; Royal Dutch Dental Association	The development of the OHO-app was funded by FDI World Dental Federation. The execution of the pilot project in the Netherlands, including the acquisition of the tablets, was funded by the Royal Dutch Dental Association.	Benzian H., 2015, CHALLENGE ORAL DIS C; Bruers J J M, 2014, Ned Tijdschr Tandheelkd, V121, P345; Bruers J J M, 2005, Adv Dent Res, V18, P50; Centraal Bureau voor de Statistiek, 2014, VOORB HEERL; da Silva OM, 2012, INT DENT J, V62, P277, DOI 10.1111/idj.12011; Dye BA, 2015, PEDIATR DENT, V37, P200; FDI Launches its Observatory for Oral Health Prevention and Control, 2013, FDI WORLDENTAL  0829; Ferreira R, 2015, COMP MED SY, P197, DOI 10.1109/CBMS.2015.30; Fontana M, 2006, J AM DENT ASSOC, V137, P1231, DOI 10.14219/jada.archive.2006.0380; Garavand A., 2016, SHIRAZ E MED J, V17; Glick M, 2012, INT DENT J, V62, P278, DOI 10.1111/idj.12009; Health Council of the Netherlands, 2012, PERSP OR HLTH CAR; Health EPfBO, 2012, STAT OR HLTH EUR; Konig J, 2010, EUR J DENT EDUC, V14, P4, DOI 10.1111/j.1600-0579.2010.00620.x; Kravitz AS, 2015, COUNC EUR DENT, V5.1; Krisdapong S, 2012, J CLIN PERIODONTOL, V39, P834, DOI 10.1111/j.1600-051X.2012.01907.x; Lawrence HP, 2008, COMMUNITY DENT ORAL, V36, P305, DOI 10.1111/j.1600-0528.2007.00395.x; Leal SC, 2012, CARIES RES, V46, P102, DOI 10.1159/000336387; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Muehlhausen W, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0362-x; Nuttall NM, 2001, BRIT DENT J, V190, P121, DOI 10.1038/sj.bdj.4800901a; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pinto RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145149; Pourat N, 2011, J AM DENT ASSOC, V142, P1050, DOI 10.14219/jada.archive.2011.0327; Ramos Renato Quirino, 2013, Rev. bras. epidemiol., V16, P716, DOI 10.1590/S1415-790X2013000300015; SCHULLER AA, 2009, MONDGEZONDHEID VOLWA; Schuller AA, 2013, VERVOLG REEKS TJZ ON; Special Eurobarometer, 2012, SPEC EUR EUR THEIR L; Tchicaya A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-7; Thomas S.L., 2015, INTRO MULTILEVEL MOD, DOI DOI 10.4324/9780429060274; United Nations, 2014, DEM YB 2013; Verrips GHW, 2013, DENT J, V1, P12, DOI DOI 10.3390/DJ1020012; Wainwright J, 2014, BRIT DENT J, V217, DOI 10.1038/sj.bdj.2014.651; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191385	10.1371/journal.pone.0191385	http://dx.doi.org/10.1371/journal.pone.0191385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415025	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300025
J	Takahashi, H; Kozhuharova, A; Sharma, H; Hirose, M; Ohyama, T; Fasolo, F; Yamazaki, T; Cotella, D; Santoro, C; Zucchelli, S; Gustincich, S; Carninci, P				Takahashi, Hazuki; Kozhuharova, Ana; Sharma, Harshita; Hirose, Masakazu; Ohyama, Takako; Fasolo, Francesca; Yamazaki, Toshio; Cotella, Diego; Santoro, Claudio; Zucchelli, Silvia; Gustincich, Stefano; Carninci, Piero			Identification of functional features of synthetic SINEUPs, antisense lncRNAs that specifically enhance protein translation	PLOS ONE			English	Article							RNA-POLYMERASE-II; LONG NONCODING RNAS; DOUBLE-STRANDED-RNA; ANALYSIS GENE-EXPRESSION; IN-VIVO; B2 RNA; REPETITIVE ELEMENTS; SECONDARY STRUCTURE; TRANSCRIPTION; GENOME	SINEUPs are antisense long noncoding RNAs, in which an embedded SINE B2 element UP-regulates translation of partially overlapping target sense mRNAs. SINEUPs contain two functional domains. First, the binding domain (BD) is located in the region antisense to the target, providing specific targeting to the overlapping mRNA. Second, the inverted SINE B2 represents the effector domain (ED) and enhances translation. To adapt SINEUP technology to a broader number of targets, we took advantage of a high-throughput, semi-automated imaging system to optimize synthetic SINEUP BD and ED design in HEK293T cell lines. Using SINEUP-GFP as a model SINEUP, we extensively screened variants of the BD to map features needed for optimal design. We found that most active SINEUPs overlap an AUG-Kozak sequence. Moreover, we report our screening of the inverted SINE B2 sequence to identify active sub-domains and map the length of the minimal active ED. Our synthetic SINEUP-GFP screening of both BDs and EDs constitutes a broad test with flexible applications to any target gene of interest.	[Takahashi, Hazuki; Kozhuharova, Ana; Sharma, Harshita; Hirose, Masakazu; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Ohyama, Takako; Yamazaki, Toshio] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Fasolo, Francesca; Zucchelli, Silvia; Gustincich, Stefano] Scuola Int Super Studi Avanzati, Area Neurosci, Trieste, Italy; [Cotella, Diego; Santoro, Claudio; Zucchelli, Silvia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Santoro, Claudio] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Gustincich, Stefano] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Carninci, Piero] TransSINE Technol, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; International School for Advanced Studies (SISSA); University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Istituto Italiano di Tecnologia - IIT	Carninci, P (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.; Carninci, P (corresponding author), TransSINE Technol, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Carninci, Piero/K-1568-2014; cotella, diego/J-8422-2019; Takahashi, Hazuki/F-9007-2017	Carninci, Piero/0000-0001-7202-7243; cotella, diego/0000-0003-2714-4744; Gustincich, Stefano/0000-0002-2749-2514; Zucchelli, Silvia/0000-0003-4556-2990; Takahashi, Hazuki/0000-0001-7315-7349; Fasolo, Francesca/0000-0002-2491-4822	MEXT; AMED; Telethon grant [GGP15004]; Italian Ministry of Education, University and Research (FIRB) [RBAP11FRE9]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED; Telethon grant(Fondazione Telethon); Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was founded by a Research Grant from MEXT to the RIKEN Center for Life Science Technologies (grant number N/A, http://www.mext.go.jp/en/) and Grant from AMED to Basic Science and Platform Technology Program for Innovative Biological Medicine (grant number N/A, http://www.i-biomed.jp/en/) to Piero Carninci in Japan. This work was also supported by Telethon grant (GGP15004, http://www.telethon.it/en) and Italian Ministry of Education, University and Research (FIRB grant RBAP11FRE9, http://www.istruzione.it/) to Stefano Gustincich in Italy. TransSINE Technologies has not provided actual funding to this research, nor direct salaries or any direct benefits to any of the members participating in this study. TransSINE Technologies has only provided information that was necessary to the design and the execution of the project. PC, who is also affiliated to TransSINE Technologies, has a key role in the design of the study.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrieri C, 2015, FRONTIERS CELLULAR N, P9; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; DAVIES MV, 1989, P NATL ACAD SCI USA, V86, P9163, DOI 10.1073/pnas.86.23.9163; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gustincich S, 2016, PROG NEUROBIOL; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Indrieri A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27315; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; JANG KL, 1992, J ACQ IMMUN DEF SYND, V5, P1142; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Lam JKW, 2015, MOL THERAPY NUCL ACI, P4; Long H, 2016, BIOTECHNOL LETT; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; PANNING B, 1993, MOL CELL BIOL, V13, P3231, DOI 10.1128/MCB.13.6.3231; Patrucco L, 2015, GENE, V569, P287, DOI 10.1016/j.gene.2015.05.070; Piskurek O, 2003, MOL BIOL EVOL, V20, P1659, DOI 10.1093/molbev/msg187; Schein A, 2016, SCI REP, P6; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Takahashi H, 2014, BIOCHEM BIOPH RES CO, V452, P294, DOI 10.1016/j.bbrc.2014.08.139; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams WP, 2004, VIROLOGY, V327, P233, DOI 10.1016/j.virol.2004.06.040; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yao Y, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv125; Zhao HW, 2005, MOL BIOL CELL, V16, P5857, DOI 10.1091/mbc.E05-08-0705; Zucchelli S, 2015, RNA BIOL, V12, P771, DOI 10.1080/15476286.2015.1060395; Zucchelli S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00174	48	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0183229	10.1371/journal.pone.0183229	http://dx.doi.org/10.1371/journal.pone.0183229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414979	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300002
J	Arendt, E; Singh, NS; Campbell, OMR				Arendt, Esther; Singh, Neha S.; Campbell, Oona M. R.			Effect of maternal height on caesarean section and neonatal mortality rates in sub-Saharan Africa: An analysis of 34 national datasets	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; FOR-GESTATIONAL-AGE; SYSTEMATIC ANALYSIS; RISK; INTERVENTIONS; NUTRITION; PRETERM; LIFE; PREVENTION; TRENDS	Rationale The lifecycle perspective reminds us that the roots of adult ill-health may start in-utero or in early childhood. Nutritional and infectious disease insults in early life, the critical first 1000 days, are associated with stunting in childhood, and subsequent short adult stature. There is limited or no opportunity for stunted children above 2 years of age to experience catch-up growth. Some previous research has shown short maternal height to lead to adverse birth outcomes. In this paper, we document the association between maternal height and caesarean section, and between maternal height and neonatal mortality in 34 sub-Saharan African countries. We also explore the appropriate height cut-offs to use. Our paper contributes arguments to support a focus on preventing non-communicable risk factors, namely early childhood under-nutrition, as part of the fight to reduce caesarean section rates and other adverse maternal and newborn health outcomes, particularly neonatal mortality. We focus on the Sub-Saharan Africa region because it carries the highest burden of maternal and neonatal ill-health. Methods We used the most recent Demographic and Health Survey for 34 sub-Saharan African countries. The distribution of heights of women who had given birth in the 5 years before the survey was explored. We adopted the following cut-offs: Very Short (<145.0cm), Short (145.0-149.9cm), Short-average (150.0-154.9cm), Average (155.0-159.9cm), Average-tall (160.0-169.9cm) and Tall (>= 170.0cm). Multivariate logistic regression was used to assess the contribution of maternal stature to the odds ratio of caesarean section delivery, adjusting for other exposures, such as age at index birth, residence, maternal BMI, maternal education, wealth index quintile, previous caesarean section, multiple birth, birth order and country of survey. We also look at its contribution to neonatal mortality adjusting for age at index birth, residence, maternal BMI, maternal education, wealth index quintile, multiple birth, birth order and country of survey. Results There was a gradual increase in the rate of caesarean section with decreasing maternal height. Compared to women of Average height (155.0-159.9cm), taller women were protected. The adjusted odds ratio (aOR) for Tall women was 0.67 (95% CI:0.52-0.87) and for Average-tall women was 0.78 (95% CI:0.69-0.89). Compared to women of Average height, shorter women were at increased risk. The aOR for Short-average women was 1.19 (95% CI:1.03-1.37), for Short women was 2.06 (95% CI:1.71-2.48), and for Very Short women was 2.50 (95% CI:1.85-3.38). There was evidence that compared to Average height women, Very Short and Short women had increased odds of experiencing a neonatal death aOR = 1.95 (95% CI 1.17-3.25) and aOR = 1.66 (95% CI 1.20-2.28) respectively. When we focused on the period of highest risk, the day of delivery and first postnatal day, these aORs increased to 2.36 (95% CI 1.57-3.55) and 2.34 (95% CI 1.19-4.60) respectively. The aORs for the first week of life (early neonatal mortality) were 1.90 (95% CI 1.07-3.36) and 1.83 (95% CI 1.30-2.59) respectively. Conclusions Short stature is associated with an increased prevalence of caesarean section and neonatal mortality, particularly on the newborn's first days. These results are even more striking because we know that caesarean section rates tend to be higher among wealthier and more educated women, who are often taller and that the same patterns may hold for neonatal survival; in such cases, adjusting for wealth, education and urban residence would attenuate these associations. Caesarean sections can be lifesaving operations; however, they cost the health system and families more, and are associated with worse health outcomes. We suggest that our findings be used to argue for policies targeting stunting in infant girls and potential catch-up growth in adolescence and early adulthood, aiming to increase their adult height and thus decrease their subsequent risk of experiencing caesarean section and adverse birth outcomes.	[Arendt, Esther; Campbell, Oona M. R.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Singh, Neha S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Arendt, E (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	arendtesther@gmail.com		Singh, Neha/0000-0003-0057-121X				Akinola OI, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-217; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Benjamin SJ, 2012, ACTA OBSTET GYNECOL, P91; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; CAMILLERI AP, 1981, EUR J OBSTET GYN R B, V12, P347, DOI 10.1016/0028-2243(81)90080-0; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, P91; Chalumeau M, 2002, INT J EPIDEMIOL, V31, P661, DOI 10.1093/ije/31.3.661; Christian P, 2013, INT J EPIDEMIOL; Crenshaw JT, 2014, J PERINAT EDUC, V23, P211, DOI 10.1891/1058-1243.23.4.211; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Derraik JGB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154304; Enwerem NY, 2014, AFR J REPROD HEALTH, V18, P54; Gebremedhin S, 2014, REPROD HLTH, P11; Gudmundsson S, 2005, BJOG-INT J OBSTET GY, V112, P764, DOI 10.1111/j.1471-0528.2004.00545.x; Harrison MS, 2016, MATERNAL HLTH NEONAT, V2, P1, DOI DOI 10.1186/s40748-016-0033-x; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Marshall N, 2014, AM J OBSTET GYNECOL, V210, pS252, DOI 10.1016/j.ajog.2013.10.541; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; Munabi Ian G, 2015, BMC Res Notes, V8, P54, DOI 10.1186/s13104-015-1013-3; Okewole IA, 2011, J OBSTET GYNAECOL, P31; Ozaltin E, 2010, JAMA-J AM MED ASSOC, P303; Perkins JM, 2016, NUTR REV, V74, P149, DOI 10.1093/nutrit/nuv105; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Program D.a.H.S., DHS FIN REP; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Rey H, 1995, Bull World Health Organ, V73 Suppl, P70; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Sear R, SOCIOECONOMIC ASPECT, P203; Sheinera E, 2005, EUR J OBSTET GYN R B, P120; Stein AD, 2004, PEDIATRICS, V113, pE270, DOI 10.1542/peds.113.3.e270; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Sutan R, 2010, J PERINATOL, V30, P311, DOI 10.1038/jp.2009.158; United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD POP PROSP 2015; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192167	10.1371/journal.pone.0192167	http://dx.doi.org/10.1371/journal.pone.0192167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408912	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000424302800047
J	Ronque, ERV; Werneck, AO; Bueno, MRO; Cyrino, ES; Stanganelli, LCR; Arruda, M				Ronque, Enio R. V.; Werneck, Andre O.; Bueno, Maria R. O.; Cyrino, Edilson S.; Stanganelli, Luiz C. R.; Arruda, Miguel			Tracking of body adiposity indicators from childhood to adolescence: Mediation by BMI	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; YOUNG ADULTHOOD; CARDIORESPIRATORY FITNESS; MASS INDEX; OBESITY; CHILDREN; FATNESS; ASSOCIATIONS; WEIGHT	Our aim was to verify the tracking of body adiposity indicators from childhood to adolescence and analyze the mediation effects of BMI on the stability of body adiposity. Our sample was composed by 375 children (197 boys). The children were followed-up over 3 years. Body mass and stature were measured as anthropometric indicators. Body adiposity was estimated through the subcutaneous skinfold method, with measures of triceps (TRSF) and subscapular skinfolds (SSSF). Skinfolds were analyzed singly and agglutinated through the sum of skinfolds (Sigma SF). The sample was categorized into tertiles, and thereafter, the kappa coefficient and McNemar test were adopted to verify stability. For continuous measures, the Intra-Class Correlation coefficient (ICC) was used. Moreover, mediation analyzes were used according to Baron and Kenny with the Sobel test to verify mediation effects. The significance level adopted was 5%. Adiposity indicators increased during the 3 years of follow-up in both sexes (p<0.05). ICCs in all indicators of adiposity were between 0.84 and 0.94 for boys and 0.86 and 0.94 for girls, indicating high tracking. Moreover, 70% of subjects remained in the highest tertile of body adiposity. However, no differences were observed in tertile changes (p>0.05). BMI at the age of adiposity rebound partially mediated all indicators of adiposity from childhood (baseline) to adolescence (3 years later) in both sexes (p<0.001). Thus, moderate to high tracking of body adiposity indicators between childhood and adolescence was verified. Moreover, BMI at the age of adiposity rebound partially mediated the relationship between adiposity in childhood (baseline) and in adolescence (3 years of follow-up).	[Ronque, Enio R. V.; Werneck, Andre O.; Bueno, Maria R. O.; Cyrino, Edilson S.; Arruda, Miguel] State Univ Londrina UEL, Study & Res Grp Phys Activ & Exercise GEPAFE, Londrina, Brazil; [Ronque, Enio R. V.; Werneck, Andre O.; Cyrino, Edilson S.] State Univ Londrina UEL, Study & Res Grp Metab Nutr & Exercise GEPEMENE, Londrina, Brazil; [Stanganelli, Luiz C. R.] Univ Estadual Londrina, Ctr Phys Educ & Sport, Londrina, Brazil; [Arruda, Miguel] Univ Estadual Campinas, Fac Phys Educ, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Campinas	Ronque, ERV (corresponding author), State Univ Londrina UEL, Study & Res Grp Phys Activ & Exercise GEPAFE, Londrina, Brazil.; Ronque, ERV (corresponding author), State Univ Londrina UEL, Study & Res Grp Metab Nutr & Exercise GEPEMENE, Londrina, Brazil.	enioronque@uel.br	Ronque, Enio Ricardo Vaz/AAP-5530-2020; CYRINO, EDILSON S/GQB-5068-2022; de Oliveira Werneck, André/N-5006-2016; CYRINO, EDILSON S/F-7196-2012	Ronque, Enio Ricardo Vaz/0000-0003-3430-3993; CYRINO, EDILSON S/0000-0001-9016-8779; de Oliveira Werneck, André/0000-0002-9166-4376; CYRINO, EDILSON S/0000-0001-9016-8779				Altman D., 1991, PRACTICAL STUDIES FO; [Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19430; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basterfield L, 2015, J SCI MED SPORT, V18, P178, DOI 10.1016/j.jsams.2014.03.005; Bergmann GG, 2014, J PHYS ACT HEALTH, V11, P375, DOI 10.1123/jpah.2011-0342; Carrel AL, 2009, J PEDIATR ENDOCR MET, V22, P409; Casonatto J, 2016, J CHILD HEALTH CARE, V20, P294, DOI 10.1177/1367493515598645; Cole T J, 2004, BMC Pediatr, V4, P6; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Da Silva SP, 2013, J SPORT SCI, V31, P104, DOI 10.1080/02640414.2012.723817; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Dietz WH, 1997, J NUTR, V127, pS1884, DOI 10.1093/jn/127.9.1884S; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Efrat M, 2013, J PEDIATR ENDOCR MET, V26, P197, DOI 10.1515/jpem-2012-0379; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Freitas D, 2012, ANN HUM BIOL, V39, P59, DOI 10.3109/03014460.2011.638322; Going SB, 2011, AM J PREV MED, V41, pS77, DOI 10.1016/j.amepre.2011.07.006; Harrison GG, 1988, ANTHROPOMETRIC STAND, P55; Hughes AR, 2014, PEDIATRICS, V134, pE1354, DOI 10.1542/peds.2014-1908; Ip EH, 2017, J PEDIATR-US, V184, P151, DOI 10.1016/j.jpeds.2017.01.051; Johnson W, 2014, ARTERIOSCL THROM VAS, V34, P654, DOI 10.1161/ATVBAHA.113.302572; Kristiansen AL, 2014, PUBLIC HEALTH NUTR, V18, P1; Liao Duanping, 2014, Curr Treat Options Cardiovasc Med, V16, P342, DOI 10.1007/s11936-014-0342-1; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Malina RM, 2001, AM J HUM BIOL, V13, P162, DOI 10.1002/1520-6300(200102/03)13:2<162::AID-AJHB1025>3.0.CO;2-T; Malina RM., 2004, GROWTH MATURATION, P300; Matton L, 2006, MED SCI SPORT EXER, V38, P1114, DOI 10.1249/01.mss.0000222840.58767.40; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Remmers T, 2014, MED SCI SPORT EXER, V46, P177, DOI 10.1249/MSS.0b013e3182a36709; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Soric M, 2014, ANN HUM BIOL, V41, P238, DOI 10.3109/03014460.2013.851739; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Toselli S, 2013, EAT WEIGHT DISORD-ST, V18, P383, DOI 10.1007/s40519-013-0074-3; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; TWISK JWR, 1994, EPIDEMIOL REV, V16, P165, DOI 10.1093/oxfordjournals.epirev.a036149; Wang YF, 2003, EUR J EPIDEMIOL, V18, P1037, DOI 10.1023/A:1026196310041; Werneck AO, 2016, CHILD OBES, V12, P377, DOI 10.1089/chi.2016.0042; Wheaton N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006963; WHO, 2015, REPORT OF THE COMMIS	43	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191908	10.1371/journal.pone.0191908	http://dx.doi.org/10.1371/journal.pone.0191908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408914	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800029
J	Sun, KF; Ji, FZ; Yan, XY; Jiang, K; Yang, SC				Sun, Kangfeng; Ji, Fenzhu; Yan, Xiaoyu; Jiang, Kai; Yang, Shichun			A particle filter for ammonia coverage ratio and input simultaneous estimations in Diesel-engine SCR system	PLOS ONE			English	Article							STATE-OF-CHARGE; ION BATTERIES; UREA-SCR; REDUCTION; EMISSIONS	As NOx emissions legislation for Diesel-engines is becoming more stringent than ever before, an aftertreatment system has been widely used in many countries. Specifically, to reduce the NOx emissions, a selective catalytic reduction(SCR) system has become one of the most promising techniques for Diesel-engine vehicle applications. In the SCR system, input ammonia concentration and ammonia coverage ratio are regarded as essential states in the control-oriental model. Currently, an ammonia sensor placed before the SCR Can is a good strategy for the input ammonia concentration value. However, physical sensor would increase the SCR system cost and the ammonia coverage ratio information cannot be directly measured by physical sensor. Aiming to tackle this problem, an observer based on particle filter(PF) is investigated to estimate the input ammonia concentration and ammonia coverage ratio. Simulation results through the experimentally-validated full vehicle simulator cX-Emission show that the performance of observer based on PF is outstanding, and the estimation error is very small.	[Sun, Kangfeng; Ji, Fenzhu; Yan, Xiaoyu; Jiang, Kai; Yang, Shichun] Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China	Beihang University	Yang, SC (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China.	yangshichun@buaa.edu.cn	JIANG, KAI/AAT-7171-2021	JIANG, KAI/0000-0001-9006-0514; yang, shichun/0000-0003-3426-7988	National Natural Science Foundation of China [51576011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, (http://www.nsfc.gov.co), grant number: 51576011 to SCY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J DYNAMIC SYSTEMS ME; [Anonymous], 2005, SAE TECHNICAL PAPER, DOI DOI 10.4271/2005-01-0966; Arnett M, 2008, CLEANER DIESEL USING; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Bidarvatan M, 2013, J ENG GAS TURB POWER, V136; Cao EM, 2016, NEUROCOMPUTING, V205, P329, DOI 10.1016/j.neucom.2016.03.065; Chen P, 2013, AM CONTR C; Devarakonda M, 2008, SAE WORLD C EXH; Dong HC, 2014, J POWER SOURCES, V271, P114, DOI 10.1016/j.jpowsour.2014.07.176; Gyorgy K, 2014, PROC TECH, V12, P65, DOI 10.1016/j.protcy.2013.12.457; Hsieh MF, 2012, J DYN SYST-T ASME, V134, DOI 10.1115/1.4005372; Hsieh MF, 2011, J DYN SYST-T ASME, V133, DOI 10.1115/1.4003380; Hsieh MF, 2011, IEEE T CONTR SYST T, V19, P1504, DOI 10.1109/TCST.2010.2098477; Jiang K, 2016, FUEL, V165, P185, DOI 10.1016/j.fuel.2015.10.019; Jiang K, 2016, NEUROCOMPUTING, V171, P569, DOI 10.1016/j.neucom.2015.06.072; Johnson TV, 2009, INT J ENGINE RES, V10, P275, DOI 10.1243/14680874JER04009; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Koebel M, 2000, CATAL TODAY, V59, P335, DOI 10.1016/S0920-5861(00)00299-6; Luenberger DG, 2007, MILITARY ELECT IEEE, V8, P74; Mallick M, 2003, INF FUS 2003 P 6 INT; Meisami-Azad M, 2012, INT J CONTROL, V85, P114, DOI 10.1080/00207179.2011.639090; Ming FH, 2010, AM CONTR C; Pournazeri M, 2017, MECHATRONICS, V46, P1, DOI 10.1016/j.mechatronics.2017.06.010; Shah S.L., 2010, IFAC P, V43, P159; Shao S, 2014, TRANSPORT RES D-TR E, V32, P207, DOI 10.1016/j.trd.2014.07.013; Song Q., 2002, ELECT CONTROL SYSTEM; Tronconi E, 1996, CHEM ENG SCI, V51, P2965, DOI 10.1016/0009-2509(96)00182-0; Tulsyan A, 2016, J POWER SOURCES, V331, P208, DOI 10.1016/j.jpowsour.2016.08.113; Upadhyay D, 2006, J DYN SYST-T ASME, V128, P737, DOI 10.1115/1.2234494; Wang J., 2010, CONTROL DIESEL ENGIN; Wang JM, 2008, IEEE T CONTR SYST T, V16, P1138, DOI 10.1109/TCST.2008.917227; Wang Y., 2015, CHINESE U TECHNOLOGY, V2015, P4, DOI DOI 10.1016/J.EXPNEUR0L.2015.04.009; Wang Y., 2015, APPL ENERG, V185, P2026; Willems F., 2007, IS CLOSED LOOP SCR C; Won SHP, 2010, IEEE T IND ELECTRON, V57, P1787, DOI 10.1109/TIE.2009.2032431; Yim SD, 2004, IND ENG CHEM RES, V43, P4856, DOI 10.1021/ie034052j; Zhang H, 2015, IEEE-ASME T MECH, V20, P2222, DOI 10.1109/TMECH.2014.2370043; Zhang H, 2015, IEEE-ASME T MECH, V20, P1585, DOI 10.1109/TMECH.2014.2355039; Zhang H, 2015, J FRANKLIN I, V352, P708, DOI 10.1016/j.jfranklin.2014.06.009; Zhang H, 2015, FUEL, V141, P200, DOI 10.1016/j.fuel.2014.10.051	40	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192217	10.1371/journal.pone.0192217	http://dx.doi.org/10.1371/journal.pone.0192217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408924	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800049
J	Terato, K; Waritani, T; Fukai, R; Shionoya, H; Itoh, H; Katayama, K				Terato, Kuniaki; Waritani, Takaki; Fukai, Richio; Shionoya, Hiroshi; Itoh, Hiroshi; Katayama, Kou			Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY COMPLEX; RAPID RADIOGRAPHIC PROGRESSION; CELL-WALL POLYMERS; PORPHYROMONAS-GINGIVALIS; AUTOIMMUNE ARTHRITIS; II COLLAGEN; ARTHROPATHIC PROPERTIES; SYSTEMIC INJECTION	Commensal bacteria and their pathogenic components in the gastrointestinal tract and oral cavity may play pathological roles in autoimmune diseases. To study the possible involvement of bacterial pathogens in autoimmune diseases, IgG and IgA antibodies against pathogenic components produced by three strains of commensal bacteria, Escherichia coli-lipopolysaccharide (E. coli-LPS), Porphyromonas gingivalis-LPS (Pg-LPS) and peptidoglycan polysaccharide (PG-PS) from Streptococcus pyogenes, were determined by an improved ELISA system for sera from two groups of patients with rheumatoid arthritis (RA), who met rapid radiographic progression (RRP) criteria and non-RRP, and compared to normal (NL) controls. Antibody responses to these bacterial pathogens are unique and consistent in individuals, and no fundamental difference was observed between RA and NL controls. Despite the similar antibody responses to pathogens, lower IgG or higher IgA and consequent higher IgA/IgG antibody ratio among the patients with RA related to disease marker levels and disease activity. Peculiarly, the IgA/IgG anti-Pg-LPS antibody ratio resulted from lower IgG and higher IgA antibody responses to Pg-LPS strongly correlated not only with rheumatoid factor (RF), but also correlated with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and disease activity score of 28 joints with ESR (DAS28-ESR) in the RRP group. In contrast, the IgA/IgG anti-E. coli-LPS and anti-PG-PS antibody ratio correlated or tended to correlate with RF, ESR, CRP, and DAS28-ESR in the non-RRP group, whereas either the IgG or IgA anti-Pg-LPS antibody levels and consequent IgA/IgG anti-Pg-LPS antibody ratio did not correlate with any clinical marker levels in this group. Notably, anti-circular-citrullinated peptide (CCP) antibody levels, which did not correlate with either IgG or IgA antibody levels to any pathogens, did not correlate with severity of arthritis in both RRP and non-RRP. Taken together, we propose that multiple environmental pathogens, which overwhelm the host antibody defense function, contribute independently or concomitantly to evoking disease makers and aggravating disease activity, and affect disease outcomes.	[Terato, Kuniaki; Waritani, Takaki] Chondrex Inc, Dept Res & Dev, Redmond, WA 98052 USA; [Fukai, Richio] Fukai Pharm, Asahikawa, Hokkaido, Japan; [Shionoya, Hiroshi] Asama Chem Inc, Res Lab, Chiyoda Ku, Sect 5, Tokyo, Japan; [Itoh, Hiroshi] Asahikawa Med Univ, Dept Orthoped Surg, Asahikawa, Hokkaido, Japan; [Katayama, Kou] Katayama Orthoped Rheumatol Clin, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Terato, K (corresponding author), Chondrex Inc, Dept Res & Dev, Redmond, WA 98052 USA.	terato@chondrex.com		Terato, Kuniaki/0000-0001-8259-1729	Chondrex Inc.; Asama Chemicals; Fukai Pharmacy; Katayama Orthopedic Rheumatology Clinic; Asahikawa Medical University	Chondrex Inc.; Asama Chemicals; Fukai Pharmacy; Katayama Orthopedic Rheumatology Clinic; Asahikawa Medical University	The authors received no specific funding for this work. KT and TW declare that they received salary support from Chondrex Inc., and HS from Asama Chemicals, respectively. RF and KK declare that they were supported by Fukai Pharmacy and Katayama Orthopedic Rheumatology Clinic, respectively. HI declares that he received salary from Asahikawa Medical University. The organizations provided support in the form of salaries for the authors (KT, TW, HS, RF, KK and HI) but did not play any roles in this study design, data collection and analysis, decision to publish or preparation of manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoki S, 1996, ANN RHEUM DIS, V55, P363, DOI 10.1136/ard.55.6.363; Arabski M, 2012, CLIN BIOCHEM, V45, P1374, DOI 10.1016/j.clinbiochem.2012.06.021; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139693; Chukkapalli S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1056-4; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; COLE BC, 1993, ARTHRITIS RHEUM-US, V36, P994, DOI 10.1002/art.1780360717; COULIE PG, 1985, J EXP MED, V161, P88, DOI 10.1084/jem.161.1.88; CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585; de Pablo P, 2008, J RHEUMATOL, V35, P70; DEVRIES DD, 1992, ANN RHEUM DIS, V51, P783, DOI 10.1136/ard.51.6.783; Edwards CJ, 2008, J RHEUMATOL, V35, P1477; FOX A, 1982, INFECT IMMUN, V35, P1003, DOI 10.1128/IAI.35.3.1003-1010.1982; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; FUJII K, 1989, J IMMUNOL METHODS, V124, P63; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Granger B, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000245; Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674; Hetland ML, 2009, ANN RHEUM DIS, V68, P384, DOI 10.1136/ard.2008.088245; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Kang Y, 2016, Z RHEUMATOL; Katayama K, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-2; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kjeldsen-Kragh J, 1999, AM J CLIN NUTR, V70, p594S, DOI 10.1093/ajcn/70.3.594s; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Konig MF, 2015, ANN RHEUM DIS, V74, P2054, DOI 10.1136/annrheumdis-2014-205385; Li MC, 2009, CURR MOL MED, V9, P365, DOI 10.2174/156652409787847137; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Mathis D, 2011, CELL HOST MICROBE, V10, P297, DOI 10.1016/j.chom.2011.09.007; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Midwood KS, 2009, CURR DRUG TARGETS, V10, P1139, DOI 10.2174/138945009789735101; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P3522, DOI 10.1002/art.34595; Mikuls TR, 2009, INT IMMUNOPHARMACOL, V9, P38, DOI 10.1016/j.intimp.2008.09.008; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Nakashima Y, 2016, J RHEUMATOL, V43, P1278, DOI 10.3899/jrheum.150988; Okada M, 2011, J PERIODONTOL, V82, P1433, DOI 10.1902/jop.2011.110020; Ostergaard M, 2005, ANN RHEUM DIS, V64, P3, DOI 10.1136/ard.2004.031773; Peltonen R, 1997, BRIT J RHEUMATOL, V36, P64; Peltonen R, 1994, BR J RHEUMATOL, V33, P56; Rashid T, 2004, CLIN RHEUMATOL, V23, P134, DOI 10.1007/s10067-003-0847-6; Rashid T, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/539282; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Sandal I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1143-6; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SARTOR RB, 1989, BAILLIERE CLIN RHEUM, V3, P223, DOI 10.1016/S0950-3579(89)80019-6; Scheinecker C, 2011, NAT REV RHEUMATOL, V7, P73, DOI 10.1038/nrrheum.2010.226; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schmidt WP, 2004, MED SCI MONITOR, V10, pHY5; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; STIMPSON SA, 1986, INFECT IMMUN, V51, P240, DOI 10.1128/IAI.51.1.240-249.1986; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Terato K, 1996, BRIT J RHEUMATOL, V35, P828; Terato K, 2004, P 11 AS PAC LEAG ASS; Terato K, 2016, VACCINE, V34, P4643, DOI 10.1016/j.vaccine.2016.08.007; Terato K, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/636207; Terato K, 2014, J IMMUNOL METHODS, V407, P15, DOI 10.1016/j.jim.2014.03.013; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Toivanen P, 2003, ANN RHEUM DIS, V62, P807, DOI 10.1136/ard.62.9.807; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Totaro MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4243; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; van den Broek M, 2012, ANN RHEUM DIS, V71, P1530, DOI 10.1136/annrheumdis-2011-201212; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Waritani T, 2017, METHODSX, V4, P153, DOI 10.1016/j.mex.2017.03.002; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; WELLS AF, 1989, INFECT IMMUN, V57, P351, DOI 10.1128/IAI.57.2.351-358.1989; WILSON C, 1995, ANN RHEUM DIS, V54, P216, DOI 10.1136/ard.54.3.216; WOOLEY PH, 1995, ANN RHEUM DIS, V54, P298, DOI 10.1136/ard.54.4.298; Wu XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030431; Yoshida A, 2001, J DENT RES, V80, P346, DOI 10.1177/00220345010800010901; Yoshino S, 1999, J IMMUNOL, V163, P3417	82	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190588	10.1371/journal.pone.0190588	http://dx.doi.org/10.1371/journal.pone.0190588			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408886	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800008
J	Busse, A; Antiqueira, PAP; Neutzling, AS; Wolf, AM; Romero, GQ; Petermann, JS				Busse, Annika; Antiqueira, Pablo A. P.; Neutzling, Alexandre S.; Wolf, Anna M.; Romero, Gustavo Q.; Petermann, Jana S.			Different in the dark: The effect of habitat characteristics on community composition and beta diversity in bromeliad microfauna	PLOS ONE			English	Article							STOCHASTIC-PROCESSES; NESTEDNESS ANALYSIS; PASSIVE DISPERSAL; SPECIES-DIVERSITY; TROPICAL FOREST; CONSERVATION; DRIVERS; MICROORGANISMS; HETEROGENEITY; SCALE	The mechanisms which structure communities have been the focus of a large body of research. Here, we address the question if habitat characteristics describing habitat quality may drive changes in community composition and beta diversity of bromeliad-inhabiting microfauna. In our system, changes in canopy cover along an environmental gradient may affect resource availability, disturbance in form of daily water temperature fluctuations and predation, and thus may lead to changes in community structure of bromeliad microfauna through differences in habitat quality along this gradient. Indeed, we observed distinct changes in microfauna community composition along the environmental gradient explained by changes in the extent of daily water temperature fluctuations. We found beta diversity to be higher under low habitat quality (low canopy cover) than under high habitat quality (high canopy cover), which could potentially be explained by a higher relative importance of stochastic processes under low habitat quality. We also partitioned beta diversity into turnover and nestedness components and we found a nested pattern of beta diversity along the environmental gradient, with communities from the lower-quality habitat being nested subsets of communities from the higher-quality habitat. However, this pattern resulted from an increase in microfauna alpha diversity with an increase in habitat quality. By providing insights into microfauna-environment relationships our results contribute to the mechanistic understanding of community dynamics in small freshwater bodies. Here, we highlight the importance of habitat characteristics representing habitat quality in structuring communities, and suggest that this information may help to improve conservation practices of small freshwater ecosystems.	[Busse, Annika; Petermann, Jana S.] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Busse, Annika; Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Antiqueira, Pablo A. P.; Neutzling, Alexandre S.] Univ Campinas UNICAMP, Inst Biol, Grad Program Ecol, Campinas, SP, Brazil; [Antiqueira, Pablo A. P.; Romero, Gustavo Q.] Univ Campinas UNICAMP, Inst Biol, Dept Anim Biol, Multitroph Interact & Biodivers Lab, Campinas, SP, Brazil; [Wolf, Anna M.] Free Univ Berlin, Inst Biol, Berlin, Germany	Salzburg University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Free University of Berlin	Busse, A; Petermann, JS (corresponding author), Univ Salzburg, Dept Biosci, Salzburg, Austria.; Busse, A; Petermann, JS (corresponding author), Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany.	annika.busse@sbg.ac.at; jana.petermann@sbg.ac.at	Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013; Busse, Annika/AFM-6382-2022	Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Busse, Annika/0000-0001-5948-2698	Deutsche Forschungsgemeinschaft (DFG); DAAD PROMOS; Sao Paulo Research Foundation (FAPESP); CNPq-Brazil; FAPESP [2014/04603-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DAAD PROMOS; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided for AB through a grant to JSP by the Deutsche Forschungsgemeinschaft (DFG) and for AMW by DAAD PROMOS. Field work was supported by a research grant from Sao Paulo Research Foundation (FAPESP), coordinated by GQR. GQR received a CNPq-Brazil grant of productivity in research. During the study, PAPA received a PhD scholarship from the FAPESP (Proc. No 2014/04603-4). The authors also acknowledge the Open Access Publication Fund of the University of Salzburg to Annika Busse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami SA, 2013, FRESHWATER BIOL, V58, P1126, DOI 10.1111/fwb.12113; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 1995, GLOBAL BIODIVERSITY; Arellano Lucrecia, 2003, Acta Zool. Mex, P27; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; BICCAMARQUES JC, 1992, FOLIA PRIMATOL, V58, P107, DOI 10.1159/000156616; Blaustein L, 2001, ISR J ZOOL, V47, P303, DOI 10.1560/CKMU-Q2PM-HTGC-P9C8; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Brendonck L, 2015, OIKOS, V124, P741, DOI 10.1111/oik.01710; Cestari C, 2008, ORNITOL NEOTROP, V19, P97; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Cotterill FPD, 2008, BIODIVERS CONSERV, V17, P427, DOI 10.1007/s10531-007-9261-8; COWELL BC, 1987, FLA ENTOMOL, V70, P1, DOI 10.2307/3495085; De Omena P. M., 2014, THESIS; Dormann C.F., 2008, INTERACTIONS, V8, P8; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunthorn M, 2012, SYST BIODIVERS, V10, P195, DOI 10.1080/14772000.2012.685195; Esteban GF, 2010, NATURE, V463, P293, DOI 10.1038/463293c; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Farjalla VF, 2016, ECOLOGY, V97, P2147, DOI 10.1002/ecy.1432; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Fernandez-Juricic E, 2002, OECOLOGIA, V131, P269, DOI 10.1007/s00442-002-0883-y; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Foissner W, 2003, EUR J PROTISTOL, V39, P365, DOI 10.1078/0932-4739-00005; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; FRYER G, 1980, FRESHWATER BIOL, V10, P41, DOI 10.1111/j.1365-2427.1980.tb01178.x; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hanazato T, 1998, ENVIRON POLLUT, V101, P361, DOI 10.1016/S0269-7491(98)00053-0; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Horvath Z, 2016, ECOGRAPHY, V39, P726, DOI 10.1111/ecog.01685; Hylander K, 2005, OIKOS, V108, P351, DOI 10.1111/j.0030-1299.2005.13400.x; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Jacobsen D, 2012, GLOBAL ECOL BIOGEOGR, V21, P647, DOI 10.1111/j.1466-8238.2011.00699.x; Jiang L, 2007, J ANIM ECOL, V76, P660, DOI 10.1111/j.1365-2656.2007.01252.x; Johnston NK, 2016, J ANIM ECOL, V85, P1161, DOI 10.1111/1365-2656.12551; Kalinkat G, 2017, CONSERV BIOL, V31, P481, DOI 10.1111/cobi.12813; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kratina P, 2017, ECOL EVOL, V7, P1627, DOI 10.1002/ece3.2797; LAESSLE AM, 1961, ECOLOGY, V42, P499, DOI 10.2307/1932236; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lopez LCS, 1999, BIOTROPICA, V31, P705, DOI 10.1111/j.1744-7429.1999.tb00421.x; Lopez Luiz Carlos Serramo, 2001, Selbyana, V22, P219; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Manoel MC, 2012, REV GEONORTE; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; Marks CO, 2016, ECOL LETT, V19, P743, DOI 10.1111/ele.12608; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mestre LAM, 2001, BRAZ ARCH BIOL TECHN, V44, P89, DOI 10.1590/S1516-89132001000100012; Minchin P.R., 2015, R PACKAGE VERSION, V2, P1; Montagnes DJS, 2000, AQUAT MICROB ECOL, V21, P97, DOI 10.3354/ame021097; NADKARNI NM, 1989, CONDOR, V91, P891, DOI 10.2307/1368074; NAEEM S, 1990, OECOLOGIA, V84, P29, DOI 10.1007/BF00665591; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peckarsky B.L., 1983, P303; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petermann JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118952; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2009, R LANG ENV STAT COMP; Rangel JV, 2016, J LIMNOL; REVILL DL, 1967, ECOLOGY, V48, P1023, DOI 10.2307/1934558; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rogerson A, 1999, ATMOS RES, V51, P35, DOI 10.1016/S0169-8095(98)00109-4; Pessenda LCR, 2012, PALAEOGEOGR PALAEOCL, V363, P57, DOI 10.1016/j.palaeo.2012.08.014; Sanders Robert W., 1993, Marine Microbial Food Webs, V7, P197; SCHLICHTING HE, 1969, J ECOL, V57, P759, DOI 10.2307/2258497; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segre H, 2014, ECOL LETT, V17, P1400, DOI 10.1111/ele.12343; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Staddon WJ, 1998, BIODIVERS CONSERV, V7, P1081, DOI 10.1023/A:1008813232395; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tonkin JD, 2016, OIKOS, V125, P686, DOI 10.1111/oik.02717; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Ulrich Werner, 2009, Ecological Questions, V11, P27, DOI 10.2478/v10090-009-0015-y; Vanschoenwinkel B, 2011, FRESHWATER BIOL, V56, P1606, DOI 10.1111/j.1365-2427.2011.02600.x; Wang XG, 2016, ECOL RES, V31, P57, DOI 10.1007/s11284-015-1313-z; Weisse T, 2013, J EUKARYOT MICROBIOL, V60, P578, DOI 10.1111/jeu.12063; Weisse T, 2013, EUR J PROTISTOL, V49, P406, DOI 10.1016/j.ejop.2013.02.001; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams D. D., 1987, ECOLOGY TEMPORARY WA; Williams DD., 2006, BIOL TEMPORARY WATER; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	100	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191426	10.1371/journal.pone.0191426	http://dx.doi.org/10.1371/journal.pone.0191426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401522	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400013
J	Li, KL; Vorkas, CK; Chaudhry, A; Bell, DL; Willis, RA; Rudensky, A; Altman, JD; Glickman, MS; Aube, J				Li, Kelin; Vorkas, Charles K.; Chaudhry, Ashutosh; Bell, Donielle L.; Willis, Richard A.; Rudensky, Alexander; Altman, John D.; Glickman, Michael S.; Aube, Jeffrey			Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU)	PLOS ONE			English	Article							INVARIANT T-CELLS; GROUP B GALACTOSYLTRANSFERASE; MAIT CELLS; RIBOFLAVIN SYNTHASE; RECEPTOR HETEROGENEITY; IMMUNE-RESPONSE; BIOSYNTHESIS; TUBERCULOSIS; SUBSTRATE; ENZYME	Mucosal-associated invariant T (MAIT) cells are an abundant class of innate T cells restricted by the MHC I-related molecule MR1. MAIT cells can recognize bacterially-derived metabolic intermediates from the riboflavin pathway presented by MR1 and are postulated to play a role in innate antibacterial immunity through production of cytokines and direct bacterial killing. MR1 tetramers, typically stabilized by the adduct of 5-amino-6-D-ribitylaminouracil (5-A-RU) and methylglyoxal (MeG), are important tools for the study of MAIT cells. A long-standing problem with 5-A-RU is that it is unstable upon storage. Herein we report an efficient synthetic approach to the HCl salt of this ligand, which has improved stability during storage. We also show that synthetic 5-A-RU center dot HCl produced by this method may be used in protocols for the stimulation of human MAIT cells and production of both human and mouse MR1 tetramers for MAIT cell identification.	[Li, Kelin; Aube, Jeffrey] Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Vorkas, Charles K.; Glickman, Michael S.] Weill Cornell Med, Div Infect Dis, New York, NY USA; [Vorkas, Charles K.; Chaudhry, Ashutosh; Rudensky, Alexander; Glickman, Michael S.] Sloan Kettering Inst, Immunol Program, New York, NY USA; [Bell, Donielle L.; Altman, John D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Willis, Richard A.; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, 1275 York Ave, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Memorial Sloan Kettering Cancer Center; Emory University; Memorial Sloan Kettering Cancer Center	Aube, J (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.	jaube@unc.edu	Ehrmann, Mass Spectrometry Core/GLQ-5891-2022; Vorkas, Charles/HII-6376-2022	Ehrmann, Mass Spectrometry Core/0000-0002-6741-7914; Aube, Jeffrey/0000-0003-1049-5767; WILLIS, RICHARD/0000-0001-6890-1268; Li, Kelin/0000-0002-8630-2928	National Institute of Allergy and Infectious Disease [U19 AI11143, U19 AI111211]; HHSN [272201300006C, T32AI007613-18]; National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007613, U19AI111143, U19AI111211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HHSN; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support from the National Institute of Allergy and Infectious Disease (niaid.nih.gov) is gratefully acknowledged: U19 AI11143, Carl Nathan, PI (supported work by KL, CKV, MSG, and JA); U19 AI111211, Henry M. Blumberg, PI (supported work by DLB, RAW, JDA); HHSN 272201300006C (supported work by DLB, RAW, JDA); and T32AI007613-18, Roy M. Gulick, PI (supported CKV). In addition support from the National Cancer Institute (nci.nih.gov) is acknowledged, through P30 CA008748 (supported AC and AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASSAN SS, 1980, J CHEM SOC PERK T 1, P2645, DOI 10.1039/p19800002645; Altman JD, 2001, CURRENT PROTOCOLS IM; Bacher A, 2001, VITAM HORM, V61, P1; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; CRESSWELL RM, 1960, J CHEM SOC, P4768, DOI 10.1039/jr9600004768; Cushman M, 2001, J ORG CHEM, V66, P8320, DOI 10.1021/jo010706r; CUSHMAN M, 1991, J ORG CHEM, V56, P4603, DOI 10.1021/jo00015a009; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Edholm ES, 2014, CELL MOL LIFE SCI, V71, P4763, DOI 10.1007/s00018-014-1701-5; Gallegos AM, 2016, NAT IMMUNOL, V17, P379, DOI 10.1038/ni.3386; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gold MC, 2015, IMMUNOL REV, V264, P154, DOI 10.1111/imr.12271; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Jiang J, 2016, J INFECTION, V72, P338, DOI 10.1016/j.jinf.2015.11.010; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; KATAGIRI H, 1959, J Vitaminol (Kyoto), V5, P287; Keller AN, 2017, CURR OPIN IMMUNOL, V46, P66, DOI 10.1016/j.coi.2017.04.002; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Kurioka A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01031; Kwon YS, 2015, TUBERCULOSIS, V95, P267, DOI 10.1016/j.tube.2015.03.004; Lamichhane R, 2017, IMMUNOLOGY, V151, P270, DOI 10.1111/imm.12744; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Mak JYW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14599; MALEY GF, 1959, J BIOL CHEM, V234, P641; Masuda T, 1959, B CHEM PHARM SCI, P361; Meermeier EW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12506; Nerdal PT, 2016, J IMMUNOL, V197, P3059, DOI 10.4049/jimmunol.1600913; NIELSEN P, 1988, Z NATURFORSCH B, V43, P1358; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; ROWAN T, 1968, J CHEM SOC C, P452, DOI 10.1039/j39680000452; Schaefer K, 2013, J MED CHEM, V56, P2150, DOI 10.1021/jm300642a; Schaefer K, 2012, CHEMBIOCHEM, V13, P443, DOI 10.1002/cbic.201100642; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sharma PK, 2015, IMMUNOLOGY, V145, P443, DOI 10.1111/imm.12461; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; WEINSTOCK C, 1961, J ORG CHEM, V26, P4456; ZEECHANG KY, 1968, J MED CHEM, V11, P1107, DOI 10.1021/jm00311a063	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191837	10.1371/journal.pone.0191837	http://dx.doi.org/10.1371/journal.pone.0191837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401462	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400023
J	Shrestha, M; Moles, R; Ranjit, E; Chaar, B				Shrestha, Mina; Moles, Rebekah; Ranjit, Eurek; Chaar, Betty			Medicine procurement in hospital pharmacies of Nepal: A qualitative study based on the Basel Statements	PLOS ONE			English	Article							LOW-INCOME; HEALTH; CONSEQUENCES; GUIDELINES; COMMITTEES; SHORTAGES; DRUGS; CARE	Background Accessibility and affordability of evidence-based medicines are issues of global concern. For low-income countries like Nepal, it is crucial to have easy and reliable access to affordable, good-quality, evidence-based medicines, especially in the aftermath of natural or man-made disasters. Availability of affordable and evidence-based high quality medicines depends on the medicine procurement procedure, which makes it an important aspect of healthcare delivery. In this study, we aimed to investigate medicine procurement practices in hospital pharmacies of Nepal within the framework of International Pharmaceutical Federation [FIP] hospital pharmacy guidelines "the Basel Statements". Method We conducted semi-structured interviews with hospital pharmacists or procurement officers in hospital pharmacies of four major regions in Nepal to explore procurement practices. Data were collected until saturation of themes, analysed using the framework approach, and organised around the statements within the procurement theme of the Basel Statements. Results Interviews conducted with 53 participants revealed that the procurement guidelines of the Basel Statements were adopted to a certain extent in hospital pharmacies of Nepal. It was found that the majority of hospital pharmacies in Nepal reported using an expensive direct-procurement model for purchasing medicines. Most had no formulary and procured medicines solely based on doctors' prescriptions, which were heavily influenced by pharmaceutical companies' marketing strategies. Whilst most procured only registered medicines, a minority reported purchasing unregistered medicines through unauthorised supply-chains. And although the majority of hospital pharmacies had some contingency plans for managing medicine shortages, a few had none. Conclusions Procurement guidelines of the Basel Statements were thus found to be partially adopted; however, there is room for improvement in current procurement practices in hospital pharmacies of Nepal. Adoption and regulation of national and international policies is recommended for enhancing medicine accessibility, as well as improving preparedness for health emergencies during natural disasters and health epidemics.	[Shrestha, Mina; Moles, Rebekah; Chaar, Betty] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Shrestha, Mina; Moles, Rebekah; Ranjit, Eurek; Chaar, Betty] World Hosp Pharm Res Consortium WHoPReC, Kathmandu, Bagmati, Nepal; [Ranjit, Eurek] Kathmandu Med Coll, Dept Pharmacol, Kathmandu, Bagmati, Nepal	University of Sydney	Shrestha, M (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.; Shrestha, M (corresponding author), World Hosp Pharm Res Consortium WHoPReC, Kathmandu, Bagmati, Nepal.	shresthamina@gmail.com						American Medical Association, 2015, AMAS COD MED ETH; American Society of Health System Pharmacists International Pharmaceutical Federation, 2009, AM J HLTH SYST PH S3, V66, pS1; [Anonymous], 2009, AM J HEALTH-SYST PH, V66, pS61, DOI 10.2146/ajhp080666; [Anonymous], 2014, MY REPUBLICA; Arney L, 2014, GLOB HEALTH-SCI PRAC, V2, P295, DOI 10.9745/GHSP-D-14-00068; Baghdadi-Sabeti G, 2010, GOOD GOVERNANCE FOR; Baghdadi-Sabeti G., 2009, MEASURING TRANSPAREN; Barraclough A, 2012, MANAGEMENT SCIENCE F; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A., 2011, WORLD MED SITUATION; Condie CK, 2008, AM J HEALTH-SYST PH, V65, P454, DOI 10.2146/ajhp070322; Department of Drug Administration, 2017, GUID SPEC REC MED; Department of Drug Administration, 2007, GUID ETH PROM MED; Dickens T., 2011, WORLD MED SITUATION; Dill S, 2014, EUR J CLIN PHARMACOL, V70, P1405, DOI 10.1007/s00228-014-1747-1; Doloresco F, 2009, AM J HEALTH-SYST PH, V66, pS13, DOI 10.2146/ajhp080674; European Association of Hospital Pharmacists, 2012, WHAT IS HOSPITAL PHA; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Government of Nepal, 2007, NAT MED POL 2007; Government of Nepal, 2014, NAT HLTH POL 2071; Government of Nepal Ministry of Health and Population, 2009, PUBL PROC GUID; Government of Nepal Ministry of Health and Population., 2013, HOSPITAL PHARMACY DI; Government of Nepal Ministry of Health and Population, 2011, NEPAL PHARMACEUTICAL; Hall C, 2012, PATHOG GLOB HEALTH, V106, P73, DOI 10.1179/204777312X13419245939485; Harper I, 2007, DRUG PROCUREMENT NEP; Hatton RC, 2008, PHARMACOTHERAPY, V28, P410, DOI 10.1592/phco.28.3.410; Health Sector Programme Ministry of Health and Population Deutsche Gesellschaft fur Technische Zusammenarbeit., 2009, ESS DRUG PROC SUPPL; Hogerzeil HV, 2006, B WORLD HEALTH ORGAN, V84, P371, DOI 10.2471/BLT.06.031153; Holloway K, 2003, DRUG THERAPEUTIC COM; Hussain Z, 2012, WORKSHOP ON FRAMEWOR; International Council of Nurses International Pharmaceutical Federation World Dental Federation World Medical Association, 2016, BE AWARE HELP FIGHT; Kafle KK, 2010, NEPALESE NATL FORMUL; Levison L., 2003, ESSENT DRUGS MONIT, P31; Lewis J, 2003, QUALITATIVE RES PRAC; Manolakis M, 2012, AM J HEALTH-SYST PH, V69, P17, DOI 10.2146/ajhp110640; Mark SM, 2001, AM J HEALTH-SYST PH, V58, P1445, DOI 10.1093/ajhp/58.15.1445; Mason M., 2010, FORUM QUAL SOC RES, V11; Medical Board of Australia, 2014, COD GOOD SCI PRACT; Medicines Australia, 2015, COD COND; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Milovanovic DR, 2004, EUR J CLIN PHARMACOL, V60, P149, DOI 10.1007/s00228-004-0736-1; Mostert S, 2012, PEDIATR BLOOD CANCER, V58, P325, DOI 10.1002/pbc.23408; Nepal Medical Council, 2016, NMC COD ETH; Nepal Pharmacy Council, 2005, NAT GOOD PHARM PRACT; Nguyen NY, 2013, JAMA INTERN MED, V173, P338, DOI 10.1001/jamainternmed.2013.2522; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Ombaka E, 2009, AM J HEALTH-SYST PH, V66, pS20, DOI 10.2146/ajhp080604; Penm J, 2014, HEALTH POLICY PLANN, V29, P849, DOI 10.1093/heapol/czt067; Penm J, 2013, AM J HEALTH-SYST PH, V70, P967, DOI 10.2146/ajhp120396; QSR International, 2014, NVIVO 10 WIND GETT S; Rankin J, 1999, OPERATIONAL PRINCIPL; Roy Nobhojit, 2007, Indian J Med Ethics, V4, P57; Sanyal D, 2015, THE RISING NEPAL; Seiter A, 2009, CLIN PHARMACOL THER, V85, P576, DOI 10.1038/clpt.2009.47; Smith Joanna, 2011, Nurse Res, V18, P52; Spencer L., 2014, QUALITATIVE RESEACH; Thapa BB, 2007, DRUG B NEPAL, V19, P3; The White House Office of Press Secretary, 2011, FACT SHEET OBAMA ADM; Tordoff JM, 2005, VALUE HEALTH, V8, P201, DOI 10.1111/j.1524-4733.2005.04040.x; Transparency International, 2014, CORR COUNTR TERR; Nguyen TA, 2015, HEALTH POLICY PLANN, V30, P267, DOI 10.1093/heapol/czt105; United Nations Development Programme, 2015, 2014 HUMAN DEVELOPME; United States Pharmacopeia Drug Quality and Information Program, 2007, ENS QUAL MED RES LTD; Vermeulen LC, 2009, AM J HEALTH-SYST PH, V66, pS7, DOI 10.2146/ajhp080690; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; Wertheimer Albert I, 2005, Expert Opin Drug Saf, V4, P619, DOI 10.1517/14740338.4.4.619; Wertheimer AI, 2009, RES SOC ADMIN PHARM, V5, P4, DOI 10.1016/j.sapharm.2008.05.002; WHO, 2007, MOD QUAL ASS SYST PR; WHO Prequalification of Medicines Programme, 2012, WHO DRUG INFORM, V26, P99; World Health Organization, 2014, GOOD GOV MED MOD FRA; World Health Organization, 2014, WHO MOD FORM; World Health Organization, 2016, GUID DEV MEAS COMB C; World Health Organization, 2002, ANTITB OTHER MED PRE; World Health Organization, 2014, NEPAL WHO STATISTICA	75	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191778	10.1371/journal.pone.0191778	http://dx.doi.org/10.1371/journal.pone.0191778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401474	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400019
J	Letizia, E; Barucca, P; Lillo, F				Letizia, Elisa; Barucca, Paolo; Lillo, Fabrizio			Resolution of ranking hierarchies in directed networks	PLOS ONE			English	Article							COMMUNITIES	Identifying hierarchies and rankings of nodes in directed graphs is fundamental in many applications such as social network analysis, biology, economics, and finance. A recently proposed method identifies the hierarchy by finding the ordered partition of nodes which minimises a score function, termed agony. This function penalises the links violating the hierarchy in a way depending on the strength of the violation. To investigate the resolution of ranking hierarchies we introduce an ensemble of random graphs, the Ranked Stochastic Block Model. We find that agony may fail to identify hierarchies when the structure is not strong enough and the size of the classes is small with respect to the whole network. We analytically characterise the resolution threshold and we show that an iterated version of agony can partly overcome this resolution limit.	[Letizia, Elisa] Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Barucca, Paolo] Univ Zurich, Schonberggasse 1, CH-8001 Zurich, Switzerland; [Barucca, Paolo] LIMS, 35a South St, London W1K 2XF, England; [Lillo, Fabrizio] Univ Bologna, Dept Math, Piazza Porta San Donato 5, I-40126 Bologna, Italy	Scuola Normale Superiore di Pisa; University of Zurich; University of Bologna	Letizia, E (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	elisa.letizia@sns.it		Barucca, Paolo/0000-0003-4588-667X; Letizia, Elisa/0000-0002-3134-1137	First Future and Emerging Technologies: Project DOLFINS [640772]; First Future and Emerging Technologies: IP Project MULTIPLEX [317532]; European Community's H2020 Program [654024]	First Future and Emerging Technologies: Project DOLFINS; First Future and Emerging Technologies: IP Project MULTIPLEX; European Community's H2020 Program	EL received no specific funding for this work. PB acknowledges support from First Future and Emerging Technologies: Project DOLFINS nr. 640772 https://ec.europa.eu/programmes/horizon2020/en/news/first-future-and-emerging-technologies-fet-proactive-projects-under-horizon-2020-framework and First Future and Emerging Technologies: IP Project MULTIPLEX nr. 317532 http://cordis.europa.eu/project/rcn/106336_en.html FL acknowledges support by the European Communitys H2020 Program under the scheme INFRAIA-1-2014-2015: Research Infrastructures, grant agreement no. 654024 SoBigData: Social Mining & Big Data Ecosystem. https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-infraia-2014-2015.html#c,topics=callIdentifier/t/H2020-INFRAIA-2014-2015/1/1/1/default-group&callStatus/t/Forthcoming/1/1/0/default-group&callStatus/t/Open/1/1/0/default-group&callStatus/t/Closed/1/1/0/default-group&+identifier/desc The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NETWORKS INTRO; Bickel PJ, 2009, P NATL ACAD SCI USA, V106, P21068, DOI 10.1073/pnas.0907096106; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Clauset A, 2007, LECT NOTES COMPUT SC, V4503, P1; Corominas-Murtra B, 2013, P NATL ACAD SCI USA, V110, P13316, DOI 10.1073/pnas.1300832110; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Cucuringu Mihai, 2016, IEEE Transactions on Network Science and Engineering, V3, P58, DOI 10.1109/TNSE.2016.2523761; EADES P, 1993, INFORM PROCESS LETT, V47, P319, DOI 10.1016/0020-0190(93)90079-O; Fama EF, 2002, REV FINANC STUD, V15, P1, DOI 10.1093/rfs/15.1.1; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frank MZ, 2003, J FINANC ECON, V67, P217, DOI 10.1016/S0304-405X(02)00252-0; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Gupte Mangesh, 2011, P 20 INT C WORLD WID, P557, DOI DOI 10.1145/1963405.1963484; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Nguyen H, 2014, IEEE ICC, P3938, DOI 10.1109/ICC.2014.6883936; Johnson S, 2014, P NATL ACAD SCI USA, V111, P17923, DOI 10.1073/pnas.1409077111; Krackhardt D., 1994, COMPUTATIONAL ORG TH, V89, P123; Kumpula JM, 2007, EUR PHYS J B, V56, P41, DOI 10.1140/epjb/e2007-00088-4; Leskovec J., 2014, SNAP DATASETS STANFO; Maiya Arun S., 2009, 2009 International Conference on Computational Science and Engineering (CSE), P245, DOI 10.1109/CSE.2009.235; Meyer Carl D., 2012, WHOS 1 SCI RATING RA; Mones E, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022817; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Nepusz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081449; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman M.E.J., 2016, COMMUNITY DETECTION; ORLIN JB, 1993, OPER RES, V41, P338, DOI 10.1287/opre.41.2.338; Peixoto TP, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011047; Peixoto TP, 2014, GRAPH TOOL PYTHON LI; Romei A, 2015, DIG IM COMP TECHN AP, P1; Shetty J., 2005, PROCEEDING 3 INT WOR, P74, DOI [10.1145/1134271.1134282, DOI 10.1145/1134271.1134282]; SLATER P, 1961, BIOMETRIKA, V48, P303; Tatti N, 2017, DATA MIN KNOWL DISC, V31, P702, DOI 10.1007/s10618-016-0485-7; Tatti N, 2015, IEEE DATA MINING, P991, DOI 10.1109/ICDM.2015.12; Tibely G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084133; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702	42	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191604	10.1371/journal.pone.0191604	http://dx.doi.org/10.1371/journal.pone.0191604			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394278	gold, Green Published, Green Submitted			2022-12-27	WOS:000424060400015
J	Wu, YH; Chen, YH; Chang, MH; Lin, CH				Wu, Yu-Hsuan; Chen, Yi-Huei; Chang, Ming-Hong; Lin, Ching-Heng			Depression in Parkinson's disease: A case-control study	PLOS ONE			English	Article							NONMOTOR FEATURES; RISK	Background To evaluate the association between Parkinson's disease (PD) prognosis and the patient's onset of depression. Methods A total of 353 patients with newly-diagnosed PD and a history of depression were enrolled. On the basis of the onset of depression before or after PD diagnosis, we divided participants into PD patients with pre- or post-diagnostic depression. Cox's regression analysis was used to detect risks between the onset of depression and outcomes (including death, accidental injury, dementia, and aspiration pneumonia). The association between the onset of depression and levodopa equivalent dosage (LED) and cumulative equivalent dosage of antidepressants were assessed. Results PD patients with post-diagnostic depression were associated with significantly higher risks of dementia (adjusted HR = 2.01, p = 0.015), and were older (58.5 +/- 17.7 vs. 53.7 +/- 18.6, p = 0.020) at the time of PD diagnosis than PD patients with pre-diagnostic depression. The higher incident rate of accidental injury was also noted in PD patients with post-diagnostic depression (48.1 vs. 31.3/1000 person-years, HR = 1.60, p = 0.041), but no statistical significance was observed in the adjusted hazard ratio (HR) (HR = 1.52, p = 0.069). Otherwise, mortality, motor condition and severity of depression revealed no significant difference between PD patients with pre-diagnostic and post-diagnostic depression. Conclusion PD patients with post-diagnostic depression had higher incidence of dementia, implying different onset time of depression could be associated with different subtypes and spreading routes which should be examined in follow-up studies.	[Wu, Yu-Hsuan; Chang, Ming-Hong] Taichung Vet Gen Hosp, Sect Neurol, Taichung, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Sect Neurol, Taichung, Taiwan.; Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.	cmh50@ms10.hinet.net; joelin99@gmail.com		Chang, Ming-Hong/0000-0002-7699-334X				Alzahrani H, 2015, J NEUROL SCI, V356, P32, DOI 10.1016/j.jns.2015.06.037; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; Guo YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107465; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Marras C, 2016, MOVEMENT DISORD, V31, P1095, DOI 10.1002/mds.26510; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Wu YM, 2015, 4TH INTERNATIONAL CONFERENCE ON MECHANICAL AUTOMATION AND MATERIALS ENGINEERING (ICMAME 2015), P6; Wu YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161271	14	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192050	10.1371/journal.pone.0192050	http://dx.doi.org/10.1371/journal.pone.0192050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390032	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400058
J	Yergey, AL; Blank, PS; Cologna, SM; Backlund, PS; Porter, FD; Darling, AJ				Yergey, Alfred L.; Blank, Paul S.; Cologna, Stephanie M.; Backlund, Peter S.; Porter, Forbes D.; Darling, Allan J.			Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 (vol 12, e0175478, 2017)	PLOS ONE			English	Correction																		Yergey AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175478	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192424	10.1371/journal.pone.0192424	http://dx.doi.org/10.1371/journal.pone.0192424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390035	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400091
J	Chen, TK; Cong, Q; Qi, YC; Jin, JF; Choy, KL				Chen, Tingkun; Cong, Qian; Qi, Yingchun; Jin, Jingfu; Choy, Kwang-Leong			Hydrophobic durability characteristics of butterfly wing surface after freezing cycles towards the design of nature inspired antiicing surfaces	PLOS ONE			English	Article							SUPERHYDROPHOBIC SURFACES; FROST FORMATION; ICE-ADHESION; GROWTH-RATE; ROUGHNESS; REPELLENCY; CONVECTION	The hydrophobicity and anti-icing performance of the surfaces of some artificial hydrophobic coatings degraded after several icing and de-icing cycles. In this paper, the frost formation on the surfaces of butterfly wings from ten different species was observed, and the contact angles were measured after 0 to 6 frosting/defrosting cycles. The results show that no obvious changes in contact angle for the butterfly wing specimens were not obvious during the frosting/defrosting process. Further, the conclusion was inferred that the topography of the butterfly wing surface forms a special space structure which has a larger space inside that can accommodate more frozen droplets; this behavior prevents destruction of the structure. The findings of this study may provide a basis and new concepts for the design of novel industrially important surfaces to inhibit frost/ice growth, such as durable anti-icing coatings, which may decrease or prevent the socio-economic loss.	[Chen, Tingkun; Cong, Qian] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China; [Cong, Qian] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Jilin, Peoples R China; [Qi, Yingchun; Jin, Jingfu] Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China; [Choy, Kwang-Leong] UCL, Inst Mat Discovery, London, England	Jilin University; Jilin University; Jilin University; University of London; University College London	Jin, JF (corresponding author), Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China.	jinjingfu@jlu.edu.cn		Choy, Kwang-Leong/0000-0002-5596-4427	National Natural Science Foundation of China [51711530236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (Grant No.51711530236 to QC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol JM, 2016, INT J THERM SCI, V104, P245, DOI 10.1016/j.ijthermalsci.2016.01.017; Bharathidasan T, 2014, APPL SURF SCI, V314, P241, DOI 10.1016/j.apsusc.2014.06.101; Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f; Chou Io, 1999, PRIMARY COLORS OF PI; Chou Io, 1998, CLASSIFICATION AND I; Dorrer C, 2009, SOFT MATTER, V5, P51, DOI 10.1039/b811945g; Farhadi S, 2011, APPL SURF SCI, V257, P6264, DOI 10.1016/j.apsusc.2011.02.057; Farzaneh M, 2011, COLD REG SCI TECHNOL, V65, P1, DOI 10.1016/j.coldregions.2010.08.012; Fossa M, 2010, INT J MULTIPHAS FLOW, V36, P210, DOI 10.1016/j.ijmultiphaseflow.2009.11.002; HAYASHI Y, 1977, J HEAT TRANS-T ASME, V99, P239, DOI 10.1115/1.3450675; Huang LY, 2010, J MECH SCI TECHNOL, V24, P1523, DOI 10.1007/s12206-010-0410-8; Kandula M, 2011, INT J HEAT MASS TRAN, V54, P3719, DOI 10.1016/j.ijheatmasstransfer.2011.02.056; Koch K, 2009, SOFT MATTER, V5, P1386, DOI 10.1039/b818940d; Kulinich SA, 2015, SOFT MATTER, V11, P856, DOI 10.1039/c4sm02204a; Kulinich SA, 2011, LANGMUIR, V27, P25, DOI 10.1021/la104277q; Kulinich SA, 2011, COLD REG SCI TECHNOL, V65, P60, DOI 10.1016/j.coldregions.2010.01.001; Makkonen L, 2012, J ADHES SCI TECHNOL, V26, P413, DOI 10.1163/016942411X574583; Max Kandula, 2011, INT J HEAT MASS TRAN, V54, P3719; Miwa M, 2000, LANGMUIR, V16, P5754, DOI 10.1021/1a991660o; Momen G, 2015, APPL SURF SCI, V349, P211, DOI 10.1016/j.apsusc.2015.04.180; Na B, 2003, INT J HEAT MASS TRAN, V46, P3797, DOI 10.1016/S0017-9310(03)00194-7; Na BC, 2004, INT J HEAT MASS TRAN, V47, P925, DOI 10.1016/j.ijheatmasstransfer.2003.09.001; Rykaczewski K, 2011, ACS NANO, V5, P5962, DOI 10.1021/nn201738n; SEKI N, 1985, WARME STOFFUBERTRAG, V19, P9, DOI 10.1007/BF01682542; Shou JX, 2006, SYSTEMATIC BUTTERFLY; Stavenga DG, 2014, J EXP BIOL, V217, P2171, DOI 10.1242/jeb.098673; Sun G, 2009, J BIONIC ENG, V6, P71, DOI 10.1016/S1672-6529(08)60094-3; Tourkine P, 2009, LANGMUIR, V25, P7214, DOI 10.1021/la900929u; Varanasi Kraipa K., 2009, APPL PHYS LETT, V95; Varanasi KK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524513; Yue XF, 2016, SURF COAT TECH, V307, P278, DOI 10.1016/j.surfcoat.2016.09.004; Zou M, 2011, APPL SURF SCI, V257, P3786, DOI 10.1016/j.apsusc.2010.11.149	32	10	10	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0188775	10.1371/journal.pone.0188775	http://dx.doi.org/10.1371/journal.pone.0188775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385390	Green Submitted, Green Published, gold			2022-12-27	WOS:000423668400005
J	Rout, ED; Burnett, RC; Labadie, JD; Yoshimoto, JA; Avery, AC				Rout, Emily D.; Burnett, Robert C.; Labadie, Julia D.; Yoshimoto, Janna A.; Avery, Anne C.			Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; MUTATIONAL STATUS; IGHV GENE; CANINE; CLASSIFICATION; ORGANIZATION; REARRANGEMENTS; GUIDELINES; DIAGNOSIS; DISEASE	Human chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease, and immunoglobulin heavy variable region (IGHV) gene mutational status is an important prognostic marker. IGHV mutational status has not been previously examined in canine CLL. We sequenced the IGHV-D-J rearrangements from 55 canine patients with CLL, including 36 non-Boxer and 19 Boxer dogs. The majority of non-Boxers (75%) had mutated IGHV genes, whereas the majority of Boxers (79%) had unmutated IGHV genes. IGHV3-41 and IGHV3-67 gene usage was significantly higher in Boxers with CLL compared to non-Boxers. Additionally, 11 Boxers with large B-cell lymphoma and the normal IGHV repertoire of six control dogs (three Boxers and three non-Boxers) were sequenced. IGHV3-41 was preferentially used in Boxers with other forms of lymphoma and without lymphoproliferative disease. However, preferential use of unmutated IGHV genes was unique to Boxers with CLL, suggesting Boxers may be a valuable model to investigate unmutated CLL.	[Rout, Emily D.; Burnett, Robert C.; Labadie, Julia D.; Yoshimoto, Janna A.; Avery, Anne C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Rout, ED (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Emily.Rout@colostate.edu		Rout, Emily/0000-0003-1435-8532				Adam F, 2009, VET COMP ONCOL, V7, P181, DOI 10.1111/j.1476-5829.2009.00189.x; Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; Braganza A, 2011, VET IMMUNOL IMMUNOP, V139, P27, DOI 10.1016/j.vetimm.2010.07.026; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bromberek JL, 2016, J VET INTERN MED, V30, P215, DOI 10.1111/jvim.13814; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Cahill N, 2012, CL LYMPH MYELOM LEUK, V12, P201, DOI 10.1016/j.clml.2012.01.009; Chen HW, 2014, VET IMMUNOL IMMUNOP, V157, P125, DOI 10.1016/j.vetimm.2013.10.020; Comazzi S, 2011, J VET INTERN MED, V25, P100, DOI 10.1111/j.1939-1676.2010.0640.x; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghia P, 2005, BLOOD, V105, P1678, DOI 10.1182/blood-2004-07-2606; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2016, LANCET ONCOL, V17, P779, DOI 10.1016/S1470-2045(16)30029-8; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Martin J, 2017, IMMUNOGENETICS; Nabhan C, 2014, JAMA-J AM MED ASSOC, V312, P2265, DOI 10.1001/jama.2014.14553; Rai KR, 2016, AM J HEMATOL, V91, P330, DOI 10.1002/ajh.24282; Rao S, 2011, J VET INTERN MED, V25, P1097, DOI 10.1111/j.1939-1676.2011.0767.x; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rosenquist R, 2017, LEUKEMIA, V31, P1477, DOI 10.1038/leu.2017.125; Rout ED, 2017, VET CLIN PATH, V46, P77, DOI 10.1111/vcp.12463; Seelig DM, 2014, J VET INTERN MED, V28, P878, DOI 10.1111/jvim.12343; Stanganelli C, 2013, CL LYMPH MYELOM LEUK, V13, P447, DOI 10.1016/j.clml.2013.02.019; Steiniger SCJ, 2014, MOL IMMUNOL, V59, P71, DOI 10.1016/j.molimm.2014.01.010; Sutton LA, 2017, HAEMATOLOGICA, V102, P968, DOI 10.3324/haematol.2017.165605; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tasca S, 2009, VET CLIN PATH, V38, P2, DOI 10.1111/j.1939-165X.2008.00099.x; Tobin G, 2005, HAEMATOLOGICA, V90, P465; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Valli VE, 2006, VET PATHOL, V43, P241, DOI 10.1354/vp.43-3-241; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vezzali E, 2010, VET COMP ONCOL, V8, P38, DOI 10.1111/j.1476-5829.2009.00201.x; Williams MJ, 2008, J VET INTERN MED, V22, P596, DOI 10.1111/j.1939-1676.2008.0041.x; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191205	10.1371/journal.pone.0191205	http://dx.doi.org/10.1371/journal.pone.0191205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385200	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400037
J	Schaefer, C; Mallela, N; Seggewiss, J; Lechtape, B; Omran, H; Dirksen, U; Korsching, E; Potratz, J				Schaefer, Christiane; Mallela, Nikhil; Seggewiss, Jochen; Lechtape, Birgit; Omran, Heymut; Dirksen, Uta; Korsching, Eberhard; Potratz, Jenny			Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm	PLOS ONE			English	Article							RNAI SCREEN; GENE; IDENTIFICATION; SENSITIVITY; SARCOMA; CELLS; TUMOR	In the search for novel therapeutic targets, RNA interference screening has become a valuable tool. High-throughput technologies are now broadly accessible but their assay development from baseline remains resource-intensive and challenging. Focusing on this assay development process, we here describe a target discovery screen using pooled shRNA libraries and next-generation sequencing (NGS) deconvolution in a cell line model of Ewing sarcoma. In a strategy designed for comparative and synthetic lethal studies, we screened for targets specific to the A673 Ewing sarcoma cell line. Methods, results and pitfalls are described for the entire multi-step screening procedure, from lentiviral shRNA delivery to bioinformatics analysis, illustrating a complete model workflow. We demonstrate that successful studies are feasible from the first assay performance and independent of specialized screening units. Furthermore, we show that a resource-saving screen depth of 100-fold average shRNA representation can suffice to generate reproducible target hits despite heterogeneity in the derived datasets. Because statistical analysis methods are debatable for such datasets, we created ProFED, an analysis package designed to facilitate descriptive data analysis and hit calling using an aim-oriented profile filtering approach. In its versatile design, this open-source online tool provides fast and easy analysis of shRNA and other count-based datasets to complement other analytical algorithms.	[Schaefer, Christiane; Lechtape, Birgit; Potratz, Jenny] Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany; [Mallela, Nikhil; Korsching, Eberhard] Westfal Wilhelms Univ Munster, Inst Bioinformat, Munster, Germany; [Seggewiss, Jochen] Univ Hosp Munster, Inst Human Genet, Munster, Germany; [Omran, Heymut; Potratz, Jenny] Univ Hosp Munster, Gen Pediat, Munster, Germany; [Schaefer, Christiane; Dirksen, Uta] Univ Hosp Essen, German Canc Consortium DKTK Ctr Essen, West German Canc Ctr, Dept Hematol & Oncol,Pediat 3, Essen, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Duisburg Essen	Potratz, J (corresponding author), Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany.; Potratz, J (corresponding author), Univ Hosp Munster, Gen Pediat, Munster, Germany.	jenny.potratz@ukmuenster.de	Dirksen, Uta/AGX-8472-2022	Omran, Heymut/0000-0003-0282-6765	Bundesministerium fur Bildung und Forschung [01GM0869]; ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program [01KT1310]; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program [EU-FP7 602856]; Deutsche Krebshilfe (German Cancer Aid) [DKH-108128]; Medical Faculty of the Westfalische Wilhelms-Universitat Munster [16-002]; Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat [PO 2 2 16 12]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program; Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Medical Faculty of the Westfalische Wilhelms-Universitat Munster; Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/de/seltene-erkrankungen-379.html), project number 01GM0869 (UD EK JP). The ERA-Net-TRANSCAN consortium, project number 01KT1310 (EK UD), and the Euro Ewing Consortium EEC, project number EU-FP7 602856 (UD), both funded under the European Commission Seventh Framework Program FP7-HEALTH (http://cordis.europa.eu/). Deutsche Krebshilfe (German Cancer Aid) (https://www.krebshilfe.de), project number DKH-108128 (UD). The Medical Faculty of the Westfalische Wilhelms-Universitat Munster (https://campus.uni-muenster.de/fakultaet/forschung), project number 16-002 (JP). Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat (https://campus.uni-muenster.de/imf/das-imf), project number PO 2 2 16 12 (JP). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fennell M, 2014, J BIOMOL SCREEN, V19, P1327, DOI 10.1177/1087057114548414; Haney SA, 2007, EXPERT OPIN THER TAR, V11, P1429, DOI 10.1517/14728222.11.11.1429; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hoshiyama H, 2012, J BIOMOL SCREEN, V17, P258, DOI 10.1177/1087057111423101; Hu G, 2012, ACTA BIOCH BIOPH SIN, V44, P103, DOI 10.1093/abbs/gmr116; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XD, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-49; Hwang GW, 2010, J TOXICOL SCI, V35, P601, DOI 10.2131/jts.35.601; Kennedy AL, 2015, ONCOTARGET, V6, P30178, DOI 10.18632/oncotarget.4903; Ketela T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-213; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Niedan S, 2014, ONCOGENE, V33, P3927, DOI 10.1038/onc.2013.361; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROBINSON MD, 2010, GENOME BIOL, V11; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shukla N, 2016, CANCER RES, V76, P4525, DOI 10.1158/0008-5472.CAN-16-1040; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taylor J, 2015, J BIOMOL SCREEN, V20, P1040, DOI 10.1177/1087057115590069; Wade M, 2015, J BIOMOL SCREEN, V20, P1027, DOI 10.1177/1087057115587916; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yuan YX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2745-8; Zhang ZZ, 2014, DNA CELL BIOL, V33, P136, DOI 10.1089/dna.2013.2179	38	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191570	10.1371/journal.pone.0191570	http://dx.doi.org/10.1371/journal.pone.0191570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385199	Green Published, gold, Green Submitted			2022-12-27	WOS:000423668400049
J	Auboire, L; Sennoga, CA; Hyvelin, JM; Ossant, F; Escoffre, JM; Tranquart, F; Bouakaz, A				Auboire, Laurent; Sennoga, Charles A.; Hyvelin, Jean-Marc; Ossant, Frederic; Escoffre, Jean-Michel; Tranquart, Francois; Bouakaz, Ayache			Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies	PLOS ONE			English	Review							BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; FOCUSED ULTRASOUND; INTRAVENOUS MICROBUBBLES; TRANSCRANIAL ULTRASOUND; INFLAMMATORY RESPONSE; ENHANCED THROMBOLYSIS; CLINICAL-TRIAL; STANDING-WAVE; RABBIT MODEL	Background Microbubbles (MBs) combined with ultrasound sonothrombolysis (STL) appears to be an alternative therapeutic strategy for acute ischemic stroke (IS), but clinical results remain controversial. Objective The aim of this systematic review is to identify the parameters tested; to assess evidence on the safety and efficacy on preclinical data on STL; and to assess the validity and publication bias. Methods Pubmed (R) and Web of Science (TM) databases were systematically searched from January 1995 to April 2017 in French and English. We included studies evaluating STL on animal stroke model. This systematic review was conducted in accordance with the PRISMA guidelines. Data were extracted following a pre-defined schedule by two of the authors. The CAMARADES criteria were used for quality assessment. A narrative synthesis was conducted. Results Sixteen studies met the inclusion criteria. The result showed that ultrasound parameters and types of MBs were heterogeneous among studies. Numerous positive outcomes on efficacy were found, but only four studies demonstrated superiority of STL versus recombinant tissue-type plasminogen activator on clinical criteria. Data available on safety are limited. Limitations Quality assessment of the studies reviewed revealed a number of biases. Conclusion Further in vivo studies are needed to demonstrate a better efficacy and safety of STL compared to currently approved therapeutic options.	[Auboire, Laurent; Sennoga, Charles A.; Ossant, Frederic; Escoffre, Jean-Michel; Bouakaz, Ayache] Univ Francois Rabelais Tours, Inserm U930, UMR Imagerie & Cerveau, Tours, France; [Auboire, Laurent] CHRU Tours, Serv Echog Doppler, Tours, France; [Hyvelin, Jean-Marc] Bracco Suisse SA, Geneva, Switzerland; [Ossant, Frederic] CHRU Tours, CIC IT, Tours, France; [Tranquart, Francois] Advice US Consulting, Nernier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Bracco; CHU Tours	Bouakaz, A (corresponding author), Univ Francois Rabelais Tours, Inserm U930, UMR Imagerie & Cerveau, Tours, France.	Ayache.bouakaz@univ-tours.fr	Escoffre, Jean-Michel/P-5606-2014; Bouakaz, Ayache/G-1757-2013	Escoffre, Jean-Michel/0000-0003-1041-6950; Bouakaz, Ayache/0000-0001-5709-7120; auboire, laurent/0000-0002-7379-8506	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was funded by INSERM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alexandrov AV, 2004, J NEUROIMAGING, V14, P113, DOI 10.1177/1051228403261462; Alonso A, 2009, THROMB RES, V124, P70, DOI 10.1016/j.thromres.2008.11.019; Ammi AY, 2008, ULTRASOUND MED BIOL, V34, P1578, DOI 10.1016/j.ultrasmedbio.2008.02.012; Azuma T, 2005, JPN J APPL PHYS 1, V44, P4625, DOI 10.1143/JJAP.44.4625; Bader KB, 2016, ADV EXP MED BIOL, V880, P339, DOI 10.1007/978-3-319-22536-4_19; Bader KB, 2015, ULTRASOUND MED BIOL, V41, P187, DOI 10.1016/j.ultrasmedbio.2014.08.018; Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014; Barreto AD, 2013, STROKE, V44, P3376, DOI 10.1161/STROKEAHA.113.002713; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Brown AT, 2011, INVEST RADIOL, V46, P202, DOI 10.1097/RLI.0b013e318200757a; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301; Culp WC, 2004, STROKE, V35, P2407, DOI 10.1161/01.STR.0000140890.86779.79; Culp WC, 2003, J VASC INTERV RADIOL, V14, P1433, DOI 10.1097/01.RVI.0000096767.47047.FA; Culp WC, 2011, STROKE, V42, P2280, DOI 10.1161/STROKEAHA.110.607150; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Flores R, 2011, INVEST RADIOL, V46, P419, DOI 10.1097/RLI.0b013e31820e143a; Gao SJ, 2014, INVEST RADIOL, V49, P593, DOI 10.1097/RLI.0000000000000059; Ghanouni P, 2015, AM J ROENTGENOL, V205, P150, DOI 10.2214/AJR.14.13632; Huang XY, 2015, LANCET NEUROL, V14, P368, DOI 10.1016/S1474-4422(15)70017-7; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Larrue V, 2007, STROKE, V38, P472; Liu WS, 2012, THROMB RES, V130, P547, DOI 10.1016/j.thromres.2012.06.020; Lu YK, 2016, STROKE, V47, P1344, DOI 10.1161/STROKEAHA.115.012056; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McMahon D, 2017, THERANOSTICS, V7, P3989, DOI 10.7150/thno.21630; Meairs S, 2008, EUR NEUROL, V59, P17, DOI 10.1159/000114456; Meairs S, 2012, STROKE, V43, P1706, DOI 10.1161/STROKEAHA.111.636332; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723; Moumouh A, 2010, ULTRASOUND MED BIOL, V36, P51, DOI 10.1016/j.ultrasmedbio.2009.06.1103; Nacu A, 2017, STROKE, V48, P335, DOI 10.1161/STROKEAHA.116.014644; Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Ren ST, 2012, J THROMB THROMBOLYS, V33, P74, DOI 10.1007/s11239-011-0644-z; Ren XP, 2015, THROMB RES, V136, P1027, DOI 10.1016/j.thromres.2015.08.027; Ricci S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008348.pub2; Saqqur M, 2014, J NEUROIMAGING, V24, P209, DOI 10.1111/jon.12026; Schleicher N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152898; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Stride E, 2015, FRONT NEUROL NEUROSC, V36, P11, DOI 10.1159/000366223; TACHIBANA K, 1995, CIRCULATION, V92, P1148, DOI 10.1161/01.CIR.92.5.1148; Tang SC, 2010, IEEE T BIO-MED ENG, V57, P203, DOI 10.1109/TBME.2009.2028653; Tomkins Amelia J, 2015, Exp Transl Stroke Med, V7, P2, DOI 10.1186/s13231-014-0014-y; Wang B, 2008, THROMB HAEMOSTASIS, V100, P356, DOI 10.1160/TH07-09-0583; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Woods Sean D, 2011, Open Neurol J, V5, P55, DOI 10.2174/1874205X01105010055; Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c; Wu SY, 2014, IEEE T ULTRASON FERR, V61, P966, DOI 10.1109/TUFFC.2014.2992	56	27	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191788	10.1371/journal.pone.0191788	http://dx.doi.org/10.1371/journal.pone.0191788			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420546	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900023
J	Schroder, C; Steimer, W				Schroeder, Charlotte; Steimer, Werner			gDNA extraction yield and methylation status of blood samples are affected by long-term storage conditions	PLOS ONE			English	Article							DNA METHYLATION; PREANALYTICAL PROCEDURES; HUMAN-DISEASE; INTEGRITY; STABILITY; TEMPERATURE; EPIGENETICS; EXPERIENCE; QUALITY	Epigenetics is believed to provide great chances for a better understanding of the development and treatment of many diseases where the analysis of genomic DNA has so far failed to provide conclusive answers. Methylcytosine is a frequently used quantitative marker of epigenetic studies. Since immediate analysis of sampled material is in most cases not possible, storage time and conditions are critical aspects regarding the quality of genomic DNA and reliability of analysis. Blood is frequently used for such analyses. We, therefore, collected blood samples of ten volunteers and stored them under various conditions for ten months: -70 degrees C, -20 degrees C, 2-8 degrees C and room temperature. An additional aliquot was frozen at -70 degrees C and thawed once a week at room temperature. We then compared the DNA extraction yields and methylation status in relation to storage time and conditions. We found significantly lower DNA extraction yields (up to -97.45%; p <= 0.001) as well as significantly higher methylation levels after ten months of storage (up to +42.0%; p <= 0.001). These results suggest that storage time has an important influence on DNA analyses of blood samples for all storage conditions. This might be due to differences in stability of methylated and non-methylated DNA. Our study indicates that storage conditions and time may be a critical factor for epigenetic methylation studies and require rigorous validation. For reliable analyses we, therefore, recommend to perform epigenetic analysis directly after sample collection.	[Schroeder, Charlotte; Steimer, Werner] Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich	Steimer, W (corresponding author), Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany.	AK.Steimer-TUM@web.de			German Research Foundation (DFG); Technical University of Munich (TUM)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Austin MA, 1996, AM J EPIDEMIOL, V144, P437; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Bulla A, 2016, BIOPRESERV BIOBANK, V14, P29, DOI 10.1089/bio.2015.0045; CUSHWA WT, 1993, BIOTECHNIQUES, V14, P204; de Oliveira RA, 2017, THERIOGENOLOGY, V89, P289, DOI 10.1016/j.theriogenology.2016.11.009; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Grouven U, 2007, Dtsch Med Wochenschr, V132 Suppl 1, pe69, DOI 10.1055/s-2007-959047; Malentacchi F, 2015, CLIN CHIM ACTA, V440, P205, DOI 10.1016/j.cca.2014.12.004; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Palmirotta R, 2011, BIOPRESERV BIOBANK, V9, P35, DOI 10.1089/bio.2010.0027; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Redshaw N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1174; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; ROSS KS, 1990, J MED GENET, V27, P569, DOI 10.1136/jmg.27.9.569; Shao W, 2012, BIOPRESERV BIOBANK, V10, P4, DOI 10.1089/bio.2011.0016; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Thalhammer A, 2011, CHEM COMMUN, V47, P5325, DOI 10.1039/c0cc05671e; Udtha M, 2014, BIOPRESERV BIOBANK, V12, P332, DOI 10.1089/bio.2014.0026; Vilahur N, 2013, EPIGENOMICS-UK, V5, P341, DOI [10.2217/EPI.13.29, 10.2217/epi.13.29]; Zini G, 2014, INT J LAB HEMATOL, V36, P111, DOI 10.1111/ijlh.12181	24	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192414	10.1371/journal.pone.0192414	http://dx.doi.org/10.1371/journal.pone.0192414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415017	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300076
J	Yang, SH; Wang, LL; Shi, ZY; Ou, XQ; Wang, W; Chen, X; Liu, GQ				Yang, Shaohua; Wang, Lu Lu; Shi, Zhaoyuan; Ou, Xiaoqian; Wang, Wei; Chen, Xue; Liu, Guoqing			Transcriptional profiling of liver tissues in chicken embryo at day 16 and 20 using RNA sequencing reveals differential antioxidant enzyme activity	PLOS ONE			English	Article							APOLIPOPROTEIN A-IV; OXIDATIVE STRESS; VITAMIN-E; EXPRESSION; SEQ; POLYMORPHISM; INDUCTION; PROTEINS; GENES	Considering the high proportion of polyunsaturated fatty acids, the antioxidant defense of chick embryo tissues is vital during the oxidative stress experienced at hatching. In order to better understand the mechanisms of the defense system during chicken embryo development, we detected the activity of antioxidant enzymes during the incubation of chicken embryo. Results showed that the activity of superoxide dismutase (SOD) and (GSH-PX) in livers were higher than those in hearts. Based on these results, liver tissues were used as the follow-up study materials, which were obtained from chicken embryo at day 16 and day 20. Thus, we used RNA sequencing (RNA-Seq) analysis to identify the transcriptome from 6 liver tissues. In total, we obtained 45,552,777-45,462,856 uniquely mapped reads and 18,837 mRNA transcripts, across the 6 liver samples. Among these, 1,154 differentially expressed genes (p<0.05, foldchange >= 1) were identified between the high and low groups, and 1,069 GO terms were significantly enriched (p<0.05). Of these, 10 GO terms were related to active oxygen defense and antioxidant enzyme activity. GO enrichment and KEGG pathway analysis indicated that GSTA2, GSTA4, MGST1, GPX3, and HAO2 participated in glutathione metabolism, and were considered as the most promising candidate genes affecting the antioxidant enzyme activity of chicken embryo at day 16 and day 20. Using RNA-Seq and differential gene expression, our study here investigated the complexity of the liver transcriptome in chick embryos and analyzed the key genes associated with the antioxidant enzyme.	[Yang, Shaohua; Wang, Lu Lu; Shi, Zhaoyuan; Ou, Xiaoqian; Chen, Xue; Liu, Guoqing] Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China; [Wang, Wei] Agr Prod Qual & Safety Supervis & Management Bur, Xuancheng, Anhui, Peoples R China	Hefei University of Technology	Liu, GQ (corresponding author), Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China.	13675512000@163.com			Fundamental Research Funds for Industry University-Research in Hefei University of Technology [XC2016JZBZ03]; Fundamental Research Funds for the Central Universities [JZ2017HGTA0228]; innovation Project for College Students [2017CXCYS235]; Wanjiang Institute of Poultry Technology [XC2015AKKG002]; Science and Technology Bureau of AnHui [XC2015XKKJ02, XC2015AKKG003]	Fundamental Research Funds for Industry University-Research in Hefei University of Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); innovation Project for College Students; Wanjiang Institute of Poultry Technology; Science and Technology Bureau of AnHui	This work was supported by the Fundamental Research Funds for Industry University-Research in Hefei University of Technology (XC2016JZBZ03), the Fundamental Research Funds for the Central Universities (JZ2017HGTA0228), the innovation Project for College Students (2017CXCYS235), Wanjiang Institute of Poultry Technology (XC2015AKKG002), and the Science and Technology Bureau of AnHui (XC2015XKKJ02; XC2015AKKG003).	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Ahmad A, 2016, J TIME SER ANAL, V37, P291, DOI 10.1111/jtsa.12167; Ahn JY, 2006, CARCINOGENESIS, V27, P1876, DOI 10.1093/carcin/bgl038; Baez-Duarte BG, 2014, ARCH MED RES, V45, P375, DOI 10.1016/j.arcmed.2014.05.001; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Cheng X, 2016, COMP ANAL LIVER TISS, P15; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Dhage PA, 2017, INT J DEV NEUROSCI, V56, P1, DOI 10.1016/j.ijdevneu.2016.10.004; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han ZJ, 2011, INT J DEV NEUROSCI, V29, P673, DOI 10.1016/j.ijdevneu.2011.06.006; He RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057732; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Kumar P, 2015, ONCOTARGET, V6, P13539, DOI 10.18632/oncotarget.3841; Li Y, 2014, INT J CARDIOL, V176, P62, DOI 10.1016/j.ijcard.2014.06.044; Magnanou E, 2014, GENE, V544, P56, DOI 10.1016/j.gene.2014.04.032; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; Monson MS, 2016, TOXINS, V8, DOI 10.3390/toxins8010016; Tran NTL, 2014, GENE REGUL SYST BIO, V8, P33, DOI 10.4137/GRSB.S13612; Niu ZY, 2017, J APPL ANIMAL RES; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Rodriguez-Serrano M, 2016, PLANT PHYSIOL, V171, P1665, DOI 10.1104/pp.16.00648; Schaffert CS, 2011, WORLD J GASTROENTERO, V17, P2552, DOI 10.3748/wjg.v17.i20.2552; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; Sodhi SS, 2014, GENE, V546, P233, DOI 10.1016/j.gene.2014.06.005; Sporer KRB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-143; Starrs AP, 2001, J EXP BIOL, V204, P3973; Surai PF, 1999, POULT AVIAN BIOL REV, V10, P1; Tetlow N, 2004, PHARMACOGENETICS, V14, P111, DOI 10.1097/00008571-200402000-00005; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Golde JC, 1998, J PHYSIOL-LONDON, V509, P289, DOI 10.1111/j.1469-7793.1998.289bo.x; Wang YX, 2011, BIOL TRACE ELEM RES, V143, P261, DOI 10.1007/s12011-010-8839-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Weng H, 2013, AM J PHYSIOL-ENDOC M, V304, P187; WILSON JX, 1992, MECH AGEING DEV, V65, P51, DOI 10.1016/0047-6374(92)90125-W; Wong WMR, 2007, ATHEROSCLEROSIS, V192, P266, DOI 10.1016/j.atherosclerosis.2006.07.017; Xu CC, 2016, GENE, V579, P47, DOI 10.1016/j.gene.2015.12.045; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yang N, 2016, FRONT PLANT SCI, P7; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Yigit AA, 2014, WORLD POULTRY SCI J, V70, P563, DOI 10.1017/S0043933914000610; Zhang W, 2015, J BIOL CHEM, V290, P5015, DOI 10.1074/jbc.M114.625822; Zhang WY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0485-6; Zhuo Z, 2015, PLOS ONE, P10	49	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192253	10.1371/journal.pone.0192253	http://dx.doi.org/10.1371/journal.pone.0192253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408927	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800053
J	Feinstein, JS; Khalsa, SS; Yeh, HW; Wohlrab, C; Simmons, WK; Stein, MB; Paulus, MP				Feinstein, Justin S.; Khalsa, Sahib S.; Yeh, Hung-wen; Wohlrab, Colleen; Simmons, W. Kyle; Stein, Murray B.; Paulus, Martin P.			Examining the short-term anxiolytic and antidepressant effect of Floatation-REST	PLOS ONE			English	Article							RESTRICTED ENVIRONMENTAL STIMULATION; GENERALIZED ANXIETY DISORDER; UNITED-STATES; PLASMA-CORTISOL; PANIC DISORDER; GLOBAL BURDEN; THERAPY REST; REPEATED CO2; DSM-IV; VALIDATION	Floatation-REST (Reduced Environmental Stimulation Therapy) reduces sensory input to the nervous system through the act of floating supine in a pool of water saturated with Epsom salt. The float experience is calibrated so that sensory signals from visual, auditory, olfactory, gustatory, thermal, tactile, vestibular, gravitational and proprioceptive channels are minimized, as is most movement and speech. This open-label study aimed to examine whether Floatation-REST would attenuate symptoms of anxiety, stress, and depression in a clinical sample. Fifty participants were recruited across a spectrum of anxiety and stress-related disorders (posttraumatic stress, generalized anxiety, panic, agoraphobia, and social anxiety), most (n = 46) with comorbid unipolar depression. Measures of self-reported affect were collected immediately before and after a 1-hour float session, with the primary outcome measure being the pre-to post-float change score on the Spielberger State Anxiety Inventory. Irrespective of diagnosis, Floatation-REST substantially reduced state anxiety (estimated Cohen's d > 2). Moreover, participants reported significant reductions in stress, muscle tension, pain, depression and negative affect, accompanied by a significant improvement in mood characterized by increases in serenity, relaxation, happiness and overall well-being (p < .0001 for all variables). In reference to a group of 30 non-anxious participants, the effects were found to be more robust in the anxious sample and approaching non-anxious levels during the post-float period. Further analysis revealed that the most severely anxious participants reported the largest effects. Overall, the procedure was well-tolerated, with no major safety concerns stemming from this single session. The findings from this initial study need to be replicated in larger controlled trials, but suggest that Floatation-REST may be a promising technique for transiently reducing the suffering in those with anxiety and depression.	[Feinstein, Justin S.; Khalsa, Sahib S.; Yeh, Hung-wen; Wohlrab, Colleen; Simmons, W. Kyle; Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Feinstein, Justin S.; Khalsa, Sahib S.; Simmons, W. Kyle] Univ Tulsa, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA; [Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA	Laureate Institute for Brain Research, Inc.; University of Tulsa; University of California System; University of California San Diego	Feinstein, JS (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.; Feinstein, JS (corresponding author), Univ Tulsa, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA.	feinstein.float@gmail.com	Simmons, W. Kyle/V-6846-2019; Khalsa, Sahib S. S/Q-1434-2018; Yeh, Hung-Wen/E-8104-2015; Khalsa, Sahib S./ABA-8359-2020	Simmons, W. Kyle/0000-0002-0399-9003; Khalsa, Sahib S. S/0000-0003-2124-8585; Yeh, Hung-Wen/0000-0003-0894-5570; Khalsa, Sahib S./0000-0003-2124-8585; Yeh, Hung-wen/0000-0002-9904-3275; Wohlrab, Colleen/0000-0002-1131-6284; Paulus, Martin/0000-0002-0825-3606	William K. Warren Foundation	William K. Warren Foundation	This study was supported by the William K. Warren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the William K. Warren Foundation for supporting this research and exploring new ways of helping those with mental illness. We also thank Colin and Gini Stanwell-Smith, who customized and built our floatation pool, and Will Schoenhals, Lauren Landwerlin, and Shane Bevel for their help producing the images of the float pool. Finally, we would like to acknowledge Caylee Winterberg for her help transcribing the debriefing interviews, and Dr. Krielle Pantino for her help administering the protocol.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], CCBYNCSA30IGO WHO; BARABASZ A, 1993, CLINICAL AND EXPERIMENTAL RESTRICTED ENVIRONMENTAL STIMULATION, P113; Baxter AJ, 2014, PSYCHOL MED, V44, P2363, DOI 10.1017/S0033291713003243; Beck JG, 1999, BEHAV RES THER, V37, P1073, DOI 10.1016/S0005-7967(98)00196-X; Beck JG, 2001, J BEHAV THER EXP PSY, V32, P1, DOI 10.1016/S0005-7916(01)00018-0; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bood SA, 2006, INT J STRESS MANAG, V13, P154, DOI [10.1037/1072-5245.13.2.154, DOI 10.1037/1072-5245.13.2.154]; Bood Sven A, 2005, Pain Res Manag, V10, P201; Boswell JF, 2013, BEHAV THER, V44, P417, DOI 10.1016/j.beth.2013.03.006; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen P, 1999, MULTIVAR BEHAV RES, V34, P315, DOI 10.1207/S15327906MBR3403_2; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 1994, PERCEIVED STRESS SCA; Collins KA, 2004, CLIN PSYCHOL REV, V24, P583, DOI 10.1016/j.cpr.2004.06.001; CRANDALL RA, 1986, J ENVIRON HEALTH, V49, P16; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; Craske MG, 2012, DEPRESS ANXIETY, V29, P749, DOI 10.1002/da.21992; DENBOER JA, 1988, INT CLIN PSYCHOPHARM, V3, P59, DOI 10.1097/00004850-198801000-00005; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; FINE TH, 1982, BEHAV RES THER, V20, P567, DOI 10.1016/0005-7967(82)90035-3; FORDYCE MW, 1988, SOC INDIC RES, V20, P355, DOI 10.1007/BF00302333; Forgays DG., 1986, J ENVIRON PSYCHOL, V6, P19, DOI DOI 10.1016/S0272-4944(86)80032-9; Hofmeijer-Sevink MK, 2012, J AFFECT DISORDERS, V137, P106, DOI 10.1016/j.jad.2011.12.008; JACOBS GD, 1984, HEALTH PSYCHOL, V3, P99, DOI 10.1037/0278-6133.3.2.99; Jonsson K, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1089-x; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Keller MB, 2003, ACTA PSYCHIAT SCAND, V108, P85, DOI 10.1034/j.1600-0447.108.s417.6.x; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kjellgren A, 2001, Pain Res Manag, V6, P181; Kjellgren A, 2013, OPEN J MED PSYCHOL, V02, P134; Kjellgren A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-417; Koula GM, 1990, REPLICATION CLIN OUT, P202; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahmann C, 2008, J AM DENT ASSOC, V139, P317, DOI 10.14219/jada.archive.2008.0161; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Lilly JC, 1961, EXPT SOLITUDE MAXIMU, P238; Lilly JC, 1977, DEEP SELF TANK METHO; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; Michalsen A, 2005, MED SCI MONITOR, V11, pCR555; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Moeller S, 2012, COMUNICAR, V20, P45, DOI 10.3916/C39-2012-02-04; Naragon-Gainey K, 2010, PSYCHOL BULL, V136, P128, DOI 10.1037/a0018055; Newby JM, 2015, CLIN PSYCHOL REV, V40, P91, DOI 10.1016/j.cpr.2015.06.002; Nolen S., 2004, PROMISED MOON UNTOLD; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; O'Leary DS, 1990, FLOTATION REST INFOR, P113; Olfson M, 2000, AM J PSYCHIAT, V157, P521, DOI 10.1176/appi.ajp.157.4.521; Pudvah MB, 1990, RESTRICTED ENV STIMU, P79; Sareen J, 2007, PSYCHIAT SERV, V58, P357, DOI 10.1176/appi.ps.58.3.357; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; SCHULZ P, 1994, BIOL PSYCHOL, V37, P161, DOI 10.1016/0301-0511(94)90029-9; Sheehan D, 1983, HDB PSYCHIAT MEASURE, P113; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheehan KH, 2008, INT CLIN PSYCHOPHARM, V23, P70, DOI 10.1097/YIC.0b013e3282f2b4d6; SHURLEY JT, 1966, MIL MED, V131, P254, DOI 10.1093/milmed/131.3.254; SHURLEY JT, 1960, AM J PSYCHIAT, V117, P539, DOI 10.1176/ajp.117.6.539; Spielberger C.D., 1970, STATE TRAIT ANXIETY, DOI DOI 10.1037/T06496-000; Stein MB, 2017, JAMA; SUEDFELD P, 1989, CAN PSYCHOL, V30, P17, DOI 10.1037/h0079795; Suedfeld P, 1999, PSYCHOL HEALTH, V14, P545, DOI 10.1080/08870449908407346; Suedfeld P., 1983, J ENVIRON PSYCHOL, V3, P147, DOI [10.1016/S0272-4944(05)80153-7, DOI 10.1016/S0272-4944(05)80153-7]; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; TURNER J, 1993, CLINICAL AND EXPERIMENTAL RESTRICTED ENVIRONMENTAL STIMULATION, P239; Turner Jr JW, 1990, EFFECTS BIOBEHAVIORA, P184; TURNER JW, 1989, BIOFEEDBACK SELF-REG, V14, P291, DOI 10.1007/BF00999120; TURNER JW, 1991, J APPL PHYSIOL, V70, P2010, DOI 10.1152/jappl.1991.70.5.2010; TURNER JW, 1983, BIOFEEDBACK SELF-REG, V8, P115, DOI 10.1007/BF01000542; UHDE TW, 1989, ARCH GEN PSYCHIAT, V46, P170; Van der Kolk Bessel, 2014, BODY KEEPS SCORE MIN; Van Dierendonck D, 2005, PSYCHOL HEALTH, V20, P405, DOI 10.1080/08870440412331337093; Wallbaum A B, 1991, Int J Psychosom, V38, P33; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT, DOI [DOI 10.17077/48VTM4T2, 10.17077/48vt-m4t2]; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wilson TD, 2014, SCIENCE, V345, P75, DOI 10.1126/science.1250830; Wong D L, 1988, Pediatr Nurs, V14, P9; Young AS, 2008, PSYCHIAT SERV, V59, P1391, DOI 10.1176/appi.ps.59.12.1391; Zubek J. P., 1969, SENSORY DEPRIVATION	87	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0190292	10.1371/journal.pone.0190292	http://dx.doi.org/10.1371/journal.pone.0190292			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394251	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400006
J	Huang, TS; Lee, CC; Tu, HZ; Lee, SSJ				Huang, Tsi-Shu; Lee, Chia-Chien; Tu, Hui-Zin; Lee, Susan Shin-Jung			Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; RESTRICTION ENZYME ANALYSIS; 16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; ROUTINE IDENTIFICATION; TUBERCULOSIS COMPLEX; LIQUID; GENE; DIAGNOSIS; HSP65	Background Rapid identification of mycobacteria is important for timely treatment and the implementation of public health measures. The MGIT system ensures rapid detection of mycobacteria, but identification is usually delayed by days to weeks due to further subculture on solid medium. Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) was demonstrated to effectively identify mycobacteria isolates subcultured from solid or liquid media. Reports of identification directly from MGIT broths of both sterile and non-sterile clinical specimens, omitting the subculture step, were limited and not satisfactory before. Our identification method dramatically shortened delay from detection to identification of mycobacteria. Methodology We assessed the performance of the Vitek MS IVD version 3.0 for direct identification of NTM and M.tuberculosis from primary MGIT cultures, and assessed two sample preparation methods. Results Direct identification of NTM from positive MGIT broths, using MALDI-TOF VITEK MS with IVD v.3.0, generated high rates of acceptable results reaching 96.4% (80/83), and up to 100% (83/83) for sample preparations including a 0.1% SDS washing step. The sensitivity of VITEK MS to identify M.tuberculosis from MGIT tubes was 58/72 (80.6%), when using immunochromatography (ICA) test as gold standard. A characteristic colony clumping, wool-like appearance was observed in 48, and all 58 (100%) were correctly identified as M.tuberculosis using MALDI-TOF. The detection rate of M.tuberculosis complex was low (10/24, 41.6%) in the 24 MGIT tubes that was polymicrobial. Our method significantly reduced both the reagent cost and turnaround time. Conclusions Based on a simplified protocol, we showed that MALDI-TOF MS can be used for rapid identification of NTM directly from primary MGIT cultures within the routine clinical laboratory workflow. However, we recommend an initial ICA test to screen for M.tuberculosis complex, due to a low identification rate of M.tuberculosis in the presence of polymicrobial cultures using MALDI-TOF.	[Huang, Tsi-Shu; Lee, Chia-Chien; Tu, Hui-Zin; Lee, Susan Shin-Jung] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Kaohsiung, Taiwan; [Lee, Susan Shin-Jung] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lee, Susan Shin-Jung] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Lee, SSJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Kaohsiung, Taiwan.; Lee, SSJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Lee, SSJ (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.	ssjlee28@yahoo.com.tw			Kaohsiung Veterans General Hospital [VGHKS105-G02-2]	Kaohsiung Veterans General Hospital	This work was financially supported by Kaohsiung Veterans General Hospital (VGHKS105-G02-2 to TSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13; BESSESEN MT, 1993, AIDS, V7, P1357, DOI 10.1097/00002030-199310000-00009; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Brent AJ, 2011, J CLIN MICROBIOL, V49, P4343, DOI 10.1128/JCM.05995-11; Brunello F, 2001, J CLIN MICROBIOL, V39, P2799, DOI 10.1128/JCM.39.8.2799-2806.2001; Buchan BW, 2014, AM J CLIN PATHOL, V141, P25, DOI 10.1309/AJCPBPUBUDEW2OAG; Buckwalter SP., 2015, J CLIN MICROBIOLOGY; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen JHK, 2013, J CLIN MICROBIOL, V51, P3981, DOI 10.1128/JCM.01437-13; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Dunne WM, 2014, J CLIN MICROBIOL, V52, P3654, DOI 10.1128/JCM.01728-14; El Khechine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024720; Euzeby J., 2013, GENUS MYCOBACTER; Gaillard T, 2011, DIAGN MICR INFEC DIS, V70, P154, DOI 10.1016/j.diagmicrobio.2010.12.011; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Henry MT, 2004, EUR RESPIR J, V23, P741, DOI 10.1183/09031936.04.00114004; HOFFNER SE, 1994, EUR J CLIN MICROBIOL, V13, P937, DOI 10.1007/BF02111495; Huang TS, 1996, J FORMOS MED ASSOC, V95, P530; Huang TS, 2001, ANN CLIN LAB SCI, V31, P279; Huang TS, 2007, ANN CLIN LAB SCI, V37, P323; Kodana M, 2016, J INFECT CHEMOTHER, V22, P32, DOI 10.1016/j.jiac.2015.09.006; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lee AS, 2009, J MED MICROBIOL, V58, P900, DOI 10.1099/jmm.0.007484-0; Leyer C, 2017, J CLIN MICROBIOLOGY; Lotz A, 2010, J CLIN MICROBIOL, V48, P4481, DOI 10.1128/JCM.01397-10; Lu JJ, 2000, J CLIN MICROBIOL, V38, P2076; Makinen J, 2006, CLIN MICROBIOL INFEC, V12, P481, DOI 10.1111/j.1469-0691.2006.01380.x; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mather CA, 2014, J CLIN MICROBIOL, V52, P130, DOI 10.1128/JCM.01996-13; Mediavilla-Gradolph M, 2015, BIOMED RES INT, V2015, P6; Mijs W, 2002, EUR J CLIN MICROBIOL, V21, P794, DOI 10.1007/s10096-002-0825-y; Muchwa Christopher, 2012, BMC Res Notes, V5, P44, DOI 10.1186/1756-0500-5-44; Muyoyeta M, 2010, J CLIN MICROBIOL, V48, P3773, DOI 10.1128/JCM.01688-09; Ngeow YF, 2011, J CLIN MICROBIOL, V49, P2776, DOI 10.1128/JCM.00711-11; Porte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177929; Pourahmad F, 2009, J MICROBIOL METH, V76, P128, DOI 10.1016/j.mimet.2008.09.021; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; SALFINGER M, 1994, EUR J CLIN MICROBIOL, V13, P961, DOI 10.1007/BF02111498; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shen GH, 2009, INT J TUBERC LUNG D, V13, P472; Shrestha NK, 2003, J CLIN MICROBIOL, V41, P5121, DOI 10.1128/JCM.41.11.5121-5126.2003; Singh Amresh Kumar, 2013, J Lab Physicians, V5, P83, DOI 10.4103/0974-2727.119847; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2006, FEMS IMMUNOL MED MIC, V48, P159, DOI 10.1111/j.1574-695X.2006.00123.x; van Eck K, 2016, J CLIN MICROBIOL, V54, P1915, DOI 10.1128/JCM.00304-16; WALLACE RJ, 1990, AM REV RESPIR DIS, V142, P940, DOI 10.1164/ajrccm/142.4.940; Wilen CB, 2015, J CLIN MICROBIOL, V53, P2308, DOI 10.1128/JCM.00567-15; WOLINSKY E, 1994, CLIN INFECT DIS, V19, P396, DOI 10.1093/clinids/19.3.396; Yu MC, 2011, J CLIN MICROBIOL, V49, P802, DOI 10.1128/JCM.02243-10	54	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192291	10.1371/journal.pone.0192291	http://dx.doi.org/10.1371/journal.pone.0192291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394275	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400033
J	Patel, N; Garikapati, KR; Makani, VKK; Nair, AD; Vangara, N; Bhadra, U; Bhadra, MP				Patel, Nibedita; Garikapati, Koteswara Rao; Makani, Venkata Krishna Kanth; Nair, Ayikkara Drishya; Vangara, Namratha; Bhadra, Utpal; Bhadra, Manika Pal			Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug	PLOS ONE			English	Article							SELF-RENEWAL; HISTONE DEACETYLASES; MIR-200 FAMILY; PROLIFERATION; MICRORNAS; GENE; TUMORIGENESIS; DIFFERENTIATION; DOWNSTREAM; PHENOTYPE	Polycomb group (PcG) proteinB lymphoma Mo-MLV insertion region 1 homolog (BMI1) is a transcriptional repressor that plays an important role in human carcinogenesis. MicroRNAs (miRNAs) are endogenous small non-coding RNAs that implicate a negative regulation on gene expression. Deregulation of the expression of miRNAs has been implicated in tumorigenesis. Here, we have shown that knock-down of BMI1 increases the expression of tumor-suppressive miRNAs. Elevated levels of expression of miR-200a, miR-200b, miR-15a, miR429, miR-203were observed upon knock-down of BMI1. Up-regulation of these miRNA-sleads to down-regulation of PRC1 group of proteins i.e. BMI1, RING1A, RING1B and Ub-H2A. Interestingly, overexpression of miR-200a, miR-200b and miR-15 a also produced decreased BMI1 and Ub-H2A protein expression in the CD44+ Cancer Stem Cellpopulation of MDAMB-231cells. Also, elevating the levels of BMI1 regulated miRNAspromoted Mesenchymal to Epithelial transition by regulating the expression of N-Cadherin, Vimentin, beta-Catenin, Zeb, Snail thereby resulting in decreased invasion, migration and proliferation. Here, we also report that miR-200a, miR-200b, miR-203 accretes the sensitivity of MDAMB-231 cells to the histone deacetylase inhibitor (HDACi) SAHA and miR-15a sensitized breast cancer cells to the chemotherapeutic drug cisplatin leading to apoptosis. These findings suggest that modulatingspecific miRNAs may serve as a therapeutic approach for the treatment of breast cancer	[Patel, Nibedita; Garikapati, Koteswara Rao; Makani, Venkata Krishna Kanth; Nair, Ayikkara Drishya; Vangara, Namratha; Bhadra, Manika Pal] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad, Telangana State, India; [Garikapati, Koteswara Rao] Acad Sci & Innovat Res AcSIR, Training & Dev Complex,CSIR Campus, Chennai, Tamil Nadu, India; [Bhadra, Utpal] Ctr Cellular & Mol Biol, Gene Silencing Grp, Hyderabad, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, MP (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad, Telangana State, India.	manikapb@gmail.com	GARIKAPATI, KOTESWARA RAO/L-4416-2014	GARIKAPATI, KOTESWARA RAO/0000-0002-1189-3356; bhadra, manika pal/0000-0002-3740-5031; Makani, Venkata Krishna Kanth/0000-0002-5454-1406	ICMR; UGC	ICMR(Indian Council of Medical Research (ICMR)); UGC(University Grants Commission, India)	NP thanks ICMR and GKR thanks UGC for their fellowship.	Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chen DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004177; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dang Z, 2014, INT J BIOL SCI, V10, P733, DOI 10.7150/ijbs.8097; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grant S., 2010, CELL CYCLE GEORGETOW, V9, P2722; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Jene-Sanz A, 2013, MOL CELL BIOL, V33, P3951, DOI 10.1128/MCB.00426-13; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Komatsu N, 2006, ONCOL REP, V15, P187; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Li LY, 2014, BIOMEDICINE-TAIWAN, V4, DOI [10.7603/s40681-014-0001-6, 10.1136/bmjopen-2014-004897]; Lopez-Arribillaga E, 2015, DEVELOPMENT, V142, P41, DOI 10.1242/dev.107714; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Maynard MA, 2014, ONCOGENE, V33, P3742, DOI 10.1038/onc.2013.333; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Ni ZL, 2010, CURR DRUG METAB, V11, P603, DOI 10.2174/138920010792927325; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patel N, 2016, LIFE SCI, V164, P60, DOI 10.1016/j.lfs.2016.08.028; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prabhakaran P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00134; Reid G, 2016, EPIGENOMICS-UK, V8, P1079, DOI 10.2217/epi-2016-0035; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; SLEDGE GW, 1988, J CLIN ONCOL, V6, P1811, DOI 10.1200/JCO.1988.6.12.1811; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang MC, 2015, ONCOL LETT, V10, P583, DOI 10.3892/ol.2015.3361; Xiang XJ, 2015, CELL PHYSIOL BIOCHEM, V36, P1382, DOI 10.1159/000430304; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; YU HD, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0051239; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	54	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0190245	10.1371/journal.pone.0190245	http://dx.doi.org/10.1371/journal.pone.0190245			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394261	Green Published, gold			2022-12-27	WOS:000424060400005
J	Annadanam, A; Varadaraj, V; Mudie, LI; Liu, A; Plum, WG; White, JK; Collins, ME; Friedman, DS				Annadanam, Anvesh; Varadaraj, Varshini; Mudie, Lucy I.; Liu, Alice; Plum, William G.; White, J. Kevin; Collins, Megan E.; Friedman, David S.			Comparison of self-refraction using a simple device, USee, with manifest refraction in adults	PLOS ONE			English	Article							VISION IMPAIRMENT; EYE HEALTH; ERROR; SPECTACLES; INDIA; POPULATION; PREVALENCE; BLINDNESS	Background The USee device is a new self-refraction tool that allows users to determine their own refractive error. We evaluated the ease of use of USee in adults, and compared the refractive error correction achieved with USee to clinical manifest refraction. Methods Sixty adults with uncorrected visual acuity <20/30 and spherical equivalent between -6.00 and +6.00 diopters completed manifest refraction and self-refraction. Results Subjects had a mean (+/- SD) age of 53.1 (+/- 18.6) years, and 27 (45.0%) were male. Mean (+/- SD) spherical equivalent measured by manifest refraction and self-refraction were -0.90 D (+/- 2.53) and +/- 1.22 diopters (+/- 2.42), respectively (p = 0.001). The proportion of subjects correctable to >= 20/30 in the better eye was higher for manifest refraction (96.7%) than self-refraction (83.3%, p = 0.005). Failure to achieve visual acuity >= 20/30 with self-refraction in right eyes was associated with increasing age (per year, OR: 1.05; 95% CI: 1.00-1.10) and higher cylindrical power (per diopter, OR: 7.26; 95% CI: 1.88-28.1). Subjectively, 95% of participants thought USee was easy to use, 85% thought self-refraction correction was better than being uncorrected, 57% thought vision with self-refraction correction was similar to their current corrective lenses, and 53% rated their vision as "very good" or "excellent" with self-refraction. Conclusion Self-refraction provides acceptable refractive error correction in the majority of adults. Programs targeting resource-poor settings could potentially use USee to provide easy on-site refractive error correction.	[Annadanam, Anvesh; Varadaraj, Varshini; Mudie, Lucy I.; Liu, Alice; Plum, William G.; Collins, Megan E.; Friedman, David S.] Johns Hopkins Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21205 USA; [White, J. Kevin] Global Vis 2020, Easton, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Friedman, DS (corresponding author), Johns Hopkins Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21205 USA.	david.friedman@jhu.edu	; Mudie, Lucy/C-2372-2017	Varadaraj, Varshini/0000-0003-2060-1316; Mudie, Lucy/0000-0003-2780-4079; Friedman, David/0000-0002-2055-5797				[Anonymous], INN TECHN DIAGN EYE; Bozzani FM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-94; Bullimore MA, 1998, OPTOMETRY VISION SCI, V75, P617, DOI 10.1097/00006324-199808000-00028; Colenbrander A, 2005, VISION REQUIREMENTS; Colligon-Bradley P, 1992, J Ophthalmic Nurs Technol, V11, P220; Dandona R, 2002, CLIN EXP OPHTHALMOL, V30, P84, DOI 10.1046/j.1442-6404.2002.00492.x; Dandona Rakhi, 2002, Indian Journal of Ophthalmology, V50, P145; De Souza N, 2012, INDIAN J OPHTHALMOL, V60, P401, DOI 10.4103/0301-4738.100534; du Toit R, 2006, OPTOMETRY VISION SCI, V83, P582, DOI 10.1097/01.opx.0000230270.39804.54; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Fricke TR, 2012, B WORLD HEALTH ORGAN, V90, P728, DOI 10.2471/BLT.12.104034; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gudlavalleti VSM, 2014, CLIN OPHTHALMOL, V8, P405, DOI 10.2147/OPTH.S46057; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Ilechie AA, 2015, OPTOMETRY VISION SCI, V92, P456, DOI 10.1097/OPX.0000000000000561; Keay L, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4793; Keay L, 2010, ARCH OPHTHALMOL-CHIC, V128, P1328, DOI 10.1001/archophthalmol.2010.215; Keay L, 2010, INT J EPIDEMIOL, V39, P877, DOI 10.1093/ije/dyp384; Likert R., 1932, TECHNIQUE MEASUREMEN, V22; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Naidoo KS, 2016, OPTOMETRY VISION SCI, V93, P227, DOI 10.1097/OPX.0000000000000796; Palmer JJ, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-44; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Zeng YF, 2009, OPHTHALMOLOGY, V116, P1839, DOI 10.1016/j.ophtha.2009.04.004; Zhang MZ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4767	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192055	10.1371/journal.pone.0192055	http://dx.doi.org/10.1371/journal.pone.0192055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390026	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400059
J	Cordoba, M; Rodriguez-Quiroga, SA; Vega, PA; Salinas, V; Perez-Maturo, J; Amartino, H; Vasquez-Dusefante, C; Medina, N; Gonzalez-Moron, D; Kauffman, MA				Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Amartino, Hernan; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo			Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach	PLOS ONE			English	Article							CHILDREN; RECOMMENDATIONS; STANDARDS; MUTATIONS; SPECTRUM; GENETICS; IMPACT; GRIK2	Background Diagnostic trajectories for neurogenetic disorders frequently require the use of considerable time and resources, exposing patients and families to so-called "diagnostic odysseys". Previous studies have provided strong evidence for increased diagnostic and clinical utility of whole-exome sequencing in medical genetics. However, specific reports assessing its utility in a setting such as ours-a neurogeneticist led academic group serving in a low-income country-are rare. Objectives To assess the diagnostic yield of WES in patients suspected of having a neurogenetic condition and explore the cost-effectiveness of its implementation in a research group located in an Argentinean public hospital. Methods This is a prospective study of the clinical utility of WES in a series of 40 consecutive patients selected from a Neurogenetic Clinic of a tertiary Hospital in Argentina. We evaluated patients retrospectively for previous diagnostic trajectories. Diagnostic yield, clinical impact on management and economic diagnostic burden were evaluated. Results We demonstrated the clinical utility of Whole Exome Sequencing in our patient cohort, obtaining a diagnostic yield of 40% (95% CI, 24.8%-55.2%) among a diverse group of neurological disorders. The average age at the time of WES was 23 (range 3-70). The mean time elapsed from symptom onset to WES was 11 years (range 3-42). The mean cost of the diagnostic workup prior to WES was USD 1646 (USD 1439 to 1853), which is 60% higher than WES cost in our center. Conclusions WES for neurogenetics proved to be an effective, cost- and time-saving approach for the molecular diagnosis of this heterogeneous and complex group of patients.	[Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo] UBA, Fac Med, Ctr Univ Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo] UBA, Fac Med, Div Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Cordoba, Marta; Salinas, Valeria; Perez-Maturo, Josefina; Andres Kauffman, Marcelo] Univ Austral, CONICET, Fac Ciencias Biomed, Programa Med Precis & Genomica Clin,Inst Invest M, Buenos Aires, DF, Argentina; [Amartino, Hernan] Hosp Univ Austral, Serv Neurol Infantil, Buenos Aires, DF, Argentina	Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University; Hospital Universitario Austral	Kauffman, MA (corresponding author), UBA, Fac Med, Ctr Univ Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina.; Kauffman, MA (corresponding author), UBA, Fac Med, Div Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina.; Kauffman, MA (corresponding author), Univ Austral, CONICET, Fac Ciencias Biomed, Programa Med Precis & Genomica Clin,Inst Invest M, Buenos Aires, DF, Argentina.	marcelokauffman@gmail.com		Cordoba, Marta/0000-0002-2814-1636; Kauffman, Marcelo/0000-0003-1680-5092	National Research Council Argentina (CONICET); Ministry of Science and Technology, Argentina	National Research Council Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministry of Science and Technology, Argentina	This study was supported by the National Research Council Argentina (CONICET) and the Ministry of Science and Technology, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; Bettencourt C, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0721-2; Carmichael N, 2015, J GENET COUNS, V24, P325, DOI 10.1007/s10897-014-9773-9; Cordoba M, 2015, CLIN GENET, V87, P293, DOI 10.1111/cge.12423; Fogel BL, 2016, NEUROL-CLIN PRACT, V6, P164, DOI 10.1212/CPJ.0000000000000239; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Kingsmore SF, 2012, GENOME MED, V4, DOI 10.1186/gm324; Kozarewa I, 2011, METHODS MOL BIOL, V733, P257, DOI 10.1007/978-1-61779-089-8_18; Li H, 2013, ARXIV13033997V1; Lionel AC, 2017, GENET MED; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Monroe GR, 2016, GENET MED, V18, P949, DOI 10.1038/gim.2015.200; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Nambot S, 2017, GENET MED; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Valencia CA, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00067; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	31	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191228	10.1371/journal.pone.0191228	http://dx.doi.org/10.1371/journal.pone.0191228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389947	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400014
J	Grainger, MJ; Aramyan, L; Piras, S; Quested, TE; Righi, S; Setti, M; Vittuari, M; Stewart, GB				Grainger, Matthew James; Aramyan, Lusine; Piras, Simone; Quested, Thomas Edward; Righi, Simone; Setti, Marco; Vittuari, Matteo; Stewart, Gavin Bruce			Model selection and averaging in the assessment of the drivers of household food waste to reduce the probability of false positives	PLOS ONE			English	Article							BEHAVIOR; ATTITUDES; SECURITY; UNCERTAINTY; COUNTRIES; DYNAMICS; BARRIERS; ECOLOGY; INCOME	Food waste from households contributes the greatest proportion to total food waste in developed countries. Therefore, food waste reduction requires an understanding of the socioeconomic (contextual and behavioural) factors that lead to its generation within the household. Addressing such a complex subject calls for sound methodological approaches that until now have been conditioned by the large number of factors involved in waste generation, by the lack of a recognised definition, and by limited available data. This work contributes to food waste generation literature by using one of the largest available datasets that includes data on the objective amount of avoidable household food waste, along with information on a series of socio-economic factors. In order to address one aspect of the complexity of the problem, machine learning algorithms (random forests and boruta) for variable selection integrated with linear modelling, model selection and averaging are implemented. Model selection addresses model structural uncertainty, which is not routinely considered in assessments of food waste in literature. The main drivers of food waste in the home selected in the most parsimonious models include household size, the presence of fussy eaters, employment status, home ownership status, and the local authority. Results, regardless of which variable set the models are run on, point toward large households as being a key target element for food waste reduction interventions.	[Grainger, Matthew James; Stewart, Gavin Bruce] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Aramyan, Lusine] Wageningen Econ Res, Wageningen, Netherlands; [Piras, Simone; Righi, Simone; Setti, Marco; Vittuari, Matteo] Univ Bologna, Dept Agr & Food Sci, Alma Mater Studiorum, Bologna, Italy; [Quested, Thomas Edward] WRAP, Second Floor, Banbury, Oxon, England	Newcastle University - UK; Wageningen University & Research; University of Bologna	Grainger, MJ (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	matthew.grainger@newcastle.ac.uk	Piras, Simone/AAY-6693-2020; Grainger, Matthew/K-6539-2019; Righi, Simone/B-3388-2013; Vittuari, Matteo/P-5274-2014	Piras, Simone/0000-0003-0334-6800; Grainger, Matthew/0000-0001-8426-6495; Righi, Simone/0000-0001-9821-8451; Aramyan, Lusine/0000-0002-7653-4768; Vittuari, Matteo/0000-0003-4327-1575	Horizon Framework Programme of the European Union [641933]	Horizon Framework Programme of the European Union	This work was carried out under the H2020 project REFRESH - Resource Efficient Food and dRink for the Entire Supply cHain. REFRESH is funded by the Horizon 2020 Framework Programme of the European Union under grant agreement no. 641933.; This work was carried out under the H2020 project REFRESH Resource Efficient Food and dRink for the Entire Supply cHain. REFRESH is funded by the Horizon 2020 Framework Programme of the European Union under Grant Agreement no. 641933. The views reflected in this article represent the professional views of the authors and do not necessarily reflect the views of the European Commission or other REFRESH project partners. We thank Toine Timmermans, Hilke Bos-Brouwers, Hans van Trijp, Erica van Herpen, Graham Moates and Keith Waldron for comments on an earlier draft of this paper.	Abeliotis K, 2014, WASTE MANAGE RES, V32, P237, DOI 10.1177/0734242X14521681; ALTMAN DG, 1989, STAT MED, V8, P771, DOI 10.1002/sim.4780080702; Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Barilla Centre for Food and Nutrition, 2012, FOOD WAST CAUS IMP P; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Buzby JC, 2009, USDA EC INFORM B, V44; Calcagno V, 2010, J STAT SOFTW, V34, P1; Canali M, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010037; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Evans D, 2012, SOCIOLOGY, V46, P41, DOI 10.1177/0038038511416150; Glanz R., 2008, THESIS; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Graham-Rowe E, 2014, RESOUR CONSERV RECY, V84, P15, DOI 10.1016/j.resconrec.2013.12.005; Grainger MJ, 2018, GLOB FOOD S IN PRESS; Gunders D., 2012, AM IS LOSING UPTO 40; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hamilton C., 2005, 77 AUSTR I; IGD, 2007, PACK FOOD WAST HOM; Jorissen J, 2015, SUSTAINABILITY-BASEL, V7, P2695, DOI 10.3390/su7032695; Koivupuro HK, 2012, INT J CONSUM STUD, V36, P183, DOI 10.1111/j.1470-6431.2011.01080.x; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; LEAMER EE, 1983, AM ECON REV, V73, P31; Lorenz BA, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050807; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mariani J.F., 2014, ENCY AM FOOD DRINK; Midgley G., SYSTEMIC INTERVENTIO, V1; Moates G., 2016, FUSIONS ESTIMATES EU; Monier V, 2010, TECHNICAL REPORT; Osner R., 1982, NUTR FOOD SCI, V82, P13, DOI [DOI 10.1108/EB058904, 10.1108/eb058904]; Ostergren K., 2014, FUSIONS DEFINITIONAL; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Qi DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159250; Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011; R Development Core Team, 2009, R LANG ENV STAT COMP; Renzaho AMN, 2017, RENEW SUST ENERG REV, V78, P503, DOI 10.1016/j.rser.2017.04.072; Secondi L, 2015, FOOD POLICY, V56, P25, DOI 10.1016/j.foodpol.2015.07.007; Setti M, 2016, BRIT FOOD J, V118, P1731, DOI 10.1108/BFJ-11-2015-0427; Sibrian R, 2006, STAT DIVISION WORKIN; Silvennoinen K, 2014, BRIT FOOD J, V116, P1058, DOI 10.1108/BFJ-12-2012-0311; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sonesson U, 2005, AMBIO, V34, P371, DOI 10.1639/0044-7447(2005)034[0371:HTAWER]2.0.CO;2; Stancu V, 2016, APPETITE, V96, P7, DOI 10.1016/j.appet.2015.08.025; Stefan V, 2013, FOOD QUAL PREFER, V28, P375, DOI 10.1016/j.foodqual.2012.11.001; Stewart GB, 2015, RES SYNTH METHODS, V6, P109, DOI 10.1002/jrsm.1152; Thyberg KL, 2016, RESOUR CONSERV RECY, V106, P110, DOI 10.1016/j.resconrec.2015.11.016; Tostivint C., 2016, FOOD WASTE QUANTIFIC; Van Herpen E, 2016, EU HORIZON 2020 REFR; VANGARDE SJ, 1987, J AM DIET ASSOC, V87, P322; Visschers VHM, 2016, J ENVIRON PSYCHOL, V45, P66, DOI 10.1016/j.jenvp.2015.11.007; Vittuari M, 2015, REV EU LEGISLATION P; Wassermann G, 2005, P 10 INT WAST MAN LA, P913; WENLOCK RW, 1980, BRIT J NUTR, V43, P53, DOI 10.1079/BJN19800064; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson A, 2012, J HUNGER ENVIRON NUT, V7, P239, DOI 10.1080/19320248.2012.704663; WRAP, 2013, HOUS FOOD DRINK WAST; WRAP, 2010, WHAT IS THROWN HOUS; WRAP, 2012, RED SUPPL CHAIN CONS; WRAP, 2009, HELP CONS RED FRUIT; WRAP, 2007, FOOD BEH CONS RES QU; WRAP, 2011, CONS INS DAT LAB STO; Wrap, 2014, EC MOD HOUS FOOD WAS; WRAP, 2010, RED FOOD WAST CHIL 1; Young C, 2009, AM SOCIOL REV, V74, P380, DOI 10.1177/000312240907400303; ZHANG P, 1992, BIOMETRIKA, V79, P741, DOI 10.1093/biomet/79.4.741	67	20	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192075	10.1371/journal.pone.0192075	http://dx.doi.org/10.1371/journal.pone.0192075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389949	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400062
J	Pometti, C; Bessega, C; Cialdella, A; Ewens, M; Saidman, B; Vilardi, J				Pometti, Carolina; Bessega, Cecilia; Cialdella, Ana; Ewens, Mauricio; Saidman, Beatriz; Vilardi, Juan			Spatial genetic structure within populations and management implications of the South American species Acacia aroma (Fabaceae)	PLOS ONE			English	Article							NATURAL-POPULATIONS; PLANT-POPULATIONS; MATING SYSTEM; DNA MARKERS; INDIVIDUALS; DIVERSITY; DOMINANT; PROGRAM; PERSPECTIVE; ARGENTINA	The identification of factors that structure intraspecific diversity is of particular interest for biological conservation and restoration ecology. All rangelands in Argentina are currently experiencing some form of deterioration or desertification. Acacia aroma is a multipurpose species widely distributed throughout this country. In this study, we used the AFLP technique to study genetic diversity, population genetic structure, and fine-scale spatial genetic structure in 170 individuals belonging to 6 natural Argentinean populations. With 401 loci, the mean heterozygosity (H-E = 0.2) and the mean percentage of polymorphic loci (PPL = 62.1%) coefficients indicated that the genetic variation is relatively high in A. aroma. The analysis with STRUCTURE showed that the number of clusters (K) was 3. With Geneland analysis, the number of clusters was K = 4, sharing the same grouping as STRUCTURE but dividing one population into two groups. When studying SGS, significant structure was detected in 3 of 6 populations. The neighbourhood size in these populations ranged from 15.2 to 64.3 individuals. The estimated gene dispersal distance depended on the effective population density and disturbance level and ranged from 45 to 864 m. The combined results suggest that a sampling strategy, which aims to maintain a considerable part of the variability contained in natural populations sampled here, would include at least 3 units defined by the clusters analyses that exhibit particular genetic properties. Moreover, the current SGS analysis suggests that within the wider management units/provinces, seed collection from A. aroma should target trees separated by a minimum distance of 50 m but preferably 150 m to reduce genetic relatedness among seeds from different trees.	[Pometti, Carolina; Bessega, Cecilia; Saidman, Beatriz; Vilardi, Juan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Genet Especies Lenosas GEEL, Buenos Aires, DF, Argentina; [Pometti, Carolina; Bessega, Cecilia; Saidman, Beatriz; Vilardi, Juan] Univ Buenos Aires, CONICET, Inst Ecol Genet & Evoluc IEGEBA, Buenos Aires, DF, Argentina; [Cialdella, Ana] Consejo Nacl Invest Cient & Tecn, IBODA, Buenos Aires, DF, Argentina; [Ewens, Mauricio] Univ Catolica Sgo del Est, Estn Expt Fernandez, UCSE Convenio Prov Sgo del Estero, Dept Robles, Santiago Del Estero, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pometti, C (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Genet Especies Lenosas GEEL, Buenos Aires, DF, Argentina.; Pometti, C (corresponding author), Univ Buenos Aires, CONICET, Inst Ecol Genet & Evoluc IEGEBA, Buenos Aires, DF, Argentina.	cpometti@ege.fcen.uba.ar	; Vilardi, Juan/O-6547-2014	Bessega, Cecilia/0000-0002-8575-1828; Vilardi, Juan/0000-0002-7247-7911	Universidad de Buenos Aires [UBA 20020130100043BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICTO 2011-0081 OTNA, PICT-2013-0478, PICT-2013-1039]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Universidad de Buenos Aires (UBA 20020130100043BA to B. O. S. (http.//www.uba.ar/secyt/contenido.php?id=42&s=378) and the Agencia Nacional de Promocion Cientifica y Tecnologica (PICTO 2011-0081 OTNA to B. O. S., PICT-2013-0478 to J. C. V. and PICT-2013-1039 to C. L. P (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors of this work want to thank the SERVICIO DE SECUENCIACION Y GENOTIPIFICADO from the Departamento de Ecologia Genetica y Evolucion, FCEyN, UBA. This work was supported by the Universidad de Buenos Aires (UBA 20020130100043BA to B.O.S.) and the Agencia Nacional de Promocion Cientifica y Tecnologica (PICTO 2011-0081 OTNA to B.O.S., PICT-2013-0478 to J.C.V. and PICT-2013-1039 to C.L.P). We wish to thank the AJE editors for the revisions to the language of our manuscript. Additionally, we acknowledge the contributions of the three reviewers and the Associate Editor of PLOS ONE, who helped improve the quality of our work.	Kalin A. M. T., 1981, Advances in legume systematics. Part 2 [Polhill, R.M.; Raven, P.H. (Editors)], P723; Bessega C, 2016, EUR J FOREST RES, V135, P495, DOI 10.1007/s10342-016-0948-9; Casiva PV, 2004, AM J BOT, V91, P58, DOI 10.3732/ajb.91.1.58; Curtu AL, 2015, IFOREST, V8, P324, DOI 10.3832/ifor1150-007; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; DYER RJ, 2008, GENETICSTUDIO POPULA; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fernandez OA, 1997, 200 RAL, P20; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Goudet J, 2014, HIERFSTAT ESTIMATION; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Gutierrez J., 1981, CIENC INVEST, V10, P3; Hamrick J.L., 1983, GENETICS CONSERVATIO, P335, DOI DOI 10.1111/J.1471-8286.2004.00845.X; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW., 2005, GENETIC POPULATIONS, V3, P505, DOI DOI 10.1038/S41421-021-00322-W; Huang CL, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0862-1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Josiah CC, 2008, AFR J BIOTECHNOL, V7, P2333; Lemos RPM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0885-7; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Pometti CL, 2015, BOT J LINN SOC, V177, P593, DOI 10.1111/boj.12262; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Omondi S. F., 2010, Tropical Plant Biology, V3, P59, DOI 10.1007/s12042-009-9037-2; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pometti CL, 2016, PLANT SYST EVOL, V302, P901, DOI 10.1007/s00606-016-1306-6; Pometti CL, 2013, PLANT SYST EVOL, V299, P761, DOI 10.1007/s00606-013-0759-0; Pometti CL, 2012, TREE GENET GENOMES, V8, P911, DOI 10.1007/s11295-012-0479-6; Pometti CL, 2011, PLANT SYST EVOL, V292, P25, DOI 10.1007/s00606-010-0389-8; Pritchard J.K., 2009, STRUCTURE VER 2 3; R Development Core Team, 2016, R LANG ENV STAT COMP; Rico-Arce ML., 2007, AM SPECIES ACACIA LE; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S., 1978, EVOLUTION GENETIC PO; Young A, TREE, V10, P413; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	52	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192107	10.1371/journal.pone.0192107	http://dx.doi.org/10.1371/journal.pone.0192107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389969	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400067
J	Reyes-Velasco, J; Manthey, JD; Bourgeois, Y; Freilich, X; Boissinot, S				Reyes-Velasco, Jacobo; Manthey, Joseph D.; Bourgeois, Yann; Freilich, Xenia; Boissinot, Stephane			Revisiting the phylogeography, demography and taxonomy of the frog genus Ptychadena in the Ethiopian highlands with the use of genome-wide SNP data	PLOS ONE			English	Article							SPECIES DELIMITATION; POPULATION-GENETICS; RIFT-VALLEY; EVOLUTION; CONSERVATION; DISPERSAL; INFERENCE; AMPHIBIA; RADIATIONS; DIVERSITY	Understanding the diversification of biological lineages is central to evolutionary studies. To properly study the process of speciation, it is necessary to link micro-evolutionary studies with macro-evolutionary mechanisms. Micro-evolutionary studies require proper sampling across a taxon's range to adequately infer genetic diversity. Here we use the grass frogs of the genus Ptychadena from the Ethiopian highlands as a model to study the process of lineage diversification in this unique biodiversity hotspot. We used thousands of genome-wide SNPs obtained from double digest restriction site associated DNA sequencing (ddRAD-seq) in populations of the Ptychadena neumanni species complex from the Ethiopian highlands in order to infer their phylogenetic relationships and genetic structure, as well as to study their demographic history. Our genome-wide phylogenetic study supports the existence of approximately 13 lineages clustered into 3 species groups. Our phylogenetic and phylogeographic reconstructions suggest that those endemic lineages diversified in allopatry, and subsequently specialized to different habitats and elevations. Demographic analyses point to a continuous decrease in the population size across the majority of lineages and populations during the Pleistocene, which is consistent with a continuous period of aridification that East Africa experienced since the Pliocene. We discuss the taxonomic implications of our analyses and, in particular, we warn against the recent practice to solely use Bayesian species delimitation methods when proposing taxonomic changes.	[Reyes-Velasco, Jacobo; Manthey, Joseph D.; Bourgeois, Yann; Boissinot, Stephane] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Freilich, Xenia] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Boissinot, S (corresponding author), New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.	stephane.boissinot@nyu.edu	; Bourgeois, Yann/D-9938-2012	Boissinot, Stephane/0000-0002-8760-1284; Bourgeois, Yann/0000-0002-1809-387X	New York University Abu Dhabi Research Funds [AD180]	New York University Abu Dhabi Research Funds	This work was supported by New York University Abu Dhabi Research Funds AD180 to SB.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Bauer AM, 2010, P ROY SOC LOND B BIO; Belay G, 2006, BIOCHEM SYST ECOL, V34, P554, DOI 10.1016/j.bse.2006.01.004; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bohme W, 2011, NORTH-WEST J ZOOL, V7, P322; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bryja J, 2018, MOL PHYLOGENET EVOL, V118, P75, DOI 10.1016/j.ympev.2017.09.020; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Cutter AD, 2013, MOL PHYLOGENET EVOL, V69, P1172, DOI 10.1016/j.ympev.2013.06.006; de la Harpe M, 2017, MOL ECOL, V26, P2608, DOI 10.1111/mec.14110; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Eaton DA, 2017, OVERCAST IPYRAD INTE; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Freilich X, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0774-1; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Fujita MK, 2011, P ROY SOC B-BIOL SCI, V278, P493, DOI 10.1098/rspb.2010.1864; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Gordon A, 2010, FASTX TOOLKIT UNPUB; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Gould S. J., 1996, MISMEASURE MAN; Gratton P, 2016, SYST BIOL, V65, P292, DOI 10.1093/sysbio/syv087; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 2005, UNPUB, V4; Jackson ND, 2017, SYST BIOL; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Largen M., 2010, AMPHIBIANS REPTILES; Largen MJ, 1997, TROP ZOOL, V10, P223, DOI 10.1080/03946975.1997.10539339; Leache A AD, 2010, P ROY SOC LOND B BIO; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Lexer C, 2013, J BIOGEOGR, V40, P1013, DOI 10.1111/jbi.12076; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Manthey JD, 2017, BIOL J LINN SOC; Mark BG, 2008, J QUATERNARY SCI, V23, P589, DOI 10.1002/jqs.1222; Mayr E, 1942, SYSTEMATICS ORIGIN S; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Mengistu AA, 2012, AMPHIBIAN DIVERSITY; Miller MA, 2010, GATEWAY COMPUTING EN, V2010; Mohammed MU, 1998, GLOBAL PLANET CHANGE, V17, P121; Nomenclature ICoZ, 1999, INT TRUST ZOOLOGICAL; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Perret Jean-Luc, 1994, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V117, P67; PERRET JL, 1980, MONIT ZOOL ITAL, V13, P151, DOI 10.1080/00269786.1980.11758552; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pritchard JK, 2000, GENETICS, V155, P945; Radwan J, 2012, P ROY SOC B-BIOL SCI, V279, P5024, DOI 10.1098/rspb.2012.2322; Renner SS, 2016, SYST BIOL, V65, P1085, DOI 10.1093/sysbio/syw032; Reyes-Velasco J, EVOLUTION FOSSORIAL; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Samadi S, 2006, BIOL J LINN SOC, V89, P509, DOI 10.1111/j.1095-8312.2006.00689.x; Schick S., 2005, AMPHIBIA, V4, P31; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Smith ML, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Taylor PJ, 2011, SPECIFIC LIMITS EMER; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Whittaker R.J., 2011, CONSERVATION BIOGEOG, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091	78	17	17	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190440	10.1371/journal.pone.0190440	http://dx.doi.org/10.1371/journal.pone.0190440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389966	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400006
J	Singh, R; Quinn, JD; Reed, PM; Keller, K				Singh, Riddhi; Quinn, Julianne D.; Reed, Patrick M.; Keller, Klaus			Skill (or lack thereof) of data-model fusion techniques to provide an early warning signal for an approaching tipping point	PLOS ONE			English	Article							DATA ASSIMILATION; CLIMATE; MANAGEMENT; THRESHOLDS; UNCERTAINTY; ECOSYSTEMS; PARAMETER; DYNAMICS; SYSTEMS; ROBUST	Many coupled human-natural systems have the potential to exhibit a highly nonlinear threshold response to external forcings resulting in fast transitions to undesirable states (such as eutrophication in a lake). Often, there are considerable uncertainties that make identifying the threshold challenging. Thus, rapid learning is critical for guiding management actions to avoid abrupt transitions. Here, we adopt the shallow lake problem as a test case to compare the performance of four common data assimilation schemes to predict an approaching transition. In order to demonstrate the complex interactions between management strategies and the ability of the data assimilation schemes to predict eutrophication, we also analyze our results across two different management strategies governing phosphorus emissions into the shallow lake. The compared data assimilation schemes are: ensemble Kalman filtering (EnKF), particle filtering (PF), pre-calibration (PC), and Markov Chain Monte Carlo (MCMC) estimation. While differing in their core assumptions, each data assimilation scheme is based on Bayes' theorem and updates prior beliefs about a system based on new information. For large computational investments, EnKF, PF and MCMC show similar skill in capturing the observed phosphorus in the lake (measured as expected root mean squared prediction error). EnKF, followed by PF, displays the highest learning rates at low computational cost, thus providing a more reliable signal of an impending transition. MCMC approaches the true probability of eutrophication only after a strong signal of an impending transition emerges from the observations. Overall, we find that learning rates are greatest near regions of abrupt transitions, posing a challenge to early learning and preemptive management of systems with such abrupt transitions.	[Singh, Riddhi] Indian Inst Technol, Dept Civil Engn, Powai, Maharashtra, India; [Quinn, Julianne D.; Reed, Patrick M.] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA; [Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University	Singh, R (corresponding author), Indian Inst Technol, Dept Civil Engn, Powai, Maharashtra, India.	riddhi@civil.iitb.ac.in	Keller, Klaus/A-6742-2013; Reed, Patrick M/E-4435-2014	Reed, Patrick M/0000-0002-7963-6102; Singh, Riddhi/0000-0002-1670-1229; Quinn, Julianne/0000-0001-7806-4416	NSF [GEO-1240507]; Penn State Center for Climate Risk Management; Early Career Research Award, Science and Engineering Research Board, Department of Science and Technology, Government of India [ECR/2015/000355]; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Penn State Center for Climate Risk Management; Early Career Research Award, Science and Engineering Research Board, Department of Science and Technology, Government of India; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by the NSF cooperative agreement GEO-1240507 and the Penn State Center for Climate Risk Management. Partial support to Riddhi Singh was provided by the Early Career Research Award, Science and Engineering Research Board, Department of Science and Technology, Government of India award number ECR/2015/000355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Bakker, and G. Garner for valuable inputs. This work was partially supported by the NSF cooperative agreement GEO-1240507 and the Penn State Center for Climate Risk Management. Partial support to Riddhi Singh was provided by the Early Career Research Award, Science and Engineering Research Board, Department of Science and Technology, Government of India award number ECR/2015/000355. Any conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies. The source code for carrying out the analysis is available at: https:// riddhisingh.weebly.com/code.html and https://github.com/scrim-network/learningmodule.	Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Bahn O, 2011, ENERG POLICY, V39, P334, DOI 10.1016/j.enpol.2010.10.002; Beven K, 2001, J HYDROL, V249, P11, DOI 10.1016/S0022-1694(01)00421-8; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brozovic N, 2011, ECOL ECON, V70, P627, DOI 10.1016/j.ecolecon.2010.10.001; Burthe SJ, 2016, J APPL ECOL, V53, P666, DOI 10.1111/1365-2664.12519; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Dakos V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0263; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dent CL, 2002, PHILOS T R SOC B, V357, P635, DOI 10.1098/rstb.2001.0991; Evensen G.J.O.d., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Eyink GL, 2004, PHYSICA D, V195, P347, DOI 10.1016/j.physd.2004.04.003; Frossard V, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00112; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Harlim J, 2010, COMMUN MATH SCI, V8, P27; Henson SM, 2002, OIKOS, V98, P17, DOI 10.1034/j.1600-0706.2002.980102.x; Keller K, 2004, J ENVIRON ECON MANAG, V48, P723, DOI 10.1016/j.jeem.2003.10.003; Keller K, 2008, CLIM DYNAM, V30, P321, DOI 10.1007/s00382-007-0290-5; Kim S, 2003, MON WEATHER REV, V131, P2586, DOI 10.1175/1520-0493(2003)131<2586:EFFND>2.0.CO;2; KLEMES V, 1974, WATER RESOUR RES, V10, P675, DOI 10.1029/WR010i004p00675; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Kruschke JK, 2014, JAGS STAN, V2nd, DOI DOI 10.1016/B978-0-12-405888-0.09996-7; Lade SJ, 2013, THEOR ECOL-NETH, V6, P359, DOI 10.1007/s12080-013-0187-3; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Law K, 2015, DATA ASSIMILATION A, V62; Lempert RJ, 2007, RISK ANAL, V27, P1009, DOI 10.1111/j.1539-6924.2007.00940.x; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Liu J, 2001, STAT ENG IN, P197; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Ludwig D, 2003, ECOL APPL, V13, P1135, DOI 10.1890/1051-0761(2003)13[1135:OPLFAP]2.0.CO;2; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; MILLER RN, 1994, J ATMOS SCI, V51, P1037, DOI 10.1175/1520-0469(1994)051<1037:ADAISN>2.0.CO;2; Moradkhani H, 2005, ADV WATER RESOUR, V28, P135, DOI 10.1016/j.advwatres.2004.09.002; Olson R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016620; Pace ML, 2015, FRONT ECOL ENVIRON, V13, P460, DOI 10.1890/150003; Peterson GD, 2003, ECOLOGY, V84, P1403, DOI 10.1890/0012-9658(2003)084[1403:UATMOM]2.0.CO;2; Pisarchik AN, 2014, PHYS REP, V540, P167, DOI 10.1016/j.physrep.2014.02.007; Quinn JD, 2017, ENVIRON MODELL SOFTW, V92, P125, DOI 10.1016/j.envsoft.2017.02.017; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Singh R, 2015, ECOL SOC, V20, DOI 10.5751/ES-07687-200312; Sriver RL, 2012, CLIMATIC CHANGE, V115, P893, DOI 10.1007/s10584-012-0610-6; Thomas ZA, 2015, CLIM PAST, V11, P1621, DOI 10.5194/cp-11-1621-2015; Urban NM, 2010, TELLUS A, V62, P737, DOI 10.1111/j.1600-0870.2010.00471.x; Ward VL, 2015, ENVIRON MODELL SOFTW, V73, P27, DOI 10.1016/j.envsoft.2015.07.020; Werners SE, 2013, CURR OPIN ENV SUST, V5, P334, DOI 10.1016/j.cosust.2013.06.005	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191768	10.1371/journal.pone.0191768	http://dx.doi.org/10.1371/journal.pone.0191768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389938	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400033
J	Sonenblum, SE; Sprigle, SH				Sonenblum, Sharon Eve; Sprigle, Stephen H.			Buttock tissue response to loading in men with spinal cord injury	PLOS ONE			English	Article							SKIN BLOOD-FLOW; SUB-DERMAL TISSUES; PRESSURE ULCERS; RISK-FACTORS; HOSPITALIZED-PATIENTS; EXTERNAL-PRESSURE; DEEP; SORES; DEFORMATION; INDIVIDUALS	Objective/Background Despite the fact that most people with a spinal cord injury who use a wheelchair for mobility are considered at-risk for pressure ulcer (PrU) development, there still exists a spectrum of risk amongst this group. Efforts to differentiate risk level would benefit from clinical tools that can measure or predict the buttocks response to loading. Therefore, the goal of this study was to identify how tissue compliance and blood flow were impacted by clinically-measurable risk factors in young men with SCI. Methods Blood flow at the ischial tuberosity was measured using laser Doppler flowmetry while the seated buttock was unloaded, and loaded at lower (40-60 mmHg) and high (>200 mmHg) loads. Tissue compliance of the buttock was measured using the Myotonometer while subject were lifted in a Guldmann Net. Results Across 28 participants, blood flow was significantly reduced at high loads, while no consistent, significant changes were found at lower loads. At 40-60 mmHg, blood flow decreased in participants with a pressure ulcer history and lower BMI, but stayed the same or increased in most other participants. The buttock displaced an average of 9.3 mm (2.7 mm) at 4.2 N, which represented 82% (7%) of maximum displacement. BMI was related to the amount of buttock tissue displacement while smoking status explained some of the variation in the percent of max displacement. Conclusion Wide variability in tissue compliance and blood flow responses across a relatively homogeneous population indicate that differences in biomechanical risk may provide an explanation for the spectrum of PrU risk among persons with SCI.	[Sonenblum, Sharon Eve; Sprigle, Stephen H.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Sprigle, Stephen H.] Georgia Inst Technol, Sch Ind Design, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sonenblum, SE (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	ss427@gatech.edu	Sonenblum, Sharon/S-9573-2019	Sonenblum, Sharon/0000-0001-9747-5683	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); RERC on Wheeled Mobility [H133E080003]	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)(United States Department of Health & Human Services); RERC on Wheeled Mobility	This work was supported by National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), https://www.acl.gov/about-acl/about-national-institute-disabiliy-independent-living-and-rehabilitation-research; and RERC on Wheeled Mobility, Grant H133E080003, PI SHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN RM, 1986, ANN INTERN MED, V105, P337, DOI 10.7326/0003-4819-105-3-337; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; [Anonymous], 2014, PRESS ULC PREV TREAT; BADER D L, 1990, Journal of Rehabilitation Research and Development, V27, P141, DOI 10.1682/JRRD.1990.04.0141; Bar C, 1988, RESPONSE TISSUE APPL; BENNETT L, 1979, ARCH PHYS MED REHAB, V60, P309; Bolton L, 2007, J WOUND OSTOMY CONT, V34, P368, DOI 10.1097/01.WON.0000281653.32955.9b; Bouten CV, 2003, ARCH PHYS MED REHAB, V84, P616, DOI 10.1053/apmr.2003.50038; Byrne DW, 1996, SPINAL CORD, V34, P255, DOI 10.1038/sc.1996.46; EK AC, 1987, SCAND J REHABIL MED, V19, P121; Elsner JJ, 2008, J BIOMECH, V41, P3322, DOI 10.1016/j.jbiomech.2008.09.036; Gawlitta D, 2007, ANN BIOMED ENG, V35, P273, DOI 10.1007/s10439-006-9222-5; Gefen Amit, 2008, Technol Health Care, V16, P141; Gefen A, 2007, MED BIOL ENG COMPUT, V45, P563, DOI 10.1007/s11517-007-0187-9; Gould LJ, 2014, MED HYPOTHESES, V83, P552, DOI 10.1016/j.mehy.2014.08.027; Haesler E, 2014, PREV TREATM PRESS UL; HOLLOWAY GA, 1976, J APPL PHYSIOL, V40, P597, DOI 10.1152/jappl.1976.40.4.597; Just M, 2007, BRIT J DERMATOL, V156, P85, DOI 10.1111/j.1365-2133.2006.07575.x; KOSIAK M, 1959, Arch Phys Med Rehabil, V40, P62; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1257, DOI 10.1016/j.apmr.2003.08.108; KROUSKOP TA, 1983, MED HYPOTHESES, V11, P255, DOI 10.1016/0306-9877(83)90067-1; LASSEN NA, 1974, SURG CLIN N AM, V54, P39; Linder-Ganz E, 2008, J BIOMECH, V41, P567, DOI 10.1016/j.jbiomech.2007.10.011; Linder-Ganz E, 2007, J BIOMECH, V40, P1443, DOI 10.1016/j.jbiomech.2006.06.020; Loerakker S, 2011, J APPL PHYSIOL, V111, P1168, DOI 10.1152/japplphysiol.00389.2011; Loerakker S, 2012, COMPUT METHODS BIOME; Luboz V, 2014, J BIOMECH, V47, P2231, DOI 10.1016/j.jbiomech.2014.05.004; Makhsous M, 2008, J SPINAL CORD MED, V31, P88, DOI 10.1080/10790268.2008.11753987; Mortenson WB, 2008, SPINAL CORD, V46, P168, DOI 10.1038/sj.sc.3102129; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Oomens CWJ, 2015, ANN BIOMED ENG, V43, P297, DOI 10.1007/s10439-014-1202-6; Oomens CW, 2009, J TISSUE VIABILITY; Raghavan P, 2003, CLIN REHABIL, V17, P879, DOI 10.1191/0269215503cr692oa; Reswick J., 1976, BED SORE BIOMECHANIC, P301, DOI [10.1007/978-1-349-02492-6_38, DOI 10.1007/978-1-349-02492-6_38]; Salzberg C A, 1998, Adv Wound Care, V11, P237; Salzberg CA, 1996, AM J PHYS MED REHAB, V75, P96, DOI 10.1097/00002060-199603000-00004; Sanada H, 1997, Adv Wound Care, V10, P29; Saunders LL, 2012, ARCH PHYS MED REHAB, V93, P972, DOI 10.1016/j.apmr.2012.02.004; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; Sonenbium SE, 2015, J TISSUE VIABILITY, V24, P51, DOI 10.1016/j.jtv.2015.03.003; Sonenblum SE, 2014, RESNA ANN M ATL GA; Sonenblum SE, 2012, 28 INT SEAT S VANC C; Sonenblum SE, 2011, J TISSUE VIABILITY; Sonenblum SE, 2014, ARCH PHYS MED REHAB, V95, P1350, DOI 10.1016/j.apmr.2014.01.007; Sopher R, 2010, J BIOMECH, V43, P280, DOI 10.1016/j.jbiomech.2009.08.021; Sprigle S, 2002, MED ENG PHYS, V24, P651, DOI 10.1016/S1350-4533(02)00149-2; Sprigle S, 2011, J REHABIL RES DEV, V48, P203, DOI 10.1682/JRRD.2010.05.0102; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Then C, 2008, Technol Health Care, V16, P61; van Marum RJ, 2002, ARCH PHYS MED REHAB, V83, P40, DOI 10.1053/apmr.2002.26827; Verver M. M., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P193, DOI 10.1080/10255840410001727832; VIDAL J, 1991, PARAPLEGIA, V29, P261, DOI 10.1038/sc.1991.37	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191868	10.1371/journal.pone.0191868	http://dx.doi.org/10.1371/journal.pone.0191868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415014	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300044
J	Tensen, L; Groom, RJ; Khuzwayo, J; van Vuuren, BJ				Tensen, Laura; Groom, Rosemary J.; Khuzwayo, Joy; van Vuuren, Bettine Jansen			The genetic tale of a recovering lion population (Panthera leo) in the Save Valley region (Zimbabwe): A better understanding of the history and managing the future	PLOS ONE			English	Article							SELOUS-GAME-RESERVE; AFRICAN LION; CONSERVATION UNITS; COMPUTER-PROGRAM; DIVERSITY; MICROSATELLITES; RELATEDNESS; BOTTLENECK; EVOLUTION; PATERNITY	The rapid decline of the African lion (Panthera leo) has raised conservation concerns. In the Save A Valley Conservancy (SVC), in the Lowveld of Zimbabwe, lions were presumably reduced to approximately 5 to 10 individuals. After ten lions were reintroduced in 2005, the population has recovered to over 200 lions in 2016. Although the increase of lions in the SVC seems promising, a question remains whether the population is genetically viable, considering their small founding population. In this study, we document the genetic diversity in the SVC lion population using both mitochondrial and nuclear genetic markers, and compare our results to literature from other lion populations across Africa. We also tested whether genetic diversity is spatially structured between lion populations residing on several reserves in the Lowveld of Zimbabwe. A total of 42 lions were genotyped successfully for 11 microsatellite loci. We confirmed that the loss of allelic richness (probably resulting from genetic drift and small number of founders) has resulted in low genetic diversity and inbreeding. The SVC lion population was also found to be genetically differentiated from surrounding population, as a result of genetic drift and restricted natural dispersal due to anthropogenic barriers. From a conservation perspective, it is important to avoid further loss of genetic variability in the SVC lion population and maintain evolutionary potential required for future survival. Genetic restoration through the introduction of unrelated individuals is recommended, as this will increase genetic heterozygosity and improve survival and reproductive fitness in populations.	[Tensen, Laura; Groom, Rosemary J.; Khuzwayo, Joy; van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Ecol Genom & Wildlife Conservat, Johannesburg, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Chishakwe Ranch, Save Valley Con, Zimbabwe	University of Johannesburg	van Vuuren, BJ (corresponding author), Univ Johannesburg, Dept Zool, Ctr Ecol Genom & Wildlife Conservat, Johannesburg, South Africa.	bettinevv@uj.ac.za	Jansen van Vuuren, Bettine/E-6227-2013	Jansen van Vuuren, Bettine/0000-0002-5334-5358; Tensen, Laura/0000-0001-9333-4955	Faculty (FRC), University of Johannesburg; University (URC) Funding, University of Johannesburg	Faculty (FRC), University of Johannesburg; University (URC) Funding, University of Johannesburg	The study was financed through Faculty (FRC) and University (URC) Funding, University of Johannesburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2002, FSTAT VERSION 2 9 3; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Baker PJ, 2004, BEHAV ECOL, V15, P766, DOI 10.1093/beheco/arh077; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bauer D, 2014, CAN J ZOOL, V92, P97, DOI 10.1139/cjz-2013-0176; Bauer H., 2016, PANTHERA LEO ERRATA, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN, 10.2305/IUCN.UK.2016-3.RLTS.T20522A71739753.en]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bertola LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30807; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertola LD, 2015, THESIS; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cohas A, 2006, BEHAV ECOL SOCIOBIOL, V59, P597, DOI 10.1007/s00265-005-0086-8; Collen B, 2011, BIOL SCI, P366; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2009, REINTRODUCTION TOP O, P1; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Greenbaum G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119663; Groom RJ, 2014, ORYX, V48, P385, DOI 10.1017/S0030605312001457; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kremer A, 2002, FOREST ECOL MANAG, V156, P75, DOI 10.1016/S0378-1127(01)00635-1; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lyke MM, 2013, MOL ECOL, V22, P2787, DOI 10.1111/mec.12279; Menotti-Raymond M, 2003, J HERED, V94, P95, DOI 10.1093/jhered/esg008; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Stein B., 1999, THESIS; Tensen L, 2016, CONSERV GENET, V17, P785, DOI 10.1007/s10592-016-0821-x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Watermeyer J, 2016, CARNIVORE DENSITIES; Williams ST, 2016, PEERJ, V4, DOI 10.7717/peerj.1537; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	69	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190369	10.1371/journal.pone.0190369	http://dx.doi.org/10.1371/journal.pone.0190369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415031	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300006
J	Tremblay, JA; Boulanger, Y; Cyr, D; Taylor, AR; Price, DT; St-Laurent, MH				Tremblay, Junior A.; Boulanger, Yan; Cyr, Dominic; Taylor, Anthony R.; Price, David T.; St-Laurent, Martin-Hugues			Harvesting interacts with climate change to affect future habitat quality of a focal species in eastern Canada's boreal forest	PLOS ONE			English	Article							SPRUCE BUDWORM OUTBREAKS; LANDSCAPE SIMULATION-MODEL; LAND-USE CHANGE; FIRE REGIMES; POPULATION TRENDS; BIRD COMMUNITIES; CHANGE IMPACTS; NORTH-AMERICA; DISTURBANCES; SUCCESSION	Many studies project future bird ranges by relying on correlative species distribution models. Such models do not usually represent important processes explicitly related to climate change and harvesting, which limits their potential for predicting and understanding the future of boreal bird assemblages at the landscape scale. In this study, we attempted to assess the cumulative and specific impacts of both harvesting and climate-induced changes on wildfires and standlevel processes (e.g., reproduction, growth) in the boreal forest of eastern Canada. The projected changes in these landscape-and stand-scale processes (referred to as "drivers of change") were then assessed for their impacts on future habitats and potential productivity of black-backed woodpecker (BBWO; Picoides arcticus), a focal species representative of deadwood and old-growth biodiversity in eastern Canada. Forest attributes were simulated using a forest landscape model, LANDIS-II, and were used to infer future landscape suitability to BBWO under three anthropogenic climate forcing scenarios (RCP 2.6, RCP 4.5 and RCP 8.5), compared to the historical baseline. We found climate change is likely to be detrimental for BBWO, with up to 92% decline in potential productivity under the worst-case climate forcing scenario (RCP 8.5). However, large declines were also projected under baseline climate, underlining the importance of harvest in determining future BBWO productivity. Present-day harvesting practices were the single most important cause of declining areas of old-growth coniferous forest, and hence appeared as the single most important driver of future BBWO productivity, regardless of the climate scenario. Climate-induced increases in fire activity would further promote young, deciduous stands at the expense of old-growth coniferous stands. This suggests that the biodiversity associated with deadwood and old-growth boreal forests may be greatly altered by the cumulative impacts of natural and anthropogenic disturbances under a changing climate. Management adaptations, including reduced harvesting levels and strategies to promote coniferous species content, may help mitigate these cumulative impacts.	[Tremblay, Junior A.] Environm & Climate Change Canada, Sci & Technol Branch, Quebec City, PQ, Canada; [Boulanger, Yan; Cyr, Dominic] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Stn Sainte Foy, Quebec City, PQ, Canada; [Taylor, Anthony R.] Nat Resources Canada, Atlantic Forestry Ctr, Canadian Forest Serv, Fredericton, NB, Canada; [Price, David T.] Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Northern Studies, Allee Ursulines, Rimouski, PQ, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Dept Biol Chim & Geog, Ctr Forest Res, Allee Ursulines, Rimouski, PQ, Canada	Environment & Climate Change Canada; Natural Resources Canada; Canadian Forest Service; Natural Resources Canada; Canadian Forest Service; Natural Resources Canada; Canadian Forest Service; University of Quebec; University of Quebec	Tremblay, JA (corresponding author), Environm & Climate Change Canada, Sci & Technol Branch, Quebec City, PQ, Canada.	junior.tremblay@canada.ca	Tremblay, Junior A./AAX-7353-2020	Tremblay, Junior A./0000-0003-4930-0939; Cyr, Dominic/0000-0001-5247-8274	Environment and Climate change Canada; Natural Resource Canada; Natural Resources Canada	Environment and Climate change Canada; Natural Resource Canada(Natural Resources Canada); Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	This study was funded by the Environment and Climate change Canada, and Natural Resource Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Environment and Climate Change Canada and Natural Resources Canada. We are thankful to A. Beaudoin and L. Guindon for providing data to initialize simulations. Anonymous reviewers provided useful comments on earlier versions of this manuscript.	Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Bayne E, 2016, CONDOR, V118, P376, DOI 10.1650/CONDOR-15-126.1; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Belisle AC, 2011, SILVA FENN, V45, P889, DOI 10.14214/sf.77; Bonnot TW, 2009, FOREST ECOL MANAG, V259, P220, DOI 10.1016/j.foreco.2009.10.021; Boucher Y, 2017, LANDSCAPE ECOL, V32, P361, DOI 10.1007/s10980-016-0448-9; Boulanger Y, 2018, J ECOL, V106, P977, DOI 10.1111/1365-2745.12892; Boulanger Y, 2017, LANDSCAPE ECOL, V32, P1415, DOI 10.1007/s10980-016-0421-7; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Boulanger Y, 2012, CAN J FOREST RES, V42, P1264, DOI [10.1139/X2012-069, 10.1139/x2012-069]; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Brown CD, 2012, FOREST ECOL MANAG, V266, P34, DOI 10.1016/j.foreco.2011.11.006; Bujold F., 2013, GUIDE INTEGRATION BE; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cumming SG, 2014, ECOGRAPHY, V37, P137, DOI 10.1111/j.1600-0587.2013.00299.x; De Caceres M, 2013, J BIOGEOGR, V40, P1535, DOI 10.1111/jbi.12111; de Groot WJ, 2003, J VEG SCI, V14, P355, DOI 10.1658/1100-9233(2003)014[0355:STEOFF]2.0.CO;2; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Dukes JS, 2009, CAN J FOREST RES, V39, P231, DOI 10.1139/X08-171; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; Farrar J.L., 1995, TREES CANADA NATURAL; Fisichelli NA, 2014, ECOGRAPHY, V37, P152, DOI 10.1111/j.1600-0587.2013.00197.x; Gauthier S, 2015, CAN J FOREST RES, V45, P1439, DOI 10.1139/cjfr-2015-0079; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Girardin MP, 2016, GLOBAL CHANGE BIOL, V22, P627, DOI 10.1111/gcb.13072; Guindon L, 2014, CAN J FOREST RES, V44, P1545, DOI 10.1139/cjfr-2014-0229; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Hennigar CR, 2008, FOREST SCI, V54, P158; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jardon Y, 2003, CAN J FOREST RES, V33, P1947, DOI 10.1139/X03-108; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2013, BIRD STUDY, V60, P60, DOI 10.1080/00063657.2012.733337; Keane RE, 2013, ECOL MODEL, V266, P172, DOI 10.1016/j.ecolmodel.2013.06.020; Klein E, 2005, CAN J FOREST RES, V35, P1931, DOI 10.1139/x05-129; La Sorte Frank A, 2010, Proc Biol Sci, V277, P3401, DOI 10.1098/rspb.2010.0612; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; LeBrun JJ, 2016, LANDSCAPE ECOL; Leduc A, 2015, CAN J FOREST RES, V45, P480, DOI 10.1139/cjfr-2014-0434; Lexer MJ, 2001, FOREST ECOL MANAG, V144, P43, DOI 10.1016/S0378-1127(00)00386-8; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; MACLEAN DA, 1980, FOREST CHRON, V56, P213, DOI 10.5558/tfc56213-5; Mahon CL, 2016, FOREST ECOL MANAG, V361, P99, DOI 10.1016/j.foreco.2015.11.007; Mahon CL, 2014, FOREST ECOL MANAG, V312, P28, DOI 10.1016/j.foreco.2013.10.025; Mansuy N, 2014, GEODERMA, V235, P59, DOI 10.1016/j.geoderma.2014.06.032; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McKenney D, 2013, FOREST CHRON, V89, P659, DOI 10.5558/tfc2013-118; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; MORIN H, 1990, CAN J FOREST RES, V20, P1, DOI 10.1139/x90-001; Nappi A, 2011, CAN J FOREST RES, V41, P994, DOI [10.1139/X11-028, 10.1139/x11-028]; Nappi A, 2009, BIOL CONSERV, V142, P1381, DOI 10.1016/j.biocon.2009.01.022; OMNR, 2000, SILV GUID MAN SO ONT; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pasher J., 2013, CANADIAN J REMOTE SE, V39, P42, DOI DOI 10.5589/M13-007; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Portier J, 2016, ANN STAT, V9, P93; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2015, R LANG ENV STAT COMP; Racey GD, 1996, TERRESTRIAL WETLAND; Regniere J, 2012, BIOL INVASIONS, V14, P1571, DOI 10.1007/s10530-010-9918-1; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Scheller R.M., 2005, LANDIS 2 BASE FIRE E; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Scheller RM, 2004, ECOL MODEL, V180, P211, DOI 10.1016/j.ecolmodel.2004.01.022; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; Schieck J, 2006, CAN J FOREST RES, V36, P1299, DOI 10.1139/X06-017; Schneider RR, 2003, CONSERV ECOL, V7; Seidl R, 2014, ENVIRON MODELL SOFTW, V51, P1, DOI 10.1016/j.envsoft.2013.09.018; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stralberg D, 2015, ECOL APPL, V25, P52, DOI 10.1890/13-2289.1; Stralberg D, 2015, DIVERS DISTRIB, V21, P1112, DOI 10.1111/ddi.12356; Sturtevant BR, 2004, ECOL MODEL, V180, P153, DOI 10.1016/j.ecolmodel.2004.01.021; Sturtevant BR, 2012, ECOL APPL, V22, P1278, DOI 10.1890/11-0590.1; Taylor AR, 2017, FOREST ECOL MANAG, V405, P284, DOI 10.1016/j.foreco.2017.07.033; Terrier A, 2013, ECOL APPL, V23, P21, DOI 10.1890/12-0425.1; Thom D, 2017, GLOBAL CHANGE BIOL, V23, P269, DOI 10.1111/gcb.13506; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tremblay JA, 2016, BLACK BACKED WOODPEC, P509; Tremblay JA, 2015, ECOSCIENCE, V22, P145, DOI 10.1080/11956860.2016.1169386; Tremblay JA, 2015, FOREST ECOL MANAG, V357, P220, DOI 10.1016/j.foreco.2015.08.024; Tremblay JA, 2010, CAN J FOREST RES, V40, P991, DOI 10.1139/X10-044; Tremblay JA, 2009, AVIAN CONSERV ECOL, V4; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Virkkala R, 2016, BIODIVERS CONSERV, V25, P151, DOI 10.1007/s10531-015-1043-0; Virkkala R, 2014, GLOBAL CHANGE BIOL, V20, P2995, DOI [10.1111/gcb.12573, 10.1111/gcb.1]; Volney WJA, 2005, FOREST CHRON, V81, P662, DOI 10.5558/tfc81662-5; Wang WJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00238.1; Ward BC, 2004, TECHNICAL DOCUMENT D; Wretenberg J, 2007, J APPL ECOL, V44, P933, DOI 10.1111/j.1365-2664.2007.01349.x	102	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191645	10.1371/journal.pone.0191645	http://dx.doi.org/10.1371/journal.pone.0191645			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414989	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300037
J	Whitaker, L; Brown, SL; Young, B; Fereday, R; Coyne, SM; Qualter, P				Whitaker, Lydia; Brown, Stephen L.; Young, Bridget; Fereday, Richard; Coyne, Sarah M.; Qualter, Pamela			Pervasive, hard-wired and male: Qualitative study of how UK adolescents view alcohol-related aggression	PLOS ONE			English	Article							MALE BARROOM AGGRESSION; VIOLENCE; BARS; PERCEPTIONS; CONSUMPTION; PREDICTORS; CONFLICT; BELIEFS; PERIOD; NORMS	Laboratory studies of alcohol-inexperienced adolescents show that aggression can be primed by alcohol-related stimuli, suggesting that alcohol-related aggression is partly socially learned. Script theory proposes that alcohol-related aggression 'scripts' for social behaviors are culturally-available and learned by individuals. The purpose of the study was to understand the content and origins of alcohol-related aggression scripts learned by adolescents. This qualitative focus group study of 40 adolescents (ages 14-16 years) examined alcohol-related aggression scripts. Participants believed aggression and severe injury to be pervasive when young people drink. Viewed through a biological lens, participants described aggression as an 'instinctive' and 'hard-wired' male trait facilitated by intoxication. As such, alcohol-related aggression was not seen as intended or personally controllable and participants did not see it in moral terms. Females were largely viewed as either bystanders of inter-male aggression or potential victims of male sexual aggression. Participants attributed their views on the frequency and nature of alcohol-related aggression to current affairs and reality television, which they felt portrayed a reality of which they had little experience. The origins of the explicitly biological frameworks that participants used seemed to lie in pre-existing beliefs about the nature of gender differences. Perceptions of the pervasiveness of male alcohol-related aggression, and the consequent failure to view alcohol-related aggression in moral terms, could dispose some young people to alcohol-related aggression. Interventions could target (1) the beliefs that alcohol-related aggression is pervasive and uncontrollable in males, and (2) participants' dysfunctional views of masculinity that underpin those beliefs.	[Whitaker, Lydia; Brown, Stephen L.; Young, Bridget; Fereday, Richard] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Coyne, Sarah M.] Brigham Young Univ, Coll Family Home & Social Sci, Provo, UT 84602 USA; [Qualter, Pamela] Univ Manchester, Inst Educ, Manchester, Lancs, England	University of Liverpool; Brigham Young University; University of Manchester	Brown, SL (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England.	slbrown@liverpool.ac.uk		Qualter, Pamela/0000-0001-6114-3820; Young, Bridget/0000-0001-6041-9901; Brown, Stephen/0000-0002-6142-0995	Economic and Social Research Council (UK) [ES/K011537/1]; ESRC [ES/J008184/1] Funding Source: UKRI; Economic and Social Research Council [ES/K011537/1, ES/J008184/1] Funding Source: researchfish	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was entirely funded by the Economic and Social Research Council (UK) Grant ES/K011537/1 to SLB. ESRC did not seek to influence the conduct of the investigation or this report.	Baker ER, 2016, SOC PSYCHOL EDUC, V19, P23, DOI 10.1007/s11218-015-9320-z; Bartholow BD, 2006, PSYCHOL SCI, V17, P30, DOI 10.1111/j.1467-9280.2005.01661.x; Benson D., 2002, PSYCHOL EVOLUTION GE, V4, P3, DOI DOI 10.1080/1461666021000013742; Boxer P., 2002, APPL PREVENTIVE PSYC, V10, P177, DOI DOI 10.5993/AJHB.24.4.3; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Brown SL, 2011, AGGRESSIVE BEHAV, V37, P430, DOI 10.1002/ab.20400; Brown SL, 2010, ADDICT BEHAV, V35, P791, DOI 10.1016/j.addbeh.2010.03.013; Bushman BJ, 2006, ARCH PEDIAT ADOL MED, V160, P348, DOI 10.1001/archpedi.160.4.348; Bushman BJ, 1993, CURR DIR PSYCHOL SCI, V2, P148, DOI DOI 10.1111/1467-8721.EP10768961; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Day K, 2003, FEM PSYCHOL, V13, P141, DOI 10.1177/0959353503013002002; Fraser C, 2006, INT J MENT HEALTH PR, V8, P9, DOI DOI 10.1080/14623730.2006.9721897; Freeman NK, 2007, EARLY CHILD EDUC J, V34, P357, DOI 10.1007/s10643-006-0123-x; Graham K, 2003, BRIT J CRIMINOL, V43, P546, DOI 10.1093/bjc/azg546; Graham K, 2006, ADDICTION, V101, P1569, DOI 10.1111/j.1360-0443.2006.01608.x; Gunther AC, 2006, J COMMUN, V56, P52, DOI 10.1111/j.1460-2466.2006.00002.x; Jayne M, 2012, DRUG-EDUC PREV POLIC, V19, P192, DOI 10.3109/09687637.2011.640720; Jones SC, 2017, PREV MED, V105, P19, DOI 10.1016/j.ypmed.2017.08.005; Kelly AB, 2012, ADDICT BEHAV, V37, P414, DOI 10.1016/j.addbeh.2011.11.038; Krueger RA, 2009, FOCUS GROUPS PRACTIC; LaPelle N., 2004, SIMPLIFYING QUALITAT; Levine M, 2011, PSYCHOL SCI, V22, P406, DOI 10.1177/0956797611398495; Lindsay J, 2012, INT J DRUG POLICY, V23, P236, DOI 10.1016/j.drugpo.2011.12.002; Maruna S, 2005, CRIME JUSTICE, V32, P221, DOI 10.1086/655355; Navis C, 2008, AGGRESSIVE BEHAV, V34, P167, DOI 10.1002/ab.20231; Patton M. Q., 2003, QUALITATIVE EVALUATI; Peralta R., 2006, J MENS STUDIES, V14, P109, DOI [10.3149/jms.1401.109, DOI 10.3149/JMS.1401.109]; Potenza BM, 2004, J TRAUMA, V56, P68, DOI 10.1097/01.TA.0000101490.32972.9F; Ritchie J., 2013, QUALITATIVE RES PRAC; Schrank RC, 1977, SCRIPTS PLANS GOALS; Tomsen S, 2005, AUST NZ J CRIMINOL, V38, P283, DOI 10.1375/acri.38.3.283; Wells S, 2013, ALCOHOL CLIN EXP RES, V37, pE260, DOI 10.1111/j.1530-0277.2012.01912.x; Wells S, 2011, ALCOHOL CLIN EXP RES, V35, P613, DOI 10.1111/j.1530-0277.2010.01375.x; Wells S, 2011, ADDICT BEHAV, V36, P416, DOI 10.1016/j.addbeh.2010.12.006; Wells S, 2009, SUBST USE MISUSE, V44, P1434, DOI 10.1080/10826080902961708; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552; Zinkiewicz L, 2016, DRUG ALCOHOL REV, V35, P549, DOI 10.1111/dar.12360	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191269	10.1371/journal.pone.0191269	http://dx.doi.org/10.1371/journal.pone.0191269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408910	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800015
J	Ferraz, R; Goncalves, B; Coutinho, D; Marinho, DA; Sampaio, J; Marques, MC				Ferraz, Ricardo; Goncalves, Bruno; Coutinho, Diogo; Marinho, Daniel A.; Sampaio, Jaime; Marques, Mario C.			Pacing behaviour of players in team sports: Influence of match status manipulation and task duration knowledge	PLOS ONE			English	Article							EXERCISE DURATION; RUGBY LEAGUE; TIME-MOTION; PERCEIVED EXERTION; DECISION-MAKING; HEART-RATE; FATIGUE; SOCCER; PERFORMANCE; STRATEGIES	The study aimed to identify the influence of prior knowledge of exercise duration associated with initial information about momentary match status (losing or winning) on the pacing behaviour displayed during soccer game-based activities. Twenty semi-professional male players participated in four game scenarios divided in two sessions. In the first game scenario, players were not informed about the time duration or initial match status. In the second, players were only informed they would be required to play a small-sided game for 12 minutes. In the third, players were told they would play a small-sided game for 12 minutes and that one of the teams was winning 2 to 0. Finally, in the fourth game scenario, players were instructed they would play a small-sided game for 12 minutes and the score lines used at the start of the previous game scenario were reversed. The results showed a tendency for the unknown task duration to elicit greater physical responses in all studied variables, compared with knowing the task duration. Knowing the task duration and starting the game winning or losing did not affect the players' activity profile between the two conditions. Thus, during small-sided soccer games, knowledge (or not) about the exercise duration alters the pacing behaviour of the players. Moreover, short and undisclosed-length exercise durations resulted in the adoption of more aggressive pacing strategies, characterised by higher initial exercise intensities. Furthermore, previous information on match status does not seem to interfere with pacing patterns if the players are aware of the exercise duration. Coaches may use knowledge of exercise duration to manipulate the small-sided games' demands.	[Ferraz, Ricardo; Marinho, Daniel A.; Marques, Mario C.] Univ Beira Interior, Dept Sports Sci, Covilha, Portugal; [Ferraz, Ricardo; Goncalves, Bruno; Coutinho, Diogo; Marinho, Daniel A.; Sampaio, Jaime; Marques, Mario C.] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Goncalves, Bruno; Coutinho, Diogo; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Dept Sports Sci, CreativeLab Res Community, Vila Real, Portugal	Universidade da Beira Interior; University of Tras-os-Montes & Alto Douro	Ferraz, R (corresponding author), Univ Beira Interior, Dept Sports Sci, Covilha, Portugal.; Ferraz, R (corresponding author), CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal.	rmpf@ubi.pt	Sampaio, Jaime/B-7392-2008; MARQUES, MÁRIO C/E-8613-2010; Gonçalves, Bruno/M-5361-2013; Coutinho, D./H-7313-2016; Ferraz, Ricardo/A-1426-2019; Ferraz, Ricardo/K-5868-2019	Sampaio, Jaime/0000-0003-2335-9991; Gonçalves, Bruno/0000-0001-7874-4104; Coutinho, D./0000-0001-6605-9505; Ferraz, Ricardo/0000-0002-7530-512X; Ferraz, Ricardo/0000-0002-7530-512X; Marinho, Daniel/0000-0003-2351-3047	Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE; Research Project NanoSTIMA:Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics [NORTE-01-0145-FEDER-000016]	Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE; Research Project NanoSTIMA:Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics	This project was supported by the Research Project NanoSTIMA:Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, NORTE-01-0145-FEDER-000016, Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE 2020.r This project was supported by the Research Project NanoSTIMA:Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, NORTE-01-0145-FEDER-000016, Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE 2020.	Abade EA, 2014, INT J SPORT PHYSIOL, V9, P463, DOI [10.1123/ijspp.2013-0120, 10.1123/IJSPP.2013-0120]; Baden DA, 2005, BRIT J SPORT MED, V39, P742, DOI 10.1136/bjsm.2004.016980; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Billaut F, 2011, MED SCI SPORT EXER, V43, P665, DOI 10.1249/MSS.0b013e3181f6ee3b; Black GM, 2014, J STRENGTH COND RES, V28, P1507, DOI 10.1519/JSC.0b013e3182a4a225; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cumming G., 2013, UNDERSTANDING NEW ST; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Edwards A, 2012, PACING SPORT EXERCIS; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Eston R, 2012, PSYCHOPHYSIOLOGY, V49, P462, DOI 10.1111/j.1469-8986.2011.01330.x; Feriche B., 2002, ARCH MED DEPORTE, V19, P377; Ferraz R, 2017, J SPORT SCI, P1, DOI DOI 10.1080/24733938.2017.1283433; Ferraz R, 2017, J SPORT HEALTH SCI, V6, P462, DOI 10.1016/j.jshs.2015.10.001; Ferraz R, 2012, J HUM KINET, V35, P97, DOI 10.2478/v10078-012-0083-8; Ferraz RMP, 2016, J SPORT HLTH SCI; Gabbett TJ, 2015, INT J SPORT PHYSIOL, V10, P298, DOI 10.1123/ijspp.2013-0543; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1623, DOI 10.1519/JSC.0b013e318274f2af; Gaudino P, 2014, HUM MOVEMENT SCI, V36, P123, DOI 10.1016/j.humov.2014.05.006; Gibson SAC, 2006, SPORTS MED; Highton J, 2017, INT J SPORT PHYSIOL, V12, P1192, DOI 10.1123/ijspp.2016-0603; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hutchinson JC, 2006, PSYCHOL SPORT EXERC; Johnston RJ, 2012, J STRENGTH COND RES, V26, P758, DOI 10.1519/JSC.0b013e318225f161; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Lander PJ, 2009, BRIT J SPORT MED, V43, P789, DOI 10.1136/bjsm.2008.056085; Malone S, 2016, INT J PERFORM ANAL S, V16; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marcora SM, 2008, EUR J APPL PHYSIOL, V104, P929, DOI 10.1007/s00421-008-0818-3; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; McLellan CP, 2011, J STRENGTH COND RES, V25, P1553, DOI 10.1519/JSC.0b013e3181db9bdd; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Schiphof-Godart L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00083; Skorski S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00102; Smits BLM, 2014, SPORTS MED, V44, P763, DOI 10.1007/s40279-014-0163-0; Sullivan C, 2014, J SCI MED SPORT, V17, P326, DOI 10.1016/j.jsams.2013.05.001; Swart J, 2012, BRIT J SPORT MED, V46, P42, DOI 10.1136/bjsports-2011-090337; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6	47	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192399	10.1371/journal.pone.0192399	http://dx.doi.org/10.1371/journal.pone.0192399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401476	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400059
J	Benedetti, S; Catalani, S; Peda, F; Luchetti, F; Citarella, R; Battistelli, S				Benedetti, Serena; Catalani, Simona; Peda, Federica; Luchetti, Francesca; Citarella, Roberto; Battistelli, Serafina			Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners	PLOS ONE			English	Article							ULTRA-ENDURANCE EXERCISE; MARATHON; INFLAMMATION; MUSCLE; DAMAGE	The impact of the 24-h ultramarathon race on homocysteine (Hcy) and oxidized low-density lipoprotein (oxLDL) levels, two well-recognized cardiovascular risk factors, has not been deeply investigated. Similarly, no information exists on paraoxonase 1 (PON1), an antioxidant enzyme associated with high-density lipoproteins, which may detoxify oxLDL and Hcy-thiolactone, hence preventing their proatherogenic action. Taking this into account, a competitive 24-h ultramarathon race was organized in Reggio-Emilia (Italy) recruiting professional runners (n = 14) from the Italian Ultramarathon and Trail Association. Blood samples were collected from each participant before, during (14 h), and immediately after (24 h) the competition, thus to monitor the serum changes in Hcy, oxLDL, and PON1 levels, as well as other oxidative stress-related parameters, namely reactive oxygen metabolites (ROM) and total antioxidant capacity (PAT). As a result, a significant PON1 increase was recorded after 14 h of racing that persisted until the end of the performance. The same trend was observed for PAT values, which positively correlated to PON1 levels (R = 0.643, P< 0.001). Hcy, oxLDL, and ROM remained almost unchanged throughout the competition. In conclusion, the present study suggested a protective role of PON1 in sustaining the antioxidant defense system and contrasting lipoprotein oxidative modifications over the 24-h race, and did not specifically evidence either Hcy or oxLDL accumulation in such challenging sporting events.	[Benedetti, Serena; Catalani, Simona; Peda, Federica; Battistelli, Serafina] Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy; [Luchetti, Francesca] Univ Urbino Carlo Bo, Sect Pharmacol & Pharmacognosy, Dept Biomol Sci, Urbino, Italy; [Citarella, Roberto] Ctr Rehabil Therapy, Reggio Emilia, Italy	University of Urbino; University of Urbino	Benedetti, S (corresponding author), Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy.	serena.benedetti@uniurb.it		Benedetti, Serena/0000-0002-9719-2381	Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy)	Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy)	This study was partially sustained by Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy). The funder had no role in data collection and analysis. There was no additional external funding received for this study. Other sources of support were internal to our organization	Chernyavskiy I, 2016, ANN NY ACAD SCI, V1363, P138, DOI 10.1111/nyas.13009; Chistiakov DA, 2017, BIOCHIMIE, V132, P19, DOI 10.1016/j.biochi.2016.10.010; Emed LGM, 2016, J SPORT SCI, V34, P1657, DOI 10.1080/02640414.2015.1130237; Gill SK, 2015, INT J SPORTS MED, V36, P688, DOI 10.1055/s-0034-1398535; Gresslien T, 2016, INT J CARDIOL, V221, P609, DOI 10.1016/j.ijcard.2016.06.243; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Jee H, 2012, J SPORT SCI MED, V11, P719; Kerschan-Schindl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132478; Khodaee M, 2015, INT J SPORTS MED, V36, P867, DOI 10.1055/s-0035-1550045; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Kupchak BR, 2014, WILD ENVIRON MED, V25, P278, DOI 10.1016/j.wem.2014.03.013; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; Marklund P, 2013, J APPL PHYSIOL, V114, P66, DOI 10.1152/japplphysiol.01538.2011; Maroto-Sanchez B, 2016, CLIN CHEM LAB MED, V54, P1561, DOI 10.1515/cclm-2015-1040; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; Morillas-Ruiz J. M., 2015, BASIC PRINCIPLES CLI, P221; Nieman DC, 2003, INT J SPORTS MED, V24, P541; Otocka-Kmiecik A., 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/230271; Passaglia DG, 2013, ARQ BRAS CARDIOL, V100, P21, DOI 10.1590/S0066-782X2012005000118; Scott JM, 2009, MED SCI SPORT EXER, V41, P25, DOI 10.1249/MSS.0b013e31818313ff; Seidl J, 2014, CURR SPORT MED REP, V13, P361, DOI 10.1249/JSR.0000000000000097; Skenderi KP, 2008, EUR J CLIN INVEST, V38, P159, DOI 10.1111/j.1365-2362.2007.01917.x; Skovierova H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101733; Trpkovic A, 2015, CRIT REV CL LAB SCI, V52, P70, DOI 10.3109/10408363.2014.992063; Turner JE, 2014, BIOCHEM SOC T, V42, P989, DOI 10.1042/BST20140120; Vezzoli A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6439037; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5; Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711	29	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192392	10.1371/journal.pone.0192392	http://dx.doi.org/10.1371/journal.pone.0192392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394290	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400042
J	He, YJ; Penney, ME; Negandhi, AA; Parfrey, PS; Savas, S; Yilmaz, YE				He, Yanjing; Penney, Michelle E.; Negandhi, Amit A.; Parfrey, Patrick S.; Savas, Sevtap; Yilmaz, Yildiz E.			XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; BREAST-CANCER; SURVIVAL-DATA; COLON-CANCER; 5-FLUOROURACIL; POPULATION; EXPRESSION; PROGNOSIS; MODELS; CHEMOTHERAPY	Background Metastasis is a major cause of mortality in cancer. Identifying prognostic factors that distinguish patients who will experience metastasis in the short-term and those that will be free of metastasis in the long-term is of particular interest in current medical research. The objective of this study was to examine if select genetic polymorphisms can differentiate colorectal cancer patients based on timing and long-term risk of metastasis. Methods The patient cohort consisted of 402 stage I-III colorectal cancer patients with microsatellite instability (MSI)-low (MSI-L) or microsatellite stable (MSS) tumors. We applied multivariable mixture cure model, which is the proper model when there is a substantial group of patients who remain free of metastasis in the long-term, to 26 polymorphisms. Time-dependent receiver operator characteristic (ROC) curve analysis was performed to determine the change in discriminatory accuracy of the models when the significant SNPs were included. Results After adjusting for significant baseline characteristics, two polymorphisms were significantly associated with time-to-metastasis: TT and TC genotypes of the XRCC3 Thr241Met (p = 0.042) and the 3R/3R genotype of TYMS 5'-UTR variable number tandem repeat (VNTR) (p = 0.009) were associated with decreased time-to-metastasis. ROC curves showed that the discriminatory accuracy of the model is increased slightly when these polymorphisms were added to the significant baseline characteristics. Conclusions Our results indicate XRCC3 Thr241Met and TYMS 5'-UTR VNTR polymorphisms are associated with time-to-metastasis, and may have potential biological roles in expediting the metastatic process. Once replicated, these associations could contribute to the development of precision medicine for colorectal cancer patients.	[He, Yanjing; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Sci, Dept Math & Stat, St John, NF, Canada; [He, Yanjing; Penney, Michelle E.; Negandhi, Amit A.; Savas, Sevtap; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Parfrey, Patrick S.; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Sci, Dept Math & Stat, St John, NF, Canada.; Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.; Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada.	yyilmaz@mun.ca			Research and Development Corporation (RDC) of Newfoundland and Labrador (NL) [5404.1723.101]; Newfoundland Colorectal Cancer Registry (NFCCR); Faculty of Medicine of Memorial University Cox Award; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto; Memorial University of Newfoundland; National Cancer Institute of Canada [18223, 18226]; Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship; CIHR Interdisciplinary Health Research Team Fellowship	Research and Development Corporation (RDC) of Newfoundland and Labrador (NL); Newfoundland Colorectal Cancer Registry (NFCCR); Faculty of Medicine of Memorial University Cox Award; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto(Canadian Institutes of Health Research (CIHR)); Memorial University of Newfoundland; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship; CIHR Interdisciplinary Health Research Team Fellowship(Canadian Institutes of Health Research (CIHR))	This work was primarily funded by the Research and Development Corporation (RDC) of Newfoundland and Labrador (NL) [5404.1723.101] and the Faculty of Medicine of Memorial University of Newfoundland awarded to Y.E. Yilmaz. Other funds that supported the Newfoundland Colorectal Cancer Registry (NFCCR) and helped collect the data used in this study are: Medical Research fund at Faculty of Medicine of Memorial University Cox Award 2010, Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University of Newfoundland, the National Cancer Institute of Canada [18223 and 18226] and the Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics. M.E. Penney is partly supported by a Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship. A.A. Negandhi was supported by a CIHR Interdisciplinary Health Research Team Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejan-Angoulvant T, 2008, EUR J EPIDEMIOL, V23, P251, DOI 10.1007/s10654-008-9226-6; Boige V, 2010, J CLIN ONCOL, V28, P2556, DOI 10.1200/JCO.2009.25.2106; Buckowitz A, 2005, BRIT J CANCER, V92, P1746, DOI 10.1038/sj.bjc.6602534; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2016, CAN CANC STAT 2016; Cui YH, 2009, J DIGEST DIS, V10, P118, DOI 10.1111/j.1751-2980.2009.00373.x; Cvancarova M, 2013, INT J CANCER, V132, P1700, DOI 10.1002/ijc.27802; FAREWELL VT, 1982, BIOMETRICS, V38, P1041, DOI 10.2307/2529885; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forse CL, 2013, BREAST CANCER RES TR, V137, P709, DOI 10.1007/s10549-012-2392-y; Gosens MI, 2008, INT J CANCER, V123, P1941, DOI 10.1002/ijc.23740; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Grimminger PP, 2010, J SURG RES, V164, pE61, DOI 10.1016/j.jss.2010.08.002; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hitre E, 2005, PHARMACOGENET GENOM, V15, P723, DOI 10.1097/01.fpc.0000175598.42141.59; Hosmer DW, 2008, APPL SURVIVAL ANAL; Howlader N, 2011, SEER CANC STAT REV 1; Kawakami K, 2001, CLIN CANCER RES, V7, P4096; Kawakami K, 1999, ANTICANCER RES, V19, P3249; Lambert PC, 2010, J R STAT SOC C-APPL, V59, P35, DOI 10.1111/j.1467-9876.2009.00677.x; Lawless J. F., 2003, STAT MODELS METHODS; Lawless JF, 2011, BIOMETRICAL J, V53, P779, DOI 10.1002/bimj.201000131; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu Y, 2012, HEPATO-GASTROENTEROL, V59, P977, DOI 10.5754/hge12187; Malesci A, 2007, CLIN CANCER RES, V13, P3831, DOI 10.1158/1078-0432.CCR-07-0366; Martinez-Balibrea E, 2008, EUR J CANCER, V44, P1229, DOI 10.1016/j.ejca.2008.03.025; Martinez-Balibrea E, 2007, ONCOL REP, V17, P637; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Paez D, 2017, INT J RADIAT ONCOL, V81, P1319; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Ruzzo A, 2008, PHARMACOGENOMICS J, V8, P278, DOI 10.1038/sj.tpj.6500463; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wish TA, 2010, CANCER EPIDEM BIOMAR, V19, P1831, DOI 10.1158/1055-9965.EPI-10-0055; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; Yilmaz YE, 2013, J CLIN ONCOL, V31, P2047, DOI 10.1200/JCO.2012.46.6615; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087	40	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192316	10.1371/journal.pone.0192316	http://dx.doi.org/10.1371/journal.pone.0192316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394274	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400034
J	Abuyassin, B; Badran, M; Ayas, NT; Laher, I				Abuyassin, Bisher; Badran, Mohammad; Ayas, Najib T.; Laher, Ismail			Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM ACTIVITY; MESANGIAL MATRIX EXPANSION; AIRWAY PRESSURE THERAPY; GLOMERULAR-DISEASE; TGF-BETA; DIABETIC-NEPHROPATHY; CARDIOVASCULAR CONSEQUENCES; OXIDATIVE STRESS; BLOOD-PRESSURE; RENAL-DISEASE	Epidemiological studies demonstrate an association between obstructive sleep apnea (OSA) and accelerated loss of kidney function. It is unclear whether the decline in function is due to OSA per se or to other confounding factors such as obesity. In addition, the structural kidney abnormalities associated with OSA are unclear. The objective of this study was to determine whether intermittent hypoxia (IH), a key pathological feature of OSA, induces renal histopathological damage using a mouse model. Ten 8-week old wild-type male CB57BL/6 mice were randomly assigned to receive either IH or intermittent air (IA) for 60 days. After euthanasia, one kidney per animal was paraformaldehyde-fixed and then sectioned for histopathological and immunohistochemical analysis. Measurements of glomerular hypertrophy and mesangial matrix expansion were made in periodic acid-Schiff stained kidney sections, while glomerular transforming growth factor-beta 1 (TGF-beta 1), connective tissue growth factor (CTGF) and vascular endothelial growth factor-A (VEGF-A) proteins were semi-quantified by immunohistochemistry. The antigen-antibody reaction was detected by 3,3'-diaminobenzidine chromogen where the color intensity semi-quantified glomerular protein expression. To enhance the accuracy of protein semi-quantification, the percentage of only highly-positive staining was used for analysis. Levels of TGF-beta, CTGF and VEGF-A proteins in the kidney cortex were further quantified by western blotting. Cellular apoptosis was also investigated by measuring cortical antiapoptotic B-cell lymphoma 2 (Bcl-2) and apoptotic Bcl-2-associated X (Bax) proteins by western blotting. Further investigation of cellular apoptosis was carried out by fluorometric terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) staining. Finally, the levels of serum creatinine and 24-hour urinary albumin were measured as a general index of renal function. Our results indicate that mice exposed to IH have an increased glomerular area (by 1.13 fold, p< 0.001) and expansion of mesangial matrix (by 1.8 fold, p< 0.01). Moreover, the glomerular expressions of TGF-beta 1, CTGF and VEGF-A proteins were 2.7, 2.2 and 3.8-fold higher in mice exposed to IH (p< 0.05 for all). Furthermore, western blotting protein analysis demonstrates that IH-exposed mice express higher levels of TGF-beta 1, CTGF and VEGF-A proteins by 1.9, 4.0 and 1.6-fold (p< 0.05 for all) respectively. Renal cellular apoptosis was greater in the IH group as shown by an increased cortical Bax/Bcl-2 protein ratio (p< 0.01) and higher fluorometric TUNEL staining (p< 0.001). Finally, 24-hr urinary albumin levels were higher in mice exposed to IH (43.4 mu g vs 9.7 mu g, p< 0.01), while there were no differences in serum creatinine levels between the two groups. We conclude that IH causes kidney injury that is accompanied by glomerular hypertrophy, mesangial matrix expansion, increased expression of glomerular growth factors and an increased cellular apoptosis.	[Abuyassin, Bisher; Ayas, Najib T.] Univ British Columbia, Dept Med, Fac Med, Vancouver, BC, Canada; [Badran, Mohammad; Laher, Ismail] Univ British Columbia, Fac Med, Dept Pharmacol, Vancouver, BC, Canada; [Badran, Mohammad; Laher, Ismail] Univ British Columbia, Fac Med, Dept Therapeut, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Laher, I (corresponding author), Univ British Columbia, Fac Med, Dept Pharmacol, Vancouver, BC, Canada.; Laher, I (corresponding author), Univ British Columbia, Fac Med, Dept Therapeut, Vancouver, BC, Canada.	ilaher@mail.ubc.ca	Badran, Mohammad/AAX-6962-2021; Laher, Ismail/X-3323-2019	Badran, Mohammad/0000-0001-7073-741X; Laher, Ismail/0000-0002-3917-4417	CIHR Sleep Team Grant; Saudi Arabian Cultural Bureau in Canada	CIHR Sleep Team Grant(Canadian Institutes of Health Research (CIHR)); Saudi Arabian Cultural Bureau in Canada	This work received project funding from CIHR Sleep Team Grant. Individual Acknowledgment: The support of the Saudi Arabian Cultural Bureau in Canada (to BA) is gratefully acknowledged.; The support of the Saudi Arabian Cultural Bureau in Canada (to BA) is gratefully acknowledged.	ABRASS CK, 1995, WESTERN J MED, V162, P318; Abuyassin B, 2015, J CLIN SLEEP MED, V11, P915, DOI 10.5664/jcsm.4946; Adeseun GA, 2010, CURR HYPERTENS REP, V12, P378, DOI 10.1007/s11906-010-0135-1; Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Almendros I, 2013, RESP PHYSIOL NEUROBI, V186, P303, DOI 10.1016/j.resp.2013.03.001; Badran M, 2015, CAN J CARDIOL, V31, P873, DOI 10.1016/j.cjca.2015.03.011; Badran M, 2014, SLEEP MED, V15, P596, DOI 10.1016/j.sleep.2014.01.013; Calvin AD, 2009, METAB SYNDR RELAT D, V7, P271, DOI 10.1089/met.2008.0093; Carpagnano GE, 2003, CHEST, V124, P1386, DOI 10.1378/chest.124.4.1386; Chou YT, 2011, NEPHROL DIAL TRANSPL, V26, P2244, DOI 10.1093/ndt/gfq821; Cravedi P, 2013, BRIT J CLIN PHARMACO, V76, P516, DOI 10.1111/bcp.12104; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Fine LG, 1998, KIDNEY INT, pS74; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Fogo AB, 1999, EXP NEPHROL, V7, P147; Friederich-Persson M, 2013, HYPERTENSION, V62, P914, DOI 10.1161/HYPERTENSIONAHA.113.01425; Ghayur A, 2013, KIDNEY RES CLIN PRAC, V32, P3, DOI 10.1016/j.krcp.2013.01.003; Golbidi S, 2012, LUNG, V190, P113, DOI 10.1007/s00408-011-9340-1; Goldschmeding R, 2000, NEPHROL DIAL TRANSPL, V15, P296, DOI 10.1093/ndt/15.3.296; Goumenos DS, 2002, NEPHROL DIAL TRANSPL, V17, P2145, DOI 10.1093/ndt/17.12.2145; Goumenos DS, 2001, NEPHRON, V87, P240, DOI 10.1159/000045921; Griffin KA, 2004, KIDNEY INT, V65, P209, DOI 10.1111/j.1523-1755.2004.00356.x; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hughson MD, 2014, NEPHROL DIAL TRANSPL, V29, P1399, DOI 10.1093/ndt/gft480; Iiyori N, 2007, AM J RESP CRIT CARE, V175, P851, DOI 10.1164/rccm.200610-1527OC; Iseki K, 2008, HYPERTENS RES, V31, P249, DOI 10.1291/hypres.31.249; Kanbay A, 2012, INT UROL NEPHROL, V44, P535, DOI 10.1007/s11255-011-9927-8; Lee HS, 2012, HISTOL HISTOPATHOL, V27, P1131, DOI 10.14670/HH-27.1131; Lee HS, 2009, HISTOL HISTOPATHOL, V24, P901, DOI 10.14670/HH-24.901; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Nicholl DDM, 2014, AM J RESP CRIT CARE, V190, P572, DOI 10.1164/rccm.201403-0526OC; Nicholl DDM, 2012, CHEST, V141, P1422, DOI 10.1378/chest.11-1809; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Parati G, 2014, HYPERTENS RES, V37, P601, DOI 10.1038/hr.2014.80; Petrosino T, 2014, CRIT REV FOOD SCI, V54, P1202, DOI 10.1080/10408398.2011.630153; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rajan P, 2015, NAT SCI SLEEP, V7, P113, DOI 10.2147/NSS.S90835; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Sun WX, 2013, DOSE-RESPONSE, V11, P385, DOI 10.2203/dose-response.12-027.Cai; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Thomson SE, 2008, J DIABETES COMPLICAT, V22, P284, DOI 10.1016/j.jdiacomp.2007.07.001; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vilaseca A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179444; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Wang X, 2013, RESPIROLOGY, V18, P140, DOI 10.1111/j.1440-1843.2012.02267.x; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu H, 2015, TOXICOL LETT, V232, P340, DOI 10.1016/j.toxlet.2014.11.015; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zalucky AA, 2015, AM J RESP CRIT CARE, V192, P873, DOI 10.1164/rccm.201502-0383OC; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	55	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192084	10.1371/journal.pone.0192084	http://dx.doi.org/10.1371/journal.pone.0192084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389945	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400065
J	Bergman, P				Bergman, Patrick			The number of repeated observations needed to estimate the habitual physical activity of an individual to a given level of precision	PLOS ONE			English	Article							OUTCOME VARIABLES; ACCELEROMETER; VARIABILITY; ADULTS; CHILDREN	Physical activity behavior varies naturally from day to day, from week to week and even across seasons. In order to assess the habitual level of physical activity of a person, the person must be monitored for long enough so that the level can be identified, taking into account this natural within-person variation. An important question, and one whose answer has implications for study-and survey design, epidemiological research and population surveillance, is, for how long does an individual need to be monitored before such a habitual level or pattern can be identified to a desired level of precision? The aim of this study was to estimate the number of repeated observations needed to identify the habitual physical activity behaviour of an individual to a given degree of precision. A convenience sample of 50 Swedish adults wore accelerometers during four consecutive weeks. The number of days needed to come within 5-50% of an individual's usual physical activity 95% of the time was calculated. To get an idea of the uncertainty of the estimates all statistical estimates were bootstrapped 2000 times. The mean number of days of measurement needed for the observation to, with 95% confidence, be within 20% of the habitual physical activity of an individual is highest for vigorous physical activity, for which 182 days are needed. For sedentary behaviour the equivalent number of days is 2.4. To capture 80% of the sample to within +/- 20% of their habitual level of physical activity, 3.4 days is needed if sedentary behavior is the outcome of interest, and 34.8 days for MVPA. The present study shows that for analyses requiring accurate data at the individual level a longer measurement collection period than the traditional 7-day protocol should be used. In addition, the amount of MVPA was negatively associated with the number of days required to identify the habitual physical activity level indicating that the least active are also those whose habitual physical activity level is the most difficult to identify. These results could have important implications for researchers whose aim is to analyse data on an individual level. Before recommendations regarding an appropriate monitoring protocol are updated, the present study should be replicated in different populations.	[Bergman, Patrick] Linnaeus Univ, Dept Sport Sci, Kalmar, Sweden	Linnaeus University	Bergman, P (corresponding author), Linnaeus Univ, Dept Sport Sci, Kalmar, Sweden.	Patrick.bergman@lnu.se	Bergman, Patrick/B-5906-2012	Bergman, Patrick/0000-0003-4934-8684				Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133296; Aadland E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-172; Augustin NH, 2015, STAT METHODS MED RES; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibson R, 2005, PRINCIPLES NUTR ASSE; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Holliday KM, 2017, MED SCI SPORT EXER, V49, P939, DOI 10.1249/MSS.0000000000001190; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; LIU K, 1978, J CHRON DIS, V31, P399, DOI 10.1016/0021-9681(78)90004-8; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Melin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153036; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385; Ridgers ND, 2016, J SCI MED SPORT; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Shephard RJ, 2009, EUR J APPL PHYSIOL, V107, P251, DOI 10.1007/s00421-009-1127-1; Team RC, 2016, R LANG ENV STAT COMP; Togo F, 2008, MED SCI SPORT EXER, V40, P1058, DOI 10.1249/MSS.0b013e318167469a; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vanhelst Jeremy, 2012, BMC Res Notes, V5, P187, DOI 10.1186/1756-0500-5-187; Wickel EE, 2006, EUR J CLIN NUTR, V60, P538, DOI 10.1038/sj.ejcn.1602348; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]; Wu YT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177767	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192117	10.1371/journal.pone.0192117	http://dx.doi.org/10.1371/journal.pone.0192117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390010	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400069
J	Wan, Z; Ostendorff, HP; Liu, ZY; Schneider, LC; Rothschild, KJ; Lim, MJ				Wan, Zhi; Ostendorff, Heather P.; Liu, Ziying; Schneider, Lynda C.; Rothschild, Kenneth J.; Lim, Mark J.			Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing	PLOS ONE			English	Article							FOOD ALLERGY; HETEROPHILE ANTIBODY; IGE CONCENTRATIONS; INTERFERENCE; PEANUT; IMMUNOASSAY; BINDING; RISK; AUTOANTIBODIES; PARAMETER	Multiplex serological immunoassays, such as implemented on microarray or microsphere-based platforms, provide greater information content and higher throughput, while lowering the cost and blood volume required. These features are particularly attractive in pediatric food allergy testing to facilitate high throughput multi-allergen analysis from finger-or heel-stick collected blood. However, the miniaturization and microfluidics necessary for creating multiplex assays make them highly susceptible to the "matrix effect" caused by interference from non-target agents in serum and other biofluids. Such interference can result in lower sensitivity, specificity, reproducibility and quantitative accuracy. These problems have in large part prevented wide-spread implementation of multiplex immunoassays in clinical laboratories. We report the development of a novel method to eliminate the matrix effect by utilizing photocleavable capture antibodies to purify and concentrate blood-based biomarkers (a process termed PC-PURE) prior to detection in a multiplex immunoassay. To evaluate this approach, it was applied to blood-based allergy testing. Patient total IgE was purified and enriched using PC-PURE followed by multiplex microsphere-based detection of allergen-specific IgEs (termed the AllerBead assay). AllerBead was formatted to detect the eight most common pediatric food allergens: milk, soy, wheat, egg, peanuts, tree nuts, fin fish and shellfish, which account for >90% of all pediatric food allergies. 205 serum samples obtained from Boston Children's Hospital were evaluated. When PC-PURE was employed with AllerBead, excellent agreement was obtained with the standard, non-multiplex, ImmunoCAP (R) assay (average sensitivity above published negative predictive cutoffs = 96% and average Pearson r = 0.90; average specificity = 97%). In contrast, poor ImmunoCAP (R)-correlation was observed when PC-PURE was not utilized (average sensitivity above published negative predictive cutoffs = 59% and average Pearson r = 0.61; average specificity = 97%). This approach should be adaptable to improve a wide range of multiplex immunoassays such as in cancer, infectious disease and autoimmune disease.	[Wan, Zhi; Ostendorff, Heather P.; Liu, Ziying; Rothschild, Kenneth J.; Lim, Mark J.] AmberGen Inc, Watertown, MA 02472 USA; [Schneider, Lynda C.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Rothschild, Kenneth J.] Boston Univ, Dept Phys, Mol Biophys Lab, 590 Commonwealth Ave, Boston, MA 02215 USA; [Rothschild, Kenneth J.] Boston Univ, Photon Ctr, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Boston University; Boston University	Rothschild, KJ; Lim, MJ (corresponding author), AmberGen Inc, Watertown, MA 02472 USA.; Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, Mol Biophys Lab, 590 Commonwealth Ave, Boston, MA 02215 USA.; Rothschild, KJ (corresponding author), Boston Univ, Photon Ctr, Boston, MA 02215 USA.	krothschild@amberen.com; mlim@ambergen.com	Rothschild, Kenneth J/P-6177-2018; Schneider, Lynda C/AAY-6545-2021	Rothschild, Kenneth J/0000-0002-2847-6671; Schneider, Lynda C/0000-0002-5633-0178; Lim, Mark/0000-0002-5784-7195	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, United States of America [R43/R44 AI100424]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, United States of America	This work was supported by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) of the National Institutes of Health, United States of America, grant R43/R44 AI100424 to AmberGen Incorporated with MJL as the Principle Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2016, ALLERGO J, V25, P18, DOI 10.1007/s40629-016-0112-6; Anderson KS, 2015, J PROTEOME RES, V14, P578, DOI 10.1021/pr500908n; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Barker DP, 1996, ARCH DIS CHILD-FETAL, V74, pF139, DOI 10.1136/fn.74.2.F139; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Branum Amy M, 2008, NCHS Data Brief, P1; Carey BS, 2016, TRANSPL IMMUNOL, V37, P23, DOI 10.1016/j.trim.2016.04.002; Carosso A, 2007, INT ARCH ALLERGY IMM, V142, P230, DOI 10.1159/000097025; Chacko M P, 2016, Indian J Nephrol, V26, P134, DOI 10.4103/0971-4065.159305; Chiu ML, 2010, JALA-J LAB AUTOM, V15, P233, DOI 10.1016/j.jala.2010.02.001; Churchman SM, 2012, CLIN EXP RHEUMATOL, V30, P534; Copple SS, 2007, ANN NY ACAD SCI, V1109, P464, DOI 10.1196/annals.1398.052; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Deinhofer K, 2004, METHODS, V32, P249, DOI 10.1016/j.ymeth.2003.08.018; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Fung KYC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120425; Guhsl EE, 2015, ALLERGY, V70, P59, DOI 10.1111/all.12534; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hofman T, 1995, Rocz Akad Med Bialymst, V40, P468; Jarvinen KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143855; Janes Marianne, 2002, J Perinatol, V22, P154, DOI 10.1038/sj.jp.7210583; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095444; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaplan IV, 1999, CLIN CHEM, V45, P616; Kenten JH, 2005, METHOD ENZYMOL, V399, P682, DOI 10.1016/S0076-6879(05)99045-9; Kim YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044960; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Kukkonen AK, 2015, ALLERGY; LAURENT J, 1985, ANN MED INTERNE, V136, P419; Lieberman JA, 2011, CURR ALLERGY ASTHM R, V11, P58, DOI 10.1007/s11882-010-0149-4; Lim M, 2008, ANAL BIOCHEM, V383, P103, DOI 10.1016/j.ab.2008.07.038; Martins TB, 2004, CLIN DIAGN LAB IMMUN, V11, P325, DOI 10.1128/CDLI.11.2.325-329.2004; Norman GL, 2015, LIVER INT, V35, P642, DOI 10.1111/liv.12690; Ostendorff HP, 2013, J IMMUNOL METHODS, V400, P58, DOI 10.1016/j.jim.2013.09.013; Ott H, 2009, ACTA DERM-VENEREOL, V89, P257, DOI 10.2340/00015555-0627; Peng Z, 2015, INT J LAB HEMATOL, V37, P56, DOI 10.1111/ijlh.12231; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Pickering JW, 2010, CLIN VACCINE IMMUNOL, V17, P185, DOI 10.1128/CVI.00329-09; Pomponi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035697; Rispens T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055566; Rosenberg-Hasson Y, 2014, IMMUNOL RES, V58, P224, DOI 10.1007/s12026-014-8491-6; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2008, J ALLERGY CLIN IMMUN, V122, P413, DOI 10.1016/j.jaci.2008.05.012; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Stern E, 2010, NAT NANOTECHNOL, V5, P138, DOI [10.1038/nnano.2009.353, 10.1038/NNANO.2009.353]; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; Togias A, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-016-0175-4; Treudler R, 2013, CURR ALLERGY ASTHM R, V13, P110, DOI 10.1007/s11882-012-0318-8; Visco V, 1996, J IMMUNOL, V157, P956; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Zachary AA, 2009, HUM IMMUNOL, V70, P496, DOI 10.1016/j.humimm.2009.04.001; Zerrouki A, 2016, TRANSPL IMMUNOL, V36, P20, DOI 10.1016/j.trim.2016.03.001	63	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191987	10.1371/journal.pone.0191987	http://dx.doi.org/10.1371/journal.pone.0191987			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389948	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400047
J	Marques, ACR; Raimundo, MM; Cavalheiro, EMB; Salles, LFP; Lyra, C; Von Zuben, FJ				Marques, Alan Caio R.; Raimundo, Marcos M.; Cavalheiro, Ellen Marianne B.; Salles, Luis F. P.; Lyra, Christiano; Von Zuben, Fernando J.			Ant genera identification using an ensemble of convolutional neural networks	PLOS ONE			English	Article							CLASSIFICATION; IMAGES	Works requiring taxonomic knowledge face several challenges, such as arduous identification of many taxa and an insufficient number of taxonomists to identify a great deal of collected organisms. Machine learning tools, particularly convolutional neural networks (CNNs), are then welcome to automatically generate high-performance classifiers from available data. Supported by the image datasets available at the largest online database on ant biology, the AntWeb (www.antweb.org), we propose here an ensemble of CNNs to identify ant genera directly from the head, profile and dorsal perspectives of ant images. Transfer learning is also considered to improve the individual performance of the CNN classifiers. The performance achieved by the classifiers is diverse enough to promote a reduction in the overall classification error when they are combined in an ensemble, achieving an accuracy rate of over 80% on top-1 classification and an accuracy of over 90% on top-3 classification.	[Marques, Alan Caio R.; Raimundo, Marcos M.; Cavalheiro, Ellen Marianne B.; Lyra, Christiano; Von Zuben, Fernando J.] Univ Estadual Campinas, UNICAMP, Sch Elect & Comp Engn, Av Albert Einstein 400, BR-13083852 Campinas, SP, Brazil; [Salles, Luis F. P.] Univ Estadual Campinas, UNICAMP, Inst Biol, Grad Program Ecol, R Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Marques, ACR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Elect & Comp Engn, Av Albert Einstein 400, BR-13083852 Campinas, SP, Brazil.	alancaiorm@gmail.com	Lyra, Christiano/A-5920-2010	Lyra, Christiano/0000-0002-5263-1977; Salles, Luis/0000-0002-5326-4603; Marques, Alan Caio/0000-0001-7233-7444; Cavalheiro, Ellen/0000-0001-6586-2101	Brazilian National Council for Scientific and Technological Development [141308/2014-1, 131488/2015-5, 311751/2013-0, 309115/2014-0]; Coordination for the Improvement of Higher Education Personnel [23038.002884/2013-38]; Sao Paulo Research Foundation [2014/13533-0]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors kindly acknowledge support from the: Brazilian National Council for Scientific and Technological Development (http://cnpq.br/), grants #141308/2014-1 (ACRM), #131488/2015-5 (LFPS) #311751/2013-0 (CL) and #309115/2014-0 (FJVZ); Coordination for the Improvement of Higher Education Personnel (http://www.capes.gov.br/) grants #23038.002884/2013-38 (EMBC); and Sao Paulo Research Foundation (http://www.fapesp.br/) grant 2014/13533-0 (MMR).; The authors kindly acknowledge support from the Brazilian National Council for Scientific and Technological Development (grants #141308/2014-1, #131488/2015-5, #311751/2013-0 and #309115/2014-0), Coordination for the Improvement of Higher Education Personnel (grants #23038.002884/2013-38) and Sao Paulo Research Foundation (grant 2014/13533-0).	Carneiro G, 2015, LECT NOTES COMPUT SC, V9351, P652, DOI 10.1007/978-3-319-24574-4_78; Chen G, 2014 IEEE INT C IM P; Ding WG, 2016, COMPUT ELECTRON AGR, V123, P17, DOI 10.1016/j.compag.2016.02.003; Drew LW, 2011, BIOSCIENCE, V61, P942, DOI 10.1525/bio.2011.61.12.4; Dyrmann M, 2016, BIOSYST ENG, V151, P72, DOI 10.1016/j.biosystemseng.2016.08.024; Favret C, 2016, SYST ENTOMOL, V41, P133, DOI 10.1111/syen.12146; Fratello M, 2017, NEUROINFORMATICS, V15, P199, DOI 10.1007/s12021-017-9324-2; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Jia Y., 2014, 22 ACM INT C MULTIME, P675, DOI 10.1145/2647868.2654889; Kan MN, 2016, PROC CVPR IEEE, P4847, DOI 10.1109/CVPR.2016.524; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Liu K, 2017, INT J IMAG SYST TECH, V27, P12, DOI 10.1002/ima.22206; Liu Z, 2016, SCI REPORTS, V6, P11; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mitchell T.M, 2003, MACH LEARN; Raitoharju J, 2016, 2016 ICPR 2ND WORKSHOP ON COMPUTER VISION FOR ANALYSIS OF UNDERWATER IMAGERY (CVAUI 2016), P43, DOI [10.1109/CVAUI.2016.020, 10.1109/CVAUI.2016.20]; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Silva RR, 2010, ECOL MONOGR, V80, P107, DOI 10.1890/08-1298.1; Weeks PJD, 1997, B ENTOMOL RES, V87, P203, DOI 10.1017/S000748530002736X; Weiser MD, 2006, ECOL ENTOMOL, V31, P131, DOI 10.1111/j.0307-6946.2006.00759.x; Wilson EO, 2004, PHILOS T R SOC B, V359, P739, DOI 10.1098/rstb.2003.1440; Xu C., 2013, ARXIV13045634, P1; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207; Zhu L-Q., 2016, ORIENT INSECTS, V51, P1	27	17	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192011	10.1371/journal.pone.0192011	http://dx.doi.org/10.1371/journal.pone.0192011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385214	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400069
J	Kooiman, J; de Vries, JPPM; Van der Heyden, J; Sijpkens, YWJ; van Dijkman, PRM; Wever, JJ; van Overhagen, H; Vahl, AC; Aarts, N; Verberk-Jonkers, IJAM; Brulez, HFH; Hamming, JF; van der Molen, AJ; Cannegieter, SC; Putter, H; van den Hout, WB; Kilicsoy, I; Rabelink, TJ; Huisman, MV				Kooiman, Judith; de Vries, Jean-Paul P. M.; Van der Heyden, Jan; Sijpkens, Yvo W. J.; van Dijkman, Paul R. M.; Wever, Jan J.; van Overhagen, Hans; Vahl, Antonie C.; Aarts, Nico; Verberk-Jonkers, Iris J. A. M.; Brulez, Harald F. H.; Hamming, Jaap F.; van der Molen, Aart J.; Cannegieter, Suzanne C.; Putter, Hein; van den Hout, Wilbert B.; Kilicsoy, Inci; Rabelink, Ton J.; Huisman, Menno V.			Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCED NEPHROPATHY; MYOCARDIAL-INFARCTION; RENAL-INSUFFICIENCY; PRACTICE GUIDELINES; N-ACETYLCYSTEINE; SERUM CREATININE; INJURY; OUTCOMES; RISK	Background Guidelines advise periprocedural saline hydration for prevention of contrast induced-acute kidney injury (CI-AKI). We analysed whether 1-hour sodium bicarbonate hydration administered solely prior to intra-arterial contrast exposure is non-inferior to standard periprocedural saline hydration in chronic kidney disease (CKD) patients undergoing elective cardiovascular diagnostic or interventional contrast procedures. Methods We performed an open-label multicentre non-inferiority trial between 2011-2014. Patients were randomized to 1 hour pre-procedure sodium bicarbonate hydration (250 ml 1.4%, N = 168) or 4-12 hours saline hydration (1000 ml 0.9%, N = 165) prior to and following contrast administration (2000 ml of saline total). Primary outcome was the relative serum creatinine increase (%) 48-96 hours post contrast exposure. Secondary outcomes were: incidence of CI-AKI (serum creatinine increase>25% or >44 mu mol/L), recovery of renal function, the need for dialysis, and hospital costs within two months follow-up. Results Mean relative creatinine increase was 3.1% (95% CI 0.9 to 5.2%) in the bicarbonate and 1.1% (95% CI -1.2 to 3.5%) in the saline arm, mean difference 1.9% (95% CI -1.2 to 5.1%, pnon- inferiority <0.001). CI-AKI occurred in 11 (6.7%) patients randomized to sodium bicarbonate and 12 (7.5%) to saline (p = 0.79). Renal function did not fully recover in 40.0% and 44.4% of CI-AKI patients, respectively (p = 0.84). No patient required dialysis. Mean costs for preventive hydration and clinical preparation for the contrast procedure were $1158 for sodium bicarbonate vs. $1561 for saline (p < 0.001). Conclusion Short hydration with sodium bicarbonate prior to elective cardiovascular diagnostic or therapeutic contrast procedures is non-inferior to standard periprocedural saline hydration in CKD patients with respect to renal safety and results in considerable healthcare savings.	[Kooiman, Judith; Kilicsoy, Inci; Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Kooiman, Judith; Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Van der Heyden, Jan] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Sijpkens, Yvo W. J.] Bronovo Hosp, Dept Internal Med, The Hague, Netherlands; [van Dijkman, Paul R. M.] Bronovo Hosp, Dept Cardiol, The Hague, Netherlands; [Wever, Jan J.] Haga Teaching Hosp, Dept Vasc Surg, The Hague, Netherlands; [van Overhagen, Hans] Haga Teaching Hosp, Dept Radiol, The Hague, Netherlands; [Vahl, Antonie C.] Onze Lieve Vrouw Hosp, Dept Vasc Surg, Amsterdam, Netherlands; [Aarts, Nico] Bronovo Hosp, Dept Radiol, The Hague, Netherlands; [Verberk-Jonkers, Iris J. A. M.] Maasstad Hosp, Dept Nephrol, Rotterdam, Netherlands; [Brulez, Harald F. H.] St Lucas Andreas Hosp, Dept Nephrol, Amsterdam, Netherlands; [Hamming, Jaap F.] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands; [van der Molen, Aart J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Putter, Hein] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [van den Hout, Wilbert B.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Haaglanden Medical Center; Bronovo Hospital; Haaglanden Medical Center; Bronovo Hospital; Haga Hospital; Haga Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Haaglanden Medical Center; Bronovo Hospital; Maasstad Hospital; Sint Lucas Andreas Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kooiman, J (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.; Kooiman, J (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	judithkooiman@hotmail.com	Rabelink, Ton J./A-5316-2008; Putter, Hein/C-2244-2018; Wever, Jan/AAJ-6870-2021; Cannegieter, Suzanne/W-3696-2019	Rabelink, Ton J./0000-0001-6780-5186; Putter, Hein/0000-0001-5395-1422; Cannegieter, Suzanne/0000-0003-4707-2303	Bronovo Hospital Research Foundation, a charity foundation	Bronovo Hospital Research Foundation, a charity foundation	The study was funded by the Bronovo Hospital Research Foundation, a charity foundation. The sponsor did not have any influence on the design of the trial, data collection, analyses, interpretation or the writing of this manuscript.	ACR Committee on Drugs, 2013, MAN CONTR MED VERS 9; Balemans CEA, 2012, RADIOLOGY, V263, P706, DOI 10.1148/radiol.12111667; Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Coyle LC, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.002; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316; Hakkaart-van Roijen L, 2010, MANUAL COST ANAL MET; Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Jo SH, 2009, AM HEART J, V157, P576, DOI 10.1016/j.ahj.2008.11.010; Jo SH, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.042; KDIGO Clinical Practice Guidelines for Acute Kidney Injury, 2012, KIDNEY INT, V2, P69; Kooiman J, 2014, J THROMB HAEMOST, V12, P1658, DOI 10.1111/jth.12701; Kooiman J, 2014, NEPHROL DIAL TRANSPL, V29, P1029, DOI 10.1093/ndt/gfu025; Kooiman J, 2014, CIRC-CARDIOVASC INTE, V7, P190, DOI 10.1161/CIRCINTERVENTIONS.113.000778; Kooiman J, 2013, AM HEART J, V165, P793, DOI 10.1016/j.ahj.2013.02.013; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Leoncini M, 2014, J AM COLL CARDIOL, V63, P71, DOI 10.1016/j.jacc.2013.04.105; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019; Mehran R, 2009, JACC-CARDIOVASC INTE, V2, P415, DOI 10.1016/j.jcin.2009.03.007; Ng TMH, 2006, INT J CARDIOL, V109, P322, DOI 10.1016/j.ijcard.2005.06.038; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Rudnick MR, 2008, AM HEART J, V156, P776, DOI 10.1016/j.ahj.2008.05.023; Schweiger MJ, 2007, CATHETER CARDIO INTE, V69, P135, DOI 10.1002/ccd.20964; Stacul F, 2006, AM J CARDIOL, V98, p59K, DOI 10.1016/j.amjcard.2006.01.024; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Tolpin DA, 2012, J THORAC CARDIOV SUR, V143, P682, DOI 10.1016/j.jtcvs.2011.09.044; Toprak O, 2007, AM J MED SCI, V334, P283, DOI 10.1097/MAJ.0b013e318068ddf9; Tsai TT, 2014, JACC-CARDIOVASC INTE, V7, P1, DOI 10.1016/j.jcin.2013.06.016; Wessely R, 2009, CIRC-CARDIOVASC INTE, V2, P430, DOI 10.1161/CIRCINTERVENTIONS.109.874933; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Yavari V, 2014, INT UROL NEPHROL, V46, P41, DOI 10.1007/s11255-013-0420-4; Zethraeus N, 2003, PHARMACOECONOMICS, V21, P39, DOI 10.2165/00019053-200321010-00003; Zhang B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006989	36	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0189372	10.1371/journal.pone.0189372	http://dx.doi.org/10.1371/journal.pone.0189372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420536	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900003
J	Belcher, DA; Ju, JA; Baek, JH; Yalamanoglu, A; Buehler, PW; Gilkes, DM; Palmer, AF				Belcher, Donald A.; Ju, Julia A.; Baek, Jin Hyen; Yalamanoglu, Ayla; Buehler, Paul W.; Gilkes, Daniele M.; Palmer, Andre F.			The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study	PLOS ONE			English	Article							PEG-CONJUGATED HEMOGLOBIN; CELL-FREE HEMOGLOBIN; BOVINE HEMOGLOBINS; TISSUE OXYGENATION; NITRIC-OXIDE; BLOOD-FLOW; BIOPHYSICAL PROPERTIES; ORTHOPEDIC-SURGERY; SOLUTION HBOC-201; 9L GLIOSARCOMA	A major constraint in the treatment of cancer is inadequate oxygenation of the tumor mass, which can reduce chemotherapeutic efficacy. We hypothesize that polymerized human hemoglobin (PolyhHb) can be transfused into the systemic circulation to increase solid tumor oxygenation, and improve chemotherapeutic outcomes. By locking PolyhHb in the relaxed (R) quaternary state, oxygen (O-2) offloading at low O-2 tensions (< 20mm Hg) may be increased, while O-2 offloading at high O-2 tensions (> 20 mm Hg) is facilitated with tense (T) state PolyhHb. Therefore, R-state PolyhHb may deliver significantly more O-2 to hypoxic tissues. Biophysical parameters of T and R-state PolyhHb were used to populate a modified Krogh tissue cylinder model to assess O-2 transport in a tumor. In general, we found that increasing the volume of transfused PolyhHb decreased the apparent viscosity of blood in the arteriole. In addition, we found that PolyhHb transfusion decreased the wall shear stress at large arteriole diameters (> 20 mu m), but increased wall shear stress for small arteriole diameters (< 10 mu m). Therefore, transfusion of PolyhHb may lead to elevated O-2 delivery at low pO(2). In addition, transfusion of R-state PolyhHb may be more effective than T-state PolyhHb for O-2 delivery at similar transfusion volumes. Reduction in the apparent viscosity resulting from PolyhHb transfusion may result in significant changes in flow distributions throughout the tumor microcirculatory network. The difference in wall shear stress implies that PolyhHb may have a more significant effect in capillary beds through mechano-transduction. Periodic top-load transfusions of PolyhHb into mice bearing breast tumors confirmed the oxygenation potential of both PolyhHbs via reduced hypoxic volume, vascular density, tumor growth, and increased expression of hypoxia inducible genes. Tissue section analysis demonstrated primary PolyhHb clearance occurred in the liver and spleen indicating a minimal risk for renal damage.	[Belcher, Donald A.; Palmer, Andre F.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Ju, Julia A.; Gilkes, Daniele M.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Baek, Jin Hyen; Yalamanoglu, Ayla; Buehler, Paul W.] US FDA, Div Blood Components & Devices, Lab Biochem & Vasc Biol, CBER, Silver Spring, MD USA; [Gilkes, Daniele M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	University System of Ohio; Ohio State University; Johns Hopkins University; US Food & Drug Administration (FDA); Johns Hopkins University	Palmer, AF (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu	Gilkes, Daniele M/AAI-8133-2020; Ju, Julia A/Y-5717-2018; Yalamanoglu, Ayla/GYJ-1306-2022; Belcher, Donald/ABC-7359-2020	Gilkes, Daniele M/0000-0003-3984-9338; Yalamanoglu, Ayla/0000-0002-0203-9297; Belcher, Donald/0000-0002-7633-6219	National Institutes of Health [R56HL123015, R01HL126945, R01EB021926, R00CA181352]; Susan G. Komen Foundation [CCR17483484]; V Scholar Foundation [V2016-024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138116, R01HL126945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); V Scholar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R56HL123015, R01HL126945, R01EB021926, R00CA181352, Susan G. Komen Foundation grant CCR17483484, and V Scholar Foundation grant V2016-024.	Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Batchelor TT, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou206.42; Belcher DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185988; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; BROOKS JJ, 1982, CANCER, V50, P1757, DOI 10.1002/1097-0142(19821101)50:9<1757::AID-CNCR2820500919>3.0.CO;2-5; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Butt OI, 2010, ANTIOXID REDOX SIGN, V12, P199, DOI 10.1089/ars.2009.2798; Cabrales P, 2010, AM J PHYSIOL-HEART C, V298, pH1062, DOI 10.1152/ajpheart.01022.2009; Camporesi EM., UNDERSEA HYPERB MED, V41, P253; Castro C, 2014, MINERVA ANESTESIOL, V80, P537; Chaturvedi P, 2012, J CLIN INVEST; CHIANCONE E, 1968, J BIOL CHEM, V243, P1212; Deuel JW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.392; DEWHIRST MW, 1992, RADIAT RES, V130, P171, DOI 10.2307/3578274; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Fedosov DA, 2010, MICROCIRCULATION, V17, P615, DOI 10.1111/j.1549-8719.2010.00056.x; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Freilich D, 2009, J TRAUMA, V66, P365, DOI 10.1097/TA.0b013e3181820d5c; Galie PA, 2014, P NATL ACAD SCI USA, V111, P7968, DOI 10.1073/pnas.1310842111; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Gottschalk A, 2005, ARTIF CELL BLOOD SUB, V33, P379, DOI 10.1080/10731190500289750; Gundersen SI, 2008, BIOTECHNOL PROGR, V24, P1353, DOI 10.1002/btpr.56; Han JQ, 2012, ARTIF CELL BLOOD SUB, V40, P239, DOI 10.3109/10731199.2012.663385; Handrigan MT, CHOICE FLUID INFLUEN; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Jahr JS, 2008, J TRAUMA, V64, P1484, DOI 10.1097/TA.0b013e318173a93f; Kanapathipillai M, 2014, ADV DRUG DELIVER REV, V79-80, P107, DOI 10.1016/j.addr.2014.05.005; Karakashev SV, 2015, CANCER MANAG RES, V7, P253, DOI 10.2147/CMAR.S58285; Linberg R, IN VIVO, V12, P167; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Marchiq I, 2016, J MOL MED, V94, P155, DOI 10.1007/s00109-015-1307-x; Marcinkowska-Gapinska A, 2007, MED BIOL ENG COMPUT, V45, P837, DOI 10.1007/s11517-007-0236-4; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Murayama C, 2014, ARTIF ORGANS, V38, P656, DOI 10.1111/aor.12354; Napolitano LM, 2009, CRIT CARE CLIN, V25, P279, DOI 10.1016/j.ccc.2009.01.003; Nozue M, 1996, J SURG ONCOL, V62, P109; Palmer AF, 2014, ANNU REV BIOMED ENG, V16, P77, DOI 10.1146/annurev-bioeng-071813-104950; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P1803, DOI 10.1002/btpr.265; Raabe A, 2005, STRAHLENTHER ONKOL, V181, P730, DOI 10.1007/s00066-005-1418-3; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; SCOTT MD, 1991, J LAB CLIN MED, V118, P7; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; SIEMANN DW, 1992, INT J RADIAT ONCOL, V22, P393, DOI 10.1016/0360-3016(92)90839-A; Song JW, 2014, VASC MORPHOG METHODS, V1214, P243; Sriram K, 2014, MICROCIRCULATION, V21, P628, DOI 10.1111/micc.12141; Strese S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-331; TEICHER BA, 1993, CANCER CHEMOTH PHARM, V33, P57, DOI 10.1007/BF00686024; TEICHER BA, 1995, INT J CANCER, V61, P732, DOI 10.1002/ijc.2910610523; TEICHER BA, 1993, J CANCER RES CLIN, V120, P85, DOI 10.1007/BF01200729; TEICHER BA, 1994, ARTIF CELL BLOOD SUB, V22, P827, DOI 10.3109/10731199409117917; Thews O, 1998, INT J ONCOL, V13, P205; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Waliszewski P, 2015, PROSTATE, V75, P399, DOI 10.1002/pros.22926; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yamamoto M, 2009, J SURG RES, V151, P48, DOI 10.1016/j.jss.2007.12.770; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yu BL, 2010, ANESTHESIOLOGY, V112, P586, DOI 10.1097/ALN.0b013e3181cd7838; Yu MH, 2008, ARTIF CELL BLOOD SUB, V36, P551, DOI 10.1080/10731190802556674; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang N, 2011, TISSUE ENG PT A, V17, P927, DOI [10.1089/ten.TEA.2010.0353, 10.1089/ten.tea.2010.0353]; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhou YP, 2012, BIOPHYS CHEM, V162, P45, DOI 10.1016/j.bpc.2011.12.006; Zhou YP, 2011, BIOTECHNOL PROGR, V27, P1172, DOI 10.1002/btpr.624	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191275	10.1371/journal.pone.0191275	http://dx.doi.org/10.1371/journal.pone.0191275			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414985	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300021
J	Soliman, S; Mohammad, MG; El-Keblawy, AA; Omar, H; Abouleish, M; Madkour, M; Elnaggar, A; Hosni, RM				Soliman, Sameh; Mohammad, Mohammad G.; El-Keblawy, Ali A.; Omar, Hany; Abouleish, Mohamed; Madkour, Mohamed; Elnaggar, Attiat; Hosni, Racha M.			Mechanical and phytochemical protection mechanisms of Calligonum comosum in arid deserts	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ESSENTIAL OILS; SECONDARY METABOLITES; CALCIUM-OXALATE; PLANT DEFENSE; MANAGEMENT; MORPHOLOGY; SCLEREIDS; PATHOGENS; MITES	Unlike animals, plants are sessile organisms, lacking circulating antibodies and specialized immune cells and are exposed to various harsh environmental conditions that make them at risk of being attacked by different pathogens and herbivores. Plants produce chemo-signals to respond to the surroundings and be able to distinguish between harmless and harmful signals. In this study, the production of phytochemicals as plant signaling mechanisms and their defensive roles in disease resistance and repelling herbivores are examined in Calligonum comosum. C. comosum is a leafless standalone perennial shrub widespread in sand dunes. The plant has the ability to survive the drastic environmental conditions of the arid/hyperarid deserts of the Arabia. Structural anatomy and phytochemicals analyses were used to identify both mechanical and chemical defensive mechanisms in C. comosum. Microscopy-based investigations indicated that stems of this species developed hard structures in its outer layers including sclerenchyma and cluster crystals of calcium oxalate (CaOx). Sclerenchyma and CaOx are difficult to be eaten by herbivores and insects and can harm their mouthparts. On the other hand, the plant developed both short-distance (local) and long-distance (systematic over limited sphere) phytochemicals-producing cells located at its outer regions that is surrounding the inner nutrient-rich vascular system (VS). Local chemical was represented by phenolic idioblasts that were released in response to plant cutting. Systematic chemical was represented by toxic volatile oil containing similar to 50% benzaldehyde derivative (cuminaldehyde). The oil caused strong killing effect on both mammalian cells and microbial pathogens via either direct addition or indirect exposure to its vapor. The plants lost the oil content and allowed fungal growth once cut and dried. The localization of both defensive mechanisms to the outer region of the plant seemed to protect the inner nutrient-rich VS and hence maintained the plant survival. Surprisingly, in relation to traditional folklore use as medicine, local people use only green parts of the plant and only during the winter, where the plant found devoid of volatile oil and phenolic idioblasts. Moreover, it turns into recommendations for local people to avoid any health problems caused by the plant supply.	[Soliman, Sameh; Mohammad, Mohammad G.; Omar, Hany; Madkour, Mohamed] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Soliman, Sameh; Omar, Hany] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates; [Soliman, Sameh] Zagazig Univ, Fac Pharm, Zagazig, Egypt; [Mohammad, Mohammad G.; Madkour, Mohamed; Hosni, Racha M.] Univ Sharjah, Collage Hlth Sci, Dept Med Lab Sci, Sharjah, U Arab Emirates; [El-Keblawy, Ali A.] Univ Sharjah, Dept Appl Biol, Sharjah, U Arab Emirates; [El-Keblawy, Ali A.; Elnaggar, Attiat] Univ Sharjah, Res Inst Sci & Engn, Sharjah, U Arab Emirates; [Abouleish, Mohamed] Amer Univ Sharjah, Coll Arts & Sci, Dept Biol Chem & Environm Sci, Sharjah, U Arab Emirates	University of Sharjah; University of Sharjah; Egyptian Knowledge Bank (EKB); Zagazig University; University of Sharjah; University of Sharjah; University of Sharjah; American University of Sharjah	Soliman, S (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.; Soliman, S (corresponding author), Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates.; Soliman, S (corresponding author), Zagazig Univ, Fac Pharm, Zagazig, Egypt.	ssoliman@sharjah.ac.ae	Abouleish, Mohamed/ABA-9060-2020; Omar, Hany/B-7440-2013	Abouleish, Mohamed/0000-0003-3234-9795; Omar, Hany/0000-0002-4670-8149; Mohammad, Mohammad/0000-0002-6775-1955; Soliman, Sameh/0000-0002-7691-615X; El-Keblawy, Ali/0000-0003-4448-6236; Madkour, Mohamed I./0000-0002-9130-4928	University of Sharjah, U.A.E. [1601110215-P]	University of Sharjah, U.A.E.	This work was supported by grants from University of Sharjah, U.A.E. (1601110215-P) to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from University of Sharjah, U.A.E. (1601110215-P) to S.S.	Ahmed HS, 2016, PLANTA MED, V82, pPC49; Al-Khalifah NS, 2006, IAWA J, V27, P299, DOI 10.1163/22941932-90000156; AlShebly MM, 2017, ECOTOXICOL ENV SA SC, V137, P149; Bannour M, 2016, CHEM BIODIVERS, V13, P1527, DOI 10.1002/cbdv.201600086; Baratto LC, 2010, BRAZ J PHARM SCI, V46, P555, DOI 10.1590/S1984-82502010000300020; Ben Hassine D, 2012, MOLECULES, V17, P9540, DOI 10.3390/molecules17089540; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Bresca P., 2009, BIOTEK APPL NOTE; Brown SL, 2013, PLANT PHYSIOL BIOCH, V73, P219, DOI 10.1016/j.plaphy.2013.10.006; Danin A., 2012, PLANTS DESERT DUNES; Dhief A, 2011, J ESSENT OIL BEAR PL, V14, P11, DOI 10.1080/0972060X.2011.10643896; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Diseases, 2008, CLIN MICROBIOL INFEC, V14, P982; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Doughari J. H., 2015, Journal of Plant Pathology and Microbiology, V6, P322; El-Keblawy A, 2016, J ARID LAND, V8, P254, DOI 10.1007/s40333-015-0023-2; Essam AA-S, 2012, TOXICOL IND HEALTH, V30, P147; Farid A Badria, Z NATURFORSCHUNG C20, P656; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Ghazanfar S.A., 1994, HDB ARABIAN MED PLAN; Harwood TD, 2011, PLANT PATHOL, V60, P545, DOI 10.1111/j.1365-3059.2010.02391.x; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karban R, 1997, ECOL APPL, V7, P183, DOI 10.1890/1051-0761(1997)007[0183:MVFSMO]2.0.CO;2; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kirkpatrick WR, 1998, J CLIN MICROBIOL, V36, P1330, DOI 10.1128/JCM.36.5.1330-1332.1998; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kokoska L, 2008, J FOOD PROTECT, V71, P2475, DOI 10.4315/0362-028X-71.12.2475; LevYadun S, 1997, ANN BOT-LONDON, V80, P125, DOI 10.1006/anbo.1997.0419; Liu XM, 2001, FITOTERAPIA, V72, P487, DOI 10.1016/S0367-326X(01)00271-4; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Manual R. M. A, 1912, FLORA EGYPT; Masaoka Y, 2010, NEUROSCI LETT, V473, P92, DOI 10.1016/j.neulet.2010.02.024; Masoum S, 2013, ANAL METHODS-UK, V5, P4639, DOI 10.1039/c3ay40451j; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Moser JC, 2010, NATURWISSENSCHAFTEN, V97, P219, DOI 10.1007/s00114-009-0630-x; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nitoda T, 2008, PHYTOTHER RES, V22, P809, DOI 10.1002/ptr.2374; Okasaka M, 2004, J NAT PROD, V67, P1044, DOI 10.1021/np0304823; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Patten AM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P1173; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Serafino A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-17; Shepherd GM, NEUROGASTRONOMY BRAI; Singhi M, 2010, STUD ETHNO-MED, V4, P121, DOI 10.1080/09735070.2010.11886369; Singla N, 2014, SCI WORLD J, V2014, P7; Taia Wafaa K., 2006, Asian Journal of Plant Sciences, V5, P570; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tjamos E. C., 1989, VASCULAR WILT DIS PL; Uddin K., 2014, INT J ADV RES, V2, P459; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Yadav K, 2001, CELL PROLIFERATION A; Yap Polly Soo Xi, 2014, Open Microbiol J, V8, P6, DOI 10.2174/1874285801408010006; Zhang W, 2011, PLANT BIOLOGY, V13, P688, DOI 10.1111/j.1438-8677.2010.00434.x; Zouari S, 2012, J ESSENT OIL BEAR PL, V15, P320, DOI 10.1080/0972060X.2012.10644054	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192576	10.1371/journal.pone.0192576	http://dx.doi.org/10.1371/journal.pone.0192576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415032	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300089
J	Bonato, M; Meloni, A; Merati, G; La Torre, A; Agnello, L; Vernillo, G				Bonato, Matteo; Meloni, Andrea; Merati, Giampiero; La Torre, Antonio; Agnello, Luca; Vernillo, Gianluca			Effect of repeated-sprints on the reliability of short-term parasympathetic reactivation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RATE RECOVERY; AUTONOMIC FUNCTION; SPORTS-MEDICINE; PERFORMANCE; FATIGUE; VALIDITY; MONITOR; ABILITY; WORK	This study determined the reliability of post-exercise heart rate recovery (HRR) and vagal-related HR variability (HRV) after repeated-sprints (RSs), and contrasted it with the smallest worthwhile change (SWC) of these indices. Fourteen healthy male participants performed on four occasions, separated by 7 days, five 30-m sprints interspersed by 25-s of recovery. Post-exercise HR during 10 min of seated rest was measured. HRR during the first 60-s of recovery was computed (HRR60s). HRV indices were calculated in time and frequency domains during the last 5-min of the recovery. Absolute and relative reliability were assessed by typical error of measurement expressed as coefficient of variation (CV) and intraclass correlation coefficients (ICCs), respectively. Sensitivity was assessed comparing SWC to the typical error of measurement. CV ranged from 3.6% to 13.5% and from 6.3% to 109.2% for the HRR and HRV indices, respectively. ICCs were from 0.78 to 0.96 and from 0.76 to 0.92, respectively. HRR and HRV indices showed large discrepancies reliability. HRR60s and the square root of the mean sum of the squared differences between R-R intervals presented the highest levels of both absolute and relative reliability. However, SWC was lower than the typical error of measurement, indicating insufficient sensitivity to confidently detect small, but meaningful, changes in HRR and HRV indices.	[Bonato, Matteo; Meloni, Andrea; Merati, Giampiero; La Torre, Antonio; Agnello, Luca; Vernillo, Gianluca] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Merati, Giampiero] IRCCS, Fdn Don Carlo Gnocchi, Milan, Italy; [La Torre, Antonio] IRCCS, Ist Ortoped Galeazzi, Milan, Italy; [Vernillo, Gianluca] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Istituto Ortopedico Galeazzi; University of Calgary	Vernillo, G (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.; Vernillo, G (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	gianluca.vernillo@unimi.it	Meloni, Andrea/GVS-7802-2022; Bonato, Matteo/R-1917-2019; Merati, Giampiero/AAT-3854-2021; Merati, Giampiero/J-9713-2018; VERNILLO, GIANLUCA/L-1571-2016	Meloni, Andrea/0000-0001-9891-406X; Bonato, Matteo/0000-0002-5589-7957; Merati, Giampiero/0000-0002-1389-7596; VERNILLO, GIANLUCA/0000-0003-2580-4470	Universita degli Studi di Milano	Universita degli Studi di Milano	This study was partly funded by an intramural grant of the Universita degli Studi di Milano for the support of research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the participants involved in the present study. We would also like to express our gratitude to Lupo Guiati for his logistical support during the investigation. This study was partly funded by an intramural grant of the Universita degli Studi di Milano for the support of research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Arduini A, 2011, J SCI MED SPORT, V14, P352, DOI 10.1016/j.jsams.2011.02.012; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Bonato M, 2017, J SPORT SCI MED, V16, P286; Bosquet L, 2008, INT J SPORTS MED, V29, P238, DOI 10.1055/s-2007-965162; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; BUCHHEIT M, 2014, FRONT PHYSIOL, V5; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Cronin JB, 2008, J STRENGTH COND RES, V22, P318, DOI 10.1519/JSC.0b013e31815fa3d3; Dupuy O, 2012, CLIN PHYSIOL FUNCT I, V32, P296, DOI 10.1111/j.1475-097X.2012.01125.x; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Glaister M, 2008, J STRENGTH COND RES, V22, P1597, DOI 10.1519/JSC.0b013e318181ab80; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Impellizzeri FM, 2009, INT J SPORT PHYSIOL, V4, P269, DOI 10.1123/ijspp.4.2.269; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kobayashi Hiromitsu, 2009, Journal of Physiological Anthropology, V28, P225, DOI 10.2114/jpa2.28.225; Lamberts RP, 2010, SCAND J MED SCI SPOR, V20, P449, DOI 10.1111/j.1600-0838.2009.00977.x; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Millar PJ, 2009, APPL PHYSIOL NUTR ME, V34, P875, DOI 10.1139/H09-086; Nakamura FY, 2009, INT J SPORTS MED, V30, P808, DOI 10.1055/s-0029-1234055; Niewiadomski W, 2007, CLIN PHYSIOL FUNCT I, V27, P309, DOI 10.1111/j.1475-097X.2007.00753.x; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Sandercock G, 2007, CLIN SCI, V113, P129, DOI 10.1042/CS20070137; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Takahashi T, 2000, EUR J APPL PHYSIOL, V81, P233, DOI 10.1007/s004210050036; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Vernillo G, 2015, EUR J APPL PHYSIOL, V115, P2445, DOI 10.1007/s00421-015-3226-5; Vianna LC, 2008, EUR J APPL PHYSIOL, V102, P283, DOI 10.1007/s00421-007-0584-7; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192231	10.1371/journal.pone.0192231	http://dx.doi.org/10.1371/journal.pone.0192231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408911	Green Published, gold			2022-12-27	WOS:000424302800051
J	Catalano, C; da Silva, MI; Frank, C; Jiraskova, K; Vymetalkova, V; Levy, M; Liska, V; Vycital, O; Naccarati, A; Vodickova, L; Hemminki, K; Vodicka, P; Weber, ANR; Forsti, A				Catalano, Calogerina; da Silva Filho, Miguel Inacio; Frank, Christoph; Jiraskova, Katerina; Vymetalkova, Veronika; Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej; Naccarati, Alessio; Vodickova, Ludmila; Hemminki, Kari; Vodicka, Pavel; Weber, Alexander N. R.; Foersti, Asta			Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer	PLOS ONE			English	Article							CLASS-I TRANSACTIVATOR; IMMUNE EVASION; T-CELLS; EXPRESSION; COLON; INFLAMMATION; SURVIVAL; PATHWAY	Constitutive activation of interferon signaling pathways has been reported in colorectal cancer (CRC), leading to a strong CD8(+) T cell response through stimulation of NLRC5 expression. Primed CD8(+) T cell expansion, however, may be negatively regulated by PD-L1 expression. Additionally, aberrant PD-L1 expression enables cancer cells to escape the immune attack. Our study aimed to select potential regulatory variants in the NLRC5 and PD-L1 genes by using several online in silico tools, such as UCSC browser, HaploReg, Regulome DB, Gtex Portal, microRNA and transcription factor binding site prediction tools and to investigate their influence on CRC risk in a Czech cohort of 1424 CRC patients and 1114 healthy controls. Logistic regression analysis adjusted for age and gender reported a moderate association between rectal cancer risk and two NLRC5 SNPs, rs1684575 T>G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model). Given that a combination of genetic variants, rather than a single polymorphism, may explain better the genetic etiology of CRC, we studied the interplay between the variants within NLRC5, PD-L1 and the previously genotyped IFNGR1 and IFNGR2variants, to evaluate their involvement in the risk of CRC development. Overall we obtained 18 pair wise interactions within and between the NLRC5ad PD-L1 genes and 6 more when IFNGR variants were added. Thirteen out of the 24 interactions were below the threshold for the FDR calculated and controlled at an arbitrary level q*<0.10. Furthermore, the interaction IFNGR2rs1059293 C>T NLRC5 rs289747 G>A (P<0.0001) remained statistically significant even after Bonferroni correction. Our data suggest that not only a single genetic variant but also an interaction between two or more variants within genes involved in immune regulation may play important roles in the onset of CRC, providing therefore novel biological information, which could eventually improve CRC risk management but also PD-1-based immunotherapy in CRC.	[Catalano, Calogerina; da Silva Filho, Miguel Inacio; Frank, Christoph; Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Jiraskova, Katerina; Vymetalkova, Veronika; Naccarati, Alessio; Vodickova, Ludmila; Vodicka, Pavel] Czech Acad Sci, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Jiraskova, Katerina; Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Med Fac 1, Inst Biol & Med Genet, Prague, Czech Republic; [Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej] Charles Univ Prague, Med Fac 1, Dept Surg, Prague, Czech Republic; [Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej] Thomayer Hosp, Prague, Czech Republic; [Liska, Vaclav; Vycital, Ondrej; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic; [Naccarati, Alessio] IIGM, Mol & Genet Epidemiol, Turin, Italy; [Hemminki, Kari; Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden; [Weber, Alexander N. R.] Univ Tubingen, Interfac Inst Cell Biol, Dept Immunol, Tubingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Thomayer Hospital; Charles University Prague; Italian Institute for Genomic Medicine (IIGM); Lund University; Eberhard Karls University of Tubingen	Catalano, C (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	c.catalano@dkfz.de	Jiraskova, Katerina/C-8232-2017	Jiraskova, Katerina/0000-0001-8462-6358; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Catalano, Calogerina/0000-0002-4047-8485	Internal Grant Agency of the Ministry of Health of the Czech Republic [AZV 15-27580A, AZV 15-26535A]; Grant Agency of the Charles University [GAUK 112515]; University of Tubingen; Federal State Baden-Wurttemberg Junior Professor Program	Internal Grant Agency of the Ministry of Health of the Czech Republic; Grant Agency of the Charles University; University of Tubingen; Federal State Baden-Wurttemberg Junior Professor Program	The work was supported by Internal Grant Agency of the Ministry of Health of the Czech Republic AZV 15-27580A (PI: PV) and AZV 15-26535A (PI: W) (http://www.azvcr.cz/o-azv-cr) and the Grant Agency of the Charles University (GAUK 112515) (PI: KJ) (http://www.cuni.cz/ukeng-33.html). AW was supported by the University of Tubingen, the Federal State Baden-Wurttemberg Junior Professor Program (https://www.medizin.uni-tuebingen.de/en/Research/Research+Funding/Gender+Equality+Prize.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Carrai M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08946-3; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Hassanzadeh Parichehr, 2011, Gastroenterol Hepatol Bed Bench, V4, P127; Hendricks AE, 2014, EUR J HUM GENET, V22, P414, DOI 10.1038/ejhg.2013.144; Janakiram NB, 2014, ADV EXP MED BIOL, V816, P25, DOI 10.1007/978-3-0348-0837-8_2; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111061; Lynch D, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.29; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mueller K, 2013, NUCLEIC ACIDS RES, V41, P2138, DOI 10.1093/nar/gks1349; Pandiyan P, 2007, J IMMUNOL, P178; Passardi A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061324; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rodriguez GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1151593; Seliger B, 2005, BIODRUGS, V19, P347, DOI 10.2165/00063030-200519060-00002; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Van L, 2016, J IMMUNOTHER CANC, V4; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Wang YP, 2016, TUMOR BIOL, V37, P3247, DOI 10.1007/s13277-015-4080-0; Weber ANR, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27763; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Yoshihama S, 2016, P NATL ACAD SCI USA, V113, P5999, DOI 10.1073/pnas.1602069113; Zhang XL, 2014, J PHYS CHEM B, V118, P2009, DOI 10.1021/jp409778e	37	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192385	10.1371/journal.pone.0192385	http://dx.doi.org/10.1371/journal.pone.0192385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408916	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800061
J	Sasaki, E; Momose, H; Hiradate, Y; Furuhata, K; Takai, M; Asanuma, H; Ishii, KJ; Mizukami, T; Hamaguchi, I				Sasaki, Eita; Momose, Haruka; Hiradate, Yuki; Furuhata, Keiko; Takai, Mamiko; Asanuma, Hideki; Ishii, Ken J.; Mizukami, Takuo; Hamaguchi, Isao			Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; IMMUNE-RESPONSE; NEEDLE LENGTH; WHOLE VIRION; VACCINATION; RISK; FORMULATION; THICKNESS; PATTERNS; VIRUSES	Historically, vaccine safety assessments have been conducted by animal testing (e.g., quality control tests and adjuvant development). However, classical evaluation methods do not provide sufficient information to make treatment decisions. We previously identified bio-marker genes as novel safety markers. Here, we developed a practical safety assessment system used to evaluate the intramuscular, intraperitoneal, and nasal inoculation routes to provide robust and comprehensive safety data. Influenza vaccines were used as model vaccines. A toxicity reference vaccine (RE) and poly I: C-adjuvanted hemagglutinin split vaccine were used as toxicity controls, while a non-adjuvanted hemagglutinin split vaccine and AddaVax (squalene-based oil-in-water nano-emulsion with a formulation similar to MF59)-adjuvanted hemagglutinin split vaccine were used as safety controls. Body weight changes, number of white blood cells, and lung biomarker gene expression profiles were determined in mice. In addition, vaccines were inoculated into mice by three different administration routes. Logistic regression analyses were carried out to determine the expression changes of each biomarker. The results showed that the regression equations clearly classified each vaccine according to its toxic potential and inoculation amount by biomarker expression levels. Interestingly, lung biomarker expression was nearly equivalent for the various inoculation routes. The results of the present safety evaluation were confirmed by the approximation rate for the toxicity control. This method may contribute to toxicity evaluation such as quality control tests and adjuvant development.	[Sasaki, Eita; Momose, Haruka; Hiradate, Yuki; Furuhata, Keiko; Takai, Mamiko; Mizukami, Takuo; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Asanuma, Hideki] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Adjuvant Innovat, Ibaraki, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Vaccine Sci, Suita, Osaka, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Osaka University	Mizukami, T; Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan.	tmiz@nih.go.jp; 130hama@nih.go.jp	Ishii, Ken J/B-1685-2012; Mizukami, Takuo/F-9248-2016	Ishii, Ken J/0000-0002-6728-3872; Mizukami, Takuo/0000-0001-6105-6049; Sasaki, Eita/0000-0002-3384-7414	Ministry of Health, Labour and Welfare; Research on Development of New Drugs, the Japan Agency for Medical Research and Development [16ak0101010j0105, 17fk0108124j0101]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Research on Development of New Drugs, the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study (Adjuvant Data Base Project) was supported by Grants from The Ministry of Health, Labour and Welfare and Research on Development of New Drugs, the Japan Agency for Medical Research and Development (16ak0101010j0105 and 17fk0108124j0101).	ABSHER M, 1969, NATURE, V223, P715, DOI 10.1038/223715a0; Adler M, 2011, J GEN VIROL, V92, P1532, DOI 10.1099/vir.0.030981-0; Ato M, 2013, VACCINE, V31, P2184, DOI 10.1016/j.vaccine.2013.02.016; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Carlow DA, 1998, J IMMUNOL, V161, P2348; Cook IF, 2008, HUM VACCINES, V4, P67, DOI 10.4161/hv.4.1.4747; Delafuente JC, 1998, PHARMACOTHERAPY, V18, P631; Diez-Domingo J, 2015, VACCINE, V33, P789, DOI 10.1016/j.vaccine.2014.12.024; Durando P, 2010, EXPERT OPIN BIOL TH, V10, P639, DOI 10.1517/14712591003724662; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Ghimire TR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0972-0; GOLDENTHAL KL, 1993, AIDS RES HUM RETROV, V9, pS47; Groswasser J, 1997, PEDIATRICS, V100, P400, DOI 10.1542/peds.100.3.400; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; KUROKAWA M, 1975, JPN J MED SCI BIOL, V28, P37, DOI 10.7883/yoken1952.28.37; KUROKAWA M, 1974, JPN J MED SCI BIOL, V27, P173, DOI 10.7883/yoken1952.27.173; Lago-Deibe FI, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-147; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mizukami T, 2017, PLOS ONE, V9; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124392; Momose H, 2010, JPN J INFECT DIS, V63, P25; National Institute of Infectious Diseases, 2006, GEN TESTS 272 336 IN, P10; Neter J, 1974, APPLIED LINEAR STATI, P214; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; ORTBALS DW, 1978, J CLIN MICROBIOL, V8, P431; Petrovsky N, 2015, VACCINE, V33, P5920, DOI 10.1016/j.vaccine.2015.09.030; Philips FS, 1971, BIOL EFFECTS POLYNUC, P45, DOI [10.1007/978-3-642-85772-0_18, DOI 10.1007/978-3-642-85772-0_18]; Poland GA, 1997, JAMA-J AM MED ASSOC, V277, P1709, DOI 10.1001/jama.277.21.1709; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; ROBINSON RA, 1976, JNCI-J NATL CANCER I, V57, P599, DOI 10.1093/jnci/57.3.599; Sasaki E, 2017, VACCINE, V35, P821, DOI 10.1016/j.vaccine.2016.12.036; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; SHAW FE, 1989, VACCINE, V7, P425, DOI 10.1016/0264-410X(89)90157-6; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191896	10.1371/journal.pone.0191896	http://dx.doi.org/10.1371/journal.pone.0191896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408882	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800027
J	Woldetensay, YK; Belachew, T; Tesfaye, M; Spielman, K; Biesalski, HK; Kantelhardt, EJ; Scherbaum, V				Woldetensay, Yitbarek Kidane; Belachew, Tefera; Tesfaye, Markos; Spielman, Kathryn; Biesalski, Hans Konrad; Kantelhardt, Eva Johanna; Scherbaum, Veronika			Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version	PLOS ONE			English	Article							MENTAL-DISORDERS; LOW-INCOME; VALIDITY; SYMPTOMS; DIAGNOSIS; SCALES; INJURY; ADULTS	Background Semantic, technical, content, criterion and conceptual equivalence must be examined in order to validate a psychological rating scale in a new cultural setting. Few validation studies have been conducted in sub-Saharan Africa for scales seeking to detect depression in pregnant women. The aim of this study is to validate the 9-item Patient Health Questionnaire (PHQ-9) as a screening instrument for depression among Afaan Oromo speaking pregnant Ethiopian women. Methods A random sample of 246 pregnant women were recruited in Seka Chekorsa District, Ethiopia during their first, second or third trimester. One week later, 29 participants were selected to answer the questionnaire for a second time to evaluate test retest reliability. The Mini International Neuropsychiatric Interview (MINI-Plus) scale was used as a gold standard to evaluate validity. PHQ-9 was compared with MINI-Plus and sensitivity, specificity, accuracy, positive likelihood ratio, negative likelihood ratio and Receiver Operating Characteristic Curves (ROC) for PHQ-9 were calculated. Rasch analysis was also carried out using Win-steps version 3.81.0. Results The reliability coefficient, Cronbach's alpha, for the PHQ-9 total score was 0.84. Both the agreement and consistency Intra-class Correlation coefficients (ICC) for the one-week test-retest reliability were 0.98. The cut-off point of a summed score of eight resulted in a sensitivity of 80.8% and a specificity of 79.5%. The calculated area under the curve (AUC) for the PHQ-9 score versus the MINI-Plus was excellent, 0.88 (SE = 0.04; CI = 0.81-0.95). The PHQ-9 meets the criteria established by Linacre for rating scale effectiveness. Conclusions The PHQ-9 proved to be a reliable and valid instrument that may be used to screen major depressive disorders among Afaan Oromo speaking Ethiopian pregnant women.	[Woldetensay, Yitbarek Kidane; Biesalski, Hans Konrad; Scherbaum, Veronika] Univ Hohenheim, Inst Biol Chem & Nutr 140a, Stuttgart, Germany; [Woldetensay, Yitbarek Kidane; Biesalski, Hans Konrad; Scherbaum, Veronika] Univ Hohenheim, Food Secur Ctr, Stuttgart, Germany; [Woldetensay, Yitbarek Kidane; Belachew, Tefera; Tesfaye, Markos] Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Spielman, Kathryn] Tufts Univ, Freidman Sch Nutr Sci & policy, Boston, MA 02111 USA; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Fac Med, Dept Gynecol, Halle, Germany; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Fac Med, Inst Med Epidemiol Biostat & Informat, Halle, Germany	University Hohenheim; University Hohenheim; Jimma University; Tufts University; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Woldetensay, YK (corresponding author), Univ Hohenheim, Inst Biol Chem & Nutr 140a, Stuttgart, Germany.; Woldetensay, YK (corresponding author), Univ Hohenheim, Food Secur Ctr, Stuttgart, Germany.; Woldetensay, YK (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	yitbarek.woldetensay@gmail.com	Tesfaye, Markos/H-9297-2019; Belachew, Tefera/AAO-5877-2020	Woldetensay, Yitbarek/0000-0001-7697-4918; Tesfaye, Markos/0000-0002-3351-701X	Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program	Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program	This study was funded by Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program. The funder had no role in the analysis and interpretation of the evidence or in writing the paper or in the decision to submit for publication.; This study was funded by Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) program. The sponsor had no role in the analysis and interpretation of the evidence or in writing the paper or in the decision to submit for publication. We would like to thank Mr. Yohannes Kebede, Mr. Geda Tolera, Mr. Muktar Beshir, for translating the English version of the instruments into Afaan Oromo and Mr. Gemechis Mekonnen for back translating the Afaan Oromo version back to English Language for consistency check. We thank Mr. Matios Seboka and Mr. Gutema for administering the MINI-Plus instrument. The authors are grateful to Dr. Charlotte Hanlone for her valuable comments on the study protocol. We are also grateful to all the women who volunteered for the study and to the enumerators for their co-operation and support.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; Akena D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-187; Ali GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156939; Altman DG, 1991, PRACTICAL STAT MED R; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Bond TG., 2021, APPL RASCH MODEL FUN, V4th ed; Bowling KJ, 1998, MODERN EPIDEMIOLOGY; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Comrey A.L., 1992, 1 COURSE FACTOR ANAL; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Gothwal VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101295; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Kalpakjian CZ, 2009, J SPINAL CORD MED, V32, P147, DOI 10.1080/10790268.2009.11760766; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEFF JP, 1973, BRIT J PSYCHIAT, V123, P299, DOI 10.1192/bjp.123.3.299; LERNER J, 1968, INT J SOC PSYCHIATR, V14, P145, DOI 10.1177/002076406801400209; Linacre JM., 2012, USERS GUIDE WINSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Medical Outcomes Trust, 1997, TRUST B, V5; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Patel V, 2001, BRIT MED BULL, V57, P33, DOI 10.1093/bmb/57.1.33; Patel V, 2007, BRIT MED BULL, V81-82, P81, DOI 10.1093/bmb/ldm010; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Reckases MD., 1979, J EDUC STATIST, V4, P207, DOI DOI 10.3102/10769986004003207; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, pS22; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Walker ER, 2012, SEIZURE-EUR J EPILEP, V21, P437, DOI 10.1016/j.seizure.2012.04.009; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Williams RT, 2009, REHABIL PSYCHOL, V54, P198, DOI 10.1037/a0015529; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P327, DOI 10.1016/j.genhosppsych.2009.03.005; Zhou H., 2011, STAT INFERENCES YOUD	42	46	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191782	10.1371/journal.pone.0191782	http://dx.doi.org/10.1371/journal.pone.0191782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408928	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800024
J	Christensen, MHE; Fadnes, DJ; Rost, TH; Pedersen, ER; Andersen, JR; Vage, V; Ulvik, A; Midttun, O; Ueland, PM; Nygard, OK; Mellgren, G				Christensen, Monika H. E.; Fadnes, Dag J.; Rost, Therese H.; Pedersen, Eva R.; Andersen, John R.; Vage, Villy; Ulvik, Arve; Midttun, Oivind; Ueland, Per M.; Nygard, Ottar K.; Mellgren, Gunnar			Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery	PLOS ONE			English	Article							INTERFERON-GAMMA; IMMUNE-RESPONSE; OBESITY; MACROPHAGES; ACTIVATION; DISEASE; ASSOCIATION; EXPRESSION; NEOPTERIN; BALANCE	Objective Obesity is associated with increased inflammation and insulin resistance. In conditions with chronic immune activation, low plasma vitamin B6-levels are described, as well as an increased kynurenine: tryptophan-ratio (KTR). We investigated circulating tryptophan, kynurenine and its metabolites, neopterin, B-vitamins, CRP, and HbA1c in individuals with obesity before and after bariatric surgery. Methods This longitudinal study included 37 patients with severe obesity, scheduled for bariatric surgery. Blood samples were taken at inclusion and at three months and one year postoperatively. Results We observed significant positive correlations between HbA1c and both 3-hydroxy-kynurenine and 3-hydroxyanthranilic acid at inclusion. After surgery, fasting glucose, HbA1C and triglycerides decreased, whereas HDL-cholesterol increased. Tryptophan, kynurenine and its metabolites, except for anthranilic acid, decreased during weight loss. The KTR and CRP decreased while vitamin B6 increased during the year following operation, indicating reduced inflammation (all p<0.05). Conclusions In patients with obesity subjected to bariatric surgery, levels of 3-hydroxykynurenine and 3-hydroxyanthranilic acid seemed to be positively correlated to impaired glucose tolerance. One year following surgery, plasma levels of the kynurenine metabolites were substantially decreased, along with a metabolic improvement. The relation of circulating kynurenine pathway metabolites with biomarkers of metabolic impairment in patients with obesity needs further evaluation.	[Christensen, Monika H. E.; Rost, Therese H.; Pedersen, Eva R.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Christensen, Monika H. E.] Haukeland Hosp, Dept Med, Bergen, Norway; [Fadnes, Dag J.] Forde Hosp Trust, Med Dept, Forde, Norway; [Pedersen, Eva R.; Nygard, Ottar K.] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Andersen, John R.] Sogn og Fjordane Univ Coll, Forde, Norway; [Pedersen, Eva R.; Andersen, John R.] Forde Hosp Trust, Ctr Hlth Res, Forde, Norway; [Vage, Villy] Bergen Hlth Trust, Voss Hosp, Dept Surg, Voss, Norway; [Ulvik, Arve; Midttun, Oivind] Bevital AS, Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Nygard, Ottar K.; Mellgren, Gunnar] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Mellgren, G (corresponding author), Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Mellgren, G (corresponding author), Haukeland Hosp, Hormone Lab, Bergen, Norway.	gunnar.mellgren@med.uib.no	Ueland, Per M/C-7340-2013; Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Ueland, Per Magne/0000-0002-1903-0571; Andersen, John Roger/0000-0001-6300-9086	West Norway Regional Health Authority	West Norway Regional Health Authority	West Norway Regional Health Authority funded costs for the analysis. The funder, Bevital, provided support in the form of salaries for authors, OM and AU. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.; The study was supported by the West Norway Regional Health Authority.	Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; AlberatiGiani D, 1996, J NEUROCHEM, V66, P996; Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cheng CH, 2008, NUTRITION, V24, P239, DOI 10.1016/j.nut.2007.12.003; Constantinopoulos P, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0626; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Favennec M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158051; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Grant RW, 2015, AM J PHYSIOL ENDOCRI; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levy P, 2007, OBES SURG, V17, P1248, DOI 10.1007/BF02802098; Lotto V, 2011, BR J NUTR, V13, P1; LUI A, 1985, J LAB CLIN MED, V106, P491; Mahuren JD, 1999, J NUTR, V129, P1905, DOI 10.1093/jn/129.10.1905; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Midttun O, 2013, ANAL BIOANAL CHEM, V405, P2009, DOI 10.1007/s00216-012-6602-6; Midttun O, 2011, J NUTR, V141, P611, DOI 10.3945/jn.110.133082; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Munipally PK, 2011, ARCH PHYSIOL BIOCHEM, V117, P254, DOI 10.3109/13813455.2011.623705; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Paul L, 2013, NUTR REV, V71, P239, DOI 10.1111/nure.12014; Rojano-Rodriguez ME, 2014, REV GASTROENTEROL ME, V79, P90, DOI 10.1016/j.rgmx.2013.11.002; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shen J, 2010, AM J CLIN NUTR, V91, P337, DOI 10.3945/ajcn.2009.28571; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Theofylaktopoulou D, 2013, CLIN EXP IMMUNOL, V173, P121, DOI 10.1111/cei.12092; Ueland PM, 2016, MOL ASPECTS MED; Ulvik A, 2012, AM J CLIN NUTR; Vage V, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-8; Vage V, 2011, OBES SURG, V21, P1864, DOI 10.1007/s11695-011-0496-9; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	40	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192169	10.1371/journal.pone.0192169	http://dx.doi.org/10.1371/journal.pone.0192169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401505	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400040
J	da Silva, RL; Labrecque, D; Caromano, FA; Higgins, J; Frak, V				da Silva, Ronaldo Luis; Labrecque, David; Caromano, Fatima Aparecida; Higgins, Johanne; Frak, Victor			Manual action verbs modulate the grip force of each hand in unimanual or symmetrical bimanual tasks	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; INTERHEMISPHERIC-TRANSFER TIME; INFERIOR FRONTAL GYRUS; CONNECTIVITY; COORDINATION; LANGUAGE; BRAIN; CORTEX; FMRI	Manual action verbs modulate the right-hand grip force in right-handed subjects. However, to our knowledge, no studies demonstrate the ability to accomplish this modulation during bimanual tasks nor describe their effect on left-hand behavior in unimanual and bimanual tasks. Using load cells and word playlists, we evaluated the occurrence of grip force modulation by manual action verbs in unimanual and symmetrical bimanual tasks across the three auditory processing phases. We found a significant grip force increase for all conditions compared to baseline, indicating the occurrence of modulation. When compared to each other, the grip force variation from baseline for the three phases of both hands in the symmetrical bimanual task was not different from the right-hand in the unimanual task. The left-hand grip force showed a lower amplitude for auditory phases 1 and 2 when compared to the other conditions. The right-hand grip force modulation became significant from baseline at 220 ms after the word onset in the unimanual task. This moment occurred earlier for both hands in bimanual task (160 ms for the right-hand and 180 for the left-hand). It occurred later for the left-hand in unimanual task (320 ms). We discuss the hypothesis that Broca's area and Broca's homologue area likely control the left-hand modulation in a unilateral or a bilateral fashion. These results provide new evidence for understanding the linguistic function processing in both hemispheres.	[da Silva, Ronaldo Luis; Labrecque, David; Frak, Victor] Univ Quebec Montre, Fac Sci, Montreal, PQ, Canada; [da Silva, Ronaldo Luis; Higgins, Johanne; Frak, Victor] CRIR, CIUSSS Ctr Sud De Ile De Montreal, CRIR, Site Inst Readaptat Gingras Lindsay Montreal, Montreal, PQ, Canada; [Caromano, Fatima Aparecida] Univ Sao Paulo, Med Sch, Dept Phys Therapy Speech & Occupat Therapy, Lab Phys Therapy & Behav, Sao Paulo, Brazil; [Higgins, Johanne] Univ Montreal, Fac Med, Ecole Readapt, Montreal, PQ, Canada	Universite de Montreal; Universidade de Sao Paulo; Universite de Montreal	da Silva, RL (corresponding author), Univ Quebec Montre, Fac Sci, Montreal, PQ, Canada.; da Silva, RL (corresponding author), CRIR, CIUSSS Ctr Sud De Ile De Montreal, CRIR, Site Inst Readaptat Gingras Lindsay Montreal, Montreal, PQ, Canada.	da_silva.ronaldo_luis@courrier.uqam.ca	da Silva, Ronaldo Luis/Q-3704-2019; da Silva, Ronaldo Luis/ABC-3801-2020; Higgins, Johanne/AAF-3672-2019	da Silva, Ronaldo Luis/0000-0003-0254-2017; Higgins, Johanne/0000-0003-1513-6587; Frak, Victor/0000-0002-3311-777X	National Council for Scientific and Technological Development (CNPq) [202464/2014-8]; Fondation de l'Institut de Readaptation de Montreal, Canada	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondation de l'Institut de Readaptation de Montreal, Canada	RLS was supported by the National Council for Scientific and Technological Development (CNPq), by means of the Brazilian Governments Science Without Borders Program (https://fondationrea.ca/en/foundation/-Grant number: 202464/2014-8). This work was aided by a grant from Fondation de lInstitut de Readaptation de Montreal, Canada (http://www.fondationirglm.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Aramaki Y, 2010, EXP BRAIN RES, V203, P407, DOI 10.1007/s00221-010-2244-0; Aravena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050287; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Bernal B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00687; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Genon S, 2016, CEREB CORTEX; Haberling IS, 2016, NEUROPSYCHOLOGIA, V80, P17, DOI 10.1016/j.neuropsychologia.2015.11.002; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; INDEFREY P, 2011, FRONT PSYCHOL, V2; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; Maki Y, 2008, NEUROIMAGE, V42, P1295, DOI 10.1016/j.neuroimage.2008.06.045; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Nazir TA, 2017, BEHAV RES METHODS, V49, P61, DOI 10.3758/s13428-015-0696-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Rapp B, 2014, LANG COGN NEUROSCI, V29, P24, DOI 10.1080/01690965.2013.848991; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2016, NAT REV NEUROSCI, V17, P757, DOI 10.1038/nrn.2016.135; Rogers BP, 2004, NEUROIMAGE, V22, P855, DOI 10.1016/j.neuroimage.2004.02.027; Rosso C, 2014, BRAIN STIMUL, V7, P122, DOI 10.1016/j.brs.2013.08.007; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Rowan A, 2004, NEUROIMAGE, V22, P665, DOI 10.1016/j.neuroimage.2004.01.034; Sadato N, 1997, J NEUROSCI, V17, P9667; Sollmann N, 2014, NEUROIMAGE, V102, P776, DOI 10.1016/j.neuroimage.2014.09.002; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192320	10.1371/journal.pone.0192320	http://dx.doi.org/10.1371/journal.pone.0192320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401468	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000424101400048
J	Diaz, GJ; Parade, MS; Barton, SL; Fajen, BR				Diaz, Gabriel J.; Parade, Melissa S.; Barton, Sean L.; Fajen, Brett R.			The pickup of visual information about size and location during approach to an obstacle	PLOS ONE			English	Article							LONG-LASTING MEMORIES; FOOT PLACEMENT; APPROACH PHASE; WALKING; LOCOMOTION; GAIT; VISION; PATTERNS; TERRAIN; STEP	The present study investigated differences in the pickup of information about the size and location of an obstacle in the path of locomotion. The main hypothesis was that information about obstacle location is most useful when it is sampled at a specific time during the approach phase, whereas information about obstacle size can be sampled at any point during the last few steps. Subjects approached and stepped over obstacles in a virtual environment viewed through a head-mounted display. In Experiment 1, a horizontal line on the ground indicating obstacle location was visible throughout the trial while information about obstacle height and depth was available only while the subject was passing through a viewing window located at one of four locations along the subject's path. Subjects exhibited more cautious behavior when the obstacle did not become visible until they were within one step length, but walking behavior was at most weakly affected in the other viewing window conditions. In Experiment 2, the horizontal line indicating obstacle location was removed, such that no information about the obstacle (size or location) was available outside of the viewing window. Subjects adopted a more cautious strategy compared to Experiment 1 and differences between the viewing window conditions and the full vision control condition were observed across several measures. The differences in walking behavior and performance across the two experiments support the hypothesis that walkers have greater flexibility in when they can sample information about obstacle size compared to location. Such flexibility may impact gaze and locomotor control strategies, especially in more complex environments with multiple objects and obstacles.	[Diaz, Gabriel J.] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA; [Parade, Melissa S.; Barton, Sean L.; Fajen, Brett R.] Rensselaer Polytech Inst, Cognit Sci Dept, Troy, NY 12181 USA	Rochester Institute of Technology; Rensselaer Polytechnic Institute	Diaz, GJ (corresponding author), Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA.; Fajen, BR (corresponding author), Rensselaer Polytech Inst, Cognit Sci Dept, Troy, NY 12181 USA.	gabriel.diaz@rit.edu; fajenb@rpi.edu			NSF BCS [1431078]	NSF BCS(National Science Foundation (NSF))	Supported by NSF BCS 1431078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Buckley JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019079; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Chou LS, 2001, GAIT POSTURE, V13, P17, DOI 10.1016/S0966-6362(00)00087-4; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; Creem-Regehr SH, 2015, PSYCHOL LEARN MOTIV, V62, P195, DOI 10.1016/bs.plm.2014.09.006; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Heijnen MJH, 2014, EXP BRAIN RES, V232, P2131, DOI 10.1007/s00221-014-3903-3; Hesse C, 2016, NEUROPSYCHOLOGIA, V91, P531, DOI 10.1016/j.neuropsychologia.2016.09.016; Krigolson A, 2004, HUM MOVEMENT SCI, V23, P861, DOI 10.1016/j.humov.2004.10.011; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Lajoie K, 2012, J NEUROPHYSIOL, V107, P2283, DOI 10.1152/jn.00756.2011; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marigold DS, 2008, EXP BRAIN RES, V188, P23, DOI 10.1007/s00221-008-1335-7; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Matthis JS, 2015, J VISION, V15, DOI 10.1167/15.3.10; Matthis JS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0700; McVea DA, 2006, J NEUROSCI, V26, P1175, DOI 10.1523/JNEUROSCI.4458-05.2006; Mcvea DA, 2007, CURR BIOL, V17, pR621, DOI 10.1016/j.cub.2007.06.026; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Muir BC, 2015, GAIT POSTURE, V41, P233, DOI 10.1016/j.gaitpost.2014.10.005; Parade M, 2014, J VISION, V14, P1353; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Rhea CK, 2007, NEUROSCI LETT, V418, P60, DOI 10.1016/j.neulet.2007.02.063; Rietdyk S, 2006, EXP BRAIN RES, V169, P272, DOI 10.1007/s00221-005-0345-y; Timmis MA, 2016, GAIT POSTURE, V44, P55, DOI 10.1016/j.gaitpost.2015.11.008; Timmis MA, 2012, GAIT POSTURE, V36, P160, DOI 10.1016/j.gaitpost.2012.02.008; Watt SJ, 2005, J VISION, V5, P834, DOI 10.1167/5.10.7; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192044	10.1371/journal.pone.0192044	http://dx.doi.org/10.1371/journal.pone.0192044			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401511	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400032
J	Eggimann, L; Blum, S; Aeschbacher, S; Reusser, A; Ammann, P; Erne, P; Moschovitis, G; Di Valentino, M; Shah, D; Schlapfer, J; Mondet, N; Kuhne, M; Sticherling, C; Osswald, S; Conen, D				Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Ammann, Peter; Erne, Paul; Moschovitis, Giorgio; Di Valentino, Marcello; Shah, Dipen; Schlapfer, Jurg; Mondet, Nadine; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David			Risk factors for heart failure hospitalizations among patients with atrial fibrillation	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; DIASTOLIC BLOOD-PRESSURE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; PROGNOSTIC IMPLICATIONS; DIABETES-MELLITUS; JAPANESE PATIENTS; OBESITY PARADOX; SERUM CHLORIDE; MORTALITY	Background Patients with atrial fibrillation (AF) have an increased risk for the development of heart failure (HF). In this study, we aimed to detect predictors of HF hospitalizations in an unselected AF population. Methods The Basel Atrial Fibrillation Cohort Study is an ongoing observational multicenter cohort study in Switzerland. For this analysis, 1193 patients with documented AF underwent clinical examination, venous blood sampling and resting 12-lead ECG at baseline. Questionnaires about lifestyle and medical history were obtained in person at baseline and during yearly follow-up phone calls. HF hospitalizations were validated by two independent physicians. Cox regression analyses were performed using a forward selection strategy. Results Overall, 29.8% of all patients were female and mean age was 69 +/- 12 years. Mean follow-up time was 3.7 +/- 1.5 years. Hospitalization for HF occurred in 110 patients, corresponding to an incidence of 2.5 events per 100 person years of follow-up. Independent predictors for HF were body mass index (HR 1.40 [95% CI 1.17; 1.66], p = 0.0002), chronic kidney disease (2.27 [1.49; 3.45], p = 0.0001), diabetes mellitus (2.13 [1.41; 3.24], p = 0.0004), QTc interval (1.25 [1.04; 1.49], p = 0.02), brain natriuretic peptide (2.19 [1.73; 2.77], p< 0.0001), diastolic blood pressure (0.79 [0.65; 0.96], p = 0.02), history of pulmonary vein isolation or electrical cardioversion (0.54 [0.36; 0.80], p = 0.003) and serum chloride (0.82 [0.70; 0.96], p = 0.02). Conclusions In this unselected AF population, several traditional cardiovascular risk factors and arrhythmia interventions predicted HF hospitalizations, providing potential opportunities for the implementation of strategies to reduce HF among AF patients.	[Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David] Univ Basel, Univ Hosp Basel, Dept Med, Div Cardiol, Basel, Switzerland; [Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Mondet, Nadine; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David] Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland; [Blum, Steffen] Univ Basel, Univ Hosp Basel, Dept Med, Div Internal Med, Basel, Switzerland; [Ammann, Peter] Kantonsspital, Div Cardiol, St Gallen, Switzerland; [Erne, Paul] Univ Hosp Basel, Dept Biomed, Lab Signal Transduct, Basel, Switzerland; [Moschovitis, Giorgio] Osped Reg Lugano, Div Cardiol, Ticino, Switzerland; [Di Valentino, Marcello] Osped San Giovanni Bellinzona, Div Cardiol, Ticino, Switzerland; [Shah, Dipen] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Schlapfer, Jurg] Univ Hosp Lausanne, Serv Cardiol, Lausanne, Switzerland; [Conen, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); McMaster University; Population Health Research Institute	Conen, D (corresponding author), Univ Basel, Univ Hosp Basel, Dept Med, Div Cardiol, Basel, Switzerland.; Conen, D (corresponding author), Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland.; Conen, D (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	conend@mcmaster.ca	Kühne, Michael/AAB-5202-2022; Aeschbacher, Stefanie/E-4935-2017; Osswald, Stefan/A-6904-2018; Sticherling, Christian/AAY-4435-2021	Kühne, Michael/0000-0002-2937-3711; Osswald, Stefan/0000-0002-9240-6731; Sticherling, Christian/0000-0001-8428-7050; /0000-0001-8134-2421	Swiss National Science Foundation; Swiss Heart Foundation; University of Basel; Boehringer Ingelheim; Sanofi-Aventis; Merck Sharp Dome; Bayer; Daiichi-Sankyo; Pfizer/Bristol-Myers Squibb	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; University of Basel; Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Merck Sharp Dome; Bayer(Bayer AG); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Pfizer/Bristol-Myers Squibb(Bristol-Myers SquibbPfizer)	This study was supported by the Swiss National Science Foundation, the Swiss Heart Foundation, the University of Basel, Boehringer Ingelheim, Sanofi-Aventis, Merck Sharp & Dome, Bayer, Daiichi-Sankyo and Pfizer/Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Beinart R, 2014, J AM COLL CARDIOL, V64, P2111, DOI 10.1016/j.jacc.2014.08.039; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Burger M, 2004, PREV MED, V39, P111, DOI 10.1016/j.ypmed.2003.11.011; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cavender MA, 2015, CIRCULATION, V132, P923, DOI 10.1161/CIRCULATIONAHA.114.014796; Chen CY, 2012, CIRC J, V76, P2372, DOI 10.1253/circj.CJ-12-0040; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Cox DR, 1972, J ROY STAT SOC B; De Bacquer D, 1998, J Cardiovasc Risk, V5, P177; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Ellinor PT, 2005, J AM COLL CARDIOL, V45, P82, DOI 10.1016/j.jacc.2004.09.045; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fukuda T, 2007, CIRC J, V71, P308, DOI 10.1253/circj.71.308; Grodin JL, 2015, J AM COLL CARDIOL, V66, P659, DOI 10.1016/j.jacc.2015.06.007; Heo S, 2007, HEART LUNG, V36, P16, DOI 10.1016/j.hrtlng.2006.06.003; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Imai K, 2014, INTERNAL MED, V53, P7, DOI 10.2169/internalmedicine.53.0962; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lip GYH, 2015, EUR J HEART FAIL, V17, P570, DOI 10.1002/ejhf.254; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; McCallum L, 2013, HYPERTENSION, V62, P836, DOI 10.1161/HYPERTENSIONAHA.113.01793; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Pandey A, 2017, JACC-HEART FAIL, V5, P44, DOI 10.1016/j.jchf.2016.09.016; Potpara TS, 2013, EUR J HEART FAIL, V15, P415, DOI 10.1093/eurjhf/hft004; Sandhu RK, 2016, EUR HEART J, V37, P2869, DOI 10.1093/eurheartj/ehw124; Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schnabel RB, 2013, EUR J HEART FAIL, V15, P843, DOI 10.1093/eurjhf/hft041; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Steinberg BA, 2014, AM HEART J, V167, P735, DOI 10.1016/j.ahj.2014.02.003; Suzuki S, 2012, AM J CARDIOL, V110, P678, DOI 10.1016/j.amjcard.2012.04.049; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Testani JM, 2016, EUR J HEART FAIL, V18, P660, DOI 10.1002/ejhf.477; Thihalolipavan S, 2015, PROG CARDIOVASC DIS, V58, P126, DOI 10.1016/j.pcad.2015.07.004; Wang J, 2014, INT J CARDIOL, V176, P1356, DOI 10.1016/j.ijcard.2014.07.264; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wozakowska-Kaplon B, 2004, AM J CARDIOL, V93, P1555, DOI 10.1016/j.amjcard.2004.03.013; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191736	10.1371/journal.pone.0191736	http://dx.doi.org/10.1371/journal.pone.0191736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394253	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400018
J	Lehrer, R; Schumacher, G				Lehrer, Roni; Schumacher, Gijs			Governator vs. Hunter and Aggregator: A simulation of party competition with vote-seeking and office-seeking rules	PLOS ONE			English	Article							AGENT-BASED MODELS; PARLIAMENTARY DEMOCRACIES; IDEOLOGICAL CONGRUENCE; GOVERNMENT FORMATION; POLITICAL COMPETITION; COALITION-FORMATION; SPATIAL THEORY; POLICY SHIFTS; INSTITUTIONS; SATISFACTION	The policy positions parties choose are central to both attracting voters and forming coalition governments. How then should parties choose positions to best represent voters? Laver and Sergenti show that in an agent-based model with boundedly rational actors a decision rule (Aggregator) that takes the mean policy position of its supporters is the best rule to achieve high congruence between voter preferences and party positions. But this result only pertains to representation by the legislature, not representation by the government. To evaluate this we add a coalition formation procedure with boundedly rational parties to the Laver and Sergenti model of party competition. We also add two new decision rules that are sensitive to government formation outcomes rather than voter positions. We develop two simulations: a single-rule one in which parties with the same rule compete and an evolutionary simulation in which parties with different rules compete. In these simulations we analyze party behavior under a large number of different parameters that describe real-world variance in political parties' motives and party system characteristics. Our most important conclusion is that Aggregators also produce the best match between government policy and voter preferences. Moreover, even though citizens often frown upon politicians' interest in the prestige and rents that come with winning political office (office pay-offs), we find that citizens actually receive better representation by the government if politicians are motivated by these office pay-offs in contrast to politicians with ideological motivations (policy pay-offs). Finally, we show that while more parties are linked to better political representation, how parties choose policy positions affects political representation as well. Overall, we conclude that to understand variation in the quality of political representation scholars should look beyond electoral systems and take into account variation in party behavior as well.	[Lehrer, Roni] Univ Mannhe, Collaborat Res Ctr SFB 884, Mannheim, Germany; [Schumacher, Gijs] Univ Amsterdam, Dept Polit Sci, Amsterdam, Netherlands	University of Amsterdam	Schumacher, G (corresponding author), Univ Amsterdam, Dept Polit Sci, Amsterdam, Netherlands.	g.schumacher@uva.nl		Schumacher, Gijs/0000-0002-6503-4514; Lehrer, Roni/0000-0002-9202-9278	state of Baden-Wurttemberg through bwHPC; German Research Foundation (DFG) [SFB 884]	state of Baden-Wurttemberg through bwHPC; German Research Foundation (DFG)(German Research Foundation (DFG))	We would like to thank Michael Laver, Ernest Sergenti, Scott de Marchi, Matt Golder, Hugh Ward, Brian Burgoon, Eric Schliesser, Wouter van der Brug, Duco Ferro, Jona Linde, Mariken van der Velden, Martijn Schoonvelde, Christian Martin, Jasper Muis, Jos Elkink, Robi Ragan, Asim Zia and the three anonymous reviewers of Plos One for help, suggestions and encouragements at various stages of this very, very long project. The authors acknowledge support by the state of Baden-Wurttemberg through bwHPC and Roni Lehrer acknowledges funding by the German Research Foundation (DFG) via SFB 884 on "The Political Economy of Reforms" (project C2). Also, many thanks to Lisa at Surfsara. Without you the simulations would still be running on some laptop.	Adams J, 2012, ANNU REV POLIT SCI, V15, P401, DOI 10.1146/annurev-polisci-031710-101450; Adams J, 2009, BRIT J POLIT SCI, V39, P825, DOI 10.1017/S0007123409000635; ALDRICH JH, 1983, AM POLIT SCI REV, V77, P974, DOI 10.2307/1957570; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; Anderson CJ, 1997, AM POLIT SCI REV, V91, P66, DOI 10.2307/2952259; BARON DP, 1987, AM ECON REV, V77, P303; Baron DP, 1989, AM POLIT SCI REV, P83; Bassi A, 2013, AM J POLIT SCI, V57, P777, DOI 10.1111/ajps.12031; Bendor J, 2011, A BEHAVIORAL THEORY; Blais A, 2006, COMP POLIT STUD, V39, P1243, DOI 10.1177/0010414005284374; BROWNE EC, 1973, AM POLIT SCI REV, V67, P453, DOI 10.2307/1958776; BUDGE I, 1994, BRIT J POLIT SCI, V24, P443, DOI 10.1017/S0007123400006955; de Marchi S, 2014, ANNU REV POLIT SCI, V17, P1, DOI 10.1146/annurev-polisci-080812-191558; DOWNS ANTHONY, 1957, AN ECONOMIC THEORY O; Ezrow L, 2011, COMP POLIT STUD, V44, P1152, DOI 10.1177/0010414011405461; Falco-Gimeno A, 2013, WEST EUR POLIT, V36, P221, DOI 10.1080/01402382.2013.742758; Fowler JH, 2008, J CONFLICT RESOLUT, V52, P68, DOI 10.1177/0022002707308598; GAMSON WA, 1961, AM SOCIOL REV, V26, P373, DOI 10.2307/2090664; Glasgow G, 2011, J POLIT, P16801; Glasgow G, 2012, POLIT ANAL, V20, P248, DOI 10.1093/pan/mpr058; Golder M, 2012, J POLIT; Golder M, 2014, EUR J POLIT RES, V53, P200, DOI 10.1111/1475-6765.12031; Golder M, 2010, AM J POLIT SCI, V54, P90, DOI 10.1111/j.1540-5907.2009.00420.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Holland J. H., 2006, Journal of Systems Science and Complexity, V19, P1, DOI 10.1007/s11424-006-0001-z; Holmberg S, 1999, POLICY REPRESENTATIO, P87; Hooghe L, 2002, COMP POLIT STUD, V35, P965, DOI 10.1177/001041402236310; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; HUBER JD, 1994, WORLD POLIT, V46, P291, DOI 10.2307/2950684; Humphreys M, 2008, ANNU REV POLIT SCI, V11, P351, DOI 10.1146/annurev.polisci.11.062206.091849; Humphreys M, 2010, BRIT J POLIT SCI, V40, P11, DOI 10.1017/S0007123409990263; Kenkel B, 2011, J STAT SOFTW, P1; Kenkel B, 2014, J STAT SOFTW, V56, P1; Klingemann H-D., 2006, MAPPING POLICY PREFE; Kollman K, 1998, BRIT J POLIT SCI, V28, P139, DOI 10.1017/S0007123498000131; Kollman K, 1992, AM POLIT SCI REV, P86; Laver M, 1998, ANNU REV POLIT SCI, V1, P1, DOI 10.1146/annurev.polisci.1.1.1; Laver M, 2005, AM POLIT SCI REV, V99, P263, DOI 10.1017/S0003055405051646; Laver M, 2012, PARTY COMPETITION AN; Laver M., 1992, POLICY PARTY COMPETI; Laver M, 2007, PHILOS T R SOC B, V362, P1711, DOI 10.1098/rstb.2007.2062; Laver M, 2011, PUBLIC CHOICE, V147, P285, DOI 10.1007/s11127-010-9627-4; Lehrer R, 2012, INTRAPARTY DEMOCRACY, P37; Lehrer R, 2017, SOC SCI QUART, V98, P1026, DOI 10.1111/ssqu.12432; Martin LW, 2001, AM J POLIT SCI, V45, P33, DOI 10.2307/2669358; Martin LW, 2004, AM J POLIT SCI, V48, P13, DOI 10.1111/j.0092-5853.2004.00053.x; Muller W. C., 1999, POLICY OFFICE OR VOT; Powell GB, 2009, COMP POLIT STUD, V42, P1475, DOI 10.1177/0010414009332147; Schofield N, 2005, EUR J POLIT RES, V44, P355, DOI 10.1111/j.1475-6765.2005.00231.x; Schofield N, 2003, J THEOR POLIT, V15, P371, DOI 10.1177/09516298030154001; Schreiber D, 2014, POLIT RES QUART, V67, P136, DOI 10.1177/1065912913487258; Schumacher G, 2015, AM J POLIT SCI, V59, P1040, DOI 10.1111/ajps.12174; Schumacher G, 2013, J POLIT, V75, P464, DOI 10.1017/S0022381613000145; Simon H, 1955, Q J ECON, P69; Simon H., 1956, PSYCHOL REV, P63; Warwick PV, 2001, COMP POLIT STUD, V34, P1212, DOI 10.1177/0010414001034010005; Warwick PV, 2001, BRIT J POLIT SCI, V31, P627; Wessels B, 1999, POLICY REPRESENTATIO, P137	59	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191649	10.1371/journal.pone.0191649	http://dx.doi.org/10.1371/journal.pone.0191649			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394268	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400017
J	Calocer, F; Dejardin, O; Droulon, K; Launoy, G; Defer, G				Calocer, Floriane; Dejardin, Olivier; Droulon, Karine; Launoy, Guy; Defer, Gilles			Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients	PLOS ONE			English	Article							DEPRIVATION INDEX; HEALTH; RISK; DIAGNOSIS; PEOPLE; CANCER; VALIDATION; CHILDHOOD; POSITION; OUTCOMES	Objective In MS, Socio-Economic status (SES) may influence healthcare and access to disease-modifying treatments (DMTs). Optimising delays to switch patients to a second-line DMT may hamper disease progression most effectively and achieve long term disease control. The objective of this study is to identify the influence of SES on the delay between first and second line DMT in RRMS patients, in Western-Normandy, France. Methods The association between SES and the delay to access a second-line DMT were studied using data from the MS registry of Western-Normandy including 733 patients with a diagnosis of RRMS during the period in question [1982 +/- 2011]. We used the European Deprivation Index (EDI), a score with a rank level inversely related to SES. We performed multivariate adjusted Cox models for studying EDI effect on the delay between first and second line DMT. Results No significant influence of SES was observed on delay to access a second-line DMT if firstline DMT exposure time was less than 5 years. After 5 years from initiation of first-line treatment the risk of accessing a second-line DMT is 3 times higher for patients with lower deprivation indices (1 st quintile of EDI) ([HR] 3.14 95% CI [1.72 +/- 5.72], p-value<0.001) compared to patients with higher values (EDI quintiles 2 to 5). Interpretation In RRMS, a high SES may facilitate access to a second-line DMT a few years after first-line DMT exposure. Greater consideration should also be given to the SES of MS patients as a risk factor in therapeutic healthcare issues throughout medical follow-up.	[Calocer, Floriane; Defer, Gilles] CHU Caen, Dept Neurol, Caen, France; [Calocer, Floriane; Defer, Gilles] Normandie Univ, UNICAEN, INSERM 1237, Physiopathol & Imaging Neurol Disorders, Caen, France; [Dejardin, Olivier; Launoy, Guy] CHU Caen, Pole Rech, Caen, France; [Dejardin, Olivier; Launoy, Guy] Normandie Univ, UNICAEN, INSERM 1086, ANTICIPE Canc & Prevent, Caen, France; [Droulon, Karine] Reseau Bas Normand SEP, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Calocer, F (corresponding author), CHU Caen, Dept Neurol, Caen, France.; Calocer, F (corresponding author), Normandie Univ, UNICAEN, INSERM 1237, Physiopathol & Imaging Neurol Disorders, Caen, France.	floriane.calocer@inserm.fr	Launoy, Guy/K-7372-2015; dejardin, olivier/L-9879-2015; DEFER, Gilles/AAM-4393-2020	dejardin, olivier/0000-0002-6561-1430; Calocer, Floriane/0000-0001-6021-7197	French State; Agence Nationale de la Recherche [ANR-10-COHO-002]; Reseau Bas-Normand pour la SEP; Regional Council of Normandy	French State; Agence Nationale de la Recherche(French National Research Agency (ANR)); Reseau Bas-Normand pour la SEP; Regional Council of Normandy(Region Normandie)	Floriane Calocer received a fellowship from the "Reseau Bas-Normand pour la SEP" and from the Regional Council of Normandy for carrying out this study. The Regional Council of Normandy had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The "Reseau BasNormand pour la SEP" had only a role in data collection.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Allgar VL, 2005, BRIT J CANCER, V92, P1959, DOI 10.1038/sj.bjc.6602587; Beltran VM, 2011, PUBLIC HEALTH REP, V126, P41, DOI 10.1177/00333549111260S309; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bjornevik K, 2016, MULT SCLER J, V22, P104, DOI 10.1177/1352458515579444; Buchanan RJ, 2006, NEUROREHABILITATION, V21, P177; Buchanan Robert J, 2006, J Health Hum Serv Adm, V29, P360; Burks J, 1998, J Spinal Cord Med, V21, P113; Cotton F, 2015, J NEURORADIOLOGY, V42, P133, DOI 10.1016/j.neurad.2014.12.001; Creange A, 2009, MULT SCLER, V15, P1085, DOI 10.1177/1352458509106710; De Saint Pol T, 2007, INSEE PREM, P4; Frier A, 2016, DISABIL REHABIL, P1; Goulden R, 2015, EUR J NEUROL, V22, P899, DOI 10.1111/ene.12586; GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269; Halper J, 1994, NeuroRehabilitation, V4, P67, DOI 10.3233/NRE-1994-4203; IRDES, 2013, COUV COMPL SANT FRAN; KAMPF C, 2012, BMC PUBLIC HLTH, V10; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Minden SL, 2008, NEUROLOGY, V70, P1141, DOI 10.1212/01.wnl.0000306411.46934.ef; Minden SL, 2007, MULT SCLER J, V13, P547, DOI 10.1177/1352458506071306; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Nielsen NM, 2013, AM J EPIDEMIOL, V177, P1289, DOI 10.1093/aje/kws350; Noyes K, 2013, AM J MANAG CARE, V19, pS321; Owens T, 2013, EUR J HEALTH ECON, V14, P315, DOI 10.1007/s10198-012-0378-7; Pampalon R, 2014, CHRON DIS INJ CAN, V34, P12; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Qian WN, 2014, INT PSYCHOGERIATR, V26, P597, DOI 10.1017/S1041610213002299; Riise T, 2011, MULT SCLER J, V17, P780, DOI 10.1177/1352458510397686; Szaflarski M, 2014, EPILEPSY BEHAV, V41, P283, DOI 10.1016/j.yebeh.2014.06.013; Vohra J, 2016, J EPIDEMIOL COMMUN H, V70, P629, DOI 10.1136/jech-2015-206274; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Ziemssen T, 2015, MULT SCLER RELAT DIS, V4, P460, DOI 10.1016/j.msard.2015.07.007	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191646	10.1371/journal.pone.0191646	http://dx.doi.org/10.1371/journal.pone.0191646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390025	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400025
J	Chen, CH; Xin, Y; Lee, KW; Lin, MJ; Lin, JJ				Chen, Che Hsiu; Xin, Ye; Lee, Kuang Wu; Lin, Ming Ju; Lin, Jiu Jenq			Acute effects of different dynamic exercises on hamstring strain risk factors	PLOS ONE			English	Article							PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION; KNEE PROPRIOCEPTION; ISOKINETIC STRENGTH; PASSIVE PROPERTIES; SPINAL CURVATURES; MUSCLE; QUADRICEPS; POSITION; FLEXIBILITY; PERFORMANCE	The purpose of the study was to examine the acute effects of different dynamic exercise interventions on hamstring muscle performance. Thirty-six young men with poor hamstring flexibility were randomly assigned to three intervention groups: jogging combined with dynamic open kinetic chain stretching (DS), jogging combined with dynamic closed kinetic chain stretching (lunge with eccentric hamstring windmills, LEC), and jogging only (CON) groups. Hamstring flexibility, muscle stiffness (area under the curve, AUC), joint position sense (JPS), maximal eccentric strength (ECC), and angle of peak torque (APT) were recorded before and immediately after the exercise interventions. The results showed that the hamstring flexibility increased in DS (p < 0.001); muscle stiffness decreased in DS and was lower than jogging (p < 0.001). Moreover, ECC increased in LEC and was higher than jogging and DS (p < 0.001). APT was different among 3 groups (p < 0.001). Decreased accuracy of JPS was found in DS and jogging (p < 0.001). In conclusion, the dynamic closed kinetic chain stretching (LEC) as compared to open kinetic chain stretching (DS) or jogging group, may be an effective technique to enhance muscle performance during the pre-competition warm-up routine.	[Chen, Che Hsiu] Natl Taiwan Univ Sport, Dept Sport Performance, Taichung, Taiwan; [Chen, Che Hsiu; Lee, Kuang Wu] Univ Taipei, Grad Inst Sports Training, Taipei, Taiwan; [Xin, Ye] Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA; [Lin, Ming Ju] Natl Chiayi Univ, Dept Phys Educ, 85 Wenlong Village, Minsyong Township, Chiayi, Taiwan; [Lin, Jiu Jenq] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan	National Taiwan University of Sport; University of Taipei; University of Mississippi; National Chiayi University; National Taiwan University	Lin, JJ (corresponding author), Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan.	jiujlin@ntu.edu.tw	lin, jiu jenq/H-4604-2014; Lin, Jiu/GRJ-5213-2022	lin, jiu jenq/0000-0001-9070-7939; 	Ministry of Science and Technology in Taiwan [101-2410-H-259-082]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology in Taiwan (101-2410-H-259-082) to Che Hsiu Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarrestad DD, 2004, J CHILD NEUROL, V19, P894, DOI 10.1177/08830738040190110801; [Anonymous], 1988, J C STAT POWER ANAL; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Ayala F, 2013, J SPORT SCI, V31, P831, DOI 10.1080/02640414.2012.751119; Bartlett MJ, 2002, BRIT J SPORT MED, V36, P132, DOI 10.1136/bjsm.36.2.132; Batista LH, 2009, AM J PHYS MED REHAB, V88, P815, DOI 10.1097/PHM.0b013e3181b72149; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Bjorklund M, 2006, J ATHL TRAINING, V41, P270; Chen CH, 2013, J SPORT REHABIL, V22, P59, DOI 10.1123/jsr.22.1.59; Chen CH, 2011, MED SCI SPORT EXER, V43, P491, DOI 10.1249/MSS.0b013e3181f315ad; Costa PB, 2014, MED SCI SPORT EXER, V46, P586, DOI 10.1249/MSS.0000000000000138; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher IM, 2007, J STRENGTH COND RES, V21, P784; Fletcher IM, 2010, EUR J APPL PHYSIOL, V109, P491, DOI 10.1007/s00421-010-1386-x; Gleim GW, 1997, SPORTS MED, V24, P291; Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632; Larsen R, 2005, BRIT J SPORT MED, V39, P43, DOI 10.1136/bjsm.2003.011056; Lopez-Minarro PA, 2012, J HUM KINET, V31, P69, DOI 10.2478/v10078-012-0007-7; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Manoel ME, 2008, J STRENGTH COND RES, V22, P1528, DOI 10.1519/JSC.0b013e31817b0433; Muyor JM, 2016, J HUM KINET, V53, P23, DOI 10.1515/hukin-2016-0007; Muyor JM, 2011, J HUM KINET, V29, P15, DOI 10.2478/v10078-011-0035-8; Pacheco L, 2011, J STRENGTH COND RES, V25, P2991, DOI 10.1519/JSC.0b013e318212dac0; Sekir U, 2010, SCAND J MED SCI SPOR, V20, P268, DOI 10.1111/j.1600-0838.2009.00923.x; Streepey JW, 2010, J STRENGTH COND RES, V24, P1037, DOI 10.1519/JSC.0b013e3181d09e87; SULLIVAN MK, 1992, MED SCI SPORT EXER, V24, P1383; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; Thompsen AG, 2007, J STRENGTH COND RES, V21, P52, DOI 10.1519/00124278-200702000-00010; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191801	10.1371/journal.pone.0191801	http://dx.doi.org/10.1371/journal.pone.0191801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390001	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400036
J	Suzuki, K; Nakashima, A; Igarashi, M; Saito, K; Konno, M; Yamazaki, N; Takimoto, H				Suzuki, Kengo; Nakashima, Ayaka; Igarashi, Masaharu; Saito, Keita; Konno, Makoto; Yamazaki, Noriyuki; Takimoto, Hiroaki			Euglena gracilis Z and its carbohydrate storage substance relieve arthritis symptoms by modulating Th17 immunity	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA; II COLLAGEN; GM-CSF; RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA; BETA-GLUCAN; MICE; PARAMYLON	Euglena gracilis Z is a microorganism classified as a microalga and is used as a food or nutritional supplement. Paramylon, the carbohydrate storage substance of E. gracilis Z, is reported to affect the immunological system. This study evaluated the symptom-relieving effects of E. gracilis Z and paramylon in rheumatoid arthritis in a collagen-induced arthritis mouse model. The efficacy of both substances was assessed based on clinical arthritis signs, as well as cytokine (interleukin [IL]-17, IL-6, and interferon [IFN]-gamma) levels in lymphoid tissues. Additionally, the knee joints were harvested and histopathologically examined. The results showed that both substances reduced the transitional changes in the visual assessment score of arthritis symptoms compared with those in the control group, indicating their symptom-relieving effects on rheumatoid arthritis. Furthermore, E. gracilis Z and paramylon significantly reduced the secretion of the cytokines, IL-17, IL-6, and IFN-gamma. The histopathological examination of the control group revealed edema, inflammation, cell hyperplasia, granulation tissue formation, fibrosis, and exudate in the synovial membrane, as well as pannus formation and articular cartilage destruction in the femoral trochlear groove. These changes were suppressed in both treatment groups. Particularly, the E. gracilis Z group showed no edema, inflammation, and fibrosis of the synovial membrane, or pannus formation and destruction of articular cartilage in the femoral trochlear groove. Furthermore, E. gracilis Z and paramylon exhibited symptom-relieving effects on rheumatoid arthritis and suppressed the secretion of cytokines IL-17, IL-6, and IFN-gamma. These effects were likely mediated by the regulatory activities of E. gracilis Z and paramylon on Th17 immunity. In addition, the symptom-relieving effects of both substances were comparable, which suggests that paramylon is the active component of Euglena gracilis Z.	[Suzuki, Kengo; Nakashima, Ayaka] Euglena Co Ltd, Minato Ku, Tokyo, Japan; [Igarashi, Masaharu; Saito, Keita; Konno, Makoto; Yamazaki, Noriyuki] New Drug Res Ctr Inc, Eniwa, Hokkaido, Japan; [Takimoto, Hiroaki] Kitasato Univ, Sch Sci, Dept Biosci, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Takimoto, H (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Minami Ku, Sagamihara, Kanagawa, Japan.	takimoto@sci.kitasato-u.ac.jp		Nakashima, Ayaka/0000-0001-7474-406X				[Anonymous], 2007, TRENDS GLYCOSCI GLYC, DOI DOI 10.4052/TIGG.19.195; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen JZ, 2013, ANTI-CANCER AGENT ME, V13, P725, DOI 10.2174/1871520611313050007; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; CHUAH CT, 1983, MACROMOLECULES, V16, P1375, DOI 10.1021/ma00242a020; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Ferber IA, 1996, J IMMUNOL, V156, P5; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KISS JZ, 1988, PROTOPLASMA, V146, P150, DOI 10.1007/BF01405924; KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O; KONDO Y, 1992, J PHARMACOBIO-DYNAM, V15, P617, DOI 10.1248/bpb1978.15.617; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Mansour MK, 2013, J BIOL CHEM, V288, P16043, DOI 10.1074/jbc.M113.473223; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; Nowak B, 2012, ARCH IMMUNOL THER EX, V60, P211, DOI 10.1007/s00005-012-0170-5; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Rossini M, 2013, ANN RHEUM DIS, V72, P409; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sakagami H, 1991, N DIMETHYLAMINO ETHY, V5, P101; Sato K., 2008, ALLERGOL INT, V27, P109; SEKI N, 1988, J IMMUNOL, V140, P1477; Shimada R, 2016, FOOD FUNCT, V7, P4655, DOI [10.1039/c6fo00606j, 10.1039/C6FO00606J]; Shinobe R, 2008, JPN J CLIN CHEM, V37, P53; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; Tada R, 2009, IMMUNOL LETT, V123, P144, DOI 10.1016/j.imlet.2009.03.005; TAGUCHI T, 1983, ADV EXP MED BIOL, V166, P181; Taylor PC, 2003, CURR PHARM DESIGN, V9, P1095, DOI 10.2174/1381612033454991; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Vermeire K, 1997, J IMMUNOL, V158, P5507; VOORTHUIS JAC, 1990, CLIN EXP IMMUNOL, V81, P183; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Widdifield J, 2013, ANN RHEUM DIS, V72, P549; Willenborg DO, 1996, J IMMUNOL, V157, P3223	47	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191462	10.1371/journal.pone.0191462	http://dx.doi.org/10.1371/journal.pone.0191462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389956	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400021
J	Wang, KH; Wang, YM; Chiu, LH; Chen, TC; Tsai, YH; Zuo, CS; Chen, KC; Changou, CA; Lai, WFT				Wang, Kuo-Hwa; Wang, Yung-Ming; Chiu, Li-Hsuan; Chen, Tze-Chien; Tsai, Yu-Hui; Zuo, Chun S.; Chen, Kuan-Chou; Changou, Chun Austin; Lai, Wen-Fu T.			Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe	PLOS ONE			English	Article							CELL INVASION; STROMELYSIN-1; PROGRESSION; EXPRESSION; GROWTH	Epithelial ovarian cancer (EOC) is the seventh most common cancer among women worldwide. The 5-year survival rate for women with EOC is only 30%-50%, which is largely due to the typically late diagnosis of this condition. EOC is difficult to detect in its early stage because of its asymptomatic nature. Recently, near-infrared fluorescent (NIRF) imaging has been developed as a potential tool for detecting EOC at the molecular level. In this study, a NIRF-sensitive probe was designed to detect matrix metalloproteinase (MMP) activity in ovarian cancer cells. A cyanine fluorochrome was conjugated to the amino terminus of a peptide substrate with enzymatic specificity for MMP-3. To analyze the novel MMP-3 probe, an in vivo EOC model was established by subcutaneously implanting SKOV3 cells, a serous-type EOC cell line, in mice. This novel MMP-3-sensitive probe specifically reacted with only the active MMP-3 enzyme, resulting in a significantly enhanced NIRF emission intensity. Histological analysis demonstrated that MMP-3 expression and activity were enhanced in the stromal cells surrounding the ovarian cancer cells. These studies establish a molecular imaging reporter for diagnosing early-stage EOC. Additional studies are required to confirm the early-stage activity of MMP-3 in EOC and its diagnostic and prognostic significance.	[Wang, Kuo-Hwa; Chen, Kuan-Chou] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wang, Kuo-Hwa] Cheng Ching Hosp, Chung Kang Branch, Dept Obstet & Gynecol, Taichung, Taiwan; [Wang, Yung-Ming] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chiu, Li-Hsuan; Zuo, Chun S.; Lai, Wen-Fu T.] Harvard Med Sch, McLean Hosp, McLean Imaging Ctr, Belmont, MA USA; [Chen, Tze-Chien] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tsai, Yu-Hui; Lai, Wen-Fu T.] Taipei Med Univ, Shuang Ho Hosp, Dept Res, New Taipei, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, New Taipei, Taiwan; [Changou, Chun Austin] Taipei Med Univ, Ctr Translat Med, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Lai, Wen-Fu T.] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; Harvard University; McLean Hospital; Mackay Memorial Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Lai, WFT (corresponding author), Harvard Med Sch, McLean Hosp, McLean Imaging Ctr, Belmont, MA USA.; Lai, WFT (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Res, New Taipei, Taiwan.; Lai, WFT (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei, Taiwan.	laitw@tmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST-103-2314-B-038-053, 104-2917-1-564-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology, Taiwan (MOST-103-2314-B-038-053 and 104-2917-1-564-006).	Banik D, 2015, ONCOTARGET, V6, P15164, DOI 10.18632/oncotarget.3897; Baruch A, 2004, TRENDS CELL BIOL, V14, P29, DOI 10.1016/j.tcb.2003.11.002; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Blum G, 2008, CURR OPIN DRUG DISC, V11, P708; Cao J, 2012, CONTRAST MEDIA MOL I, V7, P390, DOI 10.1002/cmmi.1464; Chakravarty D, 2011, CLIN CANCER RES, V17, P2250, DOI 10.1158/1078-0432.CCR-10-2718; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi JW, 2011, ONCOL LETT, V2, P1047, DOI 10.3892/ol.2011.391; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; Davidson B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00104; Doufekas K, 2014, INT J WOMENS HEALTH, V6, P537, DOI 10.2147/IJWH.S40894; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fields GB, 2000, METH MOL B, V151, P495, DOI 10.1385/1-59259-046-2:495; Funovics M, 2003, ANAL BIOANAL CHEM, V377, P956, DOI 10.1007/s00216-003-2199-0; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kwon M, 2014, INT J CANCER, V135, P48, DOI 10.1002/ijc.28662; Lai WFT, 2004, OSTEOARTHR CARTILAGE, V12, P239, DOI 10.1016/j.joca.2003.11.005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Mehner Christine, 2015, Genes Cancer, V6, P480; Nagase H, 1998, BIOL EXTRAC, P43; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Owen Jennifer L, 2004, Breast Dis, V20, P145; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shimizu Y, 2014, NANOMED-NANOTECHNOL, V10, P187, DOI 10.1016/j.nano.2013.06.009; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Sun NX, 2014, TUMOR BIOL, V35, P11359, DOI 10.1007/s13277-014-2434-7; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; WITTY JP, 1995, CANCER RES, V55, P1401; Yao DF, 2016, ACS APPL MATER INTER, V8, P5847, DOI 10.1021/acsami.5b11826; Yi XM, 2014, INT J NANOMED, V9, P1347, DOI 10.2147/IJN.S60206; Zhao HX, 2012, EXP MOL MED, V44, P633, DOI 10.3858/emm.2012.44.11.072	39	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192047	10.1371/journal.pone.0192047	http://dx.doi.org/10.1371/journal.pone.0192047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390034	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400057
J	Konig, M; Drewelies, J; Norman, K; Spira, D; Buchmann, N; Hulur, G; Eibich, P; Wagner, GG; Lindenberger, U; Steinhagen-Thiessen, E; Gerstorf, D; Demuth, I				Koenig, Maximilian; Drewelies, Johanna; Norman, Kristina; Spira, Dominik; Buchmann, Nikolaus; Hulur, Gizem; Eibich, Peter; Wagner, Gert G.; Lindenberger, Ulman; Steinhagen-Thiessen, Elisabeth; Gerstorf, Denis; Demuth, Ilja			Historical trends in modifiable indicators of cardiovascular health and self-rated health among older adults: Cohort differences over 20 years between the Berlin Aging Study (BASE) and the Berlin Aging Study II (BASE-II)	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; UNITED-STATES; US ADULTS; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; PREVALENCE; HYPERTENSION; DISEASE; OVERWEIGHT	Background The last decades have seen great advances in the understanding, treatment, and prevention of cardiovascular disease (CVD). Although mortality rates due to CVD have declined significantly in the last decades, the burden of CVD is still high, particularly in older adults. This raises the question whether contemporary populations of older adults are experiencing better or worse objective as well as subjective health than earlier-born cohorts. The aim of this study was to examine differences in modifiable indicators of cardiovascular health (CVH), comparing data obtained 20 years apart in the Berlin Aging Study (BASE, 1990-93) and the Berlin Aging Study II (BASE-II, 2009-2014). Methods Serial cross-sectional analysis of 242 propensity-score-matched participants of BASE (born 1907-1922) and BASE-II (born 1925-1942). Body mass index (BMI), blood pressure, total cholesterol, glycated hemoglobin (HbA1c), diet, smoking and physical activity were operationalized according to the "Life's simple 7" (LS7) criteria of the American Heart Association. Results 121 matched pairs were identified based on age, sex, and education. In the later-born BASE-II sample, the mean LS7 score was significantly higher than in the earlier-born sample (7.8 +/- 1.8 vs. 6.4 +/- 2.1, p<0.001), indicating better CVH. In detail, diet, physical activity, smoking, cholesterol, and HbA1c were more favorable, whereas blood pressure was significantly higher in individuals from the later-born cohort. BMI did not differ significantly between the two matched samples. Notably, despite better CVH, later-born individuals (BASE-II) reported lower self-rated health, presumably because of higher health expectations. Conclusions Overall, cardiovascular health was significantly better in the later-born cohort, but several notable exceptions exist.	[Koenig, Maximilian; Spira, Dominik; Buchmann, Nikolaus; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Charite, Lipid Clin, Interdisciplinary Metab Ctr, Berlin, Germany; [Drewelies, Johanna; Gerstorf, Denis] Humboldt Univ, Dept Psychol, Berlin, Germany; [Norman, Kristina] Charite, Geriatr Res Grp, Berlin, Germany; [Norman, Kristina] German Inst Human Nutr, Dept Nutr & Gerontol, Potsdam, Germany; [Hulur, Gizem] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Hulur, Gizem] Univ Zurich, Univ Res Prior Program URPP Dynam Hlth Aging, Zurich, Switzerland; [Eibich, Peter] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Wagner, Gert G.] German Inst Econ Res, Berlin, Germany; [Wagner, Gert G.] Max Planck Inst Human Dev, Berlin, Germany; [Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Zurich; University of Zurich; University of Oxford; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; Max Planck Society; Max Planck Society	Demuth, I (corresponding author), Charite, Lipid Clin, Interdisciplinary Metab Ctr, Berlin, Germany.	ilja.demuth@charite.de	Hülür, Gizem/Y-2755-2019; Buchmann, Nina/E-6095-2011; Demuth, Ilja/ABD-5352-2021; Wagner, Gert G./AIC-8679-2022; König, Maximilian/AAD-8221-2021	Hülür, Gizem/0000-0002-9225-3878; Buchmann, Nina/0000-0003-0826-2980; Demuth, Ilja/0000-0002-4340-2523; König, Maximilian/0000-0003-4873-5519; Norman, Kristina/0000-0003-2029-9102; Buchmann, Nikolaus/0000-0002-4345-3515; Gerstorf, Denis/0000-0002-2133-9498	Max Planck Society; Free University Berlin; German Federal Ministry for Research and Technology; German Federal Ministry for Family, Senior Citizens, Women, and Youth; Berlin-Brandenburg Academy of Sciences' Research Group on Aging and Societal Development; German Federal Ministry of education and Research, BMBF [16SV5536K, 16SV5537, 16SV5538, 16SV5837, 01UW0808]; Max Planck Society, Munich, Germany	Max Planck Society(Max Planck SocietyFoundation CELLEX); Free University Berlin; German Federal Ministry for Research and Technology; German Federal Ministry for Family, Senior Citizens, Women, and Youth; Berlin-Brandenburg Academy of Sciences' Research Group on Aging and Societal Development; German Federal Ministry of education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Max Planck Society, Munich, Germany(Max Planck Society)	BASE received financial support from the Max Planck Society, the Free University Berlin, the German Federal Ministry for Research and Technology, the German Federal Ministry for Family, Senior Citizens, Women, and Youth, and the Berlin-Brandenburg Academy of Sciences' Research Group on Aging and Societal Development. BASE-II was funded by the German Federal Ministry of education and Research, BMBF (grant numbers #16SV5536K, #16SV5537, #16SV5538, #16SV5837, and #01UW0808) and the Max Planck Society, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Capewell S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-641; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Charatan F, 2001, BRIT MED J, V323, P359, DOI 10.1136/bmj.323.7309.359; Chen H, 2007, AM J EPIDEMIOL, V166, P439, DOI 10.1093/aje/kwm100; Coffman DL, 2011, STRUCT EQU MODELING, V18, P357, DOI 10.1080/10705511.2011.582001; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finger JD, 2016, DTSCH ARZTEBL INT, V113, P712, DOI 10.3238/arztebl.2016.0712; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Gerstorf D, 2016, GERONTOLOGY, V62, P311, DOI 10.1159/000441495; Gerstorf D, 2015, PSYCHOL AGING, V30, P301, DOI 10.1037/pag0000016; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Heidemann C, 2016, DIABETIC MED, V33, P1406, DOI 10.1111/dme.13008; Jungjohann SM, 2005, BRIT J NUTR, V93, P361, DOI 10.1079/BJN20041333; Kjeldsen SE, 1998, HYPERTENSION, V31, P1014, DOI 10.1161/01.HYP.31.4.1014; Koolhaas CM, 2017, EUR J PREV CARDIOL, V24, P934, DOI 10.1177/2047487317693952; Koopman C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3526-7; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lampert T, VERBREITUNG RAUCHENS; Lindenberger U, BERLINER ALTERSSTUDI; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Nothlings U, 2007, J NUTR, V137, P2781, DOI 10.1093/jn/137.12.2781; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weisfeldt ML, 2007, HEALTH AFFAIR, V26, P25, DOI 10.1377/hlthaff.26.1.25	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191699	10.1371/journal.pone.0191699	http://dx.doi.org/10.1371/journal.pone.0191699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385202	Green Published, gold, Green Accepted			2022-12-27	WOS:000423668400053
J	Petersson, F; Kilsgard, O; Shannon, O; Lood, R				Petersson, Frida; Kilsgard, Ola; Shannon, Oonagh; Lood, Rolf			Platelet activation and aggregation by the opportunistic pathogen Cutibacterium (Propionibacterium) acnes	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERIA; PROTEINS; LOCALIZATION; ENDOCARDITIS; MECHANISMS; INFECTION; ADHESION; BINDING; PARVUM	Cutibacterium (Propionibacterium) acnes, considered a part of the skin microbiota, is one of the most commonly isolated anaerobic bacteria from medical implants in contact with plasma. However, the precise interaction of C. acnes with blood cells and plasma proteins has not been fully elucidated. Herein, we have investigated the molecular interaction of C. acnes with platelets and plasma proteins. We report that the ability of C. acnes to aggregate platelets is dependent on phylotype, with a significantly lower ability amongst type IB isolates, and the interaction of specific donor-dependent plasma proteins (or concentrations thereof) with C. acnes. Pretreatment of C. acnes with plasma reduces the lag time before aggregation demonstrating that pre-deposition of plasma proteins on C. acnes is an important step in platelet aggregation. Using mass spectrometry we identified several plasma proteins deposited on C. acnes, including IgG, fibrinogen and complement factors. Inhibition of IgG, fibrinogen or complement decreased C. acnes-mediated platelet aggregation, demonstrating the importance of these plasma proteins for aggregation. The interaction of C. acnes and platelets was visualized using fluorescence microscopy, verifying the presence of IgG and fibrinogen as components of the aggregates, and co-localization of C. acnes and platelets in the aggregates. Here, we have demonstrated the ability of C. acnes to activate and aggregate platelets in a bacterium and donor-specific fashion, as well as added mechanistic insights into this interaction.	[Petersson, Frida; Kilsgard, Ola; Shannon, Oonagh; Lood, Rolf] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden; [Kilsgard, Ola] Lund Univ, Fac Engn Lund, Dept Immunotechnol, Lund, Sweden	Lund University; Lund University	Lood, R (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden.	Rolf.Lood@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189	Crafoord Foundation; Royal Physiographic Society in Lund; Swedish Society for Medicine; foundation of Thelma Zoega; foundation of Langmanska Kulturfonden; foundation of Sven and Dagmar Salen; foundation of Sigurd and Elsa Golje; foundation of Nanna Svartz; foundation of Lars Hierta	Crafoord Foundation; Royal Physiographic Society in Lund; Swedish Society for Medicine; foundation of Thelma Zoega; foundation of Langmanska Kulturfonden; foundation of Sven and Dagmar Salen; foundation of Sigurd and Elsa Golje; foundation of Nanna Svartz; foundation of Lars Hierta	This work was supported by funding from Crafoord Foundation (OS), The Royal Physiographic Society in Lund (OS, RL), the Swedish Society for Medicine (RL), and the foundations of Thelma Zoega, Langmanska Kulturfonden, Sven and Dagmar Salen, Sigurd and Elsa Golje, Nanna Svartz, and Lars Hierta (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; Allhorn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36412; Alt E, 2004, CLIN HEMORHEOL MICRO, V30, P107; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Aubin GG, 2014, MED MALADIES INFECT, V44, P241, DOI 10.1016/j.medmal.2014.02.004; Aubin GG, 2017, ANAEROBE, V47, P73, DOI 10.1016/j.anaerobe.2017.04.009; Aubin GG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42918; Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001; Beynon RP, 2006, BMJ-BRIT MED J, V333, P334, DOI 10.1136/bmj.333.7563.334; Bhate K, 2013, BRIT J DERMATOL, V168, P474, DOI 10.1111/bjd.12149; Brennan MP, 2009, J THROMB HAEMOST, V7, P1364, DOI 10.1111/j.1538-7836.2009.03495.x; Brennan MP, 2004, BLOOD; Cederblad G, 2009, PATHOPHYSIOL HAEMO T, V6, P294; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; CLAWSON CC, 1975, AM J PATHOL, V81, P411; CLAWSON CC, 1973, AM J PATHOL, V70, P449; CLAWSON CC, 1971, AM J PATHOL, V65, P381; CLAWSON CC, 1971, AM J PATHOL, V65, P367; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Damgaard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120826; Davies EV, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw015; Dekio I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/151797; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Fischer N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603046; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Florschutz AV, 2015, J SHOULDER ELB SURG, V24, P1296, DOI 10.1016/j.jse.2014.12.036; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; Grange PA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06940-3; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; Johansson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026928; JONES PDE, 1977, BRIT J CANCER, V36, P777, DOI 10.1038/bjc.1977.261; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kumaran D, 2014, VOX SANG, V107, P188, DOI 10.1111/vox.12141; Lheure C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167237; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lood R, 2015, FUTURE MICROBIOL, V10, P1659, DOI 10.2217/fmb.15.89; Lood R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-198; Lood R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-139; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2016, INT J SYST EVOL MICR, V66, P5358, DOI 10.1099/ijsem.0.001521; MITCHESON HD, 1980, BRIT J CANCER, V41, P117, DOI 10.1038/bjc.1980.13; Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Paugam C, 2017, J EUR ACAD DERMATOL, V31, pE406, DOI 10.1111/jdv.14206; Perry AL, 2006, LETT APPL MICROBIOL, V42, P185, DOI 10.1111/j.1472-765X.2006.01866.x; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sampedro MF, 2009, DIAGN MICR INFEC DIS, V64, P138, DOI 10.1016/j.diagmicrobio.2009.01.024; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Scholz CFP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104199; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Seo HS, 2011, INFECT IMMUN, V79, P3518, DOI 10.1128/IAI.05088-11; Severi G, 2010, BRIT J CANCER, V103, P411, DOI 10.1038/sj.bjc.6605757; Shannon BA, 2008, BJU INT, V101, P429, DOI 10.1111/j.1464-410X.2007.07214.x; Shannon O, 2010, INFECT IMMUN, V78, P4268, DOI 10.1128/IAI.00469-10; Svensson L, 2014, INFECT IMMUN, V82, P4307, DOI 10.1128/IAI.02020-14; Talib WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124384; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Tsuda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029020; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; van Valen R, 2016, INTERACT CARDIOV TH, V23, P150, DOI 10.1093/icvts/ivw087; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; WEBSTER GF, 1985, INFECT IMMUN, V49, P116, DOI 10.1128/IAI.49.1.116-121.1985; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yu Y, 2016, J INVEST DERMATOL; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006	74	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192051	10.1371/journal.pone.0192051	http://dx.doi.org/10.1371/journal.pone.0192051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385206	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400073
J	Corrales-Medina, VF; Dwivedi, G; Taljaard, M; Petrcich, W; Lima, JA; Yende, S; Kronmal, RA; Chirinos, JA				Corrales-Medina, Vicente F.; Dwivedi, Girish; Taljaard, Monica; Petrcich, William; Lima, Joao A.; Yende, Sachin; Kronmal, Richard A.; Chirinos, Julio A.			Coronary artery calcium before and after hospitalization with pneumonia: The MESA study	PLOS ONE			English	Article							RISK; ATHEROSCLEROSIS; EPIDEMIOLOGY; BURDEN; PLAQUE; TESTS	Background Epidemiological analyses demonstrate that pneumonia survivors have a higher risk of myocardial infarction than people with similar load of risk factors for atherosclerotic cardiovascular disease (ASCVD) but without pneumonia. This may be due to a higher baseline burden of ASCVD in patients with pneumonia that is not captured by the accounting of known ASCVD risk factors in epidemiological analyses or to unfavorable accelerating effects of pneumonia on atherosclerosis. Methods We analyzed data from the Multi-Ethnic Study of Atherosclerosis. We identified 54 participants that were hospitalized for pneumonia during study follow-up and that also had assessment of coronary artery calcium (CAC, an objective marker of coronary atherosclerotic burden) before and after this hospitalization. We matched them to 54 participants who were not hospitalized for pneumonia but that had CAC assessments at the same study visits as the pneumonia cases. We compared baseline CAC scores and their progression between groups. Results Baseline CAC scores were similar in both groups (median [IQR]; 6.3 [0-356.8] in pneumonia participants vs. 10.8 [0-178.3] in controls; p = 0.25). After a median of 4.8 years, the direction and magnitude of CAC score change, and the slope of CAC score progression between groups was also similar (median change [IQR], 21.8 [0 to 287.29] in participants with pneumonia versus 15.8 [0 to 140.94] in controls, p = 0.28; difference in slope, 7.7, 95% CI -9.0 to 24.6, p = 0.18). However, among participants with high baseline ASCVD risk (i.e. ACC/AHA 10-year risk estimate >= 7.5%), participants with pneumonia showed a larger increase in CAC scores ( median change [IQR]; 159.10 [38.55-407.34] versus 48.72 [0.97-246.99] in controls; p = 0.02) and a trend towards a steeper slope of CAC score progression (difference in slope, 19.7, 95% CI -6.6 to 45.6, p = 0.07). Conclusion Pneumonia may accelerate the progression of atherosclerosis in people with high baseline ASCVD risk.	[Corrales-Medina, Vicente F.; Dwivedi, Girish] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Corrales-Medina, Vicente F.; Taljaard, Monica; Petrcich, William] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Dwivedi, Girish] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA, Australia; [Dwivedi, Girish] Univ Western Australia, Fiona Stanley Hosp, Perth, WA, Australia; [Lima, Joao A.] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Yende, Sachin] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA USA; [Kronmal, Richard A.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Chirinos, Julio A.] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Pennsylvania	Corrales-Medina, VF (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; Corrales-Medina, VF (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	vcorrales@toh.on.ca		Taljaard, Monica/0000-0002-3978-8961; Corrales-Medina, Vicente/0000-0002-9691-491X	National Heart, Lung, and Blood Institute [HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; NCATS [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from NCATS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos N, 2011, NAT REV CARDIOL, V8, P616, DOI 10.1038/nrcardio.2011.149; Alexopoulos N, 2009, NAT REV CARDIOL, V6, P681, DOI 10.1038/nrcardio.2009.165; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BLAND JM, 1994, BRIT MED J, V309, P248, DOI 10.1136/bmj.309.6949.248; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Hecht HS, 2010, J AM COLL CARDIOL, V55, P1118, DOI 10.1016/j.jacc.2009.09.064; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Herrington W, 2016, CIRC RES, V118, P535, DOI 10.1161/CIRCRESAHA.115.307611; Kaynar AM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0469-1; Ludbrook J, 2013, CLIN EXP PHARMACOL P, V40, P357, DOI 10.1111/1440-1681.12086; Marrie Thomas J, 2005, Can Respir J, V12, P139; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang CC, 2013, INT J CARDIOL, V168, P4480, DOI 10.1016/j.ijcard.2013.06.134	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191750	10.1371/journal.pone.0191750	http://dx.doi.org/10.1371/journal.pone.0191750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420547	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900021
J	Abbott, P; Banerjee, T; Yujra, ACA; Xie, BQ; Piette, J				Abbott, Patricia; Banerjee, Tanima; Yujra, Amparo Clara Aruquipa; Xie, Boqin; Piette, John			Exploring chronic disease in Bolivia: A cross-sectional study in La Paz	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HEALTH-CARE; PATIENT ASSESSMENT; ILLNESS; INTERVENTIONS; ADHERENCE; SYMPTOMS; VALIDITY; OUTCOMES; QUALITY	Purpose This study seeks to develop an understanding that can guide development of programs to improve health and care for individuals with Non-Communicable Diseases (NCDs) in La Paz, Bolivia, where NCDs are prevalent and primary care systems are weak. This exploratory investigation examines the characteristics of chronic disease patients in the region, key health related behaviors, and their perceptions of the care that they receive. The longer-term goal is to lay groundwork for interventional studies based on the principles of the Chronic Care Model (CCM). Subjects and methods The study is based on two surveys of adults (> 18 years old) administered in 2014 in La Paz, Bolivia. A total of 1165 adult patients participated in the first screening survey. A post-screening second survey, administered only on those who qualified based on Survey 1, collected more detailed information about the subjects' general health and health related personal circumstances, several health behaviors, health literacy, and their perceptions of care received. A final data set of 651 merged records were used for analysis. Results Characteristic of a low-income country, the majority of participants had low levels of education, income, health literacy and high rates of under/unemployment. Nearly 50% of participants reported 2 or more NCDs. Seventy-four percent (74%) of respondents reported low levels of medication adherence and 26% of the population was found to have an undiagnosed depressive disorder. Overall, the perception of care quality was low (60%), particularly in those under the age of 45. Significant relationships emerged between several sociodemographic characteristics, health behaviors, and perceptions that have major implications for improving NCD care in this population. Conclusions These findings illustrate some of the challenges facing low-income countries where reversing the tide of NCDs is of great importance. The prevalence of NCDs coupled with challenging social determinants of health, poor medication adherence, low health literacy, and perceptions of low quality of healthcare highlight several areas of opportunity for intervention.	[Abbott, Patricia] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Banerjee, Tanima] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Yujra, Amparo Clara Aruquipa] Univ Catolica Boliviana, La Paz, Bolivia; [Xie, Boqin] Fudan Univ, Sch Nursing, Shanghai, Peoples R China; [Piette, John] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; University of Michigan System; University of Michigan	Abbott, P (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	pabbott@med.umich.edu		Abbott, Patricia/0000-0002-4955-6996	NIH [P30DK092926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors received no specific funding for this work. however John Piette is a Department of Veterans Affairs Senior Career Scientist and also receives support from grant number P30DK092926 from NIH.; John Piette is a Department of Veterans Affairs Senior Career Scientist and also received support from grant number P30DK092926 from NIH.	Abbott P A, 2013, Yearb Med Inform, V8, P51; Abbott PA, 2008, NURS OUTLOOK, V56, P238, DOI 10.1016/j.outlook.2008.06.009; Abbott PA, 2013, STUD HEALTH TECHNOL, V192, P1262; Ahlstrom SK, 2004, ALCOHOL RES HEALTH, V28, P258; Alvarez FN, 2016, HEALTH POLICY PLANN, V31, P114, DOI 10.1093/heapol/czv013; [Anonymous], 2014, LANCET DIABETES ENDO, V2, P263, DOI [10.1016/S2213-8587(13)70173-6, 10.1016/S2213-8587(14)70079-8]; Aragones Abraham, 2008, Prev Chronic Dis, V5, pA113; Arena R, 2015, EUR HEART J, V36, P2097, DOI 10.1093/eurheartj/ehv207; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Christiani Y, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32505; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Danish Trade Union, 2014, BOL LAB MARK PROF; Davitte J., 2012, RESUMEN ANALISIS IND; Fuertes C., 2016, UNIVERSAL HLTH COVER; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Hampshire K, 2015, SOC SCI MED, V142, P90, DOI 10.1016/j.socscimed.2015.07.033; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jaen-Varas D, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-18; Janevic MR, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0093-3; Kamis K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0115-y; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Legetic B, 2016, EC DIMENSIONS NONCOM, V3, P172; Martinez YV, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-164; Morales D., 2017, MIDDLE CLASSES LATIN; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Moser DK, 2009, NURS RES, V58, P42, DOI 10.1097/NNR.0b013e3181900ca0; Organization WH, 2009, GLOB HLTH RISKS MORT; PAHO, 2013, HLTH AM; Pan American Health O, 2013, INN CAR CHRON COND O; Paradis G, 2011, J AM COLL CARDIOL, V57, P1775, DOI 10.1016/j.jacc.2010.11.047; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Piette JD, 2016, TELEMED E-HEALTH, V22, P261, DOI 10.1089/tmj.2015.0099; Piette JD, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00095; Romans SE, 2007, J NERV MENT DIS, V195, P905, DOI 10.1097/NMD.0b013e3181594cb7; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; Stieglitz J, 2014, J GERONTOL B-PSYCHOL, V70, P948; Tejerina H, 2014, INT J HEALTH PLAN M, V29, P90, DOI 10.1002/hpm.2149; Tran DN, 2017, CARDIOL CLIN, V35, P125, DOI 10.1016/j.ccl.2016.08.008; Twagirumukiza M, 2011, J HUM HYPERTENS, V25, P47, DOI 10.1038/jhh.2010.32; United Nations Development Project, 1980, HUM DEV DAT 1980 201; Vanek Joann., 2014, 2 WIEGO; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; World Health Organisation, 2003, ADHERENCE LONG TERM	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0189218	10.1371/journal.pone.0189218	http://dx.doi.org/10.1371/journal.pone.0189218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415037	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300004
J	Belyhun, Y; Liebert, UG; Maier, M				Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie			Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RECEIVING LAMIVUDINE THERAPY; ANTIGEN-NEGATIVE PATIENTS; CLINICAL-SIGNIFICANCE; INFECTED PATIENTS; PRECORE REGION; IN-VITRO; MUTATIONS; REPLICATION; GENOTYPE	Background We recently reported complex hepatitis B virus (HBV) drug resistant and concomitant vaccine escape hepatitis B surface antigen (HBsAg) variants during human immunodeficiency virus (HIV) co-infection and antiretroviral therapy (ART) exposure in Ethiopia. As a continuation of this report using the HBV positive sera from the same study participants, the current study further analyzed the HBV basal core promoter (BCP)/precore (PC) genes variability in patients with HBV drug resistance (at tyrosine-methionine-aspartate-aspartate (YMDD) reverse transcriptase (RT) motifs) and HIV co-infection in comparison with HBV monoinfected counterparts with no HBV drug resistant gene variants. Materials and methods A total of 143 participants of HBV-HIV co-infected (n = 48), HBV mono-infected blood donors (n = 43) and chronic liver disease (CLD) patients (n = 52) were included in the study. The BCP/PC genome regions responsible for HBeAg expression from the EcoRI site (nucleotides 1653-1959) were sequenced and analyzed for the BCP/PC mutant variants. Results Among the major mutant variants detected, double BCP mutations (A1762T/G1764A) (25.9%), Kozak sequences mutations (nt1809-1812) (51.7%) and the classical PC mutations such as A1814C/C1816T (15.4%), G1896A (25.2%) and G1862T (44.8%) were predominant mutant variants. The prevalence of the double BCP mutations was significantly lower in HIV co-infected patients (8.3%) compared with HBV mono-infected blood donors (32.6%) and CLD patients (36.5%). However, the Kozak sequences BCP mutations and the majority of PC mutations showed no significant differences among the study groups. Moreover, except for the overall BCP/PC mutant variants, co-prevalence rates of each major BCP/PC mutations and YMDDRT motif associated lamivudine (3TC)/entecavir (ETV) resistance mutations showed no significant differences when compared with the rates of BCP/PC PC mutations without YMDD RT motif drug resistance gene mutations. Unlike HIV coinfected group, no similar comparison made among HBV mono-infected blood donors and CLD patients since none of them developed the YMDD RT motif associated 3TC/ETV resistance mutations. However, HBV mono-infected blood donors and CLD patients who had no any drug resistance gene variants developed comparable G1862T (60.6% vs. 65.1%) and G1896A (24.2% vs. 11.6%) PC gene mutations. Conclusion No correlation observed between the BCP/PC genome variability and the YMDD RT motif associated HBV drug resistance gene variants during HIV co-infection. Nevertheless, irrespective of HIV co-infection status, the higher records of the BCP/PC gene variability in this study setting indicate a high risk of potential HBeAg negative chronic HBV infection in Northwest Ethiopia.	[Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie] Univ Leipzig, Med Fac, Inst Virol, Leipzig, Germany; [Belyhun, Yeshambel] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia	Leipzig University; University of Gondar	Belyhun, Y (corresponding author), Univ Leipzig, Med Fac, Inst Virol, Leipzig, Germany.; Belyhun, Y (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia.	belyhun@gmail.com		Belyhun, Yeshambel/0000-0002-5747-4034				Ahn SH, 2003, GASTROENTEROLOGY, V125, P1370, DOI 10.1016/j.gastro.2003.07.016; Alexopoulou A, 2014, WORLD J GASTROENTERO, V20, P7644, DOI 10.3748/wjg.v20.i24.7644; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Ayari R, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6191; Ayed K, 2007, J INFECTION, V54, P291, DOI 10.1016/j.jinf.2006.05.013; Belyhun Y, 2017, ANTIVIR THER, V22, P97, DOI 10.3851/IMP3060; Buckwold VE, 1997, J GEN VIROL, V78, P2055, DOI 10.1099/0022-1317-78-8-2055; Chauhan R, 2006, J MED VIROL, V78, P1047, DOI 10.1002/jmv.20661; Chen CH, 2006, J HEPATOL, V44, P76, DOI 10.1016/j.jhep.2005.08.022; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chen CY, 2008, HEPATOL RES, V38, P580, DOI 10.1111/j.1872-034X.2007.00315.x; Chen RYM, 2003, HEPATOLOGY, V37, P27, DOI 10.1053/jhep.2003.50012; Cho SW, 2000, HEPATOLOGY, V32, P1163, DOI 10.1053/jhep.2000.19618; Datta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110012; Gatanaga H, 2000, EUR J CLIN MICROBIOL, V19, P237, DOI 10.1007/s100960050468; Ghosh S, 2012, CLIN MICROBIOL INFEC, V18, pE412, DOI 10.1111/j.1469-0691.2012.03975.x; Herbers U, 2013, J VIRAL HEPATITIS, V20, P141, DOI 10.1111/j.1365-2893.2012.01639.x; Hou JL, 2002, J GEN VIROL, V83, P2291, DOI 10.1099/0022-1317-83-9-2291; Juniastuti, 2013, BIOMED REP, V1, P522, DOI 10.3892/br.2013.106; Kamijo N, 2015, WORLD J GASTROENTERO, V21, P541, DOI 10.3748/wjg.v21.i2.541; Kato H, 2001, J VIROL METHODS, V98, P153, DOI 10.1016/S0166-0934(01)00374-3; Khan A, 2013, INT J CANCER, V133, P2864, DOI 10.1002/ijc.28307; Kuwahara R, 2004, J MED VIROL, V72, P26, DOI 10.1002/jmv.10558; Laras A, 1998, J VIRAL HEPATITIS, V5, P241, DOI 10.1046/j.1365-2893.1998.00109.x; Lim Chee Kent, 2006, Int J Med Sci, V3, P14; Lin CL, 2004, LIVER INT, V24, P9, DOI 10.1111/j.1478-3231.2004.00893.x; Lok ASF, 2000, HEPATOLOGY, V32, P1145; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; de Mello FMMA, 2014, REV SOC BRAS MED TRO, V47, P701, DOI 10.1590/0037-8682-0158-2014; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Suzuki F, 2002, J HEPATOL, V37, P824, DOI 10.1016/S0168-8278(02)00281-7; Tacke F, 2004, CURR MED CHEM, V11, P2667, DOI 10.2174/0929867043364333; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Tacke F, 2012, HEPAT MON, V12, P357, DOI 10.5812/hepatmon.6131; Taffon S, 2014, INFECTION, V42, P675, DOI 10.1007/s15010-014-0616-2; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; Vutien P, 2013, ALIMENT PHARM THER, V37, P464, DOI 10.1111/apt.12193; Yuen MF, 2002, J INFECT DIS, V186, P1335, DOI 10.1086/344327; Zhu Yuao, 2011, Antiviral Chemistry & Chemotherapy, V22, P13, DOI 10.3851/IMP1791	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191970	10.1371/journal.pone.0191970	http://dx.doi.org/10.1371/journal.pone.0191970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408943	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800036
J	Falconer, DJ; Barb, AW				Falconer, Daniel J.; Barb, Adam W.			Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1	PLOS ONE			English	Article							GAMMA-RIII; THERAPEUTIC ANTIBODIES; IMMUNOGLOBULIN-G; N-GLYCOSYLATION; CARBOHYDRATE; FUCOSE; SITE	The structures of non-human antibodies are largely unstudied despite the potential for the identification of alternative structural motifs and physical properties that will benefit a basic understanding of protein and immune system evolution as well as highlight unexplored motifs to improve therapeutic monoclonal antibody. Here we probe the structure and receptor-binding properties of the mouse IgG2c crystallizable fragment (Fc) to compare to mouse IgG2b and human IgG1 Fcs. Models of mIgG2c Fc determined by x-ray crystallography with a complex-type biantennary (to 2.05 angstrom) or a truncated (1) GlcNAc asparagine-linked (N)-glycan attached (to 2.04 angstrom) show differences in key regions related to mouse Fc gamma receptor IV (mFc gamma RIV) binding. Mouse IgG2c forms different non-bonded interactions between the BC, DE and FG loops than the highly-conserved mIgG2b and binds to Fc gamma RIV with 4.7-fold greater affinity in the complex-type glycoform. Secondary structural elements surrounding the Asn297 site of glycosylation form longer beta strands in the truncated mIgG2c Fc glycoform when compared to mIgG2c with the complex-type N-glycan. Solution NMR spectroscopy of the N-linked (1) GlcNAc residues show differences between mIgG2b, 2c and hIgG1 Fc that correlate to receptor binding affinity. Mutations targeting differences in mIgG2 DE and FG loops decreased affinity of mIgG2c for Fc gamma RIV and increased affinity of mIgG2b. Changes in NMR spectra of the mutant Fc proteins mirrored these changes in affinity. Our studies identified structural and functional differences in highly conserved molecules that were not predicted from primary sequence comparison.	[Falconer, Daniel J.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	National Institutes of Health [R01 GM115489]; Department of Energy [GUP-48455]; Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Institutes of Health under Award No. R01 GM115489 (NIGMS) to AWB, a grant for synchrotron time at the Argonne National Laboratory Advanced Photon Source by the Department of Energy (GUP-48455), and by funds from the Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. D. Bruce Fulton of the Iowa State University Biomolecular NMR Facility for assistance running the NMR experiments and Mr. Joel Nott of the ISU Protein Facility for mass spectrometric analyses. We also thank Ms. Emily Knuth for assistance cloning the Fc constructs and Prof. Falk Nimmerjahn (University of Erlangen-Nuremberg) for providing the mIgG2 expression constructs. This material is based upon work supported by the National Institutes of Health under Award No. R01 GM115489 (NIGMS), a grant for synchrotron time at the Argonne National Laboratory Advanced Photon Source by the Department of Energy (GUP-48455), and by funds from the Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Institutes of Health or the Department of Energy.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Ahmed AA, 2016, J STRUCT BIOL, V194, P78, DOI 10.1016/j.jsb.2016.02.001; Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; de Haan N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00608; Dekkers G, 2018, MOL IMMUNOL, V94, P54, DOI 10.1016/j.molimm.2017.12.006; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fridman C, 2000, J MOL BIOL, V295, P213; Gardinassi LG, 2014, MBIO, V5, DOI 10.1128/mBio.01844-14; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140120; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kemna MJ, 2017, EBIOMEDICINE, V17, P108, DOI 10.1016/j.ebiom.2017.01.033; Kolenko P, 2009, IMMUNOLOGY, V126, P378, DOI 10.1111/j.1365-2567.2008.02904.x; Labrijn AF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02823-9; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; MICHAELSEN TE, 1992, MOL IMMUNOL, V29, P319, DOI 10.1016/0161-5890(92)90018-S; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruhaak LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012566; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Subedi GP, 2017, BIOCHEMISTRY-US, V56, P3174, DOI 10.1021/acs.biochem.7b00392; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Varki A., 2017, ESSENTIALS GLYCOBIOL, Vxxix; Wuhrer M, 2009, J PROTEOME RES, V8, P450, DOI 10.1021/pr800651j; Yamaguchi Y, 1998, J BIOMOL NMR, V12, P385, DOI 10.1023/A:1008392229694; Yu XW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004112; Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006; Zwolak A, 2017, MABS-AUSTIN, V9, P1306, DOI 10.1080/19420862.2017.1375639	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192123	10.1371/journal.pone.0192123	http://dx.doi.org/10.1371/journal.pone.0192123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408873	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800046
J	Kosanic, A; Anderson, K; Harrison, S; Turkington, T; Bennie, J				Kosanic, Aleksandra; Anderson, Karen; Harrison, Stephan; Turkington, Thea; Bennie, Jonathan			Changes in the geographical distribution of plant species and climatic variables on the West Cornwall peninsula (South West UK)	PLOS ONE			English	Article							ELLENBERGS INDICATOR VALUES; HERBARIUM SPECIMENS; LOCALITY DESCRIPTIONS; ECOSYSTEM SERVICES; VEGETATION CHANGE; BIODIVERSITY; MUSEUM; CONSERVATION; INFORMATICS; RESPONSES	Recent climate change has had a major impact on biodiversity and has altered the geographical distribution of vascular plant species. This trend is visible globally; however, more local and regional scale research is needed to improve understanding of the patterns of change and to develop appropriate conservation strategies that can minimise cultural, health, and economic losses at finer scales. Here we describe a method to manually geo-reference botanical records from a historical herbarium to track changes in the geographical distributions of plant species in West Cornwall (South West England) using both historical (pre-1900) and contemporary (post-1900) distribution records. We also assess the use of Ellenberg and climate indicator values as markers of responses to climate and environmental change. Using these techniques we detect a loss in 19 plant species, with 6 species losing more than 50% of their previous range. Statistical analysis showed that Ellenberg (light, moisture, nitrogen) and climate indicator values (mean January temperature, mean July temperature and mean precipitation) could be used as environmental change indicators. Significantly higher percentages of area lost were detected in species with lower January temperatures, July temperatures, light, and nitrogen values, as well as higher annual precipitation and moisture values. This study highlights the importance of historical records in examining the changes in plant species' geographical distributions. We present a method for manual geo-referencing of such records, and demonstrate how using Ellenberg and climate indicator values as environmental and climate change indicators can contribute towards directing appropriate conservation strategies.	[Kosanic, Aleksandra; Harrison, Stephan; Bennie, Jonathan] Univ Exeter, Ctr Geog Environm & Soc, Penryn Campus, Penryn, England; [Anderson, Karen] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, England; [Turkington, Thea] Ctr Climate Res Singapore, Meteorol Serv Singapore, Singapore, Singapore; [Kosanic, Aleksandra] Univ Konstanz, Biol Dept, Ecol Lab, Constance, Germany	University of Exeter; University of Exeter; Meteorological Service Singapore; University of Konstanz	Kosanic, A (corresponding author), Univ Exeter, Ctr Geog Environm & Soc, Penryn Campus, Penryn, England.; Kosanic, A (corresponding author), Univ Konstanz, Biol Dept, Ecol Lab, Constance, Germany.	ak352@exeter.ac.uk	Anderson, Karen/ABC-3524-2021	Anderson, Karen/0000-0002-3289-2598	University of Exeter and Cornwall Council	University of Exeter and Cornwall Council	Founding was provided by University of Exeter and Cornwall Council to AK for her PhD project. Neither of these founding routes have reference numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; [Anonymous], 2021, LANG ENV STAT COMP; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2009, GLOBAL CHANGE BIOL, V15, P656, DOI 10.1111/j.1365-2486.2008.01762.x; Auer T, 2011, ECOL INFORM, V6, P93, DOI 10.1016/j.ecoinf.2010.09.001; Baker DJ, 2017, DIVERS DISTRIB, V23, P329, DOI 10.1111/ddi.12527; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; Beaman R, 2004, DETERMINING SPACE PL, V10; Beaman Reed S., 2003, Telopea, V10, P43; Bellamy C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128440; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Boakes EH, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0824; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calinger KM, 2013, ECOL LETT, V16, P1037, DOI 10.1111/ele.12135; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Casalegno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107822; Chapman AD, GUIDE BEST PRACTICES, P1; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Curtis CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166407; Davey HF, 1909, THE FLORA OF CORNWAL; de Oliveira LEC, 2014, ECOL ECON, V107, P114, DOI 10.1016/j.ecolecon.2014.08.008; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Doherty P, 2011, T GIS, V15, P775, DOI 10.1111/j.1467-9671.2011.01290.x; Dzwonko Z, 2001, J APPL ECOL, V38, P942, DOI 10.1046/j.1365-2664.2001.00649.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Ellenberg H, 2001, ZEIGERWERTE PFLANZEN, V3rd ed; Feeley KJ, 2010, J BIOGEOGR, V37, P733, DOI 10.1111/j.1365-2699.2009.02240.x; Filibeck G, 2015, J ECOL, V103, P1580, DOI 10.1111/1365-2745.12478; Gallagher RV, 2009, AUST J BOT, V57, P1, DOI 10.1071/BT08051; Garcia-Milagros E, 2010, FRONTIERS BIOGEOGRAP, V2; Godefroid S, 2007, J BIOGEOGR, V34, P62, DOI 10.1111/j.1365-2699.2006.01582.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Greenwood O, 2016, J APPL ECOL, V53, P885, DOI 10.1111/1365-2664.12602; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Haring T, 2012, APPL VEGETATION SCI; Hill M.O., 2004, PLANTATT ATTRIBUTES; Hill MO, 2000, J APPL ECOL, V37, P3, DOI 10.1046/j.1365-2664.2000.00466.x; Isaac NJB, 2015, BIOL J LINN SOC, V115, P522, DOI 10.1111/bij.12532; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kollmann J, 2003, BASIC APPL ECOL, V4, P489, DOI 10.1078/1439-1791-00209; Kosanic A, 2015, GLOB ECOL CONSERV, V4, P405, DOI 10.1016/j.gecco.2015.08.006; Kosanic A, 2014, CLIMATIC CHANGE, V124, P221, DOI 10.1007/s10584-014-1101-8; Lavoie C, 2013, PERSPECT PLANT ECOL, V15, P68, DOI 10.1016/j.ppees.2012.10.002; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lienert J, 2002, BIOL CONSERV, V103, P65, DOI 10.1016/S0006-3207(01)00121-5; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maclean IMD, 2015, GLOBAL ECOL BIOGEOGR, V24, P1340, DOI 10.1111/geb.12359; Mair L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147796; Matthews ER, 2016, NEW PHYTOL, V210, P157, DOI 10.1111/nph.13751; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Naylor S, 2002, T I BRIT GEOGR, V27, P494, DOI 10.1111/1475-5661.00067; NBN, 2013, VASC PLANTS DAT VASC; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; OS, 2017, ESRI SHAP BOUND LIN; Pachauri R.K., 2014, CONTRIBUTION WORKING; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Palmer G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400220; Panchen ZA, 2012, AM J BOT, V99, P751, DOI 10.3732/ajb.1100198; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2015, ANN BOT-LONDON, V116, P849, DOI 10.1093/aob/mcv169; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Pignatti S, 2001, FINGERPRINTS OF CLIMATE CHANGE, P281; Preston C, 2002, NEW ATLAS BRIT IRISH; Renetzeder C, 2010, LANDSCAPE URBAN PLAN, V98, P150, DOI 10.1016/j.landurbplan.2010.08.022; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rivers MC, 2011, BIOL CONSERV, V144, P2541, DOI 10.1016/j.biocon.2011.07.014; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Seddon N, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2094; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Suggitt A. J., 2014, CLIMATE CHANGE REFUG; Suggitt AJ, 2015, J INSECT CONSERV, V19, P237, DOI 10.1007/s10841-014-9749-y; The Plant List, 2013, WORK LIST ALL PLANT; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Van Den Eynden V, 2008, ORYX, V42, P400, DOI 10.1017/S0030605308007321; Van der Veken S, 2004, BELG J BOT, V137, P55; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3; Wesche K, 2012, BIOL CONSERV, V150, P76, DOI 10.1016/j.biocon.2012.02.015; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wieczorek J, 2012, GEOREFERENCING QUICK; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	91	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191021	10.1371/journal.pone.0191021	http://dx.doi.org/10.1371/journal.pone.0191021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401494	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400010
J	Lee, SY; Bae, HW; Kwon, HJ; Seong, GJ; Kim, CY				Lee, Sang Yeop; Bae, Hyoung Won; Kwon, Hee Jung; Seong, Gong Je; Kim, Chan Yun			Utility of Goldmann applanation tonometry for monitoring intraocular pressure in glaucoma patients with a history of laser refractory surgery	PLOS ONE			English	Article							DYNAMIC CONTOUR TONOMETRY; IN-SITU KERATOMILEUSIS; CORNEAL THICKNESS; BIOMECHANICAL PROPERTIES; PROGRESSION; FLUCTUATION; ASSOCIATION; CURVATURE; IMPACT	The utility of Goldmann applanation tonometry (GAT) for monitoring intraocular pressure (IOP) in open-angle glaucoma (OAG) patients with a history of laser refractive surgery was investigated by comparing IOP fluctuations measured using GAT and dynamic contour tonometry (DCT) on the same day. In this retrospective study, patients were divided into one of two subgroups according to IOP fluctuation values using GAT: 43 eyes in the low IOP fluctuation group (LIFG [GAT fluctuation <= 1.7 mmHg]); and 55 eyes in the high IOP fluctuation group (HIFG [GAT fluctuation >1.7 mmHg]). IOP fluctuation was defined as the standard deviation of all IOP values during follow-up. IOP parameters using GAT were compared with those of DCT. Correlation analyses were performed among IOP parameters, and between IOP fluctuation and associated factors including central corneal thickness, corneal curvature, and axial length. All IOP parameters demonstrated significantly high values in the HIFG compared with those in the LIFG. Mean and peak IOP using DCT were significantly higher than those using GAT in both groups. However, there were no significant differences in IOP fluctuation and reduction using both tonometry methods in the HIFG (p = 0.946 and p = 0.986, respectively). Bland-Altman analysis revealed similar fluctuations using GAT and DCT. In multivariate analyses, there was a significant correlation between fluctuations using GAT and DCT in the HIFG (p = 0.043). These results suggest that IOP monitoring using GAT is a reliable method of monitoring IOP change in glaucoma patients with a history of laser refractive surgery, especially those exhibiting high IOP fluctuation. Nevertheless, several factors, including central corneal thickness, corneal curvature, and axial length, should be considered when using GAT for IOP monitoring.	[Lee, Sang Yeop; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Severance Hosp, Coll Med, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea; [Kwon, Hee Jung] CHA Univ, CHA Bundang Med Ctr, Dept Ophthalmol, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Kim, CY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea.	kcyeye@yuhs.ac	Lee, Sang Yeop/M-4685-2015	Lee, Sang Yeop/0000-0002-3834-7953; Seong, Gong Je/0000-0002-5456-4296; Bae, Hyoung Won/0000-0002-8421-5636; Kim, Chan Yun/0000-0002-8373-9999	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1A2B4012212]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2017R1A2B4012212). The funding organization played no role in study design or conduct.	Aristeidou AP, 2011, GRAEF ARCH CLIN EXP, V249, P767, DOI 10.1007/s00417-010-1431-9; Asrani S, 2000, J GLAUCOMA, V9, P134; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; Boehm AG, 2008, INVEST OPHTH VIS SCI, V49, P2472, DOI 10.1167/iovs.07-1366; Budenz DL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1136; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Firat PG, 2013, CLIN EXP OPTOM, V96, P233, DOI 10.1111/cxo.12016; Francis BA, 2007, OPHTHALMOLOGY, V114, P20, DOI 10.1016/j.ophtha.2006.06.047; Fukuchi T, 2013, J GLAUCOMA, V22, P689, DOI 10.1097/IJG.0b013e318264b779; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Halkiadakis I, 2009, ACTA OPHTHALMOL, V87, P323, DOI 10.1111/j.1755-3768.2008.01239.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; Jonas Jost B, 2010, J Ophthalmic Vis Res, V5, P92; Kaufmann C, 2004, INVEST OPHTH VIS SCI, V45, P3118, DOI 10.1167/iovs.04-0018; Kniestedt C, 2004, ARCH OPHTHALMOL-CHIC, V122, P1287, DOI 10.1001/archopht.122.9.1287; Lee PP, 2007, AM J OPHTHALMOL, V144, P901, DOI 10.1016/j.ajo.2007.07.040; Leidl MC, 2014, BRIT J OPHTHALMOL, V98, P1315, DOI 10.1136/bjophthalmol-2013-303980; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Loewen NA, 2010, INVEST OPHTH VIS SCI, V51, P933, DOI 10.1167/iovs.09-4218; Meyenberg A, 2008, CORNEA, V27, P305, DOI 10.1097/ICO.0b013e31815dcf97; Ozcura F, 2008, JPN J OPHTHALMOL, V52, P353, DOI 10.1007/s10384-008-0535-9; Ozbek Z, 2006, CORNEA, V25, P890, DOI 10.1097/01.ico.0000224649.12214.33; Qazi MA, 2009, J CATARACT REFR SURG, V35, P1774, DOI 10.1016/j.jcrs.2009.05.041; Regev G, 2011, J GLAUCOMA, V20, P282, DOI 10.1097/IJG.0b013e3181e66498; Shemesh G, 2012, CLIN OPHTHALMOL, V6, P1967, DOI 10.2147/OPTH.S38094; Shin J, 2015, J GLAUCOMA, V24, P195, DOI 10.1097/IJG.0b013e31829da1ec; Sung KR, 2013, SURGERY, V27, P103, DOI DOI 10.3341/KJ0.2013.27.2.103; Svedberg H, 2005, GRAEF ARCH CLIN EXP, V243, P1218, DOI 10.1007/s00417-005-0072-x; Tzamalis A, 2013, J OCUL PHARMACOL TH, V29, P41, DOI 10.1089/jop.2012.0115; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang J, 2011, J GLAUCOMA, V20, P482, DOI 10.1097/IJG.0b013e3181efbe8f	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192344	10.1371/journal.pone.0192344	http://dx.doi.org/10.1371/journal.pone.0192344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401477	Green Published, gold			2022-12-27	WOS:000424101400050
J	Toliczenko-Bernatowicz, D; Matuszczak, E; Tylicka, M; Szymanska, B; Komarowska, M; Gorodkiewicz, E; Debek, W; Hermanowicz, A				Toliczenko-Bernatowicz, Dorota; Matuszczak, Ewa; Tylicka, Marzena; Szymanska, Beata; Komarowska, Marta; Gorodkiewicz, Ewa; Debek, Wojciech; Hermanowicz, Adam			Overexpression of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in boys with cryptorchidism	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; SPERM QUALITY-CONTROL; GENE-PRODUCT 9.5; RECIPROCAL MODULATORS; FUNCTIONAL-ANALYSIS; THERMAL-INJURY; SPERMATOGENESIS; TESTIS; MOUSE; SERUM	Background The ubiquitin-proteasome system regulate p53, caspase and Bcl-2 family proteins, and is crucial for the degradation of the defective germ cells in testes. Purpose: to evaluate the concentration of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in the blood plasma of boys with cryptorchidism and if there is any correlation with patient age. Methods Patients-50 boys aged 1-4 years (median = 2,4y.) with unilateral cryptorchidism. Exclusion criteria were: previous human chorionic gonadotropin treatment, an abnormal karyotype, endocrine or immunological disorders or any long-term medication. The control group-50 healthy, age matched boys (aged 1-4 years, median = 2,1y.), admitted to the Pediatric Surgery Department for planned herniotomy. To investigate UCHL1 in blood plasma of boys with cryptorchidism, we used a novel technique Surface PLASMON RESONANCE Imaging (SPRI). Results The median concentration of UCHL1 in the blood plasma of boys with cryptorchidism, was 5-folds higher than in boys with inguinal hernia, whose testicles were located in the scrotum. We also noticed statistically significant difference between UCHL1 levels in boys with cryptorchidism up to 2 years old, and above 2 years old. Older boys, whose testicles since birth were located in the inguinal pouch or in the abdominal cavity, had higher concentration of UCHL1 in their blood plasma, than boys from younger group. In the group of cryptorchid boys, we also found slightly lower concentrations of INSL3, without statistical significance and no correlation with UCHL1 levels. Conclusions Uchl1 concentrations in the blood plasma of boys with cryptorchidism, may reflect the heat-induced apoptosis of germ cells. Higher UCHL1 concentrations in older boys with undescended testicles, probably express intensity of germ cell apoptosis, more extensive when testicles are subjected to heat-stress for longer period. Further analyses of UCHL1 may help to elucidate its role in mechanisms influencing spermatogenesis.	[Toliczenko-Bernatowicz, Dorota; Matuszczak, Ewa; Komarowska, Marta; Debek, Wojciech; Hermanowicz, Adam] Med Univ Bialystok, Paediat Surg Dept, Bialystok, Poland; [Tylicka, Marzena] Med Univ Bialystok, Biophys Dept, Bialystok, Poland; [Szymanska, Beata; Gorodkiewicz, Ewa] Univ Bialystok, Electrochem Dept, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; University of Bialystok	Matuszczak, E (corresponding author), Med Univ Bialystok, Paediat Surg Dept, Bialystok, Poland.	ewamat@tlen.pl	Tylicka, Marzena/AAV-7088-2020; Matuszczak, Ewa/T-3497-2018; Hermanowicz, ahermanowicz/T-3500-2018; Dębek, Wojciech/S-8168-2018; Komarowska, Marta/R-6010-2018	Tylicka, Marzena/0000-0002-9594-8173; Matuszczak, Ewa/0000-0003-2425-9589; Hermanowicz, ahermanowicz/0000-0002-5723-6941; Dębek, Wojciech/0000-0001-6023-8510; Komarowska, Marta/0000-0002-9671-6542				Agarwal A, 2012, STUDIES ON MENS HEAL; Albin AK, 2013, HORM RES PAEDIAT, V80, P100, DOI 10.1159/000353761; Berger R. P., 2012, J NEUROTRAUMA, V29; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Chung E, 2011, CUAJ-CAN UROL ASSOC, V5, P210, DOI 10.5489/cuaj.10106; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Du Ping, 2014, Shengli Xuebao, V66, P528; Ferguson I, 2011, ANN EMERG MED, V58, pS213, DOI 10.1016/j.annemergmed.2011.06.133; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Hermanowicz A, 2012, MED SCI MONITOR, V18, pCR630, DOI 10.12659/MSM.883490; Kocak I, 2002, ASIAN J ANDROL, V4, P183; Komarowska MD, 2016, ADV MED SCI-POLAND, V61, P288, DOI 10.1016/j.advms.2016.03.004; Komarowska MD, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/973154; Komarowska MD, 2012, J PEDIATR ENDOCR MET, V25, P1073, DOI 10.1515/jpem-2012-0210; Kon Y, 1999, MOL REPROD DEV, V54, P333, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;333::AID-MRD3&gt;3.0.CO;2-8; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2005, BIOL REPROD, V73, P29, DOI 10.1095/biolreprod.104.037077; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Kwon J, 2007, EXP ANIM TOKYO, V56, P71, DOI 10.1538/expanim.56.71; Marshansky V, 2001, J IMMUNOL, V166, P3130, DOI 10.4049/jimmunol.166.5.3130; Matuszczak E, 2017, J INVEST SURG, V27, P1; Matuszczak E, 2017, ADV MED SCI-POLAND, V62, P83, DOI 10.1016/j.advms.2016.07.004; Matuszczak E, 2016, ANN CLIN LAB SCI, V46, P407; Matuszczak E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/128907; Matuszczak E, 2012, ENDOCRINE, V41, P334, DOI 10.1007/s12020-011-9551-5; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Niedzielski JK, 2016, ARCH MED SCI, V12, P667, DOI 10.5114/aoms.2016.59940; Ohta H, 2003, BIOL REPROD, V68, P2249, DOI 10.1095/biolreprod.102.014779; Oldereid NB, 2001, MOL HUM REPROD, V7, P403, DOI 10.1093/molehr/7.5.403; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Sankiewicz A, 2015, ANAL BIOCHEM, V469, P4, DOI 10.1016/j.ab.2014.09.021; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tasian GE, 2009, J UROLOGY, V182, P704, DOI 10.1016/j.juro.2009.04.032; Tokarzewicz A, 2017, ANAL METHODS-UK, V9, P2407, DOI 10.1039/c7ay00786h; Wang YL, 2006, MOL REPROD DEV, V73, P40, DOI 10.1002/mrd.20364; Wilkerson ML, 2001, HORM RES, V136, P274; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191806	10.1371/journal.pone.0191806	http://dx.doi.org/10.1371/journal.pone.0191806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401475	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400021
J	Heintz, BD; Keenan, KG				Heintz, Brittany D.; Keenan, Kevin G.			Spiral tracing on a touchscreen is influenced by age, hand, implement, and friction	PLOS ONE			English	Article							OLDER-ADULTS; FORCE FLUCTUATIONS; NEURAL-CONTROL; REACTION-TIME; PERFORMANCE; FINGERTIP; INTERNET; HANDEDNESS; SCALES; TREMOR	Dexterity impairments are well documented in older adults, though it is unclear how these influence touchscreen manipulation. This study examined age-related differences while tracing on high-and low-friction touchscreens using the finger or stylus. 26 young and 24 older adults completed an Archimedes spiral tracing task on a touchscreen mounted on a force sensor. Root mean square error was calculated to quantify performance. Root mean square error increased by 29.9% for older vs. young adults using the fingertip, but was similar to young adults when using the stylus. Although other variables (e.g., touchscreen usage, sensation, and reaction time) differed between age groups, these variables were not related to increased error in older adults while using their fingertip. Root mean square error also increased on the low-friction surface for all subjects. These findings suggest that utilizing a stylus and increasing surface friction may improve touchscreen use in older adults.	[Heintz, Brittany D.; Keenan, Kevin G.] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA; [Heintz, Brittany D.; Keenan, Kevin G.] Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Keenan, KG (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.; Keenan, KG (corresponding author), Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA.	keenan@uwm.edu		Heintz Walters, Brittany/0000-0002-5418-7072	University of Wisconsin Research Growth Initiative; Helen Bader Age & Community Scholarship	University of Wisconsin Research Growth Initiative; Helen Bader Age & Community Scholarship	B. Heintz was supported by the University of Wisconsin Research Growth Initiative and the Helen Bader Age & Community Scholarship.; The authors would like to thank the University of Wisconsin Research Growth Initiative and the Helen Bader Age & Community Scholarship for support.	Albinsson PA, 2003, HIGH PRECISION TOUCH; Arif AS, 2013, IDC 13; Benko H, 2006, CHI 06; Charness N, 2004, HUM FACTORS, V46, P373, DOI 10.1518/hfes.46.3.373.3800; Chib VS, 2009, J NEUROSCI, V29, P3939, DOI 10.1523/JNEUROSCI.5856-08.2009; Cody MJ, 1999, COMMUN EDUC, V48, P269, DOI 10.1080/03634529909379178; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; COLE KJ, 1993, EXP BRAIN RES, V95, P523; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; Cole KJ, 1999, J NEUROSCI, V19, P3238; Cousineau D, 2010, INT J PSYCHOL RES, V3, P58; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Elble RJ, 2006, BRAIN, V129, P2660, DOI 10.1093/brain/awl190; Genaro LM, 2014, IHM 14; Harada S, 2013, IFIP C HUM COMP INT; Heenan M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-170; Holzinger A, 2007, LECT NOTES COMPUT SC, V4554, P923; Hoogendam YY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00259; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; JOHANSSON RS, 1980, BRAIN RES, V184, P343, DOI 10.1016/0006-8993(80)90803-3; Joshi MN, 2016, EXP BRAIN RES, V234, P1893, DOI 10.1007/s00221-016-4581-0; Kapur S, 2010, J APPL PHYSIOL, V109, P1827, DOI 10.1152/japplphysiol.00430.2010; Keenan KG, 2017, J NEUROPHYSIOL, V118, P2537, DOI 10.1152/jn.00928.2016; Keenan KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048193; Lagana L, 2008, EDUC GERONTOL, V34, P831, DOI 10.1080/03601270802243713; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Leonardi C, 2010, EXPLORATORY STUDY TO; Louis ED, 2011, NEUROEPIDEMIOLOGY, V37, P90, DOI 10.1159/000330352; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; Marquie JC, 2002, BEHAV INFORM TECHNOL, V21, P273, DOI 10.1080/0144929021000020998; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Matulic F, 2012, ITS 12; McMellon CA, 2002, J APPL GERONTOL, V21, P157, DOI 10.1177/07364802021002002; Mynatt ED, 2011, AGING INT, V27, P24; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prattichizzo D, 2015, IEEE T HAPTICS, V8, P356, DOI 10.1109/TOH.2015.2434812; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; Seo Na Jin, 2012, J Hand Ther, V25, P397, DOI 10.1016/j.jht.2012.04.004; Seo NJ, 2011, ARCH PHYS MED REHAB, V92, P24, DOI 10.1016/j.apmr.2010.08.016; Shapira N, 2007, AGING MENT HEALTH, V11, P477, DOI 10.1080/13607860601086546; Shinohara M, 2003, J APPL PHYSIOL, V94, P259, DOI 10.1152/japplphysiol.00643.2002; Slavin MJ, 1996, PSYCHOL AGING, V11, P521, DOI 10.1037/0882-7974.11.3.521; Stanley K, 2010, PARKINSONISM RELAT D, V16, P233, DOI 10.1016/j.parkreldis.2009.12.007; STEVENS JC, 1995, SOMATOSENS MOT RES, V12, P29, DOI 10.3109/08990229509063140; Stirling LA, 2013, J GERONTOL A-BIOL, V68, P938, DOI 10.1093/gerona/glt003; Tu H, 2012, CHI 12; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; Vogel D, 2007, CHI 07; Wang F, 2009, CHI 09; Wang JS, 2011, EXP BRAIN RES, V210, P283, DOI 10.1007/s00221-011-2631-1; Westin J, 2010, J NEUROSCI METH, V190, P143, DOI 10.1016/j.jneumeth.2010.04.027; Wright K, 2000, J COMMUN, V50, P100, DOI 10.1111/j.1460-2466.2000.tb02855.x; Zhai S, 2003, CHI 03	54	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191309	10.1371/journal.pone.0191309	http://dx.doi.org/10.1371/journal.pone.0191309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389940	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400015
J	Pachikian, BD; Druart, C; Catry, E; Bindels, LB; Neyrinck, AM; Larondelle, Y; Cani, PD; Delzenne, NM				Pachikian, Barbara D.; Druart, Celine; Catry, Emilie; Bindels, Laure B.; Neyrinck, Audrey M.; Larondelle, Yvan; Cani, Patrice D.; Delzenne, Nathalie M.			Implication of trans-11, trans-13 conjugated linoleic acid in the development of hepatic steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GUT MICROBIOTA; ADIPOSE-TISSUE; BIOHYDROGENATION; METABOLISM; MODULATION; MECHANISMS; EXPRESSION; RECEPTOR; HEALTH	Scope Conjugated linoleic acids are linoleic acid isomers found in the diet that can also be produced through bacterial metabolism of polyunsaturated fatty acids. Our objective was to evaluate the contribution of fatty acid metabolites produced from polyunsaturated fatty acids by the gut microbiota in vivo to regulation of hepatic lipid metabolism and steatosis. Methods and results In mice with depleted n-3 polyunsaturated fatty acids, we observed an accumulation of trans-11, trans-13 CLA and cis-9, cis-11 conjugated linoleic acids in the liver tissue that were associated with an increased triglyceride content and expression of lipogenic genes. We used an in vitro model to evaluate the impact of these two conjugated linoleic acids on hepatic lipid metabolism. In HepG2 cells, we observed that only trans-11, trans-13 conjugated linoleic acids recapitulated triglyceride accumulation and increased lipogenic gene expression, which is a phenomenon that may implicate the nuclear factors sterol regulatory element binding protein 1c (SREBP-1c) and carbohydrate-responsive element-binding protein (ChREBP). Conclusion The trans-11, trans-13 conjugated linoleic acids can stimulate hepatic lipogenesis, which supports the conclusion that gut microbiota and related metabolites should be considered in the treatment of non-alcoholic liver disease.	[Pachikian, Barbara D.; Druart, Celine; Catry, Emilie; Bindels, Laure B.; Neyrinck, Audrey M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium; [Larondelle, Yvan] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, WELBIO, WELBIO Walloon Excellence Life Sci & BIOtechnol, Metab & Nutr Res Grp,Louvain Drug Res Inst, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019; Bindels, Laure/T-7846-2019; D., Cani Patrice/M-8055-2016	Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; Bindels, Laure/0000-0003-3747-3234; D., Cani Patrice/0000-0003-2040-2448; Druart, Celine/0000-0002-7786-9172	FRS-FNRS (Fonds de la recherche scientifique) [FRSM 3.4574.07, FRFC 2.4555.08]; competitive cluster Wagralim (Walnut20); European Union's Seventh Framework Program (Mynewgut grant) [613979]; FNRS; FRFS-WELBIO [WELBIO-CR-2012S-02R]; Funds Baillet Latour (Grant for Medical Research); ERC Starting Grant [336452-ENIGMO]	FRS-FNRS (Fonds de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); competitive cluster Wagralim (Walnut20); European Union's Seventh Framework Program (Mynewgut grant); FNRS(Fonds de la Recherche Scientifique - FNRS); FRFS-WELBIO(WELBIO); Funds Baillet Latour (Grant for Medical Research); ERC Starting Grant(European Research Council (ERC))	NMD is a recipient of grants from FRS-FNRS (Fonds de la recherche scientifique) (convention FRSM 3.4574.07 and FRFC 2.4555.08), from Wallonia supported by the competitive cluster Wagralim (Walnut20) and from the European Union's Seventh Framework Program (Mynewgut grant agreement no 613979). PDC is senior research associate from the FRS-FNRS Belgium and the recipient of grants from FNRS, FRFS-WELBIO under grant: WELBIO-CR-2012S-02R, the Funds Baillet Latour (Grant for Medical Research 2015), and ERC Starting Grant 2013 (Starting grant 336452-ENIGMO). LBB is a postdoctoral fellow from the FRS-FNRS Belgium.	Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi JS, 2007, BRIT J NUTR, V98, P264, DOI 10.1017/S000711450770497X; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cui W, 2010, AM J TRANSL RES, V2, P95; Delarue J, 2016, MOL NUTR FOOD RES, V60, P147, DOI 10.1002/mnfr.201500346; Della Casa L, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0542-2; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; Druart C, 2015, MOL NUTR FOOD RES, V59, P1603, DOI 10.1002/mnfr.201500014; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Ducheix S, 2013, BIOCHEM PHARMACOL, V86, P96, DOI 10.1016/j.bcp.2013.03.016; Ducheix S, 2013, J HEPATOL, V58, P984, DOI 10.1016/j.jhep.2013.01.006; Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gwang-woong G, 2013, J MICROBIOL BIOTECHN, V23, P1569, DOI 10.4014/jmb.1308.08008; Honkanen AM, 2016, BRIT J NUTR, V115, P2093, DOI 10.1017/S0007114516001446; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Kelley DS, 2009, BRIT J NUTR, V101, P701, DOI 10.1017/S0007114508027451; Kim JH, 2016, ANNU REV FOOD SCI T, V7, P221, DOI 10.1146/annurev-food-041715-033028; Lee YJ, 2011, J NUTR, V141, P1445, DOI 10.3945/jn.111.138396; Lee Y, 2010, J NUTR BIOCHEM, V21, P490, DOI 10.1016/j.jnutbio.2009.02.005; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Marques TM, 2015, BRIT J NUTR, V113, P728, DOI 10.1017/S0007114514004206; McIntosh FM, 2009, MICROBIOL-SGM, V155, P285, DOI 10.1099/mic.0.022921-0; Mitchell PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052634; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Nagao K, 2005, J NUTR, V135, P9, DOI 10.1093/jn/135.1.9; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Pachikian B. D., 2008, BMC Physiology, V8, P21, DOI 10.1186/1472-6793-8-21; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365; Pini M, 2016, FASEB J, V30, P241, DOI 10.1096/fj.15-276675; Raimondi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8654317; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; SATTAR N, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G4596; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025	44	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192447	10.1371/journal.pone.0192447	http://dx.doi.org/10.1371/journal.pone.0192447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389988	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400092
J	Budka, M; Deoniziak, K; Tumiel, T; Wozna, JT				Budka, Michal; Deoniziak, Krzysztof; Tumiel, Tomasz; Wozna, Joanna Teresa			Vocal individuality in drumming in great spotted woodpecker-A biological perspective and implications for conservation	PLOS ONE			English	Article							CORNCRAKE CREX-CREX; ACOUSTIC-SIGNALS; SEXUAL SELECTION; RECOGNITION; IDENTIFICATION; CALLS; SONG; VOCALIZATIONS	Animals-including conservation biologists-use acoustic signals to recognise and track individuals. The majority of research on this phenomenon has focused on sounds generated by vocal organs (e.g., larynx or syrinx). However, animals also produce sounds using other parts of the body, such as the wings, tail, legs, or bill. In this study we focused on non-syrinx vocalisation of the great spotted woodpecker, called drumming. Drumming consists of strokes of a bill on a tree in short, repeated series, and is performed by both males and females to attract mates and deter rivals. Here, we considered whether the great spotted woodpecker's drumming patterns are sex-specific and whether they enable individual identification. We recorded drumming of 41 great spotted woodpeckers (26 males, 9 females, 6 unsexed). An automatic method was used to measure the intervals between succeeding strokes and to count strokes within a drumming roll. The temporal parameters of drumming that were analysed here had lower within-than between-individual coefficients of variation. Discriminant function analyses correctly assigned 70-88% of rolls to the originating individual, but this depended on whether all individuals were analysed together or split into males and females. We found slight, but significant, differences between males and females in the length of intervals between strokes-males drummed faster than females-but no difference in the number of strokes within a roll. Our study revealed that temporal patterns of drumming in the great spotted woodpecker cannot be used for unambiguous sex determination. Instead, discrimination among individuals may be possible based on the intervals between strokes and the number of strokes within a roll. Therefore, it is possible that differences in the temporal parameters of drumming may be used by birds to identify each other, as well as by researchers to aid in census and monitoring tasks.	[Budka, Michal] Adam Mickiewicz Univ, Fac Biol, Dept Behav Ecol, Poznan, Poland; [Deoniziak, Krzysztof] Univ Bialystok, Inst Biol, Lab Insect Evolutionary Biol & Ecol, Bialystok, Poland; [Tumiel, Tomasz] Wildlife Soc Dubelt, Juszkowy Grod, Poland; [Wozna, Joanna Teresa] Poznan Univ Life Sci, Inst Zool, Poznan, Poland	Adam Mickiewicz University; University of Bialystok; Poznan University of Life Sciences	Budka, M (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Behav Ecol, Poznan, Poland.	m.budka@amu.edu.pl	Bialas, Joanna T./ABG-1876-2021; Budka, Michał/R-5812-2019	Bialas, Joanna T./0000-0002-0683-4001; Budka, Michał/0000-0002-1244-013X; Deoniziak, Krzysztof/0000-0001-6447-6655				Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bragina E, 2013, CONDOR, V115, P501, DOI 10.1525/cond.2013.110123; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Budka M, 2015, J ORNITHOL, V156, P481, DOI 10.1007/s10336-014-1149-2; Budka M, 2013, J ORNITHOL, V154, P685, DOI 10.1007/s10336-013-0933-8; Campbell KA, 2016, J ACOUST SOC AM, V140, P1598, DOI 10.1121/1.4962281; Casteren A, 2010, J EXP BIOL, V213, P1602; CATCHPOLE CK, 1987, TRENDS ECOL EVOL, V2, P94, DOI 10.1016/0169-5347(87)90165-0; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Chuang MF, 2017, ANIM BEHAV, V123, P217, DOI 10.1016/j.anbehav.2016.11.001; Delport W, 2002, IBIS, V144, P30, DOI 10.1046/j.0019-1019.2001.00019.x; Dent JM, 2015, NOTORNIS, V62, P1; Dodenhoff DJ, 2001, CONDOR, V103, P143, DOI 10.1650/0010-5422(2001)103[0143:DWDEIF]2.0.CO;2; Dooling R., 2004, NATURES MUSIC SCI BI, P209; Eberhardt LS, 1997, CONDOR, V99, P798, DOI 10.2307/1370491; Eda-Fujiwara H, 2004, ZOOL SCI, V21, P817, DOI 10.2108/zsj.21.817; Elemans CPH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9978; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Florentin J, 2016, ECOL INFORM, V35, P61, DOI 10.1016/j.ecoinf.2016.08.006; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Hoodless AN, 2008, IBIS, V150, P80; Janicke T, 2007, J ORNITHOL, V148, P565, DOI 10.1007/s10336-007-0195-4; KAISER M, 1990, Beitraege zur Vogelkunde, V36, P129; Kuczynski L, 2015, ATLAS POSPOLITYCH PT, P54; Michalek KG, 2001, BEHAVIOUR, V138, P1259, DOI 10.1163/15685390152822210; Michalek Klaus G., 2003, BWP Update, V5, P101; Pasinelli G, 2006, ANN ZOOL FENN, V43, P96; Peake T. M., 2001, Animal Biodiversity and Conservation, V24, P81; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Rebbeck M, 2001, IBIS, V143, P468, DOI 10.1111/j.1474-919X.2001.tb04948.x; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Terry AMR, 2005, FRONT ZOOL, V2, P10, DOI DOI 10.1186/1742-9994-2-10; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tremain SB, 2008, WILSON J ORNITHOL, V120, P499, DOI 10.1676/07-137.1; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528; Zabka H, 1980, ANN OM S, V4, P51; Zsebok S, 2017, J ORNITHOL, V158, P213, DOI 10.1007/s10336-016-1376-9	45	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191716	10.1371/journal.pone.0191716	http://dx.doi.org/10.1371/journal.pone.0191716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415002	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300039
J	Wu, MS; Alvarado, JJ; Augelli-Szafran, CE; Ptak, RG; Smithgall, TE				Wu, Mousheng; Alvarado, John J.; Augelli-Szafran, Corinne E.; Ptak, Roger G.; Smithgall, Thomas E.			A single beta-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding	PLOS ONE			English	Article							KINASE ACTIVATION; CRYSTAL-STRUCTURE; TYROSINE KINASE; DOWN-REGULATION; SH3 DOMAIN; DIMERIZATION; FEATURES; REVEALS	The HIV-1 Nef accessory protein is essential for viral pathogenicity and AIDS progression. Nef forms complexes with multiple host cell factors to facilitate viral replication and promote immune escape of HIV-infected cells. Previous X-ray crystal structures demonstrate that Nef forms homodimers, the orientation of which are influenced by host cell binding partners. In cell-based fluorescence complementation assays, Nef forms homodimers at the plasma membrane. However, recombinant Nef proteins often exist as monomers in solution, suggesting that membrane interaction may also trigger monomer to dimer transitions. In this study, we show that monomeric Nef core proteins can be induced to form dimers in the presence of low concentrations of the non-ionic surfactant, beta-octyl glucoside (beta OG). X-ray crystallography revealed that a single beta OG molecule is present in the Nef dimer, with the 8-carbon acyl chain of the ligand binding to a hydrophobic pocket formed by the dimer interface. This Nef-beta OG dimer interface involves helix alpha B, as observed in previous dimer structures, as well as a helix formed by N-terminal residues 54 +/- 66. Nef dimer formation is stabilized in solution by the addition of beta OG, providing biochemical validation for the crystal structure. These observations together suggest that the interaction with host cell lipid mediators or other hydrophobic ligands may play a role in Nef dimerization, which has been previously linked to multiple Nef functions including host cell protein kinase activation, CD4 downregulation, and enhancement of HIV-1 replication.	[Wu, Mousheng; Augelli-Szafran, Corinne E.] Southern Res Inst, Dept Chem, Drug Discovery Div, Birmingham, AL 35205 USA; [Alvarado, John J.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ptak, Roger G.] Southern Res Inst, Dept Infect Dis Res, Frederick, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, MS (corresponding author), Southern Res Inst, Dept Chem, Drug Discovery Div, Birmingham, AL 35205 USA.; Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	mwu@southernresearch.org; tsmithga@pitt.edu			NIAID NIH HHS [R01 AI102724, R01 AI057083] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Breuer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020033; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroco JA, 2017, J MOL BIOL IN PRESS; Mujib S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93684; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Pereira EA, 2016, HIV 1 NEF TAKING CON; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Shu ST, 2017, J BIOL CHEM, V292, P2670, DOI 10.1074/jbc.M116.770016; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Smithgall T. E., 2013, DRUG DISCOV TODAY TE, V10, P523; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Trible RP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-135; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Watkins RL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0187-z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192512	10.1371/journal.pone.0192512	http://dx.doi.org/10.1371/journal.pone.0192512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415006	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300083
J	Zhao, CH; Shen, X; Guo, MR				Zhao, Changhui; Shen, Xue; Guo, Mingruo			Stability of lutein encapsulated whey protein nano-emulsion during storage	PLOS ONE			English	Article							MACULAR PIGMENT; DELIVERY; CANCER; RISK; ANTIOXIDANTS; PRETREATMENT; CAROTENOIDS; TEMPERATURE; ULTRASOUND; PREVENTION	Lutein is a hydrophobic carotenoid that has multiple health functions. However, the application of lutein is limited due to its poor solubility in water and instability under certain conditions during storage. Hereby we generated lutein loaded nano-emulsions using whey protein isolate (WPI) or polymerized whey protein isolate (PWP) with assistance of high intensity ultrasound and evaluate their stability during storage at different conditions. We measured the particle size, zeta-potential, physical stability and lutein content change. Results showed that the PWP based nano-emulsion system was not stable in the tested Oil/Water/Ethanol system indicated by the appearance of stratification within only one week. The WPI based nano-emulsion system showed stable physiochemical stability during the storage at 4 degrees C. The lutein content of the system was reduced by only 4% after four weeks storage at 4 degrees C. In conclusion, our whey protein based nano-emulsion system provides a promising strategy for encapsulation of lutein or other hydrophobic bioactive molecules to expand their applications.	[Zhao, Changhui; Shen, Xue] Jilin Univ, Coll Food Sci & Engn, Changchun, Jilin, Peoples R China; [Shen, Xue] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China; [Guo, Mingruo] Northeast Agr Univ, Dept Food Sci, Harbin, Heilongjiang, Peoples R China; [Guo, Mingruo] Univ Vermont, Dept Nutr & Food Sci, Burlington, VT USA	Jilin University; Jilin University; Northeast Agricultural University - China; University of Vermont	Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Changchun, Jilin, Peoples R China.	czhao@jlu.edu.cn	Zhao, Changhui/N-2378-2019	Zhao, Changhui/0000-0002-1882-7490	Fundamental Research Funds for Young Researchers [451160301317];  [419080500712]	Fundamental Research Funds for Young Researchers; 	The research was partly supported by the Fundamental Research Funds for Young Researchers (Grant No. 451160301317) and partly by Startup Funds to Overseas Doctorate Talents Plan B (Grant No. 419080500712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J FOOD SCI TECHN; BANKS W, 1985, FOOD CHEM, V18, P139, DOI 10.1016/0308-8146(85)90137-2; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889; Breithaupt DE, 2007, TRENDS FOOD SCI TECH, V18, P501, DOI 10.1016/j.tifs.2007.04.009; Chen C., 2015, FUNCTIONAL CHARACTER; Cooper DA, 1999, NUTR REV, V57, P201, DOI 10.1111/j.1753-4887.1999.tb06944.x; Davidov-Pardo G, 2016, FOOD CHEM, V196, P821, DOI 10.1016/j.foodchem.2015.10.018; De Stefani E, 1999, NUTR CANCER, V34, P100, DOI 10.1207/S15327914NC340114; Dickinson E, 2010, COLLOID SURFACE B, V81, P130, DOI 10.1016/j.colsurfb.2010.06.033; Frede K, 2014, J FUNCT FOODS, V8, P118, DOI 10.1016/j.jff.2014.03.011; Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929; Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001; Gunnerud U, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-83; Hadden WL, 1999, J AGR FOOD CHEM, V47, P4189, DOI 10.1021/jf990096k; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Helgason T, 2009, FOOD HYDROCOLLOID, V23, P2243, DOI 10.1016/j.foodhyd.2009.05.014; Hidalgo A, 2006, J CEREAL SCI, V44, P182, DOI 10.1016/j.jcs.2006.06.002; Hu H, 2015, J FUNCT FOODS, V19, P182, DOI 10.1016/j.jff.2015.09.023; Hu H, 2013, FOOD HYDROCOLLOID, V32, P303, DOI 10.1016/j.foodhyd.2013.01.016; Jaiswal M, 2015, 3 BIOTECH, V5, P123, DOI 10.1007/s13205-014-0214-0; Jin HY, 2009, CHINESE J CHEM ENG, V17, P672, DOI 10.1016/S1004-9541(08)60262-1; Joye IJ, 2014, TRENDS FOOD SCI TECH, V40, P168, DOI 10.1016/j.tifs.2014.08.006; Lam RSH, 2015, LWT-FOOD SCI TECHNOL, V60, P427, DOI 10.1016/j.lwt.2014.07.031; Landrum J T, 1997, Adv Pharmacol, V38, P537; Li DaJing, 2008, Jiangsu Journal of Agricultural Sciences, V24, P97; Liu D, 2017, JOURNAL OF FOOD PROC; Madadlou A, 2010, ULTRASON SONOCHEM, V17, P153, DOI 10.1016/j.ultsonch.2009.06.009; Marshall Keri, 2004, Altern Med Rev, V9, P136; Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008; Mozaffarieh M, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-20; Neuman I, 1999, ANN ALLERG ASTHMA IM, V82, P549, DOI 10.1016/S1081-1206(10)63165-1; Parlak M, 2017, THERMAL THERMOMECHAN; Pratheesh V. B., 2009, Modern Applied Science, V3, P19; Qv XY, 2011, FOOD HYDROCOLLOID, V25, P1596, DOI 10.1016/j.foodhyd.2011.01.006; Reddy L, 2003, PHARMACOL THERAPEUT, V99, P1, DOI 10.1016/S0163-7258(03)00042-1; RIGGS LK, 1955, J AGR FOOD CHEM, V3, P333, DOI 10.1021/jf60050a006; Shen X, 2016, INT J FOOD SCI TECH, P52; Shen X, 2017, ULTRASON SONOCHEM, V39, P810, DOI 10.1016/j.ultsonch.2017.05.039; Shen X, 2017, FOOD HYDROCOLLOID, V63, P668, DOI 10.1016/j.foodhyd.2016.10.003; Shi XM, 1997, NAHRUNG, V41, P38, DOI 10.1002/food.19970410110; Tavani A, 1999, EUR J CANCER, V35, P1361, DOI 10.1016/S0959-8049(99)00139-2; TYCZKOWSKI JK, 1986, POULTRY SCI, V65, P1526, DOI 10.3382/ps.0651526; TYCZKOWSKI JK, 1986, POULTRY SCI, V65, P1141, DOI 10.3382/ps.0651141; Wang YF, 2012, EUR FOOD RES TECHNOL, V234, P157, DOI 10.1007/s00217-011-1630-6; Weigel F, 2018, FOOD CHEM, V242, P395, DOI 10.1016/j.foodchem.2017.09.060; Xie YQ, 2016, INT J PHARMACEUT, V500, P110, DOI 10.1016/j.ijpharm.2016.01.032; Yi J, 2016, FOOD CHEM, V200, P91, DOI 10.1016/j.foodchem.2016.01.035; Yi J, 2014, J AGR FOOD CHEM, V62, P8900, DOI 10.1021/jf502639k; Yu HL, 2013, FOOD CHEM, V141, P29, DOI 10.1016/j.foodchem.2013.03.009; Zhang PP, 2016, ULTRASON SONOCHEM, V29, P380, DOI 10.1016/j.ultsonch.2015.10.014; Zhao CD, 2014, FOOD CHEM, V156, P123, DOI 10.1016/j.foodchem.2014.01.086	52	40	41	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192511	10.1371/journal.pone.0192511	http://dx.doi.org/10.1371/journal.pone.0192511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415071	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300082
J	Coroiu, A; Kwakkenbos, L; Moran, C; Thombs, B; Albani, C; Bourkas, S; Zenger, M; Brahler, E; Korner, A				Coroiu, Adina; Kwakkenbos, Linda; Moran, Chelsea; Thombs, Brett; Albani, Cornelia; Bourkas, Sophia; Zenger, Markus; Brahler, Elmar; Koerner, Annett			Structural validation of the Self-Compassion Scale with a German general population sample	PLOS ONE			English	Article							FIT INDEXES; QUESTIONNAIRE; MINDFULNESS; HEALTH; PHQ-9; RELIABILITY; CRITICISM; VALIDITY; CRITERIA; VERSION	Background Published validation studies have reported different factor structures for the Self-Compassion Scale (SCS). The objective of this study was to assess the factor structure of the SCS in a large general population sample representative of the German population. Methods A German population sample completed the SCS and other self-report measures. Confirmatory factor analysis (CFA) in MPlus was used to test six models previously found in factor analytic studies (unifactorial model, two-factor model, three-factor model, six-factor model, a hierarchical (second order) model with six first-order factors and two second-order factors, and a model with arbitrarily assigned items to six factors). In addition, three bifactor models were also tested: bifactor model #1 with two group factors (SCS positive items, called SCS positive) and SCS negative items, called SCS negative) and one general factor (overall SCS); bifactor model #2, which is a two-tier model with six group factors, three (SCS positive subscales) corresponding to one general dimension (SCS positive) and three (SCS negative subscales) corresponding to the second general dimension (SCS negative); bifactor model #3 with six group factors (six SCS subscales) and one general factor (overall SCS). Results The two-factor model, the six-factor model, and the hierarchical model showed less than ideal, but acceptable fit. The model fit indices for these models were comparable, with no apparent advantage of the six-factor model over the two-factor model. The one-factor model, the three-factor model, and bifactor model #3 showed poor fit. The other two bifactor models showed strong support for two factors: SCS positive and SCS negative. Conclusion The main results of this study are that, among the German general population, six SCS factors and two SCS factors fit the data reasonably well. While six factors can be modelled, the three negative factors and the three positive factors, respectively, did not reflect reliable or meaningful variance beyond the two summative positive and negative item factors. As such, we recommend the use of two subscale scores to capture a positive factor and a negative factor when administering the German SCS to general population samples and we strongly advise against the use of a total score across all SCS items.	[Coroiu, Adina; Moran, Chelsea; Bourkas, Sophia; Koerner, Annett] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Kwakkenbos, Linda; Thombs, Brett] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Kwakkenbos, Linda; Thombs, Brett; Koerner, Annett] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Kwakkenbos, Linda] Radboud Univ Nijmegen, Behav Sci Inst, Clin Psychol, Nijmegen, Netherlands; [Albani, Cornelia; Zenger, Markus] Univ Leipzig, Med Ctr, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Zenger, Markus] Univ Appl Sci Magdeburg Stendal, Fac Appl Human Studies, Stendal, Germany; [Zenger, Markus] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr IFB Adipos Dis Beh, Leipzig, Germany; [Brahler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany	McGill University; McGill University; Lady Davis Institute; McGill University; Radboud University Nijmegen; Leipzig University; Leipzig University; Johannes Gutenberg University of Mainz	Coroiu, A (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.	acoroiu@gmail.com	Braehler, Elmar/C-6535-2009; Kwakkenbos, Linda/GXH-2756-2022	Braehler, Elmar/0000-0002-2648-2728; Kwakkenbos, Linda/0000-0002-1573-4504; Moran, Chelsea/0000-0001-5843-0415				Arimitsu Kohki, 2014, Shinrigaku Kenkyu, V85, P50; Beaumont E., 2012, COUNS PSYCHOL, V27, P31, DOI DOI 10.1017/S1754470X16000209.BEAUM0NT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Birnie K, 2010, STRESS HEALTH, V26, P359, DOI 10.1002/smi.1305; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Breivik E, STRUCTURAL EQUATION; Brena RF, 2017, J SENSORS, V2017, DOI 10.1155/2017/2630413; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Castilho P, 2015, J CLIN PSYCHOL, V71, P856, DOI 10.1002/jclp.22187; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Costa J, 2015, CLIN PSYCHOL PSYCHOT, V22, P75; de Souza L.K., 2016, TEMAS PSICOLOGIA, V24, P159, DOI [10.9788/TP2016.1-11, DOI 10.9788/TP2016.1-11]; Garcia-Campayo J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-4; Gilbert P., 2005, COMPASSION CONCEPTUA, P263, DOI [DOI 10.4324/9780203003459, 10.4324/9780203003459]; Gilbert P, 2014, J DEPRESS ANXIETY S, VS2, P1, DOI DOI 10.4172/2167-1044.S2-003; Gilbert P., 2009, ADV PSYCHIAT TREATME, V15, P199, DOI [DOI 10.1192/APT.BP.107.005264, 10.1192/apt.bp.107.005264]; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hupfeld J, 2011, Z KL PSYCH PSYCHOTH, V40, P115, DOI 10.1026/1616-3443/a000088; Jazaieri H, 2013, J HAPPINESS STUD, V14, P1113, DOI 10.1007/s10902-012-9373-z; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Keng SL, 2012, J COGN PSYCHOTHER, V26, P270, DOI 10.1891/0889-8391.26.3.270; Kline RB, 2005, PRINCIPLES PRACTICE, V2; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Korner A, 2015, PLOS ONE; Kotsou I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152880; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lopez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132940; MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Meade AW, 2008, 23 ANN C SOC IND ORG; Mills A, 2007, CLIN PSYCHOL PSYCHOT, V14, P358, DOI 10.1002/cpp.537; Montero-Marin J, 2016, FRONT PSYCHOL, P7; Muris P., 2016, CLIN PSYCHOL PSYCHOT; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; NEFF K, 2003, SELF IDENTITY, V2, P85, DOI DOI 10.1080/15298860309032; Neff KD., 2009, HDB INDIVIDUAL DIFFE, P561; Neff KD, 2017, J PERS ASSESS, P1; Neff KD, 2016, MINDFULNESS, V7, P264, DOI 10.1007/s12671-015-0479-3; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Nunnally JC, 1994, THE ASSESSMENT OF RE; Petrocchi N, 2014, J MENT HEALTH, V23, P72, DOI 10.3109/09638237.2013.841869; Pfattheicher S, 2017, EUR J PERSONALITY, V31, P160, DOI 10.1002/per.2097; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Reise SP, 2013, J PERS ASSESS, V95, P129, DOI 10.1080/00223891.2012.725437; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Rodriguez A, 2016, J PERS ASSESS, V98, P223, DOI 10.1080/00223891.2015.1089249; Shapira LB, 2010, J POSIT PSYCHOL, V5, P377, DOI 10.1080/17439760.2010.516763; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stumpp T, 2010, APPL PSYCHOL-INT REV, V59, P674, DOI 10.1111/j.1464-0597.2010.00422.x; Toth-Kiraly I, 2017, MINDFULNESS, V8, P881, DOI 10.1007/s12671-016-0662-1; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Williams MJ, 2014, PSYCHOL ASSESSMENT, V26, P407, DOI 10.1037/a0035566; Ying YW, 2009, J SOC WORK EDUC, V45, P309, DOI 10.5175/JSWE.2009.200700072; Zenger M, 2015, J PERS ASSESS, V97, P310, DOI 10.1080/00223891.2014.989367; Zessin U, 2015, APPL PSYCHOL-HLTH WE, V7, P340, DOI 10.1111/aphw.12051; Zwick R, 1997, APPL MEAS EDUC, V10, P321, DOI 10.1207/s15324818ame1004_2	65	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190771	10.1371/journal.pone.0190771	http://dx.doi.org/10.1371/journal.pone.0190771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408888	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800009
J	Kinoshita, A; Baffa, O; Mascarenhas, S				Kinoshita, Angela; Baffa, Oswaldo; Mascarenhas, Sergio			Electron spin resonance (ESR) dose measurement in bone of Hiroshima A-bomb victim	PLOS ONE			English	Article							EPR-DOSIMETRY; TOOTH ENAMEL; RADIATION-DOSIMETRY; THERMOLUMINESCENCE; RECONSTRUCTION	Explosion of the bombs in Hiroshima and Nagasaki corresponds to the only historical moment when atomic bombs were used against civilians. This event triggered countless investigations into the effects and dosimetry of ionizing radiation. However, none of the investigations has used the victims' bones as dosimeter. Here, we assess samples of bones obtained from fatal victims of the explosion by Electron Spin Resonance (ESR). In 1973, one of the authors of the present study (SM) traveled to Japan and conducted a preliminary experiment on the victims' bone samples. The idea was to use the paramagnetism induced in bone after irradiation to measure the radiation dose. Technological advances involved in the construction of spectrometers, better knowledge of the paramagnetic center, and improvement in signal processing techniques have allowed us to resume the investigation. We obtained a reconstructed dose of 9.46 +/- 3.4 Gy from the jawbone, which was compatible with the dose distribution in different locations as measured in non-biological materials such as wall bricks and roof tiles.	[Kinoshita, Angela; Baffa, Oswaldo] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil; [Kinoshita, Angela] Univ Sagrado Coracao, Pro Reitoria Pesquisa Posgrad, Sao Paulo, Brazil; [Mascarenhas, Sergio] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade do Sagrado Coracao; Universidade de Sao Paulo	Kinoshita, A (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil.; Kinoshita, A (corresponding author), Univ Sagrado Coracao, Pro Reitoria Pesquisa Posgrad, Sao Paulo, Brazil.	angelamitie@gmail.com	Filho, Oswaldo Baffa/E-3251-2012; Kinoshita, Angela/C-6946-2012	Filho, Oswaldo Baffa/0000-0002-0622-2814; Kinoshita, Angela/0000-0002-5057-1667				ARAKAWA ET, 1960, NEW ENGL J MED, V263, P488, DOI 10.1056/NEJM196009082631005; Breen SL, 1995, PHYS MED BIOL, V40, P2065, DOI 10.1088/0031-9155/40/12/005; CALLENS FJ, 1987, CALCIFIED TISSUE INT, V41, P124, DOI 10.1007/BF02563791; Chumak V, 1996, APPL RADIAT ISOTOPES, V47, P1281, DOI 10.1016/S0969-8043(96)00231-X; Clairand I, 2006, RADIAT PROT DOSIM, V119, P500, DOI 10.1093/rpd/nci516; Bruno AC, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431x20165848, 10.1590/1414-431X20165848]; De TI, 2013, APPL MAGN RESON, V44, P375, DOI 10.1007/s00723-012-0379-9; Degteva MO, 2015, RADIAT ENVIRON BIOPH, V54, P433, DOI 10.1007/s00411-015-0611-8; DESROSIERS MF, 1993, APPL RADIAT ISOTOPES, V44, P459, DOI 10.1016/0969-8043(93)90267-E; DESROSIERS MF, 1991, HEALTH PHYS, V61, P859, DOI 10.1097/00004032-199112000-00018; Egersdorfer S, 1996, APPL RADIAT ISOTOPES, V47, P1299, DOI 10.1016/S0969-8043(96)00233-3; Gritzner ML., 1987, REASSESSMENT ATOMIC, V2, P342; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; HIGASHIMURA T, 1963, SCIENCE, V139, P1284, DOI 10.1126/science.139.3561.1284-a; ICHIKAWA Y, 1966, HEALTH PHYS, V12, P395, DOI 10.1097/00004032-196603000-00013; Ignatiev EA, 1999, APPL RADIAT ISOTOPES, V51, P151, DOI 10.1016/S0969-8043(98)00133-X; IKEYA M, 1984, JPN J APPL PHYS 2, V23, pL697, DOI 10.1143/JJAP.23.L697; Imanaka T, 2008, RADIAT ENVIRON BIOPH, V47, P297, DOI 10.1007/s00411-008-0176-x; JUNWANG G, 2014, PLOS ONE, V0009; Kinoshita A, 2003, HEALTH PHYS, V84, P477, DOI 10.1097/00004032-200304000-00007; Kinoshita A, 2001, APPL RADIAT ISOTOPES, V54, P269, DOI 10.1016/S0969-8043(00)00159-7; Kinoshita A, 2014, J HUM EVOL, V77, P187, DOI 10.1016/j.jhevol.2014.09.006; KOBERLE G, 1973, AN ACAD BRAS CIENC, V45, P157; Krefft K, 2014, RADIAT PROT DOSIM, V162, P38, DOI 10.1093/rpd/ncu214; MASCARENHAS S, 1973, B AM PHYS SOC, V18, P579; MASCARENHAS S, 1982, AM J PHYS ANTHROPOL, V59, P413, DOI 10.1002/ajpa.1330590411; Milton RC, 1968, TENTATIVE 1965 RAD D; Moulder JE, 2004, INT J RADIAT BIOL, V80, P3, DOI 10.1080/09553000310001642920; Nakamura N, 1998, INT J RADIAT BIOL, V73, P619, DOI 10.1080/095530098141870; Physical Measurement Laboratory, XRAY MASS ATT COEFF; Portas M, 2016, RADIAT PROT DOSIM, V171, P99, DOI 10.1093/rpd/ncw206; Schauer DA, 1996, APPL RADIAT ISOTOPES, V47, P1345, DOI 10.1016/S0969-8043(96)00203-5; Schauer DA, 2006, RADIAT MEAS, V41, pS117, DOI 10.1016/j.radmeas.2007.01.006; Shishkina EA, 2016, RADIAT ENVIRON BIOPH, V55, P477, DOI 10.1007/s00411-016-0666-1; Simon SL, 2007, RADIAT MEAS, V42, P948, DOI 10.1016/j.radmeas.2007.05.036; Skinner AR, 2000, APPL RADIAT ISOTOPES, V52, P1311, DOI 10.1016/S0969-8043(00)00089-0; Swartz HM, 2012, HEALTH PHYS, V103, P255, DOI 10.1097/HP.0b013e3182588d92; Wieser A, 2006, RADIAT PROT DOSIM, V120, P176, DOI 10.1093/rpd/nci549; Wieser A, 2000, RADIAT MEAS, V32, P549, DOI 10.1016/S1350-4487(00)00060-3; WIESER A, 1994, APPL RADIAT ISOTOPES, V45, P525, DOI 10.1016/0969-8043(94)90119-8	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192444	10.1371/journal.pone.0192444	http://dx.doi.org/10.1371/journal.pone.0192444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408890	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800066
J	Liu, HH; Wang, JW; Li, L; Han, CC; He, H; Xu, HY				Liu, Hehe; Wang, Jiwen; Li, Liang; Han, Chunchun; He, Hua; Xu, Hengyong			Transcriptome analysis revealed the possible regulatory pathways initiating female geese broodiness within the hypothalamic-pituitary-gonadal axis	PLOS ONE			English	Article							EXPRESSION; GENES; INVOLVEMENT; GRANULOSA; FOLLICLE; OVARY; KEGG	Geese have the strongest tendency toward broodiness among all poultry. The mechanisms initiating broodiness within the goose hypothalamic-pituitary-gonadal axis (HPGA) are still unclear. Here, we reported the transcriptome differences between laying and initial nesting within the HPGA tissues of geese. We constructed a unigene database based on HPGA tissues and identified 128,148 unigenes, 100% of which have been annotated. By using Digital Gene Expression (DGE) sequencing, we screened 19, 110, 289, and 211 differentially expressed genes (DEGs) in the hypothalamus, pituitary gland, stroma ovarii, and follicles, respectively, between laying and nesting geese. Expression changes of hypocretin (HCRT) and pro-opiomelanocortin (POMC) in the hypothalamus of nesting geese may cause appetite reduction, which is possibly the first step and a prerequisite to initiate broodiness. In addition to prolactin (PRL), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), genes including oxytocin-neurophysin (OXT), chordin-like protein 1 (CHRDL1) and growth hormone (GH), expressed in the pituitary gland, are new candidate molecules that may be involved in broodiness in geese. Heme oxygenase 1 (HMOX1) in the pituitary gland, the proto-oncogene c-Fos (FOS), heat shock protein 90-alpha (HSP90AA), and cyclin-dependent kinase 1 (CDK1) in the ovary that may consolidate and transduce signals regulating the HPGA during broodiness in geese.	[Liu, Hehe; Wang, Jiwen; Li, Liang; Han, Chunchun; He, Hua; Xu, Hengyong] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, JW (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	wjw2886166@163.com	Li, Liang/AAG-7614-2020	Wang, Jiwen/0000-0001-8568-7654; Li, Liang/0000-0001-9139-5025				[Anonymous], [No title captured]; Chen F, 2014, MOL BIOL REP, V41, P2767, DOI 10.1007/s11033-014-3131-8; Chou YY, 2013, INT J GYNECOL CANCER, V23, P343, DOI 10.1097/IGC.0b013e31827eaa78; Chu SC, 2014, BRIT J PHARMACOL, V171, P3223, DOI 10.1111/bph.12667; Cyrdepauw C, 2016, MOL CELLULAR BIOL; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Fukunaka Y, 2007, NEUROMOL MED, V9, P292, DOI 10.1007/s12017-007-8001-2; Gajjar K, 2012, CANCER LETT, V324, P13, DOI 10.1016/j.canlet.2012.04.021; Gao GL, 2015, ANIM SCI J, V86, P800, DOI 10.1111/asj.12356; Geng AL, 2014, BRIT POULTRY SCI, V55, P264, DOI 10.1080/00071668.2013.878782; Goldman S, 2004, FRONT BIOSCI-LANDMRK, V9, P2474, DOI 10.2741/1409; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hocking P, 2009, BIOL BREEDING POULTR, P243; Hummel S, 2004, J BIOL CHEM, V279, P23486, DOI 10.1074/jbc.M312694200; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Jones BE, 2013, SLEEP, V36, P1769, DOI 10.5665/sleep.3188; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Luan XH, 2014, MOL BIOL REP, V41, P3401, DOI 10.1007/s11033-014-3202-x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; Qi X, 2013, PLOS ONE, V8; Qi X, 2014, PLOS ONE, V9; Shimizu T, 2009, ANIM REPROD SCI, V116, P28, DOI 10.1016/j.anireprosci.2009.01.009; SOLOFF MS, 1977, FED PROC, V36, P1861; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Thakur S, 2015, J NEUROENDOCRINOL, V14, P364; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Vanderhyden B, 2002, FRONT BIOSCI-LANDMRK, V7, pD2006, DOI 10.2741/vander; Wagener FADTG, 2008, ARTHRITIS RHEUM, V58, P3388, DOI 10.1002/art.23970; Wang GY, 2005, J FUJIAN AGR FORESTR; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WITKIN JW, 1994, ENDOCRINOLOGY, V135, P956, DOI 10.1210/en.135.3.956; Yen CF, 2006, POULTRY SCI, V85, P2265, DOI 10.1093/ps/85.12.2265; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	42	16	19	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191213	10.1371/journal.pone.0191213	http://dx.doi.org/10.1371/journal.pone.0191213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408859	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800012
J	Sparks, ME; Bottner-Parker, KD; Gundersen-Rindal, DE; Lee, IM				Sparks, Michael E.; Bottner-Parker, Kristi D.; Gundersen-Rindal, Dawn E.; Lee, Ing-Ming			Draft genome sequence of the New Jersey aster yellows strain of 'Candidatus Phytoplasma asteris'	PLOS ONE			English	Article							PROTEIN; CLASSIFICATION; GENERATION; PREDICTION; ELEMENTS; INSECT	The NJAY (New Jersey aster yellows) strain of Candidatus Phytoplasma asteris' is a significant plant pathogen responsible for causing severe lettuce yellows in the U.S. state of New Jersey. A draft genome sequence was prepared for this organism. A total of 177,847 reads were assembled into 75 contigs > 518 bp with a total base value of 652,092 and an overall [G+C] content of 27.1%. A total of 733 protein coding genes were identified. This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession MAPF00000000. This draft genome was used for genome- and gene-based comparative phylogenetic analyses with other phytoplasmas, including the closely related 'Ca. Phytoplasma asteris' strain, aster yellows witches'-broom (AY-WB). NJAY and AY-WB exhibit approximately 0.5% dissimilarity at the nucleotide level among their shared genomic segments. Evidence indicated that NJAY harbors four plasmids homologous to those known to encode pathogenicity determinants in AY-WB, as well as a chromosome-encoded mobile unit. Apparent NJAY orthologs to the important AY-WB virulence factors, SAP11 and SAP54, were identified. A number of secreted proteins, both membrane-bound and soluble, were encoded, with many bearing similarity to known AY-WB effector molecules and others representing possible secreted proteins that may be novel to the NJAY lineage.	[Sparks, Michael E.; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Bottner-Parker, Kristi D.; Lee, Ing-Ming] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Lee, IM (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	ingming.lee@ars.usda.gov		Sparks, Michael/0000-0001-6251-8559				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen MT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-529; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chang SH, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01398-15; Chen WJ, 2014, 2014 INTERNATIONAL SYMPOSIUM ON ANTENNAS AND PROPAGATION (ISAP), P9, DOI 10.1109/ISANP.2014.7026484; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00297-16; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GUNDERSEN DE, 1994, J BACTERIOL, V176, P5244, DOI 10.1128/JB.176.17.5244-5254.1994; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kakizawa S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00944-14; KUBE M, 2008, BMC GENOMICS, V9, P5040; Lee I. M., 1988, Molecular Plant-Microbe Interactions, V1, P303, DOI 10.1094/MPMI-1-303; Lee IM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01117-15; Lee IM, 2004, INT J SYST EVOL MICR, V54, P1037, DOI 10.1099/ijs.0.02843-0; LEE IM, 1992, PHYTOPATHOLOGY, V82, P977, DOI 10.1094/Phyto-82-977; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; LEE IM, 1983, PHYTOPATHOLOGY, V73, P1540, DOI 10.1094/Phyto-73-1540; LIN CP, 1986, PHYTOPATHOLOGY, V76, P45, DOI 10.1094/Phyto-76-45; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitrovic J, 2014, J MOL MICROB BIOTECH, V24, P1, DOI 10.1159/000353904; Orlovskis Z, 2017, ANN BOT-LONDON, V119, P869, DOI 10.1093/aob/mcw213; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Porollo A, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-19; Quaglino F, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0487-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Zamorano A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00602-16; Zhao Y, 2016, INT J SYST EVOL MICR, V66, P2121, DOI 10.1099/ijsem.0.000999; Zhu YZ, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00430-17	43	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192379	10.1371/journalpone.0192379	http://dx.doi.org/10.1371/journalpone.0192379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408883				2022-12-27	WOS:000424302800059
J	You, JC; Stephens, GS; Fu, CH; Zhang, XH; Liu, Y; Chin, J				You, Jason C.; Stephens, Gabriel S.; Fu, Chia-Hsuan; Zhang, Xiaohong; Liu, Yin; Chin, Jeannie			Genome-wide profiling reveals functional diversification of Delta FosB gene targets in the hippocampus of an Alzheimer's disease mouse model	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; NEURONAL-ACTIVITY; EXPRESSION; INDUCTION; ASEF2; BRAIN; IDENTIFICATION; DYSFUNCTION; IMPAIRMENTS; ACTIVATION	The activity-induced transcription factor Delta FosB has been implicated in Alzheimer's disease (AD) as a critical regulator of hippocampal function and cognition downstream of seizures and network hyperexcitability. With its long half-life (> 1 week), Delta FosB is well-poised to modulate hippocampal gene expression over extended periods of time, enabling effects to persist even during seizure-free periods. However, the transcriptional mechanisms by which Delta FosB regulates hippocampal function are poorly understood due to lack of identified hippocampal gene targets. To identify putative Delta FosB gene targets, we employed high-throughput sequencing of genomic DNA bound to Delta FosB after chromatin immunoprecipitation (ChIP-sequencing). We compared ChIP-sequencing results from hippocampi of transgenic mice expressing mutant human amyloid precursor protein (APP) and nontransgenic (NTG) wild-type littermates. Surprisingly, only 52 Delta FosB gene targets were shared between NTG and APP mice; the vast majority of targets were unique to one genotype or the other. We also found a functional shift in the repertoire of Delta FosB gene targets between NTG and APP mice. A large number of targets in NTG mice are involved in neurodevelopment and/or cell morphogenesis, whereas in APP mice there is an enrichment of targets involved in regulation of membrane potential and neuronal excitability. RNA-sequencing and quantitative PCR experiments confirmed that expression of putative Delta FosB gene targets were altered in the hippocampus of APP mice. This study provides key insights into functional domains regulated by Delta FosB in the hippocampus, emphasizing remarkably different programs of gene regulation under physiological and pathological conditions.	[You, Jason C.; Zhang, Xiaohong] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Zhang, Xiaohong] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Stephens, Gabriel S.; Fu, Chia-Hsuan; Chin, Jeannie] Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Liu, Yin] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX USA	Jefferson University; Jefferson University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Chin, J (corresponding author), Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, Houston, TX 77030 USA.	Jeannie.Chin@bcm.edu		Fu, Chia-Hsuan/0000-0002-0905-8917; Chin, Jeannie/0000-0001-9902-3744; Stephens, Gabriel/0000-0001-5665-4482	National Institute of Neurological Disorders and Stroke [NS085171, NS086965]; National Institute on Aging [AG048710]; Margaret Q. Landenberger Biomedical Research Foundation; Hassel Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085171, R01NS086965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG048710] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Margaret Q. Landenberger Biomedical Research Foundation; Hassel Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Neurological Disorders and Stroke NS085171 to JC; National Institute on Aging AG048710 to JCY; Margaret Q. Landenberger Biomedical Research Foundation research grant to JC; Hassel Family Foundation research grant to JC; National Institute of Neurological Disorders and Stroke NS086965 to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagini G, 2005, NEUROMOL MED, V7, P325, DOI 10.1385/NMM:7:4:325; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Corbett BF, 2017, CELL REP, V20, P344, DOI 10.1016/j.celrep.2017.06.040; Curia G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00046; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Eagle AL, 2015, J NEUROSCI, V35, P13773, DOI 10.1523/JNEUROSCI.2083-15.2015; Evans JC, 2015, J BIOL CHEM, V290, P10295, DOI 10.1074/jbc.M114.605543; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koberstein JN, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan6500; Kurushima H, 2005, CELL DEATH DIFFER, V12, P1078, DOI 10.1038/sj.cdd.4401648; Minatohara Keiichiro, 2015, Front Mol Neurosci, V8, P78, DOI 10.3389/fnmol.2015.00078; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Ulery-Reynolds PG, 2009, NEUROSCIENCE, V158, P369, DOI 10.1016/j.neuroscience.2008.10.059; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang Y, 2017, NEURON, V95, P1103, DOI 10.1016/j.neuron.2017.08.010	49	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192508	10.1371/journal.pone.0192508	http://dx.doi.org/10.1371/journal.pone.0192508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408867	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800075
J	Koizumi, K; Tayama, J; Ishioka, T; Nakamura-Thomas, H; Suzuki, M; Hara, M; Makita, S; Hamaguchi, T				Koizumi, Kohei; Tayama, Jun; Ishioka, Toshiyuki; Nakamura-Thomas, Hiromi; Suzuki, Makoto; Hara, Motohiko; Makita, Shigeru; Hamaguchi, Toyohiro			Anxiety, fatigue, and attentional bias toward threat in patients with hematopoietic tumors	PLOS ONE			English	Article							FACIAL EXPRESSION RECOGNITION; RANDOMIZED CONTROLLED-TRIAL; CANCER-PATIENTS; PSYCHOLOGICAL DISTRESS; EMOTIONAL DISORDERS; SELECTIVE ATTENTION; TERMINALLY-ILL; BREAST-CANCER; DEPRESSION; INFORMATION	Cancer patients with hematopoietic tumors exhibit particularly high rates of anxiety disorders and depression, and often develop negative affect. In addition, psychological problems experienced by cancer patients impair their quality of life. When cancer patients feel anxious, they tend to direct their attention toward stimuli associated with threat in the surrounding environment. If attentional bias occurs in patients with hematopoietic tumors, who are at particular risk of developing negative affect, resolution of the bias could be useful in alleviating their anxiety. The current study examined the association between attentional bias and negative affect in patients with hematopoietic tumors and tested the hypothesis that negative affect would be more severe in those who exhibited greater attentional bias. Twenty-seven patients with hematopoietic tumors participated in the study. Reaction time (RT) was measured as the time between the presentation of the threatening and neutral images, and the subject's button press to indicate choice (neutral expressions). Eight combinations of "threatening" expressions with high emotional valence and "neutral" expressions with low emotional valence were presented. The images used to measure attentional bias were taken from the Japanese Female Facial Expression Database and had been rated as expressive of anger, sadness, or neutrality, with predetermined emotional valence. Psychological testing was performed with the Profile of Mood States (POMS). To examine the association between attentional bias and negative affect, we calculated Spearman's rank correlation coefficients for RTs and POMS. Subjects' mean RT was 882.9 (SD = 100.9) ms, and 19 of the 27 subjects exhibited slower RTs relative to healthy individuals. RT was significantly positively correlated with Tension-Anxiety (r = .679, p < .01) and Fatigue (r = .585, p < .01) subscale scores. The results of the study suggested that attentional bias toward threatening expressions could be positively correlated with the mental intensity of anxiety and fatigue in patients with hematopoietic tumors.	[Koizumi, Kohei; Ishioka, Toshiyuki; Nakamura-Thomas, Hiromi; Suzuki, Makoto; Hamaguchi, Toyohiro] Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Occupat Therapy, Koshigaya, Saitama, Japan; [Koizumi, Kohei; Makita, Shigeru] Saitama Med Univ, Saitama Int Med Ctr, Dept Cardiac Rehabil, Hidaka, Saitama, Japan; [Tayama, Jun] Nagasaki Univ, Grad Sch Educ, Nagasaki, Japan; [Hara, Motohiko] Saitama Prefectural Univ, Sch Hlth & Social Serv, Koshigaya, Saitama, Japan	Saitama Medical University; Nagasaki University	Hamaguchi, T (corresponding author), Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Occupat Therapy, Koshigaya, Saitama, Japan.	hamaguchi-toyohiro@spu.ac.jp	Hamaguchi, Toyohiro/J-4911-2019; Hamaguchi, Toyohiro/AAG-7808-2020	Ishioka, Toshiyuki/0000-0002-3987-0383; Hamaguchi, Toyohiro/0000-0001-5645-0439; Tayama, Jun/0000-0002-4689-6880	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15K01657]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP15K01657 to TH. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K01657/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; AKABAYASHI A, 1991, Japanese Journal of Psychosomatic Medicine, V31, P577; Akechi T, 2006, J PAIN SYMPTOM MANAG, V31, P5, DOI 10.1016/j.jpainsymman.2005.05.016; Akechi T, 2011, PSYCHO-ONCOLOGY, V20, P497, DOI 10.1002/pon.1757; ALEXANDER PJ, 1993, ACTA ONCOL, V32, P623, DOI 10.3109/02841869309092441; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Butow P, 2015, PSYCHO-ONCOLOGY, V24, P416, DOI 10.1002/pon.3659; Cassileth BR, 2003, CANCER, V98, P2723, DOI 10.1002/cncr.11842; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clinton-McHarg T, 2014, J AFFECT DISORDERS, V165, P176, DOI 10.1016/j.jad.2014.04.072; Courneya KS, 2000, PSYCHO-ONCOLOGY, V9, P127, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<127::AID-PON438>3.0.CO;2-L; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; Dailey MN, 2010, EMOTION, V10, P874, DOI 10.1037/a0020019; Deimling GT, 2006, PSYCHO-ONCOL, V15, P306, DOI 10.1002/pon.955; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eldar S, 2012, AM J PSYCHIAT, V169, P213, DOI 10.1176/appi.ajp.2011.11060886; Erblich J, 2003, HEALTH PSYCHOL, V22, P235, DOI 10.1037/0278-6133.22.3.235; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Guidelines for Cancer Rehabilitation, 2013, THE JAPANESE ASSOCIA, P113; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hankin BL, 2010, J ABNORM PSYCHOL, V119, P491, DOI 10.1037/a0019609; Hirai K, 2015, EUR J ONCOL NURS, V19, P427, DOI 10.1016/j.ejon.2014.12.004; Hou R, 2008, J PSYCHOSOM RES, V65, P47, DOI 10.1016/j.jpsychores.2008.03.008; Hou RH, 2014, BEHAV RES THER, V52, P9, DOI 10.1016/j.brat.2013.10.005; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Inui K, 2006, J NEUROPHYSIOL, V96, P775, DOI 10.1152/jn.00103.2006; Kopp M, 2001, EUR J HAEMATOL, V67, P54, DOI 10.1034/j.1600-0609.2001.067001054.x; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MAUNSELL E, 1992, CANCER-AM CANCER SOC, V70, P120, DOI 10.1002/1097-0142(19920701)70:1<120::AID-CNCR2820700120>3.0.CO;2-U; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mohlman J, 2013, J ANXIETY DISORD, V27, P585, DOI 10.1016/j.janxdis.2013.06.005; Musa C, 2003, BEHAV RES THER, V41, P1043, DOI 10.1016/S0005-7967(02)00212-7; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Patel Salil H, 2005, Int J Med Sci, V2, P147; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Tashiro M, 2001, PSYCHO-ONCOL, V10, P541, DOI 10.1002/pon.548; Traeger L, 2012, J CLIN ONCOL, V30, P1197, DOI 10.1200/JCO.2011.39.5632; Valstar MF, 2012, IEEE T SYST MAN CY B, V42, P966, DOI 10.1109/TSMCB.2012.2200675; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Yokoyama K, 1990, Nihon Koshu Eisei Zasshi, V37, P913; Yokoyama K, 1990, Sangyo Igaku, V32, P354; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x	52	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192056	10.1371/journal.pone.0192056	http://dx.doi.org/10.1371/journal.pone.0192056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401504	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400033
J	Moewis, P; Checa, S; Kutzner, I; Hommel, H; Duda, GN				Moewis, Philippe; Checa, Sara; Kutzner, Ines; Hommel, Hagen; Duda, Georg N.			Physiological joint line total knee arthroplasty designs are especially sensitive to rotational placement - A finite element analysis	PLOS ONE			English	Article							CONTACT STRESS-ANALYSIS; ALIGNMENT; REPLACEMENT; COMPONENT; VARUS; MALALIGNMENT; INSTRUMENTS; PROSTHESES; LIGAMENT; FAILURE	Mechanical and kinematical aligning techniques are the usual positioning methods during total knee arthroplasty. However, alteration of the physiological joint line and unbalanced medio-lateral load distribution are considered disadvantages in the mechanical and kinematical techniques, respectively. The aim of this study was to analyse the influence of the joint line on the strain and stress distributions in an implanted knee and their sensitivity to rotational mal-alignment. Finite element calculations were conducted to analyse the stresses in the PE-Inlay and the mechanical strains at the bone side of the tibia component-tibia bone interface during normal positioning of the components and internal and external mal-rotation of the tibial component. Two designs were included, a horizontal and a physiological implant. The loading conditions are based on internal knee joint loads during walking. A medialization of the stresses on the PE-Inlay was observed in the physiological implant in a normal position, accompanied by higher stresses in the mal-rotated positions. Within the tibia component-tibia bone interface, similar strain distributions were observed in both implant geometries in the normal position. However, a medialization of the strains was observed in the physiological implant in both mal-rotated conditions with greater bone volume affected by higher strains. Although evident changes due to mal-rotation were observed, the stresses do not suggest a local plastic deformation of the PE-Inlay. The strains values within most of the tibia component-tibia bone interface were in the physiological strain zone and no significant bone changes would be expected. The physiological cut on the articular aspect showed no detrimental effect compared to the horizontal implant.	[Moewis, Philippe; Checa, Sara; Kutzner, Ines; Duda, Georg N.] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Hommel, Hagen] Krankenhaus Markisch Oderland GmbH, Klin Orthopadie & Unfallchirurg, Strausberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Moewis, P (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.	philippe.moewis@charite.de	; Duda, Georg/H-2085-2016	Moewis, Philippe/0000-0002-0957-6300; Checa, Sara/0000-0002-1444-5858; Duda, Georg/0000-0001-7605-3908; Hommel, Hagen/0000-0002-5400-482X	German Federal Ministry of Education and Research [BMBF 01EC1408A]; EFRE [16409608]; German Research Foundation (DFG); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EFRE; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	This work was supported by the German Federal Ministry of Education and Research (BMBF 01EC1408A; Overload-PrevOP SPO3 and SPO5) and EFRE (16409608, OrthoLoadLab). The CAD Models for the analyses were provided by OHST AG. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akasaki Y, 2008, J ARTHROPLASTY, V23, P736, DOI 10.1016/j.arth.2007.05.023; Au AG, 2005, MED ENG PHYS, V27, P123, DOI 10.1016/j.medengphy.2004.09.010; Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Basso N, 2002, BONE, V30, P347, DOI 10.1016/S8756-3282(01)00678-0; Bedard M, 2011, CLIN ORTHOP RELAT R, V469, P2346, DOI 10.1007/s11999-011-1889-8; Bellemans J, 2012, CLIN ORTHOP RELAT R, V470, P45, DOI 10.1007/s11999-011-1936-5; Benjamin James, 2006, Instr Course Lect, V55, P405; Berger RA, 1998, CLIN ORTHOP RELAT R, P144, DOI 10.1097/00003086-199811000-00021; Cristofolini L, 2010, J BIOMECH, V43, P826, DOI 10.1016/j.jbiomech.2009.11.022; D'Lima DD, 2001, CLIN ORTHOP RELAT R, P232; Daniilidis K, 2014, INT ORTHOP, V38, P503, DOI 10.1007/s00264-013-2028-9; Dixon MC, 2005, J BONE JOINT SURG AM, V87A, P598, DOI 10.2106/JBJS.C.00591; Dossett HG, 2012, ORTHOPEDICS, V35, pE160, DOI 10.3928/01477447-20120123-04; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Fukuoka S, 2000, J BONE JOINT SURG BR, V82B, P222, DOI 10.1302/0301-620X.82B2.9461; Gu Y, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00306; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Howell SM, 2008, ORTHOPEDICS, V31, P857, DOI 10.3928/01477447-20080901-15; Howell SM, 2013, KNEE SURG SPORT TR A, V21, P2271, DOI 10.1007/s00167-013-2621-x; Howell SM, 2013, CLIN ORTHOP RELAT R, V471, P1000, DOI 10.1007/s11999-012-2613-z; Howell SM, 2010, CLIN ORTHOP RELAT R, V468, P1142, DOI 10.1007/s11999-009-0984-6; Howell SM, 2010, J BONE JOINT SURG AM, V92A, P98, DOI 10.2106/JBJS.H.01566; HSU RWW, 1990, CLIN ORTHOP RELAT R, P215; Hutt J, 2016, INT ORTHOP, V40, P29, DOI 10.1007/s00264-015-2733-7; Juszczyk MM, 2011, J BIOMECH, V44, P2259, DOI 10.1016/j.jbiomech.2011.05.038; Krackow KA, 1999, ORTHOPEDICS, V22, P698; Kusz D, 2008, ACTA BIOENG BIOMECH, V10, P21; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Levangie PKaCCN, JOINT STRUCTURE FUNC; Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7; Ma HM, 2005, J ARTHROPLASTY, V20, P580, DOI 10.1016/j.arth.2005.04.006; Maratt JD, 2015, J ARTHROPLASTY, V30, P1142, DOI 10.1016/j.arth.2015.01.039; Matsuda S, 1998, J ARTHROPLASTY, V13, P699, DOI 10.1016/S0883-5403(98)80016-8; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Nicoll D, 2010, J BONE JOINT SURG BR, V92B, P1238, DOI 10.1302/0301-620X.92B9.23516; Perillo-Marcone A, 2007, J BIOMECH ENG-T ASME, V129, P1, DOI 10.1115/1.2401177; Sikorski JM, 2008, J BONE JOINT SURG BR, V90B, P1121, DOI 10.1302/0301-620X.90B9.20793; Soininvaara TA, 2002, CALCIFIED TISSUE INT, V71, P472, DOI 10.1007/s00223-002-1022-9; Vanlommel L, 2013, KNEE SURG SPORT TR A, V21, P2325, DOI 10.1007/s00167-013-2481-4; Viceconti M, 2005, CLIN BIOMECH, V20, P451, DOI 10.1016/j.clinbiomech.2005.01.010; Victor JMK, 2014, CLIN ORTHOP RELAT R, V472, P98, DOI 10.1007/s11999-013-2898-6; Young SW, 2016, CLIN ORTHOP RELAT RE	42	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192225	10.1371/journal.pone.0192225	http://dx.doi.org/10.1371/journal.pone.0192225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401510	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400043
J	Zhang, R; Pu, WY; Zhang, SY; Chen, L; Zhu, WP; Xiao, L; Xing, CG; Li, K				Zhang, Rong; Pu, Wangyang; Zhang, Shuyun; Chen, Li; Zhu, Weipei; Xiao, Li; Xing, Chungen; Li, Kai			Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial	PLOS ONE			English	Article							PLASMA DNA INTEGRITY; CELL-FREE DNA; TUMOR DNA; HYPERMETHYLATION; SERUM	CA125 amounts have a large overlap in ovarian cancer and benign diseases. We conducted a retrospective cohort trial to assess the clinical value of circulating cell-free DNA concentration and integrity index for the diagnosis of ovarian cancer. A total of 150 patients were recruited. Plasma samples of 24 ovarian cancer patients, 12 benign ovarian cysts, and 12 healthy controls were assessed. By amplifying short ALU-115 repeat and long ALU-219 fragments, circulating cell-free DNA concentrations and integrity index were measured. Plasma ALU-219 fragment levels and integrity index were significantly higher in the ovarian cancer group compared with the benign disease and healthy control groups (p = 0.023 and p = 0.004, respectively). These findings indicated that plasma ALU-219 levels and integrity may have a clinical value in the early diagnosis of ovarian cancer.	[Zhang, Rong; Zhang, Shuyun; Chen, Li; Zhu, Weipei] Soochow Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Suzhou, Peoples R China; [Pu, Wangyang] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Peoples R China; [Xiao, Li; Li, Kai] Soochow Univ, Affiliated Hosp 2, Dept Mol Med Ctr, Suzhou, Peoples R China; [Xing, Chungen] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Li, K (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Mol Med Ctr, Suzhou, Peoples R China.; Xing, CG (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China.	xingcg@126.com; kaili34@yahoo.com			National Natural Science Foundation of China [81301267]; Suzhou Science and Technology Development Program [SZS201618]; research foundation of the Second Affiliated Hospital of Soochow University [SDFEYQN201302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Program; research foundation of the Second Affiliated Hospital of Soochow University	We acknowledge the financial supports of the National Natural Science Foundation of China (No. 81301267), the Suzhou Science and Technology Development Program (SZS201618), and the research foundation of the Second Affiliated Hospital of Soochow University (SDFEYQN201302) (S4 File). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2014, GYNECOL ONCOL, V132, P462, DOI 10.1016/j.ygyno.2013.12.024; Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Chiang PW, 1999, CLIN CANCER RES, V5, P1381; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Madhavan D, 2014, BREAST CANCER RES TR, V146, P163, DOI 10.1007/s10549-014-2946-2; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Moss EL, 2005, J CLIN PATHOL, V58, P308, DOI 10.1136/jcp.2004.018077; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Pu WY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2977-7; Salani R, 2007, CLIN CANCER RES, V13, P5805, DOI 10.1158/1078-0432.CCR-07-0853; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x; Wang BG, 2003, CANCER RES, V63, P3966; Zane M, 2013, BIOMED PHARMACOTHER, V67, P723, DOI 10.1016/j.biopha.2013.06.007	16	20	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191756	10.1371/journal.pone.0191756	http://dx.doi.org/10.1371/journal.pone.0191756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401471	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400018
J	Ebner-Karestinos, D; Flament, B; Arnould, C; Thonnard, JL; Bleyenheuft, Y				Ebner-Karestinos, Daniela; Flament, Benoit; Arnould, Carlyne; Thonnard, Jean-Louis; Bleyenheuft, Yannick			Precision grip control while walking down a step in children with unilateral cerebral palsy	PLOS ONE			English	Article							FINGERTIP FORCES; OBJECT MANIPULATION; DISCRETE MOVEMENTS; BASIC COORDINATION; MOTOR CONTROL; HABIT-ILE; HAND; MUSCLE; RELIABILITY; HEMIPLEGIA	Aim To compare grip force (GF) and load force (LF) coordination while walking down a step between children with unilateral cerebral palsy (UCP) and typically developing (TD) children. Methods Twenty-five children with UCP (age 9.3 +/- 1.7 y) and 25 TD controls (age 9.4 +/- 2.1 y) walked down a step while holding a grip-lift manipulandum. Dynamic and temporal variables were analyzed. The maximum voluntary contraction (MVC) was also assessed. Results The temporal course was perturbed mainly in the more affected hand of children with UCP when compared to TD children because the increases in GF and LF onset occurred in a reversed order. Compared with the TD controls, the children with UCP presented higher LF values on both hands and a higher GF on the less affected hand. In children with UCP, the GF to LF adaptation was adequate on the less affected hand but overestimated on the more affected hand. Furthermore, children with UCP presented a lower MVC in the more affected hand, leading to a higher percentage of MVC used during the task. Interpretation Our findings highlight an anticipatory control of precision grip during a stepping down task in children with UCP that is adequate for the less affected hand but altered for the more affected hand.	[Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci IoNS, Brussels, Belgium; [Flament, Benoit; Arnould, Carlyne] Haute Ecole Louvain Hainaut, Phys Therapy Dept, Paramed Category, Montignies Sur Sambre, Belgium; [Flament, Benoit; Arnould, Carlyne] Haute Ecole Louvain Hainaut, Occupat Therapy Dept, Paramed Category, Montignies Sur Sambre, Belgium; [Thonnard, Jean-Louis] Clin Univ St Luc, Phys & Rehabil Med Dept, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Bleyenheuft, Y (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Brussels, Belgium.	yannick.bleyenheuft@uclouvain.be	Bleyenheuft, Yannick/ABA-1472-2021; Arnould, Carlyne/AAI-3111-2020	Bleyenheuft, Yannick/0000-0002-6688-932X; Ebner Karestinos, Daniela/0000-0002-5941-8706				Bernshtein NA, 1967, COORDINATION REGULAT, Vxii; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; Bleyenheuft Y, 2015, NEUROREHAB NEURAL RE, V29, P645, DOI 10.1177/1545968314562109; Bleyenheuft Y, 2014, PHYS OCCUP THER PEDI, V34, P390, DOI 10.3109/01942638.2014.932884; Bleyenheuft Y, 2010, NEUROREHAB NEURAL RE, V24, P318, DOI 10.1177/1545968309353327; Bleyenheuft Y, 2009, J MOTOR BEHAV, V41, P411, DOI 10.3200/35-08-084; Ebner-Karestinos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165549; ELIASSON AC, 1992, DEV MED CHILD NEUROL, V34, P216; ELIASSON AC, 1991, DEV MED CHILD NEUROL, V33, P661; ELIASSON AC, 1995, EXP BRAIN RES, V106, P425; Eliasson AC, 2006, PEDIATRICS, V118, pE1226, DOI 10.1542/peds.2005-2768; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Forssberg H, 1999, BRAIN, V122, P1157, DOI 10.1093/brain/122.6.1157; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Gordon AM, 1999, DEV MED CHILD NEUROL, V41, P176, DOI 10.1017/S0012162299000365; Gordon AM, 1999, DEV MED CHILD NEUROL, V41, P166, DOI 10.1017/S0012162299000353; Gordon AM, 2006, PEDIATR RES, V60, P587, DOI 10.1203/01.pdr.0000242370.41469.74; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Gysin P, 2009, SENSORIMOTOR CONTROL, pxiv; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Howard IS, 2011, J NEUROPHYSIOL, V105, P1722, DOI 10.1152/jn.00780.2010; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Meyns P, 2011, RES DEV DISABIL, V32, P1957, DOI 10.1016/j.ridd.2011.03.029; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Prabhu SB, 2011, DEV MED CHILD NEUROL, V53, P865, DOI 10.1111/j.1469-8749.2011.04061.x; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Smits-Engelsman BCM, 2005, DEV MED CHILD NEUROL, V47, P337, DOI 10.1017/S0012162205000630; Steenbergen B, 1998, DEV MED CHILD NEUROL, V40, P108; Steenbergen B, 2008, EXP BRAIN RES, V186, P191, DOI 10.1007/s00221-007-1223-6; Steenbergen B, 2013, DEV MED CHILD NEUROL, V55, P43, DOI 10.1111/dmcn.12306; UVEBRANT P, 1988, ACTA PAEDIATR SCAND, P1; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	38	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191684	10.1371/journal.pone.0191684	http://dx.doi.org/10.1371/journal.pone.0191684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390012	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400027
J	Rasch, V; Van, TN; Nguyen, HTT; Manongi, R; Mushi, D; Meyrowitsch, DW; Gammeltoft, T; Sen Wu, C				Rasch, Vibeke; Toan Ngo Van; Hanh Thi Thuy Nguyen; Manongi, Rachel; Mushi, Declare; Meyrowitsch, Dan W.; Gammeltoft, Tine; Sen Wu, Chun			Intimate partner violence (IPV): The validity of an IPV screening instrument utilized among pregnant women in Tanzania and Vietnam	PLOS ONE			English	Article							HEALTH; PREVALENCE	Background Intimate partner violence (IPV) is a global problem that affects one-third of all women. The present study aims to develop and determine the validity of a screening instrument for the detection of IPV in pregnant women in Tanzania and Vietnam and to determine the minimum number of questions needed to identify IPV. Method An IPV screening instrument based on eight questions was tested on 1,116 Tanzanian and 1,309 Vietnamese women who attended antenatal care before 24 gestational weeks. The women were re-interviewed during their 30th-34th gestational week where the World Health Organization (WHO) IPV questionnaire was used as the gold standard. In all, 255 combinations of eight different questions were first tested on the Tanzanian study population where sensitivity, specificity, positive predictive value, negative predictive value and accuracy were calculated. In the evaluation of the performance of the question combinations, different IPV types and the frequency of abusive acts were considered. The question combinations that performed best in Tanzania were subsequently evaluated in the Vietnamese study population. Results In Tanzania, a combination of three selected questions including one question on emotional IPV, one on physical IPV and one on sexual IPV was found to be most effective in identifying women who are exposed to at least one type of IPV during pregnancy (sensitivity = .80; specificity = .74). The performance of the identified combination was slightly less effective in Vietnam (sensitivity = .74; specificity = .68). Focusing on different IPV types, the best performance was found for exposure to physical IPV in both Tanzania (sensitivity = .93; specificity = .70) and Vietnam (sensitivity = .96; specificity = .55). In both countries, the sensitivity increased with the frequency of abuse whereas the specificity decreased. Conclusion By asking pregnant women three simple questions we were able to identify women who were exposed to IPV during pregnancy in two different countries. The question combination performed best in assessing physical IPV where it identified 93% and 96% of Vietnamese and Tanzanian women, respectively, who were exposed to physical IPV.	[Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke; Sen Wu, Chun] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Toan Ngo Van; Hanh Thi Thuy Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Manongi, Rachel; Mushi, Declare] Kilimanjaro Christian Med Univ Coll, Dept Publ Hlth, Moshi, Tanzania; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Hanoi Medical University; University of Copenhagen; University of Copenhagen	Rasch, V (corresponding author), Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark.; Rasch, V (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	vrasch@health.sdu.dk	Mushi, Declare/H-2924-2019; Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Gammeltoft, Tine Mette/0000-0002-6723-2370; Manongi, Rachel/0000-0003-3841-974X; Meyrowitsch, Dan/0000-0003-1108-8987	DANIDA (the Danish International Development Agency), as part of a larger research project, "The Impact of Violence on Reproductive Health in Tanzania and Vietnam"	DANIDA (the Danish International Development Agency), as part of a larger research project, "The Impact of Violence on Reproductive Health in Tanzania and Vietnam"	The present study was funded by DANIDA (the Danish International Development Agency), as part of a larger research project, "The Impact of Violence on Reproductive Health in Tanzania and Vietnam", with the overall aim of assessing the associations between IPV and womens reproductive health in semi-urban areas of Tanzania and Vietnam.	Altman DG., 1995, PRACTICAL STAT MED R; [Anonymous], 2009, ELEMENTS STAT LEARNI, Vsecond; Arkins B, 2016, J PSYCHIATR MENT HLT, V23, P217, DOI 10.1111/jpm.12289; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Basile H., 2007, EDITED CTR DIS CONTR; Cherniak D, 2005, INTIMATE PARTNER VIO; Donovan BM, 2016, BJOG-INT J OBSTET GY, V123, P1289, DOI 10.1111/1471-0528.13928; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2015, LANCET, V385, P1567, DOI 10.1016/S0140-6736(14)61837-7; Hussain N, 2015, TRAUMA VIOLENCE ABUS, V16, P60, DOI 10.1177/1524838013515759; Kirst M, 2012, TRAUMA VIOLENCE ABUS, V13, P198, DOI 10.1177/1524838012454942; Kraanen FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063681; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Roelens K, 2008, EUR J OBSTET GYN R B, V137, P37, DOI 10.1016/j.ejogrb.2007.04.013; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Sigalla GN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172540; Sprague S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168502; Straus Murray A, 2004, Violence Vict, V19, P507; Hoang TN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162844; Tiet QQ, 2008, CLIN PSYCHOL REV, V28, P578, DOI 10.1016/j.cpr.2007.08.002; UNICEF, 2016, UNICEF DAT MON STIU; Waltermaurer E, 2005, J INTERPERS VIOLENCE, V20, P501, DOI 10.1177/0886260504267760; Watts C., 2001, PUTTING WOMEN 1 ETHI; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2005, WHO MULT STUD WOM HL; World Health Organization, 2021, GLOB REG EST VIOL WO	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190856	10.1371/journal.pone.0190856	http://dx.doi.org/10.1371/journal.pone.0190856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389954	Green Published, gold			2022-12-27	WOS:000423793400008
J	Rudus, I; Kepczynski, J				Rudus, Izabela; Kepczynski, Jan			Reference gene selection for molecular studies of dormancy in wild oat (Avena fatua L.) caryopses by RT-qPCR method	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; TRANSCRIPTION-PCR DATA; REAL-TIME PCR; IMBIBED DORMANT; GERMINATION; IDENTIFICATION; ARABIDOPSIS; NORMALIZATION; KAR(1); ANTIOXIDANTS	Molecular studies of primary and secondary dormancy in Avena fatua L., a serious weed of cereal and other crops, are intended to reveal the species-specific details of underlying molecular mechanisms which in turn may be useable in weed management. Among others, quantitative real-time PCR (RT-qPCR) data of comparative gene expression analysis may give some insight into the involvement of particular wild oat genes in dormancy release, maintenance or induction by unfavorable conditions. To assure obtaining biologically significant results using this method, the expression stability of selected candidate reference genes in different data subsets was evaluated using four statistical algorithms i.e. geNorm, NormFinder, Best Keeper and Delta Ct method. Although some discrepancies in their ranking outputs were noticed, evidently two ubiquitin-conjugating enzyme homologs, AfUBC1 and AfUBC2, as well as one homolog of glyceraldehyde 3-phosphate dehydrogenase AfGAPDH1 and TATA-binding protein AfTBP2 appeared as more stably expressed than AfEF1a (translation elongation factor 1 alpha), AfGAPDH2 or the least stable a-tubulin homolog AfTUA1 in caryopses and seedlings of A. fatua. Gene expression analysis of a dormancy-related wild oat transcription factor VIVIPAROUS1 (AfVP1) allowed for a validation of candidate reference genes performance. Based on the obtained results it can be recommended that the normalization factor calculated as a geometric mean of Cq values of AfUBC1, AfUBC2 and AfGAPDH1 would be optimal for RT-qPCR results normalization in the experiments comprising A. fatua caryopses of different dormancy status.	[Rudus, Izabela; Kepczynski, Jan] Szczecin Univ, Dept Plant Physiol & Genet Engn, Coll Biol, Szczecin, Poland	University of Szczecin	Rudus, I (corresponding author), Szczecin Univ, Dept Plant Physiol & Genet Engn, Coll Biol, Szczecin, Poland.	izabela.rudus@usz.edu.pl		Rudus, Izabela/0000-0003-3397-0209; Kepczynski, Jan/0000-0001-7841-0710	Ministry of Science and Higher Education [NN 310 726340]; Department of Plant Physiology and Genetic Engineering, the Faculty of Biology, Szczecin University	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Department of Plant Physiology and Genetic Engineering, the Faculty of Biology, Szczecin University	The study was partly supported by the Ministry of Science and Higher Education Grant NN 310 726340 coordinated by JK and partly funded through statutory activity of the Department of Plant Physiology and Genetic Engineering, the Faculty of Biology, Szczecin University.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], POLISH RED LIST PTER; [Anonymous], 2014, J LAWS; Atwood WM, 1914, BOT GAZ, V57, P0386, DOI 10.1086/331327; Bao WL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081198; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao J, 2016, PEERJ, V4, DOI 10.7717/peerj.1697; Cembrowska-Lech D, 2016, PLANTA, V243, P531, DOI 10.1007/s00425-015-2422-1; Cembrowska-Lech D, 2015, J PLANT PHYSIOL, V176, P169, DOI 10.1016/j.jplph.2014.11.010; CEMBROWSKALECH D, 2017, ACTA PHYSL PLANT, V39; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Chen KT, 2012, PLANT MOL BIOL REP, V30, P478, DOI 10.1007/s11105-011-0354-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Daws MI, 2007, PLANT GROWTH REGUL, V51, P73, DOI 10.1007/s10725-006-9149-8; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; dos Santos LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160646; DYER WE, 1993, PHYSIOL PLANTARUM, V88, P201, DOI 10.1111/j.1399-3054.1993.tb05490.x; Fennimore SA, 1998, HEREDITY, V81, P674, DOI 10.1046/j.1365-2540.1998.00431.x; Fennimore SA, 1999, THEOR APPL GENET, V99, P711, DOI 10.1007/s001220051288; Finch-Savage W.E., 2015, ADV PLANT DORMANCY, P35, DOI [10.1007/978-3-319-14451-1_2, DOI 10.1007/978-3-319-14451-1_2]; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Holm L. G., 1977, The world's worst weeds.; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; JOHNSON RR, 1995, PLANT MOL BIOL, V28, P113, DOI 10.1007/BF00042043; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Jones HD, 2000, PLANT J, V21, P133, DOI 10.1046/j.1365-313x.2000.00662.x; Kazimierczakowa R, 2014, POLISH RED DATA BOOK; Kepczynski J, 2003, NATO SCI SER I LIFE, V349, P209; Kepczynski J, 2013, ACTA PHYSIOL PLANT, V35, P379, DOI 10.1007/s11738-012-1080-1; Kepczynski J, 2012, PLANT GROWTH REGUL, V67, P185, DOI 10.1007/s10725-012-9675-5; Kepczynski J, 2010, PLANT GROWTH REGUL, V62, P85, DOI 10.1007/s10725-010-9493-6; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Li BL, 1995, PLANT MOL BIOL, V29, P823, DOI 10.1007/BF00041171; LI BL, 1994, J EXP BOT, V45, P275, DOI 10.1093/jxb/45.2.275; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; MEDD R W, 1990, Plant Protection Quarterly, V5, P142; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; ROBLEDO D, 2014, BMC GENOMICS, V15; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudus I, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2344-y; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saraiva KDC, 2014, PLANT CELL REP, V33, P1453, DOI 10.1007/s00299-014-1628-1; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shepherd SK, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P342, DOI 10.1079/9781845931971.0342; Shu K, 2016, MOL PLANT, V9, P34, DOI 10.1016/j.molp.2015.08.010; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stevens JC, 2007, PLANT SOIL, V298, P113, DOI 10.1007/s11104-007-9344-z; SYMONS SJ, 1987, PHYSIOL PLANTARUM, V70, P419, DOI 10.1111/j.1399-3054.1987.tb02838.x; Taylor CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148300; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Wang MZ, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.012559; Wang T, 2014, J AM SOC HORTIC SCI, V139, P113, DOI 10.21273/JASHS.139.2.113; Wrzesinska B, 2016, WEED RES, V56, P284, DOI 10.1111/wre.12209	73	14	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192343	10.1371/journal.pone.0192343	http://dx.doi.org/10.1371/journal.pone.0192343			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390041	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400089
J	Santos, D; Ribeiro, GC; Cabral, AD; Speranca, MA				Santos, Daubian; Ribeiro, Guilherme Cunha; Cabral, Aline Diniz; Speranca, Marcia Aparecida			A non-destructive enzymatic method to extract DNA from arthropod specimens: Implications for morphological and molecular studies	PLOS ONE			English	Article								There is a growing necessity to integrate morphological and genetic studies. This paper proposes a new technique that allows DNA extraction of arthropods while still keeping intact the entire morphology of the specimens. The technique uses Proteinase K to dissolve protein tissues and preserve the chitinous exoskeleton of specimens. The method is fast, cheap, non-toxic, and allows for good morphological preparations of specimens retaining much of their tridimensional structure. The methodology works fine with specimens preserved in different kinds of media, such as for dry (pinned) specimens, and specimens preserved in Ethanol. In addition, it allows the extraction of DNA from fresh specimens, as well as from specimens preserved for a long time. The technique works well for morphological studies alone, but allows the generation of an associated genomic library at an individual-scale. Among the advantages of the new technique is the possibility of extracting DNA from the entire specimen (necessary for the study of diseases transmitted by arthropod vectors), while still keeping the morphology intact for correct taxonomic identification. In addition, in comparison with methods that extract DNA from small tissue samples (e.g., from legs or wings), the method allows for the extraction of a larger amount of DNA and is better suited for small specimens.	[Santos, Daubian; Ribeiro, Guilherme Cunha; Cabral, Aline Diniz; Speranca, Marcia Aparecida] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC)	Speranca, MA (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	marcia.speranca@ufabc.edu.br	Cabral, Aline Diniz/Q-8650-2019; Sperança, Márcia Aparecida/D-2310-2012; Santos, Daubian/GYR-2062-2022; Cabral, Aline Diniz/M-5779-2018	Cabral, Aline Diniz/0000-0002-9439-4463; Sperança, Márcia Aparecida/0000-0002-1178-3747; Santos, Daubian/0000-0003-1220-1267; Cabral, Aline Diniz/0000-0002-9439-4463	CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES); Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation) [2016/14514-4, 2013/26096-4]	CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES); Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation)	DS was financially supported by CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES). MAS and ADC were financially supported by Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation): grant number 2016/14514-4 and fellowship number 2013/26096-4, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bybee SM, 2010, ENTOMOLOGY, V35, P4; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x	10	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192200	10.1371/journal.pone.0192200	http://dx.doi.org/10.1371/journal.pone.0192200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390036	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400075
J	Wang, YH; Liu, SY; Dong, YM				Wang, Yahui; Liu, Siyi; Dong, Yanmei			In vitro study of dentinal tubule penetration and filling quality of bioceramic sealer	PLOS ONE			English	Article							ROOT-CANAL SEALERS; MICRO-COMPUTED TOMOGRAPHY; PHYSICAL-PROPERTIES; ENDODONTIC SEALERS; COMPACTION TECHNIQUE; MTA FILLAPEX; IROOT SP; OBTURATION; IRRIGATION; INSTRUMENTATION	This study aimed to evaluate the dentinal tubule penetration and filling quality of a bioceramic sealer (iRoot SP). Forty-two roots of extracted adult lower incisors were selected. After instrumentation with Protaper Universal to F3, 40 roots were chosen and randomly divided into 4 groups, as follows: iRoot SP single cone group, iRoot SP warm vertical group, AH Plus single cone group, and AH Plus warm vertical group. Before root canal filling, sealers were mixed with Rhodamine B dye for visualization under confocal laser scanning microscope. All samples were sectioned at 2, 4, and 6 mm to apex. Then, the percentages of void areas, gap regions, and segments of sealer that penetrated into dentinal tubules in each section were calculated. Non-parametric test was used for statistical analysis (alpha = 0.05). We found that filling techniques and types of sealer had no statistically significant effects on the occurrence of voids and gaps. The segments of iRoot SP penetrated into dentinal tubules were statistically more than that of AH Plus in both single cone and warm vertical techniques at 2 mm to apex (P < 0.05). Regardless of the filling technique used, iRoot SP can achieve comparable filling quality and better dentinal tubules penetration than AH Plus. Considering the good bioactivity of iRoot SP, it may help improve the seal of root canal system.	[Wang, Yahui; Liu, Siyi; Dong, Yanmei] Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing, Peoples R China	Peking University	Dong, YM (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing, Peoples R China.	kqdongyanmei@bjmu.edu.cn			National Natural Science Foundation of China [51372005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 51372005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 51372005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest related to this study.	Akcay M, 2016, LASER SURG MED, V48, P70, DOI 10.1002/lsm.22446; Al-Haddad A, 2015, DENT MATER J, V34, P516, DOI 10.4012/dmj.2015-049; Amoroso-Silva PA, 2014, MICROSC RES TECHNIQ, V77, P1031, DOI 10.1002/jemt.22432; Bolles JA, 2013, J ENDODONT, V39, P708, DOI 10.1016/j.joen.2013.01.006; BRANSTETTER J, 1982, J ENDODONT, V8, P312, DOI 10.1016/S0099-2399(82)80280-X; Capar ID, 2015, DENT TRAUMATOL, V31, P302, DOI 10.1111/edt.12154; Celikten B, 2016, SCANNING, V38, P133, DOI 10.1002/sca.21249; Chang SW, 2014, J ENDODONT, V40, P1642, DOI 10.1016/j.joen.2014.04.006; Craveiro MA, 2015, J ENDODONT, V41, P836, DOI 10.1016/j.joen.2015.02.017; Candeiro GTD, 2012, J ENDODONT, V38, P842, DOI 10.1016/j.joen.2012.02.029; De-Deus G, 2017, INT ENDOD J, V50, P895, DOI 10.1111/iej.12706; De-Deus G, 2012, INT ENDOD J, V45, P642, DOI 10.1111/j.1365-2591.2012.02023.x; De -Deus G, 2017, J ENDODONT, V43, P1553, DOI 10.1016/j.joen.2017.04.027; De-Deus G, 2015, J ENDODONT, V41, P1116, DOI 10.1016/j.joen.2015.02.012; De-Deus G, 2014, J ENDODONT, V40, P1447, DOI 10.1016/j.joen.2014.02.019; De-Deus G, 2011, ORAL SURG ORAL MED O, V111, P381, DOI 10.1016/j.tripleo.2010.08.020; Desai S, 2009, J ENDODONT, V35, P475, DOI 10.1016/j.joen.2008.11.026; Du TF, 2015, J ENDODONT, V41, P1294, DOI 10.1016/j.joen.2015.04.023; Ersahan S, 2013, ACTA ODONTOL SCAND, V71, P857, DOI 10.3109/00016357.2012.734410; Fernandez R, 2016, INT ENDOD J, V49, P365, DOI 10.1111/iej.12454; Ghoneim AG, 2011, J ENDODONT, V37, P1590, DOI 10.1016/j.joen.2011.08.008; Guven EP, 2013, INT ENDOD J, V46, P1173, DOI 10.1111/iej.12115; Han L, 2013, INT ENDOD J, V46, P808, DOI 10.1111/iej.12062; Heling I, 1996, J ENDODONT, V22, P257, DOI 10.1016/S0099-2399(06)80144-5; Iglecias EF, 2017, J ENDODONT, V43, P638, DOI 10.1016/j.joen.2016.11.027; Jean-Yves Blum SE, 1997, J ENDODONT, V23, P6; KAZEMI RB, 1993, ORAL SURG ORAL MED O, V76, P766, DOI 10.1016/0030-4220(93)90050-E; Kim JA, 2017, J ENDOD; Kokkas AB, 2004, J ENDODONT, V30, P100, DOI 10.1097/00004770-200402000-00009; Leonardo MR, 2000, J ENDODONT, V26, P391, DOI 10.1097/00004770-200007000-00003; LI G, 1982, ENDODONTIC PRACTICE; McMichael GE, 2016, J ENDODONT, V42, P632, DOI 10.1016/j.joen.2015.12.012; McMichen FRS, 2003, INT ENDOD J, V36, P629, DOI 10.1046/j.1365-2591.2003.00701.x; Mjor IA, 1996, ARCH ORAL BIOL, V41, P401, DOI 10.1016/0003-9969(96)00008-8; Moon YM, 2012, J ENDODONT, V38, P531, DOI 10.1016/j.joen.2011.12.008; Mukhtar-Fayyad D, 2011, ORAL SURG ORAL MED O, V112, pE137, DOI 10.1016/j.tripleo.2011.05.042; Nirupama DN, 2014, INT J BIOMATER, V2014, DOI 10.1155/2014/383756; OGUNTEBI BR, 1994, INT ENDOD J, V27, P218, DOI 10.1111/j.1365-2591.1994.tb00257.x; Ordinola-Zapata R, 2009, ORAL SURG ORAL MED O, V108, P450, DOI 10.1016/j.tripleo.2009.04.024; Orstavik D, 2001, DENT MATER, V17, P512, DOI 10.1016/S0109-5641(01)00011-2; PETERS DD, 1986, J ENDODONT, V12, P139, DOI 10.1016/S0099-2399(86)80051-6; Qu W, 2016, J ENDODONT, V42, P1829, DOI 10.1016/j.joen.2016.08.014; Ricucci D, 1998, INT ENDOD J, V31, P384; Ricucci D, 2016, J ENDODONT, V42, P243, DOI 10.1016/j.joen.2015.11.020; Song M, 2011, J ENDODONT, V37, P1516, DOI 10.1016/j.joen.2011.06.032; Stringheta CP, 2017, J ENDODONT, V43, P2102, DOI 10.1016/j.joen.2017.07.015; van der Sluis LWM, 2007, INT ENDOD J, V40, P356, DOI 10.1111/j.1365-2591.2006.01227.x; Viapiana R, 2015, INT ENDOD J, V48, P16, DOI 10.1111/iej.12271; Wu MK, 2000, INT ENDOD J, V33, P340, DOI 10.1046/j.1365-2591.2000.00309.x; Zhang H, 2009, J ENDODONT, V35, P1051, DOI 10.1016/j.joen.2009.04.022; Zhang W, 2009, ORAL SURG ORAL MED O, V107, pE79, DOI 10.1016/j.tripleo.2009.02.024; Zhou HM, 2015, J ENDODONT, V41, P56, DOI 10.1016/j.joen.2014.09.012; Zhou HM, 2013, J ENDODONT, V39, P1281, DOI 10.1016/j.joen.2013.06.012; Zoufan K, 2011, ORAL SURG ORAL MED O, V112, P657, DOI 10.1016/j.tripleo.2011.03.050	54	43	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192248	10.1371/journal.pone.0192248	http://dx.doi.org/10.1371/journal.pone.0192248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390037	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400080
J	Owens, ACS; Meyer-Rochow, VB; Yang, EC				Owens, Avalon Celeste Stevahn; Meyer-Rochow, Victor Benno; Yang, En-Cheng			Short-and mid-wavelength artificial light influences the flash signals of Aquatica ficta fireflies (Coleoptera: Lampyridae)	PLOS ONE			English	Article							PHOTINUS-PYRALIS COLEOPTERA; SPECTRAL SENSITIVITY; OPSIN GENES; SCINTILLANS COLEOPTERA; COURTSHIP FLASHES; L. COLEOPTERA; COMPOUND EYE; NOCTILUCA L.; GLOW-WORMS; EVOLUTION	Urbanization can radically disrupt natural ecosystems through alteration of the sensory environment. Habitat disturbances are predicted to favor behaviorally flexible species capable of adapting to altered environments. When artificial light at night (ALAN) is introduced into urban areas, it has the potential to impede reproduction of local firefly populations by obscuring their bioluminescent courtship signals. Whether individual fireflies can brighten their signals to maintain visibility against an illuminated background remains unknown. In this study, we exposed male Aquatica ficta fireflies to diffused light of varying wavelength and intensity, and recorded their alarm flash signals. When exposed to wavelengths at or below 533 nm, males emitted brighter signals with decreased frequency. This is the first evidence of individual-level light signal plasticity in fireflies. In contrast, long wavelength ambient light (>= 597 nm) did not affect signal morphology, likely because A. ficta cannot perceive these wavelengths. These results suggest long wavelength lighting is less likely to impact firefly courtship, and its use in place of broad spectrum white lighting could augment firefly conservation efforts. More generally, this study demonstrates benefits of bioluminescent signal plasticity in a "noisy" signaling environment, and sheds light on an important yet understudied consequence of urbanization.	[Owens, Avalon Celeste Stevahn] Tufts Univ, Dept Biol, Medford, MA USA; [Meyer-Rochow, Victor Benno] Oulu Univ, Dept Genet & Physiol, Oulu, Finland; [Meyer-Rochow, Victor Benno] Res Inst Luminous Organisms, Tokyo, Japan; [Yang, En-Cheng] Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan	Tufts University; University of Oulu; National Taiwan University	Yang, EC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan.	ecyang@ntu.edu.tw	MEYER-ROCHOW, Victor Benno/AAJ-7258-2020	Owens, Avalon/0000-0001-7212-2275	Friends of Da'an Forest Park Foundation [FD97011]; Friends of Da'an Forest Park Foundation	Friends of Da'an Forest Park Foundation; Friends of Da'an Forest Park Foundation	Funding for firefly research provided to National Taiwan University by the Friends of Da'an Forest Park Foundation (http://www.daanforestpark.org.tw/ - grant number: FD97011). Some funding was allocated to ECY's laboratory, and used by ECY and ACSO to purchase experimental equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Leo Jeng and Phil Suslow for technical support, Duncan Wright for assistance with data collection, and Dr. Sara Lewis (Tufts University), Dr. Christian Wegener, and one anonymous reviewer for valuable comments on the manuscript. This study was supported by a grant from the Friends of Da'an Forest Park Foundation to ACSO and ECY.	Adams C.E., 2016, URBAN WILDLIFE MANAG, Vthird; Alberti M, 2015, TRENDS ECOL EVOL, V30, P114, DOI 10.1016/j.tree.2014.11.007; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bird S, 2014, J INSECT CONSERV, V18, P737, DOI 10.1007/s10841-014-9664-2; Booth D, 2004, J EXP BIOL, V207, P2373, DOI 10.1242/jeb.01044; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; BUCK JOHN BONNER, 1937, PHYSIOL ZOOL, V10, P45; Case JF, 2004, INTEGR COMP BIOL, V44, P250, DOI 10.1093/icb/44.3.250; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Cratsley CK, 2003, BEHAV ECOL, V14, P135, DOI 10.1093/beheco/14.1.135; Cratsley CK, 2000, SEXUAL SELECTION PHO; Cronin TW, 2000, J COMP PHYSIOL A, V186, P1, DOI 10.1007/s003590050001; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Demary K, 2005, FIREFLY COURTSHIP BE, V112, P485; Douglas I, 2015, URBAN ECOLOGY: AN INTRODUCTION, P1; DREISIG H, 1975, OECOLOGIA, V18, P85, DOI 10.1007/BF00348090; EGUCHI E, 1984, J INSECT PHYSIOL, V30, P607, DOI 10.1016/0022-1910(84)90044-1; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; Firebaugh A, 2016, OECOLOGIA, V182, P1203, DOI 10.1007/s00442-016-3723-1; Fu X, 2010, ZOOTAXA, V2530; Gillham O., 2002, LIMITLESS CITY PRIME; Goh KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029576; Hagen O., 2015, ADV ENTOMOLOGY, V03, P24, DOI [10.4236/ae.2015.31004, DOI 10.4236/AE.2015.31004]; Hall DW, 2016, EVOLUTION, V70, P2033, DOI 10.1111/evo.13002; Ho JZ, 2010, J ASIA-PAC ENTOMOL, V13, P189, DOI 10.1016/j.aspen.2010.03.007; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Ineichen S, 2012, IMPACT ARTIFICIAL LI; Isaksson C, 2010, ECOHEALTH, V7, P342, DOI 10.1007/s10393-010-0345-7; Jeng ML., 2013, SCI DEV, P18; Kegel B., 2013, TIERE STADT NATURGES, P21; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; Kundrata R, 2014, MOL PHYLOGENET EVOL, V76, P162, DOI 10.1016/j.ympev.2014.03.012; Kupfer JA, 2009, GEOGR COMPASS, V3, P1331, DOI 10.1111/j.1749-8198.2009.00245.x; LALL AB, 1988, J COMP PHYSIOL A, V162, P23, DOI 10.1007/BF01342700; LALL AB, 1982, J COMP PHYSIOL, V147, P195, DOI 10.1007/BF00609844; LALL AB, 1980, J COMP PHYSIOL, V135, P21, DOI 10.1007/BF00660178; Lall AB, 2000, J INSECT PHYSIOL, V46, P965, DOI 10.1016/S0022-1910(99)00206-1; LALL AB, 1994, J INSECT PHYSIOL, V40, P359, DOI 10.1016/0022-1910(94)90077-9; LALL AB, 1993, J INSECT PHYSIOL, V39, P123, DOI 10.1016/0022-1910(93)90103-X; Lau T. F. S., 2007, Journal of Asia-Pacific Entomology, V10, P27; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; LEWIS SM, 2009, BIOLUMINESCENCE FOCU, P147, DOI DOI 10.1002/BIO.1170100602/; LLOYD JE, 1971, ANNU REV ENTOMOL, V16, P97, DOI 10.1146/annurev.en.16.010171.000525; Long SM, 2012, ANIM BEHAV, V83, P81, DOI 10.1016/j.anbehav.2011.10.008; Longcore T, 2015, PHILOS T R SOC LON B, P370; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Martin GJ, 2015, ORG DIVERS EVOL, V15, P513, DOI 10.1007/s13127-015-0212-z; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merritt DJ, 2013, J INSECT CONSERV, V17, P147, DOI 10.1007/s10841-012-9493-0; Meyer-Rochow VB, 2007, LUMINESCENCE, V22, P251, DOI 10.1002/bio.955; Michaelidis CI, 2006, BEHAV ECOL, V17, P329, DOI 10.1093/beheco/arj035; Mills R, 2016, J COMP PHYSIOL A, V202, P313, DOI 10.1007/s00359-016-1077-0; Moosman PR, 2009, ANIM BEHAV, V78, P1019, DOI 10.1016/j.anbehav.2009.07.028; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1; Oba Y, 2014, ADV BIOCHEM ENG BIOT, V144, P3, DOI 10.1007/978-3-662-43385-0_1; Oba Y, 2009, GENE, V436, P66, DOI 10.1016/j.gene.2009.02.001; Picchi MS, 2013, J INSECT CONSERV, V17, P797, DOI 10.1007/s10841-013-9562-z; R Development Core Team, 2009, R LANG ENV STAT COMP; Rich C., 2006, ECOLOGICAL CONSEQUEN; Sander SE, 2015, MOL ECOL, V24, P4679, DOI 10.1111/mec.13346; Schuster S, 2012, BIOL LETTERS, V8, P913, DOI 10.1098/rsbl.2012.0676; SELIGER HH, 1982, PHOTOCHEM PHOTOBIOL, V36, P673, DOI 10.1111/j.1751-1097.1982.tb09488.x; Sharkey EK, 2010, J INSECT BEHAV, V23, P215, DOI 10.1007/s10905-010-9208-x; Stanger-Hall KF, 2015, EVOLUTION, V69, P666, DOI 10.1111/evo.12606; Vencl FV, 1998, J INSECT BEHAV, V11, P191, DOI 10.1023/A:1021091806472; Viviani VR, 2010, BIOTA NEOTROP, V10, P103, DOI 10.1590/S1676-06032010000200013; Woods WA, 2007, AM NAT, V170, P702, DOI 10.1086/521964; Wu C, 2014, INT FIR S; Zvereva EL, 2010, ENVIRON SCI POLLUT R, V17, P297, DOI 10.1007/s11356-009-0138-0	73	27	27	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191576	10.1371/journal.pone.0191576	http://dx.doi.org/10.1371/journal.pone.0191576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415023	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300033
J	Schmoeckel, K; Mrochen, DM; Huhn, J; Potschke, C; Broker, BM				Schmoeckel, Katrin; Mrochen, Daniel M.; Huehn, Jochen; Poetschke, Christian; Broeker, Barbara M.			Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMORAL IMMUNE-RESPONSES; DOWN-REGULATION; B-CELLS; INDUCED IMPAIRMENT; GAMMA-INTERFERON; CECAL LIGATION; MURINE MODEL; WHOLE-BLOOD; EXPRESSION	Sepsis is frequently complicated by a state of profound immunosuppression, in its extreme form known as immunoparalysis. We have studied the role of the adaptive immune system in the murine acute peritonitis model. To read out adaptive immunosuppression, we primed post-septic and control animals by immunization with the model antigen TNP-ovalbumin in alum, and measured the specific antibody-responses via ELISA and ELISpot assay as well as T-cell responses in a proliferation assay after restimulation. Specific antibody titers, antibody affinity and plasma cell counts in the bone marrow were reduced in post-septic animals. The antigen-induced splenic proliferation was also impaired. The adaptive immunosuppression was positively correlated with an overwhelming general antibody response to the septic insult. Remarkably, antigen "overload" by non-specific immunization induced a similar degree of adaptive immunosuppression in the absence of sepsis. In both settings, depletion of regulatory T cells before priming reversed some parameters of the immunosuppression. In conclusion, our data show that adaptive immunosuppression occurs independent of profound systemic inflammation and life-threatening illness.	[Schmoeckel, Katrin; Mrochen, Daniel M.; Poetschke, Christian; Broeker, Barbara M.] Univ Med, Inst Immunol & Transfus Med, Dept Immunol, Greifswald, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Broker, BM (corresponding author), Univ Med, Inst Immunol & Transfus Med, Dept Immunol, Greifswald, Germany.	broeker@uni-greifswald.de	Bröker, Barbara M/O-4850-2015	Bröker, Barbara M/0000-0002-5020-8542; Mrochen, Daniel Michael/0000-0002-5893-1778	Deutsche Forschungsgemeinschaft [Graduiertenkolleg 840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Katrin Schmoeckel received a grant from Deutsche Forschungsgemeinschaft: Graduiertenkolleg 840 - Host pathogen interaction, http://gepris.dfg.de/gepris/projekt/273551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barrera G, 2011, INFECT IMMUN, V79, P1280, DOI 10.1128/IAI.01127-10; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Brune IB, 1999, AM J SURG, V177, P55, DOI 10.1016/S0002-9610(98)00299-2; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Busse M, 2008, GUT, V57, P188, DOI 10.1136/gut.2007.121616; Carlei F, 1999, WORLD J SURG, V23, P18, DOI 10.1007/s002689900559; Cavassani KA, 2010, BLOOD, V115, P4403, DOI 10.1182/blood-2009-09-241083; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Davis CG, 2011, BIOCHEM BIOPH RES CO, V414, P37, DOI 10.1016/j.bbrc.2011.09.017; Decker D, 1996, SURGERY, V119, P316, DOI 10.1016/S0039-6060(96)80118-8; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Eddahri F, 2006, EUR J IMMUNOL, V36, P855, DOI 10.1002/eji.200535500; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotchkiss RS, 2005, CLIN INFECT DIS S7, V41, P9; Huehn J, 2015, SEMIN IMMUNOL, V27, P10, DOI 10.1016/j.smim.2015.02.002; Inoue S, 1950, J IMMUNOLOGY BALTIM, V184, P1401; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kelly-Scumpia KM, 2011, J EXP MED, V208, P1673, DOI 10.1084/jem.20101715; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Mohr A, 2012, EUR J IMMUNOL, V42, P341, DOI 10.1002/eji.201141692; Monaghan SF, 2012, SHOCK, V38, P117, DOI 10.1097/SHK.0b013e31825de6a3; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphey ED, 2012, MICROBES INFECT, V14, P35, DOI 10.1016/j.micinf.2011.08.002; Murphey ED, 2004, INFECT IMMUN, V72, P6892, DOI 10.1128/IAI.72.12.6892-6901.2004; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Passerini L, 2014, INT REV IMMUNOL, V33, P129, DOI 10.3109/08830185.2013.863303; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmoeckel K, 2015, SHOCK, V43, P192, DOI 10.1097/SHK.0000000000000267; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Sinistro A, 2008, CLIN VACCINE IMMUNOL, V15, P1851, DOI 10.1128/CVI.00184-08; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sundar KM, 2013, INDIAN J CRIT CARE M, V17, P162, DOI 10.4103/0972-5229.117054; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vuddamalay Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00031; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Yoon SJ, 2017, J INFECT DIS, V215, P1608, DOI 10.1093/infdis/jix142; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	95	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192197	10.1371/journal.pone.0192197	http://dx.doi.org/10.1371/journal.pone.0192197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415028	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300057
J	Hoshino, J; Furuichi, K; Yamanouchi, M; Mise, K; Sekine, A; Kawada, M; Sumida, K; Hiramatsu, R; Hasegawa, E; Hayami, N; Suwabe, T; Sawa, N; Hara, S; Fujii, T; Ohashi, K; Kitagawa, K; Toyama, T; Shimizu, M; Takaichi, K; Ubara, Y; Wada, T				Hoshino, Junichi; Furuichi, Kengo; Yamanouchi, Masayuki; Mise, Koki; Sekine, Akinari; Kawada, Masahiro; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Hara, Shigeko; Fujii, Takeshi; Ohashi, Kenichi; Kitagawa, Kiyoki; Toyama, Tadashi; Shimizu, Miho; Takaichi, Kenmei; Ubara, Yoshifumi; Wada, Takashi			A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy	PLOS ONE			English	Article							TUBULOINTERSTITIAL LESIONS; KIDNEY-DISEASE; BIOPSY; OVERT; RISK; MICROALBUMINURIA; REDUCTION; PROGNOSIS	Background and objectives The impact of the newly proposed pathological classification by the Japan Renal Pathology Society (JRPS) on renal outcome is unclear. So we evaluated that impact and created a new pathological scoring to predict outcome using this classification. Design, setting, participants, & measurements A multicenter cohort of 493 biopsy-proven Japanese patients with diabetic nephropathy (DN) were analyzed. The association between each pathological factor-Tervaert' and JRPS classifications-and renal outcome (dialysis initiation or 50% eGFR decline) was estimated by adjusted Cox regression. The overall pathological risk score (J-score) was calculated, whereupon its predictive ability for 10-year risk of renal outcome was evaluated. Results The J-scores of diffuse lesion classes 2 or 3, GBM doubling class 3, presence of mesangiolysis, polar vasculosis, and arteriolar hyalinosis were, respectively, 1, 2, 4, 1, and 2. The scores of IFTA classes 1, 2, and 3 were, respectively, 3, 4, and 4, and those of interstitial inflammation classes 1, 2, and 3 were 5, 5, and 4 (J-score range, 0-19). Renal survival curves, when dividing into four J-score grades (0-5, 6-10, 11-15, and 16-19), were significantly different from each other (p<0.01, log-rank test). After adjusting clinical factors, the J-score was a significant predictor of renal outcome. Ability to predict 10-year renal outcome was improved when the J-score was added to the basic model: c-statistics from 0.661 to 0.685; category-free net reclassification improvement, 0.154 (-0.040, 0.349, p = 0.12); and integrated discrimination improvement, 0.015 (0.003, 0.028, p = 0.02). Conclusions Mesangiolysis, polar vasculosis, and doubling of GBM-features of the JRPS system-were significantly associated with renal outcome. Prediction of DN patients' renal outcome was better with the J-score than without it.	[Hoshino, Junichi; Sekine, Akinari; Kawada, Masahiro; Hasegawa, Eiko; Hara, Shigeko; Takaichi, Kenmei] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Hoshino, Junichi; Takaichi, Kenmei; Ubara, Yoshifumi] Okinaka Mem Inst Med Res, Tokyo, Japan; [Furuichi, Kengo; Toyama, Tadashi; Shimizu, Miho; Wada, Takashi] Kanazawa Univ Hosp, Dept Nephrol, Kanazawa, Ishikawa, Japan; [Yamanouchi, Masayuki; Sumida, Keiichi; Hiramatsu, Rikako; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan; [Mise, Koki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Fujii, Takeshi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Sch Med, Dept Pathol, Kanagawa, Japan; [Kitagawa, Kiyoki] Kanazawa Med Ctr, Dept Nephrol, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan	Toranomon Hospital; Kanazawa University; Okayama University; Toranomon Hospital; Yokohama City University; Kanazawa University	Hoshino, J (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.; Hoshino, J (corresponding author), Okinaka Mem Inst Med Res, Tokyo, Japan.	hoshino@toranomon.gr.jp	FURUICHI, Kengo/AAA-5685-2019; Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Hoshino, Junichi/0000-0002-0444-101X; Mise, Koki/0000-0003-0296-7429	Japan Agency for Medical Research and Development; JSPS KAKENHI [15K08719]; Kidney Foundation, Japan [JKFB 14-13]; Okinaka Memorial Institute for Medical Research	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kidney Foundation, Japan(Kidney Foundation, Japan); Okinaka Memorial Institute for Medical Research	This study was supported in part by TW's Grant-in-Aid for Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development, in part by JH's research grants from Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grant Number 15K08719, in part by a grant from the Kidney Foundation, Japan (JKFB 14-13), and in part by a grant from the Okinaka Memorial Institute for Medical Research.	Advani A, 2012, SEMIN NEPHROL, V32, P199, DOI 10.1016/j.semnephrol.2012.02.006; An Y, 2014, NEPHROL DIAL TRANSPL; Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Ekinci EI, 2013, DIABETES CARE, V36, P3620, DOI 10.2337/dc12-2572; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fioretto P, 2014, DIABETES RES CLIN PR, V104, P323, DOI 10.1016/j.diabres.2014.01.017; Furuichi K, 2018, NEPHROL DIAL TRANSPL, V33, P138, DOI 10.1093/ndt/gfw417; Hong D, 2007, DIABETES RES CLIN PR, V78, P189, DOI 10.1016/j.diabres.2007.03.024; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Makino H, 2008, HYPERTENS RES, V31, P657, DOI 10.1291/hypres.31.657; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MIN W, 1993, VIRCHOWS ARCH A, V423, P201, DOI 10.1007/BF01614771; Mise K, 2015, DIABETIC MED, V32, P546, DOI 10.1111/dme.12633; Mise K, 2016, CLIN J AM SOC NEPHRO, V11, P593, DOI 10.2215/CJN.04980515; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Morita T, 1998, AM J KIDNEY DIS, V31, P559, DOI 10.1053/ajkd.1998.v31.pm9531171; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nyumura I, 2012, TRANSPLANTATION, V94, P612, DOI 10.1097/TP.0b013e31825e4a5f; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; Royston P, 2009, STATA J, V9, P547, DOI 10.1177/1536867X0900900403; Shimizu M, 2014, CLIN EXP NEPHROL, V18, P305, DOI 10.1007/s10157-013-0870-0; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; Steyerberg E., 2010, CLIN PREDICTION MODE; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Wolf G, 2003, J AM SOC NEPHROL, V14, P1396, DOI 10.1097/01.ASN.0000065639.19190.CF; Yokoyama H, 2013, DIABETES CARE, V36, P3227, DOI 10.2337/dc13-0281; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	35	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190923	10.1371/journal.pone.0190923	http://dx.doi.org/10.1371/journal.pone.0190923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408865	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800011
J	Nishio, A; Saito, J; Tomokawa, S; Kobayashi, J; Makino, Y; Akiyama, T; Miyake, K; Yamamoto, M				Nishio, Akihiro; Saito, Junko; Tomokawa, Sachi; Kobayashi, Jun; Makino, Yuka; Akiyama, Takeshi; Miyake, Kimihiro; Yamamoto, Mayumi			Systematic review of school tobacco prevention programs in African countries from 2000 to 2016	PLOS ONE			English	Review							HEALTHWISE SOUTH-AFRICA; SMOKING PREVENTION; DRUG-ABUSE; OCCASIONAL CIGARETTE; BEHAVIORAL-APPROACH; RISK PREVENTION; SUBSTANCE USE; ADOLESCENTS; INITIATION; ALCOHOL	Background The World Bank has reported that global smoking rates declined from 2000 to 2012, with the only exception found in males in Sub-Saharan Africa. Sub-Saharan Africa is considered to be in stage one of the tobacco epidemic continuum. To address this problem, school-based programs for smoking prevention are considered cost-effective and promising. Since tobacco prevention programs are influenced by social competence or customs of each country, tobacco prevention programs that have success in Western countries are not always effective in African countries. Therefore, the current study systematically reviewed relevant literature to examine the effects of these types of programs in African countries. Method Online bibliographic databases and a hand search were used. We included the studies that examined the impact of school-based programs on preventing tobacco use in Africa from 2000 to 2016. Results Six articles were selected. Four were conducted in South Africa and two were performed in Nigeria. Four programs were systematically incorporated into annual curriculums, targeting 8th to 9th graders, while the other two were temporary programs. All programs were based on the hypothesis that providing knowledge and/or social skills against smoking would be helpful. All studies utilized smoking or polydrug use rates to compare outcomes before/after intervention. There were no significant differences between intervention and control groups in three studies, with the other three demonstrating only partial effectiveness. Additionally, three studies also examined change of knowledge/attitudes towards smoking as an outcome. Two of these showed significant differences between groups. Conclusion All RCTs studies showed no significant change of smoking-rate by the intervention. The effectiveness of intervention was observed only in some sub-group. The cohort studies showed school-based interventions may be effective in improving knowledge and attitudes about smoking. However, they reported no significant change of smoking-rate by the intervention.	[Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu, Japan; [Nishio, Akihiro; Saito, Junko; Tomokawa, Sachi; Kobayashi, Jun; Makino, Yuka; Akiyama, Takeshi; Miyake, Kimihiro] Japanese Consortium Global Sch Hlth Res, Nishihara, Okinawa, Japan; [Saito, Junko] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Tomokawa, Sachi; Miyake, Kimihiro] Shinshu Univ, Fac Educ, Nagano, Japan; [Kobayashi, Jun] Univ Ryukyus, Fac Med, Nishihara, Okinawa, Japan; [Akiyama, Takeshi] Nagano Coll Nursing, Komagane, Japan	Gifu University; University of Tokyo; Shinshu University; University of the Ryukyus	Nishio, A (corresponding author), Gifu Univ, Hlth Adm Ctr, Gifu, Japan.	a_nishio@gifu-u.ac.jp	saito, junko/AAA-4866-2019; Akiyama, Takeshi/ABF-5703-2020; Tomokawa, Sachi/Y-8111-2019	Tomokawa, Sachi/0000-0002-9856-6306	Grant for National Center for Global Health and Medicine [27A-1]; Ministry of Health, Labour and Welfare of the Government of Japan	Grant for National Center for Global Health and Medicine; Ministry of Health, Labour and Welfare of the Government of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Grant for National Center for Global Health and Medicine (27A-1) (AN) and by Ministry of Health, Labour and Welfare of the Government of Japan (2016-2017) (ST).	Achia TNO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117219; *AM CANC SOC, 2005, CANC FACTS FIG; Botvin G J, 1999, J Am Med Womens Assoc (1972), V54, P139; Botvin G. J., 1994, PSYCHOL ADDICT BEHAV, V8, P116, DOI [DOI 10.1037/0893-164X.8.2.116, 10.1037/0893-164X.8.2.116]; BOTVIN GJ, 1992, HEALTH PSYCHOL, V11, P290, DOI 10.1037/0278-6133.11.5.290; BOTVIN GJ, 1990, J CONSULT CLIN PSYCH, V58, P437, DOI 10.1037/0022-006X.58.4.437; BOTVIN GJ, 1982, PREV MED, V11, P199, DOI 10.1016/0091-7435(82)90018-4; Botvin GJ, 2000, ADDICT BEHAV, V25, P769, DOI 10.1016/S0306-4603(99)00050-7; BOTVIN GJ, 1995, JAMA-J AM MED ASSOC, V273, P1106, DOI 10.1001/jama.273.14.1106; BOTVIN GJ, 1995, PSYCHOL ADDICT BEHAV, V9, P183, DOI 10.1037/0893-164X.9.3.183; BOTVIN GJ, 1984, ADDICT BEHAV, V9, P137, DOI 10.1016/0306-4603(84)90051-0; Botvin GJ, 2000, ADDICT BEHAV, V25, P887, DOI 10.1016/S0306-4603(00)00119-2; BOTVIN GJ, 1989, J BEHAV MED, V12, P279, DOI 10.1007/BF00844872; BOTVIN GJ, 1994, J DEV BEHAV PEDIATR, V15, P67; Brathwaite R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132401; Brook DW, 2011, SOC SCI MED, V72, P1447, DOI 10.1016/j.socscimed.2011.02.041; Caldwell L.L., 2004, WORLD LEIS J, V46, P4, DOI [10.1080/04419057.2004.9674362, DOI 10.1080/04419057.2004.9674362]; de Vries H, 2006, TOB CONTROL, V15, P83, DOI 10.1136/tc.2003.007237; Eriksen M, 2012, TOBACCO ATLAS; Hamilton G, 2000, ADDICT RES, V8, P419, DOI 10.3109/16066350009005588; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Motamedi M, 2016, PREV SCI, V17, P700, DOI 10.1007/s11121-016-0654-3; National Cancer Institute and World Health Organization, 2016, NCI TOB CONTR MON, V21; Odukoya O O, 2014, Niger Postgrad Med J, V21, P128; Peltzer K, 2011, AFR HEALTH SCI, V11, P320; Raji M., 2014, HLTH SCI J, V8, P485; Resnicow K, 1999, ADDICT BEHAV, V24, P251, DOI 10.1016/S0306-4603(98)00059-8; Resnicow K, 2008, ANN BEHAV MED, V36, P231, DOI 10.1007/s12160-008-9072-5; Seal Nuananong, 2006, Nurs Health Sci, V8, P164, DOI 10.1111/j.1442-2018.2006.00275.x; Skara S, 2003, PREV MED, V37, P451, DOI 10.1016/S0091-7435(03)00166-X; Smith E, 2008, PREV SCI, V9, P311, DOI 10.1007/s11121-008-0103-z; The World Bank, SMOK PREV MAL SMOK P; Thomas RE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006976; Tibbits MK, 2011, HEALTH EDUC RES, V26, P653, DOI 10.1093/her/cyr024; Townsend L, 2006, DRUG ALCOHOL DEPEN, V84, P14, DOI 10.1016/j.drugalcdep.2005.12.008; UNESCO, GROSS ENR RAT LEV ED; UNESCO, 2002, FRESH COMPR SCH HLTH; Wegner L, 2008, HEALTH EDUC RES, V23, P1085, DOI 10.1093/her/cym064; WHO, 2008, WORLD HLTH REPORT 20; Wiehe SE, 2005, J ADOLESCENT HEALTH, V36, P162, DOI 10.1016/j.jadohealth.2004.12.003; World Health Organization, 2009, TOB KEY FACTS; World Health Organization, 2009, HLTH PROM SCH FRAM	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192489	10.1371/journal.pone.0192489	http://dx.doi.org/10.1371/journal.pone.0192489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408895	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800072
J	Zhang, JH; Yang, J; Zhang, X; Xu, J; Sun, YY; Zhang, PR				Zhang, Jianhui; Yang, Jing; Zhang, Xin; Xu, Jia; Sun, Yiyi; Zhang, Purong			MicroRNA-10b expression in breast cancer and its clinical association	PLOS ONE			English	Article							METASTASIS; INVASION	MicroRNAs (miRNAs) are short non-coding RNA molecules that play a significant role in many types of cancers including breast cancer. In the current study, we evaluated the expression levels of microR-10b (miR-10b) in 115 breast cancer patients from Sichuan Cancer Center. Real time reverse transcription-PCR was used to assess miR-10b expression. Clinical data including disease stage, survival status, age, ER/PR/HER2 status, molecular subtypes, tumor size, lymph node status and Ki-67 expression levels were correlated with miR-10b expression levels. Our data showed that the miR-10b expression is correlated with disease stage, living status and tumor sizes. We also found that miR-10b expression levels are higher in the lymph node positive group and the Ki-67 higher scoring group (score > 20). No statistically significant differences were observed based on age or molecular sub-type grouping. In conclusion, miR-10b may be a biomarker for breast cancer and is a potential treatment target.	[Zhang, Jianhui; Yang, Jing; Zhang, Xin; Xu, Jia; Zhang, Purong] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Sichuan, Peoples R China; [Sun, Yiyi] Chengdu Med Coll, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chengdu Medical College	Zhang, PR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Sichuan, Peoples R China.	zprjournal@hotmail.com			Program for provincial universities innovative research team in Sichuan province [13TD0028]	Program for provincial universities innovative research team in Sichuan province	The work was supported by the Program for provincial universities innovative research team in Sichuan province (NO. 13TD0028. Awarded to Yiyi Sun). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Biagioni F, 2012, EMBO MOL MED, V4, P1214, DOI 10.1002/emmm.201201483; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Ma J T-F, 2008, NATURE, V455; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Milioli HH, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0250-9; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Fei, 2015, Chronic Dis Transl Med, V1, P2, DOI 10.1016/j.cdtm.2015.02.003; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	30	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192509	10.1371/journal.pone.0192509	http://dx.doi.org/10.1371/journal.pone.0192509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408861	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800076
J	Seglias, AE; Williams, E; Bilge, A; Kramer, AT				Seglias, Alexandra E.; Williams, Evelyn; Bilge, Arman; Kramer, Andrea T.			Phylogeny and source climate impact seed dormancy and germination of restoration-relevant forb species	PLOS ONE			English	Article							HABITAT-CORRELATED VARIATION; LIFE-HISTORY; EVOLUTIONARY SIGNIFICANCE; PLANT-REGENERATION; LOCAL ADAPTATION; ALPINE MEADOW; GREAT-BASIN; DIFFERENTIATION; RECRUITMENT; PATTERNS	For many species and seed sources used in restoration activities, specific seed germination requirements are often unknown. Because seed dormancy and germination traits can be constrained by phylogenetic history, related species are often assumed to have similar traits. However, significant variation in these traits is also present within species as a result of adaptation to local climatic conditions. A growing number of studies have attempted to disentangle how phylogeny and climate influence seed dormancy and germination traits, but they have focused primarily on species-level effects, ignoring potential population-level variation. We examined the relationships between phylogeny, climate, and seed dormancy and germination traits for 24 populations of eight native, restoration-relevant forb species found in a wide range of climatic conditions in the Southwest United States. The seeds were exposed to eight temperature and stratification length regimes designed to mimic regional climatic conditions. Phylogenetic relatedness, overall climatic conditions, and temperature conditions at the site were all significantly correlated with final germination response, with significant among-population variation in germination response across incubation treatments for seven of our eight study species. Notably, germination during stratification was significantly predicted by precipitation seasonality and differed significantly among populations for seven species. While previous studies have not examined germination during stratification as a potential trait influencing overall germination response, our results suggest that this trait should be included in germination studies as well as seed sourcing decisions. Results of this study deepen our understanding of the relationships between source climate, species identity, and germination, leading to improved seed sourcing decisions for restorations.	[Seglias, Alexandra E.] Northwestern Univ, Program Plant Biol & Conservat, Evanston, IL USA; [Seglias, Alexandra E.; Williams, Evelyn; Kramer, Andrea T.] Chicago Bot Garden, Dept Plant Sci & Conservat, Glencoe, IL 60022 USA; [Bilge, Arman] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Bilge, Arman] Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA	Northwestern University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Seglias, AE (corresponding author), Northwestern Univ, Program Plant Biol & Conservat, Evanston, IL USA.; Seglias, AE (corresponding author), Chicago Bot Garden, Dept Plant Sci & Conservat, Glencoe, IL 60022 USA.	alexandra.seglias@botanicgardens.org	Kramer, Andrea T/K-8427-2017	Kramer, Andrea T/0000-0002-0956-0157; Seglias, Alexandra/0000-0002-2756-7088	Northwestern University; Native Plant Society of New Mexico; Bureau of Land Management's Plant Conservation Program [DBI-0521245]; NSF MRI [DBI-1125997]	Northwestern University; Native Plant Society of New Mexico; Bureau of Land Management's Plant Conservation Program; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by Northwestern University Graduate Program in Plant Biology and Conservation (www.plantbiology.northwestern.edu) and the Native Plant Society of New Mexico (www.npsnm.org) through grants awarded to AES. Funding was also provided by the Bureau of Land Management's Plant Conservation Program (grant DBI-0521245; www.greatbasinnpp.org/usdi-blm/) and NSF MRI (grant DBI-1125997; www.nsf.gov/mri/) through grants awarded to Chicago Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; BASKIN JM, 1971, AM MIDL NAT, V85, P22, DOI 10.2307/2423908; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bower AD, 2014, ECOL APPL, V24, P913, DOI 10.1890/13-0285.1; Bu HY, 2008, PLANT ECOL, V195, P87, DOI 10.1007/s11258-007-9301-1; Bu HY, 2009, ARCT ANTARCT ALP RES, V41, P97, DOI [10.1657/1938-4246(08-014)[DU]2.0.CO;2, 10.1657/1523-0430-41.1.97]; Bureau of Land Managment, 2012, TECHN PROT COLL STUD; Bureau of Land Managment, 2014, COL PLAT NAT PLANT P; Burns JH, 2011, P NATL ACAD SCI USA, V108, P5302, DOI 10.1073/pnas.1013003108; Butterfield BJ, 2015, PLANT ECOL, V216, P1341, DOI 10.1007/s11258-015-0510-8; Butterfield BJ, 2015, OIKOS, V124, P1374, DOI 10.1111/oik.02311; Carta A, 2016, ECOL EVOL, V6, P4166, DOI 10.1002/ece3.2150; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Clausen J, 1941, AM NAT, V75, P231, DOI 10.1086/280955; COMSTOCK JP, 1992, GREAT BASIN NAT, V52, P195; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Faxitron X-Ray Corporation, SPEC RAD SYST; Fenner M., 2005, ECOLOGY SEEDS; Fernandez-Pascual E, 2017, PLANT BIOLOGY, V19, P32, DOI 10.1111/plb.12472; Fernandez-Pascual E, 2013, ANN BOT-LONDON, V112, P937, DOI 10.1093/aob/mct154; Figueroa JA, 2003, PLANT ECOL, V166, P227, DOI 10.1023/A:1023286521721; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hereford R, 2002, PRECIPITATION HIST C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hintz L, 2016, WEST N AM NATURALIST, V76, P6, DOI 10.3398/064.076.0103; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; Johnson R., 2010, Native Plants Journal, V11, P117, DOI 10.2979/NPJ.2010.11.2.117; Jurado E, 2005, J VEG SCI, V16, P559, DOI 10.1111/j.1654-1103.2005.tb02396.x; Kimball S, 2010, GLOBAL CHANGE BIOL, V16, P1555, DOI 10.1111/j.1365-2486.2009.02106.x; Kramer AT, 2015, NAT AREA J, V35, P174, DOI 10.3375/043.035.0119; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Kramer AT, 2016, PROPAGATION PROTOCOL; Larson JE, 2015, J APPL ECOL, V52, P199, DOI 10.1111/1365-2664.12350; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MEYER SE, 1992, B TORREY BOT CLUB, V119, P268, DOI 10.2307/2996758; MEYER SE, 1995, AM J BOT, V82, P377, DOI 10.2307/2445584; MEYER SE, 1994, AM MIDL NAT, V132, P349, DOI 10.2307/2426591; Morgan David R., 2003, SIDA Contributions to Botany, V20, P1387; Nikolaeva MG, 1999, RUSS J PLANT PHYSL+, V46, P369; Pendleton RL, 2014, NATIV PLANTS, V15, P17, DOI DOI 10.3368/npj.15.1.17; Percival Scientific Inc, INT ENV CONTR; Plant Conservation Alliance, 2015, NAT SEED STRAT REH R; Plummer M., 2003, P 3 INT WORKSH DISTR; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; RATCLIFFE D, 1961, J ECOL, V49, P187, DOI 10.2307/2257433; Riebkes JL., 2015, NATIV PLANTS J, V16, P96, DOI [DOI 10.3368/NPJ.16.2.96, 10.3368/npj.16.2.96]; Schwinning S, 2008, ECOL SOC, P13; THOMPSON PA, 1979, GARTENBAUWISSENSCHAF, V44, P97; Turesson G, 1922, HEREDITAS, V3, P100, DOI 10.1111/j.1601-5223.1922.tb02727.x; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Wagmann K, 2012, ANN BOT-LONDON, V110, P1205, DOI 10.1093/aob/mcs194; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walder T, 2015, PLANT ECOL, V216, P1297, DOI 10.1007/s11258-015-0509-1; Wang JH, 2009, EVOL ECOL, V23, P827, DOI 10.1007/s10682-008-9273-1; Wang ZQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9875298; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Willis CG, 2014, NEW PHYTOL, V203, P300, DOI 10.1111/nph.12782; Wood TE, 2015, NAT AREA J, V35, P134, DOI 10.3375/043.035.0117; Xu JP, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-188; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	69	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191931	10.1371/journal.pone.0191931	http://dx.doi.org/10.1371/journal.pone.0191931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401470	Green Submitted, gold, Green Published			2022-12-27	WOS:000424101400026
J	Li, BY; Yang, HX; Zhang, WY; Shi, YD; Qin, ST; Wei, YM; He, YD; Yang, WS; Jiang, SJ; Jin, HY				Li, Boya; Yang, Huixia; Zhang, Wanyi; Shi, Yundi; Qin, Shengtang; Wei, Yumei; He, Yingdong; Yang, Wenshuang; Jiang, Shiju; Jin, Hongyan			Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; NULLIPAROUS WOMEN; BLOOD-PRESSURE; GLUCOSE; AP2; ATHEROSCLEROSIS; INTOLERANCE; DISORDERS; DISEASE; FABP4	Objective Fatty acid-binding protein 4 (FABP4) has been proposed to be a potential predictive factor of gestational hypertension or preeclampsia (GH/PE) because of its integrating metabolic and inflammatory responses. Women with gestational diabetes mellitus (GDM) are more likely to develop both GH/PE, than the normal population. The aim of our study was to examine the relationship between plasma FABP4 in the second trimester of pregnancy and the risk of GH/PE in women with GDM. Methods This was a nested case-control study conducted within a large on-going prospective cohort study conducted at Peking University First Hospital. A total of 1344 women, who were diagnosed with GDM, according to a 75 g oral glucose tolerance test, participated in the GDM One-Day Clinic at Peking University First Hospital from February 24, 2016 to February 9, 2017. Of the 748 GDM women who agreed to the blood sample collection, 637 were followed until their delivery. The cases included GDM patients who developed gestational hypertension or preeclampsia (GDM-GH/PE group, n = 41). Another 41 matched GDM women without major complications were selected as the control group (GDM group). Results The incidence of GH/PE was 6.44% and 3.30% for preeclampsia. The level of the second trimester plasma FABP4 in the GDM-GH/PE group was significantly higher than the GDM group (17.53 +/- 11.35 vs. 12.79 +/- 6.04 ng/ml, P = 0.020). The AUC ROC for the second trimester plasma FABP4 predicted GH/PE in the GDM patients alone was 0.647 (95% CI 0.529-0.766). Multivariate analysis showed that the elevated second trimester FABP4 level was independently associated with GH/PE in the GDM patients (OR 1.136 [95% CI 1.003-1.286], P = 0.045). Conclusions Increased second trimester plasma FABP4 independently predicted GH/PE in GDM patients.	[Li, Boya; Yang, Huixia; Zhang, Wanyi; Qin, Shengtang; Wei, Yumei; He, Yingdong; Yang, Wenshuang; Jiang, Shiju; Jin, Hongyan] Peking Univ, Hosp 1, Beijing, Peoples R China; [Shi, Yundi] Peking Univ, Hlth Sci Ctr, Sch Basic Med, Dept Pharmacol, Beijing, Peoples R China	Peking University; Peking University	Yang, HX (corresponding author), Peking Univ, Hosp 1, Beijing, Peoples R China.	yanghuixia@bjmu.edu.cn		Yang, Huixia/0000-0001-8954-2102; Zhang, Wanyi/0000-0002-3523-6713; YANG, HUIXIA/0000-0001-9913-2721; Boya, Li/0000-0002-9402-1608	National Natural Science Foundation of China [81490745]; Major National Scientific Research Program of China [2015CB943304]; Beijing Science and Technology Project [Z151100001615051]; National Science and Technology Support Program of China [2015BAI13B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Scientific Research Program of China; Beijing Science and Technology Project; National Science and Technology Support Program of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81490745 to HY), the Major National Scientific Research Program of China (Grant No. 2015CB943304 to HY), the Beijing Science and Technology Project (Grant No. Z151100001615051 to HY), and the National Science and Technology Support Program of China (Grant No. 2015BAI13B06 to HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, 2015, Zhonghua Fu Chan Ke Za Zhi, V50, P721; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Kralisch S, 2009, EUR J ENDOCRINOL, V160, P33, DOI 10.1530/EJE-08-0540; Li Yuan-yuan, 2015, Med Sci Monit, V21, P426, DOI 10.12659/MSM.892431; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miyakoshi K, 2004, DIABETES RES CLIN PR, V64, P201, DOI 10.1016/j.diabres.2003.11.002; Obstetrics Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P561; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Salzer L, 2015, BEST PRACT RES CL OB, V29, P328, DOI 10.1016/j.bpobgyn.2014.09.008; Scifres CM, 2012, J CLIN ENDOCR METAB, V97, pE349, DOI 10.1210/jc.2011-2276; Scifres CM, 2011, J CLIN ENDOCR METAB, V96, pE1083, DOI 10.1210/jc.2010-2084; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Sun Wei-Jie, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P377; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuuri AL, 2014, PLACENTA, V35, P797, DOI 10.1016/j.placenta.2014.07.016; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Wotherspoon AC, 2016, DIABETES CARE, V39, P1827, DOI 10.2337/dc16-0803; Yamada M, 2015, J NUTR SCI VITAMINOL, V61, P291, DOI 10.3177/jnsv.61.291; Yang Hui-xia, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P577; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Zhang Y, 2016, J DIABETES INVEST, V7, P797, DOI 10.1111/jdi.12484; Zhu Yuchun ZW, 2016, CHINESE J DIABETES M, V8	29	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192347	10.1371/journal.pone.0192347	http://dx.doi.org/10.1371/journal.pone.0192347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394285	gold, Green Published, Green Submitted			2022-12-27	WOS:000424060400036
J	Shelus, V; Taylor, J; Greene, E; Stanton, J; Pack, A; Tolley, EE; Branson, BM; El-Sadr, WM; Pollydore, J; Gamble, T				Shelus, Victoria; Taylor, Jamilah; Greene, Elizabeth; Stanton, Jill; Pack, Allison; Tolley, Elizabeth E.; Branson, Bernard M.; El-Sadr, Wafaa M.; Pollydore, June; Gamble, Theresa			It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study	PLOS ONE			English	Article							CONTINGENCY MANAGEMENT; MEDICATION ADHERENCE; METHADONE PATIENTS; UNITED-STATES; REINFORCEMENT; INFECTION; PROGRAM; TRIAL	The HPTN 065 (TLC-Plus) study tested the feasibility and effectiveness of using financial incentives (FIs) to increase linkage to care (L2C) among individuals with newly diagnosed HIV and those out of care in the Bronx, NY and Washington, DC. Qualitative data collection with a subset of participating patients and staff focused on experiences with and attitudes about the FI intervention. Semi-structured interviews were conducted with 15 patients and 14 site investigators. Four focus group discussions were conducted with a total of 15 staff members. The use of FIs for L2C was generally viewed favorably. Patients were grateful and benefited financially, but sites had some challenges implementing the program. Challenges included the timing and sensitive introduction of the intervention immediately after an HIV diagnosis, negative attitudes towards paying people for health behaviors, and the existence and strength of existing linkage programs. Future programs should consider optimal timing and presentation of FIs.	[Shelus, Victoria; Greene, Elizabeth; Stanton, Jill; Pack, Allison; Gamble, Theresa] FHI 360, HPTN Leadership & Operat Ctr, Sci Facilitat, Durham, NC 27701 USA; [Taylor, Jamilah; Tolley, Elizabeth E.] FHI 360, Behav Epidemiol & Clin Sci, Durham, NC USA; [Branson, Bernard M.] Sci Affairs LLC, Atlanta, GA USA; [El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Pollydore, June] Womens Collect, Washington, DC USA; [Shelus, Victoria] Univ N Carolina, Gillings Sch Publ Hlth, Hlth Behav Dept, Chapel Hill, NC USA	FHI 360; FHI 360; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Gamble, T (corresponding author), FHI 360, HPTN Leadership & Operat Ctr, Sci Facilitat, Durham, NC 27701 USA.	tgamble@fhi360.org		Shelus, Victoria/0000-0001-7418-6002	National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH) [UM1 AI 068619]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH)	The HIV Prevention Trials Network (HPTN) 065 qualitative substudy was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH), and the National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH), under Cooperative Agreements #UM1 AI 068619. The funder provided support in the form of salaries for authors [VS, JT, EG, JS, AP, ET and WME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HIV SURV REP; Ashcroft RE, 2011, HEALTH EXPECT, V14, P191, DOI 10.1111/j.1369-7625.2011.00664.x; Barnett PG, 2009, DRUG ALCOHOL DEPEN, V100, P115, DOI 10.1016/j.drugalcdep.2008.09.017; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Centers for Disease Control and Prevention, 2016, HIV SURV SUPPL REP 2, V21; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Farber S, 2013, AIDS BEHAV, V17, P2293, DOI 10.1007/s10461-013-0416-1; Foster C, 2014, AIDS PATIENT CARE ST, V28, P28, DOI 10.1089/apc.2013.0262; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haukoos JS, 2005, ACAD EMERG MED, V12, P617, DOI 10.1111/j.1553-2712.2005.tb00916.x; Javanbakht Marjan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P143, DOI 10.1177/1545109706291706; Krawczyk CS, 2006, AIDS CARE, V18, pS35, DOI 10.1080/09540120600839280; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P1375, DOI 10.1001/jama.2012.387; Marteau TM, 2009, BMJ, V338; McCoy SI, 2013, JAIDS-J ACQ IMM DEF, V63, pE56, DOI 10.1097/QAI.0b013e31828a7629; Mehrotra A, 2010, AM J MANAG CARE, V16, P497; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Oliver A, 2012, J HEALTH POLIT POLIC, V37, P201, DOI 10.1215/03616878-1538602; Petry NM, 2010, ADDICTION, V105, P1507, DOI 10.1111/j.1360-0443.2009.02879.x; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Skinner BF., 1953, SCI HUMAN BEHAV SIM; Solomon SS, 2014, CLIN INFECT DIS, V59, P589, DOI 10.1093/cid/ciu324; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Tolley EE., 2016, QUALITATIVE METHODS; Weihs M, 2014, SAHARA J-J SOC ASP H, V11, P116, DOI 10.1080/17290376.2014.937739; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191638	10.1371/journal.pone.0191638	http://dx.doi.org/10.1371/journal.pone.0191638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394259	gold, Green Published, Green Submitted			2022-12-27	WOS:000424060400016
J	Bankier, C; Cheong, Y; Mahalingam, S; Edirisinghe, M; Ren, GG; Cloutman-Green, E; Ciric, L				Bankier, Claire; Cheong, Yuen; Mahalingam, Suntharavathanan; Edirisinghe, Mohan; Ren, Guogang; Cloutman-Green, Elaine; Ciric, Lena			A comparison of methods to assess the antimicrobial activity of nanoparticle combinations on bacterial cells	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SILVER NANOPARTICLES; STAPHYLOCOCCUS-AUREUS; OXIDE NANOPARTICLES; VIABILITY	Background Bacterial cell quantification after exposure to antimicrobial compounds varies widely throughout industry and healthcare. Numerous methods are employed to quantify these antimicrobial effects. With increasing demand for new preventative methods for disease control, we aimed to compare and assess common analytical methods used to determine antimicrobial effects of novel nanoparticle combinations on two different pathogens. Methods Plate counts of total viable cells, flow cytometry (LIVE/DEAD BacLight viability assay) and qPCR (viability qPCR) were used to assess the antimicrobial activity of engineered nanoparticle combinations (NPCs) on Gram-positive (Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa) bacteria at different concentrations (0.05, 0.10 and 0.25 w/v%). Results were analysed using linear models to assess the effectiveness of different treatments. Results Strong antimicrobial effects of the three NPCs (AMNP0-2) on both pathogens could be quantified using the plate count method and flow cytometry. The plate count method showed a high log reduction (>8-log) for bacteria exposed to high NPC concentrations. We found similar antimicrobial results using the flow cytometry live/dead assay. Viability qPCR analysis of antimicrobial activity could not be quantified due to interference of NPCs with qPCR amplification. Conclusion Flow cytometry was determined to be the best method to measure antimicrobial activity of the novel NPCs due to high-throughput, rapid and quantifiable results.	[Bankier, Claire; Cloutman-Green, Elaine; Ciric, Lena] UCL, Dept Civil Environm & Geomat Engn, London, England; [Cheong, Yuen; Ren, Guogang] Univ Hertfordshire, Sch Engn & Technol, Hatfield, Herts, England; [Mahalingam, Suntharavathanan; Edirisinghe, Mohan] UCL, Dept Mech Engn, London, England; [Cloutman-Green, Elaine] Great Ormond St Hosp NHS Fdn Trust, Dept Microbiol Virol & Infect Prevent Control, London, England	University of London; University College London; University of Hertfordshire; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Bankier, C (corresponding author), UCL, Dept Civil Environm & Geomat Engn, London, England.	c.bankier@ucl.ac.uk	Ren, Guogang/AAH-8863-2020; Cheong, Yuen-Ki/W-5617-2019; Ren, Guogang/P-4540-2017	Ren, Guogang/0000-0001-8865-1526; Cheong, Yuen-Ki/0000-0002-3737-6285; Ren, Guogang/0000-0001-8865-1526; Cloutman-Green, Elaine/0000-0001-7534-3196; Ciric, Lena/0000-0003-1476-6595	Engineering and Physical Sciences Research Council [EP/N034228/1]; Engineering and Physical Sciences Research Council [EP/N034368/1] Funding Source: researchfish; EPSRC [EP/N034228/1, EP/N034368/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council, project EP/N034228/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Blevins SM, 2010, INT J INFECT DIS, V14, pE744, DOI 10.1016/j.ijid.2009.12.003; Brescia CC, 2009, APPL ENVIRON MICROB, V75, P6856, DOI 10.1128/AEM.00540-09; Cameron P, 2016, APPL ENVIRON MICROB, V82, P431, DOI 10.1128/AEM.02806-15; Cameron R, 2014, PHARM BIOPROCESS, V2, P75, DOI 10.4155/PBP.13.61; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cheong Y, 2017, NANOMATERIALS, V7, P1; Cloutman-Green EA, 2015, THESIS; FDA, 2015, PHARM MICR MAN, P3; Ge LP, 2014, INT J NANOMED, V9, P2399, DOI 10.2147/IJN.S55015; Ghasemian E, 2015, JUNISHAPUR J MICROBI, V8, P4; Hsueh YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040793; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Li KG, 2013, ACS NANO, V7, P9664, DOI 10.1021/nn402472k; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Mirzajani F, 2011, RES MICROBIOL, V162, P542, DOI 10.1016/j.resmic.2011.04.009; Napoli C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-594; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Pan HM, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0222-6; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Ren G, 2013, Patent No. [US 2013/ 0091611 A1, 20130091611]; Ren GG, 2009, INT J ANTIMICROB AG, V33, P587, DOI 10.1016/j.ijantimicag.2008.12.004; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Richter AP, 2015, NAT NANOTECHNOL, V10, P817, DOI [10.1038/nnano.2015.141, 10.1038/NNANO.2015.141]; Schwartz T, 2006, FEMS MICROBIOL ECOL, V57, P158, DOI 10.1111/j.1574-6941.2006.00100.x; Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x; Syed MA, 2010, NEW MICROBIOL, V33, P329; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Truchado P, 2016, FOOD CONTROL, V62, P150, DOI 10.1016/j.foodcont.2015.10.014; Vyshnava SS, 2016, APPL BIOCHEM BIOTECH, V180, P426, DOI 10.1007/s12010-016-2107-7; Walker JT, 2014, WOODH PUBL SER BIOM, V62, P3, DOI 10.1533/9780857096692.1.3; Wang LL, 2017, INT J NANOMED, V12, P1227, DOI 10.2147/IJN.S121956; Wang W, 2006, J BIOMED MATER RES A, V77A, P28, DOI 10.1002/jbm.a.30627	38	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192093	10.1371/journal.pone.0192093	http://dx.doi.org/10.1371/journal.pone.0192093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390022	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400066
J	Cooper, N; Milella, F; Pinto, C; Cant, I; White, M; Meyer, G				Cooper, Natalia; Milella, Ferdinando; Pinto, Carlo; Cant, Iain; White, Mark; Meyer, Georg			The effects of substitute multisensory feedback on task performance and the sense of presence in a virtual reality environment	PLOS ONE			English	Article							MULTIMODAL FEEDBACK; IMMERSION; ATTENTION; TACTILE; CUES; FIDELITY; INPUT	Objective and subjective measures of performance in virtual reality environments increase as more sensory cues are delivered and as simulation fidelity increases. Some cues (colour or sound) are easier to present than others (object weight, vestibular cues) so that substitute cues can be used to enhance informational content in a simulation at the expense of simulation fidelity. This study evaluates how substituting cues in one modality by alternative cues in another modality affects subjective and objective performance measures in a highly immersive virtual reality environment. Participants performed a wheel change in a virtual reality (VR) environment. Auditory, haptic and visual cues, signalling critical events in the simulation, were manipulated in a factorial design. Subjective ratings were recorded via questionnaires. The time taken to complete the task was used as an objective performance measure. The results show that participants performed best and felt an increased sense of immersion and involvement, collectively referred to as 'presence', when substitute multi-modal sensory feedback was provided. Significant main effects of audio and tactile cues on task performance and on participants' subjective ratings were found. A significant negative relationship was found between the objective (overall completion times) and subjective (ratings of presence) performance measures. We conclude that increasing informational content, even if it disrupts fidelity, enhances performance and user's overall experience. On this basis we advocate the use of substitute cues in VR environments as an efficient method to enhance performance and user experience.	[Cooper, Natalia] CNR, Construct Res Ctr, Ottawa, ON, Canada; [Milella, Ferdinando] UKAEA, Culham Sci Ctr, Abingdon, Oxon, England; [Pinto, Carlo; Cant, Iain] Virtual Engn Ctr, Daresbury, England; [White, Mark; Meyer, Georg] Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England	National Research Council Canada; Culham Science Centre; UK Atomic Energy Authority; University of Liverpool	Cooper, N (corresponding author), CNR, Construct Res Ctr, Ottawa, ON, Canada.	Natalia.Cooper@nrc-cnrc.gc.ca	White, Mark/AAG-8761-2020	White, Mark/0000-0002-8611-9525; Meyer, Georg/0000-0002-3739-1653	ESRC Case award [DTC ES/J500094/1]	ESRC Case award(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by ESRC Case award (North West DTC ES/J500094/1) to NC, funder website http://www.esrc.ac.uk/. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.; This study was funded by ESRC Case award (North West DTC ES/J500094/1), funder website http://www.esrc.ac.uk/. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript. The findings of this study have been previously presented at the European Conference of Virtual Reality, EURO VR 2015, Lecco, Italy.	Adams R. J., 2001, ELECT J HAPTICS RES, V2, P1; AKAMATSU M, 1995, ERGONOMICS, V38, P816, DOI 10.1080/00140139508925152; BARFIELD W, 1995, PRESENCE-TELEOP VIRT, V4, P329, DOI 10.1162/pres.1995.4.4.329; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Bowman DA, 2007, COMPUTER, V40, P36, DOI 10.1109/MC.2007.257; Burke Jennifer L, 2006, ICMI 06 P 8 INT C MU, P108, DOI DOI 10.1145/1180995.1181017; Bystrom KE, 1999, PRESENCE-TELEOP VIRT, V8, P241, DOI 10.1162/105474699566107; Cairns P, 2006, COGSCI 2006 WORKSH C; Cao, 2006, P HUM FACT ERG SOC A, P1029; Carassa A., 2004, P 7 ANN INT WORKSH P, P7; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; Dahlstrom N, 2009, THEOR ISS ERGON SCI, V10, P305, DOI 10.1080/14639220802368864; Dalley P, 2004, ANESTH ANALG, V99, P1737, DOI 10.1213/01.ANE.0000136804.46675.EA; Davison BK., 2009, BILLBOARD, P91; Dede C, 2009, SCIENCE, V323, P66, DOI 10.1126/science.1167311; Dinh HQ, 1999, P IEEE VIRT REAL ANN, P222, DOI 10.1109/VR.1999.756955; Faas D, 2014, AI EDAM, V28, P139, DOI 10.1017/S0890060414000055; Feintuch U, 2006, CYBERPSYCHOL BEHAV, V9, P129, DOI 10.1089/cpb.2006.9.129; Ferwerda JA, 2003, PROC SPIE, V5007, P290, DOI 10.1117/12.473899; Gurusamy K, 2008, BRIT J SURG, V95, P1088, DOI 10.1002/bjs.6344; Gutierrez F, 2007, STUD HEALTH TECHNOL, V125, P155; Hecht D, 2008, EXP BRAIN RES, V185, P655, DOI 10.1007/s00221-007-1191-x; Ho C, 2005, J EXP PSYCHOL-APPL, V11, P157, DOI 10.1037/1076-898X.11.3.157; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Hopp PJ, 2005, HUM FACTORS, V47, P1, DOI 10.1518/0018720053653884; Jacko J, 2004, BEHAV INFORM TECHNOL, V23, P247, DOI 10.1080/01449290310001659213; Jennett C, 2008, INT J HUM-COMPUT ST, V66, P641, DOI 10.1016/j.ijhcs.2008.04.004; Jerome CJ, THESIS; Jia DW, 2011, PROCEEDINGS OF THE ASME WORLD CONFERENCE ON INNOVATIVE VIRTUAL REALITY - 2011, P263; Laha B, 2012, IEEE T VIS COMPUT GR, V18, P597, DOI 10.1109/TVCG.2012.42; Lee M, 2013, VIRTUAL REAL-LONDON, V17, P293, DOI 10.1007/s10055-013-0230-0; Lombard M., 1997, J COMPUT MEDIATED CO, V3; Ma RQ, 2006, INT J HUM-COMPUT ST, V64, P541, DOI 10.1016/j.ijhcs.2005.12.003; Martinez J, 2011, 2011 INTERNATIONAL CONFERENCE ON CYBERWORLDS, P62, DOI 10.1109/CW.2011.23; Massie TH, 1994, ASME S HAPT INT VIRT, V55, P295; McMahan R. P., 2006, P ACM S VIRT REAL SO, P108, DOI [DOI 10.1145/1180495.1180518, 10.1145/1180495.1180518]; Meyer GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067651; Meyer GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044381; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Nam CS, 2008, COMPUT HUM BEHAV, V24, P1404, DOI 10.1016/j.chb.2007.07.014; Oakley B., THESIS; Oviatt S, 2004, P 6 INT C MULT INT, P129, DOI DOI 10.1145/1027933.1027957; Pietschmann Daniel, 2014, Virtual, Augmented and Mixed Reality. Designing and Developing Virtual and Augmented Environments. 6th International Conference, VAMR 2014, Held as Part of HCI International 2014. Proceedings: LNCS 8525, P406, DOI 10.1007/978-3-319-07458-0_38; Ramsamy P, 2006, LECT NOTES COMPUT SC, V3992, P603, DOI 10.1007/11758525_81; Richard P, 1995, RO-MAN'95 TOKYO: 4TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN COMMUNICATION, PROCEEDINGS, P301, DOI 10.1109/ROMAN.1995.531976; Richard P., 2006, INT J VIRTUAL REALIT, V5, P37, DOI 10.20870/ijvr.2006.5.2.2687; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Schuchardt P, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P121, DOI 10.1115/IMECE2007-43781; Sebok A., 2004, P 7 INT WORKSH PRES, P266; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Shi Y, 2007, CHI 07 EXTENDED ABST, P2651, DOI [10.1145/1240866.1241057, DOI 10.1145/1240866.1241057]; Slater M, 1999, PRESENCE-TELEOP VIRT, V8, P560, DOI 10.1162/105474699566477; Slater M, 1996, P ACM S VIRT REAL SO, P163; Slater M., 2003, PRESENCE CONNECT, V3, P1; Spelmezan D, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2243; Stevens J.A., 2015, OPEN J MODEL SIMUL, V3, P41, DOI [10.4236/ojmsi.2015.32005, DOI 10.4236/OJMSI.2015.32005]; van der Linden J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P533; Van Erp JBF, 2004, TRANSPORT RES F-TRAF, V7, P247, DOI 10.1016/j.trf.2004.09.003; Viaud-Delmon I, 2006, EUR PSYCHIAT, V21, P501, DOI 10.1016/j.eurpsy.2004.10.004; Vitense HS, 2003, ERGONOMICS, V46, P68, DOI 10.1080/00140130303534; Weber B., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P349, DOI 10.1109/WHC.2011.5945511; Witmer B. G., 1994, MEASURING PRESENCE V; Witmer BG, 2005, PRESENCE-TELEOP VIRT, V14, P298, DOI 10.1162/105474605323384654; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Youngblut C, 2003, P IEEE VIRT REAL ANN, P277, DOI 10.1109/VR.2003.1191158; Youngblut C., 2002, IMAGE C 2002 AR; Youngblut Ch, 2003, IDAD2960 I DEF AN AL	69	47	47	11	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191846	10.1371/journal.pone.0191846	http://dx.doi.org/10.1371/journal.pone.0191846			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390023	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400039
J	Gurgul, A; Romanek, J; Pawlina-Tyszko, K; Szmatola, T; Opiela, J				Gurgul, Artur; Romanek, Joanna; Pawlina-Tyszko, Klaudia; Szmatola, Tomasz; Opiela, Jolanta			Evaluation of changes arising in the pig mesenchymal stromal cells transcriptome following cryopreservation and Trichostatin A treatment	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; DIFFERENTIATION; IDENTIFICATION; MITOCHONDRIA; PERMEABILITY; CYTOSKELETON; ANNOTATION; VIABILITY; APOPTOSIS	Cryopreservation is an important procedure in maintenance and clinical applications of mesenchymal stem/stromal cells (MSCs). Although the methods of cell freezing using various cryoprotectants are well developed and allow preserving structurally intact living cells, the freezing process can be considered as a severe cellular stress associated with ice formation, osmotic damage, cryoprotectants migration/cytotoxicity or rapid cell shrinkage. The cellular response to freezing stress is aimed at the restoring of homeostasis and repair of cell damage and is crucial for cell viability. In this study we evaluated the changes arising in the pig mesenchymal stromal cell transcriptome following cryopreservation and showed the vast alterations in cell transcriptional activity (5,575 genes with altered expression) suggesting the engagement in post-thawing cell recovery of processes connected with cell membrane tension regulation, membrane damage repair, cell shape maintenance, mitochondria-connected energy homeostasis and apoptosis mediation. We also evaluated the effect of known gene expression stimulator-Trichostain A (TSA) on the frozen/thawed cells transcriptome and showed that TSA is able to counteract to a certain extent transcriptome alterations, however, its specificity and advantages for cell recovery after cryopreservation require further studies.	[Gurgul, Artur; Pawlina-Tyszko, Klaudia; Szmatola, Tomasz] Natl Res Inst Anim Prod, Dept Genom & Mol Biol, Balice, Poland; [Romanek, Joanna; Opiela, Jolanta] Natl Res Inst Anim Prod, Dept Anim Reprod Biotechnol, Balice, Poland	National Research Institute of Animal Production; National Research Institute of Animal Production	Opiela, J (corresponding author), Natl Res Inst Anim Prod, Dept Anim Reprod Biotechnol, Balice, Poland.	jolanta.opiela@izoo.krakow.pl	Gurgul, Artur/M-9480-2015	Gurgul, Artur/0000-0001-5979-144X; Opiela, JOlanta/0000-0002-0194-9002; Szmatola, Tomasz/0000-0003-1588-4198; Pawlina-Tyszko, Klaudia/0000-0003-3926-9595	Polish National Science Centre [2014/15/B/NZ9/04288]	Polish National Science Centre	This research was supported by the Polish National Science Centre resources allocated on the basis of decision number 2014/15/B/NZ9/04288 to JO.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balasubramanian SK, 2011, EFFECT CELL ATTACHME; Bhakta G, 2009, BIOMATERIALS, V30, P336, DOI 10.1016/j.biomaterials.2008.09.030; Bissoyi A, 2014, BIOPRESERV BIOBANK, V12, P246, DOI 10.1089/bio.2014.0005; Bourin P, 2008, TRANSFUS MED HEMOTH, V35, P160, DOI 10.1159/000124734; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Dasiman R, 2013, MED SCI MONIT BASIC, V19, P258, DOI 10.12659/MSMBR.884019; De Rosa A., 2009, TISSUE ENG PART C-ME, V15, P660; Ding G, 2010, J CELL PHYSIOL, V223, P415, DOI 10.1002/jcp.22050; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Figueroa E, 2017, REV AQUACULT, V9, P76, DOI 10.1111/raq.12105; FISHBEIN WN, 1978, CRYOBIOLOGY, V15, P168, DOI 10.1016/0011-2240(78)90021-4; Gao D, 2000, ILAR J, V41, P187; GAO DY, 1995, HUM REPROD, V10, P1109, DOI 10.1093/oxfordjournals.humrep.a136103; Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8; Goh BC, 2007, J TISSUE ENG REGEN M, V1, P322, DOI 10.1002/term.35; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gulbins E, 2003, EXP PHYSIOL, V88, P85, DOI 10.1113/eph8802503; Gurgul A, 2017, BIOCHIMIE, V139, P56, DOI 10.1016/j.biochi.2017.05.015; Han B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081781; Hirose M, 2004, MAT SCI ENG C-BIO S, V24, P355, DOI 10.1016/j.msec.2003.12.011; Hoogendoorn RJW, 2008, J CELL MOL MED, V12, P2205, DOI 10.1111/j.1582-4934.2008.00291.x; Huang B, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0018-0; Janz FD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/649353; Katkov II, 2006, CRYOBIOLOGY, V53, P194, DOI 10.1016/j.cryobiol.2006.05.005; Katska-Ksiazkiewicz L, 2007, THERIOGENOLOGY, V68, P736, DOI 10.1016/j.theriogenology.2007.06.016; Katska-Ksiazkiewicz L, 2009, J ANIM FEED SCI, V18, P257; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kotobuki N, 2005, TISSUE ENG, V11, P663, DOI 10.1089/ten.2005.11.663; Le Bihan T, 2005, J COLLOID INTERF SCI, V288, P88, DOI 10.1016/j.jcis.2005.02.090; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu BL, 2005, P ANN INT IEEE EMBS, P4896, DOI 10.1109/IEMBS.2005.1615570; Liu GP, 2008, CRYOBIOLOGY, V57, P18, DOI 10.1016/j.cryobiol.2008.04.002; Liu K, 2000, TISSUE ENG, V6, P539, DOI 10.1089/107632700750022189; Liu Y, 2010, BIOTECHNOL PROGR, V26, P1635, DOI 10.1002/btpr.464; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marquez-Curtis LA, 2015, CRYOBIOLOGY, V71, P181, DOI 10.1016/j.cryobiol.2015.07.003; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1989, CRYOBIOLOGY, V26, P1, DOI 10.1016/0011-2240(89)90030-8; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Moon JH, 2008, STEM CELLS DEV, V17, P713, DOI 10.1089/scd.2007.0210; Nishiyama Y, 2016, NEUROSCI RES, V107, P20, DOI 10.1016/j.neures.2015.11.011; Noiles EE, 1997, CRYOBIOLOGY, V35, P79, DOI 10.1006/cryo.1997.2033; Oh IH, 2012, STEM CELLS, V30, P82, DOI 10.1002/stem.776; Opiela J, 2016, ANN ANIM SCI, V16, P369, DOI 10.1515/aoas-2015-0065; Pacheco S, 2008, THESIS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Riesco MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067614; Samiec M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814686; Samiec M, 2013, ANN ANIM SCI, V13, P275, DOI 10.2478/aoas-2013-0009; Samiec M, 2012, ANIM SCI PAP REP, V30, P383; SCHNEIDER U, 1984, THERIOGENOLOGY, V21, P68, DOI 10.1016/0093-691X(84)90307-8; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Skidmore JA, 2009, ANIM REPROD SCI, V113, P196, DOI 10.1016/j.anireprosci.2008.07.006; Steponkus P. L., 1979, Low temperature stress on crop plants. The role of the membrane., P231; Takamatsu H, 2005, J BIOMECH, V38, P117, DOI 10.1016/j.jbiomech.2004.03.011; Telles Elphine, 2012, Front Biosci (Schol Ed), V4, P831; Terry C, 2007, CELL TRANSPLANT, V16, P639, DOI 10.3727/000000007783465000; Tokumoto Sayaka, 2008, J Med Dent Sci, V55, P137; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wagh V, 2011, STEM CELL REV REP, V7, P506, DOI 10.1007/s12015-011-9230-1; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang XD, 2001, GENE DEV, V15, P2922; Wang X, 2007, CRYOBIOLOGY, V55, P60, DOI 10.1016/j.cryobiol.2007.05.006; WILLIAMS RJ, 1968, CRYOBIOLOGY, V4, P250; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0144-1; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhu XF, 2013, ZOOL SCI, V30, P1032, DOI 10.2108/zsj.30.1032	78	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192147	10.1371/journal.pone.0192147	http://dx.doi.org/10.1371/journal.pone.0192147			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390033	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400071
J	Guaricci, AI; Carita, P; Lorenzoni, V; Casavecchia, G; Rabbat, M; Ieva, R; Brunetti, ND; Andreini, D; Di Biase, M; Marenzi, G; Bartorelli, A; Pepi, M; Pontone, G				Guaricci, Andrea Igoren; Carita, Patrizia; Lorenzoni, Valentina; Casavecchia, GraziaPia; Rabbat, Mark; Ieva, Riccardo; Brunetti, Natale Daniele; Andreini, Daniele; Di Biase, Matteo; Marenzi, Giancarlo; Bartorelli, Antonio; Pepi, Mauro; Pontone, Gianluca			QT-interval evaluation in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction for prediction of myocardial salvage index	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; END-SYSTOLIC VOLUME; RECOVERY; SIZE; PROLONGATION; ANGIOPLASTY; OUTCOMES; CMR	Assessing the efficacy of revascularization therapy in patients with ST-segment elevation myocardial infarction (STEMI) is extremely important in order to guide subsequent management and assess prognosis. We aimed to determine the relationship between corrected QT-interval (QTc) changes on standard sequential ECG and myocardial salvage index in anterior STEMI patients after successful primary percutaneous coronary intervention. Fifty anterior STEMI patients treated by primary percutaneous coronary intervention underwent quantitative ECG analysis and cardiac magnetic resonance. For each patient the difference (Delta QTc) between the QTc of ischemic myocardium (maximum QTc in anterior leads) versus remote myocardium (minimum QTc in inferior leads) during the first six days after STEMI was measured. The QTc in anterior leads was significantly longer than QTc in inferior leads (p<0.0001). At multivariate analysis, Delta QT(C) and peak troponin I were the only independent predictors for late gadolium enhancement while Delta QTc and left ventricular ejection fraction were independent predictors of myocardial salvage index < 60%. The receiver operative curve of Delta QTc showed an area under the curve of 0.77 to predict a myocardial salvage index < 0.6. In conclusion, in a subset of patients with a first occurrence of early revascularized anterior STEMI, Delta QTc is inversely correlated with CMR-derived myocardial salvage index and may represent a useful parameter for assessing efficacy of reperfusion therapy.	[Guaricci, Andrea Igoren] Univ Hosp Policlin Bari, Dept Emergency & Organ Transplantat, Inst Cardiovasc Dis, Bari, Italy; [Guaricci, Andrea Igoren; Casavecchia, GraziaPia; Ieva, Riccardo; Brunetti, Natale Daniele; Di Biase, Matteo] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Carita, Patrizia] Univ Hosp P Giaccone, Dept Cardiol, Palermo, Italy; [Lorenzoni, Valentina] Scuola Super Sant Anna, Florence, Italy; [Rabbat, Mark] Loyola Univ, Chicago, IL 60611 USA; [Rabbat, Mark] Edward Hines Jr VA Hosp, Hines, IL USA; [Andreini, Daniele; Marenzi, Giancarlo; Bartorelli, Antonio; Pepi, Mauro; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Andreini, Daniele] Univ Milan, Dept Cardiovasc Sci & Community Hlth, Milan, Italy; [Bartorelli, Antonio] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy	Universita degli Studi di Bari Aldo Moro; University of Foggia; University of Palermo; Policlinico Paolo Giaccone; Scuola Superiore Sant'Anna; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; Luigi Sacco Hospital	Pontone, G (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	gianluca.pontone@ccfm.it	Brunetti, Natale Daniele/S-9131-2019; Andreini, Daniele/ABG-9647-2020; Rabbat, Mark/AAS-9710-2021; Bartorelli, Antonio/K-3955-2018; Lorenzoni, Valentina/K-5306-2018; Bartorelli, Antonio Luca/ABG-9593-2020	Brunetti, Natale Daniele/0000-0001-9610-7408; Lorenzoni, Valentina/0000-0002-9948-0301; Pontone, Gianluca/0000-0002-1339-6679; Marenzi, Giancarlo/0000-0003-4410-4461				Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Bonnemeier H, 2001, J AM COLL CARDIOL, V37, P44, DOI 10.1016/S0735-1097(00)01061-5; Brunetti ND, 2016, AM J THER, V23, pE1057, DOI 10.1097/MJT.0000000000000301; Dall'Armellina E, 2011, CIRC-CARDIOVASC IMAG, V4, P228, DOI 10.1161/CIRCIMAGING.111.963421; de Waha S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-249; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Galluzzo A, 2015, J CARDIOVASC MED, V16, P1; Greupner J, 2012, J AM COLL CARDIOL, V59, P1897, DOI 10.1016/j.jacc.2012.01.046; Guaricci AI, 2015, J CARDIOVASC MED, V16, P653, DOI 10.2459/JCM.0000000000000267; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Larose E, 2010, J AM COLL CARDIOL, V55, P2459, DOI 10.1016/j.jacc.2010.02.033; Maffei E, 2012, EUR RADIOL, V22, P1041, DOI 10.1007/s00330-011-2345-6; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Pontone G, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004956; Pontone G, 2016, EUR RADIOL, V26, P2155, DOI 10.1007/s00330-015-4064-x; Pontone G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/297696; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622; Zimarino M, 2011, HEART, V97, P466, DOI 10.1136/hrt.2010.206003	23	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192220	10.1371/journal.pone.0192220	http://dx.doi.org/10.1371/journal.pone.0192220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420570	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900054
J	Bamorovat, M; Sharifi, I; Aflatoonian, MR; Sharifi, H; Karamoozian, A; Sharifi, F; Khosravi, A; Hassanzadeh, S				Bamorovat, Mehdi; Sharifi, Iraj; Aflatoonian, Mohammad Reza; Sharifi, Hamid; Karamoozian, Ali; Sharifi, Fatemeh; Khosravi, Ahmad; Hassanzadeh, Saeid			Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; MORPHINE; DIAGNOSIS; PROVINCE; DRUGS	Cutaneous leishmaniasis (CL) is a serious health challenge at the global level due to Leishmania tropica. This study was conducted to evaluate the risk factors associated with anthroponotic CL (ACL) in unresponsive (patient who does not heal and remains with an active lesion, despite receiving two courses of intra-lesional Glucantime along with cryotherapy and one cycle of systemic Glucantime) and responsive patients in a major focus in southeastern Iran. A case-control study was conducted from April 2015 to October 2016 in the southeast of Iran. Patients were recruited in a major ACL focus from unresponsive and responsive cases. These patients were compared for environmental, clinical, and demographic characteristic factors. Twenty-five risk related factors were analyzed using multivariate logistic regression and backward elimination stepwise models. P<0.05 was defined to be statistically significant. In general, 340 patients with ACL comprising 72 (21.2%) unresponsive cases and 268 (78.8%) responsive cases with active lesions or scars were analyzed by estimating odds ratio (OR). All isolates from 15 responsive and 15 unresponsive patients were characterized as Leishmania tropica based on the BLAST and phylogenic analyses by PCR sequences of the Hsp70 and ITS1 loci. Among the 25 variables, 4 major risk factors including poor interior housing conditions (OR = 1.99, confidence interval (CI) = 1-3.93, P<0.04), history of chronic diseases (OR = 6.22, CI = 2.51-15.44, P <= 0.001), duration of lesion in the patients referred >= 13 months (OR = 74.99, CI = 17.24-326.17, P <= 0.001), and 5 +/- 12 months (OR=7.42,CI = 3.07-17.92, P <= 0.001) than lesions with <= 4 months of age and age groups >= 51 years (OR = 3.85, CI = 1.04-14.22, P<0.04) than those <= 7 years, were significantly associated with unresponsive forms. Improving interior house construction protecting high risk individuals and those with debilitating diseases from being bitten by sand flies, together with the early detection and effective treatment of older age groups with history of chronic diseases are highly important measures for preventing unresponsive forms in patients with ACL in southeastern Iran.	[Bamorovat, Mehdi; Sharifi, Iraj; Khosravi, Ahmad] Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran; [Aflatoonian, Mohammad Reza] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr, Kerman, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Karamoozian, Ali] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Sharifi, Fatemeh] Kerman Univ Med Sci, Inst Neuropharmacol, Pharmaceut Res Ctr, Kerman, Iran; [Hassanzadeh, Saeid] Shahid Bahonar Univ Kerman, Dept Pathobiol, Fac Vet Med, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Shahid Bahonar University of Kerman (SBUK)	Sharifi, I (corresponding author), Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran.	iraj.sharifi@yahoo.com	Sharifi, Fatemeh/AAA-3666-2019; Sharifi, Hamid/B-5493-2019; Karamoozian, Ali/AAX-7523-2021; Khosravi, Ahmad/AAA-5264-2019; Sharifi, Iraj/AAY-8267-2020; Bamorovat, Mehdi/AAD-3051-2021; Reza, Aflatoonian Mohammad/Y-2246-2018	Sharifi, Fatemeh/0000-0003-1711-0540; Sharifi, Hamid/0000-0002-9008-7618; Bamorovat, Mehdi/0000-0002-4900-4278; Reza, Aflatoonian Mohammad/0000-0002-2148-6690; Karamoozian, Ali/0000-0002-1677-2852; Sharifi, Iraj/0000-0002-6894-6834	Kerman University of Medical Sciences, Kerman, Iran [94.621, IR.KMU.REC.1394.115]	Kerman University of Medical Sciences, Kerman, Iran	This study was supported by the Vice-Chancellor for Research, Kerman University of Medical Sciences (ethic no. IR.KMU.REC.1394.115, contract no. 94.621), Kerman, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Vice-Chancellor for Research, Kerman University of Medical Sciences (contract no. 94.621), Kerman, Iran. We thank Mrs S. Nikpoor for editing the manuscript and Mr M.A. Mohammadi for his help in molecular examinations.	Aflatoonian B., 2016, IRANIAN J EPIDEMIOLO, V12, P28; Aflatoonian MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089043; Allahverdiyev AM, 2005, AM J TROP MED HYG, V73, P276, DOI 10.4269/ajtmh.2005.73.276; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BUSSIERE JL, 1992, IMMUNOPHARM IMMUNOT, V14, P657, DOI 10.3109/08923979209005416; Desjeux P, 2001, MED MICROBIOL IMMUN, V190, P77, DOI 10.1007/s004300100085; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Chaves LF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-164; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; Gouya M. M., 2010, NATL GUIDELINES CUTA, P1; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Karimi A, 2014, ACTA TROP, V132, P131, DOI 10.1016/j.actatropica.2014.01.004; Khazaei S, 2015, ARCH CLIN INFECT DIS, V10, DOI 10.5812/archcid.28511; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Lysle DT, 2000, IMMUNOPHARMACOLOGY, V46, P181, DOI 10.1016/S0162-3109(99)00172-1; Malaviya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106771; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; MOLITOR TW, 1992, J PHARMACOL EXP THER, V260, P581; Mostafavi R., 2013, ARCH HYG SCI, V2, P48; Murback Nathalia Dias Negrão, 2011, An. Bras. Dermatol., V86, P55, DOI 10.1590/S0365-05962011000100007; Natera S, 2007, INT J ANTIMICROB AG, V29, P637, DOI 10.1016/j.ijantimicag.2007.01.004; Norouzinezhad F, 2016, ASIAN PAC J TROP BIO, V6, P614, DOI 10.1016/j.apjtb.2016.05.005; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; PETERSON PK, 1987, J IMMUNOL, V138, P3907; Reithinger R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000639; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Sarkari B, 2012, IRAN J PUBLIC HEALTH, V41, P94; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Sharifi I, 2015, IRAN J PUBLIC HEALTH, V44, P299; SISON JP, 1995, CLIN INFECT DIS, V20, P1207, DOI 10.1093/clinids/20.5.1207; Van der Auwera G, 2013, EUROSURVEILLANCE, V18, P40, DOI 10.2807/1560-7917.ES2013.18.30.20543; van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14; Van der Auwera G, 2014, J CLIN MICROBIOL, V52, P1098, DOI 10.1128/JCM.02936-13; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; World Health Organization, 2010, CONTR LEISHM REP M W; World Health Organization, 2016, WEEKL EP REC REL EP; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zampieri RA, 2016, PLOS NEGLECT TROP D, V10, P1	41	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192236	10.1371/journal.pone.0192236	http://dx.doi.org/10.1371/journal.pone.0192236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415078	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300061
J	Jeong, J; Frohberg, NJ; Zhou, EL; Sulchek, T; Qiu, P				Jeong, Jenny; Frohberg, Nicholas J.; Zhou, Enlu; Sulchek, Todd; Qiu, Peng			Accurately tracking single-cell movement trajectories in microfluidic cell sorting devices	PLOS ONE			English	Article								Microfluidics are routinely used to study cellular properties, including the efficient quantification of single-cell biomechanics and label-free cell sorting based on the biomechanical properties, such as elasticity, viscosity, stiffness, and adhesion. Both quantification and sorting applications require optimal design of the microfluidic devices and mathematical modeling of the interactions between cells, fluid, and the channel of the device. As a first step toward building such a mathematical model, we collected video recordings of cells moving through a ridged microfluidic channel designed to compress and redirect cells according to cell biomechanics. We developed an efficient algorithm that automatically and accurately tracked the cell trajectories in the recordings. We tested the algorithm on recordings of cells with different stiffness, and showed the correlation between cell stiffness and the tracked trajectories. Moreover, the tracking algorithm successfully picked up subtle differences of cell motion when passing through consecutive ridges. The algorithm for accurately tracking cell trajectories paves the way for future efforts of modeling the flow, forces, and dynamics of cell properties in microfluidics applications.	[Jeong, Jenny; Frohberg, Nicholas J.; Qiu, Peng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Jeong, Jenny; Frohberg, Nicholas J.; Qiu, Peng] Emory Univ, Atlanta, GA 30322 USA; [Jeong, Jenny] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Zhou, Enlu] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Sulchek, Todd] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Qiu, P (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.; Qiu, P (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	peng.qiu@bme.gatech.edu		Qiu, Peng/0000-0003-3256-0734	National Science Foundation [CCF 1552784]; National Institute of Health [R01 CA163481]; Division of Computing and Communication Foundations [1552784] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants from the National Institute of Health R01 CA163481 to PQ and National Science Foundation CCF 1552784 to PQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from the National Science Foundation (CCF 1552784) and the National Institute of Health (R01 CA163481).	Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi SY, 2012, LAB CHIP, V12, P1427, DOI 10.1039/c2lc21225k; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Islam M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01807-z; Kellogg RA, 2014, NAT PROTOC, V9, P1713, DOI 10.1038/nprot.2014.120; Kimmerling RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10220; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mao WB, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3590264; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shields CW, 2015, LAB CHIP, V15, P1230, DOI 10.1039/c4lc01246a; Tasadduq B, 2017, ANAL CHEM, V89, P11545, DOI 10.1021/acs.analchem.7b02878; Wang GH, 2015, LAB CHIP, V15, P532, DOI 10.1039/c4lc01150c; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075901; Zheng Y, 2013, LAB CHIP, V13, P2464, DOI [10.1039/c31c50355k, 10.1039/c3lc50355k]	15	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192463	10.1371/journal.pone.0192463	http://dx.doi.org/10.1371/journal.pone.0192463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414993	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300077
J	Ramadan, S; Nowier, AM; Hori, Y; Inoue-Murayama, M				Ramadan, Sherif; Nowier, Amira M.; Hori, Yusuke; Inoue-Murayama, Miho			The association between glutamine repeats in the androgen receptor gene and personality traits in dromedary camel (Camelus dromedarius)	PLOS ONE			English	Article							LENGTH POLYMORPHISM; PANIC DISORDER; FEAR REACTIONS; DAIRY-COWS; BEHAVIOR; CAG; RESPONSIVENESS; TEMPERAMENT; ANXIETY; STRESS	Temperament traits such as fearfulness are important as they define an animal's responses to its environment and handling. The increasing automation of daily tasks and growing population limits contact between camels and humans. Such limitations contribute to fear of humans and changes in physical environment. Monoamine oxidase A (MAOA) and androgen receptor (AR) genes are important candidates associated with mammal personality. In our analysis, MAOA exon 15 showed no polymorphism but a novel polymorphism was seen in the camel AR exon 1; 16, 17, 18, and 19 glutamine repeats were detected. We genotyped 138 camels belonging to four Egyptian breeds: Maghrabi (n = 90), Sudani (n = 15), Somali (n = 23), and Baladi (n = 10) for AR. Out of the 90 genotyped Maghrabi camels, we evaluated responses of 33 and 32 mature females to a novel object and exposure to an unfamiliar person, respectively. AR gene showed a significant association based on the principal component (PC) score, which indicated the fear of human touch, and the PC score indicates fear during interaction with novel objects. Individuals carrying a shorter genotype in homozygote (S/S) were found to be more fearful. Furthermore, we found that Sudani and Somali breeds had a higher frequency of shorter genotype (S/S), which was associated with increased fearfulness. These findings reflect the behavioral tendency and consequently, affect the use of this breed. This is the first report showing the role of AR glutamine repeats influencing a behavioral trait in dromedary camels and leading to inter-breed differences. Fear-related traits reported here are important because camels cope with various types of stresses and fear, resulting from the demands of intensive production systems and racing events. However, further studies, employing functional genomics and linkage analysis are necessary for confirming the relationship between fearfulness and genetic variation.	[Ramadan, Sherif; Hori, Yusuke; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Ramadan, Sherif] Benha Univ, Fac Vet Med, Moshtohor, Egypt; [Nowier, Amira M.] Anim Prod Res Inst, Biotechnol Res Dept, Dokki, Egypt; [Hori, Yusuke] Kyoto Univ, Grad Sch Letters, Kyoto, Japan; [Inoue-Murayama, Miho] Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan	Kyoto University; Egyptian Knowledge Bank (EKB); Benha University; Kyoto University; National Institute for Environmental Studies - Japan	Inoue-Murayama, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.; Inoue-Murayama, M (corresponding author), Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan.	mmurayama@wrc.kyoto-u.ac.jp	Ramadan, Sherif/AAY-5228-2020; ramadann, sherif/AAX-4992-2020	ramadann, sherif/0000-0001-5151-5520	JSPS KAKENHI [25290082]; Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS); Egyptian Ministry of Higher Education; Grants-in-Aid for Scientific Research [16H05801] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by JSPS KAKENHI Grant Number 25290082 to MI-M, Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS) to MI-M, and the Egyptian Ministry of Higher Education to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Benhajali H, 2010, J ANIM SCI, V88, P3529, DOI 10.2527/jas.2010-3132; BOISSY A, 1994, HORM BEHAV, V28, P66, DOI 10.1006/hbeh.1994.1006; Bouissou MF, 1996, HORM BEHAV, V30, P93, DOI 10.1006/hbeh.1996.0013; Butovskaya ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136208; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Crabbe P, 2007, J CLIN ENDOCR METAB, V92, P3604, DOI 10.1210/jc.2007-0117; D'Eath RB, 2010, ANIM WELFARE, V19, P17; Fatnassi M, 2014, TROP ANIM HEALTH PRO, V46, P861, DOI 10.1007/s11250-014-0577-6; Faye B, 2012, P 3 ISOCARD C 29 JAN, P2; Gauly M, 2002, J ANIM BREED GENET, V119, P379, DOI 10.1046/j.1439-0388.2002.00360.x; Gibbons J, 2009, APPL ANIM BEHAV SCI, V116, P163, DOI 10.1016/j.applanim.2008.08.009; Gong PY, 2017, PSYCHONEUROENDOCRINO, V80, P74, DOI 10.1016/j.psyneuen.2017.03.008; Grandinson K, 2005, LIVEST PROD SCI, V93, P43, DOI 10.1016/j.livprodsci.2004.11.005; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hedlund L., 2013, MS THESIS; Hedlund L, 2015, J DAIRY SCI, V98, P5819, DOI 10.3168/jds.2014-8667; Hong KW, 2006, PRIMATES, V47, P248, DOI 10.1007/s10329-005-0174-4; Hong KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022144; Hori Y, 2016, ANIM GENET, V47, P62, DOI 10.1111/age.12384; Idris A, 2015, EFFECT MANAGEMENT SY; Ito H, 2015, META GENE, V5, P120, DOI 10.1016/j.mgene.2015.06.006; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Konno A, 2011, BIOL LETTERS, V7, P658, DOI 10.1098/rsbl.2011.0087; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nenonen H, 2010, MOL HUM REPROD, V16, P153, DOI 10.1093/molehr/gap097; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Rushen J, 2001, APPL ANIM BEHAV SCI, V73, P1, DOI 10.1016/S0168-1591(01)00105-8; Sheppard RL, 2011, PHYSIOL GENOMICS, V43, P1135, DOI 10.1152/physiolgenomics.00049.2011; Shih J. C., 1999, Neurobiology (Budapest), V7, P235; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tadic A, 2003, AM J MED GENET B, V117B, P1, DOI 10.1002/ajmg.b.10013; Turner SP, GENES ANIMAL BEHAV, P3537; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; VANDENHEEDE M, 1993, HORM BEHAV, V27, P435, DOI 10.1006/hbeh.1993.1032; Wardeh M. F., 1991, Proceedings of the International Conference on Camel Production and Improvement, 10-13 December, 1990, Tobruk, Libya., P78; Wu HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6188; Yasui S, 2013, ZOO BIOL, V32, P70, DOI 10.1002/zoo.21045; Ziegler C, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.41	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191119	10.1371/journal.pone.0191119	http://dx.doi.org/10.1371/journal.pone.0191119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415053	Green Submitted, gold, Green Published			2022-12-27	WOS:000424325300016
J	Dumas, SE; Kassa, L; Young, SL; Travis, AJ				Dumas, Sarah E.; Kassa, Lea; Young, Sera L.; Travis, Alexander J.			Examining the association between livestock ownership typologies and child nutrition in the Luangwa Valley, Zambia	PLOS ONE			English	Article							ANIMAL SOURCE FOODS; WILDLIFE CONSUMPTION; DEVELOPING-COUNTRIES; ADULT HEALTH; IMPACT; GROWTH; COMMUNITY; POULTRY; MILK; UNDERNUTRITION	Objective To investigate the association between livestock ownership and dietary diversity, animal-source food consumption, height-for-age z-score, and stunting among children living in wild-life "buffer zones" of Zambia's Luangwa Valley using a novel livestock typology approach. Methods We conducted a cross-sectional study of 838 children aged 6-36 months. Households were categorized into typologies based on the types and numbers of animals owned, ranging from no livestock to large numbers of mixed livestock. We used multilevel mixed-effects linear and logistic regression to examine the association between livestock typologies and four nutrition-related outcomes of interest. Results were compared with analyses using more common binary and count measures of livestock ownership. Results No measure of livestock ownership was significantly associated with children's odds of animal-source food consumption, child height-for-age z-score, or stunting odds. Livestock ownership Type 2 (having a small number of poultry) was surprisingly associated with decreased child dietary diversity (beta = -0.477; p<0.01) relative to owning no livestock. Similarly, in comparison models, chicken ownership was negatively associated with dietary diversity (beta = -0.320; p<0.01), but increasing numbers of chickens were positively associated with dietary diversity (beta = 0.022; p<0.01). Notably, neither child dietary diversity nor animal-source food consumption was significantly associated with height, perhaps due to unusually high prevalences of morbidities. Conclusions Our novel typologies methodology allowed for an efficient and a more in-depth examination of the differential impact of livestock ownership patterns compared to typical binary or count measures of livestock ownership. We found that these patterns were not positively associated with child nutrition outcomes in this context. Development and conservation programs focusing on livestock must carefully consider the complex, context-specific relationship between livestock ownership and nutrition outcomes-including how livestock are utilized by the target population-when attempting to use livestock as a means of improving child nutrition.	[Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Master Publ Hlth Program, Ithaca, NY USA; [Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Kassa, Lea] Cornell Univ, Coll Arts & Sci, Ithaca, NY USA; [Young, Sera L.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Young, Sera L.] Cornell Univ, Program Int Nutr, Ithaca, NY USA; [Young, Sera L.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Northwestern University	Travis, AJ (corresponding author), Cornell Univ, Master Publ Hlth Program, Ithaca, NY USA.; Travis, AJ (corresponding author), Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA.; Travis, AJ (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	atj32@cornell.edu		Young, Sera/0000-0002-1763-1218	Atkinson Center for a Sustainable Future [K01 M H098902]; Cornell University Master of Public Health program; Richard P. Henry '65, DVM '68 Award	Atkinson Center for a Sustainable Future; Cornell University Master of Public Health program; Richard P. Henry '65, DVM '68 Award	This work was supported by the Atkinson Center for a Sustainable Future A.J.T.); and S.L.Y., award number K01 M H098902); the Cornell University Master of Public Health program (A.J.T.); and the Richard P. Henry '65, DVM '68 Award (S.E.D.). No funder had any role in the design, analysis, or writing of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institutes of Health, the Atkinson Center for a Sustainable Future, or Cornell University.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Ahmed Mohamed M., 2000, Food and Nutrition Bulletin, V21, P460; [Anonymous], 2011, NAT HLTH STRAT PLAN; [Anonymous], 2014, REV 6 NAT DEV PLAN 2; Azzarri C, 2015, J DEV STUD, V51, P1034, DOI 10.1080/00220388.2015.1018905; Barrett M.A., 2013, JEKELS EPIDEMIOLOGY, P364; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cogill B, 2003, ANTHROPOMETRIC INDIC; CSO MOH and ICF International, 2015, ZAMB DEM HLTH SURV 2; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Distefano E, 2005, HUMAN WILDLIFE CONFL; Dumas SE, 2016, FOOD SECUR, V8, P507, DOI 10.1007/s12571-016-0579-5; Fierstein JL, 2017, AM J TROP MED HYG, V96, P74, DOI 10.4269/ajtmh.16-0646; Food and Agricultural Organisation of the United Nations (FAO), FAOSTAT DAT; George CM, 2015, AM J TROP MED HYG, V93, P269, DOI 10.4269/ajtmh.14-0694; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Good S., 2008, ANIMAL SOURCE FOODS, P1; Grosse SD, 1998, S HUM NUTR LIV DEV W, P190; Headey D, 2016, PLOONE PUBLIC LIB, V11; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Iannotti L, 2014, AM J PHYS ANTHROPOL, V155, P66, DOI 10.1002/ajpa.22547; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Knueppel D, 2010, FOOD NUTR BULL, V31, P436, DOI 10.1177/156482651003100306; Lewis D, 2011, P NATL ACAD SCI USA, V108, P13957, DOI 10.1073/pnas.1011538108; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Miller LC, 2014, FOOD NUTR BULL, V35, P312, DOI 10.1177/156482651403500304; Mosites E, 2016, J NUTR, V146, P1118, DOI 10.3945/jn.115.225961; Mosites EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136686; Mullins G, 1996, HUM ECOL, V24, P231, DOI 10.1007/BF02169128; Ngure FM, 2013, AM J TROP MED HYG, V89, P709, DOI 10.4269/ajtmh.12-0568; Nicholson C.F., 2003, DAIRY COW OWNERSHIP; Nielsen H, 2003, J NUTR, V133, p4027S, DOI 10.1093/jn/133.11.4027S; Njuki J., 2013, WOMEN LIVESTOCK OWNE, P21; Njuki J., 2011, ILRI ADD AB 2 MAY; Njuki JM, 2016, EUR J DEV RES, V28, P722, DOI 10.1057/ejdr.2015.22; Okike I, 2005, ECOL FOOD NUTR, V44, P167, DOI 10.1080/03670240590952990; Olney DK, 2009, FOOD NUTR BULL, V30, P355, DOI 10.1177/156482650903000407; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Schipani Steven, 2002, Food and Nutrition Bulletin, V23, P175; Thumbi SM, 2015, PLOS ONE, V10; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walton C, 2012, PUBLIC HEALTH NUTR, V17, P307; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; World Health Organization, 2006, WHO CHILD GROWTH STA; Wyatt AJ, 2015, MATERN CHILD NUTR, V11, P88, DOI 10.1111/mcn.12074; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191339	10.1371/journal.pone.0191339	http://dx.doi.org/10.1371/journal.pone.0191339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408920	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800016
J	Ericsson, A; Glah, D; Lorenzi, M; Jansen, JP; Fridhammar, A				Ericsson, Asa; Glah, Divina; Lorenzi, Maria; Jansen, Jeroen P.; Fridhammar, Adam			Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes	PLOS ONE			English	Article							LIFETIME HEALTH OUTCOMES; GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; MODEL; METFORMIN; ASSOCIATION; ADHERENCE; DEGLUDEC; DEGLUDEC/LIRAGLUTIDE	Background We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor agonists liraglutide 1.8 mg and lixisenatide 20 mu g (both added to basal insulin) in patients with type 2 diabetes (T2D) in Sweden. Methods The Swedish Institute for Health Economics cohort model for T2D was used to compare liraglutide and lixisenatide (both added to basal insulin), with a societal perspective and with comparative treatment effects derived by indirect treatment comparison (ITC). Drug prices were 2016 values, and all other costs 2015 values. The cost-effectiveness of IDegLira (fixed-ratio combination of insulin degludec and liraglutide) versus lixisenatide plus basal insulin was also assessed, under different sets of assumptions. Results From the ITC, decreases in HbA1c were -1.32% and -0.43% with liraglutide and lixisenatide, respectively; decreases in BMI were -1.29 and -0.65 kg/m(2), respectively. An estimated 2348 cases of retinopathy, 265 of neuropathy and 991 of nephropathy would be avoided with liraglutide compared with lixisenatide in a cohort of 10,000 patients aged over 40 years. In the base-case analysis, total direct costs were higher with liraglutide than lixisenatide, but costs associated with complications were lower. The cost/quality-adjusted life-year (QALY) for liraglutide added to basal insulin was SEK30,802. Base-case findings were robust in sensitivity analyses, except when glycated haemoglobin (HbA1c) differences for liraglutide added to basal insulin were abolished, suggesting these benefits were driving the cost/QALY. With liraglutide 1.2 mg instead of liraglutide 1.8 mg (adjusted for efficacy and cost), liraglutide added to basal insulin was dominant over lixisenatide 20 mu g. IDegLira was dominant versus lixisenatide plus basal insulin when a defined daily dose was used in the model. Conclusions The costs/QALY for liraglutide, 1.8 or 1.2 mg, added to basal insulin, and for IDegLira (all compared with lixisenatide 20 mu g added to basal insulin) were below the threshold considered low by Swedish authorities. In some scenarios, liraglutide and IDegLira were costsaving.	[Ericsson, Asa] Novo Nordisk Scandinavia AB, Diabet Mkt, Malmo, Sweden; [Glah, Divina] Novo Nordisk Ltd, Hlth Econ & Outcomes Res, Gatwick, England; [Lorenzi, Maria; Jansen, Jeroen P.] Precis Hlth Econ, Evidence Synth & Decis Modelling, San Francisco, CA USA; [Fridhammar, Adam] Swedish Inst Hlth Econ, Res Manager, Lund, Sweden	Novo Nordisk; Novo Nordisk	Ericsson, A (corresponding author), Novo Nordisk Scandinavia AB, Diabet Mkt, Malmo, Sweden.	ASAE@novonordisk.com		Jansen, Jeroen Paul/0000-0003-2686-9217; Fridhammar, Adam/0000-0003-3715-003X	Novo Nordisk Scandinavia AB; Novo Nordisk Ltd.; Precision Health Economics; Novo Nordisk	Novo Nordisk Scandinavia AB(Novo Nordisk); Novo Nordisk Ltd.(Novo Nordisk); Precision Health Economics; Novo Nordisk(Novo Nordisk)	The study was funded and supported by Novo Nordisk Scandinavia AB. Novo Nordisk Scandinavia AB provided support in the form of salary for author AE, Novo Nordisk Ltd. provided support in the form of salary for author DG, Precision Health Economics provided support in the form of salaries for authors ML and JPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Medical writing and submission support were provided by Nathan Ley PhD of Watermeadow Medical, an Ashfield company, part of UDG Healthcare plc, funded by Novo Nordisk.	Ahmann A, 2015, DIABETES OBES METAB, V17, P1056, DOI 10.1111/dom.12539; Bagust A, 2005, HEALTH ECON, V14, P217, DOI 10.1002/hec.910; Bagust A, 2001, DIABETOLOGIA, V44, P2140, DOI 10.1007/s001250100023; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bolin K, 2009, DIABETIC MED, V26, P928, DOI 10.1111/j.1464-5491.2009.02786.x; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Brown JB, 2000, DIABETES RES CLIN PR, V50, pS15, DOI 10.1016/S0168-8227(00)00215-1; Buse JB, 2014, DIABETES CARE, V37, P2926, DOI 10.2337/dc14-0785; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Evans M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-90; Freemantle N, 2015, DIABETES THER, V6, P573, DOI 10.1007/s13300-015-0142-y; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Geelhoed-Duijvestijn Petronella H, 2013, J Med Econ, V16, P1453, DOI 10.3111/13696998.2013.852098; Gough SCL, 2016, EXPERT REV ENDOCRINO, V11, P7, DOI 10.1586/17446651.2016.1113129; Hayes AJ, 2013, DIABETOLOGIA, V56, P1925, DOI 10.1007/s00125-013-2940-y; Heise T, 2012, DIABETES OBES METAB, V14, P944, DOI 10.1111/j.1463-1326.2012.01638.x; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jendle J, 2010, CURR MED RES OPIN, V26, P917, DOI 10.1185/03007991003657867; Jonsson L, 2006, VALUE HEALTH, V9, P193, DOI 10.1111/j.1524-4733.2006.00100.x; Kiadaliri AA, 2014, DIABETES THER, V5, P591, DOI 10.1007/s13300-014-0080-0; Kiadaliri AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062650; Lind M, 2016, DIABETES THER, V7, P321, DOI 10.1007/s13300-016-0173-z; Lingvay I, 2016, JAMA-J AM MED ASSOC, V315, P898, DOI 10.1001/jama.2016.1252; Lundqvist A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110235; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Nauck M, 2016, DIABETES CARE, V39, P1501, DOI 10.2337/dc15-2479; Novo Nordisk A/S, XULT SUMM PROD CHAR; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Ringborg A, 2008, INT J CLIN PRACT, V62, P708, DOI 10.1111/j.1742-1241.2008.01716.x; Saini SD, 2009, AM J MANAG CARE, V15, pE22; Sanofi-aventis, 2016, LYX SUMM PROD CHAR 2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shetty Sharashchandra, 2005, J Manag Care Pharm, V11, P559; Socialstyrelsen, 2014, NAT RIKTL STOD STYRN; Socialstyrelsen, 2015, NAT RIKTL MET BIL; Socialstyrelsen, NAT GUID DIAB CAR SU; Sorensen J., 2013, EC RES INT, V2013, P1, DOI DOI 10.1155/2013/618039; Steen Carlsson Katarina, 2014, J Med Econ, V17, P658, DOI 10.3111/13696998.2014.933110; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UPDS Group, 1998, LANCET, V12, P352; Ward Alexandra J, 2004, Cost Eff Resour Alloc, V2, P2, DOI 10.1186/1478-7547-2-2; World Health Organization Collaborating Centre for Drug Statistics Methodology, DEF GEN CONS 2016	55	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191953	10.1371/journal.pone.0191953	http://dx.doi.org/10.1371/journal.pone.0191953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408938	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800035
J	Kang, KB; Karas, FI; Rai, R; Hallak, JA; Kang, JJ; de la Cruz, J; Cortina, MS				Kang, Kai B.; Karas, Faris I.; Rai, Ruju; Hallak, Joelle A.; Kang, Joann J.; de la Cruz, Jose; Cortina, Maria S.			Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study	PLOS ONE			English	Article							STEM-CELL DEFICIENCY; UNIVERSITY-OF-CALIFORNIA; STEVENS-JOHNSON SYNDROME; LONG-TERM OUTCOMES; KERATOLIMBAL ALLOGRAFT; VISUAL OUTCOMES; IMPLANTATION; COMPLICATIONS; MANAGEMENT; MULTICENTER	Despite improved retention and reduced complication rates paving the way for the current expansion of applications and surge in prevalence for the Boston type I Keratoprosthesis (KPro), the most frequent indication for its implantation today remains prior graft failure. The purpose of this study is to evaluate the long-term outcomes of primary KPro and compare to secondary implantation in a matched cohort study. This study included patients who underwent KPro implantation in a single center by two surgeons between July 2008 and October 2014. All eyes with KPro implantation as the primary procedure with a minimum follow up of 12 months were matched with eyes with same preoperative diagnoses that underwent secondary KPro implantation. Main outcomes included visual acuity and device retention. A total of 56 eyes were included with 28 eyes in each group. Mean follow up was 5.0 years for both groups. Twenty-nine percent (8) of the eyes in the primary group had a diagnosis of chemical or thermal injuries, 25% (7) aniridia, 18% (5) autoimmune disease, 4% (1) infectious keratitis/neurotrophic cornea, 7% (2) gelatinous corneal dystrophy, 7% (2) ectrodactyly ectodermal dysplasia/limbal stem cell deficiency, and 11% (3) uveitis/hypotony. Sixty-one percent (17) of the eyes in the primary group and 39% (11) in the secondary group maintained a final best-corrected visual acuity of 20/200 or better at a mean follow up of 5.0 years; the probability of maintaining best-corrected vision is 0.83 and 0.49 for primary and secondary groups at 5.0 years (p = 0.02). There is no statistically significant difference between groups in device retention (p = 0.22) or postoperative complication rates (p >0.05). This study demonstrates that Boston KPro implantation may be successful as a primary procedure in patients at high risk of failure with traditional penetrating keratoplasty. The device has a good long-term retention rate and visual outcomes are promising however a larger study is needed for more definitive results.	[Kang, Kai B.; Karas, Faris I.; Rai, Ruju; Hallak, Joelle A.; Kang, Joann J.; de la Cruz, Jose; Cortina, Maria S.] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cortina, MS (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Chicago, IL 60607 USA.	mcortina@uic.edu		Cortina, Maria/0000-0001-7684-3424				Ahmad S, 2016, OPHTHALMOLOGY, V123, P165, DOI 10.1016/j.ophtha.2015.09.028; Ahmad S, 2015, AM J OPHTHALMOL, V159, P739, DOI 10.1016/j.ajo.2014.12.024; Aldave AJ, 2009, OPHTHALMOLOGY, V116, P640, DOI 10.1016/j.ophtha.2008.12.058; Alexander JK, 2015, CORNEA, V34, P1387, DOI 10.1097/ICO.0000000000000619; Aravena C, 2016, CORNEA, V35, P1156, DOI 10.1097/ICO.0000000000000933; Belin MW, 2016, CORNEA, V35, P143, DOI 10.1097/ICO.0000000000000703; Bradley JC, 2009, CORNEA, V28, P321, DOI 10.1097/ICO.0b013e31818b8bfa; Chang HYP, 2015, CORNEA, V34, P264, DOI 10.1097/ICO.0000000000000357; Chew HF, 2009, CORNEA, V28, P989, DOI 10.1097/ICO.0b013e3181a186dc; Ciolino JB, 2013, OPHTHALMOLOGY, V120, P1195, DOI 10.1016/j.ophtha.2012.11.025; Colby K, 2015, KERATOPROSTHESES ART, P181; Dohlman CH, 2006, EXPERT REV OPHTHALMO, V1, P41, DOI 10.1586/17469899.1.1.41; Dunlap K, 2010, OPHTHALMOLOGY, V117, P687, DOI 10.1016/j.ophtha.2009.09.024; Fadous R, 2015, BRIT J OPHTHALMOL, V99, P1664, DOI 10.1136/bjophthalmol-2014-306161; Greiner MA, 2011, OPHTHALMOLOGY, V118, P1543, DOI 10.1016/j.ophtha.2010.12.032; Han ES, 2011, GRAEF ARCH CLIN EXP, V249, P1697, DOI 10.1007/s00417-011-1760-3; Ilari L, 2002, OPHTHALMOLOGY, V109, P1278, DOI 10.1016/S0161-6420(02)01081-3; Iyer G, 2014, GRAEF ARCH CLIN EXP, V252, P457, DOI 10.1007/s00417-014-2568-8; Kang JJ, 2012, CORNEA, V31, P1436, DOI 10.1097/ICO.0b013e31823f7765; Klufas Michael A, 2010, Int Ophthalmol Clin, V50, P161, DOI 10.1097/IIO.0b013e3181e20cca; Lee WB, 2015, OPHTHALMOLOGY, V122, P1504, DOI 10.1016/j.ophtha.2015.03.025; Lenis TL, 2017, OPHTHALMOLOGY, V124, P12, DOI 10.1016/j.ophtha.2016.08.003; Robert MC, 2011, CAN J OPHTHALMOL, V46, P164, DOI 10.3129/i10-103; Saeed HN, 2017, CURR OPIN OPHTHALMOL; Schneider LR, 2015, KERATOPROSTHESES ART, P77; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Sejpal K, 2011, CORNEA, V30, P1187, DOI 10.1097/ICO.0b013e3182114467; Solomon A, 2002, OPHTHALMOLOGY, V109, P1159, DOI 10.1016/S0161-6420(02)00960-0; Vazirani J, 2016, OCUL SURF, V14, P350, DOI 10.1016/j.jtos.2016.02.006; Yaghouti F, 2001, CORNEA, V20, P19, DOI 10.1097/00003226-200101000-00003; Zerbe BL, 2006, OPHTHALMOLOGY, V113, P1779, DOI 10.1016/j.ophtha.2006.05.015	31	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192381	10.1371/journal.pone.0192381	http://dx.doi.org/10.1371/journal.pone.0192381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408907	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800060
J	Stockdale, L; Nash, S; Nalwoga, A; Painter, H; Asiki, G; Fletcher, H; Newton, R				Stockdale, Lisa; Nash, Stephen; Nalwoga, Angela; Painter, Hannah; Asiki, Gershim; Fletcher, Helen; Newton, Robert			Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INFECTION; HIV; POPULATION; ANTIBODIES; HYPERTENSION; MORTALITY; ASSOCIATION; PREVENTION; MALARIA	Human cytomegalovirus (HCMV) infection has been associated with increased mortality, specifically cardiovascular disease (CVD), in high-income countries (HICs). There is a paucity of data in low-and middle-income countries (LMICs) where HCMV seropositivity is higher. Serum samples from 2,174 Ugandan individuals were investigated for HCMV antibodies and data linked to demographic information, co-infections and a variety of CVD measurements. HCMV seropositivity was 83% by one year of age, increasing to 95% by five years. Female sex, HIV positivity and active pulmonary tuberculosis (TB) were associated with an increase in HCMV IgG levels in adjusted analyses. There was no evidence of any associations with risk factors for CVD after adjusting for age and sex. HCMV infection is ubiquitous in this rural Ugandan cohort from a young age. The association between TB disease and high HCMV IgG levels merits further research. Known CVD risk factors do not appear to be associated with higher HCMV antibody levels in this Ugandan cohort.	[Stockdale, Lisa; Nalwoga, Angela; Painter, Hannah; Fletcher, Helen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Nash, Stephen] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Nalwoga, Angela; Asiki, Gershim; Newton, Robert] Uganda Virus Res Inst, Med Res Council, Entebbe, Uganda; [Newton, Robert] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Newton, Robert] Int Agcy Res Canc, Lyon, France	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; University of York - UK; World Health Organization; International Agency for Research on Cancer (IARC)	Stockdale, L (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	lisa.stockdale@lshtm.ac.uk		Nash, Stephen/0000-0003-2086-1740; Asiki, Gershim/0000-0002-9966-1153; Nalwoga, Angela/0000-0001-8259-4735; Painter, Hannah/0000-0003-0445-7473	UK Medical Research Council [MR/J003999/1]; Medical Research Council [MR/K012126/1]; Medical Research Council [MC_UP_1204/17, 1487357] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a UK Medical Research Council studentship for LS [MR/J003999/1] and Medical Research Council funding for SN [MR/K012126/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank participants from the GPC and their families. None of the authors have a commercial or other association that might pose a conflict of interest (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding). This work was supported by a UK Medical Research Council studentship for LS [MR/J003999/1] and SN receives support from the Medical Research Council and Department for International Development (MR/K012126/1).	Aguilar R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01284; Asiki G, 2015, TROP MED INT HEALTH, V20, P1306, DOI 10.1111/tmi.12556; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Bbaale E, 2014, J HEALTH POPUL NUTR, V32, P249; BOS P, 1995, E AFR MED J, V72, P113; Cannon MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0569-1; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Cappuccio FP, 2016, INTERN EMERG MED, V11, P299, DOI 10.1007/s11739-016-1423-9; Carpenter LM, 2008, INT J CANCER, V122, P1319, DOI 10.1002/ijc.23254; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Dollard Sheila C, 2014, BMC Res Notes, V7, P776, DOI 10.1186/1756-0500-7-776; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Fielding K, 2011, PLOS ONE, V6; Firth C, 2016, QJM, P1; Fletcher HA, 2016, NAT COMMUN, P1; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124; Hamdan HZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-217; HO M, 1990, REV INFECT DIS, V12, pS701; Hui J, 2016, WIEN KLIN WOCHENSCHR, V128, P586, DOI 10.1007/s00508-016-0977-x; Hummel M, 2002, J CLIN VIROL, V25, pS123; Jarvis MA, 2007, J VIROL, V81, P2095, DOI 10.1128/JVI.01422-06; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Kamel N, 2014, MED PRIN PRACT, V23, P29, DOI 10.1159/000354758; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Li C, 2012, PLOS ONE, V7, P1999; Lichtner M, 2014, J INFECT DIS; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marsico C, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0358-8; Mugisha Joseph O, 2016, BMC Res Notes, V9, P433, DOI 10.1186/s13104-016-2217-x; Murphy GAV, 2013, INT J EPIDEMIOL, V42, P1740, DOI 10.1093/ije/dyt184; Mutalima N, 2008, PLOS ONE, P3; Nagu T, 2017, INT J INFECT DIS, V56, P136, DOI 10.1016/j.ijid.2017.01.022; Nsagha Dickson Shey, 2015, Open AIDS J, V9, P51, DOI 10.2174/1874613601509010051; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; Pletcher MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154288; Popovic M, 2012, J THROMB THROMBOLYS, V33, P160, DOI 10.1007/s11239-011-0662-x; RICE GPA, 1984, P NATL ACAD SCI-BIOL, V81, P6134, DOI 10.1073/pnas.81.19.6134; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Wakeham K, 2015, INT J CANCER, V136, P2822, DOI 10.1002/ijc.29329; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; WHO, 2014, GLOB TUB REP 2014; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; World Health Organization, 2014, NONC DIS NCD COUNTR; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2000, WHO TECHN REP SER, V894; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Zanni MV, 2014, NAT REV CARDIOL, V11, P728, DOI 10.1038/nrcardio.2014.167	58	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192086	10.1371/journal.pone.0192086	http://dx.doi.org/10.1371/journal.pone.0192086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408860	Green Published, Green Accepted, gold			2022-12-27	WOS:000424302800044
J	Harmon, AW; Moitra, R; Xu, ZL; Byrnes, AP				Harmon, Andrew W.; Moitra, Rituparna; Xu, Zhili; Byrnes, Andrew P.			Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum	PLOS ONE			English	Article							NATURAL IGM; ANTIBODIES TARGET; FACTOR-BINDING; GENE-THERAPY; IDENTIFICATION; ACTIVATION; TOXICITY; IMPACT	Adenovirus vectors are widely used in gene therapy clinical trials, and preclinical studies with these vectors are often conducted in mice. It is therefore critical to understand whether mouse studies adequately predict the behavior of adenovirus vectors in humans. The most commonly-used adenovirus vectors are derived from adenovirus serotype 5 (Ad5). The Ad5 hexon protein can bind coagulation factor X (FX), and binding of FX has a major impact on vector interactions with other blood proteins. In mouse serum, FX protects Ad5 vectors from neutralization by natural antibodies and complement. In the current study, we similarly find that human FX inhibits neutralization of Ad5 vectors by human serum, and this finding is consistent among individual human sera. We show that human IgM and human IgG can each induce complement-mediated neutralization when Ad5 vectors are not protected by FX. Although mouse and human serum had similar effects on Ad5 vectors, we found that this was not true for a chimeric Ad5 vector that incorporated hexon regions from adenovirus serotype 48. Interestingly, this hexon-chimeric vector was neutralized by human serum, but not by mouse serum. These findings indicate that studies in mouse serum accurately predict the behavior of Ad5 vectors in human serum, but mouse serum is not an accurate model system for all adenovirus vectors.	[Harmon, Andrew W.; Moitra, Rituparna; Xu, Zhili; Byrnes, Andrew P.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Byrnes, AP (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Andrew.Byrnes@fda.hhs.gov	Byrnes, Andrew/D-2808-2013	Byrnes, Andrew/0000-0003-1135-2629	U.S. Food and Drug Administration (FDA); FDA's Critical Path program; Oak Ridge Institute for Science and Education	U.S. Food and Drug Administration (FDA); FDA's Critical Path program; Oak Ridge Institute for Science and Education(General Electric)	Funding was provided by the U.S. Food and Drug Administration (FDA) to APB, including funding from the FDAs Critical Path program. This project was supported in part by fellowships administered by the Oak Ridge Institute for Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87; [Anonymous], 2017, J GENE MED GENE THER; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Baden LR, 2014, J INFECT DIS, V210, P1052, DOI 10.1093/infdis/jiu217; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; BEEBE DP, 1981, J IMMUNOL, V126, P1562; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Bruder JT, 2013, J VIROL, V87, P9661, DOI 10.1128/JVI.00462-13; Byrnes AP, 2016, ADENOVIRUS VECTORS G, P367; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Cichon G, 2001, GENE THER, V8, P1794, DOI 10.1038/sj.gt.3301611; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Coughlan L, 2012, MOL THER, V20, P2268, DOI 10.1038/mt.2012.162; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; Di Paolo NC, 2009, MOL THER, V17, P675, DOI 10.1038/mt.2008.307; Di Y, 2014, GENE THER, V21, P440, DOI 10.1038/gt.2014.2; Duffy MR, 2016, GENE THER, V23, P592, DOI 10.1038/gt.2016.32; Farrow AL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030078; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Harmon A. W., 2017, SAFETY EFFICACY GENE, P37; Irons EE, 2013, J VIROL, V87, P9610, DOI 10.1128/JVI.01070-13; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khare R, 2013, J VIROL, V87, P3678, DOI 10.1128/JVI.01392-12; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; Lachmann PJ, 2010, J IMMUNOL METHODS, V352, P195, DOI 10.1016/j.jim.2009.11.003; Lopez-Gordo E, 2014, EXPERT OPIN DRUG DEL, P1; Ma JT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004673; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Qiu Q, 2015, J VIROL, V89, P3412, DOI 10.1128/JVI.03217-14; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Teigler JE, 2014, CLIN VACCINE IMMUNOL, V21, P1137, DOI 10.1128/CVI.00207-14; Unzu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085432; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xu WD, 2014, MOL THER, V22, P1504, DOI 10.1038/mt.2014.80; Xu ZL, 2017, METHODS MOL BIOL, V1643, P187, DOI 10.1007/978-1-4939-7180-0_15; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Xu ZL, 2002, J CONTROL RELEASE, V81, P155, DOI 10.1016/S0168-3659(02)00059-7; Zaiss AK, 2016, J VIROL, V90, P412, DOI 10.1128/JVI.01939-15; Zhang ZW, 2011, HUM GENE THER, V22, P1137, DOI 10.1089/hum.2011.003; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192353	10.1371/journal.pone.0192353	http://dx.doi.org/10.1371/journal.pone.0192353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401488	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400051
J	Sabalza, M; Yasmin, R; Barber, CA; Castro, T; Malamud, D; Kim, BJ; Zhu, H; Montagna, RA; Abrams, WR				Sabalza, Maite; Yasmin, Rubina; Barber, Cheryl A.; Castro, Talita; Malamud, Daniel; Kim, Beum Jun; Zhu, Hui; Montagna, Richard A.; Abrams, William R.			Detection of Zika virus using reverse-transcription LAMP coupled with reverse dot blot analysis in saliva	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INFECTIOUS-DISEASES; MOLECULAR-DETECTION; IDENTIFICATION; EMERGENCE; SPREAD; STATES; DNA	In recent years, there have been increasing numbers of infectious disease outbreaks that spread rapidly to population centers resulting from global travel, population vulnerabilities, environmental factors, and ecological disasters such as floods and earthquakes. Some examples of the recent outbreaks are the Ebola epidemic in West Africa, Middle East respiratory syndrome coronavirus (MERS-Co) in the Middle East, and the Zika outbreak through the Americas. We have created a generic protocol for detection of pathogen RNA and/or DNA using loop-mediated isothermal amplification (LAMP) and reverse dot-blot for detection (RDB) and processed automatically in a microfluidic device. In particular, we describe how a microfluidic assay to detect HIV viral RNA was converted to detect Zika virus (ZIKV) RNA. We first optimized the RT-LAMP assay to detect ZIKV RNA using a benchtop isothermal amplification device. Then we implemented the assay in a microfluidic device that will allow analyzing 24 samples simultaneously and automatically from sample introduction to detection by RDB technique. Preliminary data using saliva samples spiked with ZIKV showed that our diagnostic system detects ZIKV RNA in saliva. These results will be validated in further experiments with well-characterized ZIKV human specimens of saliva. The described strategy and methodology to convert the HIV diagnostic assay and platform to a ZIKV RNA detection assay provides a model that can be readily utilized for detection of the next emerging or re-emerging infectious disease.	[Sabalza, Maite; Barber, Cheryl A.; Castro, Talita; Malamud, Daniel; Abrams, William R.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA; [Yasmin, Rubina; Kim, Beum Jun; Zhu, Hui; Montagna, Richard A.] Rheonix Inc, Ithaca, NY USA; [Castro, Talita] Univ Sao Paulo, Sch Dent, Stomatol Dept, Sao Paulo, SP, Brazil; [Malamud, Daniel] NYU, Sch Med, Dept Med, New York, NY USA	New York University; Universidade de Sao Paulo; New York University	Sabalza, M (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA.	ms10129@nyu.edu	KIM, BEUM JUN/G-6829-2011; Abrams, William R/A-5782-2008	KIM, BEUM JUN/0000-0003-1797-5026; Malamud, Daniel/0000-0002-9094-4122	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R44DE024456, 3R44DE024456-03S1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024456] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under Award Numbers R44DE024456 and 3R44DE024456-03S1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Four of the authors (Richard Montagna, Rubina Yasmin, Beum Jun Kim and Hui Zhu) are employees of Rheonix, Inc. Rheonix, Inc. provided support in the form of salaries for authors RM, RY, BJK and HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816; Brierley L, 2016, AM NAT, V187, pE53, DOI 10.1086/684391; Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309; Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340; CDC, 2017, WORLD MAP AR RISK ZI; CDC, 2016, CAS COUNTS US 2016; Chen Zongyuan, 2016, J AIDS Clin Res, V7; Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538; Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541; Corstjens Paul L A M, 2012, J Am Dent Assoc, V143, p12S; de Souza M, 2017, MYCOPATHOLOGIA, V182, P625, DOI 10.1007/s11046-017-0129-5; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DeSantis AS, 2015, PSYCHOSOM MED, V77, P6, DOI 10.1097/PSY.0000000000000131; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duz MB, 2016, CELL ONCOL, V39, P187, DOI 10.1007/s13402-015-0259-z; FDA, EM US AUTH 2017; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113; Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9; Hajosi-Kalcakosz S, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0392-z; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS243, DOI 10.2105/AJPH.2009.164814; Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006; Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003; Lau Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142861, 10.1371/journal.pone.0138694]; Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689; Maffert P, 2017, EUR J CLIN MICROBIOL, V36, P1717, DOI 10.1007/s10096-017-3013-9; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Mangili A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0009-2015; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martins D, 2015, BIOSENS BIOELECTRON, V72, P87, DOI 10.1016/j.bios.2015.04.063; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; Miocevic O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00133; Modak Sayli S, 2016, Infect Dis (Auckl), V9, P1, DOI [10.4137/IDRT.S32162, 10.4137/idrt.s32162]; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nakata Y, 2015, J MATH BIOL, V70, P1411, DOI 10.1007/s00285-014-0801-z; Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PAHO, 2017, COUNTR TERR AUT TRAN; Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778; Sabalza M, 2017, JOVE-J VIS EXP, DOI 10.3791/56784; SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262; Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315; Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68; Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821; Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632; Spizz G, 2015, ARCH PATHOL LAB MED, V139, P805, DOI 10.5858/arpa.2014-0059-OA; Spizz G, 2012, POINT CARE, V11, P42, DOI 10.1097/POC.0b013e318222e184; Tang HK, 2013, MOL MED REP, V7, P761, DOI 10.3892/mmr.2012.1254; Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9; WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201; Wilson ME, 2003, J APPL MICROBIOL, V94, p1S; Yadav S, 2016, J CLIN DIAGN RES, V10, pDM1, DOI 10.7860/JCDR/2016/19170.8133; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114	59	31	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192398	10.1371/journal.pone.0192398	http://dx.doi.org/10.1371/journal.pone.0192398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401479	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400058
J	Shields, MD; ALQahtani, F; Rivey, MP; McElnay, JC				Shields, Michael D.; ALQahtani, Fahad; Rivey, Michael P.; McElnay, James C.			Mobile direct observation of therapy (MDOT) - A rapid systematic review and pilot study in children with asthma	PLOS ONE			English	Review							QUALITY-OF-LIFE; ADHERENCE; CARE; TUBERCULOSIS; HEALTH	We describe, for the first time, the use of a mobile device platform for remote direct observation of inhaler use and technique. The research programme commenced with a rapid systematic review of mobile device (or videophone) use for direct observation of therapy (MDOT). Ten studies (mainly pilots) were identified involving patients with tuberculosis, sickle cell disease and Alzheimer's disease. New studies are ongoing (ClinicalTrials.gov website) in TB, stroke, sickle cell disease, HIV and opioid dependence. Having identified no prior use of MDOT in inhaler monitoring, we implemented a feasibility study in 12 healthy volunteer children (2-12 years; 8 females and 4 males) over a period of 14 days, with twice daily video upload of their 'dummy' inhaler use. Two children uploaded 100% of the requested videos, with only one child having an inhaler upload rate of <75%. The quality of uploaded videos was generally good (only 1.7% of unacceptable quality for evaluation). The final aspect of the research was a pilot study using MDOT (6 weeks) in 22 children with difficult to treat asthma. Healthcare professionals evaluated inhaler technique using uploaded videos and provided telephone instruction on improving inhaler use. The main outcomes were assessed at week 12 post initiation of MDOT. By week 5, all children still engaging in MDOT (n = 18) were judged to have effective inhaler technique. Spirometry values did not vary to a significantly significant degree between baseline and 12 weeks (P>0.05), however, mean fraction of exhaled nitric oxide (FeNO) values normalised (mean 38.7 to 19.3ppm) and mean Asthma Control Test values improved (13.1 to mean 17.8). Feedback from participants was positive. Overall the findings open up a new paradigm in device independent (can be used for any type of inhaler device) monitoring, providing a platform for evaluating / improving inhaler use at home.	[Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [ALQahtani, Fahad; Rivey, Michael P.; McElnay, James C.] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland; [Rivey, Michael P.] Univ Montana, Coll Hlth Profess & Biomed Sci, Dept Pharm Practice, Missoula, MT 59812 USA	Queens University Belfast; Queens University Belfast; University of Montana System; University of Montana	McElnay, JC (corresponding author), Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland.	j.mcelnay@qub.ac.uk						Alsous M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171863; Anagnostou K, 2012, PRIM CARE RESP J, V21, P71, DOI 10.4104/pcrj.2011.00097; Andersson K, 2005, EUR J PUBLIC HEALTH, V15, P621, DOI 10.1093/eurpub/cki053; [Anonymous], 2010, TREATM TUB GUID; [Anonymous], 2014, EUROPEAN RESP J, V43, P343; Aylward BS, 2015, J PEDIATR PSYCHOL, V40, P66, DOI 10.1093/jpepsy/jsu010; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bryant L, 2013, J PRIM HEALTH CARE, V5, P191, DOI 10.1071/HC13191; Burnard P, 2008, BRIT DENT J, V204, P429, DOI 10.1038/sj.bdj.2008.292; Chuck C, 2014, USE LIVE VIDEO DIREC; Creary SE, 2014, PEDIATR BLOOD CANCER, V61, P1068, DOI 10.1002/pbc.24931; Davis KL, 2008, EPILEPSIA, V49, P446, DOI 10.1111/j.1528-1167.2007.01414.x; DeMaio J, 2001, CLIN INFECT DIS, V33, P2082, DOI 10.1086/324506; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Eng Janice J, 2007, Top Spinal Cord Inj Rehabil, V13, P1, DOI 10.1310/sci1301-1; Fish L, 2001, ANN ALLERG ASTHMA IM, V86, P24, DOI 10.1016/S1081-1206(10)62308-3; Garfein RS, 2015, INT J TUBERC LUNG D, V19, P1057, DOI 10.5588/ijtld.14.0923; Gassanov M A, 2013, CANADIAN J PUBLIC HL, V104, P3; Global Initiative for Asthma, 2015, POCK GUID ASTHM MAN; Goodfellow NA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0038-7; GORE SM, 1981, BRIT MED J, V282, P2114, DOI 10.1136/bmj.282.6282.2114; Hamill L, 2016, PEDIATR PULM, V51, P13, DOI 10.1002/ppul.23204; Hammerlein A, 2010, J EVAL CLIN PRACT, V17, P61; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hind J, 2014, WURJ HNS, V5, P1, DOI [10.5206/wurjhns.2014-15.16, DOI 10.5206/WURJHNS.2014-15.16]; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Horne R, MEDICATION ADHERENCE; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kim YJ, 2015, DIABETES METAB J, V39, P207, DOI 10.4093/dmj.2015.39.3.207; Konnyu Kristin J, 2012, Open Med, V6, pe10; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; Lal S, 2014, PSYCHIAT SERV, V65, P24, DOI 10.1176/appi.ps.201300009; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Machira EPM, 2011, AFR J RESPIR MED, V7, P19; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Miller CWT, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/670525; Mirsaeidi M, 2015, EUR RESPIR J, V46, P871, DOI 10.1183/09031936.00011015; Molimard M, 2003, J AEROSOL MED, V16, P249, DOI 10.1089/089426803769017613; Munoz F, 2012, 6 ANN CFAR INT HIV A; Nagakumar P., 2013, PAEDIAT CHILD HLTH, V23, P291; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Otu A. A., 2013, Asian Pacific Journal of Tropical Disease, V3, P227, DOI 10.1016/S2222-1808(13)60045-6; Patterson EE, 2005, ARCH DIS CHILD, V90, P786, DOI 10.1136/adc.2004.062612; Press VG, 2012, J GEN INTERN MED, V27, P1317, DOI 10.1007/s11606-012-2090-9; Price D, 2013, RESP MED, V107, P37, DOI 10.1016/j.rmed.2012.09.017; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Schunemann HJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-4; Shah NM, 2013, EPILEPSIA, V54, P1020, DOI 10.1111/epi.12126; Smith Glenn E, 2007, Am J Alzheimers Dis Other Demen, V22, P20, DOI 10.1177/1533317506295888; Strunk RC, 2008, J ALLERGY CLIN IMMUN, V122, P1138, DOI 10.1016/j.jaci.2008.09.028; Vasylyeva TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069060; Wade V, 2009, ELECTRON J HEALTH IN, V4; Wade VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050155; World Health Organization, 2013, MEDIACENTRE ASTHMA; Zeber JE, 2010, ANN PHARMACOTHER, V44, P1896, DOI 10.1345/aph.1P385	57	38	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190031	10.1371/journal.pone.0190031	http://dx.doi.org/10.1371/journal.pone.0190031			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401500	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400002
J	Kaneko, C; Kobayashi, T; Ito, S; Sugita, N; Murasawa, A; Nakazono, K; Yoshie, H				Kaneko, Chihiro; Kobayashi, Tetsuo; Ito, Satoshi; Sugita, Noriko; Murasawa, Akira; Nakazono, Kiyoshi; Yoshie, Hiromasa			Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study	PLOS ONE			English	Article							DISEASE-ACTIVITY; PORPHYROMONAS-GINGIVALIS; SEDIMENTATION-RATE; JAPANESE PATIENTS; EPIDEMIOLOGY; CITRULLINE; CRITERIA	Objectives An interrelationship between rheumatoid arthritis (RA) and periodontitis has been suggested due to their common pathogenic mechanisms. Protein carbamylation and neutrophil extracellular traps (NETs) formation have been shown to be related to autoimmune conditions, including RA, but their association with periodontitis has not been elucidated. Therefore, we assessed whether or not circulating levels of carbamylated protein (CarP) and NETs are associated with periodontitis severity and influenced by periodontal treatment. Methods We conducted a retrospective case-control study that included 40 patients with RA and periodontitis, 30 patients with periodontitis, and 43 systemically and periodontally healthy controls to assess the circulating levels of CarP and NETs and rheumatologic and periodontal conditions. The same assessments were also performed in 22 patients with RA and periodontitis after 2 months of periodontal treatment, including oral hygiene instruction and full-mouth supragingival scaling. Results Patients with RA and periodontitis showed significantly higher serum levels of CarP and NETs than the control group (P = 0.04 and P < 0.001, respectively). The serum levels of CarP and NETs were significantly correlated positively with the mean values of probing depth (P = 0.01 and P = 0.007, respectively) and clinical attachment level (P = 0.007 and P = 0.001, respectively) in the 40 patients with RA and periodontitis. Multiple logistic regression analyses also revealed significantly positive associations between the serum levels of CarP and NETs and moderate to severe periodontitis (P = 0.03 and P = 0.001, respectively). Furthermore, periodontal treatment significantly decreased the serum levels of CarP and NETs in patients with RA and periodontitis (P = 0.03 and P = 0.02). Conclusion The circulating levels of CarP and NETs are associated with periodontitis severity and influenced by periodontal treatment in patients with RA.	[Kaneko, Chihiro; Kobayashi, Tetsuo; Sugita, Noriko; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol, Niigata, Japan; [Kobayashi, Tetsuo] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan; [Ito, Satoshi; Murasawa, Akira; Nakazono, Kiyoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan	Niigata University; Niigata University	Kobayashi, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol, Niigata, Japan.; Kobayashi, T (corresponding author), Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan.	kotetsuo@dent.niigata-u.ac.jp	Ito, Satoshi/AAL-9615-2020		KAKENHI from the Japan Society for the Promotion of Science [26463130, 17K11983]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by KAKENHI Grant-in Aid for Scientific Research (26463130 and 17K11983 to Tetsuo Kobayashi) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funding source had no involvement in the study design, data collection and analysis, writing of the report, or decision to submit the article for publication.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bright R, 2015, MED HYPOTHESES, V84, P570, DOI 10.1016/j.mehy.2015.03.006; Bright R, 2017, J PERIODONTAL RES; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dias IHK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066407; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Hirschfeld J, 2015, INT J MED MICROBIOL, V305, P453, DOI 10.1016/j.ijmm.2015.04.002; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kaur S, 2014, SEMIN ARTHRITIS RHEU, V44, P113, DOI 10.1016/j.semarthrit.2014.04.009; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kobayashi T, 2007, J PERIODONTOL, V78, P2311, DOI 10.1902/jop.2007.070136; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Kojima A, 2016, J PERIODONTAL RES, V51, P350, DOI 10.1111/jre.12314; Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001; Leppilahti JM, 2014, J CLIN PERIODONTOL, V41, P348, DOI 10.1111/jcpe.12223; Li LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159000; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Montes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161141; Nizam N, 2014, INFLAMMATION, V37, P1771, DOI 10.1007/s10753-014-9907-0; Okada M, 2013, J PERIODONTOL, V84, pE74, DOI 10.1902/jop.2013.130079; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Perez-Sanchez C, 2017, J AUTOIMMUN, V82, P31, DOI 10.1016/j.jaut.2017.04.007; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Shidara K, 2011, RHEUMATOL INT, V31, P617, DOI 10.1007/s00296-009-1336-2; Shimada A, 2016, J PERIODONTAL RES, V51, P103, DOI 10.1111/jre.12288; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Stoop JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102163; Sun JT, 2016, AM J PHYSIOL-RENAL, V310, pF511, DOI 10.1152/ajprenal.00508.2015; Sur Chowdhury Chanchal, 2014, Arthritis Res Ther, V16, pR122, DOI 10.1186/ar4579; Verheul MK, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1455-1; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148197; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; White PC, 2016, J DENT RES, V95, P26, DOI 10.1177/0022034515609097; White P, 2016, J CLIN PERIODONTOL, V43, P1041, DOI 10.1111/jcpe.12628	44	23	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192365	10.1371/journal.pone.0192365	http://dx.doi.org/10.1371/journal.pone.0192365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394286	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400040
J	Sacoor, C; Payne, B; Augusto, O; Vilanculo, F; Nhacolo, A; Vidler, M; Makanga, PT; Munguambe, K; Lee, T; Macete, E; von Dadelszen, P; Sevene, E				Sacoor, Charfudin; Payne, Beth; Augusto, Orvalho; Vilanculo, Faustino; Nhacolo, Ariel; Vidler, Marianne; Makanga, Prestige Tatenda; Munguambe, Khatia; Lee, Tang; Macete, Eusebio; von Dadelszen, Peter; Sevene, Esperanca		CLIP Working Grp	Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique	PLOS ONE			English	Article							MORTALITY	Reliable statistics on maternal morbidity and mortality are scarce in low and middle-income countries, especially in rural areas. This is the case in Mozambique where many births happen at home. Furthermore, a sizeable number of facility births have inadequate registration. Such information is crucial for developing effective national and global health policies for maternal and child health. The aim of this study was to generate reliable baseline socio-demographic information on women of reproductive age as well as to establish a demographic surveillance platform to support the planning and implementation of the Community Level Intervention for Pre-eclampsia (CLIP) study, a cluster randomized controlled trial. This study represents a census of all women of reproductive age (12 +/- 49 years) in twelve rural communities in Maputo and Gaza provinces of Mozambique. The data were collected through electronic forms implemented in Open Data Kit (ODK) (an app for android based tablets) and household and individual characteristics. Verbal autopsies were conducted on all reported maternal deaths to determine the underlying cause of death. Between March and October 2014, 50,493 households and 80,483 women of reproductive age (mean age 26.9 years) were surveyed. A total of 14,617 pregnancies were reported in the twelve months prior to the census, resulting in 9,029 completed pregnancies. Of completed pregnancies, 8,796 resulted in live births, 466 resulted in stillbirths and 288 resulted in miscarriages. The remaining pregnancies had not yet been completed during the time of the survey (5,588 pregnancies). The age specific fertility indicates that highest rate (188 live births per 1,000 women) occurs in the age 20 +/- 24 years old. The estimated stillbirth rate was 50.3/1,000 live and stillbirths; neonatal mortality rate was 13.3/1,000 live births and maternal mortality ratio was 204.6/100,000 live births. The most common direct cause of maternal death was eclampsia and tuberculosis was the most common indirect cause of death. This study found that fertility rate is high at age 20 +/- 24 years old. Pregnancy in the advanced age (>35 years of age) in this study was associated with higher poor outcomes such as miscarriage and stillbirth. The study also found high stillbirth rate indicating a need for increased attention to maternal health in southern Mozambique. Tuberculosis and HIV/AIDS are prominent indirect causes of maternal death, while eclampsia represents the number one direct obstetric cause of maternal deaths in these communities. Additional efforts to promote safe motherhood and improve child survival are crucial in these communities.	[Sacoor, Charfudin; Augusto, Orvalho; Vilanculo, Faustino; Nhacolo, Ariel; Munguambe, Khatia; Macete, Eusebio; Sevene, Esperanca] CISM, Manhica, Mozambique; [Payne, Beth; Vidler, Marianne; Lee, Tang] Univ British Columbia, Vancouver, BC, Canada; [Makanga, Prestige Tatenda] Simon Fraser Univ, Burnaby, BC, Canada; [Makanga, Prestige Tatenda] MSU, Gweru, Zimbabwe; [Munguambe, Khatia; Sevene, Esperanca] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Macete, Eusebio] Minist Saude, Direccao Nacl Saude, Maputo, Mozambique; [von Dadelszen, Peter] Kings Coll London, Dept Obstet & Gynaecol, London, England	Centro de Investigacao em Saude de Manhica; University of British Columbia; Simon Fraser University; Eduardo Mondlane University; University of London; King's College London	Sacoor, C (corresponding author), CISM, Manhica, Mozambique.	charfudin.sacoor@manhica.net	von Dadelszen, Peter/AAP-7480-2021; Sevene, Esperança/AAI-3532-2020; Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Vidler, Marianne/0000-0002-7633-8812; von Dadelszen, Peter/0000-0003-4136-3070; Makanga, Prestige Tatenda/0000-0002-9025-2564	Bill & Melinda Gates Foundation [OPP1017337]; Manhica Health Research Centre (CISM); Provincial Health Department of Maputo Province; Provincial Health Department of Gaza Province; Mozambican Obstetrics and Gynaecology Association (AMOG); Faculty of Medicine of the Eduardo Mondlane University; Ministry of Health (MISAU); University of British Columbia (UBC)	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Manhica Health Research Centre (CISM); Provincial Health Department of Maputo Province; Provincial Health Department of Gaza Province; Mozambican Obstetrics and Gynaecology Association (AMOG); Faculty of Medicine of the Eduardo Mondlane University; Ministry of Health (MISAU); University of British Columbia (UBC)	This work is part of the University of British Columbia PRE-EMPT (Pre-eclampsia/Eclampsia, Monitoring, Prevention and Treatment), an initiative supported by the Bill & Melinda Gates Foundation (Grant No. OPP1017337 to PvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all study participants. We are also grateful for the contributions of the Community Level Interventions for Pre-eclampsia (CLIP) Working Group: Rogerio Chiau, Helena Boene, Anifa Vala, Clara Menendez, Edgar Jamisse, Paulo Filimome, Corssino Tchavana, Sharla Drebit, Laura Magee, Chirag Kariya, Tabassum Firoz, Larry Li, Domena Tu, Mansun Lui, Sumedha Sharma, Dustin Dunsmuir, Michelle La. We also acknowledge the support of the Manhica Health Research Centre (CISM), the Provincial Health Departments of Maputo and Gaza Provinces, the Mozambican Obstetrics and Gynaecology Association (AMOG), Faculty of Medicine of the Eduardo Mondlane University, Ministry of Health (MISAU) and University of British Columbia (UBC). We would like to specifically acknowledge and thank a highly participative and engaged community of the 12 clusters in Maputo and Gaza provinces, with special mention of the community leaders, the women of reproductive age, the head of households, the local authorities, including the District Health Authorities and the Government of Maputo and Gaza provinces. We would like to extend our acknowledgments to the Spanish Agency for International Development and, the Barcelona Centre for International Health Research (CRESIB) of Spain, the Ministry of Health (MOH) of Mozambique and the Faculty of Medicine of the University Eduardo Mondlane of Mozambique. This work is part of the University of British Columbia PRE-EMPT (Pre-eclampsia/Eclampsia, Monitoring, Prevention and Treatment) an initiative supported by the Bill & Melinda Gates Foundation.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; [Anonymous], 2012, MORTALITY MOZAMBIQUE; Bhanji SM PN, 2014, J WOMENS HLTH CARE, V3, P161; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Cunguara BA, 2008, PATHWAYS OUT POVERTY; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; Fernandes QF, 2014, LANCET GLOB HEALTH, V2, pE468, DOI 10.1016/S2214-109X(14)70276-1; Gender Egbo B., 2000, LITERACY LIFE CHANCE; Gimbel S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-12; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Granja A C, 2000, Afr J Health Sci, V7, P83; Granja ACL, 2001, J ADOLESCENT HEALTH, V28, P303, DOI 10.1016/S1054-139X(00)00205-6; Illah Evance, 2013, Afr J Reprod Health, V17, P119; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kujala S, 2017, TROP MED INT HEALTH, V22, P63, DOI 10.1111/tmi.12807; Lehohla P., 2015, CENSUS 2011 FERTILIT; Lindelow OODEvDAWM, 2008, AN HLTH EQ US HOUS S; Marchal B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000059; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Ministerio da Saude (MISAU) INdSI, 2009, MOCAMBIQUE ESTUDO NA; Moultrie RD Tom, 2013, TOOLS DEMOGRAPHIC ES; Mozambique National Institute of Statistics USCB MEASURE Evaluation U.S. Centers for Disease Control and Prevention, 2012, MORTALITY IN MOZAMBI; Ngom P, 2001, HEALTH POLICY PLANN, V16, P337, DOI 10.1093/heapol/16.4.337; Oti SO, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-21; Republic of Mozambique, 2011, FIN REP; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Statistics TNBo. FERTILITY AND NUPTIALITY, 2015, FERT NUPT 2012 POP H; UNICEF, 2010, STRENGTH BIRTH REG A; UNICEF, 2014, SIT AN CHILDR MOZ; UNICEF, 2015, CHILD MARR AD PREGN; WHO, 2012, ADDR CHALL WOM HLTH; WHO, 2015, GLOB REF LIST 100 CO; World Health Organization, 2014, CIV REG WHY COUNT BI	34	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0184249	10.1371/journal.pone.0184249	http://dx.doi.org/10.1371/journal.pone.0184249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394247	Green Published, gold			2022-12-27	WOS:000424060400002
J	Dhooria, S; Agarwal, R; Sehgal, IS; Prasad, KT; Garg, M; Bal, A; Aggarwal, AN; Behera, D				Dhooria, Sahajal; Agarwal, Ritesh; Sehgal, Inderpaul Singh; Prasad, Kuruswamy Thurai; Garg, Mandeep; Bal, Amanjit; Aggarwal, Ashutosh Nath; Behera, Digambar			Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ILD-INDIA REGISTRY; FLEXIBLE CRYOPROBE; STATEMENT; EPIDEMIOLOGY; PIRFENIDONE; SARCOIDOSIS; BIOPSY; SPAIN	Background The spectrum of interstitial lung diseases (ILDs) have mainly been reported from the developed countries; data from developing countries is sparse and conflicting. The aim of this study is to describe the distribution of various ILDs from a developing country. Methods This is an analysis of prospectively collected clinical, radiological and histological data of consecutive subjects (age > 12 years) with ILDs from a single tertiary care medical center. The diagnosis of the specific subtype of ILD was made according to standard criteria for various ILDs. Results A total of 803 subjects (mean age, 50.6 years; 50.2% women) were enrolled between March 2015 to February 2017 of which 566 (70.5%) were diagnosed during the study period (incident cases). Sarcoidosis (42.2%), idiopathic pulmonary fibrosis (IPF, 21.2%), connective tissue disease (CTD)-related ILDs (12.7%), hypersensitivity pneumonitis (10.7%), and non-IPF idiopathic interstitial pneumonias (9.2%) were the most common ILDs. The spectrum of ILDs was not significantly different (p = 0.87) between incident and prevalent cases. A histopathological specimen was obtained in 49.9% of the subjects yielding a histologically confirmed diagnosis in 40.6%. A diagnostic procedure was not performed in 402 subjects; the most common reasons were presence of definite usual interstitial pneumonia pattern on high resolution computed tomography and patients' unwillingness to undergo the procedure. Conclusion Sarcoidosis, IPF and CTD-ILDs were the most common ILDs seen at a tertiary center in northern India similar to the spectrum reported from developed countries. More studies are required from developing countries to ascertain the spectrum of ILDs in different geographic locales.	[Dhooria, Sahajal; Agarwal, Ritesh; Sehgal, Inderpaul Singh; Prasad, Kuruswamy Thurai; Aggarwal, Ashutosh Nath; Behera, Digambar] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India; [Garg, Mandeep] Postgrad Inst Med Educ & Res, Dept Radiodiagnosis & Imaging, Chandigarh, India; [Bal, Amanjit] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Dhooria, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India.	sahajal@gmail.com	Agarwal, Ritesh/A-3063-2009; Sehgal, Inderpaul/AAA-8165-2021; Sehgal, Inderpaul/GYE-2441-2022	Agarwal, Ritesh/0000-0003-2547-7668; Sehgal, Inderpaul/0000-0002-6505-6019; Garg, Mandeep/0000-0002-4714-6299				Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Alhamad EH, 2013, ANN THORAC MED, V8, P33, DOI 10.4103/1817-1737.105717; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Dhooria S, 2017, CLIN RESP J IN PRESS; Dhooria Sahajal, 2017, J Assoc Physicians India, V65, P30; Dhooria S, 2017, AM J RESP CRIT CARE, V195, P835, DOI 10.1164/rccm.201610-2023LE; Dhooria S, 2016, SARCOIDOSIS VASC DIF, V33, P258; Dhooria S, 2016, RESP CARE, V61, P700, DOI 10.4187/respcare.04488; Dhooria S, 2016, LUNG INDIA, V33, P248, DOI 10.4103/0970-2113.177463; Dhooria S, 2016, LUNG INDIA, V33, P64, DOI 10.4103/0970-2113.173066; Dhooria S, 2015, LUNG INDIA, V32, P4, DOI 10.4103/0970-2113.148396; Dhooria S, 2014, J THORAC CARDIOV SUR, V148, P662, DOI 10.1016/j.jtcvs.2014.01.028; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; Jindal S K, 1999, Curr Opin Pulm Med, V5, P287, DOI 10.1097/00063198-199909000-00004; Jindal S K, 2001, Curr Opin Pulm Med, V7, P272, DOI 10.1097/00063198-200109000-00004; Karakatsani A, 2009, RESP MED, V103, P1122, DOI 10.1016/j.rmed.2009.03.001; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kumar Raj, 2014, Pneumonol Alergol Pol, V82, P218, DOI 10.5603/PiAP.2014.0029; Kundu S, 2014, LUNG INDIA, V31, P354, DOI 10.4103/0970-2113.142115; Lopez-Campos JL, 2004, EUR J EPIDEMIOL, V19, P155, DOI 10.1023/B:EJEP.0000017660.18541.83; Madan K, 2017, AM J RESP CRIT CARE, V195, P836, DOI 10.1164/rccm.201610-2099LE; Maheshwari U, 2004, Indian J Chest Dis Allied Sci, V46, P23; Musellim B, 2014, CLIN RESPIR J, V8, P55, DOI 10.1111/crj.12035; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ryerson CJ, 2014, EUR RESPIR J, V44, P273, DOI 10.1183/09031936.00051914; Schweisfurth H, 2003, Pneumologie, V57, P373; Schweisfurth H, 1996, Pneumologie, V50, P899; Sen Tiyas, 2010, Indian J Chest Dis Allied Sci, V52, P207; Singh S, 2017, AM J RESP CRIT CARE, V195, P801, DOI 10.1164/rccm.201607-1484OC; Thomeer M, 2001, ACTA CLIN BELG, V56, P163, DOI 10.1179/acb.2001.026; Thomeer M, 2001, EUR RESPIR J, V32, P114, DOI DOI 10.1016/S1010-7940(01)00915-0; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Udwadia ZF, 2017, AM J RESP CRIT CARE, V195, P714, DOI 10.1164/rccm.201610-2019ED; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P64	39	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191938	10.1371/journal.pone.0191938	http://dx.doi.org/10.1371/journal.pone.0191938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420550	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900033
J	Garvey, M; Suarez, NM; Kerr, K; Hector, R; Moloney-Quinn, L; Arkins, S; Davison, AJ; Cullinane, A				Garvey, Marie; Suarez, Nicolas M.; Kerr, Karen; Hector, Ralph; Moloney-Quinn, Laura; Arkins, Sean; Davison, Andrew J.; Cullinane, Ann			Equid herpesvirus 8: Complete genome sequence and association with abortion in mares	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DNA-SEQUENCE; ASININE HERPESVIRUS-3; GAZELLE HERPESVIRUS-1; THOMSONS GAZELLE; VIRUS; EHV-1; HOSTS; ZEBRA; DIFFERENTIATION	Equid herpesvirus 8 (EHV-8), formerly known as asinine herpesvirus 3, is an alphaherpes-virus that is closely related to equid herpesviruses 1 and 9 (EHV-1 and EHV-9). The pathogenesis of EHV-8 is relatively little studied and to date has only been associated with respiratory disease in donkeys in Australia and horses in China. A single EHV-8 genome sequence has been generated for strain Wh in China, but is apparently incomplete and contains frameshifts in two genes. In this study, the complete genome sequences of four EHV-8 strains isolated in Ireland between 2003 and 2015 were determined by Illumina sequencing. Two of these strains were isolated from cases of abortion in horses, and were misdiagnosed initially as EHV-1, and two were isolated from donkeys, one with neurological disease. The four genome sequences are very similar to each other, exhibiting greater than 98.4% nucleotide identity, and their phylogenetic clustering together demonstrated that genomic diversity is not dependent on the host. Comparative genomic analysis revealed 24 of the 76 predicted protein sequences are completely conserved among the Irish EHV-8 strains. Evolutionary comparisons indicate that EHV-8 is phylogenetically closer to EHV-9 than it is to EHV-1. In summary, the first complete genome sequences of EHV-8 isolates from two host species over a twelve year period are reported. The current study suggests that EHV-8 can cause abortion in horses. The potential threat of EHV-8 to the horse industry and the possibility that donkeys may act as reservoirs of infection warrant further investigation.	[Garvey, Marie; Moloney-Quinn, Laura; Cullinane, Ann] Irish Equine Ctr, Virol Unit, Naas, Kildare, Ireland; [Suarez, Nicolas M.; Kerr, Karen; Hector, Ralph; Davison, Andrew J.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [Arkins, Sean] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Hector, Ralph] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Limerick; University of Glasgow	Cullinane, A (corresponding author), Irish Equine Ctr, Virol Unit, Naas, Kildare, Ireland.; Davison, AJ (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.	andrew.davison@glasgow.ac.uk; ACullinane@irishequinecentre.ie	Hector, Ralph D/AAB-5455-2019	Hector, Ralph D/0000-0002-3778-1483	Irish Research Council [EBPPG/2014/62]; Medical Research Council [MC_UU_12014/3]; Medical Research Council [MC_UU_12014/12] Funding Source: researchfish; MRC [MC_UU_12014/3, MC_UU_12014/12] Funding Source: UKRI	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Irish Research Council (grant number EBPPG/2014/62 to MG; http://research.ie) and the Medical Research Council (grant number MC_UU_12014/3 to AD; http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090262; Abdelgawad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138370; Abdelgawad A, 2014, VET MICROBIOL, V169, P102, DOI 10.1016/j.vetmic.2013.12.011; Allen GP, 2008, EQUINE VET J, V40, P105, DOI 10.2746/042516408X253127; Allen G. P., 2004, Infectious diseases of livestock. Volume Two, P829; Allen GP, 2007, J VET DIAGN INVEST, V19, P69, DOI 10.1177/104063870701900110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Balasuriya UBR, 2015, J VET DIAGN INVEST, V27, P673, DOI 10.1177/1040638715605558; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BAUMANN RP, 1989, J VIROL, V63, P1275, DOI 10.1128/JVI.63.3.1275-1283.1989; Bazanow BA, 2014, EQUINE VET EDUC, V26, P48, DOI 10.1111/eve.12084; Bloom DC, 2016, ADV VIRUS RES, V94, P53, DOI 10.1016/bs.aivir.2015.10.001; BROWNING GF, 1988, ARCH VIROL, V101, P183, DOI 10.1007/BF01310999; CHOWDHURY SI, 1988, VIRUS RES, V11, P127, DOI 10.1016/0168-1702(88)90038-X; CHOWDHURY SI, 1990, J VIROL, V64, P873, DOI 10.1128/JVI.64.2.873-880.1990; CRABB BS, 1990, J GEN VIROL, V71, P2033, DOI 10.1099/0022-1317-71-9-2033; CRANDELL RA, 1988, AM J VET RES, V49, P1807; CULLINANE AA, 1988, J GEN VIROL, V69, P1575, DOI 10.1099/0022-1317-69-7-1575; Cuxson JL, 2014, VET MICROBIOL, V169, P50, DOI 10.1016/j.vetmic.2013.12.007; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Dayaram A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46559; Donovan TA, 2009, VET PATHOL, V46, P1138, DOI 10.1354/vp.09-VP-0007-D-CR; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FICORILLI N, 1995, ARCH VIROL, V140, P1653, DOI 10.1007/BF01322539; Fukushi H, 1997, VIROLOGY, V227, P34, DOI 10.1006/viro.1996.8296; Ghanem Y, 2008, ARCH VIROL, V153, P2297, DOI 10.1007/s00705-008-0247-y; Greenwood AD, 2012, CURR BIOL, V22, P1727, DOI 10.1016/j.cub.2012.07.035; Guo XQ, 2014, J VET MED SCI, V76, P1309, DOI 10.1292/jvms.14-0183; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kasem S, 2008, EMERG INFECT DIS, V14, P1948, DOI 10.3201/eid1412.080801; KINYILI JH, 1979, J WILDLIFE DIS, V15, P339, DOI 10.7589/0090-3558-15.2.339; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE GL, 1994, J VIROL METHODS, V47, P59, DOI 10.1016/0166-0934(94)90066-3; Liu CY, 2012, J VIROL, V86, P5407, DOI 10.1128/JVI.00445-12; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Narita M, 2000, VET PATHOL, V37, P476, DOI 10.1354/vp.37-5-476; Nugent J, 2006, J VIROL, V80, P4047, DOI 10.1128/JVI.80.8.4047-4060.2006; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; REBHUN WC, 1988, J AM VET MED ASSOC, V192, P953; Rozen S, 2000, Methods Mol Biol, V132, P365; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Smith KL, 2012, J CLIN MICROBIOL, V50, P1981, DOI 10.1128/JCM.00135-12; Smith KL, 2010, VET MICROBIOL, V141, P5, DOI 10.1016/j.vetmic.2009.07.030; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Taniguchi A, 2000, J VET MED SCI, V62, P215, DOI 10.1292/jvms.62.215; Taniguchi A, 2000, ARCH VIROL, V145, P2619, DOI 10.1007/s007050070011; Telford EAR, 1998, J GEN VIROL, V79, P1197, DOI 10.1099/0022-1317-79-5-1197; TELFORD EAR, 1992, VIROLOGY, V189, P304, DOI 10.1016/0042-6822(92)90706-U; Virus taxonomy, 1995, ARCH VIROL, V10, P1; Wagner LM, 2012, J VIROL, V86, P6862, DOI 10.1128/JVI.00651-12; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024	56	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192301	10.1371/journal.pone.0192301	http://dx.doi.org/10.1371/journal.pone.0192301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414990	Green Published, gold, Green Accepted			2022-12-27	WOS:000424325300069
J	Levy, BR; Slade, MD; Pietrzak, RH; Ferrucci, L				Levy, Becca R.; Slade, Martin D.; Pietrzak, Robert H.; Ferrucci, Luigi			Positive age beliefs protect against dementia even among elders with high-risk gene	PLOS ONE			English	Article							CENTER MORALE SCALE; COGNITIVE IMPAIRMENT; NEGATIVE STEREOTYPES; TELEPHONE INTERVIEW; SELF-STEREOTYPES; APOLIPOPROTEIN-E; METAANALYSIS; STRESS; MEMORY; ASSOCIATION	One of the strongest risk factors for dementia is the epsilon 4 variant of the APOE gene. Yet, many who carry it never develop dementia. The current study examined for the first time whether positive age beliefs that are acquired from the culture may reduce the risk of developing dementia among older individuals, including those who are APOE epsilon 4 carriers. The cohort consisted of 4,765 Health and Retirement Study participants who were aged 60 or older and dementia-free at baseline. As predicted, in the total sample those with positive age beliefs at baseline were significantly less likely to develop dementia, after adjusting for relevant covariates. Among those with APOE epsilon 4, those with positive age beliefs were 49.8% less likely to develop dementia than those with negative age beliefs. The results of this study suggest that positive age beliefs, which are modifiable and have been found to reduce stress, can act as a protective factor, even for older individuals at high risk of dementia.	[Levy, Becca R.] Yale Sch Publ Hlth, Social & Behav Sci Dept, New Haven, CT 06510 USA; [Slade, Martin D.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Pietrzak, Robert H.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Pietrzak, Robert H.] US Dept Vet Affairs, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Baltimore, MD 21224 USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Levy, BR (corresponding author), Yale Sch Publ Hlth, Social & Behav Sci Dept, New Haven, CT 06510 USA.	Becca.Levy@yale.edu			National Institute on Aging grant [`U01AG032284-05A1]; NATIONAL INSTITUTE ON AGING [U01AG032284] Funding Source: NIH RePORTER	National Institute on Aging grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Institute on Aging grant (U01AG032284-05A1) to BL, MS RP and LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Castanho TC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00016; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Faul J, 2014, HLTH RETIREMENT STUD; Ferrucci I, 1998, AGING CLIN EXP RES, V10, P332; Fisher GG, 2017, HLTH RETIREMENT STUD; Fong TG, 2009, ALZHEIMERS DEMENT, V5, P492, DOI 10.1016/j.jalz.2009.02.007; Gilsanz P, 2017, JAMA NEUROL, V74, P1056, DOI 10.1001/jamaneurol.2017.1553; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Horton S, 2008, J APPL GERONTOL, V27, P446, DOI 10.1177/0733464808315291; Lamont RA, 2015, PSYCHOL AGING, V30, P180, DOI 10.1037/a0038586; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; LEVY B, 1994, J PERS SOC PSYCHOL, V66, P989, DOI 10.1037/0022-3514.66.6.989; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2016, GEROPSYCH, V29, P141, DOI 10.1024/1662-9647/a000149; Levy BR, 2016, PSYCHOL AGING, V31, P82, DOI 10.1037/pag0000062; Levy BR, 2015, J GERONTOL B-PSYCHOL, V70, P886, DOI 10.1093/geronb/gbu082; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Levy BR, 2012, J GERONTOL B-PSYCHOL, V67, P432, DOI 10.1093/geronb/gbr120; Levy BR, 2000, J GERONTOL B-PSYCHOL, V55, pP205, DOI 10.1093/geronb/55.4.P205; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; LIANG J, 1983, J GERONTOL, V38, P181, DOI 10.1093/geronj/38.2.181; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; McEwen B. S., 2017, CHRONIC STRESS, V1; Meisner BA, 2012, J GERONTOL B-PSYCHOL, V67, P13, DOI 10.1093/geronb/gbr062; National Institute of Aging, 2007, GROW OLD AM HLTH RET; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Robertson DA, 2016, PSYCHOL AGING, V31, P71, DOI 10.1037/pag0000061; Seidler AL, 2017, GEROPSYCH, V30, P49, DOI 10.1024/1662-9647/a000165; Seo EH, 2011, ARCH GERONTOL GERIAT, V52, pE26, DOI 10.1016/j.archger.2010.04.008; Smith J., 2017, PSYCHOSOCIAL LIFESTY; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	36	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191004	10.1371/journal.pone.0191004	http://dx.doi.org/10.1371/journal.pone.0191004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414991	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300013
J	Silva, AF; Escada-Rebelo, S; Amaral, S; Tavares, RS; Schlatt, S; Ramalho-Santos, J; Mota, PC				Silva, Andreia F.; Escada-Rebelo, Sara; Amaral, Sandra; Tavares, Renata S.; Schlatt, Stefan; Ramalho-Santos, Joao; Mota, Paula C.			Can we induce spermatogenesis in the domestic cat using an in vitro tissue culture approach?	PLOS ONE			English	Article							GERM-CELL SURVIVAL; ORGAN-CULTURE; SEMINIFEROUS EPITHELIUM; TESTICULAR TISSUE; SPERM PRODUCTION; TESTIS TISSUE; IMMATURE RAT; FELIS-CATUS; DIFFERENTIATION; SPERMATOGONIA	The reduced number of animals in most wild felid populations implies a loss of genetic diversity. The death of juveniles, prior to the production of mature sperm, represents a loss of potential genetic contribution to future populations. Since 2011 mouse testicular organ culture has introduced an alternative mechanism to produce sperm in vitro from immature tissue. However, extension of this technology to other species has remained limited. We have used the domestic cat (Felis catus) as a model for wild felids to investigate spermatogenesis initiation and regulation, with the mouse serving as a control species. Testicular tissue fragments were cultured in control medium or medium supplemented with knockout serum replacement (KSR), AlbuMax, beta-estradiol or AlbuMax plus beta-estradiol. Contrary to expectations, and unlike results obtained in mouse controls, no germ cell differentiation could be detected. The only germ cells observed after six weeks of culture were spermatogonia regardless of the initial stage of tubule development in the donor tissue. Moreover, the number of spermatogonia decreased with time in culture in all media tested, especially in the medium supplemented with KSR, while AlbuMax had a slight protective effect. The combination of AlbuMax and beta-estradiol led to an increase in the area occupied by seminiferous tubules, and thus to an increase in total number of spermatogonial cells. Considering all the media combinations tested the stimulus for felid germ cell differentiation in this type of system seems to be different from the mouse. Studies using other triggers of differentiation and tissue survival factors should be performed to pursue this technology for the genetic diversity preservation in wild felids.	[Silva, Andreia F.; Escada-Rebelo, Sara; Amaral, Sandra; Tavares, Renata S.; Ramalho-Santos, Joao; Mota, Paula C.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Biol Reprod & Stem Cell Grp, Coimbra, Portugal; [Amaral, Sandra; Mota, Paula C.] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Schlatt, Stefan] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, Munster, Germany; [Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; University of Munster; Universidade de Coimbra	Mota, PC (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Biol Reprod & Stem Cell Grp, Coimbra, Portugal.; Mota, PC (corresponding author), Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal.	pccrmota@cnc.uc.pt	Santos, João/HHZ-5595-2022; Ramalho-Santos, João/F-8641-2012	Ramalho-Santos, João/0000-0002-1172-4018; Amaral, Sandra/0000-0001-5542-7763; Mota, Paula/0000-0001-9374-3476; Rebelo, Sara/0000-0001-8895-7867; Neves Silva, Andreia Filipa/0000-0002-8157-0819	Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/119477/2010]; FCT fellowships [SFRH/BPD/74252/2010, SFRH/BPD/110160/2015]; FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE; FCT [UID/NEU/04539/2013]	Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT); FCT fellowships(Portuguese Foundation for Science and Technology); FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT), research grant PTDC/CVT/119477/2010 to PC Mota. PC Mota and Amaral S were recipients of FCT fellowships (SFRH/BPD/74252/2010 and SFRH/BPD/110160/2015), and CNC was funded by FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE, and by national funds via the FCT under the project UID/NEU/04539/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2008, LIPIDS, V43, P19, DOI 10.1007/s11745-007-3117-6; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arregui L, 2014, REPROD FERT DEVELOP, V26, P817, DOI 10.1071/RD12411; Belkaid A, 2017, CARCINOGENESIS, V38, P402, DOI 10.1093/carcin/bgx020; BOITANI C, 1993, BIOL REPROD, V48, P761, DOI 10.1095/biolreprod48.4.761; CHEN YDI, 1976, P SOC EXP BIOL MED, V153, P473; Chishti YZ, 2014, GEN COMP ENDOCR, V199, P16, DOI 10.1016/j.ygcen.2014.01.004; D'Souza R, 2005, MOL CELL ENDOCRINOL, V241, P41, DOI 10.1016/j.mce.2005.04.011; Deng SL, 2017, THERIOGENOLOGY, V90, P120, DOI 10.1016/j.theriogenology.2016.12.002; Escada-Rebelo S, 2016, ANDROLOGY-US, V4, P1159, DOI 10.1111/andr.12223; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goldschmidt R, 1915, P NATL ACAD SCI USA, V1, P220, DOI 10.1073/pnas.1.4.220; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hogg K, 2015, STEM CELLS DEV, V24, P2899, DOI 10.1089/scd.2015.0196; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Jewgenow K, 2009, J ANDROL, V30, P460, DOI 10.2164/jandrol.108.006726; Kang JX, 2014, STEM CELLS, V32, P1092, DOI 10.1002/stem.1620; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Laurentino S, 2011, FERTIL STERIL, V96, P745, DOI 10.1016/j.fertnstert.2011.06.009; Lo KC, 2011, ASIAN J ANDROL, V13, P677, DOI 10.1038/aja.2011.88; LUCAS DR, 1958, J EMBRYOL EXP MORPH, V6, P178; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Maganty Avinash, 2015, FUTURE PERSPECTIVES; Mota PC, 2012, THERIOGENOLOGY, V77, P299, DOI 10.1016/j.theriogenology.2011.07.042; Muller G, 2012, THERIOGENOLOGY, V78, P1224, DOI 10.1016/j.theriogenology.2012.05.018; Neubauer K, 2004, BIOL REPROD, V71, P1517, DOI 10.1095/biolreprod.104.031062; Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057; Perrard MH, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142802; Reda A, 2016, MOL HUM REPROD, V22, P601, DOI 10.1093/molehr/gaw047; Reuter Karin, 2012, Spermatogenesis, V2, P245; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130171; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schoen J, 2012, REPROD DOMEST ANIM, V47, P30, DOI 10.1111/rda.12065; STEINBER.A, 1966, EXP CELL RES, V44, P429, DOI 10.1016/0014-4827(66)90449-6; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Steinberger A, 1970, In Vitro, V5, P17, DOI 10.1007/BF02618371; STEINBERGER A, 1965, J REPROD FERTIL, V9, P243; STEINBERGER E, 1964, ENDOCRINOLOGY, V74, P788, DOI 10.1210/endo-74-5-788; STEINBERGER E, 1964, ANAT REC, V148, P581, DOI 10.1002/ar.1091480409; Stukenborg JB, 2008, J ANDROL, V29, P312, DOI 10.2164/jandrol.107.002857; Tokunaga Y, 1999, ENDOCRINOLOGY, V140, P1875, DOI 10.1210/en.140.4.1875; Vansandt LM, 2012, REPROD DOMEST ANIM, V47, P256, DOI 10.1111/rda.12079; Wrobel KH, 2000, ANAT EMBRYOL, V202, P209, DOI 10.1007/s004290000111; Zhou Q, 2016, CELL STEM CELL, V18, P330, DOI 10.1016/j.stem.2016.01.017	49	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191912	10.1371/journal.pone.0191912	http://dx.doi.org/10.1371/journal.pone.0191912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414992	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300045
J	Biru, M; Hallstrom, I; Lundqvist, P; Jerene, D				Biru, Mulatu; Hallstrom, Inger; Lundqvist, Pia; Jerene, Degu			Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: A prospective cohort study	PLOS ONE			English	Article							CARE	Introduction Attrition from antiretroviral therapy (ART) programmes is a critical challenge among children receiving care in resource-limited settings. Our objective was to determine the rates and predictors of attrition among children on ART in Ethiopia. Methods Between December 2014 and September 2016, we conducted a prospective cohort study in eight health facilities in Ethiopia. Eligibility criteria included age 3 months-14 years; being on ART for not more than a month. Outcome was attrition due to death and/or loss to follow-up. Predictor variables were child clinical and socio-demographic characteristics, and caregiver socio-demographic characteristics. We used Cox Regression analyses to examine the association between predictors and outcome. Results Of 309 children, 304 were included, 52% were male. Their median age was 9 years (Inter-quartile range, IQR, 6-12). At ART initiation, their median CD4 was 362 cells/mm 3 (IQR 231-499); and 74.3% had WHO stage 1 or 2 disease. During 287.7 person-years of observation (PYO), 24 attritions were recorded, yielding an attrition rate of 8.3 per 100 PYO (95% CI 5.4-12.1). Of these, six children were reported dead, leading to a mortality rate of 2.1 per 100 PYO (95% CI 0.8-4.3). Eighteen were lost to follow-up (LTFU) leading to LTFU rate of 6.26 per 100 PYO (95% CI: 3.83-9.70). The majority, 14 (58%) of attrition occurred during the first six months of treatment. Age below three years [aHR] = 5.14 (95% CI: 2.07-12.96), rural residence (aHR = 3.97, 95% CI: 1.34-11.78) and baseline Hgb in g/dl < 10 g/dl [aHR] = 5.68 (95% CI: 2.03-6.23) predicted higher risk of attrition. Baseline Hgb < 10 g/dl (aHR = 16.63, 95% CI: 1.64-168.4) and WHO stage III or IV (aHR = 12.25, 95% CI: 1.26-119.05) predicted the death of the child. Higher attrition was documented among children of both biological parents alive and biologically related close family caregivers. Conclusion Younger children, those from rural areas, and children with anaemia were at higher risk of attrition, especially during the early months of treatment, and therefore should be prioritized during treatment follow-up. Further studies should examine underlying reasons for higher attrition.	[Biru, Mulatu; Hallstrom, Inger; Lundqvist, Pia] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden; [Jerene, Degu] Management Sci Hlth, Addis Ababa, Ethiopia	Lund University	Biru, M (corresponding author), Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden.	mulatu.biru@med.lu.se		Biru, Mulatu/0000-0002-8370-2571; Kristensson Hallstrom, Inger/0000-0002-9402-6230	Swedish Research Council [521-2013-2633]; Swedish Research Council for Health, Working Life and Welfare [2013-2094]; SIDA [348-2011-7394]; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare; SIDA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); SIDA	This study was supported by the Swedish Research Council [grant number 521-2013-2633], The Swedish Research Council for Health, Working Life and Welfare [grant number 2013-2094] and SIDA [grant number 348-2011-7394]. The support was received by I. Hallstrom.; This study was supported by the Swedish Research Council, The Swedish Research Council for Health, Working Life and Welfare, and SIDA	Abuogi LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156506; Alvarez-Uria Gerardo, 2014, Germs, V4, P9, DOI 10.11599/germs.2014.1049; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Asfawesen GY, 2011, ACTA PAEDIATR, V100, P1164, DOI 10.1111/j.1651-2227.2011.02243.x; Biru M, 2016, CAREGIVER REPORTED A, P1360; CSA E, 2013, POP PROJ ETH ALL REG; Federal Ministry of Health E, 2016, 2014 NAT COMPR HIV S; Federal Ministry of Health E, 2013, ACC ACT PLAN IMPR PE; Federal Ministry of Health E, 2007, GUID PAED HIV AIDS C; Federal Ministry of Health (FMOH), 2017, UNPUB; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hagstromer O, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22274; Koye DN, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-161; Melaku Z, 2017, TROPICAL MED INT HLT; office F.H.A.p.a.c. The Federal Democratic Republic of Ethiopia Ministry of Health, 2014, HIV AIDS STRAT PLAN; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; UNAIDS, 2016, END AIDS; UNICEF, 2016, 7 UNICEF; WHO, 2016, CONGUID UANT DRU; Wilhelmson S, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29943; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2016, PREV HIV TEST TREAT; World Health Organization (WHO), 2007, WHO CAS DET HIV SURV	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189777	10.1371/journal.pone.0189777	http://dx.doi.org/10.1371/journal.pone.0189777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408897	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800006
J	Garcia-Villaescusa, A; Morales-Tatay, JM; Monleon-Salvado, D; Gonzalez-Darder, JM; Bellot-Arcis, C; Montiel-Company, JM; Almerich-Silla, JAM				Garcia-Villaescusa, Alberto; Manuel Morales-Tatay, Jose; Monleon-Salvado, Daniel; Manuel Gonzalez-Darder, Jose; Bellot-Arcis, Carlos; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose			Using NMR in saliva to identify possible biomarkers of glioblastoma and chronic periodontitis	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DISEASE; GLIOMA; H-1; EPIDEMIOLOGY; PROFILES; INVASION; CELLS	Nowadays there is increasing interest in identifying-and using-metabolites that can be employed as biomarkers for diagnosing, treating and monitoring diseases. Saliva and NMR have been widely used for this purpose as they are fast and inexpensive methods. This case-control study aimed to find biomarkers that could be related to glioblastoma (GBL) and periodontal disease (PD) and studied a possible association between GBL and periodontal status. The participants numbered 130, of whom 10 were diagnosed with GBL and were assigned to the cases group, while the remaining 120 did not present any pathology and were assigned to the control group. On one hand, significantly increased (p < 0.05) metabolites were found in GBL group: leucine, valine, isoleucine, propionate, alanine, acetate, ethanolamine and sucrose. Moreover, a good tendency to separation between the two groups was observed on the scatterplot of the NMR. On the other hand, the distribution of the groups attending to the periodontal status was very similar and we didn't find any association between GBL and periodontal status (Chi-Square 0.1968, p = 0.91). Subsequently, the sample as a whole (130 individuals) was divided into three groups by periodontal status in order to identify biomarkers for PD. Group 1 was composed of periodontally healthy individuals, group 2 had gingivitis or early periodontitis and group 3 had moderate to advanced periodontitis. On comparing periodontal status, a significant increase (p < 0.05) in certain metabolites was observed. These findings along with previous reports suggest that these could be used as biomarkers of a PD: caproate, isocaproate+butyrate, isovalerate, isopropanol+methanol, 4 aminobutyrate, choline, sucrose, sucrose-glucose-lysine, lactate-proline, lactate and proline. The scatter plot showed a good tendency to wards separation between group 1 and 3.	[Garcia-Villaescusa, Alberto; Bellot-Arcis, Carlos; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Fac Med & Odontol, Dept Estomatol, Valencia, Spain; [Manuel Morales-Tatay, Jose] Univ Valencia, Fac Med & Odontol, Unidad Cent Invest & Med, Valencia, Spain; [Monleon-Salvado, Daniel] Univ Valencia, Hosp Clin, Inst Invest Sanitaria Clin Valencia, Fdn Invest, Valencia, Spain; [Manuel Gonzalez-Darder, Jose] Clin Hosp, Dept Neurosurg, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Garcia-Villaescusa, A (corresponding author), Univ Valencia, Fac Med & Odontol, Dept Estomatol, Valencia, Spain.	garvial@alumni.uv.es	BELLOT-ARCIS, CARLOS/AGP-0731-2022; Monleon, Daniel/A-5078-2010; Montiel-Company, José María/S-1836-2018; Monleon, Daniel/GNP-4083-2022; tatay, jose manuel morales/L-7972-2014	BELLOT-ARCIS, CARLOS/0000-0003-4363-2713; Monleon, Daniel/0000-0002-4803-1573; Montiel-Company, José María/0000-0002-3952-7681; Monleon, Daniel/0000-0002-4803-1573; tatay, jose manuel morales/0000-0002-4404-6735	Conselleria de Sanitat Universal i Salut Publica; Ministry of Economy and Competitiveness of Spain [SAF2014-52875R]; Institute de Salud Carlos III [PIE15/00013]; FEDER [PIE15/00013]	Conselleria de Sanitat Universal i Salut Publica; Ministry of Economy and Competitiveness of Spain(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by Conselleria de Sanitat Universal i Salut Publica, Ministry of Economy and Competitiveness of Spain (SAF2014-52875R) and Institute de Salud Carlos III and FEDER [grant number PIE15/00013]. Almerich-Silla JM is the principal researcher, http://www.san.gva.es/inicio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, CARCINOGENESIS, V33, P1055, DOI 10.1093/carcin/bgs112; Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2; Albert DA, 2012, ANN NY ACAD SCI, V1255, P1, DOI 10.1111/j.1749-6632.2011.06460.x; Araujo MWB, 2003, J PERIODONTOL, V74, P1736, DOI 10.1902/jop.2003.74.12.1736; Arora M, 2010, AM J EPIDEMIOL, V171, P253, DOI 10.1093/aje/kwp340; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Bulakbasi N, 2003, AM J NEURORADIOL, V24, P225; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; De La Pena VA, 2007, ARCH ORAL BIOL, V52, P911, DOI 10.1016/j.archoralbio.2007.04.008; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Eriksson L., 2006, MULTI MEGAVARIATE 1; Galbis-Estrada C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/542549; Gil-Gil MJ, 2013, CLIN MED INSIGHTS-ON, V7, P123, DOI 10.4137/CMO.S8503; Herrera D, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2007.01170.x; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Ide M, 2013, J CLIN PERIODONTOL, V40, pS181, DOI [10.1111/jcpe.12063, 10.1902/jop.2013.134009]; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Kim EH, 2005, ONCOGENE, V24, P6877, DOI 10.1038/sj.onc.1208851; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Lu R, 2014, J PERIODONTAL RES, V49, P574, DOI 10.1111/jre.12137; Tieu MT, 2015, J NEURO-ONCOL, V124, P119, DOI 10.1007/s11060-015-1815-0; Mohammad AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113740; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; Nicolaidis S, 2015, METABOLISM, V64, pS22, DOI 10.1016/j.metabol.2014.10.031; Nomura Y, 2012, ARCH ORAL BIOL, V57, P413, DOI 10.1016/j.archoralbio.2011.09.011; Norska A, 2010, NEUROIMAG CLIN N AM, V20, P293, DOI 10.1016/j.nic.2010.04.003; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Qiqiang L, 2012, J PERIODONTAL RES, V47, P740, DOI 10.1111/j.1600-0765.2012.01489.x; Rzeznik M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182767; Shao W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-197; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369; Tanaka S, 2014, BRAIN TUMOR PATHOL, V31, P172, DOI 10.1007/s10014-014-0192-2; Tezal M, 2001, J PERIODONTOL, V72, P183, DOI 10.1902/jop.2001.72.2.183; Yaiw Koon-Chu, 2013, Herpesviridae, V4, P3, DOI 10.1186/2042-4280-4-3; Yilmaz A, 2017, J ALZHEIMERS DIS, V58, P355, DOI 10.3233/JAD-161226; Zappacosta B, 2007, CLIN BIOCHEM, V40, P661, DOI 10.1016/j.clinbiochem.2007.01.011; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144319	42	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0188710	10.1371/journal.pone.0188710	http://dx.doi.org/10.1371/journal.pone.0188710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408884	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800002
J	Lasser, KE; Lunze, K; Cheng, DM; Blokhina, E; Walley, AY; Tindle, HA; Quinn, E; Gnatienko, N; Krupitsky, E; Samet, JH				Lasser, Karen E.; Lunze, Karsten; Cheng, Debbie M.; Blokhina, Elena; Walley, Alexander Y.; Tindle, Hilary A.; Quinn, Emily; Gnatienko, Natalia; Krupitsky, Evgeny; Samet, Jeffrey H.			Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study	PLOS ONE			English	Article							CIGARETTE-SMOKING; NICOTINE DEPENDENCE; FAGERSTROM TEST; HEALTH; CESSATION; SUBSTANCE; PATTERNS; WOMEN	Introduction Globally, persons with HIV infection, depression and substance use disorders have a higher smoking prevalence and smoke more heavily than other populations. These associations have not been explored among Russian smokers with HIV infection and substance use disorders. The purpose of this study was to examine the relationship between the presence of depressive symptoms and smoking outcomes in an HIV-positive cohort of Russian smokers with a history of substance use disorders (alcohol and/or drug use disorders). Methods We performed a cross-sectional secondary data analysis of a cohort of HIV-positive regular smokers with a history of substance use disorders recruited in St. Petersburg, Russia in 2012-2015. The primary outcome was heavy smoking, defined as smoking > 20 cigarettes per day. Nicotine dependence (moderate-very high) was a secondary outcome. The main independent variable was a high level of depressive symptoms in the past 7 days (defined as CES-D > = 24). We used multivariable logistic regression to examine associations between depressive symptoms and the outcomes, controlling for age, sex, education, income, running out of money for housing/food, injection drug use, and alcohol use measured by the AUDIT. Results Among 309 regular smokers, 79 participants (25.6%) had high levels of depressive symptoms, and 65 participants (21.0%) were heavy smokers. High levels of depressive symptoms were not significantly associated with heavy smoking (adjusted odds ratio [aOR] 1.50, 95% CI 0.78-2.89) or with moderate-very high levels of nicotine dependence (aOR 1.35, 95% CI 0.75-2.41). Conclusions This study did not detect an association between depressive symptoms and smoking outcomes among HIV-positive regular smokers in Russia.	[Lasser, Karen E.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA; [Lasser, Karen E.] Boston Univ, Boston Med Ctr, Sch Publ Hlth, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA; [Lunze, Karsten; Walley, Alexander Y.; Samet, Jeffrey H.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Clin Addict Res &, Boston, MA 02215 USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Blokhina, Elena; Krupitsky, Evgeny] First St Petersburg Pavlov State Med Univ, St Petersburg, Russia; [Tindle, Hilary A.] Vanderbilt Univ, Vanderbilt Ctr Tobacco Addict & Lifestyle, Sch Med, Nashville, TN 37235 USA; [Quinn, Emily] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02215 USA; [Gnatienko, Natalia] Boston Med Ctr, Dept Med, Sect Gen Internal Med, Clin Addict & Res Educ Unit, Boston, MA USA; [Krupitsky, Evgeny] St Petersburg Bekhterev Res Psychoneurol Inst, St Petersburg, Russia; [Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston University; Pavlov First Saint Petersburg State Medical University; Vanderbilt University; Boston University; Boston Medical Center; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Boston University	Lasser, KE (corresponding author), Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA.; Lasser, KE (corresponding author), Boston Univ, Boston Med Ctr, Sch Publ Hlth, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA.	Karen.lasser@bmc.org	Lunze, Karsten/AAL-7240-2021; Blokhina, Elena A/V-6040-2018; Krupitsky, Evgeny/M-5935-2016	Lunze, Karsten/0000-0001-8495-0350; Blokhina, Elena A/0000-0001-5811-9897; Samet, Jeffrey/0000-0002-0897-3400; Krupitsky, Evgeny/0000-0002-0529-4525	National Institute on Drug Abuse [R01DA032082]; National Institute on Alcohol Abuse and Alcoholism [U01AA020780, U01AA021989, U24AA020778, U24AA020779]; American Cancer Society [RSG-14-034-01-CPPB]; CFAR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020780, U24AA020778, U24AA020779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032082] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); CFAR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by grants R01DA032082 from the National Institute on Drug Abuse, U01AA020780, U01AA021989, U24AA020778, U24AA020779 from the National Institute on Alcohol Abuse and Alcoholism, and RSG-14-034-01-CPPB from the American Cancer Society. The work was facilitated by the Providence/Boston Center for AIDS Research (P30A1042853, PI: Susan Cu-Vin). Efforts of three co-authors, Drs. Walley, Lunze, and Samet were partially supported by the CFAR, as Drs. Walley and Lunze are faculty members of the Substance Use Research Core (SURC) and Dr. Samet is a codirector of the SURC. The funding source had no role in the study design, the data collection, analysis and interpretation of the data; in the writing of this manuscript or decision to submit this article for publication.	Abdullah ASM, 2002, AM J ADDICTION, V11, P235, DOI 10.1080/10550490290088018; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Brown JL, AIDS CARE; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Caponnetto P, 2008, RESP MED, V102, P1182, DOI 10.1016/j.rmed.2008.02.017; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cropsey KL, J ADDICTION MED JID; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Fleishman JA, 2000, AM J COMMUN PSYCHOL, V28, P421, DOI 10.1023/A:1005132430171; Gfroerer J, 2013, MORB MORTAL WEEKLY R, V62; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; Institute for Health Metrics and Evaluation, 2016, TOB BURD VIS; Janus E, 1996, HONG KONG CARDIOVASC; Kaleta D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2537-0; Khaled SM, 2011, NICOTINE TOB RES, V13, P1059, DOI 10.1093/ntr/ntr157; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lunze K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-64; Ministry of Health, FED RES CTR HIV AIDS; Munafo MR, 2010, BRIT J PSYCHIAT, V196, P425, DOI 10.1192/bjp.bp.109.074880; National Institute on Drug Abuse, 2013, HIV HCV STI TEST STA; National Institute on Drug Abuse, FAG SCOR; National Institute on Drug Abuse, WHY DO DRUG US DIS O; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; OECD, 2016, EC ENV SOC STAT; Ompad DC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-375; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Roberts B, 2013, NICOTINE TOB RES, V15, P271, DOI 10.1093/ntr/nts100; Ross H, 2008, EC TOBACCO TAXATION, P4; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; So-Armah K, 2017, 2017 C RETR OPP INF; Tyndale RF, 2001, DRUG METAB DISPOS, V29, P548; UNAIDS, 2008, REP GLOB AIDS EP; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; WHO, 2016, TOB FREE IN TAX; World Health Organization, 2005, WHO FRAM CONV TOB CO; Zhou J., 2007, PREV CHRONIC DIS, V7, pA15; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189207	10.1371/journal.pone.0189207	http://dx.doi.org/10.1371/journal.pone.0189207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408935	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800003
J	van Veldhuizen, R; Oosterbeek, H; Sonnemans, J				van Veldhuizen, Roel; Oosterbeek, Hessel; Sonnemans, Joep			Peers at work: Evidence from the lab	PLOS ONE			English	Article							PRESSURE	This paper reports the results of a lab experiment designed to study the role of observability for peer effects in the setting of a simple production task. In our experiment, participants in the role of workers engage in a team real-effort task. We vary whether they can observe, or be observed by, one of their co-workers. In contrast to earlier findings from the field, we find no evidence that low-productivity workers perform better when they are observed by high-productivity co-workers. Instead, our results imply that peer effects in our experiment are heterogeneous, with some workers reciprocating a high-productivity co-worker but others taking the opportunity to free ride.	[van Veldhuizen, Roel] WZB Berlin, Berlin, Germany; [Oosterbeek, Hessel; Sonnemans, Joep] Univ Amsterdam, Amsterdam, Netherlands; [Sonnemans, Joep] Tinbergen Inst, Amsterdam, Netherlands	University of Amsterdam; Tinbergen Institute	van Veldhuizen, R (corresponding author), WZB Berlin, Berlin, Germany.	roel.vanveldhuizen@wzb.eu		Sonnemans, Joep/0000-0001-7545-7409	Research Priority Area in Behavioral Economics at the University of Amsterdam	Research Priority Area in Behavioral Economics at the University of Amsterdam	The authors gratefully acknowledge financial support from the Research Priority Area in Behavioral Economics at the University of Amsterdam, which funded the experiments reported in this study.	Beugnot J, 2013, SOCIAL NETWORKS PEER; Buser T, 2014, Q J ECON, V129, P1409, DOI 10.1093/qje/qju009; Charness G, 2011, HBK ECON, V4, P229, DOI 10.1016/S0169-7218(11)00409-6; de Haan T, 2015, J ECON BEHAV ORGAN, V117, P47, DOI 10.1016/j.jebo.2015.06.002; Ellingsen T, 2008, AM ECON REV, V98, P990, DOI 10.1257/aer.98.3.990; Falk A, 2006, J LABOR ECON, V24, P38; Fehr E, 2009, ANNU REV ECON, V1, P355, DOI 10.1146/annurev.economics.050708.143217; Georganas S, 2015, J ECON BEHAV ORGAN, V117, P223, DOI 10.1016/j.jebo.2015.06.014; Guryan J, 2009, AM ECON J-APPL ECON, V1, P34, DOI 10.1257/app.1.4.34; Herbst D, 2015, SCIENCE, V350, P545, DOI 10.1126/science.aac9555; KANDEL E, 1992, J POLIT ECON, V100, P801, DOI 10.1086/261840; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mas A, 2009, AM ECON REV, V99, P112, DOI 10.1257/aer.99.1.112; Mohnen A, 2008, J LABOR ECON, V26, P693, DOI 10.1086/591116; Moretti E, 2011, HBK ECON, V4, P1237, DOI 10.1016/S0169-7218(11)02412-9; Niederle M., 2016, HDB EXPT EC, V2, P481; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Sausgruber R, 2009, EXP ECON, V12, P193, DOI 10.1007/s10683-008-9209-1; Sloof R, 2010, LABOUR ECON, V17, P751, DOI 10.1016/j.labeco.2010.03.001; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; Thoni C, 2015, J ECON PSYCHOL, V48, P72, DOI 10.1016/j.joep.2015.03.001; van Dijk F, 2001, EUR ECON REV, V45, P187, DOI 10.1016/S0014-2921(00)00056-8	22	8	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192038	10.1371/journal.pone.0192038	http://dx.doi.org/10.1371/journal.pone.0192038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408863	Green Published, gold			2022-12-27	WOS:000424302800042
J	Gaete, J; Montero-Marin, J; Valenzuela, D; Rojas-Barahona, CA; Olivares, E; Araya, R				Gaete, Jorge; Montero-Marin, Jesus; Valenzuela, Daniela; Rojas-Barahona, Cristian A.; Olivares, Esterbina; Araya, Ricardo			Mental health among children and adolescents: Construct validity, reliability, and parent-adolescent agreement on the 'Strengths and Difficulties Questionnaire' in Chile	PLOS ONE			English	Article							SELF-REPORT VERSION; CONFIRMATORY FACTOR-ANALYSIS; LEAST-SQUARES ESTIMATION; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; SCALE VALIDATION; COMMUNITY SAMPLE; SDQ; BEHAVIOR; CONVERGENT	The Strengths and Difficulties Questionnaire (SDQ) is a screening tool used to measure psychological functioning among children and adolescents. It has been extensively used worldwide, but its psychometric properties, such as internal structure and reliability, seem to vary across countries. This is the first study exploring the construct validity and reliability of the Spanish version of SDQ among early adolescents (self-reported) and their parents in Latin America. A total of 1,284 early adolescents (9-15 years) and their parents answered the SDQ. We also collected demographic variables. A confirmatory factor analysis was conducted to assess the latent structure of the SDQ. We also used the multitrait-multimethod analysis to separate the true variance on the constructs from variance resulting from measurement methods (self-report vs. parent report), and evaluated the agreement between adolescents and their parents. We found that the original five-factor model was a good solution and the resulting sub-scales had good internal consistency. We also found that the self-reported and parental versions of SDQ provide different information, which are complementary and provide a better picture of the emotional, social, and conduct problems of adolescents. We have added evidence for the construct validity and reliability of the Spanish selfreported and parental SDQ versions in a Chilean sample.	[Gaete, Jorge] Univ Los Andes, Fac Med, Dept Publ Hlth & Epidemiol, Santiago, Chile; [Gaete, Jorge] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Montero-Marin, Jesus] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain; [Valenzuela, Daniela] Univ Los Andes, Sch Psychol, Santiago, Chile; [Rojas-Barahona, Cristian A.] Pontificia Univ Catolica Chile, Fac Educ, Santiago, Chile; [Olivares, Esterbina] Univ Valparaiso, Sch Nursing, Campus San Felipe, San Felipe, Chile; [Araya, Ricardo] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth & Primary Care Res, London, England	Universidad de los Andes - Chile; University of London; London School of Hygiene & Tropical Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad de los Andes - Chile; Pontificia Universidad Catolica de Chile; Universidad de Valparaiso; University of London; King's College London	Gaete, J (corresponding author), Univ Los Andes, Fac Med, Dept Publ Hlth & Epidemiol, Santiago, Chile.; Gaete, J (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.	jgaete@uandes.cl	Gaete, Jorge/C-7471-2014; Montero-Marin, Jesus/ABG-8919-2020; Araya, Ricardo/S-3144-2019; Rojas, Cristian/AAI-4137-2020	Gaete, Jorge/0000-0002-6650-6018; Montero-Marin, Jesus/0000-0001-5677-1662; Araya, Ricardo/0000-0002-0420-5148; Rojas, Cristian/0000-0002-7733-6157	Joint project-New Learning Environments and Technologies [AKA-EDU/15]; Academy of Finland; CONICYT, Chile; Chilean National Grant for Research and Development in Health [FONIS- EVS-13I0100]	Joint project-New Learning Environments and Technologies; Academy of Finland(Academy of Finland); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Chilean National Grant for Research and Development in Health	This work was supported by: 1. Joint project-New Learning Environments and Technologies-AKA-EDU/15, Academy of Finland (http://www.aka.fi/en) and CONICYT, Chile (http://www.conicyt.cl) to JG; 2. Chilean National Grant for Research and Development in Health-FONIS- EVS-13I0100, CONICYT, Chile (http://www.conicyt.cl) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Almaqrami MH, 2004, SAUDI MED J, V25, P592; Altendorfer-Kling U, 2007, Z KINDER JUG-PSYCH, V35, P265, DOI 10.1024/1422-4917.35.4.265; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; Brown P., 2014, REV PSICOLOGIA, V23, P28, DOI DOI 10.5354/0719-0581.2014.36146; Byrne B. M., 2001, STRUCTURAL EQUATION; Capron C, 2007, EUR J PSYCHOL ASSESS, V23, P79, DOI 10.1027/1015-5759.23.2.79; Caqueo A, 2014, REV CHIL PEDIATR-CHI, V85, P561, DOI 10.4067/S0370-41062014000500006; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Costello DM, 2008, J CONSULT CLIN PSYCH, V76, P173, DOI 10.1037/0022-006X.76.2.173; Costello EJ, 2016, J CLIN CHILD ADOLESC, V45, P710, DOI 10.1080/15374416.2016.1236728; Dickey WC, 2004, J AM ACAD CHILD PSY, V43, P1159, DOI 10.1097/01.chi.0000132808.36708.a9; Essau CA, 2012, INT J METH PSYCH RES, V21, P232, DOI 10.1002/mpr.1364; Fisher J, 2011, INT J SOC PSYCHIATR, V57, P9, DOI 10.1177/0020764010397628; Gaete J, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1810-1; Gaete J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01901; Gaete J, 2016, J ADOLESCENCE, V50, P1, DOI 10.1016/j.adolescence.2016.04.002; Garcia E, 2000, FACTORIAL ANAL; George M., 1995, REV PSICOLOGIA, V5, P17, DOI [10.5354/0719-0581.1994.18486, DOI 10.5354/0719-0581.1994.18486]; Gomez R, 2014, ASSESSMENT, V21, P372, DOI 10.1177/1073191112457588; Gomez-Beneyto M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-95; Goodman A, 2012, SOC PSYCH PSYCH EPID, V47, P1321, DOI 10.1007/s00127-011-0440-2; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2004, EUR CHILD ADOLES PSY, V13, P25, DOI 10.1007/s00787-004-2005-3; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Guzman J, 2015, J AM ACAD CHILD PSY, V54, P799, DOI 10.1016/j.jaac.2015.07.005; Guzman MP, 2011, EUR CHILD ADOLES PSY, V20, P401, DOI 10.1007/s00787-011-0191-3; Halpern ME, 2011, EARLY DETECTION PSYC; He JP, 2013, J ABNORM CHILD PSYCH, V41, P583, DOI 10.1007/s10802-012-9696-6; Hendren R, 1994, ORG WH MENTAL HLTH P; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; Hoofs H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120930; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JELLINEK MS, 1988, J PEDIATR-US, V112, P201, DOI 10.1016/S0022-3476(88)80056-8; JELLINEK MS, 1986, J PEDIATR-US, V109, P371, DOI 10.1016/S0022-3476(86)80408-5; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; Klasen H, 2003, PRAX KINDERPSYCHOL K, V52, P491; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Lecannelier F, 2014, UNIV PSYCHOL, V13, P491, DOI 10.11144/Javeriana.UPSY13-2.vici; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levy J. P., 2006, MODELING COVARIANCE; Liu SK, 2013, COMPR PSYCHIAT, V54, P720, DOI 10.1016/j.comppsych.2013.01.002; MARDIA KV, 1974, SANKHYA SER B, V36, P115; MARSH HW, 1983, J EDUC MEAS, V20, P231, DOI 10.1111/j.1745-3984.1983.tb00202.x; Marsh HW, 1996, J PERS SOC PSYCHOL, V70, P810, DOI 10.1037/0022-3514.70.4.810; Marzocchi GM, 2004, S EUR CHILD ADOLE S2, V13, pli40; McDonald RP, 1999, TEST THEORY UNIFIED; Montenegro H, 1983, SCH MENTAL HLTH STAN; Muris P, 2004, BRIT J CLIN PSYCHOL, V43, P437, DOI 10.1348/0144665042388982; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Murphy JM, 2015, CHILD PSYCHIAT HUM D, V46, P245, DOI 10.1007/s10578-014-0464-4; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Ortuno-Sierra J, 2015, INT J CLIN HLTH PSYC, V15, P265, DOI 10.1016/j.ijchp.2015.05.005; Ortuno-Sierra J, 2015, J ADOLESCENCE, V38, P49, DOI 10.1016/j.adolescence.2014.11.001; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Ruchkin V, 2007, J CLIN PSYCHOL, V63, P861, DOI 10.1002/jclp.20401; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Tsang KLV, 2012, CHILD CARE HLTH DEV, V38, P629, DOI 10.1111/j.1365-2214.2011.01355.x; van de Looij-Jansen PM, 2011, BRIT J CLIN PSYCHOL, V50, P127, DOI 10.1348/014466510X498174; van der Meer M, 2008, EUR CHILD ADOLES PSY, V17, P491, DOI 10.1007/s00787-008-0691-y; Van Roy B, 2008, J CHILD PSYCHOL PSYC, V49, P1304, DOI 10.1111/j.1469-7610.2008.01942.x; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Verhulst FC, 1997, ACTA PSYCHIAT SCAND, V96, P75, DOI 10.1111/j.1600-0447.1997.tb09909.x; Vicente B, 2012, J CHILD PSYCHOL PSYC, V53, P1026, DOI 10.1111/j.1469-7610.2012.02566.x; Vicente B, 2012, SOC PSYCH PSYCH EPID, V47, P1099, DOI 10.1007/s00127-011-0415-3; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Woerner Wolfgang, 2004, Eur Child Adolesc Psychiatry, V13 Suppl 2, pII3; World Health Organization, 2003, CAR CHILDR AD MENT D; Yao SQ, 2009, J ADOLESCENT HEALTH, V45, P55, DOI 10.1016/j.jadohealth.2008.11.006	75	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191809	10.1371/journal.pone.0191809	http://dx.doi.org/10.1371/journal.pone.0191809			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401472	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000424101400022
J	Ma, H; Li, YY; Tang, L; Peng, X; Jiang, LL; Wan, J; Suo, FT; Zhang, GL; Luo, ZX				Ma, Huan; Li, Yuanyuan; Tang, Lin; Peng, Xin; Jiang, Lili; Wan, Jiao; Suo, Fengtao; Zhang, Guangli; Luo, Zhengxiu			Impact of childhood wheezing on lung function in adulthood: A meta-analysis	PLOS ONE			English	Article							1ST 6 YEARS; ASTHMA; GROWTH; ILLNESS; BRONCHITIS; OUTCOMES; POPULATION; PREVALENCE; PHENOTYPES; PROGNOSIS	Background A growing body of evidence shows that childhood wheezing may lead to recurrent or persistent symptoms in adulthood, such that persistent wheezing associated with lung function deficits often have their roots in the first few years of life. Objectives We summarized information from several prospective cohort studies following children with or without wheezing into adulthood, to estimate the effect of childhood wheezing on adulthood lung function. Methods Medical literatures were searched in the Medline, PubMed, ScienceDirect, Web of Science and Embase databases up to October 31, 2016. The adulthood lung function was selected as primary outcome, and chronic obstructive pulmonary disease (COPD) prevalence was selected as secondary outcome. The meta-analysis was performed with the Stata Version 14.0. A random-effects model was applied to estimate standardized mean difference (SMD) of lung function, and relative risk (RR) of COPD. Results Six articles enrolling 1141 and 1005 children with and without wheezing, respectively. Meta-analysis showed that childhood wheezing decreased adulthood lung function as compared with no-wheezing subjects (SMD = -0.365, 95% confidence interval (CI): -0.569 similar to-0.161, P = 0.000). Subgroup analyses indicated that childhood atopic wheezing reduced adulthood FEV1/FVC and FEV1% pred when compared with no-wheezing subjects. In addition, childhood atopic wheezing was significantly associated with COPD prevalence (RR = 5.307, 95% CI: 1.033 similar to 27.271, P = 0.046). Conclusions Our meta-analysis suggests that childhood wheezing may induce ongoing declined lung function that extends into adult life, as well as an increased risk of COPD prevalence when accompanied with atopy.	[Ma, Huan; Li, Yuanyuan; Tang, Lin; Peng, Xin; Jiang, Lili; Wan, Jiao; Suo, Fengtao; Zhang, Guangli; Luo, Zhengxiu] Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Ma, Huan; Li, Yuanyuan; Tang, Lin; Peng, Xin; Jiang, Lili; Wan, Jiao; Suo, Fengtao; Zhang, Guangli; Luo, Zhengxiu] Chongqing Med Univ, Dept Resp Med, Key Lab Child Dev & Disorders, Minist Educ,Childrens Hosp, Chongqing, Peoples R China; [Zhang, Guangli; Luo, Zhengxiu] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Luo, Zhengxiu] Chongqing Med Univ, Dept Resp Med, Childrens Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Luo, ZX (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.; Luo, ZX (corresponding author), Chongqing Med Univ, Dept Resp Med, Key Lab Child Dev & Disorders, Minist Educ,Childrens Hosp, Chongqing, Peoples R China.; Luo, ZX (corresponding author), China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Luo, ZX (corresponding author), Chongqing Med Univ, Dept Resp Med, Childrens Hosp, Chongqing, Peoples R China.	luozhengxiu816@163.com	li, yuanyuan/GZA-4435-2022		fund of National Key Clinical Specialty [2011-873]; Children's Hospital of Chongqing Medical University	fund of National Key Clinical Specialty; Children's Hospital of Chongqing Medical University	Our work was supported by the fund of National Key Clinical Specialty. Grant number 2011-873 to ZL.; We thank prof. Bing Peng for kindly providing advice and the Children's Hospital of Chongqing Medical University for support.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chetta A, 2005, CLIN EXP ALLERGY, V35, P1437, DOI 10.1111/j.1365-2222.2005.02360.x; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014, GLOBAL STRATEGY DIAG; GODDEN DJ, 1994, AM J RESP CRIT CARE, V149, P106, DOI 10.1164/ajrccm.149.1.8111567; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Guolo A, 2017, STAT METHODS MED RES, V26, P1500, DOI 10.1177/0962280215583568; Hallberg J, 2015, ALLERGY, V70, P667, DOI 10.1111/all.12598; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hirayama F, 2012, ASIA-PAC J PUBLIC HE, V27, P1273; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Hovland V, 2013, EUR RESPIR J, V41, P838, DOI 10.1183/09031936.00071512; Kanazawa H, 2002, THORAX, V57, P885, DOI 10.1136/thorax.57.10.885; Keglowich L F, 2015, Open Respir Med J, V9, P70, DOI 10.2174/1874306401509010070; Lodge CJ, 2014, AM J RESP CRIT CARE, V189, P1351, DOI 10.1164/rccm.201308-1487OC; Marossy AE, 2007, AM J RESP CRIT CARE, V175, P355, DOI 10.1164/rccm.200607-1023OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Merkus PJFM, 1996, PEDIATR PULM, V21, P383, DOI 10.1002/(SICI)1099-0496(199606)21:6<383::AID-PPUL6>3.0.CO;2-M; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Morton R, 2013, PEDIAT ALLER IMM PUL, V26, P168, DOI 10.1089/ped.2013.0305; Orsida BE, 1999, THORAX, V54, P289, DOI 10.1136/thx.54.4.289; Ostergaard MS, 2012, PRIM CARE RESP J, V21, P214, DOI 10.4104/pcrj.2012.00038; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; RAY CG, 1993, PEDIATR INFECT DIS J, V12, P15, DOI 10.1097/00006454-199301000-00005; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; SAMET JM, 1983, AM REV RESPIR DIS, V127, P508, DOI 10.1164/arrd.1983.127.4.508; Sears MR, 2015, J ALLERGY CLIN IMMUN, V136, P829, DOI 10.1016/j.jaci.2015.04.048; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shirtcliffe P, 2012, INTERN MED J, V42, P83, DOI 10.1111/j.1445-5994.2010.02238.x; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Strachan DP, 1996, BRIT MED J, V312, P1195; Strachan DP, 1996, AM J RESP CRIT CARE, V154, P1629, DOI 10.1164/ajrccm.154.6.8970346; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Wells GA, THE NEWCASTLE OTTAWA; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321	46	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192390	10.1371/journal.pone.0192390	http://dx.doi.org/10.1371/journal.pone.0192390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394280	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400041
J	Bougaret, L; Delort, L; Billard, H; Le Huede, C; Boby, C; De la Foye, A; Rossary, A; Mojallal, A; Damour, O; Auxenfans, C; Vasson, MP; Caldefie-Chezet, F				Bougaret, Lauriane; Delort, Laetitia; Billard, Hermine; Le Huede, Camille; Boby, Celine; De la Foye, Anne; Rossary, Adrien; Mojallal, Ali; Damour, Odile; Auxenfans, Celine; Vasson, Marie Paule; Caldefie-Chezet, Florence			Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen	PLOS ONE			English	Article							BODY-MASS-INDEX; NECROSIS-FACTOR-ALPHA; BREAST-CANCER; ADIPOSE-TISSUE; WOMEN; DIFFERENTIATION; PREADIPOCYTES; MORTALITY; MIGRATION; PROMOTE	Background Obesity is a well-known risk factor of breast cancer in post-menopausal women that also correlates with a diminished therapeutic response. The influence of adipocytes and their secretome, i.e. adipokines, on the efficacy of hormone therapy has yet to be elucidated. Methods We investigated, ex vivo, whether mature adipocytes, differentiated from adipose stem cells of normal-weight (MA20) or obese (MA30) women, and their secretions, were able to counteract the effects of tamoxifen (Tx) which is known to decrease neoplastic cell proliferation. Results In a tridimensional model and in a model of co-culture, the anti-proliferative effect of Tx on MCF-7 cancer cells was counteracted by MA30. These two models highlighted two different specific gene expression profiles for genes encoding cytokines or involved in angiogenesis based on the adipocyte microenvironment and the treatment. Thus it notably showed altered expression of genes such as TNF alpha that correlated with IL-6. In addition, leptin, IL-6 and TNF alpha, at concentrations reflecting plasma concentrations in obese patients, decreased the anti-proliferative efficacy of 4-hydroxytamoxifen (a major active metabolite of Tx). Conclusions These findings bring insights on adipocytes and mammary cancer cell interactions in Tx therapy, particularly in overweight/obese people. Indeed, patient' adipokine status would give valuable information for developing individual strategies and avoid resistance to treatment.	[Bougaret, Lauriane; Delort, Laetitia; Billard, Hermine; Rossary, Adrien; Vasson, Marie Paule; Caldefie-Chezet, Florence] Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France; [Le Huede, Camille; Damour, Odile; Auxenfans, Celine] Hop Edouard Herriot, Banque Tissus & Cellules, Lyon, France; [Boby, Celine; De la Foye, Anne] Plate Forme Explorat Metab Composante Transcripto, Site Theix, St Genes Champanelle, France; [Mojallal, Ali] Hop Edouard Herriot, Serv Chirurg Plast Reconstruct & Esthet, Lyon, France; [Vasson, Marie Paule] Ctr Anticanc Jean Perrin, Clermont Ferrand, France; [Vasson, Marie Paule; Caldefie-Chezet, Florence] CLARA, Lyon, France	INRAE; Universite Clermont Auvergne (UCA); CHU Lyon; CHU Lyon; UNICANCER; Centre Jean Perrin	Delort, L (corresponding author), Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France.	laetitia.delort@uca.fr	FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021	rossary, adrien/0000-0001-8311-2419; BOBY, Celine/0000-0002-4420-7033	Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter); Institut National du Cancer (Mammadipo, INCA) [6666]; league of cancer research [CD63]; Ministry of Research and Technology	Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter); Institut National du Cancer (Mammadipo, INCA)(Institut National du Cancer (INCA) France); league of cancer research; Ministry of Research and Technology(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study received financial support from the Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter 2012), from the Institut National du Cancer (Mammadipo 2013, INCA no 6666) and from the league of cancer research (CD63). Lauriane Bougaret is supported by a fellowship from the Ministry of Research and Technology.	Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bochet L, 2011, BIOCHEM BIOPH RES CO, V411, P102, DOI 10.1016/j.bbrc.2011.06.101; Bougoulia Maria, 2006, Hormones (Athens), V5, P192; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter JC, 2012, EXP MOL PATHOL, V92, P312, DOI 10.1016/j.yexmp.2012.03.005; Chen DR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/532161; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Dubois V, 2010, ANTICANCER RES, V30, P2919; Dubois V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058541; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; FARGIN A, 1988, CHEM-BIOL INTERACT, V66, P101, DOI 10.1016/0009-2797(88)90044-0; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Gundimeda U, 1996, J BIOL CHEM, V271, P13504, DOI 10.1074/jbc.271.23.13504; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Jarde T, 2008, HISTOPATHOLOGY, V53, P484, DOI 10.1111/j.1365-2559.2008.03121.x; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lequeux C, 2009, BIO-MED MATER ENG, V19, P283, DOI 10.3233/BME-2009-0593; Litton JK, 2008, J CLIN ONCOL, V26, P4072, DOI 10.1200/JCO.2007.14.4527; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Maehle BO, 1996, BREAST CANCER RES TR, V41, P123, DOI 10.1007/BF01807157; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Marttunen MB, 2000, MATURITAS, V35, P175, DOI 10.1016/S0378-5122(00)00121-3; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Melen-Mucha Gabriela, 2007, Endokrynol Pol, V58, P2; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; Ozet A, 2001, JPN J CLIN ONCOL, V31, P424, DOI 10.1093/jjco/hye097; Petrelli JM, 2002, CANCER CAUSE CONTROL, V13, P325, DOI 10.1023/A:1015288615472; Creydt VP, 2010, MOL MED REP, V3, P433, DOI 10.3892/mmr_00000276; Salameh TS, 2013, INT J CANCER, V132, P288, DOI 10.1002/ijc.27672; Schonherr A, 2012, BREAST CARE, V7, P289, DOI 10.1159/000341384; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Strong AL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3569; Thivat E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-648; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130	39	40	41	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191571	10.1371/journal.pone.0191571	http://dx.doi.org/10.1371/journal.pone.0191571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389973	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400023
J	Cai, T; Qi, YJ; Jergens, A; Wannemuehler, M; Barrett, TA; Wang, Q				Cai, Tenson; Qi, Yijun; Jergens, Albert; Wannemuehler, Michael; Barrett, Terrence A.; Wang, Qun			Effects of six common dietary nutrients on murine intestinal organoid growth	PLOS ONE			English	Article							CRYPT-VILLUS AXIS; EPITHELIAL-CELLS; CHLOROGENIC ACID; CAFFEIC ACID; STEM-CELLS; EXPRESSION; CURCUMIN; PROLIFERATION; BIOSYNTHESIS; MECHANISM	The intestinal epithelium of the gastrointestinal (GI) tract constantly renews itself to absorb nutrients and provide protection for the body from the outside world. Since the intestinal epithelium is constantly exposed to various chemicals and dietary components, it is critical to determine which constituents promote or inhibit intestinal epithelium health and growth rate. Intestinal organoids, three-dimensional miniature models of the intestines, represent an ex vivo tool to investigate intestinal physiology and growth patterns. In this study, we measured the growth rates of murine intestinal organoids exposed to various concentrations of different dietary constituents. Results indicate that caffeic acid inhibited organoid growth in a concentration-dependent manner, curcumin exhibited variable effectiveness, and vitamin C had no effect on organoid growth.	[Cai, Tenson; Qi, Yijun; Wang, Qun] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Cai, Tenson] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Jergens, Albert] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [Wannemuehler, Michael] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Barrett, Terrence A.] Univ Kentucky, Dept Internal Med, Div Gastroenterol, Lexington, KY USA	Iowa State University; Case Western Reserve University; Iowa State University; Iowa State University; University of Kentucky	Wang, Q (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	qunwang@iastate.edu	Qi, Yijun/M-7651-2019	Barrett, Terrence/0000-0001-6428-3271; Wang, Qun/0000-0002-5660-5602	Crohn's & Colitis Foundation of America (CCFA) Career Award [348137]; National Science Foundation [EEC 1560012]; PhRMA Foundation Research Starter Award [RSGTMT17]; McGee-Wagner Interdisciplinary Research Foundation; NIH grant [R01DK095662]; VA Merit grant [I01CX001353]	Crohn's & Colitis Foundation of America (CCFA) Career Award; National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation Research Starter Award; McGee-Wagner Interdisciplinary Research Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant	Dr. Wang is grateful for the support from Crohn's & Colitis Foundation of America (CCFA) Career Award (No. 348137), National Science Foundation (No. EEC 1560012), PhRMA Foundation Research Starter Award (No. RSGTMT17), and McGee-Wagner Interdisciplinary Research Foundation. The research was also supported (TAB) by NIH (R01DK095662) and VA Merit (I01CX001353) grants.	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Duda-Chodak A, 2009, ACTA SCI POLON-TECHN, V8, P63; Feng ZM, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0434; Fong D, 2010, CANCER LETT, V293, P65, DOI 10.1016/j.canlet.2009.12.018; HULSE JD, 1978, J BIOL CHEM, V253, P1654; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y; Leushacke M, 2014, GUT, V63, P1345, DOI 10.1136/gutjnl-2014-307204; Liu DW, 2013, J BREAST CANCER, V16, P133, DOI 10.4048/jbc.2013.16.2.133; Lu R, 2017, ALCOHOL CLIN EXP RES, V41, P727, DOI 10.1111/acer.13351; MacDonald L, 2002, BRIT J NUTR, V87, P97, DOI 10.1079/BJN2001492; Naidu K., 2003, J NUTR, V2, P1; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Peng HS, 2015, ACS BIOMATER SCI ENG, V1, P37, DOI 10.1021/ab500041d; Peng HS, 2015, NANOSCALE, V7, P4354, DOI 10.1039/c4nr06377e; Prasad NR, 2011, MOL CELL BIOCHEM, V349, P11, DOI 10.1007/s11010-010-0655-7; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Seib PA, 1982, 180 ACS NAT M LAS VE; Shibata H, 1999, BIOSCI BIOTECH BIOCH, V63, P1295, DOI 10.1271/bbb.63.1295; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tang YL, 2015, FREE RADICAL BIO MED, V89, P944, DOI 10.1016/j.freeradbiomed.2015.09.012; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang Q, 2015, ADV DRUG DELIVER REV, V91, P125, DOI 10.1016/j.addr.2014.12.003; Xiong X, 2016, FRONT BIOSCI-LANDMRK, V21, P343, DOI 10.2741/4392; Xiong X, 2015, AM J PHYSIOL-GASTR L, V309, pG229, DOI 10.1152/ajpgi.00095.2015; Yang HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36939	30	15	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191517	10.1371/journal.pone.0191517	http://dx.doi.org/10.1371/journal.pone.0191517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389993	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400022
J	Mork-Jansson, AE; Eichacker, LA				Mork-Jansson, Astrid Elisabeth; Eichacker, Lutz Andreas			Characterization of chlorophyll binding to LIL3	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; HARVESTING COMPLEXES; MEMBRANE-PROTEIN; RECONSTITUTION; AGGREGATION; SURFACTANTS	The light harvesting like protein 3 (LIL 3) from higher plants, has been linked to functions in chlorophyll and tocopherol biosynthesis, photo-protection and chlorophyll transfer. However, the binding of chlorophyll to LIL3 is unclear. We present a reconstitution protocol for chlorophyll binding to LIL3 in DDM micelles. It is shown in the absence of lipids and carotenoids that reconstitution of chlorophyll binding to in vitro expressed LIL3 requires pre-incubation of reaction partners at room temperature. We show chlorophyll a but not chlorophyll b binding to LIL3 at a molar ratio of 1:1. Neither dynamic light scattering nor native PAGE, enabled a discrimination between binding of chlorophyll a and/or b to LIL3.	[Mork-Jansson, Astrid Elisabeth; Eichacker, Lutz Andreas] Univ Stavanger, Fac Sci & Technol, Ctr Organelle Res, Stavanger, Norway	Universitetet i Stavanger	Eichacker, LA (corresponding author), Univ Stavanger, Fac Sci & Technol, Ctr Organelle Res, Stavanger, Norway.	lutz.eichacker@uis.no		Mork-Jansson, Astrid Elisabeth/0000-0003-1525-2270	Norwegian research council [NFR 240770]	Norwegian research council(Research Council of NorwayEuropean Commission)	We are grateful for research funding received from the Norwegian research council NFR 240770. NFR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank H. Paulsen for the Lhcb_pXLHCP plasmid. Financial Disclosure: We are grateful for research funding received from the Norwegian research council NFR 240770. NFR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivaliotis M, 2003, BBA-BIOMEMBRANES, V1615, P69, DOI 10.1016/S0005-2736(03)00208-6; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; CAMMARATA KV, 1992, BIOCHEMISTRY-US, V31, P2779, DOI 10.1021/bi00125a019; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Dahani M, 2015, ACTA CRYSTALLOGR F, V71, P838, DOI 10.1107/S2053230X15009516; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Ghosh S, 2013, LANGMUIR, V29, P10066, DOI 10.1021/la402053a; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Hassan PA, 2015, LANGMUIR, V31, P3, DOI 10.1021/la501789z; Hey D, 2017, PLANT PHYSIOL, V174, P1037, DOI 10.1104/pp.17.00505; Hoober JK, 2007, PHOTOSYNTH RES, V94, P387, DOI 10.1007/s11120-007-9181-1; Hoober JK, 1999, PHOTOSYNTH RES, V61, P197; Hutchison JM, 2017, BIOCHEMISTRY-US, V56, P5481, DOI 10.1021/acs.biochem.7b00810; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lawson CL, 1995, APPL MATH; Lewis EN, 2014, MOLECULES, V19, P20888, DOI 10.3390/molecules191220888; Martins AF, 2015, CHEM-EUR J, V21, P5413, DOI 10.1002/chem.201406152; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Mork-Jansson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133145; Mork-Jansson AE, 2015, FEBS LETT, V589, P3064, DOI 10.1016/j.febslet.2015.08.023; Neves P, 2009, J PHARMACEUT BIOMED, V49, P276, DOI 10.1016/j.jpba.2008.11.026; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Ouameur AA, 2005, BIOPOLYMERS, V77, P129, DOI 10.1002/bip.20173; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Ruf H, 2000, PROG COLL POL SCI S, V115, P255; Standardization IO, 2017, INT ORGAN, P34; Stromland O, 2017, DATA BRIEF, V12, P113, DOI 10.1016/j.dib.2017.03.014; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Twomey S., 1977, INTRODUCTION TO THE; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; WU MX, 1990, ARCH BIOCHEM BIOPHYS, V281, P324, DOI 10.1016/0003-9861(90)90451-4; Zhou YC, 2013, P IEEE INT C E-SCI, P9, DOI 10.1109/eScience.2013.12	39	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192228	10.1371/journal.pone.0192228	http://dx.doi.org/10.1371/journal.pone.0192228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390011	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400077
J	Sato, T; Bakhit, MS; Suzuki, K; Sakuma, J; Fujii, M; Murakami, Y; Ito, Y; Sugano, T; Saito, K				Sato, Taku; Bakhit, Mudathir S.; Suzuki, Kyouichi; Sakuma, Jun; Fujii, Masazumi; Murakami, Yuta; Ito, Yuhei; Sugano, Tetsuo; Saito, Kiyoshi			Utility and safety of a novel surgical microscope laser light source	PLOS ONE			English	Article							ILLUMINATION; RADIATION; DIFFUSER; DAMAGE; BURNS	Objective Tissue injuries caused by the thermal effects of xenon light microscopes have previously been reported. Due to this, the development of a safe microscope light source became a necessity. A newly developed laser light source is evaluated regarding its effectiveness and safety as an alternative to conventional xenon light source. Methods We developed and tested a new laser light source for surgical microscopes. Four experiments were conducted to compare xenon and laser lights: 1) visual luminance comparison, 2) luminous and light chromaticity measurements, 3) examination and analysis of visual fatigue, and 4) comparison of focal temperature elevation due to light source illumination using porcine muscle samples. Results Results revealed that the laser light could be used at a lower illumination value than the xenon light (p < 0.01). There was no significant difference in visual fatigue status between the laser light and the xenon light. The laser light was superior to the xenon light regarding luminous intensity and color chromaticity. The focal temperature elevation of the muscle samples was significantly higher when irradiated with xenon light in vitro than with laser light (p < 0.01). Conclusion The newly developed laser light source is more efficient and safer than a conventional xenon light source. It lacks harmful ultraviolet waves, has a longer lifespan, a lower focal temperature than that of other light sources, a wide range of brightness and color production, and improved safety for the user's vision. Further clinical trials are necessary to validate the impact of this new light source on the patient's outcome and prognosis.	[Sato, Taku; Bakhit, Mudathir S.; Sakuma, Jun; Fujii, Masazumi; Murakami, Yuta; Ito, Yuhei; Saito, Kiyoshi] Fukushima Med Univ, Dept Neurosurg, Fukushima, Japan; [Suzuki, Kyouichi] Fukushima Red Cross Hosp, Dept Neurosurg, Fukushima, Japan; [Sugano, Tetsuo] Mitsubishi Elect Engn Co Ltd, Kyoto Off, Kyoto, Japan	Fukushima Medical University; Mitsubishi Electric Corporation	Sato, T (corresponding author), Fukushima Med Univ, Dept Neurosurg, Fukushima, Japan.	tak-s@fmu.ac.jp			grants for the Development of Medical & Welfare Devices in Fukushima Prefecture [24-829]	grants for the Development of Medical & Welfare Devices in Fukushima Prefecture	This study was supported by grants for the Development of Medical & Welfare Devices in Fukushima Prefecture (24-829). http://www.fuku -semi.jp/iryou-pj/main/main_03_a.php. The funder provided support in the form of salaries for the coauthor (TSU (Mr. Sugano)), but he did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; Choudhry IK, 2013, J HAND SURG-AM, V38A, P545, DOI 10.1016/j.jhsa.2012.11.027; Dogru M, 2006, INVEST OPHTH VIS SCI, V47, P1895, DOI 10.1167/iovs.05-0802; Electrosuisse Schweizerische Normen- Vereinigung. Photobiologische Sicherheit von Lampen und Lampensystemen, 2006, 62471IEC624712006 SN; Gayatri P, 2013, J NEUROSURG ANESTH, V25, P267, DOI 10.1097/ANA.0b013e3182894a01; Gould R., 1959, ANN ARB C OPT PUMP J; Hashimoto M, 2003, J NEUROSURG ANESTH, V15, P6, DOI 10.1097/00008506-200301000-00002; Hibst R, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475953; Hirayama M, 2013, ACTA OPHTHALMOL, V91, P756, DOI 10.1111/j.1755-3768.2012.02485.x; Huusmann S, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1750-3; Ibrahim OMA, 2011, INVEST OPHTH VIS SCI, V52, P2194, DOI 10.1167/iovs.10-5986; Jeng WD, 2014, APPL OPTICS, V53, pH76, DOI 10.1364/AO.53.000H76; Kajita M, 2001, Fukushima J Med Sci, V47, P13; Kim I, 2014, GENES DIS, V1, P188, DOI 10.1016/j.gendis.2014.08.005; Kurita M, 2008, SCAND J PLAST RECONS, V42, P58, DOI 10.1080/02844310801924266; Latuska RF, 2014, OTOL NEUROTOL, V35, P227, DOI 10.1097/MAO.0b013e3182a5d340; Lopez J, 2016, BURNS, V42, pE74, DOI 10.1016/j.burns.2015.08.014; Matsuda F, 2017, PHOTODIAGN PHOTODYN, V20, P120, DOI 10.1016/j.pdpdt.2017.09.012; Nakayama N, 2008, J EYE, V25, P259; Pan JW, 2014, OPT EXPRESS, V22, P6464, DOI 10.1364/OE.22.006464; Schanda J., 2007, CO STANDARD ILLUMINA; Schutt CA, 2015, AM J OTOLARYNG, V36, P356, DOI 10.1016/j.amjoto.2014.12.009; Stangner T, 2017, APPL OPTICS, V56, P5427, DOI 10.1364/AO.56.005427; Tarrant AWS, 2013, RAD MEASUREMENT PHOT, P7	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192112	10.1371/journal.pone.0192112	http://dx.doi.org/10.1371/journal.pone.0192112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390016	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400068
J	Yebra, G; Frampton, D; Cassarino, TG; Raffle, J; Hubb, J; Ferns, RB; Waters, L; Tong, CYW; Kozlakidis, Z; Hayward, A; Kellam, P; Pillay, D; Clark, D; Nastouli, E; Brown, AJL				Yebra, Gonzalo; Frampton, Dan; Cassarino, Tiziano Gallo; Raffle, Jade; Hubb, Jonathan; Ferns, R. Bridget; Waters, Laura; Tong, C. Y. William; Kozlakidis, Zisis; Hayward, Andrew; Kellam, Paul; Pillay, Deenan; Clark, Duncan; Nastouli, Eleni; Brown, Andrew J. Leigh		ICONIC Consortium	A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project	PLOS ONE			English	Article							NON-B SUBTYPES; GENETIC DIVERSITY; RECOMBINANT FORM; DRUG-RESISTANCE; TYPE-1; IDENTIFICATION; RELIABILITY; COMPLEX; COHORT; SPAIN	Background & methods The ICONIC project has developed an automated high-throughput pipeline to generate HIV nearly full-length genomes (NFLG, i.e. from gag to nef) from next-generation sequencing (NGS) data. The pipeline was applied to 420 HIV samples collected at University College London Hospitals NHS Trust and Barts Health NHS Trust (London) and sequenced using an Illumina MiSeq at the Wellcome Trust Sanger Institute (Cambridge). Consensus genomes were generated and subtyped using COMET, and unique recombinants were studied with jpHMM and SimPlot. Maximum-likelihood phylogenetic trees were constructed using RAxML to identify transmission networks using the Cluster Picker. Results The pipeline generated sequences of at least 1Kb of length (median = 7.46Kb, IQR = 4.01Kb) for 375 out of the 420 samples (89%), with 174 (46.4%) being NFLG. A total of 365 sequences (169 of them NFLG) corresponded to unique subjects and were included in the down-stream analyses. The most frequent HIV subtypes were B (n = 149, 40.8%) and C (n = 77, 21.1%) and the circulating recombinant form CRF02_AG (n = 32, 8.8%). We found 14 different CRFs (n = 66, 18.1%) and multiple URFs (n = 32, 8.8%) that involved recombination between 12 different subtypes/CRFs. The most frequent URFs were B/CRF01_AE (4 cases) and A1/D, B/C, and B/CRF02_AG (3 cases each). Most URFs (19/26, 73%) lacked breakpoints in the PR+RT pol region, rendering them undetectable if only that was sequenced. Twelve (37.5%) of the URFs could have emerged within the UK, whereas the rest were probably imported from sub-Saharan Africa, South East Asia and South America. For 2 URFs we found highly similar pol sequences circulating in the UK. We detected 31 phylogenetic clusters using the full dataset: 25 pairs (mostly subtypes B and C), 4 triplets and 2 quadruplets. Some of these were not consistent across different genes due to interand intra-subtype recombination. Clusters involved 70 sequences, 19.2% of the dataset. Conclusions The initial analysis of genome sequences detected substantial hidden variability in the London HIV epidemic. Analysing full genome sequences, as opposed to only PR+RT, identified previously undetected recombinants. It provided a more reliable description of CRFs (that would be otherwise misclassified) and transmission clusters.	[Yebra, Gonzalo; Brown, Andrew J. Leigh] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Frampton, Dan; Cassarino, Tiziano Gallo; Raffle, Jade; Kozlakidis, Zisis; Pillay, Deenan] Fac Med Sci, UCL Div Infect & Immun, London, England; [Raffle, Jade; Ferns, R. Bridget; Nastouli, Eleni] UCL Hosp NHS Fdn Trust, Dept Clin Virol, London, England; [Hubb, Jonathan; Tong, C. Y. William; Clark, Duncan] Barts Hlth NHS Trust, Dept Virol, London, England; [Ferns, R. Bridget] NIHR UCLH UCL Biomed Res Ctr, London, England; [Waters, Laura] Cent & North West London NHS Trust, Dept HIV Med, Mortimer Market Ctr, London, England; [Tong, C. Y. William] Queen Mary Univ, London, England; [Kozlakidis, Zisis] Farr Inst Hlth Informat Res, UCL Inst Dis Informat, London, England; [Hayward, Andrew] UCL Inst Epidemiol & Hlth Care, London, England; [Kellam, Paul] Imperial Coll London, Div Infect Dis, Dept Med, London, England; [Clark, Duncan] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Nastouli, Eleni] UCL GOS Inst Child Hlth, Dept Populat Policy & Practice, London, England	University of Edinburgh; University of London; University College London; University of London; University College London; Barts Health NHS Trust; University of London; University College London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Imperial College London; University of Glasgow; University of London; University College London	Yebra, G (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	Gonzalo.Yebra@ed.ac.uk	Cassarino, Tiziano Gallo/AAM-2845-2020; Leigh Brown, Andrew/F-3802-2010; Tong, Cheuk Yan William/C-1312-2012; Kozlakidis, Zisis/AAX-8081-2020; Brown, Andrew Leigh/ABF-8269-2020	Cassarino, Tiziano Gallo/0000-0001-9220-2360; Leigh Brown, Andrew/0000-0002-5700-3128; Tong, Cheuk Yan William/0000-0001-8401-6832; Kozlakidis, Zisis/0000-0002-3836-7209; Brown, Andrew Leigh/0000-0002-5700-3128; Yebra, Gonzalo/0000-0002-3472-3667; Kellam, Paul/0000-0003-3166-4734	ICONIC project (Department of Health) [T5-344]; ICONIC project (Wellcome Trust) [T5-344]	ICONIC project (Department of Health); ICONIC project (Wellcome Trust)	This work was supported by the ICONIC project (supported by the Health Innovation Challenge Fund T5-344, a parallel funding partnership between the Department of Health and Wellcome Trust).; We would like to thank the clinicians and scientists at University College London Hospital and Barts Health NHS Trust. We would also like to thank Dr Anna Tostevin (UCL Research Department of Infection and Population Health) for her help with the analysis of the UK HIV Drug Resistance Database sequences and Dr Astrid Gall (University of Cambridge) for her initial guidance on the HIV whole genome sequencing methods. This work was supported by the ICONIC project (supported by the Health Innovation Challenge Fund T5-344, a parallel funding partnership between the Department of Health and Wellcome Trust). The views expressed in this publication are those of the authors and not necessarily those of their funders and employees. The members of the ICONIC Consortium are Dr A. Oliver, Dr C.Y.W. Tong, Dr D. Clark (Barts Health NHS Trust), Dr E. Nastouli (UCL Hospital NHS Foundation Trust), Prof A. Johnson, Prof D. Dunn, Prof A. Hayward, Prof D. Pillay, Prof S. Morris, Dr Z. Kozlakidis (UCL), Prof P. Kellam (Imperial College London), Prof J. Edgeworth (Guy's and St. Thomas' NHS foundation Trust) and Prof A.J. Leigh Brown (University of Edinburgh).	Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; Fernandez-Garcia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148549; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Foster GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083337; Galimand J, 2010, AIDS RES HUM RETROV, V26, P645, DOI 10.1089/aid.2009.0201; Gall A., 2014, GENOME ANNOUNC, V2; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Gallo Cassarino T, 2016, BIORXIV; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2008, J MED VIROL, V80, P383, DOI 10.1002/jmv.21105; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; LANL, 2017, LOS AL HIV DAT; LANL, 2017, HIV CIRC REC FORMS C; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Public Health England (PHE), 2017, HIV UK DECL NEW HIV; Ramirez BC, 2008, VIRUS RES, V134, P64, DOI 10.1016/j.virusres.2008.01.007; Ratmann O, 2017, AIDS RES HUM RETROVI; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Simonetti FR, 2014, INFECT GENET EVOL, V23, P176, DOI 10.1016/j.meegid.2014.02.007; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Zhao JQ, 2010, AIDS RES HUM RETROV, V26, P1033, DOI 10.1089/aid.2009.0197; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002; 2013, AIDS, V27, P2309, DOI DOI 10.1097/QAD.0B013E3283632E0C	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192081	10.1371/journal.pone.0192081	http://dx.doi.org/10.1371/journal.pone.0192081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389981	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000423793400064
J	Zhou, ZY; Liu, FR; Zhang, XY; Zhou, XX; Zhong, ZJ; Su, HY; Li, J; Li, HZ; Feng, F; Lan, JC; Zhang, ZH; Fu, HL; Hu, YC; Cao, SZ; Chen, WG; Deng, JB; Yu, JQ; Zhang, WP; Peng, GN				Zhou, Ziyao; Liu, Furui; Zhang, Xinyue; Zhou, Xiaoxiao; Zhong, Zhijun; Su, Huaiyi; Li, Jin; Li, Haozhou; Feng, Fan; Lan, Jingchao; Zhang, Zhihe; Fu, Hualin; Hu, Yanchun; Cao, Suizhong; Chen, Weigang; Deng, Jiabo; Yu, Jianqiu; Zhang, Wenping; Peng, Guangneng			Cellulose-dependent expression and antibacterial characteristics of surfactin from Bacillus subtilis HH2 isolated from the giant panda	PLOS ONE			English	Article							PROBIOTICS; LIPOPEPTIDES; FENGYCIN; ITURINS	Surfactin secreted by Bacillus subtilis can confer strong, diverse antipathogenic effects, thereby benefitting the host. Carbon source is an important factor for surfactin production. However, the mechanism that bacteria utilize cellulose, the most abundant substance in the intestines of herbivores, to produce surfactin remains unclear. Here, we used B. subtilis HH2, isolated from the feces of a giant panda, as a model to determine changes in surfactin expression in the presence of different concentrations of cellulose by quantitative polymerase chain reaction and high-performance liquid chromatography. We further investigated the antimicrobial effects of surfactin against three common intestinal pathogens (Escherichia coli, Staphylococcus aureus, and Salmonella enterica) and its resistance to high temperature (60 +/- 121 degrees C), pH (1 +/- 12), trypsin (100 +/- 300 mu g/mL, pH 8), and pepsin (100 +/- 300 mu g/mL, pH 2). The results showed that the surfactin expressed lowest in bacteria cultured in the presence of 1% glucose medium as the carbon source, whereas increased in an appropriate cellulose concentration (0.67% glucose and 0.33% cellulose). The surfactin could inhibit E. coli and Staphylococcus aureus, but did not affect efficiently for Salmonella enterica. The antibacterial ability of surfactin did not differ according to temperature (60 +/- 100 degrees C), pH (2 +/- 11), trypsin (100 +/- 300 mu g/mL), and pepsin (100 +/- 300 mu g/mL; P > 0.05), but decreased significantly at extreme environments (121 degrees C, pH 1 or 12; P < 0.05) compared with that in the control group (37 degrees C, pH = 7, without any protease). In conclusion, our findings indicated that B. subtilis HH2 could increase surfactin expression in an appropriate cellulose environment and thus provide benefits to improve the intestinal health of herbivores.	[Zhou, Ziyao; Liu, Furui; Zhang, Xinyue; Zhou, Xiaoxiao; Zhong, Zhijun; Su, Huaiyi; Li, Jin; Li, Haozhou; Feng, Fan; Fu, Hualin; Hu, Yanchun; Cao, Suizhong; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Zhou, Xiaoxiao] Chengdu Ctr Anim Dis Prevent & Control, Chengdu, Sichuan, Peoples R China; [Lan, Jingchao; Zhang, Zhihe; Zhang, Wenping] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife Sichua, Chengdu, Sichuan, Peoples R China; [Chen, Weigang; Deng, Jiabo; Yu, Jianqiu] Inst Wild Anim, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Zhang, WP (corresponding author), Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife Sichua, Chengdu, Sichuan, Peoples R China.	zhang_zoology@163.com; pgn.sicau@163.com	Li, Haozhou/GXF-3701-2022; Zhang, Wenping/H-5125-2015		Chengdu giant panda breeding research foundation [CPF2015-07, CPF2015-09]	Chengdu giant panda breeding research foundation	The study was financially supported by the Chengdu giant panda breeding research foundation (CPF2015-07, CPF2015-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was financially supported by the Chengdu giant panda breeding research foundation (CPF2015-07, CPF2015-09).	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Arutchelvi J, 2014, COLLOID SURFACE B, V116, P396, DOI 10.1016/j.colsurfb.2013.12.034; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chen WS, 2011, CELLULOSE, V18, P433, DOI 10.1007/s10570-011-9497-z; Chun J, 2000, ANTON LEEUW INT J G, V78, P123, DOI 10.1023/A:1026555830014; de Araujo LV, 2016, FOOD CONTROL, V63, P171, DOI 10.1016/j.foodcont.2015.11.036; Deleu M, 2008, BIOPHYS J, V94, P2667, DOI 10.1529/biophysj.107.114090; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Han Q, 2015, ENVIRON MICROBIOL, V17, P1166, DOI 10.1111/1462-2920.12538; Heerklotz H, 2007, EUR BIOPHYS J BIOPHY, V36, P305, DOI 10.1007/s00249-006-0091-5; Irnov I, 2010, NUCLEIC ACIDS RES; Jin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022602; Liu X, 2012, 2012 7TH INTERNATIONAL ICST CONFERENCE ON COMMUNICATIONS AND NETWORKING IN CHINA (CHINACOM), P7, DOI 10.1109/ChinaCom.2012.6417439; Loiseau C, 2015, APPL MICROBIOL BIOT, V99, P5083, DOI 10.1007/s00253-014-6317-z; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Manninen TJK, 2006, APPL ENVIRON MICROB, V72, P6539, DOI 10.1128/AEM.02977-05; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Nitschke M, 2009, LETT APPL MICROBIOL, V49, P241, DOI 10.1111/j.1472-765X.2009.02646.x; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Sabate DC, 2013, MICROBIOL RES, V168, P125, DOI 10.1016/j.micres.2012.11.004; Soccol CR, 2010, FOOD TECHNOL BIOTECH, V48, P413; Wang M, 2015, BIOMASS BIOENERG, V80, P30, DOI 10.1016/j.biombioe.2015.04.028; Wang XQ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170082; Wheat PF, 2001, J ANTIMICROB CHEMOTH, V48, P1, DOI 10.1093/jac/48.suppl_1.1; Zhang R, 2016, J ANIM PHYSIOL AN N, V100, P33, DOI 10.1111/jpn.12338; Zhang W, 2016, APPL ENVIRON MICROB; Zhang YY, 2015, INFLAMMATION, V38, P756, DOI 10.1007/s10753-014-9986-y; Zhao X, 2013, MICROBIOL RES, V168, P598, DOI 10.1016/j.micres.2013.03.001; Zhou ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116935; Zhou ZY, 2014, WORLD J MICROB BIOT, V30, P3129, DOI 10.1007/s11274-014-1740-y	33	9	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191991	10.1371/journal.pone.0191991	http://dx.doi.org/10.1371/journal.pone.0191991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385201	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400066
J	Wasserman, C; Postuvan, V; Herta, D; Iosue, M; Varnik, P; Carli, V				Wasserman, Camilla; Postuvan, Vita; Herta, Dana; Iosue, Miriam; Vaernik, Peeter; Carli, Vladimir			Interactions between youth and mental health professionals: The Youth Aware of Mental health (YAM) program experience	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; QUALITATIVE RESEARCH; EUROPEAN ADOLESCENTS; SUICIDAL-BEHAVIOR; INTERNET USE; RISK; ASSOCIATION; INTERVIEWS; CRITERIA; SAMPLE	The Youth Aware of Mental health (YAM) experience Youth stand at the core of much mental health promotion, yet little is written about their experiences of such efforts. We aimed to take this on by interviewing youth after they participated in Youth Aware of Mental Health (YAM), a universal mental health promotion program. YAM has a non-anticipatory methodology that provides youth with a safe space for reflection, role-play, and discussion. Addressing everyday mental health, YAM invites the experiences and issues relevant to the youth present to influence the program in a slightly different direction every time. The YAM instructor guides the participants but does not present the youth with given formulas on how to solve their problems. Like any mental health promotion, YAM appeals to some more than others in its intended audience and individuals engage with the program in many different ways. We set out to learn more about these experiences. Conversations about mental health Thirty-two semi-structured interviews were conducted with 15-17 year olds in Estonia, Italy, Romania and Spain. In these interviews, the researchers made an effort to discuss mental health in terms relevant to youth. Still, wide-ranging levels of motivation, ease with engaging in dialogue with mental health professionals, and comfort with the format and content of YAM were detected. The youth were clustered in five different groups relating to their positioning vis-a-vis the researcher during the interview. The following evocative labels were used: "interested", "foot in the door", "respect for authority", "careful", and "not my topic". Corresponding labels were devised for their YAM experience: "engaged", "initially hesitant", "cautious", "eager to please", or "disengaged". We also observed that the researchers brought their own expectations and employed a variety of approaches that led to anticipating answers, stating the obvious, or getting along better with some of the youth. These modes of interaction were categorized under: "favoritism", "familiarity", "frustration", "out of sync", and "insecurity". Similar power dynamics likely transpire in other encounters between youth and researchers, including interventions such as YAM. Youth and mental health professionals: Noticing the dynamics at play As mental health professionals, we need to be aware of the professional habits and biases that sometimes obstruct us in understanding the experiences of youth. By initiating dialogue and listening closely to youth we can find a way to those experiences. Qualitative research can help bring the underlying interplay between mental health professionals and youth to the surface while also orienting the conversation towards topics that matter to youth. Some youth are more interested or feel more at ease in speaking openly with mental health professionals, while others find such exchanges less appealing or almost intolerable. Future mental health promotion initiatives would benefit from involving youth in the design of interventions to create an inclusive atmosphere and engage with topics that appeal to youth with diverse experiences of mental health.	[Wasserman, Camilla] New York State Psychiat Inst & Hosp, Dept Child & Adolescent Psychiat, New York, NY 10032 USA; [Wasserman, Camilla; Carli, Vladimir] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden; [Postuvan, Vita] Univ Primorska, Slovene Ctr Suicide Res, Andrej Marus Inst, Koper, Slovenia; [Herta, Dana] Iuliu Hatieganu Univ Med & Pharm, Med Psychol Dept, Cluj Napoca, Romania; [Iosue, Miriam] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; [Vaernik, Peeter] Estonian Swedish Mental Hlth & Suicidol Inst, Tallinn, Estonia; [Carli, Vladimir] Karolinska Inst, WHO Collaborating Ctr Res Training & Methods Dev, Stockholm, Sweden	New York State Psychiatry Institute; Karolinska Institutet; University of Primorska; Iuliu Hatieganu University of Medicine & Pharmacy; University of Molise; Karolinska Institutet	Wasserman, C (corresponding author), New York State Psychiat Inst & Hosp, Dept Child & Adolescent Psychiat, New York, NY 10032 USA.; Wasserman, C (corresponding author), Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden.	Camilla.Wasserman@nyspi.columbia.edu	Herta, Dana Cristina/GXF-9698-2022; Postuvan, Vita/AAI-6910-2020	Herta, Dana Cristina/0000-0003-1437-3361; Iosue, Miriam/0000-0002-3703-1578	National Centre for Suicide Research and Prevention of Mental III-Health (NASP) at Karolinska Institutet	National Centre for Suicide Research and Prevention of Mental III-Health (NASP) at Karolinska Institutet	The authors did not receive financial support for this study other than for travel expenses from the National Centre for Suicide Research and Prevention of Mental III-Health (NASP) at Karolinska Institutet. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WEB APPL MAN AN PRES; Banzer R, 2017, EUR CHILD ADOLES PSY, V26, P1319, DOI 10.1007/s00787-017-0980-4; Boler M., 1999, FEELING POWER EMOTIO, Vxxix, P235; Bousono M, 2017, ADICCIONES, V29, P97, DOI 10.20882/adicciones.811; Brinkmann S, 2005, J CONSTRUCTIVIST PSY; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Bryman A., 2012, SOCIAL RES METHODS, p[178, 573]; Carli V, 2014, WORLD PSYCHIATRY, V13, P78, DOI 10.1002/wps.20088; Carli V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-479; Charmaz K., 2004, HDB INTERVIEW RES CO; Christensen PH, 2004, CHILDRENS PARTICIPAT; Clemence A., 2014, QUANTITATIVE ANAL SO; Coffey A, 1996, MAKING SENSE QUALITA; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Davies CA, 2007, ASA RES METHODS, P320; Durkee T, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030294; Forbat L, 2005, QUAL HEALTH RES, V15, P1114, DOI 10.1177/1049732305279065; Geertz Clifford, 1973, INTERPRETATION CULTU; Greenhalgh T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i563; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gunnell D, 2015, CRISIS, V36, P155, DOI 10.1027/0227-5910/a000317; Hansen H, 2013, ACAD PSYCHIATR, V37, P412, DOI 10.1176/appi.ap.12080141; Hjelmeland H, 2010, SUICIDE LIFE-THREAT, V40, P74, DOI 10.1521/suli.2010.40.1.74; Ibrahim A., 2014, CRITICAL YOUTH STUDI, pxv; Kaess M, 2016, J ADOLESCENT HEALTH, V59, P236, DOI 10.1016/j.jadohealth.2016.04.009; Kaess M, 2014, EUR CHILD ADOLES PSY, V23, P611, DOI 10.1007/s00787-013-0490-y; Brunstein Klomek A, 2016, EUR CHILD ADOLES PSY, V25, P1183, DOI 10.1007/s00787-016-0840-7; Koenig J, 2017, EUR CHILD ADOLES PSY, V26, P345, DOI 10.1007/s00787-016-0896-4; Kvale S., 1996, INTERVIEWS INTRO QUA, P124, DOI DOI 10.1016/S0149-7189(97)89858-8; Lesko N, 2012, KEYWORDS YOUTH STUDI, Vix, P344; Martin E., 2010, IMAGINING ILLNESS PU, P245; Mawn L, 2015, J MENT HEALTH, V24, P271, DOI 10.3109/09638237.2014.998810; McMahon EM, 2017, EUR CHILD ADOLES PSY, V26, P111, DOI 10.1007/s00787-016-0875-9; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nakar O, 2016, J AFFECT DISORDERS, V197, P231, DOI 10.1016/j.jad.2016.03.029; Ponterotto JG, 2006, QUAL REP, V11, P538; Rapley T.J., 2001, QUAL RES, V1, P303, DOI DOI 10.1177/146879410100100303; Report WE-STAY, 2013, FINAL REPORT EU COMM; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Snaza N, 2014, CRITICAL YOUTH STUDI, P349; Sofaer S, 2002, INT J QUAL HEALTH C, V14, P329, DOI 10.1093/intqhc/14.4.329; Susser E, 2014, INT J EPIDEMIOL, P1; Tilleczek KC, 2011, APPROACHING YOUTH ST, Vxii, P163; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wartberg L, 2016, PSYCHIAT RES, V240, P272, DOI 10.1016/j.psychres.2016.04.057; Wasserman C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-776; Wasserman D, 2015, LANCET, V385, P1536, DOI 10.1016/S0140-6736(14)61213-7; Wasserman D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-192; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	49	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191843	10.1371/journal.pone.0191843	http://dx.doi.org/10.1371/journal.pone.0191843			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420556	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900026
J	Beauvais, W; Gart, EV; Bean, M; Blanco, A; Wilsey, J; McWhinney, K; Bryan, L; Krath, M; Yang, CY; Alvarez, DM; Paudyal, S; Bryan, K; Stewart, S; Cook, PW; Lahodny, G; Baumgarten, K; Gautam, R; Nightingale, K; Lawhon, SD; Pinedo, P; Ivanek, R				Beauvais, Wendy; Gart, Elena V.; Bean, Melissa; Blanco, Anthony; Wilsey, Jennifer; McWhinney, Kallie; Bryan, Laura; Krath, Mary; Yang, Ching-Yuan; Alvarez, Diego Manriquez; Paudyal, Sushil; Bryan, Kelsey; Stewart, Samantha; Cook, Peter W.; Lahodny, Glenn, Jr.; Baumgarten, Karina; Gautam, Raju; Nightingale, Kendra; Lawhon, Sara D.; Pinedo, Pablo; Ivanek, Renata			The prevalence of Escherichia coli O157:H7 fecal shedding in feedlot pens is affected by the water-to-cattle ratio: A randomized controlled trial	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; UNITED-STATES; BOVINE FECES; MIDWESTERN USA; BEEF-CATTLE; FOOD SAFETY; DAIRY-HERD; O157-H7; INFECTIONS; DYNAMICS	Escherichia coli O157:H7 fecal shedding in feedlot cattle is common and is a public health concern due to the risk of foodborne transmission that can result in severe, or even fatal, disease in people. Despite a large body of research, few practical and cost-effective farm-level interventions have been identified. In this study, a randomized controlled trial was conducted to assess the effect of reducing the level of water in automatically refilling watertroughs on fecal shedding of E. coli O157:H7 in feedlot cattle. Pens in a feedlot in the Texas Panhandle were randomly allocated as control (total number:17) or intervention (total number: 18) pens. Fecal samples (2,759 in total) were collected both at baseline and three weeks after the intervention, and tested for the presence of E. coli O157:H7 using immunomagnetic bead separation and selective culture. There was a strong statistical association between sampling date and the likelihood of a fecal sample testing positive for E. coli O157: H7. Pen was also a strong predictor of fecal prevalence. Despite accounting for this high level of clustering, a statistically significant association between reduced water levels in the trough and increased prevalence of E. coli O157:H7 in the feces was observed (Odds Ratio = 1.6; 95% Confidence Interval:1.2-2.0; Likelihood Ratio Test: p = 0.02). This is the first time that such an association has been reported, and suggests that increasing watertrough levels may be effective in reducing shedding of E. coli O157:H7 in cattle feces, although further work would be needed to test this hypothesis. Controlling E. coli O157:H7 fecal shedding at the pre-harvest level may lead to a reduced burden of human foodborne illness attributed to this pathogen in beef.	[Beauvais, Wendy; Ivanek, Renata] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Gart, Elena V.; Bean, Melissa; Blanco, Anthony; Wilsey, Jennifer; McWhinney, Kallie; Bryan, Laura; Krath, Mary; Yang, Ching-Yuan; Alvarez, Diego Manriquez; Lahodny, Glenn, Jr.; Baumgarten, Karina; Gautam, Raju; Lawhon, Sara D.; Ivanek, Renata] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Paudyal, Sushil] West Texas A&M Univ, Canyon, TX USA; [Bryan, Kelsey; Pinedo, Pablo] Texas A&M Agrilife Res, Amarillo, TX USA; [Stewart, Samantha; Cook, Peter W.; Nightingale, Kendra] Texas Tech Univ, Anim & Food Sci, Lubbock, TX 79409 USA	Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; West Texas A&M University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas Tech University System; Texas Tech University	Beauvais, W (corresponding author), Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.	wab223@Cornell.edu	Manriquez, Diego/ADS-4204-2022; Bryan, Laura/ABD-5741-2020; Paudyal, Sushil/O-1899-2019; Ivanek, Renata/B-9005-2009; Lawhon, Sara D./G-5147-2011	Manriquez, Diego/0000-0003-0899-2457; Ivanek, Renata/0000-0001-6348-4709; Lawhon, Sara D./0000-0001-9154-8909; Beauvais, Wendy/0000-0001-7634-3331; Paudyal, Sushil/0000-0002-6388-921X; Bryan, Laura/0000-0002-9422-2338; Bryan, Laura K/0000-0003-0746-9461	United States Department of Agriculture [1002529, TEX09586]; National Institutes of Health (NIH) [5T35OD010991]; Texas Veterinary Medical Foundation; Merial NIH Veterinary Scholars Program; NIH [5 T32 0D 011083-8]	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Veterinary Medical Foundation; Merial NIH Veterinary Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Formula Animal Health Fund from the United States Department of Agriculture (Accession No. 1002529; Project No. TEX09586). Additionally, MB and AB were funded by the National Institutes of Health (NIH) (5T35OD010991), Texas Veterinary Medical Foundation and Merial NIH Veterinary Scholars Program. LB was supported by the NIH T32 grant (5 T32 0D 011083-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; BRUHN CM, 1992, J FOOD SAFETY, V12, P253, DOI 10.1111/j.1745-4565.1991.tb00082.x; Callaway T R, 2004, J Anim Sci, V82 E-Suppl, pE93; CDC, 2006, MMWR-MORBID MORTAL W, V57, P625; Champely S, PWR BASIC FUNCTIONS; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Dohoo I.R., 2010, VET EPIDEMIOLOGIC RE, P257; Doyle M. E., 2006, HUMAN ILLNESS CAUSED; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fox JT, 2007, APPL ENVIRON MICROB, V73, P5253, DOI 10.1128/AEM.00554-07; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Friedman MS, 1999, CLIN INFECT DIS, V29, P298, DOI 10.1086/520204; Gautam R, 2012, J BIOL DYNAM, V6, P1052, DOI 10.1080/17513758.2012.722232; Gautam R, 2013, AGR SCI, V4; Gautam R, 2011, PREV VET MED, V102, P10, DOI 10.1016/j.prevetmed.2011.06.008; HANCOCK DD, 1994, EPIDEMIOL INFECT, V113, P199, DOI 10.1017/S0950268800051633; HAYES DJ, 1995, AM J AGR ECON, V77, P40, DOI 10.2307/1243887; Hughes KJ., 2013, THESIS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Jacob ME, 2012, FOODBORNE PATHOG DIS, V9, P79, DOI 10.1089/fpd.2011.0947; Khaitsa ML, 2003, J FOOD PROTECT, V66, P1972, DOI 10.4315/0362-028X-66.11.1972; Kim NH, 2017, ADV APPL MICROBIOL, V100, P1, DOI 10.1016/bs.aambs.2017.02.001; KOHLI HS, 1994, J PUBLIC HEALTH MED, V16, P11, DOI 10.1093/oxfordjournals.pubmed.a042911; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; Lumley T., 2016, SURVEY ANAL COMPLEX, V3, P31; Machado LCP, 2004, APPL ANIM BEHAV SCI, V89, P185, DOI 10.1016/j.applanim.2004.07.002; Marsh TL, 2004, APPL ECON, V36, P897, DOI 10.1080/0003684042000233113; Mechie SC, 1997, EPIDEMIOL INFECT, V118, P17, DOI 10.1017/S0950268896007194; Mukhejee A, 2007, INT J FOOD MICROBIOL, V120, P296, DOI 10.1016/j.ijfoodmicro.2007.09.007; Ochieng BJ, 2016, FOOD POLICY, V59, P78, DOI 10.1016/j.foodpol.2015.12.004; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sargeant JA, 2004, PREV VET MED, V66, P175, DOI 10.1016/j.prevetmed.2004.09.007; Sargeant JM, 2004, PREV VET MED, V66, P207, DOI 10.1016/j.prevetmed.2004.09.006; SATO S, 1991, APPL ANIM BEHAV SCI, V32, P3, DOI 10.1016/S0168-1591(05)80158-3; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schroeder TC, 2000, J ANIM SCI, V77, P1; SIEGLER RL, 1994, PEDIATRICS, V94, P35; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Trevena W B, 1999, Commun Dis Public Health, V2, P263; Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976; Ungkuraphinunt P., 2003, THESIS; University of Nebraska-Lincoln Extension, 2011, WAT REQ BEEF CATTL; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x; Wang GD, 1996, APPL ENVIRON MICROB, V62, P2567, DOI 10.1128/AEM.62.7.2567-2570.1996	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192149	10.1371/journal.pone.0192149	http://dx.doi.org/10.1371/journal.pone.0192149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414986	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300053
J	Benforte, FC; Colonnella, MA; Ricardi, MM; Venero, ECS; Lizarraga, L; Lopez, NI; Tribelli, PM				Benforte, Florencia C.; Colonnella, Maria A.; Ricardi, Martiniano M.; Solar Venero, Esmeralda C.; Lizarraga, Leonardo; Lopez, Nancy I.; Tribelli, Paula M.			Novel role of the LPS core glycosyltransferase WapH for cold adaptation in the Antarctic bacterium Pseudomonas extremaustralis	PLOS ONE			English	Article							ESCHERICHIA-COLI; LOW-TEMPERATURE; BIOFILM FORMATION; CELL-ENVELOPE; POLYMYXIN-B; STRESS; LIPOPOLYSACCHARIDES; FLUORESCENS; RESISTANCE; SYRINGAE	Psychrotroph microorganisms have developed cellular mechanisms to cope with cold stress. Cell envelopes are key components for bacterial survival. Outer membrane is a constituent of Gram negative bacterial envelopes, consisting of several components, such as lipopolysaccharides (LPS). In this work we investigated the relevance of envelope characteristics for cold adaptation in the Antarctic bacterium Pseudomonas extremaustralis by analyzing a mini Tn5 wapH mutant strain, encoding a core LPS glycosyltransferase. Our results showed that wapH strain is impaired to grow under low temperature but not for cold survival. The mutation in wapH, provoked a strong aggregative phenotype and modifications of envelope nanomechanical properties such as lower flexibility and higher turgor pressure, cell permeability and surface area to volume ratio (S/V). Changes in these characteristics were also observed in the wild type strain grown at different temperatures, showing higher cell flexibility but lower turgor pressure under cold conditions. Cold shock experiments indicated that an acclimation period in the wild type is necessary for cell flexibility and S/V ratio adjustments. Alteration in cell-cell interaction capabilities was observed in wapH strain. Mixed cells of wild type and wapH strains, as well as those of the wild type strain grown at different temperatures, showed a mosaic pattern of aggregation. These results indicate that wapH mutation provoked marked envelope alterations showing that LPS core conservation appears as a novel essential feature for active growth under cold conditions.	[Benforte, Florencia C.; Lopez, Nancy I.; Tribelli, Paula M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Colonnella, Maria A.; Lizarraga, Leonardo] Consejo Nacl Invest Cient & Tecn, Ctr Invest Bionanociencias, Buenos Aires, DF, Argentina; [Ricardi, Martiniano M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Solar Venero, Esmeralda C.; Lopez, Nancy I.; Tribelli, Paula M.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lopez, NI; Tribelli, PM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.; Lopez, NI; Tribelli, PM (corresponding author), Consejo Nacl Invest Cient & Tecn, IQUIBICEN, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar; paulatrib@qb.fcen.uba.ar		Ricardi, Martiniano/0000-0002-7904-6305; Tribelli, Paula Maria/0000-0001-9558-6275; Solar Venero, Esmeralda/0000-0003-3516-8535; Lizarraga, Leonardo/0000-0003-3476-495X	Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo [BID-PICT 2259]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2014-2017]; Universidad de Buenos Aires [Codigo 20020130100451BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PRH-2013-0017-PICT 2015-0031]; CONICET; UBA	Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA(University of Buenos Aires)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo BID-PICT 2259. NIL, PMT, ESV; Consejo Nacional de Investigaciones Cientificas y Tecnicas. PIP 2014-2017. NIL. PMT, ESV; Universidad de Buenos Aires.Codigo 20020130100451BA. NIL, PMT, ESV, FCB and the Agencia Nacional de Promocion Cientifica y Tecnologica (grant PRH-2013-0017-PICT 2015-0031). LL, ESV and MAC have a graduate student fellowship from CONICET. FCB has an undergraduate student fellowship from UBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MMR, LL, PMT, and NIL are career investigators from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). ESV and MAC have a graduate student fellowship from CONICET. FCB has an undergraduate student fellowship from UBA.	Ansari MA, 2014, J APPL MICROBIOL, V116, P772, DOI 10.1111/jam.12423; Appanna VD, 2001, MICROBIOS, V106, P19; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Cefali E, 2002, SCANNING, V24, P274, DOI 10.1002/sca.4950240601; Chalabaev S, 2014, MBIO, V5, DOI 10.1128/mBio.01116-14; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Corsaro MM, 2008, CHEM-EUR J, V14, P9368, DOI 10.1002/chem.200800117; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Fondi M, 2014, ENV MICROBIOL; Fonseca P, 2011, ENV MICROBIOL REP, V3, P329, DOI 10.1111/j.1758-2229.2010.00229.x; Francius G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020066; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Gaboriaud F, 2008, COLLOID SURFACE B, V62, P206, DOI 10.1016/j.colsurfb.2007.10.004; Godin-Roulling A, 2015, ENVIRON MICROBIOL, V17, P2407, DOI 10.1111/1462-2920.12707; Guyard-Nicodeme M, 2008, J PROTEOME RES, V7, P1218, DOI 10.1021/pr070539x; Harris LK, 2016, CELL, V165, P1479, DOI 10.1016/j.cell.2016.05.045; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kiran MD, 2005, EXTREMOPHILES, V9, P117, DOI 10.1007/s00792-005-0435-6; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumar GS, 2002, J BACTERIOL, V184, P6746, DOI 10.1128/JB.184.23.6746-6749.2002; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Loffhagen N, 2004, BIOSCI BIOTECH BIOCH, V68, P317, DOI 10.1271/bbb.68.317; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Moreno R, 2014, ENV MICROBIOL REP, V6, P417, DOI 10.1111/1758-2229.12150; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; Iustman LJR, 2015, EXTREMOPHILES, V19, P207, DOI 10.1007/s00792-014-0700-7; RAY MK, 1994, J BACTERIOL, V176, P4243, DOI 10.1128/jb.176.14.4243-4249.1994; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Stokes JM, 2016, CELL CHEM BIOL, V23, P267, DOI 10.1016/j.chembiol.2015.12.011; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Tribelli PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145353; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2013, PLOS ONE, P8; Wang HB, 2015, ACS APPL MATER INTER, V7, P13007, DOI 10.1021/acsami.5b03041; Wang HB, 2013, SOFT MATTER, V9, P7560, DOI 10.1039/c3sm51325d	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192559	10.1371/journal.pone.0192559	http://dx.doi.org/10.1371/journal.pone.0192559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415056	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300086
J	Huber, L; Giguere, S; Berghaus, LJ; Hanafi, A; Vitosh-Sillman, S; Czerwinski, SL				Huber, Laura; Giguere, Steeve; Berghaus, Londa J.; Hanafi, Amanda; Vitosh-Sillman, Sarah; Czerwinski, Sarah L.			Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi	PLOS ONE			English	Article							AQUEOUS-HUMOR; PCR ASSAY; HORSES; RESISTANCE; PNEUMONIA; DIAGNOSIS; ARTHRITIS; RIFAMPIN	Rhodococcus equi is one of the most important causes of disease in foals. Infection is typically characterized by pyogranulomatous pneumonia although extrapulmonary infections occur occasionally. Uveitis and polysynovitis have been reported in foals naturally infected with R. equi and are thought to be the result of an immune-mediated process. However, the pathogenesis of these conditions is poorly understood. The objectives of this study were to document the occurrence of uveitis and polysynovitis after experimental infection with R. equi and to determine if these disorders are the direct result of infection at these sites. Foals between 3 and 4 weeks of age were infected intratracheally with virulent R. equi using inocula of 1x10(8) CFU (high inoculum; n = 16) or 1x10(7) CFU (low inoculum; n = 12). Foals were monitored twice daily and necropsy was performed 14 days post-infection. Aqueous humor and synovial fluid were collected aseptically and the percentage of affected lung was calculated. The mean (+/- SD) percentage of affected lung was significantly higher with the high inoculum (31.8 +/- 14.6%) than with the low inoculum (14.4 +/- 11.4%). Fourteen of 25 foals developed uveitis and 20 of 28 foals developed polysynovitis. R. equi was cultured from the aqueous humor of 11 foals and from the synovial fluid of 14 foals. The risk of development of polysynovitis and protein concentration in the aqueous humor were significantly higher in foals that received the high inoculum. These results indicate that polysynovitis and uveitis are septic complications associated with the severity of lung disease.	[Huber, Laura; Giguere, Steeve; Berghaus, Londa J.; Hanafi, Amanda] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA; [Vitosh-Sillman, Sarah] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Czerwinski, Sarah L.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA	University System of Georgia; University of Georgia; University of Nebraska System; University of Nebraska Lincoln; University System of Georgia; University of Georgia	Giguere, S (corresponding author), Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA.	gigueres@uga.edu		Huber, Laura/0000-0002-5138-0336	Merck Animal Health; Hodgson Equine Research Endowment of the University of Georgia	Merck Animal Health(Merck & Company); Hodgson Equine Research Endowment of the University of Georgia	This work was supported by the Merck Animal Health to SG and the Hodgson Equine Research Endowment of the University of Georgia to SG. The funders participated in study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotti M, 1996, SCAND J INFECT DIS, V28, P463, DOI 10.3109/00365549609037941; Cohen N.D., 2006, COMPENDIUM ON CONTIN, V1, P14; Donisi A, 1996, AIDS, V10, P359, DOI 10.1097/00002030-199604000-00002; Elmas CR, 2013, CAN J VET RES, V77, P211; Faber NA, 2000, J CLIN MICROBIOL, V38, P2731, DOI 10.1128/JCM.38.7.2731-2733.2000; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 2010, JAVMA-J AM VET MED A, V237, P74, DOI 10.2460/javma.237.1.74; KENNEY DG, 1994, EQUINE VET J, V26, P246, DOI 10.1111/j.2042-3306.1994.tb04379.x; KROHNE SG, 1995, J AM VET MED ASSOC, V206, P1167; Ladron N, 2003, J CLIN MICROBIOL, V41, P3241, DOI 10.1128/JCM.41.7.3241-3245.2003; LEADON D, 1988, VET REC, V123, P279, DOI 10.1136/vr.123.10.279-a; MADISON JB, 1988, J AM VET MED ASSOC, V192, P1581; Rankin AJ, 2002, AM J VET RES, V63, P750, DOI 10.2460/ajvr.2002.63.750; Reuss SM, 2009, J AM MED VET ASS, V235, P855, DOI DOI 10.2460/JAVMA.235.7.855; SCHNEIDER RK, 1992, EQUINE VET J, V24, P436, DOI 10.1111/j.2042-3306.1992.tb02873.x; SWEENEY CR, 1987, VET MICROBIOL, V14, P329, DOI 10.1016/0378-1135(87)90120-9; Wilkes EJA, 2016, EQUINE VET EDUC, V28, P186, DOI 10.1111/eve.12469; Yamshchikov AV, 2010, LANCET INFECT DIS, V10, P350, DOI 10.1016/S1473-3099(10)70068-2	18	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192655	10.1371/journal.pone.0192655	http://dx.doi.org/10.1371/journal.pone.0192655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415076	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300091
J	Jong, WSP; Currency, MS; ten Hagen-Jongman, CM; Luirink, J; van Ulsen, P				Jong, Wouter S. P.; Currency, Maaike Schillemans; ten Hagen-Jongman, Corinne M.; Luirink, Joen; van Ulsen, Peter			Comparing autotransporter beta-domain configurations for their capacity to secrete heterologous proteins to the cell surface	PLOS ONE			English	Article							SINGLE-CHAIN FV; OUTER-MEMBRANE; ESCHERICHIA-COLI; TRANSLOCATOR DOMAIN; TRIMERIC AUTOTRANSPORTER; PASSENGER DOMAIN; BACTERIAL AUTOTRANSPORTERS; EXTRACELLULAR SECRETION; NEISSERIA-MENINGITIDIS; SERINE-PROTEASE	Monomeric autotransporters have been extensively used for export of recombinant proteins to the cell surface of Gram-negative bacteria. A bottleneck in the biosynthesis of such constructs is the passage of the outer membrane, which is facilitated by the beta-domain at the C terminus of an autotransporter in conjunction with the Bam complex in the outer membrane. We have evaluated eight beta-domain constructs for their capacity to secrete fused proteins to the cell surface. These constructs derive from the monomeric autotransporters Hbp, IgA protease, Ag43 and EstA and the trimeric autotransporter Hia, which all were selected because they have been previously used for secretion of recombinant proteins. We fused three different protein domains to the eight beta-domain constructs, being a Myc-tag, the Hbp passenger and a nanobody or V-HH domain, and assessed expression, membrane insertion and surface exposure. Our results show that expression levels differed considerably between the constructs tested. The constructs that included the beta-domains of Hbp and IgA protease appeared the most efficient and resulted in expression levels that were detectable on Coomassie-stained SDS-PAGE gels. The V-HH domain appeared the most difficult fusion partner to export, probably due to its complex immunoglobulin-like structure with a tertiary structure stabilized by an intramolecular disulfide bond. Overall, the Hbp beta-domain compared favorably in exporting the fused recombinant proteins, because it showed in every instance tested a good level of expression, stable membrane insertion and clear surface exposure.	[Jong, Wouter S. P.; ten Hagen-Jongman, Corinne M.; Luirink, Joen; van Ulsen, Peter] Vrije Univ Amsterdam, AIMMS, Dept Mol Cell Biol, Sect Mol Microbiol, Amsterdam, Netherlands; [Jong, Wouter S. P.; van Ulsen, Peter] Abera Biosci AB, Stockholm, Sweden; [Currency, Maaike Schillemans] Sanquin Res, Dept Plasma Proteins, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Jong, WSP; van Ulsen, P (corresponding author), Vrije Univ Amsterdam, AIMMS, Dept Mol Cell Biol, Sect Mol Microbiol, Amsterdam, Netherlands.; Jong, WSP; van Ulsen, P (corresponding author), Abera Biosci AB, Stockholm, Sweden.	w.s.p.jong@vu.nl; j.p.van.ulsen@vu.nl	Luirink, Joen/AAB-8658-2021	van Ulsen, Peter/0000-0002-2164-1611; Jong, W.S.P./0000-0002-8907-6954; Luirink, J./0000-0001-8431-0804; Schillemans, Maaike/0000-0001-6253-9667				Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Baclayon M, 2016, ACS NANO, V10, P5710, DOI 10.1021/acsnano.5b07072; Bernstein HD, 2015, MOL MICROBIOL, V97, P205, DOI 10.1111/mmi.13031; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Daleke-Schermerhorn MH, 2014, APPL ENVIRON MICROB, V80, P5854, DOI 10.1128/AEM.01941-14; De E, 2008, MOL MEMBR BIOL, V25, P192, DOI 10.1080/09687680701771925; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Hashemzadeh-Bonehi L, 1998, MOL MICROBIOL, V30, P676, DOI 10.1046/j.1365-2958.1998.01116.x; Hjelm A, 2015, APPL ENVIRON MICROB, V81, P726, DOI 10.1128/AEM.02733-14; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jong WSP, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0162-8; Jong WSP, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-85; Jong WSP, 2010, CURR OPIN BIOTECH, V21, P646, DOI 10.1016/j.copbio.2010.07.009; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kjaergaard K, 2002, J BACTERIOL, V184, P4197, DOI 10.1128/JB.184.15.4197-4204.2002; KLAUSER T, 1993, J MOL BIOL, V234, P579, DOI 10.1006/jmbi.1993.1613; Konieczny MPJ, 2001, ANTON LEEUW INT J G, V80, P19, DOI 10.1023/A:1012084325728; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Lyskowski A, 2011, ADV EXP MED BIOL, V715, P143, DOI 10.1007/978-94-007-0940-9_9; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Mukherjee O, 2015, HUM VACC IMMUNOTHER, V11, P2223, DOI 10.1080/21645515.2015.1034917; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; Nicolay T, 2015, CRIT REV MICROBIOL, V41, P109, DOI 10.3109/1040841X.2013.804032; Nicolay Toon, 2012, Microb Cell Fact, V11, P158, DOI 10.1186/1475-2859-11-158; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Pyo HM, 2009, VACCINE, V27, P2030, DOI 10.1016/j.vaccine.2009.01.130; Ramesh B, 2012, J BIOL CHEM, V287, P38580, DOI 10.1074/jbc.M112.388199; Roussel-Jazede V, 2014, MICROBIOL-SGM, V160, P2421, DOI 10.1099/mic.0.082511-0; Roussel-Jazede V, 2011, MOL MEMBR BIOL, V28, P157, DOI 10.3109/09687688.2010.550328; Salema V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075126; Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schmidgen T, 2014, J BACTERIOL, V196, P2155, DOI 10.1128/JB.01461-13; SHIKATA S, 1993, J BIOCHEM, V114, P723, DOI 10.1093/oxfordjournals.jbchem.a124244; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; Sun F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0316-3; Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Tozakidis IEP, 2015, NEW BIOTECHNOL, V32, P644, DOI 10.1016/j.nbt.2014.12.008; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; van der Linden RHJ, 2000, J BIOTECHNOL, V80, P261, DOI 10.1016/S0168-1656(00)00274-1; van Ulsen P, 2014, BBA-MOL CELL RES, V1843, P1592, DOI 10.1016/j.bbamcr.2013.11.006; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973	55	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191622	10.1371/journal.pone.0191622	http://dx.doi.org/10.1371/journal.pone.0191622			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415042	Green Submitted, gold, Green Published			2022-12-27	WOS:000424325300036
J	Yang, C; Yang, SJ; Feng, CH; Zhang, C; Xu, WW; Zhang, LY; Yan, YX; Deng, JQ; Ohore, OE; Li, J				Yang, Chao; Yang, Shujuan; Feng, Chunhong; Zhang, Chuan; Xu, Weiwei; Zhang, Liyun; Yan, Yixin; Deng, Jiaqi; Ohore, Okugbe Ebiotubo; Li, Jing			Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study	PLOS ONE			English	Article							SERUM URIC-ACID; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; PREDICTOR; RISK; DYSFUNCTION; POPULATION; PREVALENCE; MORTALITY	Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that is associated with high serum uric acid (SUA) levels, although the effects of high SUA levels on NAFLD remission remain unclear. In addition, it is unclear whether obesity and high SUA levels have a combined effect on NAFLD remission. This retrospective cohort study evaluated male employees of seven Chinese companies and investigated the association between high SUA levels and NAFLD remission, as well as the potential combined effect of high SUA levels and obesity on NAFLD remission. The study followed 826 men with NAFLD for 4 years, and the NAFLD remission rate was 23.2% (192/826). Comparing to obese and non-obese individuals with normouricemia, individuals with hyperuricemia had significant higher values for total cholesterol, triglycerides, creatinine, and aspartate transaminase (all P < 0.05). Among non-obese individuals, hyperuricemia was associated with a lower NAFLD remission rate, compared to normouricemia (P < 0.001). However, no significant difference was observed between hyperuricemia and normouricemia among obese subjects (P > 0.05). Similar results were observed in the multivariate cox proportional hazard regression analyses. Compared to the normouricemia subjects, individuals with hyperuricemia had a significant lower likelihood of NAFLD remission (RR = 0.535, 95% CI: 0.312-0.916); and obese subjects had a significant lower likelihood of NAFLD remission than the non-obese individuals (RR = 0.635, 95% CI: 0.439-0.918). In addition, the interaction between hyperuricemia and obesity had a statistically significant effect on NAFLD remission (P = 0.048). In conclusion, hyperuricemia and obesity may be involved in NAFLD development and remission, with similar pathogenic mechanisms. Further studies are needed to confirm our findings and determine how to improve these individuals' conditions.	[Yang, Chao] Southwest Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Luzhou, Peoples R China; [Yang, Shujuan] Sichuan Univ, Dept Hlth Related Social & Behav Sci, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Feng, Chunhong; Xu, Weiwei; Zhang, Liyun; Yan, Yixin] Southwest Med Univ, Hlth Management Dept, Affiliated Hosp 1, Coll Med, Luzhou, Peoples R China; [Zhang, Chuan] Sichuan Univ, Dept Palliat Med, West China Teaching Hosp 1, Chengdu, Sichuan, Peoples R China; [Deng, Jiaqi] Southwest Med Univ, Dept Ultrasonog, Affiliated Hosp 1, Coll Med, Luzhou, Peoples R China; [Ohore, Okugbe Ebiotubo] Southeast Univ, Dept Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Li, Jing] Southwest Med Univ, Dept Educ Affairs, Luzhou, Peoples R China	Southwest Medical University; Sichuan University; Southwest Medical University; Sichuan University; Southwest Medical University; Southeast University - China; Southwest Medical University	Li, J (corresponding author), Southwest Med Univ, Dept Educ Affairs, Luzhou, Peoples R China.	jingl2017@tom.com	Ohore, Okugbe/GQP-8720-2022; Ohore, Okugbe/AAK-1994-2021	Ohore, Okugbe/0000-0002-0784-480X; 				Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Cardoso AS, 2013, J PEDIAT-BRAZIL, V89, P412, DOI 10.1016/j.jped.2012.12.008; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; FANG J, 1971, NATIONAL HEALTH AND, V2000, P283; Fang J, 2000, PUBMED, V283, P2404; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Jian-gao F, 2010, MEDICINE, V18, P163; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Liu CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep33472; LIU J, 2016, HEPATOLOGY RESEARCH; Liu L, 2013, CLIN RHEUMATOL, V32, P233, DOI 10.1007/s10067-012-2108-z; Liu PJ, 2014, CLIMACTERIC, V17, P692, DOI 10.3109/13697137.2014.926323; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; PMID, 2010, PUBMED; PMID, 2008, PUBMED; PMID, 2014, PUBMED; PMID, PUBMED, P3681; PMID, 2015, PUBMED; PMID, 2004, PUBMED; PMID, 1929, PUBMED; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SUN D, 2016, EXPERT OPIN THER TAR; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tulloch-Reid MK, 2004, OBES RES, V12, P1352, DOI 10.1038/oby.2004.170; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; WIJARNPREECHA K, 2016, LIVER INTERNATIONAL; Xie Y, 2013, PLOS ONE, V8; Xu C, 2010, PUBMED, V5; YANG C, 2017, PUBMED; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Yu TY, 2016, METABOLISM, V65, P432, DOI 10.1016/j.metabol.2015.11.003; Yu TY, 2016, INT J MOL SCI, V65, P432; Zelber-Sagi S, 2012, J HEPATOL, V56, P1145, DOI 10.1016/j.jhep.2011.12.011; Zhang JP, 2016, CLIN RHEUMATOL, V35, P143, DOI 10.1007/s10067-015-2867-4; Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010; ZHOU Z, 2016, PUBMED; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	54	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192396	10.1371/journal.pone.0192396	http://dx.doi.org/10.1371/journal.pone.0192396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415050	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300074
J	Dettmer, S; Ringshausen, F; Vogel-Claussen, J; Fuge, J; Faschkami, A; Shin, HO; Schwerk, N; Welte, T; Wacker, F; Rademacher, J				Dettmer, Sabine; Ringshausen, Felix; Vogel-Claussen, Jens; Fuge, Jan; Faschkami, Amir; Shin, Hoen-oh; Schwerk, Nicolaus; Welte, Tobias; Wacker, Frank; Rademacher, Jessica			Computed tomography in adult patients with primary ciliary dyskinesia: Typical imaging findings	PLOS ONE			English	Article							HIGH-RESOLUTION CT; CYSTIC FIBROSIS BRONCHIECTASIS; NON-CF BRONCHIECTASIS; THIN-SECTION CT; DIAGNOSIS; ACCURACY; DISEASES; REGISTRY; SOCIETY; AGE	Objectives Among patients with non-cystic fibrosis bronchiectasis, 1-18% have an underlying diagnosis of primary ciliary dyskinesia (PCD) and it is suspected that there is under-recognition of this disease. Our intention was to evaluate the specific features of PCD seen on computed tomography (CT) in the cohort of bronchiectasis in order to facilitate the diagnosis. Materials and methods One hundred and twenty-one CTs performed in patients with bronchiectasis were scored for the involvement, type, and lobar distribution of bronchiectasis, bronchial dilatation, and bronchial wall thickening. Later, associated findings such as mucus plugging, tree in bud, consolidations, ground glass opacities, interlobular thickening, intralobular lines, situs inversus, emphysema, mosaic attenuation, and atelectasis were registered. Patients with PCD (n = 46) were compared to patients with other underlying diseases (n = 75). Results In patients with PCD, the extent and severity of the bronchiectasis and bronchial wall thickness were significantly lower in the upper lung lobes (p<0.001-p = 0.011). The lobar distribution differed significantly with a predominance in the middle and lower lobes in patients with PCD (<0.001). Significantly more common in patients with PCD were mucous plugging (p = 0.001), tree in bud (p < 0.001), atelectasis (p = 0.009), and a history of resection of a middle or lower lobe (p = 0.047). Less common were emphysematous (p = 0.003) and fibrotic (p<0.001) changes. A situs inversus (Kartagener's Syndrome) was only seen in patients with PCD (17%, p < 0.001). Conclusion Typical imaging features in PCD include a predominance of bronchiectasis in the middle and lower lobes, severe tree in bud pattern, mucous plugging, and atelectasis. These findings may help practitioners to identify patients with bronchiectasis in whom further work-up for PCD is called for.	[Dettmer, Sabine; Vogel-Claussen, Jens; Faschkami, Amir; Shin, Hoen-oh; Wacker, Frank] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Ringshausen, Felix; Fuge, Jan; Welte, Tobias; Rademacher, Jessica] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Ringshausen, Felix; Vogel-Claussen, Jens; Fuge, Jan; Shin, Hoen-oh; Welte, Tobias; Wacker, Frank] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Schwerk, Nicolaus] Hannover Med Sch, Dept Pediat Pneumol & Neonatol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Dettmer, S (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	dettmer.sabine@mh-hannover.de	Rademacher, Jessica/ABG-1898-2020; schwerk, nicolaus/AAU-5676-2020; Vogel-Claussen, Jens/Q-3374-2019; Ringshausen, Felix C./AAA-9154-2021	Ringshausen, Felix C./0000-0001-9084-4968; Vogel-Claussen, Jens/0000-0001-5595-6948; Fuge, Jan/0000-0003-2926-3608				Altenburg J, 2015, NETH J MED, V73, P147; American Association of Physicists in Medicine, 2016, AD ROUT CHEST CT PRO; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Cartier Y, 1999, AM J ROENTGENOL, V173, P47, DOI 10.2214/ajr.173.1.10397098; Chalmers JD, 2016, ERJ OPEN RES, V2; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; GRENIER P, 1986, RADIOLOGY, V161, P95, DOI 10.1148/radiology.161.1.3763889; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kennedy MP, 2007, AM J ROENTGENOL, V188, P1232, DOI 10.2214/AJR.06.0965; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; LEE PH, 1995, CLIN RADIOL, V50, P839, DOI 10.1016/S0009-9260(05)83104-6; Lonni S, 2015, ANN AM THORAC SOC, V12, P1764, DOI 10.1513/AnnalsATS.201507-472OC; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Milliron B, 2015, RADIOGRAPHICS, V35, P1011, DOI 10.1148/rg.2015140214; NAIDICH DP, 1982, J COMPUT ASSIST TOMO, V6, P437, DOI 10.1097/00004728-198206000-00001; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Ooi GC, 2002, RADIOLOGY, V225, P663, DOI 10.1148/radiol.2253011575; Pasteur MC, 2010, THORAX, V65, P577, DOI 10.1136/thx.2010.142778; Rademacher J, 2015, PNEUMOLOGIE, V69, P391, DOI 10.1055/s-0034-1392254; REID LM, 1950, THORAX, V5, P233, DOI 10.1136/thx.5.3.233; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; Shah A, 2016, EUR RESPIR J, V48, P441, DOI 10.1183/13993003.00209-2016; Shah RM, 1997, AM J ROENTGENOL, V169, P375, DOI 10.2214/ajr.169.2.9242738; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Webb W. Richard, 2011, THORACIC IMAGING PUL; Werner C, 2016, EUR RESPIR J, V47, P849, DOI 10.1183/13993003.00776-2015	28	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191457	10.1371/journal.pone.0191457	http://dx.doi.org/10.1371/journal.pone.0191457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408869	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800018
J	Foshtomi, MY; Leliaert, F; Derycke, S; Willems, A; Vincx, M; Vanaverbeke, J				Foshtomi, Maryam Yazdani; Leliaert, Frederik; Derycke, Sofie; Willems, Anne; Vincx, Magda; Vanaverbeke, Jan			The effect of bio-irrigation by the polychaete Lanice conchilega on active denitrifiers: Distribution, diversity and composition of nosZ gene	PLOS ONE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; BACTERIAL COMMUNITIES; MARINE-SEDIMENTS; AEROBIC DENITRIFICATION; CALLIANASSA-SUBTERRANEA; MICROBIAL COMMUNITIES; BENTHIC METABOLISM; NUTRIENT FLUXES; IMPACT; BIOTURBATION	The presence of large densities of the piston-pumping polychaete Lanice conchilega can have important consequences for the functioning of marine sediments. It is considered both an allogenic and an autogenic ecosystem engineer, affecting spatial and temporal biogeochemical gradients (oxygen concentrations, oxygen penetration depth and nutrient concentrations) and physical properties (grain size) of marine sediments, which could affect functional properties of sediment-inhabiting microbial communities. Here we investigated whether density-dependent effects of L. conchilega affected horizontal (m-scale) and vertical (cm-scale) patterns in the distribution, diversity and composition of the typical nosZgene in the active denitrifying organisms. This gene plays a major role in N2O reduction in coastal ecosystems as the last step completing the denitrification pathway. We showed that both vertical and horizontal composition and richness of nosZgene were indeed significantly affected when large densities of the bio-irrigator were present. This could be directly related to allogenic ecosystem engineering effects on the environment, reflected in increased oxygen penetration depth and oxygen concentrations in the upper cm of the sediment in high densities of L. conchilega. A higher diversity (Shannon diversity and inverse Simpson) of nosZobserved in patches with high L. conchilega densities (3,185-3,440 ind. m(-2)) at deeper sediment layers could suggest a downward transport of NO3- to deeper layers resulting from bio-irrigation as well. Hence, our results show the effect of L. conchilega bio-irrigation activity on denitrifying organisms in L. conchilega reefs.	[Foshtomi, Maryam Yazdani; Leliaert, Frederik; Derycke, Sofie; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Biol Dept, Marine Biol Res Grp, Ghent, Belgium; [Foshtomi, Maryam Yazdani; Willems, Anne] Univ Ghent, CeMoFE, Ghent, Belgium; [Leliaert, Frederik] Bot Garden Meise, Meise, Belgium; [Derycke, Sofie] Inst Agr & Fisheries Res ILVO, Aquat Environm & Qual, Oostende, Belgium; [Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, Lab Microbiol, Ghent, Belgium; [Vanaverbeke, Jan] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm OD Nat, Marine Ecol & Management, Brussels, Belgium; [Foshtomi, Maryam Yazdani] Kharazmi Univ, Fac Biol Sci, Tehran, Iran	Ghent University; Ghent University; Institute For Agricultural & Fisheries Research; Ghent University; Royal Belgian Institute of Natural Sciences; Kharazmi University	Vanaverbeke, J (corresponding author), Univ Ghent, Biol Dept, Marine Biol Res Grp, Ghent, Belgium.; Vanaverbeke, J (corresponding author), Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm OD Nat, Marine Ecol & Management, Brussels, Belgium.	jvanaverbeke@naturalsciences.be	Leliaert, Frederik/A-9162-2009; Willems, Anne/B-2872-2010	Leliaert, Frederik/0000-0002-4627-7318; Willems, Anne/0000-0002-8421-2881; Vanaverbeke, Jan/0000-0003-2488-8609	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G0033.11]; Special Research Fund of Ghent University [01G01911]; Ministry of Science, Research and Technology, Iran [24-88200022]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Special Research Fund of Ghent University(Ghent University); Ministry of Science, Research and Technology, Iran	Funded by Fonds voor Wetenschappelijk Onderzoek Vlaanderen. http://www.fwo.be/. Grant number G0033.11 to MV, JV, AW. Special Research Fund of Ghent University. https://www.ugent.be/nl/onderzoek/financiering/bof. Grant number 01G01911 to MV and AW. Ministry of Science, Research and Technology, Iran. https://www.msrt.ir/en. Grant number 24-88200022 to MYF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alves RMS, 2017, ESTUAR COAST SHELF S, V188, P88, DOI 10.1016/j.ecss.2017.02.012; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bai YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037796; Bakken L., 2008, ENVIRON MICROBIOL, V10, P3070; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bertics VJ, 2012, APPL ENVIRON MICROB, V78, P3864, DOI 10.1128/AEM.00114-12; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Birchenough SNR, 2012, ECOL INDIC, V12, P8, DOI 10.1016/j.ecolind.2011.03.015; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Callaway R, 2006, MAR ECOL PROG SER, V308, P49, DOI 10.3354/meps308049; Canfield DE, 2005, ADV MAR BIOL, V48, P65; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; De Smet B, 2016, J EXP MAR BIOL ECOL, V475, P31, DOI 10.1016/j.jembe.2015.11.005; De Smet B, 2015, ESTUAR COAST SHELF S, V152, P44, DOI 10.1016/j.ecss.2014.11.002; Decleyre H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126583; Degraer S, 2006, THE MACROBENTHOS ATL; Deutsch B, 2010, BIOGEOSCIENCES, V7, P3259, DOI 10.5194/bg-7-3259-2010; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Falk S, 2007, BIOGEOSCIENCES, V4, P255, DOI 10.5194/bg-4-255-2007; Fernandes SO, 2012, MAR ENVIRON RES, V74, P9, DOI 10.1016/j.marenvres.2011.11.008; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; Foshtomi MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130116; Franco MA, 2007, AQUAT MICROB ECOL, V48, P241, DOI 10.3354/ame048241; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gao Z, 2011, CHIN J OCEANOL LIMN, V29, P1209, DOI 10.1007/s00343-011-0316-z; Gihring TM, 2009, LIMNOL OCEANOGR, V54, P1073, DOI 10.4319/lo.2009.54.4.1073; Gilbert F, 1997, HYDROBIOLOGIA, V345, P67, DOI 10.1023/A:1002931432250; Godet L, 2008, AMBIO, V37, P347, DOI 10.1579/07-A-317.1; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Heuers J., 1998, VERH GES OKOL, V28, P207; Howe RL, 2004, J MAR BIOL ASSOC UK, V84, P629, DOI 10.1017/S002531540400966Xh; Huang S, 2011, BIOGEOSCIENCES, V8, P3041, DOI 10.5194/bg-8-3041-2011; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; Jenkins BD, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1303, DOI 10.1016/B978-0-12-372522-6.00030-X; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Kampschreur MJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00370; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; Kohn RA, 2015, CABI CLIM CHANGE SER, V6, P61, DOI 10.1079/9781780644325.0061; Kristensen E, 2005, COAST ESTUAR STUD, V60, P125; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Laverock B, 2014, ENV MICROBIOL REP, V6, P113, DOI 10.1111/1758-2229.12115; Laverock B, 2011, BIOCHEM SOC T, V39, P315, DOI 10.1042/BST0390315; Li FY, 2010, SOIL SCI PLANT NUTR, V56, P66, DOI 10.1111/j.1747-0765.2010.00450.x; Liu BB, 2013, ENVIRON MICROBIOL, V15, P2816, DOI 10.1111/1462-2920.12142; Liu XD, 2003, APPL ENVIRON MICROB, V69, P3549, DOI 10.1128/AEM.69.6.3549-3560.2003; Marconi M., 2014, FUNGAL RNA BIOLOGY, V15, P371; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Nizzoli D, 2006, MAR ECOL PROG SER, V315, P151, DOI 10.3354/meps315151; Papaspyrou S, 2006, MAR BIOL, V148, P541, DOI 10.1007/s00227-005-0105-3; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Poulsen M, 2014, SYST APPL MICROBIOL, V37, P51, DOI 10.1016/j.syapm.2013.07.006; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; Queiros AM, 2013, ECOL EVOL, V3, P3958, DOI 10.1002/ece3.769; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2008, FISH RES, V90, P209, DOI 10.1016/j.fishres.2007.10.009; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; Read G., 2017, WORLD POLYCHAETA DAT; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Scala DJ, 1999, APPL ENVIRON MICROB, V65, P1681; Scala DJ, 2000, APPL ENVIRON MICROB, V66, P1980, DOI 10.1128/AEM.66.5.1980-1986.2000; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Su JJ, 2001, J APPL MICROBIOL, V90, P457, DOI 10.1046/j.1365-2672.2001.01265.x; Team RDC, 2008, R A LANGUAGE AND ENV; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiquia SM, 2006, FEMS MICROBIOL ECOL, V58, P464, DOI 10.1111/j.1574-6941.2006.00173.x; Van Hoey G, 2008, MAR BIOL, V154, P1009, DOI 10.1007/s00227-008-0992-1; Van Hoey G, 2006, HELGOLAND MAR RES, V60, P317, DOI 10.1007/s10152-006-0041-8; Wang YF, 2013, APPL MICROBIOL BIOT, V97, P7015, DOI 10.1007/s00253-012-4430-4; Wang ZL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0104657, 10.1371/journal.pone.0091755]; Webb AP, 2004, MAR ECOL PROG SER, V268, P205, DOI 10.3354/meps268205; Widdicombe S, 2013, MAR POLLUT BULL, V73, P416, DOI 10.1016/j.marpolbul.2012.11.008; Wittorf L, 2016, ENV MICROBIOL REP, V8, P486, DOI 10.1111/1758-2229.12393; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhang Y, 2014, BIOGEOSCIENCES, V11, P2131, DOI 10.5194/bg-11-2131-2014; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	92	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192391	10.1371/journal.pone.0192391	http://dx.doi.org/10.1371/journal.pone.0192391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408934	Green Published, gold			2022-12-27	WOS:000424302800062
J	Hoffmann, S; Laurier, D; Rage, E; Guihenneuc, C; Ancelet, S				Hoffmann, Sabine; Laurier, Dominique; Rage, Estelle; Guihenneuc, Chantal; Ancelet, Sophie			Shared and unshared exposure measurement error in occupational cohort studies and their effects on statistical inference in proportional hazards models	PLOS ONE			English	Article							FRENCH URANIUM MINERS; LUNG-CANCER MORTALITY; RADON EXPOSURE; REGRESSION-MODELS; RISK; UNCERTAINTY; BERKSON; EPIDEMIOLOGY; ATTENUATION; STRATEGIES	Exposure measurement error represents one of the most important sources of uncertainty in epidemiology. When exposure uncertainty is not or only poorly accounted for, it can lead to biased risk estimates and a distortion of the shape of the exposure-response relationship. In occupational cohort studies, the time-dependent nature of exposure and changes in the method of exposure assessment may create complex error structures. When a method of group-level exposure assessment is used, individual worker practices and the imprecision of the instrument used to measure the average exposure for a group of workers may give rise to errors that are shared between workers, within workers or both. In contrast to unshared measurement error, the effects of shared errors remain largely unknown. Moreover, exposure uncertainty and magnitude of exposure are typically highest for the earliest years of exposure. We conduct a simulation study based on exposure data of the French cohort of uranium miners to compare the effects of shared and unshared exposure uncertainty on risk estimation and on the shape of the exposure-response curve in proportional hazards models. Our results indicate that uncertainty components shared within workers cause more bias in risk estimation and a more severe attenuation of the exposure-response relationship than unshared exposure uncertainty or exposure uncertainty shared between individuals. These findings underline the importance of careful characterisation and modeling of exposure uncertainty in observational studies.	[Hoffmann, Sabine; Laurier, Dominique; Rage, Estelle; Ancelet, Sophie] Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France; [Guihenneuc, Chantal] Univ Paris 05, Fac Pharm, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Hoffmann, S (corresponding author), Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France.	sabine.hoffmann@irsn.fr	ANCELET, SOPHIE/HGD-5825-2022; guihenneuc, chantal/AAZ-9296-2020	guihenneuc, chantal/0000-0001-7237-7120; Laurier, Dominique/0000-0003-1432-4738	Institut de Radioprotection et de Surete Nucleaire (IRSN); Universite Paris Descartes; AREVA NC	Institut de Radioprotection et de Surete Nucleaire (IRSN); Universite Paris Descartes; AREVA NC	This work was funded by the Institut de Radioprotection et de Surete Nucleaire (IRSN) and the Universite Paris Descartes. Additionally, it was partially supported by AREVA NC, in the framework of a bilateral agreement between IRSN and AREVA NC. AREVA NC had no role in study design, data analysis, or in the interpretation of the results. There was no additional external funding received for this study.; This work was partially supported by AREVA NC, in the framework of a bilateral agreement between IRSN and AREVA NC. AREVA NC had no role in study design, data analysis, or in the interpretation of the results.	Allodji RS, 2012, STAT MED, V31, P4428, DOI 10.1002/sim.5618; Allodji RS, 2012, RADIAT ENVIRON BIOPH, V51, P151, DOI 10.1007/s00411-012-0403-3; Allodji RS, 2012, J RADIOL PROT, V32, P85, DOI 10.1088/0952-4746/32/1/85; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bartlett JW, 2016, STAT METHODS MED RES; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Carroll RJ, 2006, MEASUREMENT ERROR NO; Cocco P, 2001, AM J IND MED, V40, P674, DOI 10.1002/ajim.10022; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Greenland S, 2016, RISK ANAL, V36, P74, DOI 10.1111/risa.12438; Heid IM, 2002, STAT MED, V21, P3261, DOI 10.1002/sim.1252; Hendry DJ, 2014, STAT MED, V33, P436, DOI 10.1002/sim.5945; HERTZPICCIOTTO I, 1993, SCAND J WORK ENV HEA, V19, P217, DOI 10.5271/sjweh.1480; Hoffmann S, 2017, RADIAT RES, V187, P196, DOI 10.1667/RR14467.1; Kreuzer M, 2015, BRIT J CANCER, V113, P1367, DOI 10.1038/bjc.2015.324; Kromhout H, 2002, OCCUP ENVIRON MED, V59, P349, DOI 10.1136/oem.59.5.349; Kuchenhoff H, 2007, LIFETIME DATA ANAL, V13, P261, DOI 10.1007/s10985-007-9036-2; Kwon D, 2016, STAT MED, V35, P399, DOI 10.1002/sim.6635; Little MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085723; Lyles RH, 1997, BIOMETRICS, V53, P1008, DOI 10.2307/2533560; Mallick B, 2002, BIOMETRICS, V58, P13, DOI 10.1111/j.0006-341X.2002.00013.x; Rage E, 2015, INT ARCH OCC ENV HEA, V88, P717, DOI 10.1007/s00420-014-0998-6; Reeves GK, 1998, STAT MED, V17, P2157, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2157::AID-SIM916>3.0.CO;2-F; Simon SL, 2015, RADIAT RES, V183, P27, DOI 10.1667/RR13729.1; Stayner L, 2003, SCAND J WORK ENV HEA, V29, P317, DOI 10.5271/sjweh.737; Steenland K, 2000, SCAND J WORK ENV HEA, V26, P37, DOI 10.5271/sjweh.508; Steenland K, 2015, EPIDEMIOLOGY, V26, P395, DOI 10.1097/EDE.0000000000000259; Stram D, 1999, HLTH PHYS, V77; Stram DO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119418; Stram DO, 2003, RADIAT RES, V160, P408, DOI 10.1667/3046; Tielemans E, 1998, ANN OCCUP HYG, V42, P115, DOI 10.1093/annhyg/42.2.115; Vacquier B, 2008, OCCUP ENVIRON MED, V65, P597, DOI 10.1136/oem.2007.034959; Zettwoog P., 1981, RAD HAZARDS MINING C, P4; Zhang Z., 2017, PLOS ONE, V12	34	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190792	10.1371/journal.pone.0190792	http://dx.doi.org/10.1371/journal.pone.0190792			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408862	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800010
J	Li, X; Dai, DN; Chen, B; Tang, HL; Xie, XM; Wei, WD				Li, Xuan; Dai, Danian; Chen, Bo; Tang, Hailin; Xie, Xiaoming; Wei, Weidong			Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PHASE-II TRIAL; METASTATIC BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; PANCREATIC NEUROENDOCRINE TUMORS; DOUBLE-BLIND; INTERFERON-ALPHA; LUNG-CANCER; 1ST-LINE TREATMENT; MAMMALIAN TARGET	Background The phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway (PI3K/AKT/mTOR pathway) plays a key role in cancer. We performed this meta-analysis to assess the clinical effect of using PI3K/AKT/mTOR pathway inhibitors on advanced solid tumours. Methods All the randomised controlled trials (RCT) that compared the therapy with PI3K/AKT/mTOR pathway inhibitors with other therapies were included. The main end-point was progression-free survival (PFS); other end-points included overall survival (OS) and objective response rate (ORR). A subgroup analysis was performed mainly for PFS. Results In total, 46 eligible RCT were included. The pooled results showed that PI3K/AKT/mTOR pathway inhibitor-based regimens significantly improved the PFS of patients with advanced solid tumours (hazard ratios (HR) = 0.79; 95% confidence intervals (CI): 0.71 +/- 0.88) and PI3K pathway mutations (HR = 0.69; 95% CI: 0.56 +/- 0.85). All single PI3K/AKT/mTOR pathway inhibitor therapies were compared with other targeted therapies (HR = 0.99; 95% CI: 0.93 +/- 1.06) and dual targeted therapies, including PI3K/AKT/mTOR pathway inhibitors and other targeted therapies (HR = 1.04; 95% CI: 0.62 +/- 1.74), which showed no significant differences in the PFS. Additional PI3K/AKT/mTOR pathway inhibitors showed no advantage with respect to the OS (HR = 0.98; 95% CI: 0.90 +/- 1.07) or ORR (risk ratio (RR) = 1.02; 95% CI: 0.87 +/- 1.20). Conclusion Our meta-analysis results suggest that the addition of the PI3K pathway inhibitors to the therapy regiment for advanced solid tumours significantly improves PFS. The way that patients are selected to receive the PI3K pathway inhibitors might be more meaningful in the future.	[Li, Xuan; Dai, Danian; Chen, Bo; Tang, Hailin; Xie, Xiaoming; Wei, Weidong] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xie, XM; Wei, WD (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.	weiwd@sysucc.org.cn; xiexm@sysucc.cn		xuan, Li/0000-0003-2851-8963; Xie, Xiaoming/0000-0003-0687-4238				Andre F, 2014, LANCET ONCOL, V15, P580, DOI 10.1016/S1470-2045(14)70138-X; Armstrong AJ, 2016, LANCET ONCOL, V17, P378, DOI 10.1016/S1470-2045(15)00515-X; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2017, LANCET ONCOL, V18, P904, DOI 10.1016/S1470-2045(17)30376-5; Baselga J, 2017, BREAST CANCER RES TR, V163, P535, DOI 10.1007/s10549-017-4199-3; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bendell JC, 2011, J CLIN ONCOL, V29, P4394, DOI 10.1200/JCO.2011.36.1980; Besse B, 2014, ANN ONCOL, V25, P409, DOI 10.1093/annonc/mdt536; Bowles DW, 2016, CLINICAL COLORECTAL, V15; Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Cirkel GA, 2017, JAMA ONCOL, V3, P501, DOI 10.1001/jamaoncol.2016.5202; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Demetri GD, 2013, J CLIN ONCOL, V31, P2485, DOI 10.1200/JCO.2012.45.5766; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dutcher JP, 2009, MED ONCOL, V26, P202, DOI 10.1007/s12032-009-9177-0; Eroglu Z, 2015, BRIT J CANCER, V112, P1644, DOI 10.1038/bjc.2015.126; Feldman DR, 2009, J CLIN ONCOL, V27, P1432, DOI 10.1200/JCO.2008.19.0108; Figlin RA, 2013, INT J CANCER, V133, P788, DOI 10.1002/ijc.28023; Flaherty KT, 2015, J CLIN ONCOL, V33, P2384, DOI 10.1200/JCO.2015.60.9727; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Generali D, 2015, BREAST CANCER RES TR, V152, P95, DOI 10.1007/s10549-015-3453-9; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jehan Z, 2009, J PATHOL, V219, P337, DOI 10.1002/path.2601; Jimeno A, 2015, ANN ONCOL, V26, P556, DOI 10.1093/annonc/mdu574; Jimeno A, 2015, ORAL ONCOL, V51, P383, DOI 10.1016/j.oraloncology.2014.12.013; Jonasch E, 2017, ANN ONCOL, V28, P804, DOI 10.1093/annonc/mdw676; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kim SB, 2017, LANCET ONCOL, V18, P1360, DOI 10.1016/S1470-2045(17)30450-3; Krop IE, 2016, LANCET ONCOL, V17, P811, DOI 10.1016/S1470-2045(16)00106-6; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Lang SA, 2007, INT J CANCER, V120, P1803, DOI 10.1002/ijc.22442; Levy B, 2014, J THORAC ONCOL, V9, P1031, DOI 10.1097/JTO.0000000000000183; Margolin KA, 2012, CLIN CANCER RES, V18, P1129, DOI 10.1158/1078-0432.CCR-11-2488; Martin M, 2017, ANN ONCOL, V28, P313, DOI 10.1093/annonc/mdw562; Maruyama N, 2007, CLIN CANCER RES, V13, P408, DOI 10.1158/1078-0432.CCR-06-0267; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Molina AM, 2012, CANCER-AM CANCER SOC, V118, P1868, DOI 10.1002/cncr.26429; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2014, J CLIN ONCOL, V32, P2766, DOI 10.1200/JCO.2013.54.6911; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Ohtsu A, 2013, J CLIN ONCOL, V31, P3935, DOI 10.1200/JCO.2012.48.3552; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Oza AM, 2015, J CLIN ONCOL, V33, P3576, DOI 10.1200/JCO.2014.58.8871; Papadimitrakopoulou V, 2016, J CLIN ONCOL, V34, P3638, DOI 10.1200/JCO.2015.66.0084; Patel PH, 2009, CLIN GENITOURIN CANC, V7, P24, DOI 10.3816/CGC.2009.n.004; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Powles T, 2016, EUR UROL, V69, P450, DOI 10.1016/j.eururo.2015.08.035; Ravaud A, 2014, EUR J CANCER, V50, P486, DOI 10.1016/j.ejca.2013.11.022; Richards DA, 2011, INVEST NEW DRUG, V29, P144, DOI 10.1007/s10637-009-9307-8; Rini BI, 2014, J CLIN ONCOL, V32, P752, DOI 10.1200/JCO.2013.50.5305; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Socinski MA, 2010, J THORAC ONCOL, V5, P1963, DOI 10.1097/JTO.0b013e3181fd42eb; Soulieres D, 2017, LANCET ONCOL, V18, P323, DOI 10.1016/S1470-2045(17)30064-5; Tamaskar Ila, 2011, Clin Adv Hematol Oncol, V9, P101; Tannir NM, 2016, EUR UROL, V69, P866, DOI 10.1016/j.eururo.2015.10.049; Vuylsteke P, 2016, ANN ONCOL, V27, P2059, DOI 10.1093/annonc/mdw320; Wick W, 2016, CLIN CANCER RES, V22, P4797, DOI 10.1158/1078-0432.CCR-15-3153; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; Yamanaka K, 2013, CANCER MED-US, V2, P862, DOI 10.1002/cam4.150; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0251-x; Yardley DA, 2015, BREAST CANCER RES TR, V154, P89, DOI 10.1007/s10549-015-3599-5; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	74	37	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192464	10.1371/journal.pone.0192464	http://dx.doi.org/10.1371/journal.pone.0192464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408858	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800069
J	Raja, SG; Ilsley, C; De Robertis, F; Lane, R; Kabir, T; Bahrami, T; Simon, A; Popov, A; Dalby, MC; Mason, M; Grocott-Mason, R; Smith, RD; Iqbal, MB				Raja, Shahzad G.; Ilsley, Charles; De Robertis, Fabio; Lane, Rebecca; Kabir, Tito; Bahrami, Toufan; Simon, Andre; Popov, Aron; Dalby, Miles C.; Mason, Mark; Grocott-Mason, Richard; Smith, Robert D.; Iqbal, M. Bilal			Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel disease	PLOS ONE			English	Article							INTERNAL THORACIC ARTERY; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; BYPASS GRAFT-SURGERY; RADIAL ARTERY; SURVIVAL BENEFIT; OUTCOMES; INTERVENTION; TRIALS; METAANALYSIS	Background Studies comparing coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) have largely been performed in the bare-metal stent (BMS) and first-generation drug eluting stent (F-DES) era. Second-generation DES (S-DES) have shown improved outcomes when compared to F-DES, but data comparing CABG with PCI using S-DES is limited. We compared mortality following CABG versus PCI for patients with multivessel disease and analyzed different stent types. Methods A total of 6,682 patients underwent multivessel revascularization at Harefield Hospital, UK. We stratified CABG patients into single arterial graft (SAG) or multiple arterial grafts (MAG); and PCI patients into BMS, F-DES or S-DES groups. We analyzed all-cause mortality at 5 years. Results 4,388 patients had CABG (n[SAG] = 3,358; n[MAG] = 1,030) and 2,294 patients had PCI (n[BMS] = 416; n[F-DES] = 752; n[S-DES] = 1,126). PCI had higher 5-year mortality with BMS (HR = 2.27, 95% CI: 1.70 +/- 3.05, p<0.001); F-DES (HR = 1.52, 95% CI: 1.14-2.01, p = 0.003); and S-DES (HR = 1.84, 95% CI: 1.42-2.38, p<0.001). This was confirmed in inverse probability treatment weighted analyses. When adjusting for both measured and unmeasured factors using instrumental variable analyses, PCI had higher 5-year mortality with BMS (Delta = 15.5, 95% CI: 3.6,27.5, p = 0.011) and FDES (Delta = 16.5, 95% CI: 6.6,26.4, p<0.001), but had comparable mortality with CABG for PCI with SDES (Delta = 0.9, 95% CI: -9.6,7.9, p = 0.844), and when exclusively compared to CABG patients with SAG (Delta = 0.4, 95% CI: -8.0,8.7, p = 0.931) or MAG (Delta = 4.6, 95% CI: -0.4,9.6, p = 0.931). Conclusions In this real-world analysis, when adjusting for measured and unmeasured confounding, PCI with SDES had comparable 5-year mortality when compared to CABG. This warrants evaluation in adequately-powered randomized controlled trials.	[Raja, Shahzad G.; De Robertis, Fabio; Bahrami, Toufan; Simon, Andre; Popov, Aron] Harefield Hosp, Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiac Surg, Harefield, Middx, England; [Ilsley, Charles; Lane, Rebecca; Kabir, Tito; Dalby, Miles C.; Mason, Mark; Grocott-Mason, Richard; Smith, Robert D.; Iqbal, M. Bilal] Harefield Hosp, Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiol, Harefield, Middx, England; [Iqbal, M. Bilal] Royal Jubilee Hosp, Vancouver Isl Hlth Author, Dept Cardiol, Bay St, Victoria, BC, Canada	Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Vancouver Island Health Authority	Iqbal, MB (corresponding author), Harefield Hosp, Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiol, Harefield, Middx, England.; Iqbal, MB (corresponding author), Royal Jubilee Hosp, Vancouver Isl Hlth Author, Dept Cardiol, Bay St, Victoria, BC, Canada.	bilal.iqbal@viha.ca	Raja, Shahzad/ABG-8781-2021; Raja, Shahzad G./AAH-3818-2020; Popov, Aron-Frederik/AAA-9933-2020	Popov, Aron-Frederik/0000-0003-4226-3004; Dalby, Miles/0000-0003-0823-5093				Bangalore S, 2015, NEW ENGL J MED, V372, P1213, DOI 10.1056/NEJMoa1412168; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Buxton BF, 2014, J THORAC CARDIOV SUR, V148, P1238, DOI 10.1016/j.jtcvs.2014.06.056; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dirksen Maurits T, 2008, EuroIntervention, V4, P64, DOI 10.4244/EIJV4I1A12; Habib RH, 2015, J AM COLL CARDIOL, V66, P1417, DOI 10.1016/j.jacc.2015.07.060; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 1999, J AM COLL CARDIOL, V33, P63, DOI 10.1016/S0735-1097(98)00540-3; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Kaltoft A, 2010, J AM COLL CARDIOL, V56, P641, DOI 10.1016/j.jacc.2010.05.009; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Kurlansky PA, 2010, ANN THORAC SURG, V90, P101, DOI 10.1016/j.athoracsur.2010.04.006; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Piscione F, 2010, EUROINTERVENTION, V5, P853, DOI 10.4244/EIJV5I7A143; Puskas JD, 2012, ANN THORAC SURG, V93, P26, DOI 10.1016/j.athoracsur.2011.07.086; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Schwann TA, 2012, ANN THORAC SURG, V94, P1485, DOI 10.1016/j.athoracsur.2012.05.029; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Venkitachalam L, 2011, CIRC-CARDIOVASC QUAL, V4, P587, DOI 10.1161/CIRCOUTCOMES.111.960971; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yeh RW, 2014, CIRC-CARDIOVASC QUAL, V7, P118, DOI 10.1161/CIRCOUTCOMES.113.000476; Zacharias A, 2004, CIRCULATION, V109, P1489, DOI 10.1161/01.CIR.0000121743.10146.78	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191554	10.1371/journal.pone.0191554	http://dx.doi.org/10.1371/journal.pone.0191554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408926	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800021
J	Hsiao, PJ; Lin, HC; Chang, ST; Hsu, JT; Lin, WS; Chung, CM; Chang, JJ; Hung, KC; Shih, YW; Chen, FC; Hu, FK; Wu, YS; Chang, CW; Su, SL; Chu, CM				Hsiao, Po-Jen; Lin, Hung-Che; Chang, Shih-Tai; Hsu, Jen-Te; Lin, Wei-Shiang; Chung, Chang-Min; Chang, Jung-Jung; Hung, Kuo-Chun; Shih, Yun-Wen; Chen, Fu-Chi; Hu, Fu-Kang; Wu, Yi-Syuan; Chang, Chi-Wen; Su, Sui-Lung; Chu, Chi-Ming			Albuminuria and neck circumference are determinate factors of successful accurate estimation of glomerular filtration rate in high cardiovascular risk patients	PLOS ONE			English	Article							SERUM CYSTATIN-C; METABOLIC SYNDROME; DIABETES-MELLITUS; KIDNEY-FUNCTION; GFR ESTIMATION; CREATININE; FORMULAS; COHORT; IMPACT	Background Estimated glomerular filtration rate (eGFR) is used for diagnosis of chronic kidney disease (CKD). The eGFR models based on serum creatinine or cystatin C are used more in clinical practice. Albuminuria and neck circumference are associated with CKD and may have correlations with eGFR. Aim We explored the correlations and modelling formulates among various indicators such as serum creatinine, cystatin C, albuminuria, and neck circumference for eGFR. Design Cross-sectional study. Methods We reviewed the records of patients with high cardiovascular risk from 2010 to 2011 in Taiwan. 24-hour urine creatinine clearance was used as the standard. We utilized a decision tree to select for variables and adopted a stepwise regression method to generate five models. Model 1 was based on only serum creatinine and was adjusted for age and gender. Model 2 added serum cystatin C, models 3 and 4 added albuminuria and neck circumference, respectively. Model 5 simultaneously added both albuminuria and neck circumference. Results Total 177 patients were recruited in this study. In model 1, the bias was 2.01 and its precision was 14.04. In model 2, the bias was reduced to 1.86 with a precision of 13.48. The bias of model 3 was 1.49 with a precision of 12.89, and the bias for model 4 was 1.74 with a precision of 12.97. In model 5, the bias could be lower to 1.40 with a precision of 12.53. Conclusions In this study, the predicting ability of eGFR was improved after the addition of serum cystatin C compared to serum creatinine alone. The bias was more significantly reduced by the calculation of albuminuria. Furthermore, the model generated by combined albuminuria and neck circumference could provide the best eGFR predictions among these five eGFR models. Neck circumference can be investigated potentially in the further studies.	[Hsiao, Po-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Hsiao, Po-Jen] Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, Taoyuan, Taiwan; [Hsiao, Po-Jen; Chu, Chi-Ming] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan; [Lin, Hung-Che] Triserv Gen Hosp, Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chang, Shih-Tai; Hsu, Jen-Te; Chung, Chang-Min; Chang, Jung-Jung; Hung, Kuo-Chun] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Div Cardiol, Coll Med, Taoyuan, Taiwan; [Lin, Wei-Shiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Shih, Yun-Wen; Hu, Fu-Kang; Wu, Yi-Syuan; Su, Sui-Lung; Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Fu-Chi] Natl Def Med Ctr, Dept Biomed Engn, Taipei, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Coll Med, Sch Nursing, Taoyuan, Taiwan; [Chang, Chi-Wen] Linkou Chang Gung Mem Hosp, Dept Pediat, Div Endocrinol, Taoyuan, Taiwan; [Su, Sui-Lung; Chu, Chi-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Chi-Ming] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Chang Gung University; Chang Gung Memorial Hospital; National Defense Medical Center; China Medical University Taiwan	Chu, CM (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.; Chu, CM (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chu, CM (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chu, CM (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	chuchiming@web.de	Lin, Wei-Shiang/ABA-7928-2020	Wu, Yi-Syuan/0000-0001-9609-6489				Artunc FH, 2005, INT J CARDIOL, V102, P173, DOI 10.1016/j.ijcard.2004.04.009; Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937; Bevc S, 2012, KIDNEY BLOOD PRESS R, V35, P649, DOI 10.1159/000341918; Canales MT, 2016, AM J NEPHROL, V43, P325, DOI 10.1159/000445757; Chehade H, 2014, CLIN J AM SOC NEPHRO, V9, P54, DOI 10.2215/CJN.00940113; Cho Nam H, 2015, Sci Rep, V5, P18565, DOI 10.1038/srep18565; Delanaye P, 2008, CLIN CHIM ACTA, V398, P118, DOI 10.1016/j.cca.2008.09.001; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Ebert N, 2016, CLIN CHIM ACTA, V456, P115, DOI 10.1016/j.cca.2016.03.002; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferraro S, 2016, CLIN CHEM LAB MED, V54, P1629, DOI 10.1515/cclm-2015-1272; Go AS, 2007, NEW ENGL J MED, V351, P1296; Hoebel S, 2012, ENDOCRINE, V42, P335, DOI 10.1007/s12020-012-9642-y; Hofstra JM, 2009, KIDNEY INT, V76, P462, DOI 10.1038/ki.2009.167; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang J, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0107-x; Lin MY, 2010, NEPHROL DIAL TRANSPL, V25, P3230, DOI 10.1093/ndt/gfq158; Liu YF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745410; Ma YC, 2007, KIDNEY INT, V72, P1535, DOI 10.1038/sj.ki.5002566; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Peralta CA, 2015, AM J NEPHROL, V42, P141, DOI 10.1159/000439231; Pontillo C, 2016, NEPHROL DIAL TRANSPL; Rule AD, 2009, AM J KIDNEY DIS, V53, P932, DOI 10.1053/j.ajkd.2009.02.011; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tidman M, 2008, NEPHROL DIAL TRANSPL, V23, P154, DOI 10.1093/ndt/gfm661; White C, 2005, J AM SOC NEPHROL, V16, P3763, DOI 10.1681/ASN.2005050512	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0185693	10.1371/journal.pone.0185693	http://dx.doi.org/10.1371/journal.pone.0185693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394255	gold, Green Submitted, Green Published			2022-12-27	WOS:000424060400003
J	Liu, JC; Yu, Y; Zhu, SY; Yang, JK; Song, J; Fan, W; Yu, HB; Bian, DJ; Huo, MX				Liu, Jiancong; Yu, Yang; Zhu, Suiyi; Yang, Jiakuan; Song, Jian; Fan, Wei; Yu, Hongbin; Bian, Dejun; Huo, Mingxin			Synthesis and characterization of a magnetic adsorbent from negatively-valued iron mud for methylene blue adsorption	PLOS ONE			English	Article							ASCORBIC-ACID; RED MUD; FE3O4 NANOPARTICLES; PHASE-TRANSFORMATION; OXIDE NANOPARTICLES; TREATMENT SLUDGE; FERRIC-OXIDE; ONE-POT; REDUCTION; WASTE	With increasing awareness of reduction of energy and CO2 footprint, more waste is considered recyclable for generating value-added products. Here we reported the negatively-valued iron mud, a waste from groundwater treatment plant, was successfully converted into magnetic adsorbent. Comparing with the conventional calcination method under the high temperature and pressure, the synthesis of the magnetic particles (MPs) by Fe2+/Fe3+ coprecipitation was conducted at environment-friendly condition using ascorbic acid (H(2)A) as reduction reagent and nitric acid (or acid wastewater) as leaching solution. The MPs with major component of Fe3O4 were synthesized at the molar ratio (called ratio subsequently) of H(2)A to Fe3+ of iron mud >= 0.1; while amorphous ferrihydrite phase was formed at the ratio <= 0.05, which were confirmed by vibrating sample magnetometer (VSM), X-ray diffraction (XRD) and X-ray photoelectron spectroscopy (XPS). With the ratio increased, the crystalline size and the crystallization degree of MPs increased, and thus the Brunauer-Emmett-Teller (BET) surface and the cation-exchange capacity (CEC) decreased. MPs-3 prepared with H(2)A to Fe3+ ratio of 0.1 demonstrated the highest methylene blue (MB) adsorption of 87.3 mg/g and good magnetic response. The adsorption of MB onto MPs agreed well with the non-linear Langmuir isotherm model and the pseudo-second-order model. Pilot-scale experiment showed that 99% of MB was removed by adding 10 g/L of MPs-3. After five adsorption-desorption cycles, MPs-3 still showed 62% removal efficiency for MB adsorption. When nitric acid was replaced by acid wastewater from a propylene plant, the synthesized MPs-3w showed 3.7 emu/g of saturation magnetization (Ms) and 56.7 mg/g of MB adsorption capacity, 2.8 times of the widely used commercial adsorbent of granular active carbon (GAC). The major mechanism of MPs adsorption for MB was electrostatic attraction and cation exchange. This study synthesized a magnetic adsorbent from the negatively-valued iron mud waste by using an environment-friendly coprecipitation method, which had a potential for treatment of dye wastewater.	[Liu, Jiancong; Yu, Yang; Zhu, Suiyi; Fan, Wei; Yu, Hongbin; Bian, Dejun; Huo, Mingxin] Northeast Normal Univ, Sci & Technol Innovat Ctr Municipal Wastewater Tr, Changchun, Jilin, Peoples R China; [Yu, Yang] Jilin Jianzu Univ, Minist Educ, Key Lab Songliao Aquat Environm, Changchun, Jilin, Peoples R China; [Zhu, Suiyi; Yu, Hongbin; Huo, Mingxin] Northeast Normal Univ, Engn Lab Water Pollut Control & Resources Recover, Changchun, Jilin, Peoples R China; [Yang, Jiakuan; Song, Jian] Huazhong Univ Sci & Technol, Sch Environm Sci & Engn, Wuhan, Hubei, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Huazhong University of Science & Technology	Huo, MX (corresponding author), Northeast Normal Univ, Sci & Technol Innovat Ctr Municipal Wastewater Tr, Changchun, Jilin, Peoples R China.; Huo, MX (corresponding author), Northeast Normal Univ, Engn Lab Water Pollut Control & Resources Recover, Changchun, Jilin, Peoples R China.	papermanuscript@126.com; huomx097@nenu.edu.cn	yu, yang/W-5426-2019; Zhu, Suiyi/AAD-7613-2021	yu, yang/0000-0001-8342-9299; Yang, Jiakuan/0000-0002-1553-5679; Fan, Wei/0000-0001-7232-7668; Suiyi, Zhu/0000-0002-9784-2698	National Natural Science Foundation of China [51578118, 51238001, 51408110, 51378098]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2014ZX07201-011-004-2]; Jilin Provincial Natural Science Foundation [20150101072JC]; Long-term Program in "1000 Talent Plan for High-Level Foreign Experts" [WQ20142200209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China; Jilin Provincial Natural Science Foundation; Long-term Program in "1000 Talent Plan for High-Level Foreign Experts"	This work was supported by the National Natural Science Foundation of China (Granted No.51578118, 51238001, 51408110 and 51378098), the Major Science and Technology Program for Water Pollution Control and Treatment of China (Granted No. 2014ZX07201-011-004-2), the Jilin Provincial Natural Science Foundation (Granted No. 20150101072JC) and the Long-term Program in 1000 Talent Plan for High-Level Foreign Experts (Granted No. WQ20142200209).	Akin I, 2012, J HAZARD MATER, V235, P62, DOI [10.1016/j.jhazmat2012.06.024, 10.1016/j.jhazmat.2012.06.024]; Alibeigi S, 2008, CHEM ENG TECHNOL, V31, P1591, DOI 10.1002/ceat.200800093; Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078; Bai LJ, 1997, ACTA BIOCH BIOPH SIN, V29, P527; BLANCHARD JM, 1981, RESOUR CONSERV, V6, P21, DOI 10.1016/0166-3097(81)90004-3; BODE AM, 1990, CLIN CHEM, V36, P1807; Chang Z, 2001, CHIN J INORG CHEM, V17, P366; Chen FX, 2013, MATER LETT, V112, P177, DOI 10.1016/j.matlet.2013.09.022; Costa RCC, 2010, CHEMOSPHERE, V78, P1116, DOI 10.1016/j.chemosphere.2009.12.032; Elovich SY, 1962, B ACAD SCI USSR DIV, V11, P198, DOI [10.1007/BF00908017, DOI 10.1007/BF00908017]; Fredrickson JK, 2001, ENVIRON SCI TECHNOL, V35, P703, DOI 10.1021/es001500v; GHOSH SK, 1989, INORG CHEM, V28, P1538, DOI 10.1021/ic00307a023; Gong XM, 2014, CHINESE SCI BULL, V59, P3904, DOI 10.1007/s11434-014-0520-2; Gupta H, 2014, J COLLOID INTERF SCI, V430, P221, DOI 10.1016/j.jcis.2014.05.043; HILLS CD, 1992, CEMENT CONCRETE RES, V22, P822, DOI 10.1016/0008-8846(92)90106-6; Hou XJ, 2016, J HAZARD MATER, V310, P170, DOI 10.1016/j.jhazmat.2016.01.020; Iida H, 2007, J COLLOID INTERF SCI, V314, P274, DOI 10.1016/j.jcis.2007.05.047; Jia YF, 2006, ENVIRON SCI TECHNOL, V40, P3248, DOI 10.1021/es051872+; Khorasani-Motlagh M, 2010, J IRAN CHEM SOC, V7, pS113, DOI 10.1007/BF03246190; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Li F. W., 2009, J WATER RESOURCE PRO, V1, P35; Li XB, 2015, T NONFERR METAL SOC, V25, P3467, DOI 10.1016/S1003-6326(15)63984-X; Liu YY, 2014, THERMOCHIM ACTA, V588, P11, DOI 10.1016/j.tca.2014.04.027; Man Y, 2016, POWDER TECHNOL, V301, P674, DOI 10.1016/j.powtec.2016.06.013; Mayes WM, 2016, J SUSTAIN METALL, V2, P332, DOI 10.1007/s40831-016-0050-z; Nene AG, 2016, J NANO RES-SW, V40, P8, DOI 10.4028/www.scientific.net/JNanoR.40.8; Ngatenah SNI, 2010, INT C ENV ICENV PEN; Ovchinnikov OV, 2016, VIB SPECTROSC, V86, P181, DOI 10.1016/j.vibspec.2016.06.016; Tran PHL, 2012, ARCH PHARM RES, V35, P2045, DOI 10.1007/s12272-012-1203-7; Ramasamy V, 2008, SPECTROCHIM ACTA A, V70, P25, DOI 10.1016/j.saa.2007.07.008; Sajih M, 2014, GEOCHIM COSMOCHIM AC, V146, P150, DOI 10.1016/j.gca.2014.10.008; Sales A, 2009, CONSTR BUILD MATER, V23, P2362, DOI 10.1016/j.conbuildmat.2008.11.001; Shao Z., 1984, Acta Pedologica Sinica, V21, P153; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; Snehalatha T, 1997, J CHEM EDUC, V74, P228, DOI 10.1021/ed074p228; Sushil S, 2010, J HAZARD MATER, V180, P409, DOI 10.1016/j.jhazmat.2010.04.046; TAKAMURA K, 1977, CHEM PHARM BULL, V25, P3218; Wu S, 2011, MATER LETT, V65, P1882, DOI 10.1016/j.matlet.2011.03.065; Wu SP, 2007, MATER LETT, V61, P1125, DOI 10.1016/j.matlet.2006.06.068; Yan H, 2011, COLLOID SURFACE A, V380, P143, DOI 10.1016/j.colsurfa.2011.02.045; Yang K, 2010, APPL SURF SCI, V256, P3093, DOI 10.1016/j.apsusc.2009.11.079; Yang WB, 1996, CHINESE J ANAL CHEM, V24, P828; Yu Y, 2017, FUEL, V203, P187, DOI 10.1016/j.fuel.2017.04.118; Yukselen-Aksoy Y, 2008, ENG GEOL, V102, P38, DOI 10.1016/j.enggeo.2008.07.002; Zhang C, 2016, CHEM ENG J, V284, P247, DOI 10.1016/j.cej.2015.08.096; Zhu SY, 2015, J HAZARD MATER, V292, P173, DOI 10.1016/j.jhazmat.2015.03.028; Zong Y, 2017, J MAGN MAGN MATER, V423, P321, DOI 10.1016/j.jmmm.2016.09.132; Zuhaimi NAS, 2015, APPL CATAL A-GEN, V502, P312, DOI 10.1016/j.apcata.2015.06.024	48	22	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191229	10.1371/journal.pone.0191229	http://dx.doi.org/10.1371/journal.pone.0191229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394262	gold, Green Submitted, Green Published			2022-12-27	WOS:000424060400010
J	Zou, XM; Yang, J; Zhang, JP				Zou, Xiaomei; Yang, Jing; Zhang, Jianpei			Microblog sentiment analysis using social and topic context	PLOS ONE			English	Article								Analyzing massive user-generated microblogs is very crucial in many fields, attracting many researchers to study. However, it is very challenging to process such noisy and short microblogs. Most prior works only use texts to identify sentiment polarity and assume that microblogs are independent and identically distributed, which ignore microblogs are networked data. Therefore, their performance is not usually satisfactory. Inspired by two sociological theories (sentimental consistency and emotional contagion), in this paper, we propose a new method combining social context and topic context to analyze microblog sentiment. In particular, different from previous work using direct user relations, we introduce structure similarity context into social contexts and propose a method to measure structure similarity. In addition, we also introduce topic context to model the semantic relations between microblogs. Social context and topic context are combined by the Laplacian matrix of the graph built by these contexts and Laplacian regularization are added into the microblog sentiment analysis model. Experimental results on two real Twitter datasets demonstrate that our proposed model can outperform baseline methods consistently and significantly.	[Zou, Xiaomei; Yang, Jing; Zhang, Jianpei] Harbin Engn Univ, Sch Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Yang, J (corresponding author), Harbin Engn Univ, Sch Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	yangjing@hrbeu.edu.cn			National Natural Science Foundation of China [61672179, 61370083, 61402126]; Research Fund for the Doctoral Program of Higher Education of China [20122304110012]; Youth Science Foundation of Heilongjiang Province of China [QC2016083]; Heilongjiang postdoctoral Fund [LBH-Z14071]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Youth Science Foundation of Heilongjiang Province of China; Heilongjiang postdoctoral Fund; China Scholarship Council(China Scholarship Council)	This paper is supported by (1) the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant nos. 61672179, 61370083 and 61402126, (2) Research Fund for the Doctoral Program of Higher Education of China (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) under Grant nos. 20122304110012, (3) the Youth Science Foundation of Heilongjiang Province of China (http://www.hljkjt.gov.cn) under Grant no. QC2016083, and (4) Heilongjiang postdoctoral Fund (http://www.hljbsh.org/gywm.asp) no. LBH-Z14071. This paper is also supported by China Scholarship Council (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is supported by (1) the National Natural Science Foundation of China under Grant nos. 61672179, 61370083 and 61402126, (2) Research Fund for the Doctoral Program of Higher Education of China under Grant nos. 20122304110012, (3) the Youth Science Foundation of Heilongjiang Province of China under Grant no. QC2016083, (4) Heilongjiang postdoctoral Fund no. LBH-Z14071. This paper is also supported by China Scholarship Council.	Abelson RP, 1983, WHATEVER BECAME CONS; [Anonymous], 2012, AAAI WORKSH; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Baccianella S., 2010, P 7 INT C LANG RES O, V10, P2200, DOI DOI citeulike-article-id:9238846; Bandhakavi A, 2017, PATTERN RECOGN LETT, V93, P133, DOI 10.1016/j.patrec.2016.12.009; Cambria E., 2016, COLING; Cambria E, 2016, KNOWL-BASED SYST, V108, P1, DOI 10.1016/j.knosys.2016.07.025; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Carullo G, 2015, WORLD WIDE WEB, V18, P1579, DOI 10.1007/s11280-015-0333-5; Chen T, 2017, EXPERT SYST APPL, V72, P221, DOI 10.1016/j.eswa.2016.10.065; Chung F., 1997, SPECTRAL GRAPH THEOR; Cui AQ, 2011, LECT NOTES COMPUT SC, V7097, P238, DOI 10.1007/978-3-642-25631-8_22; Deng SY, 2017, DECIS SUPPORT SYST, V94, P65, DOI 10.1016/j.dss.2016.11.001; Friedman J., 2001, SPRINGER SERIES STAT, V1; Fu XH, 2017, NEUROCOMPUTING, V241, P18, DOI 10.1016/j.neucom.2017.01.079; Go A, 2009, CS224N PROJECT REPOR, V1, P12; Hassan Khan Farhan, 2017, ARTIF INTELL, V48, P1; Hatfield E., 1994, REV PERSONALITY SOCI; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Hu X, 2013, P 6 ACM INT C WEB SE, P537, DOI DOI 10.1145/2433396.2433465; Irene Crimaldi, 2015, HOMOPHILY TRIADIC CL; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Kernighan B. W., 1970, Bell System Technical Journal, V49, P291; Khan FH, 2017, KNOWL INF SYST, V51, P851, DOI 10.1007/s10115-016-0993-1; Kiritchenko S, 2014, J ARTIF INTELL RES, V50, P723, DOI 10.1613/jair.4272; Kotov A, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P1905, DOI 10.1145/2505515.2507892; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Liang Y, 2011, SWSM 2011; Liu J., 2009, P 25 C UNCERTAINTY A, P339, DOI DOI 10.5555/1795114.1795154; Liu K. L., 2012, AAAI; Lu TJ, 2015, INT CONF BIG DATA, P194, DOI 10.1109/35021BIGCOMP.2015.7072831; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mei Q., 2007, WWW, P171, DOI DOI 10.1145/1242572.1242596; Mike Thelwall, 2010, 1 MONDAY, V15; Nesterov Y, 2003, INTRO LECT CONVEX OP, V1st; Neviarouskaya A., P 2009 3 INT C AFF C, P1, DOI DOI 10.1109/ACII.2009.5349575; Ortigosa-Hernandez J, 2012, NEUROCOMPUTING, V92, P98, DOI 10.1016/j.neucom.2012.01.030; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pandarachalil R, 2015, COGN COMPUT, V7, P254, DOI 10.1007/s12559-014-9310-z; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Poria S, 2016, IEEE DATA MINING, P439, DOI [10.1109/ICDM.2016.178, 10.1109/ICDM.2016.0055]; Qiu GA, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1199; Read J., 2005, P ACL STUD RES WORKS, P43, DOI DOI 10.3115/1628960.1628969; Ren FJ, 2013, IEEE T AFFECT COMPUT, V4, P412, DOI 10.1109/T-AFFC.2013.22; Ren YF, 2016, AAAI CONF ARTIF INTE, P215; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P959, DOI 10.1145/2766462.2767830; Shamma D.A., 2009, P WSM 09, P3; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Speriosu M, 2011, P 1 WORKSHOP UNSUPER, P53, DOI DOI 10.1017/CB09781107415324.004; Sun Y., 2012, SYNTHESIS LECT DATA, V3, P1, DOI DOI 10.2200/S00433ED1V01Y201207DMK005; Tan C., 2011, P 17 ACM SIGKDD INT, P1397, DOI DOI 10.1145/2020408.2020614; Tang JL, 2016, AAAI CONF ARTIF INTE, P251; Tang Jiliang, 2013, IJCAI, P2712; Tang L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P817; Vosecky J, 2014, INT ACM SIG C RES DE, P53; Wang Y., 2016, P 2016 C EMPIRICAL M, P606, DOI [10.18653/v1/D16-1058, DOI 10.18653/V1/D16-1058]; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Wu FZ, 2016, NEUROCOMPUTING, V175, P599, DOI 10.1016/j.neucom.2015.10.101; Xie YB, 2008, PHYSICA A, V387, P1683, DOI 10.1016/j.physa.2007.11.005; Yang Dingqi, 2013, HT ACM, P119, DOI DOI 10.1145/2481492.2481505	63	18	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191163	10.1371/journal.pone.0191163	http://dx.doi.org/10.1371/journal.pone.0191163			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394258	gold, Green Submitted, Green Published			2022-12-27	WOS:000424060400008
J	Matsuguma, S; Kawashima, M; Negishi, K; Sano, F; Mimura, M; Tsubota, K				Matsuguma, Shinichiro; Kawashima, Motoko; Negishi, Kazuno; Sano, Fumiya; Mimura, Masaru; Tsubota, Kazuo			Strengths use as a secret of happiness: Another dimension of visually impaired individuals' psychological state	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; IMPACT; POPULATION; RELIABILITY; ASSOCIATION; PREVALENCE	It is well recognized that visual impairments (VI) worsen individuals' mental condition. However, little is known about the positive aspects including subjective happiness, positive emotions, and strengths. Therefore, the purpose of this study was to investigate the positive aspects of persons with VI including their subjective happiness, positive emotions, and strengths use. Positive aspects of persons with VI were measured using the Subjective Happiness Scale (SHS), the Scale of Positive and Negative Experience-Balance (SPANE-B), and the Strengths Use Scale (SUS). A cross-sectional analysis was utilized to examine personal information in a Tokyo sample (N = 44). We used a simple regression analysis and found significant relationships between the SHS or SPANE-B and SUS; on the contrary, VI-related variables were not correlated with them. A multiple regression analysis confirmed that SUS was a significant factor associated with both the SHS and SPANE-B. Strengths use might be a possible protective factor from the negative effects of VI.	[Matsuguma, Shinichiro; Kawashima, Motoko; Negishi, Kazuno; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Sano, Fumiya] Keio Univ Hosp, Clin & Translat Res Ctr, Shinjuku Ku, Tokyo, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Keio University	Kawashima, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	motoko-k@a3.keio.jp	Negishi, Kazuno/AAG-3260-2021; Tsubota, Kazuo/M-1915-2013	Negishi, Kazuno/0000-0002-2892-9810; Tsubota, Kazuo/0000-0002-8874-7111; Kawashima, Motoko/0000-0001-7650-7180				[Anonymous], JPN J RES EMOT; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Biswas-Diener R, 2011, J POSIT PSYCHOL, V6, P106, DOI 10.1080/17439760.2010.545429; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; Cho GE, 2015, INVEST OPHTH VIS SCI, V56, P4375, DOI 10.1167/iovs.15-16462; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Douglass RP, 2015, J HAPPINESS STUD, V16, P619, DOI 10.1007/s10902-014-9525-4; Dunn D.S., 2013, OXFORD HDB POSITIVE, P427, DOI [DOI 10.1093/OXFORDHB/9780195398786.013.013.0026, 10.1093/oxfordhb/9780195398786.013.013.0026]; Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0; Ghielen STS, 2018, J POSIT PSYCHOL, V13, P573, DOI 10.1080/17439760.2017.1365164; Govindji R., 2007, INT COACHING PSYCHOL, V2, p143?153, DOI DOI 10.1037/T01038-000; Hodges T.D., 2004, POSITIVE PSYCHOL PRA, V1, P256, DOI [10.1002/9780470939338.ch16, DOI 10.1002/9780470939338.CH16]; Huppert FA, 2003, BRIT J HEALTH PSYCH, V8, P107, DOI 10.1348/135910703762879246; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kawashima M, 2016, JPN J OPHTHALMOL, V60, P219, DOI 10.1007/s10384-016-0437-1; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975; Layous K., 2014, POSITIVE EMOTION INT, P472, DOI [10.1093/acprof:oso/9780199926725.003.0025, DOI 10.1093/ACPROF:OSO/9780199926725.003.0025]; Li FZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054801, 10.1371/journal.pone.0056303, 10.1371/journal.pone.0061137]; Linley PA, 2006, PSYCHOLOGIST, V19, P86; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Mangione CM, 1999, AM J OPHTHALMOL, V128, P45, DOI 10.1016/S0002-9394(99)00169-5; Ribeiro MVMR, 2015, ARQ BRAS OFTALMOL, V78, P197, DOI 10.5935/0004-2749.20150051; Nakae K MK, 2006, GERIATR MED, V44, P1221; Papadopoulos K, 2015, REHABIL COUNS BULL, V58, P240, DOI 10.1177/0034355214535471; Papadopoulos K, 2013, RES DEV DISABIL, V34, P4565, DOI 10.1016/j.ridd.2013.09.036; Peters ML, 2017, CLIN J PAIN, V33, P962, DOI 10.1097/AJP.0000000000000494; Peterson P., 2004, CHARACTER STRENGTHS; Scott IU, 1999, AM J OPHTHALMOL, V128, P54, DOI 10.1016/S0002-9394(99)00108-7; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Sumi K, 2014, SOC INDIC RES, V118, P601, DOI 10.1007/s11205-013-0432-6; Swanson MW, 2004, OPHTHAL EPIDEMIOL, V11, P227, DOI 10.1080/09286580490514540; Wang JJ, 1999, INVEST OPHTH VIS SCI, V40, P12; Wood AM, 2011, PERS INDIV DIFFER, V50, P15, DOI 10.1016/j.paid.2010.08.004; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192323	10.1371/journal.pone.0192323	http://dx.doi.org/10.1371/journal.pone.0192323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389991	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400087
J	Rios, NL; Pouliot, P; Papoutsis, K; Foias, A; Stikov, N; Lesage, F; Dehaes, M; Cohen-Adad, J				Rios, Nibardo Lopez; Pouliot, Philippe; Papoutsis, Konstantinos; Foias, Alexandru; Stikov, Nikola; Lesage, Frederic; Dehaes, Mathieu; Cohen-Adad, Julien			Design and construction of an optimized transmit/receive hybrid birdcage resonator to improve full body images of medium-sized animals in 7T scanner	PLOS ONE			English	Article							RABBIT MODEL; MRI; COILS	The purpose of this work was to develop an optimized transmit/receive birdcage coil to extend the possibilities of a 7T preclinical MRI system to conduct improved full body imaging in medium-sized animals, such as large New Zealand rabbits. The coil was designed by combining calculation and electromagnetic simulation tools. The construction was based on precise mechanical design and careful building practice. A 16-leg, 20 cm long, 16 cm inner diameter, shielded quadrature hybrid structure was selected. Coil parameters were assessed on the bench and images were acquired on phantoms and rabbits. The results were compared to simulations and data obtained with an available commercial coil. An inexpensive assembly with an increase of 2 cm in useful inner diameter and 50 Omega matching with larger animals was achieved. A reduction in radiofrequency (RF) power demand of 31.8%, an improvement in image uniformity of 18.5 percentage points and an increase in signal-to-noise ratio of up to 42.2% were revealed by phantom image acquisitions, which was confirmed by in vivo studies. In conclusion, the proposed coil extended the possibilities of a preclinical 7T system as it improved image studies in relatively large animals by reducing the RF power demand, and increasing image uniformity and signal-to-noise ratio. Shorter scans and time under anesthesia or reduced RF exposure, resulting in better images and lower animal health risk during in vivo experiments, were achieved.	[Rios, Nibardo Lopez; Pouliot, Philippe; Papoutsis, Konstantinos; Foias, Alexandru; Stikov, Nikola; Lesage, Frederic; Cohen-Adad, Julien] Ecole Polytech, Dept Elect Engn, Montreal, PQ, Canada; [Rios, Nibardo Lopez; Dehaes, Mathieu] St Justine Hosp Univ Ctr, Montreal, PQ, Canada; [Rios, Nibardo Lopez] Univ Oriente, Med Biophys Ctr, Santiago De Cuba, Cuba; [Pouliot, Philippe; Stikov, Nikola; Lesage, Frederic] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Papoutsis, Konstantinos] Univ Oxford, Nuffield Dept Clin Neurosci, FMRIB Ctr, Oxford, England; [Dehaes, Mathieu] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Dehaes, Mathieu] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Cohen-Adad, Julien] Univ Montreal, CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universidad de Oriente Santiago de Cuba; Universite de Montreal; University of Oxford; Universite de Montreal; Universite de Montreal; Universite de Montreal	Rios, NL (corresponding author), Ecole Polytech, Dept Elect Engn, Montreal, PQ, Canada.; Rios, NL (corresponding author), St Justine Hosp Univ Ctr, Montreal, PQ, Canada.; Rios, NL (corresponding author), Univ Oriente, Med Biophys Ctr, Santiago De Cuba, Cuba.	nibardo.lopez-rios@polymtl.ca	Stikov, Nikola Aleksandar/I-5292-2015	Stikov, Nikola Aleksandar/0000-0002-8480-5230	Canada Research Chair in Quantitative Magnetic Resonance Imaging; Canadian Institute of Health Research [CIHR FDN-143263]; Fonds de Recherche du Quebec - Sante [28826, 32600]; Fonds de Recherche du Quebec - Nature et Technologies [2015-PR-182754]; Natural Sciences and Engineering Research Council of Canada [435897-2013, 2015-04672]; Quebec BioImaging Network [5886]	Canada Research Chair in Quantitative Magnetic Resonance Imaging; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Fonds de Recherche du Quebec - Nature et Technologies; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec BioImaging Network	This work was funded by the Canada Research Chair in Quantitative Magnetic Resonance Imaging (JCA), the Canadian Institute of Health Research [CIHR FDN-143263], the Fonds de Recherche du Quebec - Sante [28826 (JCA), 32600 (MD)], the Fonds de Recherche du Quebec - Nature et Technologies [2015-PR-182754], the Natural Sciences and Engineering Research Council of Canada [435897-2013 (JCA), 2015-04672 (MD)] and the Quebec BioImaging Network [5886 (MD and JCA)].	Association NEM, 2008, DET SIGN NOIS RAT SN; Association NEM, 2008, NEMA STAND PUBL; Barberi EA, 2000, MAGNET RESON MED, V43, P284, DOI 10.1002/(SICI)1522-2594(200002)43:2<284::AID-MRM16>3.0.CO;2-C; Bowen CV, 2016, MAGNETIC RESONANCE I, V24, P857; Chen CN, 1989, BIOMEDICAL MAGNETIC; Chen YX, 2016, J MAGN RESON IMAGING, V44, P673, DOI 10.1002/jmri.25213; Chin CL, 2002, CONCEPT MAGNETIC RES, V15, P156, DOI 10.1002/cmr.10030; Doty FD, 1999, J MAGN RESON, V138, P144, DOI 10.1006/jmre.1998.1703; Duan Q, 2014, MED PHYS, V41, DOI 10.1118/1.4895823; FEKO Altair, 2010, MRI BIRDCAGE COIL DE; Frederick PS, 1994, Patent No. [US patent 5,367,261, 5367261]; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; General Electric Co, 1987, US patent, Patent No. [4642569A, 4642569]; Hayes C, 1987, U.S. Patent, Patent No. [# 4,694,255, 4694255, US patent 4,694,255. 1987]; Hayes CE, 2009, NMR BIOMED, V22, P908, DOI 10.1002/nbm.1431; Hu N, 2012, COMPARATIVE MED, V62, P116; Jung B, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-87; Li BK, 2009, NMR BIOMED, V22, P937, DOI 10.1002/nbm.1344; Milani-Nejad N, 2014, PHARMACOL THERAPEUT, V141, P235, DOI 10.1016/j.pharmthera.2013.10.007; Mispelter J, 2009, NMR PROBEHEADS BIOPH, p301 435; Nabetani A., 2006, P 14 ANN M ISMRM SEA, P2608; Peng P, 2013, J MAGN RESON IMAGING, V38, P1585, DOI 10.1002/jmri.24074; Raghuraman S, 2012, P 20 ANN M ISMRM MEL, P2810	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192035	10.1371/journal.pone.0192035	http://dx.doi.org/10.1371/journal.pone.0192035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390005	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000423793400054
J	Autilio, C; Echaide, M; De Luca, D; Perez-Gil, J				Autilio, Chiara; Echaide, Mercedes; De Luca, Daniele; Perez-Gil, Jesus			Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome	PLOS ONE			English	Article							INDUCED LUNG INJURY; PULMONARY SURFACTANT; PRETERM INFANTS; FILM FORMATION; MEMBRANES; CHOLESTEROL; VENTILATION; ADSORPTION; ENCEPHALOPATHY; TEMPERATURE	Background Whole-body hypothermia (WBH) is used to improve neurological outcomes in perinatal asphyxia. Recent studies suggested a beneficial effect of hypothermia for some types of acute respiratory failure. However, no data are available about the biophysical function of human surfactant during WBH. We investigated whether WBH improves surfactant biophysical properties in asphyxiated neonates with or without meconium aspiration syndrome (MAS). Methods Non-bronchoscopic bronchoalveolar lavage (BAL) has been collected from 10 asphyxiated neonates (2 with MAS, 8 with no lung disease (NLD)) at different time-points (pre-WBH, 24h, 48h, 72h of WBH and post-WBH). Surfactant was extracted and tested by captive bubble surfactometry (CBS) in triplicate, at 37 degrees C and 33.5 degrees C,through initial adsorption and dynamic compression-expansion cycling. Phosphatidylcholine and cholesterol were assayed using enzymatic methods. Clinical data were recorded in real-time. Results Minimum surface tension under dynamic testing was significantly improved as assessed at 33.5 degrees C compared with its behavior at 37 degrees C in NLD neonates: the difference was evident after at least 72h of WBH and remained significant at 6h after rewarming (72h: p = 0.009; rewarming: p = 0.040). Similar results were obtained in MAS patients whose surfactant activity improved already at 48h of hypothermia. Total cholesterol showed a trend to increase at the first 24-48h of hypothermia in NLD patients. Conversely, hypothermia seemed to reduce the excess of exogenous cholesterol in MAS surfactant. Conclusions Surfactant biophysical properties may improve after 48-72h of WBH in asphyxiated neonates and the improvement is maintained shortly after rewarming. Due to study limitations, further studies are warranted to better clarify the effects of hypothermia on surfactant activity.	[Autilio, Chiara; Echaide, Mercedes; Perez-Gil, Jesus] Univ Complutense Madrid, Fac Biol, Dept Biochem, Madrid, Spain; [Autilio, Chiara; Echaide, Mercedes; Perez-Gil, Jesus] Univ Complutense Madrid, Hosp Octubre 12, Res Inst, Madrid, Spain; [Autilio, Chiara] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Dept Lab Med, Lab Clin Mol Biol, Rome, Italy; [De Luca, Daniele] South Paris Univ Hosp, AP HP, A Beclere Med Ctr, Div Pediat & Neonatal Crit Care, Paris, France	Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Perez-Gil, J (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Biochem, Madrid, Spain.; Perez-Gil, J (corresponding author), Univ Complutense Madrid, Hosp Octubre 12, Res Inst, Madrid, Spain.	jperezgil@bio.ucm.es	ECHAIDE, MERCEDES/I-1649-2015; Perez-Gil, Jesus/H-3102-2019; Autilio, Chiara/A-6613-2018	ECHAIDE, MERCEDES/0000-0002-0836-0858; Perez-Gil, Jesus/0000-0003-3587-7147; Autilio, Chiara/0000-0003-3446-1692; De Luca, Daniele/0000-0002-3846-4834	Laerdal Foundation Grant; ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation; Spanish Ministry of Economy and Competitiveness [BIO2015-67930-R]; Regional Government of Madrid [P2013/MIT-2807]	Laerdal Foundation Grant; ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government); Regional Government of Madrid	The study has been funded by the Laerdal Foundation Grant 2014 (received by DLD), by a travel grant from ADRN (Association pour le Developpement et la Recherche en Neonatologie) non-profit foundation, and by grants from Spanish Ministry of Economy and Competitiveness (BIO2015-67930-R) and the Regional Government of Madrid (P2013/MIT-2807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinsoy C, 2014, J MATERN-FETAL NEO M, V27, P421, DOI 10.3109/14767058.2013.818115; Aslami H, 2012, TRANSL RES, V159, P110, DOI 10.1016/j.trsl.2011.10.005; Aslami H, 2010, RESUSCITATION, V81, P1723, DOI 10.1016/j.resuscitation.2010.09.006; Autilio C, 2017, THER HYPOTH IN PRESS; Autilio C, 2017, J PEDIATR-US, V182, P66, DOI 10.1016/j.jpeds.2016.11.057; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Ball MK, 2010, RESUSCITATION, V81, P749, DOI 10.1016/j.resuscitation.2009.12.007; de la Serna JB, 2013, FARADAY DISCUSS, V161, P535, DOI 10.1039/c2fd20096a; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Bernhard W, 2016, ANN ANAT, V208, P146, DOI 10.1016/j.aanat.2016.08.003; Bernhard W, 2011, J APPL PHYSIOL, V111, P449, DOI 10.1152/japplphysiol.00766.2010; Boet A, 2014, MINERVA ANESTESIOL, V80, P1345; BOYNTON BR, 1989, J APPL PHYSIOL, V66, P1343, DOI 10.1152/jappl.1989.66.3.1343; Casals O, 2012, BIOCHIM BIOPHYS ACTA, V1818, P2550; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P771, DOI 10.1164/ajrccm.160.3.9811048; Dargaville PA, 2011, J PEDIATR-US, V158, P383, DOI 10.1016/j.jpeds.2010.08.044; de Blic J, 2000, EUR RESPIR J, V15, P217; De Jaegere A, 2006, AM J RESP CRIT CARE, V174, P639, DOI 10.1164/rccm.200603-351OC; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; De Luca D, 2016, AM J RESP CRIT CARE, V194, P381, DOI 10.1164/rccm.201602-0422LE; De Luca D, 2014, EUR RESPIR J, V44, P1708, DOI 10.1183/09031936.00117714; De Luca D, 2013, CRIT CARE, V17, DOI 10.1186/cc12842; De Luca D, 2011, INTENS CARE MED, V37, P1158, DOI 10.1007/s00134-011-2243-z; Dhillon G, 2015, INDIAN J CRIT CARE M, V19, P353, DOI 10.4103/0972-5229.158278; DOYLE R, 1994, AM J RESP CRIT CARE, V149, P1619, DOI 10.1164/ajrccm.149.6.8004321; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Echaide M, 2017, BBA-BIOMEMBRANES, V1859, P1725, DOI 10.1016/j.bbamem.2017.03.015; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Griese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117985; Gunasekara L, 2005, BBA-MOL CELL BIOL L, V1737, P27, DOI 10.1016/j.bbalip.2005.09.002; Hall NJ, 2010, PEDIATRICS, V125, pE300, DOI 10.1542/peds.2008-3211; HAWCO MW, 1981, J APPL PHYSIOL, V51, P509, DOI 10.1152/jappl.1981.51.2.509; Hobi N, 2014, BBA-BIOMEMBRANES, V1838, P1842, DOI 10.1016/j.bbamem.2014.02.015; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Keating E, 2007, BIOPHYS J, V93, P1391, DOI 10.1529/biophysj.106.099762; LEMPERT J, 1971, J APPL PHYSIOL, V31, P380, DOI 10.1152/jappl.1971.31.3.380; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Naito H K, 1984, Lab Res Methods Biol Med, V10, P1; NANJEE MN, 1991, CLIN CHEM, V37, P868; Nespeca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153328; NOTTER RH, 1980, J LIPID RES, V21, P10; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Piastra M, 2014, EARLY HUM DEV, V90, pS41, DOI 10.1016/S0378-3782(14)50011-4; Pietrini D, 2012, EUR J PEDIATR, V171, P1855, DOI 10.1007/s00431-012-1769-6; Pietrini D, 2012, CURR DRUG TARGETS, V13, P925, DOI 10.2174/138945012800675641; Ravasio A, 2008, J LIPID RES, V49, P2479, DOI 10.1194/jlr.D800029-JLR200; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Suri LNM, 2013, BBA-BIOMEMBRANES, V1828, P1707, DOI 10.1016/j.bbamem.2013.03.005; Suri LNM, 2012, BBA-BIOMEMBRANES, V1818, P1581, DOI 10.1016/j.bbamem.2012.02.021; YU SH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P264, DOI 10.1016/0005-2760(93)90228-2	56	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192295	10.1371/journal.pone.0192295	http://dx.doi.org/10.1371/journal.pone.0192295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420583	Green Submitted, gold, Green Published			2022-12-27	WOS:000424517900062
J	Khan, R; Roy, N; Choi, K; Lee, SW				Khan, Raees; Roy, Nazish; Choi, Kihyuck; Lee, Seon-Woo			Distribution of triclosan-resistant genes in major pathogenic microorganisms revealed by metagenome and genome-wide analysis	PLOS ONE			English	Article							PREDICTS ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-AERUGINOSA; FUNCTIONAL ASSIGNMENTS; REDUCTASE FABI; BIOCIDE; TARGET; IDENTIFICATION; ENVIRONMENT; INHIBITION	The substantial use of triclosan (TCS) has been aimed to kill pathogenic bacteria, but TCS resistance seems to be prevalent in microbial species and limited knowledge exists about TCS resistance determinants in a majority of pathogenic bacteria. We aimed to evaluate the distribution of TCS resistance determinants in major pathogenic bacteria (N = 231) and to assess the enrichment of potentially pathogenic genera in TCS contaminated environments. A TCS-resistant gene (TRG) database was constructed and experimentally validated to predict TCS resistance in major pathogenic bacteria. Genome-wide in silico analysis was performed to define the distribution of TCS-resistant determinants in major pathogens. Microbiome analysis of TCS contaminated soil samples was also performed to investigate the abundance of TCS-resistant pathogens. We experimentally confirmed that TCS resistance could be accurately predicted using genome-wide in silico analysis against TRG database. Predicted TCS resistant phenotypes were observed in all of the tested bacterial strains (N = 17), and heterologous expression of selected TCS resistant genes from those strains conferred expected levels of TCS resistance in an alternative host Escherichia coli. Moreover, genome-wide analysis revealed that potential TCS resistance determinants were abundant among the majority of human-associated pathogens (79%) and soil-borne plant pathogenic bacteria (98%). These included a variety of enoyl-acyl carrier protein reductase (ENRs) homologues, AcrB efflux pumps, and ENR substitutions. FabI ENR, which is the only known effective target for TCS, was either co-localized with other TCS resistance determinants or had TCS resistance-associated substitutions. Furthermore, microbiome analysis revealed that pathogenic genera with intrinsic TCS-resistant determinants exist in TCS contaminated environments. We conclude that TCS may not be as effective against the majority of bacterial pathogens as previously presumed. Further, the excessive use of this biocide in natural environments may selectively enrich for not only TCS-resistant bacterial pathogens, but possibly for additional resistance to multiple antibiotics.	[Khan, Raees; Roy, Nazish; Choi, Kihyuck; Lee, Seon-Woo] Dong A Univ, Dept Appl Biosci, Busan, South Korea	Dong A University	Lee, SW (corresponding author), Dong A Univ, Dept Appl Biosci, Busan, South Korea.	seonlee@dau.ac.kr	Choi, Kihyuck/AAN-9759-2020; KHAN, RAEES/AAT-8621-2020	KHAN, RAEES/0000-0002-8324-5702; Choi, Kihyuck/0000-0002-7031-3075; Lee, Seon-Woo/0000-0001-6142-7612	Cooperative Research Program for Agricultural Science & Technology Development, Republic of Korea [PJ01093901]	Cooperative Research Program for Agricultural Science & Technology Development, Republic of Korea	This study was funded by the Cooperative Research Program for Agricultural Science & Technology Development (Under the grant number PJ01093901 to SWL), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FDA ISS FIN RUL SAF; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bester K, 2003, WATER RES, V37, P3891, DOI 10.1016/S0043-1354(03)00335-X; Biswas S, 2008, INT J ANTIMICROB AG, V32, P207, DOI 10.1016/j.ijantimicag.2008.03.017; Butler E, 2012, ENVIRON POLLUT, V167, P101, DOI 10.1016/j.envpol.2012.03.036; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chong Chan-Eng, 2006, In Silico Biology, V6, P341; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Dinwiddie MT, 2014, INT J ENV RES PUB HE, V11, P2209, DOI 10.3390/ijerph110202209; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; Fernando DM, 2014, ANTIMICROB AGENTS CH, V58, P6424, DOI 10.1128/AAC.03074-14; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Fraise AP, 2002, J ANTIMICROB CHEMOTH, V49, P11, DOI 10.1093/jac/49.1.11; Gao B, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0150-9; Halden RU, 2014, ENVIRON SCI TECHNOL, V48, P3603, DOI 10.1021/es500495p; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; JACKOWSKI S, 1989, J BIOL CHEM, V264, P7624; James M., 2015, FASEB J, V29, P622, DOI DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.622.4; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Khan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32322; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Macri D, 2017, CONTEMP CLIN DENT, V8, P7, DOI 10.4103/ccd.ccd_225_17; Marshall N., 2014, J IMMUNOL S, V192, P119; Marshall NB, 2015, TOXICOL SCI, V147, P127, DOI 10.1093/toxsci/kfv113; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Pal C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2153-5; Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252; Parkpian P, 2002, J ENVIRON SCI HEAL A, V37, P1099, DOI 10.1081/ESE-120004526; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rout S, 2015, J MICROBIOL METH, V109, P1, DOI 10.1016/j.mimet.2014.11.016; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Saleh S, 2011, LETT APPL MICROBIOL, V52, P87, DOI 10.1111/j.1472-765X.2010.02976.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Sippel KH, 2014, J BIOL CHEM, V289, P33287, DOI 10.1074/jbc.M114.608547; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Tyson GH, 2015, J ANTIMICROB CHEMOTH, V70, P2763, DOI 10.1093/jac/dkv186; Walsh F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00019; Walters GI, 2017, ANN ALLERG ASTHMA IM, V118, P370, DOI 10.1016/j.anai.2016.12.001; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Yee AL, 2016, SCIENCE, V353, P348, DOI 10.1126/science.aag2698; Yu BJ, 2010, J ANTIMICROB CHEMOTH, V65, P1171, DOI 10.1093/jac/dkq114; Yueh MF, 2016, ANNU REV PHARMACOL, V56, P251, DOI 10.1146/annurev-pharmtox-010715-103417; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	65	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192277	10.1371/journal.pone.0192277	http://dx.doi.org/10.1371/journal.pone.0192277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420585	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900060
J	Wagner, N; Dieteren, S; Franz, N; Kohler, K; Mors, K; Nicin, L; Schmidt, J; Perl, M; Marzi, I; Relja, B				Wagner, Nils; Dieteren, Scott; Franz, Niklas; Koehler, Kernt; Moers, Katharina; Nicin, Luka; Schmidt, Julia; Perl, Mario; Marzi, Ingo; Relja, Borna			Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SODIUM PYRUVATE; LIVER-INJURY; BASE DEFICIT; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; TERMINAL KINASE; IN-VITRO; RESUSCITATION; RESPONSES	Background The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the reperfusion (R) phase plays a key role in triggering inflammation and worsening outcome. Ethyl pyruvate (EP), a stable lipophilic ester, has anti-inflammatory properties. Here, the influence of EP on the inflammatory reaction and liver injury in a double hit model of TxT and H/R in rats was explored. Methods Female Lewis rats were subjected to TxT followed by hemorrhage/H (60 min, 35 +/- 3mm Hg) and resuscitation/R (TxT+H/R). Reperfusion was performed by either Ringer's lactated solution (RL) alone or RL supplemented with EP (50 mg/kg). Sham animals underwent all surgical procedures without TxT+H/R. After 2h, blood and liver tissue were collected for analyses, and survival was assessed after 24h. Results Resuscitation with EP significantly improved haemoglobin levels and base excess recovery compared with controls after TxT+H/R, respectively (p<0.05). TxT+H/R-induced significant increase in alanine aminotransferase levels and liver injury were attenuated by EP compared with controls (p<0.05). Local inflammation as shown by increased gene expression of IL-6 and ICAM-1, enhanced ICAM-1 and HMGB1 protein expression and infiltration of the liver with neutrophils were also significantly attenuated by EP compared with controls after TxT+H/R (p<0.05). EP significantly reduced TxT+H/R-induced p65 activation in liver tissue. Survival rates improved by EP from 50% to 70% after TxT+H/R. Conclusions These data support the concept that the pronounced local pro-inflammatory response in the liver after blunt chest trauma and hemorrhagic shock is associated with NF-kappa B. In particular, the beneficial anti-inflammatory effects of ethyl pyruvate seem to be regulated by the HMGB1/NF-kappa B axis in the liver, thereby, restraining inflammatory responses and liver injury after double hit trauma in the rat.	[Wagner, Nils; Dieteren, Scott; Franz, Niklas; Moers, Katharina; Nicin, Luka; Schmidt, Julia; Marzi, Ingo; Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Surg, Frankfurt, Germany; [Koehler, Kernt] Justus Liebig Univ Giessen, Inst Vet Pathol, Giessen, Germany; [Perl, Mario] BG Trauma Ctr Murnau, Murnau, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Justus Liebig University Giessen	Relja, B (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Surg, Frankfurt, Germany.	info@bornarelja.com	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823; Nicin, Luka/0000-0002-3618-2438	DFG [RE 3304/5-1, PE 908/3-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG RE 3304/5-1 and PE 908/3-1. We thank Katrin Jurida, Kerstin Kontradowitz and Alexander Schaible for outstanding technical assistance. Grant support: The work was supported by grants from the DFG RE 3304/5-1 and PE 908/3-1.	Abt R, 2009, EUR J TRAUMA EMERG S, V35, P429, DOI 10.1007/s00068-009-8245-7; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dong WH, 2010, SHOCK, V34, P205, DOI 10.1097/SHK.0b013e3181cc0c63; Esmer E, 2016, PREHOSPITAL ASSESSME; Fang R, 2016, ACTA NEUROCHIR, V158, P1069, DOI 10.1007/s00701-016-2795-3; Fink MP, 2008, CURR OPIN ANESTHESIO, V21, P160, DOI 10.1097/ACO.0b013e3282f63c2e; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Hauser B, 2005, CRIT CARE MED, V33, P2034, DOI 10.1097/01.CCM.0000178177.03979.CE; Hietbrink F, 2006, World J Emerg Surg, V1, P15, DOI 10.1186/1749-7922-1-15; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Huber-Lang M, 2016, SEMIN IMMUNOL, V28, P278, DOI 10.1016/j.smim.2016.04.005; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kao RLC, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0030-7; Karmaniolou II, 2013, J ANESTH, V27, P447, DOI 10.1007/s00540-012-1543-y; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lehnert M, 2008, SHOCK, V30, P159, DOI 10.1097/SHK.0b013e31815dd623; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Liener UC, 2003, SHOCK, V20, P511, DOI 10.1097/01.shk.0000095057.62263.fb; Luan ZG, 2012, PANCREAS, V41, P729, DOI 10.1097/MPA.0b013e31823cd3ef; Maier M, 2009, EUR J TRAUMA EMERG S, V35, P463, DOI 10.1007/s00068-009-9123-z; Mongan PD, 1999, AM J PHYSIOL-HEART C, V277, pH2253, DOI 10.1152/ajpheart.1999.277.6.H2253; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Partrick D A, 1996, New Horiz, V4, P194; Pierce A, 2014, CURR OPIN ANESTHESIO, V27, P246, DOI 10.1097/ACO.0000000000000047; Polito F, 2016, INT J IMMUNOPATH PH, V29, P504, DOI 10.1177/0394632016656187; Pulathan Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857109; Relja B, 2016, INT J MOL MED, V37, P517, DOI 10.3892/ijmm.2015.2431; Relja B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/983427; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Relja B, 2012, EUR J NUTR, V51, P311, DOI 10.1007/s00394-011-0216-1; Relja B, 2009, SHOCK, V32, P509, DOI 10.1097/SHK.0b013e3181a2530d; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz DH, 2008, SHOCK, V30, P537, DOI 10.1097/SHK.0b013e31816a394b; Sharma P, 2010, SHOCK, V33, P532, DOI 10.1097/SHK.0b013e3181cc02b3; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/461536; Shen M., 2014, PLOS ONE, V2, P87977, DOI DOI 10.1371/J0URNAL.P0NE; Sileri P, 2001, TRANSPLANTATION, V72, P27, DOI 10.1097/00007890-200107150-00008; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Slovin PN, 2001, RESUSCITATION, V50, P109, DOI 10.1016/S0300-9572(01)00325-2; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tsung A, 2005, TRANSPLANTATION, V79, P196, DOI 10.1097/01.TP.0000151681.07474.2E; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Worlein JM, 2011, AM J PRIMATOL, V73, P98; Wutzler S, 2013, CHIRURG, V84, P753, DOI 10.1007/s00104-013-2477-0; Yang RK, 2003, J LAB CLIN MED, V142, P322, DOI 10.1016/S0022-2143(03)00138-0; Yang RK, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0144-1; Yang RK, 2009, J SURG RES, V153, P302, DOI 10.1016/j.jss.2008.04.004; Yu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2607-5; Zeng JY, 2007, ANESTHESIOLOGY, V107, P630, DOI 10.1097/01.anes.0000281898.01966.1e; Zhang M, 2017, CLIN RES HEPATOLOGY	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192171	10.1371/journal.pone.0192171	http://dx.doi.org/10.1371/journal.pone.0192171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420582	gold, Green Published, Green Submitted			2022-12-27	WOS:000424517900045
J	Dzneladze, I; Woolley, JF; Rossell, C; Han, YQ; Rashid, A; Jain, M; Reimand, J; Minden, MD; Salmena, L				Dzneladze, Irakli; Woolley, John F.; Rossell, Carla; Han, Youqi; Rashid, Ayesha; Jain, Michael; Reimand, Juri; Minden, Mark D.; Salmena, Leonardo			SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; PHOSPHATASE; SGK3	Our previous studies demonstrated that INPP4B, a member of the PI3K/Akt signaling pathway, is overexpressed in a subset of AML patients and is associated with lower response to chemotherapy and shorter survival. INPP4B expression analysis in AML revealed a right skewed frequency distribution with 25% of patients expressing significantly higher levels than the majority. The 75% low/25% high cut-off revealed the prognostic power of INPP4B expression status in AML, which would not have been apparent with a standard median cutoff approach. Our identification of a clinically relevant non-median cut-off for INPP4B indicated a need for a generalizable non-median dichotomization approach to optimally study clinically relevant genes. To address this need, we developed Subgroup Identifier (SubID), a tool which examines the relationship between a continuous variable (e.g. gene expression), and a test parameter (e.g. CoxPH or Fisher's exact P values). In our study, Fisher's exact SubID was used to reveal EVI1 as a transcriptional regulator of INPP4B in AML; a finding which was validated in vitro. Next, we used CoxPH SubID to conduct a pan-cancer analysis of INPP4B's prognostic significance. Our analysis revealed that INPP4B low is associated with shorter survival in kidney clear cell, liver hepatocellular, and bladder urothelial carcinomas. Conversely, INPP4B low was shown to be associated with increased survival in pancreatic adenocarcinoma in three independent datasets. Overall, our study describes the development and application of a novel subgroup identification tool used to identify prognostically significant rare subgroups based upon gene expression, and for investigating the association between a gene with skewed frequency distribution and potentially important upstream and downstream genes that relate to the index gene.	[Dzneladze, Irakli; Woolley, John F.; Han, Youqi; Rashid, Ayesha; Jain, Michael; Minden, Mark D.; Salmena, Leonardo] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Dzneladze, Irakli; Rashid, Ayesha; Reimand, Juri; Minden, Mark D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Dzneladze, Irakli; Rossell, Carla; Reimand, Juri] Ontario Inst Canc Res, Toronto, ON, Canada; [Woolley, John F.; Salmena, Leonardo] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Minden, MD; Salmena, L (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Minden, MD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Salmena, L (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.	mark.minden@uhn.ca; leonardo.salmena@utoronto.ca	Reimand, Jüri/U-9264-2019; Jain, Michael/AAI-2741-2020	Reimand, Jüri/0000-0002-2299-2309; Jain, Michael/0000-0002-7789-1257; Salmena, Leonardo/0000-0003-4023-658X	Orsino Chair in Leukemia Research; Marvin and Linda Barnett leukemia Research Fund; Brian Steck Leukemia Research Fund; Canada Research Chair	Orsino Chair in Leukemia Research; Marvin and Linda Barnett leukemia Research Fund; Brian Steck Leukemia Research Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	MDM is a recipient of the Orsino Chair in Leukemia Research, the Marvin and Linda Barnett leukemia Research Fund, and the Brian Steck Leukemia Research Fund. LS is the recipient of a Tier II Canada Research Chair.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Chi MN, 2015, ONCOTARGET, V6, P39891, DOI 10.18632/oncotarget.5359; Dzneladze I, 2015, LEUKEMIA, V29, P1485, DOI 10.1038/leu.2015.51; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Guo ST, 2016, ONCOGENE, V35, P3049, DOI 10.1038/onc.2015.361; Hodgson MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0061-y; Hsu IW, 2014, ONCOTARGET, V5, P7917, DOI 10.18632/oncotarget.1421; Kofuji S, 2015, CANCER DISCOV, V5, P730, DOI 10.1158/2159-8290.CD-14-1329; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Rijal S, 2015, BLOOD, V125, P2815, DOI 10.1182/blood-2014-09-603555; Rodgers SJ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160432; Salmena L, 2015, EUR J GYNAECOL ONCOL, V36, P260; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Tokunaga E, 2016, BREAST, V25, P62, DOI 10.1016/j.breast.2015.10.006; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Won JR, 2013, MODERN PATHOL, V26, P1438, DOI 10.1038/modpathol.2013.97; Woolley JF, 2015, TRENDS MOL MED, V21, P530, DOI 10.1016/j.molmed.2015.06.006; Zhang L, 2016, LIFE SCI, V155, P110, DOI 10.1016/j.lfs.2016.05.014	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191510	10.1371/journal.pone.0191510	http://dx.doi.org/10.1371/journal.pone.0191510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415082	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300030
J	Maioli, M; Basoli, V; Carta, P; Fabbri, D; Dettori, MA; Cruciani, S; Serra, PA; Delogu, G				Maioli, Margherita; Basoli, Valentina; Carta, Paola; Fabbri, Davide; Dettori, Maria Antonietta; Cruciani, Sara; Serra, Pier Andrea; Delogu, Giovanna			Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA; ANTIOXIDANT ACTIVITY; SODIUM-BUTYRATE; BIPHENYL DERIVATIVES; OXIDATIVE STRESS; PEROXYL RADICALS; NATURAL-PRODUCTS; HEPG2 CELLS; APOPTOSIS	The hepatocellular carcinoma is one of the most common malignant tumour with high level of mortality rate due to its rapid progression and high resistance to conventional chemotherapies. Thus, the search for novel therapeutic leads is of global interest. Herein, a small set of derivatives of magnolol 1 and honokiol 2, the main components of Magnolia grandiflora and Magnolia obovata, were evaluated in in vitro assay using tumoral hepatocytes. The prodrug approach was applied as versatile strategy to the improve bioactivity of the compounds by careful transformation of the hydroxyl groups of magnolol 1 and honokiol 2 in suitable ester derivatives. Compounds 10 and 11 resulted to be more potent than the parental honokiol 2 at concentration down to 1 mu M with complete viability of treated fibroblast cells up to concentrations of 80 mu M. The combination of a butyrate ester and a bare phenol-OH group in the honokiol structure seemed to play a significant role in the antiproliferative activity identifying an interesting pharmacological clue against hepatocellular carcinoma.	[Maioli, Margherita; Basoli, Valentina; Cruciani, Sara] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Maioli, Margherita; Cruciani, Sara] Natl Inst Biostruct & Biosyst, Lab Mol Biol & Stem Cell Engn, Bologna, Italy; [Maioli, Margherita] CNR, Inst Neurogenet & Neuropharmacol, Cagliari, Italy; [Maioli, Margherita; Serra, Pier Andrea] Univ Sassari, Dept Biomed Sci, Ctr Dev Biol & Reprogramming CEDEBIOR, Sassari, Italy; [Basoli, Valentina] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria; [Carta, Paola; Dettori, Maria Antonietta; Delogu, Giovanna] CNR, Inst Biomol Chem, Sassari, Italy; [Serra, Pier Andrea] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); University of Sassari	Delogu, G (corresponding author), CNR, Inst Biomol Chem, Sassari, Italy.	giovanna.delogu@icb.cnr.it	Basoli, Valentina/AEX-6502-2022; Cruciani, Sara/ABI-3491-2020; Carta, Paola/H-2026-2013; CARTA, PAOLA/AAT-5918-2020; fabbri, davide/AAJ-7021-2021; Dettori, Maria Antonietta/AAJ-7013-2021	Carta, Paola/0000-0001-8749-6093; CARTA, PAOLA/0000-0001-8749-6093; Dettori, Maria Antonietta/0000-0002-8776-9271; Basoli, Valentina/0000-0002-4703-7308; SERRA, Pier Andrea/0000-0003-2401-5146; FABBRI, DAVIDEGAETANO/0000-0002-3947-5164	Sardinia Region (Italy) [000411 9/2/2016]; Fondazione Sardegna (IT) [U858.2014/AI.741.MGB]; Sardinia Region (Italy); Fondazione Sardegna	Sardinia Region (Italy); Fondazione Sardegna (IT); Sardinia Region (Italy); Fondazione Sardegna(Fondazione Banco di Sardegna)	(PC) Sardinia Region (Italy) for a grant associated to the project 'Strategie di sintesi per l'accesso a nuovi lead antitumorali', Number 000411 9/2/2016. (MM) Fondazione Sardegna (IT) for the project 'Myrtus 2.0: from waste to resource (Bioactivity of myrtle by-products)', Number U858.2014/AI.741.MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PC gratefully acknowledges the financial support from Sardinia Region (Italy) for a grant associated with the project 'Strategie di sintesi per l'accesso a nuovi lead antitumorali'. The authors acknowledge the financial support from Fondazione Sardegna for the project 'Myrtus 2.0: from waste to resource (Bioactivity of myrtle by-products)'.	Amorati R, 2003, J ORG CHEM, V68, P5198, DOI 10.1021/jo0342931; Amorati R, 2015, J ORG CHEM, V80, P10651, DOI 10.1021/acs.joc.5b01772; Appendino G, 2014, NAT PROD REP, V31, P880, DOI 10.1039/c4np00010b; Bao K, 2010, BIOORGAN MED CHEM, V18, P6708, DOI 10.1016/j.bmc.2010.07.062; Baschieri A, 2017, ORG BIOMOL CHEM, V15, P6177, DOI 10.1039/c7ob01195d; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Bringmann G, 2011, CHEM REV, V111, P563, DOI 10.1021/cr100155e; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chen MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143594; Criton M, 2011, BIOL PHARM BULL, V34, P420, DOI 10.1248/bpb.34.420; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Fan SL, 2014, INFLAMMATION, V37, P17, DOI 10.1007/s10753-013-9707-y; Fujisawa S, 2005, ARCH IMMUNOL THER EX, V53, P28; Hajduk PJ, 2000, J MED CHEM, V43, P3443, DOI 10.1021/jm000164q; Han LL, 2009, ENVIRON TOXICOL PHAR, V28, P97, DOI 10.1016/j.etap.2009.03.005; Jornada DH, 2016, MOLECULES, V21, DOI 10.3390/molecules21010042; Jung Roh H J, 2009, BIOMOL THER, V23, P283; Kancheva V, 2014, FOOD CHEM, V157, P263, DOI 10.1016/j.foodchem.2014.02.036; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Li HM, 2011, J FLUORESC, V21, P265, DOI 10.1007/s10895-010-0714-1; Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846; Li S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4234061; Lin CJ, 2016, TOXICOL APPL PHARM, V304, P59, DOI 10.1016/j.taap.2016.05.018; Lin CJ, 2016, PHYTOMEDICINE, V23, P517, DOI 10.1016/j.phymed.2016.02.021; Lin CF, 2016, PHARM RES-DORDR, V33, P2152, DOI 10.1007/s11095-016-1953-x; Liu RX, 2017, INT J ONCOL, V51, P907, DOI 10.3892/ijo.2017.4078; Luo LX, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00199; Maioli M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2056416; Maioli M, 2013, DRUG DES DEV THER, V7, P1063, DOI 10.2147/DDDT.S44706; Marchiani A, 2013, AMINO ACIDS, V45, P327, DOI 10.1007/s00726-013-1503-3; Mascia MP, 2012, EUR J PHARMACOL, V693, P45, DOI 10.1016/j.ejphar.2012.07.048; McKeown BT, 2014, ANTICANCER RES, V34, P6333; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Moura FA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4047362; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Pandey KB, 2009, CURR NUTR FOOD SCI, V5, P249, DOI 10.2174/157340109790218058; Pant K, 2017, CHEM-BIOL INTERACT, V273, P99, DOI 10.1016/j.cbi.2017.06.001; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Park EJ, 2003, PLANTA MED, V69, P33, DOI 10.1055/s-2003-37027; Pedotti S, 2016, POLYHEDRON, V117, P80, DOI 10.1016/j.poly.2016.05.039; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Rajendran P, 2012, J CELL PHYSIOL, V227, P2184, DOI 10.1002/jcp.22954; Rajgopal A, 2016, J ETHNOPHARMACOL, V193, P657, DOI 10.1016/j.jep.2016.10.016; Ran Y, 2012, MOLECULES, V17, P8091, DOI 10.3390/molecules17078091; Ruzza P, 2017, EUR J MED CHEM, V126, P1034, DOI 10.1016/j.ejmech.2016.12.028; Schuhly W, 2009, BIOORGAN MED CHEM, V17, P4459, DOI 10.1016/j.bmc.2009.05.018; Sengupta S, 2017, ONCOGENE, V36, P5709, DOI 10.1038/onc.2017.164; Shen J, 2017, CELL PHYSIOL BIOCHEM, V42, P1789, DOI 10.1159/000479458; Shen JL, 2010, MOLECULES, V15, P6452, DOI 10.3390/molecules15096452; Shen L, 2017, ONCOL LETT, V14, P4294, DOI 10.3892/ol.2017.6665; Sun LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172228; Trojan J, 2016, VISC MED, V32, P116, DOI 10.1159/000445730; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Waller LP, 2015, WORLD J HEPATOL, V7, P2648, DOI 10.4254/wjh.v7.i26.2648; Woodbury A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00130; Xing XG, 2016, J PHYSIOL BIOCHEM, V73, P405, DOI 10.1007/s13105-017-0568-y; YAHARA S, 1991, CHEM PHARM BULL, V39, P2024, DOI 10.1248/cpb.39.2024; Yang JH, 2017, ONCOTARGET, V8, P915, DOI 10.18632/oncotarget.13687; Yeh PS, 2016, CANCER LETT, V370, P66, DOI 10.1016/j.canlet.2015.08.030; Zhang HX, 2015, INT J CLIN EXP MED, V8, P16880; Zhang YX, 2015, CARBOHYD POLYM, V133, P31, DOI 10.1016/j.carbpol.2015.06.102; Zhou MM, 2010, J CELL BIOCHEM, V109, P606, DOI 10.1002/jcb.22442	63	24	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192178	10.1371/journal.pone.0192178	http://dx.doi.org/10.1371/journal.pone.0192178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415009	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300055
J	Saera-Vila, A; Louie, KW; Sha, C; Kelly, RM; Kish, PE; Kahana, A				Saera-Vila, Alfonso; Louie, Ke'ale W.; Sha, Cuilee; Kelly, Ryan M.; Kish, Phillip E.; Kahana, Alon			Extraocular muscle regeneration in zebrafish requires late signals from Insulin-like growth factors	PLOS ONE			English	Article							FACTOR-I; SKELETAL-MUSCLE; IGF-I; SATELLITE CELLS; FIN REGENERATION; GENE-EXPRESSION; ADULT ZEBRAFISH; MULLER GLIA; DIFFERENTIATION; AUTOPHAGY	Insulin-like growth factors (Igfs) are key regulators of key biological processes such as embryonic development, growth, and tissue repair and regeneration. The role of Igf in myogenesis is well documented and, in zebrafish, promotes fin and heart regeneration. However, the mechanism of action of Igf in muscle repair and regeneration is not well understood. Using adult zebrafish extraocular muscle (EOM) regeneration as an experimental model, we show that Igf1 receptor blockage using either chemical inhibitors (BMS754807 and NVP-AEW541) or translation-blocking morpholino oligonucleotides (MOs) reduced EOM regeneration. Zebrafish EOMs regeneration depends on myocyte dedifferentiation, which is driven by early epigenetic reprogramming and requires autophagy activation and cell cycle reentry. Inhibition of Igf signaling had no effect on either autophagy activation or cell proliferation, indicating that Igf signaling was not involved in the early reprogramming steps of regeneration. Instead, blocking Igf signaling produced hypercellularity of regenerating EOMs and diminished myosin expression, resulting in lack of mature differentiated muscle fibers even many days after injury, indicating that Igf was involved in late re-differentiation steps. Although it is considered the main mediator of myogenic Igf actions, Akt activation decreased in regenerating EOMs, suggesting that alternative signaling pathways mediate Igf activity in muscle regeneration. In conclusion, Igf signaling is critical for re-differentiation of reprogrammed myoblasts during late steps of zebrafish EOM regeneration, suggesting a regulatory mechanism for determining regenerated muscle size and timing of differentiation, and a potential target for regenerative therapy.	[Saera-Vila, Alfonso; Louie, Ke'ale W.; Sha, Cuilee; Kelly, Ryan M.; Kish, Phillip E.; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Louie, Ke'ale W.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saera-Vila, A; Kahana, A (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	alfonsosaera@gmail.com; akahana@med.umich.edu	Kish, Phil E/H-6051-2011; Saera-Vila, Alfonso/O-7438-2017	Kahana, Alon/0000-0002-5667-2274; Kelly, Ryan/0000-0002-0328-8025; Saera-Vila, Alfonso/0000-0003-0106-2353	Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB); NEI of the NIH [R01 EY022633]; RPB; Vision Research Core at the University of Michigan [P30 EY007003]; Cancer Center Research Core at the University of Michigan [P30 CA046592]; Michigan Diabetes Research Center at the University of Michigan [P30 DK020572]; A. Alfred Taubman Medical Research Institute; NIH NCRR [P40 RR012546]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY022633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER	Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB); NEI of the NIH; RPB(Research to Prevent Blindness (RPB)); Vision Research Core at the University of Michigan; Cancer Center Research Core at the University of Michigan; Michigan Diabetes Research Center at the University of Michigan; A. Alfred Taubman Medical Research Institute; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Alliance for Vision Research, a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB), grant R01 EY022633 from the NEI of the NIH (AK), and an unrestricted grant from RPB to the Department of Ophthalmology and Visual Sciences. This research utilized the Vision Research Core (P30 EY007003), the Cancer Center Research Core (P30 CA046592), and the Michigan Diabetes Research Center (P30 DK020572) at the University of Michigan. AK is supported by the Mrs. William Davidson Emerging Scholar Award from the A. Alfred Taubman Medical Research Institute. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the NIH NCRR. Funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Ayaso E, 2002, MOL CELL ENDOCRINOL, V191, P137, DOI 10.1016/S0303-7207(02)00083-7; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Berridge BR, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P1567, DOI 10.1016/B978-0-12-415759-0.00046-7; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chen J, 2004, INVEST OPHTH VIS SCI, V45, P3538, DOI 10.1167/iovs.04-0393; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Doherty JT, 2011, J BIOL CHEM, V286, P25903, DOI 10.1074/jbc.M111.243030; EDWALL D, 1989, ENDOCRINOLOGY, V124, P820, DOI 10.1210/endo-124-2-820; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Feng CY, 2011, GROWTH HORM IGF RES, V21, P228, DOI 10.1016/j.ghir.2011.06.001; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; GREENE EA, 1991, J ANIM SCI, V69, P146; Haddad F, 2004, J APPL PHYSIOL, V96, P203, DOI 10.1152/japplphysiol.00856.2003; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Krishan K, 1996, J MUSCLE RES CELL M, V17, P513, DOI 10.1007/BF00124351; Larkindale J, 2014, MUSCLE NERVE, V49, P431, DOI 10.1002/mus.23942; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Li T, 2010, INVEST OPHTH VIS SCI, V51, P2479, DOI 10.1167/iovs.09-4414; Louie KW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4236-y; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; MCFARLAND DC, 1993, GEN COMP ENDOCR, V89, P415, DOI 10.1006/gcen.1993.1049; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P3866, DOI 10.1167/iovs.03-0223; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Onuma TA, 2011, J NEUROSCI, V31, P11814, DOI 10.1523/JNEUROSCI.6804-10.2011; Ovalle WK, 2007, NETTERS ESSENTIAL HI; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Renna M, 2013, HUM MOL GENET, V22, P4528, DOI 10.1093/hmg/ddt300; Saera-Vila A, 2016, AUTOPHAGY, V12, P1864, DOI 10.1080/15548627.2016.1207015; Saera-Vila A, 2016, CELL SIGNAL, V28, P1196, DOI 10.1016/j.cellsig.2016.06.001; Saera-Vila A, 2015, INVEST OPHTH VIS SCI, V56, P4977, DOI 10.1167/iovs.14-16103; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Shi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1040, DOI 10.1152/ajpcell.00475.2008; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; TOLLEFSEN SE, 1989, J BIOL CHEM, V264, P13810; Troncoso R, 2013, IUBMB LIFE, V65, P593, DOI 10.1002/iub.1172; VANDENBURGH HH, 1991, AM J PHYSIOL, V260, pC475, DOI 10.1152/ajpcell.1991.260.3.C475; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Willoughby CL, 2012, INVEST OPHTH VIS SCI, V53, P68, DOI 10.1167/iovs.11-8356; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	58	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192214	10.1371/journal.pone.0192214	http://dx.doi.org/10.1371/journal.pone.0192214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415074	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300059
J	Cui, F; Sun, LQ; Xiong, JM; Li, JY; Zhao, YG; Huang, XS				Cui, Fang; Sun, Liuqing; Xiong, Jianmei; Li, Jianyong; Zhao, Yangang; Huang, Xusheng			Therapeutic effects of percutaneous endoscopic gastrostomy on survival in patients with amyotrophic lateral sclerosis: A meta-analysis	PLOS ONE			English	Article							ENTERAL NUTRITION; TUBE PLACEMENT; ALS; COMPLICATIONS; MANAGEMENT; ONSET	Percutaneous endoscopic gastrostomy (PEG) is a method widely used for patients with amyotrophic lateral sclerosis (ALS); nevertheless, its effect on survival remains unclear. The purpose of this meta-analysis study was to determine the effects of PEG on survival in ALS patients. Relevant studies were retrieved from PubMed, EmBase, and the Cochrane Library databases, from inception to June 2017. Studies comparing PEG with other procedures in ALS patients were included. Odds ratios (ORs) in a random-effects model were used to assess the survival at different follow-up periods. Briefly, ten studies involving a total of 996 ALS patients were included. Summary ORs indicated that PEG administration was not associated with 30-day (OR = 1.59; 95% CI 0.93-2.71; P = 0.092), 10-month (OR = 1.25; 95% CI 0.72-2.17; P = 0.436), and 30-month (OR = 1.28; 95% CI 0.77-2.11; P = 0.338) survival rates, while they showed a beneficial effect in 20-month survival rate (OR = 1.97; 95% CI 1.21-3.21; P = 0.007). The survival rate was significantly prominent in reports published before 2005, and in studies with a retrospective design, sample size < 100, mean age <60.0 years, and percentage male >= 50.0%. To sum up, these findings suggested that ALS patients administered with PEG had an increased 20-month survival rates, while there was no significant effect in 30-day, 10-month, and 30-month survival rates.	[Cui, Fang; Sun, Liuqing; Xiong, Jianmei; Li, Jianyong; Zhao, Yangang] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Hainan Branch, Sanya, Hainan, Peoples R China; [Huang, Xusheng] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Huang, XS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China.	lewish301@sina.com	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022		National Natural Science Foundation of China [81601096]; Key Research & Developement Plan of Hainan Province [ZDYF2016120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research & Developement Plan of Hainan Province	This study was supported by the National Natural Science Foundation of China (Grant number 81601096) (http://www.nsfc.gov.cn/); Key Research & Developement Plan of Hainan Province (Grant number ZDYF2016120) (http://dost.hainan.gov.cn/).	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Allen JA, 2013, AMYOTROPH LAT SCL FR, V14, P308, DOI 10.3109/21678421.2012.751613; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blondet A, 2010, J VASC INTERV RADIOL, V21, P527, DOI 10.1016/j.jvir.2009.11.022; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Bradley WG, 2001, NEUROLOGY, V57, P500, DOI 10.1212/WNL.57.3.500; Chio A, 2004, J NEUROL NEUROSUR PS, V75, P645, DOI 10.1136/jnnp.2003.020347; CHRISTENSEN PB, 1990, NEUROLOGY, V40, P600, DOI 10.1212/WNL.40.4.600; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2005, AMYOTROPH LATERAL SC, V6, P88, DOI 10.1080/14660820410021258a; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; LEE JRJ, 1995, J NEUROL SCI, V132, P207, DOI 10.1016/0022-510X(95)00154-T; LOPES J, 1982, AM J CLIN NUTR, V36, P602, DOI 10.1093/ajcn/36.4.602; MATHUSVLIEGEN LMH, 1994, GASTROINTEST ENDOSC, V40, P463, DOI 10.1016/S0016-5107(94)70211-X; MAZZINI L, 1995, J NEUROL, V242, P695, DOI 10.1007/BF00866922; McDermott CJ, 2008, BMJ-BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; McDermott CJ, 2015, LANCET NEUROL, V14, P702, DOI 10.1016/S1474-4422(15)00104-0; Mitchell SL, 2000, J GERONTOL A-BIOL, V55, pM735, DOI 10.1093/gerona/55.12.M735; Mitsumoto H, 2003, AMYOTROPH LATERAL SC, V4, P177, DOI 10.1080/14660820310011728; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; NORRIS F, 1993, J NEUROL SCI, V118, P48, DOI 10.1016/0022-510X(93)90245-T; Preux PM, 1996, NEUROEPIDEMIOLOGY, V15, P153, DOI 10.1159/000109902; Rigaud D, 1997, AM J CLIN NUTR, V65, P1845, DOI 10.1093/ajcn/65.6.1845; RUSSELL TR, 1984, AM J SURG, V148, P132, DOI 10.1016/0002-9610(84)90300-3; Shaw AS, 2006, AMYOTROPH LATERAL SC, V7, P16, DOI 10.1080/14660820510012013; Spataro R, 2011, J NEUROL SCI, V304, P44, DOI 10.1016/j.jns.2011.02.016; Thornton FJ, 2002, RADIOLOGY, V224, P713, DOI 10.1148/radiol.2243010909; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Vaisman N, 2009, J NEUROL SCI, V279, P26, DOI 10.1016/j.jns.2008.12.027; Wells G, 2000, NEWCASTLE OTTAWA SCA	37	13	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192243	10.1371/journal.pone.0192243	http://dx.doi.org/10.1371/journal.pone.0192243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408898	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800052
J	Gilbert, AN; DiVerdi, JA				Gilbert, Avery N.; DiVerdi, Joseph A.			Consumer perceptions of strain differences in Cannabis aroma	PLOS ONE			English	Article							SATIVA	The smell of marijuana (Cannabis sativa L.) is of interest to users, growers, plant breeders, law enforcement and, increasingly, to state-licensed retail businesses. The numerous varieties and strains of Cannabis produce strikingly different scents but to date there have been few, if any, attempts to quantify these olfactory profiles directly. Using standard sensory evaluation techniques with untrained consumers we have validated a preliminary olfactory lexicon for dried cannabis flower, and characterized the aroma profile of eleven strains sold in the legal recreational market in Colorado. We show that consumers perceive differences among strains, that the strains form distinct clusters based on odor similarity, and that strain aroma profiles are linked to perceptions of potency, price, and smoking interest.	[Gilbert, Avery N.] Headspace Sensory LLC, Ft Collins, CO 80528 USA; [DiVerdi, Joseph A.] XTR Syst LLC, Ft Collins, CO USA		Gilbert, AN (corresponding author), Headspace Sensory LLC, Ft Collins, CO 80528 USA.	avery@headspacesensory.com		Gilbert, Avery/0000-0002-8806-8557	Headspace Sensory	Headspace Sensory	This work was supported by funds provided by Headspace Sensory, LLC which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; [Anonymous], 2016, WORLD COFFEE RES SEN; Burness A., 2016, DAILY CAMERA    1105; Clarke RC, 2013, CANNABIS: EVOLUTION AND ETHNOBOTANY, P1; Dufresnes C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170522; Elinson Z., 2017, WALL STREET J; Fischedick JT, 2010, PHYTOCHEMISTRY, V71, P2058, DOI 10.1016/j.phytochem.2010.10.001; Giese MW, 2015, J AOAC INT, V98, P1503, DOI 10.5740/jaoacint.15-116; Gilbert A. N., 2008, WHAT NOSE KNOWS SCI; Gilbert AN, 2016, FOOD QUAL PREFER, V52, P203, DOI 10.1016/j.foodqual.2016.04.007; Goetzl R, 2013, AM CRIM LAW REV, V50, P607; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00463, 10.3389/fpls.2016.00019]; Hazekamp A, 2012, DRUG TEST ANAL, V4, P660, DOI 10.1002/dta.407; Hillig KW, 2004, BIOCHEM SYST ECOL, V32, P875, DOI 10.1016/j.bse.2004.04.004; Mariotti KD, 2016, SCI JUSTICE, V56, P35, DOI 10.1016/j.scijus.2015.09.002; McDowell E, 2016, CHEM SENSES, V41, pE52; McPartland JM, 2000, HEMP DISEASES PESTS; Mediavilla V., 1997, Journal of the International Hemp Association, V4, P82; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P237, DOI 10.1007/978-3-642-12541-6_9; NOBLE AC, 1987, AM J ENOL VITICULT, V38, P143; Rahn B, 2016, CRIT REV PLANT SCI, V35, P328, DOI 10.1080/07352689.2016.1273626; Rice S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144160; Ross SA, 1996, J NAT PROD, V59, P49, DOI 10.1021/np960004a; Rothschild M, 2005, BOT J LINN SOC; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; Small E, 2015, BOT REV, V81, P189, DOI 10.1007/s12229-015-9157-3; Strong E, 2015, STYLE GUIDELINES BEE; Sweeney C., 2016, N BAY BUSINESS  0613; Vandrey R, 2015, JAMA-J AM MED ASSOC, V313, P2491, DOI 10.1001/jama.2015.6613	29	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192247	10.1371/journal.pone.0192247	http://dx.doi.org/10.1371/journal.pone.0192247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401526	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400045
J	Pati, S; Peng, ZL; Wataha, K; Miyazawa, B; Potter, DR; Kozar, RA				Pati, Shibani; Peng, Zhanglong; Wataha, Katherine; Miyazawa, Byron; Potter, Daniel R.; Kozar, Rosemary A.			Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GLYCOCALYX DEGRADATION; DAMAGE CONTROL RESUSCITATION; SPRAY-DRIED PLASMA; LEUKOCYTE ADHESION; SYNDECAN 1; MODEL; SURVIVAL; COAGULOPATHY	In severe trauma and hemorrhage the early and empiric use of fresh frozen plasma (FFP) is associated with decreased morbidity and mortality. However, utilization of FFP comes with the significant burden of shipping and storage of frozen blood products. Dried or lyophilized plasma (LP) can be stored at room temperature, transported easily, reconstituted rapidly with ready availability in remote and austere environments. We have previously demonstrated that FFP mitigates the endothelial injury that ensues after hemorrhagic shock (HS). In the current study, we sought to determine whether LP has similar properties to FFP in its ability to modulate endothelial dysfunction in vitro and in vivo. Single donor LP was compared to single donor FFP using the following measures of endothelial cell (EC) function in vitro: permeability and transendothelial monolayer resistance; adherens junction preservation; and leukocyte-EC adhesion. In vivo, using a model of murine HS, LP and FFP were compared in measures of HS-induced pulmonary vascular inflammation and edema. Both in vitro and in vivo in all measures of EC function, LP demonstrated similar effects to FFP. Both FFP and LP similarly reduced EC permeability, increased transendothelial resistance, decreased leukocyte-EC binding and persevered adherens junctions. In vivo, LP and FFP both comparably reduced pulmonary injury, inflammation and vascular leak. Both FFP and LP have similar potent protective effects on the vascular endothelium in vitro and in lung function in vivo following hemorrhagic shock. These data support the further development of LP as an effective plasma product for human use after trauma and hemorrhagic shock.	[Pati, Shibani; Wataha, Katherine; Miyazawa, Byron; Potter, Daniel R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Peng, Zhanglong] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesia, Houston, TX 77030 USA; [Kozar, Rosemary A.] Univ Maryland, Sch Med, Shock Trauma Ctr, Baltimore, MD 21201 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University System of Maryland; University of Maryland Baltimore	Pati, S (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	shibani.pati@ucsf.edu			National Institutes of Health [RO1GM107482]; Department of Defense [W81XWH-11-2-006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1GM107482 (to RAK) and the Department of Defense W81XWH-11-2-006 (to SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health RO1GM107482 and the Department of Defense W81XWH-11-2-006. There are no conflicts of interest reported.	[Anonymous], 2017, SHOCK, P1; [Anonymous], 2009, SAFETY AUTOLOGOUS LY; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Holcomb JB, 2013, JAMA SURG; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jenkins DH, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000140; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2011, BIOMED CENTRAL, V15, pR272; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lee TH, 2013, TRANSFUSION, V53, p72S, DOI 10.1111/trf.12039; Letourneau PA, 2011, J TISSUE SCI ENG S3; Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x; Matijevic N, 2011, J TRAUMA, V70, P71, DOI 10.1097/TA.0b013e318207abec; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Pati S, 2016, J TRAUMA ACUTE CARE, V80, P576, DOI 10.1097/TA.0000000000000961; Peng ZL, 2016, J TRAUMA ACUTE CARE, V81, pS171, DOI 10.1097/TA.0000000000001221; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Peng ZL, 2012, SHOCK, V38, P57, DOI 10.1097/SHK.0b013e31825a188a; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Query C, 2010, REPORTING SYSTEM WIS; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Wataha K, 2013, TRANSFUSION, V53, p80S, DOI 10.1111/trf.12040	41	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192363	10.1371/journal.pone.0192363	http://dx.doi.org/10.1371/journal.pone.0192363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394283	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400039
J	Wang, J; Hou, DH; Wang, QR; Kuang, WH; Zhang, L; Li, J; Shen, S; Deng, F; Wang, HL; Hu, ZH; Wang, ML				Wang, Jun; Hou, Dianhai; Wang, Qianran; Kuang, Wenhua; Zhang, Lei; Li, Jiang; Shen, Shu; Deng, Fei; Wang, Hualin; Hu, Zhihong; Wang, Manli			Genome analysis of a novel Group I alphabaculovirus obtained from Oxyplax ochracea	PLOS ONE			English	Article							PER-OS INFECTIVITY; ENVELOPE FUSION PROTEIN; EXPRESSION FACTOR GENES; NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; HOMOLOGOUS DNA; BOMBYX-MORI; BACULOVIRUS; VIRUS; IDENTIFICATION; SEQUENCE	Oxyplax ochracea (Moore) is a pest that causes severe damage to a wide range of crops, forests and fruit trees. The complete genome sequence of Oxyplax ochracea nucleopolyhedrovirus (OxocNPV) was determined using a Roche 454 pyrosequencing system. OxocNPV has a double-stranded DNA (dsDNA) genome of 113,971 bp with a G+C content of 31.1%. One hundred and twenty-four putative open reading frames (ORFs) encoding proteins of >50 amino acids in length and with minimal overlapping were predicted, which covered 92% of the whole genome. Six baculoviral typical homologous regions (hrs) were identified. Phylogenetic analysis and gene parity plot analysis showed that OxocNPV belongs to clade "a" of Group I alphabaculoviruses, and it seems to be close to the most recent common ancestor of Group I alphabaculoviruses. Three unique ORFs (with no homologs in the National Center for Biotechnology Information database) were identified. Interestingly, OxocNPV lacks three auxiliary genes (lef7, ie-2 and pcna) related to viral DNA replication and RNA transcription. In addition, OxocNPV has significantly different sequences for several genes (including ie1 and odv-e66) in comparison with those of other baculoviruses. However, three dimensional structure prediction showed that OxocNPV ODV-E66 contain the conserved catalytic residues, implying that it might possess polysaccharide lyase activity as AcMNPV ODV-E66. All these unique features suggest that OxocNPV represents a novel species of the Group I alphabaculovirus lineage.	[Wang, Jun; Hou, Dianhai; Wang, Qianran; Kuang, Wenhua; Zhang, Lei; Li, Jiang; Shen, Shu; Deng, Fei; Wang, Hualin; Hu, Zhihong; Wang, Manli] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Hou, Dianhai] Weifang Med Univ, Sch Biosci & Technol, Weifang, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Weifang Medical University	Wang, ML (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	wangml@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928; shen, shu/0000-0002-0013-5365	National Key R&D Program of China [2017YFD0200400, 2016YFE0113500]; National Natural Science Foundation of China [31621061, 31400140]; Key Research Program of Frontier Sciences of Chinese Academy of Sciences [QYZDJ-SSW-SMC021]; Virology Key Frontier Science Program of State Key Laboratory of Virology [klv-2016-03]; National Natural Science Foundation of China	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences of Chinese Academy of Sciences; Virology Key Frontier Science Program of State Key Laboratory of Virology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Key R&D Program of China (Grants No. 2017YFD0200400 to FD and 2016YFE0113500 to ZH); the National Natural Science Foundation of China (Grant No. 31621061) to ZH; the Key Research Program of Frontier Sciences of Chinese Academy of Sciences (Grant No. QYZDJ-SSW-SMC021) to ZH, the Virology Key Frontier Science Program of State Key Laboratory of Virology (Grant No. klv-2016-03) to ZH and HW, and the National Natural Science Foundation of China (Grant No. 31400140) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardisson-Araujo DMP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2408-9; Ardisson-Araujo DMP, 2016, J VIROL, V90, P1668, DOI 10.1128/JVI.02491-15; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; CARSON DD, 1988, VIROLOGY, V162, P444, DOI 10.1016/0042-6822(88)90485-0; CARSON DD, 1991, VIROLOGY, V182, P279, DOI 10.1016/0042-6822(91)90671-W; Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Chen CJ, 1997, VIROLOGY, V227, P88, DOI 10.1006/viro.1996.8341; CRAWFORD AM, 1988, J VIROL, V62, P2773, DOI 10.1128/JVI.62.8.2773-2781.1988; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Ferrelli ML, 2012, BACULOVIRAL GENOME; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Guarino LA, 2002, J VIROL, V76, P12663, DOI 10.1128/JVI.76.24.12663-12675.2002; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZH, 1998, VIRUS RES, V55, P71, DOI 10.1016/S0168-1702(98)00029-X; Huang GH, 2017, VIROL SIN, V32, P147, DOI 10.1007/s12250-016-3929-8; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Ishihara G, 2013, VIRUS RES, V174, P52, DOI 10.1016/j.virusres.2013.02.014; Javed MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02115-16; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kawaguchi Y, 2013, FEBS LETT, V587, P3943, DOI 10.1016/j.febslet.2013.10.021; Ke JH, 2008, VIROLOGY, V374, P421, DOI 10.1016/j.virol.2007.12.033; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LU A, 1995, J VIROL, V69, P6265, DOI 10.1128/JVI.69.10.6265-6272.1995; Martignoni ME, 1986, CATALOG VIRAL DIS IN, P897; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; MORRIS TD, 1994, VIROLOGY, V200, P360; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; O'Reilly DR, 1997, BACULOVIRUSES; Olson VA, 2002, J VIROL, V76, P9505, DOI 10.1128/JVI.76.18.9505-9515.2002; PASSARELLI AL, 1994, J VIROL, V68, P1186, DOI 10.1128/JVI.68.2.1186-1190.1994; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack JM, 1997, J VIROL, V71, P9579, DOI 10.1128/JVI.71.12.9579-9587.1997; Solovyev A. V., 2009, ENTOMOFAUNA, V16, P193; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Sugiura N, 2013, GLYCOBIOLOGY, V23, P1520, DOI 10.1093/glycob/cwt082; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Xianchun, 1993, Virologica Sinica, V8, P158; THIEM SM, 1989, J VIROL, V63, P2008, DOI 10.1128/JVI.63.5.2008-2018.1989; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155134; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Xiang XW, 2011, VIRUS RES, V158, P72, DOI 10.1016/j.virusres.2011.03.012; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	68	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192279	10.1371/journal.pone.0192279	http://dx.doi.org/10.1371/journal.pone.0192279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390020	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400086
J	Guan, HJ; Dai, ZL; Zhao, AW; He, J				Guan, Hongjun; Dai, Zongli; Zhao, Aiwu; He, Jie			A novel stock forecasting model based on High-order-fuzzy-fluctuation Trends and Back Propagation Neural Network	PLOS ONE			English	Article							TIME-SERIES; ENERGY; SYSTEM	In this paper, we propose a hybrid method to forecast the stock prices called High-order-fuzzy-fluctuation-Trends-based Back Propagation(HTBP) Neural Network model. First, we compare each value of the historical training data with the previous day's value to obtain a fluctuation trend time series (FTTS). On this basis, the FTTS blur into fuzzy time series (FFTS) based on the fluctuation of the increasing, equality, decreasing amplitude and direction. Since the relationship between FFTS and future wave trends is nonlinear, the HTBP neural network algorithm is used to find the mapping rules in the form of self-learning. Finally, the results of the algorithm output are used to predict future fluctuations. The proposed model provides some innovative features:(1) It combines fuzzy set theory and neural network algorithm to avoid overfitting problems existed in traditional models. (2) BP neural network algorithm can intelligently explore the internal rules of the actual existence of sequential data, without the need to analyze the influence factors of specific rules and the path of action. (3) The hybrid modal can reasonably remove noises from the internal rules by proper fuzzy treatment. This paper takes the TAIEX data set of Taiwan stock exchange as an example, and compares and analyzes the prediction performance of the model. The experimental results show that this method can predict the stock market in a very simple way. At the same time, we use this method to predict the Shanghai stock exchange composite index, and further verify the effectiveness and universality of the method.	[Guan, Hongjun; Dai, Zongli; He, Jie] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China; [Zhao, Aiwu] Jiangsu Univ, Sch Management, Zhenjiang, Jiangsu, Peoples R China	Shandong University of Finance & Economics; Jiangsu University	Zhao, AW (corresponding author), Jiangsu Univ, Sch Management, Zhenjiang, Jiangsu, Peoples R China.	aiwuzh@126.comor			National Natural Science Foundation of China [71471076]; Ministry of Education of Humanities and Social Sciences [14YJAZH025]; China Nation Tourism Administration [15TACK003]; Natural Science Foundation of Shandong Province [ZR2013GM003]; Foundation Program of Jiangsu University [16JDG005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of Humanities and Social Sciences; China Nation Tourism Administration; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation Program of Jiangsu University	This work was supported by the National Natural Science Foundation of China 71471076 to Aiwu Zhao; The Fund of the Ministry of Education of Humanities and Social Sciences 14YJAZH025 to Dr. Hongjun Guan; The Fund of the China Nation Tourism Administration 15TACK003 to Dr. Hongjun Guan; The Natural Science Foundation of Shandong Province ZR2013GM003 to Dr. Hongjun Guan and the Foundation Program of Jiangsu University 16JDG005 to Aiwu Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot J, 2017, ATMOS RES, V197, P289, DOI 10.1016/j.atmosres.2017.07.015; Aladag CH, 2009, EXPERT SYST APPL, V36, P4228, DOI 10.1016/j.eswa.2008.04.001; Badrzadeh H, 2013, J HYDROL, V507, P75, DOI 10.1016/j.jhydrol.2013.10.017; Bing Y., 2012, ADV ENG FORUM, V6-7, P1055; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Chen SM, 2013, IEEE T CYBERNETICS, V43, P1102, DOI 10.1109/TSMCB.2012.2223815; Chen SM, 2011, IEEE T FUZZY SYST, V19, P1, DOI 10.1109/TFUZZ.2010.2073712; Chen SM, 2010, INFORM SCIENCES, V180, P4772, DOI 10.1016/j.ins.2010.08.026; Chen SM, 2017, FUZZY FORECASTING BA; Chen SM, 2013, TAIEX FORECASTING BA; Cheng SH, 2016, INFORM SCIENCES, V327, P272, DOI 10.1016/j.ins.2015.08.024; Daut MAM, 2017, RENEW SUST ENERG REV, V70, P1108, DOI 10.1016/j.rser.2016.12.015; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng ZH, 2015, IEEE T FUZZY SYST, V23, P813, DOI 10.1109/TFUZZ.2014.2328014; Dumitru CD, 2017, PROCEDIA ENGINEER, V181, P829, DOI 10.1016/j.proeng.2017.02.474; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Friedman M, 1939, J AM STAT ASSOC, V34, P109, DOI 10.2307/2279169; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Guan HJ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9090191; GUAN S, 2017, SYMMETRY-BASEL, V9, DOI DOI 10.3390/SYM9100207; Herrera F, 1996, FUZZY SET SYST, V78, P73, DOI 10.1016/0165-0114(95)00107-7; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Jenkins GM., 1976, TIME SERIES ANAL FOR, P303; Jia JY, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9070124; Jiang YZ, 2017, IEEE T SYST MAN CY-S, V47, P145, DOI 10.1109/TSMC.2016.2577558; Kisi O, 2012, COMPUT GEOSCI-UK, V41, P169, DOI 10.1016/j.cageo.2011.08.027; Mishra D, 2015, ATMOS ENVIRON, V102, P239, DOI 10.1016/j.atmosenv.2014.11.050; Nemenyi P. B., 1963, THESIS; Ratnayaka RMKT, 2015, PROCEEDINGS OF 2015 IEEE INTERNATIONAL CONFERENCE ON BEHAVIORAL, ECONOMIC, SOCIO-CULTURAL COMPUTING (BESC), P54, DOI 10.1109/BESC.2015.7365958; Raza MQ, 2015, RENEW SUST ENERG REV, V50, P1352, DOI 10.1016/j.rser.2015.04.065; Sadaei HJ, 2017, INT J APPROX REASON, V83, P196, DOI 10.1016/j.ijar.2017.01.006; Song Q, 1993, FORECASTING ENROLL 1; Song Q., 1994, FUZZY SETS SYST; Song Q, 1993, FUZZY SETS SYST; Tu CC, 2012, EXPERT SYST APPL, V39, P2479, DOI 10.1016/j.eswa.2011.08.100; Wang JZ, 2011, EXPERT SYST APPL, V38, P14346, DOI 10.1016/j.eswa.2011.04.222; Wang LX, 2017, IEEE T FUZZY SYST, V25, P277, DOI 10.1109/TFUZZ.2016.2574911; Wu JM, 2016, J ADV CERAM, V5, P176, DOI 10.1007/s40145-016-0187-z; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	40	19	21	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192366	10.1371/journal.pone.0192366	http://dx.doi.org/10.1371/journal.pone.0192366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420584	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900067
J	Oh, SY; Kim, M; Eimes, JA; Lim, YW				Oh, Seung-Yoon; Kim, Misong; Eimes, John A.; Lim, Young Woon			Effect of fruiting body bacteria on the growth of Tricholoma matsutake and its related molds	PLOS ONE			English	Article							HELPER BACTERIA; PSEUDOMONAS-FLUORESCENS; EWINGELLA-AMERICANA; ANTIFUNGAL ACTIVITY; IN-VITRO; SP NOV.; MUSHROOM; BODIES; FUNGI; IDENTIFICATION	Tricholoma matsutake (pine mushroom, PM) is a prized mushroom in Asia due to its unique flavor and pine aroma. The fruiting body of PM forms only in its natural habitat (pine forest), and little is known regarding the natural conditions required for successful generation of the fruiting bodies in this species. Recent studies suggest that microbial interactions may be associated with the growth of PM; however, there have been few studies of the bacterial effects on PM growth. In this study, we surveyed which bacteria can directly and indirectly promote the growth of PM by using co-cultures with PM and molds associated with the fruiting body. Among 16 bacterial species isolated from the fruiting body, some species significantly influenced the mycelial growth of PM and molds. Most bacteria negatively affected PM growth and exhibited various enzyme activities, which suggests that they use the fruiting body as nutrient source. However, growth-promoting bacteria belonging to the Dietzia, Ewingella, Pseudomonas, Paenibacillus, and Rodococcus were also found. In addition, many bacteria suppressed molds, which suggests an indirect positive effect on PM as a biocontrol agent. Our results provide important insights toward a better understanding of the microbial interactions in the fruiting body of PM, and indicate that growth-promoting bacteria may be an important component in successful cultivation of PM.	[Oh, Seung-Yoon; Kim, Misong; Lim, Young Woon] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Eimes, John A.] Sungkyunkwan Univ, Univ Coll, Suwon, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU)	Lim, YW (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	ywlim@snu.ac.kr	Oh, Seung-Yoon/H-4958-2018	Oh, Seung-Yoon/0000-0002-9745-1849				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend A, 2010, CONSERV GENET, V11, P795, DOI 10.1007/s10592-009-9894-0; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernas E, 2006, ACTA SCI POLON-TECHN, V5, P5; BOWEN GD, 1979, SOIL BIOL BIOCHEM, V11, P119, DOI 10.1016/0038-0717(79)90087-7; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; Brick D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05739-6; Brule C, 2001, SOIL BIOL BIOCHEM, V33, P1683, DOI 10.1016/S0038-0717(01)00090-6; Chen HB, 2010, BIOCHEM ENG J, V49, P337, DOI 10.1016/j.bej.2010.01.008; Choi In-Young, 2010, Mycobiology, V38, P310, DOI 10.4489/MYCO.2010.38.4.310; Dahm H, 2003, B POL ACAD BIOL SCI, V3, P167; DANELL E, 1993, MYCOL RES, V97, P1148, DOI 10.1016/S0953-7562(09)80519-4; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DUPONNOIS R, 1991, ANN SCI FOREST, V48, P239, DOI 10.1051/forest:19910301; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Gazzanelli G, 1999, SYMBIOSIS, V26, P211; Guerin-Laguette Alexis, 2003, Mycological Progress, V2, P37, DOI 10.1007/s11557-006-0042-7; Hoster F, 2005, APPL MICROBIOL BIOT, V66, P434, DOI 10.1007/s00253-004-1664-9; Inglis PW, 1997, FEMS MICROBIOL LETT, V157, P189, DOI 10.1016/S0378-1097(97)00475-8; Inglis PW, 1996, MICROBIOL-UK, V142, P3253, DOI 10.1099/13500872-142-11-3253; Izo I., 1964, J JPN SOC NUTR FOOD, V17, P69; Ka Kang-Hyeon, 1999, Korean Journal of Mycology, V27, P345; KANG A-S, 1989, Korean Journal of Mycology, V17, P51; Kataoka R, 2012, J MICROBIOL, V50, P199, DOI 10.1007/s12275-012-1371-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAZANAS N, 1987, J FOOD PROTECT, V50, P933, DOI 10.4315/0362-028X-50.11.933; Kobayashi DY, 2002, APPL ENVIRON MICROB, V68, P1047, DOI 10.1128/AEM.68.3.1047-1054.2002; Kredics L., 2010, CURRENT RES TECHNOLO, P295; Kumari D, 2013, ANN MICROBIOL, V63, P845, DOI 10.1007/s13213-012-0535-3; LANYI B, 1987, METHOD MICROBIOL, V19, P1; Lee H, 2015, BIORESOURCES, V10, P8450; Lee Won-Ho, 2007, Mycobiology, V35, P54, DOI 10.4489/MYCO.2007.35.2.054; Leon M, 2009, Int J Microbiol, V2009, P572049, DOI 10.1155/2009/572049; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Li Q, 2016, MICROBIOLOGY+, V85, P531, DOI 10.1134/S0026261716050106; Li Q, 2016, J MICROBIOL BIOTECHN, V26, P89, DOI 10.4014/jmb.1505.05008; Liu G, 2010, J MED PLANTS RES, V4, P1222; Miles P.G., 1997, MUSHROOM BIOL CONCIS; 김인엽, 2005, [The Korean Journal of Mycology, 한국균학회지], V33, P22; Nagy A., 2012, IOBC/WPRS Bulletin, V78, P289; Nielsen MN, 1999, FEMS MICROBIOL ECOL, V30, P217, DOI 10.1111/j.1574-6941.1999.tb00650.x; OGAWA M, 1976, T MYCOL SOC JPN, V17, P492; Oh SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168573; ORDENTLICH A, 1988, PHYTOPATHOLOGY, V78, P84; Park MS, 2014, ANTON LEEUW INT J G, V106, P593, DOI 10.1007/s10482-014-0230-4; Pavic A, 2013, FUNGAL ECOL, V6, P527, DOI 10.1016/j.funeco.2013.05.006; Pent M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00836; RAINEY PB, 1991, MYCOL RES, V95, P699, DOI 10.1016/S0953-7562(09)80817-4; RAINEY PB, 1991, PHYSIOL MOL PLANT P, V39, P57, DOI 10.1016/0885-5765(91)90031-C; Ramirez-Bahena MH, 2015, INT J SYST EVOL MICR, V65, P2110, DOI 10.1099/ijs.0.000230; Rangel-Castro JI, 2002, MYCOLOGIA, V94, P190, DOI 10.2307/3761795; 유영현, 2011, [The Korean Journal of Mycology, 한국균학회지], V39, P223; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; RUDAKOV OL, 1978, MYCOLOGIA, V70, P150, DOI 10.2307/3758695; Sbrana C, 2000, CAN J MICROBIOL, V46, P259, DOI 10.1139/cjm-46-3-259; Schrey SD, 2005, NEW PHYTOL, V168, P205, DOI 10.1111/j.1469-8137.2005.01518.x; Someya Nobutaka, 2001, Journal of General Plant Pathology, V67, P312, DOI 10.1007/PL00013038; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; Splivallo R, 2015, ENVIRON MICROBIOL, V17, P2647, DOI 10.1111/1462-2920.12521; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng WL, 2001, CARBOHYD RES, V332, P305, DOI 10.1016/S0008-6215(01)00084-2; Tsukamoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P2201, DOI 10.1271/bbb.66.2201; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Varese GC, 1996, SYMBIOSIS, V21, P129; Wang EunJin, 2016, Korean Journal of Mycology, V44, P166; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Williams J, 2003, APPL ENVIRON MICROB, V69, P4192, DOI 10.1128/AEM.69.7.4192-4199.2003; Yamada A, 2006, MYCORRHIZA, V16, P111, DOI 10.1007/s00572-005-0021-x; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zagriadskaia YA, 2013, BIOL BULL+, V40, P358, DOI 10.1134/S106235901304016X; Zagryadskaya YA, 2015, EURASIAN SOIL SCI+, V48, P620, DOI 10.1134/S1064229315060137	76	24	24	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0190948	10.1371/journal.pone.0190948	http://dx.doi.org/10.1371/journal.pone.0190948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420560	Green Submitted, gold, Green Published			2022-12-27	WOS:000424517900008
J	Kilvaer, TK; Rakaee, M; Hellevik, T; Ostman, A; Strell, C; Bremnes, RM; Busund, LT; Donnem, T; Martinez-Zubiaurre, I				Kilvaer, Thomas Karsten; Rakaee, Mehrdad; Hellevik, Turid; Ostman, Arne; Strell, Carina; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom; Martinez-Zubiaurre, Inigo			Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; PREDICTS POOR-PROGNOSIS; STROMAL CELLS; PODOPLANIN EXPRESSION; LYMPH-NODES; E-CADHERIN; IMPACT; ACTIVATION; MARKER; COMPARTMENT	Objectives Selective targeting of cancer-associated fibroblasts (CAFs) has been proposed to synergize with immune-checkpoint inhibitors. While the roles of CAFs in cancer development are well described, their immune-regulatory properties remain incompletely understood. This study investigates correlations between CAF and immune-markers in tumor stroma from non-small cell lung cancer (NSCLC) patients, and examines whether a combination of CAF and immune cell scores impact patient prognosis. Methods Tumor specimens from 536 primary operable stage I-III NSCLC patients were organized in tissue microarrays. Expression of protein-markers was evaluated by immunohistochemistry. Results Fibroblast and stromal markers PDGFR alpha, PDGFR beta, FAP-1 and vimentin showed weak correlations while alpha SMA, and Masson's trichrome did not correlate with any of the investigated markers. Hierarchical clustering indicated the existence of different CAF-subsets. No relevant correlations were found between any CAF-marker and the immune-markers CD3, CD4, CD8, CD20, CD68, CD1a, CD56, FoxP3 and CD45RO. High density of fibroblast-activation protein positive mesenchymal cells (CAF(FAP)) was associated with better prognosis in tumors with high infiltration of CD8 and CD3 T-lymphocytes. Conclusions The presented data suggest that CAFs, irrespective of identity, have low influence on the degree of tumor infiltration by inflammatory-and/or immune-cells. However, CAF(FAP) may exert immuno-adjuvant roles in NSCLC, and targeting CAFs should be cautiously considered.	[Kilvaer, Thomas Karsten; Hellevik, Turid; Bremnes, Roy M.; Donnem, Tom] Univ Hosp Northern Norway, Dept Oncol, Tromso, Norway; [Kilvaer, Thomas Karsten; Bremnes, Roy M.; Donnem, Tom; Martinez-Zubiaurre, Inigo] UiT Artic Univ Norway, Dept Clin Med, Tromso, Norway; [Rakaee, Mehrdad; Busund, Lill-Tove] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Ostman, Arne; Strell, Carina] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Busund, Lill-Tove] Univ Hosp Northern Norway, Dept Clin Pathol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Karolinska Institutet; UiT The Arctic University of Tromso; University Hospital of North Norway	Martinez-Zubiaurre, I (corresponding author), UiT Artic Univ Norway, Dept Clin Med, Tromso, Norway.	inigo.martinez@uit.no	Rakaee, Mehrdad/GMX-0729-2022; Kilvaer, Thomas/AAI-7418-2020	Rakaee, Mehrdad/0000-0002-9080-0153; Kilvaer, Thomas/0000-0003-1669-0117; Hellevik, Turid/0000-0002-7979-5189; Strell, Carina/0000-0002-3783-7256; Martinez, Inigo/0000-0001-5408-9088	Northern Norway Regional Health Authority [SPP1137-13, SFP1138-13]; Norwegian Cancer Society [9223]; Erna & Olav Aakre Foundation for Cancer Research; UiT The Arctic University of Norway	Northern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Erna & Olav Aakre Foundation for Cancer Research; UiT The Arctic University of Norway	This work was supported by the Northern Norway Regional Health Authority with URL: https://helse-nord.no/ (grant no: SPP1137-13 to TH and SFP1138-13), the Norwegian Cancer Society with URL: https://kreftforeningen.no; (grant no: 9223 to IMZ) and Erna & Olav Aakre Foundation for Cancer Research to IMZ. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank pathologists Samer Al-Saad, Khalid Al-Shibli and Elin Richardsen for providing human lung tissue samples. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Al-Shibli K, 2009, HISTOPATHOLOGY, V55, P301, DOI 10.1111/j.1365-2559.2009.03379.x; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Barnas JL, 2010, CANCER MICROENVIRON, V3, P29, DOI 10.1007/s12307-010-0044-5; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chen YB, 2014, TUMOR BIOL, V35, P6707, DOI 10.1007/s13277-014-1908-y; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; De Boeck A, 2013, PROTEOMICS, V13, P379, DOI 10.1002/pmic.201200179; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Donnem T, 2010, ANN ONCOL, V21, P223, DOI 10.1093/annonc/mdp296; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Edlund K, 2012, INT J CANCER, V131, P2264, DOI 10.1002/ijc.27518; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Hellevik T, 2013, TRANSL ONCOL, V6, P66, DOI 10.1593/tlo.12349; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kilvaer TK, 2016, BRIT J CANCER, V114, P1145, DOI 10.1038/bjc.2016.92; Kilvaer TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134965; Kitano H, 2010, ARCH PATHOL LAB MED, V134, P1520, DOI 10.1043/2009-0114-OA.1; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Koriyama H, 2015, J CANCER RES CLIN, V141, P1163, DOI 10.1007/s00432-014-1891-0; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P623, DOI 10.14670/HH-17.623; Leinonen T, 2008, HISTOL HISTOPATHOL, V23, P693, DOI 10.14670/HH-23.693; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mattsson JSM, 2015, CANCER LETT, V356, P837, DOI 10.1016/j.canlet.2014.10.032; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Neri S, 2012, ANN SURG ONCOL, V19, P3953, DOI 10.1245/s10434-012-2421-4; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Paulsen EE, 2015, NEOPLASIA, V17, P839, DOI 10.1016/j.neo.2015.11.004; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Rakaee M, 2016, ONCOTARGET, V7, P72184, DOI 10.18632/oncotarget.12360; Reid A, 2013, CHEST, V144, DOI 10.1378/chest.1662734; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shu H, 2012, NEOPLASMA, V59, P658, DOI 10.4149/neo_2012_083; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Takahashi A, 2015, ONCOTARGET, V6, P9531, DOI 10.18632/oncotarget.3371; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902	51	28	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192157	10.1371/journal.pone.0192157	http://dx.doi.org/10.1371/journal.pone.0192157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415055	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300054
J	Liu, YE; Tong, CC; Zhang, YB; Cong, PF; Shi, XY; Liu, Y; Shi, L; Tong, Z; Jin, HX; Hou, MX				Liu, Yun-En; Tong, Cang-Ci; Zhang, Yu-Biao; Cong, Pei-Fang; Shi, Xiu-Yun; Liu, Ying; Shi, Lin; Tong, Zhou; Jin, Hong-Xu; Hou, Ming-Xiao			Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; OXIDATIVE STRESS; BIOLOGICAL-ACTIVITIES; INFLAMMATION; ACTIVATION; APOPTOSIS; CELLS; RATS; CHITOOLIGOSACCHARIDES; MITOCHONDRIA	Objective To investigate the protective effect of chitosan oligosaccharide (COS) on acute lung injury (ALI) caused by blast injury, and explore possible molecular mechanisms. Methods A mouse model of blast injury-induced ALI was established using a self-made explosive device. Thirty mice were randomly assigned to control, ALI and ALI + COS groups. An eight-channel physiological monitor was used to determine the mouse physiological index. Enzyme linked immunosorbent assay was used to measure serum inflammatory factors. Hematoxylin-eosin staining, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, immunofluorescence staining, real time-polymerase chain reaction and western blot assay were used to detect inflammatory reactions, oxidative stress and apoptosis. Results Mice were sacrificed 24 hours after successful model induction. Compared with the ALI group, the heart rate, respiration and PCO2 were significantly lower, but the PO2, TCO2 and HCO3- were significantly higher in the ALI + COS group. Compared to ALI alone, COS treatment of ALI caused a significant decrease in the wet/dry lung weight ratio, indicating a reduction in lung edema, inflammatory cell infiltration, levels of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-4, IL-6 and nuclear factor kappa B mRNA and protein expression were reduced and IL-10 mRNA and protein expression was increased (P<0.05). COS significantly inhibited reactive oxygen species, MDA5 and IRE alpha mRNA and protein expressions, cell apoptosis and Bax and Caspase-3 mRNA and protein expressions, and significantly increased superoxide dismutase-1 mRNA expression, and Bcl-2 and Caspase-8 mRNA and protein expression (all P<0.05). COS significantly increased dimethylarginine dimethylaminohydrolase 1 (DDAH1) protein expression, and reduced ADMA and p38 protein expression (P<0.05). Conclusion Blast injury causes inflammation, oxidative stress and apoptosis in the lung tissues of mice. COS has protective effects on blast injury-induced ALI, possibly by promoting DDAH1 expression and inhibiting ADMA and mitogen-activated protein kinase pathways.	[Liu, Yun-En; Tong, Cang-Ci; Zhang, Yu-Biao; Cong, Pei-Fang; Shi, Xiu-Yun; Liu, Ying; Shi, Lin; Tong, Zhou; Jin, Hong-Xu; Hou, Ming-Xiao] PLA, Emergency Med Dept, Gen Hosp Shenyang Mil Command, Lab Rescue,Ctr Severe Wound & Trauma, Shenyang, Liaoning, Peoples R China		Hou, MX (corresponding author), PLA, Emergency Med Dept, Gen Hosp Shenyang Mil Command, Lab Rescue,Ctr Severe Wound & Trauma, Shenyang, Liaoning, Peoples R China.	houmingxiao188@163.com	Yunen, Liu/X-4121-2019		Liaoning Province Key Scientific and Technological Project [2012125007, 2013225089, 20170540947]; PLA Foundation of China [CSY12J002, AMS14L008]	Liaoning Province Key Scientific and Technological Project; PLA Foundation of China	This work was supported by the grants of Liaoning Province Key Scientific and Technological Project (No. 2012125007; No. 2013225089; No. 20170540947), and PLA Foundation of China during the Twelfth Five-year Plan Period (No. CSY12J002; No. AMS14L008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekera AT, 2016, DIABETES METAB, V42, P378, DOI 10.1016/j.diabet.2016.05.002; Aminzadeh A, 2017, METAB BRAIN DIS, V32, P819, DOI 10.1007/s11011-017-9976-5; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Buhrer Steven, 2012, Air Med J, V31, P10, DOI 10.1016/j.amj.2011.10.005; Calabrese C, 2015, Minerva Med, V106, P9; Charytan DM, 2012, CIRCULATION, V126, pS164, DOI 10.1161/CIRCULATIONAHA.111.083568; Chou TC, 2003, BIOCHEM BIOPH RES CO, V308, P403, DOI 10.1016/S0006-291X(03)01407-4; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Hewedy WA, 2016, PHARMACOL REP, V68, P1319, DOI 10.1016/j.pharep.2016.08.009; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Huang B, 2016, J AGR FOOD CHEM, V64, P245, DOI 10.1021/acs.jafc.5b05195; Huang HC, 2015, NEUROTOX RES, V27, P411, DOI 10.1007/s12640-014-9512-x; Jangale NM, 2016, J PHYSIOL BIOCHEM, V72, P327, DOI 10.1007/s13105-016-0482-8; Jia SL, 2016, INT J BIOL MACROMOL, V83, P416, DOI 10.1016/j.ijbiomac.2015.11.011; Kim HY, 2016, CYTOKINE, V77, P203, DOI 10.1016/j.cyto.2015.09.002; Kim JA, 2017, BMB REP, V50, P257, DOI 10.5483/BMBRep.2017.50.5.023; Kinker KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085148; Kunanusornchai W, 2016, PHARMACOL RES, V113, P458, DOI 10.1016/j.phrs.2016.09.016; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Li CJ, 2016, GENE REGUL SYST BIO, V10, P1, DOI 10.4137/GRSB.S35607; Li KC, 2016, CARBOHYD POLYM, V139, P178, DOI 10.1016/j.carbpol.2015.12.016; Li TM, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5602142; Lin YC, 2017, MOL IMMUNOL, V83, P82, DOI 10.1016/j.molimm.2017.01.009; Lind L, 2013, VASC MED, V18, P192, DOI 10.1177/1358863X13496488; Luneburg N, 2016, PULM MED, V2016, DOI 10.1155/2016/6578578; Matrozova J, 2016, INT J ENDOCRINOL MET, V14, DOI 10.5812/ijem.30324; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Seferian PG, 2000, VACCINE, V19, P661, DOI 10.1016/S0264-410X(00)00248-6; Wada-Hiraike O, 2006, BIOCHEM SOC T, V34, P1114, DOI 10.1042/BST0341114; Wang HY, 2016, BBA-GEN SUBJECTS, V1860, P2793, DOI 10.1016/j.bbagen.2016.03.022; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xu W, 2010, BIOORG MED CHEM LETT, V20, P3084, DOI 10.1016/j.bmcl.2010.03.105; Zhang Jianfeng, 2017, BIOMED RES INT, V2017, P1, DOI DOI 10.1002/SMTD.201700258	39	22	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192135	10.1371/journal.pone.0192135	http://dx.doi.org/10.1371/journal.pone.0192135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415054	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300052
J	Rickert, C; Luer, K; Vef, O; Technau, GM				Rickert, Christof; Lueer, Karin; Vef, Olaf; Technau, Gerhard M.			Progressive derivation of serially homologous neuroblast lineages in the gnathal CNS of Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; EMBRYONIC CNS; GENE-EXPRESSION; IDENTIFIED NEUROBLASTS; MOLECULAR MARKERS; BRAIN-DEVELOPMENT; HOMEOBOX GENES; INSECT BRAIN; MELANOGASTER	Along the anterior-posterior axis the central nervous system is subdivided into segmental units (neuromeres) the composition of which is adapted to their region-specific functional requirements. In Drosophila melanogaster each neuromere is formed by a specific set of identified neural stem cells (neuroblasts, NBs). In the thoracic and anterior abdominal region of the embryonic ventral nerve cord segmental sets of NBs resemble the ground state (2nd thoracic segment, which does not require input of homeotic genes), and serial (segmental) homologs generate similar types of lineages. The three gnathal head segments form a transitional zone between the brain and the ventral nerve cord. It has been shown recently that although all NBs of this zone are serial homologs of NBs in more posterior segments, they progressively differ from the ground state in anterior direction (labial > maxillary > mandibular segment) with regard to numbers and expression profiles. To study the consequences of their derived characters we traced the embryonic lineages of gnathal NBs using the Flybow and Dil-labelling techniques. For a number of clonal types serial homology is rather clearly reflected by their morphology (location and projection patterns) and cell specific markers, despite of reproducible segment-specific differences. However, many lineages, particularly in the mandibular segment, show a degree of derivation that impedes their assignment to ground state serial homologs. These findings demonstrate that differences in gene expression profiles of gnathal NBs go along with anteriorly directed progressive derivation in the composition of their lineages. Furthermore, lineage sizes decrease from labial to mandibular segments, which in concert with decreasing NB-numbers lead to reduced volumes of gnathal neuromeres, most significantly in the mandibular segment.	[Rickert, Christof; Lueer, Karin; Vef, Olaf; Technau, Gerhard M.] Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, JJ Becherweg 32, Mainz, Germany	Johannes Gutenberg University of Mainz	Rickert, C; Technau, GM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, JJ Becherweg 32, Mainz, Germany.	rickert@uni-mainz.de; technau@uni-mainz.de			German Research Foundation (DFG) [TE 130/10-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG) to GMT (Grant TE 130/10-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgardt M, 2014, DEV CELL, V30, P192, DOI 10.1016/j.devcel.2014.06.021; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Becker H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005961; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Birkholz O, 2015, BIOL OPEN, V4, P420, DOI 10.1242/bio.201411072; Birkholz O, 2013, DEVELOPMENT, V140, P1830, DOI 10.1242/dev.090043; Bivik C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005984; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Boyan G, 2003, ARTHROPOD STRUCT DEV, V32, P61, DOI 10.1016/S1467-8039(03)00037-9; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Cobeta IM, 2017, CURR BIOL, V27, P1161, DOI 10.1016/j.cub.2017.03.023; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; Dittrich R, 1997, DEVELOPMENT, V124, P2515; DOE CQ, 1992, DEVELOPMENT, V116, P855; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Friedrich J, 2016, CELL REP, V14, P850, DOI 10.1016/j.celrep.2015.12.077; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Gunnar E, 2016, DEVELOPMENT, V143, P3774, DOI 10.1242/dev.139998; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P213; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hartenstein V, 2017, J COMP NEUROL; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hirth F, 1998, DEVELOPMENT, V125, P1579; Huckesfeld S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135011; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jagla K, 1997, DEVELOPMENT, V124, P91; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Kendroud S, 2017, J COMP NEUROL; Kuert PA, 2014, DEV BIOL, V390, P102, DOI 10.1016/j.ydbio.2014.03.021; Lacin H, 2016, ELIFE, V5, DOI 10.7554/eLife.13399; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Nassif C, 1998, J COMP NEUROL, V402, P10; Page DT, 2004, EVOL DEV, V6, P25, DOI 10.1111/j.1525-142X.2004.04003.x; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Peterson C, 2002, DEVELOPMENT, V129, P1467; PROKOP A, 1991, DEVELOPMENT, V111, P79; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Ruiz S, 2010, GENE EXPR PATTERNS, V10, P274, DOI 10.1016/j.gep.2010.06.001; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shimosako N, 2014, METHODS MOL BIOL, V1082, P57, DOI 10.1007/978-1-62703-655-9_4; SKEATH JB, 1995, NATURE, V376, P427, DOI 10.1038/376427a0; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Technau GM, 2014, J NEUROGENET, V28, P171, DOI 10.3109/01677063.2013.868459; TECHNAU GM, 1985, ROUX ARCH DEV BIOL, V194, P196; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; UDOLPH G, 1993, DEVELOPMENT, V118, P765; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532; Urbach R, 2016, DEVELOPMENT, V143, P1290, DOI 10.1242/dev.133546; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wreden CC, 2017, CURR BIOL, V27, P1521, DOI 10.1016/j.cub.2017.04.024; YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7	65	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191453	10.1371/journal.pone.0191453	http://dx.doi.org/10.1371/journal.pone.0191453			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415052	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300028
J	Saavedra, I; Amo, L				Saavedra, Irene; Amo, Luisa			Insectivorous birds eavesdrop on the pheromones of their prey	PLOS ONE			English	Article							VOLE SCENT MARKS; DIMETHYL SULFIDE; OLFACTORY NAVIGATION; OPEROPHTERA-BRUMATA; ODOR RECOGNITION; KIN RECOGNITION; SEX-PHEROMONE; WINTER MOTH; PREDATION; TITS	Chemical cues play a fundamental role in mate attraction and mate choice. Lepidopteran females, such as the winter moth (Operophtera brumata), emit pheromones to attract males in the reproductive period. However, these chemical cues could also be eavesdropped by predators. To our knowledge, no studies have examined whether birds can detect pheromones of their prey. O. brumata adults are part of the winter diet of some insectivorous tit species, such as the great tit (Parus major) and blue tit (Cyanistes caeruleus). We performed a field experiment aimed to disentangle whether insectivorous birds can exploit the pheromones emitted by their prey for prey location. We placed artificial larvae and a dispenser on branches of Pyrenean oak trees (Quercus pyrenaica). In half of the trees we placed an O. brumata pheromone dispenser and in the other half we placed a control dispenser. We measured the predation rate of birds on artificial larvae. Our results show that more trees had larvae with signs of avian predation when they contained an O. brumata pheromone than when they contained a control dispenser. Furthermore, the proportion of artificial larvae with signs of avian predation was greater in trees that contained the pheromone than in control trees. Our results indicate that insectivorous birds can exploit the pheromones emitted by moth females to attract males, as a method of prey detection. These results highlight the potential use of insectivorous birds in the biological control of insect pests.	[Saavedra, Irene; Amo, Luisa] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Saavedra, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain.	irene.saavedra.garces@gmail.com	Amo, Luisa/K-5960-2014; Saavedra, Irene/AAA-4640-2021	Amo, Luisa/0000-0003-4621-3493; 	Ministry of Economy and Competitiveness [CGL2014-58890-P]; FPI grant from Spanish Ministry of Economy and Competitiveness; Ramon y Cajal programme	Ministry of Economy and Competitiveness; FPI grant from Spanish Ministry of Economy and Competitiveness; Ramon y Cajal programme(Spanish Government)	This work was supported by the Ministry of Economy and Competitiveness (CGL2014-58890-P).; We especially thank L.M. Carrascal for statistical advice and I. Lopez Rull for spectral measurements. We also thank Jose Luis Viejo Montesinos for entomological information and the Oficina Comarcal Agroambiental-Comarca del Jiloca for their help with O. brumata phenology. I. Saavedra was supported by a FPI grant from Spanish Ministry of Economy and Competitiveness. L. Amo was supported by Ramon y Cajal programme.	Alma P. J., 1970, Entomologist's mon. Mag., V105, P258; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2004, J HERPETOL, V38, P451, DOI 10.1670/177-03N; Amo L, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2281-9; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Amo L, 2013, MAR ECOL PROG SER, V474, P277, DOI 10.3354/meps10081; Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; [Anonymous], 2014, PHEROMONES ANIMAL BE; ASKENMO C, 1977, OIKOS, V28, P90, DOI 10.2307/3543327; BESTMANN HJ, 1982, TETRAHEDRON LETT, V23, P4007, DOI 10.1016/S0040-4039(00)88681-5; BETTS MM, 1955, J ANIM ECOL, V24, P282, DOI 10.2307/1715; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bradbury Jack W., 1998, pi; Carde R. T., 1984, CHEM ECOLOGY INSECTS, P355, DOI DOI 10.1007/978-1-4899-3368-3_13; Caro SP, 2015, HORM BEHAV, V68, P25, DOI 10.1016/j.yhbeh.2014.06.001; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Cross JV, 1999, BIOCONTROL SCI TECHN, V9, P125, DOI 10.1080/09583159929721; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; CUSHING BS, 1984, ANIM BEHAV, V32, P1263, DOI 10.1016/S0003-3472(84)80250-X; Darwin Charles, 1871, DESCENT MAN; Eichholz MW, 2012, AUK, V129, P638, DOI 10.1525/auk.2012.12040; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GRAVES GR, 1992, J RAPTOR RES, V26, P38; Gunnarsson B, 1996, J ANIM ECOL, V65, P389, DOI 10.2307/5885; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagelin JC, 2004, IBIS, V146, P161, DOI 10.1111/j.1474-919X.2004.00212.x; Harari AR, 2011, EVOLUTION, V65, P1572, DOI 10.1111/j.1558-5646.2011.01252.x; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P11; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; Hughes NK, 2012, ECOL LETT, V15, P1326, DOI 10.1111/j.1461-0248.2012.01856.x; Hughes NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013114; JAIN SC, 1983, J ORG CHEM, V48, P2274, DOI 10.1021/jo00161a026; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Koivula M, 1999, J AVIAN BIOL, V30, P329, DOI 10.2307/3677362; Koski TM, 2015, ETHOLOGY, V121, P1131, DOI 10.1111/eth.12426; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krebs JR, 1983, BEHAV ECOLOGY EVOLUT, P380; Mantyla E, 2004, ECOL LETT, V7, P915, DOI 10.1111/j.1461-0248.2004.00653.x; Mantyla E, 2017, J ORNITHOL, V158, P479, DOI 10.1007/s10336-016-1412-9; Mantyla E, 2014, ARTHROPOD-PLANT INTE, V8, P143, DOI 10.1007/s11829-014-9296-1; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; Minguez E, 1997, ANIM BEHAV, V53, P701, DOI 10.1006/anbe.1996.0308; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Mrazova A, 2018, ARTHROPOD-PLANT INTE, V12, P1, DOI 10.1007/s11829-017-9558-9; Muiruri EW, 2016, OECOLOGIA, V180, P619, DOI 10.1007/s00442-015-3391-6; Naef-Daenzer B, 1999, J ANIM ECOL, V68, P708, DOI 10.1046/j.1365-2656.1999.00318.x; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Posa MRC, 2007, J TROP ECOL, V23, P27, DOI 10.1017/S0266467406003671; Probst R, 2002, J AVIAN BIOL, V33, P437, DOI 10.1034/j.1600-048X.2002.02760.x; Remmel T, 2011, BIOL J LINN SOC, V104, P1, DOI 10.1111/j.1095-8312.2011.01721.x; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; ROELOFS WL, 1982, SCIENCE, V217, P657, DOI 10.1126/science.217.4560.657; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Sam K, 2015, ECOGRAPHY, V38, P293, DOI 10.1111/ecog.00979; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; Soria S., 1987, LEPIDOPTEROS DEFOLIA, P79; STAGER KE, 1967, AM ZOOL, V7, P415; Stauss MJ, 2005, J AVIAN BIOL, V36, P47, DOI 10.1111/j.0908-8857.2005.02855.x; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; Team RC., 2013, R LANG ENV STAT COMP; Tvardikova K, 2012, J TROP ECOL, V28, P331, DOI 10.1017/S0266467412000235; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Vel'ky M, 2011, FOLIA ZOOL, V60, P228, DOI 10.25225/fozo.v60.i3.a7.2011; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Yang SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116168; Yew JY, 2015, PROG LIPID RES, V59, P88, DOI 10.1016/j.plipres.2015.06.001; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zampiga E, 2006, J AVIAN BIOL, V37, P318, DOI 10.1111/j.2006.0908-8857.03825.x; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	90	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190415	10.1371/journal.pone.0190415	http://dx.doi.org/10.1371/journal.pone.0190415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414994	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300008
J	West, J; Romu, T; Thorell, S; Lindblom, H; Berin, E; Holm, ACS; Astrand, LL; Karlsson, A; Borga, M; Hammar, M; Leinhard, OD				West, Janne; Romu, Thobias; Thorell, Sofia; Lindblom, Hanna; Berin, Emilia; Holm, Anna-Clara Spetz; Astrand, Lotta Lindh; Karlsson, Anette; Borga, Magnus; Hammar, Mats; Leinhard, Olof Dahlqvist			Precision of MRI-based body composition measurements of postmenopausal women	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; TEST-RETEST RELIABILITY; WHOLE-BODY; AUTOMATIC QUANTIFICATION; INSULIN-RESISTANCE; MUSCLE VOLUME; FAT; OBESITY; TOMOGRAPHY; SARCOPENIA	Objectives To determine precision of magnetic resonance imaging (MRI) based fat and muscle quantification in a group of postmenopausal women. Furthermore, to extend the method to individual muscles relevant to upper-body exercise. Materials and methods This was a sub-study to a randomized control trial investigating effects of resistance training to decrease hot flushes in postmenopausal women. Thirty-six women were included, mean age 56 +/- 6 years. Each subject was scanned twice with a 3.0T MR-scanner using a whole-body Dixon protocol. Water and fat images were calculated using a 6-peak lipid model including R2*-correction. Body composition analyses were performed to measure visceral and subcutaneous fat volumes, lean volumes and muscle fat infiltration (MFI) of the muscle groups' thigh muscles, lower leg muscles, and abdominal muscles, as well as the three individual muscles pectoralis, latissimus, and rhomboideus. Analysis was performed using a multi-atlas, calibrated water-fat separated quantification method. Liver-fat was measured as average proton density fat-fraction (PDFF) of three regions-of-interest. Precision was determined with Bland-Altman analysis, repeatability, and coefficient of variation. Results All of the 36 included women were successfully scanned and analysed. The coefficient of variation was 1.1% to 1.5% for abdominal fat compartments (visceral and subcutaneous), 0.8% to 1.9% for volumes of muscle groups (thigh, lower leg, and abdomen), and 2.3% to 7.0% for individual muscle volumes (pectoralis, latissimus, and rhomboideus). Limits of agreement for MFI was within +/- 2.06% for muscle groups and within +/- 5.13% for individual muscles. The limits of agreement for liver PDFF was within +/- 1.9%. Conclusion Whole-body Dixon MRI could characterize a range of different fat and muscle compartments with high precision, including individual muscles, in the study-group of postmenopausal women. The inclusion of individual muscles, calculated from the same scan, enables analysis for specific intervention programs and studies.	[West, Janne; Thorell, Sofia; Lindblom, Hanna; Leinhard, Olof Dahlqvist] Linkoping Univ, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [West, Janne; Romu, Thobias; Thorell, Sofia; Karlsson, Anette; Borga, Magnus; Leinhard, Olof Dahlqvist] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [West, Janne; Romu, Thobias; Borga, Magnus; Leinhard, Olof Dahlqvist] Adv MR Analyt AB, Linkoping, Sweden; [Romu, Thobias; Karlsson, Anette; Borga, Magnus] Linkoping Univ, Dept Biomed Engn IMT, Linkoping, Sweden; [Thorell, Sofia; Berin, Emilia; Holm, Anna-Clara Spetz; Astrand, Lotta Lindh; Hammar, Mats] Linkoping Univ, Dept Clin & Expt Med IKE, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	West, J (corresponding author), Linkoping Univ, Dept Med & Hlth Sci IMH, Linkoping, Sweden.; West, J (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.; West, J (corresponding author), Adv MR Analyt AB, Linkoping, Sweden.	janne.west@liu.se	West, Janne/H-3681-2019; Hammar, Mats/R-7908-2019	West, Janne/0000-0001-8369-0075; Hammar, Mats/0000-0002-4593-7273; Thorell, Sofia/0000-0003-0555-163X; Lindblom, Hanna/0000-0002-1533-6872; Berin, Emilia/0000-0002-3805-8705	Swedish Research Council, Region Ostergotland, Sweden, LIST [2014-2781]	Swedish Research Council, Region Ostergotland, Sweden, LIST	This study was supported by grants from The Swedish Research Council (ID: 2014-2781), Region Ostergotland, Sweden, LIST. JW, TR, MB, and ODL receive salaries and are stock holders of Advanced MR Analytics AB. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bandera EV, 2016, INT J CANCER, V139, P2391, DOI 10.1002/ijc.30248; Baudin PY, 2012, LECT NOTES COMPUT SC, V7510, P569, DOI 10.1007/978-3-642-33415-3_70; Berin E, 2016, MATURITAS, V85, P96, DOI 10.1016/j.maturitas.2015.12.015; Bland JM, 1996, BRIT MED J, V313, P744; Borga M, 2015, NMR BIOMED, V28, P1747, DOI 10.1002/nbm.3432; Bosy-Westphal A, 2013, EUR J CLIN NUTR, V67, pS14, DOI 10.1038/ejcn.2012.160; Brennan DD, 2005, AM J ROENTGENOL, V185, P418, DOI 10.2214/ajr.185.2.01850418; Broderick BJ, 2010, MED ENG PHYS, V32, P926, DOI 10.1016/j.medengphy.2010.06.008; Brunner G, 2011, MAGN RESON IMAGING, V29, P1065, DOI 10.1016/j.mri.2011.02.033; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dahlqvist Leinhard O, 2008, P 19 INT C PATT REC; Daley A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006108.pub4; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Freeman EW, 2007, OBSTET GYNECOL, V110, P230, DOI 10.1097/01.AOG.0000270153.59102.40; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Karlsson A, 2014, J MAGNETIC RESONANCE; Karvonen-Gutierrez C, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030042; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Malietzis G, 2015, EJSO-EUR J SURG ONC, V41, P186, DOI 10.1016/j.ejso.2014.10.056; Middleton MS, 2017, RADIOLOGY, V283, P438, DOI 10.1148/radiol.2017160606; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Newman D, 2016, J MAGN RESON IMAGING, V44, P1464, DOI 10.1002/jmri.25326; Perkisas S, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2010011; Peterson P, 2016, J MAGN RESON IMAGING, V43, P203, DOI 10.1002/jmri.24972; Positano V, 2009, J MAGN RESON IMAGING, V29, P677, DOI 10.1002/jmri.21699; Rose DP, 2015, CANCERS, V7, P2147, DOI 10.3390/cancers7040883; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Thomas MS, 2014, EUR RADIOL, V24, P2279, DOI 10.1007/s00330-014-3226-6; Wald D, 2012, J MAGN RESON IMAGING, V36, P1421, DOI 10.1002/jmri.23775; West JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148657; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Yip C, 2015, INSIGHTS IMAGING, V6, P489, DOI 10.1007/s13244-015-0414-0; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737	35	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192495	10.1371/journal.pone.0192495	http://dx.doi.org/10.1371/journal.pone.0192495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415060	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300080
J	Lu, GH; Tang, CY; Hua, XM; Cheng, J; Wang, GH; Zhu, YL; Zhang, LY; Shou, HX; Qi, JL; Yang, YH				Lu, Gui-Hua; Tang, Cheng-Yi; Hua, Xiao-Mei; Cheng, Jing; Wang, Gu-Hao; Zhu, Yin-Ling; Zhang, Li-Ya; Shou, Hui-Xia; Qi, Jin-Liang; Yang, Yong-Hua			Effects of an EPSPS-transgenic soybean line ZUTS31 on root-associated bacterial communities during field growth	PLOS ONE			English	Article							GLYPHOSATE-RESISTANCE GENE; RHIZOSPHERE MICROBIOME; BRASSICA-NAPUS; PLANT GENOTYPE; DIVERSITY; IMPACT; HERBICIDES; ENDOPHYTES; PARADIGM; CROP	The increased worldwide commercial cultivation of transgenic crops during the past 20 years is accompanied with potential effects on the soil microbial communities, because many rhizosphere and endosphere bacteria play important roles in promoting plant health and growth. Previous studies reported that transgenic plants exert differential effects on soil microbial communities, especially rhizobacteria. Thus, this study compared the soybean root-associated bacterial communities between a 5-enolpyruvylshikimate-3-phosphate synthase -transgenic soybean line (ZUTS31 or simply Z31) and its recipient cultivar (Huachun3 or simply HC3) at the vegetative, flowering, and seed-filling stages. High-throughput sequencing of 16S rRNA gene (16S rDNA) V4 hypervariable region amplicons via Illumina MiSeq and real-time quantitative PCR (qPCR) were performed. Our results revealed no significant differences in the overall alpha diversity of root-associated bacterial communities at the three developmental stages and in the beta diversity of root-associated bacterial communities at the flowering stage between Z31 and HC3 under field growth. However, significant differences in the beta diversity of rhizosphere bacterial communities were found at the vegetative and seed-filling stages between the two groups. Furthermore, the results of next generation sequencing and qPCR showed that the relative abundances of root-associated main nitrogen-fixing bacterial genera, especially Bradyrhizobium in the roots, evidently changed from the flowering stage to the seed-filling stage. In conclusion, Z31 exerts transitory effects on the taxonomic diversity of rhizosphere bacterial communities at the vegetative and seed-filling stages compared to the control under field conditions. In addition, soybean developmental change evidently influences the main symbiotic nitrogen-fixing bacterial genera in the roots from the flowering stage to the seed-filling stage.	[Lu, Gui-Hua; Tang, Cheng-Yi; Cheng, Jing; Wang, Gu-Hao; Zhu, Yin-Ling; Qi, Jin-Liang; Yang, Yong-Hua] Nanjing Univ, Sch Life Sci, NJU NJFU Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Lu, Gui-Hua] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China; [Hua, Xiao-Mei] Nanjing Inst Environm Sci, MEP, Res Ctr Soil Pollut Prevent & Control, Nanjing, Peoples R China; [Zhang, Li-Ya] Anhui Acad Agr Sci, Crop Res Inst, Hefei, Anhui, Peoples R China; [Shou, Hui-Xia] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou, Zhejiang, Peoples R China	Nanjing University; Nanjing Agricultural University; Anhui Academy of Agricultural Sciences; Zhejiang University	Qi, JL; Yang, YH (corresponding author), Nanjing Univ, Sch Life Sci, NJU NJFU Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China.	qijl@nju.edu.cn; yangyh@nju.edu.cn	Shou, Huixia/I-3052-2015; Lu, Gui-Hua/H-6419-2016	Lu, Gui-Hua/0000-0002-5922-6528	National Important Science & Technology Specific Project [2014ZX08011-003]; National Natural Science Foundation of China [31372140]; Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China [IRT_14R27]; Fundamental Research Funds for the Central Universities [020814380002]	National Important Science & Technology Specific Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Important Science & Technology Specific Project (2014ZX08011-003) to Yong-Hua Yang, the National Natural Science Foundation of China (31372140) to Yong-Hua Yang, Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China (IRT_14R27) to Yong-Hua Yang, and the Fundamental Research Funds for the Central Universities (No. 020814380002) to Yong-Hua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We were grateful to Aliya Fazal for checking English language. This work was supported by grants from the National Important Science & Technology Specific Project (2014ZX08011003) to Yong-Hua Yang, the National Natural Science Foundation of China (31372140) to Yong-Hua Yang, Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China (IRT_14R27) to Yong-Hua Yang, and the Fundamental Research Funds for the Central Universities (No. 020814380002) to Yong-Hua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2010, SOIL BIOL BIOCHEM, V42, P2276, DOI 10.1016/j.soilbio.2010.08.029; Arango L, 2014, EUR J SOIL BIOL, V63, P41, DOI 10.1016/j.ejsobi.2014.05.005; Babujia LC, 2016, TRANSGENIC RES, V25, P425, DOI 10.1007/s11248-016-9938-4; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Benbrook CM, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0070-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; BERG G, 2014, FRONT MICROBIOL, V0005; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Lopes KBD, 2016, J APPL MICROBIOL, V120, P740, DOI 10.1111/jam.13046; Dunfield KE, 2004, J ENVIRON QUAL, V33, P806, DOI 10.2134/jeq2004.0806; Dunfield KE, 2003, APPL ENVIRON MICROB, V69, P7310, DOI 10.1128/AEM.69.12.7310-7318.2003; Dunfield KE, 2001, FEMS MICROBIOL ECOL, V38, P1, DOI 10.1111/j.1574-6941.2001.tb00876.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hungria M, 2014, FIELD CROP RES, V158, P43, DOI 10.1016/j.fcr.2013.12.022; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; James C., 2016, CHINA BIOTECHNOLOGY, V36, P1; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Kondorosi E, 2013, ANNU REV MICROBIOL, V67, P611, DOI 10.1146/annurev-micro-092412-155630; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lee YE, 2011, J MICROBIOL BIOTECHN, V21, P333, DOI 10.4014/jmb.1010.10004; Liang JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103343; Liu B, 2005, PLANT SOIL, V271, P1, DOI 10.1007/s11104-004-1610-8; Lu GH, 2017, J MICROBIOL BIOTECHN, V27, P561, DOI 10.4014/jmb.1609.09008; [陆玲鸿 Lu Linghong], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P406; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Nakatani AS, 2014, FIELD CROP RES, V162, P20, DOI 10.1016/j.fcr.2014.03.010; Nimusiima J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18078; Nunes CC, 2012, MOL PLANT PATHOL, V13, P519, DOI 10.1111/j.1364-3703.2011.00766.x; Ofek M, 2014, ENVIRON MICROBIOL, V16, P2157, DOI 10.1111/1462-2920.12228; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Peix A, 2015, CRIT REV PLANT SCI, V34, P17, DOI 10.1080/07352689.2014.897899; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Rascovan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28084; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siciliano SD, 1999, FEMS MICROBIOL ECOL, V29, P263, DOI 10.1111/j.1574-6941.1999.tb00617.x; Sohn SI, 2016, J MICROBIOL BIOTECHN, V26, P1303, DOI 10.4014/jmb.1601.01058; Souza RA, 2013, TRANSGENIC RES, V22, P877, DOI 10.1007/s11248-013-9691-x; Sugiyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100709; Tang CY, 2015, RSC ADV, V5, P85383, DOI 10.1039/c5ra14672k; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turrini A, 2015, RES MICROBIOL, V166, P121, DOI 10.1016/j.resmic.2015.02.006; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Venturi V, 2016, TRENDS PLANT SCI, V21, P187, DOI 10.1016/j.tplants.2016.01.005; Weiberg A, 2014, ANNU REV PHYTOPATHOL, V52, P495, DOI 10.1146/annurev-phyto-102313-045933; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang TY, 2012, BIOL FERT SOILS, V48, P97, DOI 10.1007/s00374-011-0608-7; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00324-13; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	65	17	21	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192008	10.1371/journal.pone.0192008	http://dx.doi.org/10.1371/journal.pone.0192008			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408918	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800039
J	Wu, CY; Hu, HY; Li, CP; Chou, YJ; Chang, YT				Wu, Chen-Yi; Hu, Hsiao-Yun; Li, Chung-Pin; Chou, Yiing-Jeng; Chang, Yun-Ting			Comorbidity profiles of psoriasis in Taiwan: A latent class analysis	PLOS ONE			English	Article							NUTRITION-EXAMINATION-SURVEY; POPULATION-BASED COHORT; FATTY LIVER-DISEASE; METABOLIC SYNDROME; NATIONAL-HEALTH; RISK; PREVALENCE; ASSOCIATION; DEPRESSION; ARTHRITIS	Background Psoriasis is associated with many comorbidities. An understanding of these comorbidity patterns can help foster better care of patients with psoriasis. Objective To identify the heterogeneity of psoriasis comorbidities using latent class analysis (LCA). Methods LCA was used to empirically identify psoriasis comorbidity patterns in a nationwide sample of 110,729 incident cases of psoriasis (2002-2012) from the National Health Insurance database in Taiwan. Results The mean age of incident psoriasis was 46.1 years. Hypertension (28.8%), dyslipidemia (18.9%), and chronic liver disease/cirrhosis/hepatitis (18.1%) were the top three comorbidities in patients with psoriasis. LCA identified four distinct comorbidity classes among these patients, including 9.9% of patients in the "multi-comorbidity" class, 17.9% in the "metabolic syndrome" class, 11.3% in the "hypertension and chronic obstructive pulmonary disease (COPD)" class, and 60.9% in the "relatively healthy" class. Psoriatic arthritis was evenly distributed among each class. Relative to membership in the "relative healthy" class, an increase of one year of age had a higher probability of membership in the "multi-comorbidity" (odds ratio [OR], 1.25), "metabolic syndrome" (OR, 1.11), or "hypertension and COPD" (OR, 1.34) classes. Relative to membership in the "relative healthy" class, compared to women, men had a higher probability of membership in the "multi-comorbidity" (OR, 1.39), "metabolic syndrome" (OR, 1.77), or "hypertension and COPD" (OR, 1.22) classes. Conclusion We observed four distinct classes of psoriasis comorbidities, including the "multi-comorbidity", "metabolic syndrome", "hypertension and COPD", and "relatively healthy" classes, as well as the clustering of liver diseases with metabolic syndrome and clustering of COPD with hypertension.	[Wu, Chen-Yi; Chang, Yun-Ting] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jeng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jeng] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Wu, Chen-Yi; Chang, Yun-Ting] Natl Yang Ming Univ, Dept Dermatol, Taipei, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, CY (corresponding author), Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Dept Dermatol, Taipei, Taiwan.	chenyiok@gmail.com			Ministry of Science and Technology [MOST 104-2314-6-075-044-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a grant from Ministry of Science and Technology (MOST 104-2314-6-075-044-MY2).	Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1; Boehncke S, 2007, BRIT J DERMATOL, V157, P1249, DOI 10.1111/j.1365-2133.2007.08190.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Cohen BE, 2016, JAMA DERMATOL, V152, P73, DOI 10.1001/jamadermatol.2015.3605; Collins LM, 2010, LATEN CLASS LATENT T; Eder L, 2013, ANN RHEUM DIS, V72, P715, DOI 10.1136/annrheumdis-2012-201497; Evans-Polce R, 2016, ADDICT BEHAV, V53, P80, DOI 10.1016/j.addbeh.2015.10.010; Fitzpatrick KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153447; Ganzetti G, 2016, WORLD J CARDIOL, V8, P120, DOI 10.4330/wjc.v8.i2.120; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Husted JA, 2011, ARTHRIT CARE RES, V63, P1729, DOI 10.1002/acr.20627; Kim Y, 2016, J EPIDEMIOL, V26, P137, DOI 10.2188/jea.JE20150068; Kulkarni NM, 2015, PHARM BIOL, V53, P1110, DOI 10.3109/13880209.2014.960944; Lamb RC, 2016, BR J DERMATOL; Lanza ST DJ, LCA STATA PLUGIN USE; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Love TJ, 2011, ARCH DERMATOL, V147, P419, DOI 10.1001/archdermatol.2010.370; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Raychaudhuri SP, 2001, J EUR ACAD DERMATOL, V15, P16, DOI 10.1046/j.1468-3083.2001.00192.x; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Tee SI, 2016, J EUR ACAD DERMATOL, V30, P1159, DOI 10.1111/jdv.13615; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Ungprasert P, 2016, J DERMATOL TREAT, V27, P316, DOI 10.3109/09546634.2015.1107180; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Wang JP, 2015, CANCER-AM CANCER SOC, V121, P1446, DOI 10.1002/cncr.29159; Wu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130993; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x	30	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192537	10.1371/journal.pone.0192537	http://dx.doi.org/10.1371/journal.pone.0192537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408915	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800079
J	Zhang, C; Ward, J; Dauch, JR; Tanzi, RE; Cheng, HT				Zhang, Can; Ward, Joseph; Dauch, Jacqueline R.; Tanzi, Rudolph E.; Cheng, Hsinlin T.			Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; MOUSE MODEL; IDIOPATHIC NEUROPATHY; PERIPHERAL-NERVE; INTERLEUKIN-10; INCREASES; MICE; PREVALENCE; EXPRESSION	Painful neuropathy (PN) is a prevalent condition in patients with metabolic syndrome (MetS). However, the pathogenic mechanisms of metabolic syndrome-associated painful neuropathy (MetSPN) remain unclear. In the current study, high-fat-fed mice (HF mice) were used to study MetSPN. HF mice developed MetS phenotypes, including increased body weight, elevated plasma cholesterol levels, and insulin resistance in comparison with control-fat-fed (CF) mice. Subsequently, HF mice developed mechanical allodynia and thermal hyperalgesia in hind paws after 8 wk of diet treatment. These pain behaviors coincided with increased densities of nociceptive epidermal nerve fibers and inflammatory cells such as Langerhans cells and macrophages in hind paw skin. To study the effect of MetS on profiles of cytokine expression in HF mice, we used a multiplex cytokine assay to study the protein expression of 12 pro-inflammatory and anti-inflammatory cytokines in dorsal root ganglion and serum samples. This method detected the elevated levels of proinflammatory cytokines, including tumor necrosis factor (TNF)-alpha, and interleukin (IL)-6, IL-1 beta as well as reduced anti-inflammatory IL-10 in lumbar dorsal root ganglia (LDRG) of HF mice. Intraperitoneal administration of IL-10 reduced the upregulation of pro-inflammatory cytokines and alleviated pain behaviors in HF mice without affecting MetS phenotypes. Our findings suggested targeting HF-induced cytokine dysregulation could be an effective strategy for treating MetSPN.	[Zhang, Can; Ward, Joseph; Tanzi, Rudolph E.; Cheng, Hsinlin T.] Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA; [Dauch, Jacqueline R.] Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan	Cheng, HT (corresponding author), Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA.	htcheng@mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Cheng, Hsinlin/0000-0002-6309-7298	National Institute of Health [1K08NS061039]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HC received a K award (1K08NS061039) from National Institute of Health: https://www.nih.govt. The funder supported the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Burguillos Miguel A, 2013, Methods Mol Biol, V1041, P93, DOI 10.1007/978-1-62703-520-0_11; Callaghan BC, 2016, DIABETES CARE; Callaghan BC, 2012, THE COCHRANE DATABAS, V6; Callaghan B, 2015, NEUROLOGY, V85, P71, DOI 10.1212/WNL.0000000000001714; Callaghan B, 2013, ANN NEUROL, V74, P397, DOI 10.1002/ana.23986; Callaghan BC, 2016, DIABETES CARE, V39, P801, DOI 10.2337/dc16-0081; Casanova-Molla J, 2012, PAIN, V153, P982, DOI 10.1016/j.pain.2012.01.021; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng HT, 2012, NEUROBIOL DIS, V45, P280, DOI 10.1016/j.nbd.2011.08.011; Cheng HT, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-28; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Choi S.H., 2014, NATURE; Clausen BE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23186; Cooper MA, 2016, JOURNAL OF THE PERIP; Dauch JR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-64; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Della Vedova MC, 2016, NUTR METAB INSIGHTS, V9, P93, DOI 10.4137/NMI.S32907; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Fernandes MR, 2016, ACTA CIR BRAS, V31, P840, DOI [10.1590/S0102-865020160120000010, 10.1590/s0102-865020160120000010]; FEUGEAS JP, 1993, CR ACAD SCI III-VIE, V316, P1255; Galloway C, 2013, CYTOKINE, V63, P1, DOI 10.1016/j.cyto.2013.04.009; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Groover AL, 2013, PAIN; Guilford BL, 2013, EXP NEUROL, V248, P504, DOI 10.1016/j.expneurol.2013.07.016; Haase J, 2013, DIABETOLOGIA; Han L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0010-y; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Jones Nick, 2010, Nat Rev Neurol, V6, P416, DOI 10.1038/nrneurol.2010.100; Kabashi E, 2008, J NEUROCHEM; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Makker PGS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170814; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mietto BS, 2015, J NEUROSCI, V35, P16431, DOI 10.1523/JNEUROSCI.2119-15.2015; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Moalem G, 2005, NEUROSCIENCE, V134, P1399, DOI 10.1016/j.neuroscience.2005.05.046; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Nishimura Satoshi, 2009, Discov Med, V8, P55; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Ozkul A, 2013, NEUROENDOCRINOL LETT, V34, P52; Padhi Tanmay, 2013, Indian J Dermatol, V58, P299, DOI 10.4103/0019-5154.113950; Paris MM, 1997, J INFECT DIS, V176, P1239, DOI 10.1086/514118; Richardson VR, 2013, IMMUNOBIOLOGY; Samson SL, 2014, ENDOCRIN METAB CLIN, V43, P1, DOI 10.1016/j.ecl.2013.09.009; Satoh-Asahara N, 2012, DIABETES CARE, V35, P2631, DOI 10.2337/dc12-0269; Shen KF, 2013, EXPERIMENTAL NEUROLO; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Smith AG, 2008, J NEUROL SCI, V273, P25, DOI 10.1016/j.jns.2008.06.005; Smith AG, 2012, J PERIPHER NERV SYST, V17, P15, DOI 10.1111/j.1529-8027.2012.00390.x; Smith AG, 2006, J NEUROL SCI, V242, P9, DOI 10.1016/j.jns.2005.11.020; Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Uski OJ, 2012, INHAL TOXICOL, V24, P952, DOI 10.3109/08958378.2012.742172; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Veresiu AI, 2015, J DIABETES COMPLICAT, V29, P644, DOI 10.1016/j.jdiacomp.2015.04.001; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Volz T, 2013, THE JOURNAL OF INVES; Wagner SL, 2014, BIOCHEMISTRY; WANG X, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/847246; Wang YP, 2012, J BIOMED RES, V26, P219, DOI 10.7555/JBR.26.20120013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	72	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192333	10.1371/journal.pone.0192333	http://dx.doi.org/10.1371/journal.pone.0192333			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408929	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800056
J	Hurlimann, T; Pena-Rosas, JP; Saxena, A; Zamora, G; Godard, B				Hurlimann, Thierry; Pena-Rosas, Juan Pablo; Saxena, Abha; Zamora, Gerardo; Godard, Beatrice			Ethical issues in the development and implementation of nutrition-related public health policies and interventions: A scoping review (vol 12, e0186897, 2017)	PLOS ONE			English	Correction													Saxena, Abha/AAA-1764-2021					Hurlimann T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186897	1	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192356	10.1371/journal.pone.0192356	http://dx.doi.org/10.1371/journal.pone.0192356			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401487	gold, Green Submitted, Green Published			2022-12-27	WOS:000424101400053
J	Laterza, C; Uoshima, N; Tornero, D; Wilhelmsson, U; Stokowska, A; Ge, RM; Pekny, M; Lindvall, O; Kokaia, Z				Laterza, Cecilia; Uoshima, Naomi; Tornero, Daniel; Wilhelmsson, Ulrika; Stokowska, Anna; Ge, Ruimin; Pekny, Milos; Lindvall, Olle; Kokaia, Zaal			Attenuation of reactive gliosis in stroke-injured mouse brain does not affect neurogenesis from grafted human iPSC-derived neural progenitors	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; ASTROCYTE ACTIVATION; ISCHEMIC-STROKE; CORTICAL-NEURONS; MICE DEFICIENT; DENTATE GYRUS; HUMAN CNS; VIMENTIN	Induced pluripotent stem cells (iPSCs) or their progeny, derived from human somatic cells, can give rise to functional improvements after intracerebral transplantation in animal models of stroke. Previous studies have indicated that reactive gliosis, which is associated with stroke, inhibits neurogenesis from both endogenous and grafted neural stem/progenitor cells (NSPCs) of rodent origin. Here we have assessed whether reactive astrocytes affect the fate of human iPSC-derived NSPCs transplanted into stroke-injured brain. Mice with genetically attenuated reactive gliosis (deficient for GFAP and vimentin) were subjected to cortical stroke and cells were implanted adjacent to the ischemic lesion one week later. At 8 weeks after transplantation, immunohistochemical analysis showed that attenuated reactive gliosis did not affect neurogenesis or commitment towards glial lineage of the grafted NSPCs. Our findings, obtained in a human-to-mouse xenograft experiment, provide evidence that the reactive gliosis in stroke-injured brain does not affect the formation of new neurons from intracortically grafted human iPSC-derived NSPCs. However, for a potential clinical translation of these cells in stroke, it will be important to clarify whether the lack of effect of reactive gliosis on neurogenesis is observed also in a human-to-human experimental setting.	[Laterza, Cecilia; Uoshima, Naomi; Tornero, Daniel; Ge, Ruimin; Lindvall, Olle; Kokaia, Zaal] Univ Hosp, Lund Stem Cell Ctr, Dept Clin Sci, Lab Stem Cells & Restorat Neurol, Lund, Sweden; [Uoshima, Naomi] Tokyo Med Univ, Dept Anesthesiol, Shinjuku Ku, Tokyo, Japan; [Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair, Inst Neurosci & Physiol,Dept Clin Neurosci,Lab As, Gothenburg, Sweden; [Stokowska, Anna] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair, Inst Neurosci & Physiol,Dept Clin Neurosci,Lab Re, Gothenburg, Sweden	Lund University; Skane University Hospital; Tokyo Medical University; University of Gothenburg; University of Gothenburg	Kokaia, Z (corresponding author), Univ Hosp, Lund Stem Cell Ctr, Dept Clin Sci, Lab Stem Cells & Restorat Neurol, Lund, Sweden.	zaal.kokaia@med.lu.se	Laterza, Cecilia/ABG-6504-2021; Kokaia, Zaal/AAL-6009-2020; Tornero, Daniel/N-2049-2014; Laterza, Cecilia/AAP-7932-2020	Kokaia, Zaal/0000-0003-2296-2449; Tornero, Daniel/0000-0002-4812-4091; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Research Council; European Union project TargetBrain; AFA Foundation; Swedish Brain Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); Sten A. Olsson Foundation for Research and Culture; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; Swedish Stroke Foundation; EuroCellNet COST Action [CM15214]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union project TargetBrain; AFA Foundation; Swedish Brain Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); Sten A. Olsson Foundation for Research and Culture; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; Swedish Stroke Foundation; EuroCellNet COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Swedish Research Council, European Union FP7 project TargetBrain, AFA Foundation, Swedish Brain Foundation, Torsten and Ragnar Soderberg Foundations, Region Skane, Sparbanksstiftelsen Fars & Frosta, Swedish Government Initiative for Strategic Research Areas (StemTherapy), Sten A. Olsson Foundation for Research and Culture, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, Swedish Stroke Foundation, and EuroCellNet COST Action (CM15214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; BASS NH, 1971, J COMP NEUROL, V143, P481, DOI 10.1002/cne.901430405; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Chow A, 2016, STEM CELL RES, V16, P79, DOI 10.1016/j.scr.2015.12.007; Culbreth ME, 2012, NEUROTOXICOLOGY, V33, P1499, DOI 10.1016/j.neuro.2012.05.012; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; Gao ZW, 2013, MOL NEUROBIOL, V48, P690, DOI 10.1007/s12035-013-8460-4; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gliem M, 2015, GLIA, V63, P2198, DOI 10.1002/glia.22885; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kokaia Z, 2017, PROG BRAIN RES, V231, P245, DOI 10.1016/bs.pbr.2016.11.013; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Laterza C, 2017, EXP NEUROL, V297, P129, DOI 10.1016/j.expneurol.2017.07.012; Lebkuechner I, 2015, J NEUROCHEM, V135, P234, DOI 10.1111/jnc.13213; LEUBA G, 1989, EXP BRAIN RES, V77, P31; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Malik N, 2014, NEUROTOXICOLOGY, V45, P192, DOI 10.1016/j.neuro.2014.10.007; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Miller DW, 2004, NEURON GLIA BIOL, V1, P13, DOI 10.1017/s1740925x04000043; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tornero D, 2017, BRAIN, V140, P692, DOI 10.1093/brain/aww347; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wunderlich KA, 2015, FASEB J, V29, P4815, DOI 10.1096/fj.15-272963; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	66	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192118	10.1371/journal.pone.0192118	http://dx.doi.org/10.1371/journal.pone.0192118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401502	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400037
J	Lei, CL; Dancause, KN; Elgbeili, G; Laplante, DP; Szyf, M; King, S				Lei Cao-Lei; Dancause, Kelsey N.; Elgbeili, Guillaume; Laplante, David P.; Szyf, Moshe; King, Suzanne			DNA methylation mediates the effect of maternal cognitive appraisal of a disaster in pregnancy on the child's C-peptide secretion in adolescence: Project Ice Storm	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR EXPRESSION; PRENATAL STRESS; NATURAL DISASTER; 51/2-YEAR-OLD CHILDREN; GLUCOSE-INTOLERANCE; GROWTH RESTRICTION; CENTRAL ADIPOSITY; HEALTH OUTCOMES; BIRTH OUTCOMES; ADULT DISEASE	Animal and human studies suggest that prenatal exposure to stress is associated with adverse health outcomes such as type 2 diabetes. Epigenetic modification, such as DNA methylation, is considered one possible underlying mechanism. The 1998 Quebec ice storm provides a unique opportunity to study an independent prenatal stressor on child outcomes. C-peptide is the best measure of endogenous insulin secretion and is widely used in the clinical management of patients with diabetes. The objectives of this study are to determine 1) the extent to which prenatal exposure to disaster-related stress (maternal objective hardship and maternal cognitive appraisal) influences children's C-peptide secretion, and 2) whether DNA methylation of diabetes-related genes mediates the effects of prenatal stress on C-peptide secretion. Children's (n = 30) C-peptide secretion in response to an oral glucose tolerance test were assessed in blood at 13 1/2 years. DNA methylation levels of selected type 1 and 2 diabetes-related genes were chosen based upon the genes associated with prenatal maternal objective hardship and/or cognitive appraisal levels. Bootstrapping analyses were performed to determine the mediation effect of DNA methylation. We found that children whose mothers experienced higher objective hardship exhibited higher C-peptide secretion. Cognitive appraisal was not directly associated with C-peptide secretion. DNA methylation of diabetes-related genes had a positive mediation effect of objective hardship on C-peptide secretion: higher objective hardship predicted higher C-peptide secretion through DNA methylation. Negative mediation effects of cognitive appraisal were observed: negative cognitive appraisal predicted higher C-peptide secretion through DNA methylation. However, only one gene, LTA, remained a significant mediator of cognitive appraisal on C-peptide secretion after the conservative Bonferroni multiple corrections. Our findings suggest that DNA methylation could act as an intervening variable between prenatal stress and metabolic outcomes, highlighting the importance of epigenetic mechanisms in response to environmental factors.	[Lei Cao-Lei; King, Suzanne] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Lei Cao-Lei; Elgbeili, Guillaume; Laplante, David P.; King, Suzanne] Douglas Hosp, Res Ctr, Montreal, PQ, Canada; [Dancause, Kelsey N.] Univ Quebec Montreal, Dept Phys Act Sci, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada	McGill University; McGill University; University of Quebec; University of Quebec Montreal; McGill University; McGill University	King, S (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; King, S (corresponding author), Douglas Hosp, Res Ctr, Montreal, PQ, Canada.	suzanne.king@mcgill.ca	King, Suzanne/AAM-8541-2020	King, Suzanne/0000-0003-3055-6846; Dancause, Kelsey/0000-0002-8677-9953; Laplante, David P./0000-0002-9723-1141	Canadian Institutes of Health Research (CIHR) [MOP-1150067]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant Number: MOP-1150067, Canadian Institutes of Health Research (CIHR):http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIAB PUBL HLTH RES C; Balasubramanian P, 2015, AM J PHYSIOL-ENDOC M, V309, pE582, DOI 10.1152/ajpendo.00167.2015; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Braun J, 1998, EUR J CLIN INVEST, V28, P538; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P117, DOI 10.1002/dev.21085; Cao-Lei L, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.13; Cao-Lei L, 2016, CLIN EPIGENETICS, V8, P1; Cao-Lei L, 2016, EARLY HUM DEV, V103, P189, DOI 10.1016/j.earlhumdev.2016.09.013; Cao-Lei L, 2015, EPIGENETICS-US, V10, P749, DOI 10.1080/15592294.2015.1063771; CAOLEI L, 2014, PLOS ONE, V0009; Cleasby ME, 2003, EUR J ENDOCRINOL, V148, P129, DOI 10.1530/eje.0.1480129; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Dancause KN, 2013, EARLY HUM DEV, V89, P773, DOI 10.1016/j.earlhumdev.2013.06.006; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Dancause KN, 2012, PEDIATR RES, V71, P126, DOI 10.1038/pr.2011.18; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.006; Eriksson JG, 2005, MATERN CHILD NUTR, V1, P149, DOI 10.1111/j.1740-8709.2005.00017.x; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hayakawa T, 2000, METABOLISM, V49, P1506, DOI 10.1053/meta.2000.17710; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hollingshead A. B., 1973, 4 FACTOR INDEX SOCIA; Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; King S., 2009, ANN BEHAV MED, V37, ps212; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2003, STRESS PREGNANCY AFF; Laplante DP, 2002, BIENN INT C INF STUD; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; Lei CL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0219-0; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Liu GT, 2016, ENVIRON RES, V150, P1, DOI 10.1016/j.envres.2016.04.039; MCFARLANE AC, 1988, PSYCHOL MED, V18, P129, DOI 10.1017/S0033291700001963; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Risk Management Solutions Inc, 1998 IC STORM 10 YEA; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; SANDMAN CA, 1994, ANN NY ACAD SCI, V739, P198, DOI 10.1111/j.1749-6632.1994.tb19822.x; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Statistics Canada, 1998, ST LAWR RIV VALL 199; Turcotte-Tremblay AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/201717; VENDRELL J, 1995, METABOLISM, V44, P691, DOI 10.1016/0026-0495(95)90177-9; Veru F, 2014, STRESS, V17, P133, DOI 10.3109/10253890.2013.876404; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192199	10.1371/journal.pone.0192199	http://dx.doi.org/10.1371/journal.pone.0192199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401509	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400041
J	Joffe, M; Ayeni, O; Norris, SA; McCormack, VA; Ruff, P; Das, I; Neugut, AI; Jacobson, JS; Cubasch, H				Joffe, Maureen; Ayeni, Oluwatosin; Norris, Shane Anthony; McCormack, Valerie Ann; Ruff, Paul; Das, Ishani; Neugut, Alfred I.; Jacobson, Judith S.; Cubasch, Herbert			Barriers to early presentation of breast cancer among women in Soweto, South Africa	PLOS ONE			English	Article							DISPARITIES; CHALLENGES; HEALTH; BLACK; RISK; OPPORTUNITIES; EXPERIENCES; MORTALITY; KNOWLEDGE; FATALISM	Purpose Reported breast cancer incidence is rising in South Africa, where some women are diagnosed late and have poor outcomes. We studied patient and provider factors associated with clinical stage at diagnosis among women diagnosed at the Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg in 2015 +/- 2016. Methods From face-to-face interviewer-administered questionnaires we compared self-reported socioeconomics, demographics, comorbidities, risk factors, personal and health system barriers, and from patient clinical records, clinical staging, receptor subtype, and tumor grade among 499 consecutive women newly diagnosed with advanced stage (III/IV) breast cancer versus those diagnosed early (stage 0/I/II). Logistic regression models were used to identify factors associated with advanced stage at diagnosis. Results Among the women, 243 (49%) were diagnosed at early and 256 (51%) at advanced stages. In the multiple logistic regression adjusted model, completion of high school or beyond (odds ratio (OR) 0.59, and greater breast cancer knowledge and awareness (OR 0.86) were associated with lower stage of breast cancer at presentation. Advanced stage was associated with Luminal B (OR 2.25) and triple-negative subtypes (OR 3.17) compared to luminal A, with delays > 3 months from first breast symptoms to accessing the health system (OR 2.79) and with having more than 1 visit within the referral health system (OR 3.19) for 2 visits; OR 2.73 for >= 3 visits). Conclusions Limited patient education, breast cancer knowledge and awareness, and health system inefficiencies were associated with advanced stage at diagnosis. Sustained community and healthcare worker education may down-stage disease and improve cancer outcomes.	[Joffe, Maureen; Ayeni, Oluwatosin; Norris, Shane Anthony; Ruff, Paul; Cubasch, Herbert] Wits Hlth Consortium PTY Ltd, Noncommunicable Dis Res Div, Johannesburg, South Africa; [Joffe, Maureen; Norris, Shane Anthony] Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [McCormack, Valerie Ann] Int Agcy Res Canc, Sect Environm & Radiat, Lyon, France; [Ruff, Paul] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Med Oncol, Johannesburg, South Africa; [Das, Ishani; Neugut, Alfred I.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Neugut, Alfred I.; Jacobson, Judith S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Cubasch, Herbert] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Johannesburg, South Africa	University of Witwatersrand; World Health Organization; International Agency for Research on Cancer (IARC); University of Witwatersrand; Columbia University; Columbia University; Columbia University; University of Witwatersrand	Joffe, M (corresponding author), Wits Hlth Consortium PTY Ltd, Noncommunicable Dis Res Div, Johannesburg, South Africa.; Joffe, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	mjoffe@witshealth.co.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; McCormack, Valerie/0000-0001-7397-3442; Joffe, Maureen/0000-0001-8616-9672	NIH [NCI 1R01CA192627]; South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC); Cancer Association of South Africa (CANSA); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa; Wits Health Consortium (PTY) Ltd; NATIONAL CANCER INSTITUTE [R01CA192627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC); Cancer Association of South Africa (CANSA); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa; Wits Health Consortium (PTY) Ltd; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant (NCI 1R01CA192627) http://grantome.com/grant/NIH/R01-CA192627-01 to Drs. Jacobson, Joffe, Neugut and Ruff; (ii) the South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC) http://www.mrc.ac.za/epithelial/Epithelial.htm led by Dr. Ruff; and (iii) the Cancer Association of South Africa (CANSA) grant Down-staging and improving survival of breast cancer in South Africa http://www.cansa.org.za/down-staging-and-improving-survival-of-breast-cancer-in-sa-dr-herbert-cubasch(Dr Cubasch). Dr Norris is supported by the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa https://www.wits.ac.za/coe-human. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Wits Health Consortium (PTY) Ltd provided support in the form of payroll administration of salaries from grant funds for authors M Joffe, O Ayeni and S Norris, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ADAY LA, 1974, EALTH SERV RES; AKUOKO CP, 2017, PLOS ONE, DOI DOI 10.1634/THEONCOLOGIST.2014-0493; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P1173; [Anonymous], 2012, CANCER, V23, pvi7; [Anonymous], 2016, ONCOLOGIST; Arora NK, 2002, PATIENT EDUC COUNS, V47, P37, DOI 10.1016/S0738-3991(01)00170-7; Banegas MP, 2012, J WOMENS HEALTH, V21, P101, DOI 10.1089/jwh.2010.2638; Bird Y, 2011, J IMMIGR MINOR HEALT, V13, P867, DOI 10.1007/s10903-010-9418-5; Blackman DJ, 2006, J CLIN ONCOL, V24, P2170, DOI 10.1200/JCO.2005.05.4734; Brewster AM, 2014, LANCET ONCOL, V15, pE625, DOI 10.1016/S1470-2045(14)70364-X; Brinton LA, 2014, BREAST CANCER RES TR, V144, P467, DOI 10.1007/s10549-014-2868-z; BUSOLO DS, 2015, GLOB HEALTH PROMOT, DOI DOI 10.1089/JWH.2010.2638; CACALA SR, JOURNAL OF GLOBAL ON, P2; Cacala SR, 2017, CANCER EPIDEMIOL, V3, P497; *CANC S AFR, 2012, FULL REPORT, V2011, P1, DOI DOI 10.1111/TBJ.12369; Caplan L., 2014, BMC FAM PRACT, V2, P87; Caplan L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00087; Champion VL, 2004, J HEALTH PSYCHOL, V9, P753, DOI 10.1177/1359105304045383; Champion VL, 1999, RES NURS HEALTH, V22, P341, DOI 10.1002/(SICI)1098-240X(199908)22:4<341::AID-NUR8>3.0.CO;2-P; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Edge J, 2014, SAMJ S AFR MED J, V104, P377, DOI 10.7196/SAMJ.8249; Elzawawy A, 2015, WORLD J SURG, V39, P693, DOI 10.1007/s00268-014-2913-4; Eng A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001720; Facione NC, 2000, CANCER NURS, V23, P258, DOI 10.1097/00002820-200008000-00002; Ferlay J., 2015, INT J CANCER, V136, pE359; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Gerend MA, 2008, CANCER EPIDEM BIOMAR, V17, P2913, DOI 10.1158/1055-9965.EPI-07-0633; Grunfeld EA, 2002, BRIT J CANCER, V86, P1373, DOI 10.1038/sj.bjc.6600260; Guidry JJ, 2003, CANCER, V97, P318; HARFORD JB, 2011, BREAST S2, V20, pS2, DOI DOI 10.1016/S1470-2045(09)70335-3; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; JONES CE, 2014, BMJ OPEN, V4, P2, DOI DOI 10.1038/SJ.BJC.6605385; K, MIRANDA, DOI DOI 10.1002/CNCR.29331; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krok-Schoen JL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00002; LAA Z, 2006, CANCER, V12, pS1; LAA Z, 2013, CANCER, DOI DOI 10.1007/S10903-010-9418-5; LAA Z, 2015, CANCER; LAA Z, 2011, CANCER; LAA Z, 1968, CANCER; LAA Z, CANCER; LAA Z, 1920, CANCER, DOI DOI 10.1186/1471-2296-14-197; LAA Z, 2003, CANCER, DOI DOI 10.7196/SAMJ.8249; Loerzel VW, 2005, FAM COMMUNITY HEALTH, V28, P79, DOI 10.1097/00003727-200501000-00010; McCormack VA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3478; Micklesfield LK, 2010, OBESITY, V18, P619, DOI 10.1038/oby.2009.292; Mousa SM, 2011, BREAST, V20, P555, DOI 10.1016/j.breast.2011.07.001; Murugan N, 2014, SAMJ S AFR MED J, V104, P380, DOI 10.7196/SAMJ.8243; Newman LA, 2015, BREAST J, V21, P133, DOI 10.1111/tbj.12369; Newman LA, 2014, SURG ONCOL CLIN N AM, V23, P579, DOI 10.1016/j.soc.2014.03.014; Ngo-Metzger Q, 2003, J GEN INTERN MED, V18, P44, DOI 10.1046/j.1525-1497.2003.20205.x; Pace LE, 2016, ONCOLOGIST, V21, P739, DOI 10.1634/theoncologist.2015-0429; Pace LE, 2015, ONCOLOGIST, V20, P780, DOI 10.1634/theoncologist.2014-0493; POWE BD, 1995, CANCER NURS, V18, P385; Remennick L, 2006, BREAST J, V12, pS103, DOI 10.1111/j.1075-122X.2006.00204.x; RoyakSchaler R, 1996, J CLIN PSYCHOL MED S, V3, P185, DOI 10.1007/BF01993905; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Shen LJ, 2009, PSYCHOL HEALTH, V24, P597, DOI 10.1080/08870440801902535; STORY H, 2011, INTERNATIONAL JOURNA, P2012; STUBBINGS S, 2009, BRITISH JOURNAL OF C, V2, P17, DOI DOI 10.1177/135910304045383; Talbert P. Y., 2008, J SOCIAL BEHAV HLTH, V2, P96, DOI DOI 10.5590/JSBHS.2008.02.1.07; Thomas VN, 2005, INT J PALLIAT NURS, V11, P562, DOI 10.12968/ijpn.2005.11.11.20096; WU TY, 2012, INTERNATIONAL JOURNA, P2012, DOI DOI 10.1200/JCO.2005.05.4734; Yedjou CG, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050486; YIP CH, 2015, WORLD J SURG; Yip CH, 2012, FUTURE ONCOL, V8, P1575, DOI [10.2217/FON.12.141, 10.2217/fon.12.141]; 2012, ANNALS OF ONCOLOGY O, V6, pV17, DOI DOI 10.7196/SAMJ.8243	67	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192071	10.1371/journal.pone.0192071	http://dx.doi.org/10.1371/journal.pone.0192071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394271	gold, Green Published, Green Submitted			2022-12-27	WOS:000424060400024
J	Earwaker, P; Anderson, C; Willenbrock, F; Harris, AL; Protheroe, AS; Macaulay, VM				Earwaker, Philip; Anderson, Caroline; Willenbrock, Frances; Harris, Adrian L.; Protheroe, Andrew S.; Macaulay, Valentine M.			RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITOR; MTOR KINASE INHIBITORS; PHASE-II TRIAL; MAMMALIAN TARGET; TYROSINE KINASE; DUAL INHIBITOR; PROTEIN-KINASE; BREAST-CANCER	The outlook for patients with advanced renal cell cancer (RCC) has been improved by targeted agents including inhibitors of the PI3 kinase (PI3K)-AKT-mTOR axis, although treatment resistance is a major problem. Here, we aimed to understand how RCC cells acquire resistance to PI3K-mTOR inhibition. We used the RCC4 cell line to generate a model of in vitro resistance by continuous culture in PI3K-mTOR kinase inhibitor NVP-BEZ235 (BEZ235, Dactolisib). Resistant cells were cross-resistant to mTOR inhibitor AZD2014. Sensitivity was regained after 4 months drug withdrawal, and resistance was partially suppressed by HDAC inhibition, supporting an epigenetic mechanism. BEZ235-resistant cells up-regulated and/or activated numerous proteins including MET, ABL, Notch, IGF-1R, INSR and MEK/ERK. However, resistance was not reversed by inhibiting or depleting these pathways, suggesting that many induced changes were passengers not drivers of resistance. BEZ235 blocked phosphorylation of mTOR targets S6 and 4E-BP1 in parental cells, but 4E-BP1 remained phosphorylated in resistant cells, suggesting BEZ235-refractory mTORC1 activity. Consistent with this, resistant cells over-expressed mTORC1 component RAPTOR at the mRNA and protein level. Furthermore, BEZ235 resistance was suppressed by RAPTOR depletion, or allosteric mTORC1 inhibitor rapamycin. These data reveal that RAPTOR up-regulation contributes to PI3K-mTOR inhibitor resistance, and suggest that RAPTOR expression should be included in the pharmacodynamic assessment of mTOR kinase inhibitor trials.	[Earwaker, Philip; Anderson, Caroline; Willenbrock, Frances; Macaulay, Valentine M.] Dept Oncol, Oxford, England; [Harris, Adrian L.; Protheroe, Andrew S.; Macaulay, Valentine M.] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Canc & Haematol Ctr, Oxford, England; [Earwaker, Philip] Univ Hosp Birmingham NHS Fdn Trust, Ctr Canc, Birmingham, W Midlands, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Birmingham	Macaulay, VM (corresponding author), Dept Oncol, Oxford, England.; Macaulay, VM (corresponding author), Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Canc & Haematol Ctr, Oxford, England.	valentine.macaulay@oncology.ox.ac.uk	Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	Cancer Research UK [C602/A6292]; Oxford University Clinical Academic Graduate School; Cancer Research UK award [C5255/A20758]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre [A93024]; Cancer Research UK program grant; Oxford University Clinical Academic Graduate School grant; Cancer Research UK Oxford Cancer Research Centre; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Cancer Research UK [18974, 16466, 11359] Funding Source: researchfish; Medical Research Council [G0300648, G0601061] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; MRC [G0601061] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Oxford University Clinical Academic Graduate School; Cancer Research UK award(Cancer Research UK); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK program grant(Cancer Research UK); Oxford University Clinical Academic Graduate School grant; Cancer Research UK Oxford Cancer Research Centre; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the award to PE of a Clinical Research Fellowship supported by Cancer Research UK (www.cancerresearchuk.org) program grant C602/A6292 to ALH, Oxford University Clinical Academic Graduate School (www.oucags.ox.ac.uk) grant to CA, support to FW from the Cancer Research UK award to the Oxford Cancer Research Centre (C5255/A20758) and to VMM from the National Institute for Health Research (NIHR; www.nihr.ac.uk) Oxford Biomedical Research Centre (award A93024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the award to PE of a Clinical Research Fellowship supported by Cancer Research UK program grant to ALH, Oxford University Clinical Academic Graduate School grant to CA, support to FW from the Cancer Research UK Oxford Cancer Research Centre and to VMM from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. We are grateful to Tamara Aleksic and Guillaume Rieunier for comments on the manuscript.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Alhamdani MSS, 2009, GENOME MED, V1, DOI 10.1186/gm68; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Bailey ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104413; Basu B, 2015, CLIN CANCER RES, V21, P3412, DOI 10.1158/1078-0432.CCR-14-2422; Behbahani TE, 2012, WORLD J UROL, V30, P559, DOI 10.1007/s00345-011-0767-z; Bendell JC, 2015, INVEST NEW DRUG, V33, P187, DOI 10.1007/s10637-014-0177-3; Bhola NE, 2016, CANCER RES, V76, P440, DOI 10.1158/0008-5472.CAN-15-1640-T; Bianchi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121567; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Calvo E, 2016, CANCER TREAT REV, V50, P109, DOI 10.1016/j.ctrv.2016.09.002; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Chen JZ, 2015, CLIN EXP PHARMACOL P, V42, P1317, DOI 10.1111/1440-1681.12493; Chen L, 2017, ONCOTARGET; Chia S, 2015, CURR ONCOL, V22, P33, DOI 10.3747/co.22.2393; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cope CL, 2014, J CELL SCI, V127, P788, DOI 10.1242/jcs.137588; Darwish OM, 2013, UROLOGY, V81, P581, DOI 10.1016/j.urology.2012.11.030; Dolly SO, 2016, CLIN CANCER RES, V22, P2874, DOI 10.1158/1078-0432.CCR-15-2225; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Ducker GS, 2013, ONCOGENE; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fazio N, 2016, ANTICANCER RES, V36, P713; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Greef B, 2016, BRIT J CANCER, V115, P505, DOI 10.1038/bjc.2016.230; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hainsworth JD, 2011, CANCER INVEST, V29, P451, DOI 10.3109/07357907.2011.590568; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Heikkinen T, 2013, BREAST CANCER RES TR, V141, P79, DOI 10.1007/s10549-013-2671-2; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Juengel E, 2016, ONCOTARGET, V7, P85208, DOI 10.18632/oncotarget.13421; Juengel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-152; Juengel E, 2012, CANCER LETT, V324, P83, DOI 10.1016/j.canlet.2012.05.003; Kim ST, 2016, ANN ONCOL; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu JY, 2013, J BIOL CHEM, V288, P23225, DOI 10.1074/jbc.M113.492371; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Markman B, 2012, ANN ONCOL, V23, P2399, DOI 10.1093/annonc/mds011; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Mateo F, 2017, ONCOGENE, V36, P2737, DOI 10.1038/onc.2016.427; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Mohan S, 2015, CLIN CANCER RES, V21, P3946, DOI 10.1158/1078-0432.CCR-14-3377; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Naing A, 2012, BRIT J CANCER, V107, P1093, DOI 10.1038/bjc.2012.368; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048548; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Piao JJ, 2016, ONCOTARGET, V7, P60169, DOI 10.18632/oncotarget.11109; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Powles T, 2016, EUR UROL, V69, P450, DOI 10.1016/j.eururo.2015.08.035; Ramcharan R, 2015, ONCOTARGET, V6, P39877, DOI 10.18632/oncotarget.5631; Ricci C, 2002, CANCER RES, V62, P5995; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; Ryan CW, 2011, INVEST NEW DRUG, V29, P374, DOI 10.1007/s10637-009-9365-y; Sakre N, 2016, ONCOTARGET; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shapiro GI, 2015, CLIN CANCER RES, V21, P1888, DOI 10.1158/1078-0432.CCR-14-1306; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; Venkannagari S, 2012, ONCOTARGET, V3, P1416; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; Vuky J, 2006, INVEST NEW DRUG, V24, P85, DOI 10.1007/s10637-005-4543-z; Wise-Draper TM, 2017, TARGET ONCOL, V12, P323, DOI 10.1007/s11523-017-0482-9; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zibelman M, 2015, INVEST NEW DRUG, V33, P1040, DOI 10.1007/s10637-015-0261-3	82	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191890	10.1371/journal.pone.0191890	http://dx.doi.org/10.1371/journal.pone.0191890			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389967	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400040
J	Ladle, A; Steenweg, R; Shepherd, B; Boyce, MS				Ladle, Andrew; Steenweg, Robin; Shepherd, Brenda; Boyce, Mark S.			The role of human outdoor recreation in shaping patterns of grizzly bear-black bear co-occurrence	PLOS ONE			English	Article							HABITAT SELECTION; WILDLIFE; LANDSCAPE; PREDATION; RESPONSES; MODELS; RISK; PARAMETERIZATION; DISTURBANCE; COMPETITION	Species' distributions are influenced by a combination of landscape variables and biotic interactions with other species, including people. Grizzly bears and black bears are sympatric, competing omnivores that also share habitats with human recreationists. By adapting models for multi-species occupancy analysis, we analyzed trail camera data from 192 trail camera locations in and around Jasper National Park, Canada to estimate grizzly bear and black bear occurrence and intensity of trail use. We documented (a) occurrence of grizzly bears and black bears relative to habitat variables (b) occurrence and intensity of use relative to competing bear species and motorised and non-motorised recreational activity, and (c) temporal overlap in activity patterns among the two bear species and recreationists. Grizzly bears were spatially separated from black bears, selecting higher elevations and locations farther from roads. Both species co-occurred with motorised and non-motorised recreation, however, grizzly bears reduced their intensity of use of sites with motorised recreation present. Black bears showed higher temporal activity overlap with recreational activity than grizzly bears, however differences in bear daily activity patterns between sites with and without motorised and non-motorised recreation were not significant. Reduced intensity of use by grizzly bears of sites where motorised recreation was present is a concern given off-road recreation is becoming increasingly popular in North America, and can negatively influence grizzly bear recovery by reducing foraging opportunities near or on trails. Camera traps and multi-species occurrence models offer non-invasive methods for identifying how habitat use by animals changes relative to sympatric species, including humans. These conclusions emphasise the need for integrated land-use planning, access management, and grizzly bear conservation efforts to consider the implications of continued access for motorised recreation in areas occupied by grizzly bears.	[Ladle, Andrew; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Steenweg, Robin] Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Shepherd, Brenda] Pk Canada, Jasper, AB, Canada	University of Alberta; University of Montana System; University of Montana	Ladle, A (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ladle@ualberta.ca		Shepherd, Brenda/0000-0003-0165-7795	Alberta Conservation Association [RES0021375]; Alberta Environment and Parks [RES0021375]; International Bear Association [RES0021389]; Safari Club International: Northern Alberta Chapter [RES0021611]; Alberta Biodiversity Monitoring Institute; Mountain Equipment Co-op; Friends of the Environment	Alberta Conservation Association; Alberta Environment and Parks; International Bear Association; Safari Club International: Northern Alberta Chapter; Alberta Biodiversity Monitoring Institute; Mountain Equipment Co-op; Friends of the Environment	This research was supported by Alberta Conservation Association RES0021375 to MSB and AL, Alberta Environment and Parks RES0021375 to MSB and AL, International Bear Association RES0021389 to AL, Safari Club International: Northern Alberta Chapter RES0021611 to MSB and AL, Alberta Biodiversity Monitoring Institute to AL, Mountain Equipment Co-op to MSB, and TD: Friends of the Environment to MSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Grizzly Bear Recovery Team, 2008, ALB GRIZZL BEAR ALB; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; [Anonymous], 1990, URSUS; [Anonymous], 2014, R LANG ENV STAT COMP; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; Baldwin RA, 2010, WEST N AM NATURALIST, V70, P48, DOI 10.3398/064.070.0106; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Cusack J. J., 2016, OIKOS; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Farris ZJ, 2015, ANIM CONSERV, P189; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Frid A, 2002, CONSERV ECOL, V6; Gelman A., 2021, BAYESIAN DATA ANAL; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gomes C. B., 2016, INDIVIDUAL BEHAV POP, P247; Hammitt W. E., 2015, WILDLAND RECREATION, V2nd; Hines J., 2006, PRESENCE2 SOFTWARE E; HOLCROFT AC, 1991, CAN FIELD NAT, V105, P335; Holm Greg W., 1999, Ursus, V11, P99; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; KASWORM WF, 1990, INT C BEAR, V8, P79; Ladle A, 2017, METHODS ECOL EVOL, V8, P329, DOI 10.1111/2041-210X.12660; Latif QS, 2016, J WILDLIFE MANAGE, V80, P192, DOI 10.1002/jwmg.1022; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Meredith M, 2016, ESTIMATES COEFFICIEN, V18; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Moreira-Arce D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137854; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Ordiz A, 2014, BIOL CONSERV, V173, P1, DOI 10.1016/j.biocon.2014.03.006; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pigeon KE, 2016, OECOLOGIA, V181, P1101, DOI 10.1007/s00442-016-3630-5; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Sahlen V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121576; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849	69	30	31	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191730	10.1371/journal.pone.0191730	http://dx.doi.org/10.1371/journal.pone.0191730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389939	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400030
J	Noll, LW; Worley, JN; Yang, X; Shridhar, PB; Ludwig, JB; Shi, XR; Bai, JF; Caragea, D; Meng, JH; Nagaraja, TG				Noll, Lance W.; Worley, Jay N.; Yang, Xun; Shridhar, Pragathi B.; Ludwig, Justin B.; Shi, Xiaorong; Bai, Jianfa; Caragea, Doina; Meng, Jianghong; Nagaraja, T. G.			Comparative genomics reveals differences in mobile virulence genes of Escherichia coli O103 pathotypes of bovine fecal origin	PLOS ONE			English	Article							III EFFECTOR PROTEIN; LARGE PLASMID; SERINE-PROTEASE; FEEDLOT CATTLE; O157; SEQUENCE; IDENTIFICATION; PREVALENCE; LOCUS; TOXB	Escherichia coli O103, harbored in the hindgut and shed in the feces of cattle, can be enterohemorrhagic (EHEC), enteropathogenic (EPEC), or putative non-pathotype. The genetic diversity particularly that of virulence gene profiles within O103 serogroup is likely to be broad, considering the wide range in severity of illness. However, virulence descriptions of the E. coli O103 strains isolated from cattle feces have been primarily limited to major genes, such as Shiga toxin and intimin genes. Less is known about the frequency at which other virulence genes exist or about genes associated with the mobile genetic elements of E. coli O103 pathotypes. Our objective was to utilize whole genome sequencing (WGS) to identify and compare major and putative virulence genes of EHEC O103 (positive for Shiga toxin gene, stx1, and intimin gene, eae; n = 43), EPEC O103 (negative for stx1 and positive for eae; n = 13) and putative non-pathotype O103 strains (negative for stx and eae; n = 13) isolated from cattle feces. Six strains of EHEC O103 from human clinical cases were also included. All bovine EHEC strains (43/43) and a majority of EPEC (12/13) and putative nonpathotype strains (12/13) were O103: H2 serotype. Both bovine and human EHEC strains had significantly larger average genome sizes (P < 0.0001) and were positive for a higher number of adherence and toxin-based virulence genes and genes on mobile elements (prophages, transposable elements, and plasmids) than EPEC or putative non-pathotype strains. The genome size of the three pathotypes positively correlated (R-2 = 0.7) with the number of genes carried on mobile genetic elements. Bovine strains clustered phylogenetically by pathotypes, which differed in several key virulence genes. The diversity of E. coli O103 pathotypes shed in cattle feces is likely reflective of the acquisition or loss of virulence genes carried on mobile genetic elements.	[Noll, Lance W.; Shridhar, Pragathi B.; Ludwig, Justin B.; Shi, Xiaorong; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Worley, Jay N.; Yang, Xun; Meng, Jianghong] Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Worley, Jay N.; Yang, Xun; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Bai, Jianfa] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA; [Caragea, Doina] Kansas State Univ, Dept Comp & Informat Sci, Manhattan, KS 66506 USA	Kansas State University; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; Kansas State University; Kansas State University	Nagaraja, TG (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	tnagaraj@vet.k-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Nagaraja, T. G./0000-0002-0899-878X; Caragea, Doina/0000-0002-6440-0914	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2012-68003-30155]; FOOD AND DRUG ADMINISTRATION [U01FD001418] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This research was supported in part by the Agriculture and Food Research Initiative Competitive Grant no. 2012-68003-30155 from the United States Department of Agriculture National Institute of Food and Agriculture (to TGN). The funders had no role in the study design, data collection and analyses, preparation of manuscript or decision to publish.	Abdullah UY, 2014, CLONING TRANSGENESIS, V3, P1; Abe A, 1998, J EXP MED, V188, P1907, DOI 10.1084/jem.188.10.1907; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-151; Carattoli A, 2014, ANTIMICROB AGENTS CH; Carter MQ, 2016, APPL ENVIRON MICROB, V82, P1090, DOI 10.1128/AEM.03172-15; Centers for Disease Control and Prevention (CDC), 2012, SHIG TOX PROD ESCH C; Cull CA, 2017, FOODBORNE PATHOG DIS, V14, P309, DOI 10.1089/fpd.2016.2227; Dahan S, 2005, INFECT IMMUN, V73, P679, DOI 10.1128/IAI.73.2.679-686.2005; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003; Ewers C, 2002, BERLINER MUNCHENER T, V116, P381; Ferdous M, 2015, J CLIN MICROBIOL, V53, P3530, DOI 10.1128/JCM.01899-15; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2012, J CLIN MICROBIOL, V50, P2894, DOI 10.1128/JCM.00789-12; Ison SA, 2015, APPL ENVIRON MICROB, V81, P3671, DOI 10.1128/AEM.00397-15; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P2360, DOI 10.1128/AEM.02634-07; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Kruger A, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00074; Kwon T, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0096-2; Makino K, 1998, DNA Res, V5, P1, DOI 10.1093/dnares/5.1.1; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Nadya S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00036; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Noll LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135446; Norman KN, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00021; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Padola NL, 2004, VET MICROBIOL, V100, P3, DOI 10.1016/S0378-1135(03)00127-5; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rambaut A., 2014, FIGTREE TREE FIGURE; Sandhu KS, 1999, CAN J VET RES, V63, P177; Schmidt H, 1997, FEMS MICROBIOL LETT, V148, P265, DOI 10.1016/S0378-1097(97)00047-5; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Schmidt H, 1996, MICROBIOL-UK, V142, P907, DOI 10.1099/00221287-142-4-907; Sekse C, 2013, APPL ENVIRON MICROB, V79, P7502, DOI 10.1128/AEM.01825-13; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Soderlund Robert, 2016, Infection Ecology & Epidemiology, V6, P30246, DOI 10.3402/iee.v6.30246; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; Taneike I, 2002, FEBS LETT, V524, P219, DOI 10.1016/S0014-5793(02)03027-2; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001; Tozzoli R, 2005, J CLIN MICROBIOL, V43, P4052, DOI 10.1128/JCM.43.8.4052-4056.2005; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	71	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191362	10.1371/journal.pone.0191362	http://dx.doi.org/10.1371/journal.pone.0191362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389941	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400018
J	Steiniger, BS; Ulrich, C; Berthold, M; Guthe, M; Lobachev, O				Steiniger, Birte S.; Ulrich, Christine; Berthold, Moritz; Guthe, Michael; Lobachev, Oleg			Capillary networks and follicular marginal zones in human spleens. Three-dimensional models based on immunostained serial sections	PLOS ONE			English	Article							SPLENIC WHITE PULP; B-CELLS; LYMPHOID ORGANS; RECONSTRUCTION; MIGRATION; ANTIGEN; NORMALIZATION; HETEROGENEITY; COMPARTMENTS; RESPONSES	We have reconstructed small parts of capillary networks in the human splenic white pulp using serial sections immunostained for CD34 alone or for CD34 and CD271. The three-dimensional (3D) models show three types of interconnected networks: a network with very few long capillaries inside the white pulp originating from central arteries, a denser network surrounding follicles plus periarterial T-cell regions and a network in the red pulp. Capillaries of the perifollicular network and the red pulp network have open ends. Perifollicular capillaries form an arrangement similar to a basketball net located in the outer marginal zone. The marginal zone is defined by MAdCAM-1(+) marginal reticular stromal cells. Perifollicular capillaries are connected to red pulp capillaries surrounded by CD271(+) stromal capillary sheath cells. The scarcity of capillaries inside the splenic white pulp is astonishing, as non-polarised germinal centres with proliferating B-cells occur in adult human spleens. We suggest that specialized stromal marginal reticular cells form a barrier inside the splenic marginal zone, which together with the scarcity of capillaries guarantees the maintenance of gradients necessary for positioning of migratory B-and T-lymphocytes in the human splenic white pulp.	[Steiniger, Birte S.] Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany; [Ulrich, Christine] Univ Marburg, Inst Psychol, Marburg, Germany; [Berthold, Moritz; Guthe, Michael; Lobachev, Oleg] Univ Bayreuth, Inst Comp Sci, Bayreuth, Germany	Philipps University Marburg; Philipps University Marburg; University of Bayreuth	Steiniger, BS (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Marburg, Germany.; Lobachev, O (corresponding author), Univ Bayreuth, Inst Comp Sci, Bayreuth, Germany.	steinigb@staff.uni-marburg.de; oleg.lobachev@uni-bayreuth.de	Lobachev, Oleg/F-2843-2012	Lobachev, Oleg/0000-0002-7193-6258; Steiniger, Birte/0000-0002-3602-7331	DFG; University Bayreuth; Philipps-University Marburg	DFG(German Research Foundation (DFG)); University Bayreuth; Philipps-University Marburg	We shall receive funding of open access publication by a joint programme of of DFG, University Bayreuth and Philipps-University Marburg. At present, the study is not specifically funded.	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Bradski G., 2008, LEARNING OPENCV COMP; Carata L., 2011, P 27 SPRING C COMPUT, P103; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Egger J, 2017, PLOS ONE, V12, P1; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Fasnacht N, 2014, J EXP MED, V211, P2265, DOI 10.1084/jem.20132528; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; GRAY D, 1984, IMMUNOLOGY, V52, P659; Hammad H, 2017, NAT IMMUNOL, V18, P313, DOI 10.1038/ni.3657; Ju T, 2004, ACM T GRAPHIC, V23, P888, DOI 10.1145/1015706.1015815; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Khan AM, 2014, IEEE T BIO-MED ENG, V61, P1729, DOI 10.1109/TBME.2014.2303294; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Kusumi S, 2015, BIOMED RES-TOKYO, V36, P195, DOI 10.2220/biomedres.36.195; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lobachev O, 2017, SPRING C CO IN PRESS; Lobachev O, 2017, MED IMAGE ANAL, V35, P288, DOI 10.1016/j.media.2016.07.010; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Ma B, 2008, MICRON, V39, P967, DOI 10.1016/j.micron.2007.10.007; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; OLAH I, 1982, AM J ANAT, V165, P445, DOI 10.1002/aja.1001650408; OLAH I, 1984, J LEUKOCYTE BIOL, V35, P501; Olah I, 2008, AVIAN IMMUNOLOGY, P13, DOI 10.1016/B978-012370634-8.50005-6; Onder D, 2014, APPL IMMUNOHISTO M M, V22, P713, DOI 10.1097/PAI.0000000000000003; Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SNOOK T, 1964, ANAT RECORD, V148, P149, DOI 10.1002/ar.1091480205; Steiniger B, 2003, J HISTOCHEM CYTOCHEM, V51, P655, DOI 10.1177/002215540305100511; Steiniger B, 2005, IMMUNOLOGY, V116, P429, DOI 10.1111/j.1365-2567.2005.02242.x; Steiniger B, 2000, MICROANATOMY FUNCTIO, P15; Steiniger B, 2007, HISTOCHEM CELL BIOL, V128, P391, DOI 10.1007/s00418-007-0320-8; Steiniger B, 2006, HISTOCHEM CELL BIOL, V126, P641, DOI 10.1007/s00418-006-0210-5; Steiniger B, 2011, J HISTOCHEM CYTOCHEM, V59, P639, DOI 10.1369/0022155411408315; Steiniger BS, 2015, IMMUNOLOGY, V145, P334, DOI 10.1111/imm.12469; Steiniger BS, 2014, IMMUNOLOGY, V143, P462, DOI 10.1111/imm.12325; Steiniger BS, 2014, HISTOCHEM CELL BIOL, V141, P507, DOI 10.1007/s00418-013-1172-z; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Turner VM, 2017, IMMUNOLOGY, V151, P349, DOI 10.1111/imm.12737; Ulrich C., 2014, WSCG 2014 COMM PAP P, P361; Ulrich C., 2014, P 4 EUROGRAPHICS WOR, P69, DOI DOI 10.2312/VCBM.20141185; VEERMAN AJP, 1975, CELL TISSUE RES, V156, P417, DOI 10.1007/BF00225103	54	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191019	10.1371/journal.pone.0191019	http://dx.doi.org/10.1371/journal.pone.0191019			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420557	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900009
J	de Leon, MJ; Pirraglia, E; Osorio, RS; Glodzik, L; Saint-Louis, L; Kim, HJ; Fortea, J; Fossati, S; Laska, E; Siegel, C; Butler, T; Li, Y; Rusinek, H; Zetterberg, H; Blennow, K				de Leon, Mony J.; Pirraglia, Elizabeth; Osorio, Ricardo S.; Glodzik, Lidia; Saint-Louis, Les; Kim, Hee-Jin; Fortea, Juan; Fossati, Silvia; Laska, Eugene; Siegel, Carole; Butler, Tracy; Li, Yi; Rusinek, Henry; Zetterberg, Henrik; Blennow, Kaj		Alzheimer's Dis Neuroimaging; Natl Alzheimer's Coordinating Ctr	The nonlinear relationship between cerebrospinal fluid A beta(42) and tau in preclinical Alzheimer's disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; CSF BIOMARKERS; AGE; DEPOSITION; A-BETA-42; ADULTS; STANDARDIZATION; CLEARANCE	Cerebrospinal fluid (CSF) studies consistently show that CSF levels of amyloid-beta 1-42 (A beta(42)) are reduced and tau levels increased prior to the onset of cognitive decline related to Alzheimer's disease (AD). However, the preclinical prediction accuracy for low CSF A beta(42) levels, a surrogate for brain A beta(42) deposits, is not high. Moreover, the pathology data suggests a course initiated by tauopathy contradicting the contemporary clinical view of an A beta initiated cascade. CSF A beta(42) and tau data from 3 normal aging cohorts (45-90 years) were combined to test both cross-sectional (n = 766) and longitudinal (n = 651) hypotheses: 1) that the relationship between CSF levels of A beta(42) and tau are not linear over the adult life-span; and 2) that non-linear models improve the prediction of cognitive decline. Supporting the hypotheses, the results showed that a u-shaped quadratic fit (A beta(2)) best describes the relationship for CSF A beta(42) with CSF tau levels. Furthermore we found that the relationship between A beta(42) and tau changes with age-between 45 and 70 years there is a positive linear association, whereas between 71 and 90 years there is a negative linear association between A beta(42) and tau. The quadratic effect appears to be unique to A beta(42), as A beta(38) and A beta(40) showed only positive linear relationships with age and CSF tau. Importantly, we observed the prediction of cognitive decline was improved by considering both high and low levels of A beta(42). Overall, these data suggest an earlier preclinical stage than currently appreciated, marked by CSF elevations in tau and accompanied by either elevations or reductions in A beta(42). Future studies are needed to examine potential mechanisms such as failing CSF clearance as a common factor elevating CSF A beta(xx) analyte levels prior to A beta(42) deposition in brain.	[de Leon, Mony J.; Pirraglia, Elizabeth; Osorio, Ricardo S.; Glodzik, Lidia; Fossati, Silvia; Laska, Eugene; Siegel, Carole; Butler, Tracy; Li, Yi] NYU Med Ctr, Dept Psychiat, Ctr Brain Hlth, New York, NY 10016 USA; [Pirraglia, Elizabeth] NYU Med Ctr, Dept Populat Hlth, Div Biostat, New York, NY 10016 USA; [Osorio, Ricardo S.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Glodzik, Lidia; Rusinek, Henry] NYU Med Ctr, Dept Radiol, New York, NY 10016 USA; [Saint-Louis, Les] Lennox Hill Radiol, New York, NY USA; [Kim, Hee-Jin] Hanyang Univ, Dept Neurol, Memory Unit, Seoul, South Korea; [Fortea, Juan] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst, London, England	New York University; New York University; Nathan Kline Institute for Psychiatric Research; New York University; Hanyang University; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of London; University College London	de Leon, MJ (corresponding author), NYU Med Ctr, Dept Psychiat, Ctr Brain Hlth, New York, NY 10016 USA.	Mony.deLeon@nyumc.org	Kim, Hee-Jin/P-1903-2015; Fortea, Juan/AFU-3179-2022; de Leon, Mony/AAP-7890-2021	Kim, Hee-Jin/0000-0001-7880-690X; Fortea, Juan/0000-0002-1340-638X; Pirraglia, Elizabeth/0000-0003-0419-559X; de Leon, Mony/0000-0003-2245-4380; Fossati, Silvia/0000-0002-2047-222X; Siegel, Carole/0000-0002-7460-788X; li, yi/0000-0002-3875-3513; Laska, Eugene/0000-0001-6799-1361	National Institutes of Health [AG13616, AG022374, AG12101, AG057570, AG032554, HL118624, AG049348, HL111724]; National Institute on Aging [U01 AG024904, W81XWH 12 2 0012]; National Institute of Biomedical Imaging and Bioengineering [U01 AG024904, W81XWH 12 2 0012]; AbbVie [U01 AG024904, W81XWH 12 2 0012]; Alzheimer's Association [U01 AG024904, W81XWH 12 2 0012]; Alzheimer's Drug Discovery Foundation [U01 AG024904, W81XWH 12 2 0012]; Araclon Biotech [U01 AG024904, W81XWH 12 2 0012]; BioClinica, Inc. [U01 AG024904, W81XWH 12 2 0012]; Biogen [U01 AG024904, W81XWH 12 2 0012]; Bristol Myers Squibb Company [U01 AG024904, W81XWH 12 2 0012]; CereSpir, Inc. [U01 AG024904, W81XWH 12 2 0012]; Cogstate [U01 AG024904, W81XWH 12 2 0012]; Eisai Inc. [U01 AG024904, W81XWH 12 2 0012]; Elan Pharmaceuticals, Inc.; [U01 AG024904, W81XWH 12 2 0012]; Eli Lilly and Company [U01 AG024904, W81XWH 12 2 0012]; Eurolmmun [U01 AG024904, W81XWH 12 2 0012]; F. Hoffmann La Roche Ltd [U01 AG024904, W81XWH 12 2 0012]; Genentech, Inc. [U01 AG024904, W81XWH 12 2 0012]; Fujirebio [U01 AG024904, W81XWH 12 2 0012]; GE Healthcare [U01 AG024904, W81XWH 12 2 0012]; IXICO Ltd. [U01 AG024904, W81XWH 12 2 0012]; Janssen Alzheimer I mmunotherapy Research & Development, LLC. [U01 AG024904, W81XWH 12 2 0012]; Johnson & Johnson Pharmaceutical Research & Development LLC. [U01 AG024904, W81XWH 12 2 0012]; Lumosity [U01 AG024904, W81XWH 12 2 0012]; Lundbeck [U01 AG024904, W81XWH 12 2 0012]; Merck Co., Inc. [U01 AG024904, W81XWH 12 2 0012]; Meso Scale Diagnostics, LLC. [U01 AG024904, W81XWH 12 2 0012]; NeuroRx Research [U01 AG024904, W81XWH 12 2 0012]; Neurotrack Technologies [U01 AG024904, W81XWH 12 2 0012]; Novartis Pharmaceuticals Corporation [U01 AG024904, W81XWH 12 2 0012]; Pfizer Inc. [U01 AG024904, W81XWH 12 2 0012]; Piramal Imaging [U01 AG024904, W81XWH 12 2 0012]; Servier [U01 AG024904, W81XWH 12 2 0012]; Takeda Pharmaceutical Company [U01 AG024904, W81XWH 12 2 0012]; Transition Therapeutics [U01 AG024904, W81XWH 12 2 0012]; Canadian Institutes of Health Research; NIA/NIH Grant [U01 AG016976]; Swedish Research Council [2017-00915, 2013-2546]; Swedish Alzheimer Foundation [AF 553101]; Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project [ALFGBG-715986]; European Research Council [681712]; Knut and Alice Wallenberg Foundation [2013HZ]; NIA [P30 AG019610, P30, AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146];  [P50 AG005134];  [P50 AG016574];  [P50];  [AG005138];  [P30 AG008051];  [AG013854];  [P30 AG008017];  [AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGING [P30AG008051, U01AG016976, R01AG022374, R21AG049348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.;; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIA/NIH Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer Foundation; Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project; European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The NYU study was supported by National Institutes of Health (https://urldefense. proofpoint.com/v2/url?u=https-3A_www.nih.gov_&d=DwlGaQ&c=j5oPp00e8H1iio48Dtsedb OBGma15iFiLigvtN2r4ell&r=pgURDIMRVf FwMnUonrj4ZXYtKgxaWlxc-LhDyy62ZY&m=0awcrQ4Elao5w1T8t14JaTKdfOlcYFIzbq3 DM0qkasC8&s=f6hj-5HuGxw-GZ0d2LM6hs ZWXmo865oZPLb1OvKITLs&e=) grants AG13616 (MdeL), AG022374 (MdeL), AG12101 (MdeL), AG057570 (MdeL), AG032554 (MdeL), HL118624 (RSO), AG049348 (RSO), HL111724 (LG). The Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH 12 2 0012) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.friiii.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The NACC database is funded by NIA/NIH Grant U01 AG016976. Kaj Blennow and Henrik Zetterberg received funding from the Swedish Research Council grants 2017-00915 (KB) and 2013-2546 (HZ), the Swedish Alzheimer Foundation grant AF 553101 (KB), the Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences LUA/ALF VGR project ALFGBG-715986 (KB), the European Research Council grant 681712 (HZ), and the Knut and Alice Wallenberg Foundation grant 2013HZ (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30, AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688, (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133, (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134, (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50, AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30, AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30, AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Blennow K, 2013, MED CLIN N AM, V97, P369, DOI 10.1016/j.mcna.2012.12.012; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braak H, 2013, ACTA NEUROPATHOL; de Leon MJ, 2017, J NUCL MED, V58, P1471, DOI 10.2967/jnumed.116.187211; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glodzik-Sobanska L, 2009, NEUROBIOL AGING, V30, P672, DOI 10.1016/j.neurobiolaging.2007.08.019; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kakuda N, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0477-x; Lauridsen C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00210; Maia LF, 2015, EMBO MOL MED, V7, P895, DOI 10.15252/emmm.201505026; Mattsson N, 2015, JAMA NEUROL, V72, P554, DOI 10.1001/jamaneurol.2014.4530; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Paternico D, 2012, ALZHEIMERS DEMENT, V8, P520, DOI 10.1016/j.jalz.2011.10.003; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; REISBERG B, 1993, AM J PSYCHIAT, V150, P680; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shoji M, 2001, NEUROBIOL AGING, V22, P209, DOI 10.1016/S0197-4580(00)00229-3; Sjogren M, 2001, CLIN CHEM, V47, P1776; Spiegel J, 2016, J ALZHEIMERS DIS, V49, P93, DOI 10.3233/JAD-150167; Sutphen CL, 2015, JAMA NEUROL, V72, P1029, DOI 10.1001/jamaneurol.2015.1285; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tijms BM, 2017, ANN NEUROL, V81, P749, DOI 10.1002/ana.24921; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3	36	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191240	10.1371/journal.pone.0191240	http://dx.doi.org/10.1371/journal.pone.0191240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415068	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300018
J	Kuscu, M; Akan, OB				Kuscu, Murat; Akan, Ozgur B.			Modeling convection-diffusion-reaction systems for microfluidic molecular communications with surface-based receivers in Internet of Bio-Nano Things	PLOS ONE			English	Article							ON-A-CHIP; MASS-TRANSPORT; RATE CONSTANTS; BIOSENSORS; CHANNELS; INFORMATION; TECHNOLOGY; BIACORE; BINDING; DESIGN	We consider a microfluidic molecular communication (MC) system, where the concentration-encoded molecular messages are transported via fluid flow-induced convection and diffusion, and detected by a surface-based MC receiver with ligand receptors placed at the bottom of the microfluidic channel. The overall system is a convection-diffusion-reaction system that can only be solved by numerical methods, e.g., finite element analysis (FEA). However, analytical models are key for the information and communication technology (ICT), as they enable an optimisation framework to develop advanced communication techniques, such as optimum detection methods and reliable transmission schemes. In this direction, we develop an analytical model to approximate the expected time course of bound receptor concentration, i.e., the received signal used to decode the transmitted messages. The model obviates the need for computationally expensive numerical methods by capturing the nonlinearities caused by laminar flow resulting in parabolic velocity profile, and finite number of ligand receptors leading to receiver saturation. The model also captures the effects of reactive surface depletion layer resulting from the mass transport limitations and moving reaction boundary originated from the passage of finite-duration molecular concentration pulse over the receiver surface. Based on the proposed model, we derive closed form analytical expressions that approximate the received pulse width, pulse delay and pulse amplitude, which can be used to optimize the system from an ICT perspective. We evaluate the accuracy of the proposed model by comparing model-based analytical results to the numerical results obtained by solving the exact system model with COMSOL Multiphysics.	[Kuscu, Murat; Akan, Ozgur B.] Univ Cambridge, Internet Everything IoE Grp, Elect Engn Div, Dept Engn, Cambridge CB3 0FA, England; [Akan, Ozgur B.] Koc Univ, Next Generat & Wireless Commun Lab NWCL, Dept Elect & Elect Engn, TR-34450 Istanbul, Turkey	University of Cambridge; Koc University	Kuscu, M (corresponding author), Univ Cambridge, Internet Everything IoE Grp, Elect Engn Div, Dept Engn, Cambridge CB3 0FA, England.	mk959@cam.ac.uk	Kuscu, Murat/U-5300-2019	Kuscu, Murat/0000-0002-8463-6027	ERC project MINERVA [ERC-2013-CoG 616922]; EU project CIRCLE [EU-H2020-FET-Open 665564]	ERC project MINERVA; EU project CIRCLE	This work was financially supported in part by the ERC project MINERVA (ERC-2013-CoG 616922), and the EU project CIRCLE (EU-H2020-FET-Open 665564).	Akan OB, 2017, P IEEE, V105, P306, DOI 10.1109/JPROC.2016.2537306; Akyildiz I., 2012, IEEE WIRELESS COMMUN, V19; Akyildiz IF, 2015, IEEE COMMUN MAG, V53, P32, DOI 10.1109/MCOM.2015.7060516; Bicen AO, 2015, IEEE T BIOMED CIRC S, V9, P505, DOI 10.1109/TBCAS.2015.2465182; Bicen AO, 2015, IEEE T NANOTECHNOL, V14, P570, DOI 10.1109/TNANO.2015.2418175; Bicen AO, 2014, IEEE T COMMUN, V62, P2432, DOI 10.1109/TCOMM.2014.2323293; Bicen AO, 2013, IEEE T SIGNAL PROCES, V61, P5000, DOI 10.1109/TSP.2013.2274959; Bilgin BA, 2017, IEEE T NANOBIOSCI, V16, P408, DOI 10.1109/TNB.2017.2730582; Caplin JD, 2015, ADV HEALTHC MATER, V4, P1426, DOI 10.1002/adhm.201500040; Choi K, 2012, LAB CHIP, V12, P1533, DOI 10.1039/c2lc21203j; De Leo E, 2013, IEEE T COMMUN, V61, P4663, DOI 10.1109/TCOMM.2013.100813.130332; De Leo E., 2012, NANO COMMUN NETW, V3, P217; Felicetti L, 2016, NANO COMMUN NETW, V7, P27, DOI 10.1016/j.nancom.2015.08.004; Gervais T, 2006, CHEM ENG SCI, V61, P1102, DOI 10.1016/j.ces.2005.06.024; Goldstein B, 1999, J MOL RECOGNIT, V12, P293, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<293::AID-JMR472>3.0.CO;2-M; Golicnik M, 2012, BIOCHEM ENG J, V63, P116, DOI 10.1016/j.bej.2012.01.010; Hansen R, 2012, LANGMUIR, V28, P7557, DOI 10.1021/la3000763; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Karsenty M, 2014, ANAL CHEM, V86, P3028, DOI 10.1021/ac403838j; Khan T, 2017, IEEE T NANOBIOSCI, V16, P299, DOI 10.1109/TNB.2017.2707482; Kuscu M, 2016, IEEE ENG MED BIO, P3043, DOI 10.1109/EMBC.2016.7591371; Kuscu M, 2016, IEEE T COMMUN, V64, P3708, DOI 10.1109/TCOMM.2016.2589935; Kuscu M, 2016, IEEE SENS J, V16, P2228, DOI 10.1109/JSEN.2016.2519150; Kuscu M, 2015, 2015 IEEE 2ND WORLD FORUM ON INTERNET OF THINGS (WF-IOT), P669, DOI 10.1109/WF-IoT.2015.7389134; Kuscu M, 2016, IEEE INTERNET THINGS, V3, P4, DOI 10.1109/JIOT.2015.2439045; Kuscu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07831; Llatser I., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P467, DOI 10.1109/INFCOMW.2011.5928858; Malmstadt N, 2003, ANAL CHEM, V75, P2943, DOI 10.1021/ac034274r; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Sigmundsson K, 2002, BIOCHEMISTRY-US, V41, P8263, DOI 10.1021/bi020099h; Squires TM, 2008, NAT BIOTECHNOL, V26, P417, DOI 10.1038/nbt1388; WANG DS, 2016, SENSORS BASEL, V16, P81175, DOI DOI 10.3390/S16081175	32	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192202	10.1371/journal.pone.0192202	http://dx.doi.org/10.1371/journal.pone.0192202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415019	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300058
J	Morgan, SJ; McDonald, CL; Halsne, EG; Cheever, SM; Salem, R; Kramer, PA; Hafner, BJ				Morgan, Sara J.; McDonald, Cody L.; Halsne, Elizabeth G.; Cheever, Sarah M.; Salem, Rana; Kramer, Patricia A.; Hafner, Brian J.			Laboratory- and community-based health outcomes in people with transtibial amputation using crossover and energy-storing prosthetic feet: A randomized crossover trial	PLOS ONE			English	Article							LOWER-LIMB AMPUTATION; 6-MINUTE WALK TEST; BALANCE CONFIDENCE SCALE; TIBIAL AMPUTEE GAIT; SELF-REPORT; LONG-TERM; PERCEIVED EXERTION; TRINITY AMPUTATION; EXPERIENCE SCALES; ACTIVITY MONITOR	Contemporary prosthetic feet are generally optimized for either daily or high-level activities. Prosthesis users, therefore, often require multiple prostheses to participate in activities that span a range of mobility. Crossover feet (XF) are designed to increase the range of activities that can be performed with a single prosthesis. However, little evidence exists to guide clinical prescription of XF relative to traditional energy storing feet (ESF). The objective of this study was to assess the effects of XF and ESF on health outcomes in people with transtibial amputation. A randomized crossover study was conducted to assess changes in laboratory-based (endurance, perceived exertion, walking performance) and community-based (step activity and self-reported mobility, fatigue, balance confidence, activity restrictions, and satisfaction) outcomes. Twenty-seven participants were fit with XF and ESF prostheses with standardized sockets, interfaces, and suspensions. Participants were not blinded to the intervention, and wore each prosthesis for one month while their steps were counted with an activity monitor. After each accommodation period, participants returned for data collection. Endurance and perceived exertion were measured with the Six-Minute Walk Test and Borg-CR100, respectively. Walking performance was measured using an electronic walkway. Self-reported mobility, fatigue, balance confidence, activity restrictions, and satisfaction were measured with survey instruments. Participants also reported foot preferences upon conclusion of the study. Differences between feet were assessed with a crossover analysis. While using XF, users experienced improvements in most community-based outcomes, including mobility (p = .001), fatigue (p = .001), balance confidence (p = .005), activity restrictions (p = .002), and functional satisfaction (p < .001). Participants also exhibited longer sound side steps in XF compared to ESF (p < .001). Most participants (89%) reported an overall preference for XF; others (11%) reported no preference. Results indicate that XF may be a promising alternative to ESF for people with transtibial amputation who engage in a range of mobility activities.	[Morgan, Sara J.; McDonald, Cody L.; Halsne, Elizabeth G.; Cheever, Sarah M.; Salem, Rana; Hafner, Brian J.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Kramer, Patricia A.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hafner, BJ (corresponding author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.	bhafner@uw.edu	Halsne, Elizabeth/ABD-1819-2020; McDonald, Cody/AAK-4783-2020	Halsne, Elizabeth/0000-0003-0640-1051; Morgan, Sara/0000-0001-8059-3659; Kramer, Patricia Ann/0000-0002-6435-9130; Hafner, Brian/0000-0001-6175-1869	University of Washington Royalty Research Fund [A97186]; Office of the Assistant Secretary of Defense for Health Affairs through the Orthotics and Prosthetics Outcomes Research Program [W81XWH-15-1-0458]	University of Washington Royalty Research Fund(University of Washington); Office of the Assistant Secretary of Defense for Health Affairs through the Orthotics and Prosthetics Outcomes Research Program	Funding/Support: This work was supported by the University of Washington Royalty Research Fund (https://www.washington.edu/research/or/royalty-research-fund-rrf/) under Award No. A97186 (BH) and Office of the Assistant Secretary of Defense for Health Affairs through the Orthotics and Prosthetics Outcomes Research Program (http://cdmrp.army.mil/funding/oporp) under Award No. W81XWH-15-1-0458 (BH). Disclaimer: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Amtmann D, 2014, P ISOQOL 20 ANN C BE; Amtmann D, 2015, ARCH PHYS MED REHAB, V96, P1474, DOI 10.1016/j.apmr.2015.03.024; [Anonymous], 2005, MEDICARE REGION C DU; [Anonymous], 2014, PROSTHETIC LIMB USER; Bassett DR, 2010, PHYS THER REV, V15, P135, DOI 10.1179/1743288X10Y.0000000004; Beauchet O, 2009, GERONTOLOGY, V55, P702, DOI 10.1159/000235905; Borg E, 2002, ACTA PSYCHOL, V109, P157, DOI 10.1016/S0001-6918(01)00055-5; Borg G. A., 1998, BORGS RATING PERCEIV; Brown MB, 2009, MED SCI SPORT EXER, V41, P1080, DOI 10.1249/MSS.0b013e3181923cee; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Coleman KL, 1999, J REHABIL RES DEV, V36, P8; Coman L, 2006, CAN J AGING, V25, P253, DOI 10.1353/cja.2007.0001; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dillingham TR, 2001, AM J PHYS MED REHAB, V80, P563, DOI 10.1097/00002060-200108000-00003; Fergason J R, 2000, Phys Med Rehabil Clin N Am, V11, P681; Fridman A, 2003, PROSTHET ORTHOT INT, V27, P17; Gailey R., 2005, JPO J PROSTHETICS OR, V17, pS39, DOI [10.1097/00008526-200510001-00014, DOI 10.1097/00008526-200510001-00014]; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Gailey RS, 2013, J REHABIL RES DEV, V50, P905, DOI 10.1682/JRRD.2012.05.0099; Gailey RS, 2012, J REHABIL RES DEV, V49, P597, DOI 10.1682/JRRD.2011.04.0077; Gallagher P, 2004, ARCH PHYS MED REHAB, V85, P730, DOI 10.1016/j.apmr.2003.07.009; Gallagher P, 2010, AM J PHYS MED REHAB, V89, P487, DOI 10.1097/PHM.0b013e3181dd8cf1; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Hafner B, 2017, J PROSTHET ORTHOT; Hafner B, 2013, AM AC ORTH PROSTH AA; Hafner BJ, 2002, CLIN BIOMECH, V17, P325, DOI 10.1016/S0268-0033(02)00020-7; Hafner BJ, 2016, J REHABIL RES DEV, V53, P797, DOI 10.1682/JRRD.2015.12.0228; Hafner BJ, 2017, ARCH PHYS MED REHAB, V98, P277, DOI 10.1016/j.apmr.2016.07.026; Hafner BJ, 2016, PROSTHET ORTHOT INT, V40, P582, DOI 10.1177/0309364615579315; Hanspal RS, 2003, DISABIL REHABIL, V25, P1278, DOI 10.1080/09638280310001603983; Highsmith MJ., 2010, J PROSTHET ORTHOT, V22, P26, DOI [10.1097/jpo.0b013e3181cc0e34, DOI 10.1097/JPO.0b013e3181cc0e34]; Hofstad Cheriel J, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD003978.PUB2]; HOLM S, 1979, SCAND J STAT, V6, P65; Hordacre B, 2014, SENSORS-BASEL, V14, P5845, DOI 10.3390/s140405845; Isakov E, 2000, PROSTHET ORTHOT INT, V24, P216, DOI 10.1080/03093640008726550; Klodd E, 2010, J REHABIL RES DEV, V47, P899, DOI 10.1682/JRRD.2009.10.0166; Klute GK, 2006, ARCH PHYS MED REHAB, V87, P717, DOI 10.1016/j.apmr.2006.02.007; Klute GK, 2009, J REHABIL RES DEV, V46, P293, DOI 10.1682/JRRD.2008.02.0031; Lie HH, 2010, J CLIN EPIDEMIOL, V63, P1169, DOI 10.1016/j.jclinepi.2009.11.021; Lin SJ, 2008, ARCH PHYS MED REHAB, V89, P2354, DOI 10.1016/j.apmr.2008.05.021; Linendoll K., 2012, OSSURS CHEETAH GOES; Matthews D, 2014, J SPORT MED PHYS FIT, V54, P481; Miller WC, 2003, ARCH PHYS MED REHAB, V84, P656, DOI 10.1016/S0003-9993(03)04807-4; Norvell DC, 2005, ARCH PHYS MED REHAB, V86, P487, DOI 10.1016/j.apmr.2004.04.034; Orendurff MS, 2008, J REHABIL RES DEV, V45, P1077, DOI 10.1682/JRRD.2007.11.0197; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; POWERS CM, 1994, ARCH PHYS MED REHAB, V75, P825; Raschke SU, 2015, J BIOMECH, V48, P146, DOI 10.1016/j.jbiomech.2014.10.002; Resnik L, 2011, PHYS THER, V91, P555, DOI 10.2522/ptj.20100287; Ries Andrew L, 2005, COPD, V2, P105; Sakakibara BM, 2011, ARCH PHYS MED REHAB, V92, P1257, DOI 10.1016/j.apmr.2011.03.013; Shaw A., 2012, IS 1 DOUBLE AMPUTEE; Snyder RD, 1995, J REHABIL RES DEV, V32, P309; Struyf PA, 2009, ARCH PHYS MED REHAB, V90, P440, DOI 10.1016/j.apmr.2008.08.220; van der Linde H, 2004, J REHABIL RES DEV, V41, P555, DOI 10.1682/JRRD.2003.06.0102; Versluys R, 2009, DISABIL REHABIL-ASSI, V4, P65, DOI 10.1080/17483100802715092; Webster JB, 2001, ARCH PHYS MED REHAB, V82, pS38, DOI 10.1016/S0003-9993(01)80036-8; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Wurdeman SR, 2017, AM J PHYS MED REHAB, V96, P294, DOI 10.1097/PHM.0000000000000607	65	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0189652	10.1371/journal.pone.0189652	http://dx.doi.org/10.1371/journal.pone.0189652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414988	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300005
J	Raynor, EJ; Powell, LA; Schacht, WH				Raynor, Edward J.; Powell, Larkin A.; Schacht, Walter H.			Present and future thermal environments available to Sharp-tailed Grouse in an intact grassland	PLOS ONE			English	Article							EVAPORATIVE COOLING CAPACITY; OPERATIVE TEMPERATURE; VEGETATION STRUCTURE; HABITAT SELECTION; CLIMATE-CHANGE; WATER-LOSS; THERMOREGULATION; BEHAVIOR; ECOLOGY; TOLERANCE	Better understanding animal ecology in terms of thermal habitat use has become a focus of ecological studies, in large part due to the predicted temperature increases associated with global climate change. To further our knowledge on how ground-nesting endotherms respond to thermal landscapes, we examined the thermal ecology of Sharp-tailed Grouse (Tympanuchus phasianellus) during the nesting period. We measured site-specific iButton temperatures (T-iB) and vegetation characteristics at nest sites, nearby random sites, and landscape sites to assess thermal patterns at scales relevant to nesting birds. We asked if microhabitat vegetation characteristics at nest sites matched the characteristics that directed macrohabitat nest-site selection. Grouse selected sites sheltered by dense vegetation for nesting that moderated TiB on average up to 2.7 degrees C more than available landscape sites. Successful nests were positioned in a way that reduced exposure to thermal extremes by as much as 4 degrees C relative to failed nests with an overall mean daytime difference (+/- SE) of 0.4 +/- 0.03 degrees C. We found that macrohabitat nest-site selection was guided by dense vegetation cover and minimal bare ground as also seen at the microhabitat scale. Global climate projections for 2080 suggest that TiB at nest sites may approach temperatures currently avoided on the landscape, emphasizing a need for future conservation plans that acknowledge fine-scale thermal space in climate change scenarios. These data show that features of grassland landscapes can buffer organisms from unfavorable microclimatic conditions and highlight how thermal heterogeneity at the individual-level can drive decisions guiding nest site selection.	[Raynor, Edward J.; Powell, Larkin A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Raynor, Edward J.; Schacht, Walter H.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Raynor, EJ (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.; Raynor, EJ (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	edwardraynor@gmail.com	Raynor, Edward/J-8717-2015; Powell, Larkin A/G-4570-2010	Raynor, Edward/0000-0003-2483-4694; 	Nebraska Game & Parks Commission	Nebraska Game & Parks Commission	LAP and WHS received funding from Nebraska Game & Parks Commission for this project.	Albright TP, 2017, P NATL ACAD SCI USA, V114, P2283, DOI 10.1073/pnas.1613625114; Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beever EA, 2015, CONSERVATION LETT; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Bleed AS, 1998, ATLAS SAND HILLS CON; Bragg T. B, 1996, PRAIRIE CONSERVATION, P53; BUHNERKEMPE JE, 1984, WILDLIFE SOC B, V12, P382; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Carroll JM, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00163.1; Carroll JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118467; Connelly J. W., 1998, BIRDS N AM; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Dallmann Josiah D., 2016, Great Plains Research, V26, P117; Deeming C., 2002, AVIAN INCUBATION BEH; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Elmore RD, 2017, WILDLIFE SOC B, V41, P183, DOI 10.1002/wsb.772; EVANS KE, 1975, CONDOR, V77, P160, DOI 10.2307/1365786; Gillis H, 2012, CAN J ZOOL, V90, P694, DOI 10.1139/Z2012-035; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Grisham BA, 2016, CONDOR, V118, P728, DOI 10.1650/CONDOR-16-38.1; Grisham BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068225; Gunderson AR, 2012, FUNCT ECOL, V26, P783, DOI 10.1111/j.1365-2435.2012.01987.x; Guthery FS, 2005, WILDLIFE MONOGR, P1; Hamerstrom F, 1957, GUIDE PRAIRIE CHICKE; Hansell MH, 2002, OX ORN SER, V13, P8; Hepp GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047777; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00340.1; Huey R.B., 1991, American Naturalist, V137, P91; HUEY RB, 1974, SCIENCE, V184, P1001, DOI 10.1126/science.184.4140.1001; JOHNSON DB, 1988, J WILDLIFE MANAGE, V52, P464, DOI 10.2307/3801592; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; KOBRIGER GERALD D., 1965, J WILDLIFE MANAGE, V29, P788, DOI 10.2307/3798555; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Long RA, 2014, ECOL MONOGR, V84, P513, DOI 10.1890/13-1273.1; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Matthews TW, 2013, J WILDLIFE MANAGE, V77, P1202, DOI 10.1002/jwmg.564; McKechnie AE, 2016, J EXP BIOL, V219, P2137, DOI 10.1242/jeb.139733; Melin M, 2014, GLOBAL CHANGE BIOL, V20, P1115, DOI 10.1111/gcb.12405; Monteith J., 2007, PRINCIPLES ENV PHYS; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Noakes MJ, 2016, J EXP BIOL, V219, P859, DOI 10.1242/jeb.132001; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Powell LA, 2014, EC305; Prose BL., 1987, HABITAT SUITABILITY; R Development Core Team, 2009, R LANG ENV STAT COMP; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; RICHARDS SA, 1976, J AGR SCI, V87, P527, DOI 10.1017/S002185960003313X; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rowe JW, 2014, J THERM BIOL, V40, P9, DOI 10.1016/j.jtherbio.2013.12.002; Sato CF, 2014, J APPL ECOL, V51, P13, DOI 10.1111/1365-2664.12168; Sauer JR, 2017, N AM BREEDING BIRD S; SCHROEDER MA, 1991, J FIELD ORNITHOL, V62, P378; Sliwinski MS, 2017, MANAGING WILDLIFE HA; Sliwinski MS, 2017, THESIS; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; Street GM, 2016, LANDSCAPE ECOL, V31, P1939, DOI 10.1007/s10980-016-0372-z; Swinehart JB., 1990, ATLAS SAND HILLS RES, P43; Tanner EP, 2016, GLOBAL CHANGE BIOL; Therneau T., 2015, PACKAGE SURVIVAL ANA; Tuff KT, 2016, ECOL LETT, V19, P361, DOI 10.1111/ele.12579; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Walsberg GE, 1996, J THERM BIOL, V21, P275, DOI 10.1016/S0306-4565(96)00017-4; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Wiebe KL, 2000, BEHAV ECOL SOCIOBIOL, V48, P463; Wiens J.A., 1985, P169; Winder VL, 2018, J WILDLIFE MANAGE, V82, P113, DOI 10.1002/jwmg.21331; Winder VL, 2016, J ORNITHOL, V157, P733, DOI 10.1007/s10336-016-1330-x; Wolf BO, 1996, J EXP BIOL, V199, P451	79	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191233	10.1371/journal.pone.0191233	http://dx.doi.org/10.1371/journal.pone.0191233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415080	gold, Green Published			2022-12-27	WOS:000424325300017
J	Villalobos, G				Villalobos, Gabriel			Brownian orientational lath model (BOLD): A computational model relating the self-assembly in a fluid of lath like particles with its rheology and gelation	PLOS ONE			English	Article							THIOPHENE DIMER; POLY(3-HEXYLTHIOPHENE); SIMULATIONS; STACKING; FORCE; GELS	By means of a computational model, we study the relation between two complementary views of gelation, rheological tests against the characterization of a network of consecutive particles. The model we propose consists of slender, plane, colloidal sized particles, which we name laths, which self-assemble into long ordered aggregates of several particles; called whiskers in the literature. Within a whisker, the interaction potential is a minimum when: the planes of two consecutive laths are aligned, thus favoring their alignment; when the center of three consecutive laths lie in a straight line, thus favoring stacking; and when the center of two consecutive laths are located at a certain distance, which mimics excluded volume. A threshold value of the potential gives a condition for sticking free laths into whiskers, and for the breaking of whiskers. The simplicity of the model allows the simulation to reach large enough times, of the order of minutes, needed to simulate numerical rheology tests. We are able to characterize the whisker formation, as well as to simulate the gel transition, by means of an oscillatory shear numerical experiment. We conclude that according to the usual rheological definition a gel transition occurs at about 250K, even though there is no branching and less than 10% of whiskers are long enough as to percolate the system.	[Villalobos, Gabriel] Univ Twente, Computat Biophys, POB 217, NL-7500 AE Enschede, Netherlands; [Villalobos, Gabriel] Univ Bogota Jorge Tadeo Lozano, Dept Ciencias Basicas, Carrera 4 22-61 Modulo 6, Bogota 110311, Colombia	University of Twente	Villalobos, G (corresponding author), Univ Twente, Computat Biophys, POB 217, NL-7500 AE Enschede, Netherlands.; Villalobos, G (corresponding author), Univ Bogota Jorge Tadeo Lozano, Dept Ciencias Basicas, Carrera 4 22-61 Modulo 6, Bogota 110311, Colombia.	gabriel.villalobosc@utadeo.edu.co		Villalobos, Gabriel/0000-0003-4582-265X	Ozofab [EOST-10023-OZOFAB]; ESMI [262348]	Ozofab; ESMI	Some of the simulations for this paper used computational time from the "Centro de Informatica y Biologia Computacional BIOS," and ran through the "Red Nacional Academica de Tecnologia Avanzada, RENATA." This work was partially funded by Ozofab, EOST-10023-OZOFAB; and ESMI, Grant Agreement No. 262348 "ESMI."	Abrams CF, 2003, MACROMOLECULES, V36, P260, DOI 10.1021/ma0213495; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Bhatta RS, 2013, J PHYS CHEM B, V117, P10035, DOI 10.1021/jp404629a; Briels WJ, 2009, SOFT MATTER, V5, P4401, DOI 10.1039/b911310j; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Cobb PD, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1997149; Dag S, 2010, J PHYS CHEM B, V114, P5997, DOI 10.1021/jp1008219; de Oliveira ISS, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633701; Doi M., 1988, THEORY POLYM DYNAMIC; Hayashi N, 2009, X PI INTERACTIONS AR, P103; Hore MJA, 2014, MACROMOLECULES, V47, P875, DOI 10.1021/ma402179w; Kazem N, 2015, SOFT MATTER, V11, P7877, DOI 10.1039/c5sm01845e; Keller A, 1995, FARADAY DISCUSS, V101, P1, DOI 10.1039/fd9950100001; Koppe M, 2009, MACROMOLECULES, V42, P4661, DOI 10.1021/ma9005445; Larson R. G., 1999, STRUCTURE RHEOLOGY C, V150; Lee CK, 2013, MACROMOLECULES, V46, P1932, DOI 10.1021/ma302343e; Lee CK, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3687241; Lee CK, 2009, J PHYS CHEM B, V113, P15937, DOI 10.1021/jp907338j; Lim JA, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70080-8; MCCULLOUGH RD, 1993, J AM CHEM SOC, V115, P4910, DOI 10.1021/ja00064a070; Newbloom GM, 2012, MACROMOLECULES, V45, P3452, DOI 10.1021/ma202564k; Newbloom GM, 2011, MACROMOLECULES, V44, P3801, DOI 10.1021/ma2000515; Ngo T. T., 2012, ADV NAT SCI NANOSCI, V3; Padding JT, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/23/233101; Rodriguez-Ropero F, 2008, J COMPUT CHEM, V29, P69, DOI 10.1002/jcc.20763; Scherlis DA, 2005, J AM CHEM SOC, V127, P3207, DOI 10.1021/ja043557d; Schwarz KN, 2013, NANOSCALE, V5, P2017, DOI 10.1039/c3nr33324h; Tao YG, 2006, KAYAKING WAGGING RIG; Tschop W, 1998, ACTA POLYM, V49, P61, DOI 10.1002/(SICI)1521-4044(199802)49:2/3<61::AID-APOL61>3.0.CO;2-V; Tsuzuki S, 2002, J AM CHEM SOC, V124, P12200, DOI 10.1021/ja0204877; Villalobos G, DATA SET BROWNIAN OR; Zhao J, 2009, J PHYS CHEM B, V113, P1587, DOI 10.1021/jp804151a	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191785	10.1371/journal.pone.0191785	http://dx.doi.org/10.1371/journal.pone.0191785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414981	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300041
J	Ben-Abu, Y; Beiles, A; Flom, D; Nevo, E				Ben-Abu, Yuval; Beiles, Avigdor; Flom, Dvir; Nevo, Eviatar			Adaptive evolution of benzoxazinoids in wild emmer wheat, Triticum dicoccoides, at "Evolution Canyon", Mount Carmel, Israel	PLOS ONE			English	Article							MOLECULAR EVOLUTION; HORDEUM-SPONTANEUM; ECOLOGICAL STRESS; BARLEY; DIMBOA; MAIZE; FUNGI; ADAPTATION; DIVERGENCE; DIVERSITY	Background "Evolution Canyon" (ECI) at Lower Nahal Oren, Mount Carmel, Israel, is an optimal natural microscale model for unraveling evolution-in-action, highlighting the evolutionary processes of biodiversity evolution, adaptation, and incipient sympatric speciation. A major model organism in ECI is the tetraploid wild emmer wheat, Triticum dicoccoides (TD), the progenitor of cultivated emmer and durum wheat. TD displays dramatic interslope adaptive evolutionary divergence on the tropical, savannoid-hot and dry south-facing, "African" slope (AS), and on the temperate, forested, cool and humid, north-facing, "European" slope (ES), separated on average by 250 m. From the perspective of chemical evolution and metabolomics, it is important to unravel interslope divergence in biologically relevant secondary metabolites between the abutting slope populations. Here, in TD we examined hydroxamic acid (Hx), which is a family of secondary cereal metabolites, and plays a major role in defending the plant against fungi, insects and weeds. Results Our examination revealed that higher concentrations of DIBOA and DIMBOA were found in seedlings growing in the same greenhouse from seeds collected from the cool and humid forested ES, whereas the seedlings of seeds collected from the savannoid AS (both in root and shoot tissues), showed no DIMBOA. Remarkably, only DIBOA appears in both shoots and roots of the AS seedlings. It rises to a peak and then decreases in both organs and in seedlings from both slopes. The DIMBOA, which appears only in the ES seedlings, rises to a peak and decreases in the shoot, but increased and remained in a plateau in the root, till the end of the experiment. Conculsions/Significance The results suggest stronger genetic resistance of defense compounds DIBOA and DIMBOA against biotic stresses (fungi and other pathogens) by ES seedlings. However, AS seedlings responded earlier but were to the same biotic stresses. The genetic difference found in AS seedlings was caused by the main adaptive selection in AS, which was against climatic, abiotic stresses, and was weaker, or not at all, against biotic stresses. The distinct genetic interslope differences appear important and is very significant and are elaborated in the discussion.	[Ben-Abu, Yuval] Sapir Acad Coll, DN Hof Ashkelon, Projects & Phys Sect, Ashqelon, Israel; [Beiles, Avigdor; Nevo, Eviatar] Univ Haifa, Inst Evolut, Haifa, Israel; [Flom, Dvir] Ben Gurion Univ Negev, Dept Phys, Beer Sheva, Israel	University of Haifa; Ben Gurion University	Ben-Abu, Y (corresponding author), Sapir Acad Coll, DN Hof Ashkelon, Projects & Phys Sect, Ashqelon, Israel.; Nevo, E (corresponding author), Univ Haifa, Inst Evolut, Haifa, Israel.	yuvalb@sapir.ac.il; nevo@research.haifa.ac.il	Abu, Yuval Ben/AAD-1402-2020					Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; Carlsen SCK, 2009, NAT PROD COMMUN, V4, P199; Chen KJ, 2010, J AGR FOOD CHEM, V58, P12710, DOI 10.1021/jf1032608; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dick R, 2012, PLANT CELL, V24, P915, DOI 10.1105/tpc.112.096461; Ebisui K, 1998, Z NATURFORSCH C, V53, P793; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Flors V, 2007, PLANT J, V52, P1027, DOI 10.1111/j.1365-313X.2007.03299.x; GIVOVICH A, 1992, J CHEM ECOL, V18, P841, DOI 10.1007/BF00988324; Gupta PK, 2002, THEOR APPL GENET, V104, P473, DOI 10.1007/s001220100690; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Korol A, 2006, ISR J ECOL EVOL, V52, P507, DOI 10.1560/IJEE_52_3-4_507; Li YC, 1998, BARLEY GENETICS NEWS, V28, P58; Macias FA, 2005, J AGR FOOD CHEM, V53, P538, DOI 10.1021/jf0484071; Maresh J, 2006, ACS CHEM BIOL, V1, P165, DOI 10.1021/cb600051w; MARTOS A, 1992, J CHEM ECOL, V18, P469, DOI 10.1007/BF00994245; Martyniuk S, 2006, J AGR FOOD CHEM, V54, P1036, DOI 10.1021/jf050901x; McMillan VE, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0212-8; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Nevo E, 1998, J EXP ZOOL, V282, P95, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;95::AID-JEZ12&gt;3.0.CO;2-F; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; Nevo E., 2004, DYNAMICAL GENETICS, V81, P7231; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2014, ISR J ECOL EVOL, V60, P85, DOI 10.1080/15659801.2014.986879; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Owuor ED, 1997, MOL ECOL, V6, P1177, DOI 10.1046/j.1365-294X.1997.00296.x; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; PEREZ FJ, 1990, PHYTOCHEMISTRY, V29, P773, DOI 10.1016/0031-9422(90)80016-A; Sikorski J, 2007, ENVIRON MICROBIOL, V9, P716, DOI 10.1111/j.1462-2920.2006.01193.x; Urban K., 2011, ADV GENETIC RES, P67; WEIBULL J, 1995, PHYSIOL MOL PLANT P, V47, P201, DOI 10.1006/pmpp.1995.1052; Wilkes MA, 1999, SOIL BIOL BIOCHEM, V31, P1831, DOI 10.1016/S0038-0717(99)00104-2; Yin HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122344; ZDERO C, 1990, PHYTOCHEMISTRY, V29, P2611, DOI 10.1016/0031-9422(90)85198-O; ZDERO C, 1988, J NAT PROD, V51, P509, DOI 10.1021/np50057a009	41	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190424	10.1371/journal.pone.0190424	http://dx.doi.org/10.1371/journal.pone.0190424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408917	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800007
J	Haberfehlner, H; Jaspers, RT; Rutz, E; Harlaar, J; van der Sluijs, JA; Witbreuk, MM; van Hutten, K; Romkes, J; Freslier, M; Brunner, R; Becher, JG; Maas, H; Buizer, AI				Haberfehlner, Helga; Jaspers, Richard T.; Rutz, Erich; Harlaar, Jaap; van der Sluijs, Johannes A.; Witbreuk, Melinda M.; van Hutten, Kim; Romkes, Jacqueline; Freslier, Marie; Brunner, Reinald; Becher, Jules G.; Maas, Huub; Buizer, Annemieke I.			Outcome of medial hamstring lengthening in children with spastic paresis: A biomechanical and morphological observational study	PLOS ONE			English	Article							DIPLEGIC CEREBRAL-PALSY; EVENT MULTILEVEL SURGERY; MUSCLE-TENDON SURGERY; ORTHOPEDIC-SURGERY; LOWER-EXTREMITY; CROUCH GAIT; WALKING; GASTROCNEMIUS; HEMIPLEGIA; KINEMATICS	To improve gait in children with spastic paresis due to cerebral palsy or hereditary spastic paresis, the semitendinosus muscle is frequently lengthened amongst other medial hamstring muscles by orthopaedic surgery. Side effects on gait due to weakening of the hamstring muscles and overcorrections have been reported. How these side effects relate to semitendinosus morphology is unknown. This study assessed the effects of bilateral medial hamstring lengthening as part of single-event multilevel surgery (SEMLS) on (1) knee joint mechanics (2) semitendinosus muscle morphology and (3) gait kinematics. All variables were assessed for the right side only. Six children with spastic paresis selected for surgery to counteract limited knee range of motion were measured before and about a year after surgery. After surgery, in most subjects popliteal angle decreased and knee moment-angle curves were shifted towards a more extended knee joint, semitendinosus muscle belly length was approximately 30% decreased, while at all assessed knee angles tendon length was increased by about 80%. In the majority of children muscle volume of the semitendinosus muscle decreased substantially suggesting a reduction of physiological cross-sectional area. Gait kinematics showed more knee extension during stance (mean change standard deviation: 34 13), but also increased pelvic anterior tilt (mean change standard deviation: 23 5). In most subjects, surgical lengthening of semitendinosus tendon contributed to more extended knee joint angle during static measurements as well as during gait, whereas extensibility of semitendinosus muscle belly was decreased. Post-surgical treatment to maintain muscle belly length and physiological cross-sectional area may improve treatment outcome of medial hamstring lengthening.	[Haberfehlner, Helga; Jaspers, Richard T.; Maas, Huub] Vrije Univ Amsterdam, Fac Behav & Movement Sci Amsterdam Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands; [Rutz, Erich; Brunner, Reinald] Univ Childrens Hosp Basle, Pediat Orthopaed Dept, Basel, Switzerland; [Harlaar, Jaap; van Hutten, Kim; Becher, Jules G.; Buizer, Annemieke I.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Movement Sci, Dept Rehabil Med, Amsterdam, Netherlands; [Harlaar, Jaap] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [van der Sluijs, Johannes A.; Witbreuk, Melinda M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Movement Sci, Dept Orthopaed Surg, Amsterdam, Netherlands; [Romkes, Jacqueline; Freslier, Marie] Univ Childrens Hosp Basle, Lab Movement Anal, Basel, Switzerland	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Delft University of Technology; Vrije Universiteit Amsterdam	Jaspers, RT (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci Amsterdam Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands.	r.t.jaspers@vu.nl	Buizer, Annemieke/G-9500-2016; Becher, Jules/AAE-2246-2020; Kehoe, Clare/ABC-7984-2020	Buizer, Annemieke/0000-0001-5662-2843; Harlaar, Jaap/0000-0003-2889-271X; Maas, Huub/0000-0002-2304-2735; Jaspers, Richard/0000-0002-6951-0952; Rutz, Erich/0000-0002-2292-0946; Haberfehlner, Helga/0000-0001-9307-4102	Phelps Stichting voor Spastici, Bussum, The Netherlands; Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]	Phelps Stichting voor Spastici, Bussum, The Netherlands(Netherlands Government); Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research	This research is financially supported by the Phelps Stichting voor Spastici, Bussum, The Netherlands (http://phelps-stichting.nl/). Huub Maas was supported by the Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MF, 1999, J PEDIATR ORTHOPED, V19, P366; Adolfsen SE, 2007, J PEDIATR ORTHOPED, V27, P658, DOI 10.1097/BPO.0b013e3180dca114; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/00004694-200209000-00020; Bleck EE, 1987, ORTHOPEDIC MANAGEMEN; Brunner R, 2000, CLIN ORTHOP RELAT R, P264; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Cave EF, 1936, J BONE JOINT SURG, V18, P455; Chang WN, 2004, GAIT POSTURE, V19, P298, DOI 10.1016/S0966-6362(03)00070-5; Cooney KM, 2006, CLIN BIOMECH, V21, P59, DOI 10.1016/j.clinbiomech.2005.08.014; Dagge B, 2012, ANZ J SURG, V82, P355, DOI 10.1111/j.1445-2197.2012.06030.x; Damiano DL, 1999, J PEDIATR ORTHOPED, V19, P352, DOI 10.1097/00004694-199905000-00013; Delp SL, 1996, J ORTHOP RES, V14, P144, DOI 10.1002/jor.1100140123; DELP SL, 1992, CLIN ORTHOP RELAT R, P247; DHAWLIKAR SH, 1992, J BONE JOINT SURG AM, V74A, P1385, DOI 10.2106/00004623-199274090-00012; Dreher T, 2012, J BONE JOINT SURG AM, V94A, P121, DOI [10.2106/JBJSJ.00890, 10.2106/JBJS.J.00890]; Fry NR, 2007, J PEDIATR ORTHOPED, V27, P769, DOI 10.1097/BPO.0b013e3181558943; GAGE JR, 1990, CLIN ORTHOP RELAT R, P45; Grunt S, 2010, GAIT POSTURE, V31, P489, DOI 10.1016/j.gaitpost.2010.02.006; Haberfehlner H., 2016, J ANAT; Haberfehlner H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166401; Haberfehlner H, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0056-y; Handsfield GG, 2016, MUSCLE NERVE, V53, P933, DOI 10.1002/mus.24972; Inam M, 2015, J PEDIATR ORTHOPED, V35, P290, DOI 10.1097/BPO.0000000000000264; Johnson DC, 1997, J PEDIATR ORTHOPED, V17, P392, DOI 10.1097/00004694-199705000-00022; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Karol LA, 2008, J PEDIATR ORTHOPED, V28, P773, DOI 10.1097/BPO.0b013e318186bdbb; Kay RM, 2002, J PEDIATR ORTHOPED, V22, P169, DOI 10.1097/00004694-200203000-00006; Kerkum YL, 2016, GAIT POSTURE, V46, P104, DOI 10.1016/j.gaitpost.2016.03.001; Krautwurst BK, 2016, GAIT POSTURE, V46, P184, DOI 10.1016/j.gaitpost.2016.03.014; Lampe R, 2006, BRAIN DEV-JPN, V28, P500, DOI 10.1016/j.braindev.2006.02.009; Lee SY, 2015, J KOREAN MED SCI, V30, P489, DOI 10.3346/jkms.2015.30.4.489; Mallet C, 2016, ORTHOP TRAUMATOL-SUR, V102, P501, DOI 10.1016/j.otsr.2016.01.022; Morais MC, 2006, J PEDIATR ORTHOPED, V26, P260, DOI 10.1097/01.bpo.0000194700.06398.a2; Noble JJ, 2014, BRAIN DEV-JPN, V36, P294, DOI 10.1016/j.braindev.2013.05.008; Novacheck TF, 2009, IDENTIFICATION TREAT, P445; Oberhofer K, 2010, CLIN BIOMECH, V25, P88, DOI 10.1016/j.clinbiomech.2009.09.007; Ounpuu S, 2015, GAIT POSTURE; Palisano R., 2007, GROSS MOTOR FUNCTION; Park MS, 2009, GAIT POSTURE, V30, P487, DOI 10.1016/j.gaitpost.2009.07.115; REIMERS J, 1974, J BONE JOINT SURG BR, VB 56, P102; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rutz E, 2013, CLIN ORTHOP RELAT R, V471, P1028, DOI 10.1007/s11999-012-2766-9; Seniorou M, 2007, GAIT POSTURE, V26, P475, DOI 10.1016/j.gaitpost.2007.07.008; Shortland AP, 2004, DEV MED CHILD NEUROL, V46, P667, DOI 10.1017/s0012162204001124; Smith LR, 2011, J PHYSL; Stout JL, 2008, J BONE JOINT SURG AM, V90A, P2470, DOI 10.2106/JBJS.G.00327; Van Dyke JM, 2012, MUSCLE NERVE, V45, P367, DOI 10.1002/mus.22286; Zhao H, 2011, J APPL PHYSIOL, V111, P435, DOI 10.1152/japplphysiol.01361.2010; Zwick EB, 2002, GAIT POSTURE, V16, P288, DOI 10.1016/S0966-6362(02)00022-X	49	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192573	10.1371/journal.pone.0192573	http://dx.doi.org/10.1371/journal.pone.0192573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408925	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800081
J	Pansch, C; Hattich, GSI; Heinrichs, ME; Pansch, A; Zagrodzka, Z; Havenhand, JN				Pansch, Christian; Hattich, Giannina S. I.; Heinrichs, Mara E.; Pansch, Andreas; Zagrodzka, Zuzanna; Havenhand, Jonathan N.			Long-term exposure to acidification disrupts reproduction in a marine invertebrate	PLOS ONE			English	Article							BARNACLE SEMIBALANUS-BALANOIDES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; SELF-FERTILIZATION; CO2 CONCENTRATIONS; LARVAL DEVELOPMENT; CARBONIC-ACID; SEA-URCHIN; IMPACTS; TEMPERATURE	Climate change research is advancing to more complex and more comprehensive studies that include long-term experiments, multiple life-history stages, multi-population, and multi-trait approaches. We used a population of the barnacle Balanus improvisus known to be sensitive to short-term acidification to determine its potential for long-term acclimation to acidification. We reared laboratory-bred individuals (as singles or pairs), and field-collected assemblages of barnacles, at pH 8.1 and 7.5 (approximate to 400 and 1600 mu atm pCO(2) respectively) for up to 16 months. Acidification caused strong mortality and reduced growth rates. Acidification suppressed respiration rates and induced a higher feeding activity of barnacles after 6 months, but this suppression of respiration rate was absent after 15 months. Laboratory-bred barnacles developed mature gonads only when they were held in pairs, but nonetheless failed to produce fertilized embryos. Field-collected barnacles reared in the laboratory for 8 months at the same pH's developed mature gonads, but only those in pH 8.1 produced viable embryos and larvae. Because survivors of long-term acidification were not capable of reproducing, this demonstrates that B. improvisus can only partially acclimate to long-term acidification. This represents a clear and significant bottleneck in the ontogeny of this barnacle population that may limit its potential to persist in a future ocean.	[Pansch, Christian; Hattich, Giannina S. I.; Heinrichs, Mara E.; Zagrodzka, Zuzanna; Havenhand, Jonathan N.] Univ Gothenburg, Dept Marine Sci Tjarno, Tjarno, Stromstad, Sweden; [Pansch, Andreas] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforschung, Wattenmeerstation Sylt, List Auf Sylt, Germany; [Pansch, Christian; Hattich, Giannina S. I.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dept Marine Ecol, Kiel, Germany; [Heinrichs, Mara E.] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Zagrodzka, Zuzanna] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England	University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Carl von Ossietzky Universitat Oldenburg; University of Sheffield	Pansch, C (corresponding author), Univ Gothenburg, Dept Marine Sci Tjarno, Tjarno, Stromstad, Sweden.	ch.pansch@gmail.com	Zagrodzka, Zuzanna/AAE-4541-2021; Pansch, Christian/I-9170-2012	Pansch, Christian/0000-0001-8442-4502; Havenhand, Jonathan/0000-0001-6721-7763; Hattich, Giannina Saskia Isabelle/0000-0003-4660-7759	Royal Swedish Academy of Sciences; Royal Society of Arts and Sciences in Gothenburg; Swedish Research Council VR; Swedish Research Council FORMAS	Royal Swedish Academy of Sciences; Royal Society of Arts and Sciences in Gothenburg; Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This project was financed by The Royal Swedish Academy of Sciences, partly supported by The Royal Society of Arts and Sciences in Gothenburg to CP and a Linnaeus-grant from the Swedish Research Councils VR and FORMAS to JNH (http://www.cemeb.science.gu.se).	Alsterberg C, 2013, PHYCOLOGIA, V52, P2; Anderson D.T., 1994, BARNACLES STRUCTURE; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Barazandeh M, 2013, P ROY SOC LOND B BIO, P280; BARNES H, 1977, J EXP MAR BIOL ECOL, V27, P219, DOI 10.1016/0022-0981(77)90125-3; BARNES H, 1956, J MAR BIOL ASSOC UK, V35, P631, DOI 10.1017/S002531540001047X; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Bishop JDD, 2006, INTEGR COMP BIOL, V46, P398, DOI 10.1093/icb/icj037; Bishop JDD, 2000, P ROY SOC B-BIOL SCI, V267, P1165, DOI 10.1098/rspb.2000.1124; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Carey N, 2016, J EXP BIOL, V219, P1178, DOI 10.1242/jeb.136101; CRISP D. J., 1959, OIKOS, V10, P275, DOI 10.2307/3565151; Darwin C., 1854, MONOGRAPH SUBCLASS C; Dickson A., 2007, PICES SPEC PUBL; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Eriander L, 2016, ICES J MAR SCI, V73, P596, DOI 10.1093/icesjms/fsv214; Findlay HS, 2010, ECOLOGY, V91, P2931, DOI 10.1890/09-1987.1; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; Findlay HS, 2010, ESTUAR COAST SHELF S, V86, P675, DOI 10.1016/j.ecss.2009.11.036; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; FURMAN ER, 1990, J EXP MAR BIOL ECOL, V144, P235, DOI 10.1016/0022-0981(90)90030-G; Gaonkar CA, 2010, J MAR BIOL ASSOC UK, V90, P1241, DOI 10.1017/S0025315409991238; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; HANSSON I, 1973, DEEP-SEA RES, V20, P461, DOI 10.1016/0011-7471(73)90100-9; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; JONES LWG, 1954, P ZOOL SOC LOND, V123, P765; Kelly MW, 2012, MOL ECOL, V21, P5088, DOI 10.1111/mec.12009; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Leppakoski Erkki, 2000, Biological Invasions, V2, P151, DOI 10.1023/A:1010052809567; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Morley Simon A., 2016, BIODIVERSITY-OTTAWA, V17, P34, DOI 10.1080/14888386.2016.1174956; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Nakamura M, 2012, AQUAT BIOL, V15, P299, DOI 10.3354/ab00436; Nasrolahi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32263; Nasrolahi A, 2013, MAR BIOL, V160, P1109, DOI 10.1007/s00227-012-2162-8; Niehoff B, 2013, BIOGEOSCIENCES, V10, P1391, DOI 10.5194/bg-10-1391-2013; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Pansch C, 2017, BIOFOULING, V33, P613, DOI 10.1080/08927014.2017.1349897; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; Perez-Losada M, 2014, MOL PHYLOGENET EVOL, V81, P147, DOI 10.1016/j.ympev.2014.09.013; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Robbins L. L., 2010, USGS NUMBERED SERIES; Saderne V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062689; Schlegel P, 2015, J EXP BIOL, V218, P1084, DOI 10.1242/jeb.114900; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Suckling CC, 2015, J ANIM ECOL, V84, P773, DOI 10.1111/1365-2656.12316; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Thiyagarajan V, 2010, J EXP MAR BIOL ECOL, V392, P22, DOI 10.1016/j.jembe.2010.04.030; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Werner FJ, 2016, OECOLOGIA, V180, P889, DOI 10.1007/s00442-015-3489-x; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Wrange AL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-156; Zittier ZMC, 2015, J EXP MAR BIOL ECOL, V473, P16, DOI 10.1016/j.jembe.2015.08.001	81	8	8	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192036	10.1371/journal.pone.0192036	http://dx.doi.org/10.1371/journal.pone.0192036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408893	Green Accepted, Green Published, gold			2022-12-27	WOS:000424302800041
J	Sugi, K; Hsieh, PN; Ilkayeva, O; Shelkay, S; Moroney, B; Baadh, P; Haynes, B; Pophal, M; Fan, L; Newgard, CB; Prosdocimo, DA; Jain, MK				Sugi, Keiki; Hsieh, Paishiun N.; Ilkayeva, Olga; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Newgard, Christopher B.; Prosdocimo, Domenick A.; Jain, Mukesh K.			Kruppel-like factor 15 is required for the cardiac adaptive response to fasting	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; ACID OXIDATION DISORDERS; INSULIN-RESISTANCE; LIPID-ACCUMULATION; HEART-FAILURE; RAT-HEART; METABOLISM; CARDIOMYOPATHY; MECHANISMS; EXPRESSION	Cardiac metabolism is highly adaptive in response to changes in substrate availability, as occur during fasting. This metabolic flexibility is essential to the maintenance of contractile function and is under the control of a group of select transcriptional regulators, notably the nuclear receptor family of factors member PPARa. However, the diversity of physiologic and pathologic states through which the heart must sustain function suggests the possible existence of additional transcriptional regulators that play a role in matching cardiac metabolism to energetic demand. Here we show that cardiac KLF15 is required for the normal cardiac response to fasting. Specifically, we find that cardiac function is impaired upon fasting in systemic and cardiac specific K/f/5-null mice. Further, cardiac specific K/f/5-null mice display a fasting-dependent accumulation of long chain acylcarnitine species along with a decrease in expression of the carnitine translocase Slc25a20. Treatment with a diet high in short chain fatty acids relieves the KLF15-dependent long chain acylcarnitine accumulation and impaired cardiac function in response to fasting. Our observations establish KLF15 as a critical mediator of the cardiac adaptive response to fasting through its regulation of myocardial lipid utilization.	[Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Cardiovasc Res Inst, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Dept Med, Cleveland, OH USA; [Fan, Liyan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ilkayeva, Olga] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Sch Med, Dept Med & Pharmacol & Canc Biol, Durham, NC USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Duke University	Sugi, K; Jain, MK (corresponding author), Case Cardiovasc Res Inst, Cleveland, OH USA.; Sugi, K; Jain, MK (corresponding author), Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA.	mxj84@case.edu		Sugi, Keiki/0000-0002-7608-4541	National Institutes of Health [F32HL110538, K01DK104922, R01HL112486, R01HL119195, R01HL123098, F30AG054237]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134622, R35HL135789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG054237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HL110538 and K01DK104922 (to D.A.P.), R01HL112486, R01HL119195, and R01HL123098 (to M.J.K.), F30AG054237 (to P.N.H), along with generous gifts by Tom F. Peterson (TFP Lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; BrownHarrison MC, 1996, BIOCHEM MOL MED, V58, P59, DOI 10.1006/bmme.1996.0033; Cox GF, 1998, J PEDIATR-US, V133, P247, DOI 10.1016/S0022-3476(98)70228-8; DENTON RM, 1967, BIOCHEM J, V104, P416, DOI 10.1042/bj1040416; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gillingham MB, 2006, MOL GENET METAB, V89, P58, DOI 10.1016/j.ymgme.2006.06.004; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Prosdocimo DA, 2014, TRENDS IN CAR DIOVAS; Prosdocimo DA, 2015, PPAR RES, V2015, DOI 10.1155/2015/201625; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Touma EH, 2001, ARCH DIS CHILD, V84, P58, DOI 10.1136/adc.84.1.58; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; York B, 2012, CELL METAB, V15, P752, DOI 10.1016/j.cmet.2012.03.020; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192376	10.1371/journal.pone.0192376	http://dx.doi.org/10.1371/journal.pone.0192376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408889	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800058
J	Bhise, MD; Patra, S				Bhise, Mahadev D.; Patra, Shraboni			Prevalence and correlates of hypertension in Maharashtra, India: A multilevel analysis	PLOS ONE			English	Article							AWARENESS	Background and aim In the last few decades, the prevalence of hypertension has been drastically increased in India. The present study estimates the current prevalence of hypertension and its correlates in the state of Maharashtra. The variation in the prevalence of hypertension associated with individual-level characteristics is explained at the community and district level. Methods Data is used from the recent round of District Level Household & Facility Survey (DLHS-4), 2012-13. The DLHS-4 has used the nationally representative sample, collected through multistage stratified sampling procedure. A similar sampling frame, used in NSSO-2007-08, has been followed. The chi-square test is used to show the significance level of the association between the estimated prevalence of hypertension and its correlates. Multilevel regression analysis is carried out to investigate the effects of individual and community level factors on the prevalence of hypertension. Results The overall prevalence of hypertension is 25% in Maharashtra, and a huge variation in the prevalence of hypertension is found across the districts. Dhule, Gadchiroli (with a low HDI rank), Mumbai and Satara (with higher HDI rank) are the districts with the higher (above 30%) prevalence of high blood pressure. The prevalence also significantly varies according to different correlates. The prevalence of high blood pressure is higher among elderly population (40%), among males (28%), in the urban areas (27%) and in the richest wealth quintile (28%). The prevalence is also higher among cigarette smokers (31%), alcohol consumers (30%) and people with obesity (38%) as compared to their counterparts. The results of the multilevel analysis show that the older and obese persons are at four-time higher risk of hypertension. Again, age, sex, marital status, place of residence, wealth status, unhealthy habits (i.e. smoking and alcohol consumption) and BMI are significantly associated with hypertension. The results of VPC statistics show that 14% of hypertension prevalence could be attributed to differences at the community level. Conclusion The prevalence of hypertension largely varies in the districts of Maharashtra irrespective of their level of socio-economic development (i.e. HDI rank). The variation in the rate of prevalence of hypertension is higher in the community (PSU) level as compared to the variation in the prevalence rate at the district level. Hypertension is attributable to the modifiable factors like risky lifestyle practices.	[Bhise, Mahadev D.; Patra, Shraboni] Int Inst Populat Sci, Populat Studies, Govandi Stn Rd, Bombay, Maharashtra, India	International Institute for Population Sciences	Patra, S (corresponding author), Int Inst Populat Sci, Populat Studies, Govandi Stn Rd, Bombay, Maharashtra, India.	shrageo@gmail.com		Bhise, Mahadev/0000-0002-9477-3498				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2012, MAH HUM DEV REP; Banerji Monali, 2003, Journal of Human Ecology, V14, P377; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Cai L, 2011, PUBLIC HEALTH REP, V126, P420; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Geleijnse JM, 2005, J HUM HYPERTENS, V19, pS1, DOI 10.1038/sj.jhh.1001953; Gorman BK, 2011, POPUL RES POLICY REV, V30, P885, DOI 10.1007/s11113-011-9215-4; Gupta R, 2014, INDIAN J MED RES, V139, P657; International Institute for Population Sciences (IIPS), 2014, DISTR LEV HOUS FAC S; Kanagarajan P, 2015, INDIAN J FORENSIC CO, V2, P100; Kashyap V, 2015, PREVALENCE HYPERTENS, V14, P1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khan HR., 2011, J DATA SCI, V9, P93; Kini S, 2016, PLOS ONE, P20; Laxmaiah A., 2014, INT J HLTH SCI RES, V4, P130; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Midha T, 2009, INDIAN J PREV SOC ME, V40, P5; Mittal P, 2013, RECENT RES SCI TECHN, V5, P21; MOHFW, 2017, NATL FAMILY HLTH SUR; Nagammanavar R, 2015, J SCI-ADV MATER DEV, V5, P459; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rahman MM, 2015, J CLEAN PROD, V105, P406, DOI 10.1016/j.jclepro.2014.04.068; Sathish Kumar K., 2015, INT J INTERDISCIPLIN, V2, P61; SIMONSON DC, 1988, DIABETES CARE, V11, P821, DOI 10.2337/diacare.11.10.821; Snijders T.A., 1999, INTRO BASIC ADV MULT; Tiwaskar Mangesh, 2016, J Assoc Physicians India, V64, P11; Undhad A. M., 2011, National Journal of Community Medicine, V2, P123; WHO, 2013, GLOB BIREF HYP; World Health Organization, 2012, WORLD HLTH STAT SNAP	33	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191948	10.1371/journal.pone.0191948	http://dx.doi.org/10.1371/journal.pone.0191948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401464	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400027
J	Shen, LJ; Yang, L; Zhang, J; Zhang, M				Shen, Lujun; Yang, Lei; Zhang, Jing; Zhang, Meng			Benefits of expressive writing in reducing test anxiety: A randomized controlled trial in Chinese samples	PLOS ONE			English	Article							EMOTIONAL COMPONENTS; INTERVENTIONS; PERFORMANCE; INSTRUCTIONS; METAANALYSIS; DEPRESSION; ETHNICITY; SURVIVORS; SYMPTOMS; DISORDER	Purpose To explore the effect of expressive writing of positive emotions on test anxiety among senior-high-school students. Methods The Test Anxiety Scale (TAS) was used to assess the anxiety level of 200 senior-high-school students. Seventy-five students with high anxiety were recruited and divided randomly into experimental and control groups. Each day for 30 days, the experimental group engaged in 20 minutes of expressive writing of positive emotions, while the control group was asked to merely write down their daily events. A second test was given after the month-long experiment to analyze whether there had been a reduction in anxiety among the sample. Quantitative data was obtained from TAS scores. The NVivo10.0 software program was used to examine the frequency of particular word categories used in participants' writing manuscripts. Results Senior-high-school students indicated moderate to high test anxiety. There was a significant difference in post-test results (P < 0.001), with the experimental group scoring obviously lower than the control group. The interaction effect of group and gender in the post-test results was non-significant (P > 0.05). Students' writing manuscripts were mainly encoded on five code categories: cause, anxiety manifestation, positive emotion, insight and evaluation. There was a negative relation between positive emotion, insight codes and test anxiety. There were significant differences in the positive emotion, anxiety manifestation, and insight code categories between the first 10 days' manuscripts and the last 10 days' ones. Conclusions Long-term expressive writing of positive emotions appears to help reduce test anxiety by using insight and positive emotion words for Chinese students. Efficient and effective intervention programs to ease test anxiety can be designed based on this study.	[Shen, Lujun; Yang, Lei; Zhang, Jing; Zhang, Meng] Xinxiang Med Univ, Sch Psychol, Xinxiang City, Henan, Peoples R China	Xinxiang Medical University	Shen, LJ (corresponding author), Xinxiang Med Univ, Sch Psychol, Xinxiang City, Henan, Peoples R China.	shenlj945@163.com	Shen, Lujun/GQQ-3457-2022		Philosophy and Social Sciences Planning Projects of Henan Province [2015BJY019]; Major University Research Projects of Henan Province [15A190005]; Scientific Research Fund of Xinxiang Medicial University [2014YB215]	Philosophy and Social Sciences Planning Projects of Henan Province; Major University Research Projects of Henan Province; Scientific Research Fund of Xinxiang Medicial University	This work was supported by the Philosophy and Social Sciences Planning Projects of Henan Province (2015BJY019, http://www.hnpopss.gov.cn/finance/default.aspx) (LS); Major University Research Projects of Henan Province (15A190005, http://www.haedu.gov.cn/2015/03/04/1425450368290.html) (LS); and Scientific Research Fund of Xinxiang Medicial University (2014YB215, http://www.xxmu.edu.cn) (LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baikie KA, 2012, J AFFECT DISORDERS, V136, P310, DOI 10.1016/j.jad.2011.11.032; Bedell JR, 1995, EVALUATION TEST ANXI; Bodas J, 2005, CLIN CHILD FAM PSYCH, V8, P65, DOI 10.1007/s10567-005-2342-x; Broderick JE, 2004, ANN BEHAV MED, V27, P50, DOI 10.1207/s15324796abm2701_7; Burton CM, 2010, J RES PERS, V38, P150; Cassady JC, 2014, EDUC ASSESS, V19, P229, DOI 10.1080/10627197.2014.934604; [柴明莉 Chai Mingli], 2014, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V22, P1128; Chapell MS, 2005, J EDUC PSYCHOL, V97, P268, DOI 10.1037/0022-0663.97.2.268; Craft MA, 2013, J ADV NURS, V69, P305, DOI 10.1111/j.1365-2648.2012.06008.x; Ergene T, 2003, SCHOOL PSYCHOL INT, V24, P313, DOI 10.1177/01430343030243004; Fiori M, 2009, PERS SOC PSYCHOL REV, V13, P21, DOI 10.1177/1088868308326909; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Frattaroli J, 2011, EMOTION, V11, P691, DOI 10.1037/a0022946; Gortner EM, 2006, BEHAV THER, V37, P292, DOI 10.1016/j.beth.2006.01.004; Gregor A, 2005, SCHOOL PSYCHOL INT, V26, P617, DOI 10.1177/0143034305060802; Gudykunst W. B., 1988, CULTURE INTERPERSONA; HEMBREE R, 1988, REV EDUC RES, V58, P47, DOI 10.2307/1170348; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P507, DOI 10.1177/1745691611418241; Kim HS, 2008, J PERS SOC PSYCHOL, V94, P32, DOI 10.1037/0022-3514.94.1.32; Knowles ED, 2011, SOC PSYCHOL PERS SCI, V2, P408, DOI 10.1177/1948550610395780; Kong B, 2012, SHANGHAI ACAD ED SCI, P59; Koopman C, 2005, J HEALTH PSYCHOL, V10, P211, DOI 10.1177/1359105305049769; Kreuter EA, 2014, J POETRY THER, V27, P13, DOI 10.1080/08893675.2014.871808; Krpan KM, 2013, J AFFECT DISORDERS, V150, P1148, DOI 10.1016/j.jad.2013.05.065; Lang JWB, 2010, PSYCHOL SCI, V21, P811, DOI 10.1177/0956797610369492; Li N., 2013, SCI ED ARTICLE COLLE; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; LIEBERT RM, 1967, PSYCHOL REP, V20, P975, DOI 10.2466/pr0.1967.20.3.975; Liu LM, 2015, MODERN ED J, V12, P89; Lu QA, 2010, PSYCHOL HEALTH, V25, P669, DOI 10.1080/08870440902883196; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Merz EL, 2014, HEALTH PSYCHOL REV, V8, P339, DOI 10.1080/17437199.2014.882007; MORRIS LW, 1981, J EDUC PSYCHOL, V73, P541, DOI 10.1037/0022-0663.73.4.541; Pang V. O., 1991, J RES DEV EDUC, V24, P1; Park D, 2014, J EXP PSYCHOL-APPL, V20, P103, DOI 10.1037/xap0000013; Parker RS, 2009, J INT BUSINESS RES, V8; Patton M.Q., 2004, QUALITATIVE RES EVAL; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; Putwain DW, 2010, LEARN INDIVID DIFFER, V20, P8, DOI 10.1016/j.lindif.2009.10.006; Ramirez G, 2011, SCIENCE, V331, P211, DOI 10.1126/science.1199427; Saeide Majidifar MRO, 2015, INT J LANGUAGE LINGU, V3, P323; Sansgiry S. S., 2006, AM J PHARM EDUC, V70, P1, DOI 10.5688/aj700226; SARASON IG, 1984, J PERS SOC PSYCHOL, V46, P929, DOI 10.1037/0022-3514.46.4.929; SARASON SB, 1953, J ABNORM SOC PSYCH, V48, P447, DOI 10.1037/h0055887; Seipp B., 1996, STRESS ANXIETY COPIN, P13; Sexton JD, 2009, PROG PALLIAT CARE, V17, P307, DOI 10.1179/096992609X12455871937620; Smith HE, 2015, PSYCHOSOMATIC MED, V77; Stober J, 2004, ANXIETY STRESS COPIN, V17, P205, DOI 10.1080/1061580412331303225; Suzuki LK, 2002, CROSS-CULT RES, V36, P200, DOI 10.1177/10697102036003002; Troop NA, 2013, PSYCHOL PSYCHOTHER-T, V86, P374, DOI 10.1111/j.2044-8341.2012.02065.x; Twenge JM, 2005, J RES PERS, V39, P336, DOI 10.1016/j.jrp.2004.01.004; Volokhov RN, 2010, BRAIN COGNITION, V73, P1, DOI 10.1016/j.bandc.2009.10.015; von der Embse N, 2013, PSYCHOL SCHOOLS, V50, P57, DOI 10.1002/pits.21660; Wang C., 2001, CHINESE MENTAL HLTH; [王永 Wang Yong], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P130; Wang YP, 2001, CLIN CHILD FAM PSYCH, V4, P253, DOI 10.1023/A:1017551215413; WINE J, 1971, PSYCHOL BULL, V76, P92, DOI 10.1037/h0031332; Xia Z, 2011, OVERSEAS ENGLISH, P61; Xing LF, 2005, CHINESE MENTAL HLTH; Zeidner M., 1998, TEST ANXIETY STATE A; [张婉莉 Zhang Wanli], 2013, [中国心理卫生杂志, Chinese Mental Health Journal], V27, P674; Zhang X, 2015, CHINESE J SPECIAL ED, V3; Zhao X., 2010, CHINESE J SPECIAL ED, V12, P89; Zhou T, 2012, CHINESE J CLIN PSYCH	64	17	19	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191779	10.1371/journal.pone.0191779	http://dx.doi.org/10.1371/journal.pone.0191779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401473	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400020
J	Ufimtseva, E; Eremeeva, N; Petrunina, E; Umpeleva, T; Karskanova, S; Bayborodin, S; Vakhrusheva, D; Kravchenko, M; Skornyakov, S				Ufimtseva, Elena; Eremeeva, Natalya; Petrunina, Ekaterina; Umpeleva, Tatiana; Karskanova, Svetlana; Bayborodin, Sergey; Vakhrusheva, Diana; Kravchenko, Marionella; Skornyakov, Sergey			Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis	PLOS ONE			English	Article							IMMUNE-RESPONSE; DENDRITIC CELLS; INFLAMMATION; NEUTROPHILS; GRANULOMAS; MECHANISMS; PATHOLOGY; MICE	Tuberculosis (TB), with the Mycobacterium tuberculosis (Mtb) as the causative agent, remains to be a serious world health problem. Traditional methods used for the study of Mtb in the lungs of TB patients do not provide information about the number and functional status of Mtb, especially if Mtb are located in alveolar macrophages. We have developed a technique to produce ex vivo cultures of cells from different parts of lung tissues surgically removed from patients with pulmonary TB and compared data on the number of cells with Mtb inferred by the proposed technique to the results of bacteriological and histological analyses used for examination of the resected lungs. The ex vivo cultures of cells obtained from the resected lungs of all patients were largely composed of CD14-positive alveolar macrophages, foamy or not, with or without Mtb. Lymphocytes, fibroblasts, neutrophils, and multinucleate Langhans giant cells were also observed. We found alveolar macrophages with Mtb in the ex vivo cultures of cells from the resected lungs of even those TB patients, whose sputum smears and lung tissues did not contain acid-fast Mtb or reveal growing Mtb colonies on dense medium. The detection of alveolar macrophages with Mtb in ex vivo culture as soon as 16-18 h after isolation of cells from the resected lungs of all TB patients suggests that the technique proposed for assessing the level of infection in alveolar macrophages of TB patients has higher sensitivity than do prolonged bacteriological or pathomorphological methods. The proposed technique allowed us to rapidly (in two days after surgery) determine the level of infection with Mtb in the cells of the resected lungs of TB patients and, by the presence or absence of Mtb colonies, including those with cording morphology, the functional status of the TB agent at the time of surgery.	[Ufimtseva, Elena] Res Inst Biochem, Lab Med Biotechnol, Novosibirsk, Russia; [Ufimtseva, Elena; Eremeeva, Natalya; Petrunina, Ekaterina; Umpeleva, Tatiana; Karskanova, Svetlana; Vakhrusheva, Diana; Kravchenko, Marionella; Skornyakov, Sergey] Minist Hlth Russian Federat, Natl Med Res Ctr TB & Infect Dis, Ural Res Inst Phthisiopulmonol, Sci Dept, Ekaterinburg, Russia; [Bayborodin, Sergey] Fed Res Ctr, Inst Cytol & Genet, Shared Ctr Microscop Anal Biol Objects, Novosibirsk, Russia	Ministry of Health of the Russian Federation; National Medical Research Center of Phthisiopulmonology & Infectious Diseases; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ufimtseva, E (corresponding author), Res Inst Biochem, Lab Med Biotechnol, Novosibirsk, Russia.; Ufimtseva, E (corresponding author), Minist Hlth Russian Federat, Natl Med Res Ctr TB & Infect Dis, Ural Res Inst Phthisiopulmonol, Sci Dept, Ekaterinburg, Russia.	ufim1@ngs.ru	Skornyakov, Sergey/AAB-4703-2020; Vakhrusheva, Diana/R-4409-2017; Ufimtseva, Elena/E-5277-2017; Umpeleva, Tatiana/N-8878-2016	Skornyakov, Sergey/0000-0002-9942-3008; Vakhrusheva, Diana/0000-0001-6085-6466; Umpeleva, Tatiana/0000-0001-8014-1230				Arnett E, 2016, DRUG DELIVERY SYSTEM, P11; Barry C, 2015, SCIENCE, V348, P633, DOI 10.1126/science.aaa2886; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates JH., 1994, CURRENT CONCEPTS TRE, P81; Belousova KV, 2014, FUNDAMENTAL RES RUSS, V9, P2452; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Brown RE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00078; Cardona PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00612; Cole ST, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0506; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Donoghue HD, 2009, MICROBES INFECT, V11, P1156, DOI 10.1016/j.micinf.2009.08.008; Erokhin VV, 2008, CULTURAL METHODS TUB; Espitia C, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P43; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Fu LM, 2013, SCI J CLIN MED, V2, P92; Halse TA, 2011, J CLIN MICROBIOL, V49, P2562, DOI 10.1128/JCM.00467-11; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Hunter RL, 2016, TUBERCULOSIS, V97, P8, DOI 10.1016/j.tube.2015.11.010; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Lerner TR, 2015, CELL MICROBIOL, V17, P1277, DOI 10.1111/cmi.12480; Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Lyadova I, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P19; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Mortellaro A, 2009, EMBO MOL MED, V1, P19, DOI 10.1002/emmm.200900008; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Ndlovu H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00434; Ni Cheallaigh C., 2012, HDB MACROPHAGES LIFE, P1; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Santucci P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00122; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; Schreiber HA, 2010, IMMUNOL LETT, V130, P26, DOI 10.1016/j.imlet.2009.12.009; Singh Ananya, 2014, Recent Pat Antiinfect Drug Discov, V9, P25; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Subbian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132249; Ufimtseva E., ISOLATION EX VIVO CU; Ufimtseva EG, 2016, B IZOBRET, V22, P1; Ufimtseva E, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4325646; Ufimtseva E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/948131; Ufimtseva E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/371249; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; World Health Organization, GLOB TUB REP 2016; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	56	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191918	10.1371/journal.pone.0191918	http://dx.doi.org/10.1371/journal.pone.0191918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401466	gold, Green Published			2022-12-27	WOS:000424101400025
J	Usongo, V; Berry, C; Yousfi, K; Doualla-Bell, F; Labbe, G; Johnson, R; Fournier, E; Nadon, C; Goodridge, L; Bekal, S				Usongo, Valentine; Berry, Chrystal; Yousfi, Khadidja; Doualla-Bell, Florence; Labbe, Genevieve; Johnson, Roger; Fournier, Eric; Nadon, Celine; Goodridge, Lawrence; Bekal, Sadjia			Impact of the choice of reference genome on the ability of the core genome SNV methodology to distinguish strains of Salmonella enterica serovar Heidelberg	PLOS ONE			English	Article							PHYLOGENETIC TREES	Salmonella enterica serovar Heidelberg (S. Heidelberg) is one of the top serovars causing human salmonellosis. The core genome single nucleotide variant pipeline (cgSNV) is one of several whole genome based sequence typing methods used for the laboratory investigation of foodborne pathogens. SNV detection using this method requires a reference genome. The purpose of this study was to investigate the impact of the choice of the reference genome on the cgSNV-informed phylogenetic clustering and inferred isolate relationships. We found that using a draft or closed genome of S. Heidelberg as reference did not impact the ability of the cgSNV methodology to differentiate among 145 S. Heidelberg isolates involved in foodborne outbreaks. We also found that using a distantly related genome such as S. Dublin as choice of reference led to a loss in resolution since some sporadic isolates were found to cluster together with outbreak isolates. In addition, the genetic distances between outbreak isolates as well as between outbreak and sporadic isolates were overall reduced when S. Dublin was used as the reference genome as opposed to S. Heidelberg.	[Usongo, Valentine; Yousfi, Khadidja; Doualla-Bell, Florence; Fournier, Eric; Bekal, Sadjia] Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Usongo, Valentine; Goodridge, Lawrence] McGill Univ, Dept Food Sci & Agr Chem, Food Safety & Qual Program, Ste Anne De Bellevue, PQ, Canada; [Berry, Chrystal; Nadon, Celine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada; [Labbe, Genevieve; Johnson, Roger] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada; [Bekal, Sadjia] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	McGill University; Public Health Agency of Canada; Public Health Agency of Canada; Universite de Montreal	Bekal, S (corresponding author), Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Bekal, S (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.	sadjia.bekal@inspq.qc.ca	Usongo, Valentine/CAG-1903-2022; Labbé, Geneviève/N-4531-2017	Labbé, Geneviève/0000-0001-9720-7574; Bekal, Sadjia/0000-0001-9840-0114	Genome Canada; Genome Quebec provincial genome center	Genome Canada(Genome Canada); Genome Quebec provincial genome center	We express our gratitude to members of the genomics analysis and bioinformatics platforms at the National Microbiology Laboratory and the Bacteriology Unit staff at the Laboratoire de Sante Publique du Quebec. Lawrence Goodridge, Celine Nadon and Sadjia Bekal are funded by Genome Canada and by the Genome Quebec provincial genome center.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bekal S, 2016, J CLIN MICROBIOL, V54, P289, DOI 10.1128/JCM.02200-15; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Croxen MA, 2017, PLOSCURR, V1; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Kwong JC, 2016, J CLIN MICROBIOL, V54, P333, DOI 10.1128/JCM.02344-15; Labbe G, 2016, COMPLETE GENOME SEQU, V15; Land M, 2014, STAND GENOMIC SCI, P9; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Leekitcharoenphon P., 2014, PLOS ONE, V9; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Moura A., 2016, NAT MICROBIOL; Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544; Olson ND, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00235; Petkau A., 2016, SNVPHYL SINGLE NUCLE; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; The National Microbiology Laboratory (NML), 2014, NAT ENT SURV PROGR N	22	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192233	10.1371/journal.pone.0192233	http://dx.doi.org/10.1371/journal.pone.0192233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401524	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400044
J	Abadia, B; Sunen, I; Calvo, P; Bartol, F; Verdes, G; Ferreras, A				Abadia, Beatriz; Sunen, Ines; Calvo, Pilar; Bartol, Francisco; Verdes, Guayente; Ferreras, Antonio			Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes	PLOS ONE			English	Article							SPECTRAL-DOMAIN; RETINAL THICKNESS; DIURNAL-VARIATION; HEALTHY-SUBJECTS; MACULAR EDEMA; AXIAL LENGTH; RETINOPATHY; PREDICTOR; SEVERITY; ADULTS	Objective To compare choroidal thickness between patients with type 2 diabetes (T2D) and healthy controls measured using swept-source optical coherence tomography (SS-OCT). Methods The sample comprised 157 eyes of 94 T2D patients, 48 eyes of which had diabetic macular edema (DME), and 71 normal eyes of 38 healthy patients. Subfoveal (SF) choroidal thickness, and choroidal thickness at 500-mu m intervals up to 2500 mu m nasal and temporal from the fovea were measured using the SS-OCT. Choroidal thicknesses were compared between groups using Student's t-test. Additionally, Pearson correlations were calculated between diabetes duration, glycosylated hemoglobin (HbA1c) levels, and choroidal thickness. Results Mean diabetes duration was 16.6 +/- 9.5 years, while mean glycosylated hemoglobin was 7.7 +/- 1.3%. Overall, the choroid was significantly thinner in T2D patients. Individuals with DME had reduced choroidal thickness in all measurements, except at 2000 and 2500-mu m nasal positions, compared to healthy controls. There was a moderate correlation between choroidal thickness and HbA1c levels in DME patients (SF: r = 0.342; p = 0.017). Diabetes duration did not correlate significantly with choroidal thickness. Conclusion SS-OCT measurements revealed that the choroid was significantly thinner in T2D patients, moderate non-proliferative diabetic retinopathy patients, and DME patients than in healthy individuals. Further studies are needed to clarify the effect of diabetes on this layer and the relationship between choroidal thickness and DME.	[Abadia, Beatriz; Calvo, Pilar; Bartol, Francisco; Ferreras, Antonio] Miguel Servet Univ Hosp, Dept Ophthalmol, IIS Aragon, Zaragoza, Spain; [Sunen, Ines; Calvo, Pilar; Ferreras, Antonio] Univ Zaragoza, Dept Surg Gynecol & Obstet, Zaragoza, Spain; [Verdes, Guayente] Hosp Alcaniz, Dept Endocrinol, Teruel, Spain	Miguel Servet University Hospital; University of Zaragoza	Ferreras, A (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, IIS Aragon, Zaragoza, Spain.; Ferreras, A (corresponding author), Univ Zaragoza, Dept Surg Gynecol & Obstet, Zaragoza, Spain.	aferreras@msn.com	Ferreras, Antonio/AAF-4220-2020; de Asís Bartol-Puyal, Francisco/AAF-8095-2020	de Asís Bartol-Puyal, Francisco/0000-0002-4476-6003; Ferreras, Antonio/0000-0002-2914-2593; Sunen, Ines/0000-0001-6335-797X				Adhi M, 2013, JAMA OPHTHALMOL, V131, P1267, DOI 10.1001/jamaophthalmol.2013.4321; Barteselli G, 2016, RETINA-J RET VIT DIS, V36, P1153, DOI 10.1097/IAE.0000000000000842; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Chhablani J, 2014, SAUDI J OPHTHALMOL, V28, P123, DOI 10.1016/j.sjopt.2014.03.004; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Esmaeelpour M, 2011, INVEST OPHTH VIS SCI, V52, P5311, DOI 10.1167/iovs.10-6875; Ferrara D, 2015, PROG RETIN EYE RES, V23, P82; Gupta P, 2016, ACTA OPHTHALMOL, V94, pE142, DOI 10.1111/aos.12777; Han YS, 2015, OPHTHALMOLOGICA, V233, P192, DOI 10.1159/000375538; International Diabetes Federation, 2015, IDF DIAB ATL, V7; Kang HM, 2014, AM J OPHTHALMOL, V157, P1013, DOI 10.1016/j.ajo.2014.01.019; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Michalewski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639160; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P6017, DOI 10.1167/iovs.12-9692; Rayess N, 2015, AM J OPHTHALMOL, V159, P85, DOI 10.1016/j.ajo.2014.09.033; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Ruiz-Medrano J, 2014, INVEST OPHTH VIS SCI, V55, P3532, DOI 10.1167/iovs.14-13868; Sanchez-Cano A, 2014, AM J OPHTHALMOL, V158, P574, DOI 10.1016/j.ajo.2014.05.035; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tan CSH, 2014, INVEST OPHTH VIS SCI, V55, P6452, DOI 10.1167/iovs.13-13771; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P3202, DOI 10.1167/iovs.14-15669	26	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191977	10.1371/journal.pone.0191977	http://dx.doi.org/10.1371/journal.pone.0191977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394291	Green Submitted, gold, Green Published			2022-12-27	WOS:000424060400021
J	Limbu, R; Cottrell, GS; McNeish, AJ				Limbu, Roshan; Cottrell, Graeme S.; McNeish, Alister J.			Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; CA2+-ACTIVATED K+ CHANNELS; POSTPRANDIAL VASCULAR REACTIVITY; ACTIVATED POTASSIUM CHANNELS; AGED HUMAN SKIN; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; FATTY-ACIDS; EPOXYGENASE METABOLITES	Background and purpose Increasing evidence suggests that the omega-3 polyunsaturated acids (n-3 PUFA), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are beneficial to cardiovascular health, promoting relaxation of vascular smooth muscle cells and vasodilation. Numerous studies have attempted to study these responses, but to date there has not been a systematic characterisation of both DHA and EPA mediated vasodilation in conduit and resistance arteries. Therefore, we aimed to fully characterise the n-3 PUFA-induced vasodilation pathways in rat aorta and mesenteric artery. Methods Wire myography was used to measure the vasomotor responses of freshly dissected rat mesenteric artery and aorta. Arteries were pre-constricted with U46619 and cumulative concentrations of either DHA or EPA (10 nM-30 mu M) were added. The mechanisms by which n-3 PUFA relaxed arteries were investigated using inhibitors of vasodilator pathways, which include: nitric oxide synthase (NOS; L-NAME), cycloxygenase (COX; indomethacin), cytochrome P450 epoxygenase (CYP450; clotrimazole); and calcium-activated potassium channels (K-Ca), SKCa (apamin), IKCa (TRAM-34) and BKCa (paxilline). Results Both DHA-and EPA-induced relaxations were partially inhibited following endothelium removal in rat mesenteric arteries. Similarly, in aorta EPA-induced relaxation was partially suppressed due to endothelium removal. CYP450 also contributed to EPA-induced relaxation in mesenteric artery. Inhibition of IKCa partially attenuated DHA-induced relaxation in aorta and mesenteric artery along with EPA-induced relaxation in mesenteric artery. Furthermore, this inhibition of DHA-and EPA-induced relaxation was increased following the additional blockade of BKCa in these arteries. Conclusions This study provides evidence of heterogeneity in the vasodilation mechanisms of DHA and EPA in different vascular beds. Our data also demonstrates that endothelium removal has little effect on relaxations produced by either PUFA. We demonstrate IKCa and BKCa are involved in DHA-induced relaxation in rat aorta and mesenteric artery; and EPA-induced relaxation in rat mesenteric artery only. CYP450 derived metabolites of EPA may also be involved in BKCa dependent relaxation. To our knowledge this is the first study indicating the involvement of IKCa in n-3 PUFA mediated relaxation.	[McNeish, Alister J.] Univ Reading, Reading Sch Pharm, Reading, Berks, England; Univ Reading, ICMR, Reading, Berks, England	University of Reading; University of Reading	McNeish, AJ (corresponding author), Univ Reading, Reading Sch Pharm, Reading, Berks, England.	a.mcneish@reading.ac.uk	; McNeish, Alister James/K-4521-2017	Cottrell, Graeme/0000-0001-9098-7627; McNeish, Alister James/0000-0002-3466-8442	British Heart Foundation PhD studentship [FS/14/33/30799]; British Heart Foundation [FS/14/33/30799] Funding Source: researchfish	British Heart Foundation PhD studentship; British Heart Foundation(British Heart Foundation)	Roshan Limbu was supported by British Heart Foundation PhD studentship FS/14/33/30799 with Alister J McNeish as the Principal investigator and Graeme S Cottrell as Co-investigator, www.bhf.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah CK, 2008, CLIN SCI, V114, P679, DOI 10.1042/CS20070277; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Birch EE, 2007, EARLY HUM DEV, V83, P279, DOI 10.1016/j.earlhumdev.2006.11.003; Bruno RS, 2016, MED CHEM, V12, P1; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chin JP, 1993, J HYPERTENS, V11; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DAVIS MJ, 1986, AM J PHYSIOL, V250, pH291, DOI 10.1152/ajpheart.1986.250.2.H291; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Eguchi S, 2007, J CARDIOVASC PHARM, V50, P686, DOI 10.1097/FJC.0b013e3181583d9b; Engler M B, 2000, Biol Res Nurs, V2, P85, DOI 10.1177/109980040000200202; Engler MB, 2000, BRIT J PHARMACOL, V131, P1793, DOI 10.1038/sj.bjp.0703754; Fleming I, 2016, VASC PHARMACOL, V86, P31, DOI 10.1016/j.vph.2016.03.001; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Garland CJ, 2017, ACTA PHYSIOL, V219, P152, DOI 10.1111/apha.12649; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Hirafuji M, 2002, BRIT J PHARMACOL, V136, P613, DOI 10.1038/sj.bjp.0704768; Holowatz LA, 2007, EXERC SPORT SCI REV, V35, P119; Holowatz LA, 2006, J PHYSIOL-LONDON, V574, P573, DOI 10.1113/jphysiol.2006.108993; Jackson KG, 2009, BRIT J NUTR, V102, P1414, DOI 10.1017/S0007114509990742; Jiang JH, 1999, BRIT J PHARMACOL, V128, P637, DOI 10.1038/sj.bjp.0702855; Kacik M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112081; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kemse NG, 2016, PROSTAG LEUKOTR ESS, V104, P25, DOI 10.1016/j.plefa.2015.11.003; Khan F, 2003, CARDIOVASC RES, V59, P955, DOI 10.1016/S0008-6363(03)00395-X; KUKOVETZ WR, 1979, J CYCLIC NUCL PROT, V5, P469; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Lai LH, 2009, ACTA PHARMACOL SIN, V30, P314, DOI 10.1038/aps.2009.7; Li XA, 2011, J PHARMACOL EXP THER, V336, P891, DOI 10.1124/jpet.110.176461; Li ZY, 2001, J CARDIOVASC PHARM, V37, P41, DOI 10.1097/00005344-200101000-00005; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; London G M, 1997, Blood Press Suppl, V2, P48; Lopez D, 2004, AM J PHYSIOL-HEART C, V287, pH567, DOI 10.1152/ajpheart.01145.2003; Maroon JC, 2006, SURG NEUROL, V65, P326, DOI 10.1016/j.surneu.2005.10.023; McNeish AJ, 2007, BRIT J PHARMACOL, V151, P441, DOI 10.1038/sj.bjp.0707240; Mies F, 2004, AM J PHYSIOL-RENAL, V287, pF850, DOI 10.1152/ajprenal.00078.2004; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Newens KJ, 2011, AM J CLIN NUTR, V94, P742, DOI 10.3945/ajcn.110.009233; Nicholson WT, 2009, HYPERTENSION, V53, P973, DOI 10.1161/HYPERTENSIONAHA.108.121483; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Parkington HC, 2004, PHARMACOL RES, V49, P509, DOI 10.1016/j.phrs.2003.11.012; Peter Soumia, 2013, Indian J Endocrinol Metab, V17, P422, DOI 10.4103/2230-8210.111630; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sansom SC, 1996, CLIN EXP PHARMACOL P, V23, P76; Sato K, 2014, BIOL PHARM BULL, V37, P394, DOI 10.1248/bpb.b13-00746; Sato Kyosuke, 2013, J Smooth Muscle Res, V49, P63; Sawada T, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0437-y; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Shimokawa H, 2016, J CARDIOVASC PHARM, V67, P361, DOI 10.1097/FJC.0000000000000348; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Sirot V, 2008, J FOOD COMPOS ANAL, V21, P8, DOI 10.1016/j.jfca.2007.05.006; Strokin M, 2004, INT J DEV NEUROSCI, V22, P551, DOI 10.1016/j.ijdevneu.2004.07.002; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Tai CC, 2009, J BIOL CHEM, V284, P32239, DOI 10.1074/jbc.M109.024661; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	78	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192484	10.1371/journal.pone.0192484	http://dx.doi.org/10.1371/journal.pone.0192484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394279	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000424060400045
J	Lai, CY; Lin, FH; Chu, H; Ku, CH; Tsai, SH; Chung, CH; Chien, WC; Wu, CH; Chu, CM; Chang, CW				Lai, Chung-Yu; Lin, Fu-Huang; Chu, Hsin; Ku, Chih-Hung; Tsai, Shih-Hung; Chung, Chi-Hsiang; Chien, Wu-Chien; Wu, Chun-Hsien; Chu, Chi-Ming; Chang, Chi-Wen			Survival factors of hospitalized out-of-hospital cardiac arrest patients in Taiwan: A retrospective study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; ONLY CARDIOPULMONARY-RESUSCITATION; RECOMMENDED GUIDELINES; UTSTEIN STYLE; LAY RESCUERS; OUTCOMES; CARE; MORTALITY; DISEASE; DEFIBRILLATION	The chain of survival has been shown to improve the chances of survival for victims of cardiac arrest. Post-cardiac arrest care has been demonstrated to significantly impact the survival of out-of-hospital cardiac arrest (OHCA). How post-cardiac arrest care influences the survival of OHCA patients has been a main concern in recent years. The objective of this study was to assess the survival outcome of hospitalized OHCA patients and determine the factors associated with improved survival in terms of survival to discharge. We conducted a retrospective observational study by analyzing records from the National Health Insurance Research Database of Taiwan from 2007 to 2013. We collected cases with an International Classification of Disease Clinical Modification, 9 th revision primary diagnosis codes of 427.41 (ventricular fibrillation, VF) or 427.5 (cardiac arrest) and excluded patients less than 18 years old, as well as cases with an unknown outcome or a combination of traumatic comorbidities. We then calculated the proportion of survival to discharge among hospitalized OHCA patients. Factors associated with the dependent variable were examined by logistic regression. Statistical analysis was conducted using SPSS 22 (IBM, Armonk, NY). Of the 11,000 cases, 2,499 patients (22.7%) survived to hospital discharge. The mean age of subjects who survived to hospital discharge and those who did not was 66.7 +/- 16.7 and 71.7 +/- 15.2 years, respectively. After adjusting for covariates, neurological failure, cardiac comorbidities, hospital level, intensive care unit beds, transfer to another hospital, and length of hospital stay were independent predictors of improved survival. Cardiac rhythm on admission was a strong factor associated with survival to discharge (VF vs. non-VF: adjusted odds ratio: 3.51; 95% confidence interval: 3.06 +/- 4.01). In conclusion, cardiac comorbidities, hospital volume, cardiac rhythm on admission, transfer to another hospital and length of hospital stay had a significant positive association with survival to discharge in hospitalized OHCA patients in Taiwan.	[Lai, Chung-Yu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Fu-Huang; Ku, Chih-Hung; Chung, Chi-Hsiang; Chien, Wu-Chien; Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Ku, Chih-Hung] Kainan Univ, Dept Hlth Ind Management, Taoyuan, Taiwan; [Tsai, Shih-Hung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Wu, Chun-Hsien] Triserv Gen Hosp, Natl Def Med Ctr, Div Cardiol, Taipei, Taiwan; [Chu, Chi-Ming] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chu, Chi-Ming] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan; [Chang, Chi-Wen] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Nan Kai University Technology; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; Fu Jen Catholic University; Chang Gung University; Chang Gung Memorial Hospital	Lin, FH; Chu, CM (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chu, CM (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Chu, CM (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.; Chang, CW (corresponding author), Chang Gung Univ, Sch Nursing, Coll Med, Taoyuan, Taiwan.; Chang, CW (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	noldling@ms10.hinet.net; chuchiming@web.de; cwchang@mail.cgu.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	Ku, Chih-Hung/0000-0003-4065-6066				American Heart Association, AB CARD ARR; [Anonymous], AM HEART ASS CIRC, DOI DOI 10.1161/01.CIR.95.8.2213; Arrich J, 2006, MEDICINE, V85, P288, DOI 10.1097/01.md.0000236954.72342.20; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Carr BG, 2009, INTENS CARE MED, V35, P505, DOI 10.1007/s00134-008-1335-x; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chinese Hospital Association, 2000, ICD 9 CM ENGL CHIN D; Chokengarmwong N, 2016, AM J EMERG MED, V34, P1595, DOI 10.1016/j.ajem.2016.05.060; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Cummins RO, 1997, RESUSCITATION, V34, P151, DOI 10.1016/S0300-9572(97)01112-X; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Fugate JE, 2012, CIRCULATION, V126, P546, DOI 10.1161/CIRCULATIONAHA.111.088807; Girotra S, 2016, CIRCULATION, V133, P2159, DOI 10.1161/CIRCULATIONAHA.115.018175; Iwami T, 2012, CIRCULATION, V126, P2844, DOI 10.1161/CIRCULATIONAHA.112.109504; JENNETT B, 1975, LANCET, V1, P480; Lin MH, 2012, RESUSCITATION, V83, P343, DOI 10.1016/j.resuscitation.2011.09.006; Merchant RM, 2008, RESUSCITATION, V79, P398, DOI 10.1016/j.resuscitation.2008.07.015; Myerburg RJ, 2015, HARRISONS PRINCIPLE, P1764; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Ong MEH, 2011, ACAD EMERG MED, V18, P890, DOI 10.1111/j.1553-2712.2011.01132.x; Panchal AR, 2013, RESUSCITATION, V84, P435, DOI 10.1016/j.resuscitation.2012.07.038; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Redpath C, 2010, AM HEART J, V159, P577, DOI 10.1016/j.ahj.2009.12.030; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saba S, 2009, PACE, V32, P1444, DOI 10.1111/j.1540-8159.2009.02509.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stromsoe A, 2015, EUR HEART J, V36, P863, DOI 10.1093/eurheartj/ehu240; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Wallmuller C, 2012, RESUSCITATION, V83, P1206, DOI 10.1016/j.resuscitation.2012.05.001; Wang HE, 2012, RESUSCITATION, V83, P1343, DOI 10.1016/j.resuscitation.2012.07.013; Wolbinski M, 2016, HEART LUNG CIRC, V25, P639, DOI 10.1016/j.hlc.2016.02.001; Wong MKY, 2014, CIRCULATION, V130, P1883, DOI 10.1161/CIRCULATIONAHA.114.010633	37	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191954	10.1371/journal.pone.0191954	http://dx.doi.org/10.1371/journal.pone.0191954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420551	gold, Green Submitted, Green Published			2022-12-27	WOS:000424517900034
J	Rathmann, K; Herke, MG; Hurrelmann, K; Richter, M				Rathmann, Katharina; Herke, Max G.; Hurrelmann, Klaus; Richter, Matthias			Perceived class climate and school-aged children's life satisfaction: The role of the learning environment in classrooms	PLOS ONE			English	Article							SUBJECTIVE HEALTH COMPLAINTS; EARLY ADOLESCENCE; MENTAL-HEALTH; MULTILEVEL; STUDENT; STRESS; PERCEPTIONS; PREDICTORS; ENGAGEMENT; EXPERIENCE	The aim of this study is to examine the impact of class-level class climate on school-aged children's life satisfaction. Data was derived from the German National Educational Panel Study (NEPS) using sixth grade school-aged children (n = 4,764, 483 classes). Class climate includes indicators of teachers' care and monitoring, demands, interaction, autonomy, as well as school-aged children's attitudes towards schoolwork at the class-and individual-level. Results showed that individual perceived class climate in terms of teachers' care and monitoring and autonomy was positively related to life satisfaction, whereas school-related demands were related to lower life satisfaction. Besides teachers' care and monitoring at class-level, indicators of class climate were not associated with school-aged children's life satisfaction, while the individual perceived class climate is more important for life satisfaction.	[Rathmann, Katharina; Herke, Max G.; Richter, Matthias] Martin Luther Univ Halle Wittenberg, Med Fac, Inst Med Sociol, Halle An Der Saale, Sachsen Anhalt, Germany; [Rathmann, Katharina] Tech Univ Dortmund, Fac Rehabil Sci, Dept Sociol Rehabil, Dortmund, Germany; [Hurrelmann, Klaus] Hertie Sch Governance, Berlin, Germany	Martin Luther University Halle Wittenberg; Dortmund University of Technology	Rathmann, K (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Inst Med Sociol, Halle An Der Saale, Sachsen Anhalt, Germany.; Rathmann, K (corresponding author), Tech Univ Dortmund, Fac Rehabil Sci, Dept Sociol Rehabil, Dortmund, Germany.	katharina.rathmann@tu-dortmund.de	Hurrelmann, Klaus/AAB-7404-2019	Rathmann, Katharina/0000-0002-2892-1624; Richter, Matthias/0000-0003-3898-3332	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the DFG Priority Programme [DFG-RI2467/3-1, 1646]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the DFG Priority Programme(German Research Foundation (DFG))	The study is funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the DFG Priority Programme 1646 (Education as a Life long Process. Analyzing Data of the National Educational Panel Study (NEPS) (Grant DFG-RI2467/3-1) to MR.	Almquist YB, 2013, J SCHOOL HEALTH, V83, P690, DOI 10.1111/josh.12082; Assmann C, 2011, Z ERZIEHWISS, V14, P51, DOI 10.1007/s11618-011-0181-8; Barnekow V., 2008, INEQUALITIES YOUNG P; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battistich V, 2005, CHARACTER ED PREVENT; Bayer M, 2014, NEPS TECHNICAL REPOR; Belfi B, 2012, EDUC RES REV-NETH, V7, P62, DOI 10.1016/j.edurev.2011.09.002; Blossfeld H., 2011, ED LIFELONG PROCESS; Bond L, 2007, J ADOLESCENT HEALTH, V40, DOI DOI 10.1016/J.JADOHEALTH.2006.10.013; Bradshaw CP, 2014, J SCHOOL HEALTH, V84, P593, DOI 10.1111/josh.12186; Cantril H., 1965, PATTERN HUMAN; Carter M, 2007, J ADOLESCENCE, V30, P51, DOI 10.1016/j.adolescence.2005.04.002; Csikszentmihalyi M, 1992, Nebr Symp Motiv, V40, P57; Currie C., 2012, SOCIAL DETERMINANTS; De Jong Rob., 2001, LEARNING ENVIRON RES, V4, P51, DOI [DOI 10.1023/A:1011402608575, 10.1023/A:1011402608575]; Deci E.L., 2002, HDB SELF DETERMINATI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2009, SOC INDIC RES SER, V38, P71, DOI 10.1007/978-90-481-2352-0_4; Eccles JS, 2011, J RES ADOLESCENCE, V21, P225, DOI 10.1111/j.1532-7795.2010.00725.x; ECCLES JS, 1991, AM J EDUC, V99, P521, DOI 10.1086/443996; Eriksson U, 2010, SCAND J PUBLIC HEALT, V38, P344, DOI 10.1177/1403494810364683; Gadermann AM, 2010, SOC INDIC RES, V96, P229, DOI 10.1007/s11205-009-9474-1; Gilman R, 2003, SCHOOL PSYCHOL QUART, V18, P192, DOI 10.1521/scpq.18.2.192.21858; Gilstad-Hayden K, 2014, J SCHOOL HEALTH, V84, P502, DOI 10.1111/josh.12177; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hardre PL, 2003, J EDUC PSYCHOL, V95, P347, DOI 10.1037/0022-0663.95.2.347; Harker R, 2004, SCH EFF SCH IMPROV, V15, P177, DOI 10.1076/sesi.15.2.177.30432; Hattie J. A. C., 2002, INT J EDUC RES, V37, P449, DOI [10.1016/S0883-0355(03)00015-6, DOI 10.1016/S0883-0355(03)00015-6, 10.1016/S0883-0355(03]; Hellrung M, 2011, METHODENBERICHT NEPS, V3, pA 29; Hox J.J., 2010, MULTILEVEL ANAL TECH; Huebner ES, 2004, PSYCHOL SCHOOLS, V41, P81, DOI 10.1002/pits.10140; Huebner ES, 2004, SOC INDIC RES, V66, P3, DOI 10.1023/B:SOCI.0000007497.57754.e3; Inchley D., 2016, GROWING UNEQUAL GEND, V7; Katja R, 2002, J SCHOOL HEALTH, V72, P243, DOI 10.1111/j.1746-1561.2002.tb07337.x; Kidger J, 2012, PEDIATRICS, V129, P925, DOI 10.1542/peds.2011-2248; Koth CW, 2008, J EDUC PSYCHOL, V100, P96, DOI 10.1037/0022-0663.100.1.96; Kuperminc GP, 2001, J SCHOOL PSYCHOL, V39, P141, DOI 10.1016/S0022-4405(01)00059-0; Lewis AD, 2011, J YOUTH ADOLESCENCE, V40, P249, DOI 10.1007/s10964-010-9517-6; Li DP, 2016, J SCHOOL HEALTH, V86, P75, DOI 10.1111/josh.12354; Libbey HP, 2004, J SCHOOL HEALTH, V74, P274, DOI 10.1111/j.1746-1561.2004.tb08284.x; Longest KC, 2012, SOC MENT HEALTH, V2, P187, DOI 10.1177/2156869312451151; Marsh HW, 2009, MULTIVAR BEHAV RES, V44, P764, DOI 10.1080/00273170903333665; Marsh HW, 2005, Z PADAGOG PSYCHOL, V19, P119, DOI 10.1024/1010-0652.19.3.119; Meilstrup C, 2015, EUR J PUBLIC HEALTH, V25, P644, DOI 10.1093/eurpub/ckv046; Mitchell MM, 2010, J SCHOOL HEALTH, V80, P271, DOI 10.1111/j.1746-1561.2010.00501.x; Modin B, 2011, J ADOLESCENCE, V34, P129, DOI 10.1016/j.adolescence.2010.01.004; Modin B, 2009, SCH EFF SCH IMPROV, V20, P433, DOI 10.1080/09243450903251507; Morgan A, 2008, SOCIAL COHESION MENT, P12; Mortimore P, 1998, ROAD IMPROVEMENT REF; Niemiec CP, 2009, THEORY RES EDUC, V7, P133, DOI 10.1177/1477878509104318; Nygren K, 2014, J SCH NURS, V30, P114, DOI 10.1177/1059840513489709; Oberle E, 2011, J YOUTH ADOLESCENCE, V40, P889, DOI 10.1007/s10964-010-9599-1; Opdenakker MC, 2000, SCH EFF SCH IMPROV, V11, P165, DOI 10.1076/0924-3453(200006)11:2;1-Q;FT165; Ostberg V, 2007, HLTH INEQUALITIES WE, P109; Peguero AA, 2015, J RES ADOLESCENCE, V25, P412, DOI 10.1111/jora.12138; Plenty S, 2014, J ADOLESCENCE, V37, P407, DOI 10.1016/j.adolescence.2014.03.008; Proctor CL, 2009, J HAPPINESS STUD, V10, P583, DOI 10.1007/s10902-008-9110-9; R Development Core Team, 2009, R LANG ENV STAT COMP; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roeser RW, 1998, DEV PSYCHOPATHOL, V10, P321, DOI 10.1017/S0954579498001631; Rumberger RW, 2005, TEACH COLL REC, V107, P1999, DOI 10.1111/j.1467-9620.2005.00583.x; Ryan AM, 2001, AM EDUC RES J, V38, P437, DOI 10.3102/00028312038002437; Saab H, 2010, SOC SCI MED, V70, P850, DOI 10.1016/j.socscimed.2009.11.012; Samdal O, 1998, HEALTH EDUC RES, V13, P383, DOI 10.1093/her/13.3.383; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Skopek J. S., 2012, DATA MANUAL STARTING; Somersalo H, 2002, NORD J PSYCHIAT, V56, P285, DOI 10.1080/08039480260242787; Stewart T, 2011, PSYCHOL SCHOOLS, V48, P1016, DOI 10.1002/pits.20607; Suldo SM, 2008, SCHOOL PSYCHOL QUART, V23, P56, DOI 10.1037/1045-3830.23.1.56; Suldo SM, 2006, SOC INDIC RES, V78, P179, DOI 10.1007/s11205-005-8208-2; Suldo SM, 2012, SCH MENT HEALTH, V4, P69, DOI 10.1007/s12310-012-9073-1; Suldo SM, 2013, APPL RES QUAL LIFE, V8, P169, DOI 10.1007/s11482-012-9185-7; Thapa A, 2013, REV EDUC RES, V83, P357, DOI 10.3102/0034654313483907; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; Thrupp M., 2002, INT J EDUC RES, V37, P483, DOI DOI 10.1016/S0883-0355(03)00016-8; Torsheim T, 2001, J ADOLESCENCE, V24, P701, DOI 10.1006/jado.2001.0440; Torsheim T, 2001, J ADOLESCENT RES, V16, P293, DOI 10.1177/0743558401163003; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wagner W, 2009, DTSCH ENGLISCH SCHU; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wigfield A., 2006, HDB CHILD PSYCHOL SO, V3, P933, DOI DOI 10.1002/9780470147658.CHPSY0315; Zullig KJ, 2010, J PSYCHOEDUC ASSESS, V28, P139, DOI 10.1177/0734282909344205	83	10	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0189335	10.1371/journal.pone.0189335	http://dx.doi.org/10.1371/journal.pone.0189335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420540	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900002
J	Sumasgutner, P; Adrion, M; Gamauf, A				Sumasgutner, Petra; Adrion, Marius; Gamauf, Anita			Carotenoid coloration and health status of urban Eurasian kestrels (Falco tinnunculus)	PLOS ONE			English	Article							NEST-SITE SELECTION; OXIDATIVE STRESS; BODY-MASS; IMMUNE RESPONSIVENESS; SEXUAL ATTRACTIVENESS; HABITAT ASSOCIATIONS; ENVIRONMENTAL-STRESS; FOOD AVAILABILITY; ALTERNATIVE PREY; GREAT TITS	As the world experiences rapid urban expansion, natural landscapes are being transformed into cities at an alarming rate. Consequently, urbanization is identified as one of the biggest environmental challenges of our time, yet we lack a clear understanding of how urbanization affects free-living organisms. Urbanization leads to habitat fragmentation and increased impervious surfaces affecting for example availability and quality of food. Urbanization is also associated with increased pollution levels that can affect organisms directly, via ecophysiological constraints and indirectly by disrupting trophic interactions in multispecies networks. Birds are highly mobile, while an individual is not necessarily exposed to urban stressors around the clock, but nestlings of altricial birds are. Such a city-dwelling species with a long nestling phase is the Eurasian kestrel (Falco tinnunculus) in Vienna, Austria, which forage on a diverse diet differing in composition from rural habitats. Furthermore, prey items vary in nutritional value and contents of micronutrients like carotenoids, which might impact the nestlings' health. Carotenoids are pigments that are incorporated into integument tissues but also have antioxidant and immunostimulatory capacity, resulting in a trade-off between these functions. In nestlings these pigments function in parent-offspring communication or sibling competition by advertising an individual's physical or physiological condition. Anthropogenic disturbance and pollutants could have disruptive effects on the coloration of these traits. In this study, we measured carotenoid based coloration and other indicators of individual health (body condition and susceptibility to the ectoparasite Carnus hemapterus) of 154 nestling kestrels (n = 91 nests) along an urban gradient from 2010 to 2015. We found skin yellowness of nestlings from nest-sites in the city-center to be least pronounced. This result might indicate that inner-city nestlings are strongly affected by urban stressors and depleted their stores of dietary carotenoids for health-related functions rather than coloration. In addition, skin yellowness intensified with age and was stronger pronounced in earlier nests. Since the immune system of nestlings is still developing, younger chicks might need more antioxidants to combat environmental stress. Additionally, parasite infection intensity was highest in nestlings with less intense skin yellowness (paler or less yellow pigmented integuments) and in earlier nests of the season. In combination with results from previous studies, our findings provide further support for the low quality of the inner-city habitat, both in terms of productivity and individual health.	[Sumasgutner, Petra; Adrion, Marius; Gamauf, Anita] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Sumasgutner, Petra; Adrion, Marius; Gamauf, Anita] Museum Nat Hist Vienna, Vienna, Austria; [Sumasgutner, Petra] Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa	University of Vienna; National Research Foundation - South Africa; University of Cape Town	Sumasgutner, P (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.; Sumasgutner, P (corresponding author), Museum Nat Hist Vienna, Vienna, Austria.; Sumasgutner, P (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa.	petra.sumasgutner@univie.ac.at		Sumasgutner, Petra/0000-0001-7042-3461	Vienna Science and Technology Fund; Vienna Environmental Protection Bureau; Natural History Museum Vienna; Research Grant of the University of Vienna	Vienna Science and Technology Fund; Vienna Environmental Protection Bureau; Natural History Museum Vienna; Research Grant of the University of Vienna	The Viennese kestrel project is financially supported by the Vienna Science and Technology Fund (https://www.wien.gv.at/amtshelfer/kultur/archiv/forschung/hochschuljubilaeurrisstiftung.html) and the Vienna Environmental Protection Bureau (https://wwm/wien.gv.at/umweltschutz/). Marius Adrion received funding from the Natural History Museum Vienna and the Research Grant of the University of Vienna (https://studienpraeses.univie.ac.at/stipendien/foerderungsstipendien-nach-dem-studfg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Andersson Staffan, 2006, P41; Atwell JW, 2012, BEHAV ECOL, V23, P960, DOI 10.1093/beheco/ars059; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Blair R, 2004, ECOL SOC, V9; Blanco G, 2003, BEHAV ECOL, V14, P702, DOI 10.1093/beheco/arg049; Blas J, 2005, FUNCT ECOL, V19, P315, DOI 10.1111/j.1365-2435.2005.00976.x; Blas J, 2013, J RAPTOR RES, V47, P174, DOI 10.3356/JRR-12-46.1; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Caballero IC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159054; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; Casagrande S, 2007, J COMP PHYSIOL B, V177, P237, DOI 10.1007/s00360-006-0125-4; Casagrande S, 2009, ECOL RES, V24, P273, DOI 10.1007/s11284-008-0503-3; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chakarov N, 2016, EVOL ECOL, P1; Chew BP, 1996, ANIM FEED SCI TECH, V59, P103, DOI 10.1016/0377-8401(95)00891-8; Cockrem JF, 2006, GEN COMP ENDOCR, V149, P244, DOI 10.1016/j.ygcen.2006.06.002; Costantini D, 2005, BEHAVIOUR, V142, P1403, DOI 10.1163/156853905774539409; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; Delgado CA, 2012, LANDSCAPE URBAN PLAN, V105, P5, DOI 10.1016/j.landurbplan.2011.12.019; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Eck S, 2011, DO G DTSCH ORNITHOLO; Eeva T, 1998, FUNCT ECOL, V12, P607, DOI 10.1046/j.1365-2435.1998.00221.x; Eeva T, 2009, J AVIAN BIOL, V40, P491, DOI 10.1111/j.1600-048X.2008.04535.x; Eeva T, 2008, ECOHEALTH, V5, P328, DOI 10.1007/s10393-008-0184-y; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fattorini Simone, 1999, Fragmenta Entomologica, V31, P57; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fox J., 2019, R COMPANION APPL REG; Fox J, 2009, J STAT SOFTW, V32, P1; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gamauf A., 1991, GREIFVOGEL OSTERREIC; Garcia-Heras MS, 2017, SCI TOTAL ENVIRON, V603, P299, DOI 10.1016/j.scitotenv.2017.06.048; Giraudeau M, 2015, SCI TOTAL ENVIRON, V532, P512, DOI 10.1016/j.scitotenv.2015.06.021; Giraudeau M, 2015, BEHAV ECOL SOCIOBIOL, V69, P957, DOI 10.1007/s00265-015-1908-y; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Glutz von Blotzheim U. N, 1980, HDB VOGEL MITTELEURO, V9; Hardey J., 2013, RAPTORS FIELD GUIDE; Hervu M., 2015, RVAIDEMEMOIRE DIVERS; Hill GE, 1998, J FIELD ORNITHOL, V69, P353; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hogg JR, 2015, URBAN ECOSYST, V18, P267, DOI 10.1007/s11252-014-0394-8; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Isaksson C, 2007, FUNCT ECOL, V21, P1123, DOI 10.1111/j.1365-2435.2007.01317.x; Isaksson C, 2007, J AVIAN BIOL, V38, P564, DOI 10.1111/j.2007.0908-8857.04030.x; Isaksson Caroline, 2005, EcoHealth, V2, P138, DOI 10.1007/s10393-005-3869-5; Isaksson C, 2015, FUNCT ECOL, V29, P913, DOI 10.1111/1365-2435.12477; Isaksson C, 2010, ECOHEALTH, V7, P342, DOI 10.1007/s10393-010-0345-7; Isaksson C, 2009, ARDEA, V97, P125, DOI 10.5253/078.097.0116; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jenni-Eiermann S, 2008, GEN COMP ENDOCR, V155, P558, DOI 10.1016/j.ygcen.2007.08.011; Joshi PC, 2009, J ENVIRON BIOL, V30, P295; Kal'avsky Martin, 2010, Slovak Raptor Journal, V4, P45; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kimball S, 2015, TEAM TGD GIMP; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Kostrzewa R., 1993, TURMFALKE UBERLEBENS; Kreiderits A, 2016, BIRD STUDY, V63, P369, DOI 10.1080/00063657.2016.1213791; Kruger O, 2005, EVOL ECOL, V19, P467, DOI 10.1007/s10682-005-0293-9; Kubler S, 2005, J ORNITHOL, V146, P271, DOI 10.1007/s10336-005-0089-2; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lyly MS, 2015, ECOL EVOL, V5, P503, DOI 10.1002/ece3.1370; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Mannan R. William, 2008, Urban Ecosystems, V11, P141, DOI 10.1007/s11252-008-0056-9; Manosa S, 2003, ENVIRON POLLUT, V122, P351, DOI 10.1016/S0269-7491(02)00334-2; Martinez-Padilla J, 2004, FUNCT ECOL, V18, P426, DOI 10.1111/j.0269-8463.2004.00874.x; Martinez-Padilla J, 2011, IBIS, V153, P601, DOI 10.1111/j.1474-919X.2011.01133.x; Marzluff John M., 2001, P19; McGraw KJ, 2006, BIRD COLORATION FUNC, V2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McPherson SC, 2016, URBAN ECOSYST, V19, P383, DOI 10.1007/s11252-015-0500-6; McPherson SC, 2016, LANDSCAPE URBAN PLAN, V146, P43, DOI 10.1016/j.landurbplan.2015.10.004; Mebs T., 2006, GREIFVOGEL EUROPAS N; Meillere A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135685; MICHEL, 2000, MICH FARBF; Moller AP, 2010, OECOLOGIA, V163, P35, DOI 10.1007/s00442-009-1525-4; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Montgomerie Robert, 2006, P90; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mougeot F, 2009, J AVIAN BIOL, V40, P67, DOI 10.1111/j.1600-048X.2008.04439.x; Mueller A- K, 2016, J ANIM ECOL; Mueller C, 2011, FUNCT ECOL, V25, P566, DOI 10.1111/j.1365-2435.2010.01816.x; MuMIn K., 2016, MUMIN MULTI MODEL IN; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Newton I., 1979, POPULATION ECOLOGY R; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palomino D, 2007, LANDSCAPE URBAN PLAN, V83, P268, DOI 10.1016/j.landurbplan.2007.04.011; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Partecke J, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P131; Pereyra ME, 2003, GEN COMP ENDOCR, V130, P222, DOI 10.1016/S0016-6480(02)00568-3; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Piattella E, 1999, J RAPTOR RES, V33, P172; Piechocki R., 1991, TURMFALKE FALCO TIN; R Development Core Team, 2009, R LANG ENV STAT COMP; Riegert J, 2004, ORNIS FENNICA, V81, P23; Riegert J, 2007, BIRD STUDY, V54, P353, DOI 10.1080/00063650709461495; Roulin A, 2003, J ANIM ECOL, V72, P75, DOI 10.1046/j.1365-2656.2003.00677.x; Roulin A, 2008, EVOL ECOL RES, V10, P463; Roulin A, 2007, BIOL J LINN SOC, V90, P703, DOI 10.1111/j.1095-8312.2007.00759.x; RStudio, 2021, RSTUDIO INT DEV ENV; Rutz C, 2008, J ANIM ECOL, V77, P1008, DOI 10.1111/j.1365-2656.2008.01420.x; Sarkar D, 2008, USE R, P1; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schoech SJ, 1997, PHYSIOL ZOOL, V70, P68, DOI 10.1086/639545; Shanahan DF, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P3; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Sternalski A, 2012, PHYSIOL BIOCHEM ZOOL, V85, P364, DOI 10.1086/665981; Sternalski A, 2012, BIOL J LINN SOC, V105, P13, DOI 10.1111/j.1095-8312.2011.01773.x; Sternalski A, 2010, J COMP PHYSIOL B, V180, P33, DOI 10.1007/s00360-009-0384-y; Sumasgutner P., 2009, GREIFVOGEL MARCH THA; Sumasgutner P, 2014, BEHAV ECOL SOCIOBIOL, V68, P2023, DOI 10.1007/s00265-014-1808-6; Sumasgutner P, 2014, LANDSCAPE URBAN PLAN, V127, P94, DOI 10.1016/j.landurbplan.2014.03.009; Sumasgutner Petra, 2013, Beitraege zur Jagd- und Wildforschung, V38, P385; Sumasgutner P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-48; Surai PF, 1998, J NUTR BIOCHEM, V9, P645, DOI 10.1016/S0955-2863(98)00068-0; Suri J, 2017, IBIS, V159, P38, DOI 10.1111/ibi.12422; Tryjanowski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063482; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Villafuerte R, 1998, ECOL LETT, V1, P151; Village A., 1990, THE KESTREL; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WARKENTIN IG, 1988, CONDOR, V90, P734, DOI 10.2307/1368372; Welch BC, 2015, J RAPTOR RES, V49, P141, DOI 10.3356/0892-1016-49.2.141	138	20	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191956	10.1371/journal.pone.0191956	http://dx.doi.org/10.1371/journal.pone.0191956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420544	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900035
J	Eguchi, T; Sogawa, C; Okusha, Y; Uchibe, K; Iinuma, R; Ono, K; Nakano, K; Murakami, J; Itoh, M; Arai, K; Fujiwara, T; Namba, Y; Murata, Y; Ohyama, K; Shimomura, M; Okamura, H; Takigawa, M; Nakatsura, T; Kozaki, K; Okamoto, K; Calderwood, SK				Eguchi, Takanori; Sogawa, Chiharu; Okusha, Yuka; Uchibe, Kenta; Iinuma, Ryosuke; Ono, Kisho; Nakano, Keisuke; Murakami, Jun; Itoh, Manabu; Arai, Kazuya; Fujiwara, Toshifumi; Namba, Yuri; Murata, Yoshiki; Ohyama, Kazumi; Shimomura, Manami; Okamura, Hirohiko; Takigawa, Masaharu; Nakatsura, Tetsuya; Kozaki, Ken-ichi; Okamoto, Kuniaki; Calderwood, Stuart K.			Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEAT-SHOCK PROTEINS; FATE DETERMINATION FACTOR; PROSTATE-CANCER; CLONAL EVOLUTION; BREAST-CANCER; PANCREATIC-CANCER; NEUROENDOCRINE DIFFERENTIATION; EXTRACELLULAR VESICLES; TUMOR-DEVELOPMENT	Ability to form cellular aggregations such as tumorspheres and spheroids have been used as a morphological marker of malignant cancer cells and in particular cancer stem cells (CSC). However, the common definition of the types of cellular aggregation formed by cancer cells has not been available. We examined morphologies of 67 cell lines cultured on three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarcinoma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly growing asymmetric tumors that metastasized to lymph nodes in immunocompromised mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after transplantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion molecules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained environment reduced intercellular adhesion and induced mesenchymal transition and promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroendocrine organoids. These findings indicate that the NCP-based 3D environment enables cells to form stem cell tumoroids with multipotency and model more accurately the in vivo tumor status at the levels of morphology and gene expression.	[Eguchi, Takanori; Sogawa, Chiharu; Okusha, Yuka; Ono, Kisho; Fujiwara, Toshifumi; Namba, Yuri; Murata, Yoshiki; Kozaki, Ken-ichi; Okamoto, Kuniaki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan; [Eguchi, Takanori; Nakano, Keisuke; Murakami, Jun; Takigawa, Masaharu] Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Dent Sch, Okayama, Japan; [Uchibe, Kenta; Okamura, Hirohiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Morphol, Okayama, Japan; [Iinuma, Ryosuke; Itoh, Manabu; Arai, Kazuya] JSR Life Sci Corp, Tsukuba, Ibaraki, Japan; [Nakano, Keisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama, Japan; [Murakami, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Diag & Dent Maxillofacial Radiol, Okayama, Japan; [Ohyama, Kazumi] Okayama Univ, Radio Isotope Res Ctr, Dent Sch, Okayama, Japan; [Shimomura, Manami; Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan; [Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA USA	Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; National Cancer Center - Japan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Eguchi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan.; Eguchi, T (corresponding author), Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Dent Sch, Okayama, Japan.	eguchi@okayama-u.ac.jp	SOGAWA, Chiharu/B-1994-2011; Okamura, Hirohiko/I-5917-2019	Okamura, Hirohiko/0000-0002-3254-5238; Okusha, Yuka/0000-0002-1399-2294; Eguchi, Takanori/0000-0002-3297-6126	JSR Life Sciences Corporation; JSPS KAKENHI [JP17K11642, JP16K11722, JP17K11669]; JSR joint research program; Ryobi Teien Memorial Foundation Grant	JSR Life Sciences Corporation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSR joint research program; Ryobi Teien Memorial Foundation Grant	JSR Life Sciences Corporation provided support in the form of salaries for authors RI, MI, and KA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by JSPS KAKENHI, grant numbers JP17K11642 (to TE), JP16K11722 (to JM TE), JP17K11669 (to CS TE), and JP17K11669 (to KO CS TE), a JSR joint research program (to TE), and a Ryobi Teien Memorial Foundation Grant (to TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal B, 1998, NAT MED, V4, P43, DOI 10.1038/nm0198-043; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calderwood SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00159; Calderwood Stuart K, 2015, Subcell Biochem, V78, P103, DOI 10.1007/978-3-319-11731-7_5; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chou SD, 2015, ONCOGENE, V34, P2178, DOI 10.1038/onc.2014.177; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Day KC, 2017, CANCER RES, V77, P74, DOI 10.1158/0008-5472.CAN-16-1656; Desiderio V, 2014, ONCOTARGET, V6; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dong PX, 2014, CARCINOGENESIS, V35, P760, DOI 10.1093/carcin/bgt369; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Eguchi T, 2017, J CELL BIOCHEM, V118, P43, DOI 10.1002/jcb.25607; Eguchi T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7530942; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fujita Y, 2016, CANCER SCI, V107, P385, DOI 10.1111/cas.12896; Gimmi CD, 1996, NAT MED, V2, P1367, DOI 10.1038/nm1296-1367; Gong J, 2015, ONCOGENE, V34, P5460, DOI 10.1038/onc.2015.1; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; Hara ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083545; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hida K, 2017, CANC LETT; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ishiguro T, 2017, CANCER SCI, V108, P283, DOI 10.1111/cas.13155; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Jayaprakash P, 2015, J CELL SCI, V128, P1475, DOI 10.1242/jcs.166363; Jeter CR, 2015, STEM CELLS, V33, P2381, DOI 10.1002/stem.2007; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kharmate G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154967; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Komohara Y, 2017, CANCER SCI, V108, P290, DOI 10.1111/cas.13137; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Li ZH, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-79; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mathiyalagan P, 2017, CIRC RES, V120, P1466, DOI 10.1161/CIRCRESAHA.116.310557; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; MAYER B, 1993, LANCET, V342, P1019, DOI 10.1016/0140-6736(93)92879-X; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Murshid A, 2013, INT J HYPERTHER, V29, P442, DOI 10.3109/02656736.2013.798873; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Palmgren JS, 2007, SEMIN ONCOL, V34, P22, DOI 10.1053/j.seminoncol.2006.10.026; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Raj D, 2015, STEM CELLS, V33, P2893, DOI 10.1002/stem.2114; Ramteke A, 2015, MOL CARCINOGEN, V54, P554, DOI 10.1002/mc.22124; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakata K, 1996, JPN J CANCER RES, V87, P78, DOI 10.1111/j.1349-7006.1996.tb00203.x; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sowell RT, 2016, CELL, V166, P1362, DOI 10.1016/j.cell.2016.08.058; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Takahashi Kazutoshi, 2006, V329, P449; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANABE KK, 1993, LANCET, V341, P725, DOI 10.1016/0140-6736(93)90490-8; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yan T, 2014, J CANCER, V5, P572, DOI 10.7150/jca.8865; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yoshida GJ, 2016, CANCER SCI, V107, P5, DOI 10.1111/cas.12817; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Zeng Y, 2013, CANCER RES, V73, P4123, DOI 10.1158/0008-5472.CAN-12-1343; Zhuang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11924	141	71	72	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191109	10.1371/journal.pone.0191109	http://dx.doi.org/10.1371/journal.pone.0191109			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415026	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300015
J	Jung, SY; Kwon, J; Park, S; Jhee, JH; Yun, HR; Kim, H; Kee, YK; Yoon, CY; Chang, TI; Kang, EW; Park, JT; Yoo, TH; Kang, SW; Han, SH				Jung, Su-Young; Kwon, Jaeyeol; Park, Seohyun; Jhee, Jong Hyun; Yun, Hae-Ryong; Kim, HyoungNae; Kee, Youn Kyung; Yoon, Chang-Yun; Chang, Tae-Ik; Kang, Ea Wha; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok			Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; GROWTH-FACTOR 23; MORTALITY RISK; PARATHYROID-HORMONE; FAILURE; HYPERPHOSPHATEMIA; ASSOCIATION; PHOSPHORUS	Hyperphosphatemia is associated with mortality in patients with chronic kidney disease, and is common in critically ill patients with acute kidney injury (AKI); however, its clinical implication in these patients is unknown. We conducted an observational study in 1144 patients (mean age, 63.2 years; male, 705 [61.6%]) with AKI who received continuous renal replacement therapy (CRRT) between January 2009 and September 2016. Phosphate levels were measured before (0 h) and 24 h after CRRT initiation. We assessed disease severity using various clinical parameters. Phosphate at 0 h positively correlated with the Acute Physiology and Chronic Health Evaluation II (APACHE II; P < 0.001) and Sequential Organ Failure Assessment (SOFA; P < 0.001) scores, and inversely with mean arterial pressure (MAP; P = 0.02) and urine output (UO; P = 0.01). In a fully adjusted linear regression analysis for age, sex, Charlson comorbidity index (CCI), MAP, and estimated glomerular filtration rate (eGFR), higher 0 h phosphate level was significantly associated with high APACHE II (P < 0.001) and SOFA (P = 0.04) scores, suggesting that phosphate represents disease severity. A multivariable Cox model also showed that hyperphosphatemia was significantly associated with increased 28-day (HR 1.05, 95% CI 1.02 +/- 1.08, P = 0.001) and 90-day (HR 1.05, 95% CI 1.02 +/- 1.08, P = 0.001) mortality. Furthermore, patients with increased phosphate level during 24 h were at higher risk of death than those with stable or decreased phosphate levels. Finally, c-statistics significantly increased when phosphate was added to a model that included age, sex, CCI, body mass index, eGFR, MAP, hemoglobin, serum albumin, C-reactive protein, and APACHE II score. This study shows that phosphate is a potential biomarker that can reflect disease severity and predict mortality in critically ill patients receiving CRRT.	[Jung, Su-Young; Kwon, Jaeyeol; Park, Seohyun; Jhee, Jong Hyun; Yun, Hae-Ryong; Kim, HyoungNae; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea; [Chang, Tae-Ik; Kang, Ea Wha] Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Ilsan, South Korea	Yonsei University; Yonsei University Health System; NHIS Ilsan Hospital	Han, SH (corresponding author), Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Park, Jung Tak/0000-0002-2325-8982; Yun, Hae-Ryong/0000-0002-7038-0251; Yoo, Tae-Hyun/0000-0002-9183-4507; Kang, Shin-Wook/0000-0002-5677-4756				Ali FN, 2013, PEDIATR NEPHROL, V28, P959, DOI 10.1007/s00467-012-2395-2; Badve SV, 2016, AM J KIDNEY DIS, V68, P554, DOI 10.1053/j.ajkd.2016.03.418; Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Demirjian S, 2011, CLIN J AM SOC NEPHRO, V6, P2114, DOI 10.2215/CJN.02900311; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P1136, DOI 10.2215/CJN.01660309; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Jung SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004542; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Leaf DE, 2012, CLIN J AM SOC NEPHRO, V7, P1217, DOI 10.2215/CJN.00550112; Leaf DE, 2016, J AM SOC NEPHROL; Liangos O, 2007, J AM SOC NEPHROL, V18, P904, DOI 10.1681/ASN.2006030221; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Ozmen S, 2007, RENAL FAILURE, V29, P509, DOI 10.1080/08860220701275006; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; PEPPERS MP, 1991, CRIT CARE CLIN, V7, P201, DOI 10.1016/S0749-0704(18)30332-4; Sanjeevani Scienthia, 2014, Int J Crit Illn Inj Sci, V4, P223, DOI 10.4103/2229-5151.141420; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Zhang M, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-21	33	31	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191290	10.1371/journal.pone.0191290	http://dx.doi.org/10.1371/journal.pone.0191290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415048	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300022
J	Rahman, A; Yamazaki, D; Sufiun, A; Kitada, K; Hitomi, H; Nakano, D; Nishiyama, A				Rahman, Asadur; Yamazaki, Daisuke; Sufiun, Abu; Kitada, Kento; Hitomi, Hirofumi; Nakano, Daisuke; Nishiyama, Akira			A novel approach to adenine-induced chronic kidney disease associated anemia in rodents	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; VASCULAR CALCIFICATION; GENDER-DIFFERENCES; HEART-FAILURE; ANIMAL-MODELS; ERYTHROPOIETIN; RATS; GROWTH; DYSFUNCTION; PHOSPHATE	To date, good experimental animal models of renal anemia are not available. Therefore, the purpose of this study was to establish a novel approach to induce chronic kidney disease (CKD) with severe anemia by oral administration of adenine in rodents. Adenine was administered to 6-week-old male C57BL/6 mice (25 and 50 mg/kg body weight) by oral gavage daily for 28 days. Serum creatinine and BUN as well as hematocrit, hemoglobin (Hb) and plasma erythropoietin (EPO) levels were monitored to assess renal function and anemia, respectively. Adenine at 25 mg/kg for 28 days slightly increased plasma creatinine levels, but did not induce anemia. In contrast, 50 mg/kg of adenine daily for 28 days showed severe renal dysfunction (plasma creatinine 1.9 +/- 0.10 mg/dL) and anemia (hematocrit 36.5 +/- 1.0% and EPO 28 +/- 2.4 pg/mL) as compared with vehicle-treated mice (0.4 +/- 0.02 mg/dL, 49.6 +/- 1.6% and 61 +/- 4.0 pg/mL, respectively). At the end of experiment, level of Hb also significantly reduced in 50 mg/kg adenine administration group. Remarkable histological changes of kidney tissues characterized by interstitial fibrosis and cystic appearance in tubules were observed in 50 mg/kg of adenine treatment group. These results have demonstrated that oral dosing with adenine at 50 mg/kg for 28 days is suitable to induce a stable anemia associated with CKD in mice.	[Rahman, Asadur; Yamazaki, Daisuke; Sufiun, Abu; Kitada, Kento; Hitomi, Hirofumi; Nakano, Daisuke; Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa, Japan; [Rahman, Asadur] Int Univ Hlth & Welf, Sch Med, Dept Pharmacol, Narita, Japan; [Kitada, Kento] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA	Kagawa University; International University of Health & Welfare; Vanderbilt University	Rahman, A (corresponding author), Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa, Japan.; Rahman, A (corresponding author), Int Univ Hlth & Welf, Sch Med, Dept Pharmacol, Narita, Japan.	rahmanma@med.kagawa-u.ac.jp	Hitomi, Hirofumi/ABA-2086-2021; Rahman, Asadur/A-2367-2017	Rahman, Asadur/0000-0002-9172-5343; Kitada, Kento/0000-0002-6738-1253; Nishiyama, Akira/0000-0001-5971-820X	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26460343]; Hoansha Foundation	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hoansha Foundation(Hoansha Foundation)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (26460343 to Akira Nishiyama) and the Hoansha Foundation (to Akira Nishiyama). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2014, J MOL MED, V92, P871, DOI 10.1007/s00109-014-1151-4; Akchurin O, 2016, AM J PHYSIOL-RENAL, V311, pF877, DOI 10.1152/ajprenal.00089.2016; Ali BH, 2014, PHYSIOL RES, V63, P351, DOI 10.33549/physiolres.932685; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Artunc F, 2007, NEPHROL DIAL TRANSPL, V22, P2900, DOI 10.1093/ndt/gfm316; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Ataka K, 2003, AM J NEPHROL, V23, P315, DOI 10.1159/000072913; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; Bissinger R, 2016, KIDNEY BLOOD PRESS R, V41, P966, DOI 10.1159/000452600; Claramunt D, 2015, AM J PHYSIOL-RENAL, V309, pF57, DOI 10.1152/ajprenal.00051.2015; Diwan V, 2014, AM J PHYSIOL-RENAL, V307, pF1169, DOI 10.1152/ajprenal.00676.2013; Diwan V, 2013, J PHARMACOL TOX MET, V68, P197, DOI 10.1016/j.vascn.2013.05.006; Fong D, 2016, CLIN EXP PHARMACOL P, V43, P896, DOI 10.1111/1440-1681.12621; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Hung SC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001480; Hussien NI, 2016, ALEX J MED, V52, P325, DOI 10.1016/j.ajme.2015.12.001; Igarashi T, 2014, CLIN EXP NEPHROL, V18, P525, DOI 10.1007/s10157-014-0995-9; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Kang KP, 2014, MOL MED REP, V9, P2061, DOI 10.3892/mmr.2014.2089; Lang F, 2017, KIDNEY BLOOD PRESS R, V42, P749, DOI 10.1159/000484215; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Macdougall IC, 2013, NEW ENGL J MED, V368, P320, DOI 10.1056/NEJMoa1203166; Morgera S., 1997, International Urology and Nephrology, V29, P245, DOI 10.1007/BF02551350; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Nishioka S, 2014, KIDNEY INT, V85, P871, DOI 10.1038/ki.2013.496; Ogino A, 2010, J AM COLL CARDIOL, V56, P1949, DOI 10.1016/j.jacc.2010.04.068; OKADA H, 1999, CLIN EXP NEPHROL, V3, P82, DOI DOI 10.1007/S101570050015; Okada YM Hideto, 2001, CLIN EXP NEPHROL, V5, P28; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rahman A, 2016, J HYPERTENS, V34, P893, DOI 10.1097/HJH.0000000000000871; Rosenberger C, 2005, KIDNEY INT, V67, P531, DOI 10.1111/j.1523-1755.2005.67110.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sun CC, 2013, NEPHROL DIAL TRANSPL, V28, P1733, DOI 10.1093/ndt/gfs584; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Virani SA, 2008, CAN J CARDIOL, V24, p22B, DOI 10.1016/S0828-282X(08)71026-2; Wang XY, 2015, J THORAC DIS, V7, P1951, DOI 10.3978/j.issn.2072-1439.2015.10.66; Yang C, 2015, INDIAN J PHARM SCI, V77, P103; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; YOKOZAWA T, 1984, J NUTR SCI VITAMINOL, V30, P245, DOI 10.3177/jnsv.30.245; Yokozawa T, 1985, Nihon Jinzo Gakkai Shi, V27, P371; Zhang ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22151	48	41	44	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192531	10.1371/journal.pone.0192531	http://dx.doi.org/10.1371/journal.pone.0192531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415057	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300084
J	dos Santos, EA; de Almeida, AAF; Branco, MCD; dos Santos, IC; Ahnert, D; Baligar, VC; Valle, RR				dos Santos, Emerson Alves; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; dos Santos, Ivanildes Conceicao; Ahnert, Dario; Baligar, Virupax C.; Valle, Raul Rene			Path analysis of phenotypic traits in young cacao plants under drought conditions	PLOS ONE			English	Article							COCOA THEOBROMA-CACAO; WATER-STRESS; IRRIGATION; RESPONSES; YIELD; TOLERANCE; SALINITY; QUALITY; ROOTS	Drought is worldwide considered one of the most limiting factors of Theobroma cacao production, which can be intensified by global climate changes. In this study, we aimed to investigate the phenotypic correlation among morphological characteristics of cacao progenies submitted to irrigation and drought conditions and their partitions into direct and indirect effects. Path analysis with phenotypic plasticity index was used as criteria for estimation of basic and explanatory variables. The experiment was conducted in a greenhouse at the Cacao Research Center (CEPEC), Ilheus, Bahia, Brazil, in a randomized block 21 x 2 factorial arrangement [21 cacao progenies obtained from complete diallel crosses and two water regimes (control and drought)] and six replications. In general, drought conditions influenced biomass production in most progenies, causing significant reductions in total leaf area, leaf number, leaf biomass, fine-roots length (diameter <1 mm), root volume and root area for considered drought intolerant. All progenies showed alterations in growth due to drought. Phenotypic plasticity was most strongly pronounced in root volume. Stem and root diameters, as well as stem dry biomass were the growth variables with the greatest direct effects on root volume under drought conditions, these characters being indicated in screening of cacao progenies drought tolerant.	[dos Santos, Emerson Alves; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; dos Santos, Ivanildes Conceicao; Ahnert, Dario] Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare Andrade, Ilhe Aeus, BA, Brazil; [Baligar, Virupax C.] USDA, Agr Res Serv, Beltsville, MD 20705 USA; [Valle, Raul Rene] CEPLAC, CEPEC, Ctr Pesquisas Cacau Comissao Executiva Plano Lavo, Ilhe Aeus, BA, Brazil	Universidade Estadual de Santa Cruz; United States Department of Agriculture (USDA)	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare Andrade, Ilhe Aeus, BA, Brazil.	alexalan@uesc.br		da Silva Branco, Marcia Christina/0000-0001-9998-713X; Baligar, Virupax/0000-0002-6441-4638				Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Alvim P., 1977, ECOPHYSIOLOGY TROPIC, P279, DOI DOI 10.1016/C2013-0-07134-4; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Arvalo AR, 1975, P 5 INT COC RES C IB, P78; Bae H, 2008, PLANT PHYSIOL BIOCH, V46, P174, DOI 10.1016/j.plaphy.2007.10.014; BALASIMHA D, 1988, INDIAN J AGR SCI, V58, P213; Belsky JM, 2003, AGR HUM VALUES, V20, P277, DOI 10.1023/A:1026100714149; Bizeti HS, 2004, BRAZ ARCH BIOL TECHN, V47, P669, DOI 10.1590/S1516-89132004000500001; Carr MKV, 2011, EXP AGR, V47, P653, DOI 10.1017/S0014479711000421; Carvalho S P, 1999, GENET MOL BIOL, V22, P109; Coimbra JLM, 2005, MULTICOLINEARIDADE A; CRUZ C. D., 2006, MODELOS BIOMETRICOS, V2; Cruz C.D., 2006, PROGRAMA GENES ESTAT; DaMatta Fábio Murilo, 2004, Braz. J. Plant Physiol., V16, P1, DOI 10.1590/S1677-04202004000100001; DaMatta FM, 2003, PLANT SCI, V164, P111, DOI 10.1016/S0168-9452(02)00342-4; de Araujo EC, 2007, CROP BREED APPL BIOT, V7, P148; Junior JOD, 2008, REV BRAS CIENC SOLO, V32, P2367, DOI 10.1590/S0100-06832008000600015; DEALMEIDA CMVC, 1994, REV BRAS GENET, V17, P181; dos Santos A, 2014, CROP BREED APPL BIOT, V14, P82, DOI 10.1590/1984-70332014v14n2a15; Falconer DS, 1996, INTRO QUANTITATIVE G; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gao HJ, 2009, SCI HORTIC-AMSTERDAM, V119, P147, DOI 10.1016/j.scienta.2008.07.034; Garcia-Sanchez F, 2003, EUR J AGRON, V19, P427, DOI 10.1016/S1161-0301(02)00138-7; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hutcheon W. V., 1977, Proceedings, V International Cocoa Research Conference., P222; KHAN MN, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P185; Kramer P.J., 1995, WATER RELATIONS PLAN, P377; Kummerow J., 1981, Revista Theobroma, V11, P77; Li CC, 1975, PATH ANAL APRIMER; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; MCCREE KJ, 1989, CROP SCI, V29, P353, DOI 10.2135/cropsci1989.0011183X002900020025x; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; ORCHARD JE, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P193; Ortuno MF, 2004, PLANT SCI, V167, P275, DOI 10.1016/j.plantsci.2004.03.023; Padi FK, 2013, PLANT BREEDING, V132, P229, DOI 10.1111/pbr.12039; Pinto EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105127; Quinones A, 2007, AGR ECOSYST ENVIRON, V122, P399, DOI 10.1016/j.agee.2007.02.004; Rada F., 2005, Rev. Fac. Agron., V22, P112; RAZI IM, 1992, ASIAN JOURNAL OF PLA, V6, P709; SALE PJM, 1970, J HORTIC SCI BIOTECH, V45, P99, DOI 10.1080/00221589.1970.11514337; Santos R. F., 1998, Revista Brasileira de Engenharia Agricola e Ambiental, V2, P287; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schuppler U, 1998, PLANT PHYSIOL, V117, P667, DOI 10.1104/pp.117.2.667; Silva W. S. da, 1998, Agrotropica, V10, P31; Turner NC, 1997, ADV AGRON, V58, P293; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Valladares F, 1997, PLANT CELL ENVIRON, V20, P25, DOI 10.1046/j.1365-3040.1997.d01-8.x; VALLADARES F, 2000, ECOLOGY, V81, P1925; Vencovsky R, 1992, REV BRAS GENET; Wright S, 1920, J AGRIC RES, V20, P0557; Yagdi K, 2009, PAK J BOT, V41, P753	51	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191847	10.1371/journal.pone.0191847	http://dx.doi.org/10.1371/journal.pone.0191847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408854	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800025
J	Azar, D; Ohadi, D; Rachev, A; Eberth, JF; Uline, MJ; Shazly, T				Azar, Dara; Ohadi, Donya; Rachev, Alexander; Eberth, John F.; Uline, Mark J.; Shazly, Tarek			Mechanical and geometrical determinants of wall stress in abdominal aortic aneurysms: A computational study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DAMAGE EXPERIMENTS; RUPTURE RISK; REPAIR; PATHOPHYSIOLOGY; SURVEILLANCE; TORTUOSITY; THICKNESS; DIAMETER; SURVIVAL	An aortic aneurysm (AA) is a focal dilatation of the aortic wall. Occurrence of AA rupture is an all too common event that is associated with high levels of patient morbidity and mortality. The decision to surgically intervene prior to AA rupture is made with recognition of significant procedural risks, and is primarily based on the maximal diameter and/or growth rate of the AA. Despite established thresholds for intervention, rupture occurs in a notable subset of patients exhibiting sub-critical maximal diameters and/or growth rates. Therefore, a pressing need remains to identify better predictors of rupture risk and ultimately integrate their measurement into clinical decision making. In this study, we use a series of finite element-based computational models that represent a range of plausible AA scenarios, and evaluate the relative sensitivity of wall stress to geometrical and mechanical properties of the aneurysmal tissue. Taken together, our findings encourage an expansion of geometrical parameters considered for rupture risk assessment, and provide perspective on the degree to which tissue mechanical properties may modulate peak stress values within aneurysmal tissue.	[Azar, Dara; Rachev, Alexander; Eberth, John F.; Uline, Mark J.; Shazly, Tarek] Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA; [Ohadi, Donya; Uline, Mark J.] Univ South Carolina, Coll Engn & Comp, Dept Chem Engn, Columbia, SC 29208 USA; [Rachev, Alexander] Bulgarian Acad Sci, Inst Mech, Sofia, Bulgaria; [Eberth, John F.] Univ South Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Shazly, Tarek] Univ South Carolina, Dept Mech Engn, Coll Engn & Comp, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Bulgarian Academy of Sciences; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Uline, MJ; Shazly, T (corresponding author), Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA.; Uline, MJ (corresponding author), Univ South Carolina, Coll Engn & Comp, Dept Chem Engn, Columbia, SC 29208 USA.; Shazly, T (corresponding author), Univ South Carolina, Dept Mech Engn, Coll Engn & Comp, Columbia, SC 29208 USA.	uline@cec.sc.edu; shazly@mailbox.sc.edu	Uline, Mark Jacob/GZL-2712-2022; Azar, Dara/AAE-6353-2019	Azar, Dara/0000-0002-4670-3997	NIH INBRE [P20GM103499, R01HL133662]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	NIH INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH INBRE Grant for South Carolina (P20GM103499) to Mark J Uline and Tarek Shazly and R01HL133662 to John F Eberth.; This research was supported by the NIH INBRE Grant for South Carolina (P20GM103499) and (R01HL133662).	Aljabri B, 2006, J VASC SURG, V44, P1182, DOI 10.1016/j.jvs.2006.08.015; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bottasso CL, 2002, ENG COMPUT-GERMANY, V18, P66, DOI 10.1007/s003660200006; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Celi S, 2010, EUR HEART J, V31, P284; Chauhan SS, 2017, ANN BIOMED ENG, V45, P1908, DOI 10.1007/s10439-017-1837-1; Danyi P, 2012, TRENDS CARDIOVAS MED, V22, P180, DOI 10.1016/j.tcm.2012.07.017; Del Corso L, 1998, ANGIOLOGY, V49, P361, DOI 10.1177/000331979804900505; Di Martino ES, 2006, J VASC SURG, V43, P570, DOI 10.1016/j.jvs.2005.10.072; DOBRIN PB, 1989, SURG CLIN N AM, V69, P687; Dorfmann A, 2010, BIOMECH MODEL MECHAN, V9, P127, DOI 10.1007/s10237-009-0163-4; Doyle BJ, 2009, J VASC SURG, V49, P443, DOI 10.1016/j.jvs.2008.08.064; Fillinger M, 2007, SEMIN VASC SURG, V20, P121, DOI 10.1053/j.semvascsurg.2007.04.001; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Fujikura K, 2007, ULTRASONIC IMAGING, V29, P137, DOI 10.1177/016173460702900301; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Geest JPV, 2008, ANN BIOMED ENG, V36, P921, DOI 10.1007/s10439-008-9490-3; Georgakarakos E, 2010, EUR J VASC ENDOVASC, V39, P42, DOI 10.1016/j.ejvs.2009.09.026; Giannakoulas G, 2005, MED HYPOTHESES, V65, P1191, DOI 10.1016/j.mehy.2005.06.017; Giannoglou G, 2006, ANGIOLOGY, V57, P487, DOI 10.1177/0003319706290741; Hinterseher I, 2013, ANN VASC SURG, V27, P553, DOI 10.1016/j.avsg.2012.05.028; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey J.D., 2013, CARDIOVASCULAR SOLID; Kent KC, 2004, J VASC SURG, V39, P267, DOI 10.1016/j.jvs.2003.08.019; Koskas F, 1997, ANN VASC SURG, V11, P473, DOI 10.1007/s100169900078; LUND GB, 1995, AM J KIDNEY DIS, V25, P732, DOI 10.1016/0272-6386(95)90549-9; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Nanayakkara BG, 2007, GALLE MED J, V12, P8; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Papaharilaou Y, 2007, J BIOMECH, V40, P367, DOI 10.1016/j.jbiomech.2005.12.013; Pappu S, 2008, ANN VASC SURG, V22, P88, DOI 10.1016/j.avsg.2007.09.004; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Raghavan ML, 2006, J BIOMECH, V39, P3010, DOI 10.1016/j.jbiomech.2005.10.021; Raghavan ML, 1996, ANN BIOMED ENG, V24, P573, DOI 10.1007/BF02684226; Raghavan ML, 2000, J VASC SURG, V31, P760, DOI 10.1067/mva.2000.103971; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Rissland P, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005200; Rodriguez JF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898830; Roy D, 2014, IMA J APPL MATH, V79, P1011, DOI 10.1093/imamat/hxu037; Ruddy JM, 2013, PROG CARDIOVASC DIS, V56, P68, DOI 10.1016/j.pcad.2013.04.002; Sacks MS, 1999, ANN BIOMED ENG, V27, P469, DOI 10.1114/1.202; Scotti CM, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-64; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Stevens RRF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187421; Stroupe KT, 2012, J VASC SURG, V56, P901, DOI 10.1016/j.jvs.2012.01.086; Timaran CH, 2007, ARCH SURG-CHICAGO, V142, P520, DOI 10.1001/archsurg.142.6.520; Tran AP, 2000, FAST AND HIGH QUALIT, P1; Uchida N, 2013, GEN THORAC CARDIOVAS, V61, P118, DOI 10.1007/s11748-012-0151-y; Vande Geest JP, 2006, ANN BIOMED ENG, V34, P1098, DOI 10.1007/s10439-006-9132-6; Vandy F, 2012, CIRC-CARDIOVASC INTE, V5, P871, DOI 10.1161/CIRCINTERVENTIONS.111.966184; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Vorp DA, 1998, J VASC SURG, V27, P632, DOI 10.1016/S0741-5214(98)70227-7; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Weiford BC, 2005, BRAUNWALDS HEART DIS; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Zarins CK, 2001, ATHEROSCLEROSIS, V155, P157, DOI 10.1016/S0021-9150(00)00527-X	60	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192032	10.1371/journal.pone.0192032	http://dx.doi.org/10.1371/journal.pone.0192032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401512	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400031
J	Bayerl, C; Lorbeer, R; Heier, M; Meisinger, C; Rospleszcz, S; Schafnitzel, A; Patscheider, H; Auweter, S; Peters, A; Ertl-Wagner, B; Reiser, M; Bamberg, F; Hetterich, H				Bayerl, Christian; Lorbeer, Roberto; Heier, Margit; Meisinger, Christa; Rospleszcz, Susanne; Schafnitzel, Anina; Patscheider, Hannah; Auweter, Sigrid; Peters, Annette; Ertl-Wagner, Birgit; Reiser, Maximilian; Bamberg, Fabian; Hetterich, Holger			Alcohol consumption, but not smoking is associated with higher MR-derived liver fat in an asymptomatic study population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; HEPATIC STEATOSIS; BODY-FAT; CIGARETTE-SMOKING; TRIGLYCERIDE CONTENT; METABOLIC SYNDROME; TOBACCO SMOKING; RISK-FACTORS; PREVALENCE	Background The aim of our study was to determine the relation of alcohol consumption and cigarette smoking on continuous-measured hepatic fat fraction (HFF) in a population free of cardiovascular disease. We suggested a direct correlation of alcohol consumption with HFF and increased HFF in former smokers compared to current smokers. Methods Data from 384 subjects (mean age: 56 years, 58% men) of a population-based cohort study (KORA) were included in a cross-sectional design. Liver fat was assessed by 3 Tesla magnetic resonance imaging (MRI) using a multi-echo Dixon sequence and T2-corrected single voxel multi-echo spectroscopy (H-1-MRS). Smoking status was classified as never, former or current smoker and alcohol consumption as non-, moderate (0.1-39.9 g/day for men and 0.1-19.9 g/day for women), or heavy drinker (>= 40 g/day for men and >= 20 g/day for women). Fatty liver disease was defined as HFF >= 5.56%. Results Average HFF was 8.8% by H-1-MRS and 8.5% by MRI. Former smokers showed a higher HFF (MRI: beta = 2.64; p = 0.006) and a higher FLD prevalence (MRI: OR = 1.91; p = 0.006) compared to never smokers. Current smokers showed decreased odds for FLD measured by H-1-MRS after multivariable adjustment (OR = 0.37; p = 0.007) with never smoker as reference. Heavy drinking was positively associated with HFF (H-1-MRS: beta = 2.99; p = 0.003) and showed highest odds for FLD (H-1-MRS: OR = 3.05; p = 0.008) with non-drinker as reference. Moderate drinking showed a positive association with HFF (H-1-MRS: beta = 1.54; p = 0.061 and MRI: beta = 1.75; p = 0.050). Conclusions Our data revealed lowest odds for FLD in current smokers, moderate drinkers showing higher HFF than non-drinkers and heavy drinkers showing highest HFF and odds for FLD. These findings partly conflict with former literature and underline the importance of further studies to investigate the complex effects on liver metabolism.	[Bayerl, Christian; Lorbeer, Roberto; Schafnitzel, Anina; Patscheider, Hannah; Auweter, Sigrid; Ertl-Wagner, Birgit; Reiser, Maximilian; Bamberg, Fabian; Hetterich, Holger] Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany; [Heier, Margit; Meisinger, Christa; Rospleszcz, Susanne; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Heier, Margit] Cent Hosp Augsburg, KORA Myocardial Infarct Regis, Augsburg, Germany; [Meisinger, Christa] Ludwig Maximilians Univ Munchen, UNIKA T, Augsburg, Germany; [Peters, Annette] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany; [Bamberg, Fabian] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bayerl, C (corresponding author), Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany.	christian.bayerl@med.uni-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Rospleszcz, Susanne/AGF-1630-2022; Peters, Annette/A-6117-2011; Ertl-Wagner, Birgit/AAD-5708-2020	Rospleszcz, Susanne/0000-0002-4788-2341; Peters, Annette/0000-0001-6645-0985; Ertl-Wagner, Birgit/0000-0002-7896-7049	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilian University, as part of LMUinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [BA 4233/4-1]; Siemens Healthcare	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilian University, as part of LMUinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Siemens Healthcare(Siemens AG)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health (https://www.helmholtz-muenchen.de), which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health, http://www.en.mc-health.uni-muenchen.de/index.html), Ludwig-Maximilian University, as part of LMUinnovativ. The KORA-MRI sub-study received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft, BA 4233/4-1, http://www.dfg.de). The KORA-MRI sub-study was supported by an unrestricted grant from Siemens Healthcare (https://www.healthcare.siemens.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Asvold BO, 2014, INT J EPIDEMIOL, V43, P1458, DOI 10.1093/ije/dyu113; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bashir MR, 2015, AM J ROENTGENOL, V204, P297, DOI 10.2214/AJR.14.12457; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; CAAN B, 1994, INT J OBESITY, V18, P397; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Dare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123579; DAY CP, 1994, BBA-LIPID LIPID MET, V1215, P33, DOI 10.1016/0005-2760(94)90089-2; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Du SS, 2016, DIABETES RES CLIN PR, V116, P183, DOI 10.1016/j.diabres.2016.04.047; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Ekstedt M, 2009, SCAND J GASTROENTERO, V44, P366, DOI 10.1080/00365520802555991; Eliasson B, 1999, EUR J CLIN INVEST, V29, P145, DOI 10.1046/j.1365-2362.1999.00420.x; Ely M, 1999, ALCOHOL ALCOHOLISM, V34, P894, DOI 10.1093/alcalc/34.6.894; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; Koopmann A, 2011, HORM BEHAV, V60, P58, DOI 10.1016/j.yhbeh.2011.02.013; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Peres W, 2000, J HEPATOL, V33, P742, DOI 10.1016/S0168-8278(00)80305-0; Pineda N, 2009, RADIOLOGY, V252, P568, DOI [10.1148/radiol.2523082084, 10.1148/radiol.25230820B4]; Pozzato C, 2008, J PEDIATR GASTR NUTR, V47, P493, DOI 10.1097/MPG.0b013e31817b6e10; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Runge JH, 2014, MAGN RESON MATER PHY, V27, P317, DOI 10.1007/s10334-013-0414-3; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; SEIDELL JC, 1991, AM J EPIDEMIOL, V133, P257, DOI 10.1093/oxfordjournals.aje.a115870; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Stadler M, 2014, EUR J ENDOCRINOL, V170, P219, DOI 10.1530/EJE-13-0590; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wellmann J, 2004, EUR J CARDIOV PREV R, V11, P48, DOI 10.1097/01.hjr.0000118174.70522.20; Yilmaz Y, 2010, HEPATOLOGY, V52, P391, DOI 10.1002/hep.23718; Zhong XD, 2014, MAGN RESON MED, V72, P1353, DOI 10.1002/mrm.25054	50	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192448	10.1371/journal.pone.0192448	http://dx.doi.org/10.1371/journal.pone.0192448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401483	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400061
J	Lee, HS; Chung, MJ; Park, JY; Bang, S; Park, SW; Song, SY; Chung, JB				Lee, Hee Seung; Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Song, Si Young; Chung, Jae Bock			Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis	PLOS ONE			English	Article							GALLSTONE PANCREATITIS; CONSERVATIVE MANAGEMENT; INTERVENTION; METAANALYSIS; PAPILLOTOMY; TRIAL	Acute pancreatitis is a common diagnosis worldwide, with gallstone disease being the most prevalent cause (50%). The American College of Gastroenterology recommends urgent endoscopic retrograde cholangiopancreatography (ERCP) (within 24 h) for patients with biliary pancreatitis accompanied by cholangitis. Most international guidelines recommend that ERCP be performed within 72 h in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, but the optimal timing for endoscopy is controversial. We investigated the optimal timing for ERCP in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, and whether performing endoscopy within 24 h is superior to performing it after 24 h. We analyzed the clinical data of 505 patients with newly diagnosed acute pancreatitis, from January 1, 2005 to December 31, 2014. We divided the patients into two groups according to the timing of ERCP: <24 h (urgent) and 24-72 h (early). Among the 505 patients, 73 were diagnosed with biliary pancreatitis and a bile duct obstruction without cholangitis. The mean age of the patients was 55 years (range: 26-90 years). Bile duct stones and biliary sludge were identified on endoscopy in 45 (61.6%) and 11 (15.0%) patients, respectively. The timing of ERCP within 72 h was not associated with ERCP-related complications (P = 0.113), and the total length of hospital stay was not different between urgent and early ERCP (5.9 vs. 5.7 days, P = 0.174). No significant differences were found in total length of hospitalization or procedural-related complications, in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, according to the timing of ERCP (<24 h vs. 24-72 h).	[Lee, Hee Seung; Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Song, Si Young; Chung, Jae Bock] Yonsei Univ, Inst Gastroenterol, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chung, MJ (corresponding author), Yonsei Univ, Inst Gastroenterol, Coll Med, Dept Internal Med, Seoul, South Korea.	mjchung@yuhs.ac	Song, SY/E-2891-2012	Park, Seung Woo/0000-0001-8230-964X; Song, Si Young/0000-0002-1417-4314; Bang, Seungmin/0000-0001-5209-8351; Lee, HEE SEUNG/0000-0002-2825-3160; Park, Jeong Youp/0000-0003-0110-8606; Chung, Moon Jae/0000-0002-5920-8549				Acosta JM, 1997, J AM COLL SURGEONS, V184, P499; Ammori B J, 2003, Pancreas, V26, pe32, DOI 10.1097/00006676-200303000-00023; Bae SH, 2013, WORKPLACE HEALTH SAF, V61, P203, DOI 10.3928/21650799-20130418-73; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bradley EL, 1992, ARCH SURG, V257; Cavdar F, 2014, PANCREATOLOGY, V14, P411, DOI 10.1016/j.pan.2014.08.002; Chen P, 2010, PANCREAS, V39, P398, DOI 10.1097/MPA.0b013e3181bd6821; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; Fogel EL, 2014, NEW ENGL J MED, V370, P150, DOI 10.1056/NEJMct1208450; Folsch UR, 1997, NEW ENGL J MED, V336, P237, DOI 10.1056/NEJM199701233360401; Frakes JT, 1999, J CLIN GASTROENTEROL, V28, P97, DOI 10.1097/00004836-199903000-00004; Kapetanos DJ, 2010, WORLD J GASTRO ENDOS, V2, P25, DOI 10.4253/wjge.v2.i1.25; Liu CL, 2005, ALIMENT PHARM THERAP, V22, P423, DOI 10.1111/j.1365-2036.2005.02580.x; NEOPTOLEMOS JP, 1988, LANCET, V2, P979, DOI 10.1016/S0140-6736(88)90740-4; Oria A, 2007, ANN SURG, V245, P10, DOI 10.1097/01.sla.0000232539.88254.80; Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622; Petrov MS, 2008, ANN SURG, V247, P250, DOI 10.1097/SLA.0b013e31815edddd; Rondonotti E, 2013, DIGEST LIVER DIS, V45, P179, DOI 10.1016/j.dld.2012.07.012; RUNZI M, 1993, GASTROENTEROLOGY, V105, P157; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tse F, 2012, COCHRANE DATABASE SY; van Santvoort HC, 2009, ANN SURG, V250, P68, DOI 10.1097/SLA.0b013e3181a77bb4; Zhou Ming-Qing, 2002, Hepatobiliary Pancreat Dis Int, V1, P608	25	12	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190835	10.1371/journal.pone.0190835	http://dx.doi.org/10.1371/journal.pone.0190835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401491	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400005
J	Marques, LH; Santos, AC; Castro, BA; Storer, NP; Babcock, JM; Lepping, MD; Sa, V; Moscardini, VF; Rule, DM; Fernandes, OA				Marques, Luiz H.; Santos, Antonio C.; Castro, Boris A.; Storer, Nicholas P.; Babcock, Jonathan M.; Lepping, Miles D.; Sa, Verissimo; Moscardini, Valeria F.; Rule, Dwain M.; Fernandes, Odair A.			Impact of transgenic soybean expressing Cry1Ac and Cry1F proteins on the non-target arthropod community associated with soybean in Brazil	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; INTEGRATED PEST-MANAGEMENT; GENETICALLY-MODIFIED CROPS; BT COTTON; NO-TILLAGE; HELIOTHIS-VIRESCENS; PROBLEM FORMULATION; LEPIDOPTERAN PESTS; CARABID BEETLES; TERM ASSESSMENT	Field-scale studies that examine the potential for adverse effects of Bt crop technology on non-target arthropods may supplement data from laboratory studies to support an environmental risk assessment. A three year field study was conducted in Brazil to evaluate potential for adverse effects of cultivating soybean event DAS-81419-2 that produces the Cry1Ac and Cry1F proteins. To do so, we examined the diversity and abundance of non-target arthropods (NTAs) in Bt soybean in comparison with its non-Bt near isoline, with and without conventional insecticide applications, in three Brazilian soybean producing regions. Non-target arthropod abundance was surveyed using Moericke traps (yellow pan) and pitfall trapping. Total abundance (N), richness (S), Shannon-Wiener (H'), Simpson's (D) and Pielou's evenness (J) values for arthropod samples were calculated for each treatment and sampling period (soybean growth stages). A faunistic analysis was used to select the most representative NTAs which were used to describe the NTA community structure associated with soybean, and to test for effects due to the treatments effects via application of the Principal Response Curve (PRC) method. Across all years and sites, a total of 254,054 individuals from 190 taxa were collected by Moericke traps, while 29,813 individuals from 100 taxa were collected using pitfall traps. Across sites and sampling dates, the abundance and diversity measurements of representative NTAs were not significantly affected by Bt soybean as compared with non-sprayed non-Bt soybean. Similarly, community analyses and repeated measures ANOVA, when applicable, indicated that neither Bt soybean nor insecticide sprays altered the structure of the NTA communities under study. These results support the conclusion that transgenic soybean event DAS-81419-2 producing Cry1Ac and Cry1F toxins does not adversely affect the NTA community associated with soybean.	[Marques, Luiz H.; Santos, Antonio C.; Sa, Verissimo; Moscardini, Valeria F.] Dow AgroSci Ind Ltda, Sao Paulo, SP, Brazil; [Castro, Boris A.; Storer, Nicholas P.; Babcock, Jonathan M.; Lepping, Miles D.; Rule, Dwain M.] Dow AgroSci LLC, Indianapolis, IN USA; [Fernandes, Odair A.] Univ Estadual Paulista, UNESP, FCAV, Jaboticabal, SP, Brazil	Dow Chemical Company; Universidade Estadual Paulista	Marques, LH (corresponding author), Dow AgroSci Ind Ltda, Sao Paulo, SP, Brazil.	ldmarques@dow.com	Fernandes, Odair A/C-1345-2013	Fernandes, Odair A/0000-0003-3489-4754	Dow AgroSciences	Dow AgroSciences	No independent third party funding was used in the research for this article. Dow AgroSciences provided salary to the authors who are employees of Dow AgroSciences. Dow AgroSciences authors participated in the study design which must be submitted for approval by the Brazilian government authority. Also, authors participated in the decision to publish, and the preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ali I, 2016, J APPL ENTOMOL  0309; [Anonymous], 2008, SAS WIND VERS 9 0; [Anonymous], 2016, TECNICA NACL BIOSSEG, P1; Araujo RA, 2004, NEOTROP ENTOMOL, V33, P379, DOI 10.1590/S1519-566X2004000300017; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; Badji CA, 2007, J APPL ENTOMOL, V131, P50, DOI 10.1111/j.1439-0418.2006.01118.x; Badji CA, 2004, CROP PROT, V23, P1031, DOI 10.1016/j.cropro.2004.03.003; Badji CA, 2006, SOCIOBIOLOGY, V48, P701; Bernardi O, 2014, PEST MANAG SCI, V70, P588, DOI 10.1002/ps.3581; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Carstens Keri, 2014, GM Crops Food, V5, P11, DOI 10.4161/gmcr.26560; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; Chong CS, 2007, ENVIRON ENTOMOL, V36, P1374, DOI 10.1603/0046-225X(2007)36[1374:CAAIVD]2.0.CO;2; Cutler GC, 2017, ACS SYM SER, V1249, P101; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Fast BJ, 2015, J AGR FOOD CHEM, V63, P2063, DOI 10.1021/jf505015y; Fernandes OA, 2007, SCI AGR, V64, P249, DOI 10.1590/S0103-90162007000300006; Ferreira BS, 2000, PRAGAS SOJA BRASIL S, P22102; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Gonzalez E, 2015, INSECT CONSERV DIVER, V8, P359, DOI 10.1111/icad.12117; Gonzalez-Zamora JE, 2007, ENVIRON ENTOMOL, V36, P1246, DOI 10.1603/0046-225X(2007)36[1246:EOBTCT]2.0.CO;2; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guo J, 2016, MICROSYST TECHNOL, V2016, P1, DOI [10.1007/s00542-016-2961-9, DOI 10.1007/S00542-016-2961-9]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han P, 2016, J PEST SCI, V89, P859, DOI 10.1007/s10340-016-0791-2; Hatten TD, 2007, ENVIRON ENTOMOL, V36, P356, DOI 10.1603/0046-225X(2007)36[356:EOTOTA]2.0.CO;2; ILSI Research Foundation, 2016, REV ENV SAF CRY1F PR; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lara R.I.R., 2009, Arq. Inst. Biol., V76, P55, DOI 10.1590/1808-1657v76p0552009; Lee MK, 2006, BIOCHEM BIOPH RES CO, V339, P1043, DOI 10.1016/j.bbrc.2005.11.112; Leps J, 2003, MULTIVARIATE ANAL EC; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Marques LH, 2016, J ECON ENTOMOL, V109, P1922, DOI 10.1093/jee/tow153; Marques LH, 2017, CROP PROT, V96, P109, DOI 10.1016/j.cropro.2017.02.014; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; Monzo C, 2014, B ENTOMOL RES, V104, P576, DOI 10.1017/S0007485314000315; MORAES R. C. B., 2003, S CONTROLE BIOL, V8, P195; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Nakai S, 2015, TRANSGENIC RES, V24, P929, DOI 10.1007/s11248-015-9892-6; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Nash MA, 2010, ECOL APPL, V20, P1693, DOI 10.1890/09-1065.1; Panizzi AR, 2013, NEOTROP ENTOMOL, V42, P119, DOI 10.1007/s13744-013-0111-y; Paula DP, 2016, ECOTOXICOLOGY, V25, P601, DOI 10.1007/s10646-016-1619-9; Pekar S, 1999, AGR ECOSYST ENVIRON, V73, P155, DOI 10.1016/S0167-8809(99)00024-9; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rang C, 2004, CURR MICROBIOL, V49, P22, DOI 10.1007/s00284-003-4258-3; Raybould Alan, 2006, Environmental Biosafety Research, V5, P119, DOI 10.1051/ebr:2007004; Ritchie S.W., 1982, SPECIAL REPORT; Rodrigo-Simon A, 2006, APPL ENVIRON MICROB, V72, P1595, DOI 10.1128/AEM.72.2.1595-1603.2006; Roger-Estrade J, 2010, SOIL TILL RES, V111, P33, DOI 10.1016/j.still.2010.08.010; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2014, TRANSGENIC RES, V23, P995, DOI 10.1007/s11248-014-9791-2; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rose RI, 2007, WHITEPAPER TIER BASE; Rusch A, 2010, ADV AGRON, V109, P219, DOI 10.1016/S0065-2113(10)09006-1; Sanvido O, 2007, ADV BIOCHEM ENG BIOT, V107, P235, DOI 10.1007/10_2007_048; Shannon C.E., 1949, MATH THEORY COMMUNIC; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Silveira-Neto S., 1976, MANUAL ECOLOGIA INSE; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; Sleper DA, 1998, CROP SCI, V38, P549, DOI 10.2135/cropsci1998.0011183X003800020072x; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Su HH, 2015, J APPL ENTOMOL, V139, P23, DOI 10.1111/jen.12184; Szenasi A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05315; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tian JC, 2014, ENVIRON ENTOMOL, V43, P242, DOI 10.1603/EN13184; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2005, ENVIRON ENTOMOL, V34, P1242, DOI 10.1603/0046-225X(2005)034[1242:CAGPAI]2.0.CO;2; Triplehorn C. A., 2005, BORROR DELONGS INTRO, V7th; US EPA, 2005, BIOP REG ACT DOC BAC, P1; USDA, 2012, POULTR SLAUGHT, P1; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Wach M, 2016, TRANSGENIC RES, V25, P499, DOI 10.1007/s11248-016-9945-5; Wang ZX, 2016, INSECT SCI; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wolt JD, 2010, TRANSGENIC RES, V19, P425, DOI 10.1007/s11248-009-9321-9; Yao YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166771; Yu HL, 2014, ENVIRON ENTOMOL, V43, P1124, DOI 10.1603/EN13337	92	17	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191567	10.1371/journal.pone.0191567	http://dx.doi.org/10.1371/journal.pone.0191567			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394266	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400014
J	Schaub, P; Rodriguez-Franco, M; Cazzonelli, CI; Alvarez, D; Wuest, F; Welsch, R				Schaub, Patrick; Rodriguez-Franco, Marta; Cazzonelli, Christopher Ian; Alvarez, Daniel; Wuest, Florian; Welsch, Ralf			Establishment of an Arabidopsis callus system to study the interrelations of biosynthesis, degradation and accumulation of carotenoids	PLOS ONE			English	Article							INCREASES BETA-CAROTENE; PHYTOENE SYNTHASE; CLEAVAGE DIOXYGENASE; GOLDEN RICE; FUNCTIONAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; LIPOXYGENASE GENE; PROVIDES INSIGHT; SINGLET OXYGEN; ABIOTIC STRESS	The net amounts of carotenoids accumulating in plant tissues are determined by the rates of biosynthesis and degradation. While biosynthesis is rate-limited by the activity of PHYTOENE SYNTHASE (PSY), carotenoid losses are caused by catabolic enzymatic and nonenzymatic degradation. We established a system based on non-green Arabidopsis callus which allowed investigating major determinants for high steady-state levels of beta-carotene. Wild-type callus development was characterized by strong carotenoid degradation which was only marginally caused by the activity of carotenoid cleavage oxygenases. In contrast, carotenoid degradation occurred mostly non-enzymatically and selectively affected carotenoids in a molecule-dependent manner. Using carotenogenic pathway mutants, we found that linear carotenes such as phytoene, phytofluene and pro-lycopene resisted degradation and accumulated while beta-carotene was highly susceptible towards degradation. Moderately increased pathway activity through PSY overexpression was compensated by degradation revealing no net increase in beta-carotene. However, higher pathway activities outcompeted carotenoid degradation and efficiently increased steady-state beta-carotene amounts to up to 500 mu g g(-1) dry mass. Furthermore, we identified oxidative beta-carotene degradation products which correlated with pathway activities, yielding beta-apocarotenals of different chain length and various apocarotene-dialdehydes. The latter included methylglyoxal and glyoxal as putative oxidative end products suggesting a potential recovery of carotenoid-derived carbon for primary metabolic pathways. Moreover, we investigated the site of beta-carotene sequestration by co-localization experiments which revealed that beta-carotene accumulated as intra-plastid crystals which was confirmed by electron microscopy with carotenoid-accumulating roots. The results are discussed in the context of using the non-green calli carotenoid assay system for approaches targeting high steady-state beta-carotene levels prior to their application in crops.	[Schaub, Patrick; Rodriguez-Franco, Marta; Alvarez, Daniel; Wuest, Florian; Welsch, Ralf] Univ Freiburg, Fac Biol, Inst Biol 2, Freiburg, Germany; [Cazzonelli, Christopher Ian] Univ Western Sydney, Hawkesbury Inst Environm, Hawkesbury Campus, Richmond, NSW, Australia	University of Freiburg; Western Sydney University	Welsch, R (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 2, Freiburg, Germany.	ralf.welsch@biologie.uni-freiburg.de	Welsch, Ralf/H-3157-2019; Cazzonelli, Christopher I/A-5347-2010	Welsch, Ralf/0000-0002-2865-2743; Cazzonelli, Christopher I/0000-0003-3096-3193; Rodriguez Franco, Marta/0000-0003-1183-2075; Wust, Florian/0000-0002-9941-5550; Alvarez, Daniel/0000-0002-5930-2295	HarvestPlus [2014H6320.FRE]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	HarvestPlus; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This research was supported by funds from the HarvestPlus (http://www.harvestplus.org/) research consortium (grant 2014H6320.FRE) to PS, FW and RW. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Prof. Peter Beyer for his suggestions to improve the manuscript. We thank Jamie van Norman for nced and max mutants, Li-Jia Qu for the pds mutant, Dean Della-Penna for lutl, lut5 and ccd1-4 mutants and Barry Pogson for ccr2.1. We gratefully acknowledge the excellent technical supports from Roland Nitschke, Carmen Schubert and Rosula Hinnenberg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing.	Ahrazem O, 2015, J AGR FOOD CHEM, V63, P8751, DOI 10.1021/acs.jafc.5b03194; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Alvarez D, 2016, PLANT PHYSIOL, V172, P2314, DOI 10.1104/pp.16.01262; Arango J, 2014, PLANT CELL, V26, P2223, DOI 10.1105/tpc.113.122127; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bai C, 2014, PLANT J, V77, P464, DOI 10.1111/tpj.12384; Baranski R, 2016, CAROTENOID BIOSYNTHE, P159; Barr J, 2004, PLANT CELL ENVIRON, V27, P840, DOI 10.1111/j.1365-3040.2004.01190.x; Beisel KG, 2010, PLANT PHYSIOL, V152, P2188, DOI 10.1104/pp.109.151647; Biacs PA, 2000, BIOCHEM SOC T, V28, P839, DOI 10.1042/BST0280839; BISWAL B, 1995, J PHOTOCH PHOTOBIO B, V30, P3, DOI 10.1016/1011-1344(95)07197-A; Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889; Bradbury LMT, 2012, P NATL ACAD SCI USA, V109, pE1888, DOI 10.1073/pnas.1206002109; Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24; Brausemann A, 2017, STRUCTURE, V25, P1222, DOI 10.1016/j.str.2017.06.002; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Bruno M, 2016, J EXP BOT, V67, P5993, DOI 10.1093/jxb/erw356; Burton GW, 2016, J AGR FOOD CHEM, V64, P3767, DOI 10.1021/acs.jafc.6b00503; Cao HB, 2012, J EXP BOT, V63, P4403, DOI 10.1093/jxb/ers115; Carrera A, 2007, J CEREAL SCI, V45, P67, DOI 10.1016/j.jcs.2006.07.001; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Cazzonelli CI, 2009, PLANT CELL, V21, P39, DOI 10.1105/tpc.108.063131; Chayut N, 2016, PLANT PHYSIOL, V2016; Che P, 2016, P NATL ACAD SCI USA, P113; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Cooperstone JL, 2015, MOL NUTR FOOD RES, V59, P658, DOI 10.1002/mnfr.201400658; Benevides CMD, 2011, FOOD CHEM, V126, P927, DOI 10.1016/j.foodchem.2010.11.082; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Diretto G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-11; Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; Galpaz N, 2013, ARCH BIOCHEM BIOPHYS, V539, P117, DOI 10.1016/j.abb.2013.08.006; Gayen D, 2015, PLANTA, V242, P353, DOI 10.1007/s00425-015-2314-4; Gayen D, 2014, PLANT CELL TISS ORG, V118, P229, DOI 10.1007/s11240-014-0476-6; Gemmecker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131717; Giuliano G, 2002, TRENDS PLANT SCI, V7, P427, DOI 10.1016/S1360-1385(02)02329-4; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Gonzalez-Jorge S, 2013, PLANT CELL, V113; Granchi C, 2017, J AGR FOOD CHEM, V65, P5639, DOI 10.1021/acs.jafc.7b01668; HARRIS WM, 1969, AM J BOT, V56, P380, DOI 10.2307/2440813; Havaux M, 2014, PLANT J, V79, P597, DOI 10.1111/tpj.12386; Hoque TS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01341; Hou X, 2016, TRENDS PLANT SCI, V21, P792, DOI 10.1016/j.tplants.2016.06.001; Huang FC, 2009, PHYTOCHEMISTRY, V70, P457, DOI 10.1016/j.phytochem.2009.01.020; Ibdah M, 2006, PHYTOCHEMISTRY, V67, P1579, DOI 10.1016/j.phytochem.2006.02.009; Ilg A, 2014, FEBS OPEN BIO, V4, P584, DOI 10.1016/j.fob.2014.06.005; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Iskandar AR, 2016, CANCER PREV RES, V9, P875, DOI 10.1158/1940-6207.CAPR-16-0161; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jeffery J, 2012, J SCI FOOD AGR, V92, P2594, DOI 10.1002/jsfa.5767; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Kang L, 2017, PLANT PHYSIOL BIOCH, V117, P24, DOI 10.1016/j.plaphy.2017.05.017; Karuppusamy S, 2009, J MED PLANTS RES, V3, P1222; Kim JE, 2010, PHYTOCHEMISTRY, V71, P168, DOI 10.1016/j.phytochem.2009.10.011; Kim J, 2009, PLANT CELL PHYSIOL, V50, P463, DOI 10.1093/pcp/pcp005; Kloer DP, 2006, BIOCHEMISTRY-US, V45, P15197, DOI 10.1021/bi061572k; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; Koch TC, 2005, J AGR FOOD CHEM, V53, P325, DOI 10.1021/jf048272z; Latari K, 2015, PLANT PHYSIOL, V168, P1550, DOI 10.1104/pp.15.00243; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; Li L, 2013, ARCH BIOCHEM BIOPHYS, V539, P102, DOI 10.1016/j.abb.2013.07.002; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Mapelli-Brahm P, 2017, FOOD CHEM, V229, P304, DOI 10.1016/j.foodchem.2017.02.074; Melendez-Martinez AJ, 2015, ARCH BIOCHEM BIOPHYS; Mor A, 2014, PLANT PHYSIOL, V165, P249, DOI 10.1104/pp.114.236380; Muller L, 2011, J AGR FOOD CHEM, V59, P4504, DOI 10.1021/jf1045969; Mueller L, 2011, MOLECULES, V16, P1055, DOI 10.3390/molecules16021055; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Nogueira M, 2013, PLANT CELL, V25, P4560, DOI 10.1105/tpc.113.116210; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Palozza P, 1998, NUTR REV, V56, P257, DOI 10.1111/j.1753-4887.1998.tb01762.x; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Park SY, 2016, FOOD SCI BIOTECHNOL, V25, P283, DOI 10.1007/s10068-016-0041-7; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; RABOURN WJ, 1954, ARCH BIOCHEM BIOPHYS, V48, P267, DOI 10.1016/0003-9861(54)90341-0; Ramel F, 2013, J EXP BOT, V64, P799, DOI 10.1093/jxb/ers223; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Rischer H, 2013, CURR PHARM DESIGN, V19, P5640, DOI 10.2174/1381612811319310017; Rodrigo MJ, 2013, J EXP BOT, V64, P4461, DOI 10.1093/jxb/ert260; Rodriguez-Villalon A, 2009, PLANT SIGNAL BEHAV, V4, P965, DOI 10.4161/psb.4.10.9672; Rottet S, 2015, BBA-BIOENERGETICS, V1847, P889, DOI 10.1016/j.bbabio.2015.02.002; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Schaub P, 2017, J AGR FOOD CHEM, V65, P6588, DOI 10.1021/acs.jafc.7b01693; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schuessele C, 2016, NEW PHYTOL, V209, P1014, DOI 10.1111/nph.13656; Schweiggert RM, 2017, CRIT REV FOOD SCI, V57, P1807, DOI 10.1080/10408398.2015.1012756; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Sitte P, 1980, PIGMENTS PLANTS, P117; Stinco CM, 2016, LWT-FOOD SCI TECHNOL, V65, P718, DOI 10.1016/j.lwt.2015.08.068; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; Vazquez A-O, 2014, PLANT CELL, V26, P2524; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Yadav Sudesh Kumar, 2008, Drug Metabolism and Drug Interactions, V23, P51; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yue W, 2016, CRIT REV BIOTECHNOL, V36, P215, DOI 10.3109/07388551.2014.923986; Zhang MK, 2014, PLANTA, V240, P1063, DOI 10.1007/s00425-014-2147-6; Zhou XJ, 2015, P NATL ACAD SCI USA, V112, P3558, DOI 10.1073/pnas.1420831112	112	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192158	10.1371/journal.pone.0192158	http://dx.doi.org/10.1371/journal.pone.0192158			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394270	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400028
J	Yamaguchi, K; Okada, K				Yamaguchi, Kazuhiro; Okada, Kensuke			Comparison among cognitive diagnostic models for the TIMSS 2007 fourth grade mathematics assessment	PLOS ONE			English	Article							LATENT CLASS MODELS; Q-MATRIX; RULE-SPACE; IDENTIFIABILITY; SAMPLE; SKILLS	A variety of cognitive diagnostic models (CDMs) have been developed in recent years to help with the diagnostic assessment and evaluation of students. Each model makes different assumptions about the relationship between students' achievement and skills, which makes it important to empirically investigate which CDMs better fit the actual data. In this study, we examined this question by comparatively fitting representative CDMs to the Trends in International Mathematics and Science Study (TIMSS) 2007 assessment data across seven countries. The following two major findings emerged. First, in accordance with former studies, CDMs had a better fit than did the item response theory models. Second, main effects models generally had a better fit than other parsimonious or the saturated models. Related to the second finding, the fit of the traditional parsimonious models such as the DINA and DINO models were not optimal. The empirical educational implications of these findings are discussed.	[Yamaguchi, Kazuhiro] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Okada, Kensuke] Senshu Univ, Dept Psychol, Kawazaki, Kanagawa, Japan	University of Tokyo	Yamaguchi, K (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	kazz530@p.u-tokyo.ac.jp	Yamaguchi, Kazuhiro/ABD-6860-2021	Yamaguchi, Kazuhiro/0000-0001-8011-8575; Okada, Kensuke/0000-0003-1663-5812	JSPS KAKENHI [17H04787]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by JSPS KAKENHI(https://www.jsps.go.jp/english/e-grants/) Grant Number 17H04787.	Alducin-Ochoa JM, 2016, INT ED STUD, V9, P1; Anders J, 2016, AERA OPEN, V2; Birenbaum M., 2004, STUD EDUC EVAL, V30, P151, DOI DOI 10.1016/J.STUEDUC.2004.06.004; Birenbaum M, 2005, ASSESS EDUC, V12, P167, DOI 10.1080/09695940500143852; Birnbaum A., 1968, STAT THEORIES MENTAL, P397; Chen J., 2014, PSYCHOLOGY, V5, P1967, DOI [10.4236/psych.2014.518200, DOI 10.4236/PSYCH.2014.518200, DOI 10.4236/psych.2014.518200]; Chen JS, 2017, APPL PSYCH MEAS, V41, P277, DOI 10.1177/0146621616686021; Chen Y, PSYCHOMETRIKA; Chen YH, 2008, INT J TEST, V8, P251, DOI 10.1080/15305050802262217; Chmielewski AK, 2016, AERA OPEN, V2; Choi KM, 2015, EURASIA J MATH SCI T; de la Torre J, 2016, PSYCHOMETRIKA, V81, P253, DOI 10.1007/s11336-015-9467-8; de la Torre J, 2011, PSYCHOMETRIKA, V76, P179, DOI 10.1007/s11336-011-9207-7; DiBello LV, 2007, HANDB STAT, V26, P979, DOI 10.1016/S0169-7161(06)26031-0; Dogan E, 2007, EDUC STUD MATH, V68, P263; HAERTEL EH, 1989, J EDUC MEAS, V26, P301, DOI 10.1111/j.1745-3984.1989.tb00336.x; Hartz S., 2008, ETS RES REPORT SERIE, V1, pI; Im S, 2010, EDUC RES EVAL, V16, P287, DOI 10.1080/13803611.2010.523294; Jang EE, 2009, LANG ASSESS Q, V6, P210, DOI 10.1080/15434300903071817; Junker BW, 2001, APPL PSYCH MEAS, V25, P258, DOI 10.1177/01466210122032064; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Lee YW, 2009, LANG ASSESS Q, V6, P172, DOI 10.1080/15434300902985108; Lee YS, 2011, INT J TEST, V11, P144, DOI 10.1080/15305058.2010.534571; Leighton JP, 2004, J EDUC MEAS, V41, P205, DOI 10.1111/j.1745-3984.2004.tb01163.x; Leighton JP, 2007, COGNITIVE DIAGNOSTIC ASSESSMENT FOR EDUCATION: THEORY AND APPLICATIONS, P1, DOI 10.1017/CBO9780511611186; Li HL, 2016, LANG TEST, V33, P391, DOI 10.1177/0265532215590848; Lord F. M., 1968, STAT THEORIES MENTAL; Ma W, GENERALIZED DINA MOD; Maris E, 1999, PSYCHOMETRIKA, V64, P187, DOI 10.1007/BF02294535; Maydeu-Olivares A, 2013, MEAS-INTERDISCIP RES, V11, P71, DOI 10.1080/15366367.2013.831680; Mullis I. V. S., 2008, INT MATH REPORT FIND; Rizopoulos D, 2006, J STAT SOFTW, V17; Robitzsch A, COGNITIVE DIAGNOSIS; Robitzsch A., TEST ANAL MODULES R; Roussos LA, 2007, J EDUC MEAS, V44, P293, DOI 10.1111/j.1745-3984.2007.00040.x; Rupp AA, 2008, MEAS-INTERDISCIP RES, V6, P219, DOI 10.1080/15366360802490866; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sun Y, 2013, ADV EDUC RES, V7, P140; Suzuki M., 2015, JPN J RES TEST, V11, P81; Tatsuoka KK, 2004, AM EDUC RES J, V41, P901, DOI 10.3102/00028312041004901; Tatsuoka KK, 2009, MULTIVAR APPL SER, P1; Tatsuoka KK, 1997, J EDUC MEAS, V34, P3, DOI 10.1111/j.1745-3984.1997.tb00504.x; TATSUOKA KK, 1983, J EDUC MEAS, V20, P345, DOI 10.1111/j.1745-3984.1983.tb00212.x; Templin JL, 2006, PSYCHOL METHODS, V11, P287, DOI 10.1037/1082-989X.11.3.287; Toker T., 2010, ELEC THES DISS, V653, P1; Xu G, J AM STAT ASS; Xu GJ, 2017, ANN STAT, V45, P675, DOI 10.1214/16-AOS1464; Xu GJ, 2016, PSYCHOMETRIKA, V81, P625, DOI 10.1007/s11336-015-9471-z; Yamaguchi K., 2017, JPN J RES TEST, V13, P1; YEANY RH, 1983, J RES SCI TEACH, V20, P19, DOI 10.1002/tea.3660200103	50	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0188691	10.1371/journal.pone.0188691	http://dx.doi.org/10.1371/journal.pone.0188691			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394257	Green Submitted, gold, Green Published			2022-12-27	WOS:000424060400004
J	Glaesener, S; Jaenke, C; Habener, A; Geffers, R; Hagendorff, P; Witzlau, K; Imelmann, E; Krueger, A; Meyer-Bahlburg, A				Glaesener, Stephanie; Jaenke, Christine; Habener, Anika; Geffers, Robert; Hagendorff, Petra; Witzlau, Katrin; Imelmann, Esther; Krueger, Andreas; Meyer-Bahlburg, Almut			Decreased production of class-switched antibodies in neonatal B cells is associated with increased expression of miR-181b	PLOS ONE			English	Article							T-CELLS; COSTIMULATOR MOLECULES; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; REFERENCE VALUES; LYMPHOCYTES; CORD; BAFF; ACTIVATION; FAMILY	The increased susceptibility to infections of neonates is caused by an immaturity of the immune system as a result of both qualitative and quantitative differences between neonatal and adult immune cells. With respect to B cells, neonatal antibody responses are known to be decreased. Accountable for this is an altered composition of the neonatal B cell compartment towards more immature B cells. However, it remains unclear whether the functionality of individual neonatal B cell subsets is altered as well. In the current study we therefore compared phenotypical and functional characteristics of corresponding neonatal and adult B cell subpopulations. No phenotypic differences could be identified with the exception of higher IgM expression in neonatal B cells. Functional analysis revealed differences in proliferation, survival, and B cell receptor signaling. Most importantly, neonatal B cells showed severely impaired class-switch recombination (CSR) to IgG and IgA. This was associated with increased expression of miR-181b in neonatal B cells. Deficiency of miR-181b resulted in increased CSR. With this, our results highlight intrinsic differences that contribute to weaker B cell antibody responses in newborns.	[Glaesener, Stephanie; Jaenke, Christine; Habener, Anika; Meyer-Bahlburg, Almut] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Habener, Anika; Meyer-Bahlburg, Almut] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany; [Geffers, Robert; Hagendorff, Petra] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany; [Witzlau, Katrin; Krueger, Andreas] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Imelmann, Esther] Goethe Univ, Inst Mol Med, Frankfurt, Germany; [Meyer-Bahlburg, Almut] Univ Med Greifswald, Dept Pediat, Greifswald, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Goethe University Frankfurt; Greifswald Medical School	Meyer-Bahlburg, A (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany.; Meyer-Bahlburg, A (corresponding author), German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany.; Meyer-Bahlburg, A (corresponding author), Univ Med Greifswald, Dept Pediat, Greifswald, Germany.	almut.meyer-bahlburg@uni-greifswald.de	Krueger, Andreas/M-9769-2019; von Kaisenberg, Constantin/AAR-2756-2021	Krueger, Andreas/0000-0001-7873-7334; Glaesener, Stephanie/0000-0002-3971-7282	German Research Foundation [ME2709/2-3, KR2320/5-1, SFB902-B15]; European Union Marie-Curie International Re-integration Grant [IRG 256372]; Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft	German Research Foundation(German Research Foundation (DFG)); European Union Marie-Curie International Re-integration Grant; Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by grants from the German Research Foundation (http://www.dfg.de/) (ME2709/2-3 (AMB); KR2320/5-1 and SFB902-B15 (AK)), and a European Union Marie-Curie International Re-integration Grant IRG 256372 (https://ec.europa.eu/research/mariecurieactions/about/individual-fellowships_en) (AMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the assistance of the Cell Sorting Core Facility at Hannover Medical School supported by Braukmann-Wittenberg-Herz-Stiftung and Deutsche Forschungsgemeinschaft; and Prof. Dr. von Kaisenberg and Marion Haidukiewicz of the Clinic for Gynaecology and Obstetrics, Medical School Hannover, Germany for their help in providing us with cord blood. We also thank Christin Albrecht and Anika Dreier for the assistance in performing additional mice experiments.	Adderson EE, 2001, SPRINGER SEMIN IMMUN, V23, P387, DOI 10.1007/s281-001-8166-x; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 2003, J IMMUNOL, V170, P4548, DOI 10.4049/jimmunol.170.9.4548; Adkins B, 2013, IMMUNOL RES, V57, P246, DOI 10.1007/s12026-013-8439-2; Aranburu A, 2010, J IMMUNOL, V185, P7293, DOI 10.4049/jimmunol.1002722; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Bao Y, 2016, CLIN REV ALLERG IMMU, V50, P301, DOI 10.1007/s12016-015-8494-7; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Belderbos ME, 2013, PEDIAT ALLERG IMM-UK, V24, P102, DOI 10.1111/pai.12023; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Capolunghi F, 2013, IMMUNOL LETT, V152, P114, DOI 10.1016/j.imlet.2013.04.007; Chalmers IMH, 1998, BLOOD, V92, P11, DOI 10.1182/blood.V92.1.11.413a39_11_18; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; de Candia P, 2016, EUR J IMMUNOL, V46, P725, DOI 10.1002/eji.201545787; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Debock I, 2013, J IMMUNOL, V191, P1231, DOI 10.4049/jimmunol.1203288; Drohan L, 2004, HUM IMMUNOL, V65, P1356, DOI 10.1016/j.humimm.2004.09.011; Duchamp M, 2014, IMMUN INFLAMM DIS, V2, P131, DOI 10.1002/iid3.26; DURANDY A, 1995, J IMMUNOL, V154, P1560; Durandy A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3904; Elliott SR, 2000, HUM IMMUNOL, V61, P378, DOI 10.1016/S0198-8859(99)00189-5; Elliott SR, 1999, HUM IMMUNOL, V60, P1039, DOI 10.1016/S0198-8859(99)00090-7; Feng C, 2017, J CELL MOL MED, V21, P278, DOI 10.1111/jcmm.12963; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; HAYWARD AR, 1977, J IMMUNOL, V119, P1213; Hori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174108; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Jin HY, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006623; Kaminski BA, 2003, BLOOD, V102, P4608, DOI 10.1182/blood-2003-05-1732; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khuu C, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/1379643; Klouwenberg PK, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/628963; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lai MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12207; Landers CD, 2005, CLIN IMMUNOL, V116, P236, DOI 10.1016/j.clim.2005.04.013; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Li JY, 2013, CELL MOL IMMUNOL, V10, P107, DOI 10.1038/cmi.2012.62; Li TJ, 2015, INT J CLIN EXP PATHO, V8, P10375; Lou Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00537; Macardle PJ, 1997, IMMUNOLOGY, V90, P376, DOI 10.1111/j.1365-2567.1997.00376.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Marie-Cardine A, 2008, CLIN IMMUNOL, V127, P14, DOI 10.1016/j.clim.2007.11.013; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Meyer-Bahlburg A, 2009, J IMMUNOL, V182, P4065, DOI 10.4049/jimmunol.0802961; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Palin AC, 2013, J IMMUNOL, V190, P2682, DOI 10.4049/jimmunol.1202534; Pettengill MA, 2016, INNATE IMMUNITY; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roth A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152215; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tasker L, 1997, INT IMMUNOL, V9, P475, DOI 10.1093/intimm/9.4.475; Tasker L, 2003, CLIN EXP IMMUNOL, V134, P409, DOI 10.1111/j.1365-2249.2003.02318.x; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsai DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17957; TSUJI T, 1994, J IMMUNOL, V152, P4417; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viemann D, 2000, EUR J IMMUNOL, V30, P550, DOI 10.1002/1521-4141(200002)30:2<550::AID-IMMU550>3.0.CO;2-X; Wang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17618; White CA, 2014, J IMMUNOL, V193, P5933, DOI 10.4049/jimmunol.1401702; Xu DD, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0521-7; Xu XF, 2015, ONCOL REP, V33, P2789, DOI 10.3892/or.2015.3900; Zan H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00631; Zhang JM, 2015, IMMUNOLOGY, V144, P56, DOI 10.1111/imm.12347; Zheng YB, 2016, ONCOL REP, V35, P683, DOI 10.3892/or.2015.4417; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	83	17	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192230	10.1371/journal.pone.0192230	http://dx.doi.org/10.1371/journal.pone.0192230			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389970	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400078
J	Jazaeri, SZ; Azad, A; Mehdizadeh, H; Habibi, SA; Najafabadi, MM; Saberi, ZS; Rahimzadegan, H; Moradi, S; Behzadipour, S; Parnianpour, M; Taghizadeh, G; Khalaf, K				Jazaeri, Seyede Zohreh; Azad, Akram; Mehdizadeh, Hajar; Habibi, Seyed Amirhassan; Najafabadi, Mahbubeh Mandehgary; Saberi, Zakieh Sadat; Rahimzadegan, Hawre; Moradi, Saeed; Behzadipour, Saeed; Parnianpour, Mohamad; Taghizadeh, Ghorban; Khalaf, Kinda			The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease	PLOS ONE			English	Article							BALANCE; INSTABILITY; DEPRESSION; AUTOMATICITY; LEVODOPA; WALKING; SCALE; DOPA; GAIT; CUES	Background Although anxiety is a common non-motor outcome of Parkinson's disease (PD) affecting 40% of patients, little attention has been paid so far to its effects on balance impairment and postural control. Improvement of postural control through focusing on the environment (i.e. external focus) has been reported, but the role of anxiety, as a confounding variable, remains unclear. Objectives This study aimed to investigate the influence of anxiety and attentional focus instruction on the standing postural control of PD patients. Methods Thirty-four patients with PD (17 with high anxiety (HA-PD) and 17 with low anxiety (LA-PD)), as well as 17 gender-and age-matched healthy control subjects (HC) participated in the study. Postural control was evaluated using a combination of two levels of postural difficulty (standing on a rigid force plate surface with open eyes (RO) and standing on a foam surface with open eyes (FO)), as well as three attentional focus instructions (internal, external and no focus). Results Only the HA-PD group demonstrated significant postural control impairment as compared to the control, as indicated by significantly greater postural sway measures. Moreover, external focus significantly reduced postural sway in all participants especially during the FO condition. Conclusion The results of the current study provide evidence that anxiety influences balance control and postural stability in patients with PD, particularly those with high levels of anxiety. The results also confirmed that external focus is a potential strategy that significantly improves the postural control of these patients. Further investigation of clinical applicability is warranted towards developing effective therapeutic and rehabilitative treatment plans.	[Jazaeri, Seyede Zohreh; Azad, Akram; Najafabadi, Mahbubeh Mandehgary; Saberi, Zakieh Sadat; Rahimzadegan, Hawre; Taghizadeh, Ghorban] Iran Univ Med Sci, Sch Rehabil Sci, Dept Occupat Therapy, Tehran, Iran; [Mehdizadeh, Hajar] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran; [Mehdizadeh, Hajar] Univ Tehran Med Sci, Sch Rehabil, Dept Occupat Therapy, Tehran, Iran; [Habibi, Seyed Amirhassan] Iran Univ Med Sci, Rasool Akram Hosp, Dept Neurol, Movement Disorder Clin, Tehran, Iran; [Moradi, Saeed] Iran Univ Med Sci, Rasool Akram Hosp, Tehran, Iran; [Behzadipour, Saeed; Parnianpour, Mohamad] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Behzadipour, Saeed] Mowafaghian Res Ctr Neurorehabil Technol, Tehran, Iran; [Taghizadeh, Ghorban] Iran Univ Med Sci, Sch Rehabil Sci, Rehabil Res Ctr, Tehran, Iran; [Khalaf, Kinda] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	Iran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Sharif University of Technology; Iran University of Medical Sciences; Khalifa University of Science & Technology	Taghizadeh, G (corresponding author), Iran Univ Med Sci, Sch Rehabil Sci, Dept Occupat Therapy, Tehran, Iran.; Taghizadeh, G (corresponding author), Iran Univ Med Sci, Sch Rehabil Sci, Rehabil Res Ctr, Tehran, Iran.	taghizadeh.gh@iums.ac.ir	Azad, Akram/M-6351-2018; Taghizadeh, Ghorban/AAD-7167-2022; Behzadipour, Saeed/ABC-6740-2020; Mehdizadeh, Hajar/HCI-6580-2022; Taghizadeh, Ghorban/L-8609-2018	Azad, Akram/0000-0001-7544-4878; Taghizadeh, Ghorban/0000-0002-0145-9599; Taghizadeh, Ghorban/0000-0002-0145-9599; Behzadipour, Saeed/0000-0001-9313-315X; Khalaf, Kinda/0000-0002-3878-2621	Iran University of Medical Sciences, Tehran, Iran	Iran University of Medical Sciences, Tehran, Iran	This study was supported by Iran University of Medical Sciences, Tehran, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Iran University of Medical Sciences, Tehran, Iran.	Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Beck EN, 2016, PHYS THERAPY; Bekkers EMJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00939; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; Bohnen NI, 2006, CLIN GERIATR MED, V22, P797, DOI 10.1016/j.cger.2006.06.009; Cunnington R, 1999, MOVEMENT DISORD, V14, P63; DAMASIO AR, 1971, J NEUROL NEUROSUR PS, V34, P502, DOI 10.1136/jnnp.34.5.502; de Kam D, 2014, J NEUROL, V261, P2330, DOI 10.1007/s00415-014-7496-3; ELLGRING H, 1990, ADV NEUROL, V53, P349; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fergus TA, 2014, BEHAV RES THER, V61, P150, DOI 10.1016/j.brat.2014.08.007; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; Kim SD, 2013, CNS DRUGS, V27, P97, DOI 10.1007/s40263-012-0012-3; Landers M, 2005, PHYSIOTHERAPY, V91, P152, DOI 10.1016/j.physio.2004.11.010; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; MARICLE RA, 1995, NEUROLOGY, V45, P1757, DOI 10.1212/WNL.45.9.1757; Martens KAE, 2017, NEUROSCIENCE, V340, P436, DOI 10.1016/j.neuroscience.2016.11.011; Martens KAE, 2015, NEUROPSYCHOLOGIA, V79, P322, DOI 10.1016/j.neuropsychologia.2015.05.015; Mehdizadeh H, 2017, EXP BRAIN RES; Mehdizadeh Maryam, 2016, Med J Islam Repub Iran, V30, P453; Prediger RDS, 2012, NEUROPHARMACOLOGY, V62, P115, DOI 10.1016/j.neuropharm.2011.08.039; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Richard IH, 1996, J NEUROPSYCH CLIN N, V8, P383; Richer N, 2017, GAIT POSTURE, V54, P45, DOI 10.1016/j.gaitpost.2017.02.022; Riedel O, 2013, J GERIATR PSYCH NEUR, V26, P151, DOI 10.1177/0891988713490994; Rodriguez-Blazquez C, 2009, MOVEMENT DISORD, V24, P519, DOI 10.1002/mds.22321; Schiehser DM, 2013, PARKINSONISM RELAT D, V19, P335, DOI 10.1016/j.parkreldis.2012.11.013; Smania N, 2010, NEUROREHAB NEURAL RE, V24, P826, DOI 10.1177/1545968310376057; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; Weisskopf MG, 2003, MOVEMENT DISORD, V18, P646, DOI 10.1002/mds.10425; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336; Wulf G, 2009, PHYS THER, V89, P162, DOI 10.2522/ptj.20080045; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192168	10.1371/journal.pone.0192168	http://dx.doi.org/10.1371/journal.pone.0192168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390029	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400074
J	Laws, MB; Lee, Y; Taubin, T; Rogers, WH; Wilson, IB				Laws, M. Barton; Lee, Yoojin; Taubin, Tatiana; Rogers, William H.; Wilson, Ira B.			Factors associated with patient recall of key information in ambulatory specialty care visits: Results of an innovative methodology	PLOS ONE			English	Article							SHARED DECISION-MAKING; MEDICAL ENCOUNTERS; COMMUNICATION; PHYSICIAN; OUTCOMES; SATISFACTION; INVOLVEMENT; ADHERENCE; MODEL; NONADHERENCE	While some studies have assessed patient recall of important information from ambulatory care visits, none has done so recently. Furthermore, little is known about features of clinical interactions which are associated with patient understanding and recall, without which shared decision making, a widely shared ideal for patient care, cannot occur. Our objective was to evaluate characteristics of patients and outpatient encounters associated with patient recall of information after one week, along with observation of elements of shared decision making. This was an observational study based on coded transcripts of 189 outpatient encounters, and post-visit interviews with patients 1 week later. Coding used three previously validated systems, adopted for this study. Forty-nine percent of decisions and recommendations were recalled accurately without prompting; 36% recalled with a prompt; 15% recalled erroneously or not at all. Provider behaviors hypothesized to be associated with patient recall, such as open-questioning and "teach back," were rare. Patients with less than high school education recalled 38% of items freely and accurately, while patients with a college degree recalled 65% (p<.0001). In a multivariate model, the total number of items to be recalled per visit, and percentage of utterances in decision-making processes by the provider ("verbal dominance"), were significant predictors of poorer recall. The item count was associated with poorer recall for lower, but not higher, educated patients.	[Laws, M. Barton; Lee, Yoojin; Taubin, Tatiana; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Rogers, William H.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA	Brown University; Tufts Medical Center	Laws, MB (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	Michael_Barton_Laws@Brown.edu		Laws, M. Barton/0000-0002-0790-5879	Patient Centered Outcomes Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115677] Funding Source: NIH RePORTER	Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Patient Centered Outcomes Research Institute (PCORI does not use grant numbers), PCORI.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JL, 1979, RHEUMATOL REHABIL, V18, P18, DOI 10.1093/rheumatology/18.1.18; Austin JohnLangshaw., 1976, DO THINGS WORDS, V2nd ed.; Barry MJ, 2012, J AMBUL CARE MANAG, V35, P90, DOI 10.1097/JAC.0b013e318249482f; Beach MC, 2005, ANN FAM MED, V3, P331, DOI 10.1370/afm.328; BERTAKIS KD, 1977, J FAM PRACTICE, V5, P217; BERTAKIS KD, 1991, J FAM PRACTICE, V32, P175; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549; Covey J, 2011, J HEALTH COMMUN, V16, P788, DOI 10.1080/10810730.2011.561916; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; Elwyn G, 2013, PATIENT EDUC COUNS, V93, P265, DOI 10.1016/j.pec.2013.08.005; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Ford S, 2000, SOC SCI MED, V50, P553, DOI 10.1016/S0277-9536(99)00308-1; Friedman DS, 2008, OPHTHALMOLOGY, V115, P1320, DOI 10.1016/j.ophtha.2007.11.023; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; Heisler M, 2003, J GEN INTERN MED, V18, P893, DOI 10.1046/j.1525-1497.2003.21132.x; Hoffman RM, 2010, MED DECIS MAKING, V30, p53S, DOI 10.1177/0272989X10378701; Jenkins V, 2011, J CLIN ONCOL, V29, P61, DOI 10.1200/JCO.2010.30.0814; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; KING A, 1992, AM EDUC RES J, V29, P303, DOI 10.3102/00028312029002303; KUPST MJ, 1975, AM J ORTHOPSYCHIAT, V45, P420, DOI 10.1111/j.1939-0025.1975.tb02553.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langewitz W, 2015, PATIENT EDUC COUNS, V98, P716, DOI 10.1016/j.pec.2015.02.003; Laws MB, 2013, PATIENT EDUC COUNS, V91, P192, DOI 10.1016/j.pec.2012.12.012; Laws MB, 2013, AIDS BEHAV, V17, P148, DOI 10.1007/s10461-012-0143-z; LERMAN CE, 1990, J GEN INTERN MED, V5, P29, DOI 10.1007/BF02602306; LEY P, 1979, BRIT J SOC CLIN PSYC, V18, P245, DOI 10.1111/j.2044-8260.1979.tb00333.x; LIPKIN M, 1984, ANN INTERN MED, V100, P277, DOI 10.7326/0003-4819-100-2-277; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Marinker M, 2003, BRIT MED J, V326, P348, DOI 10.1136/bmj.326.7385.348; Bravo BN, 2010, PATIENT EDUC COUNS, V81, P272, DOI 10.1016/j.pec.2010.01.022; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Pilnick A, 2011, SOC SCI MED, V72, P1374, DOI 10.1016/j.socscimed.2011.02.033; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Searle JR, 1969, ESSAY PHILOS LANGUAG; Silberman J, 2008, J GEN INTERN MED, V23, P1487, DOI 10.1007/s11606-008-0597-x; Smith RA, 1994, J PERS SOC PSYCHOL, V47, P415; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Wilson IB, 2007, J GEN INTERN MED, V22, P6, DOI 10.1007/s11606-006-0093-0; Zikmund-Fisher BJ, 2010, MED DECIS MAKING, V30, p85S, DOI 10.1177/0272989X10380466	47	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191940	10.1371/journal.pone.0191940	http://dx.doi.org/10.1371/journal.pone.0191940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389994	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400044
J	Mayfield, AB; Chen, YJ; Lu, CY; Chen, CS				Mayfield, Anderson B.; Chen, Yi-Jyun; Lu, Chi-Yu; Chen, Chii-Shiarng			The proteomic response of the reef coral Pocillopora acuta to experimentally elevated temperatures	PLOS ONE			English	Article							GENE-EXPRESSION; BUILDING CORAL; PHYSIOLOGICAL-RESPONSE; CLIMATE-CHANGE; STRESS; RESILIENCE; MECHANISMS; DAMICORNIS; RUBISCO; KINASE	Although most reef-building corals live near the upper threshold of their thermotolerance, some scleractinians are resilient to temperature increases. For instance, Pocillopora acuta specimens from an upwelling habitat in Southern Taiwan survived a nine-month experimental exposure to 30 degrees C, a temperature hypothesized to induce stress. To gain a greater understanding of the molecular pathways underlying such high-temperature acclimation, the protein profiles of experimental controls incubated at 27 degrees C were compared to those of conspecific P. acuta specimens exposed to 30 degrees C for two, four, or eight weeks, and differentially concentrated proteins (DCPs) were removed from the gels and sequenced with mass spectrometry. Sixty unique DCPs were uncovered across both eukaryotic compartments of the P. acuta-dinoflagellate (genus Symbiodinium) mutualism, and Symbiodinium were more responsive to high temperature at the protein-level than the coral hosts in which they resided at the two-week sampling time. Furthermore, proteins involved in the stress response were more likely to be documented at different cellular concentrations across temperature treatments in Symbiodinium, whereas the temperature-sensitive host coral proteome featured numerous proteins involved in cytoskeletal structure, immunity, and metabolism. These proteome-scale data suggest that the coral host and its intracellular dinoflagellates have differing strategies for acclimating to elevated temperatures.	[Mayfield, Anderson B.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD 21403 USA; [Mayfield, Anderson B.; Chen, Yi-Jyun; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Ctr Res Resources & Dev, Kaohsiung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Dong Hwa University	Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD 21403 USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	United States National Science Foundation [OISE-0852960]; Khaled bin Sultan Living Oceans Foundation	United States National Science Foundation(National Science Foundation (NSF)); Khaled bin Sultan Living Oceans Foundation	This work was funded by the United States National Science Foundation (postdoctoral research fellowship to ABM; OISE-0852960) and the Khaled bin Sultan Living Oceans Foundation (postdoctoral research fellowship to ABM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Chen HK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02722-z; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Chen WNU, 2016, PEERJ, V4, DOI 10.7717/peerj.2358; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Doo SS, 2013, APPROACHES STUDY LIV; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Du Clos TW, 2013, ISRN INFLAMM; Gates RD, 1999, AM ZOOL, V39, P30; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Krueger T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170038; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Lundgren P, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-9; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield A. B., 2017, PLOS ONE, DOI [10.1371/journal.pone.0185857, DOI 10.1371/JOURNAL.PONE.0185857]; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; MAYFIELD AB, 2013, J MAR BIOL, V2013, P69369, DOI DOI 10.1155/2013/569361; Mayfield AR, 2018, CHILD NEUROPSYCHOL, V24, P166, DOI 10.1080/09297049.2016.1236186; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177267; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield AB, 2014, MAR BIOTECHNOL, V16, P371, DOI 10.1007/s10126-014-9558-z; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Mente Eleni, 2017, Biochem Biophys Rep, V9, P79, DOI 10.1016/j.bbrep.2016.10.012; Oakley CA, 2016, CELL MICROBIOL, V18, P1009, DOI 10.1111/cmi.12564; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Pinzon JH, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140214; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Putnam HM, 2017, CURR BIOL, V27, pR528, DOI 10.1016/j.cub.2017.04.047; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Ruiz-Jones LJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601298; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Takeuichi T, 2017, PLOS ONE; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Wang LH, 2013, PLOS ONE; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Weston AJ, 2015, MOL CELL PROTEOMICS, V14, P585, DOI 10.1074/mcp.M114.043125; Weston AJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015487	60	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192001	10.1371/journal.pone.0192001	http://dx.doi.org/10.1371/journal.pone.0192001			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385204	gold, Green Published, Green Submitted			2022-12-27	WOS:000423668400067
J	Choi, JY; Jeong, S; Jung, JK				Choi, Jae Young; Jeong, Seongkyoon; Jung, Jung-Kyu			Evolution of technology convergence networks in Korea: Characteristics of temporal changes in R&D according to institution type	PLOS ONE			English	Article							COLLABORATION NETWORK; PUBLIC RESEARCH; INNOVATION; PERFORMANCE; DIRECTIONS; MANAGEMENT; INDUSTRY; PATENTS; MARKET; FIRMS	This study investigates the temporal changes in development of technology convergence networks by institution type, i.e., public research institute (PRI), university and industry. Using the co-classification of technological domains of patents, we identified technology convergence of Korean patents, which were filed at Korea Intellectual Properties Office (KIPO) from 1997 to 2011. We conducted a network analysis at the technology level to search for the key technology fields and frequent instances of technology convergence. The results show that technology convergence networks have grown significantly in the recent period regardless of the institution type. While industries started to conspicuously engage in technology convergence in the late 1990s, universities or PRIs did not do so until the mid-2000s. This discrepancy in the phase of technology convergence is attributed to the temporal difference in R&D stage (e.g., basic research and commercial product development). Our findings imply that corporal and governmental R&D management decision on promising technology fields will be more effective if the decision makers carefully consider the type of R&D entity in analyzing technological landscapes.	[Choi, Jae Young] Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul, South Korea; [Jeong, Seongkyoon] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA; [Jung, Jung-Kyu] KISTEP, Seoul, South Korea	Hanyang University; Arizona State University; Arizona State University-Tempe	Jung, JK (corresponding author), KISTEP, Seoul, South Korea.	j2key@kistep.re.kr	Jeong, Seongkyoon/AAI-9759-2021	Jeong, Seongkyoon/0000-0002-8663-9280				Athreye S, 2000, TECHNOVATION, V20, P227, DOI 10.1016/S0166-4972(99)00135-2; Balconi M, 2004, RES POLICY, V33, P127, DOI 10.1016/S0048-7333(03)00108-2; Barnes JA, 1954, HUM RELAT, V7, P39, DOI 10.1177/001872675400700102; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bayona-Saez C, 2002, R&D MANAGE, V32, P321, DOI 10.1111/1467-9310.00264; Boyack KW, 2008, J INFORMETR, V2, P173, DOI 10.1016/j.joi.2008.03.001; Bradley CA., 1996, VA J INT LAW, V37, P505; Buter RK, 2011, SCIENTOMETRICS, V86, P325, DOI 10.1007/s11192-010-0246-0; Choi JY, 2015, SUSTAINABILITY-BASEL, V7, P11546, DOI 10.3390/su70911546; Cohen WM, 2002, MANAGE SCI, V48, P1, DOI 10.1287/mnsc.48.1.1.14273; Curran C.-S., 2013, ANTICIPATION CONVERG; Curran CS, 2011, TECHNOL FORECAST SOC, V78, P256, DOI 10.1016/j.techfore.2010.06.021; Curran CS, 2010, TECHNOL FORECAST SOC, V77, P385, DOI 10.1016/j.techfore.2009.10.002; Dang Y, 2010, J NANOPART RES, V12, P687, DOI 10.1007/s11051-009-9831-7; Diaz-Perez C, 2007, 2007 ATL C SCI TECHN, P1; DOSI G, 1982, RES POLICY, V11, P147, DOI 10.1016/0048-7333(82)90016-6; Ernst H., 2003, World Patent Information, V25, P233, DOI 10.1016/S0172-2190(03)00077-2; Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4; Fai F., 2001, Structural Change and Economic Dynamics, V12, P141, DOI 10.1016/S0954-349X(00)00035-7; Farre-Perdiguer M, 2016, INT J EDUC TECHNOL H, V13, DOI 10.1186/s41239-016-0012-3; Featherston C, 2014, REV INT PUBLIC SECTO; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GALASKIEWICZ J, 1993, SOCIOL METHOD RES, V22, P3, DOI 10.1177/0049124193022001001; Gambardella A, 2007, RES POLICY, V36, P1163, DOI 10.1016/j.respol.2007.07.006; Geum Y, 2012, ETRI J, V34, P439, DOI 10.4218/etrij.12.1711.0010; Godin Benoit, 2005, MEASUREMENT STAT SCI; Hacklin F, 2008, CONTRIB MANAG SCI, P1, DOI 10.1007/978-3-7908-1990-8; Hacklin F, 2013, SERV IND J, V33, P774, DOI 10.1080/02642069.2013.740471; Haeussler C, 2010, J BUS VENTUR, V27, P217, DOI DOI 10.1016/J.JBUSVENT.2010.10.002; Jaccard P., 1902, B SOCIE TE VAUDOISE, V38, P67; JAFFE AB, 1986, AM ECON REV, V76, P984; Jeong S, 2012, INT J SOCIAL BEHAV E, V6, P1989; Jeong S, 2015, SCIENTOMETRICS, V104, P841, DOI 10.1007/s11192-015-1606-6; Jeong S, 2014, J MANAGE ORGAN, V20, P227, DOI 10.1017/jmo.2014.31; Karvonen M, 2013, TECHNOL FORECAST SOC, V80, P1094, DOI 10.1016/j.techfore.2012.05.006; Karvonen M, 2012, INT J INNOV TECHNOL, V9, DOI 10.1142/S0219877012500204; Katila R., 2000, INT J BUS PERFORM MA, V2, DOI [10.1504/IJBPM.2000.000072, DOI 10.1504/IJBPM.2000.000072]; Kay L, 2014, J ASSOC INF SCI TECH, V65, P2432, DOI 10.1002/asi.23146; Kim H, 2009, EXPERT SYST APPL, V36, P8986, DOI 10.1016/j.eswa.2008.11.039; Kim MS, 2012, PROCD SOC BEHV, V40, P657, DOI 10.1016/j.sbspro.2012.03.245; Lee DH, 2012, SCIENTOMETRICS, V91, P925, DOI 10.1007/s11192-011-0602-8; Lee H, 2016, P 2016 INT C INF COM, DOI [10.1109/ICTC.2016.7763492, DOI 10.1109/ICTC.2016.7763492]; Lee WS, 2015, TECHNOL FORECAST SOC, V100, P317, DOI 10.1016/j.techfore.2015.07.022; Lee Y., 2013, MEASURES PROMOTE TEC; Leydesdorff L, 2014, SCIENTOMETRICS, V98, P1583, DOI 10.1007/s11192-012-0923-2; Leydesdorff L, 2012, J INFORMETR, V6, P318, DOI 10.1016/j.joi.2011.11.003; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Lind J., 2004, P ITS 15 BIENN C 200; McDowall W, 2012, TECHNOL FORECAST SOC, V79, P530, DOI 10.1016/j.techfore.2011.10.002; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Myers J. L., 2010, RES DESIGN STAT ANAL; Nalwa H. S., 2001, SILICON BASED MAT DE; National Science Foundation (NSF), 2002, SCI ENG IND NAT SCI; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; OECD, 2010, MEASURING INNOVATION; OECD, 2014, OECD REV INN POL SCI; Padula G, 2008, LONG RANGE PLANN, V41, P395, DOI 10.1016/j.lrp.2008.01.004; Parkhe A, 2006, ACAD MANAGE REV, V31, P560, DOI [10.2307/20159228, 10.5465/AMR.2006.21318917]; Peercy PS, 2000, NATURE, V406, P1023, DOI 10.1038/35023223; Porter AL, 2009, J NANOPART RES, V11, P1023, DOI 10.1007/s11051-009-9607-0; Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637; Rikkiev A, 2013, INT J INNOV TECHNOL, V10, DOI 10.1142/S0219877013500090; Roco Mihail C., 2002, NSF DOC SPONSORED RE, pix; Rosenberg N., 2004, SCI TECHNOLOGY WHICH; Rost K, 2011, RES POLICY, V40, P588, DOI 10.1016/j.respol.2010.12.001; Schmoch U, 2008, CONCEPT TECHNOLOGY C; Schoen A., 2012, STI 2012 INT C SCI T, P733; Scott J., 2000, SOCIAL STRUCTURE, V2nd; U.N.I.D. Organization, 2006, ROL MEAS CAL MAN PRO; Veugelers R, 1998, ECONOMIST, V146, P419, DOI 10.1023/A:1003243727470; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WIPO, 1967, IPC CONC TABL 2 SCRE; WIPO, 2012, WORLD INT PROP IND 2; Wise M. N., 1997, VALUES PRECISION; Wissema J.G., 2009, 3 GENERATION U MANAG; Xing W, 2011, TELECOMMUN POLICY, V35, P301, DOI 10.1016/j.telpol.2011.02.003; 서중해, 2010, KDI Journal of Economic Policy, V32, P115	77	7	7	8	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192195	10.1371/journal.pone.0192195	http://dx.doi.org/10.1371/journal.pone.0192195			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420574	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900051
J	Wang, GJ; Cao, XQ; Cai, X; Sun, JZ; Li, XY; Wang, H				Wang, Guangjie; Cao, Xiaoqun; Cai, Xun; Sun, Jingzhe; Li, Xiaoyong; Wang, Heng			A new data assimilation method for high-dimensional models	PLOS ONE			English	Article							VARIATIONAL ASSIMILATION; DUAL NUMBERS; EQUATION; ADJOINT	In the variational data assimilation (VarDA), the typical way for gradient computation is using the adjoint method. However, the adjoint method has many problems, such as low accuracy, difficult implementation and considerable complexity, for high-dimensional models. To overcome these shortcomings, a new data assimilation method based on dual number automatic differentiation (AD) is proposed. The important advantages of the method lies in that the coding of the tangent-linear/adjoint model is no longer necessary and that the value of the cost function and its corresponding gradient vector can be obtained simultaneously through only one forward computation in dual number space. The numerical simulations for data assimilation are implemented for a typical nonlinear advection equation and a parabolic equation. The results demonstrate that the new method can reconstruct the initial conditions of the high-dimensional nonlinear dynamical system conveniently and accurately. Additionally, the estimated initial values can converge to the true values quickly, even if noise is present in the observations.	[Wang, Guangjie; Cao, Xiaoqun; Cai, Xun; Sun, Jingzhe; Li, Xiaoyong; Wang, Heng] Natl Univ Def Technol, Coll Meteorol & Oceanol, Changsha 410073, Hunan, Peoples R China; [Wang, Guangjie; Cao, Xiaoqun; Cai, Xun; Sun, Jingzhe; Li, Xiaoyong; Wang, Heng] Natl Univ Def Technol, Coll Comp, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China	Cao, XQ (corresponding author), Natl Univ Def Technol, Coll Meteorol & Oceanol, Changsha 410073, Hunan, Peoples R China.; Cao, XQ (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha 410073, Hunan, Peoples R China.	caoxiaoqun@nudt.edu.cn	Li, Xiaoyong/E-4274-2019	Li, Xiaoyong/0000-0002-0497-5978	National Natural Science Foundation of China [41475094, 41105063, 61502511]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was jointly supported by grants of National Natural Science Foundation (41475094, and 41105063 to XQC, and 61502511 to XYL) of China.	Brodsky V, 1999, MECH MACH THEORY, V34, P693, DOI 10.1016/S0094-114X(98)00049-4; Can XQ, 2008, ACTA PHYS SIN-CH ED, V57, P1984, DOI 10.7498/aps.57.1984; Cao XQ, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.170504; Cao XQ, 2015, ACTA PHYS SINICA, V64, P8; Cheng Qiang, 2009, Mathematica Numerica Sinica, V31, P15; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Giering R, 1998, ACM T MATH SOFTWARE, V24, P437, DOI 10.1145/293686.293695; Guan Y.H., 2007, METEOROL DISASTER RE, V30, P938; He JH, 2007, COMPUT MATH APPL, V54, P881, DOI 10.1016/j.camwa.2006.12.083; He JH, 2009, PHYS LETT A, V373, P2614, DOI 10.1016/j.physleta.2009.05.039; Isakov V, 2000, INVERSE PROBL, V16, P665, DOI 10.1088/0266-5611/16/3/309; [李宏 LI Hong], 2011, [海洋通报, Marine Science Bulletin], V30, P463; Mahfouf JF, 2000, Q J ROY METEOR SOC, V126, P1171, DOI 10.1256/smsqj.56415; [沈浙奇 Shen Zheqi], 2016, [海洋学报, Acta Oceanologica Sinica], V38, P1; Spall RE, 2012, J FLUIDS ENG, V135, P279; THEPAUT JN, 1991, Q J ROY METEOR SOC, V117, P1225, DOI 10.1002/qj.49711750206; [王剑颖 Wang Jianying], 2010, [宇航学报, Journal of Chinese Society of Astronautics], V31, P1711; Yang XZ, 1999, J CHINA ELECT POWER, V26, P84; Yu WB, 2013, COMPUT PHYS COMMUN, V184, P1446, DOI 10.1016/j.cpc.2012.12.025; Zhang WM, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.249202; Zhou BB, 1995, SCI ATMOSPHERICA SIN, V19, P252; [朱国富 Zhu Guofu], 2015, [气象, Meteorological Monthly], V41, P456	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191714	10.1371/journal.pone.0191714	http://dx.doi.org/10.1371/journal.pone.0191714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420553	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900019
J	Wu, D; Yang, HJ; Zhang, Y; Li, XE; Jia, YR; Wang, CM				Wu, Di; Yang, Hai Jing; Zhang, Yan; Li, Xiu E.; Jia, Yu Rong; Wang, Chun Mei			Prediction of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis	PLOS ONE			English	Article							SELF-EFFICACY; ORAL HYGIENE; DIABETIC-PATIENTS; BEHAVIOR; COMPLIANT; INTERVENTION; DEFINITIONS; DISEASE; COHORT; RISK	Aim This study examined the predictors of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis. Methods A total of 280 patients with moderate to severe chronic periodontitis in a tertiary care hospital in China were investigated and followed over the course of study. Questionnaires on clinical and demographic characteristics, self-efficacy for oral self-care and dental fear at baseline were completed. Participants were followed to determine whether they could adhere to long-term supportive periodontal therapy. Binary logistic regression analysis was used to examine the association between clinical and demographic characteristics, self-efficacy for oral self-care, dental fear and loss to follow-up in long-term supportive periodontal therapy. Results The loss to follow-up in long-term supportive periodontal therapy was significantly associated with age [adjusted OR = 1.042, 95% confidence interval (CI): 1.012-1.074, p = 0.006], severe periodontitis [adjusted OR = 4.892, 95% CI: 2.280-10.499, p<0.001], periodontal surgery [adjusted OR = 11.334, 95% CI: 2.235-57.472, p = 0.003], and middle and low-scoring of self-efficacy scale for self-care groups. The adjusted ORs of loss to follow-up for the middle- (54-59) and low-scoring groups (15-53) were 71.899 (95% CI: 23.926-216.062, p<0.001) and 4.800 (95% CI: 2.263-10.182, p<0.001), respectively, compared with the high-scoring SESS group (60-75). Conclusion Age, severity of periodontitis, periodontal surgery and the level of self-efficacy for self-care may be effective predictors of loss to follow-up in long-term supportive periodontal therapy in patients with chronic periodontitis.	[Wu, Di; Li, Xiu E.] Peking Univ, Sch & Hosp Stomatol, Dept Nursing, Beijing, Peoples R China; [Wu, Di; Li, Xiu E.] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Wu, Di; Li, Xiu E.] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Yang, Hai Jing; Zhang, Yan; Wang, Chun Mei] Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China; [Jia, Yu Rong] Tianjin Med Univ, Sch Stomatol, Dept Periodontol, Tianjin, Peoples R China	Peking University; Tianjin Medical University; Tianjin Medical University	Wang, CM (corresponding author), Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China.	cmwang8543@126.com						ALOGNA M, 1980, DIABETES CARE, V3, P533, DOI 10.2337/diacare.3.4.533; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BADERSTEN A, 1985, J CLIN PERIODONTOL, V12, P351, DOI 10.1111/j.1600-051X.1985.tb00925.x; Bandura A., 1977, SELF EFFICACY UNIFYI, P191; Bao Xuan Zhe, 2008, ANAL INFLUENCING FAC; Barz Daniela Luminita, 2016, Clujul Med, V89, P32, DOI 10.15386/cjmed-530; BASS C C, 1948, New Orleans Med Surg J, V101, P52; Chen X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155592; Chen Xingcan, 2005, SEEKING ROOTS, P63; Delatola C, 2014, J CLIN PERIODONTOL, V41, P791, DOI 10.1111/jcpe.12271; Di Wu, 2015, CHINESE J NURSING, V6, P758; Editorial, 2014, CHINESE GEN PRACTIC, V17, P3033; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; FANG Ji-qian, 2001, CHINA CANC, V10, P9; Fardal Oystein, 2003, Oral Health Prev Dent, V1, P93; Gokulanathan S, 2014, J PHARM BIOALLIED SC, V6, P171, DOI 10.4103/0975-7406.137443; Graetz C, 2013, J CLIN PERIODONTOL, V40, P1087, DOI 10.1111/jcpe.12159; Guttersrud O, 2015, PUBLIC HEALTH NUTR, V18, P2565, DOI 10.1017/S1368980014003152; Kakudate N, 2010, ORAL DIS, V16, P747, DOI 10.1111/j.1601-0825.2010.01703.x; Kakudate N., 2007, J JAPANESE SOC PERIO, V49, P285; Kakudate N, 2008, J PERIODONTOL, V79, P1041, DOI [10.1902/jop.2008.070552, 10.1902/jop.2008.070552 ]; Kerry GJ, 1995, PERIODONTOL 2000, V9, P176, DOI 10.1111/j.1600-0757.1995.tb00064.x; Konig J, 2001, J CLIN PERIODONTOL, V28, P227, DOI 10.1034/j.1600-051x.2001.028003227.x; Li Juchao, 1976, PEOPLES MILITARY SUR, P31; Little SJ, 1997, J PERIODONTAL RES, V32, P315, DOI 10.1111/j.1600-0765.1997.tb00540.x; Ng MCH, 2011, J CLIN PERIODONTOL, V38, P499, DOI 10.1111/j.1600-051X.2011.01708.x; Novaes AB, 1999, J PERIODONTOL, V70, P679, DOI 10.1902/jop.1999.70.6.679; Ojima M, 2001, J CLIN PERIODONTOL, V28, P1091, DOI 10.1034/j.1600-051X.2001.281202.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Qi Xiao Qiu, 2008, 3 NATL ORAL HLTH EPI, P268; Ramseier CA, 2014, J CLIN PERIODONTOL, V41, P473, DOI 10.1111/jcpe.12242; Steeves EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052122; Stewart JE, 1997, COMMUNITY DENT ORAL, V25, P337, DOI 10.1111/j.1600-0528.1997.tb00951.x; Syrjala AMH, 1999, J CLIN PERIODONTOL, V26, P616, DOI 10.1034/j.1600-051X.1999.260909.x; TEDESCO LA, 1992, J PERIODONTOL, V63, P567, DOI 10.1902/jop.1992.63.7.567; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Woelber JP, 2015, J CLIN PERIODONTOL, V42, P142, DOI 10.1111/jcpe.12348; Wolfe GR, 1996, COMMUNITY DENT ORAL, V24, P37, DOI 10.1111/j.1600-0528.1996.tb00810.x; Yang Liping, 2013, STUDIES DESIGNING PH; Zhuo Wang, 2015, Hua Xi Kou Qiang Yi Xue Za Zhi, V33, P178	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192221	10.1371/journal.pone.0192221	http://dx.doi.org/10.1371/journal.pone.0192221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420586	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900055
J	Gladkov, A; Grinchuk, O; Pigareva, Y; Mukhina, I; Kazantsev, V; Pimashkin, A				Gladkov, Arseniy; Grinchuk, Oleg; Pigareva, Yana; Mukhina, Irina; Kazantsev, Victor; Pimashkin, Alexey			Theta rhythm-like bidirectional cycling dynamics of living neuronal networks in vitro	PLOS ONE			English	Article							SYNCHRONIZED BURSTS; GAMMA RHYTHMS; OSCILLATIONS; INHIBITION; PATTERNS; HIPPOCAMPUS; FREQUENCY; CORTEX; PROLIFERATION; MECHANISMS	The phenomena of synchronization, rhythmogenesis and coherence observed in brain networks are believed to be a dynamic substrate for cognitive functions such as learning and memory. However, researchers are still debating whether the rhythmic activity emerges from the network morphology that developed during neurogenesis or as a result of neuronal dynamics achieved under certain conditions. In the present study, we observed self-organized spiking activity that converged to long, complex and rhythmically repeated superbursts in neural networks formed by mature hippocampal cultures with a high cellular density. The superburst lasted for tens of seconds and consisted of hundreds of short (50-100 ms) small bursts with a high spiking rate of 139.0-78.6 Hz that is associated with high-frequency oscillations in the hippocampus. In turn, the bursting frequency represents a theta rhythm (11.2-1.5 Hz). The distribution of spikes within the bursts was non-random, representing a set of well-defined spatio-temporal base patterns or motifs. The long superburst was classified into two types. Each type was associated with a unique direction of spike propagation and, hence, was encoded by a binary sequence with random switching between the two "functional" states. The precisely structured bidirectional rhythmic activity that developed in self-organizing cultured networks was quite similar to the activity observed in the in vivo experiments.	[Gladkov, Arseniy; Pigareva, Yana; Mukhina, Irina; Kazantsev, Victor; Pimashkin, Alexey] Lobachevsky State Univ Nizhni Novgorod, Lab Neuroengn, Ctr Translat Technol, Nizhnii Novgorod, Russia; [Gladkov, Arseniy; Mukhina, Irina] Nizhny Novgorod State Med Acad, Cell Technol Dept, Cent Res Lab, Nizhnii Novgorod, Russia; [Grinchuk, Oleg] Skolkovo Inst Sci & Technol, Informat Sci & Technol Dept, Moscow, Russia	Lobachevsky State University of Nizhni Novgorod; Privolzhsky Research Medical University; Skolkovo Institute of Science & Technology	Pimashkin, A (corresponding author), Lobachevsky State Univ Nizhni Novgorod, Lab Neuroengn, Ctr Translat Technol, Nizhnii Novgorod, Russia.	pimashkin@neuro.nnov.ru	Gladkov, Arseniy A/B-7451-2013; Kazantsev, Victor B/L-1424-2013; Grinchuk, Oleg/AAH-9301-2019; Mukhina, Irina/E-3257-2014; Pigareva, Yana/AAM-7211-2021	Gladkov, Arseniy A/0000-0002-1831-808X; Mukhina, Irina/0000-0002-8811-0049; Pimashkin, Alexey/0000-0001-7024-8827; Kazantsev, Viktor/0000-0002-2881-6648	Russian Science Foundation [16-19-00144]	Russian Science Foundation(Russian Science Foundation (RSF))	This research is supported by the Russian Science Foundation (No 16-19-00144).; This research was supported by the Russian Science Foundation (No 16-19-00144).	Bao WL, 2003, J NEUROPHYSIOL, V90, P333, DOI 10.1152/jn.00715.2002; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Chen X., 2010, J NANOMATER, V2010, P1, DOI DOI 10.1016/J.JALLC0M.2010.06.029.ISSN; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Colombi I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00409; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de Lima AD, 1999, EUR J NEUROSCI, V11, P3845, DOI 10.1046/j.1460-9568.1999.00804.x; Ferrer-Acosta Y, 2017, JOVE-J VIS EXP, DOI 10.3791/55108; Frega M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05489; Gandolfo M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056001; Gladkov AA, 2014, VESTN LOBACHEVSKY ST, V1, P57; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Huang YT, 2012, 8 INT M SUBSTR INT M, P86; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Ide N, 2010, J NEURAL ENG, V7, P1; Idelson MS, 2010, PLOS ONE, V5, P1; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito D, 2010, NEUROSCIENCE, V171, P50, DOI 10.1016/j.neuroscience.2010.08.038; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; Keren H, 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP36837; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kim JH, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/04/P04019; Kiyohara A, 2011, IEEJ T ELECTR ELECTR, V6, P163, DOI 10.1002/tee.20639; Konopacki J, 2000, ACTA NEUROBIOL EXP, V60, P67; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Koryagina EA, 2011, VESTN LOBACHEVSKY U, V2, P254; Kowalczyk T, 2001, BRAIN RES, V901, P184, DOI 10.1016/S0006-8993(01)02355-1; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Krushel LA, 1998, P NATL ACAD SCI USA, V95, P2592, DOI 10.1073/pnas.95.5.2592; le Feber J, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/3/036005; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Leondopulos SS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026015; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maeda E, 1998, EUR J NEUROSCI, V10, P488, DOI 10.1046/j.1460-9568.1998.00062.x; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Mok SY, 2012, NEUROSCIENCE, V206, P17, DOI 10.1016/j.neuroscience.2012.01.009; Nakatsuji Y, 1998, GLIA, V22, P379, DOI 10.1002/(SICI)1098-1136(199804)22:4<379::AID-GLIA7>3.0.CO;2-Z; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Pavlov I, 2014, P NATL ACAD SCI USA, V111, P504, DOI 10.1073/pnas.1308388110; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pimashkin A, 2016, COGN NEURODYNAMICS, V10, P287, DOI 10.1007/s11571-016-9380-6; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Reimer T., 2012, J CHEM CHEM ENG, V6, P1033; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; Shahaf G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000228; Shirokova OM, 2013, SOVREM TEHNOL MED, V5, P6; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Tokuda Minori, 2009, 2009 International Symposium on Micro-NanoMechatronics and Human Science (MHS), P118, DOI 10.1109/MHS.2009.5352068; Tort ABL, 2013, PROG NEUROBIOL, V100, P1, DOI 10.1016/j.pneurobio.2012.09.002; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wagenaar D. A., 2006, PHYS REV, V73, P1; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, THESIS CALIFORNIA I; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zhao X, 2017, NEUROSCIENCE, V362, P1, DOI 10.1016/j.neuroscience.2017.08.027; Zhu G, 2010, BIOMED MICRODEVICES, V12, P153, DOI 10.1007/s10544-009-9370-0	78	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192468	10.1371/journal.pone.0192468	http://dx.doi.org/10.1371/journal.pone.0192468			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415033	Green Submitted, gold, Green Published			2022-12-27	WOS:000424325300079
J	McNerney, MW; Sheng, T; Nechvatal, JM; Lee, AG; Lyons, DM; Soman, S; Liao, CP; O'Hara, R; Hallmayer, J; Taylor, J; Ashford, JW; Yesavage, J; Adamson, MM				McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Lee, Alex G.; Lyons, David M.; Soman, Salil; Liao, Chun-Ping; O'Hara, Ruth; Hallmayer, Joachim; Taylor, Joy; Ashford, J. Wesson; Yesavage, Jerome; Adamson, Maheen M.			Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation	PLOS ONE			English	Article							POPULATION-BASED SURVEY; DNA METHYLATION; PSYCHOMETRIC PROPERTIES; GULF-WAR; DISORDER; VETERANS; BRAIN; PTSD; NEUROENDOCRINE; SEGMENTATION	Many Veterans exposed to physical and psychological trauma experience symptoms of posttraumatic stress disorder (PTSD). As the etiology of PTSD symptoms is complex, a better understanding of the underlying biological mechanisms may improve preventative care and treatment for PTSD. Recent findings from the fields of neuroimaging and epigenetics offer important insights into the potential brain structures and biochemical pathways of modified gene expression associated with PTSD. We combined neuroimaging and epigenetic measures to assess current PTSD symptoms by measuring overall hippocampal volume and methylation of the glucocorticoid receptor (GR) gene (promoter region). Multiple regression analyses indicated that the hippocampal volume/GR methylation interaction was a predictor of PTSD symptoms. Our findings suggest that neuroimaging and epigenetic measures contribute interactively to PTSD symptoms. Incorporation of these metrics may aid in the identification and treatment of PTSD patients.	[McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Lee, Alex G.; Lyons, David M.; O'Hara, Ruth; Hallmayer, Joachim; Taylor, Joy; Ashford, J. Wesson; Yesavage, Jerome; Adamson, Maheen M.] Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [McNerney, M. Windy; Sheng, Tong; Nechvatal, Jordan M.; Taylor, Joy; Ashford, J. Wesson] VA Palo Alto Hlth Care Syst, WRIISC, Palo Alto, CA 94304 USA; [Soman, Salil] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Liao, Chun-Ping; O'Hara, Ruth; Hallmayer, Joachim; Yesavage, Jerome] VA Palo Alto, MIRECC, Palo Alto, CA USA; [Adamson, Maheen M.] VA Palo Alto, DVBIC, Palo Alto, CA USA; [Adamson, Maheen M.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	McNerney, MW (corresponding author), Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; McNerney, MW (corresponding author), VA Palo Alto Hlth Care Syst, WRIISC, Palo Alto, CA 94304 USA.	windymc@stanford.edu	Ashford, J. Wesson/D-3929-2009; Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608; Adamson, Maheen/0000-0002-1534-4063	WRIISC at the VA Palo Alto	WRIISC at the VA Palo Alto	WRIISC at the VA Palo Alto supported this project (www.warrelatedillness.va.gov).	Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Braithwaite EC, 2015, EPIGENETICS-US, V10, P408, DOI 10.1080/15592294.2015.1039221; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Daskalakis NP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00369; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Endler G, 1999, BONE MARROW TRANSPL, V24, P95, DOI 10.1038/sj.bmt.1701815; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hayes JP, 2017, J PSYCHIATR RES, V95, P247, DOI 10.1016/j.jpsychires.2017.09.007; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Lee RS, 2014, NEUROENDOCRINOLOGY, V100, P278, DOI 10.1159/000369585; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Na Kyoung-Sae, 2014, PLoS One, V9, pe85425, DOI 10.1371/journal.pone.0085425; Nelson MD, 2017, CNS SPECTRUMS, V22, P363, DOI 10.1017/S1092852916000833; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Romens Sarah E, 2015, Child Dev, V86, P303, DOI 10.1111/cdev.12270; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Soper DS, 2017, EFFECT SIZE COHENSD; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Terri Tenielian LHJ, 2008, INVISIBLE WOUNDS WAR; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Torrone DZ, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-3; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Veer IM, 2015, PSYCHIAT RES-NEUROIM, V233, P436, DOI 10.1016/j.pscychresns.2015.07.016; Vukojevic V, 2014, J NEUROSCI, V34, P10274, DOI 10.1523/JNEUROSCI.1526-14.2014; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang Q, 2013, NEUROBIOL AGING, V34, P1662, DOI 10.1016/j.neurobiolaging.2012.11.019; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wren ME, 2015, CLIN THER, V37, P529, DOI 10.1016/j.clinthera.2015.02.022; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2015, BIOL PSYCHIAT, V77, P356, DOI 10.1016/j.biopsych.2014.02.006; Yehuda R, 2013, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00118; Yehuda R, 2009, J TRAUMA STRESS, V22, P427, DOI 10.1002/jts.20448; Zovkic Iva B, 2013, Front Psychiatry, V4, P60, DOI 10.3389/fpsyt.2013.00060	59	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192222	10.1371/journal.pone.0192222	http://dx.doi.org/10.1371/journal.pone.0192222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415058	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300060
J	Zardo, P; Barnett, AG; Suzor, N; Cahill, T				Zardo, Pauline; Barnett, Adrian G.; Suzor, Nicolas; Cahill, Tim			Does engagement predict research use? An analysis of The Conversation Annual Survey 2016	PLOS ONE			English	Article							EVIDENCE-BASED POLICY; PUBLIC-HEALTH POLICY; PROGRAM DECISION-MAKING; LOGISTIC-REGRESSION; RESEARCH IMPACT; KNOWLEDGE TRANSLATION; GOVERNMENT AGENCIES; UNIVERSITY-RESEARCH; POPULATION HEALTH; MAKERS	The impact of research on the world beyond academia has increasingly become an area of focus in research performance assessments internationally. Impact assessment is expected to incentivise researchers to increase engagement with industry, government and the public more broadly. Increased engagement is in turn expected to increase translation of research so decision-makers can use research to inform development of policies, programs, practices, processes, products, and other mechanisms, through which impact can be realised. However, research has shown that various factors affect research use, and evidence on 'what works' to increase decision-makers' use of research is limited. The Conversation is an open access research communication platform, published under Creative Commons licence, which translates research into news articles to engage a general audience, aiming to improve understanding of current issues and complex social problems. To identify factors that predict use of academic research and expertise reported in The Conversation, regression analyses were performed using The Conversation Australia 2016 Annual Survey data. A broad range of factors predicted use, with engagement actions being the most common. Interestingly, different types of engagement actions predicted different types of use. This suggests that to achieve impact through increased engagement, a deeper understanding of how and why different engagement actions elicit different types of use is needed. Findings also indicate The Conversation is overcoming some of the most commonly identified barriers to the use of research: access, relevance, actionable outcomes, and timeliness. As such, The Conversation offers an effective model for providing access to and communicating research in a way that enables use, a necessary precursor to achieving research impact.	[Zardo, Pauline; Suzor, Nicolas] Queensland Univ Technol, Fac Law, Brisbane, Qld, Australia; [Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Cahill, Tim] KPMG, Melbourne, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Zardo, P (corresponding author), Queensland Univ Technol, Fac Law, Brisbane, Qld, Australia.	pauline.zardo@gmail.com	Suzor, Nicolas/I-9996-2012	Suzor, Nicolas/0000-0003-3029-0646; Barnett, Adrian/0000-0001-6339-0374; Zardo, Pauline/0000-0002-6027-9010	The Conversation	The Conversation	No funding was received for this conduct of this study. Dr Tim Cahill was employed by The Conversation at the time of the survey development and as his employer The Conversation paid his salary. No salary was provided specifically for the survey development as this was done as part of Dr Cahill's normal duties. Dr Cahill invited Dr Zardo to contribute to the survey design. Dr Zardo contributed to the survey design as outlined in the methods section of the paper and was not paid for this work or any other work on this paper, in either funding or salary from The Conversation. Dr Tim Cahill was employed at KPMG Australia at the time of reviewing the manuscript. This review was done on personal time. KPMG did not provide funding for this project. Neither the Conversation nor KPMG had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Zardo, Associate Professor Barnett and Associate Professor Suzor did not receive any funding nor salary from The Conversation to undertake this project, the study design, data collection and analysis, decision to publish, or preparation of the manuscript was undertaken in their roles as academics at Queensland University of Technology.	Alperin J. P, 2015, PUBLIC IMPACT LATIN; Amara N, 2004, SCI COMMUN, V26, P75, DOI 10.1177/1075547004267491; [Anonymous], 2017, ENG IMP ASS; Armstrong R, 2007, HEALTH PROMOT INT, V22, P254, DOI 10.1093/heapro/dam017; Armstrong R, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-121; Australian Government, 2015, MEAS IMP ENG U RES; Australian Government Innovation and Science Australia, 2016, PERF REV AUSTR INN S; Australian Research Council, 2016, ENG IMP ASS CONS PAP; Bankier J-G, 2016, 100 STORIES IMPACT O; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Brennan SE, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-016-0162-8; Cahill T, 2016, RES ENGAGEMENT AUSTR; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Crowe S, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0643-3; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davies HTO, 2015, NIHR J LIB; Dinsmore A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002003; Dobbins M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-20; ElSabry E, 2017, REV FR SCI INFORM CO; Estabrooks CA, 2003, J ADV NURS, V43, P506, DOI 10.1046/j.1365-2648.2003.02748.x; Felicisimo A, 2013, LANDSLIDES, V10, P175, DOI 10.1007/s10346-012-0320-1; Fixsen DL, 2009, RES SOCIAL WORK PRAC, V19, P531, DOI 10.1177/1049731509335549; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0467-4; Hanney Stephen R, 2003, Health Res Policy Syst, V1, P2, DOI 10.1186/1478-4505-1-2; Haynes AS, 2011, MILBANK Q, V89, P564, DOI 10.1111/j.1468-0009.2011.00643.x; Haynes AS, 2011, SOC SCI MED, V72, P1047, DOI 10.1016/j.socscimed.2011.02.004; Hinrichs-Krapels S, 2016, 2881917 SOC SCI RES; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Ke Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175368; Kingdon JohnW., 2003, AGENDAS ALTERNATIVES; Landry R, 2003, PUBLIC ADMIN REV, V63, P192, DOI 10.1111/1540-6210.00279; Langer L, 2016, EVIDENCE POLICY PRAC; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; Lavis John N, 2006, Healthc Policy, V1, P59; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; Lavis JN, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-53; Lei Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1582-z; Makkar SR, 2016, HLTH RES POLICY SYST, V14; Marmot MG, 2004, BRIT MED J, V328, P906, DOI 10.1136/bmj.328.7445.906; Meagher L, 2008, RES EVALUAT, V17, P163, DOI 10.3152/095820208X331720; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; Moore G, 2011, EVID POLICY, V7, P277, DOI 10.1332/174426411X579199; Morton S, 2015, RES EVALUAT, V24, P405, DOI 10.1093/reseval/rvv016; Newson R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008153; Oborn E, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-104; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Oliver K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-34; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Ouimet M, 2010, EVID POLICY, V6, P433, DOI 10.1332/174426410X535846; Pawson R., 2006, EVIDENCE BASED POLIC, DOI DOI 10.4135/9781849209120; Penfield T, 2014, RES EVALUAT, V23, P21, DOI 10.1093/reseval/rvt021; Perrier L, 2011, IMPLEMENT SCI, V6; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; Powell A, 2017, EVID POLICY, V13, P201, DOI 10.1332/174426416X14534671325644; Powell K, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-98; Priem Piwowar, 2017, PEERJ PREPR; Redman S, 2015, SOC SCI MED, V136, P147, DOI 10.1016/j.socscimed.2015.05.009; Ritter A, 2009, INT J DRUG POLICY, V20, P70, DOI 10.1016/j.drugpo.2007.11.017; Rowley E, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-40; Russell J, 2008, J HEALTH SERV RES PO, V13, P40, DOI 10.1258/jhsrp.2007.006029; Rychetnik L, 2012, J EPIDEMIOL COMMUNIT; Rycroft-Malone J, 2004, J ADV NURS, V47, P81, DOI 10.1111/j.1365-2648.2004.03068.x; Sanderson I, 2002, PUBLIC ADMIN, V80, P1, DOI 10.1111/1467-9299.00292; Sarkies MN, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0662-0; Strassheim H, 2014, EVID POLICY, V10, P259, DOI 10.1332/174426514X13990433991320; Tennant J P, 2016, F1000RESEARCH, V5; The Conversation, 2016, 2016 STAK REP; TRICCO AC, 2016, IMPLEMENT SCI, V11, DOI DOI 10.1186/S13012-016-0370-1; Varda D, 2012, AM J PUBLIC HEALTH, V102, P564, DOI 10.2105/AJPH.2011.300286; Watermeyer R, 2014, STUD HIGH EDUC, V39, P359, DOI 10.1080/03075079.2012.709490; Watt I., 2015, REV RES POLICY FUNDI; Weiss CH, 2005, AM J EVAL, V26, P12, DOI 10.1177/1098214004273337; Weiss CH, 1979, PUBLIC ADM REV, V39; Wilkinson C., 2017, STUD HIGH ED, V44, P72, DOI [10.1080/03075079.2017.1339028, DOI 10.1080/03075079.2017.1339028]; Zardo P, 2015, EVID POLICY, V11, P509, DOI 10.1332/174426414X14170304008766; Zardo P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1581-0	79	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192290	10.1371/journal.pone.0192290	http://dx.doi.org/10.1371/journal.pone.0192290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415047	Green Published, gold			2022-12-27	WOS:000424325300068
J	Georgiadis, K; Wray, S; Ourselin, S; Warren, JD; Modat, M				Georgiadis, Konstantinos; Wray, Selina; Ourselin, Sebastien; Warren, Jason D.; Modat, Marc			Computational modelling of pathogenic protein spread in neurodegenerative diseases	PLOS ONE			English	Article							TAU PROPAGATION; PATHOLOGY; PATTERNS; BETA	Pathogenic protein accumulation and spread are fundamental principles of neurodegenerative diseases and ultimately account for the atrophy patterns that distinguish these diseases clinically. However, the biological mechanisms that link pathogenic proteins to specific neural network damage patterns have not been defined. We developed computational models for mechanisms of pathogenic protein accumulation, spread and toxic effects in an artificial neural network of cortical columns. By varying simulation parameters we assessed the effects of modelled mechanisms on network breakdown patterns. Our findings suggest that patterns of network breakdown and the convergence of patterns follow rules determined by particular protein parameters. These rules can account for empirical data on pathogenic protein spread in neural networks. This work provides a basis for understanding the effects of pathogenic proteins on neural circuits and predicting progression of neurodegeneration.	[Georgiadis, Konstantinos; Ourselin, Sebastien; Modat, Marc] UCL, Dept Med Phys & Biomed Engn, Ctr Med Image Comp, Translat Imaging Grp, London NW1 2HE, England; [Wray, Selina] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Ourselin, Sebastien; Warren, Jason D.; Modat, Marc] UCL, Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Georgiadis, K (corresponding author), UCL, Dept Med Phys & Biomed Engn, Ctr Med Image Comp, Translat Imaging Grp, London NW1 2HE, England.	konstantinos.georgiadis.14@ucl.ac.uk	Wray, Selina/C-3682-2009; Ourselin, Sebastien/K-6960-2015	Wray, Selina/0000-0003-3062-7050; Ourselin, Sebastien/0000-0002-5694-5340; Georgiadis, Konstantinos/0000-0003-4460-9021; Modat, Marc/0000-0002-5277-8530; Warren, Jason/0000-0002-5405-0826	Engineering and Physical Sciences Research Council [EP/L016478/1, EP/J020990/1]; University College London Leonard Wolfson Experimental Neurology Centre [PR/ylr/18575]; National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimer's Research UK Senior Fellowship; NC3R Crack IT grant; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative) [BW.mn.BRC10269]; Wellcome Trust Senior Clinical Fellowship [091673/Z/10/Z]; Alzheimer's Society UK [AS-PG-15-025]; Brain Research Trust; Wolfson Foundation; Alzheimer's Society; UK Medical Research Council; National Institute for Health Research University College London Hospitals Biomedical Research Centre; EPSRC [EP/L016478/1, EP/J020990/1]; UCL Leonard Wolfson Experimental Neurology Centre [PR/ylr/18575]; NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship; Alzheimers Research UK [ARUK-SRF2016B-2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [2038134, 1676031] Funding Source: researchfish; National Centre for the Replacement [NC/C013103/1, NC/C013201/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University College London Leonard Wolfson Experimental Neurology Centre; National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimer's Research UK Senior Fellowship; NC3R Crack IT grant; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative)(General Electric); Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Alzheimer's Society UK; Brain Research Trust; Wolfson Foundation; Alzheimer's Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCL Leonard Wolfson Experimental Neurology Centre; NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement	KG is funded by the Engineering and Physical Sciences Research Council (EP/L016478/1 - http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/L016478/1). KG and MM are supported by the University College London Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575 - http://www.ucl.ac.uk/lwenc). SW is supported by the National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimers Research UK Senior Fellowship and an NC3R Crack IT grant (https://www.nc3rs.org.uk/). SO is funded by the Engineering and Physical Sciences Research Council (EP/J020990/1 - http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/J020990/1) and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative - BW.mn.BRC10269 - http://www.uclhospitals.brc.nihr.ac.uk/). JDW was supported by a Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z - https://wellcome.ac.uk/). MM is also funded by the Alzheimers Society UK (AS-PG-15-025 - https://www.alzheimers.org.uk/). The Dementia Research Centre is supported by the Brain Research Trust (https://brt.org.uk/), the Wolfson Foundation (http://www.wolfson.org.uk/), the Alzheimers Society (https://www.alzheimers.org.uk/) and the UK Medical Research Council (https://www.mrc.ac.uk/). This work was also funded by the Alzheimers Society (https://www.alzheimers.org.uk/) and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre (http://www.uclhospitals.brc.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Samuel A. Neymotin and William W. Lytton for helping with the NEURON network. KG is funded by the EPSRC (EP/L016478/1). KG and MM are supported by the UCL Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575) SW is supported by the NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship and an NC3R Crack IT grant. SO is funded by the EPSRC (EP/J020990/1) and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative- BW.mn.BRC10269). JDW was supported by a Wellcome Trust Senior Clinical Fellowship [091673/Z/10/Z]. MM is also funded by the Alzheimers Society UK (AS-PG-15-025). The Dementia Research Centre is supported by the Brain Research Trust, the Wolfson Foundation, the Alzheimers Society and the UK Medical Research Council. This work was also funded by the Alzheimers Society and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Garden GA, 2012, NEURON, V73, P886, DOI 10.1016/j.neuron.2012.02.017; Goedert M, 2016, BRAIN 2; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kerr CC, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00039; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Proctor CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073631; Raj A, 2015, CELL REP, V10, P359, DOI 10.1016/j.celrep.2014.12.034; Rowan MS, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00039; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Sepulcre J, 2017, JAMA NEUROLOGY; Shepherd G.M., 2003, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	30	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192518	10.1371/journal.pone.0192518	http://dx.doi.org/10.1371/journal.pone.0192518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401516	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400064
J	Liversage, K				Liversage, Kiran			First evidence of biogenic habitat from tubeworms providing a near-absolute habitat requirement for high-intertidal Ulva macroalgae (vol 12, e0176952, 2017)	PLOS ONE			English	Correction																		Liversage K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176952	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192579	10.1371/journal.pone.0192579	http://dx.doi.org/10.1371/journal.pone.0192579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401518	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400066
J	Guo, SX; Huang, CC; Zhao, W; Yang, AC; Lin, CP; Nichols, T; Tsai, SJ				Guo, Shuixia; Huang, Chu-Chung; Zhao, Wei; Yang, Albert C.; Lin, Ching-Po; Nichols, Thomas; Tsai, Shih-Jen			Combining multi-modality data for searching biomarkers in schizophrenia	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CANONICAL CORRELATION-ANALYSIS; STATE FUNCTIONAL CONNECTIVITY; IMAGING BIOMARKERS; STRUCTURAL MRI; SNP DATA; FMRI; FUSION; RISK; EEG	Identification of imaging biomarkers for schizophrenia is an important but still challenging problem. Even though considerable efforts have been made over the past decades, quantitative alterations between patients and healthy subjects have not yet provided a diagnostic measure with sufficient high sensitivity and specificity. One of the most important reasons is the lack of consistent findings, which is in part due to single-mode study, which only detects single dimensional information by each modality, and thus misses the most crucial differences between groups. Here, we hypothesize that multimodal integration of functional MRI (fMRI), structural MRI (sMRI), and diffusion tensor imaging (DTI) might yield more power for the diagnosis of schizophrenia. A novel multivariate data fusion method for combining these modalities is introduced without reducing the dimension or using the priors from 161 schizophrenia patients and 168 matched healthy controls. The multi-index feature for each ROI is constructed and summarized with Wilk's lambda by performing multivariate analysis of variance to calculate the significant difference between different groups. Our results show that, among these modalities, fMRI has the most significant featureby calculating the Jaccard similarity coefficient (0.7416) and Kappa index (0.4833). Furthermore, fusion of these modalities provides the most plentiful information and the highest predictive accuracy of 86.52%. This work indicates that multimodal integration can improve the ability of distinguishing differences between groups and might be assisting in further diagnosis of schizophrenia.	[Guo, Shuixia; Zhao, Wei] Hunan Normal Univ, Coll Math & Comp Sci, Key Lab High Performance Comp & Stochast Informat, Minist Educ China, Changsha, Hunan, Peoples R China; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan; [Yang, Albert C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA USA; [Yang, Albert C.; Lin, Ching-Po; Tsai, Shih-Jen] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan; [Nichols, Thomas] Univ Warwick, Dept Stat, Coventry, W Midlands, England	Hunan Normal University; Ministry of Education, China; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Warwick	Guo, SX (corresponding author), Hunan Normal Univ, Coll Math & Comp Sci, Key Lab High Performance Comp & Stochast Informat, Minist Educ China, Changsha, Hunan, Peoples R China.; Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan.	guoshuixia75@163.com; tsai610913@gmail.com	Nichols, Thomas E./N-9902-2017; Tsai, Shih-Jen/AAK-7944-2020	Nichols, Thomas E./0000-0002-4516-5103; Tsai, Shih-Jen/0000-0002-9987-022X; Huang, Chu-Chung/0000-0002-9096-9610	National Natural Science Foundation of China (NSFC) [11671129]; Natural Science Foundation of Hunan Province [2015JJ1010]; Ministry of Science and Technology [104-2218-E-010-007-MY3, MOST 105-B-2633-400-001, MOST 106-2321-B-010-011]; National Health Research Institutes [NHRI-EX106-10611EI]; Taipei Veterans General Hospital, Taiwan [VGHUST102-G1-2-1, VGHUST103-G1- 4-1]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	SXG is supported by the National Natural Science Foundation of China (NSFC) grant (No. 11671129), Natural Science Foundation of Hunan Province (2015JJ1010). CPL is supported in part by funding from Ministry of Science and Technology (104-2218-E-010-007-MY3, MOST 105-B-2633-400-001, and MOST 106-2321-B-010-011) and National Health Research Institutes (zNHRI-EX106-10611EI), and Taipei Veterans General Hospital, Taiwan (grants VGHUST102-G1-2-1, and VGHUST103-G1- 4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Babiloni F, 2004, MAGN RESON IMAGING, V22, P1471, DOI 10.1016/j.mri.2004.10.007; Bartlett MS, 1938, P CAMB PHILOS SOC, V34, P33, DOI 10.1017/S0305004100019897; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cao HB, 2014, NEUROIMAGE, V102, P220, DOI 10.1016/j.neuroimage.2014.01.021; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cook RJ, 1998, ENCY BIOSTATISTICS; Correa NM, 2010, IEEE SIGNAL PROC MAG, V27, P39, DOI 10.1109/MSP.2010.936725; Correa NM, 2010, NEUROIMAGE, V50, P1438, DOI 10.1016/j.neuroimage.2010.01.062; Correa NM, 2009, INT CONF ACOUST SPEE, P385, DOI 10.1109/ICASSP.2009.4959601; Cox DR., 1989, ANAL BINARY DATA; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; Fodor IK, 2002, SURVEY DIMENSION RED, DOI [10.2172/15002155, DOI 10.2172/15002155]; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Guo S, 2016, PSYCHOL MED, V46, P2201, DOI 10.1017/S0033291716000994; Guo SX, 2014, SCHIZOPHRENIA BULL, V40, P449, DOI 10.1093/schbul/sbt163; Guo SX, 2014, HUM BRAIN MAPP, V35, P123, DOI 10.1002/hbm.22162; Guo SX, 2015, BRIT J PSYCHIAT, P1, DOI [10.1192, DOI 10.1192]; GUPTA T, 1990, INT J PROD RES, V28, P1247, DOI 10.1080/00207549008942791; Hamid JS, 2009, HUMAN GENOMICS PROTE, V1; Hamshere ML, 2012, MOL PSYCHIAT; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hasnain MK, 2001, CEREB CORTEX, V11, P702, DOI 10.1093/cercor/11.8.702; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Hu WX, 2016, IEEE ENG MED BIO, P3310, DOI 10.1109/EMBC.2016.7591436; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Karageorgiou E, 2011, NEUROINFORMATICS, V9, P321, DOI 10.1007/s12021-010-9094-6; Kim DI, 2010, NEUROINFORMATICS, V8, P213, DOI 10.1007/s12021-010-9077-7; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Lin D, 2014, MED IMAGE ANAL, V18, P891, DOI 10.1016/j.media.2013.10.010; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; McCarley RW, 2008, CLIN EEG NEUROSCI, V39, P57, DOI 10.1177/155005940803900206; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; Michael AM, 2010, NEUROIMAGE, V49, P2626, DOI 10.1016/j.neuroimage.2009.08.056; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Oertel-Knochel V, 2012, CURR TOP MED CHEM, V12, P2434, DOI 10.2174/156802612805289926; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pettersson-Yeo W, 2013, PSYCHOL MED, V43, P2547, DOI 10.1017/S003329171300024X; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pu WD, 2014, NEUROIMAGE-CLIN, V6, P463, DOI 10.1016/j.nicl.2014.10.004; Ramnani Narender, 2002, Trends in Neurosciences, V25, P496, DOI 10.1016/S0166-2236(02)02227-0; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Sui J, 2014, IEEE ENG MED BIO, P3889, DOI 10.1109/EMBC.2014.6944473; Sui J, 2012, J NEUROSCI METH, V204, P68, DOI 10.1016/j.jneumeth.2011.10.031; Sui J, 2011, NEUROIMAGE, V57, P839, DOI 10.1016/j.neuroimage.2011.05.055; Sui J, 2009, HUM BRAIN MAPP, V30, P2953, DOI 10.1002/hbm.20721; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Tregellas JR, 2014, AM J PSYCHIAT, V171, P549, DOI 10.1176/appi.ajp.2013.13070981; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wagner M, 2001, INT J BIOELECTROMAG, V3; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	69	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191202	10.1371/journal.pone.0191202	http://dx.doi.org/10.1371/journal.pone.0191202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389986	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400013
J	Menon, M; Coghill, A; Mutyaba, I; Okuku, F; Phipps, W; Harlan, J; Orem, J; Casper, C				Menon, Manoj; Coghill, Anna; Mutyaba, Innocent; Okuku, Fred; Phipps, Warren; Harlan, John; Orem, Jackson; Casper, Corey			Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CLINICAL-PRACTICE GUIDELINE; COLONY-STIMULATING FACTOR; SUB-SAHARAN AFRICA; ELDERLY-PATIENTS; FEBRILE NEUTROPENIA; CHOP CHEMOTHERAPY; 2010 UPDATE; MORTALITY; SURVIVAL	Introduction Cancer treatment options in sub-Saharan Africa are scarce despite an increasing burden of disease. Identification of those cancer patients who would benefit most from the limited resources available would allow broader and more effective therapy. Methods We conducted a retrospective analysis of patients over the age of 18 at the time of a pathologic diagnosis of NHL between 2003 and 2010 who were residents of Kyandondo County (Uganda) and presented to the Uganda Cancer Institute for care. Results A total of 128 patients were included in this analysis. Chemotherapy was recommended to 117 (91.4%) of the patients; the odds of recommending chemotherapy decreased for each additional month of reported symptoms prior to diagnosis. Of the 117 patients to whom chemotherapy was recommended, 111 (86.7%) patients received at least 1 cycle of chemotherapy; HIV infected patients, as well as those with a lower hemoglobin and advanced disease at the time of diagnosis were significantly less likely to complete therapy. Among the patients who initiated chemotherapy, twenty patients died prior to treatment completion (including nine who died within 30 days). Hemoglobin level at the time of presentation was the only variable associated with early mortality in the adjusted model. Conclusion In resource-poor areas, it is essential to align health care expenditures with interventions likely to provide benefit to affected populations. Targeting cancer therapy to those with a favorable chance of responding will not only save limited resources, but will also prevent harm in those patients unlikely to realize an effect of cancer-directed therapy.	[Menon, Manoj; Coghill, Anna; Phipps, Warren; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Menon, Manoj; Phipps, Warren; Harlan, John; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mutyaba, Innocent; Okuku, Fred; Orem, Jackson] Uganda Canc Inst, Kampala, Uganda; [Mutyaba, Innocent; Okuku, Fred; Phipps, Warren; Orem, Jackson] Hutchinson Ctr Res Inst, Kampala, Uganda; [Casper, Corey] Infect Dis Res Inst, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Menon, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Menon, M (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mmenon@fhcrc.org			AIDS Malignancy Consortium [5 K12 HL 087165, UM1 CA121947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	AIDS Malignancy Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for MPM was provided, in part, via a Career Development in Clinical Hematology award (5 K12 HL 087165) and a fellowship from the AIDS Malignancy Consortium (UM1 CA121947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Bairey O, 2006, ANN ONCOL, V17, P928, DOI 10.1093/annonc/mdl034; Bateganya MH, 2011, JAIDS-J ACQ IMM DEF, V56, P312, DOI 10.1097/QAI.0b013e31820c011a; Bates I, 2008, BJOG-INT J OBSTET GY, V115, P1331, DOI 10.1111/j.1471-0528.2008.01866.x; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Coghill AE, 2013, AIDS, V27, P2933, DOI 10.1097/01.aids.0000433236.55937.cb; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cuttner J, 2002, LEUKEMIA RES, V26, P447, DOI 10.1016/S0145-2126(01)00163-1; Ethier M-C, 2011, LACK CLARITY DEFINIT, P5080; Ferlay J, 2013, IARC CANCERBASE; Field SP, 2007, J CLIN PATHOL, V60, P1073, DOI 10.1136/jcp.2006.043505; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Garcia M, 2007, GLOBAL CANC FACTS FI; Gomez H, 1998, J CLIN ONCOL, V16, P2065, DOI 10.1200/JCO.1998.16.6.2065; Gregory SA, 2005, ANN ONCOL, V16, P1413, DOI 10.1093/annonc/mdi264; Hauser CA, 2006, SUPPORT CARE CANCER, V14, P999, DOI 10.1007/s00520-006-0079-9; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; MALTONI M, 1995, CANCER-AM CANCER SOC, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; Mutyaba IOJ, 2013, J CLIN ONCOL; NCCN. National Comprehensive Cancer Network, MYEL GROWTH FACT; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Orem Jackson, 2012, Clin Epidemiol, V4, P339, DOI 10.2147/CLEP.S35671; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Prigerson HG, 2015, JAMA ONCOLOGY; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191967	10.1371/journal.pone.0191967	http://dx.doi.org/10.1371/journal.pone.0191967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389998	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400045
J	Kauhl, B; Maier, W; Schweikart, J; Keste, A; Moskwyn, M				Kauhl, Boris; Maier, Werner; Schweikart, Juergen; Keste, Andrea; Moskwyn, Marita			Who is where at risk for Chronic Obstructive Pulmonary Disease? A spatial epidemiological analysis of health insurance claims for COPD in Northeastern Germany	PLOS ONE			English	Article							REGIONAL DEPRIVATION; AIR-POLLUTION; SOCIOECONOMIC-STATUS; GENERAL-PRACTICE; UNITED-STATES; PREVALENCE; MORTALITY; INDEX; INEQUALITIES; DISPARITIES	Background Chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Germany and a further increase is expected within the next years. Although risk factors on an individual level are widely understood, only little is known about the spatial heterogeneity and population-based risk factors of COPD. Background knowledge about broader, population-based processes could help to plan the future provision of healthcare and prevention strategies more aligned to the expected demand. The aim of this study is to analyze how the prevalence of COPD varies across northeastern Germany on the smallest spatial-scale possible and to identify the location-specific population-based risk factors using health insurance claims of the AOK Nordost. Methods To visualize the spatial distribution of COPD prevalence at the level of municipalities and urban districts, we used the conditional autoregressive Besag-York-Mollie A (BYM) model. Geographically weighted regression modelling (GWR) was applied to analyze the location-specific ecological risk factors for COPD. Results The sex-and age-adjusted prevalence of COPD was 6.5% in 2012 and varied widely across northeastern Germany. Population-based risk factors consist of the proportions of insurants aged 65 and older, insurants with migration background, household size and area deprivation. The results of the GWR model revealed that the population at risk for COPD varies considerably across northeastern Germany. Conclusion Area deprivation has a direct and an indirect influence on the prevalence of COPD. Persons ageing in socially disadvantaged areas have a higher chance of developing COPD, even when they are not necessarily directly affected by deprivation on an individual level. This underlines the importance of considering the impact of area deprivation on health for planning of healthcare. Additionally, our results reveal that in some parts of the study area, insurants with migration background and persons living in multi-persons households are at elevated risk of COPD.	[Kauhl, Boris; Keste, Andrea; Moskwyn, Marita] AOK Nordost Die Gesundheitskasse, Dept Med Care, Berlin, Germany; [Kauhl, Boris; Schweikart, Juergen] Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany; [Maier, Werner] German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Helmholtz Zentrum Munchen, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kauhl, B (corresponding author), AOK Nordost Die Gesundheitskasse, Dept Med Care, Berlin, Germany.; Kauhl, B (corresponding author), Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany.	boris.kauhl@nordost.aok.de			AOK Nordost - Die Gesundheitskasse	AOK Nordost - Die Gesundheitskasse	The funder, AOK Nordost - Die Gesundheitskasse (www.nordost.aok.de), provided support in the form of salaries for authors BK, AK and MM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2009, ATMOS ENVIRON, V43, P1650, DOI 10.1016/j.atmosenv.2008.12.009; ANSELIN L., 2017, PACKAGE SPDEP; Aumann I, 2013, KLINIKARZT, V42, P168; Bevolkerungsforschung Bf, 2016, DURCHSCHN HAUSH MEHR; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098170; Crighton EJ, 2015, HEALTH REP, V26, P10; Crighton EJ, 2012, CAN J PUBLIC HEALTH, V103, pE384, DOI 10.1007/BF03404447; Croft JB, 2016, CHEST, V150, P544, DOI 10.1016/j.chest.2016.05.014; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Ford MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146085; Gebreab SY, 2012, HEALTH PLACE, V18, P1006, DOI 10.1016/j.healthplace.2012.06.006; Geldmacher H, 2008, DEUT MED WOCHENSCHR, V133, P2609, DOI 10.1055/s-0028-1105858; Geodasie BfKu, VERW EINW; Gesundheit Bf, 2012, JAHR 2012; Gingter C, 2009, FAM PRACT, V26, P3, DOI 10.1093/fampra/cmn084; Glaab T, 2006, DEUT MED WOCHENSCHR, V131, P1203, DOI 10.1055/s-2006-941752; Gollini I., 2013, ARXIV PREPRINT ARXIV; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Heart L National, 1998, GLOB STRAT DIAGN MAN; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Hofmeister C, 2016, GESUNDHEITSWESEN, V78, P42, DOI 10.1055/s-0034-1390421; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Kanervisto M, 2011, RESP MED, V105, P1140, DOI 10.1016/j.rmed.2011.03.008; Kauhl B, 2017, BMC PUBLIC IN PRESS; Kauhl B, 2017, GESUNDHEITSWESEN; Kauhl B, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0068-2; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; KBV, 2013, NEUE BED; Kitaguchi Y, 2006, RESP MED, V100, P1742, DOI 10.1016/j.rmed.2006.02.003; Krankenkasseninfo, MITGL VERS JE KRANK; Kroll LE, 2012, BUNDESGESUNDHEITSBLA, V55, P129, DOI 10.1007/s00103-011-1403-1; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lampert T, 2010, BUNDESGESUNDHEITSBLA, V53, P108, DOI 10.1007/s00103-009-1014-2; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lawson AB., 2013, BAYESIAN DISEASE MAP; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; LINDGREN A, 2009, INT J HEALTH GEOGR, V8; Lipton Robert, 2007, Int J Med Sci, V4, P179; Lipton Robert, 2005, COPD, V2, P435, DOI 10.1080/15412550500346543; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lu B, 2014, GEO-SPAT INF SCI, V17, P85, DOI 10.1080/10095020.2014.917453; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Miravitlles M, 2009, THORAX; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Nacul L, 2011, J PUBLIC HEALTH-UK, V33, P108, DOI 10.1093/pubmed/fdq031; Ocana-Riola R, 2008, J EPIDEMIOL COMMUN H, V62, P147, DOI 10.1136/jech.2006.053280; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Ozegowski S, 2012, GESUNDHEITSWESEN, V74, P618, DOI 10.1055/s-0032-1321748; Pampalon R, 2009, CHRONIC DIS CAN, V29, P178; Pritzkuleit R, 2010, Pneumologie, V64, P535, DOI 10.1055/s-0030-1255637; Pujades-Rodriguez M, 2009, OCCUP ENVIRON MED, V66, P679, DOI 10.1136/oem.2008.043885; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schafer T, 2013, OSTEOARTHR CARTILAGE, V21, P279, DOI 10.1016/j.joca.2012.11.006; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schnee M, 2008, GESUNDHEITSMONITOR, P88; Schulz M, ZUSAMMENHANG ZWISCHE; Schulze A, 2006, BUNDES GESUNDHEITSSU; Siordia Carlos, 2012, Human Geogr, V6, P5, DOI 10.5719/hgeo.2012.62.5; Skapinakis P, 2005, BRIT J PSYCHIAT, V186, P417, DOI 10.1192/bjp.186.5.417; Song QK, 2014, INT J ENV RES PUB HE, V11, P11822, DOI 10.3390/ijerph111111822; Tanser F., 2009, INT J EPIDEMIOL; Volzke H, 2006, RAUCHEN REGIONALE UN; Welte T, 2000, EUR RESP J S31, V16, P111; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]; Wheeler D. C., 2013, HDB REGIONAL SCI, P1435, DOI 10.1007/978-3-642-23430-9_77; Ziegler U, 2009, GESUNDHEITSWESEN, V71, P281, DOI 10.1055/s-0028-1119384	75	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190865	10.1371/journal.pone.0190865	http://dx.doi.org/10.1371/journal.pone.0190865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414997	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300011
J	Moller, P; Liu, XC; Schuster, S; Boley, D				Moeller, Philip; Liu, Xiaochen; Schuster, Stefan; Boley, Daniel			Linear programming model can explain respiration of fermentation products	PLOS ONE			English	Article							ESCHERICHIA-COLI; HUMAN BRAIN; METABOLISM; GLUCOSE; GLYCOLYSIS; EVOLUTION; PATHWAYS; LACTATE; GROWTH	Many differentiated cells rely primarily on mitochondrial oxidative phosphorylation for generating energy in the form of ATP needed for cellular metabolism. In contrast most tumor cells instead rely on aerobic glycolysis leading to lactate to about the same extent as on respiration. Warburg found that cancer cells to support oxidative phosphorylation, tend to ferment glucose or other energy source into lactate even in the presence of sufficient oxygen, which is an inefficient way to generate ATP. This effect also occurs in striated muscle cells, activated lymphocytes and microglia, endothelial cells and several mammalian cell types, a phenomenon termed the "Warburg effect". The effect is paradoxical at first glance because the ATP production rate of aerobic glycolysis is much slower than that of respiration and the energy demands are better to be met by pure oxidative phosphorylation. We tackle this question by building a minimal model including three combined reactions. The new aspect in extension to earlier models is that we take into account the possible uptake and oxidation of the fermentation products. We examine the case where the cell can allocate protein on several enzymes in a varying distribution and model this by a linear programming problem in which the objective is to maximize the ATP production rate under different combinations of constraints on enzymes. Depending on the cost of reactions and limitation of the substrates, this leads to pure respiration, pure fermentation, and a mixture of respiration and fermentation. The model predicts that fermentation products are only oxidized when glucose is scarce or its uptake is severely limited.	[Moeller, Philip; Schuster, Stefan] Friedrich Schiller Univ, Dept Bioinformat, Jena, Germany; [Liu, Xiaochen; Boley, Daniel] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Liu, Xiaochen] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Friedrich Schiller University of Jena; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Boley, D (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	boley@umn.edu		Boley, Daniel/0000-0002-2685-8449	U.S. National Science Foundation [1319749]; Deutsche Forschungsgemeinschaft [RTG 1715]; University of Jena fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Jena fellowship	This work was supported by grant 1319749 from the U.S. National Science Foundation to D.B., by the Deutsche Forschungsgemeinschaft (RTG 1715) to P.M. and S.S. and by a University of Jena fellowship to P.M. No other external funding was received for this study. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of any funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedpour N, 1988, AM J PHYSIOL, V254, pe555; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BERTSIMAS D, 1997, ATHENA SCIENTIFIC; Bertsimas D, 1997, SD, DOI DOI 10.1073/PNAS.0609845104; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Figley CR, 2011, J NEUROSCI, V31, P4768, DOI 10.1523/JNEUROSCI.6612-10.2011; HEINRICH R, 1987, B MATH BIOL, V49, P539, DOI 10.1016/S0092-8240(87)90003-6; HTTPS, 1973, FA, P45104, DOI DOI 10.1073/PNAS.0609845104; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; KLAMT S, 2017, PLOS COMPUT BIOL, DOI DOI 10.1371/J0URNAL.PCBI.1005409; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MUELLER S, 2014, JOURNAL OF THEORETIC, P95962, DOI DOI 10.1016/J.JTBI.2013.11.015; NOOR E, 2016, PLOS COMPUT BIOL, DOI DOI 10.1371/J0URNAL.PCBI.1005167; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; RICHTER EA, 1988, AM J PHYSIOL, V254, pE555, DOI 10.1152/ajpendo.1988.254.5.E555; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Sajitz-Hermstein M, 2010, BIOINFORMATICS, V26, pi582, DOI 10.1093/bioinformatics/btq390; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Schuster S., 2015, PEERJ PREPRINTS, V3, pE1609; Schuster S, 2015, BIOCHEM SOC T, V43, P1187, DOI 10.1042/BST20150153; Schuster S, 2011, BIOSYSTEMS, V105, P147, DOI 10.1016/j.biosystems.2011.05.007; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Tournier L, 2017, J MATH BIOL, V75, P1349, DOI 10.1007/s00285-017-1118-5; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; WALEY SG, 1964, BIOCHEM J, V91, P514, DOI 10.1042/bj0910514; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wortel MT, 2014, FEBS J, V281, P1547, DOI 10.1111/febs.12722	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191803	10.1371/journal.pone.0191803	http://dx.doi.org/10.1371/journal.pone.0191803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415045	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300042
J	Saavedra-Avendano, B; Schiavon, R; Sanhueza, P; Rios-Polanco, R; Garcia-Martinez, L; Darney, BG				Saavedra-Avendano, Biani; Schiavon, Raffaela; Sanhueza, Patricio; Rios-Polanco, Ranulfo; Garcia-Martinez, Laura; Darney, Blair G.			Who presents past the gestational age limit for first trimester abortion in the public sector in Mexico City?	PLOS ONE			English	Article							WOMEN; PREGNANCY; CARE; TERMINATION; SERVICES; REASONS; DELAYS	Objective To identify socio-demographic factors associated with presenting for abortion services past the gestational age (GA) limit (12 weeks), and thus not receiving services, in Mexico City's public sector first trimester abortion program. Methods We used clinical data from four high volume sites in the Interrupcion Legal de Embarazo (ILE) program, 2007-2015. We used descriptive statistics to quantify the proportion of women who did not receive an abortion due to presenting past the gestational age limit. We used multivariable logistic regression to identify associations between women's characteristics and presenting past the GA limit and calculated predicted probabilities of late presentation for key characteristics. Results Our sample included 52,391 women, 8.10% (n = 4,246) of whom did not receive abortion services due to presenting past the GA limit. Adolescents (12-17) made up 8.69% of the total sample and 13.40% of those presenting past the GA limit (p<0.05). In multivariable analyses, all age groups of adult women had significantly lower odds than adolescents of presenting past the limit (aOR = 0.77, aOR = 0.63, aOR = 0.58 and aOR = 0.37 for 19-24, 25-29, 30-39, and > = 40 years' old respectively). Women living in Mexico City and with higher levels of education had lower odds of presenting past the GA limit, and there was an educational gradient across all age groups. In the multivariable predicted probability models, adolescents at every level of education have significantly higher probabilities of not receiving an abortion due to presenting past the gestational age limit compared with adults (among women with a primary education: 11.75% adolescents vs. 9.02-4.26% across adult age groups). Conclusions Our results suggest that continued efforts are needed to educate women, especially younger and less educated women, about early pregnancy recognition. In addition, all women need information about the availability of first trimester legal abortion to ensure timely access to abortion services.	[Saavedra-Avendano, Biani; Darney, Blair G.] Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Schiavon, Raffaela] Int Pregnancy Advisory Serv Ipas Mexico, Mexico City, DF, Mexico; [Sanhueza, Patricio; Rios-Polanco, Ranulfo; Garcia-Martinez, Laura] Secretaria Salud Ciudad Mexico, Mexico City, DF, Mexico; [Saavedra-Avendano, Biani] Ctr Invest & Docencia Econ AC, Dept Publ Adm, Mexico City, DF, Mexico; [Darney, Blair G.] Oregon Hlth & Sci Univ, Dept Obstet & Gynaecol, Portland, OR 97201 USA	Instituto Nacional de Salud Publica; Centro de Investigacion y Docencia Economicas A.C. (CIDE); Oregon Health & Science University	Darney, BG (corresponding author), Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico.; Darney, BG (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynaecol, Portland, OR 97201 USA.	bgdarney@gmail.com	Schiavon, Raffaela/AAP-4303-2020	Schiavon, Raffaela/0000-0002-6917-0986; Darney, Blair/0000-0001-8120-028X; Saavedra-Avendano, Biani/0000-0002-2080-4458	Society of Family Planning Research Fund Jr. Investigator Award [SFPRF9-JI2]; Agency for Healthcare Research and Quality [K12HS022981]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022981] Funding Source: NIH RePORTER	Society of Family Planning Research Fund Jr. Investigator Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study is supported by a Society of Family Planning Research Fund Jr. Investigator Award (SFPRF9-JI2; Darney, PI), http://www.societyfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Darney is partially supported by grant number K12HS022981 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.	Aggarwal P, 2013, ANN MED HEALTH SCI R, V3, P187, DOI 10.4103/2141-9248.113659; [Anonymous], 2002, CODIGO PENAL DISTRIT; Assifi AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152224; Baum S, 2015, INT J GYNECOL OBSTET, V131, P285, DOI 10.1016/j.ijgo.2015.06.036; Becker D, 2002, INT FAM PLAN PERSPEC, V28, P205, DOI 10.2307/3088223; Becker D, 2011, WOMEN HEALTH ISS, V21, pS16, DOI 10.1016/j.whi.2011.02.009; Branum AM, 2016, MATERN CHILD HLTH J; Consejo Nacional de Poblacion, AN C MET EST IND MAR; Drey EA, 2006, OBSTET GYNECOL, V107, P128, DOI 10.1097/01.AOG.0000189095.32382.d0; Finer LB, 2006, CONTRACEPTION, V74, P334, DOI 10.1016/j.contraception.2006.04.010; Foster DG, 2008, CONTRACEPTION, V77, P289, DOI 10.1016/j.contraception.2007.10.010; Grimes DA, LANCET, V368, P1908; Guttmacher Institute, 2013, MAK AB SERV ACC WAK; Hajri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145338; Harries Jane, 2007, Reprod Health, V4, P7, DOI 10.1186/1742-4755-4-7; Harries J, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0014-y; Heredia-Pi I, 2013, SALUD PUBLICA MEXICO, V55, pS249; Hossain A, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0199-8; Ingham R, 2008, REPROD HEALTH MATTER, V16, P18, DOI 10.1016/S0968-8080(08)31375-5; Jones RK, 2013, J WOMENS HEALTH, V22, P706, DOI 10.1089/jwh.2013.4283; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kalb MMY, 2011, STUD FAMILY PLANN, V42, P159, DOI 10.1111/j.1728-4465.2011.00277.x; Mundo-Rosas V, 2014, SALUD PUBLICA MEXICO, V56, pS12; Puri M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0241-y; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Saavedra-Avendano B, 2016, SALUD PUBLICA MEXICO, V58; Secretaria de Salud de la Ciudad de Mexcio, INT LEG EMB MEX CIT; Silva M, 2008, AUST NZ J PUBL HEAL, V32, P519, DOI 10.1111/j.1753-6405.2008.00302.x; Sowmini CV, 2013, REPROD HEALTH MATTER, V21, P243, DOI 10.1016/S0968-8080(13)41700-7; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Upadhyay UD, 2014, AM J PUBLIC HEALTH, V104, P1687, DOI 10.2105/AJPH.2013.301378; Zyzanski SJ, 2004, ANN FAM MED, V2, P199, DOI 10.1370/afm.197	32	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192547	10.1371/journal.pone.0192547	http://dx.doi.org/10.1371/journal.pone.0192547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414987	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300085
J	Molino, JVD; de Carvalho, JCM; Mayfield, SP				Dutra Molino, Joao Vitor; Monteiro de Carvalho, Joao Carlos; Mayfield, Stephen Patrick			Comparison of secretory signal peptides for heterologous protein expression in microalgae: Expanding the secretion portfolio for Chlamydomonas reinhardtii	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; RECOMBINANT PROTEIN; GREEN-ALGA; NUCLEAR TRANSGENES; BINDING-PROTEIN; REPORTER GENE; LUCIFERASE; MUTATIONS; PROMOTER; OPTIMIZATION	Efficient protein secretion is a desirable trait for any recombinant protein expression system, together with simple, low-cost, and defined media, such as the typical media used for photosynthetic cultures of microalgae. However, low titers of secreted heterologous proteins are usually obtained, even with the most extensively studied microalga Chlamydomonas reinhardtii, preventing their industrial application. In this study, we aimed to expand and evaluate secretory signal peptides (SP) for heterologous protein secretion in C. reinhardtii by comparing previously described SP with untested sequences. We compared the SPs from arylsulfatase 1 and carbonic anhydrase 1, with those of untried SPs from binding protein 1, an ice binding protein, and six sequences identified in silico. We identified over 2000 unique SPs using the SignalP 4.0 software. mCherry fluorescence was used to compare the protein secretion of up to 96 colonies for each construct, non-secretion construct, and parental wild type cc1690 cells. Supernatant fluorescence varied according to the SP used, with a 10-fold difference observed between the highest and lowest secretors. Moreover, two SPs identified in silico secreted the highest amount of mCherry. Our results demonstrate that the SP should be carefully selected and that efficient sequences can be coded in the C. reinhardtii genome. The SPs described here expand the portfolio available for research on heterologous protein secretion and for biomanufacturing applications.	[Dutra Molino, Joao Vitor; Monteiro de Carvalho, Joao Carlos] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, SP, Brazil; [Mayfield, Stephen Patrick] Univ Calif San Diego, Calif Ctr Algae Biotechnol, Div Biol Sci, San Diego, CA 92103 USA	Universidade de Sao Paulo; University of California System; University of California San Diego	Molino, JVD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, SP, Brazil.; Mayfield, SP (corresponding author), Univ Calif San Diego, Calif Ctr Algae Biotechnol, Div Biol Sci, San Diego, CA 92103 USA.	molino@usp.br; smayfield@ucsd.edu	Molino, Joao Vitor/E-7516-2017	Molino, Joao Vitor/0000-0003-2475-9807	US Department of Energy Algae PEAK award [EE0008246]; Sao Paulo Research Foundation (FAPESP) [2013/18224-2]; FAPESP	US Department of Energy Algae PEAK award; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by funding from the US Department of Energy Algae PEAK award EE0008246 (https://energy.gov/) (SM) and the Sao Paulo Research Foundation (FAPESP) grant 2013/18224-2 (http://www.fapesp.bren/) (JVDM). JVDM was funded by the PhD grant from FAPESP. The funding source was not involved in study design, data collection, analysis and interpretation of data, in the writing of the report, nor in the decision to submit the article for publication.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Baba M, 2011, PLANT CELL PHYSIOL, V52, P1302, DOI 10.1093/pcp/pcr078; Baur A, 2005, PLANT BIOTECHNOL J, V3, P331, DOI 10.1111/j.1467-7652.2005.00127.x; Borowitzka MA, 2013, J APPL PHYCOL, V25, P743, DOI 10.1007/s10811-013-9983-9; Diaz-Santos E, 2016, J APPL PHYCOL, V28, P1611, DOI 10.1007/s10811-015-0706-2; Doron L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00505; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; Enzing C, 2014, MICROALGAE BASED PRO, DOI DOI 10.2791/3339; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harmsen MM, 1996, APPL MICROBIOL BIOT, V46, P365, DOI 10.1007/s002530050831; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hempel F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-126; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Kang Z, 2016, APPL MICROBIOL BIOT, V100, P707, DOI 10.1007/s00253-015-7056-5; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Klatt S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-97; Klutz S, 2016, CHEM ENG SCI, V141, P63, DOI 10.1016/j.ces.2015.10.029; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; Kong F, 2015, J BIOSCI BIOENG, V120, P239, DOI 10.1016/j.jbiosc.2015.01.005; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lauersen KJ, 2015, J BIOTECHNOL, V215, P62, DOI 10.1016/j.jbiotec.2015.05.001; Lauersen KJ, 2015, APPL MICROBIOL BIOT, V99, P3491, DOI 10.1007/s00253-014-6354-7; Lauersen KJ, 2013, APPL MICROBIOL BIOT, V97, P9763, DOI 10.1007/s00253-013-5226-x; Lauersen KJ, 2013, J BIOTECHNOL, V167, P101, DOI 10.1016/j.jbiotec.2012.10.010; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Lin-Cereghino GP, 2013, GENE, V519, P311, DOI 10.1016/j.gene.2013.01.062; Lodi T, 2005, APPL ENVIRON MICROB, V71, P4359, DOI 10.1128/AEM.71.8.4359-4363.2005; Mathieu-Rivet E, 2013, MOL CELL PROTEOMICS, V12, P3160, DOI 10.1074/mcp.M113.028191; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mori A, 2015, J BIOSCI BIOENG, V120, P518, DOI 10.1016/j.jbiosc.2015.03.003; Nordberg H., 2014, NUCLEIC ACIDS RES, V42, P31; Ohresser M, 1997, CURR GENET, V31, P264, DOI 10.1007/s002940050204; Parekh RN, 1997, BIOTECHNOL PROGR, V13, P117, DOI 10.1021/bp970009d; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pollock J, 2013, BIOTECHNOL BIOENG, V110, P206, DOI 10.1002/bit.24608; Radzun KA, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0238-7; Ramos-Martinez EM, 2017, PLANT BIOTECHNOL J, V15, P1214, DOI 10.1111/pbi.12710; Rasala BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094028; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Scranton MA, 2016, ALGAL RES, V15, P135, DOI 10.1016/j.algal.2016.02.011; Scranton MA, 2015, PLANT J, V82, P523, DOI 10.1111/tpj.12780; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Tran M, 2013, P NATL ACAD SCI USA, V110, pE15, DOI 10.1073/pnas.1214638110; Tuse A D, 2014, BIOMED RES INT, V2014; Tyo KEJ, 2014, APPL MICROBIOL BIOT, V98, P7149, DOI 10.1007/s00253-014-5783-7; Van K, 1999, PLANT PHYSIOL, V120, P757, DOI 10.1104/pp.120.3.757; Vanier G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139282; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Wolf J, 2015, ALGAL RES, V11, P313, DOI 10.1016/j.algal.2015.07.005; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	66	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192433	10.1371/journal.pone.0192433	http://dx.doi.org/10.1371/journal.pone.0192433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408937	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800064
J	Gupta, N; Srivastava, N; Bhagyawant, SS				Gupta, Neha; Srivastava, Nidhi; Bhagyawant, Sameer S.			Vicilin-A major storage protein of mungbean exhibits antioxidative potential, antiproliferative effects and ACE inhibitory activity	PLOS ONE			English	Article							CONVERTING-ENZYME; FUNCTIONAL-PROPERTIES; BIOACTIVE PEPTIDES; FRAME PROTEIN; IN-VITRO; PLANT; PURIFICATION; HYDROLYSATE; IDENTIFICATION; ASSAY	Enzymatic hydrolysates of different food proteins demonstrate health benefits. Search for diet related food protein hydrolysates is therefore of interest within the scope of functional foods. Mungbean is one of the popular foods in India because of rich protein source. In this study, mungbean vicilin protein (MBVP) was enzymatically hydrolysed by alcalase and trypsin under optimal conditions. We have studied the antioxidant, antiproliferative and angiotensin-converting enzyme (ACE) inhibitory activities of mungbean vicilin protein hydrolysate (MBVPH) vis-a-vis alcalase-generated mungbean vicilin protein hydrolysate (AMBVPH) and trypsin-generated mungbean vicilin protein hydrolysate (TMBVPH). The results showed that MBVPH exhibited higher antioxidant potential, ACE inhibitory and antiproliferative activities than MBVP. The alcalase treated hydrolysate displayed highest ACE inhibitory activity with IC50 value of 0.32 mg protein/ml. The MBVP showed significant antiproliferative activity against both MCF-7 and MDA-MB-231 breast cancer cells at the doses between 0.2-1.0 mg/ml. The data suggested that MBVPH can be utilized as physiologically active functional foods with sufficient antihypertensive activity. The results indicate that mungbean can be utilized as a rich resource of functional foods.	[Gupta, Neha; Bhagyawant, Sameer S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India; [Srivastava, Nidhi] Banasthali Univ, Dept Biosci & Biotechnol, Banasthali, India	Jiwaji University Gwalior; Banasthali Vidyapith	Bhagyawant, SS (corresponding author), Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India.	sameerbhagyawant@gmail.com		Bhagyawant, Sameer/0000-0002-4405-5930				Ahmad M, 2015, J FOOD SCI TECH MYS, V52, P5799, DOI 10.1007/s13197-014-1701-3; ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; [Anonymous], 2011, CEREALS OILS; Antolovich M, 2002, ANALYST, V127, P183, DOI 10.1039/b009171p; Asoodeh A, 2012, FOOD CHEM, V131, P291, DOI 10.1016/j.foodchem.2011.08.039; Awah FM, 2010, FOOD CHEM, V119, P1409, DOI 10.1016/j.foodchem.2009.09.020; Benjamin T B, 2003, J CHEM EDUC, V80, P2; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Cancer I. A. f. R. o., 2014, WORLD CANC REPORT 20; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DECKER EA, 1990, J AGR FOOD CHEM, V38, P674, DOI 10.1021/jf00093a019; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ERICSON MC, 1973, PLANT PHYSIOL, V52, P98, DOI 10.1104/pp.52.2.98; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; GATEHOUSE JA, 1981, EUR J BIOCHEM, V118, P627, DOI 10.1111/j.1432-1033.1981.tb05565.x; Ghassem M, 2011, FOOD CHEM, V129, P1770, DOI 10.1016/j.foodchem.2011.06.051; Gu RZ, 2011, FOOD RES INT, V44, P1536, DOI 10.1016/j.foodres.2011.04.006; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Gulcin I, 2004, PHARMACOL RES, V49, P59, DOI 10.1016/j.phrs.2003.07.012; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; GyamfM A, 1999, GEN PHARMACOL, V32, P61; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95; Hamada JS, 2000, J FOOD SCI, V65, P305, DOI 10.1111/j.1365-2621.2000.tb15998.x; HOYLE NT, 1994, J FOOD SCI, V59, P76, DOI 10.1111/j.1365-2621.1994.tb06901.x; Hyun CK, 2000, PROCESS BIOCHEM, V36, P65, DOI 10.1016/S0032-9592(00)00176-X; Intarasirisawat R, 2013, J FUNCT FOODS, V5, P1854, DOI 10.1016/j.jff.2013.09.006; Jakubczyk A, 2013, INT J FOOD SCI TECH, V48, P2363, DOI 10.1111/ijfs.12226; Jung WK, 2006, FOOD CHEM, V94, P26, DOI 10.1016/j.foodchem.2004.09.048; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; KORTT AA, 1986, INT J PEPT PROT RES, V28, P613; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JK, 2009, BIORESOURCE TECHNOL, V100, P5255, DOI 10.1016/j.biortech.2009.05.057; Li GH, 2006, EUR FOOD RES TECHNOL, V222, P733, DOI 10.1007/s00217-005-0147-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majumder K, 2011, FOOD CHEM, V126, P1614, DOI 10.1016/j.foodchem.2010.12.039; Mendoza EMT, 2001, J AGR FOOD CHEM, V49, P1552, DOI 10.1021/jf001041h; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pahor M, 2000, DIABETES CARE, V23, P888, DOI 10.2337/diacare.23.7.888; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Pownall TL, 2010, J AGR FOOD CHEM, V58, P4712, DOI 10.1021/jf904456r; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sharma GM, 2010, J AGR FOOD CHEM, V58, P5714, DOI 10.1021/jf9036326; Tang CH, 2009, FOOD CHEM, V115, P672, DOI 10.1016/j.foodchem.2008.12.068; Tanzadehpanah H, 2016, PROCESS BIOCHEM, V51, P2067, DOI 10.1016/j.procbio.2016.09.017; Tanzadehpanah H, 2013, INNOV FOOD SCI EMERG, V18, P212, DOI 10.1016/j.ifset.2013.02.002; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; TSOU C S, 1979, Acta Horticulturae (Wageningen), P279; Viernes L. B. G., 2012, Journal of Biological Sciences, V12, P393; Wang FJ, 2016, EUR FOOD RES TECHNOL, V242, P911, DOI 10.1007/s00217-015-2597-5; Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068; Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x; Wijesekara I, 2010, MAR DRUGS, V8, P1080, DOI 10.3390/md8041080; Wu H, 2008, PROCESS BIOCHEM, V43, P457, DOI 10.1016/j.procbio.2008.01.018; Wu WL, 2006, MOD FOOD SCI TECH, V22, P251; Yan QJ, 2015, FOOD CHEM, V179, P290, DOI 10.1016/j.foodchem.2015.01.137; Zheng YJ, 2017, J FUNCT FOODS, V28, P48, DOI 10.1016/j.jff.2016.11.021; Zhu KX, 2006, PROCESS BIOCHEM, V41, P1296, DOI 10.1016/j.procbio.2005.12.029	59	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191265	10.1371/journal.pone.0191265	http://dx.doi.org/10.1371/journal.pone.0191265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408872	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800014
J	Lamas, L; Drezner, R; Otranto, G; Barrera, J				Lamas, Leonardo; Drezner, Rene; Otranto, Guilherme; Barrera, Junior			Analytic method for evaluating players' decisions in team sports: Applications to the soccer goalkeeper	PLOS ONE			English	Article							MINIMAX PLAY; ANTICIPATION; PERFORMANCE	The aim of this study was to define a method for evaluating a player's decisions during a game based on the success probability of his actions and for analyzing the player strategy inferred from game actions. There were developed formal definitions of i) the stochastic process of player decisions in game situations and ii) the inference process of player strategy based on his game decisions. The method was applied to the context of soccer goalkeepers. A model of goalkeeper positioning, with geometric parameters and solutions to optimize his position based on the ball position and trajectory, was developed. The model was tested with a sample of 65 professional goalkeepers (28.8-4.1 years old) playing for their national teams in 2010 and 2014 World Cups. The goalkeeper's decisions were compared to decisions from a large dataset of other goalkeepers, defining the probability of success in each game circumstance. There were assessed i) performance in a defined set of classes of game plays; ii) entropy of goalkeepers' decisions; and iii) the effect of goalkeepers' positioning updates on the outcome (save or goal). Goalkeepers' decisions were similar to the ones with the lowest probability of goal on the dataset. Goalkeepers' entropy varied between 24% and 71% of the maximum possible entropy. Positioning dynamics in the instants that preceded the shot indicated that, in goals and saves, goalkeepers optimized their position before the shot in 21.87% and 83.33% of the situations, respectively. These results validate a method to discriminate successful performance. In conclusion, this method enables a more precise assessment of a player's decision-making ability by consulting a representative dataset of equivalent actions to define the probability of his success. Therefore, it supports the evaluation of the player's decision separately from his technical skill execution, which overcomes the scientific challenge of discriminating the evaluation of a player's decision performance from the action result.	[Lamas, Leonardo] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil; [Drezner, Rene] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil; [Otranto, Guilherme; Barrera, Junior] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, SP, Brazil	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo	Lamas, L (corresponding author), Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.	llamas@unb.br	Lamas, Leonardo/Q-9767-2018	Lamas, Leonardo/0000-0003-2682-9856	Sao Paulo Research Foundation [2015/01587-0]; Conselho Nacional de Pesquisa [306442/2011-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa	This work received support from the following sources: JB received funding from Sao Paulo Research Foundation (2015/01587-0). http://www.fapesp.br/en/ and Conselho Nacional de Pesquisa (306442/2011-6). http://cnpq.br/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cervone D, 2014, P 8 MIT SLOAN SPORTS; De Baranda PS, 2008, EUR J SPORT SCI, V8, P127, DOI 10.1080/17461390801919045; Denardi RA, 2017, INT J PERF ANAL SPOR, V17, P442, DOI 10.1080/24748668.2017.1350450; Duarte R, 2012, SPORTS MED, V42, P633, DOI 10.2165/11632450-000000000-00000; Emara N., 2014, MINIMAX GRIDIRON SER; Furley P, 2017, J SPORT SCI, V35, P873, DOI 10.1080/02640414.2016.1195912; Gonzalez-Villora S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1462-0; Hsu SH, 2007, AM ECON REV, V97, P517, DOI 10.1257/aer.97.1.517; Kovash Kenneth, 2009, 15347 NAT BUR EC RES; Lamas L, 2014, P 20 SIGKDD C WORKSH; Lamas L, 2014, INT J PERF ANAL SPOR, V14, P307, DOI 10.1080/24748668.2014.11868723; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennartsson J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125453; O'Donoghue P., 2007, INT J PERF ANAL SPOR, V7, P35; Palacios-Huerta I, 2003, REV ECON STUD, V70, P395, DOI 10.1111/1467-937X.00249; Pollard R, 1997, J ROY STAT SOC D-STA, V46, P541; Pollard R., 2004, INT J SOCCER SCI, V2, P50; Savelsbergh GJP, 2010, INT J SPORT PSYCHOL, V41, P24; Shafizadeh M, 2016, J SPORT SCI, V34, P1596, DOI 10.1080/02640414.2015.1125011; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Skinner B, 2012, PLOS ONE, V7, P1; Vilar L, 2014, HUM MOVEMENT SCI, V33, P14, DOI 10.1016/j.humov.2013.08.012; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Williams AM, 2004, J APPL SPORT PSYCHOL, V16, P350, DOI 10.1080/10413200490518002	25	3	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191431	10.1371/journal.pone.0191431	http://dx.doi.org/10.1371/journal.pone.0191431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408923	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800017
J	Mozo, A; Ordozgoiti, B; Gomez-Canaval, S				Mozo, Alberto; Ordozgoiti, Bruno; Gomez-Canaval, Sandra			Forecasting short-term data center network traffic load with convolutional neural networks	PLOS ONE			English	Article							WAVELET	Efficient resource management in data centers is of central importance to content service providers as 90 percent of the network traffic is expected to go through them in the coming years. In this context we propose the use of convolutional neural networks (CNNs) to forecast short-term changes in the amount of traffic crossing a data center network. This value is an indicator of virtual machine activity and can be utilized to shape the data center infrastructure accordingly. The behaviour of network traffic at the seconds scale is highly chaotic and therefore traditional time-series-analysis approaches such as ARIMA fail to obtain accurate forecasts. We show that our convolutional neural network approach can exploit the non-linear regularities of network traffic, providing significant improvements with respect to the mean absolute and standard deviation of the data, and outperforming ARIMA by an increasingly significant margin as the forecasting granularity is above the 16-second resolution. In order to increase the accuracy of the forecasting model, we exploit the architecture of the CNNs using multiresolution input distributed among separate channels of the first convolutional layer. We validate our approach with an extensive set of experiments using a data set collected at the core network of an Internet Service Provider over a period of 5 months, totalling 70 days of traffic at the one-second resolution.	[Mozo, Alberto; Ordozgoiti, Bruno; Gomez-Canaval, Sandra] Univ Politeccn Madrid, Dept Sistemas Informat, Madrid, Spain	Universidad Politecnica de Madrid	Mozo, A (corresponding author), Univ Politeccn Madrid, Dept Sistemas Informat, Madrid, Spain.	a.mozo@upm.es	Canaval, Sandra Gómez/AAM-2549-2021; VELASCO, BONIFACIO ALBERTO MOZO/AAB-1376-2019	Canaval, Sandra Gómez/0000-0002-9757-7871; VELASCO, BONIFACIO ALBERTO MOZO/0000-0001-9743-8604	European Union under the FP7 grant agreement [619633]; H grant agreement [671625]	European Union under the FP7 grant agreement; H grant agreement	The research leading to these results has received funding from the European Union under the FP7 grant agreement n. 619633 (project ONTIC, http://ict-ontic.eu) and H2020 grant agreement n. 671625 (project CogNet, http://www.cognet.5g-ppp.euf).	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Brockwell P.J., 2016, INTRO TIME SERIES FO; Bui Nicola, 2015, 2015 IEEE 16th International Symposium on a World of Wireless, Mobile and Multimedia Networks (WoWMoM), P1, DOI 10.1109/WoWMoM.2015.7158161; Fang W., 2012, 2012 IEEE 9 INT C SE, P609, DOI DOI 10.1109/SCC.2012.47; Gmach Daniel, 2007, 2007 IEEE International Symposium on Workload Characterization, P171, DOI 10.1109/IISWC.2007.4362193; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Hinton G, 2009, SCIENCE, V1, P39, DOI DOI 10.4249/SCHOLARPEDIA.5947; Humphrey EJ, 2013, J INTELL INF SYST, V41, P461, DOI 10.1007/s10844-013-0248-5; Jiang Ming, 2009, Acta Electronica Sinica, V37, P2353; Kim Y, 2014, P 2014 C EMPIRICAL M, P1746, DOI [10.3115/v1/D14-1181, DOI 10.3115/V1/D14-1181]; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y., 1995, HDB BRAIN THEORY NEU, V3361, DOI DOI 10.1109/IJCNN.2004.1381049; Liu H, 2013, APPL ENERG, V107, P191, DOI 10.1016/j.apenergy.2013.02.002; Lu NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124601; Ming Mao, 2012, 2012 IEEE 5th International Conference on Cloud Computing (CLOUD), P423, DOI 10.1109/CLOUD.2012.103; Moayedi H.Z., 2008, P INT S INF TECHN, V4, P1, DOI DOI 10.1109/ITSIM.2008.4631947; Ordozgoiti B, 2017, P 25 EUR S ART NEUR; Papagiannaki K, 2003, IEEE INFOCOM SER, P1178; Piacentini M, 2011, COMPUT MANAG SCI, V8, P371, DOI 10.1007/s10287-010-0121-8; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Prevost J. J., 2011, Proceedings of the 2011 6th International Conference on System of Systems Engineering (SoSE), P276, DOI 10.1109/SYSOSE.2011.5966610; Sadek N, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, VOLS 1-7, P2148, DOI 10.1109/ICC.2004.1312898; Salakhutdinov R., 2007, P 24 INT C MACH LEAR, V24, P791, DOI DOI 10.1145/1273496.1273596; Sayeed Z, 2015, 2015 IEEE 8TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, P995, DOI 10.1109/CLOUD.2015.135; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Shafiq M. Zubair, 2011, Performance Evaluation Review, V39, P265, DOI 10.1145/2007116.2007148; Sutskever I., 2007, J MACH LEARN RES, P548; Tan ZF, 2010, APPL ENERG, V87, P3606, DOI 10.1016/j.apenergy.2010.05.012; Taylor Graham W, 2007, ADV NEURAL INFORM PR, P1345; Lora AT, 2007, IEEE T POWER SYST, V22, P1294, DOI 10.1109/TPWRS.2007.901670; Willinger W., 2000, SELF SIMILAR NETWORK, DOI 10.1002/047120644X; Yang JB, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3995; Zaharia M., 2012, NSDI, P2; Zheng Y, 2007, INT C WEB AG INF MAN, P18; Zhou B., 2005, PROC HET NETS, P1	38	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191939	10.1371/journal.pone.0191939	http://dx.doi.org/10.1371/journal.pone.0191939			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408936	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800032
J	Slipher, GA; Hairston, WD; Bradford, JC; Bain, ED; Mrozek, RA				Slipher, Geoffrey A.; Hairston, W. David; Bradford, J. Cortney; Bain, Erich D.; Mrozek, Randy A.			Carbon nanofiber-filled conductive silicone elastomers as soft, dry bioelectronic interfaces	PLOS ONE			English	Article							EEG; ELECTROENCEPHALOGRAPHY	Soft and pliable conductive polymer composites hold promise for application as bioelectronic interfaces such as for electroencephalography (EEG). In clinical, laboratory, and real-world EEG there is a desire for dry, soft, and comfortable interfaces to the scalp that are capable of relaying the mu V-level scalp potentials to signal processing electronics. A key challenge is that most material approaches are sensitive to deformation-induced shifts in electrical impedance associated with decreased signal-to-noise ratio. This is a particular concern in real-world environments where human motion is present. The entire set of brain information outside of tightly controlled laboratory or clinical settings are currently unobtainable due to this challenge. Here we explore the performance of an elastomeric material solution purposefully designed for dry, soft, comfortable scalp contact electrodes for EEG that is specifically targeted to have flat electrical impedance response to deformation to enable utilization in real world environments. A conductive carbon nanofiber filled polydimethylsiloxane (CNFPDMS) elastomer was evaluated at three fill ratios (3, 4 and 7 volume percent). Electromechanical testing data is presented showing the influence of large compressive deformations on electrical impedance as well as the impact of filler loading on the elastomer stiffness. To evaluate usability for EEG, pre-recorded human EEG signals were replayed through the contact electrodes subjected to quasi-static compressive strains between zero and 35%. These tests show that conductive filler ratios well above the electrical percolation threshold are desirable in order to maximize signal-to-noise ratio and signal correlation with an ideal baseline. Increasing fill ratios yield increasingly flat electrical impedance response to large applied compressive deformations with a trade in increased material stiffness, and with nominal electrical impedance tunable over greater than 4 orders of magnitude. EEG performance was independent of filler loading above 4 vol% CNF (< 10(3) ohms).	[Slipher, Geoffrey A.] US Army, Res Lab, Vehicle Technol Directorate, Adelphi, MD 20783 USA; [Hairston, W. David; Bradford, J. Cortney] US Army, Res Lab, Human Res & Engn Directorate, Adelphi, MD 20783 USA; [Bain, Erich D.; Mrozek, Randy A.] US Army, Res Lab, Weap & Mat Res Directorate, Adelphi, MD 20783 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Slipher, GA (corresponding author), US Army, Res Lab, Vehicle Technol Directorate, Adelphi, MD 20783 USA.	geoffrey.a.slipher.civ@mail.mil; william.d.hairston4.civ@mail.mil		Bain, Erich/0000-0002-2195-7798	US Army Research Lab, Center for Adaptive Soldier Technologies; US Army Research Lab [H70-HR51, DRI-13-VTD-009];  [076910227001]	US Army Research Lab, Center for Adaptive Soldier Technologies; US Army Research Lab(United States Department of DefenseUS Army Research Laboratory (ARL)); 	Funded by US Army Research Lab, Center for Adaptive Soldier Technologies. 076910227001. https://www.arl.army.mil/cast/. US Army Research Lab. H70-HR51 and DRI-13-VTD-009. https://www.arl.army.mil/www/default.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau N, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4943628; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fiedler P, 2015, BRAIN TOPOGR, V28, P647, DOI 10.1007/s10548-015-0435-5; Geoffrey Slipher, 2016, STRETCHABLE CONDUCTI; GEVINS A, 1995, BIOL PSYCHOL, V40, P169, DOI 10.1016/0301-0511(95)05105-8; Hairston WD, 2015, LECT NOTES ARTIF INT, V9183, P221, DOI 10.1007/978-3-319-20816-9_22; Hairston WD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046018; Kumar M, 2016, NANOCOMPOSITES, V2, P109, DOI 10.1080/20550324.2016.1221876; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Lance BJ, 2012, P IEEE, V100, P1585, DOI 10.1109/JPROC.2012.2184830; Lazarus N, 2015, ACS APPL MATER INTER, V7, P10080, DOI 10.1021/acsami.5b02189; Liao LD, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-5; Liao LD, 2011, SENSORS-BASEL, V11, P5819, DOI 10.3390/s110605819; Lin CT, 2011, IEEE T BIO-MED ENG, V58, P1200, DOI 10.1109/TBME.2010.2102353; Lofhede J, 2012, SENSORS-BASEL, V12, P16907, DOI 10.3390/s121216907; Lopez-Gordo MA, 2014, SENSORS-BASEL, V14, P12847, DOI 10.3390/s140712847; Mahar B, 2007, IEEE SENS J, V7, P266, DOI 10.1109/JSEN.2006.886863; Marathe AR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00270; McDowell K, 2013, IEEE ACCESS, V1, P131, DOI 10.1109/ACCESS.2013.2260791; Moore MM, 2003, IEEE T NEUR SYS REH, V11, P162, DOI 10.1109/TNSRE.2003.814433; Mrozek RA, 2011, POLYMER, V52, P3422, DOI 10.1016/j.polymer.2011.05.021; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Ries AJ, 2014, J NEUROSCI NEUROENG, V3, P10, DOI [10.1166/jnsne.2014.1092, DOI 10.1166/JNSNE.2014.1092]; Ruffini Giulio, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1826	26	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189415	10.1371/journal.pone.0189415	http://dx.doi.org/10.1371/journal.pone.0189415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408942	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800004
J	Sumiya, M; Igarashi, K; Miyahara, M				Sumiya, Motofumi; Igarashi, Kazue; Miyahara, Motohide			Emotions surrounding friendships of adolescents with autism spectrum disorder in Japan: A qualitative interview study	PLOS ONE			English	Article							HIGH-FUNCTIONING CHILDREN; LONELINESS; INDIVIDUALS; BOYS; ALEXITHYMIA; EXPERIENCES; ANXIETY; VERSION; IMPACT; SCHOOL	Emotions are embedded in culture and play a pivotal role in making friends and interacting with peers. To support the social participation of students with autism spectrum disorders (ASD) it is essential to understand their emotional life in the context of ethnic and school cultures. We are particularly interested in how anxiety and loneliness are experienced in developing and maintaining friendships in the daily encounters of adolescents with ASD in the specific context of Japanese schools, because these emotions could serve either as facilitators or barriers to social interaction, depending on how individuals manage them. The present qualitative study investigated perceptions of emotions related to friendship in the everyday school life of 11 adolescents with ASD in Japan. Data were collected by means of semi-structured individual interviews, which revealed a wide range of motivations for socialization, limited future prospects to deepen friendships, robust self-awareness of one's own social challenges, and conscious efforts to cope with these challenges. An inductive approach to data analysis resulted in four themes: social motivation, loneliness, anxiety, and distress. To our knowledge this is the first study to uncover the rich emotional life of adolescents with ASD in the context of their friendships in an Asian culture.	[Sumiya, Motofumi; Miyahara, Motohide] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi, Japan; [Sumiya, Motofumi; Igarashi, Kazue] Shirayuri Coll, Dept Child Studies, Chofu, Tokyo, Japan; [Miyahara, Motohide] Univ Otago, Sch Phys Educ Sport & Exercise Sci, Dunedin, New Zealand	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Otago	Sumiya, M (corresponding author), Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi, Japan.; Sumiya, M (corresponding author), Shirayuri Coll, Dept Child Studies, Chofu, Tokyo, Japan.	motofumisumiya@gmail.com	Sumiya, Motofumi/ABA-3947-2021	Sumiya, Motofumi/0000-0002-2021-0414	KAKENHI grant [17H07336]; Japan Society for the Promotion of Science (JSPS)	KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors declare no competing financial interests. This work was supported by a KAKENHI grant (17H07336) to MS from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; [Anonymous], 1985, J EARLY ADOLESCENCE, DOI [10.1177/0272431685053010, DOI 10.1177/0272431685053010]; APA, 2000, DIAGN STAT MAN MENT; Bagwell CL, 2013, FRIENDSHIPS CHILDHOO, P225; Bauminger N, 2000, CHILD DEV, V71, P447, DOI 10.1111/1467-8624.00156; Bauminger N, 2003, J AUTISM DEV DISORD, V33, P489, DOI 10.1023/A:1025827427901; Bellini S., 2006, FOCUS AUTISM DEV DIS, V21, P138, DOI [DOI 10.1177/10883576060210030201, 10.1177/10883576060210030201]; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Bolte S, 2014, AUTISM, V18, P67, DOI 10.1177/1362361313517367; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Byrne BM, 1996, J PERS SOC PSYCHOL, V70, P599, DOI 10.1037/0022-3514.70.3.599; Cage E, 2016, RES AUTISM SPECT DIS, V25, P12, DOI 10.1016/j.rasd.2016.01.010; Calder L, 2013, AUTISM, V17, P296, DOI 10.1177/1362361312467866; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; Carrington S, 2001, AUTISM, V5, P37, DOI 10.1177/1362361301005001004; Carrington S., 2003, AUSTR J LEARNING DIS, V8, P15, DOI DOI 10.1080/19404150309546734; Carrington S, 2003, FOCUS AUTISM OTHER D, V18, P211, DOI DOI 10.1177/10883576030180040201; Chen YW, 2015, NEUROPSYCH DIS TREAT, V11, P2699, DOI 10.2147/NDT.S87844; Chun CA, 2006, INT CUL PSY, P29; Cook A., 2017, EUR J SPEC NEEDS EDU, P1; Daniel LS, 2010, FOCUS AUTISM DEV DIS, V25, P220, DOI 10.1177/1088357610378290; Dean M, 2014, J CHILD PSYCHOL PSYC, V55, P1218, DOI 10.1111/jcpp.12242; Deckers A, 2017, CHILD PSYCHIAT HUM D, V48, P828, DOI 10.1007/s10578-016-0707-7; Dekovic M, 2002, J CROSS CULT PSYCHOL, V33, P577, DOI 10.1177/022022102238270; Dyches TT, 2004, J AUTISM DEV DISORD, V34, P211, DOI 10.1023/B:JADD.0000022611.80478.73; Fiske S.T., 2005, SOCIAL OUTCAST OSTRA, P185; Fitzgerald M, 2006, J AUTISM DEV DISORD, V36, P573, DOI 10.1007/s10803-006-0096-z; Gaigg S. B., 2016, AUTISM; Hartup WW, 1999, CURR DIR PSYCHOL SCI, V8, P76, DOI 10.1111/1467-8721.00018; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Howard B, 2006, AUTISM, V10, P619, DOI 10.1177/1362361306068508; Hudson M, 2012, J AUTISM DEV DISORD, V42, P1684, DOI 10.1007/s10803-011-1410-y; Huguet P, 2001, EUR J SOC PSYCHOL, V31, P557, DOI 10.1002/ejsp.81; Humphrey N, 2008, AUTISM, V12, P23, DOI 10.1177/1362361307085267; Humphrey N, 2010, J RES SPEC EDUC NEED, V10, P82, DOI 10.1111/j.1471-3802.2010.01146.x; Kasari C, 2011, J AUTISM DEV DISORD, V41, P533, DOI 10.1007/s10803-010-1076-x; Kelly AB, 2008, J ABNORM CHILD PSYCH, V36, P1069, DOI 10.1007/s10802-008-9234-8; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Long CR, 2003, J THEOR SOC BEHAV, V33, P21, DOI 10.1111/1468-5914.00204; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maeda E, 2003, J SOC PERS RELAT, V20, P579, DOI 10.1177/02654075030205001; Maes M, 2016, J YOUTH ADOLESCENCE, V45, P547, DOI 10.1007/s10964-015-0354-5; Mazefsky CA, 2007, J AUTISM DEV DISORD, V37, P1086, DOI 10.1007/s10803-006-0251-6; Mazurek MO, 2010, J AUTISM DEV DISORD, V40, P1512, DOI 10.1007/s10803-010-1014-y; Pellicano E, 2014, AUTISM, V18, P756, DOI 10.1177/1362361314529627; Perepa P., 2014, CULTURAL BASIS SOCIA, V29, P313; Petrina N, 2014, RES AUTISM SPECT DIS, V8, P111, DOI 10.1016/j.rasd.2013.10.016; Rosenthal M, 2013, NEUROPSYCHOLOGY, V27, P13, DOI 10.1037/a0031299; Rutter M., 2003, SOCIAL COMMUNICATION; Sebastian C, 2009, J AUTISM DEV DISORD, V39, P1122, DOI 10.1007/s10803-009-0725-4; Shah P, 2016, CORTEX, V81, P215, DOI 10.1016/j.cortex.2016.03.021; Smith PK, 2002, CHILD DEV, V73, P1119, DOI 10.1111/1467-8624.00461; Taniguchi H, 2015, J HAPPINESS STUD, V16, P1475, DOI 10.1007/s10902-014-9570-z; Trembath D, 2005, J INTELLECT DEV DIS, V30, P240, DOI 10.1080/13668250500349458; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P491, DOI 10.1007/s10803-006-0181-3; White SW, 2012, J AUTISM DEV DISORD, V42, P874, DOI 10.1007/s10803-011-1325-7; White SW, 2009, J AUTISM DEV DISORD, V39, P1006, DOI 10.1007/s10803-009-0713-8; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Wilder L. K., 2004, FOCUS AUTISM OTHER D, V19, P105, DOI DOI 10.1177/10883576040190020601	59	14	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191538	10.1371/journal.pone.0191538	http://dx.doi.org/10.1371/journal.pone.0191538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408894	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800020
J	Tanaka, A; Fujii, Y; Kasai, N; Okajima, T; Nakashima, H				Tanaka, Aya; Fujii, Yuki; Kasai, Nahoko; Okajima, Takaharu; Nakashima, Hiroshi			Regulation of neuritogenesis in hippocampal neurons using stiffness of extracellular microenvironment	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBSTRATE STIFFNESS; GROWTH CONES; ACTIN ARCS; RIGIDITY; FILOPODIA; BRAIN; CELLS; MICROTUBULE; INSTABILITY	The mechanosensitivity of neurons in the central nervous system (CNS) is an interesting issue as regards understanding neuronal development and designing compliant materials as neural interfaces between neurons and external devices for treating CNS injuries and disorders. Although neurite initiation from a cell body is known to be the first step towards forming a functional nervous network during development or regeneration, less is known about how the mechanical properties of the extracellular microenvironment affect neuritogenesis. Here, we investigated the filamentous actin (F-actin) cytoskeletal structures of neurons, which are a key factor in neuritogenesis, on gel substrates with a stiffness-controlled substrate, to reveal the relationship between substrate stiffness and neuritogenesis. We found that neuritogenesis was significantly suppressed on a gel substrate with an elastic modulus higher than the stiffness of in vivo brain. Fluorescent images of the F-actin cytoskeletal structures showed that the F-actin organization depended on the substrate stiffness. Circumferential actin meshworks and arcs were formed at the edge of the cell body on the stiff gel substrates unlike with soft substrates. The suppression of F-actin cytoskeleton formation improved neuritogenesis. The results indicate that the organization of neuronal F-actin cytoskeletons is strongly regulated by the mechanical properties of the surrounding environment, and the mechanically-induced F-actin cytoskeletons regulate neuritogenesis.	[Tanaka, Aya; Kasai, Nahoko; Nakashima, Hiroshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa, Japan; [Fujii, Yuki; Okajima, Takaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Nippon Telegraph & Telephone Corporation; Hokkaido University	Tanaka, A (corresponding author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa, Japan.	tanaka.aya@lab.ntt.co.jp		Okajima, Takaharu/0000-0003-4230-1568; Tanaka, Aya/0000-0002-5402-752X	Nippon Telegraph and Telephone (NTT) Corporation; Japan Society for the Promotion of Science (JSPS) [16K17499]	Nippon Telegraph and Telephone (NTT) Corporation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Nippon Telegraph and Telephone (NTT) Corporation and in part by a Grant-in-Aid for Young Scientists (B) (No. 16K17499) from the Japan Society for the Promotion of Science (JSPS) to AT. NTT supported the employer of following authors; Aya Tanaka, Nahoko Kasai, and Hiroshi Nakashima. The funder provided support in the form of salaries for these authors [AT, NK, HN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Hayashi S, 2015, MOL BIOL CELL, V26, P1743, DOI 10.1091/mbc.E14-08-1287; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; Mullen CA, 2015, BIOPHYS J, V108, P1604, DOI 10.1016/j.bpj.2015.02.022; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Norman LL, 2010, CELL MOL BIOENG, V3, P398, DOI 10.1007/s12195-010-0137-8; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Saha K, 2010, BIOPHYS J, V99, pL94, DOI 10.1016/j.bpj.2010.09.045; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p	40	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191928	10.1371/journal.pone.0191928	http://dx.doi.org/10.1371/journal.pone.0191928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408940	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800031
J	Zhang, MJ; Wang, XJ; Cui, MY; Wang, YP; Jiao, Z; Tan, ZF				Zhang, Miao; Wang, Xiaojie; Cui, Meiyan; Wang, Yanping; Jiao, Zhen; Tan, Zhongfang			Ensilage of oats and wheatgrass under natural alpine climatic conditions by indigenous lactic acid bacteria species isolated from high-cold areas	PLOS ONE			English	Article							AEROBIC STABILITY; LACTOBACILLUS-BUCHNERI; FERMENTATION QUALITY; SILAGE ADDITIVES; ACETIC-ACID; IN-VITRO; METABOLISM; BIOGAS; FRESH; STRAW	Five different species of selected broad-spectrum antibiotic lactic acid bacteria isolated from extremely high cold areas were used as starters to ferment indigenous forage oats and wheatgrass under rigid alpine climatic conditions. The five isolates were Lactobacillus plantarum QZ227, Enterococcus mundtiiQZ251, Pediococcus cellicola QZ311, Leuconostoc mesenteroides QZ1137 and Lactococcus lactis QZ613, and commercial Lactobacillus plantarum FG1 was used as the positive control and sterile water as the negative control. The minimum and maximum temperatures were -22 degrees C and 23 degrees C during the fermentation process, respectively. The pH of wheatgrass silage fermented by the QZ227 and FG1 inocula reached the expected values (<= 4.15) although the pathogens detected in the silage should be further investigated. All of the inocula additives used in this study were effective in improving the fermentation quality of oat silage as indicated by the higher content of lactic acid, lower pH values (<= 4.17) and significant inhibition of pathogens. QZ227 exhibited a fermentation ability that was comparable with the commercial inoculum FG1 for the whole process, and the deterioration rate was significantly lower than for FG1 after storage for 7 months. The pathogens Escherichia coli, mold and yeast were counted and isolated from the deteriorated silage. E. coli were the main NH3-N producer while F. fungi and yeast produced very little.	[Zhang, Miao; Wang, Xiaojie; Cui, Meiyan; Wang, Yanping; Jiao, Zhen; Tan, Zhongfang] Zhengzhou Univ, Coll Phys & Engn, Henan Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Tan, ZF (corresponding author), Zhengzhou Univ, Coll Phys & Engn, Henan Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China.	tzhongfang@sina.com			National Natural Science Foundation of China [41101244]; Henan Province of China [152300410037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province of China	This work was supported by the National Natural Science Foundation of China (Grant No. 41101244 to ZFT), a grant (No. 152300410037) from Henan Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso VA, 2013, J APPL MICROBIOL, V115, P637, DOI 10.1111/jam.12178; AOAC International, 2016, OFFICIAL METHODS ANA; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Bastidas-Oyanedel JR, 2015, REV ENVIRON SCI BIO, V14, P473, DOI 10.1007/s11157-015-9369-3; Cao Y, 2011, ANIM SCI J, V82, P259, DOI 10.1111/j.1740-0929.2010.00840.x; Coelho MC, 2014, INT J FOOD MICROBIOL, V191, P53, DOI 10.1016/j.ijfoodmicro.2014.08.029; Driehuis F, 1999, J APPL MICROBIOL, V87, P583, DOI 10.1046/j.1365-2672.1999.00856.x; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Ge J, 2015, INT J AGRIC BIOL, V17, P761, DOI 10.17957/IJAB/14.0003; Herrmann C, 2015, BIORESOURCE TECHNOL, V197, P393, DOI 10.1016/j.biortech.2015.08.114; Johnson D, 2002, NATURE, V416, P82, DOI 10.1038/416082a; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Kong X, 2017, SCI REPORTS, V6, P37224; Li XX, 2016, ANIM NUTR, V2, P229, DOI 10.1016/j.aninu.2016.04.003; Li Y., 2013, GUANGDONG TECHNOL, V20, P154; Lv H, 2014, IDENTIFICATION PRELI; Mansouri M, 2015, COMPUT ELECTRON AGR, V114, P145, DOI 10.1016/j.compag.2015.04.006; Menardo S, 2015, BIOENERG RES, V8, P1810, DOI 10.1007/s12155-015-9637-7; Ni KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121967; Ogunade IM, 2016, J DAIRY SCI, V99, P4427, DOI 10.3168/jds.2015-10766; Oliveira AS, 2017, J DAIRY SCI, V100, P4587, DOI 10.3168/jds.2016-11815; Qiu J, 2015, NATL SCI REV, V2, P489, DOI 10.1093/nsr/nwv076; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493; Wilkinson JM, 2013, GRASS FORAGE SCI, V68, P1, DOI 10.1111/j.1365-2494.2012.00891.x; Xu ZS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14052-1; Yang YF, 2014, ISME J, V8, P430, DOI 10.1038/ismej.2013.146; Zhang M, 2017, CROP PASTURE SCI, V68, P225, DOI [10.1071/CP16324, 10.1071/cp16324]; Zhang M, 2017, ANIM SCI J, V88, P277, DOI 10.1111/asj.12632	29	10	10	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192368	10.1371/journal.pone.0192368	http://dx.doi.org/10.1371/journal.pone.0192368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408855	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800057
J	Koivisto, M; Grassini, S				Koivisto, Mika; Grassini, Simone			Unconscious response priming during continuous flash suppression	PLOS ONE			English	Article							NO CONCLUSIVE EVIDENCE; INTEROCULAR SUPPRESSION; HUMAN DORSAL; AWARENESS; STREAM; VISION; IDENTIFICATION; INTEGRATION; ACTIVATION; PATHWAYS	Continuous flash suppression (CFS) has become a popular tool for studying unconscious processing, but the level at which unconscious processing of visual stimuli occurs under CFS is not clear. Response priming is a robust and well-understood phenomenon, in which the prime stimulus facilitates overt responses to targets if the prime and target are associated with the same response. We used CFS to study unconscious response priming of shape: arrows with left or right orientation served as primes and targets. The prime was presented near the limen of consciousness and each trial was followed by subjective rating of visibility and a forced-choice response concerning the orientation of the prime in counterbalanced order. In trials without any reported awareness of the presence of the prime, discrimination of the prime's orientation was at chance level. However, priming was elicited in such unconscious trials. Unconscious priming was not influenced by the prime-target onset-asynchrony (SOA)/prime duration, whereas conscious processing, as indicated by the enhanced discriminability of the prime's orientation and conscious priming, increased at the longest SOAs/prime durations. These results show that conscious and unconscious processes can be dissociated with CFS and that CFS-masking does not completely suppress unconscious visual processing of shape.	[Koivisto, Mika; Grassini, Simone] Univ Turku, Dept Psychol, Turku, Finland	University of Turku	Koivisto, M (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	mika.koivisto@utu.fi	Grassini, Simone/T-7638-2019	Grassini, Simone/0000-0002-4189-7585; Koivisto, Mika/0000-0002-5227-0091	Academy of Finland [269156]	Academy of Finland(Academy of Finland)	SG was supported by Academy of Finland, grant 269156, http://www.aka.fi/en.; This study was supported by the Academy of Finland (project no. 269156).	Almeida J, 2013, COGN AFFECT BEHAV NE, V13, P94, DOI 10.3758/s13415-012-0133-7; Almeida J, 2010, PSYCHOL SCI, V21, P772, DOI 10.1177/0956797610371343; Almeida J, 2008, P NATL ACAD SCI USA, V105, P15214, DOI 10.1073/pnas.0805867105; Anderson E, 2012, EMOTION, V12, P1210, DOI 10.1037/a0027514; Bahrami B, 2010, PSYCHOL SCI, V21, P224, DOI 10.1177/0956797609360664; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; Barbot A, 2012, ATTEN PERCEPT PSYCHO, V74, P174, DOI 10.3758/s13414-011-0226-3; Bates D., 2012, LME4 LINEAR MIXED EF; Breitmeyer B., 2006, VISUAL MASKING; Breitmeyer BG, 2015, CONSCIOUS COGN, V35, P234, DOI 10.1016/j.concog.2015.01.012; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gelbard-Sagiv H, 2016, J VISION, V16, DOI 10.1167/16.1.3; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Han S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35723; Hesselmann G, 2015, CONSCIOUS COGN, V31, P60, DOI 10.1016/j.concog.2014.10.009; Hesselmann G, 2016, J VISION, V16, DOI 10.1167/16.3.17; Hesselmann G, 2014, PSYCHOL SCI, V25, P2116, DOI 10.1177/0956797614548876; Hesselmann G, 2011, CEREB CORTEX, V21, P2829, DOI 10.1093/cercor/bhr085; Jolij J, PROC NATL ACAD SCI U, V102, P10747; Kang MS, 2011, J NEUROSCI, V31, P13535, DOI 10.1523/JNEUROSCI.1691-11.2011; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Koivisto M, 2017, J COGNITIVE NEUROSCI, V29, P1621, DOI 10.1162/jocn_a_01149; Koivisto M, 2016, CONSCIOUS COGN, V41, P10, DOI 10.1016/j.concog.2016.01.008; LEGGE GE, 1979, J OPT SOC AM, V69, P838, DOI 10.1364/JOSA.69.000838; Ludwig K, 2015, CONSCIOUS COGN, V35, P251, DOI 10.1016/j.concog.2014.12.010; Ludwig K, 2015, HUM BRAIN MAPP, V36, P137, DOI 10.1002/hbm.22618; Moors P, 2016, PSYCHOL SCI, V27, P945, DOI 10.1177/0956797616642525; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Peremen Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00969; R Core Team, 2012, R A LANGUAGE AND ENV; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Sakuraba S, 2012, J NEUROSCI, V32, P3949, DOI 10.1523/JNEUROSCI.3973-11.2012; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Schmidt F, 2012, ADV COGN PSYCHOL, V7, P120; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Tapia E, 2011, PSYCHOL SCI, V22, P934, DOI 10.1177/0956797611413471; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Vermeiren A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031595; Vorberg D, 2013, P NATL ACAD SCI USA, V100, P6275; Ye X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105156; Yuval-Greenberg S, 2013, J NEUROSCI, V33, P9635, DOI 10.1523/JNEUROSCI.4612-12.2013; Zabelina DL, 2013, PSYCHON B REV, V20, P581, DOI 10.3758/s13423-012-0364-1	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192201	10.1371/journal.pone.0192201	http://dx.doi.org/10.1371/journal.pone.0192201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401503	Green Submitted, gold, Green Published			2022-12-27	WOS:000424101400042
J	Lin, YS; Kuo, KT; Chen, SK; Huang, HS				Lin, Yi-Sian; Kuo, Kuan-Ting; Chen, Shih-Kuo; Huang, Hsien-Sung			RBFOX3/NeuN is dispensable for visual function	PLOS ONE			English	Article							MOUSE RETINA; GANGLION; DIFFERENTIATION; PROTEIN; SYSTEM; CELLS	w RBFOX3/NeuN is a neuronal splicing regulator involved in neural circuitry balance, as well as neurogenesis and synaptogenesis. Rbfox3 is expressed in neurons; however, in the retina, expression is restricted to cells in the ganglion cell layer and some cells of the inner nuclear layer. Rbfox3 is expressed in a layer-specific manner in the retina, which implies a functional role, however, the role of RBFOX3 in the retina is unknown. Rbfox3 homozygous knockout (Rbfox3(-/-)) mice exhibit deficits in visual learning; therefore, understanding the role of RBFOX3 in the retina is critical for interpreting behavioral results. We found Rbfox3 expression was developmentally regulated in the retina and specifically expressed in ganglion cells, amacrine cells and horizontal cells of the retina. We demonstrate deletion of Rbfox3 resulted in a reduction in the thickness of the inner plexiform layer of the retina, where synapses are formed. Number of ganglion cells and amacrine cells is normal with loss of Rbfox3. Innervation of retinal ganglion cells into their targeted brain regions is normal in Rbfox3(-/-)mice. Importantly, Rbfox3(-/-)mice displayed normal non-image and image forming functions. Taken together, our results suggest RBFOX3 is dispensable for visual function.	[Lin, Yi-Sian; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Kuo, Kuan-Ting] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Chen, Shih-Kuo] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan; [Chen, Shih-Kuo; Huang, Hsien-Sung] Neurodev Club Taiwan, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Neurodev Club Taiwan, Taipei, Taiwan.	huang.hsiensung@gmail.com		Huang, Hsien-Sung/0000-0003-2657-3635; CHEN, SHIH-KUO/0000-0002-7921-1358	Ministry of Science and Technology, Taiwan [MOST 104-2314-B-002-078-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-078-MY3). The recipient of this funding is H-S. H. The URL of this funding agency is (https://www.most.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-078-MY3). We thank the staff of the imaging core at the First Core Labs, National Taiwan University College of Medicine, for technical assistance.	Aldiri I, 2017, NEURON, V94, P550, DOI 10.1016/j.neuron.2017.04.022; Amin N, 2016, EUR J HUM GENET, V24, P1488, DOI 10.1038/ejhg.2016.31; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chen Y., 2016, OXIDATIVE MED CELLUL, V2016, P9, DOI DOI 10.3390/A9040070; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Duan W, 2015, MOL NEUROBIOLOGY; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Lai D, 2013, PLOS ONE, V8; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Lucas CH, 2014, NEUROSCI LETT, V558, P97, DOI 10.1016/j.neulet.2013.10.037; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Raymond ID, 2008, MOL VIS, V14, P1559; Reese BE, 2011, VISION RES, V51, P613, DOI 10.1016/j.visres.2010.07.010; Templeton JP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-90; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhu YL, 2013, INVEST OPHTH VIS SCI, V54, P25, DOI 10.1167/iovs.12-10861	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192355	10.1371/journal.pone.0192355	http://dx.doi.org/10.1371/journal.pone.0192355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401485	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400052
J	Zito, M; Emanuel, F; Molino, M; Cortese, CG; Ghislieri, C; Colombo, L				Zito, Margherita; Emanuel, Federica; Molino, Monica; Cortese, Claudio Giovanni; Ghislieri, Chiara; Colombo, Lara			Turnover intentions in a call center: The role of emotional dissonance, job resources, and job satisfaction	PLOS ONE			English	Article							WORK; DEMANDS; NURSES; FLOW; DETERMINANTS; ABSENTEEISM; SALESPEOPLE; PREDICTORS; EXHAUSTION; INVENTORY	Background Turnover intentions refer to employees' intent to leave the organization and, within call centers, it can be influenced by factors such as relational variables or the perception of the quality of working life, which can be affected by emotional dissonance. This specific job demand to express emotions not felt is peculiar in call centers, and can influence job satisfaction and turnover intentions, a crucial problem among these working contexts. This study aims to detect, within the theoretical framework of the Job Demands-Resources Model, the role of emotional dissonance (job demand), and two resources, job autonomy and supervisors' support, in the perception of job satisfaction and turnover intentions among an Italian call center. Method The study involved 318 call center agents of an Italian Telecommunication Company. Data analysis first performed descriptive statistics through SPSS 22. A path analysis was then performed through LISREL 8.72 and tested both direct and indirect effects. Results Results suggest the role of resources in fostering job satisfaction and in decreasing turnover intentions. Emotional dissonance reveals a negative relation with job satisfaction and a positive relation with turnover. Moreover, job satisfaction is negatively related with turnover and mediates the relationship between job resources and turnover. Conclusion This study contributes to extend the knowledge about the variables influencing turnover intentions, a crucial problem among call centers. Moreover, the study identifies theoretical considerations and practical implications to promote well-being among call center employees. To foster job satisfaction and reduce turnover intentions, in fact, it is important to make resources available, but also to offer specific training programs to make employees and supervisors aware about the consequences of emotional dissonance.	[Zito, Margherita; Emanuel, Federica; Molino, Monica; Cortese, Claudio Giovanni; Ghislieri, Chiara; Colombo, Lara] Univ Turin, Dept Psychol, Turin, Italy	University of Turin	Emanuel, F (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	federica.emanuel@unito.it	Ghislieri, Chiara/F-8547-2013; Emanuel, Federica/AGD-5481-2022	Ghislieri, Chiara/0000-0003-4002-8756; MOLINO, MONICA/0000-0002-7002-0088; Zito, Margherita/0000-0002-5604-9693				[Anonymous], 1997, JOB SATISFACTION APP; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327, https://doi.org/10.1007/BF02723327]; Bakker A.B., 2003, EUR J WORK ORGAN PSY, V12, P393, DOI DOI 10.1080/13594320344000165; Bakker A.B., 2014, WELLBEING COMPLETE R, P1, DOI [DOI 10.1002/9781118539415.WBWELL019, 10.1002/9781118539415.wbwell019]; Bakker A.B., 2007, J MANAGE PSYCHOL, V22, P309, DOI [DOI 10.1108/02683940710733115, 10.1108/02683940710733115]; Bakker AB, 2008, J VOCAT BEHAV, V72, P400, DOI 10.1016/j.jvb.2007.11.007; Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170; Blau P., 2003, EUROPEAN J WORK ORG, V12, P311, DOI [10.1080/13594320344000183, DOI 10.1080/13594320344000183]; Bruk-Lee V, 2009, HUM PERFORM, V22, P156, DOI 10.1080/08959280902743709; Cammann C, ASSESSING ORG CHANGE; Caplan RD, 1995, JOB DEMANDS WORKER H; Celik DA, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.491; Congregado E, 2016, APPL ECON, V48, P411, DOI 10.1080/00036846.2015.1083080; Cooper CL, 1998, OSI OCCUPATIONAL STR; Cortese C, 2006, TESTING PSYCHOMETRIC, V13, P305; Cortese CG, 2013, ASSIST INFERM RIC, V32, P20, DOI 10.1702/1267.13987; COTTON JL, 1986, ACAD MANAGE REV, V11, P55, DOI 10.2307/258331; Das D, 2013, INT J HUM RESOUR MAN, V24, P15, DOI 10.1080/09585192.2012.665067; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2012, J ORGAN BEHAV, V33, P276, DOI 10.1002/job.760; Diefendorff JM, 2016, APPL PSYCHOL-INT REV, V65, P2, DOI 10.1111/apps.12034; Dorman Christian, 2003, EUROPEAN J WORK ORG, V12, P305, DOI [10.1080/13594320344000219, DOI 10.1080/13594320344000219]; Dormann C, 2004, J OCCUP HEALTH PSYCH, V9, P61, DOI 10.1037/1076-8998.9.1.61; Emanuel F, 2016, MED LAV, V107, P367; Emanuel F., 2016, PSICOL SALUTE, V3, P26, DOI [10.3280/PDS2016-003002, DOI 10.3280/PDS2016-003002]; Emanuel Federica, 2014, G Ital Med Lav Ergon, V36, P95; Erdogan B, 2012, J MANAGE, V38, P1038, DOI 10.1177/0149206311429379; Flint D, 2013, PERS REV, V42, P552, DOI 10.1108/PR-03-2012-0051; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gazzoli G, 2010, J HOSP TOUR RES, V34, P56, DOI 10.1177/1096348009344235; Gefen D., 2000, COMMUN ASSOC INF SYS, V4, P7, DOI [10.17705/1CAIS.00407, 10.17705/1cais.00407, DOI 10.17705/1CAIS.00407]; Giunchi M, 2016, CAREER DEV INT, V21, P3, DOI 10.1108/CDI-07-2015-0103; Glomb TM, 2004, J APPL PSYCHOL, V89, P700, DOI 10.1037/0021-9010.89.4.700; Grandey A A, 2000, J Occup Health Psychol, V5, P95, DOI 10.1037/1076-8998.5.1.95; Gregory J.B., 2011, CONSULT PSYCH J, V63, P67, DOI [10.1037/a0024152, DOI 10.1037/A0024152]; Heuven E., 2003, EUR J WORK ORGAN PSY, V12, P81, DOI [10.1080/13594320344000039, DOI 10.1080/13594320344000039]; Hochschild AR., 1983, THE MANAGEMENT HEART; Holman D., 2006, HUM RESOUR MANAG J, V12, P35, DOI [https://doi.org/10.1111/j.1748-8583.2002.tb00076.x, DOI 10.1111/J.1748-8583.2002.TB00076.X]; Homburg C, 2004, J ACAD MARKET SCI, V32, P144, DOI 10.1177/0092070303261415; Hulsheger UR, 2011, J OCCUP HEALTH PSYCH, V16, P361, DOI 10.1037/a0022876; James LR, 2006, ORGAN RES METHODS, V9, P233, DOI 10.1177/1094428105285144; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kelloway K. E., 1998, USING LISREL STRUCTU; Kenworthy J, 2014, J APPL SOC PSYCHOL, V44, P94, DOI 10.1111/jasp.12211; Kim E, 2013, PERS PSYCHOL, V66, P613, DOI 10.1111/peps.12028; Lambert EG, 2015, J APPL SEC RES, V10, P1, DOI 10.1080/19361610.2015.972260; Lewig K. A., 2003, EUR J WORK ORGAN PSY, V12, P366; Lewin JE, 2007, J BUS RES, V60, P1216, DOI 10.1016/j.jbusres.2007.04.009; Malik O. F., 2010, INT J BUSINESS MANAG, V5, P223, DOI DOI 10.5539/IJBM.V5N11P223; Millan JM, 2013, SMALL BUS ECON, V40, P651, DOI 10.1007/s11187-011-9380-1; McAuliffe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058415; Miao R.-T., 2011, J BEHAV APPL MANAGEM, V12, P105, DOI [DOI 10.1109/ICMSS.2010.5578122, https://doi.org/10.21818/001C.17632, DOI 10.21818/001C.17632]; Molino M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01133; Molino M, 2016, ANXIETY STRESS COPIN, V29, P400, DOI 10.1080/10615806.2015.1070833; Molino M, 2015, CAREER DEV INT, V20, P686, DOI 10.1108/CDI-01-2015-0011; Molino M, 2013, J WORKPLACE LEARN, V25, P98, DOI 10.1108/13665621311299780; Mount M, 2006, PERS PSYCHOL, V59, P591, DOI 10.1111/j.1744-6570.2006.00048.x; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Osbourne R., 2015, JOB SATISFACTION DET; Park HY, 2014, SAGE OPEN, V1, P1; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Quaglino GP, 2010, MED LAV, V101, P169; Rehman MS., 2011, INTERDISCIPLINARY J, V2, P167; Ro H, 2017, J QUAL ASSUR HOSPIT, P1; Robinson G, 2006, INT J SERV IND MANAG, V17, P284, DOI 10.1108/09564230610667122; Ruyter K., 2001, J INTERACT MARK, V15, P23, DOI DOI 10.1002/DIR.1008; Schalk R, 2007, NEW TECH WORK EMPLOY, V22, P260, DOI 10.1111/j.1468-005X.2007.00198.x; Silla I, 2014, EUR J WORK ORGAN PSY, V23, P405, DOI 10.1080/1359432X.2012.752898; Taylor P, 2002, WORK EMPLOY SOC, V16, P133, DOI 10.1177/09500170222119281; Theorell T., 1990, HEALTHY WORK STRESS; Thite M, 2010, NEW TECH WORK EMPLOY, V25, P2, DOI 10.1111/j.1468-005X.2009.00235.x; Tourigny L, 2010, INT J HUM RESOUR MAN, V21, P2741, DOI 10.1080/09585192.2010.528656; Tung-Chun H, 2007, SOC BEHAV PERSONAL, V35, P735; Tuten TL, 2004, J BUS RES, V57, P26, DOI 10.1016/S0148-2963(02)00281-3; van Dam K, 2013, J ADV NURS, V69, P31, DOI 10.1111/j.1365-2648.2012.05981.x; van Saane N, 2003, OCCUP MED-OXFORD, V53, P191, DOI 10.1093/occmed/kqg038; Wanous J. P., 1992, ORGANIZATIONAL ENTRY; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553; Weiss H. M., 2002, HUMAN RESOURCE MANAG, V12, P173, DOI [DOI 10.1016/S1053-482200045-1, 10.1016/S1053-4822(02)00045-1]; World Medical Association, 2001, B WORLD HEALTH ORGAN, V79, P373, DOI DOI 10.1111/DDG.13528; Wright TA, 2007, J MANAGE, V33, P141, DOI 10.1177/0149206306297582; Ybema JF, 2010, EUR J WORK ORGAN PSY, V19, P102, DOI 10.1080/13594320902793691; Zalewska AM, 2011, PERS INDIV DIFFER, V50, P977, DOI 10.1016/j.paid.2010.10.013; Zapf D., 1999, EUR J WORK ORGAN PSY, V8, P371, DOI DOI 10.1080/135943299398230; Zapf D., 2002, HUM RESOUR MANAG REV, V12, P237, DOI DOI 10.1016/S1053-4822(02)00048-7; Zhou H, 2009, INT J SERV TECHNOL M, V12, P129, DOI 10.1504/IJSTM.2009.025231; Zito M, 2015, TPM-TEST PSYCHOM MET, V22, P553, DOI 10.4473/TPM22.4.8; Zito M, 2016, J NURS MANAGE, V24, pE12, DOI 10.1111/jonm.12284	88	30	30	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192126	10.1371/journal.pone.0192126	http://dx.doi.org/10.1371/journal.pone.0192126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401507	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400038
J	Neeraja, CN; Kulkarni, KS; Babu, PM; Rao, DS; Surekha, K; Babu, VR				Neeraja, C. N.; Kulkarni, Kalyani S.; Babu, P. Madhu; Rao, D. Sanjeeva; Surekha, K.; Babu, V. Ravindra			Transporter genes identified in landraces associated with high zinc in polished rice through panicle transcriptome for biofortification	PLOS ONE			English	Article							ORYZA-SATIVA L.; STAPLE FOOD CROPS; HIGH GRAIN ZINC; PHOSPHATE HOMEOSTASIS; GENOTYPIC VARIATION; MINERAL ELEMENTS; IRON TRANSPORT; ZN; EXPRESSION; METAL	Polished rice is poor source of micronutrients, however wide genotypic variability exists for zinc uptake and remobilization and zinc content in brown and polished grains in rice. Two landraces (Chittimutyalu and Kala Jeera Joha) and one popular improved variety (BPT 5204) were grown under zinc sufficient soil and their analyses showed high zinc in straw of improved variety, but high zinc in polished rice in landraces suggesting better translocation ability of zinc into the grain in landraces. Transcriptome analyses of the panicle tissue showed 41182 novel transcripts across three samples. Out of 1011 differentially expressed exclusive transcripts by two landraces, 311 were up regulated and 534 were down regulated. Phosphate transporter-exporter (PHO), proton-coupled peptide transporters (POT) and vacuolar iron transporter (VIT) showed enhanced and significant differential expression in landraces. Out of 24 genes subjected to quantitative real time analyses for confirmation, eight genes showed significant differential expression in landraces. Through mapping, six rice microsatellite markers spanning the genomic regions of six differentially expressed genes were validated for their association with zinc in brown and polished rice using recombinant inbred lines (RIL) of BPT 5204/Chittimutyalu. Thus, this study reports repertoire of genes associated with high zinc in polished rice and a proof concept for deployment of transcriptome information for validation in mapping population and its use in marker assisted selection for biofortification of rice with zinc.	[Neeraja, C. N.; Kulkarni, Kalyani S.; Babu, P. Madhu; Rao, D. Sanjeeva; Surekha, K.; Babu, V. Ravindra] ICAR Indian Inst Rice Res, Dept Crop Improvement, Hyderabad, Andhra Prades, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Neeraja, CN (corresponding author), ICAR Indian Inst Rice Res, Dept Crop Improvement, Hyderabad, Andhra Prades, India.	cnneeraja@gmail.com	Durbha, Sanjeeva Rao/ABQ-8624-2022	Durbha, Sanjeeva Rao/0000-0001-9191-5510; Neeraja, C N/0000-0002-2418-986X	Indian Council of Agricultural Research (ICAR)	Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR))	Funds for this study were received from Indian Council of Agricultural Research (ICAR) to Indian Institute of Rice Research, Hyderabad under Consortia for Research Platform (CRP)-Biofortification (www.icar.org.in/; www.drricar.org/).	Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Agarwal S, 2014, GENE, V546, P430, DOI 10.1016/j.gene.2014.05.069; Amrutha RN, 2007, PLANT SCI, V172, P708, DOI 10.1016/j.plantsci.2006.11.019; Anandan A, 2011, J FOOD SCI, V76, pH122, DOI 10.1111/j.1750-3841.2011.02135.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Astudillo-Reyes C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137157; Babu V.R, 2013, J SAT, V1, P1; Bashir K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01192; Bashir K, 2014, RICE, V7, DOI 10.1186/s12284-014-0018-1; Bashir K, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00015, 10.3389/fpls.2013.00090]; Bhullar NK, 2013, BIOTECHNOL ADV, V31, P50, DOI 10.1016/j.biotechadv.2012.02.001; Boonyaves K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00130; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Chen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077455; Chen WR, 2008, RUSS J PLANT PHYSL+, V55, P400, DOI 10.1134/S1021443708030175; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; Dwivedi SL, 2016, TRENDS PLANT SCI, V21, P31, DOI 10.1016/j.tplants.2015.10.012; Graham R, 1999, FIELD CROP RES, V60, P57, DOI 10.1016/S0378-4290(98)00133-6; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Huang Y, 2016, FOOD CHEM, V192, P873, DOI 10.1016/j.foodchem.2015.07.087; ICAR-Indian Institute of Rice Research, 2015, PROGR REP 2014, V1; ICAR-Indian Institute of Rice Research, 2014, PROGR REP 2013, V1; ICAR-Indian Institute of Rice Research, 2016, PROGR REP 2015, V1; Impa SM, 2012, PLANT SOIL, V361, P3, DOI 10.1007/s11104-012-1315-3; Impa SM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00534; Impa SM, 2013, J EXP BOT, V64, P2739, DOI 10.1093/jxb/ert118; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Ishimaru Y, RICE, V201, P21; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jaksomsak P, 2017, PLANT SOIL, V411, P101, DOI 10.1007/s11104-016-3056-1; Jiang W, 2008, ANN APPL BIOL, V153, P135, DOI 10.1111/j.1744-7348.2008.00243.x; Jiang W, 2007, ANN APPL BIOL, V150, P383, DOI 10.1111/j.1744-7348.2007.00138.x; Jin TT, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0176-1; Johnson-Beebout SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep38301; Juliano B.O, 1993, RICE HUMAN NUTR; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Krishnaswami K., 1998, LANCET, V351, P1268; Lee S, 2011, PLANT BIOTECHNOL J, V9, P865, DOI 10.1111/j.1467-7652.2011.00606.x; Lee S, 2009, PLANT CELL ENVIRON, V32, P408, DOI 10.1111/j.1365-3040.2009.01935.x; Lee SC, 2010, PLANT MOL BIOL, V73, P409, DOI 10.1007/s11103-010-9629-0; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McDonald GK, 2008, PLANT SOIL, V306, P49, DOI 10.1007/s11104-008-9555-y; Moreno-Moyano LT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01463; Mori A, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01160; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Myers SS, 2015, LANCET GLOB HEALTH, V3, pE639, DOI 10.1016/S2214-109X(15)00093-5; Nachimuthu V.V., 2014, INDIAN J SCI TECHNOL, V7, P1414, DOI 10.17485/ijst/2014/v7i9.15; Nakandalage N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00764; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Olsen LI, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00030; Oono Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9739505; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pineau C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003120; Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780; Prom-u-thai C, 2010, FOOD CHEM, V120, P858, DOI 10.1016/j.foodchem.2009.11.027; Quinet M, 2012, PLANT CELL ENVIRON, V35, P1837, DOI 10.1111/j.1365-3040.2012.02521.x; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rao D. S, 2014, J RICE RES, V7, P45; Renger Z., 2002, IMPACTS AGR HUMAN HL, P363; Ricachenevsky FK, 2015, PLANT SCI, V236, P1, DOI 10.1016/j.plantsci.2015.03.009; Ricachenevsky FK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00226; Ricachenevsky FK, 2010, MOL BIOL REP, V37, P3735, DOI 10.1007/s11033-010-0027-0; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saenchai C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00396; Sasaki A, 2016, J EXP BOT, V67, P3645, DOI 10.1093/jxb/erw060; Sasaki A, 2015, PLANT J, V84, P374, DOI 10.1111/tpj.13005; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Secco D, 2010, PLANT PHYSIOL, V152, P1693, DOI 10.1104/pp.109.149872; Shankar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23719; Sharma A, 2013, PHYSIOL MOL BIOL PLA, V19, P11, DOI 10.1007/s12298-012-0139-1; Sperotto RA, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00144, 10.3389/fpls.2013.00464]; Sperotto RA, 2010, J PLANT PHYSIOL, V167, P1500, DOI 10.1016/j.jplph.2010.05.003; Sperotto RA, 2012, PLANT SCI, V190, P24, DOI 10.1016/j.plantsci.2012.03.004; Stomph TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00008; Stomph TJ, 2009, TRENDS PLANT SCI, V14, P123, DOI 10.1016/j.tplants.2009.01.001; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Surekha K, 2014, COMMUN SOIL SCI PLAN, V45, P415, DOI 10.1080/00103624.2013.872250; Suresh PB, 2012, EUPHYTICA, V187, P421, DOI 10.1007/s10681-012-0737-6; Suzuki M, 2012, RICE, V5, DOI 10.1186/1939-8433-5-9; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Takehisa H, 2016, PLANT SIGNAL BEHAV, V8, P6; Trijatmiko K.R., 2016, SCI REP-UK, V6, P1, DOI DOI 10.1038/SREP19792; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Widodo, 2010, NEW PHYTOL, V186, P400, DOI 10.1111/j.1469-8137.2009.03177.x; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Wissuwa M, 2008, PLANT SOIL, V306, P37, DOI 10.1007/s11104-007-9368-4; Wu CY, 2010, J AGR FOOD CHEM, V58, P6767, DOI 10.1021/jf100017e; Yang WZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0425-5; Yoneyama T, 2015, INT J MOL SCI, V16, P19111, DOI 10.3390/ijms160819111; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zeng YW, 2010, ENVIRON GEOCHEM HLTH, V32, P165, DOI 10.1007/s10653-009-9272-3; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhao XB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-92	122	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192362	10.1371/journal.pone.0192362	http://dx.doi.org/10.1371/journal.pone.0192362			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394277	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400038
J	Dalinjong, PA; Wang, AY; Homer, CSE				Dalinjong, Philip Ayizem; Wang, Alex Y.; Homer, Caroline S. E.			Has the free maternal health policy eliminated out of pocket payments for maternal health services? Views of women, health providers and insurance managers in Northern Ghana	PLOS ONE			English	Article							ANTENATAL CARE; DELIVERY; INDIA; EXPENDITURE; BANGLADESH; COST	Introduction The free maternal health policy was implemented in Ghana in 2008 under the National Health Insurance Scheme (NHIS). The policy sought to eliminate out of pocket (OOP) payments and enhance the utilisation of maternal health services. It is unclear whether the policy had altered OOP payments for services. The study explored views on costs and actual OOP payments during pregnancy. The source of funding for payments was also explored. Methods A convergent parallel mixed methods design, involving quantitative and qualitative data collection approaches. The study was set in the Kassena-Nankana municipality, a rural area in Ghana. Women (n = 406) who utilised services during pregnancy were surveyed. Also, 10 focus groups discussions (FGDs) were held with women who used services during pregnancy as well as 28 in-depth interviews (IDIs) with midwives/nurses (n = 25) and insurance managers/directors (n = 3). The survey was analysed using descriptive statistics, focussing on costs from the women's perspective. Qualitative data were audio recorded, transcribed and translated verbatim into English where necessary. The transcripts were read and coded into themes and sub-themes. Results The NHIS did not cover all expenses in relation to maternal health services. The overall mean for OOP cost during pregnancy was GH cent 17.50 (US$8.60). Both FGDs and IDIs showed that women especially paid for drugs and ultrasound scan services. Sixty-five percent of the women used savings, whilst twenty-two percent sold assets to meet the OOP cost. Some women were unable to afford payments due to poverty and had to forgo treatment. Participants called for payments to be eliminated and for the NHIS to absorb the cost of emergency referrals. All participants admitted the benefits of the policy. Conclusion Women needed to make payments despite the policy. Measures should be put in place to eliminate payments to enable all women to receive services and promote universal health coverage.	[Dalinjong, Philip Ayizem; Wang, Alex Y.; Homer, Caroline S. E.] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia	University of Technology Sydney	Dalinjong, PA (corresponding author), Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia.	PhilipAyizem.Dalinjong@student.uts.edu.au	Dalinjong, Philip Ayizem/M-4564-2015	Dalinjong, Philip Ayizem/0000-0002-7982-9975	University of Technology Sydney (UTS), New South Wales, Australia; UTS World Health Organisation Collaborating Centre for Nursing, Midwifery and Health Development	University of Technology Sydney (UTS), New South Wales, Australia; UTS World Health Organisation Collaborating Centre for Nursing, Midwifery and Health Development	The University of Technology Sydney (UTS), New South Wales, Australia, awarded two PhD scholarships to the first author for the study of a doctoral degree. The UTS World Health Organisation Collaborating Centre for Nursing, Midwifery and Health Development also awarded a Travel Scholarship to support data collection for this study.	Amoakoh-Coleman M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007810; [Anonymous], 2012, GHAN STAT SERV 2010; Arthur E, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-14; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Borghi J, 2006, J HEALTH POPUL NUTR, V24, P446; Creswell J. W., 2014, RES DESIGN QUALITATI, V4th; Dalaba MA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0659-1; Der EM, 2013, GHANA MED J, V47; Dixon J, 2014, TROP MED INT HEALTH, V19, P98, DOI 10.1111/tmi.12223; Dzakpasu S, 2013, HLTH POLICY PLANNING; Ghana Statistical Service (GSS), 2014, 2010 POP HOUS CENS D; GHS, 2014, ANN REP 2014; Gorstein J, 2007, INDICATORS METHODS C; Govil D, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0051-3; GSS (Ghana Statistical Service), 2015, GHAN POV MAPP REP; Gumanga SK, 2011, GHANA MED J TRENDS M, V45; Hatt LE, 2013, J HEALTH POPUL NUTR, V31, P67; Hoque ME, 2015, TROP MED INT HEALTH, V20, P1368, DOI 10.1111/tmi.12546; Institute for Health Metrics and Evaluation (IHME), 2015, HLTH SERV PROV GHAN; Kalu-Umeh Nnennaya N, 2013, Int J MCH AIDS, V2, P163; Kerketta S., 2015, INT J REPROD CONTRAC, V4, P1704, DOI [10.18203/2320-1770.ijrcog20151126, DOI 10.18203/2320-1770.IJRCOG20151126]; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lee QY, 2012, ACTA OBSTET GYN SCAN, V91, P87, DOI 10.1111/j.1600-0412.2011.01249.x; Leone T, 2013, MATERN CHILD HLTH J, V17, P1622, DOI 10.1007/s10995-012-1174-9; Amaya-Lara JL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0472-z; Manthalu G, 2016, HLTH POLICY PLANNING; MOH, 2014, HOL ASS 2014 PROGR W; NHIA, 2015, NHIS SUBSCR HDB GUID; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Rahman MM, 2013, INT Q COMMUNITY HEAL, V33, P143, DOI 10.2190/IQ.33.2.d; Saksena P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001701; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; UN, 2019, IMPROVING SUSTAINABL; UN, 2015, TRENDS MAT MORT 1999; Weeks A, 2016, LANCET, V388, P2574, DOI 10.1016/S0140-6736(16)32233-4; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2007, WHO REC INT IMPR MAT; Xu K, DESIGNING HLTH FINAN; 2010, WORLD HLTH REP 2010, P1	39	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0184830	10.1371/journal.pone.0184830	http://dx.doi.org/10.1371/journal.pone.0184830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389995	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400002
J	Han, JH; Harmoney, KM; Dokmeci, E; Torrez, J; Chavez, CM; de Ortega, LC; Kuttesch, JF; Muller, M; Winter, SS				Han, Jennifer H.; Harmoney, Kathryn M.; Dokmeci, Elif; Torrez, Jacqueline; Chavez, Cathy M.; de Ortega, Loretta Cordova; Kuttesch, John F.; Muller, Martha; Winter, Stuart S.			Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STANDARD CHEMOTHERAPY; HUMORAL IMMUNITY; CHILDREN; VACCINATION; COMPLETION; THERAPY; IMMUNODEFICIENCY; REVACCINATION; ANTIBODIES	There are no universally approved re-vaccination guidelines for non-transplant pediatric cancer survivors. We hypothesized that by utilizing a response-based re-vaccination schedule, we could tailor vaccine schedules in off-treatment cancer survivors. Pre-vaccination antibody levels were obtained in 7 patients at an average of 20 days after the end of treatment date. In those without protective antibody levels, we administered vaccines 3 months after completion of treatment. Revaccinating patients 3 months after the end of treatment date resulted in protective antibody levels for most vaccines. We showed, on a preliminary basis, that vaccinating non-transplanted pediatric cancer survivors can be dynamically implemented in children with recovering immune function.	[Han, Jennifer H.; de Ortega, Loretta Cordova] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Harmoney, Kathryn M.] Univ Iowa, Dept Pediat, Stead Family Childrens Hosp, Div Hematol Oncol, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Dokmeci, Elif] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Allergy Immunol, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Torrez, Jacqueline; Chavez, Cathy M.; Kuttesch, John F.] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Hematol Oncol, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Muller, Martha] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Infect Dis, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Winter, Stuart S.] Childrens Hosp & Clin Minnesota, Canc & Blood Disorders Program, 2525 Chicago Ave South, Minneapolis, MN USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of Iowa; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Children's Hospitals & Clinics of Minnesota	Han, JH (corresponding author), Univ New Mexico, Dept Pediat, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA.; Harmoney, KM (corresponding author), Univ Iowa, Dept Pediat, Stead Family Childrens Hosp, Div Hematol Oncol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jhhan@salud.unm.edu; kathryn-harmoney@uiowa.edu						Brodtman DH, 2005, J PEDIATR-US, V146, P654, DOI 10.1016/j.jpeds.2004.12.043; Caver TE, 1998, LEUKEMIA, V12, P619, DOI 10.1038/sj.leu.2400970; DEVAAN GAM, 1982, EUR J PEDIATR, V139, P113, DOI 10.1007/BF00441492; Ercan TE, 2005, J PEDIAT HEMATOL ONC, V27, P273, DOI 10.1097/01.mph.0000163214.37147.5a; Esposito S, 2010, VACCINE, V28, P3278, DOI 10.1016/j.vaccine.2010.02.096; KOMADA Y, 1992, CANCER IMMUNOL IMMUN, V35, P271, DOI 10.1007/BF01789334; Lehrnbecher T, 2011, BRIT J HAEMATOL, V152, P754, DOI 10.1111/j.1365-2141.2010.08522.x; Ljungman P, 1999, BONE MARROW TRANSPL, V23, P635, DOI 10.1038/sj.bmt.1701641; Mackall CL, 2000, STEM CELLS, V18, P10, DOI 10.1634/stemcells.18-1-10; Nilsson A, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e91; Patel SR, 2007, CLIN INFECT DIS, V44, P635, DOI 10.1086/511636; Reinhardt D, 2003, SCAND J INFECT DIS, V35, P851, DOI 10.1080/00365540310016600; RIDGWAY D, 1991, AM J DIS CHILD, V145, P887, DOI 10.1001/archpedi.1991.02160080065022; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; Ruggiero A, 2011, PEDIATR BLOOD CANCER, V57, P1104, DOI 10.1002/pbc.23333; Shetty AK, 2012, OCHSNER J, V12, P228; van Tilburg CM, 2006, LEUKEMIA, V20, P1717, DOI 10.1038/sj.leu.2404326; Zignol M, 2004, CANCER-AM CANCER SOC, V101, P635, DOI 10.1002/cncr.20384	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191804	10.1371/journal.pone.0191804	http://dx.doi.org/10.1371/journal.pone.0191804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389976	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400038
J	Matcho, A; Ryan, P; Fife, D; Gifkins, D; Knoll, C; Friedman, A				Matcho, Amy; Ryan, Patrick; Fife, Daniel; Gifkins, Dina; Knoll, Chris; Friedman, Andrew			Inferring pregnancy episodes and outcomes within a network of observational databases	PLOS ONE			English	Article							MEDICAL-RECORDS; HEALTH; ALGORITHM; QUALITY; SYSTEM; TOOLS; WOMEN	Administrative claims and electronic health records are valuable resources for evaluating pharmaceutical effects during pregnancy. However, direct measures of gestational age are generally not available. Establishing a reliable approach to infer the duration and outcome of a pregnancy could improve pharmacovigilance activities. We developed and applied an algorithm to define pregnancy episodes in four observational databases: three US-based claims databases: Truven MarketScan (R) Commercial Claims and Encounters (CCAE), Truven MarketScan (R) Multi-state Medicaid (MDCD), and the Optum ClinFormatics (R) (Optum) database and one non-US database, the United Kingdom (UK) based Clinical Practice Research Datalink (CPRD). Pregnancy outcomes were classified as live births, stillbirths, abortions and ectopic pregnancies. Start dates were estimated using a derived hierarchy of available pregnancy markers, including records such as last menstrual period and nuchal ultrasound dates. Validation included clinical adjudication of 700 electronic Optum and CPRD pregnancy episode profiles to assess the operating characteristics of the algorithm, and a comparison of the algorithm's Optum pregnancy start estimates to starts based on dates of assisted conception procedures. Distributions of pregnancy outcome types were similar across all four data sources and pregnancy episode lengths found were as expected for all outcomes, excepting term lengths in episodes that used amenorrhea and urine pregnancy tests for start estimation. Validation survey results found highest agreement between reviewer chosen and algorithm operating characteristics for questions assessing pregnancy status and accuracy of outcome category with 99-100% agreement for Optum and CPRD. Outcome date agreement within seven days in either direction ranged from 95-100%, while start date agreement within seven days in either direction ranged from 90-97%. In Optum validation sensitivity analysis, a total of 73% of algorithm estimated starts for live births were in agreement with fertility procedure estimated starts within two weeks in either direction; ectopic pregnancy 77%, stillbirth 47%, and abortion 36%. An algorithm to infer live birth and ectopic pregnancy episodes and outcomes can be applied to multiple observational databases with acceptable accuracy for further epidemiologic research. Less accuracy was found for start date estimations in stillbirth and abortion outcomes in our sensitivity analysis, which may be expected given the nature of the outcomes.	[Matcho, Amy; Knoll, Chris] Janssen Res & Dev LLC, Epidemiol Analyt, Raritan, NJ 08869 USA; [Ryan, Patrick; Fife, Daniel; Gifkins, Dina] Janssen Res & Dev LLC, Epidemiol, Titusville, NJ USA; [Friedman, Andrew] Janssen Res & Dev LLC, Global Labeling, Titusville, NJ USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Matcho, A (corresponding author), Janssen Res & Dev LLC, Epidemiol Analyt, Raritan, NJ 08869 USA.	Amatcho@its.jnj.com	Ryan, Patrick/HDO-1133-2022		Janssen Research and Development, LLC	Janssen Research and Development, LLC	At the time of work the authors, AM, PR, DF, DG, CK and AF were full-time employees of Janssen Research and Development, LLC, 920 US Route 202, Raritan, NJ, 08869, USA and stockholders of Johnson & Johnson. Janssen Research and Development is a unit of Johnson & Johnson. Janssen Research and Development, LLC provided support in the form of salaries for authors (AM, PR, DF, DG, CK and AF) and access to pre-collected observational databases, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P546, DOI 10.1002/pds.1235; Andrade SE, 2016, ARCH WOMEN MENT HLTH, V19, P969, DOI 10.1007/s00737-016-0637-1; Cea-Soriano L, 2013, PHARMACOEPIDEM DR S, V22, P977, DOI 10.1002/pds.3472; Devine S, 2010, PHARMACOEPIDEM DR S, V19, P45, DOI 10.1002/pds.1862; Hardy JR, 2004, PHARMACOEPIDEM DR S, V13, P749, DOI 10.1002/pds.935; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; Li Q, 2013, PHARMACOEPIDEM DR S, V22, P524, DOI 10.1002/pds.3407; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Matcho A, 2014, DRUG SAFETY; Mikolajczyk RT, 2013, PHARMACOEPIDEM DR S, V22, P873, DOI 10.1002/pds.3467; Observational Health Data Sciences and Informatics, 2016, OMOP COMM DAT MOD; Reich C, 2012, J BIOMED INFORM, V45, P689, DOI 10.1016/j.jbi.2012.05.002; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Scholes D, 2011, HUM REPROD, V26, P3163, DOI 10.1093/humrep/der299; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Taylor LG, 2015, PHARMACOEPIDEM DR S, V24, P510, DOI 10.1002/pds.3759; Voss EA, 2015, J AM MED INFORM ASSN, V22, P553, DOI 10.1093/jamia/ocu023	17	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							0192033	10.1371/journal.pone.0192033	http://dx.doi.org/10.1371/journal.pone.0192033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389968	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400053
J	Meza-Lopez, MM; Mooney, KA; Thompson, AL; Ho, NK; Pratt, JD				Meza-Lopez, Maria M.; Mooney, Kailen A.; Thompson, Amanda L.; Ho, Nicole K.; Pratt, Jessica D.			A test for clinal variation in Artemisia californica and associated arthropod responses to nitrogen addition	PLOS ONE			English	Article							COASTAL SAGE SCRUB; CLIMATE-CHANGE; TERRESTRIAL ECOSYSTEMS; SPECIES INTERACTIONS; SEMIARID SHRUBLANDS; ALTERED WATER; NATIVE SHRUB; N DEPOSITION; PLANT; COMMUNITY	The response of plant traits to global change is of fundamental importance to understanding anthropogenic impacts on natural systems. Nevertheless, little is known about plant genetic variation in such responses or the indirect effect of environmental change on higher trophic levels. In a three-year common garden experiment, we grew the shrub Artemisia californica from five populations sourced along a 700 km latitudinal gradient under ambient and nitrogen (N) addition (20 kg N ha(-1)) and measured plant traits and associated arthropods. N addition increased plant biomass to a similar extent among all populations. In contrast, N addition effects on most other plant traits varied among plant populations; N addition reduced specific leaf area and leaf percent N and increased carbon to nitrogen ratios in the two northern populations, but had the opposite or no effect on the three southern populations. N addition increased arthropod abundance to a similar extent among all populations in parallel with an increase in plant biomass, suggesting that N addition did not alter plant resistance to herbivores. N addition had no effect on arthropod diversity, richness, or evenness. In summary, genetic variation among A. californica populations mediated leaf-trait responses to N addition, but positive direct effects of N addition on plant biomass and indirect effects on arthropod abundance were consistent among all populations.	[Meza-Lopez, Maria M.; Mooney, Kailen A.; Thompson, Amanda L.; Ho, Nicole K.; Pratt, Jessica D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Pratt, JD (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	jdpratt@uci.edu		Meza-Lopez, Maria/0000-0002-8120-4747	Ford Foundation Postdoctoral Fellowship; National Science Foundation [NSF-DEB-1354734, NSF-GK12 DGE-0638751]; Environmental Protection Agency [EPA-STAR FP-91724101]; UC-Irvine Graduate Division; Newkirk Center for Science Society; Orange County Association of Environmental Professionals; Newport Bay Conservancy; Lake Forest Garden Club	Ford Foundation Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); UC-Irvine Graduate Division; Newkirk Center for Science Society; Orange County Association of Environmental Professionals; Newport Bay Conservancy; Lake Forest Garden Club	MMML was supported by a Ford Foundation Postdoctoral Fellowship (http://sites.nationalacademies.org/PGA/FordFellowships/index.htm). KAM received a research grant from National Science Foundation NSF-DEB-1354734 (https://www.nsf.gov/). Fellowship assistance was provided to JDP from National Science Foundation NSF-GK12 DGE-0638751 (https://www.nsf.gov), and Environmental Protection Agency EPA-STAR FP-91724101 (https://www.nsf.gov/), and the UC-Irvine Graduate Division, as well as grants from the Newkirk Center for Science & Society, Orange County Association of Environmental Professionals, Newport Bay Conservancy, and the Lake Forest Garden Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank L. Liu, A. Datu, S. Luu, C. Hertler, and D. Tran for help with field data collection. The UC Irvine Arboretum provided logistical support and space for plant propagation; Orange County Parks provided logistical support and storage space at our field site. This work was supported by grants to JDP from the Newkirk Center for Science & Society, Orange County Association of Environmental Professionals, Newport Bay Conservancy, and the Lake Forest Garden Club. MMML was supported by a Ford Foundation Postdoctoral Fellowship. A research grant to KAM was provided by NSF-DEB-1354734. Fellowship assistance to JDP was provided by NSF-GK12 DGE-0638751, EPA-STAR FP-91724101, and the UC-Irvine Graduate Division. This publication has not been formally reviewed by the EPA; the views expressed herein are solely those of the authors.	Allen EB, 1998, NITROGEN DEPOSITION, P131; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Burger JC, 2003, CONSERV BIOL, V17, P460, DOI 10.1046/j.1523-1739.2003.01325.x; Bytnerowicz A, 1996, ENVIRON POLLUT, V92, P127, DOI 10.1016/0269-7491(95)00106-9; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; DAVIS FW, 1994, J VEG SCI, V5, P743, DOI 10.2307/3235887; Egerton-Warburton LM, 2000, ECOL APPL, V10, P484, DOI 10.1890/1051-0761(2000)010[0484:SIAMCA]2.0.CO;2; Egerton-Warburton LM, 2007, ECOL MONOGR, V77, P527, DOI 10.1890/06-1772.1; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Gornish ES, 2013, AM J BOT, V100, P1422, DOI 10.3732/ajb.1300046; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kimball S, 2014, ECOL APPL, V24, P1390, DOI 10.1890/13-1313.1; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Meza-Lopez MM, 2017, PLANT ECOL, V218, P835, DOI 10.1007/s11258-017-0733-y; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Nahum S, 2008, TREE GENET GENOMES, V4, P777, DOI 10.1007/s11295-008-0150-4; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Pivovaroff AL, 2016, OECOLOGIA, V181, P721, DOI 10.1007/s00442-016-3609-2; Poyry J, 2017, GLOBAL ECOL BIOGEOGR, V26, P18, DOI 10.1111/geb.12521; Pratt JD, 2017, ECOLOGY, V98, P79, DOI 10.1002/ecy.1620; Pratt JD, 2014, OIKOS, V123, P953, DOI 10.1111/oik.01156; Pratt JD, 2013, GLOBAL CHANGE BIOL, V19, P2454, DOI 10.1111/gcb.12199; Rasband WS, 1997, IMAGE J; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; SAS Institute, 2010, STAT AN SOFTW; Schwede D.B., 2014, ATMOS ENVIRON, V92, P207, DOI [DOI 10.1016/j.atmosenv.2014.04.008, 10.1016/j.atmosenv.2014.04.008]; Siguenza C, 2006, PLANT SOIL, V286, P153, DOI 10.1007/s11104-006-9034-2; Smith BM, 2009, RESTOR ECOL, V17, P12, DOI 10.1111/j.1526-100X.2007.00327.x; Thompson JD, 2007, ECOL MONOGR, V77, P421, DOI 10.1890/06-1973.1; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valliere JM, 2017, GLOBAL CHANGE BIOL, P1; Vourlitis GL, 2012, J ARID ENVIRON, V82, P115, DOI 10.1016/j.jaridenv.2012.02.006; Vourlitis GL, 2007, ECOSYSTEMS, V10, P263, DOI 10.1007/s10021-007-9030-2; Vourlitis GL, 2017, OECOLOGIA, V184, P267, DOI 10.1007/s00442-017-3860-1; White T.C, 2012, INADEQUATE ENV NITRO; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; Wolkovich EM, 2010, ECOLOGY, V91, P756, DOI 10.1890/09-0147.1	45	0	0	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191997	10.1371/journal.pone.0191997	http://dx.doi.org/10.1371/journal.pone.0191997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390030	Green Published, gold			2022-12-27	WOS:000423793400048
J	Wassmann, R; Alberto, MC; Tirol-Padre, A; Hoang, NT; Romasanta, R; Centeno, CA; Sander, BO				Wassmann, Reiner; Alberto, Ma. Carmelita; Tirol-Padre, Agnes; Nghia Trong Hoang; Romasanta, Ryan; Centeno, Caesar Arloo; Sander, Bjoern Ole			Increasing sensitivity of methane emission measurements in rice through deployment of 'closed chambers' at nighttime	PLOS ONE			English	Article							DIFFERENT GROWTH-STAGES; DIURNAL-VARIATION; EDDY COVARIANCE; ROOT EXUDATION; CH4 EMISSIONS; FIELDS; CULTIVARS; IMPACT; TEMPERATURE; TRANSPORT	This study comprises field experiments on methane emissions from rice fields conducted with an Eddy-Covariance (EC) system as well as test runs for a modified closed chamber approach based on measurements at nighttime. The EC data set covers 4 cropping seasons with highly resolved emission rates (raw data in 10 Hz frequency have been aggregated to 30-min records). The diel patterns were very pronounced in the two dry seasons with peak emissions at early afternoon and low emissions at nighttime. These diel patterns were observed at all growing stages of the dry seasons. In the two wet seasons, the diel patterns were only visible during the vegetative stages while emission rates during reproductive and ripening stages remained within a fairly steady range and did not show any diel patterns. In totality, however, the data set revealed a very strong linear relationship between nocturnal emissions (12-h periods) and the full 24-h periods resulting in an R-2-value of 0.8419 for all data points. In the second experiment, we conducted test runs for chamber measurements at nighttime with much longer deployment times (6 h) as compared to measurements at daylight (typically for 30 min). Conducting chamber measurements at nighttime excluded drastic changes of temperatures and CO2 concentrations. The data also shows that increases in CH4 concentrations remained on linear trajectory over a 6h period at night. While end CH4 concentrations were consistently >3.5 ppm, this long-term enclosure represents a very robust approach to quantify emissions as compared to assessing short-term concentration increases over time near the analytical detection limit. Finally, we have discussed the potential applications of this new approach that would allow emission measurements even when conventional (daytime) measurements will not be suitable. Nighttime chamber measurements offer an alternative to conventional (daytime) measurements if either (i) baseline emissions are at a very low level, (ii) differences of tested crop treatments or varieties are very small or (iii) the objective is to screen a large number of rice varieties for taking advantage of progress in genome sequencing.	[Wassmann, Reiner; Alberto, Ma. Carmelita; Tirol-Padre, Agnes; Romasanta, Ryan; Centeno, Caesar Arloo; Sander, Bjoern Ole] Int Rice Res Inst, Los Banos, Philippines; [Wassmann, Reiner] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Garmisch Partenkirchen, Germany; [Nghia Trong Hoang] Hue Univ Agr & Forestry, Hue City, Vietnam	CGIAR; International Rice Research Institute (IRRI); Helmholtz Association; Karlsruhe Institute of Technology; Hue University	Wassmann, R (corresponding author), Int Rice Res Inst, Los Banos, Philippines.; Wassmann, R (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Garmisch Partenkirchen, Germany.	r.wassmann@irri.org	Nghia, Hoang Trong/AAK-4905-2021	Nghia, Hoang Trong/0000-0002-6700-7018	CGIAR Research Program on Rice Agri-Food Systems (RICE); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS); Climate and Clean Air Coalition to Reduce Short-lived Climate Pollutants (CCAC); Climate, Food and Farming (CLIFF) Network, an initiative of CCAFS; Climate, Food and Farming (CLIFF) Network; Climate, Food and Farming (CLIFF) Network [C-079-17]; CGIAR RICE agrifood research program [CRP 15]; Climate and Clean Air Coalition (CCAC) [DTIE16-EN050]	CGIAR Research Program on Rice Agri-Food Systems (RICE)(CGIAR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); Climate and Clean Air Coalition to Reduce Short-lived Climate Pollutants (CCAC); Climate, Food and Farming (CLIFF) Network, an initiative of CCAFS; Climate, Food and Farming (CLIFF) Network; Climate, Food and Farming (CLIFF) Network; CGIAR RICE agrifood research program(CGIAR); Climate and Clean Air Coalition (CCAC)	This work was funded through a grant from the Climate, Food and Farming (CLIFF) Network, implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements (Agreement #:C-079-17). For details please visit https://ccafs.cgiar.org/donors. The views expressed in this document cannot be taken to reflect the official opinions of these organizations. This work was further supported through the CGIAR RICE agrifood research program (CRP 15). The position of B.O. Sander at IRRI was funded by the Climate and Clean Air Coalition (CCAC) to reduce short-lived climate pollutants (DTIE16-EN050).	Alberto MCR, 2014, FIELD CROP RES, V160, P12, DOI 10.1016/j.fcr.2014.02.008; Alberto MCR, 2012, FIELD CROP RES, V134, P80, DOI 10.1016/j.fcr.2012.05.002; [Anonymous], GEOPHYS RES LETT; Aulakh MS, 2001, PLANT SOIL, V230, P77, DOI 10.1023/A:1004817212321; Aulakh MS, 2000, NUTR CYCL AGROECOSYS, V58, P367, DOI 10.1023/A:1009839929441; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Buendia LV, 1998, CHEMOSPHERE, V36, P395, DOI 10.1016/S0045-6535(97)00283-X; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Centeno CAR, 2017, ATMOS ENVIRON, V167, P23, DOI 10.1016/j.atmosenv.2017.08.007; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Das K, 2008, PHYSIOL PLANTARUM, V134, P303, DOI 10.1111/j.1399-3054.2008.01137.x; Ding A, 1999, GLOBAL BIOGEOCHEM CY, V13, P1045, DOI 10.1029/1999GB900084; Eggleston S., 2006, 2006 IPCC GUIDELINES; Gogoi N, 2008, AGRON SUSTAIN DEV, V28, P181, DOI 10.1051/agro:2008005; Gutierrez J, 2014, BIOL FERT SOILS, V50, P861, DOI 10.1007/s00374-014-0904-0; Gutierrez J, 2013, FIELD CROP RES, V146, P16, DOI 10.1016/j.fcr.2013.03.003; Hatala JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051303; Hosono T, 1997, PLANT SOIL, V191, P233, DOI 10.1023/A:1004203208686; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Komiya S, 2015, INT SCHOLARLY RES NO; Kumar JIN, 2009, PADDY WATER ENVIRON, V7, P11, DOI 10.1007/s10333-008-0147-5; Lu Y, 1999, BIOGEOCHEMISTRY, V47, P203, DOI 10.1007/bf00994923; Ma K, 2010, GLOBAL CHANGE BIOL, V16, P3085, DOI 10.1111/j.1365-2486.2009.02145.x; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Minamikawa K., 2012, GREENHOUSE GAS MEAS, V2, P118, DOI DOI 10.1080/20430779.2012.729988; Minamikawa K., 2015, GUIDELINES MEASURING; Neue H.U., 1994, NIAES SERIES, V2, P55; Qin XB, 2015, J INTEGR ENVIRON SCI, V12, P47, DOI 10.1080/1943815X.2015.1118388; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ripp J, 1996, ANAL DETECTION LIMIT; Rolston D.E., 1986, METHODS SOIL ANAL 1; Sander B.O., 2014, GREENH GAS MEAS MANA; SAS Institute Inc, 2011, SASQC R 93 USERS GUI, P1313; Sass RL, 1991, GLOBAL BIOGEOCHEM CY, V5, P335, DOI 10.1029/91GB02586; Satpathy SN, 1997, PLANT SOIL, V195, P267, DOI 10.1023/A:1004202515767; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; SIMPSON IJ, 1995, J GEOPHYS RES-ATMOS, V100, P7283, DOI 10.1029/94JD03326; Soil Survey Staff, 2010, KEYS SOIL TAXONOMY, Veleventh; Su J, 2015, NATURE, V523, P602, DOI 10.1038/nature14673; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599; Wang B, 2000, NUTR CYCL AGROECOSYS, V58, P349, DOI 10.1023/A:1009879610785; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P107, DOI 10.1023/A:1009838401699; Weller S, 2015, J PLANT NUTR SOIL SC, V178, P755, DOI 10.1002/jpln.201500092; Yagi K, 1997, NUTR CYCL AGROECOSYS, V49, P213, DOI 10.1023/A:1009743909716; Yang SS, 1999, AGR ECOSYST ENVIRON, V76, P75, DOI 10.1016/S0167-8809(99)00074-2; Yang W, 2008, AGRON J, V100, P1390, DOI 10.2134/agronj2007.0356; Yu LF, 2013, ENVIRON POLLUT, V181, P81, DOI 10.1016/j.envpol.2013.06.018	48	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191352	10.1371/journal.pone.0191352	http://dx.doi.org/10.1371/journal.pone.0191352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390000	Green Published, gold			2022-12-27	WOS:000423793400017
J	Di Paola, N; Freire, CCD; Zanotto, PMD				Di Paola, Nicholas; de Melo Freire, Caio Cesar; de Andrade Zanotto, Paolo Marinho			Does adaptation to vertebrate codon usage relate to flavivirus emergence potential?	PLOS ONE			English	Article							WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUSES; HUMAN HOUSEKEEPING GENES; TIME RT-PCR; MOLECULAR EVOLUTION; YELLOW-FEVER; LINEAGE 2; RIG-I; HOST; BIAS	Codon adaptation index (CAI) is a measure of synonymous codon usage biases given a usage reference. Through mutation, selection, and drift, viruses can optimize their replication efficiency and produce more offspring, which could increase the chance of secondary transmission. To evaluate how higher CAI towards the host has been associated with higher viral titers, we explored temporal trends of several historic and extensively sequenced zoonotic flaviviruses and relationships within the genus itself. To showcase evolutionary and epidemiological relationships associated with silent, adaptive synonymous changes of viruses, we used codon usage tables from human housekeeping and antiviral immune genes, as well as tables from arthropod vectors and vertebrate species involved in the flavivirus maintenance cycle. We argue that temporal trends of CAI changes could lead to a better understanding of zoonotic emergences, evolutionary dynamics, and host adaptation. CAI appears to help illustrate historically relevant trends of well-characterized viruses, in different viral species and genetic diversity within a single species. CAI can be a useful tool together with in vivo and in vitro kinetics, phylodynamics, and additional functional genomics studies to better understand species trafficking and viral emergence in a new host.	[Di Paola, Nicholas; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil; [de Melo Freire, Caio Cesar] UFSCar Fed Univ Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Zanotto, PMD (corresponding author), Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [441105/2016-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/22136-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	P.M.A.Z received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://cnpq.br/), grant number 441105/2016-5. N.D. received funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://fapesp.br/), grant number 2013/22136-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allison AB, 2004, EMERG INFECT DIS, V10, P2252, DOI 10.3201/eid1012.040511; Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bagnarelli P., 2011, EUROSURVEILLANCE, V2011, P16; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910; Behura SK, 2014, MOL GENET GENOMICS, V289, P885, DOI 10.1007/s00438-014-0857-x; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781; Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Day T, 2001, FITNESS, P1; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis AP, 2003, EMERG INFECT DIS, V9, P860; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fall G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006078; Fall G, 2014, AM J TROP MED HYG, V90, P747, DOI 10.4269/ajtmh.13-0405; Freire CCdM, 2015, SPREAD PANDEMIC ZIKA; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gould E.A, 1997, GENETIC EVOLUTION FL; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Hoshino K, 2012, J MED ENTOMOL, V49, P175, DOI 10.1603/ME11123; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; LIU ZY, 2016, ELIFE, V5, DOI DOI 10.7554/ELIFE.17636; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Magassouba N, 2015, PLOS MED, V12, P1; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; McMullen AR, 2013, J GEN VIROL, V94, P318, DOI 10.1099/vir.0.046888-0; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pachler K, 2014, EMERG INFECT DIS, V20, P2119, DOI 10.3201/eid2012.140921; Papa A, 2010, EUROSURVEILLANCE, V15; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Sall AA, 2010, J VIROL, V84, P765, DOI 10.1128/JVI.01738-09; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112; Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15; Shin YC, 2015, P NATL ACAD SCI USA, V112, P14030, DOI 10.1073/pnas.1515387112; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; Urrutia AO, 2001, GENETICS, V159, P1191; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zanotto PMD, 1999, GENETICS, V153, P1077; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	92	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191652	10.1371/journal.pone.0191652	http://dx.doi.org/10.1371/journal.pone.0191652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385205	gold, Green Submitted, Green Published			2022-12-27	WOS:000423668400051
J	Hiwaki, O; Miyaguchi, H				Hiwaki, Osamu; Miyaguchi, Hideki			Noninvasive measurement of dynamic brain signals using light penetrating the brain	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED RESPONSES; FAST OPTICAL SIGNAL; FMRI; ACTIVATION; SCATTERING; SYNCHRONY	Conventional techniques for the noninvasive measurement of brain activity involve critical limitations in spatial or temporal resolution. Here, we propose the method for noninvasive brain function measurement with high spatiotemporal resolution using optical signals. We verified that diffused near-infrared light penetrating through the upper jaw and into the skull, which we term as optoencephalography (OEG), leads to the detection of dynamic brain signals that vary concurrently with the electrophysiological neural activity. We measured the OEG signals following the stimulation of the median nerve in common marmosets. The OEG signal response was tightly coupled with the electrophysiological response represented by the somatosensory evoked potential (SSEP). The OEG measurement is also shown to offer rather clear discrimination of brain signals.	[Hiwaki, Osamu] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Japan; [Miyaguchi, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Hiwaki, O (corresponding author), Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Japan.	hiwaki@hiroshima-cu.ac.jp	HIWAKI, OSAMU/AAI-3096-2020	Hiwaki, Osamu/0000-0003-4628-390X	CASIO Science Promotion Foundation; Hiroshima City University Grant for Special Academic Research (General Studies)	CASIO Science Promotion Foundation; Hiroshima City University Grant for Special Academic Research (General Studies)	This work was supported in part by CASIO Science Promotion Foundation, and Hiroshima City University Grant for Special Academic Research (General Studies) to OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; FENG SC, 1995, APPL OPTICS, V34, P3826, DOI 10.1364/AO.34.003826; Foust AJ, 2007, NEUROSCIENCE, V145, P887, DOI 10.1016/j.neuroscience.2006.12.068; GOFF WR, 1962, ELECTROEN CLIN NEURO, V14, P697, DOI 10.1016/0013-4694(62)90084-6; Gratton G, 1997, NEUROIMAGE, V6, P168, DOI 10.1006/nimg.1997.0298; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P505, DOI 10.1111/j.1469-8986.1995.tb02102.x; He Bin, 2008, IEEE Rev Biomed Eng, V1, P23, DOI 10.1109/RBME.2008.2008233; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Radhakrishnan H, 2009, NEUROIMAGE, V45, P410, DOI 10.1016/j.neuroimage.2008.12.014; Steinbrink J, 2005, NEUROIMAGE, V26, P996, DOI 10.1016/j.neuroimage.2005.03.006; STEPNOSKI RA, 1991, P NATL ACAD SCI USA, V88, P9382, DOI 10.1073/pnas.88.21.9382; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Yao XC, 2005, BIOPHYS J, V88, P4170, DOI 10.1529/biophysj.104.052506	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192095	10.1371/journal.pone.0192095	http://dx.doi.org/10.1371/journal.pone.0192095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385211	Green Published, gold, Green Submitted			2022-12-27	WOS:000423668400076
J	Jaiswal, P; Datta, S; Sardar, B; Chaudhuri, SJ; Maji, D; Ghosh, M; Saha, B; Mukhopadhyay, S				Jaiswal, Priyank; Datta, Souvik; Sardar, Bikash; Chaudhuri, Surya Jyoti; Maji, Dipankar; Ghosh, Manab; Saha, Bibhuti; Mukhopadhyay, Sumi			Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India	PLOS ONE			English	Article							AZAR DERMAL LEISHMANIASIS; LINKED-IMMUNOSORBENT-ASSAY; KALA-AZAR; VISCERAL LEISHMANIASIS; RHEUMATOID-ARTHRITIS; FIELD DIAGNOSIS; GLYCOSYLATION; ANTIBODIES; DONOVANI; ANTIGEN	Background Post Kala Azar Dermal Leishmaniasis (PKDL) occurs as dermal consequence of previous Visceral Leishmaniasis (VL) infection and serves as an important reservoir for transmission of VL. Diagnosis of PKDL is often challenging for its symptomatic resemblance to other coendemic diseases like Leprosy or Vitiligo. Parasitological examination by slit-skin smear and culture are the standard methods but lack high sensitivity. Thus, for efficient control of VL, reliable diagnostic and prognostic assay of PKDL are required. Objective Previously, glycoproteins (9-OAcSA) have been reported as promising biomarkers of Indian VL patients. However, till date, the status of glycans in Indian PKDL patients remains unexplored. Accordingly, in this study, the glyco-profile of PKDL Circulating Immune Complexes (CICs) as compared to other cross diseases like Vitiligo and Leprosyhas been investigated. Further, a novel Glyco CIC assay has been developed for efficient Indian PKDL patient diagnosis. Methods/principal finding In the present study, 90 PKDL patients were enrolled from 3 VL endemic districts of West Bengal during 2015 +/- 16. Glycosylation profile of isolated CICs from sera of PKDL patients were initially analyzed through gradient SDS gel electrophoresis followed by PAS silver double staining, which revealed the presence of several glycan rich PKDL specific proteins of varying molecular weights. To further characterize the glyco-profile of acid dissociated affinity purified immuno-reactive antigens present in the CICs, glycosylation was demonstrated in these purified CIC antigens by DIG glycan differentiation kit with or without glycosidase as well as neuraminidase treatment. Diagnostic evaluation of the newly developed colorimetric Glyco CIC assay through Receiver Operating Characteristic (ROC) curve analysis revealed excellent (0.99) AUC value as compared to other conventional serodiagnostic assays like PEG CIC, Parasite ELISA (IgG and IgM). Additionally, longitudinal monitoring of 18 PKDL patients further revealed its good prognostic utility. Conclusion These results highlight the glycosylation status of CICs among Indian PKDL patients present in all the studied endemic districts of West Bengal. These PKDL biomarkers were completely absent in cross diseases like Vitiligo and Leprosy. Further, the newly developed Glyco CIC assay had an improved sensitivity of 95.6%, specificity of 99.3%, NPV of 97.1% and PPV of 98.9%.	[Jaiswal, Priyank; Datta, Souvik; Mukhopadhyay, Sumi] Sch Trop Med, Dept Lab Med, Kolkata, W Bengal, India; [Sardar, Bikash; Ghosh, Manab; Saha, Bibhuti] Govt West Bengal, Sch Trop Med, Dept Trop Med, Howrah, W Bengal, India; [Chaudhuri, Surya Jyoti] Govt West Bengal, Ranaghat Sub Div Hosp, Nadia, W Bengal, India; [Maji, Dipankar] Govt West Bengal, Dept Hlth & Family Welf, Howrah, W Bengal, India	Calcutta School of Tropical Medicine (CSTM)	Mukhopadhyay, S (corresponding author), Sch Trop Med, Dept Lab Med, Kolkata, W Bengal, India.	drsumimukhopadhyay@gmail.com	DATTA, SOUVIK/AAF-7954-2021	Datta, Souvik/0000-0001-8274-2435; MUKHOPADHYAY, SUMI/0000-0003-1400-3715	Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme [YSS/2014/000934]; ICMR [5/8-7(96) V-2011-ECD-11]	Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme; ICMR(Indian Council of Medical Research (ICMR))	SM is grateful for the financial support by Science and Engineering Research Board, Department of Science and Technology, Govt of India under the Young Scientist Scheme (YSS/2014/000934) and also ICMR (file no: 5/8-7(96) V-2011-ECD-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bandyopadhyay SMN, 2008, ADV EXP MED BIOL, V625, P87; Blum JJ, 2001, J EUKARYOT MICROBIOL, V48, P102, DOI 10.1111/j.1550-7408.2001.tb00421.x; BOND A, 1990, EUR J IMMUNOL, V20, P2229, DOI 10.1002/eji.1830201011; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; CREIGHTON WD, 1973, J IMMUNOL, V111, P1219; Das NK, 2011, AM J TROP MED HYG, V84, P688, DOI 10.4269/ajtmh.2011.10-0590; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Datta S, 2015, INDIAN J EXP BIOL, V53, P321; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; Desjeux P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-196; EVANS TG, 1988, INFECT IMMUN, V56, P3139, DOI 10.1128/IAI.56.12.3139-3144.1988; Faleiro RJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002914; Fernandes R, 2006, BIOCHEM MOL BIOL EDU, V34, P294, DOI 10.1002/bmb.2006.494034042636; Ganguly S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004138; GUPTA RC, 1981, CLIN EXP IMMUNOL, V46, P9; Jamal F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182474; JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOLLER HJ, 1995, ANAL BIOCHEM, V226, P371, DOI 10.1006/abio.1995.1238; Mukhopadhyay S, 2006, INDIAN J MED RES, V123, P203; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Parveen Sameena, 2010, Indian J Dent Res, V21, P10, DOI 10.4103/0970-9290.62800; Perry D, 2013, AM J TROP MED HYG, V88, P778, DOI 10.4269/ajtmh.12-0442; Phi NC, 1988, ACTA MED HUNG, V46, P109; Raja A, 2006, DIAGN MICR INFEC DIS, V56, P281, DOI 10.1016/j.diagmicrobio.2006.06.003; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; Ramesh V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2424-8; RAMESH V, 1995, INT J DERMATOL, V34, P85, DOI 10.1111/j.1365-4362.1995.tb03584.x; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Saha P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005391; Saha S, 2005, J CLIN MICROBIOL, V43, P1269, DOI 10.1128/JCM.43.3.1269-1277.2005; Salotra P, 2003, J CLIN PATHOL, V56, P840, DOI 10.1136/jcp.56.11.840; Salotra P, 2002, CLIN DIAGN LAB IMMUN, V9, P370, DOI 10.1128/CDLI.9.2.370-373.2002; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Salotra P, 2001, BRIT J DERMATOL, V145, P630, DOI 10.1046/j.1365-2133.2001.04434.x; Salotra P., 2016, CONTAINING POSTKALA, P7; Salotra P, 2006, INDIAN J MED RES, V123, P295; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; SATA T, 1990, HISTOCHEMISTRY, V94, P1; Schomig VJ, 2016, RSC ADV, V6, P44932, DOI 10.1039/c6ra07424c; Senbagavalli P, 2012, CLIN VACCINE IMMUNOL, V19, P1965, DOI 10.1128/CVI.00437-12; Sharma M. C., 2000, Journal of Communicable Diseases, V32, P67; SINGH R P, 1968, Indian Journal of Dermatology and Venereology, V13, P59; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Singh S. K., 2005, American Journal of Immunology, V1, P96; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Thakur CP, 2016, INDIAN J MED RES, V144, P799, DOI 10.4103/ijmr.IJMR_335_16; Weissmann G, 2009, BULL HOSP JT DIS, V67, P251; WHO, 2010, WHO TECH REP SER, V949, P1; Zijlstra EE, 2000, BRIT J DERMATOL, V143, P136, DOI 10.1046/j.1365-2133.2000.03603.x; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	58	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192302	10.1371/journal.pone.0192302	http://dx.doi.org/10.1371/journal.pone.0192302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420575	gold, Green Published, Green Submitted			2022-12-27	WOS:000424517900063
J	Veesa, KS; John, KR; Moonan, PK; Kaliappan, SP; Manjunath, K; Sagili, KD; Ravichandra, C; Menon, PA; Dolla, C; Luke, N; Munshi, K; George, K; Minz, S				Veesa, Karun Sandeep; John, Kamalabhai Russell; Moonan, Patrick K.; Kaliappan, Saravanakumar Puthupalayam; Manjunath, Krishna; Sagili, Karuna D.; Ravichandra, Chinnappareddy; Menon, Pradeep Aravindan; Dolla, Chandrakumar; Luke, Nancy; Munshi, Kaivan; George, Kuryan; Minz, Shantidani			Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India	PLOS ONE			English	Article							PUBLIC-PRIVATE MIX; SEEKING BEHAVIOR; SOUTH-INDIA; DELAYS; CARE; NORTHWEST; ETHIOPIA; PROGRAM; BURDEN; DOTS	Background Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India. Methods This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures. Results Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age <= 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age <= 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay. Conclusion The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently.	[Veesa, Karun Sandeep; Kaliappan, Saravanakumar Puthupalayam; Manjunath, Krishna; George, Kuryan; Minz, Shantidani] Christian Med Coll & Hosp, Dept Community Hlth, Vellore, Tamil Nadu, India; [John, Kamalabhai Russell] Apollo Inst Med Sci, Dept Community Med, Chittoor, Andhra Pradesh, India; [Moonan, Patrick K.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Sagili, Karuna D.] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Ravichandra, Chinnappareddy] Natl TB Inst, Bangalore, Karnataka, India; [Menon, Pradeep Aravindan; Dolla, Chandrakumar] Natl Inst Res TB, Madras, Tamil Nadu, India; [Luke, Nancy] Penn State Univ, Populat Res Inst, Dept Sociol & Criminol, University Pk, PA 16802 USA; [Munshi, Kaivan] Univ Cambridge, Dept Econ, Cambridge, England	Christian Medical College & Hospital (CMCH) Vellore; Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge	Minz, S (corresponding author), Christian Med Coll & Hosp, Dept Community Hlth, Vellore, Tamil Nadu, India.	shantidani@cmcvellore.ac.in	SOUNDRARAJAN, JOYSON/I-1779-2019; Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065; KALIAPPAN, SARAVANAKUMAR/0000-0002-1904-6880; Veesa, Karun Sandeep/0000-0002-6777-5885	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD058831-01]; Population Research Institute at Penn State University; NICHD [P2CHD041025]; Newton Trust at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041025] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Population Research Institute at Penn State University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Newton Trust at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The data used in this paper are from a project directed by Kaivan Munshi, University of Cambridge, Nancy Luke, Pennsylvania State University, Soumya Swaminathan, Indian Council of Medical Research, and Shantidani Minz, Christian Medical College, Vellore. The project was supported by a grant (R01 HD058831-01) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Support was also provided by the Population Research Institute at Penn State University, which is supported by an infrastructure grant from NICHD (P2CHD041025); the Newton Trust at the University of Cambridge; and the Population Studies and Training Center at Brown University. The study was conducted as a part of the 'TB Operations Research Training Project' aimed to build operational research capacity within the Government of India's RNTCP. This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), the National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, Bangalore, India), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and U.S. Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, USA).; The project was supported by a grant (R01 HD058831-01) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Support was also provided by the Population Research Institute at Penn State University, which is supported by an infrastructure grant from NICHD (P2CHD041025); the Newton Trust at the University of Cambridge; and the Population Studies and Training Center at Brown University.	Adenager Getinet Shewaseged, 2017, Tuberc Res Treat, V2017, P5120841, DOI 10.1155/2017/5120841; [Anonymous], 2016, NAT STRAT PLAN TUB C, V7, P19; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Bawankule S, 2010, ONLINE J HLTH ALLIED; Bogale S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2240-0; Central Tuberculosis Division Ministry of Health and Family Welfare Government of India, TECHN OP GUID TUB CO; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Dhanvij P, DELAY DIAGNOSIS TUBE; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Gebreegziabher SB, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1995-z; Goal K, 2011, INDAN J COMMUNITY HE, V23, P87; John KR, 2009, INT J TUBERC LUNG D, V13, P1281; Kelkar-Khambete A, 2008, INT J TUBERC LUNG D, V12, P87; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Laokri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096912; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Moghaddam HT, 2016, INT J PEDIATR-MASSHA, V4, P1243; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Tegegn A, 2009, ETHIOP J HLTH SCI, V19; Thakur Rajesh, 2013, Indian J Tuberc, V60, P37; Uplekar MW, 2003, INT J TUBERC LUNG D, V7, P1113; World Health Organisation, 2017, TUB FACT SHEET, V6, P30; World Health Organisation, 2017, GLOB TUB REP 2016, V6, P30; World Health Organisation. WHO-EM, 2017, DIAGN TREATM DEL TUB, V6, P30	33	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191591	10.1371/journal.pone.0191591	http://dx.doi.org/10.1371/journal.pone.0191591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414980	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000424325300034
J	Freundt-Revilla, J; Heinrich, F; Zoerner, A; Gesell, F; Beyerbach, M; Shamir, M; Oevermann, A; Baumgartner, W; Tipold, A				Freundt-Revilla, Jessica; Heinrich, Franciska; Zoerner, Alexander; Gesell, Felix; Beyerbach, Martin; Shamir, Merav; Oevermann, Anna; Baumgaertner, Wolfgang; Tipold, Andrea			The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis	PLOS ONE			English	Article							CANNABINOID CB2 RECEPTOR; PERIPHERAL-BLOOD EOSINOPHILS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; MICROGLIAL CELLS; ENDOGENOUS CANNABINOIDS; MULTIPLE-SCLEROSIS; DISTEMPER VIRUS; LUPI INFECTION; HUMAN BRAIN	Endocannabinoids (ECs) are involved in immunomodulation, neuroprotection and control of inflammation in the central nervous system (CNS). Activation of cannabinoid type 2 receptors (CB2) is known to diminish the release of pro-inflammatory factors and enhance the secretion of anti-inflammatory cytokines. Furthermore, the endocannabinoid 2-arachidonoyl glycerol (2-AG) has been proved to induce the migration of eosinophils in a CB2 receptor-dependent manner in peripheral blood and activate neutrophils independent of CB activation in humans. The aim of the current study was to investigate the influence of the endocannabinoid system in two different CNS inflammatory diseases of the dog, i.e. Steroid-Responsive Meningitis-Arteritis (SRMA) and Intraspinal Spirocercosis (IS). The two main endocannabinoids, anandamide (AEA) and 2-AG, were quantified by mass spectrometry in CSF and serum samples of dogs affected with Steroid-Responsive Meningitis-Arteritis in the acute phase (SRMA A), SRMA under treatment with prednisolone (SRMA Tr), intraspinal Spirocercosis and healthy dogs. Moreover, expression of the CB2 receptor was evaluated in inflammatory lesions of SRMA and IS and compared to healthy controls using immunohistochemistry (IHC). Dogs with SRMA A showed significantly higher concentrations of total AG and AEA in serum in comparison to healthy controls and in CSF compared to SRMA Tr (p<0.05). Furthermore, dogs with IS displayed the highest ECs concentrations in CSF, being significantly higher than in CSF samples of dogs with SRMA A (p<0.05). CSF samples that demonstrated an eosinophilic pleocytosis had the highest levels of ECs, exceeding those with neutrophilic pleocytosis, suggesting that ECs have a major effect on migration of eosinophils in the CSF. Furthermore, CB2 receptor expression was found in glial cells in the spinal cord of healthy dogs, whereas in dogs with SRMA and IS, CB2 was strongly expressed not only in glial cells but also on the cellular surface of infiltrating leukocytes (i.e. neutrophils, eosinophils, lymphocytes, plasma cells, and macrophages) at lesion sites. The present study revealed an upregulated endocannabinoid system in dogs with inflammatory CNS diseases, highlighting the endocannabinoid system as a potential target for treatment of inflammatory CNS diseases.	[Freundt-Revilla, Jessica; Gesell, Felix; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany; [Freundt-Revilla, Jessica; Heinrich, Franciska; Baumgaertner, Wolfgang; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Germany; [Heinrich, Franciska; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Zoerner, Alexander] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Beyerbach, Martin] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Shamir, Merav] Hebrew Univ Jerusalem, Koret Sch Vet Med, Jerusalem, Israel; [Oevermann, Anna] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hebrew University of Jerusalem; University of Bern	Freundt-Revilla, J (corresponding author), Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany.; Freundt-Revilla, J (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	Jessica.Freundt.Revilla@tiho-hannover.de			Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation; Deutscher Akademischer Austauschdienst (DAAD) [PKZ/12/92958]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. JFR recieved funding from the Deutscher Akademischer Austauschdienst (DAAD), Grant number: PKZ/12/92958 (http://www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baker D, 2001, FASEB J, V15, P300, DOI 10.1096/fj.00-0399fje; Battista N, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00009; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chai O, 2008, VET RADIOL ULTRASOUN, V49, P456, DOI 10.1111/j.1740-8261.2008.00407.x; Chiarlone A, 2014, P NATL ACAD SCI USA, V111, P8257, DOI 10.1073/pnas.1400988111; Chiurchiu V, 2016, CANNABIS CANNABINOID, V1, P59, DOI 10.1089/can.2016.0002; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Comelli F, 2007, BRIT J PHARMACOL, V152, P787, DOI 10.1038/sj.bjp.0707425; De Lahunta A., 2014, VET NEUROANATOMY CLI, P243; De Lahunta A., 2021, LAHUNTAS VET NEUROAN, V5th, P6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Du Plessis CJ, 2007, J SMALL ANIM PRACT, V48, P275, DOI 10.1111/j.1748-5827.2006.00262.x; Dvir E, 2007, J VET INTERN MED, V21, P860, DOI 10.1892/0891-6640(2007)21[860:SIASLM]2.0.CO;2; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Gal A, 2005, VET PARASITOL, V130, P331, DOI 10.1016/j.vetpar.2005.03.037; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Galve-Roperh I, 2013, PROG LIPID RES, V52, P633, DOI 10.1016/j.plipres.2013.05.004; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; Gesell FK, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-262; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Grundy RI, 2002, EXPERT OPIN INV DRUG, V11, P1365, DOI 10.1517/13543784.11.10.1365; Gui H, 2015, INT IMMUNOPHARMACOL, V26, P86, DOI 10.1016/j.intimp.2015.03.006; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; HARCOURT RA, 1978, VET REC, V102, P519, DOI 10.1136/vr.102.24.519; Harrus S, 1996, J AM ANIM HOSP ASSOC, V32, P125, DOI 10.5326/15473317-32-2-125; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kegler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133916; Kishimoto S, 2004, J BIOCHEM, V135, P517, DOI 10.1093/jb/mvh063; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Krishnan G, 2012, GLIA, V60, P1629, DOI 10.1002/glia.22380; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Luongo L, 2010, NEUROBIOL DIS, V37, P177, DOI 10.1016/j.nbd.2009.09.021; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mestre L, 2005, J NEUROCHEM, V92, P1327, DOI 10.1111/j.1471-4159.2004.02979.x; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Mylonakis ME, 2008, COMPENDIUM, V30, P111; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Ndong C, 2011, EUR J PHARMACOL, V669, P24, DOI 10.1016/j.ejphar.2011.08.002; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Rayman N, 2004, J IMMUNOL, V172, P2111, DOI 10.4049/jimmunol.172.4.2111; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Spitzbarth I, 2012, VET IMMUNOL IMMUNOP, V147, P6, DOI 10.1016/j.vetimm.2012.04.005; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; TIPOLD A, 1994, J SMALL ANIM PRACT, V35, P311, DOI 10.1111/j.1748-5827.1994.tb03293.x; Tipold A, 2010, J SMALL ANIM PRACT, V51, P150, DOI 10.1111/j.1748-5827.2009.00848.x; TIPOLD A, 1995, J VET INTERN MED, V9, P304, DOI 10.1111/j.1939-1676.1995.tb01089.x; Tipold A, 2003, CLIN NEUROLOGY SMALL; Tudury EA, 1995, RELATO CASO, V32, P5; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Witting A, 2004, J NEUROCHEM, V89, P1555, DOI 10.1111/j.1471-4159.2004.02544.x; Yu XJ, 2010, DECIS ENG, P11, DOI 10.1109/IECON.2010.5675382; Zoerner AA, 2012, J CHROMATOGR B, V883, P161, DOI 10.1016/j.jchromb.2011.06.025; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004	98	14	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0187197	10.1371/journal.pone.0187197	http://dx.doi.org/10.1371/journal.pone.0187197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408878	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800001
J	Oliver, SV; Brooke, BD				Oliver, Shune V.; Brooke, Basil D.			The effect of metal pollution on the life history and insecticide resistance phenotype of the major malaria vector Anopheles arabiensis (Diptera: Culicidae)	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; SOUTH-AFRICA; PLASMODIUM-FALCIPARUM; PYRETHROID RESISTANCE; DETOXIFICATION GENES; LARVAL NUTRITION; HEAVY-METALS; BODY-SIZE; GAMBIAE; SELECTION	Metal exposure is one of the commonest anthropogenic pollutants mosquito larvae are exposed to, both in agricultural and urban settings. As members of the Anopheles gambiae complex, which contains several major malaria vector species including An. arabiensis, are increasingly adapting to polluted environments, this study examined the effects of larval metal exposure on various life history traits of epidemiological importance. Two laboratory strains of An. arabiensis, SENN (insecticide susceptible) and SENN DDT (insecticide resistant), were reared in maximum acceptable toxicity concentrations, (MATC the highest legally accepted concentration) of cadmium chloride, lead nitrate and copper nitrate. Following these exposures, time to pupation, adult size and longevity were determined. Larvae reared in double the MATC were assessed for changes in malathion and deltamethrin tolerance, measured by lethal time bottle bioassay, as well as changes in detoxification enzyme activity. As defence against oxidative stress has previously been demonstrated to affect the expression of insecticide resistance, catalase, glutathione peroxidase and superoxide dismutase activity was assessed. The relative metal toxicity to metal naive larvae was also assessed. SENN DDT larvae were more tolerant of metal pollution than SENN larvae. Pupation in SENN larvae was significantly reduced by metal exposure, while adult longevity was not affected. SENN DDT showed decreased adult size after larval metal exposure. Adult insecticide tolerance was increased after larval metal exposure, and this effect appeared to be mediated by increased (3-esterase, cytochrome P450 and superoxide dismutase activity. These data suggest an enzyme-mediated positive link between tolerance to metal pollutants and insecticide resistance in adult mosquitoes. Furthermore, exposure of larvae to metal pollutants may have operational consequences under an insecticide-based vector control scenario by increasing the expression of insecticide resistance in adults.	[Oliver, Shune V.; Brooke, Basil D.] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Oliver, Shune V.; Brooke, Basil D.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Oliver, SV (corresponding author), Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.; Oliver, SV (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa.	shuneo@nicd.ac.za	Oliver, Shune/AAH-4961-2019	Oliver, Shune/0000-0003-0658-6658; Brooke, Basil/0000-0002-8857-1304	National Research Foundation Thuthuka post-PhD track grant [TTK160622173523]; National Health Laboratory Service development grant [2014-DEV31-SOLIVER]	National Research Foundation Thuthuka post-PhD track grant; National Health Laboratory Service development grant	This study was funded by a National Research Foundation Thuthuka post-PhD track grant (TTK160622173523) and a National Health Laboratory Service development grant (2014-DEV31-SOLIVER) to SVO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Chambers GM, 2001, J VECTOR ECOL, V26, P196; CHIN TA, 1993, TOXICOLOGY, V77, P145, DOI 10.1016/0300-483X(93)90145-I; COOGAN TP, 1994, J TOXICOL ENV HEALTH, V41, P233, DOI 10.1080/15287399409531839; Dandalo LC, 2017, J MED ENTOMOL, V54, P1758, DOI 10.1093/jme/tjx169; DJOUAKA RF, 2007, MALARIA J, V6; Eisler R, 2004, REV ENVIRON CONTAM T, V181, P139, DOI 10.1007/0-387-21733-9_4; Finney DJ, 1964, J BIOMETRICAL, V7, P206, DOI [10.1002/bimj.19650070318, DOI 10.1002/BIMJ.19650070318]; Huber M, 2016, SCI TOTAL ENVIRON, V541, P895, DOI 10.1016/j.scitotenv.2015.09.033; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Mattingly KS, 2001, AQUAT TOXICOL, V54, P249, DOI 10.1016/S0166-445X(00)00181-8; Mireji PO, 2010, MED VET ENTOMOL, V24, P101, DOI 10.1111/j.1365-2915.2010.00863.x; Mireji PO, 2010, ECOTOX ENVIRON SAFE, V73, P46, DOI 10.1016/j.ecoenv.2009.08.004; Mireji Paul Odhiambo, 2006, International Journal of Tropical Insect Science, V26, P214, DOI 10.1017/S1742758406658955; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Musasia Fauzia K, 2013, Malar J, V12, P97, DOI 10.1186/1475-2875-12-97; Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Oliver SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151049; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Oliver SV, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-44; Oliver SV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180909; Oliver SV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1720-4; Padmanabha H, 2011, MED VET ENTOMOL, V25, P445, DOI 10.1111/j.1365-2915.2011.00950.x; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Rayms-Keller A, 1998, ECOTOX ENVIRON SAFE, V39, P41, DOI 10.1006/eesa.1997.1605; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Sawadogo SP, 2013, J MED ENTOMOL, V50, P285, DOI 10.1603/ME12041; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; SINKA ME, 2010, PARASITE VECTOR, V0003; Suwanchaichinda C, 1998, J MED ENTOMOL, V35, P157, DOI 10.1093/jmedent/35.2.157; TAKKEN W, 2013, PARASITE VECTOR, V6; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Walters CR, 2011, J ENVIRON SCI HEAL A, V46, P1129, DOI 10.1080/10934529.2011.590729; Zhang L, 2015, INT J ENV RES PUB HE, V12, P14115, DOI 10.3390/ijerph121114115	46	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192551	10.1371/journal.pone.0192551	http://dx.doi.org/10.1371/journal.pone.0192551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408922	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800080
J	Tao, SY; Jiao, ZL; Wen, GG; Zhang, LH; Wang, GX				Tao, Siying; Jiao, Zhenlong; Wen, Guigui; Zhang, Lihong; Wang, Guoxiu			Cloning and expression analysis of the DEAD-box/RNA helicase Oslaf-1 in Ovomermis sinensis	PLOS ONE			English	Article							BOX RNA HELICASE; PROTEIN; TRANSLATION; GENE; HYDROLYSIS; NEMATODES; ELEGANS; BINDING; FAMILY; VBH-1	Ovomermis sinensis is a potentially-valuable nematode for controlling insect pests. The parasitic stage of the nematode absorbs nutrients in its host's hemolymph to maintain its growth development and then kills the host when it emerges. At present, little known about its reproductive development, particularly the responsible molecular mechanism. More detailed research on the genes of reproductive development will not only help us understand the mechanisms underlying sex differentiation in the nematode, but would also be valuable for successfully cultivating them in vitro and using them for biocontrol. In this study, we used the homology cloning method to clone the full-length cDNA of a DEAD-box family gene (Oslaf-1) from O. sinensis. Then, using qRT-PCR technology to detect the expression pattern of the Oslaf-1 gene at different development stages and tissues, the gene was found to be highly expressed in the post-parasitic stage (P < 0.01) and ovarian (P < 0.05) of O. sinensis. Western blot analysis showed the same result that the gene is associated with gonadal development and function, but is not gonad-specific. In situ hybridization further demonstrated that the gene is widely expressed in early embryos and is mainly distributed in the gonadal area. However, the signal was mainly concentrated in the reproductive primordia in pre-parasitic juveniles. RNA interference (RNAi) studies revealed that the sex ratio of O. sinensis soaked in dsRNA of Oslaf-1 was not statistically different than the gfp dsRNA treated groups. Our results suggest that Oslaf-1 may play a vital role in the reproductive systems of the nematode. In addition, we speculate that the Oslaf-1 gene plays an important role during embryonic development and that it occurs and develops in the gonads of pre-parasitic juveniles of O. sinensis.	[Tao, Siying; Jiao, Zhenlong; Wen, Guigui; Zhang, Lihong; Wang, Guoxiu] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Central China Normal University	Wang, GX (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	wanggx@mail.ccnu.edu.cn			National Natural Science Foundation of China [31572279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31572279) to GW.; This work was supported by the National Natural Science Foundation of China (Grant No. 31572279).	Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; CHAUDHARY BR, 1988, ARCH PROTISTENKD, V136, P389, DOI 10.1016/S0003-9365(88)80019-8; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Duan MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163127; Goodwin EB, 1997, DEVELOPMENT, V124, P749; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GURURAJAN R, 1991, NATURE, V349, P717, DOI 10.1038/349717a0; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; Hubert A, 2009, DEV BIOL, V330, P358, DOI 10.1016/j.ydbio.2009.04.003; Jiao Z, 2016, BIOCONTROL SCI TECHN, V26, P1; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; [李俊莉 LI Junli], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P265; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Marracci S, 2007, DEV GENES EVOL, V217, P395, DOI 10.1007/s00427-007-0143-6; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PETERSEN JJ, 1981, J NEMATOL, V13, P228; Edward EG, 2007, J AM MOSQUITO CONTR, V23, P58, DOI 10.2987/8756-971X(2007)23[58:MN]2.0.CO;2; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Salinas LS, 2007, GENESIS, V45, P533, DOI 10.1002/dvg.20323; Salinas LS, 2012, GENESIS, V50, P801, DOI 10.1002/dvg.22043; Stuart RJ, 1998, J INVERTEBR PATHOL, V72, P288, DOI 10.1006/jipa.1998.4789; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson RC, 2006, DEV DYNAM, V235, P2538; Tuteja N, 2014, PLANT MOL BIOL, V85, P639, DOI 10.1007/s11103-014-0209-6; Wang Guo-Xiu, 2001, Acta Zoologica Sinica, V47, P235; Wang W. H., 2009, THESIS; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Zhao N. L., 2010, THESIS	35	1	1	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192101	10.1371/journal.pone.0192101	http://dx.doi.org/10.1371/journal.pone.0192101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408876	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800045
J	Corcoran, AW; Groot, C; Bruno, A; Johnston, A; Cropper, SJ				Corcoran, Andrew W.; Groot, Christopher; Bruno, Aurelio; Johnston, Alan; Cropper, Simon J.			Individual differences in first- and second-order temporal judgment	PLOS ONE			English	Article							TIME PERCEPTION NETWORKS; LATENT PROFILE ANALYSIS; SCHIZOTYPAL PERSONALITY; HEALTHY SCHIZOTYPY; VISUAL CONFIDENCE; SUBJECTIVE TIME; SCHIZOPHRENIA; COGNITION; NEUROCOGNITION; SCALES	The ability of subjects to identify and reproduce brief temporal intervals is influenced by many factors whether they be stimulus-based, task-based or subject-based. The current study examines the role individual differences play in subsecond and suprasecond timing judgments, using the schizoptypy personality scale as a test-case approach for quantifying a broad range of individual differences. In two experiments, 129 (Experiment 1) and 141 (Experiment 2) subjects completed the O-LIFE personality questionnaire prior to performing a modified temporal-bisection task. In the bisection task, subjects responded to two identical instantiations of a luminance grating presented in a 4deg window, 4deg above fixation for 1.5 s (Experiment 1) or 3 s (Experiment 2). Subjects initiated presentation with a button-press, and released the button when they considered the stimulus to be half-way through (750/1500 ms). Subjects were then asked to indicate their 'most accurate estimate' of the two intervals. In this way we measure both performance on the task (a first-order measure) and the subjects' knowledge of their performance (a second-order measure). In Experiment 1 the effect of grating-drift and feedback on performance was also examined. Experiment 2 focused on the static/no-feedback condition. For the group data, Experiment 1 showed a significant effect of presentation order in the baseline condition (no feedback), which disappeared when feedback was provided. Moving the stimulus had no effect on perceived duration. Experiment 2 showed no effect of stimulus presentation order. This elimination of the subsecond order-effect was at the expense of accuracy, as the mid-point of the suprasecond interval was generally underestimated. Response precision increased as a proportion of total duration, reducing the variance below that predicted by Weber's law. This result is consistent with a breakdown of the scalar properties of time perception in the early suprasecond range. All subjects showed good insight into their own performance, though that insight did not necessarily correlate with the veridical bisection point. In terms of personality, we found evidence of significant differences in performance along the Unusual Experiences subscale, of most theoretical interest here, in the subsecond condition only. There was also significant correlation with Impulsive Nonconformity and Cognitive Disorganisation in the sub-and suprasecond conditions, respectively. Overall, these data support a partial dissociation of timing mechanisms at very short and slightly longer intervals. Further, these results suggest that perception is not the only critical mitigator of confidence in temporal experience, since individuals can effectively compensate for differences in perception at the level of metacognition in early suprasecond time. Though there are individual differences in performance, these are perhaps less than expected from previous reports and indicate an effective timing mechanism dealing with brief durations independent of the influence of significant personality trait differences.	[Corcoran, Andrew W.; Groot, Christopher; Cropper, Simon J.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Corcoran, Andrew W.] Monash Univ, Sch Philosoph Hist & Int Studies, Melbourne, Vic, Australia; [Bruno, Aurelio] UCL, Dept Expt Psychol, London, England; [Johnston, Alan] Univ Nottingham, Sch Psychol, Nottingham, England	University of Melbourne; Monash University; University of London; University College London; University of Nottingham	Cropper, SJ (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	scropper@unimelb.edu.au	Bruno, Aurelio/AFJ-9492-2022; Corcoran, Andrew W/AAG-9877-2019; Johnston, Alan/B-5393-2008	Bruno, Aurelio/0000-0002-4899-1769; Corcoran, Andrew W/0000-0002-0449-4883; Johnston, Alan/0000-0001-9026-1199; Cropper, Simon James/0000-0002-3574-6414				Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Antinori A, 2017, J RES PERS, V68, P15, DOI 10.1016/j.jrp.2017.03.005; Balcetis E, 2006, J PERS SOC PSYCHOL, V91, P612, DOI 10.1037/0022-3514.91.4.612; Barbato M, 2012, COGN NEUROPSYCHIATRY, V17, P115, DOI 10.1080/13546805.2011.576864; Barthelme S, 2010, P NATL ACAD SCI USA, V107, P20834, DOI 10.1073/pnas.1007704107; Barthelme S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000504; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; Bedwell JS, 2013, J PSYCHIATR RES, V47, P542, DOI 10.1016/j.jpsychires.2012.12.012; Block RA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00648; Bonnot O, 2011, J PHYSIOL-PARIS, V105, P164, DOI 10.1016/j.jphysparis.2011.07.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN SW, 1995, PERCEPTION, V24, P525, DOI 10.1068/p240525; BRUNO A, 2012, FRONT PSYCHOL, V3; Bruno A, 2016, CURR OPIN BEHAV SCI, V8, P131, DOI 10.1016/j.cobeha.2016.02.028; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chun CA, 2013, J INT NEUROPSYCH SOC, V19, P324, DOI 10.1017/S135561771200152X; Claridge G., 1995, SCHIZOTYPAL PERSONAL, P192, DOI DOI 10.1017/CBO9780511759031.010; Cohen AS, 2010, J PERS DISORD, V24, P516, DOI 10.1521/pedi.2010.24.4.516; Corvi AP, 2012, MOTIV EMOTION, V36, P483, DOI 10.1007/s11031-011-9275-0; Cropper SJ, 2014, ARTISTS HALLUCINATIO; de Gardelle V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147901; de Gardelle V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120870; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Ettinger U, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00018; Geisler WS, 2011, VISION RES, V51, P771, DOI 10.1016/j.visres.2010.09.027; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Giersch A., 2013, FRONT PSYCHOL, V4; Gilaie-Dotan S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00076; Gomez J, 2014, PSYCHIAT RES, V220, P737, DOI 10.1016/j.psychres.2014.07.048; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Goto SG, 2010, SOC COGN AFFECT NEUR, V5, P242, DOI 10.1093/scan/nsp038; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Grondin S, 2008, PSYCHOLOGY OF TIME, P51, DOI 10.1016/B978-0-08046-977-5.00002-8; Hancock PA, 2016, AM J PSYCHOL, V129, P111; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V26, P1685, DOI 10.1162/jocn_a_00580; Hori H, 2014, J PSYCHIATR RES, V48, P56, DOI 10.1016/j.jpsychires.2013.10.006; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; JAMIESON DG, 1975, PERCEPT PSYCHOPHYS, V17, P197, DOI 10.3758/BF03203886; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Keilp JG, 2007, PSYCHIAT RES, V149, P139, DOI 10.1016/j.psychres.2006.09.014; Kent BW, 2011, SCHIZOPHR RES, V127, P144, DOI 10.1016/j.schres.2010.05.013; Koychev I, 2010, NEUROPSYCHOLOGIA, V48, P2205, DOI 10.1016/j.neuropsychologia.2010.04.014; Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Lee KH, 2009, PSYCHIAT RES, V166, P174, DOI 10.1016/j.psychres.2008.03.004; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Mamassian P, 2016, ANNU REV VIS SCI, V2, P459, DOI 10.1146/annurev-vision-111815-114630; MASON O, 1995, PERS INDIV DIFFER, V18, P7, DOI 10.1016/0191-8869(94)00132-C; Mason O, 2006, SCHIZOPHR RES, V82, P203, DOI 10.1016/j.schres.2005.12.845; Mason O, 2005, SCHIZOPHR RES, V78, P293, DOI 10.1016/j.schres.2005.06.020; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matthews WJ, 2016, CURR OPIN BEHAV SCI, V8, P110, DOI 10.1016/j.cobeha.2016.02.019; Matthews WJ, 2016, PSYCHOL BULL, V142, P865, DOI 10.1037/bul0000045; Matthews WJ, 2015, J EXP PSYCHOL GEN, V144, P172, DOI 10.1037/xge0000041; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; McCreery C, 2002, PERS INDIV DIFFER, V32, P141, DOI 10.1016/S0191-8869(01)00013-7; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 2016, CURRENT OPINION BEHA, V18, P145; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; Meyniel F, 2015, NEURON, V88, P78, DOI 10.1016/j.neuron.2015.09.039; Mohr C, 2015, SCHIZOPHRENIA BULL, V41, pS436, DOI 10.1093/schbul/sbu185; Muniz J, 2005, PERS INDIV DIFFER, V38, P61, DOI 10.1016/j.paid.2004.03.021; Nelson B, 2010, SCHIZOPHRENIA BULL, V36, P388, DOI 10.1093/schbul/sbn098; Nichols H., 1891, AM J PSYCHOL, V3, P453, DOI [10.2307/1412061, DOI 10.2307/1412061]; Partos TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150615; Rammsayer T, 2011, ACTA PSYCHOL, V137, P127, DOI 10.1016/j.actpsy.2011.03.010; Reed P, 2014, PSYCHIAT RES, V220, P211, DOI 10.1016/j.psychres.2014.08.007; Roalf D, 2006, BRAIN COGNITION, V60, P32, DOI 10.1016/j.bandc.2005.09.008; Sarkin AJ, 2002, J NERV MENT DIS, V190, P483, DOI 10.1097/00005053-200207000-00012; Tabak NT, 2013, PSYCHIAT RES, V210, P1008, DOI 10.1016/j.psychres.2013.08.006; Tsai YY, 2014, PERS INDIV DIFFER, V70, P92, DOI 10.1016/j.paid.2014.06.044; Webb ME, 2017, THINK REASONING, V23, P235, DOI 10.1080/13546783.2017.1295105; Webb ME, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01424; Wiener M, 2014, NEUROIMAGE, V89, P10, DOI 10.1016/j.neuroimage.2013.11.019; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Woods RL, 2010, INVEST OPHTH VIS SCI, V51, P6077, DOI 10.1167/iovs.09-5013; Wuthrich VM, 2006, J PERS ASSESS, V87, P292, DOI 10.1207/s15327752jpa8703_10; Xavier S, 2015, COGN NEUROPSYCHIATRY, V20, P53, DOI 10.1080/13546805.2014.969419; Zakay D., 1990, COGNITIVE MODELS PSY, P59	87	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191422	10.1371/journal.pone.0191422	http://dx.doi.org/10.1371/journal.pone.0191422			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401520	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400012
J	Babu, MS; Mahanta, S; Lakhter, AJ; Hato, T; Paul, S; Naidu, SR				Babu, Mani Shankar; Mahanta, Sailendra; Lakhter, Alexander J.; Hato, Takashi; Paul, Subhankar; Naidu, Samisubbu R.			Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2	PLOS ONE			English	Article							BRAF INHIBITION; TUMOR-GROWTH; MELANOMA; METABOLISM; IDENTIFICATION; VEMURAFENIB; PGC1-ALPHA; EXPRESSION; RESISTANCE; SHIKONIN	Reliance on aerobic glycolysis is one of the hallmarks of cancer. Although pyruvate kinase M2 (PKM2) is a key mediator of glycolysis in cancer cells, lack of selective agents that target PKM2 remains a challenge in exploiting metabolic pathways for cancer therapy. We report that unlike its structural analog shikonin, a known inhibitor of PKM2, lapachol failed to induce non-apoptotic cell death ferroxitosis in hypoxia. However, melanoma cells treated with lapachol showed a dose-dependent inhibition of glycolysis and a corresponding increase in oxygen consumption. Accordingly, in silico studies revealed a high affinity-binding pocket for lapachol on PKM2 structure. Lapachol inhibited PKM2 activity of purified enzyme as well as in melanoma cell extracts. Blockade of glycolysis by lapachol in melanoma cells led to decreased ATP levels and inhibition of cell proliferation. Furthermore, perturbation of glycolysis in melanoma cells with lapachol sensitized cells to mitochondrial protonophore and promoted apoptosis. These results present lapachol as an inhibitor of PKM2 to interrogate metabolic plasticity in tumor cells.	[Babu, Mani Shankar; Lakhter, Alexander J.; Naidu, Samisubbu R.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Mahanta, Sailendra; Paul, Subhankar] Natl Inst Technol, Dept Biotechnol & Med Engn, Struct Biol & Nanomed Lab, Rourkela, Odisha, India; [Hato, Takashi] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; National Institute of Technology (NIT System); National Institute of Technology Rourkela; Indiana University System; Indiana University Bloomington	Naidu, SR (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	naidus@iu.edu	Mahanta, Sailendra Kumar/U-8237-2019; MAHANTA, SAILENDRA/GQQ-8093-2022	Mahanta, Sailendra Kumar/0000-0003-1254-2264; Naidu, Samisubbu/0000-0001-9411-660X; Shankar Babu, Mani/0000-0002-2693-1634; Hato, Takashi/0000-0002-0446-6575	Indiana CTSI; Showalter Award; Indiana University School of Medicine; Government of India	Indiana CTSI; Showalter Award; Indiana University School of Medicine; Government of India	This work was in part supported by grants from Indiana CTSI, Showalter Award and Biomedical Research Grant from Indiana University School of Medicine (to SRN). MSB is a recipient of Raman Postdoctoral Fellowship from the Government of India. Hal E Broxmeyer contributed significant financial support for the study and the authors thank him for reading the manuscript.; This work was in part supported by grants from Indiana CTSI, Showalter Award and Biomedical Research Grant from Indiana University School of Medicine (to S.R.N). MSB is a recipient of Raman Postdoctoral Fellowship from the Government of India. Hal E Broxmeyer contributed significant financial support for the study and the authors thank him for reading the manuscript.	ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BLOCK JB, 1974, CANCER CHEMOTH REP 2, V4, P27; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DEALMEIDA ER, 1990, J ETHNOPHARMACOL, V29, P239, DOI 10.1016/0378-8741(90)90061-W; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Felicio AC, 2002, CONTRACEPTION, V66, P289, DOI 10.1016/S0010-7824(02)00356-6; FIESER L F, 1946, Rec Chem Prog, V7, P26; Filipp Fabian V, 2013, J Carcinog, V12, P14, DOI 10.4103/1477-3163.115423; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hussain H, 2017, EXPERT OPIN THER PAT, V27, P1111, DOI 10.1080/13543776.2017.1339792; Lakhter AJ, 2014, ONCOTARGET, V5, P12694, DOI 10.18632/oncotarget.3031; Li WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094079; Li WJ, 2014, MOL CARCINOGEN, V53, P403, DOI 10.1002/mc.21988; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Ning XL, 2017, EUR J MED CHEM, V138, P343, DOI 10.1016/j.ejmech.2017.06.064; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; OTTEN S, 1978, APPL ENVIRON MICROB, V35, P554, DOI 10.1128/AEM.35.3.554-557.1978; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Pinho BR, 2013, BRIT J PHARMACOL, V169, P1072, DOI 10.1111/bph.12186; PINTO A V, 1987, Revista Latinoamericana de Microbiologia, V29, P15; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; RAO KV, 1968, CANCER RES, V28, P1952; RAO KV, 1974, CANCER CHEMOTH REP 3, V4, P11; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; SIEBER SM, 1976, CANCER TREAT REP, V60, P1127; Theodosakis N, 2015, MOL CANCER THER, V14, P1680, DOI 10.1158/1535-7163.MCT-15-0080; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; VANVEELEN CWM, 1978, CANCER RES, V38, P4681; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Viale A, 2016, RECENT RESULTS CANC, V207, P135, DOI 10.1007/978-3-319-42118-6_6; Wang YW, 2014, BIOCHEM PHARMACOL, V88, P322, DOI 10.1016/j.bcp.2014.01.041; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009	45	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191419	10.1371/journal.pone.0191419	http://dx.doi.org/10.1371/journal.pone.0191419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394289	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400011
J	Dedman, S; Officer, R; Clarke, M; Reid, DG; Brophy, D				Dedman, Simon; Officer, Rick; Clarke, Maurice; Reid, David G.; Brophy, Deirdre			Gbm.auto: A software tool to simplify spatial modelling and Marine Protected Area planning (vol 12, e0188955, 2017)	PLOS ONE			English	Correction													Reid, David/ABC-5916-2021; Dedman, Simon/E-9668-2017	Dedman, Simon/0000-0002-9108-972X; Brophy, Deirdre/0000-0003-4111-762X				Dedman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188955	1	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192520	10.1371/journal.pone.0192520	http://dx.doi.org/10.1371/journal.pone.0192520			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394292	gold, Green Published, Green Submitted			2022-12-27	WOS:000424060400046
J	Giri, S; Risnes, K; Uleberg, O; Rogne, T; Shrestha, SK; Nygaard, OP; Koju, R; Solligard, E				Giri, Samita; Risnes, Kari; Uleberg, Oddvar; Rogne, Tormod; Shrestha, Sanu Krishna; Nygaard, Oystein Petter; Koju, Rajendra; Solligard, Erik			Impact of 2015 earthquakes on a local hospital in Nepal: A prospective hospital-based study	PLOS ONE			English	Article							MUSCULOSKELETAL INJURIES; DISASTER MANAGEMENT; CHINA; PREPAREDNESS; PROFILE	Introduction Natural disasters pose a great challenge to the health systems and individual health facilities. In low-resource settings, disaster preparedness systems are often limited and not been well described. Two devastating earthquakes hit Nepal within a 17-days period in 2015. This study aims to describe the burden and distribution of emergency cases to a local hospital. Methods This is a prospective observational study of patients presenting to a local hospital for a period of 21 days following the earthquake on April 25, 2015. Demographic and clinical information was prospectively registered for all patients in the systematic emergency registry. Systematic telephone interviews were conducted in a random sample of the patients 90 days after admission to the hospital. Results A total of 2,003 emergency patients were registered during the period. The average daily number of emergency patients during the first five days was almost five times higher (n = 150) than the pre-incident daily average (n = 35). The majority of injuries were fractures (58%), 348 (56%) in the lower extremities. A total of 345 surgical procedures were performed and the hospital treated 111 patients with severe injuries related to the earthquake (compartment syndrome, crush injury, and internal injury). Among those with follow-up interviews, over 90% reported that they had been severely affected by the earthquakes; complete house damage, living in temporary shelter, or loss of close family member. Conclusion The hospital experienced a very high caseload during the first days, and the majority of patients needed orthopaedic services. The proportion of severely injured and in-hospital deaths were relatively low, probably indicating that the most severely injured did not reach the hospital in time. The experiences underline the need for robust and easily available local health services that can respond to disasters.	[Giri, Samita; Uleberg, Oddvar; Rogne, Tormod; Solligard, Erik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Giri, Samita] Kathmandu Univ Hosp, Dhulikhel Hosp, Dept Community Programs, Dhulikhel, Nepal; [Giri, Samita; Uleberg, Oddvar; Solligard, Erik] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Anaesthesia & Intens Care, Trondheim, Norway; [Risnes, Kari] Trondheim Reg & Univ Hosp, St Olavs Hosp, Childrens Clin, Trondheim, Norway; [Risnes, Kari] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Shrestha, Sanu Krishna] Kathmandu Univ Hosp, Dhulikhel Hosp, Dept Emergency, Dhulikhel, Nepal; [Nygaard, Oystein Petter] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Nygaard, Oystein Petter] Norwegian Univ Sci & Technol, Fac Med, Inst Neurosci, Trondheim, Norway; [Nygaard, Oystein Petter] Trondheim Reg & Univ Hosp, St Olavs Hosp, Natl Advisory Unit Spinal Surg, Trondheim, Norway; [Koju, Rajendra] Kathmandu Univ Hosp, Dhulikhel Hosp, Dept Internal Med, Dhulikhel, Nepal; [Solligard, Erik] Norwegian Univ Sci & Technol, Mid Norway Sepsis Res Grp, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Kathmandu University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Kathmandu University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Kathmandu University; Norwegian University of Science & Technology (NTNU)	Giri, S (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Giri, S (corresponding author), Kathmandu Univ Hosp, Dhulikhel Hosp, Dept Community Programs, Dhulikhel, Nepal.; Giri, S (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Anaesthesia & Intens Care, Trondheim, Norway.	samita.giri@ntnu.no	Dangal, Ganesh/O-1989-2017; Rogne, Tormod/E-7522-2018	Dangal, Ganesh/0000-0002-5834-5525; Rogne, Tormod/0000-0002-9581-7384; Risnes, Kari/0000-0001-6599-0146	St. Olav's Hospital, Trondheim University Hospital; Liaison Committee [46056902]	St. Olav's Hospital, Trondheim University Hospital; Liaison Committee	This work was supported by grant from St. Olav's Hospital, Trondheim University Hospital and Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (project number 46056902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; Amundsen MS, 2016, ALCOHOL, V57, P9, DOI 10.1016/j.alcohol.2016.10.008; [Anonymous], 2009, NEP COUNTR REP GLOB; [Anonymous], 2013, PLOS CURRENTS; Bar-On E, 2016, WORLD J SURG, V40, P2117, DOI 10.1007/s00268-016-3581-3; BBC, NEP EARTHQ PEOPL FLE; Bennett L.., 2008, CASTE ETHNIC REGIONA; Briggs SM, 2006, SURG CLIN N AM, V86, P537, DOI 10.1016/j.suc.2006.02.003; Cartwright C, 2017, PUBLIC HEALTH, V150, P60, DOI 10.1016/j.puhe.2017.04.024; Clover AJP, 2014, WORLD J SURG, V38, P2543, DOI 10.1007/s00268-014-2607-y; Cousins S, 2016, LANCET, V387, P16, DOI 10.1016/S0140-6736(15)01352-5; Dai ZY, 2010, ULUS TRAVMA ACIL CER, V16, P503; Ding S, 2015, CHIN J TRAUMATOL, V18, P157, DOI 10.1016/j.cjtee.2015.08.001; Donnem M, 2016, THESIS; EM-DAT, 2022, INT DIS DAT; Gennarelli TA, 2005, AIS 2005 ABBREVIATED; Government of Nepal, 2015, NEP EARTHQ 2015 POST; Groves CC, 2016, PM&R, V8, pS154; Hall ML, 2017, PUBLIC HEALTH, V145, P39, DOI 10.1016/j.puhe.2016.12.031; Ho MLL, 2016, SINGAP MED J, V57, P426, DOI 10.11622/smedj.2016132; Hospital D, DHUL HOSP KATH U HOS; Kang P, 2016, AM J EMERG MED, V34, P2132, DOI 10.1016/j.ajem.2016.07.064; Kang P, 2015, INT J ENV RES PUB HE, V12, P10723, DOI 10.3390/ijerph120910723; Karki R K, 2016, Kathmandu Univ Med J (KUMJ), V14, P65; Kumar A, 2016, GEOMATICS NATURAL HA; Landry MD, 2016, PHYS THER, V96, P1714, DOI 10.2522/ptj.20150677; Lee ACK, 2016, PUBLIC HEALTH, V133, P99, DOI 10.1016/j.puhe.2016.01.007; Lee ACK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-884; Lee ACK, 2014, EMERG MED J, V31, pE78, DOI 10.1136/emermed-2013-203298; MacKenzie JS, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0115-8; Matsuoka Y, 2011, LINKING RESILIENCE P, P129; NDHS. Ministry of Health Nepal; New ERA; and ICF, 2011, NEP DEM HLTH SURV; Nielsen MJ, 2016, LANCET GLOB HEALTH, V4, pE161, DOI 10.1016/S2214-109X(15)00279-X; NRA, 2016, NEPAL EARTHQUAKE 201; ReliefWeb, 2015, HUM COST NAT DIS 201; Report WD, 2007, FOC DISCR INT FED RE; Sharma DC, 2015, LANCET, V385, P1819, DOI 10.1016/S0140-6736(15)60913-8; The Ministry of Home Affairs Government of Nepal, 2015, NEP EARTHQ 2015 DIS; UNHCR, NEP 2015 EARTHQ; United Nations International Strategy for Disaster Reduction (UN ISDR), 2005, HYOG FRAM ACT 2005 2; WHO, 2015, NEPAL; World Health Organization [WHO, 2015, RAP HOSP NEEDS ASS R	42	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192076	10.1371/journal.pone.0192076	http://dx.doi.org/10.1371/journal.pone.0192076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394265	Green Published, gold			2022-12-27	WOS:000424060400025
J	Guest, JF; Ingram, A; Ayoub, N; Hendriksz, CJ; Murphy, E; Rahman, Y; McKiernan, P; Mundy, H; Deegan, P				Guest, Julian F.; Ingram, Andy; Ayoub, Nadia; Hendriksz, Christian J.; Murphy, Elaine; Rahman, Yusof; McKiernan, Patrick; Mundy, Helen; Deegan, Patrick			Healthcare resource use and costs of managing children and adults with lysosomal acid lipase deficiency at a tertiary referral centre in the United Kingdom	PLOS ONE			English	Article							ESTER STORAGE DISEASE	Objective To estimate clinical progression and resource utilisation together with the associated costs of managing children and adults with LAL Deficiency, at a tertiary referral centre in the UK. Methods A retrospective chart review was undertaken of patients in the UK with a confirmed diagnosis of LAL Deficiency who were managed at a LAL Deficiency tertiary referral treatment centre. Patients' pathways, treatment patterns, health outcomes and resource use were quantified over differing lengths of time for each patient enabling the NHS cost of patient management in tertiary care to be estimated. Results The study population comprised 19 patients of whom 58% were male. Mean age at the time of initial presentation was 15.5 years and the mean age at diagnosis was 18.0 years. 63%, 53% and 42% of patients had hepatomegaly, abnormal lipid storage and splenomegaly at a mean age of presentation of 17.8, 17.1 and 20.9 years, respectively. Over a period of 50 years there were a mean of 48.5 clinician visits and 3.4 hospital admissions per patient. The mean NHS cost of patient management at a LAL Deficiency tertiary referral treatment centre, spanning a period of over 50 years was 61,454 pound per patient. Conclusion This study provides important insights into a number of aspects of the disease that are difficult to ascertain from published case reports. Additionally, it provides the best estimate available of NHS resource use and costs with which to inform policy and budgetary decisions pertaining to managing this ultra-orphan disease.	[Guest, Julian F.; Ingram, Andy; Ayoub, Nadia] Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England; [Guest, Julian F.] Kings Coll London, Fac Life Sci & Med, London, England; [Hendriksz, Christian J.] Salford Royal NHS Fdn Trust, Adult Inherited Metab Disorders, Salford, Lancs, England; [Hendriksz, Christian J.] Univ Pretoria, Paediat & Child Hlth, Pretoria, South Africa; [Murphy, Elaine] Natl Hosp Neurol & Neurosurg, Charles Dent Metab Unit, London, England; [Rahman, Yusof] Guys & St Thomas Hosp, Adult Inherited Metab Dis, London, England; [McKiernan, Patrick] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England; [Mundy, Helen] Guys & St Thomas Hosp, Evelina Childrens Hosp, London, England; [Deegan, Patrick] Addenbrookes Hosp, Lysosomal Disorders Unit, Cambridge, England	University of London; King's College London; Salford Royal NHS Foundation Trust; University of Pretoria; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Guest, JF (corresponding author), Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England.; Guest, JF (corresponding author), Kings Coll London, Fac Life Sci & Med, London, England.	julian.guest@catalyst-health.com	; Hendriksz, Christian/E-7377-2013	Guest, Julian F./0000-0003-0162-2007; Deegan, Patrick/0000-0001-9427-9900; Hendriksz, Christian/0000-0003-2179-3639	Synageva Biopharma Corp, Lexington, MA, US	Synageva Biopharma Corp, Lexington, MA, US	This study was part funded by Synageva Biopharma Corp, Lexington, MA, US, now part of Alexion Pharmaceuticals Inc., Cheshire, CT, US. However, the funders had no role in study design, data collection and analysis or preparation of the manuscript. The funders commissioned Catalyst Health Economics Consultants (Catalyst) to conduct the study. However, the funders did not provide support in the form of salaries for Catalyst employees.	Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Burton BK, 2015, NEW ENGL J MED, V373, P1010, DOI 10.1056/NEJMoa1501365; Burton BK, 2015, J PEDIATR GASTR NUTR, V61, P619, DOI 10.1097/MPG.0000000000000935; Department of Health, NHS REF COSTS 2014 2; Department of Health, UK STRAT RAR DIS; Grabowski GA, ONLINE METABOLIC MOL; Guest JF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009283; Muntoni S, 2007, ARTERIOSCL THROM VAS, V27, P1866, DOI 10.1161/ATVBAHA.107.146639; Orphanet, WOLM DIS; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-29; Tapper EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147237; Unit A. L. D., 2014, LYSOSOMAL ACID LIPAS; van Dussen L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-51	13	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191945	10.1371/journal.pone.0191945	http://dx.doi.org/10.1371/journal.pone.0191945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394260	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400020
J	Jiang, H; Liu, Y; Wei, YT; Shi, YY; Wright, CB; Sun, XY; Rundek, T; Baumel, BS; Landman, J; Wang, JH				Jiang, Hong; Liu, Yi; Wei, Yantao; Shi, Yingying; Wright, Clinton B.; Sun, Xiaoyan; Rundek, Tatjana; Baumel, Bernard S.; Landman, Jonathan; Wang, Jianhua			Impaired retinal microcirculation in patients with Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BLOOD-FLOW-VELOCITY; OPTICAL COHERENCE TOMOGRAPHY; CEREBRAL AMYLOID ANGIOPATHY; A-BETA-DEPOSITION; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; FUNCTION IMAGER; HYPOPERFUSION	The goal of this study was to determine the retinal blood flow rate (BFR) and blood flow velocity (BFV) of pre-capillary arterioles and post-capillary venules in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Forty patients (20 AD and 20 MCI) and 21 cognitively normal (CN) controls with a similar age range (+/- 5 yrs) were recruited. A retinal function imager (RFI) was used to measure BFRs and BFVs of arterioles and venules in the macular region. The thickness of the ganglion cell-inner plexiform layer (GCIPL) was measured using Zeiss Cirrus optical coherence tomography. Macular BFRs in AD group were 2.64 +/- 0.20 nl/s (mean +/- standard deviation) in arterioles and 2.23 +/- 0.19 nl/s in venules, which were significantly lower than in MCI and CN groups (P < 0.05). In addition, BFRs in MCI were lower than in CN in both arterioles and venules (P < 0.05). The BFV of the arterioles was 3.20 +/- 1.07 mm/s in AD patients, which was significantly lower than in CN controls (3.91 +/- 0.77 mm/s, P = 0.01). The thicknesses of GCIPL in patients with AD and MCI were significantly lower than in CN controls (P < 0.05). Neither BFV nor BFR in arterioles and venules was related to age, GCIPL thickness, mini mental state examination (MMSE) score and disease duration in patients with AD and MCI (P > 0.05). The lower BFR in both arterioles and venules in AD and MCI patients together with the loss of GCIPL were evident, indicating the impairment of the two components in the neurovascular-hemodynamic system, which may play a role in disease progression.	[Jiang, Hong; Liu, Yi; Wei, Yantao; Shi, Yingying; Wang, Jianhua] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Jiang, Hong; Sun, Xiaoyan; Rundek, Tatjana; Baumel, Bernard S.; Landman, Jonathan] Univ Miami, Miller Sch Med, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA; [Liu, Yi] Nanjing Univ Chinese Med, Affiliated Hosp 3, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Wei, Yantao] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Wright, Clinton B.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Nanjing University of Chinese Medicine; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Jiang, H (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.; Jiang, H (corresponding author), Univ Miami, Miller Sch Med, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA.	hjiang@med.miami.edu			North American Neuro-ophthalmology Society; McKnight Brain Institute, NIH Center [P30 EY014801]; Research to Prevent Blindness (RPB)	North American Neuro-ophthalmology Society; McKnight Brain Institute, NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	This study was supported by the North American Neuro-ophthalmology Society, McKnight Brain Institute, NIH Center Grant P30 EY014801, and a grant from Research to Prevent Blindness (RPB).	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Austin BP, 2011, J ALZHEIMERS DIS, V26, P123, DOI 10.3233/JAD-2011-0010; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Blaise R, 2012, AGING CELL, V11, P384, DOI 10.1111/j.1474-9726.2012.00797.x; Brown WR, 2000, ANN NY ACAD SCI, V903, P39, DOI 10.1111/j.1749-6632.2000.tb06348.x; Burgansky-Eliash Z, 2013, OSLI RETINA, V44, P51, DOI 10.3928/23258160-20121221-13; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Choi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162202; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Feke Gilbert T, 2015, Alzheimers Dement (Amst), V1, P144, DOI 10.1016/j.dadm.2015.01.004; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jiang H, 2016, MULT SCLER J, V22, P1812, DOI 10.1177/1352458516631035; Jiang H, 2013, MICROVASC RES, V89, P172, DOI 10.1016/j.mvr.2013.06.008; Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8; Kalaria RN, 1996, MOL BRAIN RES, V35, P58, DOI 10.1016/0169-328X(95)00180-Z; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Knight MJ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00139; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375; Landa G, 2010, BRIT J OPHTHALMOL, V94, P54, DOI 10.1136/bjo.2009.161257; Landa Gennady, 2012, International Ophthalmology, V32, P211, DOI 10.1007/s10792-012-9547-z; Landa G, 2009, OPHTHALMOLOGICA, V223, P155, DOI 10.1159/000189819; de Faria JML, 2014, BRIT J OPHTHALMOL, V98, P726, DOI 10.1136/bjophthalmol-2013-304100; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ong YT, 2015, NEUROSCI LETT, V584, P12, DOI 10.1016/j.neulet.2014.10.010; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Poels MMF, 2008, J CEREBR BLOOD F MET, V28, P1652, DOI 10.1038/jcbfm.2008.62; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Protogerou AD, 2007, HYPERTENSION, V50, P172, DOI 10.1161/HYPERTENSIONAHA.107.089797; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Snyder Peter J, 2016, Alzheimers Dement (Amst), V4, P169; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; Tian J, 2006, NEUROPATH APPL NEURO, V32, P332, DOI 10.1111/j.1365-2990.2006.00732.x; Vinters HV, 1996, BRAIN PATHOL, V6, P179, DOI 10.1111/j.1750-3639.1996.tb00799.x; Wei YT, 2017, INVEST OPHTH VIS SCI, V58, P3804, DOI 10.1167/iovs.17-21460; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Williams Michael A, 2015, Alzheimers Dement (Amst), V1, P229; Zhou J, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/2895982	42	32	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192154	10.1371/journal.pone.0192154	http://dx.doi.org/10.1371/journal.pone.0192154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394263	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400027
J	Laktabai, J; Platt, A; Menya, D; Turner, EL; Menya, D; Turner, EL; Aswa, D; Kinoti, S; O'Meara, WP				Laktabai, Jeremiah; Platt, Alyssa; Menya, Diana; Turner, Elizabeth L.; Menya, Diana; Turner, Elizabeth L.; Aswa, Daniel; Kinoti, Stephen; O'Meara, Wendy Prudhomme			A mobile health technology platform for quality assurance and quality improvement of malaria diagnosis by community health workers	PLOS ONE			English	Article							CASE-MANAGEMENT; CLUSTERED DATA; TESTS; SIZE	Background Community health workers (CHWs) play an important role in improving access to services in areas with limited health infrastructure or workforce. Supervision of CHWs by qualified health professionals is the main link between this lay workforce and the formal health system. The quality of services provided by lay health workers is dependent on adequate supportive supervision. It is however one of the weakest links in CHW programs due to logistical and resource constraints, especially in large scale programs. Interventions such as point of care testing using malaria rapid diagnostic tests (RDTs) require real time monitoring to ensure diagnostic accuracy. In this study, we evaluated the utility of a mobile health technology platform to remotely monitor malaria RDT (mRDT) testing by CHWs for quality improvement. Methods As part of a large implementation trial involving mRDT testing by CHWs, we introduced the Fionet system composed of a mobile device (Deki Reader, DR) to assist in processing and automated interpretation of mRDTs, which connects to a cloud-based database which captures reports from the field in real time, displaying results in a custom dashboard of key performance indicators. A random sample of 100 CHWs were trained and provided with the Deki Readers and instructed to use it on 10 successive patients. The CHWs interpretation was compared with the Deki Reader's automatic interpretation, with the errors in processing and interpreting the RDTs recorded. After the CHW entered their interpretation on the DR, the DR provided immediate, automated feedback and interpretation based on its reading of the same cassette. The study team monitored the CHW performance remotely and provided additional support. Results A total of 1251 primary and 113 repeat tests were performed by the 97 CHWs who used the DR. 91.6% of the tests had agreement between the DR and the CHWs. There were 61 (4.9%) processing and 52 (4.2%) interpretation errors among the primary tests. There was a tendency towards lower odds of errors with increasing number and frequency of tests, though not statistically significant. Of the 62 tests that were repeated due to errors, 79% achieved concordance between the CHW and the DR. Satisfaction with the use of the DR by the CHWs was high. Conclusions Use of innovative mHealth strategies for monitoring and quality control can ensure quality within a large scale implementation of community level testing by lay health workers.	[Laktabai, Jeremiah] Moi Univ, Sch Med, Dept Family Med, Eldoret, Kenya; [Laktabai, Jeremiah; Aswa, Daniel; O'Meara, Wendy Prudhomme] AMPATH, Eldoret, Kenya; [Platt, Alyssa; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Platt, Alyssa; Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [O'Meara, Wendy Prudhomme] Moi Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Epidemiol & Biostat, Eldoret, Kenya; [Kinoti, Stephen] Fio Corp, Toronto, ON, Canada; [O'Meara, Wendy Prudhomme] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA	Moi University; Duke University; Duke University; Moi University; Duke University	Laktabai, J (corresponding author), Moi Univ, Sch Med, Dept Family Med, Eldoret, Kenya.; Laktabai, J (corresponding author), AMPATH, Eldoret, Kenya.	jklaktabai@gmail.com	Laktabai, Jeremiah/AAE-8952-2021; Urzua, Andrea Silva/AAS-7284-2020	Laktabai, Jeremiah/0000-0003-2198-6414; Platt, Alyssa/0000-0001-6396-0170	CTSA grant [UL1TR001117]; National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) [R01AI110478]; Fio Corporation	CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fio Corporation	This study was supported by CTSA grant (UL1TR001117) and by the National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) grant number R01AI110478. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The study sponsor had no influence on the study design; data collection, analysis or interpretation; content of the manuscript, nor the authors decision to submit this manuscript. The researchers operated independently from the funder in these matters. All authors had full access to all data and take responsibility for the integrity and accurate analysis of the data. Fio Corporation provided support in the form of salaries for author [SK], but did provide any additional funding and did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The project rented the DRs from Fio for use during the study. As part of the rental service, the Fio team conducted trainings for the study team on the use of the devices, and provided technical support including device repairs and/or replacement. They created and maintained the electronic portal for aggregation of the data transmitted from the DRs.	[Anonymous], ROLL BACK MAL STRAT; [Anonymous], PUBLIC HLTH IMPACT R; [Anonymous], 2015, MALARIA J, V14, P26; [Anonymous], PEDIAT HLTH, V25; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-158; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; Crigler L., 2013, SUPERVISION COMMUNIT; Degefie T, 2010, ETHIOPIAN J HLTH DEV, V23; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Herrera S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-87; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Laktabai J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013972; Lewin S., 2006, LAY HLTH WORKERS PRI; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Seaman S, 2014, STAT MED, V33, P5371, DOI 10.1002/sim.6277; Shekalaghe S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-141; USAID, 2010, COMM HLTH WORK PROGR; WHO, 2006, WORLD HLTH REP; Williamson JM, 2003, BIOMETRICS, V59, P36, DOI 10.1111/1541-0420.00005; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	24	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191968	10.1371/journal.pone.0191968	http://dx.doi.org/10.1371/journal.pone.0191968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389958	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400046
J	Thibault, M; Vidal, E; Potter, MA; Sanchez, T; Brescia, F				Thibault, Martin; Vidal, Eric; Potter, Murray Alan; Sanchez, Thierry; Brescia, Fabrice			The invasive Red-vented bulbul (Pycnonotus cafer) outcompetes native birds in a tropical biodiversity hotspot	PLOS ONE			English	Article							ACRIDOTHERES-TRISTIS; COMMON MYNA; RISK-ASSESSMENT; NEW-CALEDONIA; IMPACT; ECOLOGY; ISLAND; URBAN; ERADICATION; POPULATION	Invasive alien species are a major cause of biodiversity loss globally, but especially on islands where high species richness and levels of endemism accentuate their impacts. The Red vented bulbul (Pycnonotus cafer), a tropical passerine bird that has been introduced widely across locations of high conservation value, is considered an extreme pest. It is currently expanding its range in New Caledonia, one of the world's biodiversity hotspots. Decisive recommendations on management strategies are required urgently to inform local managers and policy makers, but they should be based on quantitative local evidence, not just on expert opinion. The Red-vented bulbul is widely blamed for its impacts on biodiversity, especially through competition. We used data from 2,472 point counts to explore the abundance relationships between the Red-vented bulbul and 14 other species of bird. Our results revealed a negative relationship between the occurrence of the bulbul and the mean abundance of nine species, all native (or endemic, n = 3) to the New Caledonia archipelago. In contrast, the abundance of other introduced species such as Acridotheres tristis (Common myna), Passer domesticus (House sparrow) and Spilopelia chinensis (Spotted dove) were not affected by the Red-vented bulbul. Moreover, temporal trends in the abundance of impacted species suggest that the Red-vented bulbul may cause niche contractions rather than mortality for native species in man-modified habitats. Monitoring and control of the Red-vented bulbul is recommended to prevent on-going impacts on native bird communities throughout New Caledonia, and its impact on native bird communities elsewhere should be quantified.	[Thibault, Martin; Brescia, Fabrice] Inst Agron Neocaledonien IAC, Equipe ARBOREAL Agr BiOdiversite & VAlorisat, Paita, New Caledonia; [Thibault, Martin; Potter, Murray Alan] Massey Univ, Sch Agr & Environm, Wildlife & Ecol Grp, Palmerston North, New Zealand; [Vidal, Eric] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, IRD,Avignon Univ,Ctr IRD Noumea, Noumea, New Caledonia; [Sanchez, Thierry] Soc Caledonienne Ornithol, Noumea, New Caledonia	Massey University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Thibault, M (corresponding author), Inst Agron Neocaledonien IAC, Equipe ARBOREAL Agr BiOdiversite & VAlorisat, Paita, New Caledonia.; Thibault, M (corresponding author), Massey Univ, Sch Agr & Environm, Wildlife & Ecol Grp, Palmerston North, New Zealand.	thibault@iac.nc	THIBAULT, Martin/J-5856-2019	THIBAULT, Martin/0000-0002-2386-4501; Potter, Murray/0000-0002-0246-8294				[Anonymous], 2016, DIRECTION DE L ENVIR; [Anonymous], 2008, DIRECTION DEV EC ENV; Barnagaud JY, 2014, ECOLOGY, V95, P78, DOI 10.1890/13-0791.1; Barre Nicolas, 2009, Alauda, V77, P287; Barton K., 2016, MULTIMODEL INFERENCE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates JH, 2014, NOTORNIS, V61, P35; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Bivand R, 2017, RGEOS INTERFACE GEOM; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blanvillain C, 2003, BIOL CONSERV, V109, P197, DOI 10.1016/S0006-3207(02)00147-7; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brooks DM, 2013, WILSON J ORNITHOL, V125, P800, DOI 10.1676/13-037.1; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canning Gregory, 2011, Phelsuma, V19, P43; Corlett Richard T., 2005, Urban Ecosystems, V8, P275, DOI 10.1007/s11252-005-3260-x; David P, 2017, ADV ECOL RES, V56, P1, DOI 10.1016/bs.aecr.2016.10.001; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Davis MA, 2017, TRENDS ECOL EVOL, V32, P229, DOI 10.1016/j.tree.2017.02.008; del Hoyo J, 2017, HDB BIRDS WORLD ALIV; Delorme Q, 2016, ZOOTAXA, V4092, P301, DOI 10.11646/zootaxa.4092.3.1; Dutson G., 2011, BIRDS MELANESIA BISM, P446; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Evans T, 2014, ECOL EVOL, V4, P2957, DOI 10.1002/ece3.1144; Feare CJ, 2017, PEST MANAG SCI, V73, P295, DOI 10.1002/ps.4263; Firake DM, 2016, FIELD CROP RES, V188, P74, DOI 10.1016/j.fcr.2016.01.008; Geraghty AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161206; Gill B. J., 1995, Notornis, V42, P214; GORMAN M L, 1972, Fiji Agricultural Journal, V34, P35; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Gren IM, 2016, REG ENVIRON CHANGE, V16, P445, DOI 10.1007/s10113-015-0754-9; Grey Merilyn J., 1998, Pacific Conservation Biology, V4, P55; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Islam K, 2000, BIRDS N AM LIFE HIST; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Kumschick S, 2016, BIRD CONSERV INT, V26, P154, DOI 10.1017/S0959270915000167; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Martin-Albarracin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143070; Moller AP, 2015, OECOLOGIA, V178, P943, DOI 10.1007/s00442-015-3268-8; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Old JM, 2014, EMU, V114, P241, DOI 10.1071/MU13029; Peacock DS, 2007, S AFR J SCI, V103, P465; POWLESLAND M H, 1982, Notornis, V29, P181; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; R Development Core Team, 2009, R LANG ENV STAT COMP; Ralph C.J., 1995, MONITORING BIRD POPU; Rogers HS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14557; Russell JC, 2017, TRENDS ECOL EVOL, V32, P3, DOI 10.1016/j.tree.2016.10.012; Saavedra S., 2013, 2 CONTROL CAMPAIGN C; Saxena A, 2015, INT J MED PHARM RES, V3, P1246; Scheele BC, 2017, TRENDS ECOL EVOL, V32, P346, DOI 10.1016/j.tree.2017.02.013; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Sherman JA, 2010, TERRA AUSTRALIS, V32, P101; Shukuroglou P, 2006, AUSTRAL ECOL, V31, P240, DOI 10.1111/j.1442-9993.2006.01588.x; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smith SA, 2007, MOL PHYLOGENET EVOL, V43, P1151, DOI 10.1016/j.ympev.2007.02.007; Soh MCK, 2006, BIOL CONSERV, V129, P149, DOI 10.1016/j.biocon.2005.10.030; Spotswood EN, 2013, BIOL INVASIONS, V15, P2147, DOI 10.1007/s10530-013-0441-z; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Summers-Smith J. Denis, 2003, British Birds, V96, P439; Tershy BR, 2015, BIOSCIENCE, V65, P592, DOI 10.1093/biosci/biv031; Thibault JC, 2002, BIOL CONSERV, V108, P161, DOI 10.1016/S0006-3207(02)00102-7; Thibault M, 2017, BIOL INVASI IN PRESS; Vijayan VS, 1975, ECOLOGICAL ISOLATION; von der Lippe M, 2008, DIVERS DISTRIB, V14, P18, DOI 10.1111/j.1472-4642.2007.00401.x; Walker R, 2008, ELEPAIO, V68, P71; Walsh JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P841, DOI 10.1111/j.1466-8238.2011.00724.x; WATLING D, 1979, NEW SCI, V81, P963; WATLING D, 1978, Notornis, V25, P109; Young HS, 2017, TRENDS ECOL EVOL, V32, P41, DOI 10.1016/j.tree.2016.09.008; Zuur Alain F., 2009, P1	79	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192249	10.1371/journal.pone.0192249	http://dx.doi.org/10.1371/journal.pone.0192249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390027	Green Published, gold			2022-12-27	WOS:000423793400081
J	Zhan, XY; Zhu, QY				Zhan, Xiao-Yong; Zhu, Qing-Yi			Molecular typing of Legionella pneumophila isolates from environmental water samples and clinical samples using a five-gene sequence typing and standard Sequence-Based Typing	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; DISCRIMINATORY ABILITY; POPULATION-STRUCTURE; RECOMBINATION; SEROGROUP-1; SCHEME; SECRETION; EVOLUTION; NETWORKS; STRAINS	Inadequate discriminatory power to distinguish between L. pneumophila isolates, especially those belonging to disease-related prevalent sequence types (STs) such as ST1, ST36 and ST47, is an issue of SBT scheme. In this study, we developed a multilocus sequence typing (MLST) scheme based on two non-virulence loci (trpA, cca) and three virulence loci (icmK, lspE, lssD), to genotype 110 L. pneumophila isolates from various natural and artificial water sources in Guangdong province of China, and compared with the SBT. The isolates were assigned to 33 STs of the SBT and 91 new sequence types (nSTs) of the MLST. The indices of discrimination (IODs) of SBT and MLST were 0.920 and 0.985, respectively. Maximum likelihood trees of the concatenated SBT and MLST sequences both showed distinct phylogenetic relationships between the isolates from the two environments. More intragenic recombinations were detected in nSTs than in STs, and they were both more abundant in natural water isolates. We found out the MLST had a high discriminatory ability for the disease-associated ST1 isolates: 22 ST1 isolates were assigned to 19 nSTs. Furthermore, we assayed the discrimination of the MLST for 29 reference strains (19 clinical and 10 environmental). The clinical strains were assigned to eight STs and ten nSTs. The MLST could also subtype the prevalent clinical ST36 or ST47 strains: eight ST36 strains were subtyped into three nSTs and two ST47 strains were subtyped into two nSTs. We found different distribution patterns of nSTs between the environmental and clinical ST36 isolates, and between the outbreak clinical ST36 isolates and the sporadic clinical ST36 isolates. These results together revealed the MLST scheme could be used as part of a typing scheme that increased discrimination when necessary.	[Zhan, Xiao-Yong; Zhu, Qing-Yi] Guangzhou KingMed Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China; [Zhan, Xiao-Yong; Zhu, Qing-Yi] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China; [Zhan, Xiao-Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University	Zhan, XY (corresponding author), Guangzhou KingMed Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China.; Zhan, XY (corresponding author), Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China.; Zhan, XY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	tsinghan@126.com	zhan, xiao yong/C-9449-2016	zhan, xiao yong/0000-0002-5809-7904	National Natural Science Foundation of China [31500002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (grant number 31500002) to Xiao-Yong Zhan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (grant number 31500002).	Borges V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26261; Bosch T, 2015, J CLIN MICROBIOL, V53, P3234, DOI 10.1128/JCM.01369-15; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campese C, 2011, INT J INFECT DIS, V15, pE30, DOI 10.1016/j.ijid.2010.09.007; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2009, INFECT GENET EVOL, V9, P882, DOI 10.1016/j.meegid.2009.05.013; Costa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109840; Costa J, 2012, ENVIRON MICROBIOL, V14, P2017, DOI 10.1111/j.1462-2920.2011.02646.x; David S, 2016, J CLIN MICROBIOL, V54, P2135, DOI 10.1128/JCM.00432-16; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Den Boer JW, 2015, EMERG INFECT DIS, V21, P1167, DOI 10.3201/eid2107.141130; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Furuhata K, 2014, BIOCONTROL SCI, V19, P33, DOI 10.4265/bio.19.33; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Ginevra C., 2013, LEGIONELLA PNEUMOPHI; Ginevra C, 2008, EMERG INFECT DIS, V14, P673, DOI 10.3201/eid1404.070961; Gomez-Valero L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0505-0; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Graham RMA, 2014, EPIDEMIOL INFECT, V142, P2347, DOI 10.1017/S0950268814000375; Guo JY, 2015, INFECT GENET EVOL, V29, P35, DOI 10.1016/j.meegid.2014.10.023; [郭玉梅 Guo Yumei], 2014, [微生物学杂志, Journal of Mirobiology], V34, P72; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lepeuple AS, 2004, WATER SCI TECHNOL, V50, P281, DOI 10.2166/wst.2004.0068; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McAdam PR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0504-1; Mercante JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164074; Moran-Gilad J, 2015, EUROSURVEILLANCE, V20; Morrison DA, 2005, INT J PARASITOL, V35, P567, DOI 10.1016/j.ijpara.2005.02.007; Pancer K, 2013, ANN AGR ENV MED, V20, P436; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Qin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21356; Qin T, 2012, J MED MICROBIOL, V61, P1023, DOI 10.1099/jmm.0.040170-0; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sanchez-Buso L, 2014, NAT GENET, V46, P1205, DOI 10.1038/ng.3114; SMITH JM, 1992, J MOL EVOL, V34, P126; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Yuan M, 2010, CHINESE J PUBLIC HLT; Zhan XY, 2017, PEERJ, V5, DOI 10.7717/peerj.4114; Zhan XY, 2016, ARCH MICROBIOL, V198, P241, DOI 10.1007/s00203-015-1186-0; Zhang LY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030222	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190986	10.1371/journal.pone.0190986	http://dx.doi.org/10.1371/journal.pone.0190986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389983	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400012
J	DePasquale, B; Cueva, CJ; Rajan, K; Escola, GS; Abbott, LF				DePasquale, Brian; Cueva, Christopher J.; Rajan, Kanaka; Escola, G. Sean; Abbott, L. F.			full-FORCE: A target-based method for training recurrent networks	PLOS ONE			English	Article							PARAMETRIC WORKING-MEMORY; NEURAL-NETWORK; MODELS; CHAOS; FRAMEWORK; PATTERNS	Trained recurrent networks are powerful tools for modeling dynamic neural computations. We present a target-based method for modifying the full connectivity matrix of a recurrent network to train it to perform tasks involving temporally complex input/output transformations. The method introduces a second network during training to provide suitable "target" dynamics useful for performing the task. Because it exploits the full recurrent connectivity, the method produces networks that perform tasks with fewer neurons and greater noise robustness than traditional least-squares (FORCE) approaches. In addition, we show how introducing additional input signals into the target-generating network, which act as task hints, greatly extends the range of tasks that can be learned and provides control over the complexity and nature of the dynamics of the trained, task-performing network.	[DePasquale, Brian; Cueva, Christopher J.; Abbott, L. F.] Columbia Univ, Dept Neurosci, Zuckerman Inst, New York, NY 10027 USA; [Rajan, Kanaka] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Rajan, Kanaka] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rajan, Kanaka] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Escola, G. Sean] Columbia Univ, Dept Psychiat, Coll Physicians & Surg, New York, NY USA; [Abbott, L. F.] Columbia Univ, Dept Physiol & Cellular Biophys, Coll Physicians & Surg, New York, NY USA; [DePasquale, Brian] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Columbia University; Princeton University; Princeton University; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Princeton University	DePasquale, B (corresponding author), Columbia Univ, Dept Neurosci, Zuckerman Inst, New York, NY 10027 USA.; DePasquale, B (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	depasquale@princeton.edu		Rajan, Kanaka/0000-0003-2749-2917	NIH [MH093338]; Gatsby Charitable Foundation; Simons Foundation; NSF NeuroNex Award [DBI-1707398]; NSF Graduate Research Fellowship; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Simons Foundation; NSF NeuroNex Award; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research supported by NIH grant MH093338, the Gatsby Charitable Foundation (http.//www.gatsby.org.uk/neuroscience/programmes/neuroscience-at-columbia-university-new-york), the Simons Foundation (https://www.simonsfoundation.org/collaborations/global-brain/) and NSF NeuroNex Award DBI-1707398 (LFA). BD supported by a NSF Graduate Research Fellowship (https://www.nsfgrfp.org).; We thank Raoul-Martin Memmesheimer for fruitful discussions regarding an earlier version of this work. We thank Ben Dongsung Huh for suggesting the name full-FORCE that integrates the original FORCE acronym and David Sussillo, Omri Barak and Vishwa Goudar for helpful suggestions and conversations. We also thank Eli Pollock for providing a Python implementation of our algorithm. Research supported by NIH grant MH093338, the Gatsby Charitable Foundation and the Simons Foundation. BD supported by a NSF Graduate Research Fellowship.	Abbott LF, 2016, NAT NEUROSCI, V19, P350, DOI 10.1038/nn.4241; Abu-Mostafa Y. S., 1994, Journal of Complexity, V10, P165, DOI 10.1006/jcom.1994.1007; ABUMOSTAFA YS, 1995, NEURAL COMPUT, V7, P639, DOI 10.1162/neco.1995.7.4.639; Barak O, 2013, PROG NEUROBIOL, V103, P214, DOI 10.1016/j.pneurobio.2013.02.002; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Fisher D, 2013, NEURON, V79, P987, DOI 10.1016/j.neuron.2013.06.041; GIRKO VL, 1985, THEOR PROBAB APPL+, V29, P694, DOI 10.1137/1129095; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Haykin S, 2002, ADAPTIVE FILTER THEO; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee D-H, 2015, PREPRINT; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Rajan K, 2010, ADV NEURAL INFORM PR, V23; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2015, NAT NEUROSCI, V18, P1025, DOI 10.1038/nn.4042; Sussillo D, 2014, CURR OPIN NEUROBIOL, V25, P156, DOI 10.1016/j.conb.2014.01.008; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037372; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Triefenbach F., 2010, NIPS, V23, P2307; Vincent-Lamarre P, 2016, J COMPUT NEUROSCI, V41, P305, DOI 10.1007/s10827-016-0619-3; WERBOS PJ, 1988, NEURAL NETWORKS, V1, P339, DOI 10.1016/0893-6080(88)90007-X	33	41	41	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191527	10.1371/journal.pone.0191527	http://dx.doi.org/10.1371/journal.pone.0191527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415041	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300032
J	Fiocchi, S; Chiaramello, E; Parazzini, M; Ravazzani, P				Fiocchi, Serena; Chiaramello, Emma; Parazzini, Marta; Ravazzani, Paolo			Influence of tissue conductivity on foetal exposure to extremely low frequency magnetic fields at 50 Hz using stochastic dosimetry	PLOS ONE			English	Article							INDUCED CURRENT DENSITIES; DIELECTRIC-PROPERTIES; MATHEMATICAL-MODELS; POLYNOMIAL CHAOS; ELECTRIC-FIELDS; RISK-ASSESSMENT; POOLED ANALYSIS; PREGNANT-WOMEN; SAR; CHILDREN	Human exposure to extremely low frequency magnetic fields (ELF-MF) at 50 Hz is still a topic of great interest due to the possible correlation with childhood leukaemia. The estimation of induced electric fields in human tissues exposed to electromagnetic fields (EMFs) strictly depends on several variables which include the dielectric properties of the tissues. In this paper, the influence of the conductivity assignment to foetal tissues at different gestational ages on the estimation of the induced electric field due to ELF-MF exposure at 50 Hz has been quantified by means of a stochastic approach using polynomial chaos theory. The range of variation in conductivity values for each foetal tissue at each stage of pregnancy have been defined through three empirical approaches and the induced electric field in each tissue has been modelled through stochastic dosimetry. The main results suggest that both the peak and median induced electric fields in foetal fat vary by more than 8% at all gestational ages. On the contrary, the electric field induced in foetal brain does not seem to be significantly affected by conductivity data changes. The maximum exposure levels, in terms of the induced electric field found in each specific tissue, were found to be significantly below the basic restrictions indicated in the ICNIRP Guidelines, 2010.	[Fiocchi, Serena; Chiaramello, Emma; Parazzini, Marta; Ravazzani, Paolo] CNR, IEIIT, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Fiocchi, S (corresponding author), CNR, IEIIT, Milan, Italy.	serena.fiocchi@ieiit.cnr.it	Parazzini, Marta/J-8175-2014; Chiaramello, Emma/AAY-8463-2020; Fiocchi, Serena/AAT-5362-2021; Fiocchi, Serena/C-3475-2015	Parazzini, Marta/0000-0001-9008-7530; Chiaramello, Emma/0000-0003-2503-4779; Fiocchi, Serena/0000-0002-6568-8841; Fiocchi, Serena/0000-0002-6568-8841	French National Research Program for Environmental and Occupational Health of ANSES: Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies [2015/1/202]	French National Research Program for Environmental and Occupational Health of ANSES: Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies	The study is funded by the French National Research Program for Environmental and Occupational Health of ANSES (2015/1/202): Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies, 2015-2019.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Bellieni C V, 2012, BIOINITIATIVE REPORT, V19; Blatman G, 2011, J COMPUT PHYS, V230, P2345, DOI 10.1016/j.jcp.2010.12.021; Cech R, 2007, PHYS MED BIOL, V52, P879, DOI 10.1088/0031-9155/52/4/001; Chiaramello E, 2017, IEEE J ELECTROMAG RF, V1, P26, DOI 10.1109/JERM.2017.2727279; Christ A, 2012, BIOELECTROMAGNETICS, V33, P695, DOI 10.1002/bem.21739; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dimbylow P, 2005, PHYS MED BIOL, V50, P1047, DOI 10.1088/0031-9155/50/6/002; Dimbylow P, 2006, PHYS MED BIOL, V51, P2383, DOI 10.1088/0031-9155/51/10/003; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fiocchi S, 2013, BIOELECTROMAGNETICS, V34, P443, DOI 10.1002/bem.21789; Fiocchi S, 2011, PROG BIOPHYS MOL BIO, V107, P443, DOI 10.1016/j.pbiomolbio.2011.09.019; Forbes G, 1987, HUMAN BODY COMPOSITI; FORBES RM, 1953, J BIOL CHEM, V203, P359; Gabriel C, 2006, PHYS MED BIOL, V51, P6033, DOI 10.1088/0031-9155/51/23/006; Gabriel C, 2005, BIOELECTROMAGNETICS, pS12, DOI 10.1002/bem.20147; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Hasgall P. A., 2012, ITIS DATABASE THERMA; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Kawai H, 2006, IEICE T COMMUN, VE89B, P3401, DOI 10.1093/ietcom/e89-b.12.3401; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Liorni I, 2015, INT J ENV RES PUB HE, V12, P5934, DOI 10.3390/ijerph120605934; Liorni I, 2014, BIOELECTROMAGNETICS, V35, P580, DOI 10.1002/bem.21878; Lu YJ, 1996, BIOELECTROMAGNETICS, V17, P425, DOI 10.1002/(SICI)1521-186X(1996)17:5<425::AID-BEM10>3.0.CO;2-L; Peters MJ, 2001, BIOELECTROCHEMISTRY, V53, P155, DOI 10.1016/S0302-4598(00)00117-3; Peyman A, 2009, PHYS MED BIOL, V54, P227, DOI 10.1088/0031-9155/54/2/004; Peyman A, 2012, PHYS MED BIOL, V57, P2103, DOI 10.1088/0031-9155/57/8/2103; Peyman A, 2011, PHYS MED BIOL, V56, pN93, DOI 10.1088/0031-9155/56/7/N01; Peyman A, 2011, PROG BIOPHYS MOL BIO, V107, P434, DOI 10.1016/j.pbiomolbio.2011.08.007; Preston RJ, 2004, TOXICOL APPL PHARM, V199, P132, DOI 10.1016/j.taap.2003.12.030; Repacholi M, 2005, BIOELECTROMAGNETICS, pS2, DOI 10.1002/bem.20157; SCENIHR, 2014, HLTH EFF EMF PREL OP; Schuz J, 2016, BIOELECTROMAGNETICS, V37, P183, DOI 10.1002/bem.21963; Smith S R, 1985, PHYS MED BIOL, V49, P5185; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Soize C, 2004, SIAM J SCI COMPUT, V26, P395, DOI 10.1137/S1064827503424505; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Taub JW, 2004, LEUKEMIA LYMPHOMA, V45, P19, DOI 10.1080/1042819031000149403; Wang JQ, 2006, IEEE T ELECTROMAGN C, V48, P408, DOI 10.1109/TEMC.2006.874085; WHITE DR, 1991, BRIT J RADIOL, V64, P149, DOI 10.1259/0007-1285-64-758-149; WIDDOWSON EM, 1960, BIOCHEM J, V77, P30, DOI 10.1042/bj0770030; Wiener N, 1938, AM J MATH, V60, P897, DOI 10.2307/2371268; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; World Health Organization WHO, 2007, WHO RES AG EXTR LOW; Xiu DB, 2002, SIAM J SCI COMPUT, V24, P619, DOI 10.1137/S1064827501387826; Zoppetti N, 2011, PROG BIOPHYS MOL BIO, V107, P456, DOI 10.1016/j.pbiomolbio.2011.10.003; Zupanic A, 2007, IFMBE PROC, V16, P226	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192131	10.1371/journal.pone.0192131	http://dx.doi.org/10.1371/journal.pone.0192131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415005	gold, Green Submitted, Green Published			2022-12-27	WOS:000424325300051
J	Gim, HJ; Ho, CH; Kim, J; Lee, EJ				Gim, Hyeon-Ju; Ho, Chang-Hoi; Kim, Jinwon; Lee, Eun Ju			Urbanization may reduce the risk of frost damage to spring flowers: A case study of two shrub species in South Korea	PLOS ONE			English	Article							URBAN HEAT-ISLAND; CLIMATE-CHANGE; UNITED-STATES; TRENDS; TEMPERATURE; INTENSITY; PHENOLOGY; EUROPE; IMPACT; SEASON	Regional warming, owing to urbanization, leads to earlier spring phenological events and may expose plants to hard freeze damage. This study examined the influence of urbanization on the risk of frost damage to spring flowers in South Korea from 1973 to 2015. For the analysis period, we categorized 25 cities into two groups: those showing rapid population growth (rPG) >= 200,000, including 13 cities, and those showing no or decreased population growth (nPG), including 12 cities. We then investigated the time from the last frost dates (LFDs) in spring to the first flowering dates (FFDs) for each group. The rPG group experienced significant spring warming of 0.47 degrees C per decade, resulting in earlier LFDs and FFDs. For this group, the advancement of LFD was more rapid than that of FFD, and the days between these two dates increased from 0.42 to 0.47 days per decade, implying a reduced risk of frost damage. Spring warming and the advancement of FFDs and LFDs were relatively small for the nPG group, and the LFDs were rather delayed. Consequently, the days between LFDs and FFDs were reduced from -1.05 to -1.67 days per decade, indicating an increased risk of frost damage. The contrasting changes in the frost-damage risk between the two city groups can be attributed to distinct urban warming at night, which makes the LFDs substantially earlier in the rPG group. Therefore, this study suggests that the warming associated with urbanization may lessen the risk of spring frost damage to plants in rapidly growing urban areas.	[Gim, Hyeon-Ju; Ho, Chang-Hoi] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Kim, Jinwon] Natl Inst Meteorol Sci, Climate Res Div, Seogwipo Si, South Korea; [Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); National Institute of Meteorological Sciences; Seoul National University (SNU)	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015	Ho, Chang-Hoi/0000-0002-1372-0037	Korea Meteorological Administration Research and Development Program [KMIPA2015-6110]; National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration [NIMS-2016-3100]; Korea Meteorological Administration [KMIPA2015-6110]	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA)); National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration(Korea Meteorological Administration (KMA)); Korea Meteorological Administration(Korea Meteorological Administration (KMA))	Prof. Chang-Hoi Ho and Mr. Hyeon-Ju Gim were supported by Korea Meteorological Administration (http://www.kma.go.kr) with the grant numbers of KMIPA2015-6110, and Dr. Jinwon Kim was supported by Korea Meteorological Administration with the grant numbers of NIMS-2016-3100. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-6110. The work by Jinwon Kim was supported by the National Institute of Meteorological Sciences (NIMS) - Korea Meteorological Administration (NIMS-2016-3100). We thank two reviewers, David Inouye and one anonymous reviewer, whose comments helped improve and clarify this manuscript.	Alizadeh-Choobari O, 2016, ATMOS RES, V170, P176, DOI 10.1016/j.atmosres.2015.12.001; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Atkinson BW, 2003, BOUND-LAY METEOROL, V109, P285, DOI 10.1023/A:1025820326672; Augspurger CK, 2013, ECOLOGY, V94, P41, DOI 10.1890/12-0200.1; Beaubien E, 2011, BIOSCIENCE, V61, P514, DOI 10.1525/bio.2011.61.7.6; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chow WTL, 2006, INT J CLIMATOL, V26, P2243, DOI 10.1002/joc.1364; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chung U, 2004, CLIMATIC CHANGE, V66, P127, DOI 10.1023/B:CLIM.0000043136.58100.ce; Cline B, 1998, BLUEBERRY FREEZE DAM; Comrie AC, 2000, B AM METEOROL SOC, V81, P2417, DOI 10.1175/1520-0477(2000)081<2417:MAWMUH>2.3.CO;2; COOTER EJ, 1995, INT J CLIMATOL, V15, P65, DOI 10.1002/joc.3370150108; Easterling DR, 2002, B AM METEOROL SOC, V83, P1327, DOI 10.1175/1520-0477(2002)083&lt;1327:RCIFDA&gt;2.3.CO;2; Field CB, 2008, ECOLOGICAL IMPACTS C; Fujibe F, 2009, INT J CLIMATOL, V29, P1811, DOI 10.1002/joc.1822; Garrett PM, 2011, ENVIRON RES LETT, V6; Gedzelman SD, 2003, THEOR APPL CLIMATOL, V75, P29, DOI 10.1007/s00704-002-0724-2; Grimmond S, 2007, GEOGR J, V173, P83, DOI 10.1111/j.1475-4959.2007.232_3.x; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Hanninen H., 1987, Silva Fennica, V21, P279; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hufkens K, 2012, GLOBAL CHANGE BIOL, V18, P2365, DOI 10.1111/j.1365-2486.2012.02712.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Inouye DW, 2000, ECOL LETT, V3, P457, DOI 10.1046/j.1461-0248.2000.00165.x; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong S. J., 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI DOI 10.1111/J.1365-2486.2011.02397.X; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kataoka K, 2009, SCI TOTAL ENVIRON, V407, P3112, DOI 10.1016/j.scitotenv.2008.09.015; Kim MK, 2011, ATMOS ENVIRON, V45, P5778, DOI 10.1016/j.atmosenv.2011.07.028; Kim YH, 2004, THEOR APPL CLIMATOL, V79, P151, DOI 10.1007/s00704-004-0070-7; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; Kug JS, 2013, ASIA-PAC J ATMOS SCI, V49, P151, DOI 10.1007/s13143-013-0016-z; Larcher W., 2003, PHYSL PLANT ECOLOGY, pXX; Lee SH, 2010, THEOR APPL CLIMATOL, V100, P227, DOI 10.1007/s00704-009-0247-1; Malcolm J.R., 2000, ECOSYSTEMS GLOBAL CL; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Mohan M, 2015, SCI TOTAL ENVIRON, V506, P453, DOI 10.1016/j.scitotenv.2014.11.006; OKE TR, 1981, J CLIMATOL, V1, P237, DOI 10.1002/joc.3370010304; Peterson AG, 2014, GEOPHYS RES LETT, V41, P2156, DOI 10.1002/2014GL059266; Richardson Andrew D., 2009, P87, DOI 10.1007/978-1-4419-0026-5_4; Rigby JR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033955; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Ryu YH, 2012, J APPL METEOROL CLIM, V51, P842, DOI 10.1175/JAMC-D-11-098.1; Sarvas R., 1974, INVESTIGATIONS ANN C; Scheifinger H, 2003, THEOR APPL CLIMATOL, V74, P41, DOI 10.1007/s00704-002-0704-6; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Snyder RL., 2005, FROST PROTECT, V1, P87; Sun Y, 2016, NAT CLIM CHANGE, V6, P706, DOI [10.1038/nclimate2956, 10.1038/NCLIMATE2956]; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571	54	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191428	10.1371/journal.pone.0191428	http://dx.doi.org/10.1371/journal.pone.0191428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415073	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300027
J	Jones, T; Jones, PL				Jones, Takako; Jones, Peter L.			A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy	PLOS ONE			English	Article							MUSCLE REGENERATION; DNA REARRANGEMENTS; SKELETAL-MUSCLE; GENE-EXPRESSION; CANDIDATE GENE; MESSENGER-RNA; ANIMAL-MODELS; FSHD; MICE; FAMILY	The Double homeobox 4 (DUX4) gene is an important regulator of early human development and its aberrant expression is causal for facioscapulohumeral muscular dystrophy (FSHD). The DUX4-full length (DUX4-fl) mRNA splice isoform encodes a transcriptional activator; however, DUX4 and its unique DNA binding preferences are specific to old-world primates. Regardless, the somatic cytotoxicity caused by DUX4 expression is conserved when expressed in cells and animals ranging from fly to mouse. Thus, viable animal models based on DUX4-fl expression have been difficult to generate due in large part to overt developmental toxicity of low DUX4-fl expression from leaky transgenes. We have overcome this obstacle and here we report the generation and initial characterization of a line of conditional floxed DUX4-fl transgenic mice, FLExDUX4, that is viable and fertile. In the absence of cre, these mice express a very low level of DUX4-fl mRNA from the transgene, resulting in mild phenotypes. However, when crossed with appropriate cre-driver lines of mice, the double transgenic offspring readily express DUX4-fl mRNA, protein, and target genes with the spatiotemporal pattern of nuclear cre expression dictated by the chosen system. When cre is expressed from the ACTA1 skeletal muscle-specific promoter, the double transgenic animals exhibit a developmental myopathy. When crossed with tamoxifen-inducible cre lines, DUX4-mediated pathology can be induced in adult animals. Thus, the appearance and progression of pathology can be controlled to provide readily screenable phenotypes useful for assessing therapeutic approaches targeting DUX4-fl mRNA and protein. Overall, the FLExDUX4 line of mice is quite versatile and will allow new investigations into mechanisms of DUX4-mediated pathophysiology as well as much-needed pre-clinical testing of DUX4-targeted FSHD interventions in vivo.	[Jones, Takako; Jones, Peter L.] Univ Nevada, Dept Pharmacol, Ctr Mol Med, Reno Sch Med, Reno, NV 89557 USA; [Jones, Takako; Jones, Peter L.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Massachusetts System; University of Massachusetts Worcester	Jones, T; Jones, PL (corresponding author), Univ Nevada, Dept Pharmacol, Ctr Mol Med, Reno Sch Med, Reno, NV 89557 USA.; Jones, T; Jones, PL (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	takakojones@med.unr.edu; peterjones@med.unr.edu		Jones, Peter/0000-0003-4283-1016	Chris Carrino Foundation for FSHD; FSH Society [FSHS-22012-01]; Muscular Dystrophy Association [MDA383364]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR070432, R21AR070438]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070432, R21AR070438] Funding Source: NIH RePORTER	Chris Carrino Foundation for FSHD; FSH Society; Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by grants from the Chris Carrino Foundation for FSHD (http://chriscarrinofoundation.org/) to TJ, the FSH Society (FSHS-22012-01) (https://www.fshsociety.org/) to PLJ, the Muscular Dystrophy Association (MDA383364) (https://www.mda.org/) to PLJ, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070432 and R21AR070438) (https://www.niams.nih.gov/) to PLJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ansseau E, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030093; ARAHATA K, 1995, MUSCLE NERVE, pS56; Bosnakovski D, 2017, DIS MODEL MECH, V10, P1211, DOI 10.1242/dmm.030064; Bosnakovski D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00730-1; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen TH, 2013, NEUROMUSCULAR DISORD, V23, P298, DOI 10.1016/j.nmd.2013.01.005; Dandapat A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151467; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; de Greef JC, 2017, HUM MOL GENET; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng Q, 2015, ELIFE, V4, DOI 10.7554/eLife.04996; Ferreboeuf M, 2013, HUM MOL GENET; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Frisullo G, 2010, J CLIN IMMUNOL; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Himeda CL, 2015, ANTIOXID REDOX SIGN, V22, P1463, DOI 10.1089/ars.2014.6090; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones TI, 2017, NEUROMUSCULAR DISORD, V27, P221, DOI 10.1016/j.nmd.2016.12.007; Jones TI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0072-6; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Klinge L, 2006, NEUROMUSCULAR DISORD, V16, P553, DOI 10.1016/j.nmd.2006.06.008; Klingler Werner, 2012, Acta Myol, V31, P184; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lek A, 2015, TRENDS MOL MED, V21, P295, DOI 10.1016/j.molmed.2015.02.011; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marsollier AC, 2016, HUM MOL GENET, V25, P1468, DOI 10.1093/hmg/ddw015; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nagy A, 2009, COLD SPRING HARB PRO, V4; Peart N, 2017, HUM GENET, V136, P1291, DOI 10.1007/s00439-017-1813-8; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Statland JM, 2015, MUSCLE NERVE, V52, P521, DOI 10.1002/mus.24621; Tasca G, 2017, MOL NEUROBIOLOGY; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wang JX, 2012, BLOOD, V120, P1489, DOI 10.1182/blood-2012-01-404046; Wang LH, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0667-0; Whiddon JL, 2017, NAT GENET, V49, P935, DOI 10.1038/ng.3846; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251	77	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192657	10.1371/journal.pone.0192657	http://dx.doi.org/10.1371/journal.pone.0192657			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415061	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300092
J	Liu, XY; Lv, SS; Liu, R; Fan, SX; Liu, CJ; Liu, RY; Han, YY				Liu, Xueying; Lv, Shanshan; Liu, Ran; Fan, Shuangxi; Liu, Chaojie; Liu, Renyi; Han, Yingyan			Transcriptomic analysis reveals the roles of gibberellin-regulated genes and transcription factors in regulating bolting in lettuce (Lactuca sativa L.)	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; GENOME-WIDE ANALYSIS; EXPRESSION DATA; RESPONSIVE GENES; CHINESE-CABBAGE; STEM ELONGATION; ARABIDOPSIS; STRESS; RESISTANCE; SUPERMAN	A cool temperature is preferred for lettuce cultivation, as high temperatures cause premature bolting. Accordingly, exploring the mechanism of bolting and preventing premature bolting is important for agriculture. To explore this relationship in depth, morphological, physiological, and transcriptomic analyses of the bolting-sensitive line S39 at the five-leaf stage grown at 37 degrees C were performed in the present study. Based on paraffin section results, we observed that S39 began bolting on the seventh day at 37 degrees C. During bolting in the heat-treated plants, GA3 and GA4 levels in leaves and the indoleacetic acid (IAA) level in the stem reached a maximum on the sixth day, and these high contents were maintained. Additionally, bolting begins in the fifth day after GA3 treatment in S39 plants, GA3 and GA4 increased and then decreased, reaching a maximum on the fourth day in leaves. Similarly, IAA contents reached a maximum in the stem on the fifth day. No bolting was observed in the control group grown at 25 degrees C, and significant changes were not observed in GA3 and GA4 levels in the controls during the observation period. RNA-sequencing data implicated transcription factors (TFs) in regulating bolting in lettuce, suggesting that the high GA contents in the leaves and IAA in the stem promote bolting. TFs possibly modulate the expression of related genes, such as those encoding hormones, potentially regulating bolting in lettuce. Compared to the control group, 258 TFs were identified in the stem of the treatment group, among which 98 and 156 were differentially up-and down-regulated, respectively; in leaves, 202 and 115 TFs were differentially up-and down-regulated, respectively. Significant changes in the treated group were observed for C2H2 zinc finger, AP2-EREBP, and WRKY families, indicating that these TFs may play important roles in regulating bolting.	[Liu, Xueying; Liu, Ran; Fan, Shuangxi; Liu, Chaojie; Han, Yingyan] Beijing Univ Agr, Plant Sci & Technol Coll, New Technol Lab Agr Applicat Beijing, Minist Agr PR China,Key Lab Urban Agr North, Beijing, Peoples R China; [Lv, Shanshan; Liu, Renyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China	Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Han, YY (corresponding author), Beijing Univ Agr, Plant Sci & Technol Coll, New Technol Lab Agr Applicat Beijing, Minist Agr PR China,Key Lab Urban Agr North, Beijing, Peoples R China.	hyybac@126.com	Liu, Renyi/AAA-6449-2020		National Natural Science Foundation of China [31772321]; Beijing Municipal National Science Foundation [KZ201610020019]; Scientific Research Quality Improvement Funds of Beijing University of Agriculture [YQ201604]; Earmarked Fund for Beijing Leaf Vegetables Innovation Team of Modern Agro-industry Technology Research System [BLVT-21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal National Science Foundation; Scientific Research Quality Improvement Funds of Beijing University of Agriculture; Earmarked Fund for Beijing Leaf Vegetables Innovation Team of Modern Agro-industry Technology Research System	This work was supported by the National Natural Science Foundation of China [31772321], the Beijing Municipal National Science Foundation (KZ201610020019), and the Scientific Research Quality Improvement Funds of Beijing University of Agriculture (YQ201604), and Earmarked Fund for Beijing Leaf Vegetables Innovation Team of Modern Agro-industry Technology Research System [BLVT-21].	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Begara-Morales JC, 2014, PLANT CELL PHYSIOL, V55, P1080, DOI 10.1093/pcp/pcu044; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; BOWMAN JL, 1992, DEVELOPMENT, V114, P599; Cai XF, 2013, J INTEGR PLANT BIOL, V55, P552, DOI 10.1111/jipb.12043; Chen CH, 2002, PLANT PHYSIOL, V129, P706, DOI 10.1104/pp.001057; Currey CJ, 2012, HORTTECHNOLOGY, V22, P338, DOI 10.21273/HORTTECH.22.3.338; Dong XS, 2016, EUPHYTICA, V212, P65, DOI 10.1007/s10681-016-1759-2; Fu YongFu, 1998, Journal of China Agricultural University, V3, P1; Fukuda M, 2009, J PLANT PHYSIOL, V166, P2077, DOI 10.1016/j.jplph.2009.06.003; Gao L.M., 2011, SHANDONG AGR SCI, V8, P40; Gibson JL, 2003, HORTTECHNOLOGY, V13, P132, DOI 10.21273/HORTTECH.13.1.0132; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Han YY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01889; Jiang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08031; Joseph MP, 2014, PLANT PHYSIOL, V165, P1203, DOI 10.1104/pp.113.234294; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; [李岢 Li Ke], 2014, [植物生理学报, Plant Physiology Journal], V50, P1329; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Liu RX, 2010, J BIOSCIENCES, V35, P435, DOI 10.1007/s12038-010-0049-8; Liu YT, 2016, EUPHYTICA, V210, P427, DOI 10.1007/s10681-016-1710-6; Liu YH, 2017, BIOCHEM BIOPH RES CO, V483, P209, DOI 10.1016/j.bbrc.2016.12.164; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; MOE R, 1985, SCI HORTIC-AMSTERDAM, V27, P49, DOI 10.1016/0304-4238(85)90054-8; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song Xian-Yong, 2007, Bulletin of Botanical Research, V27, P182; Sun R.F., 1999, CHINA VEGETABLES, V3, P14; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wang BingLiang, 2004, Acta Horticulturae Sinica, V31, P375; Xiao D., 1957, COMPUTER SCI, V15, P276; Zhang N, 2016, PLANT PHYSIOL BIOCH, V107, P228, DOI 10.1016/j.plaphy.2016.06.008; Zhang SW, 2016, PLANT PHYSIOL BIOCH, V107, P178, DOI 10.1016/j.plaphy.2016.06.005; Zhang T.T., 2014, CHEM BIOENGINEERING, P31; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhen J. L., 2016, PLANT CELL PHYSL, V57, P1657; Ziauka J, 2010, PLANT CELL TISS ORG, V102, P221, DOI 10.1007/s11240-010-9725-5	42	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191518	10.1371/journal.pone.0191518	http://dx.doi.org/10.1371/journal.pone.0191518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415067	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300031
J	Castor, T; Yogev, N; Blank, T; Barwig, C; Prinz, M; Waisman, A; Bros, M; Reske-Kunz, AB				Castor, Timo; Yogev, Nir; Blank, Thomas; Barwig, Christina; Prinz, Marco; Waisman, Ari; Bros, Matthias; Reske-Kunz, Angelika B.			Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NF-KAPPA-B; ANTIGEN PRESENTATION; T-CELLS; REGULATORY CYTOKINE; IMMUNE DEVIATION; GM-CSF; GENE; INDUCTION; VACCINES	In this study we analysed the effects of prophylactic biolistic DNA vaccination with plasmids encoding the encephalitogenic protein myelin oligodendrocyte glycoprotein (MOG) on the severity of a subsequently MOGp35-55-induced EAE and on the underlying immune response. We compared the outcome of vaccination with MOG-encoding plasmids alone or in combination with vectors encoding the regulatory cytokines IL-10 and TGF-beta 1, respectively. MOG expression was restricted to skin dendritic cells (DCs) by the use of the DC-specific promoter of the fascin1 gene (pFscn-MOG). For comparison, the strong and ubiquitously active CMV promoter was employed (pCMV-MOG), which allows MOG expression in all transfected cells. Expression of IL-10 and TGF-beta 1 was controlled by the CMV promoter to yield maximal synthesis (pCMV-IL10, pCMV-TGF beta). Co-application of pFscn-MOG and pCMV-IL10 significantly ameliorated EAE pathology, while vaccination with pCMV-MOG plus pCMV-IL10 did not affect EAE outcome. In contrast, vaccination with either of the two MOG-encoding plasmids in combination with pCMV-TGF beta significantly attenuated the clinical EAE symptoms. Mechanistically, we observed diminished infiltration of Th17 and Th1 cells as well as macrophages/DCs into the CNS, which correlated with decreased MOGp35-55-specific production of IL-17 and IFN-gamma by spleen cells and reduced peptidespecific T cell proliferation. Our findings suggest deletion of or anergy induction in MOG-specific CD4(+) T cells by the suppressive vaccination platform employed. MOG expression driven by the DC-specific fascin1 promoter yielded similar inhibitory effects on EAE progression as the ubiquitously active viral CMV promoter, when coapplying pCMV-TGF beta. Our finding that pCMV-IL10 promoted tolerogenic effects only, when coapplied with pFscn-MOG, but not pCMV-MOG suggests that IL-10 affected only directly transfected DCs (pFscn-MOG), but not neighbouring DCs that engulfed MOG-containing vesicles derived from transfected keratinocytes (pCMV-MOG). Thus, due to its DC-restricted expression, the fascin1 promoter might be an interesting alternative to ubiquitously expressed promoters for vaccination strategies.	[Castor, Timo; Barwig, Christina; Bros, Matthias; Reske-Kunz, Angelika B.] Univ Med Ctr, Dept Dermatol, Mainz, Germany; [Yogev, Nir; Waisman, Ari] Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Blank, Thomas; Prinz, Marco] Univ Freiburg, Med Fac, Inst Neuropathol, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Freiburg; University of Freiburg	Reske-Kunz, AB (corresponding author), Univ Med Ctr, Dept Dermatol, Mainz, Germany.	reskekun@uni-mainz.de		Blank, Thomas/0000-0002-3969-405X	Stiftung Rheinland-Pfalz fur Innovation [15202-386261/280]	Stiftung Rheinland-Pfalz fur Innovation	This work was supported by a grant of the Stiftung Rheinland-Pfalz fur Innovation to AR-K (15202-386261/280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; Andersson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003682; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bourquin C, 2000, EUR J IMMUNOL, V30, P3663; Bros M, 2007, BLOOD, V109, P3820, DOI 10.1182/blood-2006-07-035576; Bros M, 2009, J IMMUNOL METHODS, V343, P13, DOI 10.1016/j.jim.2009.01.006; Brown AJ, 2015, BIOTECHNOL J, V10, P1019, DOI 10.1002/biot.201400744; Challa DK, 2016, J AUTOIMMUN, V72, P84, DOI 10.1016/j.jaut.2016.05.007; Cho JH, 2001, J IMMUNOL, V167, P5549, DOI 10.4049/jimmunol.167.10.5549; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fissolo N, 2012, CLIN IMMUNOL, V142, P76, DOI 10.1016/j.clim.2010.11.011; Flanagan EP, 2016, HAND CLINIC, V133, P327, DOI 10.1016/B978-0-444-63432-0.00019-0; FORD AL, 1995, J IMMUNOL, V154, P4309; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Haase C, 2002, IMMUNOLOGY, V107, P489, DOI 10.1046/j.1365-2567.2002.01529.x; Hohn Yvonne, 2013, Methods Mol Biol, V940, P199, DOI 10.1007/978-1-62703-110-3_17; Jegou JF, 2007, MOL IMMUNOL, V44, P3691, DOI 10.1016/j.molimm.2007.04.008; Jones A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00532; Keegan BM, 2013, SEMIN NEUROL, V33, P5, DOI 10.1055/s-0033-1345709; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Korn T, 2007, J NEUROIMMUNOL, V191, P51, DOI 10.1016/j.jneuroim.2007.09.009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Ludewig P, 2016, BBA-MOL BASIS DIS, V1862, P352, DOI 10.1016/j.bbadis.2015.11.003; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P7235, DOI 10.1167/iovs.12-10587; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Perona-Wright G, 2007, INT IMMUNOL, V19, P1123, DOI 10.1093/intimm/dxm084; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ramshaw IA, 1997, IMMUNOL CELL BIOL, V75, P409, DOI 10.1038/icb.1997.64; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Ross R, 1998, J IMMUNOL, V160, P3776; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; Song SS, 2014, INT IMMUNOPHARMACOL, V20, P117, DOI 10.1016/j.intimp.2014.02.027; Sudowe S, 2006, J ALLERGY CLIN IMMUN, V117, P196, DOI 10.1016/j.jaci.2005.08.058; Sudowe S, 2003, MOL THER, V8, P567, DOI 10.1016/S1525-0016(03)00242-9; SUDOWE S, 1995, INT IMMUNOL, V7, P1799, DOI 10.1093/intimm/7.11.1799; Sudowe S, 2009, IMMUNOLOGY, V128, pe193, DOI 10.1111/j.1365-2567.2008.02947.x; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Treacy O, 2016, METHODS MOL BIOL, V1371, P205, DOI 10.1007/978-1-4939-3139-2_13; Wahren B, 2014, VACCINES-BASEL, V2, P785, DOI 10.3390/vaccines2040785; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Walczak A, 2004, CLIN NEUROL NEUROSUR, V106, P241, DOI 10.1016/j.clineuro.2004.02.022; Weiss R, 2002, VACCINE, V20, P3148, DOI 10.1016/S0264-410X(02)00250-5; Williams JA, 2013, VACCINES, V1, P225, DOI 10.3390/vaccines1030225; Wu GF, 2011, NEUROL CLIN, V29, P257, DOI 10.1016/j.ncl.2010.12.009	62	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191927	10.1371/journal.pone.0191927	http://dx.doi.org/10.1371/journal.pone.0191927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408931	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800030
J	Frolich, AM; Nawka, MT; Ernst, M; Frischmuth, I; Fiehler, J; Buhk, JH				Froelich, Andreas Maximilian; Nawka, Marie Teresa; Ernst, Marielle; Frischmuth, Isabell; Fiehler, Jens; Buhk, Jan-Hendrik			Intra-aneurysmal flow disruption after implantation of the Medina (R) Embolization Device depends on aneurysm neck coverage	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; EXPERIENCE	Background and purpose Flow disruption achieved by braided intrasaccular implants is a novel treatment strategy for cerebrovascular aneurysms. We hypothesized that the degree of intra-aneurysmal flow disruption can be quantified in vitro and is influenced by device position across the aneurysm neck. We tested this hypothesis using the Medina (R) Embolization Device (MED). Methods Ten different patient-specific elastic vascular models were manufactured. Models were connected to a pulsatile flow circuit, filled with a blood-mimicking fluid and treated by two operators using a single MED. Intra-aneurysmal flow velocity was measured using conventional and high-frequency digital subtraction angiography (HF-DSA) before and after each deployment. Aneurysm neck coverage by the implanted devices was assessed with flat detector computed tomography on a three-point Likert scale. Results A total of 80 individual MED deployments were performed by the two operators. The mean intra-aneurysmal flow velocity reduction after MED implantation was 33.6% (27.5-39.7%). No significant differences in neck coverage (p = 0.99) or flow disruption (p = 0.84) were observed between operators. The degree of flow disruption significantly correlated with neck coverage (rho = 0.42, 95% CI: 0.21-0.59, p = 0.002) as well as with neck area (rho = -0,35, 95% CI: -0.54 - -0.13, p = 0.024). On multiple regression analysis, both neck coverage and total neck area were independent predictors of flow disruption. Conclusions The degree of intra-aneurysmal flow disruption after MED implantation can be quantified in vitro and varies considerably between different aneurysms and different device configurations. Optimal device coverage across the aneurysm neck improves flow disruption and may thus contribute to aneurysm occlusion.	[Froelich, Andreas Maximilian; Nawka, Marie Teresa; Ernst, Marielle; Frischmuth, Isabell; Fiehler, Jens; Buhk, Jan-Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Frolich, AM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	a.froelich@gmail.com		Nawka, Marie Teresa/0000-0001-7423-9725	Philips Healthcare; Medtronic, Dublin, Ireland	Philips Healthcare; Medtronic, Dublin, Ireland(Medtronic)	The authors thank Philips Healthcare for the support and realization of the "Hermann Zeumer Research Laboratory" including a Philips Allura Clarity Angiography system. The study was supported by a research agreement with Medtronic, Dublin, Ireland which included provision of the endovascular devices used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Johanna Spallek for help in post-processing of image data. The authors also thank Philips Healthcare for the support and realization of the "Hermann Zeumer Research Laboratory" including a Philips Allura Clarity Angiography system. The devices used in this study were provided by Medtronic, Dublin, Ireland.	Bhogal P, 2017, INTERV NEURORADIOL; Bodily KD, 2011, AM J NEURORADIOL, V32, P1232, DOI 10.3174/ajnr.A2478; Cebral JR, 2017, AM J NEURORADIOL, V38, P1180, DOI 10.3174/ajnr.A5158; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Frolich AMJ, 2016, AM J NEURORADIOL, V37, P120, DOI 10.3174/ajnr.A4486; Jeon JP, 2017, CLIN NEURORADIOL, V27, P205, DOI 10.1007/s00062-015-0485-9; Jou LD, 2017, INTERV NEURORADIOL, V23, P260, DOI 10.1177/1591019917694023; Mine B, 2016, J NEUROINTERV SURG, V8, P615, DOI 10.1136/neurintsurg-2015-011644; Pereira VM, 2013, AM J NEURORADIOL, V34, P808, DOI 10.3174/ajnr.A3322; Perez MA, 2017, J NEUROINTERV SURG, V9, P77, DOI 10.1136/neurintsurg-2016-012539; Pierot L, 2012, AM J NEURORADIOL, V33, P1232, DOI 10.3174/ajnr.A3191; Sourour NA, 2017, NEUROSURGERY; Turk AS, 2016, J NEUROINTERV SURG, V8, P168, DOI 10.1136/neurintsurg-2014-011585	13	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191975	10.1371/journal.pone.0191975	http://dx.doi.org/10.1371/journal.pone.0191975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408857	Green Submitted, gold, Green Published			2022-12-27	WOS:000424302800037
J	Kent, MS; Burton, JH; Dank, G; Bannasch, DL; Rebhun, RB				Kent, Michael S.; Burton, Jenna H.; Dank, Gillian; Bannasch, Danika L.; Rebhun, Robert B.			Association of cancer-related mortality, age and gonadectomy in golden retriever dogs at a veterinary academic center (1989-2016)	PLOS ONE			English	Article							INSURED SWEDISH DOGS; EXCEPTIONAL LONGEVITY; PET DOGS; BREED; DEATH; EXPOSURE; RISK; SEX	Golden retriever dogs have been reported to have an increased prevalence of cancer compared to other breeds. There is also controversy over the effect spay or neuter status might have on longevity and the risk for developing cancer. The electronic medical records system at an academic center was searched for all dogs who had a necropsy exam from 1989-2016. 9,677 canine necropsy examinations were completed of which 655 were golden retrievers. Age was known for 652 with a median age of death 9.15 years. 424 of the 652 (65.0%) were determined to have died because of cancer. The median age for dying of a cause other than cancer was 6.93 years while those dying of cancer had a median age of 9.83 years (p<0.0001). There was no significant difference in the proportion of intact males and castrated males dying of cancer (p = 0.43) but a greater proportion of spayed females died of cancer compared to intact females (p = 0.001). Intact female dogs had shorter life spans than spayed female dogs (p<0.0001), but there were no differences between intact and castrated males. Intriguingly, being spayed or neutered did not affect the risk of a cancer related death but increasing age did. The most common histologic diagnosis found in golden retrievers dying of cancer was hemangiosarcoma (22.64%) followed by lymphoid neoplasia (18.40%). Overall golden retriever dogs have a substantial risk of cancer related mortality in a referral population and age appears to have a larger effect on cancer related mortality than reproductive status.	[Kent, Michael S.; Burton, Jenna H.; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Dank, Gillian] Hebrew Univ Jerusalem, Koret Sch Vet Med, Rehovot, Israel; [Bannasch, Danika L.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; Hebrew University of Jerusalem; University of California System; University of California Davis	Kent, MS (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	mskent@ucdavis.edu	Bannasch, Danika/GZL-8044-2022; Burton, Jenna H/AAK-6753-2021	Burton, Jenna H/0000-0002-1895-8298; Bannasch, Danika/0000-0002-7614-7207; Rebhun, Robert/0000-0002-8047-3494; Kent, Michael/0000-0002-7703-7720	Center for Companion Animal Health, School of Veterinary Medicine, University of California [2016-70-F]; National Cancer Institute of the National Institutes of Health [K12CA138464]; NATIONAL CANCER INSTITUTE [K12CA138464, P30CA093373] Funding Source: NIH RePORTER	Center for Companion Animal Health, School of Veterinary Medicine, University of California(University of California System); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by award 2016-70-F from the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. http://www.vetmed.ucdavis.edu/CCAH/. JHB is supported by the National Cancer Institute of the National Institutes of Health under Award Number K12CA138464. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; [Anonymous], 2017, SEER CANC STAT REV 1; Belanger Janelle M, 2017, Canine Genet Epidemiol, V4, P6, DOI 10.1186/s40575-017-0044-6; Boerkamp KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-34; Bonnett BN, 2005, ACTA VET SCAND, V46, P105, DOI 10.1186/1751-0147-46-105; BRONSON RT, 1982, AM J VET RES, V43, P2057; Cooley DM, 2003, J GERONTOL A-BIOL, V58, P1078, DOI 10.1093/gerona/58.12.B1078; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; Craig LE, 2001, J AM ANIM HOSP ASSOC, V37, P438, DOI 10.5326/15473317-37-5-438; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Egenvall A, 2005, ACTA VET SCAND, V46, P121, DOI 10.1186/1751-0147-46-121; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Guy MK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0230; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Inoue M, 2015, PREV VET MED, V120, P210, DOI 10.1016/j.prevetmed.2015.03.018; Kengeri SS, 2013, AGE, V35, P2503, DOI 10.1007/s11357-013-9529-8; Komazawa S, 2016, J VET MED SCI, V78, P1269, DOI 10.1292/jvms.15-0584; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; Priester W A, 1980, Natl Cancer Inst Monogr, P1; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Ramos-Vara JA, 2000, VET PATHOL, V37, P597, DOI 10.1354/vp.37-6-597; Smith AN, 2014, VET CLIN N AM-SMALL, V44, P965, DOI 10.1016/j.cvsm.2014.06.003; Sturges BK, 2008, J VET INTERN MED, V22, P586, DOI 10.1111/j.1939-1676.2008.00042.x; U. S. Pet Ownership, 2017, COMM CAT SHELT POP E; Waters DJ, 2017, VET J, V224, P25, DOI 10.1016/j.tvjl.2017.05.006; Waters DJ, 2014, VET J, V200, P3, DOI 10.1016/j.tvjl.2013.11.024; Waters DJ, 2009, AGING CELL, V8, P752, DOI 10.1111/j.1474-9726.2009.00513.x; Zink MC, 2014, JAVMA-J AM VET MED A, V244, P309, DOI 10.2460/javma.244.3.309	33	26	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192578	10.1371/journal.pone.0192578	http://dx.doi.org/10.1371/journal.pone.0192578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408871	Green Published, gold			2022-12-27	WOS:000424302800082
J	Nemtsova, Y; Wiseman, JA; El-Banna, M; Lobel, P; Sleat, DE				Nemtsova, Yuliya; Wiseman, Jennifer A.; El-Banna, Mukarram; Lobel, Peter; Sleat, David E.			Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis	PLOS ONE			English	Article							IN-VIVO; SURVIVAL; CELLS; MICE; DISEASE	Late-infantile neuronal ceroid lipofuscinosis is a fatal neurodegenerative disease of children caused by mutations resulting in loss of activity of the lysosomal protease, tripeptidyl peptidase 1 (TPP1). While Tpp1-targeted mouse models of LINCL exist, the goal of this study was to create a transgenic mouse with inducible TPP1 to benchmark treatment approaches, evaluate efficacy of treatment at different stages of disease, and to provide insights into the pathobiology of disease. A construct containing a loxP-flanked stop cassette inserted between the chicken-actin promoter and a sequence encoding murine TPP1 (Tg(LSL-TPP1)) was integrated into the ROSA26 locus in mice by homologous recombination. Tested in both transfected CHO cells and in transgenic mice, the Tg(LSL-TPP1) did not express TPP1 until cre-mediated removal of the LSL cassette, which resulted in supraphysiological levels of TPP1 activity. We tested four cre/ERT2 transgenes to allow tamoxifen-inducible removal of the LSL cassette and subsequent TPP1 expression at any stage of disease. However, two of the cre/ERT2 driver transgenes had significant cre activity in the absence of tamoxifen, while cre-mediated recombination could not be induced by tamoxifen by two others. These results highlight potential problems with the use of cre/ERT2 transgenes in applications that are sensitive to low levels of basal cre expression. However, the germline-recombined mouse transgenic that constitutively overexpresses TPP1 will allow long-term evaluation of overexposure to the enzyme and in cell culture, the inducible transgene may be a useful tool in biomarker discovery projects.	[Nemtsova, Yuliya; Wiseman, Jennifer A.; El-Banna, Mukarram; Lobel, Peter; Sleat, David E.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Lobel, Peter; Sleat, David E.] Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lobel, P; Sleat, DE (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.; Lobel, P; Sleat, DE (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu; sleat@cabm.rutgers.edu		Sleat, David/0000-0002-5159-9928	National Institute of Neurological Disorders and Stroke; National Institutes of Health [R01NS37918]; NIH [R01NS37918];  [P30CA072720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institute of Neurological Disorders and Stroke and the National Institutes of Health grant R01NS37918 (P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Istvan Sohar, Dr. Dieter Saur for generously providing the LSL cassette and Dr. Mantu Bhaumik of the Transgenic and Knockout Mouse Shared Resource of The Cancer Institute of New Jersey (supported by P30CA072720). This project was supported by NIH grant R01NS37918 (P.L.).	Brake Rachael L, 2004, Genet Mol Res, V3, P456; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Geraets RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176526; Goebel HH, 2011, NEURONAL CEROID LIPO, Vxiv; Kristianto J, 2017, TRANSGENIC RES, V26, P411, DOI 10.1007/s11248-017-0018-1; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Markham A, 2017, DRUGS, V77, P1247, DOI 10.1007/s40265-017-0771-8; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Seime T, 2015, DEV GROWTH DIFFER, V57, P10, DOI 10.1111/dgd.12184; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 2016, GENE, V593, P284, DOI 10.1016/j.gene.2016.08.031; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Sohar I, 2000, CLIN CHEM, V46, P1005; Sondhi D, 2008, EXP NEUROL, V213, P18, DOI 10.1016/j.expneurol.2008.04.022; Wiseman JA, 2017, MOL THER-METH CLIN D, V4, P204, DOI 10.1016/j.omtm.2017.01.004; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192286	10.1371/journal.pone.0192286	http://dx.doi.org/10.1371/journal.pone.0192286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408933	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800054
J	Pal, E; Hadjadj, L; Fontanyi, Z; Monori-Kiss, A; Mezei, Z; Lippai, N; Magyar, A; Heinzlmann, A; Karvaly, G; Monos, E; Nadasy, G; Benyo, Z; Varbiro, S				Pal, Eva; Hadjadj, Leila; Fontanyi, Zoltan; Monori-Kiss, Anna; Mezei, Zsuzsanna; Lippai, Norbert; Magyar, Attila; Heinzlmann, Andrea; Karvaly, Gellert; Monos, Emil; Nadasy, Gyorgy; Benyo, Zoltan; Varbiro, Szabolcs			Vitamin D deficiency causes inward hypertrophic remodeling and alters vascular reactivity of rat cerebral arterioles	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; 25-HYDROXYVITAMIN D; BLOOD-PRESSURE; OXIDATIVE STRESS; NITRIC-OXIDE; RISK-FACTORS; HYPERTENSION; DISEASE; STROKE; ADOLESCENTS	Background and purpose Vitamin D deficiency (VDD) is a global health problem, which can lead to several pathophysiological consequences including cardiovascular diseases. Its impact on the cerebrovascular system is not well understood. The goal of the present work was to examine the effects of VDD on the morphological, biomechanical and functional properties of cerebral arterioles. Methods Four-week-old male Wistar rats (n = 11 per group) were either fed with vitamin D deficient diet or received conventional rat chow with per os vitamin D supplementation. Cardiovascular parameters and hormone levels (testosterone, androstenedione, progesterone and 25-hydroxyvitamin D) were measured during the study. After 8 weeks of treatment anterior cerebral artery segments were prepared and their morphological, biomechanical and functional properties were examined using pressure microangiometry. Resorcin-fuchsin and smooth muscle actin staining were used to detect elastic fiber density and smooth muscle cell counts in the vessel wall, respectively. Sections were immunostained for eNOS and COX-2 as well. Results VDD markedly increased the wall thickness, the wall-to-lumen ratio and the wall cross-sectional area of arterioles as well as the number of smooth muscle cells in the tunica media. As a consequence, tangential wall stress was significantly lower in the VDD group. In addition, VDD increased the myogenic as well as the uridine 5'-triphosphate-induced tone and impaired bradykinin-induced relaxation. Decreased eNOS and increased COX-2 expression were also observed in the endothelium of VDD animals. Conclusions VDD causes inward hypertrophic remodeling due to vascular smooth muscle cell proliferation and enhances the vessel tone probably because of increased vasoconstrictor prostanoid levels in young adult rats. In addition, the decreased eNOS expression results in endothelial dysfunction. These morphological and functional alterations can potentially compromise the cerebral circulation and lead to cerebrovascular disorders in VDD.	[Pal, Eva; Hadjadj, Leila; Monori-Kiss, Anna; Monos, Emil; Benyo, Zoltan] Semmelweis Univ, Inst Clin Expt Res, Budapest, Hungary; [Fontanyi, Zoltan; Varbiro, Szabolcs] Semmelweis Univ, Dept Obstet & Gynecol 2, Budapest, Hungary; [Mezei, Zsuzsanna; Nadasy, Gyorgy] Semmelweis Univ, Dept Physiol, Budapest, Hungary; [Lippai, Norbert] Jasz Nagykun Szolnok Cty Hetenyi Geza Hosp, Dept Pathol, Szolnok, Hungary; [Magyar, Attila; Heinzlmann, Andrea] Semmelweis Univ, Dept Anat Histol & Embryol, Budapest, Hungary; [Karvaly, Gellert] Semmelweis Univ, Dept Lab Med, Budapest, Hungary; [Karvaly, Gellert] Bion Innovat Ctr, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University	Pal, E (corresponding author), Semmelweis Univ, Inst Clin Expt Res, Budapest, Hungary.	pal.eva@med.semmelweis-univ.hu		Hadjadj, Leila/0000-0001-6829-8462	Hungarian National Research, Development and Innovation Office [OTKA K-112964, OTKA K-101775, NVKP_16-1-2016-0042, ED_14-1-2014-0002]; Hungarian Society of Hypertension; Faculty of Medicine, Semmelweis University	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Society of Hypertension; Faculty of Medicine, Semmelweis University	This study has been supported by the Hungarian National Research, Development and Innovation Office (http://nkfih.gov.hu/; OTKA K-112964, OTKA K-101775 and NVKP_16-1-2016-0042, to ZB; ED_14-1-2014-0002, to GK), the Hungarian Society of Hypertension (http://www.hypertension.hu/; to SzV) and by the Dean of Faculty of Medicine, Semmelweis University (http://semmelweis.hu/english/faculties/medicine/; to SzV and GyN). The funders had no role in study design data collection and analysis, decision to publish,or preparation of the manuscript.	Andersen LB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001417; Argacha JF, 2011, J CARDIOVASC PHARM, V58, P65, DOI 10.1097/FJC.0b013e31821c832f; Balden R, 2012, ENDOCRINOLOGY, V153, P2420, DOI 10.1210/en.2011-1783; Black LJ, 2016, BRIT J NUTR, V115, P1994, DOI 10.1017/S0007114516001185; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Canale D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103055; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Chowdhury R, 2012, EUR J EPIDEMIOL, V27, P581, DOI 10.1007/s10654-012-9729-z; Chung PW, 2015, STROKE, V46, P248, DOI 10.1161/STROKEAHA.114.007706; Del Gobbo LC, 2011, J NUTR, V141, P290, DOI 10.3945/jn.110.129619; Dong JH, 2013, KIDNEY INT, V84, P54, DOI 10.1038/ki.2013.12; Feletou M, 2010, ADV PHARMACOL, V60, P85, DOI [10.1016/S1054-3589(10)60006-3, 10.1016/B978-0-12-385061-4.00004-0]; Gezmish O, 2013, J CARDIOVASC TRANSL, V6, P588, DOI 10.1007/s12265-013-9475-y; Goncalves JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107228; HARDEBO JE, 1987, EUR J PHARMACOL, V144, P343, DOI 10.1016/0014-2999(87)90387-6; Hetthessy JR, 2017, PHLEBOLOGY; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Husain K, 2010, AM J NEPHROL, V32, P296, DOI 10.1159/000319445; Izzard AS, 2005, J HYPERTENS, V23, P247, DOI 10.1097/00004872-200502000-00002; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Kojima G, 2012, STROKE, V43, P2163, DOI 10.1161/STROKEAHA.112.651752; Lacza Z, 2001, BRAIN RES, V896, P169, DOI 10.1016/S0006-8993(01)02083-2; Laursen JB, 2001, CIRCULATION, V103, P1282; Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x; Li XX, 2017, J NEUROL SCI, V380, P1, DOI 10.1016/j.jns.2017.06.018; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Martinez-Miguel P, 2014, AM J PHYSIOL-ENDOC M, V307, pE1085, DOI 10.1152/ajpendo.00156.2014; Masszi G, 2013, LIFE SCI, V93, P133, DOI 10.1016/j.lfs.2013.05.003; Meems LMG, 2016, AM J PHYSIOL-HEART C, V311, pH1459, DOI 10.1152/ajpheart.00141.2016; Mehta V, 2017, CUREUS, V9, DOI 10.7759/cureus.1038; Menezes AR, 2014, CURR OPIN CARDIOL, V29, P571, DOI 10.1097/HCO.0000000000000108; Milazzo V, 2017, WORLD J CARDIOL, V9, P14, DOI 10.4330/wjc.v9.i1.14; Mirhosseini NZ, 2016, BRIT J NUTR, V116, P1889, DOI 10.1017/S0007114516004098; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; More AS, 2014, J CARDIOVASC PHARM, V64, P209, DOI 10.1097/FJC.0000000000000105; Moretti R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00169; Mozos I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/109275; Muhairi SJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-33; Nascimento Fernanda A M, 2012, PLoS One, V7, pe41740, DOI 10.1371/journal.pone.0041740; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; Pelham CJ, 2016, J MOL CELL CARDIOL, V98, P1, DOI 10.1016/j.yjmcc.2016.06.067; Poomthavorn P, 2012, INT J OBESITY, V36, P491, DOI 10.1038/ijo.2011.260; Prabhakar P, 2015, J NEUROL SCI, V359, P108, DOI 10.1016/j.jns.2015.10.050; Rafraf M, 2014, PUBLIC HEALTH NUTR, V17, P803, DOI 10.1017/S1368980013003340; Rangan GK, 2013, AM J PHYSIOL-RENAL, V305, pF574, DOI 10.1152/ajprenal.00411.2012; Rizzoni D, 1996, HYPERTENSION, V28, P785, DOI 10.1161/01.HYP.28.5.785; Shi YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41796; Sierra C, 2011, CURR HYPERTENS REP, V13, P200, DOI 10.1007/s11906-011-0195-x; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Sundersingh F, 2015, BIOCHEM BIOPH RES CO, V461, P589, DOI 10.1016/j.bbrc.2015.04.069; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; Tare M, 2011, J PHYSIOL-LONDON, V589, P4777, DOI 10.1113/jphysiol.2011.214726; Turetsky A, 2015, J STROKE CEREBROVASC, V24, P1555, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.051; Wahl M., 1999, Acta Physiologica Hungarica, V86, P155; Wang HM, 2017, AGING DIS, V8, P346, DOI 10.14336/AD.2016.1021; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zittermann A, 2014, ANTICANCER RES, V34, P4641	64	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192480	10.1371/journal.pone.0192480	http://dx.doi.org/10.1371/journal.pone.0192480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408903	gold, Green Published			2022-12-27	WOS:000424302800070
J	Afify, EAMR; Elsayed, I; Gad, MK; Mohamed, MI; Afify, AMR				Afify, Enas A. M. R.; Elsayed, Ibrahim; Gad, Mary K.; Mohamed, Magdy I.; Afify, Abd El-Moneim M. R.			Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures	PLOS ONE			English	Article							DRUG-DELIVERY; INTERFACIAL-TENSION; NANOPARTICLES; RELEASE; DESIGN; EYE; MEMBRANE; GLAUCOMA; RABBIT; PHOSPHATIDYLCHOLINE	Dorzolamide hydrochloride is frequently administered for the control of the intra-ocular pressure associated with glaucoma. The aim of this study is to develop and optimize self-assembled nanostructures of dorzolamide hydrochloride and L-alpha-Phosphatidylcholine to improve the pharmacokinetic parameters and extend the drug pharmacological action. Self-assembled nanostructures were prepared using a modified thin-film hydration technique. The formulae compositions were designed based on response surface statistical design. The prepared self-assembled nanostructures were characterized by testing their drug content, particle size, polydispersity index, zeta potential, partition coefficient, release half-life and extent. The optimized formulae having the highest drug content, zeta potential, partition coefficient, release half-life and extent with the lowest particle size and polydispersity index were subjected to further investigations including investigation of their physicochemical, morphological characteristics, in vivo pharmacokinetic and pharmacodynamic profiles. The optimized formulae were prepared at pH 8.7 (F5 and F6) and composed of L-alpha-Phosphatidylcholine and drug mixed in a ratio of 1:1 and 2:1 w/w, respectively. They showed significantly higher C-max, AUC(0)(24) and AUC(0)(infinity) at the aqueous humor with extended control over the intra-ocular pressure, when compared to the marketed product; Trusopt (R). The study introduced novel and promising self-assembled formulae able to permeate higher drug amount through the cornea and achieve sustained pharmacological effect at the site of action.	[Afify, Enas A. M. R.; Gad, Mary K.] NODCAR, Giza, Egypt; [Elsayed, Ibrahim; Mohamed, Magdy I.] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt; [Elsayed, Ibrahim] Gulf Med Univ, Coll Pharm, Dept Pharmaceut Sci, Ajman, U Arab Emirates; [Afify, Abd El-Moneim M. R.] Cairo Univ, Fac Agr, Biochem Dept, Cairo, Egypt	National Organization for Drug Control & Research (NODCAR); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Afify, AMR (corresponding author), Cairo Univ, Fac Agr, Biochem Dept, Cairo, Egypt.	abdelmoneimafify@yahoo.com		Elsayed, Ibrahim/0000-0001-5724-0724				Alam S, 2016, DRUG DELIV, V23, P601, DOI 10.3109/10717544.2014.923958; Asgharinezhad AA, 2016, J CHROMATOGR A, V1435, P18, DOI 10.1016/j.chroma.2016.01.027; Babazadeh A, 2017, J FUNCT FOODS, V33, P134, DOI 10.1016/j.jff.2017.03.038; Bhuiyan MHU, 2015, PROCEDIA ENGINEER, V105, P431, DOI 10.1016/j.proeng.2015.05.030; de Oliveira GGG, 2017, SAUDI PHARM J, V25, P99, DOI 10.1016/j.jsps.2016.05.001; Dinslage S, 1998, INVEST OPHTH VIS SCI, V39, P2485; Elsayed I, 2014, INT J NANOMED, V9, P2943, DOI 10.2147/IJN.S63395; GRASS GM, 1988, J PHARM SCI-US, V77, P3, DOI 10.1002/jps.2600770103; Habibi N, 2016, NANO TODAY, V11, P41, DOI 10.1016/j.nantod.2016.02.004; Hasan AA, 2014, PHARM DEV TECHNOL, V19, P748, DOI 10.3109/10837450.2013.829095; HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210; Hussain SA, 2017, IRAQI J PHARM SCI, V16, P39; Johannesson G, 2014, ACTA OPHTHALMOL, V92, P550, DOI 10.1111/aos.12334; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Lee JH, 2010, EXPERT OPIN DRUG DEL, V7, P341, DOI 10.1517/17425240903559841; Lewis RA, 2017, AM J OPHTHALMOL, V175, P137, DOI 10.1016/j.ajo.2016.11.020; Lipka E, 1999, J CONTROL RELEASE, V62, P41, DOI 10.1016/S0168-3659(99)00022-X; Loftsson T, 2012, ACTA OPHTHALMOL, V90, P603, DOI 10.1111/j.1755-3768.2011.02299.x; Mahmoud AA, 2011, INT J PHARMACEUT, V413, P229, DOI 10.1016/j.ijpharm.2011.04.031; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Mohamed AMI, 2014, TALANTA, V130, P495, DOI 10.1016/j.talanta.2014.06.074; Mourabet M, 2017, ARAB J CHEM, V10, pS3292, DOI 10.1016/j.arabjc.2013.12.028; Nguyen MA, 2017, EUR J PHARM SCI, V102, P1, DOI 10.1016/j.ejps.2017.02.029; Othman R, 2016, LANGMUIR, V32, P10685, DOI 10.1021/acs.langmuir.6b03178; Panda JJ, 2014, POLYM CHEM-UK, V5, P4418, DOI 10.1039/c4py00173g; Pandita A., 2013, ISRN PHARM, V2013, P10, DOI DOI 10.1155/2013/348186; Park CG, 2017, INT J PHARMACEUT, V522, P66, DOI 10.1016/j.ijpharm.2017.02.035; Petelska AD, 2002, BBA-BIOMEMBRANES, V1561, P135, DOI 10.1016/S0005-2736(01)00463-1; Petelska AD, 2000, BIOPHYS J, V78, P812, DOI 10.1016/S0006-3495(00)76638-0; Quaranta L, 2016, ADV THER, V33, P1305, DOI 10.1007/s12325-016-0358-x; Sanchez-Lopez E, 2017, EUR J PHARM BIOPHARM, V110, P70, DOI 10.1016/j.ejpb.2016.10.009; SCHOENWALD RD, 1978, J PHARM SCI-US, V67, P786, DOI 10.1002/jps.2600670614; Scozzatava A, 2014, GLAUCOMA APPL CARBON, P349; Semalty A, 2012, J INCL PHENOM MACRO, V73, P377, DOI 10.1007/s10847-011-0074-8; Semalty A, 2010, J INCL PHENOM MACRO, V67, P253, DOI 10.1007/s10847-009-9705-8; Semalty A, 2009, ACTA PHARMACEUT, V59, P335, DOI 10.2478/v10007-009-0023-x; Sharma N, 2016, ASIAN J PHARM SCI, V11, P404, DOI 10.1016/j.ajps.2015.09.004; Sigurdsson HH, 2005, J CONTROL RELEASE, V102, P255, DOI 10.1016/j.jconrel.2004.10.004; Stone Jordan S, 2015, N C Med J, V76, P211, DOI 10.18043/ncm.76.4.211; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tita D, 2013, J THERM ANAL CALORIM, V112, P407, DOI 10.1007/s10973-013-2937-2; Tiwari M, 2017, ADV SCI LETT, V23, P1792, DOI 10.1166/asl.2017.8536; Toropainen E, 2003, EUR J PHARM SCI, V20, P99, DOI 10.1016/S0928-0987(03)00173-8; WANG W, 1991, CURR EYE RES, V10, P571, DOI 10.3109/02713689109001766; Zhang HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10099; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; ZHU MD, 1992, AUST NZ J OPHTHALMOL, V20, P225, DOI 10.1111/j.1442-9071.1992.tb00944.x	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191415	10.1371/journal.pone.0191415	http://dx.doi.org/10.1371/journal.pone.0191415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401498	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400011
J	Saini, A; Rullman, E; Lilja, M; Mandic, M; Melin, M; Olsson, K; Gustafsson, T				Saini, Amarjit; Rullman, Eric; Lilja, Mats; Mandic, Mirko; Melin, Michael; Olsson, Karl; Gustafsson, Thomas			Asymmetric cellular responses in primary human myoblasts using sera of different origin and specification	PLOS ONE			English	Article							SKELETAL-MUSCLE; CELLS; EXPRESSION; CULTURE; INHIBITORS; MECHANISM; SURVIVAL; MYOTUBES; ASSAY	For successful growth and maintenance of primary myogenic cells in vitro, culture medium and addition of sera are the most important factors. At present it is not established as to what extent sera of different origin and composition, supplemented in media or serum-free media conditions influence myoblast function and responses to different stimuli. By assessing markers of proliferation, differentiation/fusion, quiescence, apoptosis and protein synthesis the aim of the current study was to elucidate how primary human myoblasts and myotubes are modulated by different commonly used serum using FCS (foetal calf serum), (CS-FCS charcoal-stripped FCS, a manufacturing process to remove hormones and growth factors from sera), HS (horse serum) as well as in serum free conditions (DMEM). To characterise the biological impact of the different serum, myoblasts were stimulated with Insulin (100 nM) and Vitamin D (100 nM; 1 alpha, 25(OH)(2)D-3, 1 alpha, 25-Dihydroxycholecalciferol, Calcitriol), two factors with characterised effects on promoting fusion and protein synthesis or quiescence, respectively in human myoblasts/myotubes. We demonstrate that sera of different origin/formulation differentially affect myoblast proliferation and myotube protein synthesis. Importantly, we showed that quantifying the extent to which Insulin effects myoblasts in vitro is highly dependent upon serum addition and which type is present in the media. Upregulation of mRNA markers for myogenic fusion, Myogenin, with Insulin stimulation, relative to DMEM, appeared dampened at varying degrees with serum addition and effects on p70S6K phosphorylation as a marker of protein synthesis could not be identified unless serum was removed from media. We propose that these asymmetric molecular and biochemical responses in human myoblasts reflect the variable composition of mitogenic and anabolic factors in each of the sera. The results have implications for both the reproducibility and interpretation of results from experimental models in myoblast cells/myotubes.	[Saini, Amarjit; Rullman, Eric; Lilja, Mats; Mandic, Mirko; Melin, Michael; Olsson, Karl; Gustafsson, Thomas] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Div Clin Physiol,Dept Lab Med, Stockholm, Sweden; [Rullman, Eric; Melin, Michael] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Cardiovasc Theme, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Saini, A (corresponding author), Karolinska Univ, Hosp Huddinge, Karolinska Inst, Div Clin Physiol,Dept Lab Med, Stockholm, Sweden.	amarjit.saini@ki.se	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206; Lilja, Mats/0000-0003-3473-7265; Mandic, Mirko/0000-0002-7414-482X				Baker M, 2016, NATURE, V537, P433, DOI 10.1038/537433a; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BJARE U, 1992, PHARMACOL THERAPEUT, V53, P355, DOI 10.1016/0163-7258(92)90056-6; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Cho YS, 2009, ANAL BIOCHEM, V392, P110, DOI 10.1016/j.ab.2009.04.038; Cui ZY, 2009, PROTEOMICS, V9, P1274, DOI 10.1002/pmic.200800354; Gran Petra, 2011, BMC Physiology, V11, P10, DOI 10.1186/1472-6793-11-10; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Martin NRW, 2013, BIOMATERIALS, V34, P5759, DOI 10.1016/j.biomaterials.2013.04.002; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Middelbeek RJW, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.13; Olsson K, 2016, ENDOCRINOLOGY, V157, P98, DOI 10.1210/en.2015-1685; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Park YG, 2006, YONSEI MED J, V47, P179, DOI 10.3349/ymj.2006.47.2.179; PRICE PJ, 1982, IN VITRO CELL DEV B, V18, P576; Saini A, 2008, GROWTH FACTORS, V26, P239, DOI 10.1080/08977190802291634; Saini A, 2017, BIOGERONTOLOGY, V18, P109, DOI 10.1007/s10522-016-9667-3; Saini A, 2010, CELL PHYSIOL BIOCHEM, V25, P253, DOI 10.1159/000276559; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; World Health Organization, 2012, GOOD HLTH ADDS LIF Y; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192384	10.1371/journal.pone.0192384	http://dx.doi.org/10.1371/journal.pone.0192384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401478	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400057
J	van der Steen, JT; van den Bogert, CA; van Soest-Poortvliet, MC; Farsani, SF; Otten, RHJ; ter Riet, G; Bouter, LM				van der Steen, Jenny T.; van den Bogert, Cornelis A.; van Soest-Poortvliet, Mirjam C.; Farsani, Soulmaz Fazeli; Otten, Rene H. J.; ter Riet, Gerben; Bouter, Lex M.			Determinants of selective reporting: A taxonomy based on content analysis of a random selection of the literature	PLOS ONE			English	Article							PUBLICATION BIAS; QUALITATIVE RESEARCH; PROTOCOLS; SCIENCE; WASTE; FATE	Background Selective reporting is wasteful, leads to bias in the published record and harms the credibility of science. Studies on potential determinants of selective reporting currently lack a shared taxonomy and a causal framework. Objective To develop a taxonomy of determinants of selective reporting in science. Design Inductive qualitative content analysis of a random selection of the pertinent literature including empirical research and theoretical reflections. Methods Using search terms for bias and selection combined with terms for reporting and publication, we systematically searched the PubMed, Embase, PsycINFO and Web of Science databases up to January 8, 2015. Of the 918 articles identified, we screened a 25 percent random selection. From eligible articles, we extracted phrases that mentioned putative or possible determinants of selective reporting, which we used to create meaningful categories. We stopped when no new categories emerged in the most recently analyzed articles (saturation). Results Saturation was reached after analyzing 64 articles. We identified 497 putative determinants, of which 145 (29%) were supported by empirical findings. The determinants represented 12 categories (leaving 3% unspecified): focus on preferred findings (36%), poor or overly flexible research design (22%), high-risk area and its development (8%), dependence upon sponsors (8%), prejudice (7%), lack of resources including time (3%), doubts about reporting being worth the effort (3%), limitations in reporting and editorial practices (3%), academic publication system hurdles (3%), unfavorable geographical and regulatory environment (2%), relationship and collaboration issues (2%), and potential harm (0.4%). Conclusions We designed a taxonomy of putative determinants of selective reporting consisting of 12 categories. The taxonomy may help develop theory about causes of selection bias and guide policies to prevent selective reporting.	[van der Steen, Jenny T.] Leiden Univ, Med Ctr, PHEG, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [van der Steen, Jenny T.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [van den Bogert, Cornelis A.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van Soest-Poortvliet, Mirjam C.] Trimbos Inst, Netherlands Inst Mental Hlth & Addict, Program Aging, Utrecht, Netherlands; [Farsani, Soulmaz Fazeli] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Otten, Rene H. J.] Vrije Univ, Med Lib, Amsterdam, Netherlands; [ter Riet, Gerben] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Bouter, Lex M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Bouter, Lex M.] Vrije Univ, Fac Humanities, Dept Philosophy, Amsterdam, Netherlands; [Farsani, Soulmaz Fazeli] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Utrecht University; Trimbos Institute; Utrecht University; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Boehringer Ingelheim	van der Steen, JT (corresponding author), Leiden Univ, Med Ctr, PHEG, Dept Publ Hlth & Primary Care, Leiden, Netherlands.; van der Steen, JT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.	jtvandersteen@lumc.nl	van der Steen, Jenny T./E-5118-2016; Riet, Gerben ter/A-6943-2011; Bouter, Lex/X-1003-2019; Farsani, Soulmaz Fazeli/AAG-9598-2020	van der Steen, Jenny T./0000-0002-9063-7501; Riet, Gerben ter/0000-0002-2231-7637; Bouter, Lex/0000-0002-2659-5482; 	Netherlands Organisation for Scientific Research (NWO; Innovational Research Incentives Scheme) [917.11.339]; Leiden University Medical Center, Leiden, The Netherlands; Dutch Ministry of Health, Welfare and Sports	Netherlands Organisation for Scientific Research (NWO; Innovational Research Incentives Scheme)(Netherlands Organization for Scientific Research (NWO)); Leiden University Medical Center, Leiden, The Netherlands(Netherlands Government); Dutch Ministry of Health, Welfare and Sports	The design of the study and writing of the article was funded by a career award for JTS from the Netherlands Organisation for Scientific Research (NWO; Innovational Research Incentives Scheme: Vidi grant number 917.11.339), and Leiden University Medical Center, Leiden, The Netherlands. CAvdB was supported by a PhD grant from the Dutch Ministry of Health, Welfare and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SYSTEMATIC REV CRDS; [Anonymous], BMJ BRIT MED J; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Bassler D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010024; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2017, JAMA-J AM MED ASSOC, V318, P1709, DOI 10.1001/jama.2017.13001; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; Dunkelberg S., 2005, Z ALLGEMEINMEDIZIN, V81, P145; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; FISHER M, 1994, JAMA-J AM MED ASSOC, V272, P143, DOI 10.1001/jama.272.2.143; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Greenland S, 2009, J EPIDEMIOL COMMUN H, V63, P593, DOI 10.1136/jech.2008.084913; Gyles C, 2012, CAN VET J, V53, P587; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Preston C, 2004, J EVAL CLIN PRACT, V10, P313, DOI 10.1111/j.1365-2753.2003.00457.x; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; van den Bogert CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167709	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0188247	10.1371/journal.pone.0188247	http://dx.doi.org/10.1371/journal.pone.0188247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401492	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400001
J	Li, L; Kubasova, T; Rychlik, I; Hoerr, FJ; Rautenschlein, S				Li, Li; Kubasova, Tereza; Rychlik, Ivan; Hoerr, Frederic J.; Rautenschlein, Silke			Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition	PLOS ONE			English	Article							PATHOGEN-FREE CHICKENS; GOBLET CELLS; T-CELLS; IMMUNE-RESPONSES; MUCOSAL; LYMPHOCYTES; IMBALANCES; MODULATION; VACCINE; SYSTEM	Infectious bursal disease (IBD) is an acute, highly contagious and immunosuppressive poultry disease. IBD virus (IBDV) is the causative agent, which may lead to high morbidity and mortality rates in susceptible birds. IBDV-pathogenesis studies have focused mainly on primary lymphoid organs. It is not known if IBDV infection may modify the development of the gut associated lymphoid tissues (GALT) as well as the microbiota composition. The aim of the present study was to investigate the effects of IBDV-infection on the bursa of Fabricius (BF), caecal tonsils (CT) and caecum, and to determine the effects on the gut microbiota composition in the caecum. Commercial broiler chickens were inoculated with a very virulent (vv) strain of IBDV at 14 (Experiment 2) or 15 (Experiment 1) days post hatch (dph). Virus replication, lesion development, immune parameters including numbers of T and B lymphocytes, macrophages, as well as the gut microbiota composition were compared between groups. Rapid IBDV-replication was detected in the BF, CT and caecum. It was accompanied by histological lesions including an infiltration of heterophils. In addition a significant reduction in the total mucosal thickness of the caecum was observed in vvIBDV-infected birds compared to virus-free controls (P < 0.05). vvIBDV infection also led to an increase in T lymphocyte numbers and macrophages, as well as a decrease in the number of B lymphocytes in the lamina propria of the caecum, and in the caecal tonsils. Illumina sequencing analysis indicated that vvIBDV infection also induced changes in the abundance of Clostridium XIVa and Faecalibacterium over time. Overall, our results suggested that vvIBDV infection had a significant impact on the GALT and led to a modulation of gut microbiota composition, which may lead to a higher susceptibility of affected birds for pathogens invading through the gut.	[Li, Li; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Kubasova, Tereza; Rychlik, Ivan] Vet Res Inst, Brno, Czech Republic; [Hoerr, Frederic J.] Vet Diagnost Pathol, Ft Valley, VA USA	University of Veterinary Medicine Hannover, Foundation; Czech Veterinary Research Institute	Rautenschlein, S (corresponding author), Univ Vet Med Hannover, Clin Poultry, Hannover, Germany.	Silke.Rautenschlein@tiho-hannover.de	, Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Chinese Scholar Council; AdmireVet project from the Czech Ministry of Education [CZ.1.05/2.1.00/01.0006 - ED0006/01/01]	Chinese Scholar Council; AdmireVet project from the Czech Ministry of Education	Li Li was supported by the Chinese Scholar Council and Ivan Rychlik was partially supported by AdmireVet project CZ.1.05/2.1.00/01.0006 - ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Veterinary Diagnostic Pathology, LLC provided support in the form of salaries for authors [FH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aricibasi M, 2010, VET IMMUNOL IMMUNOP, V135, P79, DOI 10.1016/j.vetimm.2009.11.005; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bautista DA, 2004, AVIAN DIS, V48, P361, DOI 10.1637/7130; BEFUS AD, 1980, J IMMUNOL, V125, P2626; Block H, 2007, AVIAN PATHOL, V36, P401, DOI 10.1080/03079450701589175; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; De Wit J.J., 1998, POLISH VET J, V3, P19; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Eterradossi N, 1997, ARCH VIROL, V142, P255, DOI 10.1007/s007050050075; FADLY AM, 1983, AVIAN DIS, V27, P714, DOI 10.2307/1590314; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Han ZF, 2016, DEV COMP IMMUNOL, V62, P58, DOI 10.1016/j.dci.2016.04.020; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hoerr FJ, 2010, AVIAN DIS, V54, P2, DOI 10.1637/8909-043009-Review.1; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; Khan WI, 2008, PARASITOLOGY, V135, P671, DOI 10.1017/S0031182008004381; Kim IJ, 1999, AVIAN DIS, V43, P401, DOI 10.2307/1592637; LEY DH, 1983, AVIAN DIS, V27, P1060, DOI 10.2307/1590207; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Lozupone CA, 2013, CELL HOST MICROBE, V14, P329, DOI 10.1016/j.chom.2013.08.006; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MILLER HRP, 1979, EXP PARASITOL, V47, P81, DOI 10.1016/0014-4894(79)90010-9; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; MULLER R, 1979, ZBL VET MED B, V26, P345; NAKAMURA K, 1990, AVIAN PATHOL, V19, P713, DOI 10.1080/03079459008418726; Noujaim JC, 2008, POULTRY SCI, V87, P927, DOI 10.3382/ps.2007-00476; OLAH I, 1979, POULTRY SCI, V58, P195, DOI 10.3382/ps.0580195; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Perumbakkam S, 2014, FEMS MICROBIOL ECOL, V90, P300, DOI 10.1111/1574-6941.12392; Petkov DI, 2009, AVIAN DIS, V53, P347, DOI 10.1637/8456-082208-Reg.1; Polansky O, 2015, APPL ENVIRON MICROB; Qi XL, 2014, VACCINE, V32, P1436, DOI 10.1016/j.vaccine.2014.01.042; Rauf Abdul, 2012, Results Immunol, V2, P112, DOI 10.1016/j.rinim.2012.05.003; Rautenschlein S, 2007, VET IMMUNOL IMMUNOP, V115, P251, DOI 10.1016/j.vetimm.2006.11.002; Rehman ZU, 2016, WORLD POULTRY SCI J, V72, P805, DOI 10.1017/S0043933916000775; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saif YM, 1998, POULTRY SCI, V77, P1186, DOI 10.1093/ps/77.8.1186; Schwarz A, 2011, DEV COMP IMMUNOL, V35, P774, DOI 10.1016/j.dci.2011.02.012; SHARMA JM, 2003, DIS POULTRY, P5; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Sun Q, 2013, AVIAN PATHOL, V42, P541, DOI 10.1080/03079457.2013.845292; Tanimura N, 1997, AVIAN DIS, V41, P638, DOI 10.2307/1592155; TANIMURA N, 1995, AVIAN DIS, V39, P9, DOI 10.2307/1591976; Thompson G, 1997, AVIAN DIS, V41, P519, DOI 10.2307/1592140; Tippenhauer M, 2013, DEV COMP IMMUNOL, V40, P1, DOI 10.1016/j.dci.2012.10.013; Toro H, 2009, AVIAN DIS, V53, P94, DOI 10.1637/8408-071408-Reg.1; Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242; Wang D, 2009, POULTRY SCI, V88, P1623, DOI 10.3382/ps.2009-00124; Wang DC, 2008, VET IMMUNOL IMMUNOP, V124, P19, DOI 10.1016/j.vetimm.2008.01.005; Wang DC, 2009, VET IMMUNOL IMMUNOP, V131, P229, DOI 10.1016/j.vetimm.2009.04.014; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	65	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192066	10.1371/journal.pone.0192066	http://dx.doi.org/10.1371/journal.pone.0192066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390031	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400061
J	Wang, RL; Li, Q; He, SA; Liu, Y; Wang, MT; Jiang, G				Wang, Rulin; Li, Qing; He, Shisong; Liu, Yuan; Wang, Mingtian; Jiang, Gan			Modeling and mapping the current and future distribution of Pseudomonas syringae pv. actinidiae under climate change in China	PLOS ONE			English	Article							BACTERIAL CANKER; SPECIES DISTRIBUTIONS; KIWIFRUIT; EPIDEMICS	Objective Bacterial canker of kiwifruit caused by Pseudomonas syringae pv. actinidiae (Psa) is a major threat to the kiwifruit industry throughout the world and accounts for substantial economic losses in China. The aim of the present study was to test and explore the possibility of using MaxEnt (maximum entropy models) to predict and analyze the future large-scale distribution of Psa in China. Method Based on the current environmental factors, three future climate scenarios, which were suggested by the fifth IPCC report, and the current distribution sites of Psa, MaxEnt combined with ArcGIS was applied to predict the potential suitable areas and the changing trend of Psa in China. The jackknife test and correlation analysis were used to choose dominant climatic factors. The receiver operating characteristic curve (ROC) drawn by MaxEnt was used to evaluate the accuracy of the simulation. Result The results showed that under current climatic conditions, the area from latitude 25 degrees to 36 degrees N and from longitude 101 E to 122 E E is the primary potential suitable area of Psa in China. The highly suitable area (with suitability between 66 and 100) was mainly concentrated in Northeast Sichuan, South Shaanxi, most of Chongqing, West Hubei and Southwest Gansu and occupied 4.94% of land in China. Under different future emission scenarios, both the areas and the centers of the suitable areas all showed differences compared with the current situation. Four climatic variables, i.e., maximum April temperature (19%), mean temperature of the coldest quarter (14%), precipitation in May (11.5%) and minimum temperature in October (10.8%), had the largest impact on the distribution of Psa. Conclusion The MaxEnt model is potentially useful for forecasting the future adaptive distribution of Psa under climate change, and it provides important guidance for comprehensive management.	[Wang, Rulin; Li, Qing] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Wang, Rulin; Jiang, Gan] Sichuan Prov Rural Econ Informat Ctr, Chengdu, Sichuan, Peoples R China; [He, Shisong; Liu, Yuan] Kiwifruit Inst Cangxi Country, Cangxi, Sichuan, Peoples R China; [Wang, Mingtian] Sichuan Meteorol Observ, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, Q (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.	liq8633@163.com	WANG, Rulin/AAE-6849-2019	Wang, Rulin/0000-0002-1431-0769	modern agricultural industry technology system of Sichuan innovation team; project of meteorological service for agriculture, rural areas and farmers in Sichuan	modern agricultural industry technology system of Sichuan innovation team; project of meteorological service for agriculture, rural areas and farmers in Sichuan	Our work was supported by the modern agricultural industry technology http://www.scnycxtd.com/ system of Sichuan innovation team and the project of meteorological service for agriculture, rural areas and farmers in Sichuan, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2014, PLANT PATHOL, V63, P691, DOI 10.1111/ppa.12125; Andolfi A, 2011, PLANT DIS, V95, P1311; Balestra GM, 1999, ACTA HORTIC, P355, DOI 10.17660/ActaHortic.1999.498.43; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bosso L, 2016, BIOL INVASIONS, V18, P1759, DOI 10.1007/s10530-016-1118-1; Bradie J, 2017, J BIOGEOGR, V44, P1344, DOI 10.1111/jbi.12894; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cai Jing-yun, 2014, Jingji Dongwu Xuebao, V18, P47; Cameron A, 2014, PLANT PATHOL, V63, P1, DOI 10.1111/ppa.12066; Cao XR, 2011, PLANT PROTECTION, V37, P80; Choudhury MR, 2016, ECOL ENG, V97, P23, DOI 10.1016/j.ecoleng.2016.07.018; Cunty A, 2015, PLANT PATHOL, V64, P582, DOI 10.1111/ppa.12297; Das T, 2017, SAARC J AGR, V2, P200; David H., 2013, DIVERS DISTRIB, V1, P43; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elad Y, 2014, J CROP IMPROV, V28, P99, DOI 10.1080/15427528.2014.865412; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fand BB, 2014, J ENVIRON BIOL, V35, P973; Fang Y., 1990, SICHUAN FRUIT SCI TE, V18, P28; Ferrante P, 2015, PLANT PATHOL, V64, P51, DOI 10.1111/ppa.12236; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Froud KJ, 2017, AUSTRALAS PLANT PATH, V46, P421, DOI 10.1007/s13313-017-0504-1; Gelviz-Gelvez SM, 2015, ECOL ENG, P302; Ghini R, 2012, TROP PLANT PATHOL, V37, P5, DOI 10.1590/S1982-56762012000100002; Ghods S, 2015, APPL ENVIRON MICROB, V81, P4026, DOI 10.1128/AEM.00194-15; Han Yangyang, 2015, Journal of Nanjing Forestry University Natural Sciences Edition, V39, P6; Hannah L, 2017, CLIMATIC CHANGE, P1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Jiang HJ, 2016, PLOS ONE, V9; Jo WS, 2017, J KOREAN PHYS SOC, V70, P108, DOI 10.3938/jkps.70.108; Kalle R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079295; Kim GH, 2017, PLANT PATHOLOGY J, V33, P351, DOI 10.5423/PPJ.RW.01.2017.0021; Kim GH, 2016, PLANT PATHOLOGY J, V32, P545, DOI 10.5423/PPJ.OA.05.2016.0122; Koh YJ, 2002, MOL CELLS, V13, P309; Krishnan S, 2015, CLIMATIC CHANGE, V131, P259, DOI 10.1007/s10584-015-1385-3; Kumar S, 2016, J ECON ENTOMOL, V5; Leach K, 2016, ECOL MODEL, V337, P96, DOI 10.1016/j.ecolmodel.2016.06.008; Li GQ, 2012, ACTA ECOLOGICAL SINI, V16, P4827; Li M., 2002, J ANHUI AGR SCI, V30, P401; [李淼 Li Miao], 2002, [安徽农业科学, Anhui agricultural sciences], V30, P391; Li YZ, 2000, J NW FORESTRY U, V2, P53; Lopez-Martinez V, 2016, AGR FOREST ENTOMOL, V18, P409, DOI 10.1111/afe.12174; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Moran-Ordonez A, 2017, GLOBAL ECOL BIOGEOGR, V26, P371, DOI 10.1111/geb.12545; Narouei-Khandan HA, 2016, EUR J PLANT PATHOL, V144, P655, DOI 10.1007/s10658-015-0804-7; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penado A, 2016, INSECT CONSERV DIVER, V9, P391, DOI 10.1111/icad.12190; Petersen MJ, 2013, BIOL INVASIONS, V15, P885, DOI 10.1007/s10530-012-0337-3; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qin Z, 2015, J PLANT RES, V5, P1; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; Rameshprabu N, 2015, J ENVIRON BIOL, V36, P565; Remya K, 2015, ECOL ENG, V82, P184, DOI 10.1016/j.ecoleng.2015.04.053; Renzi M, 2012, PHYTOPATHOLOGY, V102, P827, DOI 10.1094/PHYTO-02-12-0019-R; Sambaraju KR, 2012, ECOGRAPHY, V35, P211, DOI 10.1111/j.1600-0587.2011.06847.x; Sawada H, 1997, APPL ENVIRON MICROB, V63, P282, DOI 10.1128/AEM.63.1.282-288.1997; Schatz AM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160975; Scortichini M, 2014, EUR J PLANT PATHOL, V140, P887, DOI 10.1007/s10658-014-0515-5; Serena C, 2015, PLOS ONE, V10, P2018; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P460, DOI 10.3186/jjphytopath.59.460; [邵宝林 Shao Baolin], 2016, [植物保护, Plant Protection], V42, P146; Shrestha UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106405; Sivaraj N, 2016, MAXIMUM ENTROPY MAXE, V1, P16; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Testolin R, 2009, NEW ZEAL J CROP HORT, V37, P1, DOI 10.1080/01140670909510246; Thakur MP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700866; Tondou R, 2016, J BERRY RES, V4, P1; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P241; Vanneste JL, 2017, ANNU REV PHYTOPATHOL, V55, P377, DOI 10.1146/annurev-phyto-080516-035530; Wang WC, 2016, PLOS ONE, V9; Wilstermann A., 2017, Bulletin OEPP, V47, P255, DOI 10.1111/epp.12385; Worthington TA, 2016, ECOL MODEL, V342, P1, DOI 10.1016/j.ecolmodel.2016.09.016; [徐小彪 Xu Xiaobiao], 2003, [植物学通报, Chinese Bulletin of Botany], V20, P648; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Yi YJ, 2016, ECOL ENG, V92, P260, DOI 10.1016/j.ecoleng.2016.04.010; Yue TX, 2011, ECOL MODEL, V222, P2342, DOI 10.1016/j.ecolmodel.2010.11.026; [曾辉 Zeng Hui], 2008, [植物保护, Plant Protection], V34, P88; [张计育 Zhang Jiyu], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P48; Zhang LL, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5133-9; Zhang Y, 2013, BIOL DISASTER SCI, V1, P69; [赵文娟 Zhao Wenjuan], 2009, [植物保护, Plant Protection], V35, P32; Zhao ZB, 2015, CROP PROT, V75, P55, DOI 10.1016/j.cropro.2015.05.008; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	93	78	92	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192153	10.1371/journal.pone.0192153	http://dx.doi.org/10.1371/journal.pone.0192153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389964	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400073
J	Ding, JW; Zhao, JY; Zhou, JM; Li, XY; Wu, YB; Ge, M; Cen, S				Ding, Jiwei; Zhao, Jianyuan; Zhou, Jinming; Li, Xiaoyu; Wu, Yanbin; Ge, Mei; Cen, Shan			Association of gene polymorphism of SDF1 (CXCR12) with susceptibility to HIV-1 infection and AIDS disease progression: A meta-analysis	PLOS ONE			English	Article							TYPE-1 INFECTION; CLINICAL-COURSE; CXCL12 GENE; DRUG-USERS; DC-SIGNR; CHEMOKINE; CCR5; VARIANTS; RISK; INDIVIDUALS	Objectives Genetic polymorphism of viral receptors is relevant to risks of HIV-1 infection, while it is still under debated whether the polymorphism of SDF1, a unique ligand for HIV-1 coreceptor CXCR4, is associated with HIV susceptibility and AIDS disease progression. Therefore, we provided an updated quantitative assessment by meta-analysis from 16 case-control and 7 cohort studies. Methods Articles reporting the relationship between SDF1 polymorphism and HIV susceptibility or AIDS progression were retrieved from PubMed, Embase and Ovid electronic databases up to Apr 2017. Data were pooled by odds ratios (ORs) for HIV-1 infection with 95% confidence intervals (CIs) and summary relative hazards (RHs) for AIDS progression with 95% CIs using 1987 Center for Disease Control (CDC) case definition of AIDS (CDC87) and 1993 Center for Disease Control (CDC) case definition of AIDS (CDC93) and death as endpoints. Results As a result, 16 studies regarding susceptibility to HIV-1 infection with 2803 HIV-infected patients and 3697 healthy individuals and 7 studies regarding disease progression with 4239 subjects were included in the meta-analysis. For risks of infection, no evidences indicated SDF1 polymorphism was associated with the risk of HIV-1 infection in all genetic models (recessive model: OR = 0.94, 95% Cl: 0.75-1.17; homozygous model: OR = 0.89, 95% Cl: 0.70-1.15; heterozygous model: OR = 1.06, 95% Cl: 0.83-1.35; allele model: OR = 0.95, 95% Cl: 0.79-1.13), Furthermore, we failed to find an delayed AIDS progression except in some specific cohorts including MACS cohorts (RH = 0.38, 95% Cl: 0.17-0.59 for time to AIDS; RH = 0.27, 95% Cl: 0.07-0.46 for time to death at the study entry). Conclusions Overall, no significant association was found between SDF1 polymorphism and HIV susceptibility. A protective effect of SDF1 on AIDS progression and death was seen especially in two studies based on the same cohorts. In conclusion, SDF1 polymorphism exerts a moderate protective effect against AIDS disease deterioration in some specific populations.	[Ding, Jiwei; Zhao, Jianyuan; Zhou, Jinming; Li, Xiaoyu; Wu, Yanbin; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China; [Ding, Jiwei; Zhao, Jianyuan; Zhou, Jinming; Li, Xiaoyu; Wu, Yanbin; Cen, Shan] Peking Union Med Sch, Beijing, Peoples R China; [Ge, Mei] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University	Cen, S (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China.; Cen, S (corresponding author), Peking Union Med Sch, Beijing, Peoples R China.; Ge, M (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China.	hccbred@gmail.com; shancen@imb.pumc.edu.cn	Ding, Jiwei/HDO-3529-2022		National Key Research and Development program of China [2016YFD0500307]; National Natural Science Foundation of China [81772205, 81361128017]; CAMS Innovation Fund for Medical Sciences [2016-12M-2-002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042] Funding Source: NIH RePORTER	National Key Research and Development program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Key Research and Development program of China (grant no. 2016YFD0500307 CS), the National Natural Science Foundation of China (grant no. 81772205 CS and grant no. 81361128017 CS), and the CAMS Innovation Fund for Medical Sciences (grant no. 2016-12M-2-002 LX) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Key Research and Development program of China (2016YFD0500307 CS), The National Natural Science Foundation of China (81772205 CS, 81361128017 CS), CAMS Innovation Fund for Medical Sciences (2016-12M-2-002 LX) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara S, 2010, HIV AIDS-RES PALLIAT, V2, P203, DOI 10.2147/HIV.S13609; Balotta C, 1999, J INFECT DIS, V180, P285, DOI 10.1086/314864; Bardeskar NS, 2016, HLA, V88, P221, DOI 10.1111/tan.12882; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Chaudhary O, 2013, SEX TRANSM INFECT, V89, pA146, DOI 10.1136/sextrans-2013-051184.0455; Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005; Chaudhuri RP, 2014, INDIAN PEDIATR, V51, P801, DOI 10.1007/s13312-014-0505-x; Daar ES, 2005, J INFECT DIS, V192, P1597, DOI 10.1086/496893; Easterbrook PJ, 1999, J INFECT DIS, V180, P1096, DOI 10.1086/314997; Gianesin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044460; Gong XH, 2015, INFECT GENET EVOL, V34, P137, DOI 10.1016/j.meegid.2015.07.012; Gupta A, 2015, INT J IMMUNOGENET, V42, P270, DOI 10.1111/iji.12215; He Xiao-feng, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P791; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Li H, 2014, INFECT GENET EVOL, V24, P99, DOI 10.1016/j.meegid.2014.03.009; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu SJ, 2011, CURR HIV RES, V9, P112, DOI 10.2174/157016211795569113; Ma LY, 2005, JAIDS-J ACQ IMM DEF, V40, P89, DOI 10.1097/01.qai.0000157008.66584.d6; Mangano A, 2000, J ACQ IMMUN DEF SYND, V23, P52; Modi WS, 2005, GENES IMMUN, V6, P691, DOI 10.1038/sj.gene.6364258; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28; Puissant B, 2006, AIDS RES HUM RETROV, V22, P153, DOI 10.1089/aid.2006.22.153; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; Reiche EMV, 2006, INT J IMMUNOGENET, V33, P127, DOI 10.1111/j.1744-313X.2006.00583.x; Roman Francois, 2002, HIV Clin Trials, V3, P195; Velarde-Felix JS, 2015, INTERVIROLOGY, V58, P357, DOI 10.1159/000443374; Sarkar K, 2010, J HEALTH POPUL NUTR, V28, P130; Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038; Suresh P, 2006, J CLIN IMMUNOL, V26, P476, DOI 10.1007/s10875-006-9036-0; Tan XH, 2010, INFECT GENET EVOL, V10, P268, DOI 10.1016/j.meegid.2009.11.015; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Wang YY, 2008, AIDS RES HUM RETROV, V24, P1341, DOI 10.1089/aid.2008.0066; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191930	10.1371/journal.pone.0191930	http://dx.doi.org/10.1371/journal.pone.0191930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420545	Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900031
J	Gutierrez-Fonseca, PE; Ramirez, A; Pringle, CM				Gutierrez-Fonseca, Pablo E.; Ramirez, Alonso; Pringle, Catherine M.			Large-scale climatic phenomena drive fluctuations in macroinvertebrate assemblages in lowland tropical streams, Costa Rica: The importance of ENSO events in determining long-term (15y) patterns	PLOS ONE			English	Article							FRESH-WATER MACROINVERTEBRATES; NINO-SOUTHERN-OSCILLATION; EL-NINO; CENTRAL-AMERICA; RAIN-FOREST; PHOSPHORUS LEVELS; TREE GROWTH; TEMPERATURE; DYNAMICS; DROUGHT	Understanding how environmental variables influence the distribution and density of organisms over relatively long temporal scales is a central question in ecology given increased climatic variability (e.g., precipitation, ENSO events). The primary goal of our study was to evaluate long-term (15y time span) patterns of climate, as well as environmental parameters in two Neotropical streams in lowland Costa Rica, to assess potential effects on aquatic macroinvertebrates. We also examined the relative effects of an 8y whole-stream P-enrichment experiment on macroinvertebrate assemblages against the backdrop of this long-term study. Climate, environmental variables and macroinvertebrate samples were measured monthly for 7y and then quarterly for an additional 8y in each stream. Temporal patterns in climatic and environmental variables showed high variability over time, without clear inter-annual or intra-annual patterns. Macroinvertebrate richness and abundance decreased with increasing discharge and was positively related to the number of days since the last high discharge event. Findings show that fluctuations in stream physicochemistry and macroinvertebrate assemblage structure are ultimately the result of large-scale climatic phenomena, such as ENSO events, while the 8y P-enrichment did not appear to affect macroinvertebrates. Our study demonstrates that Neotropical lowland streams are highly dynamic and not as stable as is commonly presumed, with high intra- and inter-annual variability in environmental parameters that change the structure and composition of freshwater macroinvertebrate assemblages.	[Gutierrez-Fonseca, Pablo E.] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA; [Ramirez, Alonso] Univ Puerto Rico Rio Piedras, Dept Environm Sci, San Juan, PR 00931 USA; [Pringle, Catherine M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; University System of Georgia; University of Georgia	Gutierrez-Fonseca, PE (corresponding author), Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA.	gutifp@gmail.com	Gutiérrez-Fonseca, Pablo E./X-8494-2018	Gutiérrez-Fonseca, Pablo E./0000-0003-0777-8889	National Science Foundation [DEB 1122389]	National Science Foundation(National Science Foundation (NSF))	This study was financed by National Science Foundation (DEB 1122389) to Catherine M. Pringle. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Angeler DG, 2012, ECOL APPL, V22, P1172, DOI 10.1890/11-1474.1; APHA, 1992, STANDARD METHODS EXA; Ardon M, 2006, FRESHWATER BIOL, V51, P618, DOI 10.1111/j.1365-2427.2006.01515.x; Ardon M, 2013, SCI TOTAL ENVIRON, V443, P267, DOI 10.1016/j.scitotenv.2012.10.068; Arrington DA, 2006, J N AM BENTHOL SOC, V25, P126, DOI 10.1899/0887-3593(2006)25[126:HATSFP]2.0.CO;2; Ayon P, 2004, ICES J MAR SCI, V61, P478, DOI 10.1016/j.icesjms.2004.03.027; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Beche LA, 2009, ECOGRAPHY, V32, P778, DOI 10.1111/j.1600-0587.2009.05612.x; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Blanco JF, 2003, B ECOTROPICA ECOSIST, V37; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; BOULTON AJ, 1992, HYDROBIOLOGIA, V241, P107, DOI 10.1007/BF00008263; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI [10.1038/NCLIMATE2492, 10.1038/nclimate2492]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Covich AP, 2006, J N AM BENTHOL SOC, V25, P99, DOI 10.1899/0887-3593(2006)25[99:EODAHD]2.0.CO;2; Covich AP, 1996, STREAM COMMUNITY FOO; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Dudgeon D., 2011, TROPICAL STREAM ECOL; Durance I, 2009, FRESHWATER BIOL, V54, P388, DOI 10.1111/j.1365-2427.2008.02112.x; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Faramarzi M, 2013, J HYDROL, V480, P85, DOI 10.1016/j.jhydrol.2012.12.016; Feio MJ, 2010, J N AM BENTHOL SOC, V29, P1397, DOI 10.1899/09-158.1; Field C.B.V., 2012, MANAGING RISKS EXTRE, P582; Foley JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001872; FUGITA DK, 1969, STANDARD PROCEDURES; Gilbert B, 2008, CAN J FISH AQUAT SCI, V65, P890, DOI 10.1139/F08-057; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Gordon N.D., 1992, STREAM HYDROLOGY INT; Hanson P, 2010, REV BIOL TROP, V58, P3; Hart DD, 1999, ANNU REV ECOL SYST, V30, P363, DOI 10.1146/annurev.ecolsys.30.1.363; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hidalgo HG, 2013, J HYDROL, V495, P94, DOI 10.1016/j.jhydrol.2013.05.004; Holdridge LR, 1967, LIFE ZONE ECOLOGY; HYNES HBN, 1970, ANNU REV ENTOMOL, V15, P25, DOI 10.1146/annurev.en.15.010170.000325; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Jackson JK, 2006, FRESHWATER BIOL, V51, P591, DOI 10.1111/j.1365-2427.2006.01503.x; JACKSON JK, 1995, J N AM BENTHOL SOC, V14, P115, DOI 10.2307/1467728; Jacobsen D, 2014, FRESHW SCI, V33, P32, DOI 10.1086/674745; Jassby A. D., 2015, WQ SOME TOOLS EXPLOR; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Kim DH, 2008, J WILDLIFE MANAGE, V72, P231, DOI 10.2193/2007-040; Lawrence JE, 2010, J N AM BENTHOL SOC, V29, P1424, DOI 10.1899/09-178.1; Lee T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044007; Liaw A., 2015, R PACKAGE VERSION, V4, P6; Magnusson WE, 2010, GLOBAL CHANGE BIOL, V16, P2401, DOI 10.1111/j.1365-2486.2009.02140.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Mascaro J, 2004, FOREST ECOL MANAG, V190, P3, DOI 10.1016/j.foreco.2003.10.002; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; McCune B., 2011, PC ORD MULTIVARIATE; McLeod AI, 2015, KENDAL KENDALL RANK; McMullen LE, 2012, ECOL APPL, V22, P2164, DOI 10.1890/11-1650.1; Mohseni O, 1999, J HYDROL, V218, P128, DOI 10.1016/S0022-1694(99)00034-7; Mol JH, 2000, ENVIRON BIOL FISH, V59, P429, DOI 10.1023/A:1026529200610; Mouthon J, 2006, GLOBAL CHANGE BIOL, V12, P441, DOI 10.1111/j.1365-2486.2006.01095.x; Negishi JN, 2006, J ANIM ECOL, V75, P118, DOI 10.1111/j.1365-2656.2005.01027.x; Nepstad D., 2004, Global Change Biology, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu OJ, 2007, AFR J ECOL, V46, P132; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; PRINGLE CM, 1990, HYDROBIOLOGIA, V206, P73, DOI 10.1007/BF00018971; PRINGLE CM, 1991, ECOLOGY, V72, P951, DOI 10.2307/1940596; PRINGLE CM, 1991, BIOTROPICA, V23, P523, DOI 10.2307/2388390; PRINGLE CM, 2000, STREAMS GROUND WATER, P167; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez A, 2006, J N AM BENTHOL SOC, V25, P108, DOI 10.1899/0887-3593(2006)25[108:TASPIS]2.0.CO;2; Ramirez A, 2006, LIMNOL OCEANOGR, V51, P189, DOI 10.4319/lo.2006.51.1.0189; Ramirez A, 1998, J N AM BENTHOL SOC, V17, P443, DOI 10.2307/1468365; Ramirez A, 2003, FRESHWATER BIOL, V48, P88, DOI 10.1046/j.1365-2427.2003.00973.x; Rauscher SA, 2011, J CLIMATE, V24, P2003, DOI 10.1175/2010JCLI3536.1; RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; Riascos JM, 2006, MAR BIOL, V148, P1283, DOI 10.1007/s00227-005-0165-4; Rosemond AD, 2002, LIMNOL OCEANOGR, V47, P278, DOI 10.4319/lo.2002.47.1.0278; Rosemond AD, 2001, ECOLOGY, V82, P2279, DOI 10.1890/0012-9658(2001)082[2279:ATOTDA]2.0.CO;2; Rueda-Delgado G, 2006, J N AM BENTHOL SOC, V25, P233, DOI 10.1899/0887-3593(2006)25[233:LDIAAF]2.0.CO;2; Sanford Jr RL, 1994, LA SELVA ECOLOGY NAT, P19; Schonher T, 1998, J CLIMATOL, V2, P1258; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Small GE, 2008, INT VER THEOR ANGEW, V30, P551; Small GE, 2012, ECOSYSTEMS, V15, P974, DOI 10.1007/s10021-012-9559-6; Small GE, 2011, LIMNOL OCEANOGR, V56, P268, DOI 10.4319/lo.2011.56.1.0268; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; Stallcup LA, 2006, FRESHWATER BIOL, V51, P1515, DOI 10.1111/j.1365-2427.2006.01588.x; Steinhoff DF, 2015, CLIM DYNAM, V44, P1329, DOI 10.1007/s00382-014-2196-3; Triska FJ, 2006, BIOGEOCHEMISTRY, V81, P131, DOI 10.1007/s10533-006-9026-6; Tuv E, 2009, J MACH LEARN RES, V10, P1341; Vaughan IP, 2012, GLOBAL CHANGE BIOL, V18, P2184, DOI 10.1111/j.1365-2486.2012.02662.x; Vecchi GA, 2010, WIRES CLIM CHANGE, V1, P260, DOI 10.1002/wcc.33; WALLACE JB, 1980, ANNU REV ENTOMOL, V25, P103, DOI 10.1146/annurev.en.25.010180.000535; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; Williams D.D., 1981, P155; Winemiller KO, 2014, ECOL MONOGR, V84, P621, DOI 10.1890/13-1822.1; Wohl E, 2017, FRONT EARTH SCI-PRC, V11, P447, DOI 10.1007/s11707-017-0647-y; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Woodward G, 2005, PHILOS T R SOC LON B, V365, P2093; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; YU YS, 1993, J HYDROL, V150, P61, DOI 10.1016/0022-1694(93)90156-4; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Yule CM, 1996, ARCH HYDROBIOL, V137, P227; Zuur A, 2010, MIXED EFFECTS MODELS, P574	110	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191781	10.1371/journal.pone.0191781	http://dx.doi.org/10.1371/journal.pone.0191781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420548	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900022
J	Khan, MM; Mendes, A; Chalup, SK				Khan, Maryam Mahsal; Mendes, Alexandre; Chalup, Stephan K.			Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction	PLOS ONE			English	Article							CLASSIFIER; DIVERSITY; ALGORITHM	Wavelet Neural Networks are a combination of neural networks and wavelets and have been mostly used in the area of time-series prediction and control. Recently, Evolutionary Wavelet Neural Networks have been employed to develop cancer prediction models. The present study proposes to use ensembles of Evolutionary Wavelet Neural Networks. The search for a high quality ensemble is directed by a fitness function that incorporates the accuracy of the classifiers both independently and as part of the ensemble itself. The ensemble approach is tested on three publicly available biomedical benchmark datasets, one on Breast Cancer and two on Parkinson's disease, using a 10-fold cross-validation strategy. Our experimental results show that, for the first dataset, the performance was similar to previous studies reported in literature. On the second dataset, the Evolutionary Wavelet Neural Network ensembles performed better than all previous methods. The third dataset is relatively new and this study is the first to report benchmark results.	[Khan, Maryam Mahsal; Mendes, Alexandre; Chalup, Stephan K.] Univ Newcastle, Sch Elect Engn & Comp, IMLRG, Callaghan, NSW 2308, Australia	University of Newcastle	Khan, MM (corresponding author), Univ Newcastle, Sch Elect Engn & Comp, IMLRG, Callaghan, NSW 2308, Australia.	maryammahsal.khan@uon.edu.au	Chalup, Stephan/O-8914-2019; CHALUP, STEPHAN KONRAD/G-7560-2013; Mendes, Alexandre/C-1832-2013	Chalup, Stephan/0000-0002-7886-3653; Mendes, Alexandre/0000-0003-1759-3765	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	The first author would like to acknowledge the support through an Australian Government Research Training Program Scholarship.	Alexandridis AK, 2013, NEURAL NETWORKS, V42, P1, DOI 10.1016/j.neunet.2013.01.008; [Anonymous], LIV PARK DIS UPD OCT; [Anonymous], 2014, DIGITAL DATABASE SCR; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Astrom F, 2011, EXPERT SYST APPL, V38, P12470, DOI 10.1016/j.eswa.2011.04.028; Banfield R. E., 2005, Information Fusion, V6, P49, DOI 10.1016/j.inffus.2004.04.005; Bias Breiman L., 1996, 460 U CAL STAT DEP; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; CAGLAR M. F., 2010, J ENG SCI DESIGN, V1, P59; Caruana R., 2004, P 21 INT C MACHINE L, P18, DOI [10.1145/1015330.1015432, DOI 10.1145/1015330.1015432]; Cavalcanti GDC, 2016, PATTERN RECOGN LETT, V74, P38, DOI 10.1016/j.patrec.2016.01.029; Chalup SK, 2007, CONNECT SCI, V19, P183, DOI 10.1080/09540090701398017; Fan W, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P146; Gul A, 2018, ADV DATA ANAL CLASSI, V12, P827, DOI 10.1007/s11634-015-0227-5; Haque MZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154151; Heath M, 1998, COMP IMAG VIS, V13, P457; Heath M., 2001, P IWDM, V212, P218; HO TK, 1994, IEEE T PATTERN ANAL, V16, P66, DOI 10.1109/34.273716; Huang MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0161501; Huang YC, 2002, IEEE T POWER DELIVER, V17, P412, DOI 10.1109/61.997908; Khan MM, 2017, NEUROCOMPUTING, V247, P39, DOI 10.1016/j.neucom.2017.03.048; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Lang KJ., 1988, P 1988 CONN MOD SUMM, P52; Leod PMC, 2011, INT J COMPUT INTELL, V10, P481, DOI 10.1142/S1469026811003203; Liao G. C., 2012, AS PAC POW EN ENG C, P1, DOI DOI 10.1109/APPEEC.2012.6307573; Lichman M, 2014, UCI MACHINE LEARNING; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McLeod Peter, 2013, Neural Information Processing. 20th International Conference, ICONIP 2013. Proceedings: LNCS 8228, P525, DOI 10.1007/978-3-642-42051-1_65; Osowski S, 1996, NEURAL NETWORKS, V9, P1583, DOI 10.1016/S0893-6080(96)00029-9; Ozcift A, 2012, J MED SYST, V36, P2141, DOI 10.1007/s10916-011-9678-1; Partalas I, 2010, MACH LEARN, V81, P257, DOI 10.1007/s10994-010-5172-0; Partalas I, 2008, FRONT ARTIF INTEL AP, V178, P117, DOI 10.3233/978-1-58603-891-5-117; Pour S. G., 2012, P 2 AUSTR WORKSH ART, P55; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; Qiu FC, 2014, 2014 5TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING AND SERVICE SCIENCE (ICSESS), P1162, DOI 10.1109/ICSESS.2014.6933773; Sahoo D, 2006, P 11 MULT AN OPT C A, P1; Sakar BE, 2013, IEEE J BIOMED HEALTH, V17, P828, DOI 10.1109/JBHI.2013.2245674; Sakar CO, 2010, J MED SYST, V34, P591, DOI 10.1007/s10916-009-9272-y; Taghavi ZS, 2013, 2013 3RD JOINT CONFERENCE OF AI & ROBOTICS AND 5TH ROBOCUP IRAN OPEN INTERNATIONAL SYMPOSIUM (RIOS), P1; Tsoumakas G, 2009, STUD COMPUT INTELL, V245, P1, DOI 10.1007/978-3-642-03999-7_1; Vazquez LA, 2015, MATH PROBL ENG, V2015, P1; Verma B, 2010, EXPERT SYST APPL, V37, P3344, DOI 10.1016/j.eswa.2009.10.016; Verma B, 2009, PATTERN RECOGN, V42, P1845, DOI 10.1016/j.patcog.2009.02.009; Xu JH, 2006, LECT NOTES COMPUT SC, V4113, P286, DOI 10.1007/11816157_29; Yang HJ, 2016, OPTIK, V127, P8103, DOI 10.1016/j.ijleo.2016.06.017; Yao G, 2016, SOFT COMPUT, V20, P2995, DOI 10.1007/s00500-015-1927-7; ZAKI FW, 1988, PATTERN RECOGN, V21, P327, DOI 10.1016/0031-3203(88)90046-5; ZHANG J, 1995, IEEE T SIGNAL PROCES, V43, P1485, DOI 10.1109/78.388860; Zhang P, 2005, LECT NOTES ARTIF INT, V3614, P316; Zhang P, 2006, INT C COMP INT MOD C, P141, DOI DOI 10.1109/CIMCA.2006.46; ZHANG QG, 1992, IEEE T NEURAL NETWOR, V3, P889, DOI 10.1109/72.165591; Zhang Y, 2006, J MACH LEARN RES, V7, P1315; Zhao H, 2011, 3 INT WORKSH INT SYS, P1; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207; Zhou ZH, 2003, LECT NOTES ARTIF INT, V2639, P476	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192192	10.1371/journal.pone.0192192	http://dx.doi.org/10.1371/journal.pone.0192192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420578	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900049
J	Kolivand, H; Fern, BM; Rahim, MSM; Sulong, G; Baker, T; Tully, D				Kolivand, Hoshang; Fern, Bong Mei; Rahim, Mohd Shafry Mohd; Sulong, Ghazali; Baker, Thar; Tully, David			An expert botanical feature extraction technique based on phenetic features for identifying plant species	PLOS ONE			English	Article							RECOGNITION	In this paper, we present a new method to recognise the leaf type and identify plant species using phenetic parts of the leaf; lobes, apex and base detection. Most of the research in this area focuses on the popular features such as the shape, colour, vein, and texture, which consumes large amounts of computational processing and are not efficient, especially in the Acer database with a high complexity structure of the leaves. This paper is focused on phenetic parts of the leaf which increases accuracy. Detecting the local maxima and local minima are done based on Centroid Contour Distance for Every Boundary Point, using north and south region to recognise the apex and base. Digital morphology is used to measure the leaf shape and the leaf margin. Centroid Contour Gradient is presented to extract the curvature of leaf apex and base. We analyse 32 leaf images of tropical plants and evaluated with two different datasets, Flavia, and Acer. The best accuracy obtained is 94.76% and 82.6% respectively. Experimental results show the effectiveness of the proposed technique without considering the commonly used features with high computational cost.	[Kolivand, Hoshang; Baker, Thar; Tully, David] Liverpool John Moores Univ, Dept Comp Sci, Liverpool, Merseyside, England; [Fern, Bong Mei] Univ Tunku Abdul Rahman, Jalan Sungai Long, Kajang, Selangor, Malaysia; [Rahim, Mohd Shafry Mohd] UTM, UTM IRDA Digital Media Ctr, Media & Games Innovat Ctr Excellence MaGIC X, UIRL,Inst Human Ctr, Skudai, Johor, Malaysia; [Sulong, Ghazali] Univ Malaysia Terengganu, Terengganu, Malaysia	Liverpool John Moores University; University of Liverpool; Universiti Tunku Abdul Rahman (UTAR); Universiti Teknologi Malaysia; Universiti Malaysia Terengganu	Kolivand, H (corresponding author), Liverpool John Moores Univ, Dept Comp Sci, Liverpool, Merseyside, England.	H.Kolivand@ljmu.ac.uk	Baker, Thar/H-6073-2019; Kolivand, Hoshang/B-2501-2016	Baker, Thar/0000-0002-5166-4873; Kolivand, Hoshang/0000-0001-5460-5679				AbJabal MF., 2013, J COMPUT SCI-NETH, V9, P1295, DOI [10.3844/jcssp.2013.1295.1304, DOI 10.3844/JCSSP.2013.1295.1304, DOI 10.3844/J.CSSP.2013.1295.1304]; An N, 2016, COMPUT ELECTRON AGR, V127, P376, DOI 10.1016/j.compag.2016.04.002; Arora A., 2012, CLEF ONLINE WORKING; Arun Priya C., 2012, Proceedings of the 2012 International Conference on Pattern Recognition, Informatics and Medical Engineering (PRIME), P428, DOI 10.1109/ICPRIME.2012.6208384; Cope JS, 2012, LECT NOTES COMPUT SC, V7517, P258, DOI 10.1007/978-3-642-33140-4_23; Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112; Fern BM, 2014, ADV SCI LETT, V20, P209, DOI 10.1166/asl.2014.5300; Goeau H, 2013, P 21 ACM INT C MULT, P423; Gouveia F, 1997, ISIE '97 - PROCEEDINGS OF THE IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-3, P757, DOI 10.1109/ISIE.1997.648634; Hati S., 2013, INT J COMPUTER APPL, V62; Jelinkova H, 2014, TREES-STRUCT FUNCT, V28, P389, DOI 10.1007/s00468-013-0957-y; Larese M. G., 2014, EXPERT SYSTEMS APPL; Mallah C., 2013, SIGNAL PROCESS PATTE, V5, P45; Mouine S., 2013, P 3 ACM C INT C MULT, P127; Mouine S., 2012, P 2 ACM INT C MULT R, P49; Mouine S, 2013, P 3 ACM C INT C MULT, P309; Mouine S, 2013, LECT NOTES COMPUT SC, V7950, P205, DOI 10.1007/978-3-642-39094-4_24; Mzoughi O, 2013, IEEE IMAGE PROC, P3967, DOI 10.1109/ICIP.2013.6738817; Mzoughi O, 2012, IEEE IMAGE PROC, P1033, DOI 10.1109/ICIP.2012.6467039; Narayan V., 2014, RATIO, V13, P885; Pahalawatta K.K, 2008, THESIS U CANTERBURY; Petchsri S, 2012, SCIENCEASIA, V38, P1, DOI 10.2306/scienceasia1513-1874.2012.38.001; Pornpanomchai C., 2011, Kasetsart Journal, Natural Sciences, V45, P551; Pornpanomchai C., 2011, INT J ENG TECHNOLOGY, V3, P347, DOI DOI 10.7763/IJET.2011.V3.251; Prance GT, 2017, KEW BULL, V72, DOI 10.1007/S12225-017-9712-7; Sule Tekkesinoglu, 2014, Research Journal of Applied Sciences, Engineering and Technology, V7, P2447; Watchareeruetai U., 2015, COMP SCI ENG C ICSEC, P1; Yahiaoui I., 2012, 2012 IEEE International Conference on Multimedia and Expo (ICME), P254, DOI 10.1109/ICME.2012.130	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191447	10.1371/journal.pone.0191447	http://dx.doi.org/10.1371/journal.pone.0191447			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420568	Green Published, Green Accepted, gold			2022-12-27	WOS:000424517900014
J	Leon-de la O, DI; Thorsteinsdottir, H; Calderon-Salinas, JV				Israel Leon-de la O, Dante; Thorsteinsdottir, Halla; Calderon-Salinas, Jose Victor			The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico	PLOS ONE			English	Article							JOURNALS; PREVALENCE; COUNTRY; SCIENCE; OUTPUT	This paper analyzes the patterns of health biotechnology publications in six Latin American countries from 2001 to 2015. The countries studied were Argentina, Brazil, Chile, Colombia, Cuba and Mexico. Before our study, there were no data available on HBT development in half of the Latin-American countries we studied, i.e., Argentina, Colombia and Chile. To include these countries in a scientometric analysis of HBT provides fuller coverage of HBT development in Latin America. The scientometric study used the Web of Science database to identify health biotechnology publications. The total amount of health biotechnology production in the world during the period studied was about 400,000 papers. A total of 1.2% of these papers, were authored by the six Latin American countries in this study. The results show a significant growth in health biotechnology publications in Latin America despite some of the countries having social and political instability, fluctuations in their gross domestic expenditure in research and development or a trade embargo that limits opportunities for scientific development. The growth in the field of some of the Latin American countries studied was larger than the growth of most industrialized nations. Still, the visibility of the Latin American research (measured in the number of citations) did not reach the world average, with the exception of Colombia. The main producers of health biotechnology papers in Latin America were universities, except in Cuba were governmental institutions were the most frequent producers. The countries studied were active in international research collaboration with Colombia being the most active (64% of papers co-authored internationally), whereas Brazil was the least active (35% of papers). Still, the domestic collaboration was even more prevalent, with Chile being the most active in such collaboration (85% of papers co-authored domestically) and Argentina the least active (49% of papers). We conclude that the Latin American countries studied are increasing their health biotechnology publishing. This strategy could contribute to the development of innovations that may solve local health problems in the region.	[Israel Leon-de la O, Dante] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Doctorate Program Sci Technol & Soc, Mexico City, DF, Mexico; [Thorsteinsdottir, Halla] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Thorsteinsdottir, Halla] Small Globe Inc, Toronto, ON, Canada; [Calderon-Salinas, Jose Victor] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Biochem Dept, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Toronto; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Leon-de la O, DI (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Doctorate Program Sci Technol & Soc, Mexico City, DF, Mexico.	dleono@cinvestav.mx		Leon de la O, Dante Israel/0000-0003-3579-9417	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico [367868]; Conacyt-Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conacyt-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work has been supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico, under grant number: 367868. DILO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.;; We would like to thank Gunther Beutelspacher Hurtado and Laura Varas Sarzo, for their support and continued discussion on biotechnology medicines and treatments developed in Mexico and Cuba. We would also like to acknowledge Miguel Angel Perez-AngOn for his assistance with the preparation of the manuscript. We are grateful to Marco Antonio ZamudioReyes, Jose Alvarez -Flores for their support in QDA mining and to Ismael Rafolds for his support in scientometric research. We also acknowledge the support from Conacyt-Mexico.	Agosin M, 2011, CHILE ANOS 2000 EVOL; [Anonymous], 2011, IND BIOT CLIM CHANG; [Anonymous], 2015, CUB GAST 1 D GAST 1; [Anonymous], 2013, EL CRONISTA; [Anonymous], 2014, PROMEXICO, V1, P28; [Anonymous], 2016, SCIELO CITATION INDE; [Anonymous], 2016, HEB P YA HAC MIL KUW; [Anonymous], 2010, EL HIST; Apter D, 2015, CLIN VACCINE IMMUNOL, V22, P361, DOI 10.1128/CVI.00591-14; Arundel A, 2009, OECD J GEN PAP, V2009, P113; Barrera MF, 2014, ACERCAMIENTO REDES C; Benito E, 2014, CREAMOS MED INDIOS S; BioCubaFarma, 2016, GRUP IND BIOT FARM; Bisang R, 2009, BIOTECNOLOGIA DESARR; Buitrago HG, 2012, REV COLOMB BIOTECNOL, VXIV, P5; Campos JE, 2014, REV CUBA INF CIENCIA, V25, P172; Canadian Institutes of Health, 2009, ANN C AV REL CIT FAC; Carmona-Fonseca J, 2012, IATREIA, V25, P334; Chang C, 2010, REV NACL ADM, V1, P85, DOI [10.22458/rna.v1i1.286, DOI 10.22458/RNA.V1I1.286]; Chile CONICYT., 2012, PROGRAMA BICENTENARI; Clarivate Analytics, 2017, SCI CIT IND EXP SCOP; Colciencias Departamento Nacional de Planeacion, 2006, PLAN NAC DES CIENT T; Collazo-Reyes F, 2014, SCIENTOMETRICS, V98, P197, DOI 10.1007/s11192-013-1036-2; COLWELL R R, 1986, MIRCEN Journal of Applied Microbiology and Biotechnology, V2, P5, DOI 10.1007/BF00937179; Comision Europea, 2008, COOP CIENT RET SOC M; CONACyT, 2014, CONS NAC CIENC TECN; Confraria H, 2017, J TECHNOL TRANSF; CONICET, 2016, CONS NAC INV CIENT T; CORFO, 2006, BIOT CHIL PARTN BUS; Council of Canadian Academies, 2013, PAR LOST EXPL CAN RE; de Ebole SM F, 2016, INT J MANAG STUD RES, V4, P52; Dimova M, 2009, MICROECONOMICS COMPE; Donner P, 2017, SCIENTOMETRICS, V113, P219, DOI 10.1007/s11192-017-2483-y; Ernst & Young, 2016, BIOT REP 2016; Ernst & Young, 2007, BIOT REP 2007; Evenson Debra, 2007, MEDICC Rev, V9, P8, DOI 10.37757/MR2007V9.N1.5; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; Filippo D, 2010, REV IBEROAM CIENC TE; Fondo Monetario Internacional, 2013, PERS EC MUND TRANS T, P90; Frasca T, 2005, AIDS LATIN AM; Frew SE, 2008, HEALTH AFFAIR, V27, P1029, DOI 10.1377/hlthaff.27.4.1029; GARMON L, 1983, BIO-TECHNOL, V1, P26; Giacomazzi E., 2011, BRAZILS BIOTECH INIT; Gibbons M., 2010, NEW PRODUCTION KNOWL; Gobierno de Colombia, 2016, COL CREC CONF OP INV; Gonzalez S., 2011, 6 C PROP IND; Gonzalez-Brambila CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151328; Gortari E, 1981, CIENCIA CONCIENCIA M; GrupoBios, 2016, PROD PROP; Harzing A., 2010, WORKING ISI DATA BEW; Hernandez-Garcia YI, 2016, J ASSOC INF SCI TECH, V67, P1245, DOI 10.1002/asi.23493; Hutchins BI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002541; ICite, 2017, NEW AN STATS; Izquierdo TAG, 2014, BIOTECNOLOGIA; Jamil K., 2009, MAGAZINE UN; Karpagam R, 2014, CURR SCI INDIA, V106, P1490; Kleiche-Dray M., 2014, COOPERACION COLABORA; Kurzwell R., 2006, SINGULARITY IS NEAR; Latin America & Caribbean Islands, 2015, NATURE, V522, pS26; Lee V, 1983, NAT BIOTECHNOL, P293; Lopez-Illescas C, 2009, J INF SCI, V35, P244, DOI 10.1177/0165551508098603; Mello E, 2011, COLOMBIA AGR BIOTECH; Mfutso-Bengo J M, 2007, Afr J Med Med Sci, V36 Suppl, P63; Milojevic S, 2013, SCIENTOMETRICS, V95, P141, DOI 10.1007/s11192-012-0861-z; Ministerio da Ciencia Tecnologia e Inovacao, 2007, PLAN ACAO CIENCIA TE; Ministerio de Ciencia Tecnologia e Innovacion Productiva, 2016, POL CIENT TECN; Ministerio de Economia y Finanzas Publicas, 2012, MACR ARG 2003 2012; Mitka M., 2017, JAMA-J AM MED ASSOC, V291, P4925; Miyares M, 2012, CAMBIOS EN CUBA 2012; Mongeon P, 2015, PRO INT CONF SCI INF, P584; MUNOZ Emilio, 2001, BIOTECNOLOGIA SOC EN; Nieto Gómez Libia Esperanza, 2015, Luna Azul, V0, P348, DOI 10.17151/luaz.2015.41.19; Niosi J, 2013, BIOTECHNOLOGY SERVIC; OECD, 2006, OECD BIOT STAT 2006; OECD, 1998, EC ASP BIOT REL HUM, P269; OECD, 2006, RISK AWARENESS TOOL, P12; OECD (Organisation for Economic Co-operation and Development), 2016, OECD DAT; OPS, 2014, INF GEN LEISHM; OPS OMS, 2015, MAS 100 MILL PERS PA; Orellana C, 2004, NAT BIOTECHNOL, V22, P7, DOI 10.1038/nbt0104-7; Organisation for Economic Co-operation and Development (OECD), 2006, BIOEC 2030 DES POL A, P12; Paz-Avendano R, 2013, MENOS 32 MIL PERSONA; Perez THE, 2008, ESTADISTICA CIENCIAS; Pollitt A, 2016, MAPPING GLOBAL MENTA; Primer. SA, 2001, APPL BIOTECHNOLOGY I; R Project, 2015, R PROJECT STAT COMPU; Rangel-Aldao R, 2004, NAT BIOTECHNOL, V22, P20, DOI 10.1038/nbt0104-20; Rau B, 2016, COLOMBIA AGR BIOTECH; Redaccion Internacional, 2016, GRANMA; Resende V., 2012, BIOTECHNOLOGY MARKET, P9; Rezaie A., 2011, HLTH TECHNOLOGY INNO; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Russell J. M., 2007, REV ESP DOC CIENT, V30, P178, DOI DOI 10.3989/REDC.2007.V30.I2.378; Salimullah S, 2016, SILVER JUBILEE SPECI; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Secretaria de Economia Fomento y Reconstruccion, 2005, INN CHIL PROGR DES I; Sigogneau A, 2000, SCIENTOMETRICS, V47, P589, DOI 10.1023/A:1005628218890; Stone M, 1983, NAT BIOTECHNOL, P544; Sveikauskas L., 2007, US BUR LABOR STAT WO, V408, P1; Tamayo OH, 2015, EL MUNDO; TAY ZJ, 2004, REV FAC MED UNAM, V47, P6; Thomson Reuters, 2013, WEB OF SCI; Thomson Reuters, 2012, CIT TM HELP; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC19, DOI 10.1038/nbt1204supp-DC19; Thorsteinsdottir H., 2011, 9 GLOB C, P1; Thorsteinsdottir Halla, 2006, International Journal of Biotechnology, V8, P23; Thorsteinsdottir H, 2010, NAT BIOTECHNOL, V28, P1308, DOI 10.1038/nbt1210-1308b; UN System Task Team, 2014, SCI TECHN INN SUST D; United Nations, 2015, ESAPWP241 UN; Universidad de Oviedo, 2013, GUIA RAP IND REC RED; Vargas Rodríguez Angel Reinaldo, 2014, Rev Hum Med, V14, P206; Vasic-Racki D., 2006, HIST IND BIOTRANSFOR, V2, P1; Vaxira, 2017, QUE VAXIRA QUE SE UT; Veugelers R, 2014, CONTRIBUTION ACAD RE; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Web of Science, 2017, WEB OF SCI; WHO, 2016, DIAB COUNTR PROF; WHO, 2017, ENF CHAG TRIP AM; WHO, 2012, RES DEV MEET HLTH NE; World Bank Group, 2016, RES DEV EXP; Yang W, 2016, NAT BIOTECHNOL, V34, P456, DOI 10.1038/nbt.3574; Zajtchuk R, 1999, DM-DIS MON, V45, P453, DOI 10.1016/S0011-5029(99)90018-4	122	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191267	10.1371/journal.pone.0191267	http://dx.doi.org/10.1371/journal.pone.0191267			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415003	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300019
J	Manfre, G; Novati, A; Faccini, I; Rossetti, AC; Bosch, K; Molteni, R; Riva, MA; Van der Harst, JE; Nguyen, HP; Homberg, JR				Manfre, Giuseppe; Novati, Arianna; Faccini, Ilaria; Rossetti, Andrea C.; Bosch, Kari; Molteni, Raffaella; Riva, Marco A.; Van der Harst, Johanneke E.; Huu Phuc Nguyen; Homberg, Judith R.			BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates	PLOS ONE			English	Article							PREDICT-HD; DISEASE; MODEL; PLAY; ABNORMALITIES; DIAGNOSIS; DEFICITS; SYSTEM; GENE	Background Huntington disease (HD) is a devastating inherited neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric symptoms without any cure to slow down or stop the progress of the disease. The BACHD rat model for HD carrying the human full-length mutant huntingtin protein (mHTT) with 97 polyQ repeats has been recently established as a promising model which reproduces several HD-like features. While motor and cognitive functions have been characterized in BACHD rats, little is known about their social phenotype. Objective This study focuses especially on social behavior since evidence for social disturbances exists in human patients. Our objective was to compare social behavior in BACHD and wildtype (WT) rats at different ages, using two different measures of sociability. Methods Animals were tested longitudinally at the age of 2, 4 and 8 months in the social interaction test to examine different parameters of sociability. A separate cohort of 7 month old rats was tested in the three chamber social test to measure both sociability and social novelty. Gene expression analyses in 8 months old animals were performed by real time qRT-PCR to evaluate a potential involvement of D1 and D2 dopaminergic receptors and the contribution of Brain-derived neurotrophic factor (BDNF) to the observed behavioral alterations. Results In the social interaction test, BACHD rats showed age-dependent changes in behaviour when they were-re introduced to their cagemate after a 24 hours-period of individual housing. The time spent on nape attacks increased with aging. Furthermore, a significant higher level of pinning at 2 months of age was shown in the BACHD rats compared to wild-types, followed by a reduction at 4 and 8 months. On the other hand, BACHD rats exhibited a decreased active social behaviour compared to wild-types, reflected by genotype-effects on approaching, following and social nose contact. In the three chamber social test, BACHD rats seemed to show a mild deficit in preference for social novelty, but no changes in social interest. Molecular analyses revealed that BACHD animals exposed to the social interaction test displayed decreased mRNA levels of the total form of BDNF in ventral striatum and unaltered striatal expression of D1 and D2 dopamine receptors. Conclusions Taken together, these results indicate deficits in several parameters representative of sociability. Altered BDNF expression in the ventral striatum may contribute to the deficits in sociability in 8 months old BACHD rats. These data support the validity of the BACHD rat model in mimicking features of certain social deficits that could be relevant to symptoms in patients.	[Manfre, Giuseppe; Bosch, Kari; Van der Harst, Johanneke E.; Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Manfre, Giuseppe; Van der Harst, Johanneke E.] Noldus Informat Technol BV, Wageningen, Netherlands; [Manfre, Giuseppe; Novati, Arianna; Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Novati, Arianna; Huu Phuc Nguyen] Univ Tubingen, Ctr Rare Dis, Tubingen, Germany; [Faccini, Ilaria; Riva, Marco A.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Rossetti, Andrea C.; Molteni, Raffaella] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Milan; University of Milan	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.; Nguyen, HP (corresponding author), Univ Tubingen, Ctr Rare Dis, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Homberg, J.R./N-4172-2019; Homberg, Judith R/D-2473-2010; Nguyen, Huu Phuc/HDO-3462-2022; Riva, Marco Andrea/N-7418-2017; Molteni, Raffaella/Q-5011-2017	Nguyen, Huu Phuc/0000-0001-6139-788X; Riva, Marco Andrea/0000-0002-1699-5060; Molteni, Raffaella/0000-0002-5481-7572; Rossetti, Andrea Carlo/0000-0003-0320-591X	Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat" [317259]; Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD" [324495]	Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat"; Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD"	This study was supported by Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat" (FP7/2012 under grant agreement No. 317259) and the Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD" (FP7-PEOPLE-2012; grant agreement No. 324495). Funding was used to breed and maintain animals, acquire materials, perform experiments, analyze data and support the authors' salaries. The funders, Noldus Information Technology and QPS Austria had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [GM, AN, JVDH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Abada YSK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068584, 10.1371/journal.pone.0071633]; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Baez-Mendoza Raymundo, 2013, FRONTIERS NEUROSCIEN, V7, P1; Cepeda C, 2014, PROG BRAIN RES, V211, P235, DOI 10.1016/B978-0-444-63425-2.00010-6; Ciamei A, 2008, NEUROBIOL LEARN MEM; Clemensson EKH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169051; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Himmler BT, 2013, JOVE-J VIS EXP, DOI 10.3791/4288; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Johnson SA, 2007, BRAIN, V130, P1732, DOI 10.1093/brain/awm107; Kirkwood SC, 1999, ARCH NEUROL-CHICAGO, V56, P563, DOI 10.1001/archneur.56.5.563; Kumar A, 2015, GENE, V556, P91, DOI 10.1016/j.gene.2014.11.022; Lamirault C, 2017, NEUROPHARMACOLOGY, V123, P136, DOI 10.1016/j.neuropharm.2017.05.032; Larsen IU, 2016, PUBLIC LIB SCI, V8; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manfre G, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00218; Manfre G, 2016, BEHAV BRAIN RES, V299, P6, DOI 10.1016/j.bbr.2015.11.007; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Martin P, 2007, MEASURING BEHAV INTR; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Oakeshott S, 2012, PLOS CURR, V4, DOI [10.1371/4f972cffe82c0, DOI 10.1371/4F972CFFE82C0]; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Peters SM, 2016, J NEUROSCI METH, V268, P163, DOI 10.1016/j.jneumeth.2016.02.020; Pietsch SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024601; Rossetti AC, 2016, PHARMACOL RES, V103, P1, DOI 10.1016/j.phrs.2015.10.022; Rudenko O, 2010, NEUROSCI RES, V68, P35, DOI 10.1016/j.neures.2010.05.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Spruijt BM, 2014, J NEUROSCI METH, V234, P2, DOI 10.1016/j.jneumeth.2014.03.001; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; Vamos M, 2007, PSYCHOSOMATICS, V48, P400, DOI 10.1176/appi.psy.48.5.400; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; Varlinskaya EI, 2008, BEHAV BRAIN RES, V188, P398, DOI 10.1016/j.bbr.2007.11.024; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Wood NI, 2015, J HUNTINGTONS DIS, V4, P61, DOI 10.3233/JHD-140132; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192289	10.1371/journal.pone.0192289	http://dx.doi.org/10.1371/journal.pone.0192289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415038	Green Published, gold			2022-12-27	WOS:000424325300067
J	Manlhiot, C; Mueller, B; O'Shea, S; Majeed, H; Bernknopf, B; Labelle, M; Westcott, KV; Bai, HM; Chahal, N; Birken, CS; Yeung, RSM; McCrindle, BW				Manlhiot, Cedric; Mueller, Brigitte; O'Shea, Sunita; Majeed, Haris; Bernknopf, Bailey; Labelle, Michael; Westcott, Katherine V.; Bai, Heming; Chahal, Nita; Birken, Catherine S.; Yeung, Rae S. M.; McCrindle, Brian W.			Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution	PLOS ONE			English	Article							CORONARY-ARTERY ANEURYSMS; TROPOSPHERIC WINDS; NATIONWIDE SURVEYS; ALLERGIC DISEASES; ASSOCIATION; JAPAN; RISK; SUSCEPTIBILITY; AGE; RUG	Background The pathogenesis of Kawasaki disease (KD) is commonly ascribed to an exaggerated immunologic response to an unidentified environmental or infectious trigger in susceptible children. A comprehensive framework linking epidemiological data and global distribution of KD has not yet been proposed. Methods and findings Patients with KD (n = 81) were enrolled within 6 weeks of diagnosis along with control subjects (n = 87). All completed an extensive epidemiological questionnaire. Geographic localization software characterized the subjects' neighborhood. KD incidence was compared to atmospheric biological particles counts and winds patterns. These data were used to create a comprehensive risk framework for KD, which we tested against published data on the global distribution. Compared to controls, patients with KD were more likely to be of Asian ancestry and were more likely to live in an environment with low exposure to environmental allergens. Higher atmospheric counts of biological particles other than fungus/spores were associated with a temporal reduction in incidence of KD. Finally, westerly winds were associated with increased fungal particles in the atmosphere and increased incidence of KD over the Greater Toronto Area. Our proposed framework was able to explain approximately 80% of the variation in the global distribution of KD. The main limitations of the study are that the majority of data used in this study are limited to the Canadian context and our proposed disease framework is theoretical and circumstantial rather than the result of a single simulation. Conclusions Our proposed etiologic framework incorporates the 1) proportion of population that are genetically susceptible; 2) modulation of risk, determined by habitual exposure to environmental allergens, seasonal variations of atmospheric biological particles and contact with infectious diseases; and 3) exposure to the putative trigger. Future modelling of individual risk and global distribution will be strengthened by taking into consideration all of these non-traditional elements.	[Manlhiot, Cedric; Mueller, Brigitte; O'Shea, Sunita; Majeed, Haris; Bernknopf, Bailey; Labelle, Michael; Westcott, Katherine V.; Bai, Heming; Chahal, Nita; McCrindle, Brian W.] Univ Toronto, Hosp Sick Children, Dept Pediat, Labatt Family Heart Ctr, Toronto, ON, Canada; [Birken, Catherine S.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gen Pediat, Toronto, ON, Canada; [Yeung, Rae S. M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McCrindle, BW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Labatt Family Heart Ctr, Toronto, ON, Canada.	brian.mccrindle@sickkids.ca	Mueller, Brigitte/E-2594-2011	Mueller, Brigitte/0000-0003-1876-4722; Yeung, Rae/0000-0003-2361-725X	CIBC Endowed Chair in Child Health Research	CIBC Endowed Chair in Child Health Research	This study was supported by the CIBC Endowed Chair in Child Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester J, 2013, GEOPHYS RES LETT, V40, P2284, DOI 10.1002/grl.50388; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074529; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Carsley S, 2015, INT J EPIDEMIOL, V44, P776, DOI 10.1093/ije/dyu123; Chahal N, 2012, PEDIATR INT, V54, P383, DOI 10.1111/j.1442-200X.2012.03628.x; Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008; Crump C, 2011, J ALLERGY CLIN IMMUN, V127, P1173, DOI 10.1016/j.jaci.2011.02.023; DANIELS SR, 1991, J PEDIATR-US, V118, P485, DOI 10.1016/S0022-3476(05)82173-0; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; FATICA NS, 1989, PEDIATRICS, V84, P231; FUJITA Y, 1989, PEDIATRICS, V84, P666; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hwang CY, 2013, J PEDIATR-US, V163, P811, DOI 10.1016/j.jpeds.2013.03.068; Jorquera H, 2015, ENVIRON INT, V78, P32, DOI 10.1016/j.envint.2015.02.007; Jung CR, 2017, ENVIRON HEALTH PERSP, V125, P670, DOI 10.1289/EHP137; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Maddox RA, 2015, PEDIATR INT, V57, P1116, DOI 10.1111/ped.12733; Manlhiot C, 2017, CMAJ IN PRESS; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Nakamura Y, 2004, PROG PEDIATR CARDIOL, V19, P99; Nakamura Y, 2008, J EPIDEMIOL, V18, P273, DOI 10.2188/jea.JE2008030; Okubo Y, 2017, CLIN RHEUMATOL, V36, P413, DOI 10.1007/s10067-016-3512-6; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Pitzer VE, 2012, P ROY SOC B-BIOL SCI, V279, P2736, DOI 10.1098/rspb.2011.2464; RAUCH AM, 1991, PEDIATRICS, V87, P663; Rigante D, 2016, IMMUNOL RES, V64, P51, DOI 10.1007/s12026-015-8679-4; Rodo X, 2016, ANN NY ACAD SCI, V1382, P84, DOI 10.1111/nyas.13201; Rodo X, 2014, P NATL ACAD SCI USA, V111, P7952, DOI 10.1073/pnas.1400380111; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; SANDWELL DT, 1984, J GEOPHYS RES-OCEANS, V89, P2041, DOI 10.1029/JC089iC02p02041; Sano T, 2016, PEDIATR INT, V58, P1140, DOI 10.1111/ped.12970; Singh S, 2015, ARCH DIS CHILD, V100, P1084, DOI 10.1136/archdischild-2014-307536; Sudo D, 2017, ACTA PAEDIATR, V106, P796, DOI 10.1111/apa.13773; Tsai HC, 2015, J FORMOS MED ASSOC, V114, P72, DOI 10.1016/j.jfma.2014.07.005; Tsai YJ, 2013, ALLERGY ASTHMA PROC, V34, P467, DOI 10.2500/aap.2013.34.3697; Turnier JL, 2015, PEDIATRICS, V136, pE609, DOI 10.1542/peds.2015-0950; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Wei CC, 2014, ANN EPIDEMIOL, V24, P340, DOI 10.1016/j.annepidem.2014.02.003; Wong D, 2004, CAN J CARDIOL, V20, P1147; Yorifuji T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3919; Zeft AS, 2016, J PEDIATR-US, V177, P179, DOI 10.1016/j.jpeds.2016.06.061	45	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191087	10.1371/journal.pone.0191087	http://dx.doi.org/10.1371/journal.pone.0191087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415012	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300014
J	Schaefer, CP; Arkwright, NB; Jacobs, LM; Jarvis, CK; Hunn, KC; Largent-Milnes, TM; Tome, ME; Davis, TP				Schaefer, Charles P.; Arkwright, Nathan B.; Jacobs, Leigh M.; Jarvis, Chelsea K.; Hunn, Kristen C.; Largent-Milnes, Tally M.; Tome, Margaret E.; Davis, Thomas P.			Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels	PLOS ONE			English	Article							PERIPHERAL INFLAMMATORY HYPERALGESIA; OPIOID TOLERANCE; TIGHT JUNCTIONS; BARRIER; PAIN; DRUG; DELIVERY; INHIBITOR; KETAMINE; MODULATION	The rates of opioid prescription and use have continued to increase over the last few decades resulting in a greater number of opioid tolerant patients. Treatment of acute pain from surgery and injury is a clinical challenge for these patients. Several pain management strategies including prescribing increased opioids are used clinically with limited success; all currently available strategies have significant limitations. Many opioids are a substrate for p-glycoprotein (p-gp), an efflux transporter at the blood-brain barrier (BBB). Increased p-gp is associated with a decreased central nervous system uptake and analgesic efficacy of morphine. Our laboratory previously found that acute peripheral inflammatory pain (PIP) induces p-gp trafficking from the nucleus to the luminal surface of endothelial cells making up the BBB concomitant with increased p-gp activity and decreased morphine analgesic efficacy. In the current study, we tested whether PIP-induced p-gp trafficking could contribute to decreased opioid efficacy in morphine tolerant rats. A 6-day continuous dosing of morphine from osmotic minipumps was used to establish morphine tolerance in female rats. PIP induced p-gp trafficking away from nuclear stores showed a 2-fold increase in morphine tolerant rats. This observation suggests that p-gp trafficking contributes to the decreased morphine analgesic effects in morphine tolerant rats experiencing an acute pain stimulus. Attenuating p-gp trafficking during an acute pain stimulus could improve pain management by increasing the amount of opioid that could reach CNS analgesic targets and decrease the need for the dose escalation that is a serious challenge in pain management.	[Schaefer, Charles P.; Arkwright, Nathan B.; Jacobs, Leigh M.; Jarvis, Chelsea K.; Hunn, Kristen C.; Largent-Milnes, Tally M.; Tome, Margaret E.; Davis, Thomas P.] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA	University of Arizona	Tome, ME (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA.	mtome@email.arizona.edu			National Institutes of Health: National Institute on Drug Abuse [011271]; National Institutes of Health: National Institute of Neurological Disorders and Stroke [042652]	National Institutes of Health: National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health: National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health: National Institute on Drug Abuse (011271) (T.P.D.); National Institutes of Health: National Institute of Neurological Disorders and Stroke (042652) (T.P.D.).	Aasvang EK, 2016, ACTA ANAESTH SCAND, V60, P529, DOI 10.1111/aas.12667; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Aquilante CL, 1999, LIFE SCI, V66, pPL47; Balayssac D, 2009, NEUROSCI LETT, V465, P108, DOI 10.1016/j.neulet.2009.09.003; Bansal T, 2009, J PHARM PHARM SCI, V12, P46, DOI 10.18433/J3RC77; Barreveld AM, 2013, PAIN MED, V14, P925, DOI 10.1111/pme.12086; CAMPBELL AW, 2016, ALTERN THER HEALTH M, V22, P6; Campos CR, 2008, BRAIN RES, V1221, P6, DOI 10.1016/j.brainres.2008.05.013; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dixon M, 2014, AM J PHYSL HEART CIR; DIXON M, 2014, SPRING CONFERENCE OF; Dumas EO, 2008, AAPS J, V10, P537, DOI 10.1208/s12248-008-9056-1; Duncan MA, 2002, J PAIN SYMPTOM MANAG, V24, P8, DOI 10.1016/S0885-3924(02)00429-3; Dyrna F, 2013, J NEUROIMMUNE PHARM, V8, P763, DOI 10.1007/s11481-013-9473-5; Faul F, BEHAV RES METHODS; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HUBER JD, AM J PHYSL HEART CIR; HUBER JD, AM J PHYSIOL HEART C, V3, P1; Huber JD, 2002, AM J PHYSL HEART CIR, V283, pH1531; HUBER JD, AM J PHYSIOL HEART C; HUBER JD, 2002, AM J PHYSIOL HEART C; HUBER JD, 2009, AM J PHYSIOL HEART C; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; JUNCO JJ, 2013, MOL CANCER RES, V1521, P30; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kobori T, 2014, DRUG METAB PHARMACOK, V29, P482, DOI 10.2133/dmpk.DMPK-14-RG-042; Letrent SP, 1999, DRUG METAB DISPOS, V27, P827; Liang XJ, 2006, CURR DRUG TARGETS, V7, P911, DOI 10.2174/138945006778019264; Lilius TO, 2015, BRIT J PHARMACOL, V172, P2799, DOI 10.1111/bph.12974; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Mahathanaruk Marchyarn, 2014, Anesthesiol Clin, V32, P923, DOI 10.1016/j.anclin.2014.08.009; McCaffrey G, 2008, J NEUROCHEM, V106, P2395, DOI 10.1111/j.1471-4159.2008.05582.x; McCaffrey G, 2012, J NEUROCHEM, V122, P962, DOI 10.1111/j.1471-4159.2012.07831.x; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2014, CURR PHARM DESIGN, V20, P1463, DOI 10.2174/13816128113199990457; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; MYERS JL, 2003, RESEARCH DESIGN AND, P2; Nelson LS, 2015, JAMA-J AM MED ASSOC, V314, P1453, DOI 10.1001/jama.2015.12397; Rathmell JP, 2006, REGION ANESTH PAIN M, V31, P1, DOI 10.1016/j.rapm.2006.05.002; Rivat C, 2005, ANESTHESIOLOGY, V102, P421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seelbach MJ, 2007, J NEUROCHEM, V102, P1677, DOI 10.1111/j.1471-4159.2007.04644.x; Sivak L, 2017, BIOMATERIALS, V115, P65, DOI 10.1016/j.biomaterials.2016.11.013; Thomas Hilary, 2003, Cancer Control, V10, P159; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; Tome ME, 2016, J CEREBR BLOOD F MET, V36, P1913, DOI 10.1177/0271678X16661728; Uhelski ML, 2011, PHARMACOL BIOCHEM BE, V98, P325, DOI 10.1016/j.pbb.2011.01.012; URQUHART J, 1984, ANNU REV PHARMACOL, V24, P199; *US DEP HHS, 2016, THE OPIOID EPIDEMIC; Yousif S, 2008, J NEUROCHEM, V107, P647, DOI 10.1111/j.1471-4159.2008.05647.x; Zong J, 2003, J PHARMACOL EXP THER, V306, P556, DOI 10.1124/jpet.103.049452	52	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192340	10.1371/journal.pone.0192340	http://dx.doi.org/10.1371/journal.pone.0192340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414996	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300072
J	Han, K				Han, Kyungsik			How do you perceive this author? Understanding and modeling authors' communication quality in social media	PLOS ONE			English	Article							NETWORK SITES; INFORMATION; TRUST; CREDIBILITY; PERCEPTIONS; GENDER; THINK; IF	In this study, we leverage human evaluations, content analysis, and computational modeling to generate a comprehensive analysis of readers' evaluations of authors' communication quality in social media with respect to four factors: author credibility, interpersonal attraction, communication competence, and intent to interact. We review previous research on the human evaluation process and highlight its limitations in providing sufficient information for readers to assess authors' communication quality. From our analysis of the evaluations of 1,000 Twitter authors' communication quality from 300 human evaluators, we provide empirical evidence of the impact of the characteristics of the reader (demographic, social media experience, and personality), author (profile and social media engagement), and content (linguistic, syntactic, similarity, and sentiment) on the evaluation of an author's communication quality. In addition, based on the author and message characteristics, we demonstrate the potential for building accurate models that can indicate an author's communication quality.	[Han, Kyungsik] Ajou Univ, Dept Software & Compute Engn, Suwon, South Korea	Ajou University	Han, K (corresponding author), Ajou Univ, Dept Software & Compute Engn, Suwon, South Korea.	kyungsikhan@ajou.ac.kr	Han, Kyungsik/O-2416-2019; Han, Kyungsik/D-3010-2017	Han, Kyungsik/0000-0001-5535-0081	National Research Foundation of Korea [2017R1C1B5017391]; Ajou University [S-2017-G0001-00040]	National Research Foundation of Korea(National Research Foundation of Korea); Ajou University	This work was supported by National Research Foundation of Korea (received by Kyungsik Han), Funding number (2017R1C1B5017391). No URL is available. And by Ajou University (received by Kyungsik Han), Funding number (S-2017-G0001-00040). No URL is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agichtein E., 2008, PROC INT C WEB SEARC, P183; AlMansour A, 2014, P 14 INT C KNOWL TEC, P32; Batista GE, 2003, WOB; Benevenuto F, 2010, COLL EL MESS ANT SPA, V6; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Buchan NR, 2008, J ECON BEHAV ORGAN, V68, P466, DOI 10.1016/j.jebo.2007.10.006; Castillo C., 2011, PROC 20 INT C WORLD, P675, DOI DOI 10.1145/1963405.1963500; Chung JE, 2010, COMPUT HUM BEHAV, V26, P1674, DOI 10.1016/j.chb.2010.06.016; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Edwards C, 2014, COMPUT HUM BEHAV, V33, P372, DOI 10.1016/j.chb.2013.08.013; Edwards C, 2013, COMPUT HUM BEHAV, V29, pA12, DOI 10.1016/j.chb.2012.12.034; Ferrara E, 2016, COMMUN ACM, V59, P96, DOI 10.1145/2818717; Flanagin AJ, 2003, COMPUT HUM BEHAV, V19, P683, DOI 10.1016/S0747-5632(03)00021-9; Fogg BJ, 1999, P SIGCHI C HUM FACT, DOI DOI 10.1145/302979.303001; Gal Y, 2007, LECT NOTES ARTIF INT, V4635, P206; Gupta A, 2014, P INT C SOC INF; Haas C, 2013, L1 ED STUDIES LANGUA, V3, P169; Hentschel M, 2014, P INT C WEB SOC MED; Johnson TJ, 2014, J COMPUT-MEDIAT COMM, V19, P957, DOI 10.1111/jcc4.12084; Kang M., 2010, MEASURING SOCIAL MED; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kumar KK, 2014, HUMAN CTR COMPUTING, V4; Lachlan KA, 2014, COMPUT HUM BEHAV, V33, P377, DOI 10.1016/j.chb.2013.08.014; Lee K, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P435, DOI 10.1145/1835449.1835522; Louis D, 2010, J PROD BRAND MANAG, V19, P114, DOI 10.1108/10610421011033467; McCroskey JC, 1999, COMMUNICATIONS MONOG, V66; McCroskey JC, 1974, SPEECH MONOGRAPHS, V4; Melchers MC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00290; Mohd Shariff Shafiza, 2016, Advances in Information Retrieval. 38th European Conference on IR Research, ECIR 2016. Proceedings; LNCS 9626, P453, DOI 10.1007/978-3-319-30671-1_33; Morris M., 2012, P ASS COMPUTING MACH, P441, DOI [10.1145/, 10.1145/2145204.2145274, DOI 10.1145/2145204.2145274]; Neter J., 1996, APPL LINEAR STAT MOD; O'Donovan J, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P293, DOI 10.1109/SocialCom-PASSAT.2012.128; Park G, 2015, J PERS SOC PSYCHOL, V108, P934, DOI 10.1037/pspp0000020; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Riedl R, 2010, MIS QUART, V34, P397; Salton G, 1988, INFORM PROCESSING MA, P24; Schwartz HA, 2014, PLOS ONE, V8; Spence PR, 2016, COMMUN Q, V64, P55, DOI 10.1080/01463373.2015.1100644; Spence PR, 2013, COMPUT HUM BEHAV, V29, P1255, DOI 10.1016/j.chb.2012.12.013; Spitzberg B. H., 2006, J COMPUT-MEDIAT COMM, V11, P629, DOI DOI 10.1111/J.1083-6101.2006.00030.X; Steinbach M, 2000, KDD WORKSH TEXT MIN, V400; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Thomas K., 2011, P 2011 ACM SIGCOMM C, P243, DOI [10.1145/2068816.2068840, DOI 10.1145/2068816.2068840]; Van der Heide B, 2012, J COMMUN, V62, P98, DOI 10.1111/j.1460-2466.2011.01617.x; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; Wang G., 2013, SYBIL, V9, P1, DOI DOI 10.1007/S00521-013-1485-9; Westerman D, 2012, COMPUT HUM BEHAV, V28, P199, DOI 10.1016/j.chb.2011.09.001; Xin Xia, 2012, Intelligence and Security Informatics. Proceedings Pacific Asia Workshop, PAISI 2012, P45, DOI 10.1007/978-3-642-30428-6_4; Yang C, 2013, IEEE T INF FOREN SEC, V8, P1280, DOI 10.1109/TIFS.2013.2267732; Yang J., 2013, P 2013 C COMP SUPP C, P575; [No title captured]; [No title captured]	55	5	5	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192061	10.1371/journal.pone.0192061	http://dx.doi.org/10.1371/journal.pone.0192061			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389979	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400060
J	Park, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW				Park, So Young; Kim, Hae In; Oh, Hyun-Kyung; Kim, Tae Hyuk; Jang, Hye Won; Chung, Jae Hoon; Shin, Myung-Hee; Kim, Sun Wook			Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)	PLOS ONE			English	Article							SUBCLINICAL THYROID-DISEASE; UNITED-STATES POPULATION; SERUM TSH; URINARY IODINE; REFERENCE RANGE; FOLLOW-UP; THYROTROPIN; DYSFUNCTION; DISORDERS; EXCRETION	Background Establishment of the reference interval of thyroid-stimulating hormone (TSH) is critical in the diagnosis of thyroid dysfunction and is affected by age, gender, iodine nutrition, and ethnicity. The aim of this study was to determine the reference intervals of TSH and free thyroxin (FT4) from a large, nationwide data of Korea where iodine intake is more than adequate. Methods We analyzed data from the Korea National Health and Nutrition Examination Survey VI that measured serum TSH, FT4, and thyroid peroxidase antibody from 7,061 individuals (urinary iodine measurement in 6,565). Age-and gender-specific reference intervals were established from 95% confidence limits from the 2.5 to 97.5 percentile of TSH (log-transformed) and FT4 in reference populations. Results The geometric mean of TSH was 2.16 +/- 0.01 mIU/L, with the lowest value found in the middle aged group (2.04 +/- 0.02 mIU/L) and higher values noted in age groups of 10-19 and over 70 years (2.38 +/- 0.02 and 2.32 +/- 0.07 mIU/L, respectively). The association of TSH and age was U-shaped. The overall reference interval of TSH was 0.59-7.03 mIU/L. Mean FT4 was 1.25 +/- 0.003 ng/dL (16.09 +/- 0.039 pmol/L), and it showed a small but continuous decrease after 20 years of age (P < 0.001). There was a significant positive correlation between TSH and urine iodine concentration (r = 0.154, P < 0.001). Conclusions The reference interval of TSH in Korea, where iodine intake is above the requirement, was 0.59-7.03 mIU/L and showed U-shaped change with age, which was a similar pattern to iodine intake. The reference interval of FT4 was 0.92-1.60 ng/dL. The geometric mean and upper limit of TSH were higher than those of Western populations, reflecting the paramount importance of iodine intake on thyroid function.	[Park, So Young; Kim, Hae In; Kim, Tae Hyuk; Chung, Jae Hoon; Kim, Sun Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea; [Oh, Hyun-Kyung; Shin, Myung-Hee] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Seoul, South Korea; [Jang, Hye Won] Sungkyunkwan Univ, Sch Med, Dept Med Educ, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Kim, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea.; Shin, MH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Seoul, South Korea.	myunghee.shin@gmail.com; swkimmd@skku.edu	Kim, Sun/GSN-4867-2022	Kim, Tae Hyuk/0000-0002-7975-2437				[Anonymous], 2003, THYROID, V13, P3; [Anonymous], 2007, ASS IOD DEF DIS MON; Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P1251, DOI 10.1210/jc.2008-2325; Biondi B, 2012, BEST PRACT RES CL EN, V26, P431, DOI 10.1016/j.beem.2011.12.004; Bjergved L, 2012, J CLIN ENDOCR METAB, V97, P4022, DOI 10.1210/jc.2012-2508; Braverman LE, 2013, WERNER INGBARS THYRO; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Chaker L, 2016, THYROID, V26, P1195, DOI 10.1089/thy.2016.0133; Cho YY, 2016, EUR J NUTR, V55, P469, DOI 10.1007/s00394-015-0864-7; Choi HS, 2009, J KOREAN THYROID ASS, V3; Choi J, 2012, CLIN BIOCHEM, V45, P596, DOI 10.1016/j.clinbiochem.2012.02.018; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Guan HX, 2008, CLIN ENDOCRINOL, V69, P136, DOI 10.1111/j.1365-2265.2007.03150.x; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hansen PS, 2007, CLIN ENDOCRINOL, V66, P827, DOI 10.1111/j.1365-2265.2007.02820.x; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Ittermann T, 2015, EUR J ENDOCRINOL, V172, P261, DOI 10.1530/EJE-14-0898; Kim JY, 1998, YONSEI MED J, V39, P355, DOI 10.3349/ymj.1998.39.4.355; Kim M, 2015, KOREAN J INTERN MED, V30, P335, DOI 10.3904/kjim.2015.30.3.335; Kim YA, 2014, ENDOCRINOL METAB, V29, P20, DOI 10.3803/EnM.2014.29.1.20; Lee J, 2014, EUR J NUTR, V53, P683, DOI 10.1007/s00394-013-0558-y; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Li CY, 2011, ENDOCR J, V58, P995, DOI 10.1507/endocrj.K11E-101; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Razvi S, 2010, J CLIN PATHOL, V63, P379, DOI 10.1136/jcp.2008.057414; Samollow PB, 2004, J CLIN ENDOCR METAB, V89, P3276, DOI 10.1210/jc.2003-031706; Schalin-Jantti C, 2011, SCAND J CLIN LAB INV, V71, P344, DOI 10.3109/00365513.2011.568630; Sheehan MT, 2016, CLIN MED RES, V14, P83, DOI 10.3121/cmr.2016.1309; Sun X, 2014, ENDOCRINOL METAB, V29, P240, DOI 10.3803/EnM.2014.29.3.240; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; TIETZ NW, 1992, CLIN CHEM, V38, P1167; Volzke H, 2005, THYROID, V15, P279, DOI 10.1089/thy.2005.15.279; Yoshihara A, 2011, ENDOCR J, V58, P585, DOI 10.1507/endocrj.K11E-082	34	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190738	10.1371/journal.pone.0190738	http://dx.doi.org/10.1371/journal.pone.0190738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390008	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400007
J	Albersmeier, JP; Bremer, JP; Dammermann, W; Luth, S; Hagenmuller, F; Ruther, C; Otto, H; Nielsen, AM; Schumacher, U; Ullrich, S				Albersmeier, J. P.; Bremer, J. P.; Dammermann, W.; Lueth, S.; Hagenmueller, F.; Ruether, C.; Otto, H.; Nielsen, A. M.; Schumacher, U.; Ullrich, S.			Outcome and clinical course of EHEC O104 infection in hospitalized patients: A prospective single center study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; OUTBREAK; TERM	Objectives Shiga-toxin producing O157:H7 Entero Haemorrhagic E. coli [STEC/EHEC] are the most common cause of Haemolytic Uraemic Syndrome [HUS] related to infectious haemorrhagic colitis. Nearly all recommendations on long term treatment of EHEC infections refer to this strain. The 2011 outbreak in Northern Europe was the first of this dimension to be caused by the serotype O104:H4. We report on the 3.5 year follow up of 61 patients diagnosed with symptomatic EHEC O104: H4 infection in spring 2011. Methods Patients with EHEC O104 infection were followed in a monocentric, prospective observational study at four time points: 4, 12, 24 and 36 months. These data include the patients' histories, clinical findings, and complications. Results Sixty-one patients suffering from EHEC O104: H4 associated enterocolitis participated in the study at the time of hospital discharge. The mean age of patients was 43 +/- 2 years, 37 females and 24 males. 48 patients participated in follow up 1 [FU 1], 34 patients in follow up 2 [FU 2], 23 patients in follow up 3 [FU 3] and 18 patients in follow up 4 [FU 4]. Out of 61 patients discharged from the hospital and included in the study, 54 [84%] were examined at least at one additional follow up. Serum creatinine decreased significantly between discharge and FU 1 from 1.3 +/- 0.1 mg/dl to 0.7 +/- 0.1 mg/dl [p = 0.0045]. From FU 1 until FU 4, no further change in creatinine levels could be observed. The patients need of antihypertensive medications decreased significantly [p = 0.0005] between discharge and FU 1 after four months. From FU 1 until FU 3, 24 months later, no further significant change in antihypertensive treatment was observed. Conclusions Our findings suggest that patients free of pathological findings at time of discharge do not need a specific follow up. Patients with persistent health problems at hospital discharge should be clinically monitored over four months to evaluate chronic organ damage. Progressive or new emerging renal damage could not be observed over time in any patient.	[Albersmeier, J. P.; Schumacher, U.; Ullrich, S.] Univ Klinikum Hamburg Eppendorf, Anat & Expt Morphol, Hamburg, Germany; [Bremer, J. P.] Klinikum Bad Bramstedt, Abt Rheumatol & Immunol, Bad Bramstedt, Germany; [Dammermann, W.; Lueth, S.] Brandenburg Med Sch, Ctr Internal Med 2, Campus Brandenburg Adh, Brandenburg, Germany; [Hagenmueller, F.; Ruether, C.; Otto, H.; Nielsen, A. M.] Asklepios Klin Altona, Med Klin 1, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Asklepios Klinik Altona	Ullrich, S (corresponding author), Univ Klinikum Hamburg Eppendorf, Anat & Expt Morphol, Hamburg, Germany.	hsullrich@aol.com	Dammermann, Werner/G-5811-2016; Dammermann, Werner/GZN-1268-2022; Bremer, Phillip/AAE-7842-2020	Dammermann, Werner/0000-0001-6847-3769; Luth, Stefan/0000-0001-9946-0960				Alexandra Kleimann, 2014, PLOS ONE, V9; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bea Sebastian Ullrich P, 2013, PLOS ONE, V8; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; Inge Derad BO, 2015, NEPHROL DIAL TRANSPL, P1; Institut RK, 2011, ABSCHL DARST BEW EP; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Krogvold L, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-44; Lowe B, 2014, CLIN GASTROENTEROL H, V12, P1848, DOI 10.1016/j.cgh.2014.02.035; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Otukesh H, 2008, J NEPHROL, V21, P694; Riegel B, 2015, NEUROGASTROENT MOTIL, V27, P370, DOI 10.1111/nmo.12503; Rosales A, 2012, CLIN INFECT DIS, V54, P1413, DOI 10.1093/cid/cis196; SCHIEPPATI A, 1992, J AM SOC NEPHROL, V2, P1640; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191544	10.1371/journal.pone.0191544	http://dx.doi.org/10.1371/journal.pone.0191544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420567	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900017
J	Bertoli, FMD; Bruzamolin, CD; Pizzatto, E; Losso, EM; Brancher, JA; de Souza, JF				de Paiva Bertoli, Fernanda Mara; Bruzamolin, Carolina Dea; Pizzatto, Eduardo; Losso, Estela Maris; Brancher, Joao Armando; de Souza, Juliana Feltrin			Prevalence of diagnosed temporomandibular disorders: A cross-sectional study in Brazilian adolescents	PLOS ONE			English	Article							PARAFUNCTIONAL HABITS; SYMPTOMS; CHILDREN; SIGNS; PAIN; DYSFUNCTION; RELIABILITY; HEADACHE; SOUNDS	Background The prevalence of signs and symptoms of temporomandibular disorders (TMD) increases during adolescence and adulthood. Few studies have examined TMD prevalence in Brazilian adolescents. Aim To investigate the prevalence of TMD in Brazilian adolescents. Methods A representative population-based sample of 934 adolescents (10 +/- 14-years-old) was examined. TMD screening was performed using a questionnaire by the American Academy of Orofacial Pain. TMD diagnoses used research diagnostic criteria for temporomandibular disorders (RDC/TMD-Axis-I). Examinations were performed by a single calibrated examiner (kappa > 0.80). Results The prevalence of TMD symptoms was 34.9%; the most frequently reported symptoms were headache and neck ache (20.9%), followed by joint sounds (18.5%). Myofascial pain was the most prevalent type (10.3%), followed by disc displacement with reduction (8.0%) and arthralgia (3.5%). There was a significant association between sex and TMD symptoms; prevalence was significantly higher in girls (RP = 1.37; 95% CI = 1.14 +/- 1.65; p = 0.001). Myofascial pain of TMD and displacement with reduction were more prevalent in girls (RP = 1.76; p = 0.007 and RP = 2.06; p = 0.004, respectively). Conclusion TMD symptoms were present in 34.9% of adolescents, with myofascial pain being the most prevalent type (10.3%). TMD was significantly more common in girls. Routine pediatric dental care should include a TMD screening.	[de Paiva Bertoli, Fernanda Mara; Bruzamolin, Carolina Dea; Pizzatto, Eduardo; Losso, Estela Maris; Brancher, Joao Armando] Positivo Univ, Grad Program Dent, Curitiba, Parana, Brazil; [de Souza, Juliana Feltrin] Univ Fed Parana, Sch Dent, Dept Stomatol, Curitiba, Parana, Brazil	Universidade Positivo; Universidade Federal do Parana	Brancher, JA (corresponding author), Positivo Univ, Grad Program Dent, Curitiba, Parana, Brazil.	brancher.1@gmail.com	Brancher, João Armando/AAQ-4858-2020; Brancher, João Armando/C-7758-2014; de Souza, Juliana Feltrin/G-4588-2012	Brancher, João Armando/0000-0002-8914-702X; Brancher, João Armando/0000-0002-8914-702X; de Souza, Juliana Feltrin/0000-0001-9969-3721				Adern B, 2014, ACTA ODONTOL SCAND, V72, P585, DOI 10.3109/00016357.2013.878390; Al-Khotani A, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0642-9; Barbosa TD, 2008, INT J PEDIATR OTORHI, V72, P299, DOI 10.1016/j.ijporl.2007.11.006; Bonjardim Leonardo Rigoldi, 2005, Braz. oral res., V19, P93, DOI 10.1590/S1806-83242005000200004; de Santis TO, 2014, J BODYW MOV THER, V18, P87, DOI 10.1016/j.jbmt.2013.05.018; Campos JADB, 2014, J ORAL FACIAL PAIN H, V28, P147, DOI 10.11607/ofph.1194; Weiler RME, 2010, INT J PEDIATR OTORHI, V74, P896, DOI 10.1016/j.ijporl.2010.05.007; Farsi NMA, 2003, J ORAL REHABIL, V30, P1200, DOI 10.1111/j.1365-2842.2003.01187.x; Fernandes G, 2015, J ORAL REHABIL, V42, P113, DOI 10.1111/joor.12238; Fernandes G, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0015; Franco AL, 2014, CLIN J PAIN, V30, P340, DOI 10.1097/AJP.0b013e31829ca62f; Franco-Micheloni AL, 2015, J ORAL FACIAL PAIN H, V29, P242, DOI 10.11607/ofph.1262; Franco-Micheloni AL, 2014, J APPL ORAL SCI, V22, P314, DOI 10.1590/1678-775720130694; Hongxing L, 2016, J ORAL REHABIL, V43, P241, DOI 10.1111/joor.12366; Karibe H, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-8; Kim TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145002; Kobayashi FY, 2014, J ORAL REHABIL, V41, P496, DOI 10.1111/joor.12163; Kohler AA, 2009, EUR ARCH PAEDIATR DE, V10, P16; Lauriti L, 2013, J PHYS THER SCI, V25, P1331, DOI 10.1589/jpts.25.1331; LeResche L, 2005, PAIN, V118, P201, DOI 10.1016/j.pain.2005.08.011; Moyaho-Bernal Angeles, 2010, Acta odontol. latinoam., V23, P228; Paiva Bertoli FMD, 2007, ARQ NEURO-PSIQUIAT, V65, P251, DOI 10.1590/S0004-282X2007000200012; Rapkin Andrea J, 2006, J Pediatr Adolesc Gynecol, V19, P181, DOI 10.1016/j.jpag.2006.02.004; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Sena Marina Fernandes de, 2013, Rev. paul. pediatr., V31, P538, DOI 10.1590/S0103-05822013000400018; Sonmez H, 2001, J ORAL REHABIL, V28, P280, DOI 10.1111/j.1365-2842.2001.tb01678.x; Tecco S, 2011, CRANIO, V29, P71, DOI 10.1179/crn.2011.010; Torii K, 2011, HEAD FACE MED, V7, DOI 10.1186/1746-160X-7-17; Tuerlings V, 2004, EUR J ORTHODONT, V26, P311, DOI 10.1093/ejo/26.3.311; Wahlund K, 1998, J OROFAC PAIN, V12, P42; WANMAN A, 1990, ORAL SURG ORAL MED O, V69, P2, DOI 10.1016/0030-4220(90)90259-U; Wieckiewicz M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/469187	32	51	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192254	10.1371/journal.pone.0192254	http://dx.doi.org/10.1371/journal.pone.0192254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420573	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900057
J	Csordas, BG; Cunha, RC; Garcia, MV; da Silva, SS; Leite, FL; Andreotti, R				Csordas, Barbara Guimaraes; Cunha, Rodrigo Casquero; Garcia, Marcos Valeario; da Silva, Seargio Silva; Leite, Fabio Leivas; Andreotti, Renato			Molecular characterization of the recombinant protein RmLTI-BmCG-LTB: Protective immunity against Rhipicephalus (Boophilus) microplus	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; B-SUBUNIT; PICHIA-PASTORIS; TICK; VACCINE; ANTIGEN; CATTLE; BM86; IMMUNOPROTECTION	The bovine tick Rhipicephalus (Boophilus) microplus is found in several tropical and subtropical regions of the world. This parasite transmits pathogens that cause disease, such as babesiosis (Babesia bovis and B. bigemina) and anaplasmosis (Anaplasma marginale). Tick infestations cause enormous livestock losses, and controlling tick infestations and the transmission of tick-borne diseases remains a challenge for the livestock industry. Because the currently available commercial vaccines offer only partial protection against R. (B.) microplus, there is a need for more efficient vaccines. Several recombinant antigens have been evaluated using different immunization strategies, and they show great promise. This work describes the construction and immunological characterization of a multi-antigen chimera composed of two R. (B.) microplus antigens (RmLTI and BmCG) and one Escherichia coli antigen (B subunit, LTB). The immunogenic regions of each antigen were selected and combined to encode a single polypeptide. The gene was cloned and expressed in E. coli. For all of the experiments, two groups (treated and control) of four Angus heifers (3-6 months old) were used. The inoculation was performed via intramuscular injection with 200 mu g of purified recombinant chimeric protein and adjuvated. The chimeric protein was recognized by specific antibodies against each subunit and by sera from cattle inoculated with the chimera. Immunization of RmLTI-BmCG-LTB cattle reduced the number of adult female ticks by 6.29% and vaccination of cattle with the chimeric antigen provided 55.6% efficacy against R. (B.) microplus infestation. The results of this study indicate that the novel chimeric protein is a potential candidate for the future development of a more effective vaccine against R. (B.) microplus.	[Csordas, Barbara Guimaraes] Univ Fed Mato Grosso do Sul, Fac Med, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, Mato Grosso Do, Brazil; [Cunha, Rodrigo Casquero; Leite, Fabio Leivas] Univ Fed Pelotas, Programa Posgrad Biotecnol, Pelotas, Rio Grande Do S, Brazil; [Garcia, Marcos Valeario] Fundacao Apoio Desenvolvimento Ensino Ciencia & T, Campo Grande, Mato Grosso Do, Brazil; [Garcia, Marcos Valeario; Andreotti, Renato] Embrapa Gado Corte, Dept Sanidade Anim, Lab Biol Mol Carrapato, Campo Grande, Mato Grosso Do, Brazil; [da Silva, Seargio Silva] Univ Fed Pelotas, Fac Med Vet, Lab Doencas Parasitarias, Pelotas, Rio Grande Do S, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Pelotas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Pelotas	Andreotti, R (corresponding author), Embrapa Gado Corte, Dept Sanidade Anim, Lab Biol Mol Carrapato, Campo Grande, Mato Grosso Do, Brazil.	renato.andreotti@embrapa.br	Cunha, Rodrigo Casquero/AFZ-3898-2022; andreotti, renato/W-9503-2019	Cunha, Rodrigo Casquero/0000-0003-0145-0321; Guimaraes Csordas, Barbara/0000-0002-4493-6359; Andreotti, Renato/0000-0002-0739-2997	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul	This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2010, BIOCHEM ENG J, V49, P379, DOI 10.1016/j.bej.2010.01.014; Andreotti R, 2002, INT IMMUNOPHARMACOL, V2, P557, DOI 10.1016/S1567-5769(01)00203-X; Andreotti R, 2001, J PROTEIN CHEM, V20, P337, DOI 10.1023/A:1012242817869; Andreotti Renato, 2006, Rev Bras Parasitol Vet, V15, P97; Andreotti R, 2008, REV BRAS PARASITOL V, V17, P93, DOI 10.1590/S1984-29612008000200006; Andreotti R, 2012, VACCINE, V30, P6678, DOI 10.1016/j.vaccine.2012.08.066; [Anonymous], 2006, VACCINE, V24, p[5734, 5743]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Cunha RC, 2012, REV BRAS PARASITOL V, V21, P254, DOI 10.1590/S1984-29612012000300014; Cunha RC, 2011, REV BRAS PARASITOL V, V20, P103, DOI 10.1590/S1984-29612011000200003; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Garcia-Garcia JC, 1999, EXP APPL ACAROL, V23, P883, DOI 10.1023/A:1006270615158; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gil LAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069692; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Jawale CV, 2014, CLIN VACCINE IMMUNOL, V21, P799, DOI 10.1128/CVI.00016-14; Kram KE, 2015, APPL ENVIRON MICROB, V81, P4442, DOI 10.1128/AEM.00722-15; Kumar B, 2016, METHODS MOL BIOL, V1404, P459, DOI 10.1007/978-1-4939-3389-1_30; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lessard JC, 2013, METHOD ENZYMOL, V533, P181, DOI 10.1016/B978-0-12-420067-8.00011-8; Maritz-Olivier C, 2012, TICKS TICK-BORNE DIS, V3, P179, DOI 10.1016/j.ttbdis.2012.01.003; Maruyama SR, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2136-2; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Pei XL, 2011, APPL BIOCHEM BIOTECH, V165, P416, DOI 10.1007/s12010-011-9261-8; Petermann J, 2017, EXP APPL ACAROL, V72, P303, DOI 10.1007/s10493-017-0156-4; Popara M, 2013, VACCINE, V31, P4728, DOI 10.1016/j.vaccine.2013.08.031; Rocha ADR, 2008, CAN J MICROBIOL, V54, P677, DOI [10.1139/W08-056, 10.1139/w08-056]; Aguirre ADR, 2016, VET PARASITOL, V221, P30, DOI 10.1016/j.vetpar.2016.02.032; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Sambrook J., 2001, MOL CLONING LAB MANU; Sugumar P, 2011, RES VET SCI, V90, P262, DOI 10.1016/j.rvsc.2010.05.037; TAMURA S, 1994, VACCINE, V12, P419, DOI 10.1016/0264-410X(94)90118-X; Tomazetto G, 2007, ENZYME MICROB TECH, V41, P821, DOI 10.1016/j.enzmictec.2007.07.006; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Vargas M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-43	38	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191596	10.1371/journal.pone.0191596	http://dx.doi.org/10.1371/journal.pone.0191596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415034	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300035
J	Hodova, I; Sonnek, R; Gelnar, M; Valigurova, A				Hodova, Iveta; Sonnek, Radim; Gelnar, Milan; Valigurova, Andrea			Architecture of Paradiplozoon homoion: A diplozoid monogenean exhibiting highly-eveloped equipment for ectoparasitism	PLOS ONE			English	Article							EUDIPLOZOON-NIPPONICUM MONOGENEA; SURFACE-STRUCTURES; MEGAN MONOGENEA; TELEOST FISH; PARASITE; ULTRASTRUCTURE; SCLERITES; SYSTEM; GILLS; IDENTIFICATION	Diplozoidae (Monogenea) are blood-feeding freshwater fish gill ectoparasites with extraordinary body architecture and a unique sexual behaviour in which two larval worms fuse and transform into one functioning individual. In this study, we describe the body organisation of Paradiplozoon homoion adult stage using a combined approach of confocal laser scanning and electron microscopy, with emphasis on the forebody and hindbody. Special attention is given to structures involved in functional adaptation to ectoparasitism, i.e. host searching, attachment and feeding/metabolism. Our observations indicate clear adaptations for blood sucking, with a well-innervated mouth opening surrounded by sensory structures, prominent muscular buccal suckers and a pharynx. The buccal cavity surface is covered with numerous tegumentary digitations that increase the area in contact with host tissue and, subsequently, with its blood. The buccal suckers and the well-innervated haptor (with sclerotised clamps controlled by noticeable musculature) cooperate in attaching to and moving over the host. Putative gland cells accumulate in the region of apical circular structures, pharynx area and in the haptor middle region. Paired club-shaped sacs lying laterally to the pharynx might serve as secretory reservoirs. Furthermore, we were able to visualise the body wall musculature, including peripheral innervation, the distribution of uniciliated sensory structures essential for reception of external environmental information, and flame cells involved in excretion. Our results confirm in detail that P. homoion displays a range of sophisticated adaptations to an ectoparasitic life style, characteristic for diplozoid monogeneans.	[Hodova, Iveta; Sonnek, Radim; Gelnar, Milan; Valigurova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic	Masaryk University Brno	Hodova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic.	hodova@sci.muni.cz	Valigurová, Andrea/B-4522-2012	Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation (ECIP - European Centre of lchthyoparasitology) [P505/12/G112]; Department of Botany and Zoology of the Faculty of Science at Masaryk University; ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation [P505/12/G112]	Czech Science Foundation (ECIP - European Centre of lchthyoparasitology); Department of Botany and Zoology of the Faculty of Science at Masaryk University; ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation	We acknowledge the financial support from Czech Science Foundation Project No. P505/12/G112 (ECIP - European Centre of lchthyoparasitology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors acknowledge support from the Department of Botany and Zoology of the Faculty of Science at Masaryk University towards the preparation of this manuscript.; The study was financially supported by ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation Project No. P505/12/G112. All authors acknowledge support from the Department of Botany and Zoology of the Faculty of Science at Masaryk University towards the preparation of this manuscript.	Arafa SZ, 2003, ACTA PARASITOL, V48, P163; Avenant-Oldewage A, 2014, ACTA PARASITOL, V59, P247, DOI 10.2478/s11686-014-0235-1; Bombarova M, 2014, PARASITOL RES, V113, P4111, DOI 10.1007/s00436-014-4082-7; BOVET J, 1967, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V90, P63; Buchmann K, 2002, INT J PARASITOL, V32, P309, DOI 10.1016/S0020-7519(01)00332-0; Civanova K, 2013, PARASITOL RES, V112, P3053, DOI 10.1007/s00436-013-3480-6; Cohen SC, 2001, MEM I OSWALDO CRUZ, V96, P555, DOI 10.1590/S0074-02762001000400019; Collins JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001009; Cooper GM, 2000, CELL MOL APPROACH; Dos Santos QM, 2015, J PARASITOL, V101, P94, DOI 10.1645/14-521.1; DUOBINISGRAY LF, 1985, P HELM SOC WASH, V52, P175; ELNAGGAR MM, 1991, INT J PARASITOL, V21, P707, DOI 10.1016/0020-7519(91)90083-J; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gilbert BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177558; Goto S., 1891, J COLL SCI IMP U TOK, V4, P151; Halton DW, 1998, INT J PARASITOL, V28, P1609, DOI 10.1016/S0020-7519(98)00063-0; HALTON DW, 1979, Z PARASITENKD, V61, P1, DOI 10.1007/BF00927082; Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001; HIROSE H, 1987, NIPPON SUISAN GAKK, V53, P953, DOI 10.2331/suisan.53.953; Hodova I, 2010, CENT EUR J BIOL, V5, P702, DOI 10.2478/s11535-010-0040-2; Ilgova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17598-2; Jedlickova L, 2016, PARASITOLOGY, V143, P494, DOI 10.1017/S0031182015001808; Kamegai S, 1966, MONTH REP MEGURO PAR, V83-84, P1; Kearn G. C., 1998, PARASITISM PLATYHELM; Khotenovsky IA, 1985, FAUNA USSR MONOGENEA; Konstanzova V, 2016, PARASITOL RES, V115, P1493, DOI 10.1007/s00436-015-4882-4; Konstanzova V, 2015, PARASITOL RES, V114, P1485, DOI 10.1007/s00436-015-4331-4; Konstanzova V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2203-8; Koskova E, 2011, PARASITOL RES, V108, P935, DOI 10.1007/s00436-010-2135-0; Koskova E, 2010, PARASITOL RES, V107, P909, DOI 10.1007/s00436-010-1949-0; LANE NJ, 1988, TISSUE CELL, V20, P211, DOI 10.1016/0040-8166(88)90042-0; Lyons K.M., 1973, Advances Parasit, V11, P193, DOI 10.1016/S0065-308X(08)60187-6; LYONS KM, 1969, PARASITOLOGY, V59, P611, DOI 10.1017/S0031182000031152; Mair GR, 1998, PARASITOL TODAY, V14, P73, DOI 10.1016/S0169-4758(97)01182-4; Matejusova I, 2004, J PARASITOL, V90, P817, DOI 10.1645/GE-138R; Matejusova I, 2002, SYST PARASITOL, V53, P39, DOI 10.1023/A:1019945921143; Matejusova I, 2001, PARASITOLOGY, V123, P465, DOI 10.1017/S0031182001008617; Milne SJ, 2006, ONDERSTEPOORT J VET, V73, P149; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Nordmann A., 1832, ACAD BERLIN, V2, P57; Pecinkova M, 2007, J FISH BIOL, V71, P1358, DOI 10.1111/j.1095-8649.2007.01599.x; Pecinkova M, 2007, J ZOOL, V272, P406, DOI 10.1111/j.1469-7998.2006.00284.x; Pecinkova M, 2005, DIS AQUAT ORGAN, V64, P63, DOI 10.3354/dao064063; Pecinkova M, 2007, PARASITOL INT, V56, P179, DOI 10.1016/j.parint.2007.01.010; Poddubnaya LG, 2012, SYST PARASITOL, V82, P89, DOI 10.1007/s11230-012-9359-6; POULIN R, 1998, EVOLUTIONARY ECOLOGY; RAMASAMY P, 1995, INT J PARASITOL, V25, P43, DOI 10.1016/0020-7519(94)E0039-P; RAMASAMY P, 1987, INT J PARASITOL, V17, P1187, DOI 10.1016/0020-7519(87)90171-8; Ramasamy P, 2000, PARASITOL RES, V86, P129, DOI 10.1007/s004360050022; Schabussova I, 2004, J HELMINTHOL, V78, P63, DOI 10.1079/JOH2003212; Schabussova I, 2003, HELMINTHOLOGIA, V40, P135; Smyth J.D., 1983, PHYSL TREMATODES; Sterba G., 1957, Zoologischer Anzeiger, V158, P181; Valigurova A, 2011, PARASITOL RES, V108, P383, DOI 10.1007/s00436-010-2077-6; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; WILSON RA, 1974, BIOL REV, V49, P127, DOI 10.1111/j.1469-185X.1974.tb01572.x; Zeller E., 1872, Z WISS ZOOL, V22, P168; Zurawski TH, 2003, PARASITOLOGY, V126, P349, DOI 10.1017/S0031182002002871; Zurawski TH, 2003, J PARASITOL, V89, P198, DOI 10.1645/0022-3395(2003)089[0198:MEONCB]2.0.CO;2; Zurawski TH, 2001, INT J PARASITOL, V31, P783, DOI 10.1016/S0020-7519(01)00192-8	60	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192285	10.1371/journal.pone.0192285	http://dx.doi.org/10.1371/journal.pone.0192285			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414983	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300066
J	Wood, S; Krishnamurthy, N; Santini, T; Raval, SB; Farhat, N; Holmes, JA; Ibrahim, TS				Wood, Sossena; Krishnamurthy, Narayanan; Santini, Tales; Raval, Shailesh B.; Farhat, Nadim; Holmes, John Andy; Ibrahim, Tamer S.			Design and fabrication of a realistic anthropomorphic heterogeneous head phantom for MR purposes (vol 12, e0183168, 2017)	PLOS ONE			English	Correction									[Raval, Shailesh B.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NIBIB NIH HHS [F31 EB019872] Funding Source: Medline	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Wood S, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0183168, 10.1371/journal.pone.0186060]	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192794	10.1371/journal.pone.0192794	http://dx.doi.org/10.1371/journal.pone.0192794			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415085	Green Submitted, gold, Green Published			2022-12-27	WOS:000424325300094
J	Bradford, JR; Cox, A; Bernard, P; Camp, NJ				Bradford, James R.; Cox, Angela; Bernard, Philip; Camp, Nicola J.			Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment (vol 19, e0163238, 2016)	PLOS ONE			English	Correction																		Bradford JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163238	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192589	10.1371/journal.pone.0192589	http://dx.doi.org/10.1371/journal.pone.0192589			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408913	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800083
J	Jenkins, AR; Reid, T; du Plessis, J; Colyn, R; Benn, G; Millikin, R				Jenkins, Andrew R.; Reid, Tim; du Plessis, Johan; Colyn, Robin; Benn, Grant; Millikin, Rhonda			Combining radar and direct observation to estimate pelican collision risk at a proposed wind farm on the Cape west coast, South Africa	PLOS ONE			English	Article							BIRD MORTALITY; BEHAVIOR; AVOIDANCE; IMPACTS	Pre-construction assessments of bird collision risk at proposed wind farms are often confounded by insufficient or poor quality data describing avian flight paths through the development area. These limitations can compromise the practical value of wind farm impact studies. We used radar- and observer-based methods to quantify great white pelican flights in the vicinity of a planned wind farm on the Cape west coast, South Africa, and modelled turbine collision risk under various scenarios. Model outputs were combined with pre-existing demographic data to evaluate the possible influence of the wind farm on the pelican population, and to examine impact mitigation options. We recorded high volumes of great white pelican movement through the wind farm area, coincident with the breeding cycle of the nearby colony and associated with flights to feeding areas located about 50 km away. Pelicans were exposed to collision risk at a mean rate of 2.02 High Risk flights.h(-1). Risk was confined to daylight hours, highest during the middle of the day and in conditions of strong north-westerly winds, and 82% of High Risk flights were focused on only five of the proposed 35 turbine placements. Predicted mean mortality rates (22 fatalities.yr(-1)(1, 95% CI, 16-29, with average bird and blade speeds and 95% avoidance rates) were not sustainable, resulting in a negative population growth rate (lambda = 0.991). Models suggested that removal of the five highest risk turbines from the project, or institution of a curtailment regimen that shuts down at least these turbines at peak traffic times, could theoretically reduce impacts to manageable levels. However, in spite of the large quantities of high quality data used in our analyses, our collision risk model remains compromised by untested assumptions about pelican avoidance rates and uncertainties about the existing dynamics of the pelican population, and our findings are probably not reliable enough to ensure sustainable development.	[Jenkins, Andrew R.; du Plessis, Johan] AVISENSE Consulting, Cape Town, Western Cape, South Africa; [Jenkins, Andrew R.; Reid, Tim] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, Cape Town, Western Cape, South Africa; [du Plessis, Johan; Colyn, Robin] NCC Environm Serv, Cape Town, Western Cape, South Africa; [Benn, Grant] Geocline Consulting, Cape Town, Western Cape, South Africa; [Millikin, Rhonda] EchoTrack Inc, Ottawa, ON, Canada; [Colyn, Robin] Birdlife South Africa, Johannesburg, Gauteng, South Africa	National Research Foundation - South Africa; University of Cape Town	Jenkins, AR (corresponding author), AVISENSE Consulting, Cape Town, Western Cape, South Africa.; Jenkins, AR (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, Cape Town, Western Cape, South Africa.	andrew@avisense.co.za			AVISENSE; NCC Environmental Services; Geocline Consulting; EchoTrack Inc.	AVISENSE; NCC Environmental Services; Geocline Consulting; EchoTrack Inc.	This study was conducted under contract to the developer of the proposed wind farm Moyeng Energy (Pty) Ltd. The developer funded all cost aspects of the project, and all the contributing authors were remunerated for the various roles they played in completing the work. However, it must be stressed that Moyeng Energy did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AJ and JdP received funding in the form of salaries from AVISENSE. JdP received funding in the form of salary from NCC Environmental Services. GB received funding in the form of salary from Geocline Consulting. RM received funding in the form of salary from EchoTrack Inc. The specific roles of each contributing author are articulated in the 'author contributions' section.	Band W., 2007, P259; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Beason RC, 2010, J ZOOL, V282, P157, DOI 10.1111/j.1469-7998.2010.00723.x; Bellebaum J, 2013, J NAT CONSERV, V21, P394, DOI 10.1016/j.jnc.2013.06.001; Bolker B, 2008, ECOLOGICAL MODELS DA; Breiman L., 1993, CLASSIFICATION REGRE; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Caswell H, 1989, MATRIX POPULATION MO; Crawford R. J. M., 2005, ROBERTS BIRDS SO AFR, P614; CRAWFORD RJM, 1995, S AFR J MARINE SCI, V15, P33; Crawford RJM, 2013, OSTRICH, V84, P5; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; de Ponte Machado M., 2010, THESIS; Dokter AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074129; Douglas DJT, 2012, IBIS, V154, P858, DOI 10.1111/j.1474-919X.2012.01239.x; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Ferrer M, J APPL ECOLOGY; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Hull CL, 2013, WILDLIFE SOC B, V37, P49, DOI 10.1002/wsb.254; Jenkins AR, 2015, BEST PRACTICE GUIDEL; KERLINGER P, 1985, AUK, V102, P735; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Masden EA, 2016, ENVIRON IMPACT ASSES, V56, P43, DOI 10.1016/j.eiar.2015.09.001; May RF, 2015, BIOL CONSERV, V190, P179, DOI 10.1016/j.biocon.2015.06.004; Meesters HWG, 2007, ANAL ECOLOGICAL DATA; Mentis D, 2015, RENEW ENERG, V83, P110, DOI 10.1016/j.renene.2015.03.072; Millikin RL, 2001, INT GEOSCI REMOTE SE, P2010, DOI 10.1109/IGARSS.2001.977886; Millikin RL, 2002, THESIS; Mwema Martin M., 2010, Endangered Species Research, V9, P125, DOI 10.3354/esr00243; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosa IMD, 2016, IBIS, V158, P28, DOI 10.1111/ibi.12333; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; SNH, 2014, GUID REC BIRD SURV M; Strickland M.D., 2011, COMPREHENSIVE GUIDE; Taylor M. R., 2015, RED DATA BOOK TAJIKI; Wang SF, 2015, RENEW SUST ENERG REV, V44, P599, DOI 10.1016/j.rser.2015.01.031	37	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192515	10.1371/journal.pone.0192515	http://dx.doi.org/10.1371/journal.pone.0192515			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408877	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800077
J	Wu, JL; Lee, CH; Yang, CT; Chang, CM; Li, GA; Cheng, CK; Chen, CH; Huang, HS; Lai, YS				Wu, Jia-Lin; Lee, Chian-Her; Yang, Chan-Tsung; Chang, Chia-Ming; Li, Guoan; Cheng, Cheng-Kung; Chen, Chih-Hwa; Huang, Hsu-Shan; Lai, Yu-Shu			Novel technique for repairing posterior medial meniscus root tears using porcine knees and biomechanical study	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PULL-OUT REPAIR; RADIAL TEARS; FOLLOW-UP; SPONTANEOUS OSTEONECROSIS; REFIXATION TECHNIQUE; PROGNOSTIC-FACTORS; AVULSION FRACTURE; CONTACT MECHANICS; HORN AVULSION	Transtibial pullout suture (TPS) repair of posterior medial meniscus root (PMMR) tears was shown to achieve good clinical outcomes. The purpose of this study was to compare biomechanically, a novel technique designed to repair PMMR tears using tendon graft (TG) and conventional TPS repair. Twelve porcine tibiae (n = 6 each) TG group: flexor digitorum profundus tendon was passed through an incision in the root area, created 5 mm postero-medially along the edge of the attachment area. TPS group: a modified Mason-Allen suture was created using no. 2 FiberWire. The tendon grafts and sutures were threaded through the bone tunnel and then fixed to the anterolateral cortex of the tibia. The two groups underwent cyclic loading followed by a load-to-failure test. Displacements of the constructs after 100, 500, and 1000 loading cycles, and the maximum load, stiffness, and elongation at failure were recorded. The TG technique had significantly lower elongation and higher stiffness compared with the TPS. The maximum load of the TG group was significantly lower than that of the TPS group. Failure modes for all specimens were caused by the suture or graft cutting through the meniscus. Lesser elongation and higher stiffness of the constructs in TG technique over those in the standard TPS technique might be beneficial for postoperative biological healing between the meniscus and tibial plateau. However, a slower rehabilitation program might be necessary due to its relatively lower maximum failure load.	[Wu, Jia-Lin; Lee, Chian-Her; Chen, Chih-Hwa] Taipei Med Univ, Coll Med, Sch Med, Dept Orthoped & Traumatol, Taipei, Taiwan; [Wu, Jia-Lin; Lee, Chian-Her; Chen, Chih-Hwa] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Yang, Chan-Tsung; Cheng, Cheng-Kung; Lai, Yu-Shu] Natl Yang Ming Univ, Orthopaed Devices Res Ctr, Taipei, Taiwan; [Chang, Chia-Ming; Cheng, Cheng-Kung] Natl Yang Ming Univ, Inst Biomed Engn, Taipei, Taiwan; [Li, Guoan] Massachusetts Gen Hosp, Dept Orthoped Surg, Bioengn Lab, Boston, MA 02114 USA; [Li, Guoan] Harvard Med Sch, Boston, MA USA; [Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Taipei Medical University	Lai, YS (corresponding author), Natl Yang Ming Univ, Orthopaed Devices Res Ctr, Taipei, Taiwan.; Huang, HS (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.	huanghs99@tmu.edu.tw; uesu@ortho.ym.edu.tw		Chang, Chia-Ming/0000-0002-6073-8272; Wu, Jia-Lin/0000-0002-2843-405X; Huang, Hsu-Shan/0000-0001-8162-5608	Taipei Medical University [TMU103-AE-1-637, 106TMU-TMUH-16, TMU105-AE-1-1329, A-106-001]; Ministry of Science and Technology [105-2113-M-038-001]	Taipei Medical University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by Taipei Medical University (TMU103-AE-1-637 and 106TMU-TMUH-16) to Jia-Lin Wu; Ministry of Science and Technology (105-2113-M-038-001) to Hsu-Shan Huang; and Taipei Medical University (TMU105-AE-1-1329, and A-106-001) to Hsu-Shan Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Alhalki MM, 1999, AM J SPORT MED, V27, P320, DOI 10.1177/03635465990270030901; Allaire R, 2008, J BONE JOINT SURG AM, V90A, P1922, DOI 10.2106/JBJS.G.00748; Bin SI, 2004, ARTHROSCOPY, V20, P373, DOI 10.1016/j.arthro.2004.01.004; Burks RT, 1997, ARTHROSCOPY, V13, P673, DOI 10.1016/S0749-8063(97)90000-1; Chen MI, 1996, ARTHROSCOPY, V12, P174, DOI 10.1016/S0749-8063(96)90007-9; Cho JH, 2012, J ORTHOP SCI, V17, P98, DOI 10.1007/s00776-011-0078-7; Choi SH, 2012, KNEE SURG SPORT TR A, V20, P2094, DOI 10.1007/s00167-011-1794-4; Chung KS, 2016, ARTHROSCOPY, V32, P1319, DOI 10.1016/j.arthro.2015.12.046; Chung KS, 2016, KNEE SURG SPORT TR A, V24, P1455, DOI 10.1007/s00167-015-3832-0; Donahue TLH, 2001, J BIOMECH ENG-T ASME, V123, P162, DOI 10.1115/1.1351889; Donahue TLH, 2003, J BIOMECH, V36, P19, DOI 10.1016/S0021-9290(02)00305-6; Feucht MJ, 2015, ARTHROSCOPY, V31, P1808, DOI 10.1016/j.arthro.2015.03.022; Feucht MJ, 2015, KNEE SURG SPORT TR A, V23, P132, DOI 10.1007/s00167-013-2656-z; Feucht MJ, 2014, AM J SPORT MED, V42, P187, DOI 10.1177/0363546513502946; Feucht MJ, 2013, AM J SPORT MED, V41, P2784, DOI 10.1177/0363546513502464; Griffith CJ, 2008, AM J SPORT MED, V36, P789, DOI 10.1177/0363546507308195; Han SB, 2010, ARTHROSCOPY, V26, P1326, DOI 10.1016/j.arthro.2010.01.032; Herbort M, 2010, AM J SPORT MED, V38, P2281, DOI 10.1177/0363546510382847; Hong Jang-Hee, 2011, Knee Surg Relat Res, V23, P164, DOI 10.5792/ksrr.2011.23.3.164; Johannsen AM, 2012, AM J SPORT MED, V40, P2342, DOI 10.1177/0363546512457642; Kim JH, 2011, ARTHROSCOPY, V27, P1644, DOI 10.1016/j.arthro.2011.06.033; Kim JG, 2013, KNEE SURG SPORT TR A, V21, P2121, DOI 10.1007/s00167-012-2182-4; Kim YM, 2013, KNEE SURG SPORT TR A, V21, P1546, DOI 10.1007/s00167-012-2131-2; Krych AJ, 2017, KNEE SURG SPORT TR A, V25, P383, DOI 10.1007/s00167-016-4359-8; LaPrade CM, 2015, AM J SPORT MED, V43, P899, DOI 10.1177/0363546514563278; LaPrade CM, 2015, AM J SPORT MED, V43, P912, DOI 10.1177/0363546514566191; LaPrade RF, 2017, AM J SPORT MED, V45, P884, DOI 10.1177/0363546516673996; Lavender CD, 2015, ARTHROSC TEC, V4, pE781, DOI 10.1016/j.eats.2015.07.028; Lee CK, 2011, KNEE SURG SPORT TR A, V19, P165, DOI 10.1007/s00167-010-1060-1; Lee Dhong Won, 2014, Knee Surg Relat Res, V26, P125, DOI 10.5792/ksrr.2014.26.3.125; Lee DW, 2013, KNEE SURG SPORT TR A, V21, P654, DOI 10.1007/s00167-012-1992-8; Lee JH, 2009, ARTHROSCOPY, V25, P951, DOI 10.1016/j.arthro.2009.03.018; Lee YHD, 2013, AM J SPORT MED, V41, P1074, DOI 10.1177/0363546513479775; Marzo JM, 2009, J AM ACAD ORTHOP SUR, V17, P276, DOI 10.5435/00124635-200905000-00002; Marzo JM, 2009, AM J SPORT MED, V37, P124, DOI 10.1177/0363546508323254; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Miyata K, 2000, J Orthop Sci, V5, P585; Moon HK, 2012, AM J SPORT MED, V40, P1138, DOI 10.1177/0363546511435622; Ozeki N, 2015, STEM CELLS, V33, P1927, DOI 10.1002/stem.2030; Ozeki N, 2013, ARTHRITIS RHEUM-US, V65, P2876, DOI 10.1002/art.38099; Ozkoc G, 2008, KNEE SURG SPORT TR A, V16, P849, DOI 10.1007/s00167-008-0569-z; PAGNANI M J, 1991, Arthroscopy, V7, P297, DOI 10.1016/0749-8063(91)90131-G; Poulsen MR, 2011, PHYSICIAN SPORTSMED, V39, P123, DOI 10.3810/psm.2011.02.1870; Raustol OA, 2006, ARTHROSCOPY, V22, DOI 10.1016/j.arthro.2005.12.022; Robertson DD, 2009, J BONE JOINT SURG BR, V91B, P190, DOI 10.1302/0301-620X.91B2.21097; Ropke EF, 2015, KNEE SURG SPORT TR A, V23, P45, DOI 10.1007/s00167-013-2589-6; Rosslenbroich SB, 2013, ARCH ORTHOP TRAUM SU, V133, P111, DOI 10.1007/s00402-012-1625-1; Seo HS, 2011, AM J SPORT MED, V39, P99, DOI 10.1177/0363546510382225; Seo JH, 2009, ARTHROSCOPY, V25, P1281, DOI 10.1016/j.arthro.2009.05.014; Smith GN, 2002, OSTEOARTHR CARTILAGE, V10, P321, DOI 10.1053/joca.2002.0520; Starke C, 2010, ARTHROSCOPY, V26, P358, DOI 10.1016/j.arthro.2009.08.013; Steineman BD, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702452; STOLLER NH, 1990, J PERIODONTOL, V61, P306; Sung JH, 2013, ARTHROSCOPY, V29, P726, DOI 10.1016/j.arthro.2012.11.016; Thompson SM, 2016, AM J SPORT MED, V44, P3083, DOI 10.1177/0363546516658041; Villegas DF, 2008, ANN BIOMED ENG, V36, P123, DOI 10.1007/s10439-007-9403-x; Villegas DF, 2007, J BIOMECH, V40, P2655, DOI 10.1016/j.jbiomech.2007.01.015; Xerogeanes JW, 1998, ANN BIOMED ENG, V26, P345, DOI 10.1114/1.91	59	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192027	10.1371/journal.pone.0192027	http://dx.doi.org/10.1371/journal.pone.0192027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408892	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800040
J	Denet, E; Vasselon, V; Burdin, B; Nazaret, S; Favre-Bonte, S				Denet, Elodie; Vasselon, Valentin; Burdin, Beatrice; Nazaret, Sylvie; Favre-Bonte, Sabine			Survival and growth of Stenotrophomonas maltophilia in free-living amoebae (FLA) and bacterial virulence properties	PLOS ONE			English	Article							EFFLUX PUMP SMEDEF; MOLECULAR CHARACTERIZATION; VERMAMOEBA-VERMIFORMIS; LEGIONELLA-PNEUMOPHILA; WATER; RESISTANCE; STRAINS; INFECTION; DISEASE; BIOREMEDIATION	Stenotrophomonas maltophilia is found ubiquitously in the environment and is an important emerging nosocomial pathogen. S. maltophilia has been recently described as an Amoebae-Resistant Bacteria (ARB) that exists as part of the microbiome of various free-living amoebae (FLA) from waters. Co-culture approaches with Vermamoeba vermiformis demonstrated the ability of this bacterium to resist amoebal digestion. In the present study, we assessed the survival and growth of six environmental and one clinical S. maltophilia strains within two amoebal species: Acanthamoeba castellanii and Willaertia magna. We also evaluated bacterial virulence properties using the social amoeba Dictyostelium discoideum. A co-culture approach was carried out over 96 hours and the abundance of S. maltophilia cells was measured using quantitative PCR and culture approach. The presence of bacteria inside the amoeba was confirmed using confocal microscopy. Our results showed that some S. maltophilia strains were able to multiply within both amoebae and exhibited multiplication rates up to 17.5 and 1166 for A. castellanii and W. magna, respectively. In contrast, some strains were unable to multiply in either amoeba. Out of the six environmental S. maltophilia strains tested, one was found to be virulent. Surprisingly, this strain previously isolated from a soil amoeba, Micriamoeba, was unable to infect both amoebal species tested. We further performed an assay with a mutant strain of S. maltophilia BurA1 lacking the efflux pump ebyCAB gene and found the mutant to be more virulent and more efficient for intra-amoebal multiplication. Overall, the results obtained strongly indicated that free-living amoebae could be an important ecological niche for S. maltophilia.	[Denet, Elodie; Vasselon, Valentin; Nazaret, Sylvie; Favre-Bonte, Sabine] Univ Lyon 1, UMR CNRS 5557, UMR INRA 1418 Ecol Microbienne, Villeurbanne, France; [Burdin, Beatrice] Univ Lyon 1, Ctr Technol Microstruct, Villeurbanne, France; [Vasselon, Valentin] INRA, Ctr Alpin Rech Reseaux Troph & Ecosyst Limn, Thonon Les Bains, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Denet, E (corresponding author), Univ Lyon 1, UMR CNRS 5557, UMR INRA 1418 Ecol Microbienne, Villeurbanne, France.	elodie.denet@live.fr	Vasselon, Valentin/Q-7670-2019; Vasselon, Valentin/X-8504-2018	Vasselon, Valentin/0000-0001-5038-7918; Vasselon, Valentin/0000-0001-5038-7918	Centre National de la Recherche Scientifique; FR BioEnviS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); FR BioEnviS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	The work was supported by "Centre National de la Recherche Scientifique" in order to perform experiments, and by a research program of the FR BioEnviS. E. Denet, phD Student was supported by the "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche.	Adamek M, 2014, MICROB PATHOGENESIS, V67-68, P20, DOI 10.1016/j.micpath.2014.02.001; Adamek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027615; Albini S, 2009, SCHWEIZ ARCH TIERH, V151, P323, DOI 10.1024/0036-7281.151.7.323; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 2001, ANTIMICROB AGENTS CH, V45, P1879, DOI 10.1128/AAC.45.6.1879-1881.2001; Antonioli P, 2007, APPL ENVIRON MICROB, V73, P6854, DOI 10.1128/AEM.00957-07; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Cateau E, 2014, RES MICROBIOL, V165, P847, DOI 10.1016/j.resmic.2014.10.004; Chen SN, 2013, CHEMOSPHERE, V90, P1811, DOI 10.1016/j.chemosphere.2012.09.009; Corsaro D, 2013, EXP PARASITOL, V133, P383, DOI 10.1016/j.exppara.2012.12.016; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047; Denet E, 2017, PARASITOL RES, V116, P3151, DOI 10.1007/s00436-017-5632-6; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; Dubey KK, 2012, WORLD J MICROB BIOT, V28, P1715, DOI 10.1007/s11274-011-0982-1; Dungan RS, 2003, ENVIRON MICROBIOL, V5, P287, DOI 10.1046/j.1462-2920.2003.00410.x; Dupuy M, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw022; Evstigneeva A, 2009, MICROBIOL-SGM, V155, P657, DOI 10.1099/mic.0.022970-0; Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guimaraes AJ, 2016, MICROBIOL RES, V193, P30, DOI 10.1016/j.micres.2016.08.001; Hassanshahian M, 2013, MAR POLLUT BULL, V73, P300, DOI 10.1016/j.marpolbul.2013.05.002; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P4067, DOI 10.1128/AAC.00372-15; Loret JF, 2010, INT J HYG ENVIR HEAL, V213, P167, DOI 10.1016/j.ijheh.2010.03.004; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Ohnishi M, 2012, LETT APPL MICROBIOL, V54, P572, DOI 10.1111/j.1472-765X.2012.03246.x; Pagnier I, 2015, MICROB PATHOGENESIS, V80, P14, DOI 10.1016/j.micpath.2015.02.006; Patrizia M, 2013, ARCH MICROBIOL, V195, P89, DOI 10.1007/s00203-012-0851-9; Peralta KD, 2012, WORLD J MICROB BIOT, V28, P2003, DOI 10.1007/s11274-012-1003-8; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P2084, DOI 10.1128/AAC.05509-11; Pinot C, 2011, J APPL MICROBIOL, V111, P1185, DOI 10.1111/j.1365-2672.2011.05120.x; Romanenko LA, 2008, ARCH MICROBIOL, V189, P337, DOI 10.1007/s00203-007-0324-8; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Siddiqui R, 2011, EXP PARASITOL, V128, P409, DOI 10.1016/j.exppara.2011.05.008; Somaraja PK, 2013, B ENVIRON CONTAM TOX, V91, P148, DOI 10.1007/s00128-013-1044-1; Steinert M, 2011, SEMIN CELL DEV BIOL, V22, P70, DOI 10.1016/j.semcdb.2010.11.003; Tacao M, 2015, MICROB DRUG RESIST, V21, P497, DOI 10.1089/mdr.2015.0072; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Winther L, 2010, VET J, V186, P358, DOI 10.1016/j.tvjl.2009.08.026; Youenou B, 2015, GENOME BIOL EVOL, V7, P2484, DOI 10.1093/gbe/evv161; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192308	10.1371/journal.pone.0192308	http://dx.doi.org/10.1371/journal.pone.0192308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401523	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400046
J	Duque, V; Pilkauskas, NV; Garfinkel, I				Duque, Valentina; Pilkauskas, Natasha V.; Garfinkel, Irwin			Assets among low-income families in the Great Recession	PLOS ONE			English	Article							HOUSING INSTABILITY; WEALTH-ACCUMULATION; FRAGILE FAMILIES; MARRIAGE; HEALTH; ACHIEVEMENT; DISPARITIES; OWNERSHIP; TRANSFERS; POVERTY	This paper examines the association between the Great Recession and real assets among families with young children. Real assets such as homes and cars are key indicators of economic well-being that may be especially valuable to low-income families. Using longitudinal data from the Fragile Families and Child Wellbeing Study (N = 4,898), we investigate the association between the city unemployment rate and home and car ownership and how the relationship varies by family structure (married, cohabiting, and single parents) and by race/ethnicity (White, Black, and Hispanic mothers). Using mother fixed-effects models, we find that a one percentage point increase in the unemployment rate is associated with a -0.5 percentage point decline in the probability of home ownership and a -0.7 percentage point decline in the probability of car ownership. We also find that the recession was associated with lower levels of home ownership for cohabiting families and for Hispanic families, as well as lower car ownership among single mothers and among Black mothers, whereas no change was observed among married families or White households. Considering that homes and cars are the most important assets among middle and low-income households in the U.S., these results suggest that the rise in the unemployment rate during the Great Recession may have increased household asset inequality across family structures and race/ethnicities, limiting economic mobility, and exacerbating the cycle of poverty.	[Duque, Valentina] Univ Michigan, Ctr Populat Studies, Ann Arbor, MI USA; [Duque, Valentina] Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA; [Pilkauskas, Natasha V.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Garfinkel, Irwin] Columbia Univ, Sch Social Work, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University	Pilkauskas, NV (corresponding author), Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA.	npilkaus@umich.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD066054, R01HD036916, P2CHD058486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036916, P2CHD058486] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development Award Numbers R01HD066054 (to IG), R01HD036916 (to IG), and P2CHD058486 (to IG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altonji JG, 2005, J HUM RESOUR, V40, P1; [Anonymous], 2013, YOUNG ADULTS RECESSI, P21; [Anonymous], 2010, RECENT TRENDS HOUSEH; [Anonymous], 2010, SOCIAL EC NETWORKS; Baum CL, 2009, J URBAN ECON, V66, P151, DOI 10.1016/j.jue.2009.06.003; Becker G., 1991, TREATISE FAMILY ENLA; Bernanke B. S., 2011, 47 ANN C BANK STRUCT; Beverly S., 2008, ASSET BUILDING LOW I, P89; Bitler M, 2016, J LABOR ECON, V34, pS403, DOI 10.1086/683096; Blank R, 2009, INSUFFICIENT FUNDS S; BLAU FD, 1990, Q J ECON, V105, P321, DOI 10.2307/2937789; Blumenberg E, 2004, J AM PLANN ASSOC, V70, P269, DOI 10.1080/01944360408976378; Blumenberg E., 2016, ACCESS MAGAZINE, V1; Bocian D.G., 2010, CTR RESPONSIBLE LEND, P4; Boehm TP, 2008, CITYSCAPE, V10, P225; Bosworth B., 2012, EC CONSEQUENCES GREA; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bricker J., 2011, DROWNING WEATHERING; Brown J. R., 2014, FINANCIAL CRISIS GRE; Browning M, 1996, J ECON LIT, V34, P1797; Cameron A, 2006, ROBUST INFERENCE MUL, V327; Chakrabarti R, 2013, HOUSEHOLD DEBT SAVIN, P273; Conger RD, 1994, FAMILIES TROUBLED TI; Currie J, 2015, EC J, V125; Desmond M, 2016, SOC PROBL, V63, P46, DOI 10.1093/socpro/spv025; Desmond matthew, 2016, EVICTED POVERTY PROF; Domhoff G. W., 2011, WHO RULES AM WEALTH; Elder GH, 1998, CHILD DEV, V69, P1, DOI 10.2307/1132065; Emmons William R., 2012, REGIONAL EC; Flippen CA, 2001, SOCIOL QUART, V42, P121, DOI 10.1111/j.1533-8525.2001.tb00028.x; Garfinkel I., 2016, CHILDREN GREAT RECES; Garfinkel Irwin, 1986, SINGLE MOTHERS THEIR; Gascon CS, 2017, HOMEOWNERSHIP EXPERI; Golub B, 2012, Q J ECON, V127, P1287, DOI 10.1093/qje/qjs021; Gottlieb A, 2014, J MARRIAGE FAM, V76, P1011, DOI 10.1111/jomf.12134; Grinstein-Weiss M, 2015, HOUS POLICY DEBATE, V25, P419, DOI 10.1080/10511482.2014.971042; Grusky DB, 2011, GREAT RECESSION, P1; Haurin DR, 2002, IMPACT HOMEOWNERSHIP; Haveman R., 1994, SUCCEEDING GENERATIO; Hellevik O, 2009, QUAL QUANT, V43, P59, DOI 10.1007/s11135-007-9077-3; Hendey L., 2012, WEATHERING RECESSION; Herbert CE, 2008, CITYSCAPE, V10, P5; Hoynes H, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.3.27; Hoynes HW, 2006, J ECON PERSPECT, V20, P47, DOI 10.1257/089533006776526102; Hummer RA, 2010, FUTURE CHILD, V20, P113, DOI 10.1353/foc.2010.0003; Kennickell Arthur B., 2017, Statistical Journal of the IAOS, V33, P175, DOI 10.3233/SJI-160297; Kennickell Arthur B., 2017, Statistical Journal of the IAOS, V33, P185, DOI 10.3233/SJI-160298; LAM D, 1988, J HUM RESOUR, V23, P462, DOI 10.2307/145809; Lamas EJ, 1986, HOUSEHOLD EC STUDIES, P1; Lillard LA, 1997, J BUS ECON STAT, V15, P254, DOI 10.2307/1392309; Lupton JP., 2003, MARRIAGE EC THEORY E, P129, DOI DOI 10.1017/CBO9780511615863.008; Manning WD, 2001, FAM PLANN PERSPECT, V33, P217, DOI 10.2307/2673785; Manning WD, 1996, J MARRIAGE FAM, V58, P998, DOI 10.2307/353986; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; McKernan S., 2009, DO ASSETS HELP FAMIL; McKernan SM, 2014, AM ECON REV, V104, P240, DOI 10.1257/aer.104.5.240; McLanahan S, 2004, DEMOGRAPHY, V41, P607, DOI 10.1353/dem.2004.0033; MCLANAHAN S, 1989, J MARRIAGE FAM, V51, P557, DOI 10.2307/352157; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Oliver M. L., 2006, BLACK WEALTH WHITE W; Ong P, 1998, URBAN STUD, V35, P77, DOI 10.1080/0042098985087; Osili Una Okonkwo, 2004, PROSPECTS IMMIGRANT; Pendall R., 2014, DRIVING OPPORTUNITY; Pfeffer FT, 2013, ANN AM ACAD POLIT SS, V650, P98, DOI 10.1177/0002716213497452; Pilkauskas N, 2016, CHILDREN GREAT RECES, P58; Pilkauskas NV, 2012, SOC SERV REV, V86, P401, DOI 10.1086/667993; Raphael S, 2002, J URBAN ECON, V52, P109, DOI 10.1016/S0094-1190(02)00017-7; Raphael S, 2001, BROOKINGS WHARTON PA, P99, DOI DOI 10.1353/URB.2001.0013; Reichman NE, 2001, CHILD YOUTH SERV REV, V23, P303, DOI 10.1016/S0190-7409(01)00141-4; Scott E., 2004, U CHI LEGAL F, P225; Sherraden M., 1991, ASSETS POOR NEW AM W; Sierminska E, JOB FLOWS DEMOGRAPHI; Smith JP, 1995, J HUM RESOUR, V30, pS158, DOI 10.2307/146282; Spilerman S, 2000, ANNU REV SOCIOL, V26, P497, DOI 10.1146/annurev.soc.26.1.497; Suglia SF, 2011, J URBAN HEALTH, V88, P1105, DOI 10.1007/s11524-011-9587-0; Sullivan JX, 2006, J HUM RESOUR, V41, P72, DOI 10.3368/jhr.XLI.1.72; Sum A, 2010, CTR LABOR MARKET STU, V26; Taylor P., 2011, WEALTH GAPS RISE REC, P37; U.S. Census Bureau, 2014, RES VAC HOM 1 Q; Vespa J, 2011, DEMOGRAPHY, V48, P983, DOI 10.1007/s13524-011-0043-2; Waite LJ, 1995, DEMOGRAPHY, V32, P483, DOI 10.2307/2061670; Weiss Y., 1997, HDB POPULATION FAMIL, V1, P81; Wimer, 2016, CHILDREN GREAT RECES, P31; Wolff EN, 1998, J ECON PERSPECT, V12, P131, DOI 10.1257/jep.12.3.131; Wolff EN, 2012, ASSET PRICE MELTDOWN; Wolff EN., 2016, HOUSEHOLD WEALTH TRE; Yeung WJ, 2008, CHILD DEV, V79, P303, DOI 10.1111/j.1467-8624.2007.01127.x; Zhan M, 2003, SOC SERV REV, V77, P191, DOI 10.1086/373905; Ziol-Guest KM, 2014, CHILD DEV, V85, P103, DOI 10.1111/cdev.12105	89	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192370	10.1371/journal.pone.0192370	http://dx.doi.org/10.1371/journal.pone.0192370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401482	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400055
J	Maestro-Gonzalez, A; Bilbao-Leon, MC; Zuazua-Rico, D; Fernandez-Carreira, JM; Baldonedo-Cernuda, RF; Mosteiro-Diaz, MP				Maestro-Gonzalez, Alba; Cruz Bilbao-Leon, M.; Zuazua-Rico, David; Fernandez-Carreira, Jose M.; Baldonedo-Cernuda, Ricardo F.; Pilar Mosteiro-Diaz, M.			Quality of life as assessed by adults with cerebral palsy	PLOS ONE			English	Article							YOUNG-ADULTS; ROMANTIC RELATIONSHIPS; SEXUAL-ACTIVITY; HEALTH; CHILDREN; ADOLESCENTS; CLASSIFICATION; PARENTS; YOUTH	Aim We explored the quality of life of adults with cerebral palsy without an intellectual disability and the predictors of quality of life. Background Because cerebral palsy is a disease that manifests in childhood, much of the research into quality of life for those dealing with it focuses on children; there are few studies that evaluate the quality of life of adults with cerebral palsy. Therefore, it is important to consider their perceptions in order to improve their general wellbeing and self-determination. Design This was a descriptive, cross-sectional study. Method Quality of life was measured using the GENCAT Quality of Life Scale. Demographic and personal variables were also collected and examined. Participants comprised 75 adults (58.7 percent men, mean age = 40.84 years) with cerebral palsy who were members of the National Cerebral Palsy Association of Spain between 2014 and 2015. A linear multivariate model was examined as well. Results The overall mean score indicator of participants' quality of life was 103.29, which corresponds to the 56.6th percentile on the GENCAT scale. Examining the level of qualification, we found significant differences in the factors "personal development" and "self-determination," and those with a university education obtained higher scores than their less-educated counterparts. Having a partner was related to higher quality of life standard scores. After constructing a linear model, it was observed that maintaining sexual relationships was another factor that increased participants' quality of life. Conclusion This study highlights the importance of social and romantic relationships to achieve a better quality of life in adults with cerebral palsy who do not have an intellectual disability. Social integration and sexuality education programs should be developed to improve their quality of life.	[Maestro-Gonzalez, Alba; Zuazua-Rico, David; Baldonedo-Cernuda, Ricardo F.; Pilar Mosteiro-Diaz, M.] Univ Oviedo, Dept Med, Nursing Area, Oviedo, Spain; [Maestro-Gonzalez, Alba; Zuazua-Rico, David; Baldonedo-Cernuda, Ricardo F.] Hosp Univ Cent Asturias, Oviedo, Spain; [Cruz Bilbao-Leon, M.] Univ Burgos, Dept Educ Sci, Burgos, Spain; [Fernandez-Carreira, Jose M.] Hosp Publ Comarcal Jarrio, Hlth Serv Principal Asturias, Jarrio, Spain	University of Oviedo; Central University Hospital Asturias; Universidad de Burgos	Maestro-Gonzalez, A (corresponding author), Univ Oviedo, Dept Med, Nursing Area, Oviedo, Spain.; Maestro-Gonzalez, A (corresponding author), Hosp Univ Cent Asturias, Oviedo, Spain.	maestroalba@uniovi.es	Zuazua-Rico, David/HDM-2392-2022; Maestro-Gonzalez, Alba/ABH-7539-2020	Zuazua-Rico, David/0000-0002-5945-5945; Maestro-Gonzalez, Alba/0000-0002-1588-9362; Mosteiro-Diaz, Maria Pilar/0000-0002-3375-9334; Baldonedo-Cernuda, Ricardo Felipe/0000-0003-3650-7121				Alonso MA Verdugo, 2009, COMO MEJORAR CALIDAD; Andersson C, 2001, DEV MED CHILD NEUROL, V43, P76, DOI 10.1017/S0012162201; Verdugo MA, 2010, INT J CLIN HLTH PSYC, V10, P105; [Anonymous], QUALITY LIFE; Barbosa-Resende W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115643; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BLUM RW, 1991, PEDIATRICS, V88, P280; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cerebral Palsy Alliance, 2017, GMFCS E R GROSS MOT; Colver A, 2015, LANCET, V385, P705, DOI 10.1016/S0140-6736(14)61229-0; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Davis E, 2009, DEV MED CHILD NEUROL, V51, P193, DOI 10.1111/j.1469-8749.2008.03194.x; Donnelly C, 2008, J ADV NURS, V61, P557, DOI 10.1111/j.1365-2648.2007.04470.x; Foley KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108413; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; Hergenroder H, 2009, DEV MED CHILD NEUROL, V51, P389, DOI 10.1111/j.1469-8749.2008.03169.x; HIROSE T, 1990, J ADV NURS, V15, P762, DOI 10.1111/j.1365-2648.1990.tb01904.x; Kearney PM, 2004, J ADV NURS, V46, P162, DOI 10.1111/j.1365-2648.2003.02976.x; Kingsnorth S, 2015, CHILD CARE HLTH DEV, V41, P374, DOI 10.1111/cch.12196; Liptak GS, 2008, CURR OPIN NEUROL, V21, P136, DOI 10.1097/WCO.0b013e3282f6a499; Little W J, 1966, Clin Orthop Relat Res, V46, P7; Monbaliu E, 2017, EUR J PAEDIATR NEURO, V21, P327, DOI 10.1016/j.ejpn.2016.09.003; Morgan PE, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0132-1; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Opheim A, 2011, J REHABIL MED, V43, P382, DOI 10.2340/16501977-0787; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Parkes J, 2009, J ADV NURS, V65, P2311, DOI 10.1111/j.1365-2648.2009.05089.x; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Schalock RL, 2007, QUALITY LIFE PEOPLE; Soyupek F, 2010, DISABIL REHABIL, V32, P1109, DOI 10.3109/09638280903391120; Tadic V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146225; Tarsuslu T, 2010, DISABIL REHABIL, V32, P1658, DOI 10.3109/09638281003649904; van der Dussen L, 2001, CLIN REHABIL, V15, P84, DOI 10.1191/026921501670159475; Vitale MG, 2005, J PEDIATR ORTHOPED, V25, P792, DOI 10.1097/01.bpo.0000164870.26632.6b; Wechsler David, 2013, WAIS 4 MANUAL ADM CO; Wehmeyer M.L., 1998, TEACHING SELF DETERM; Wiegerink DJ, 2010, ARCH PHYS MED REHAB, V91, P1423, DOI 10.1016/j.apmr.2010.06.011; Wiegerink DJHG, 2008, J REHABIL MED, V40, P112, DOI 10.2340/16501977-0137; Wiegerink DJHG, 2010, DEV MED CHILD NEUROL, V52, P576, DOI 10.1111/j.1469-8749.2010.03620.x; Young NL, 2010, ARCH PHYS MED REHAB, V91, P143, DOI 10.1016/j.apmr.2009.08.152	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191960	10.1371/journal.pone.0191960	http://dx.doi.org/10.1371/journal.pone.0191960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401489	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400028
J	Avivi-Arber, L; Avivi, D; Perez, M; Arber, N; Shapira, S				Avivi-Arber, Limor; Avivi, Doran; Perez, Marilena; Arber, Nadir; Shapira, Shiran			Impaired bone healing at tooth extraction sites in CD24-deficient mice: A pilot study	PLOS ONE			English	Article							STEM-CELLS; COLORECTAL-CANCER; CD24; EXPRESSION; PROLIFERATION; APOPTOSIS; MODEL	Aim To use a micro-computed tomography (micro-CT) to quantify bone healing at maxillary first molar extraction sites, and test the hypothesis that bone healing is impaired in CD24-knockout mice as compared with wild-type C57BL/6J mice. Materials and methods Under ketamine-xylazine general anaesthesia, mice had either extraction of the right maxillary first molar tooth or sham operation. Mice were sacrificed 1 (n = 12/group), 2 (n = 6/group) or 4 (n = 6/group) weeks postoperatively. The right maxillae was disected. Micro-CT was used to quantify differences in bone microstructural features at extrction sites, between CD24-knockout mice and wild-type mice. Results CD24-Knockout mice displayed impaired bone healing at extraction sites that was manifested as decreased trabecular bone density, and decreased number and thickness of trabeculae. Conclusions This pilot study suggests that CD24 plays an important role in extraction socket bone healing and may be used as a novel biomarker of bone quality and potential therapeutic target to improve bone healing and density following alveolar bone injury.	[Avivi-Arber, Limor; Perez, Marilena] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Avivi, Doran; Arber, Nadir; Shapira, Shiran] Tel Aviv Univ, Sackler Fac Med, Integrated Canc Prevent Ctr, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel	University of Toronto; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Avivi-Arber, L (corresponding author), Univ Toronto, Fac Dent, Toronto, ON, Canada.	Limor.avivi.arber@utoronto.ca	Avivi-Arber, Limor/C-4658-2017	Avivi-Arber, Limor/0000-0002-0567-6101; Arber, Nadir/0000-0001-5283-6991	Tel Aviv Medical Center research Grant; Tel Aviv Medical Center-research Grant	Tel Aviv Medical Center research Grant; Tel Aviv Medical Center-research Grant	This research was supported by Tel Aviv Medical Center research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nancy Valiquette for assisting with the micro-CT. The authors declare that they have no conflict of interests. This research was supported by Tel Aviv Medical Center-research Grant.	Aguilar P, 2016, TISSUE CELL, V48, P397, DOI 10.1016/j.tice.2016.08.008; Allegrini Sergio Jr., 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P70; Bakopoulou A, 2013, ARCH ORAL BIOL, V58, P1556, DOI 10.1016/j.archoralbio.2013.06.018; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chappel MS, 1996, J EXP MED, V184, P1639, DOI 10.1084/jem.184.5.1639; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Fokra A, 2016, J CANC SCI THER, V8, P135; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Guo W, 2014, IMMUN INFLAMM DIS, V2, P239, DOI 10.1002/iid3.40; Huber MB, 2011, IEEE T BIO-MED ENG, V58, P1820, DOI 10.1109/TBME.2011.2119484; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Liu Y, 2009, TRENDS IMMUNOL, V30, P557, DOI 10.1016/j.it.2009.09.006; Martin W, 2009, INT J ORAL MAX IMPL, V24, P28; Naumov I, 2014, INT J CANCER, V135, P1048, DOI 10.1002/ijc.28762; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Salaria S, 2015, AM J CLIN PATHOL, V144, P642, DOI 10.1309/AJCPMZY5P9TWNJJV; Shapira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139787; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Stroncek John D., 2008, P3; Taguchi T, 2003, J IMMUNOL, V170, P252, DOI 10.4049/jimmunol.170.1.252; Tomlin Elizabeth M, 2014, Open Dent J, V8, P66, DOI 10.2174/1874210601408010066; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Vieira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128021; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Ye P, 2006, BIOCHEM BIOPH RES CO, V349, P229, DOI 10.1016/j.bbrc.2006.08.033; Ye P, 2005, CLIN EXP IMMUNOL, V139, P328, DOI 10.1111/j.1365-2249.2005.02692.x; Ye P, 2014, J PERIODONTAL RES, V49, P253, DOI 10.1111/jre.12102; Ye P, 2011, BIOCHEM BIOPH RES CO, V412, P165, DOI 10.1016/j.bbrc.2011.07.067; Ye P, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-2	34	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191665	10.1371/journal.pone.0191665	http://dx.doi.org/10.1371/journal.pone.0191665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390019	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400026
J	Baraka, V; Mavoko, HM; Nabasumba, C; Francis, F; Lutumba, P; Alifrangis, M; Van Geertruyden, JP				Baraka, Vito; Mavoko, Hypolite Muhindo; Nabasumba, Carolyn; Francis, Filbert; Lutumba, Pascal; Alifrangis, Michael; Van Geertruyden, Jean-Pierre			Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda	PLOS ONE			English	Article							DIHYDROARTEMISININ-PIPERAQUINE; COMBINATION THERAPIES; MALARIA; PFMDR1; MEFLOQUINE; SUSCEPTIBILITY; ALLELES; QUININE; PFCRT; CHLOROQUINE	Background The emergence of resistance against artemisinin combination treatment is a major concern for malaria control. ACTs are recommended as the rescue treatment, however, there is limited evidence as to whether treatment and re-treatment with ACTs select for drug-resistant P. falciparum parasites. Thus, the purpose of the present study is to investigate the impact of (re-) treatment using artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) on the selection of P. falciparum multidrug resistance-1 (Pfmdr1) alleles in clinical settings. Methods P. falciparum positive samples were collected from children aged 12 +/- 59 months in a clinical trial in DR Congo and Uganda. Pfmdr1 single nucleotide polymorphisms (SNPs) analysis at codons N86Y, Y184F, and D1246Y were performed at baseline and post-treatment with either AL or ASAQ as a rescue treatment using nested PCR followed by restriction fragment length polymorphism (RFLP) assays. Results The pre-treatment prevalence of Pfmdr1 N86 and D1246Y varied significantly between the sites, (p>0.001) and (p = 0.013), respectively. There was borderline significant directional selection for Pfmdr1 184F in recurrent malaria infections after treatment with AL in Uganda site (p = 0.05). Pfmdr1 NFD haplotype did not significantly change in post-treatment infections after re-treatment with either AL or ASAQ. Comparison between pre-treatment and post-treatment recurrences did not indicate directional selection of Pfmdr1 N86, D1246 alleles in the pre-RCT, RCT and post-RCT phases in both AL and ASAQ treatment arms. Pfmdr1 86Y was significantly associated with reduced risk of AL treatment failure (RR = 0.34, 95% CI: 0.11 +/- 1.05, p = 0.04) while no evidence for D1246 allele (RR = 1.02; 95% CI: 0.42 +/- 2.47, p = 1.0). Survival estimates showed that the Pfmdr1 alleles had comparable mean-time to PCR-corrected recrudescence and new infections in both AL and ASAQ treatment arms. Conclusion We found limited impact of (re-) treatment with AL or ASAQ on selection for Pfmdr1 variants and haplotypes associated with resistance to partner drugs. These findings further supplement the evidence use of same or alternative ACTs as a rescue therapy for recurrent P. falciparum infections. Continued monitoring of genetic signatures of resistance is warranted to timely inform malaria (re-) treatment policies and guidelines.	[Baraka, Vito; Francis, Filbert] Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania; [Baraka, Vito; Mavoko, Hypolite Muhindo; Nabasumba, Carolyn; Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Mavoko, Hypolite Muhindo; Lutumba, Pascal] Univ Kinshasa, Fac Med, Dept Med, Kinshasa, DEM REP CONGO; [Nabasumba, Carolyn] Epictr Mbarara Res Base, Mbarara, Uganda; [Alifrangis, Michael] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Alifrangis, Michael] Rigshosp, Natl Univ Hosp, Dept Infect Dis, Copenhagen, Denmark	National Institute of Medical Research; University of Antwerp; Universite de Kinshasa; University of Copenhagen; Rigshospitalet; University of Copenhagen	Baraka, V (corresponding author), Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania.; Baraka, V (corresponding author), Univ Antwerp, Global Hlth Inst, Antwerp, Belgium.	vitobaraka@gmail.com	Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Alifrangis, Michael/0000-0002-3835-3333; Baraka, Vito/0000-0001-9694-9293	Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS South Initiative project) [ZAIN2014Z168]; Fonds Wetenschappelijk Onderzoek (FWO) [G.078.11]; Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking (VLIR-UOS) [ZRDC2012MP076, ZEIN2013PR401]; European and Developing Countries Clinical Trials Partnership (EDCTP) [MS.2010.10800.004]; VLIR-UOS ICP PhD scholarship, Belgium	Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS South Initiative project); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking (VLIR-UOS); European and Developing Countries Clinical Trials Partnership (EDCTP); VLIR-UOS ICP PhD scholarship, Belgium	The project was supported by the Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS South Initiative project under award number Code ZAIN2014Z168). The QuiNACT trial was co-funded by Fonds Wetenschappelijk Onderzoek (FWO, Grant reference G.078.11), Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking (VLIR-UOS, Grant references ZRDC2012MP076 and ZEIN2013PR401), European and Developing Countries Clinical Trials Partnership (EDCTP, Grant reference MS.2010.10800.004). Vito Baraka fellowship is fully supported by VLIR-UOS ICP PhD scholarship, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Antonia AL, 2014, AM J TROP MED HYG, V90, P1094, DOI 10.4269/ajtmh.13-0378; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Baliraine FN, 2011, J INFECT DIS, V204, P1120, DOI 10.1093/infdis/jir486; Baraka V, 2015, ANTIMICROB AGENTS CH, V59, P734, DOI 10.1128/AAC.03647-14; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Boni MF, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001984; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Collet L, 2016, N ENGL J MED; Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141; Dama S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1700-8; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2004, AM J TROP MED HYG; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299; Froberg G, 2013, ANTIMICROB AGENTS CH, V57, P887, DOI 10.1128/AAC.00950-12; Group TPS, 2016, 4 ART BAS TREATM AFR; Happi CT, 2005, ACTA TROP, V95, P183, DOI 10.1016/j.actatropica.2005.06.015; Henriques G, 2014, J INFECT DIS, V210, P2001, DOI 10.1093/infdis/jiu358; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Malmberg M, 2013, J INFECT DIS, V207, P842, DOI 10.1093/infdis/jis747; Mavoko HM, 2017, LANCET GLOB HEALTH, V5, pE60, DOI 10.1016/S2214-109X(16)30236-4; Mavoko HM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-307; Mbaye A, 2016, MALAR J; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Nguyen TD, 2015, LANCET GLOB HLTH; Nosten F, 2007, ARTEMISININ BASED CO; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012-07; OMS (Organisation Mondiale de la Sante A, 2016, WORLD MALARIA REPORT, V186; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Price R, 2001, AM J TROP MED HYG; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sirima SB, 2016, LANCET INFECT DIS, V16, P1123, DOI 10.1016/S1473-3099(16)30020-2; Sisowath C, 2005, J INFECT DIS; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sondo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151565; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Sutherland CJ, 2017, ANTIMICROB AGENTS CH; Thomsen TT, 2011, AM J TROP MED HYG, V85, P979, DOI 10.4269/ajtmh.2011.11-0071; Tinto H, 2016, BURKINA FASO, V8, P10; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; World Health Organization, 2010, NATURE, V284; World Health Organization, 2015, GUID TREATM MAL, Vthird; Wurtz N, 2014, ANTIMICROB AGENTS CH, V58, P7032, DOI 10.1128/AAC.03494-14; Yeka A, 2016, J INFECT DIS, V213, P1134, DOI 10.1093/infdis/jiv551	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191922	10.1371/journal.pone.0191922	http://dx.doi.org/10.1371/journal.pone.0191922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390014	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400042
J	Bergs, A; Schultheis, C; Fischer, E; Tsunoda, SP; Erbguth, K; Husson, SJ; Govorunova, E; Spudich, JL; Nagel, G; Gottschalk, A; Liewald, JF				Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Husson, Steven J.; Govorunova, Elena; Spudich, John L.; Nagel, Georg; Gottschalk, Alexander; Liewald, Jana F.			Rhodopsin optogenetic toolbox v2.0 for light-sensitive excitation and inhibition in Caenorhabditis elegans	PLOS ONE			English	Article							ANION CHANNELRHODOPSINS; MILLISECOND-TIMESCALE; CHLORIDE CHANNEL; NEURAL ACTIVITY; OPTICAL CONTROL; IN-VIVO; BEHAVIOR; ACTIVATION; TRANSFORMATION; STIMULATION	In optogenetics, rhodopsins were established as light-driven tools to manipulate neuronal activity. However, during long-term photostimulation using channelrhodopsin (ChR), desensitization can reduce effects. Furthermore, requirement for continuous presence of the chromophore all-trans retinal (ATR) in model systems lacking sufficient endogenous concentrations limits its applicability. We tested known, and engineered and characterized new variants of de-and hyperpolarizing rhodopsins in Caenorhabditis elegans. ChR2 variants combined previously described point mutations that may synergize to enable prolonged stimulation. Following brief light pulses ChR2(C128S; H134R) induced muscle activation for minutes or even for hours ('Quint': ChR2(C128S; L132C; H134R; D156A; T159C)), thus featuring longer open state lifetime than previously described variants. Furthermore, stability after ATR removal was increased compared to the step-function opsin ChR2(C128S). The double mutants C128S; H134R and H134R; D156C enabled increased effects during repetitive stimulation. We also tested new hyperpolarizers (ACR1, ACR2, ACR1(C102A), ZipACR). Particularly ACR1 and ACR2 showed strong effects in behavioral assays and very large currents with fast kinetics. In sum, we introduce highly light-sensitive optogenetic tools, bypassing previous shortcomings, and thus constituting new tools that feature high effectiveness and fast kinetics, allowing better repetitive stimulation or investigating prolonged neuronal activity states in C. elegans and, possibly, other systems.	[Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Gottschalk, Alexander; Liewald, Jana F.] Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Gottschalk, Alexander; Liewald, Jana F.] Goethe Univ, Inst Biophys Chem, Dept Biochem Chem & Pharm, Frankfurt, Germany; [Bergs, Amelie] Int Max Planck Res Sch Struct & Funct Biol Membra, Frankfurt, Germany; [Husson, Steven J.] Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Antwerp, Belgium; [Govorunova, Elena; Spudich, John L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Nagel, Georg] Julius Maximilians Univ Wurzburg, Dept Biol, Inst Mol Plant Physiol & Biophys, Wurzburg, Germany; [Gottschalk, Alexander] Goethe Univ, CEF MC, Frankfurt, Germany; [Schultheis, Christian] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Fischer, Elisabeth] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh, Midlothian, Scotland; [Tsunoda, Satoshi P.] JST Presto, 4-1-8 Honcho, Kawaguchi, Saitama, Japan	Goethe University Frankfurt; Goethe University Frankfurt; University of Antwerp; University of Texas System; University of Texas Health Science Center Houston; University of Wurzburg; Goethe University Frankfurt; Boehringer Ingelheim; University of Edinburgh; Japan Science & Technology Agency (JST)	Gottschalk, A; Liewald, JF (corresponding author), Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany.; Gottschalk, A; Liewald, JF (corresponding author), Goethe Univ, Inst Biophys Chem, Dept Biochem Chem & Pharm, Frankfurt, Germany.; Gottschalk, A (corresponding author), Goethe Univ, CEF MC, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de; liewald@biochem.uni-frankfurt.de	Tsunoda, Satoshi/AAN-7023-2021; Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Govorunova, Elena/0000-0003-0522-9683; Tsunoda, Satoshi/0000-0003-3636-1521; Bergs, Amelie/0000-0002-3417-6157	Deutsche Forschungsgemeinschaft (DFG) [G01011/31/3-2, G01011/4-1/4-2 (FOR1279), SFB807, EXC115]; European Commission, FP7 [HEALTH-F2-2009-241526]; ANR-DFG [GO1011/8-1]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Commission, FP7(European CommissionEuropean Commission Joint Research Centre); ANR-DFG(German Research Foundation (DFG)French National Research Agency (ANR)); NIH Office of Research Infrastructure Programs	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grants G01011/31/3-2, G01011/4-1/4-2 (FOR1279), SFB807, and EXC115 (Cluster of Excellence Frankfurt), by the European Commission, FP7/2007-2013 under grant agreement No HEALTH-F2-2009-241526 (EUTrigTreat), and by the ANR-DFG-funded project "NewOptogeneticsTools" (GO1011/8-1). Website of Deutsche Forschungsgemeinschaft: http://www.dfg.de/ Website of FP7 Health (European Commission): https://ec.europa.eu/research/fp7/index_en cfm?pg=health.; We thank Peter Hegemann for providing plasmids and for sharing information prior to publication. We thank Wagner Steuer Costa, Heike Fettermann and Mona Floret for technical assistance. We are grateful to Arunas Damijonaitis for initial work. The lin-15(n765ts-) strain was provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grants G01011/3-1/3-2, G01011/4-1/4-2 (FOR1279), SFB807, and EXC115 (Cluster of Excellence Frankfurt), by the European Commission, FP7/2007-2013 under grant agreement No HEALTH-F2-2009-241526 (EUTrigTreat), and by the ANR-DFG-funded project "NewOptogeneticsTools" (GO1011/8-1).	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Burgess P., 2009, CONTINUOUS COVER FOR; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Costa WS, 2017, CURR BIOL, V27, P495, DOI 10.1016/j.cub.2016.12.055; Dawydow A, 2014, P NATL ACAD SCI US; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Edelstein A. D., J BIOL METHODS, V1; Erbguth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046827; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Husson SJ, 2013, BIOL CELL, V105, P235, DOI [10.1111/boc.201200069, 10.1111/boc.201390011]; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kittelmann M, 2013, P NATL ACAD SCI USA, V110, pE3007, DOI 10.1073/pnas.1305679110; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LIU P, 2013, NATURE COMMUNICATION, V4; Mohammad F, 2017, NAT METHODS, V14, P271, DOI [10.1038/NMETH.4148, 10.1038/nmeth.4148]; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Schild LC, 2015, GENETICS, V200, P1029, DOI 10.1534/genetics.115.177956; Schmitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043164; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Sineshchekov OA, 2015, P NATL ACAD SCI USA, V112, P14236, DOI 10.1073/pnas.1513602112; Stauffer WR, 2016, CELL, V166, P1564, DOI 10.1016/j.cell.2016.08.024; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	59	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191802	10.1371/journal.pone.0191802	http://dx.doi.org/10.1371/journal.pone.0191802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389997	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400037
J	Boehmer, KR; Abu Dabrh, A; Gionfriddo, MR; Erwin, P; Montori, VM				Boehmer, Kasey R.; Abu Dabrh, Abd Moain; Gionfriddo, Michael R.; Erwin, Patricia; Montori, Victor M.			Does the chronic care model meet the emerging needs of people living with multimorbidity? A systematic review and thematic synthesis	PLOS ONE			English	Review							HEALTH-CARE; TREATMENT BURDEN; MANAGEMENT; BARRIERS; EXPERIENCES; OUTCOMES; DISEASE; SENIORS	Background The Chronic Care Model (CCM) emerged in the 1990s as an approach to re-organize primary care and implement critical elements that enable it to proactively attend to patients with chronic conditions. The chronic care landscape has evolved further, as most patients now present with multiple chronic conditions and increasing psychosocial complexity. These patients face accumulating and overwhelming complexity resulting from the sum of uncoordinated responses to each of their problems. Minimally Disruptive Medicine (MDM) was proposed to respond to this challenge, aiming at improving outcomes that matter to patients with the smallest burden of treatment. We sought to critically appraise the extent to which MDM constructs (e.g., reducing patient work, improving patients' capacity) have been adopted within CCM implementations. Methods We conducted a systematic review and qualitative thematic synthesis of reports of CCM implementations published from 2011-2016. Results CCM implementations were mostly aligned with the healthcare system's goals, condition-specific, and targeted disease-specific outcomes or healthcare utilization. No CCM implementation addressed patient work. Few reduced treatment workload without adding additional tasks. Implementations supported patient capacity by offering information, but rarely offered practical resources (e.g., financial assistance, transportation), helped patients reframe their biography with chronic illness, or assisted them in engaging with a supportive social network. Few implementations aimed at improving functional status or quality of life, and only one-third of studies were targeted for patients of low socioeconomic status. Conclusion MDM provides a lens to operationalize how to care for patients with multiple chronic conditions, but its constructs remain mostly absent from how implementations of the CCM are currently reported. Improvements to the primary care of patients with multimorbidity may benefit from the application of MDM, and the current CCM implementations that do apply MDM constructs should be considered exemplars for future implementation work.	[Boehmer, Kasey R.; Abu Dabrh, Abd Moain; Gionfriddo, Michael R.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res KER Unit, Rochester, MN 55905 USA; [Abu Dabrh, Abd Moain] Mayo Clin Florida, Dept Family Med, Jacksonville, FL USA; [Gionfriddo, Michael R.] Geisinger, Ctr Pharm Innovat & Outcomes, Forty Ft, PA USA; [Erwin, Patricia] Mayo Clin, Mayo Med Lib, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Boehmer, KR (corresponding author), Mayo Clin, Knowledge & Evaluat Res KER Unit, Rochester, MN 55905 USA.	Boehmer.Kasey@mayo.edu	Gionfriddo, Michael R./S-8359-2016	Gionfriddo, Michael R./0000-0003-1391-7072; Abu Dabrh, Abd Moain/0000-0002-2481-483X				Adams SG, 2007, ARCH INTERN MED, V167, P551, DOI 10.1001/archinte.167.6.551; Agency for Healthcare Research and Quality, 2014, TOOLK IMPL CHRON CAR; Anderson G, 2010, CHRONIC CARE MAKING; Baptista DR, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-015-0119-z; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barr VJ, 2003, HEALTHCARE Q, V7, P29; Bayliss EA, 2007, ANN FAM MED, V5, P395, DOI 10.1370/afm.722; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Bayliss EA, 2009, J CLIN EPIDEMIOL, V62, P550, DOI 10.1016/j.jclinepi.2008.05.002; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boehmer K, 2015, J CLIN EPIDEMIOLOGY; Boehmer KR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0525-9; Britto MT, 2014, PEDIATRICS, V133, pE418, DOI 10.1542/peds.2013-0684; Bury M., 1982, CHRONIC ILLNESS BIOG; Busetto L, 2016, J EVAL CLIN PRACT, V22, P299, DOI 10.1111/jep.12478; Corbin J., 1985, QUALITATIVE SOCIOLOG, V8, P224, DOI [10.1007/BF00989485, DOI 10.1007/BF00989485]; Cottrell E, 2015, CHRONIC ILLN, V11, P279, DOI 10.1177/1742395315574764; Eton DT, 2013, PATIENT-RELAT OUTCOM, V4, P7, DOI 10.2147/PROM.S44694; Eton DT, 2012, PATIENT-RELAT OUTCOM, V3, P39, DOI 10.2147/PROM.S34681; Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gill Ashlinder, 2014, Healthc Policy, V9, P73; Giovannetti ER, 2012, J GEN INTERN MED, V27, P37, DOI 10.1007/s11606-011-1831-5; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Godlee F., 2015, CONTENT IS KING; Heinelt M, 2015, PREHOSP EMERG CARE, V19, P548, DOI 10.3109/10903127.2015.1005261; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Holm AL, 2012, INT J MENT HEALTH NU, V21, P513, DOI 10.1111/j.1447-0349.2012.00827.x; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Improving Chronic Illness Care, 2017, INT CHRON CAR BUS ST; Li R, 2004, DIABETES CARE, V27, P2312, DOI 10.2337/diacare.27.10.2312; Massoud M, 2015, AIDS, V29, P1731, DOI 10.1097/QAD.0000000000000742; May C., 2015, NORMALIZATION PROCES; May C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-86; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; McLean G, 2015, BRIT J GEN PRACT, V65, pE799, DOI 10.3399/bjgp15X687829; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; O'Brien Rosaleen, 2014, J Comorb, V4, P1, DOI 10.15256/joc.2014.4.32; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; Roland M, 2012, INT J INTEGR CARE, V12, pe130, DOI DOI 10.5334/IJIC.850; Sack C, 2012, J CROHNS COLITIS, V6, P302, DOI 10.1016/j.crohns.2011.08.019; Sav A, 2013, HLTH EXPECTATIONS IN; Sav A, 2013, HEALTH SOC CARE COMM, V21, P665, DOI 10.1111/hsc.12052; Shippee ND, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-62; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Smidth M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-385; Smith S., 2016, INTERVENTIONS IMPROV; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391	55	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0190852	10.1371/journal.pone.0190852	http://dx.doi.org/10.1371/journal.pone.0190852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420543	gold, Green Published, Green Submitted			2022-12-27	WOS:000424517900007
J	Chen, DL; Huang, HJ; Byers, DE; Shifren, A; Belikoff, B; Engle, JT; Arentson, E; Kemp, D; Phillips, S; Scherrer, DE; Fujiwara, H; Spayd, KJ; Brooks, FJ; Pierce, RA; Castro, M; Isakow, W				Chen, Delphine L.; Huang, Howard J.; Byers, Derek E.; Shifren, Adrian; Belikoff, Bryan; Engle, Jacquelyn T.; Arentson, Elizabeth; Kemp, Debra; Phillips, Sharon; Scherrer, David E.; Fujiwara, Hideji; Spayd, Katherine J.; Brooks, Frank J.; Pierce, Richard A.; Castro, Mario; Isakow, Warren			The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; OBSTRUCTIVE PULMONARY-DISEASE; BRAIN TRANSFER CONSTANTS; AIR-FLOW LIMITATION; TIME UPTAKE DATA; GRAPHICAL EVALUATION; CELL ACTIVATION; ASTHMA; INJURY; GAMMA	Background Anti-inflammatory drug development efforts for lung disease have been hampered in part by the lack of noninvasive inflammation biomarkers and the limited ability of animal models to predict efficacy in humans. We used F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) in a human model of lung inflammation to assess whether pioglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, and zileuton, a 5-lipoxygenase inhibitor, reduce lung inflammation. Methods For this single center, single-blind, placebo-controlled cohort study, we enrolled healthy volunteers sequentially into the following treatment cohorts (N = 6 per cohort): pioglitazone plus placebo, zileuton plus placebo, or dual placebo prior to bronchoscopic endotoxin instillation. F-18-FDG uptake pre- and post-endotoxin was quantified as the Patlak graphical analysis-determined K-i (primary outcome measure). Secondary outcome measures included the mean standard uptake value (SUVmean), post-endotoxin bronchoalveolar lavage (BAL) cell counts and differentials and blood adiponectin and urinary leukotriene E-4 (LTE4) levels, determined by enzyme-linked immunosorbent assay, to verify treatment compliance. Oneor two-way analysis of variance assessed for differences among cohorts in the outcome measures (expressed as mean +/- standard deviation). Results Ten females and eight males (29 +/- 6 years of age) completed all study procedures except for one volunteer who did not complete the post-endotoxin BAL. K-i and SUVmean increased in all cohorts after endotoxin instillation (Ki increased by 0.0021 +/- 0.0019, 0.0023 +/- 0.0017, and 0.0024 +/- 0.0020 and SUVmean by 0.47 +/- 0.14, 0.55 +/- 0.15, and 0.54 +/- 0.38 in placebo, pioglitazone, and zileuton cohorts, respectively, p<0.001) with no differences among treatment cohorts (p = 0.933). Adiponectin levels increased as expected with pioglitazone treatment but not urinary LTE4 levels as expected with zileuton treatment. BAL cell counts (p = 0.442) and neutrophil percentage (p = 0.773) were similar among the treatment cohorts. Conclusions Endotoxin-induced lung inflammation in humans is not responsive to pioglitazone or zileuton, highlighting the challenge in translating anti-inflammatory drug efficacy results from murine models to humans.	[Chen, Delphine L.; Belikoff, Bryan; Engle, Jacquelyn T.; Arentson, Elizabeth; Phillips, Sharon; Spayd, Katherine J.; Brooks, Frank J.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO USA; [Chen, Delphine L.; Byers, Derek E.; Shifren, Adrian; Pierce, Richard A.; Castro, Mario; Isakow, Warren] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Huang, Howard J.] Baylor Univ, Med Ctr, Annette C & Harold C Simmons Transplant Inst, Dallas, TX USA; [Kemp, Debra] Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO USA; [Scherrer, David E.] Washington Univ, Sch Med, Dept Internal Med, Cardiovasc Div, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Baylor University; Baylor University Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Chen, DL (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO USA.; Chen, DL (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA.	chend@wustl.edu	Brooks, Frank/AAM-3677-2021	Chen, Delphine/0000-0002-0150-5401	Doris Duke Clinical Scientist Development Award [2010060]; National Heart, Lung and Blood Institute [R01 HL116389]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences [UL1 TR000448]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) [P30 DK020579]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Doris Duke Clinical Scientist Development Award 2010060 to DLC (http://www.ddcf.org/what-we-fund/medical-research/goals-and-strategies/encourage-and-develop-clinical-research-careers/clinical-scientist-development-award/) as well as the National Heart, Lung and Blood Institute grant R01 HL116389 to DLC, the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences, and P30 DK020579 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bastarache JA, 2009, DIS MODEL MECH, V2, P218, DOI 10.1242/dmm.001677; Bellani G, 2011, AM J RESP CRIT CARE, V183, P1193, DOI 10.1164/rccm.201008-1318OC; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Broughton KS, 1997, AM J CLIN NUTR, V65, P1011, DOI 10.1093/ajcn/65.4.1011; Chen DL, 2017, J NUCL MED, V58, P201, DOI 10.2967/jnumed.116.184796; Chen DL, 2009, AM J RESP CRIT CARE, V180, P533, DOI 10.1164/rccm.200904-0501OC; Chen DL, 2006, J APPL PHYSIOL, V100, P1602, DOI 10.1152/japplphysiol.01429.2005; Chen DL, 2004, J NUCL MED, V45, P1583; Collin M, 2004, J LEUKOCYTE BIOL, V76, P961, DOI 10.1189/jlb.0604338; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Franciosi LG, 2006, PULM PHARMACOL THER, V19, P189, DOI 10.1016/j.pupt.2005.05.001; Genovese S, 2013, ADV THER, V30, P190, DOI 10.1007/s12325-013-0003-x; Grommes J, 2012, EUR RESPIR J, V40, P416, DOI 10.1183/09031936.00091011; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hashemian SMR, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-21; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holman BF, 2016, PHYS MED BIOL, V61, P3148, DOI 10.1088/0031-9155/61/8/3148; Huang HJ, 2015, J NUCL MED, V56, P76, DOI 10.2967/jnumed.114.146381; Ito K, 2004, EUR J CARDIO-THORAC, V25, P530, DOI 10.1016/j.ejcts.2003.12.017; Jennings JE, 2008, AM J HEMATOL, V83, P640, DOI 10.1002/ajh.21199; Jones HA, 2003, EUR RESPIR J, V21, P567, DOI 10.1183/09031936.03.00048502; Kane GC, 1996, J ALLERGY CLIN IMMUN, V97, P646, DOI 10.1016/S0091-6749(96)70310-X; Langley GR, 2016, DRUG DISCOV TODAY; Larsson BM, 2006, RESP MED, V100, P226, DOI 10.1016/j.rmed.2005.04.020; Lauredo IT, 1998, J APPL PHYSIOL, V85, P2298, DOI 10.1152/jappl.1998.85.6.2298; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Levitt JE, 2016, EXPERT REV PROTEOMIC, V13, P457, DOI 10.1586/14789450.2016.1172481; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Marder W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000441; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; Musther H, 2014, EUR J PHARM SCI, V57, P280, DOI 10.1016/j.ejps.2013.08.018; National Institutes of Health National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Ruthman CA, 2015, THER ADV RESPIR DIS, V9, P173, DOI 10.1177/1753465815585716; Schaller G, 2008, HORM METAB RES, V40, P549, DOI 10.1055/s-2008-1076698; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; Sidhu JS, 2003, J AM COLL CARDIOL, V42, P1757, DOI 10.1016/j.jacc.2003.04.001; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Spencer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102190; Subramanian DR, 2012, AM J RESP CRIT CARE, V186, P1125, DOI 10.1164/rccm.201201-0051OC; Tecklenburg SL, 2007, RESP MED, V101, P1770, DOI 10.1016/j.rmed.2007.02.014; Thomson NC, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02061-2016; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Wang ACC, 2001, AM J RESP CELL MOL, V24, P688, DOI 10.1165/ajrcmb.24.6.4376; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191783	10.1371/journal.pone.0191783	http://dx.doi.org/10.1371/journal.pone.0191783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414995	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300040
J	Gill, MM; Mofenson, LM; Phalatse, M; Tukei, V; Guay, L; Nchephe, M				Gill, Michelle M.; Mofenson, Lynne M.; Phalatse, Mamakhetha; Tukei, Vincent; Guay, Laura; Nchephe, Matsepeli			Piloting very early infant diagnosis of HIV in Lesotho: Acceptability and feasibility among mothers, health workers and laboratory personnel	PLOS ONE			English	Article							SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; MORTALITY; TRANSMISSION; INFECTION	Introduction Mortality associated with in-utero HIV infection rises rapidly within weeks after birth. Very early infant diagnosis of HIV (VEID)-testing within 2 weeks of birth-followed by immediate initiation of antiretroviral therapy has potential to avert mortality associated with in-utero transmission. However, our understanding of acceptability and feasibility of VEID is limited. Methods VEID was piloted in an observational prospective cohort of HIV-positive pregnant women and their infants in 13 Lesotho health facilities. Between March-July 2016, semi-structured interviews were conducted with HIV-positive women attending 6-week or 14-week postnatal visits and health workers (HWs) in 8 study facilities in 3 districts as well as with district and central laboratory staff. Interview themes included acceptability of birth and subsequent HIV testing and early treatment, perceived VEID challenges, and HIV birth testing procedures and how well they were performed. Results Interviews were conducted with 20 women, 18 HWs and 9 district/central laboratory staff. Nearly all mothers perceived knowing their child's HIV status at birth positively. Mothers and HWs did not indicate that birth testing affected subsequent acceptance of infant HIV testing or clinic attendance. HWs and laboratory staff reported weak follow-up systems for mothers with home deliveries, and concern regarding the increased workload associated with additional testing requirements. All groups reported turnaround time delays for EID, and that sometimes results were never received. Conclusions Women, HWs, and laboratory staff found VEID acceptable and were supportive of national implementation of birth testing. However, they identified challenges within the EID system that could be exacerbated by adding a test to the diagnostic algorithm, such as delays in receiving test results, suggesting VEID may not be feasible in certain settings. Policymakers will need to consider whether adding birth testing or strengthening the current clinic and laboratory system is the most appropriate course of action.	[Gill, Michelle M.; Mofenson, Lynne M.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Washington, DC 20036 USA; [Phalatse, Mamakhetha; Nchephe, Matsepeli] Minist Hlth, Maseru, Lesotho; [Tukei, Vincent] Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Maseru, Lesotho; [Guay, Laura] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA	George Washington University	Gill, MM (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Washington, DC 20036 USA.	mgill@pedaids.org	Mofenson, Lynne/P-9631-2019; Tukei, Vincent/GNH-5270-2022	Mofenson, Lynne/0000-0002-2818-9808; Tukei, Vincent Joseph/0000-0002-9525-2600	United States Agency for International Development [AID-OAA-14-00060]	United States Agency for International Development(United States Agency for International Development (USAID))	This work was supported by United States Agency for International Development: Cooperative Agreement AID-OAA-14-00060 (https://www.usaid.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 8 INT WORKSH HIV PED; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Francke JA, 2016, J INFECT DIS, V214, P1319, DOI 10.1093/infdis/jiw379; Gous NM, 2016, JAIDS-J ACQ IMM DEF, V71, pE34, DOI 10.1097/QAI.0000000000000872; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; International Community of Women Living with HIV (ICW) and Global Network of People Living with HIV (GNP+), 2015, EARL INF DIAGN UND P; Lesotho Ministry of Health and ICF International, 2016, LES DEM HLTH SURV; Lilian RR, 2014, JAIDS-J ACQ IMM DEF, V67, P341, DOI 10.1097/QAI.0000000000000307; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Maritz J, 2016, C RETR OPP INF BOST; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pham MD, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1588-y; Smith SJ, 2014, PAEDIATR INT CHILD H, V34, P203, DOI 10.1179/2046905514Y.0000000119; Technau K-G, 2015, C RETR OPP INF SEATT; Tiam A, 2016, 8 INT WORKSH HIV PED; UNAIDS, 2016, FAST TRACK AIDS FREE; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	21	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190874	10.1371/journal.pone.0190874	http://dx.doi.org/10.1371/journal.pone.0190874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415011	Green Submitted, gold, Green Published			2022-12-27	WOS:000424325300012
J	Simeonovic, CJ; Popp, SK; Starrs, LM; Brown, DJ; Ziolkowski, AF; Ludwig, B; Bornstein, SR; Wilson, JD; Pugliese, A; Kay, TWH; Thomas, HE; Loudovaris, T; Choong, FJ; Freeman, C; Parish, CR				Simeonovic, Charmaine J.; Popp, Sarah K.; Starrs, Lora M.; Brown, Debra J.; Ziolkowski, Andrew F.; Ludwig, Barbara; Bornstein, Stefan R.; Wilson, J. Dennis; Pugliese, Alberto; Kay, Thomas W. H.; Thomas, Helen E.; Loudovaris, Thomas; Choong, Fui Jiun; Freeman, Craig; Parish, Christopher R.			Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans	PLOS ONE			English	Article							INSULIN-SECRETION; IN-VITRO; MAMMALIAN HEPARANASE; PANCREATIC BIOPSY; BASEMENT-MEMBRANE; RECENT-ONSET; T-CELLS; MICE; TRANSPLANTATION; INFLAMMATION	Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells in pancreatic islets are progressively destroyed. Clinical trials of immunotherapies in recently diagnosed T1D patients have only transiently and partially impacted the disease course, suggesting that other approaches are required. Our previous studies have demonstrated that heparan sulfate (HS), a glycosaminoglycan conventionally expressed in extracellular matrix, is present at high levels inside normal mouse beta cells. Intracellular HS was shown to be critical for beta cell survival and protection from oxidative damage. T1D development in Non-Obese Diabetic (NOD) mice correlated with loss of islet HS and was prevented by inhibiting HS degradation by the endoglycosidase, heparanase. In this study we investigated the distribution of HS and heparan sulfate proteoglycan (HSPG) core proteins in normal human islets, a role for HS in human beta cell viability and the clinical relevance of intraislet HS and HSPG levels, compared to insulin, in human T1D. In normal human islets, HS (identified by 10E4 mAb) co-localized with insulin but not glucagon and correlated with the HSPG core proteins for collagen type XVIII (Col18) and syndecan-1 (Sdc1). Insulin-positive islets of T1D pancreases showed significant loss of HS, Col18 and Sdc1 and heparanase was strongly expressed by islet-infiltrating leukocytes. Human beta cells cultured with HS mimetics showed significantly improved survival and protection against hydrogen peroxide-induced death, suggesting that loss of HS could contribute to beta cell death in T1D. We conclude that HS depletion in beta cells, possibly due to heparanase produced by insulitis leukocytes, may function as an important mechanism in the pathogenesis of human T1D. Our findings raise the possibility that intervention therapy with dual activity HS replacers/heparanase inhibitors could help to protect the residual beta cell mass in patients recently diagnosed with T1D.	[Simeonovic, Charmaine J.; Popp, Sarah K.; Starrs, Lora M.; Brown, Debra J.; Ziolkowski, Andrew F.; Choong, Fui Jiun] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Internal Med 3, Dresden, Germany; [Wilson, J. Dennis] Canberra Hosp, Dept Endocrinol, Woden, ACT, Australia; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Dept Med, Miami, FL 33136 USA; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Kay, Thomas W. H.; Thomas, Helen E.; Loudovaris, Thomas] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Freeman, Craig; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Ziolkowski, Andrew F.] John Hunter Hosp, Dept Mol Med, Newcastle, NSW, Australia	Australian National University; John Curtin School of Medical Research; Technische Universitat Dresden; Australian National University; Canberra Hospital; University of Miami; University of Miami; St. Vincent's Institute of Medical Research; Australian National University; John Curtin School of Medical Research; John Hunter Hospital	Simeonovic, CJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.	Charmaine.Simeonovic@anu.edu.au	Simeonovic, Charmaine/AAG-9945-2020	Simeonovic, Charmaine/0000-0002-7161-5825; Loudovaris, Thomas/0000-0002-7038-2302; Parish, Christopher/0000-0001-7740-0430	National Health and Medical Research Council of Australia (NHMRC)/Juvenile Diabetes Research Foundation (JDRF) [418138]; Canberra Hospital Private Practice Fund; JDRF nPOD Research Grant [25-2010-716]; JDRF [47-2012-746]; NHMRC [1043284]; Network for Pancreatic Organ Donors with Diabetes (nPOD) - JDRF [25-2013-268]; Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science	National Health and Medical Research Council of Australia (NHMRC)/Juvenile Diabetes Research Foundation (JDRF); Canberra Hospital Private Practice Fund; JDRF nPOD Research Grant; JDRF(Juvenile Diabetes Research Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Network for Pancreatic Organ Donors with Diabetes (nPOD) - JDRF; Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science	This work was supported by a National Health and Medical Research Council of Australia (NHMRC; https://www.nhmrc.gov.au/)/Juvenile Diabetes Research Foundation (JDRF) Special Program Grant in Type 1 Diabetes (#418138), The Canberra Hospital Private Practice Fund (http://www.health.act.gov.au/research-publications/research/ppf-major-grants), JDRF nPOD Research Grant (#25-2010-716; http://www.jdrf.org), JDRF Research Grant (#47-2012-746) and NHMRC Project Grant (#1043284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD, www.JDRFnPOD.org), a collaborative Type 1 diabetes research project sponsored by JDRF (#25-2013-268). Organ Procurement Organizations (OPO) partnering with nPOD to provide research resources are listed at http://-wwwjdrinpod,org/for-partners/ npod partners/. A.P. was supported by the Helmsley Charitable Trust George Eisenbarth nPOD Award for Team Science. We thank the Tom Mandel Islet Program, St Vincent's Institute, Melbourne, Australia and the Integrated Islet Distribution Program (IIDP), City of Hope, CA, USA for providing isolated human islets. We are grateful to Progen Pharmaceuticals Limited (Brisbane, Queensland, Australia) for providing PI-88 and Beta Therapeutics (Canberra, ACT, Australia) for the use of BT548. We thank Anne Prins for preparing the histology of isolated human islets, Dr Harpreet Vohra for assistance with flow cytometry and Cathy Gillespie and Michael Devoy for their help with confocal and immunofluorescence microscopy.	Abu El-Asrar AM, 2015, INVEST OPHTH VIS SCI, V56, P8239, DOI 10.1167/iovs.15-18025; Anagandula M, 2014, J MED VIROL, V86, P1402, DOI 10.1002/jmv.23835; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Battaglia M, 2015, DIABETES, V64, P1081, DOI 10.2337/db14-1208; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Campbell-Thompson ML, 2013, DIABETOLOGIA, V56, P2541, DOI 10.1007/s00125-013-3043-5; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Choong FJ, 2015, AM J TRANSPLANT, V15, P2851, DOI 10.1111/ajt.13366; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Garsen M, 2016, AM J PATHOL, V186, P805, DOI 10.1016/j.ajpath.2015.12.008; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Greenbaum CJ, 2012, DIABETES, V61, P1323, DOI 10.2337/db11-1452; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; In't Veld P, 2014, SEMIN IMMUNOPATHOL, V36, P569, DOI 10.1007/s00281-014-0438-4; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Irving-Rodgers HF, 2008, DIABETOLOGIA, V51, P1680, DOI 10.1007/s00125-008-1085-x; Khamaysi I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00715-6; Korpos E, 2013, DIABETES, V62, P531, DOI 10.2337/db12-0432; Krogvold L, 2015, DIABETES, V64, P2506, DOI 10.2337/db14-1911; Krogvold L, 2014, DIABETOLOGIA, V57, P841, DOI 10.1007/s00125-013-3155-y; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; LINDAHL U, 1973, J BIOL CHEM, V248, P7234; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Morgan NG, 2014, IUBMB LIFE, V66, P723, DOI 10.1002/iub.1330; Nepom GT, 2013, CLIN IMMUNOL, V149, P279, DOI 10.1016/j.clim.2013.02.003; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 1999, CANCER RES, V59, P3433; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Richardson SJ, 2014, DIABETOLOGIA, V57, P647, DOI 10.1007/s00125-014-3167-2; Richardson SJ, 2011, SEMIN IMMUNOPATHOL, V33, P9, DOI 10.1007/s00281-010-0205-0; Rota C, 2005, ANAL BIOCHEM, V344, P193, DOI 10.1016/j.ab.2005.06.043; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Simeonovic CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00471; Skyler JS, 2015, DIABETES TECHNOL THE, V17, pS80, DOI 10.1089/dia.2015.1510; Staeva TP, 2013, DIABETES, V62, P9, DOI 10.2337/db12-0562; Takahashi I, 2017, MOL CELL ENDOCRINOL; Takahashi I, 2012, J DIABETES INVEST, V3, P362, DOI 10.1111/j.2040-1124.2012.00205.x; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Theodoraki A, 2015, MOL CELL ENDOCRINOL, V399, P296, DOI 10.1016/j.mce.2014.09.011; Valle A, 2013, DIABETES, V62, P2072, DOI 10.2337/db12-1345; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Wang YD, 2014, DIABETES, V63, P4239, DOI 10.2337/db14-0480; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	57	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191360	10.1371/journal.pone.0191360	http://dx.doi.org/10.1371/journal.pone.0191360			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415062	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000424325300024
J	Yang, HL; Chen, JK				Yang, Haile; Chen, Jiakuan			Integrating landscape system and meta-ecosystem frameworks to advance the understanding of ecosystem function in heterogeneous landscapes: An analysis on the carbon fluxes in the Northern Highlands Lake District (NHLD) of Wisconsin and Michigan	PLOS ONE			English	Article							ECOLOGICAL BOUNDARIES; BAIYANGDIAN BASIN; NETWORK-ANALYSIS; SUBSIDIES; DYNAMICS; EMISSIONS; FEEDBACKS; STATE	The successful integration of ecosystem ecology with landscape ecology would be conducive to understanding how landscapes function. There have been several attempts at this, with two main approaches: (1) an ecosystem-based approach, such as the meta-ecosystem framework and (2) a landscape-based approach, such as the landscape system framework. These two frameworks are currently disconnected. To integrate these two frameworks, we introduce a protocol, and then demonstrate application of the protocol using a case study. The protocol includes four steps: 1) delineating landscape systems; 2) classifying landscape systems; 3) adjusting landscape systems to meta-ecosystems and 4) integrating landscape system and meta-ecosystem frameworks through meta-ecosystems. The case study is the analyzing of the carbon fluxes in the Northern Highlands Lake District (NHLD) of Wisconsin and Michigan using this protocol. The application of this protocol revealed that one could follow this protocol to construct a meta-ecosystem and analyze it using the integrative framework of landscape system and meta-ecosystem frameworks. That is, one could (1) appropriately describe and analyze the spatial heterogeneity of the meta-ecosystem; (2) understand the emergent properties arising from spatial coupling of local ecosystems in the meta-ecosystem. In conclusion, this protocol is a useful approach for integrating the meta-ecosystem framework and the landscape system framework, which advances the describing and analyzing of the spatial heterogeneity and ecosystem function of interconnected ecosystems.	[Yang, Haile; Chen, Jiakuan] Fudan Univ, Inst Biodivers Sci, Shanghai, Peoples R China; [Yang, Haile; Chen, Jiakuan] Fudan Univ, Sch Life Sci, Dept Ecol & Evolutionary Biol, Shanghai, Peoples R China; [Chen, Jiakuan] Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Nanchang University	Chen, JK (corresponding author), Fudan Univ, Inst Biodivers Sci, Shanghai, Peoples R China.; Chen, JK (corresponding author), Fudan Univ, Sch Life Sci, Dept Ecol & Evolutionary Biol, Shanghai, Peoples R China.; Chen, JK (corresponding author), Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China.	jkchen@fudan.edu.cn	Yang, Haile/J-9661-2019	Yang, Haile/0000-0003-2240-4236				Buffam I, 2011, GLOBAL CHANGE BIOL, V17, P1193, DOI 10.1111/j.1365-2486.2010.02313.x; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Cloern JE, 2007, AM NAT, V169, pE21, DOI 10.1086/510258; Crawford JT, 2016, GEOPHYS RES LETT, V43, P1973, DOI 10.1002/2015GL067599; Crawford JT, 2014, GLOBAL CHANGE BIOL, V20, P3408, DOI 10.1111/gcb.12614; Crawford JT, 2014, GLOBAL BIOGEOCHEM CY, V28, P197, DOI 10.1002/2013GB004661; Gounand I, 2018, TRENDS ECOL EVOL, V33, P36, DOI 10.1016/j.tree.2017.10.006; Gounand I, 2017, OIKOS, V126, P972, DOI 10.1111/oik.03922; Gounand I, 2014, AM NAT, V184, P752, DOI 10.1086/678406; Gravel D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12457; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Haegeman B, 2014, ECOL LETT, V17, P175, DOI 10.1111/ele.12214; Harvey E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1496; Huang J, 2014, PLOS ONE, V9; Ireland AW, 2012, J ECOL, V100, P586, DOI 10.1111/j.1365-2745.2012.01961.x; Jager CG, 2014, ECOL MONOGR, V84, P287, DOI 10.1890/13-0613.1; Largaespada C, 2012, ECOLOGY, V93, P324, DOI 10.1890/10-2359.1; Leroux SJ, 2012, ECOSYSTEMS, V15, P48, DOI 10.1007/s10021-011-9492-0; Limberger R, 2017, ECOLOGY, V98, P1082, DOI [10.1002/ecy.1742/suppinfo, 10.1002/ecy.1742]; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P463, DOI 10.1007/0-387-24091-8_24; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P1, DOI 10.1007/0-387-24091-8_1; Mao XF, 2011, ECOL MODEL, V222, P3811, DOI 10.1016/j.ecolmodel.2011.10.002; Marleau JN, 2015, ECOL LETT, V18, P1163, DOI 10.1111/ele.12495; Marleau JN, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2094; Marleau JN, 2010, J THEOR BIOL, V266, P162, DOI 10.1016/j.jtbi.2010.06.022; Patricio J, 2004, ESTUAR COAST SHELF S, V60, P23, DOI 10.1016/j.ecss.2003.11.017; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Small GE, 2014, ECOL MODEL, V293, P150, DOI 10.1016/j.ecolmodel.2014.02.001; Spiecker B, 2016, ECOL APPL, V26, P264, DOI 10.1890/15-0478; Stanley EH, 2016, ECOL MONOGR, V86, P146, DOI 10.1890/15-1027; Turner M.G., 2015, LANDSCAPE ECOLOGY TH, P287; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Yang ZF, 2011, ECOL MODEL, V222, P3785, DOI 10.1016/j.ecolmodel.2011.09.013	36	0	0	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192569	10.1371/journal.pone.0192569	http://dx.doi.org/10.1371/journal.pone.0192569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415066	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300088
J	Lopes, AM; Machado, JAT; Huffstot, JS; Mata, ME				Lopes, Antonio M.; Tenreiro Machado, J. A.; Huffstot, John S.; Mata, Maria Eugenia			Dynamical analysis of the global business-cycle synchronization	PLOS ONE			English	Article							EUROPEAN-COUNTRIES; US RECESSIONS; GLOBALIZATION; COMOVEMENT; ENTROPY; GROWTH; MODEL; TIME; G7	This paper reports the dynamical analysis of the business cycles of 12 (developed and developing) countries over the last 56 years by applying computational techniques used for tackling complex systems. They reveal long-term convergence and country-level interconnections because of close contagion effects caused by bilateral networking exposure. Inter-connectivity determines the magnitude of cross-border impacts. Local features and shock propagation complexity also may be true engines for local configuration of cycles. The algorithmic modeling proves to represent a solid approach to study the complex dynamics involved in the world economies.	[Lopes, Antonio M.] Univ Porto, Fac Engn, INEGI, UISPA,LAETA, Porto, Portugal; [Tenreiro Machado, J. A.] Polytech Porto, Dept Elect Engn, Inst Engn, Porto, Portugal; [Huffstot, John S.; Mata, Maria Eugenia] Univ Nova Lisboa, Fac Econ, Nova Sch Business & Econ, Lisbon, Portugal	Universidade do Porto; Polytechnic Institute of Porto; Universidade Nova de Lisboa	Lopes, AM (corresponding author), Univ Porto, Fac Engn, INEGI, UISPA,LAETA, Porto, Portugal.	aml@fe.up.pt	Machado, J. A. Tenreiro/M-2173-2013; Lopes, António M./A-2740-2016	Machado, J. A. Tenreiro/0000-0003-4274-4879; Lopes, António M./0000-0001-7359-4370; Mata, Maria Eugenia/0000-0003-0461-1338	Nova School of Business and Economics; Banco de Portugal; Fundacao para a Ciencia e a Tecnologia [UID/ECO/00124/2013]; Fundacao para a Ciencia e a Tecnologia ( Social Sciences DataLab) [22209]; POR Norte (Social Sciences DataLab) [22209]	Nova School of Business and Economics; Banco de Portugal; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia ( Social Sciences DataLab); POR Norte (Social Sciences DataLab)	The authors received support from Nova School of Business and Economics and from Banco de Portugal. Additional funding was received from Fundacao para a Ciencia e a Tecnologia (UID/ECO/00124/2013 and Social Sciences DataLab, Project 22209), POR Lisboa (LISBOA-01-0145-FEDER-007722 and Social Sciences DataLab, Project 22209) and POR Norte (Social Sciences DataLab, Project 22209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R., 2014, SOC MANAG REV, V2, P157, DOI [10.1177/2277975213507836, DOI 10.1177/2277975213507836]; Aletti G, 2010, MODEL SIMUL SCI ENG, P203, DOI 10.1007/978-0-8176-4946-3_8; Antonakakis N, 2012, ECON LETT, V117, P467, DOI 10.1016/j.econlet.2012.06.034; Antonakakis N, 2012, APPL ECON LETT, V19, P7, DOI 10.1080/13504851.2011.564126; Artis M, 2011, MANCH SCH, V79, P173, DOI 10.1111/j.1467-9957.2010.02239.x; Artis MJ, 2008, ECON TRANSIT, V16, P559, DOI 10.1111/j.1468-0351.2008.00325.x; Artis MJ, 1997, J BUS, V70, P249, DOI 10.1086/209717; Artis MJ, 1999, OXFORD ECON PAP, V51, P120, DOI 10.1093/oep/51.1.120; Artis MJ, 2004, MACROECONOMIC POLICI; BACKUS DK, 1992, J POLIT ECON, V100, P745, DOI 10.1086/261838; Baxter M, 2005, J MONETARY ECON, V52, P113, DOI 10.1016/j.jmoneco.2004.08.002; Bordo M, 2001, ECON POLICY, P51; Bordo M, 2010, FINANC HIST REV, V17, P127, DOI 10.1017/S0968565010000193; Bouali S, 2012, NONLINEAR ANAL-REAL, V13, P2459, DOI 10.1016/j.nonrwa.2012.02.010; Camacho M, 2008, J ECON DYN CONTROL, V32, P2165, DOI 10.1016/j.jedc.2007.09.018; Castren O, 2014, J BANK FINANC, V46, P43, DOI 10.1016/j.jbankfin.2014.04.027; Chian ACL, 2005, CHAOS SOLITON FRACT, V24, P869, DOI 10.1016/j.chaos.2004.09.080; Deaton A, 2010, J ECON PERSPECT, V24, P3, DOI 10.1257/jep.24.3.3; Del Negro M, 2008, 326 FED RES BANK N Y, V326; Deza M. M., 2009, ENCY DISTANCES; Dibeh G, 2005, REV POLIT ECON, V17, P253, DOI 10.1080/09538250500067304; Diebold FX, 1999, MEASURING BUSINESS C; Doyle BM, 2005, REV ECON STAT, V87, P721, DOI 10.1162/003465305775098134; Ductor L, 2016, J INT ECON, V102, P110, DOI 10.1016/j.jinteco.2016.07.003; Eickmeier S, 2005, SYNCHRONIZED ARE CEN; Filar J. A., 2009, MATH MODELS EC, V3; Gun D., 2017, END GLOBALISATION WE; Harding D, 2006, J ECONOMETRICS, V132, P59, DOI 10.1016/j.jeconom.2005.01.023; Hartigan J., 1975, CLUSTERING ALGORITHM; Helbling T, 2003, ARE THEY ALL SAME BO; Helpman E., 1987, MARKET STRUCTURE FOR; Holoborodko P, 2008, SMOOTH NOISE ROBUST; Hritonenko, 2013, MATH MODELING EC ECO; Imbs J, 2004, REV ECON STAT, V86, P723, DOI 10.1162/0034653041811707; Imbs J, 2010, IMF ECON REV, V58, P327, DOI 10.1057/imfer.2010.13; Johansen S, 2006, CONFRONTING EC MODEL; Juvenal L, 2017, EUR ECON REV, V92, P385, DOI 10.1016/j.euroecorev.2016.06.005; Kalemli-Ozcan S, 2013, J FINANC, V68, P1179, DOI 10.1111/jofi.12025; Kose MA, 2008, J INT ECON, V75, P110, DOI 10.1016/j.jinteco.2007.10.002; Kose MA, 2012, INT ECON REV, V53, P511, DOI 10.1111/j.1468-2354.2012.00690.x; Kose MA, 2003, AM ECON REV, V93, P57, DOI 10.1257/000282803321946804; Krugman Paul, 2009, RETURN DEPRESSION EC; KYDLAND FE, 1982, ECONOMETRICA, V50, P1345, DOI 10.2307/1913386; Lopes AM, 2016, NONLINEAR DYNAM, V85, P1547, DOI 10.1007/s11071-016-2778-1; Lopes AM, 2014, COMMUN NONLINEAR SCI, V19, P851, DOI 10.1016/j.cnsns.2013.08.031; MUNDELL RA, 1961, AM ECON REV, V51, P657; Mutanov G., 2015, MATH METHODS MODELS; Nahorski Z, 2000, ANN OPER RES, V97, P165, DOI 10.1023/A:1018913316076; Peters E.E., 1994, FRACTAL MARKET ANAL; Rose AK, 2002, J MONEY CREDIT BANK, V34, P1067, DOI 10.1353/mcb.2002.0058; ROTE G, 1991, INFORM PROCESS LETT, V38, P123, DOI 10.1016/0020-0190(91)90233-8; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Spatafora N, 2007, CHANGING DYNAMICS GL; STOCKMAN AC, 1988, J MONETARY ECON, V21, P387, DOI 10.1016/0304-3932(88)90037-2; Machado JT, 2014, FRACT CALC APPL ANAL, V17, P1188, DOI 10.2478/s13540-014-0206-0; Machado JAT, 2016, NONLINEAR DYNAM, V86, P1613, DOI 10.1007/s11071-016-2980-1; Machado JAT, 2015, ENTROPY-SWITZ, V17, P5402, DOI 10.3390/e17085402; Machado JAT, 2015, NONLINEAR DYNAM, V80, P1839, DOI 10.1007/s11071-014-1334-0; Machado JAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121277; Machado JAT, 2015, NONLINEAR DYNAM, V79, P63, DOI 10.1007/s11071-014-1645-1; Machado JAT, 2015, COMMUN NONLINEAR SCI, V22, P396, DOI 10.1016/j.cnsns.2014.08.032; Machado JAT, 2014, NONLINEAR DYNAM, V75, P735, DOI 10.1007/s11071-013-1100-8; Machado JAT, 2013, ENTROPY-SWITZ, V15, P3892, DOI 10.3390/e15093892; Van der Wee Herman, 1988, PROSPERITY UPHEAVAL; Xi N, 2014, PHYSICA A, V413, P189, DOI 10.1016/j.physa.2014.07.005; Yetman J, 2011, ECON LETT, V110, P12, DOI 10.1016/j.econlet.2010.09.013	67	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191491	10.1371/journal.pone.0191491	http://dx.doi.org/10.1371/journal.pone.0191491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408909	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800019
J	Zhai, SS; Xu, HT; Fan, CM; Yang, YJ; Hang, F; Guo, XY; Wang, HY; Duan, FJ; Yan, J				Zhai, Shanshan; Xu, Haitao; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying; Wang, Hongyue; Duan, Fujian; Yan, Jun			Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							PRESSURE-GRADIENTS; SURGICAL-TREATMENT; SEPTAL MYECTOMY; CIBENZOLINE; MANAGEMENT; DIAGNOSIS; FUTURE; DEATH	Background Data on the outcomes of hypertrophic cardiomyopathy (HCM) with biventricular obstruction are limited. Objective Our aim is to compare mid-term outcomes of biventricular outflow tract obstruction (BVOTO) HCM, left ventricular outflow tract obstruction (LVOTO) HCM and nonobstructive hypertrophic cardiomyopathy (NO-HCM) in children and adolescents who were treated with standard medication or surgical resection. Methods This retrospective study identified 21 BVOTO patients and recruited 27 LVOTO and 24 NO-HCM patients younger than 18 years presenting at our institution. The primary endpoint was all-cause death, and secondary endpoints were cardiovascular events. Results More BVOTO patients (61.9%) than LVOTO (19.2%) and NO-HCM patients (25%) exhibited New York Heart Association (NYHA) III/IV status (p < 0.01). Fourteen BVOTO and 16 LVOTO patients obtained a significant reduction of outflow tract pressure gradients after surgery (vs. preoperative baseline, p < 0.001). One of the 14 BVOTO patients died, whereas no deaths occurred among LVOTO patients. Three of 14 BVOTO surgery patients had complete heart block (CHB) and 4 had new right bundle branch block (RBBB), while no CHB or RBBB occurred in the LVOTO surgery patients. The BVOTO patients had a longer duration of aortic cross-clamping and postoperative hospital days than the LVOTO patients (p < 0.05). During a median 42-month follow-up, no deaths occurred among the remaining patients. The primary and secondary endpoint-free survival rates of the BVOTO group were comparable to those of the LVOTO and NO-HCM groups. Conclusions In children and adolescents, BVOTO patients were associated with more severe symptoms than LVOTO and NO-HCM patients; however, good mid-term outcomes similar to those of the LVOTO and NO-HCM groups can be achieved with the application of contemporary cardiovascular treatment strategies. Notably, BVOTO surgery was associated with an increased risk of CHB and RBBB compared to LVOTO surgery.	[Zhai, Shanshan; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Minist HlthKey Lab Clinical Trial Res Cardiovascu, Beijing, Peoples R China; [Zhai, Shanshan; Xu, Haitao; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying; Wang, Hongyue; Duan, Fujian; Yan, Jun] Peking Union Med Coll, Beijing, Peoples R China; [Xu, Haitao; Yan, Jun] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pediat Cardiovasc Surg, Beijing, Peoples R China; [Wang, Hongyue] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pathol, Beijing, Peoples R China; [Duan, Fujian] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Echocardiog, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yan, J (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pediat Cardiovasc Surg, Beijing, Peoples R China.	yanjun1112aliyun@163.com						BARR PA, 1973, BRIT HEART J, V35, P1109; BRIK H, 1978, J CLIN ULTRASOUND, V6, P121, DOI 10.1002/jcu.1870060216; Butz T, 2008, EUR J ECHOCARDIOGR, V9, P403, DOI [10.1093/ejechocard/jen153, 10.1093/ejechocard/jem074, 10.1016/j.euje.2007.02.006, 10.1093/ejechocard/jen018, 10.1093/ejechocard/jen026]; Christiaans I, 2010, EUROPACE, V12, P313, DOI 10.1093/europace/eup431; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Guo XY, 2015, CARDIOLOGY, V133, P35, DOI 10.1159/000439345; Heper G, 2010, TURK KARDIYOL DERN A, V38, P206; Hiasa G, 2002, CIRC J, V66, P1173, DOI 10.1253/circj.66.1173; Hirapur I, 2014, BMJ CASE REP, V2014; Howell N, 2015, ECHO RES PRACT, V2, pR37, DOI 10.1530/ERP-15-0005; Ishikawa T, 2010, PEDIATR CARDIOL, V31, P707, DOI 10.1007/s00246-010-9651-7; Krecki R, 2007, CIRCULATION, V116, pE551, DOI 10.1161/CIRCULATIONAHA.107.703843; Malik R, 2014, ECHOCARDIOGR-J CARD, V31, P682, DOI 10.1111/echo.12543; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; MARON BJ, 1982, CIRCULATION, V65, P7, DOI 10.1161/01.CIR.65.1.7; MARON BJ, 1993, AM J CARDIOL, V71, P1089, DOI 10.1016/0002-9149(93)90578-Z; Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061; McCully RB, 1996, CIRCULATION, V94, P467, DOI 10.1161/01.CIR.94.3.467; Nelson SE, 2013, TEX HEART I J, V40, P367; Ommen SR, 2008, HEART, V94, P1276, DOI 10.1136/hrt.2008.154435; Parato VM, 2016, CARDIOVASC ULTRASOUN, V14, DOI 10.1186/s12947-016-0072-5; Quintana E, 2015, EUR J CARDIO-THORAC, V47, P1006, DOI 10.1093/ejcts/ezu313; Recupero A, 2010, INT J CARDIOL, V144, pE56, DOI 10.1016/j.ijcard.2008.12.082; Schaff HV, 2012, J THORAC CARDIOV SUR, V143, P303, DOI 10.1016/j.jtcvs.2011.10.059; Shimizu M, 2003, CIRC J, V67, P855, DOI 10.1253/circj.67.855; Theodoro DA, 1996, J THORAC CARDIOV SUR, V112, P1589, DOI 10.1016/S0022-5223(96)70018-1; Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055; Vriesendorp PA, 2014, JACC-HEART FAIL, V2, P630, DOI 10.1016/j.jchf.2014.06.012; Woo Anna, 2007, Heart Fail Clin, V3, P275, DOI 10.1016/j.hfc.2007.04.010	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192218	10.1371/journal.pone.0192218	http://dx.doi.org/10.1371/journal.pone.0192218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408870	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800050
J	Chandrasegaran, K; Kandregula, SR; Quader, S; Juliano, SA				Chandrasegaran, Karthikeyan; Kandregula, Samyuktha Rao; Quader, Suhel; Juliano, Steven A.			Context-dependent interactive effects of non-lethal predation on larvae impact adult longevity and body composition	PLOS ONE			English	Article							INDUCED PHENOTYPIC PLASTICITY; CONTAINER-DWELLING MOSQUITOS; AEDES-AEGYPTI DIPTERA; LIFE-HISTORY TRAITS; WATER-BORNE CUES; PREY INTERACTIONS; BEHAVIORAL-RESPONSES; FOOD AVAILABILITY; DEVELOPMENT TIME; ECOLOGICAL CONSEQUENCES	Predation impacts development, behavior and morphology of prey species thereby shaping their abundances, distribution and community structure. Non-lethal threat of predation, specifically, can have a strong influence on prey lifehistory characteristics. While investigations often focus on the impact of predation threat on prey in isolation, tests of its interactive effects with food availability and resource competition on prey survival and fitness can improve understanding of costs, benefits and trade-offs of anti-predator strategies. This study, involving Aedes aegypti mosquitoes as a model organism, investigates both simple and interactive effects of predation threat during the larval stage on survival, size at and time to maturity, stored teneral reserves of glycogen, protein and lipid in adults, and adult longevity. Our results show that development times of mosquito larvae were increased (by 14.84% in males and by 97.63% in females), and size of eclosing adults decreased (by 62.30% in males and by 58.33% in females) when exposed to lowered nutrition and elevated intraspecific competition, but that predation had no detectable effect on these simple traits. Teneral reserves of glycogen, protein and lipid and adult longevity were positively correlated with adult body size. Non-lethal predation threat had significant interactive effects with nutrition and larval competition on teneral reserves in males and adult longevity in males and females. The sexes responded differently to conditions encountered as larvae, with the larval environment affecting development and adult characteristics more acutely for females than for males. The outcome of this study shows how threat of predation on juveniles can have long-lasting effects on adults that are likely to impact mosquito population dynamics and that may impact disease transmission.	[Chandrasegaran, Karthikeyan; Kandregula, Samyuktha Rao; Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, Karnataka, India; [Chandrasegaran, Karthikeyan; Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [Chandrasegaran, Karthikeyan] SASTRA Univ, Thanjavur, Tamil Nadu, India; [Chandrasegaran, Karthikeyan] Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India; [Quader, Suhel] Nat Conservat Fdn, Mysuru, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Illinois State University; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Indian Institute of Science (IISC) - Bangalore	Chandrasegaran, K (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, Karnataka, India.; Chandrasegaran, K (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.; Chandrasegaran, K (corresponding author), SASTRA Univ, Thanjavur, Tamil Nadu, India.; Chandrasegaran, K (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India.	karthikeyanc@ncbs.res.in	Chandrasegaran, Karthikeyan/I-4037-2019	Chandrasegaran, Karthikeyan/0000-0001-8262-1510; Juliano, Steven/0000-0002-6178-4553	US-India Educational Foundation, New Delhi (India); Institute of International Education, New York (USA); Institute of International Education; School of Biological Sciences, Illinois State University; National Institute of Health [1R15AI094322-01A1]; National Centre for Biological Sciences, India	US-India Educational Foundation, New Delhi (India); Institute of International Education, New York (USA); Institute of International Education; School of Biological Sciences, Illinois State University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centre for Biological Sciences, India	This research was supported by: Fulbright-Nehru Doctoral Research Fellowship 2014-15 from the US-India Educational Foundation, New Delhi (India) and the Institute of International Education, New York (USA) to KC; 2015 Patel Grant sponsored by the Institute of International Education to KC; R.D.Wiegel Phi Sigma Research Grant from the School of Biological Sciences, Illinois State University all to KC; by National Institute of Health grant 1R15AI094322-01A1 to SAJ; and by National Centre for Biological Sciences, India support to SQ.	ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Alto BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045785; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BALL SL, 1995, FRESHWATER BIOL, V34, P1, DOI 10.1111/j.1365-2427.1995.tb00417.x; BAY EC, 1974, ANNU REV ENTOMOL, V19, P441, DOI 10.1146/annurev.en.19.010174.002301; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; Bridges CM, 2002, J HERPETOL, V36, P627; Briegel H, 2003, J VECTOR ECOL, V28, P1; Briegel H, 2001, J VECTOR ECOL, V26, P21; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; Carlsson N, 2004, FRESHWATER BIOL, V49, P1269, DOI 10.1111/j.1365-2427.2004.01269.x; Chandra K., 2017, ENCY DATABASE SYSTEM, P1; Chivers DP, 2001, J CHEM ECOL, V27, P45, DOI 10.1023/A:1005663815856; Christophers, 1960, AEDES AEGYPTI L YELL; Costanzo KS, 2011, ECOL ENTOMOL, V36, P605, DOI 10.1111/j.1365-2311.2011.01302.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DILL LM, 1987, CAN J ZOOL, V65, P803, DOI 10.1139/z87-128; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V62, P1079, DOI 10.1007/s00265-007-0535-7; Ferrari MCO, 2007, CHEMOECOLOGY, V17, P223, DOI 10.1007/s00049-007-0380-1; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Foray V, 2012, PHYSIOL ENTOMOL, V37, P295, DOI 10.1111/j.1365-3032.2012.00831.x; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Grill CP, 1996, J ANIM ECOL, V65, P63, DOI 10.2307/5700; HEADS PA, 1986, ECOL ENTOMOL, V11, P369, DOI 10.1111/j.1365-2311.1986.tb00315.x; Hechtel LJ, 1997, ECOLOGY, V78, P838, DOI 10.1890/0012-9658(1997)078[0838:EOAPOP]2.0.CO;2; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; Jourdan J, 2016, AQUAT SCI, V78, P303, DOI 10.1007/s00027-015-0432-5; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; JULIANO SA, 1992, OIKOS, V63, P465, DOI 10.2307/3544974; Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455; Kaplan I, 2012, ARTHROPOD-PLANT INTE, V6, P181, DOI 10.1007/s11829-011-9175-y; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Kesavaraju B, 2004, ANN ENTOMOL SOC AM, V97, P194, DOI 10.1603/0013-8746(2004)097[0194:DBRTWC]2.0.CO;2; Kesavaraju B, 2007, ECOL ENTOMOL, V32, P262, DOI 10.1111/j.1365-2311.2006.00846.x; Kesavaraju B, 2007, ETHOLOGY, V113, P199, DOI 10.1111/j.1439-0310.2006.01317.x; Kesavaraju B, 2010, ANN ENTOMOL SOC AM, V103, P1038, DOI 10.1603/AN10007; KLECKNER CA, 1995, ECOLOGY, V76, P1242, DOI 10.2307/1940931; Knight TM, 2004, J VECTOR ECOL, V29, P277; LEA AO, 1978, PHYSIOL ENTOMOL, V3, P309, DOI 10.1111/j.1365-3032.1978.tb00164.x; LEONARD PM, 1995, ECOL ENTOMOL, V20, P125, DOI 10.1111/j.1365-2311.1995.tb00438.x; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lind MI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1651; Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Mercer DR, 2008, J MED ENTOMOL, V45, P861, DOI 10.1603/0022-2585(2008)45[861:SDILMR]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mostowy WM, 2004, J VECTOR ECOL, V29, P84; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; Naksathit AT, 1998, J AM MOSQUITO CONTR, V14, P148; Nicieza AG, 2000, OECOLOGIA, V123, P497, DOI 10.1007/s004420000343; Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015; Plaistow SJ, 2004, P ROY SOC B-BIOL SCI, V271, P919, DOI 10.1098/rspb.2004.2682; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Resetarits WJ, 2001, OECOLOGIA, V129, P155, DOI 10.1007/s004420100704; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roper C, 1996, J EVOLUTION BIOL, V9, P609, DOI 10.1046/j.1420-9101.1996.9050609.x; *SAS I INC, 1989, SAS STAT USERS GUIDE, V2; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Silberbush A, 2015, ACTA TROP, V150, P196, DOI 10.1016/j.actatropica.2015.08.001; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Timmermann SE, 1999, J INSECT PHYSIOL, V45, P461, DOI 10.1016/S0022-1910(98)00147-4; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; van Uitregt VO, 2012, J ANIM ECOL, V81, P108, DOI 10.1111/j.1365-2656.2011.01880.x; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WIKLUND C, 1977, OECOLOGIA, V31, P153, DOI 10.1007/BF00346917; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wormington JD, 2014, EVOL ECOL RES, V16, P223; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X; Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115	108	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192104	10.1371/journal.pone.0192104	http://dx.doi.org/10.1371/journal.pone.0192104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401513	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400035
J	Hoffmans, R; Wagemakers, A; van Drunen, C; Hellings, P; Fokkens, W				Hoffmans, Ruth; Wagemakers, Alex; van Drunen, Cornelis; Hellings, Peter; Fokkens, Wytske			Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment	PLOS ONE			English	Article							UPPER AIRWAY DISEASE; SOCIOECONOMIC-STATUS; OCCUPATIONAL RHINITIS; CHRONIC URTICARIA; GENERAL-PRACTICE; RISK-FACTORS; ASTHMA; PREVALENCE; POPULATION; IMPACT	Background This study was conducted to assess the effect of comorbidity, ethnicity, occupation, smoking and place of residence on allergic rhinitis (AR), acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS). Methods A GA(2) LEN (The Global Allergy and Asthma European Network) screening questionnaire was sent to a random sample of the Dutch population (n = 16700) in three different areas of the Netherlands. Results Fifty percent (8347) of the questionnaires sent were returned. A total of 29% respondents (27-31% in different areas) met the criteria for AR, 18% (17-21%) for ARS and 16% (13-18%) for CRS. Risk factors for AR were itchy rash, eczema, adverse response after taking a painkiller, asthma, CRS and ARS. Moreover, the risk of AR was twice as low for full-time housewives/househusbands than for people with jobs. The risk of ARS or CRS was significantly higher in respondents with a doctor's diagnosis of CRS, AR, itchy rash or smoking. The risk of CRS was also significantly higher in respondents with an adverse response after taking painkillers, active smoking or asthma. Caucasians are generally less likely to have AR or CRS than Latin-Americans, Hindustani and African-Creoles, and more likely to have ARS than Asian, Hindustani, Mediterranean and African-Creoles. Conclusions This study found shared and distinct risk factors for AR, ARS and CRS and therefore provides support for the belief that they have shared symptoms but are different diseases with different aetiologies.	[Hoffmans, Ruth; Wagemakers, Alex; van Drunen, Cornelis; Hellings, Peter; Fokkens, Wytske] Acad Med Ctr, Amsterdam, Netherlands; [Hellings, Peter] UZ Leuven, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven	Hoffmans, R (corresponding author), Acad Med Ctr, Amsterdam, Netherlands.	r.hoffmans@amc.nl	Fokkens, Wytske WJ/ABF-2185-2020; Hellings, Peter W/I-4068-2018	Hellings, Peter W/0000-0001-6898-688X; van Drunen, Cornelis M/0000-0001-5503-066X; Wagemakers, Alex/0000-0001-9632-7830				Baroody FM, 2012, OTOLARYNG HEAD NECK, V146, P880, DOI 10.1177/0194599811435972; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2003, ALLERGY, P41; Buss Yiling Andrea, 2007, J Dtsch Dermatol Ges, V5, P22, DOI 10.1111/j.1610-0387.2007.06194.x; Chung SD, 2014, LARYNGOSCOPE, V124, P1536, DOI 10.1002/lary.24581; Dixon AE, 2009, CURR OPIN PULM MED, V15, P19, DOI 10.1097/MCP.0b013e32831da87e; Eriksson J, 2013, ALLERGY, V68, P347, DOI 10.1111/all.12095; Ertam I, 2007, J EUR ACAD DERMATOL, V21, P777, DOI 10.1111/j.1468-3083.2006.02083.x; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Giavina-Bianchi P, 2016, J ASTHMA ALLERGY, V9, P93, DOI 10.2147/JAA.S81541; GILLAM SJ, 1989, BRIT MED J, V299, P953, DOI 10.1136/bmj.299.6705.953; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hellings PW, 2006, ALLERGY, V61, P656, DOI 10.1111/j.1398-9995.2006.01109.x; Higgins TS, 2012, CURR OPIN OTOLARYNGO, V20, P209, DOI 10.1097/MOO.0b013e3283534821; Hirsch AG, 2017, ALLERGY, V72, P274, DOI 10.1111/all.13042; Hirsch AG, 2015, ALLERGY, V70, P1613, DOI 10.1111/all.12759; Hoffmans R, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0332-8; Hoffmans R, 2011, PRIM CARE RESP J, V20, P64, DOI 10.4104/pcrj.2010.00064; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Hox V, 2012, ALLERGY, V67, P560, DOI 10.1111/j.1398-9995.2011.02779.x; Hytonen M, 1997, INT ARCH OCC ENV HEA, V69, P487, DOI 10.1007/s004200050178; Jang AS, 2016, CURR OPIN ALLERGY CL, V16, P13, DOI 10.1097/ACI.0000000000000235; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kilty SJ, 2011, RHINOLOGY, V49, P533, DOI 10.4193/Rhino10.298; Krouse JH, 2007, OTOLARYNG HEAD NECK, V136, pS75, DOI 10.1016/j.otohns.2007.02.019; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-2; Montnemery P, 2003, RESP MED, V97, P970, DOI 10.1016/S0954-6111(03)00126-4; Moscato G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-16; Moscato G, 2009, CURR OPIN ALLERGY CL, V9, P110, DOI 10.1097/ACI.0b013e328328cfe7; Nachman KE, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-25; Olivieri M, 2016, ALLERGY, V71, P859, DOI 10.1111/all.12841; Olivieri M, 2002, ALLERGY, V57, P600, DOI 10.1034/j.1398-9995.2002.23537.x; Olze H, 2011, CURR OPIN ALLERGY CL, V11, P457, DOI 10.1097/ACI.0b013e32834a9764; Ozdemir N, 2000, RESP MED, V94, P536, DOI 10.1053/rmed.1999.0728; Park DJ, 2015, ANN RHEUM DIS, V74, P569, DOI 10.1136/annrheumdis-2015-eular.2735; Philpott C, 2016, RHINOLOGY, V54, P134, DOI [10.4193/Rhino15.272, 10.4193/Rhin15.272]; Radon K, 2008, OCCUP ENVIRON MED, V65, P38, DOI 10.1136/oem.2006.031542; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, P197, DOI 10.1177/0194599814562166; Smith DF, 2013, OTOLARYNG HEAD NECK, V149, P639, DOI 10.1177/0194599813498206; Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P110, DOI 10.2500/ajra.2012.26.3741; Stevens WW, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0487-8; Sundaresan AS, 2015, INT FORUM ALLERGY RH, V5, P996, DOI 10.1002/alr.21573; Tan BK, 2013, AM J RESP CRIT CARE, V188, P1275, DOI 10.1164/rccm.201308-1500ED; Tan T. Y., 1998, SMJ, V39, P59; Thilsing T, 2012, AM J IND MED, V55, P1037, DOI 10.1002/ajim.22074; Tomassen P, 2011, ALLERGY, V66, P556, DOI 10.1111/j.1398-9995.2010.02503.x; Wedi Bettina, 2009, Allergy Asthma Clin Immunol, V5, P10, DOI 10.1186/1710-1492-5-10	54	24	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192330	10.1371/journal.pone.0192330	http://dx.doi.org/10.1371/journal.pone.0192330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401486	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400049
J	Pigeault, R; Villa, M				Pigeault, Romain; Villa, Manon			Long-term pathogenic response to Plasmodium relictum infection in Culex pipiens mosquito	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; MALARIA INFECTION; TRADE-OFFS; FECUNDITY; TRANSMISSION; MANIPULATION; REDUCTION; MORTALITY; APOPTOSIS; SURVIVAL	The transmission of Plasmodium within a vertebrate host population is strongly associated with the life history traits of its vector. Therefore the effect of malaria infection on mosquito fecundity and longevity has traditionally received a lot of attention. Several species of malaria parasites reduce mosquito fecundity, nevertheless almost all of the studies have focused only on the first gonotrophic cycle. Yet, during their lifetime, female mosquitoes go through several gonotrophic cycles, which raises the question of whether they are able to compensate the fecundity costs induced by the parasite. The impact of Plasmodium infection on female longevity is not so clear and has produced conflicting results. Here we measured the impact of Plasmodium relictum on its vector's longevity and fecundity during three consecutive gonotrophic cycles. In accordance with previous studies, we observed a negative impact of Plasmodium infection on mosquito (Culex pipiens) fecundity in the first gonotrophic cycle. Interestingly, despite having taken two subsequent uninfected blood meals, the negative impact of malaria parasite persisted. Nevertheless no impact of infection on mosquito longevity was observed. Our results are not in line with the hypothesis that the reduction of fecundity observed in infected mosquitoes is an adaptive strategy of Plasmodium to increase the longevity of its vector. We discuss the different underlying mechanisms that may explain our results.	[Pigeault, Romain] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Pigeault, Romain; Villa, Manon] Univ Montpellier, CNRS 5290, MIVEGEC, UMR IRD 224, Montpellier, France	University of Lausanne; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pigeault, R (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.; Pigeault, R (corresponding author), Univ Montpellier, CNRS 5290, MIVEGEC, UMR IRD 224, Montpellier, France.	romain.pigeault@unil.ch		pigeault, romain/0000-0002-8011-4600				Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Delhaye J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1905-7; Ferguson HM, 2003, PARASITOLOGY, V127, P9, DOI 10.1017/S0031182003003287; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gray EM, 2006, PARASITOLOGY, V132, P169, DOI 10.1017/S0031182005008966; Han YS, 2002, INSECT BIOCHEM MOLEC, V32, P1311, DOI 10.1016/S0965-1748(02)00093-0; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hogg JC, 1995, PARASITOLOGY, V111, P555, DOI 10.1017/S0031182000077027; Hopwood JA, 2001, J EXP BIOL, V204, P2773; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; HURD H, 1995, PARASITOL TODAY, V11, P411, DOI 10.1016/0169-4758(95)80021-2; Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4; Hurd H., 2009, PARASITOLOGY B A, P85; Lalubin F, 2014, J ANIM ECOL, V83, P850, DOI 10.1111/1365-2656.12190; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; LI XH, 1992, MED VET ENTOMOL, V6, P57, DOI 10.1111/j.1365-2915.1992.tb00036.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Pigeault R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0300; Richards SL, 2012, J VECTOR ECOL, V37, P1, DOI 10.1111/j.1948-7134.2012.00194.x; Schwartz A, 2001, TRENDS PARASITOL, V17, P189, DOI 10.1016/S1471-4922(00)01945-0; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Taylor PJ, 2001, PARASITOLOGY, V122, P491, DOI 10.1017/S0031182001007776; Valkiunas G, 2004, AVIAN MALARIA PARASI; Vezilier J, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0840; Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394; Vezilier J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-379; Zele F, 2012, J EVOLUTION BIOL, V25, P1243, DOI 10.1111/j.1420-9101.2012.02519.x; Zele F, 2017, PARASITOLOGY, P1	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192315	10.1371/journal.pone.0192315	http://dx.doi.org/10.1371/journal.pone.0192315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401525	gold, Green Published			2022-12-27	WOS:000424101400047
J	Wang, JF; Zhou, ZH; He, F; Ruan, Z; Jiang, Y; Hua, XT; Yu, YS				Wang, Jianfeng; Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong			The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606	PLOS ONE			English	Article							CARBAPENEM RESISTANCE; ESCHERICHIA-COLI; EPITHELIAL-CELLS; OMPA	The Type VI Secretion System (T6SS) is an important virulence system that exists in many bacterial pathogens, and has emerged as a potent mediator of pathogenicity in Acinetobacter baumannii. In this study, we inactivated one of the T6SS components vgrG (valine-glycine repeat G) gene in A. baumannii ATCC 19606 and constructed a complementation strain. BEAS-2b human alveolar epithelial cells was adopted to assess bacterial adhesion, and wild female BALB/c mice were used for in vivo experiments to assess the bacterial killing ability to host. Upon deletion of the vgrG gene, increased antimicrobial resistance to ampicillin/sulbactam, but reduced resistance to chloramphenicol were observed. The vgrG mutant strain showed lower growth rate, reduced eukaryotic cell adherence and impaired lethality in mice. However, the vgrG mutant strain is not implicated in biofilm formation. Our study suggests that the Type VI Secretion System core component VgrG contributes to both virulence and antimicrobial resistance in A. baumannii ATCC 19606.	[Wang, Jianfeng] Hangzhou Normal Univ, Affiliated Hosp, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong] Key Lab Microbial Technol & Bioinformat Zhejiang, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China.; Yu, YS (corresponding author), Key Lab Microbial Technol & Bioinformat Zhejiang, Hangzhou, Zhejiang, Peoples R China.	yvys119@zju.edu.cn	Hua, Xiaoting/B-5786-2011; Ruan, Zhi/P-3987-2015	Hua, Xiaoting/0000-0001-8215-916X; Ruan, Zhi/0000-0001-8648-4592	National Natural Science Foundation of China [81371858]; 973 Preliminary Research Program [2014CB560707]; Zhejiang Provincial Natural Science Foundation of China [LQY18H190001]; Zhejiang Provincial Medical and Health Science and Technology Plan [2017KY125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Preliminary Research Program; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical and Health Science and Technology Plan	This study was supported by research grants from National Natural Science Foundation of China (81371858 to YJ), the 973 Preliminary Research Program (2014CB560707 to YY), Zhejiang Provincial Natural Science Foundation of China (LQY18H190001 to JW), and Zhejiang Provincial Medical and Health Science and Technology Plan (2017KY125 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Aubert DF, 2015, MICROBIOL-SGM, V161, P2161, DOI 10.1099/mic.0.000174; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Chatterjee S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01126; Davenport K.W., 2014, GENOME ANNOUNCEMENTS, V2; Desilets M, 2015, INFLAMMATORY BOWEL D; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hu FP, 2016, CLIN MICROBIOL INFEC, V22, pS9, DOI 10.1016/j.cmi.2016.01.001; Jones C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081132; Li X M, 2016, 2016 INT C ADV MECH, V2016, P26, DOI DOI 10.1007/S10096-016-2674-0; Lin MF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-119; Linkevicius M, 2013, J ANTIMICROB CHEMOTH, V68, P2809, DOI 10.1093/jac/dkt263; Ma JL, 2014, INFECT IMMUN, V82, P3867, DOI 10.1128/IAI.01769-14; Miyata ST, 2013, J MED MICROBIOL, V62, P663, DOI 10.1099/jmm.0.053983-0; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pournaras S, 2017, INT J ANTIMICROB AG, V49, P749, DOI 10.1016/j.ijantimicag.2017.01.028; Repizo GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138265; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Roussel L, 2017, BIOCHEM BIOPH RES CO, V483, P829, DOI 10.1016/j.bbrc.2017.01.009; Ruiz FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129691; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Smani Y, 2014, ANTIMICROB AGENTS CH, V58, P1806, DOI 10.1128/AAC.02101-13; Tal-Jasper R, 2016, ANTIMICROB AGENTS CH, V60, P3127, DOI 10.1128/AAC.02656-15; Tipton KA, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.418; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112	29	26	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192288	10.1371/journal.pone.0192288	http://dx.doi.org/10.1371/journal.pone.0192288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394284	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400032
J	Cheng, CH; Lin, CC; Chen, HL; Lin, IT; Wu, CH; Lee, YK; Bair, MJ				Cheng, Chun-Han; Lin, Ching-Chung; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong			Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection	PLOS ONE			English	Article							PRISON-INMATES; CLINICAL-IMPLICATIONS; MOLECULAR EPIDEMIOLOGY; VIRUS GENOTYPES; PLUS RIBAVIRIN; HCV TREATMENT; PREVALENCE; TAIWAN; POPULATION; USERS	The prevalence of hepatitis C virus (HCV) infection is disproportionately high among prisoners, especially among those who are drug-dependent. However, current screening and treatment recommendations are inconsistent for this population, and appropriate care is not reliably provided. To address these problems, the present study aimed to identify unique characteristics and clinical manifestations of incarcerated patients with HCV infection. We included incarcerated patients who received treatment with pegylated-interferon combined with ribavirin at Mackay Memorial Hospital in Taitung and were serving sentences at either the Taiyuan Skill Training Institute or the Yanwan Training Institute. HCV genotypes 1 (41.4%), 3 (25.9%), and 6 (24.1%) were the most prevalent in the incarcerated patients. During the study period, we analyzed treatment response among 58 incarcerated patients and compared obtained results with treatment response among 52 patients who were living in the community. Higher sustained virological response rate was observed among patients with incarceration and HCV genotype other than 1. The odds ratios (corresponding 95% confidence intervals) for incarceration and genotype 1 were 2.75 (1.06-7.11) and 0.37 (0.14-0.99), respectively. Better treatment compliance among incarcerated patients might partially explain these results. The results of this study suggest that treatment of prisoners with HCV infection is feasible and effective. More appropriate and timely methods are needed to prevent HCV transmission among injection drug users inside prisons.	[Cheng, Chun-Han; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong] Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan; [Cheng, Chun-Han; Lin, Ching-Chung; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong] Mackay Med Coll, New Taipei, Taiwan; [Lin, Ching-Chung] Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital	Bair, MJ (corresponding author), Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan.; Bair, MJ (corresponding author), Mackay Med Coll, New Taipei, Taiwan.	a5963@mmh.org.tw		Cheng, Chun-han/0000-0002-7262-861X				Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; Almasio PL, 2011, DIGEST LIVER DIS, V43, P589, DOI 10.1016/j.dld.2010.12.004; Boonwaat L, 2010, MED J AUSTRALIA, V192, P496, DOI 10.5694/j.1326-5377.2010.tb03605.x; Bretschneider W, 2014, J BIOETHIC INQ, V11, P319, DOI 10.1007/s11673-014-9547-y; Cheng CH, 2017, KAOHSIUNG J MED SCI, V33, P510, DOI 10.1016/j.kjms.2017.06.005; Cheng CH, 2015, KAOHSIUNG J MED SCI, V31, P597, DOI 10.1016/j.kjms.2015.09.006; Chew KW, 2009, J CLIN GASTROENTEROL, V43, P686, DOI 10.1097/MCG.0b013e31818dd94c; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Farley J, 2005, AM J PUBLIC HEALTH, V95, P1737, DOI 10.2105/AJPH.2004.056150; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Iacomi F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-374; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lee CM, 2006, T ROY SOC TROP MED H, V100, P767, DOI 10.1016/j.trstmh.2005.10.008; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Meyer MF, 2007, EPIDEMIOL INFECT, V135, P274, DOI 10.1017/S0950268806006820; Pena-Orellana M, 2011, J HEALTH CARE POOR U, V22, P962, DOI 10.1353/hpu.2011.0084; Rice JP, 2012, HEPATOLOGY, V56, P1252, DOI 10.1002/hep.25770; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Spaulding AC, 2006, ANN INTERN MED, V144, P762, DOI 10.7326/0003-4819-144-10-200605160-00010; Sterling RK, 2004, AM J GASTROENTEROL, V99, P866, DOI 10.1111/j.1572-0241.2004.30310.x; Stone J, 2017, ADDICTION, V112, P1302, DOI 10.1111/add.13783; Strock P, 2009, DIGEST DIS SCI, V54, P1325, DOI 10.1007/s10620-008-0483-8; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Tyczyno M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14559; Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001; Zampino R, 2015, WORLD J HEPATOL, V7, P2323, DOI 10.4254/wjh.v7.i21.2323	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191799	10.1371/journal.pone.0191799	http://dx.doi.org/10.1371/journal.pone.0191799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389957	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400035
J	Choudhary, N; Bawa, V; Paliwal, R; Singh, B; Bhat, MA; Mir, JI; Gupta, M; Sofi, PA; Thudi, M; Varshney, RK; Mir, RR				Choudhary, Neeraj; Bawa, Vanya; Paliwal, Rajneesh; Singh, Bikram; Bhat, Mohd. Ashraf; Mir, Javid Iqbal; Gupta, Moni; Sofi, Parvaze A.; Thudi, Mahendar; Varshney, Rajeev K.; Mir, Reyazul Rouf			Gene/QTL discovery for Anthracnose in common bean (Phaseolus vulgaris L.) from North-western Himalayas	PLOS ONE			English	Article							RACE-SPECIFIC RESISTANCE; COLLETOTRICHUM-LINDEMUTHIANUM; SSR MARKERS; DIVERSITY; GENES; GENOTYPE; TRAITS; MEXICO; SET; MAP	Common bean (Phaseolus vulgaris L.) is one of the most important grain legume crops in the world. The beans grown in north-western Himalayas possess huge diversity for seed color, shape and size but are mostly susceptible to Anthracnose disease caused by seed born fungus Colletotrichum lindemuthianum. Dozens of QTLs/genes have been already identified for this disease in common bean world-wide. However, this is the first report of gene/QTL discovery for Anthracnose using bean germplasm from north-western Himalayas of state Jammu & Kashmir, India. A core set of 96 bean lines comprising 54 indigenous local landraces from 11 hot-spots and 42 exotic lines from 10 different countries were phenotyped at two locations (SKUAST-Jammu and Bhaderwah, Jammu) for Anthracnose resistance. The core set was also genotyped with genome-wide (91) random and trait linked SSR markers. The study of marker-trait associations (MTAs) led to the identification of 10 QTLs/genes for Anthracnose resistance. Among the 10 QTLs/genes identified, two MTAs are stable (BM45 & BM211), two MTAs (PVctt1 & BM211) are major explaining more than 20% phenotypic variation for Anthracnose and one MTA (BM211) is both stable and major. Six (06) genomic regions are reported for the first time, while as four (04) genomic regions validated the already known QTL/gene regions/clusters for Anthracnose. The major, stable and validated markers reported during the present study associated with Anthracnose resistance will prove useful in common bean molecular breeding programs aimed at enhancing Anthracnose resistance of local bean landraces grown in north-western Himalayas of state Jammu and Kashmir.	[Choudhary, Neeraj; Bawa, Vanya; Singh, Bikram; Gupta, Moni] SKUAST J, Div Plant Breeding & Genet, Jammu, Jammu & Kashmir, India; [Paliwal, Rajneesh] IITA, Ibadan, Oyo State, Nigeria; [Bhat, Mohd. Ashraf; Sofi, Parvaze A.; Mir, Reyazul Rouf] SKUAST K, Div Genet & Plant Breeding, FoA, Wadoora Campus, Sopore, Jammu & Kashmir, India; [Mir, Javid Iqbal] CITH, Plant Biotechnol Ctr, Srinagar, Jammu & Kashmir, India; [Thudi, Mahendar; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Res Program Grain Legumes, Hyderabad, Telangana State, India	Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); CGIAR; International Institute of Tropical Agriculture (IITA); Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Temperate Horticulture; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Mir, RR (corresponding author), SKUAST K, Div Genet & Plant Breeding, FoA, Wadoora Campus, Sopore, Jammu & Kashmir, India.	imrouf2006@gmail.com	Sofi, Parvaze/ABH-3359-2021; THUDI, MAHENDAR/GXA-1578-2022; Varshney, Rajeev K/C-5295-2014; Mir, Reyazul rouf/H-4232-2019; Mir, Javid/GLT-6517-2022; Paliwal, Rajneesh/GXH-3616-2022	Sofi, Parvaze/0000-0001-8283-5420; THUDI, MAHENDAR/0000-0003-2851-6837; Varshney, Rajeev K/0000-0002-4562-9131; Mir, Reyazul rouf/0000-0002-3196-211X; Sofi, Parvez Ahmad/0000-0002-7296-2167	Science and Engineering Research Board (SERB) India [SB/FT/LS-355/2012]; SERB, DST, Govt. of India; Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India [SB/FT/LS-355/2012]	Science and Engineering Research Board (SERB) India; SERB, DST, Govt. of India; Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India	This work was supported by the Science and Engineering Research Board (SERB) India (No. SB/FT/LS-355/2012) to RRM. Neeraj Choudhary received a fellowship from SERB, DST, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are highly thankful to Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India for providing funds under Young Scientist Award (Grant ID No: SB/FT/LS-355/2012) to Dr. Reyazul Rouf Mir. Neeraj Choudhary is thankful to SERB, DST, Govt. of India for providing her fellowship. Thanks are also due to Head Division of Plant Breeding &Genetics and Director Research, SKUAST-Jammu for facilitating this work.	Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; Beebe Stephen, 2000, Food and Nutrition Bulletin, V21, P387; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; Choudhary N, 2017, GENET RESOUR CROP EV; DRIJFHOUT E, 1989, PLANT PATHOL, V38, P391, DOI 10.1111/j.1365-3059.1989.tb02158.x; Fernandez MT, 2000, EUPHYTICA, V114, P143, DOI 10.1023/A:1003937812700; Food and Agriculture Organization of the United Nations (FAO), 2014, FOOD AGR COMM PROD; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Garzon LN, 2014, CROP J, V2, P183, DOI 10.1016/j.cj.2014.04.002; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; Gonzalez-Chavira M, 2004, PLANT DIS, V88, P152, DOI 10.1094/PDIS.2004.88.2.152; Grisi MCM, 2007, GENET MOL RES, V6, P691; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Melotto M, 2000, COLLETOTRICHUM, P346; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Oblessuc PR, 2014, MOL BREEDING, V34, P1313, DOI 10.1007/s11032-014-0118-z; Pritchard JK, 2000, GENETICS, V155, P945; Rana JC, 2015, EUPHYTICA, V205, P441, DOI 10.1007/s10681-015-1406-3; Rodino AP, 2006, CROP SCI, V46, P2540, DOI 10.2135/cropsci2006.02.0104; Rodriguez-Guerra R, 2003, PLANT PATHOL, V52, P228, DOI 10.1046/j.1365-3059.2003.00808.x; Rodriguez-Suarez C, 2008, THEOR APPL GENET, V116, P807, DOI 10.1007/s00122-008-0714-6; Santalla M., 1999, BASE: Biotechnologie, Agronomie, Societe et Environnement, V3, P225; Sharma PN, 2007, AUSTRALAS PLANT PATH, V36, P191, DOI 10.1071/AP07013; Singh N, 2012, FOOD RES INT, V47, P174, DOI 10.1016/j.foodres.2011.05.007; Sousa L.L., 2013, ANN REP BEAN IMPROV, V56, P45; Tegelstrom H., 1992, DETECTION MITOCHONDR, P89; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; Zuiderveen GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156391	35	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191700	10.1371/journal.pone.0191700	http://dx.doi.org/10.1371/journal.pone.0191700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389971	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000423793400028
J	Mahajan, T; Rai, K				Mahajan, Tarun; Rai, Kshitij			A novel optogenetically tunable frequency modulating oscillator	PLOS ONE			English	Article							GENE-EXPRESSION; TOGGLE SWITCH; FEEDBACK; DESIGN; QUORUM; ROBUST	Synthetic biology has enabled the creation of biological reconfigurable circuits, which perform multiple functions monopolizing a single biological machine; Such a system can switch between different behaviours in response to environmental cues. Previous work has demonstrated switchable dynamical behaviour employing reconfigurable logic gate genetic networks. Here we describe a computational framework for reconfigurable circuits in E. coli using combinations of logic gates, and also propose the biological implementation. The proposed system is an oscillator that can exhibit tunability of frequency and amplitude of oscillations. Further, the frequency of operation can be changed optogenetically. Insilico analysis revealed that two-component light systems, in response to light within a frequency range, can be used for modulating the frequency of the oscillator or stopping the oscillations altogether. Computational modelling reveals that mixing two colonies of E. coli oscillating at different frequencies generates spatial beat patterns. Further, we show that these oscillations more robustly respond to input perturbations compared to the base oscillator, to which the proposed oscillator is a modification. Compared to the base oscillator, the proposed system shows faster synchronization in a colony of cells for a larger region of the parameter space. Additionally, the proposed oscillator also exhibits lesser synchronization error in the transient period after input perturbations. This provides a strong basis for the construction of synthetic reconfigurable circuits in bacteria and other organisms, which can be scaled up to perform functions in the field of time dependent drug delivery with tunable dosages, and sets the stage for further development of circuits with synchronized population level behaviour.	[Mahajan, Tarun] Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India; [Rai, Kshitij] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Mahajan, T (corresponding author), Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India.	eey147542@iitd.ac.in		Rai, Kshitij/0000-0003-0193-369X; Mahajan, Tarun/0000-0003-3453-9517	Department of Biotechnology, government of India	Department of Biotechnology, government of India(Department of Biotechnology (DBT) India)	Funding for the project was provided by the Department of Biotechnology, government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Babb JW, 2011, BIO FIELD PROGRAMMAB; Bacchus W, 2012, CURR OPIN BIOTECH, V23, P695, DOI 10.1016/j.copbio.2011.12.004; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Chen BS, 2009, BIOINFORMATICS, V25, P1822, DOI 10.1093/bioinformatics/btp310; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Courbet A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3601; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Engelborghs K, 2002, ACM T MATH SOFTWARE, V28, P1, DOI 10.1145/513001.513002; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Fu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090666; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2009, BIOINFORMATICS, V25, pI101, DOI 10.1093/bioinformatics/btp214; Goni-Moreno A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-126; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; Hillenbrand P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068345; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Olson EJ, 2014, NAT CHEM BIOL, V10, P502, DOI [10.1038/NCHEMBIO.1559, 10.1038/nchembio.1559]; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; Perry N, 2011, METHODS MOL BIOL, V813, P287, DOI 10.1007/978-1-61779-412-4_17; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Potapov I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031901; Potvin-Trottier L, 2016, NATURE, V538, P514, DOI 10.1038/nature19841; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Ramakrishnan P, 2016, ACS SYNTH BIOL, V5, P733, DOI 10.1021/acssynbio.6b00068; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Siuti P, 2014, NAT PROTOC, V9, P1292, DOI 10.1038/nprot.2014.089; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Uhlendorf J, 2012, P NATL ACAD SCI USA, V109, P14271, DOI 10.1073/pnas.1206810109; Wang BJ, 2012, TRENDS MICROBIOL, V20, P376, DOI 10.1016/j.tim.2012.05.001; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yang D, 2009, CHAOS, V19, DOI 10.1063/1.3176943; Zhu LJ, 2012, TRENDS MICROBIOL, V20, P94, DOI 10.1016/j.tim.2011.12.003	55	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0183242	10.1371/journal.pone.0183242	http://dx.doi.org/10.1371/journal.pone.0183242			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389936	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400001
J	Sena-Lopes, A; Bezerra, FSB; das Neves, RN; de Pinho, RB; Silva, MTD; Savegnago, L; Collares, T; Seixas, F; Begnini, K; Henriques, JAP; Ely, MR; Rufatto, LC; Moura, S; Barcellos, T; Padilha, F; Dellagostin, O; Borsuk, S				Sena-Lopes, Angela; Brilhante Bezerra, Francisco Silvestre; das Neves, Raquel Nascimento; de Pinho, Rodrigo Barros; de Oliveira Silva, Mara Thais; Savegnago, Lucielli; Collares, Tiago; Seixas, Fabiana; Begnini, Karine; Pegas Henriques, Joao Antonio; Ely, Mariana Roesch; Rufatto, Luciane C.; Moura, Sidnei; Barcellos, Thiago; Padilha, Francine; Dellagostin, Odir; Borsuk, Sibele			Chemical composition, immunostimulatory, cytotoxic and antiparasitic activities of the essential oil from Brazilian red propolis	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL ACTIVITY; BIOLOGICAL-ACTIVITY; GAS-CHROMATOGRAPHY; BOTANICAL ORIGIN; CELL-DEATH; CONSTITUENTS; ANTIOXIDANT; EXTRACT; MICE	Most studies of Brazilian red propolis have explored the composition and biological properties of its ethanolic extracts. In this work, we chemically extracted and characterized the essential oil of Brazilian red propolis (EOP) and assessed its adjuvant, antiparasitic and cytotoxic activities. The chemical composition of EOP was analyzed using gas chromatography with mass spectrometry (GC-MS). EOP was tested for in vitro activity against Trichomonas vaginalis (ATCC 30236 isolate); trophozoites were treated with different concentrations of EOP (ranging from 25 to 500 mu g/mL) in order to establish the MIC and IC50 values. A cytotoxicity assay was performed in CHO-K1 cells submitted to different EOP concentrations. BALB/c mice were used to test the adjuvant effect of EOP. The animals were divided in 3 groups and inoculated as follows: 0.4 ng/kg BW EOP (G1); 50 mu g of rCP40 protein (G2); or a combination of 0.4 ng/kg BW EOP and 50 mu g of rCP40 (G3). Total IgG, IgG1 and IgG2a levels were assessed by ELISA. The major constituent compounds of EOP were methyl eugenol (13.1%), (E)-beta-farnesene (2.50%), and d-amorphene (2.3%). Exposure to EOP inhibited the growth of T. vaginalis, with an IC50 value of 100 mu g/mL of EOP. An EOP concentration of 500 mu g/mL was able to kill 100% of the T. vaginalis trophozoites. The EOP kinetic growth curve showed a 36% decrease in trophozoite growth after a 12 h exposure to 500 mu g/mL of EOP, while complete parasite death was induced at 24 h. With regard to CHO-K1 cells, the CC50 was 266 mu g/mL, and 92% cytotoxicity was observed after exposure to 500 mu g/mL of EOP. Otherwise, a concentration of 200 mu g/mL of EOP was able to reduce parasite proliferation by 70% and was not cytotoxic to CHO-K1 cells. As an adjuvant, a synergistic effect was observed when EOP was combined with the rCP40 protein (G3) in comparison to the administration of each component alone (G1 and G2), resulting in higher concentrations of IgG, IgG1 and IgG2a. EOP is constituted by biologically active components with promising antiparasitic and immunostimulatory activities and can be investigated for the formulation of new vaccines or trichomonacidal drugs.	[Sena-Lopes, Angela; Brilhante Bezerra, Francisco Silvestre; das Neves, Raquel Nascimento; de Pinho, Rodrigo Barros; de Oliveira Silva, Mara Thais; Savegnago, Lucielli; Collares, Tiago; Seixas, Fabiana; Begnini, Karine; Dellagostin, Odir; Borsuk, Sibele] Univ Fed Pelotas UFPel, Ctr Desenvolvimento Tecnol CDTEc, Campus Capao Leao, Capao Do Leao, RS, Brazil; [Pegas Henriques, Joao Antonio; Ely, Mariana Roesch; Rufatto, Luciane C.; Moura, Sidnei; Barcellos, Thiago] Univ Caxias Sul, Inst Biotecnol, Dept Tecnol, Caxias Do Sul, RS, Brazil; [Padilha, Francine] Univ Tiradente, ITP, Aracaju, Sergipe, Brazil	Universidade Federal de Pelotas; Universidade de Caxias do Sul; Universidade Tiradentes	Borsuk, S (corresponding author), Univ Fed Pelotas UFPel, Ctr Desenvolvimento Tecnol CDTEc, Campus Capao Leao, Capao Do Leao, RS, Brazil.	sibeleborsuk@gmail.com	Collares, Tiago/K-2779-2019; da Silva, Thiago Barcellos/AAY-6367-2021; Savegnago, Lucielli/L-7287-2013; Dellagostin, Odir/C-2331-2009; Begnini, Karine Rech/J-2516-2016; Barcellos, Thiago/C-7806-2018; Roesch-Ely, Mariana/H-5981-2013; Neves, Raquel/AAV-2530-2020; Seixas, Fabiana Kommling/X-2706-2018; Bezerra, Francisco/G-2954-2012	Collares, Tiago/0000-0002-1535-3795; da Silva, Thiago Barcellos/0000-0001-9872-4602; Savegnago, Lucielli/0000-0003-0494-5610; Dellagostin, Odir/0000-0003-2803-4088; Barcellos, Thiago/0000-0001-9872-4602; Neves, Raquel/0000-0002-0153-6291; Seixas, Fabiana Kommling/0000-0003-4204-2500; Bezerra, Francisco/0000-0001-6484-143X; Rech Begnini, Karine/0000-0002-1099-3304	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [1608/2011]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Grant #1608/2011 from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) to Joao Antonio Pegas Henriques. URL:http://www. capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank the Post-Graduation Program in Pharmaceutical Sciences, UFRGS, especially T. Tasca (*) from Laboratorio de Pesquisa em Parasitologia, Faculdade de Farmacia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil, for the helping with T. vaginalis protocols assays. We are thankful for the financial support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Grant #1608/2011.	Abikim G, 2011, SHIJIE HUAREN XIAOHU, V19, P1469; Alday-Provencio S, 2015, PLANTA MED, V81, P742, DOI 10.1055/s-0035-1545982; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Aligiannis N, 2001, COMPOSITION ANTIMICR; Alvarez-Sanchez ME, 2017, CURR PHARM DESIGN, V23, P3359, DOI 10.2174/1381612823666170703162754; Calleja MA, 2013, BRIT J NUTR, V109, P394, DOI 10.1017/S0007114512001298; Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004; Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020; Bankova V., 1998, Journal of Essential Oil Research, V10, P693; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Begnini KR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639856; Bezerra GB, 2017, BIOMED PHARMACOTHER, V85, P687, DOI 10.1016/j.biopha.2016.11.080; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; Boussaada O, 2008, MICROBIOL RES, V163, P87, DOI 10.1016/j.micres.2007.02.010; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2017, J ETHNOPHARMACOL, V207, P100, DOI 10.1016/j.jep.2017.06.015; Bueno-Silva B, 2016, PHYTOMEDICINE, V23, P1583, DOI 10.1016/j.phymed.2016.09.009; Bueno-Silva B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144954; Cavendish RL, 2015, J ETHNOPHARMACOL, V173, P127, DOI 10.1016/j.jep.2015.07.022; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; Frozza COD, 2017, BIOMED PHARMACOTHER, V91, P951, DOI 10.1016/j.biopha.2017.05.027; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Silva RPD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172585; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; do Nascimento TG, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1517-3; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Droppa-Almeida D, 2016, VACCINE, V34, P1091, DOI 10.1016/j.vaccine.2015.12.064; El Ashry ESH, 2012, VACCINE, V31, P31, DOI 10.1016/j.vaccine.2012.10.095; Fischer G., 2008, Arq. Inst. Biol., V75, P247, DOI 10.1590/1808-1657v75p2472008; Fischer G, 2010, MEM I OSWALDO CRUZ, V105, P908, DOI 10.1590/S0074-02762010000700012; Flach A, 2004, J CHEM ECOL, V30, P1045, DOI 10.1023/B:JOEC.0000028466.50392.ed; Flamini G, 2005, FOOD CHEM, V91, P63, DOI 10.1016/j.foodchem.2004.05.047; Fokialakis N, 2002, Z NATURFORSCH C, V57, P791; Freires IA, 2016, EUR J MED CHEM, V110, P267, DOI 10.1016/j.ejmech.2016.01.033; Freitas SF, 2006, PHYTOMEDICINE, V13, P170, DOI 10.1016/j.phymed.2004.07.008; Gause KT, 2017, ACS NANO, V11, P54, DOI 10.1021/acsnano.6b07343; de Mendonca ICG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0888-9; Hubner DPG, 2016, BIOMED PHARMACOTHER, V84, P476, DOI 10.1016/j.biopha.2016.09.064; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hazzit M, 2006, J AGR FOOD CHEM, V54, P6314, DOI 10.1021/jf0606104; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Ioshida MD, 2010, J ESSENT OIL BEAR PL, V13, P633, DOI 10.1080/0972060X.2010.10643873; Isidorov VA, 2003, ATMOS ENVIRON, V37, P4645, DOI 10.1016/j.atmosenv.2003.07.005; Lemberkovics Eva, 2007, Acta Pharm Hung, V77, P19; Li F, 2008, BIOORGAN MED CHEM, V16, P5434, DOI 10.1016/j.bmc.2008.04.016; Li HQ, 2013, MOLECULES, V18, P4170, DOI 10.3390/molecules18044170; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Lopez-Anton N, 2007, APOPTOSIS, V12, P141, DOI 10.1007/s10495-006-0331-2; das Nevesa MVM, 2016, BRAZ J MICROBIOL, V47, P159, DOI 10.1016/j.bjm.2015.11.009; Oliveira AP, 2010, J VENOM ANIM TOXINS, V16, P121, DOI 10.1590/S1678-91992010005000007; Omar RMK, 2016, PHYTOCHEM ANALYSIS, V27, P107, DOI 10.1002/pca.2605; Palmer-Young EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127296; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Quijano CE, 2007, FLAVOUR FRAG J, V22, P401, DOI 10.1002/ffj.1812; Neto MSR, 2017, FOOD CHEM TOXICOL, V107, P572, DOI 10.1016/j.fct.2017.03.052; Roslindawani MN, 2016, J ANIM HEAL PROD, V4, P23; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shellie RA, 2003, ANALYST, V128, P879, DOI 10.1039/b304371a; Silva JW, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0304-6; Correa FRS, 2017, BIOMED PHARMACOTHER, V86, P162, DOI 10.1016/j.biopha.2016.12.018; STARZYK J, 1977, ARZNEIMITTEL-FORSCH, V27, P1198; Suzuki Seiko, 2009, International Journal of Industrial Entomology, V19, P193; Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/nel006; Tzakou O, 2003, FLAVOUR FRAG J, V18, P2, DOI 10.1002/ffj.1132; VISHTEH A, 1986, IMMUNOPHARMACOLOGY, V12, P187, DOI 10.1016/0162-3109(86)90002-0; Wachter B, 2014, WIEN KLIN WOCHENSCHR, V126, pS32, DOI 10.1007/s00508-014-0522-8; Yanez X, 2002, MOLECULES, V7, P712, DOI 10.3390/70900712; Yayli N, 2005, PHYTOCHEMISTRY, V66, P1741, DOI 10.1016/j.phytochem.2005.04.006; ZEMEK J, 1987, FOLIA MICROBIOL, V32, P421, DOI 10.1007/BF02887573	70	31	32	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191797	10.1371/journal.pone.0191797	http://dx.doi.org/10.1371/journal.pone.0191797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390009	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400034
J	Itoh, M; Kajihara, R; Kato, Y; Takano-Shimizu, T; Inoue, Y				Itoh, Masanobu; Kajihara, Ryutaro; Kato, Yasuko; Takano-Shimizu, Toshiyuki; Inoue, Yutaka			Frequencies of chromosomal inversions in Drosophila melanogaster in Fukushima after the nuclear power plant accident	PLOS ONE			English	Article							INDUCED GENETIC-DAMAGE; NATURAL-POPULATIONS; MUTATION FREQUENCY; POLYMORPHIC INVERSIONS; TRANSPOSABLE ELEMENTS; HYBRID DYSGENESIS; RADIATION; CHERNOBYL; DNA; IRRADIATION	In order to investigate genetic impact of a large amount of radionuclides released by the Fukushima Dai-ichi Nuclear Power Plant accident in 2011, we surveyed 2,304 haploid genomes of Drosophila melanogaster collected in three localities in Fukushima in 2012 and 2013 for chromosomal inversions. No unique inversion was found in 298 genomes in 2012 and only two in 2,006 genomes in 2013. The observed frequencies were even lower than the long-term average frequency of unique inversions in Japan. The common cosmopolitan inversions were also examined in Fukushima, Kyoto, and Iriomote (Okinawa) in 2012. Among three samples in Fukushima, the flies in Iizaka, where environmental radiation level was the highest, showed the lowest frequency of In(2L)t, but the highest frequency of In(3R)P, contrary to the expectation of decreasing of their frequencies in higher polluted areas. These results suggest that, at this level of genetic analysis, Fukushima populations of D. melanogaster would not have been negatively impacted following the release of radionuclides. Transposable P-element mobility was not likely to induce DNA damage solely or synergistically with radioactivity, because their transposition activity was totally repressed in the Fukushima strains. However, it should be noted that, because of limitations in access to the exclusion zone, we could only sample the populations in areas of relatively low radioactive contamination (0.39 +/- 0.63 mu Sv/h). Therefore, the present study is likely to be underpowered to detect any effects that might be expected in heavily contaminated areas.	[Itoh, Masanobu; Kajihara, Ryutaro] Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan; [Itoh, Masanobu; Kato, Yasuko; Takano-Shimizu, Toshiyuki] Kyoto Inst Technol, Adv Insect Res Promot Ctr, Kyoto, Japan; [Kato, Yasuko] Kyoto Inst Technol, Inst Promot Univ Strategy, Global Excellence, Kyoto, Japan; [Inoue, Yutaka] Osaka Univ, Ctr Educ Liberal Arts & Sci, Toyonaka, Osaka, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; Kyoto Institute of Technology; Osaka University	Itoh, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan.; Itoh, M (corresponding author), Kyoto Inst Technol, Adv Insect Res Promot Ctr, Kyoto, Japan.	mitoh@kit.ac.jp						Andolfatto P, 1999, GENETICS, V153, P1297; ANXOLABEHERE D, 1985, P NATL ACAD SCI USA, V82, P5418, DOI 10.1073/pnas.82.16.5418; ANXOLABEHERE D, 1988, MOL BIOL EVOL, V5, P252; Ashburner M, 2005, DROSOPHILA LAB HDB, pxxviii; BALTER H, 1992, MUTAT RES, V267, P31, DOI 10.1016/0027-5107(92)90108-E; Bonisoli-Alquati A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09432; Bonnivard E, 1999, J EVOLUTION BIOL, V12, P633, DOI 10.1046/j.1420-9101.1999.00063.x; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Callaway E, 2013, NATURE, V499, P265, DOI 10.1038/499265a; Corbett-Detig RB, 2012, GENETICS, V192, P131, DOI 10.1534/genetics.112.141622; Cuttler JM, 2013, DOSE-RESPONSE, V11, P432, DOI 10.2203/dose-response.13-008.Cuttler; ENGELS WR, 1980, GENETICS, V95, P111; Fujita Y, 2014, EUR J WILDLIFE RES, V60, P145, DOI 10.1007/s10344-013-0767-y; Garnier-Laplace J, 2011, ENVIRON SCI TECHNOL, V45, P5077, DOI 10.1021/es201637c; Hatano Y, 1999, GENES GENET SYST, V74, P219, DOI 10.1266/ggs.74.219; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; INOUE Y, 1994, JPN J GENET, V69, P105, DOI 10.1266/jjg.69.105; INOUE Y, 1988, MUTAT RES, V197, P85, DOI 10.1016/0027-5107(88)90143-1; INOUE Y, 1979, JPN J GENET, V54, P69, DOI 10.1266/jjg.54.69; INOUE Y, 2011, DROS INF SERV, V94, P69; Kennington WJ, 2006, GENETICS, V172, P1655, DOI 10.1534/genetics.105.053173; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1994, J HERED, V85, P339, DOI 10.1093/oxfordjournals.jhered.a111478; KNIBB WR, 1981, GENETICS, V98, P833; Koana T, 2012, RADIAT RES, V177, P265, DOI 10.1667/RR2630.1; Kozeretska IA, 2008, CYTOL GENET+, V42, P267, DOI 10.3103/S0095452708040099; Kubota Y, 2015, ENVIRON SCI TECHNOL, V49, P10074, DOI 10.1021/acs.est.5b01554; Lachaise D, 2004, GENETICA, V120, P17, DOI 10.1023/B:GENE.0000017627.27537.ef; Lefevre G., 1976, PHOTOGRAPHIC REPRSEN, P31; MARGULIES L, 1987, MUTAT RES, V179, P183, DOI 10.1016/0027-5107(87)90309-5; METTLER LE, 1977, GENETICS, V87, P169; Moller AP, 2017, INT J PLANT SCI, V178, P537, DOI 10.1086/692763; Moller AP, 2015, J ORNITHOL, V156, pS287, DOI 10.1007/s10336-015-1173-x; Moller AP, 2015, J ORNITHOL, V156, pS297, DOI 10.1007/s10336-015-1197-2; Moller AP, 2016, INT J PLANT SCI, V177, P727, DOI 10.1086/688873; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; Mousseau TA, 2014, J HERED, V105, P704, DOI 10.1093/jhered/esu040; MUKAI T, 1985, P NATL ACAD SCI USA, V82, P7671, DOI 10.1073/pnas.82.22.7671; Ochiai K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05793; Ogura K, 2009, RADIAT RES, V171, P1, DOI 10.1667/RR1288.1; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Qiu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43156; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Sankaranarayanan K, 1976, ABERRATION INDUCTION, P1251; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; Schiermeier Q, 2011, NATURE, V472, P505, DOI 10.1038/nj7344-505a; STONE WS, 1958, P NATL ACAD SCI USA, V44, P565, DOI 10.1073/pnas.44.6.565; Tubiana M, 2005, DOSE EFFECT RELATION; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; UNSCEAR, 2012, REP UN SCI COMM EFF; VANDELDEN W, 1991, GENETICS, V127, P507; WATANABE TK, 1976, GENETICS, V82, P697; Yablokov Alexey V, 2009, Ann N Y Acad Sci, V1181, P221, DOI 10.1111/j.1749-6632.2009.04830.x; ZAINULLIN VG, 1992, SCI TOTAL ENVIRON, V112, P37, DOI 10.1016/0048-9697(92)90236-L	54	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192096	10.1371/journal.pone.0192096	http://dx.doi.org/10.1371/journal.pone.0192096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420572	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900039
J	Krause, PJ; Carroll, M; Fedorova, N; Brancato, J; Dumouchel, C; Akosa, F; Narasimhan, S; Fikrig, E; Lane, RS				Krause, Peter J.; Carroll, Madeleine; Fedorova, Natalia; Brancato, Janna; Dumouchel, Cecilia; Akosa, Fredua; Narasimhan, Sukanya; Fikrig, Erol; Lane, Robert S.			Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; LYME-DISEASE; RELAPSING-FEVER; IXODES-PACIFICUS; NORTHWESTERN CALIFORNIA; TICK; SPIROCHETE; VECTOR; MENINGOENCEPHALITIS; COMMUNITY	To determine whether human Borrelia miyamotoi infection occurs in the far-western United States, we tested archived sera from northwestern California residents for antibodies to this emerging relapsing fever spirochete. These residents frequently were exposed to I. pacificus ticks in a region where B. miyamotoi tick infection has been reported. We used a two-step B. miyamotoi rGlpQ assay and a B. miyamotoi whole-cell lysate (WCL) assay to detect B. miyamotoi antibody. We also employed Borrelia hermsii and Borrelia burgdorferi WCL assays to examine if these Borrelia induce cross reacting antibody to B. miyamotoi. Sera were collected from 101 residents in each of two consecutive years. The sera of 12 and 14 residents in years one and two, respectively, were B. miyamotoi rGlpQ seroreactive. Sufficient sera were available to test 15 of the 26 seropositive samples using B. miyamotoi and B. hermsii WCL assays. Two residents in year one and seven residents in year two were seroreactive to both Borrelia antigens. Although discernible differences in seroreactivity were evident between the B. miyamotoi and B. hermsii WCL assays, infection with one or the other could not be determined with certainty. Sera from two Borrelia burgdorferi/B. miyamotoi seropositive subjects reacted strongly against B. miyamotoi and B. hermsii WCL antigens. Ecological, epidemiological, and clinical data implicated B. miyamotoi as the probable cause of infection among those whose sera reacted against both antigens. Our findings suggest that human B. miyamotoi infection occurs in northern California and that B. hermsii and B. burgdorferi infections produce antibodies that cross-react with B. miyamotoi antigens. Health care professionals in the far-western United States should be aware that B. miyamotoi disease may occur throughout the geographic distribution of I. pacificus and that improved relapsing fever group spirochete antibody assays are urgently needed.	[Krause, Peter J.; Carroll, Madeleine; Brancato, Janna; Dumouchel, Cecilia; Akosa, Fredua] Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT 06510 USA; [Krause, Peter J.; Narasimhan, Sukanya; Fikrig, Erol] Yale Sch Med, Dept Infect Dis, New Haven, CT 06511 USA; [Fedorova, Natalia; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Yale University; Yale University; University of California System; University of California Berkeley	Krause, PJ (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT 06510 USA.; Krause, PJ (corresponding author), Yale Sch Med, Dept Infect Dis, New Haven, CT 06511 USA.	peter.krause@yale.edu		krause, peter/0000-0003-3498-9454	NIH [1R56AI114859-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported in part by generous gifts from The Gordon and Llura Gund Foundation to PJK, Tom Eames and Geneva Anderson to RSL and by NIH grant 1R56AI114859-01 to PJK, SN, and EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Boden K, 2016, EMERG INFECT DIS, V22, P1617, DOI 10.3201/eid2209.152034; Cook VJ, 2016, EMERG INFECT DIS, V22, P2205, DOI 10.3201/eid2212.152046; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Davis GE, 1941, PUBLIC HEALTH REP, V56, P2426, DOI 10.2307/4583956; Division of Communicable Disease Control Center for Infectious Diseases California Department of Public Health, 2001, YEARL SUMM SEL GEN C; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Jobe DA, 2016, EMERG INFECT DIS, V22, P1471, DOI 10.3201/eid2208.151878; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; LANE RS, 1985, SCIENCE, V230, P85, DOI 10.1126/science.3898367; LANE RS, 1992, AM J EPIDEMIOL, V136, P1358, DOI 10.1093/oxfordjournals.aje.a116448; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; LANE RS, 1990, J CLIN MICROBIOL, V28, P1774, DOI 10.1128/JCM.28.8.1774-1779.1990; MAGNARELLI LA, 1984, J CLIN MICROBIOL, V20, P181, DOI 10.1128/JCM.20.2.181-184.1984; MAGNARELLI LA, 1987, J INFECT DIS, V156, P183, DOI 10.1093/infdis/156.1.183; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Molloy PJ, 2017, CLIN INFECT DIS; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Salkeld DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134812; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Sudhindra P, 2016, DIAGN MICR INFEC DIS, V86, P93, DOI 10.1016/j.diagmicrobio.2016.06.015; Wagemakers A, 2016, J IMMUNOL, V196, P4185, DOI 10.4049/jimmunol.1600014	35	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191725	10.1371/journal.pone.0191725	http://dx.doi.org/10.1371/journal.pone.0191725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420552	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900020
J	Kribus-Shmiel, L; Zeilig, G; Sokolovski, B; Plotnik, M				Kribus-Shmiel, Lotem; Zeilig, Gabi; Sokolovski, Boris; Plotnik, Meir			How many strides are required for a reliable estimation of temporal gait parameters? Implementation of a new algorithm on the phase coordination index	PLOS ONE			English	Article							BILATERAL COORDINATION; PARKINSONS-DISEASE; DATA RECONCILIATION; TREADMILL WALKING; OLDER-ADULTS; VARIABILITY; IDENTIFICATION; SPEED	Background The Phase coordination index (PCI), a temporal gait measure that quantifies consistency and accuracy in generating the anti-phased left-right stepping pattern, assesses bilateral coordination of gait in various cohorts (e.g., Parkinson's disease, post stroke). As PCI is based on mean values calculated across a series of gait cycles, individuals are required to perform lengthy walking trials, prolonging gait assessments which cause discomfort to some of them. This study introduces an algorithm to identify the required number of strides to obtain a reliable, characteristic PCI value. Methods Simulated data sets, as well as physiological data (obtained from healthy elderly and young persons, from over ground and treadmill trials) were used in this research. A series of N-1 PCI values was calculated for i = 2,3,4... N gait cycles for each participant. There is a value i = k, representing certain number of cycles, for which no significant change in PCI occurs as additional cycles are added, termed point of stabilization (POS). The algorithm presented here uses a 2-stage iterative process to determine POS. Stage 1 searches for the gross location of the interval of PCI values containing the POS. In stage 2, the algorithm performs a high-resolution recursive, iterative process within this interval to find the exact point. The criterion for defining stability within a window of PCI values is a coefficient of variation (CV) of <= 5%. Results Our recursive, iterative algorithm indicates that similar to 23 strides on average should be captured to attain a characteristic PCI. Conclusions Gait trials with at least 23 strides on average should suffice to obtain a reliable estimation of PCI in healthy young adults. While this methodology may be considered generic, future studies should obtain POS values based on additional cohorts (e.g., disabled participants, fixed walking speeds).	[Kribus-Shmiel, Lotem; Plotnik, Meir] Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi; Sokolovski, Boris] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Zeilig, Gabi] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Ramat Gan, Israel; [Plotnik, Meir] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Plotnik, Meir] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Plotnik, M (corresponding author), Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	meir.plontik@sheba.health.gov.il		Plotnik, Meir/0000-0003-2637-3457				Beauchet O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-37; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bethea R.M., 1991, APPL ENG STAT; Bhat SA, 2004, IND ENG CHEM RES, V43, P4323, DOI 10.1021/ie030563u; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Cash C. R., 1992, P 24 C WINT SIM; Chufu Li B C, 2004, J TSINGHUA U NATURAL, V44, P1160; Crow E.L., 1960, STAT MANUAL EXAMPLES; Dingwell JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124879; Flehmig F, 1998, COMPUT CHEM ENG, V22, pS491, DOI 10.1016/S0098-1354(98)00092-1; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Hoad K, 2010, J OPER RES SOC, V61, P1389, DOI 10.1057/jors.2009.87; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; HOLLY W, 1989, CAN J CHEM ENG, V67, P595, DOI 10.1002/cjce.5450670411; Jackway P, 1992, METHODOLOGY INITIALI; Jiang TW, 2003, COMPUT CHEM ENG, V27, P569, DOI 10.1016/S0098-1354(02)00235-1; Kribus-Shmiel L, 2017, INT SOC POST GAINT R; Lada EK, P 35 C WINT SIM DRIV; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; NARASIMHAN S, 1987, AICHE J, V33, P1930, DOI 10.1002/aic.690331125; Nelson BL, 1992, HDB IND ENG TECHNOLO, P2469; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Pawlikowski K., 1990, ACM COMPUT SURV, V22, P123; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Plotnik M., 2008, MOVEMENT DISORDERS, V23; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Plotnik M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0002-z; Priest AW, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-29; Robinson S., 2004, SIMULATION PRACTICE, V1, P5; Robinson S, 2007, EUR J OPER RES, V176, P332, DOI 10.1016/j.ejor.2005.07.014; Rossetti MD, P 37 C WINT SIM 2005; Schladt M, 2007, CHEM ENG PROCESS, V46, P1107, DOI 10.1016/j.cep.2006.06.022; Sloot LH, 2014, GAIT POSTURE, V39, P939, DOI 10.1016/j.gaitpost.2013.12.005; Sloot LH, 2014, GAIT POSTURE, V39, P478, DOI 10.1016/j.gaitpost.2013.08.022; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; White Jr KP, P 32 C WINT SIM 2000; White KP, 1997, SIMULATION, V69, P323, DOI 10.1177/003754979706900601; Wu JG, 2016, IEEE T AUTOM SCI ENG, V13, P688, DOI 10.1109/TASE.2014.2378150; Wu JG, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4024041; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	47	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192049	10.1371/journal.pone.0192049	http://dx.doi.org/10.1371/journal.pone.0192049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420580	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900036
J	Gibson-Helm, ME; Bailie, J; Matthews, V; Laycock, AF; Boyle, JA; Bailie, RS				Gibson-Helm, Melanie E.; Bailie, Jodie; Matthews, Veronica; Laycock, Alison F.; Boyle, Jacqueline A.; Bailie, Ross S.			Identifying evidence-practice gaps and strategies for improvement in Aboriginal and Torres Strait Islander maternal health care	PLOS ONE			English	Article							CONTINUOUS QUALITY IMPROVEMENT; PREGNANCY; DELIVERY; WOMEN; BIRTH	Introduction Adverse pregnancy outcomes are more common among Aboriginal and Torres Strait Islander populations than non-Indigenous populations in Australia. Later in life, most of the difference in life expectancy between Aboriginal and Torres Strait Islander women and non-Indigenous women is due to non-communicable diseases (NCDs). Most Aboriginal and Torres Strait Islander women attend health services regularly during pregnancy. Providing high-quality care within these appointments has an important role to play in improving the current and future health of women and babies. Aim This study engaged stakeholders in a theory-informed process to use aggregated continuous quality improvement (CQI) data to identify 1) priority evidence-practice gaps in Aboriginal and Torres Strait Islander maternal health care, 2) barriers and enablers to high-quality care, and 3) strategies to address identified priorities. Methods Three phases of reporting and feedback were implemented using de-identified CQI data from 91 health services between 2007 and 2014 (4,402 client records). Stakeholders (n = 172) from a range of professions and organisations participated. Results Stakeholders identified four priority areas relating to NCDs: smoking, alcohol, psychosocial wellbeing and nutrition. Barriers or enablers to high-quality care included workforce support, professional development, teamwork, woman-centred care, decision support, equipment and community engagement. Strategies to address the priorities included upskilling staff to provide best practice care in priority areas, advocating for availability of healthy food, housing and local referral options, partnering with communities on health promotion projects, systems to facilitate continuity of care and clear referral pathways. Conclusions This novel use of large-scale aggregate CQI data facilitated stakeholder input on priority evidence-practice gaps in maternal health care in Australia. Evidence-practice gaps relating to NCD risk factors and social determinants of health were prioritised, and stakeholders suggested both healthcare-focussed initiatives and approaches involving the community and the wider health sector. The findings can inform health service planning, advocacy, inter-agency strategies, and future research.	[Gibson-Helm, Melanie E.; Boyle, Jacqueline A.] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia; [Bailie, Jodie; Bailie, Ross S.] Univ Sydney, Univ Ctr Rural Hlth, Lismore, NSW, Australia; [Matthews, Veronica; Laycock, Alison F.] Charles Darwin Univ, Menzies Sch Hlth Res, Brisbane, Qld, Australia	Monash University; University of Sydney; Charles Darwin University; Menzies School of Health Research	Gibson-Helm, ME (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia.	melanie.gibson@monash.edu	Boyle, Jacqueline/AAD-3246-2019; Matthews, Veronica/AAS-5160-2021; Laycock, Alison/AAF-4274-2019; Bailie, Jodie/D-6626-2018; Dangal, Ganesh/O-1989-2017; Bailie, Ross/K-8141-2013	Laycock, Alison/0000-0001-7756-4398; Bailie, Jodie/0000-0003-4393-5773; Dangal, Ganesh/0000-0002-5834-5525; Bailie, Ross/0000-0001-5966-3368; Boyle, Jacqueline/0000-0002-3616-1637	National Health and Medical Research Council [545267]; Centre for Research Excellence in Integrated Quality Improvement [1078927]; Lowitja Institute;  [1110701];  [1122540]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Centre for Research Excellence in Integrated Quality Improvement; Lowitja Institute; ; 	The National Health and Medical Research Council (www.nhmrc.gov.au) funded the ABCD National Research Partnership Project (#545267) and the Centre for Research Excellence in Integrated Quality Improvement (#1078927). In-kind and financial support has been provided by the Lowitja Institute (www.lowitja.org.au) and a range of Community-Controlled and Government agencies. M Gibson-Helm and J Boyle are National Health and Medical Research Council Fellows (#1110701 and #1122540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell SK, 2016, SEMIN REPROD MED, V34, P110, DOI 10.1055/s-0035-1571196; [Anonymous], 2005, NAT AB TORR STRAIT I; [Australian Health Ministers Advisory Council Ageing AGDoHa], 2012, CLIN PRACT GUID ANT; Australian Indigenous HealthInfoNet, 2016, OV AB TORR STRAIT IS; Australian Institute of Health and Welfare, 2021, AUSTR BURD DIS STUD; Australian Institute of Health and Welfare, 2016, AUSTR MOTH BAB 2014; Australian Institute of Health and Welfare, 2010, CONTR CHRON DIS GAP; Bailie J, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00086; Bailie R, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-143; Bailie R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-129; Bailie RS, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-15; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Central Australian Aboriginal Congress, 2008, MIN KUTJ TJUK WOM BU; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Crinall B, 2016, AUSTR NZ J PUBLIC HL; Crossland L, 2014, MED J AUSTRALIA, V201, pS47, DOI 10.5694/mja14.00305; Cunningham FC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1810-y; Cunningham J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-95; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Elwyn G, 2010, J EVAL CLIN PRACT, V16, P627, DOI 10.1111/j.1365-2753.2009.01262.x; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gibson-Helm ME, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0892-1; Gibson-Helm ME, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja14.01660; Herceg A., 2005, IMPROVING HLTH ABORI; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-11; Jackson CL, 2014, MED J AUSTRALIA, V201, pS42, DOI 10.5694/mja14.00063; Janamian T, 2014, MED J AUSTRALIA, V201, pS44, DOI 10.5694/mja14.00273; LAFFEL G, 1989, JAMA-J AM MED ASSOC, V262, P2869; Laycock A, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00084; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McIntyre S, 2010, DEV MED CHILD NEUROL, V52, P270, DOI 10.1111/j.1469-8749.2009.03358.x; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Menzies School of Health Research, MAT HLTH CLIN AUD 20; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; National Aboriginal Community Controlled Health Organisation, NACCHO AB HLTH DEF; National Public Health Partnership, 2000, NAT AB TORR STRAIT I; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Prandl KJ, 2012, ARCH WOMEN MENT HLTH, V15, P149, DOI 10.1007/s00737-012-0276-0; Primary Health care directorate,Ministry of Health, 2005, SITUATION ANAL CHILD; Reibel Tracy, 2010, Qual Prim Care, V18, P65; Rumbold AR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-16; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schierhout G, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1812-9; Schierhout G, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-119; Stewart RJ, 2011, HEALTH EXPECT, V14, P439, DOI 10.1111/j.1369-7625.2010.00648.x; Three Centres Collaboration, 2001, 3 CTR CONS GUID ANT; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	49	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192262	10.1371/journal.pone.0192262	http://dx.doi.org/10.1371/journal.pone.0192262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415024	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300065
J	Latten, T; Westra, D; Angeli, F; Paulus, A; Struss, M; Ruwaard, D				Latten, Tom; Westra, Daan; Angeli, Federica; Paulus, Aggie; Struss, Marleen; Ruwaard, Dirk			Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review	PLOS ONE			English	Review							CONFLICTS-OF-INTEREST; PHYSICIAN PRESCRIBING PATTERNS; INDUSTRY PAYMENTS; DRUG COMPANIES; GUIDELINES; IMPACT; DOCTORS; ETHICS; TRIAL; TIES	Introduction Interactions between pharmaceutical companies and healthcare providers are increasingly scrutinized by academics, professionals, media, and politicians. Most empirical studies and professional guidelines focus on unilateral donor-recipient types of interaction and overlook, or fail to distinguish between, more reciprocal types of interaction. However, the degree of goal alignment and potential for value creation differs in these two types of interactions. Failing to differentiate between these two forms of interaction between pharmaceutical companies and healthcare providers could thus lead to biased conclusions regarding their desirability. This study reviews the empirical literature regarding the effects of bilateral forms of interactions between pharmaceutical companies and healthcare providers in order to explore their effects. Material and methods We searched two medical databases (i.e. PubMed and Cochrane Library) and one business database (i.e. EBSCO) for empirical, peer-reviewed articles concerning any type of bilateral interaction between pharmaceutical companies and healthcare providers. We included quantitative articles which were written in English and published between January 1 st, 2000 and October 31 st, 2016, and where the title or abstract included a combination of synonyms of the following keywords: pharmaceutical companies, healthcare providers, interaction, and effects. Results Our search results yielded 10 studies which were included in our analysis. These studies focused on either research-oriented interaction or on education-oriented interaction. The included studies reported various outcomes of interaction such as prescribing behavior, ethical dilemmas, and research output. Regardless of the type of interaction, the studies either reported no significant effects or ambivalent outcomes such as affected clinical practice or ethical issues. Discussion and conclusion The effects of bilateral interactions reported in the literature are similar to those reported in studies concerning unilateral interactions. The theoretical notion that bilateral interactions between pharmaceutical companies and healthcare providers have different effects given their increased level of goal alignment thus does not seem to hold. However, most of the empirical studies focus on intermediary, provider-level, outcomes such as altered prescribing behavior. Outcomes at the health system level such as overall costs and quality of care are overlooked. Further research is necessary in order to disentangle various forms of value created by different types of interactions between pharmaceutical companies and healthcare providers.	[Latten, Tom; Westra, Daan; Angeli, Federica; Paulus, Aggie; Struss, Marleen; Ruwaard, Dirk] Maastricht Univ, Dept Hlth Serv Res, CAPHRI, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Angeli, Federica] Tilburg Univ, Sch Social & Behav Sci, Dept Org Studies, Tilburg, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Tilburg University	Latten, T (corresponding author), Maastricht Univ, Dept Hlth Serv Res, CAPHRI, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	t.latten@maastrichtuniversity.nl		Angeli, Federica/0000-0003-4010-3103; Westra, Daan/0000-0003-1791-3626; Ruwaard, Dirk/0000-0003-4887-8413				Aitken P, 2005, BMJ CAREER FOCUS, V330, P73; Andersen M, 2006, JAMA-J AM MED ASSOC, V295, P2759, DOI 10.1001/jama.295.23.2759; [Anonymous], 2000, LANCET, V356, P781; Felicio JA, 2013, J BUS RES, V66, P2139, DOI 10.1016/j.jbusres.2013.02.040; Austin James, 2000, NONPROF VOLUNT SEC Q, V29, P69, DOI DOI 10.1177/089976400773746346; Austin JE, 2012, NONPROF VOLUNT SEC Q, V41, P929, DOI 10.1177/0899764012454685; Austin JE, 2012, NONPROF VOLUNT SEC Q, V41, P726, DOI 10.1177/0899764012450777; Barringer BR, 2000, J MANAGE, V26, P367, DOI 10.1177/014920630002600301; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Coleman DL, 2006, ACAD MED, V81, P154, DOI 10.1097/00001888-200602000-00011; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056; Fadlallah R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160540; Feng H, 2016, JAMA DERMATOLOGY; Fisher JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001271; Glass Harold E, 2004, Dis Manag, V7, P77, DOI 10.1089/109350704322919014; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Gray GC, 2013, J LAW MED ETHICS, V41, P629, DOI 10.1111/jlme.12072; Gulati R, 2000, STRATEGIC MANAGE J, V21, P203, DOI 10.1002/(SICI)1097-0266(200003)21:3<203::AID-SMJ102>3.0.CO;2-K; Henry D, 2005, ARCH INTERN MED, V165, P2493, DOI 10.1001/archinte.165.21.2493; Horsley T, 2011, CHECKING REFERENCE L; JARILLO JC, 1988, STRATEGIC MANAGE J, V9, P31, DOI 10.1002/smj.4250090104; Komesaroff PA, 2005, J PAEDIATR CHILD H, V41, P558, DOI 10.1111/j.1440-1754.2005.00719.x; LEVINE S, 1961, ADMIN SCI QUART, V5, P583, DOI 10.2307/2390622; Lexchin J, 1997, CAN FAM PHYSICIAN, V43, P941; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moynihan R, 2003, BMJ-BRIT MED J, V326, P1189, DOI 10.1136/bmj.326.7400.1189; Myers RP, 2007, CAN J GASTROENTEROL, V21, P169, DOI 10.1155/2007/945630; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Oshikoya KA, 2011, PAN AFR MED J, V9; PROVAN KG, 1995, ADMIN SCI QUART, V40, P1, DOI 10.2307/2393698; Sackett D, 1998, LEVELS EVIDENCE GRAD; Sah S, 2013, J LAW MED ETHICS, V41, P665, DOI 10.1111/jlme.12076; Sillup GP, 2013, INT J HEALTHCARE MAN, V6, P276, DOI 10.1179/2047971913Y.0000000049; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinbrook R, 2016, JAMA INTERN MED, V176, P1123, DOI 10.1001/jamainternmed.2016.2959; Stossel TP, 2005, NEW ENGL J MED, V353, P1060, DOI 10.1056/NEJMsb051758; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; Svider PF, 2017, LARYNGOSCOPE, V127, P87, DOI 10.1002/lary.26027; Tasker J, 2001, Aust Health Rev, V24, P80; Taylor SC, 2016, JAMA OPHTHALMOL, V134, P897, DOI 10.1001/jamaophthalmol.2016.1678; Tejani Aaron M, 2015, Can J Hosp Pharm, V68, P378; van Raak A, 2005, HEALTH POLICY, V74, P13, DOI 10.1016/j.healthpol.2004.12.006; Vashi NA, 2012, CLIN DERMATOL, V30, P188, DOI 10.1016/j.clindermatol.2011.06.006; Villani E, 2017, J MANAGEMENT STUDIES; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Weber C, 2017, J MANAGEMENT STUDIES; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709; Zycher B, TRUTH DRUG INNOVATIO, V6	57	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191856	10.1371/journal.pone.0191856	http://dx.doi.org/10.1371/journal.pone.0191856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414998	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300043
J	Li, SB; Ma, LL; Wang, YC; Wang, XJ; Li, YZ; Qin, L				Li, Sibin; Ma, Lanlan; Wang, Yuchen; Wang, Xuejiao; Li, Yingzhuo; Qin, Ling			Auditory steady-state responses in primary and non-primary regions of the auditory cortex in neonatal ventral hippocampal lesion rats	PLOS ONE			English	Article							EFFERENT CONNECTIONS; EXCITOTOXIC LESIONS; 40 HZ; SCHIZOPHRENIA; MODEL; FIELD; ORGANIZATION; STIMULATION; HALLUCINATIONS; PROJECTIONS	Auditory steady-state responses (ASSRs) represent the electrophysiological activity of the auditory nervous system in response to a periodic acoustic stimulus. Spectrogram analysis can reveal the frequency and phase information entrained in ASSRs. Clinically, the ASSR is used to detect abnormalities in electroencephalographs obtained from schizophrenia patients, who show reduced power and phase locking of ASSRs. The neonatal ventral hippocampal lesion (NVHL) rat is a widely used model to investigate the neurodevelopmental mechanisms of schizophrenia. It has been established that NVHL rats exhibit several schizophrenia-like behavioral and molecular abnormalities. However, no clear abnormalities in ASSRs have been reported to date. The present study compared ASSRs of adult NVHL and sham-operated rats. We inserted microelectrodes into the primary auditory cortex (A1) or posterior auditory field (PAF) and recorded the local field potential (LFP) in response to 40- and 80-Hz click train stimuli. Spectrogram analysis was performed to obtain the mean trial power (MTP) and phase-locking factor (PLF) of the click train-evoked LFPs. We found that in the control animals, A1 showed a stronger MTP and PLF of ASSR than PAF, and NVHL operation mainly impaired the ASSR in PAF. Analysis of spike activity also indicated that NVHL operation extended the duration of tone-evoked responses in PAF neurons. Our results reveal, for the first time, that NVHL may distinctly influence the neural activities of primary and non-primary fields of the auditory cortex.	[Li, Sibin; Ma, Lanlan; Wang, Yuchen; Wang, Xuejiao; Li, Yingzhuo; Qin, Ling] China Med Univ, Coll Basic Med Sci, Dept Physiol, Shenyang, Liaoning, Peoples R China	China Medical University	Qin, L (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Physiol, Shenyang, Liaoning, Peoples R China.	qinlingling@yahoo.com			National Nature Science Foundation of China [31471057, 31671080]; Research project of Liaoning Provincial Department of Education [LK201631]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research project of Liaoning Provincial Department of Education	The study design, data collection and analysis, decision to publish, and preparation of the manuscript were supported by the following grants: National Nature Science Foundation of China under a grant (31471057 and 31671080 to LQ), Research project of Liaoning Provincial Department of Education (LK201631 to LM).	Atiani S, 2014, NEURON, V82, P486, DOI 10.1016/j.neuron.2014.02.029; Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Brady A.M., 2016, CURR PROTOC NEUROSCI, V77; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; Halim ND, 2000, BRAIN RES, V873, P60, DOI 10.1016/S0006-8993(00)02497-5; IMIG TJ, 1985, J NEUROPHYSIOL, V53, P309, DOI 10.1152/jn.1985.53.1.309; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2007, EUR J NEUROSCI, V25, P2819, DOI 10.1111/j.1460-9568.2007.05519.x; Kimura A, 2004, NEUROSCIENCE, V128, P399, DOI 10.1016/j.neuroscience.2004.07.010; Krishnan GP, 2009, NEUROIMAGE, V47, P1711, DOI 10.1016/j.neuroimage.2009.03.085; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; LINS OG, 1995, EVOKED POTENTIAL, V96, P420, DOI 10.1016/0168-5597(95)00048-W; Ma HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052942; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; MacDonald ML, 2015, BIOL PSYCHIAT, V77, P959, DOI 10.1016/j.biopsych.2014.09.006; Macedo CE, 2010, BEHAV BRAIN RES, V207, P161, DOI 10.1016/j.bbr.2009.10.002; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Plourde G, 1998, ANESTHESIOLOGY, V89, P844, DOI 10.1097/00000542-199810000-00008; Plourde G, 1996, ANESTH ANALG, V82, P75, DOI 10.1097/00000539-199601000-00013; PLOURDE G, 1991, BRIT J ANAESTH, V66, P683, DOI 10.1093/bja/66.6.683; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Profant O, 2013, HEARING RES, V296, P51, DOI 10.1016/j.heares.2012.11.021; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Romero-Pimentel AL, 2014, SCHIZOPHR RES, V159, P450, DOI 10.1016/j.schres.2014.09.009; Sandner G, 2010, NEUROIMAGE, V53, P44, DOI 10.1016/j.neuroimage.2010.06.007; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Sivarao DV, 2016, NEUROPSYCHOPHARMACOL, V41, P2232, DOI 10.1038/npp.2016.17; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Stevens KE, 2012, SENSORY SENSORIMOTOR, P240; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Swerdlow NR, 2001, BRAIN RES BULL, V55, P71, DOI 10.1016/S0361-9230(01)00492-0; Szalda K, 2005, HEARING RES, V203, P32, DOI 10.1016/j.heares.2004.11.014; Tahraoui SL, 2001, BRAIN PATHOL, V11, P56; Thune H, 2016, JAMA PSYCHIAT, V73, P1145, DOI 10.1001/jamapsychiatry.2016.2619; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Vohs JL, 2012, INT J PSYCHOPHYSIOL, V86, P136, DOI 10.1016/j.ijpsycho.2012.04.002; Vohs JL, 2010, INT J NEUROPSYCHOPH, V13, P487, DOI 10.1017/S1461145709990307; Vohs JL, 2009, NEUROPSYCHOBIOLOGY, V60, P12, DOI 10.1159/000234813; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006	52	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192103	10.1371/journal.pone.0192103	http://dx.doi.org/10.1371/journal.pone.0192103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415081	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300049
J	Cheng, L; Wong, LJ; Yan, NH; Han, RC; Yu, HH; Guo, CY; Batsuuri, K; Zinzuwadia, A; Guan, R; Cho, KS; Chen, DF				Cheng, Lin; Wong, Lucy J.; Yan, Naihong; Han, Richard C.; Yu, Honghua; Guo, Chenying; Batsuuri, Khulan; Zinzuwadia, Aniket; Guan, Ryan; Cho, Kin-Sang; Chen, Dong Feng			Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury	PLOS ONE			English	Article							DOMAIN FACTOR BRN-3B; EPIGENETIC MECHANISMS; GENE-EXPRESSION; RNA-SEQ; INTRAOCULAR-PRESSURE; COMPETENCE STATE; MATH5; GLAUCOMA; METHYLATION; ROLES	Epigenetic predisposition is thought to critically contribute to adult-onset disorders, such as retinal neurodegeneration. The histone methyltransferase, enhancer of zeste homolog 2 (Ezh2), is transiently expressed in the perinatal retina, particularly enriched in retinal ganglion cells (RGCs). We previously showed that embryonic deletion of Ezh2 from retinal progenitors led to progressive photoreceptor degeneration throughout life, demonstrating a role for embryonic predisposition of Ezh2-mediated repressive mark in maintaining the survival and function of photoreceptors in the adult. Enrichment of Ezh2 in RGCs leads to the question if Ezh2 also mediates gene expression and function in postnatal RGCs, and if its deficiency changes RGC susceptibility to cell death under injury or disease in the adult. To test this, we generated mice carrying targeted deletion of Ezh2 from RGC progenitors driven by Math5-Cre (mKO). mKO mice showed no detectable defect in RGC development, survival, or cell homeostasis as determined by physiological analysis, live imaging, histology, and immunohistochemistry. Moreover, RGCs of Ezh2 deficient mice revealed similar susceptibility against glaucomatous and acute optic nerve trauma-induced neurodegeneration compared to littermate floxed or wild-type control mice. In agreement with the above findings, analysis of RNA sequencing of RGCs purified from Ezh2 deficient mice revealed few gene changes that were related to RGC development, survival and function. These results, together with our previous report, support a cell lineage-specific mechanism of Ezh2-mediated gene repression, especially those critically involved in cellular function and homeostasis.	[Cheng, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Cheng, Lin; Wong, Lucy J.; Yan, Naihong; Han, Richard C.; Yu, Honghua; Guo, Chenying; Batsuuri, Khulan; Zinzuwadia, Aniket; Guan, Ryan; Cho, Kin-Sang; Chen, Dong Feng] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02115 USA; [Wong, Lucy J.] Univ Freiburg, Fac Med, Med Ctr, Eye Ctr, Freiburg, Germany; [Yan, Naihong] Sichuan Univ, West China Hosp, Dept Ophthalmol & Ophthalm Labs, State Key Lab Biotherapy & Canc Ctr, Chengdu, Sichuan, Peoples R China	Sun Yat Sen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; University of Freiburg; Sichuan University	Chen, DF (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02115 USA.	dongfeng_chen@meei.harvard.edu		Cheng, Lin/0000-0002-4960-8186; Cho, Kin-Sang/0000-0003-4285-615X; Kessler, Lucy Joanne/0000-0002-5322-9875	NIH/NEI [R41 EY025913, R01EY025259]; Curing Kids Fund; Core Grant for Vision Research from NIH/NEI [P30EY03790]; Postdoctoral Foundation [2015M580758]; Natural Science Foundation of Guangdong Province [2016A030310201]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [P30EY003790, R01EY025259] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Curing Kids Fund; Core Grant for Vision Research from NIH/NEI; Postdoctoral Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from the NIH/NEI (R41 EY025913 and R01EY025259) and Curing Kids Fund to D.F.C.; the Core Grant for Vision Research from NIH/NEI to the Schepens Eye Research Institute (P30EY03790), and the Postdoctoral Foundation to L. C. (No. 2015M580758), the Natural Science Foundation of Guangdong Province (2016A030310201) to L.C and Massachusetts Lions Eye Research Fund to DFC. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERS S, 2010, GENOME BIOL, V11; Barth P. G., 2016, NEUROPATHOL APPL NEU; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Camp AS, 2011, INVEST OPHTH VIS SCI, V52, P5226, DOI 10.1167/iovs.10-6307; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen SD, 2015, ASIA-PAC J OPHTHALMO, V4, P236, DOI 10.1097/APO.0000000000000122; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Chou RH, 2011, AM J TRANSL RES, V3, P243; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; He SK, 2013, MOL VIS, V19, P665; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hufnagel RB, 2007, MOL CELL NEUROSCI, V36, P435, DOI 10.1016/j.mcn.2007.08.006; Iida A, 2015, DEV NEUROBIOL, V75, P947, DOI 10.1002/dneu.22261; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Lange CA, 2012, OPHTHALMOLOGY, V119, P1924, DOI 10.1016/j.ophtha.2012.03.037; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Li JL, 2013, NAT NEUROSCI, V16, P1745, DOI 10.1038/nn.3564; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Pennington KL, 2015, J EXP NEUROSCI, V9, P51, DOI 10.4137/JEN.S25513; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rao RC, 2010, INVEST OPHTH VIS SCI, V51, P6784, DOI 10.1167/iovs.09-4730; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Saeki T, 2008, CURR EYE RES, V33, P247, DOI 10.1080/02713680801919716; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29264; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vogel T, 2006, DEV DYNAM, V235, P2574, DOI 10.1002/dvdy.20876; Vu THK, 2012, ASIA-PAC J OPHTHALMO, V1, P303, DOI 10.1097/APO.0b013e31826f57a3; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wiggs JL, 2012, INVEST OPHTH VIS SCI, V53, P2467, DOI 10.1167/iovs.12-9483e; Yan NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33887; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zhang JM, 2015, DEV BIOL, V403, P128, DOI 10.1016/j.ydbio.2015.05.010	57	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191853	10.1371/journal.pone.0191853	http://dx.doi.org/10.1371/journal.pone.0191853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408885	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800026
J	Hu, WJ; Pan, XL; Li, FF; Dong, WB				Hu, Wenjin; Pan, Xinli; Li, Fengfeng; Dong, Wubei			UPLC-QTOF-MS metabolomics analysis revealed the contributions of metabolites to the pathogenesis of Rhizoctonia solani strain AG-1-IA	PLOS ONE			English	Article							SYSTEMIC WOUND RESPONSE; CHAIN FATTY-ACID; DEFENSE RESPONSES; ARABIDOPSIS-THALIANA; ANTIOXIDANT ACTIVITY; MASS-SPECTROMETRY; TRANSGENIC MAIZE; STRESS; IDENTIFICATION; BIOSYNTHESIS	To explore the pathogenesis of Rhizoctonia solani and its phytotoxin phenylacetic acid (PAA) on maize leaves and sheaths, treated leaf and sheath tissues were analyzed and interpreted by ultra-performance liquid chromatography-mass spectrometry combined with chemometrics. The PAA treatment had similar effects to those of R. solani on maize leaves regarding the metabolism of traumatin, phytosphingosine, vitexin 2'' O-beta-D-glucoside, rutin and DIBOA-glucoside, which were up-regulated, while the synthesis of OPC-8:0 and 12-OPDA, precursors for the synthesis of jasmonic acid, a plant defense signaling molecule, was down-regulated under both treatments. However, there were also discrepancies in the influences exhibited by R. solani and PAA as the metabolic concentration of zeaxanthin diglucoside in the R. solani infected leaf group decreased. Conversely, in the PAA-treated leaf group, the synthesis of zeaxanthin diglucoside was enhanced. Moreover, although the synthesis of 12 metabolites were suppressed in both the R. solani- and PAA-treated leaf tissues, the inhibitory effect of R. solani was stronger than that of PAA. An increased expression of quercitrin and quercetin 3-O-glucoside was observed in maize sheaths treated by R. solani, while their concentrations were not changed significantly in the PAA-treated sheaths. Furthermore, a significant decrease in the concentration of L-Glutamate, which plays important roles in plant resistance to necrotrophic pathogens, only occurred in the R. solani-treated sheath tissues. The differentiated metabolite levels may be the partial reason of why maize sheaths were more susceptible to R. solani than leaves and may explain the underlying mechanisms of R. solani pathogenesis.	[Hu, Wenjin; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Dept Plant Pathol, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Hu, Wenjin; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei, Peoples R China; [Pan, Xinli] Tech Univ Dortmund, Dept Biochem & Chem Engn, Dortmund, Germany	Huazhong Agricultural University; Huazhong Agricultural University; Dortmund University of Technology	Dong, WB (corresponding author), Huazhong Agr Univ, Dept Plant Pathol, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Dong, WB (corresponding author), Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei, Peoples R China.	dwb@mail.hzau.edu.cn		Dong, Wubei/0000-0001-8513-8751	National Major Project for Transgenic Organism Breeding [2016ZX08003-001]; Hubei Provincial Technology Innovation Program [2016ABA093]	National Major Project for Transgenic Organism Breeding; Hubei Provincial Technology Innovation Program	This work was supported by the National Major Project for Transgenic Organism Breeding (2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093).	Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2013, METABOLOMICS, V9, pS159, DOI 10.1007/s11306-011-0340-1; AOKI H, 1963, NATURE, V200, P575, DOI 10.1038/200575a0; Bartz FE, 2012, MYCOLOGIA, V104, P793, DOI 10.3852/11-084; Bernardes-de-Assis J, 2009, PHYTOPATHOLOGY, V99, P1090, DOI 10.1094/PHYTO-99-9-1090; Betsiashvili M, 2015, J EXP BOT, V66, P571, DOI 10.1093/jxb/eru379; Brauc S, 2011, J PLANT PHYSIOL, V168, P1813, DOI 10.1016/j.jplph.2011.05.012; Broyart C, 2010, PHYTOCHEM ANALYSIS, V21, P102, DOI 10.1002/pca.1177; Castro C, 2008, J EXP BOT, V59, P3913, DOI 10.1093/jxb/ern239; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Ding XP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00830; Dulermo T, 2009, PLANT SIGNAL BEHAV, V4, P859, DOI 10.4161/psb.4.9.9397; Frank T, 2012, J AGR FOOD CHEM, V60, P3005, DOI 10.1021/jf204167t; Gao J, 2014, MOL BIOL REP, V41, P2471, DOI 10.1007/s11033-014-3103-z; Gavaghan CL, 2011, PHYTOCHEM ANALYSIS, V22, P214, DOI 10.1002/pca.1268; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Guo R, 2007, J PHARMACEUT BIOMED, V43, P1580, DOI 10.1016/j.jpba.2006.11.029; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177464; Huan JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02303; Jayasinghe CK, 2004, MYCOPATHOLOGIA, V157, P73, DOI 10.1023/B:MYCO.0000012210.64378.97; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; KLINGNER A, 1995, PHYTOCHEMISTRY, V38, P53, DOI 10.1016/0031-9422(94)00538-5; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kuhnen S, 2010, J AGR FOOD CHEM, V58, P2194, DOI 10.1021/jf9037776; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; Li X, 2011, AGR SYST, V104, P348, DOI 10.1016/j.agsy.2010.12.006; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; LIM BP, 1992, BIOCHIM BIOPHYS ACTA, V1126, P178; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; Magnin-Robert M, 2015, PLANT PHYSIOL, V169, P2255, DOI 10.1104/pp.15.01126; Makoi J.H., 2007, AFR J BIOTECHNOL, V6; Manetti C, 2004, PHYTOCHEMISTRY, V65, P3187, DOI 10.1016/j.phytochem.2004.10.015; Manetti C, 2006, J EXP BOT, V57, P2613, DOI 10.1093/jxb/erl025; Navarre DA, 1999, PLANT CELL, V11, P237; Ndakidemi PA, 2003, FUNCT PLANT BIOL, V30, P729, DOI 10.1071/FP03042; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Parvez MM, 2004, BIOCHEM SYST ECOL, V32, P631, DOI 10.1016/j.bse.2003.12.002; Pietryczuk A, 2011, PLANT GROWTH REGUL, V65, P279, DOI 10.1007/s10725-011-9599-5; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4, P94, DOI 10.4161/psb.4.2.7580; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Ruttkies C, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0115-9; Seifi HS, 2013, MOL PLANT MICROBE IN, V26, P475, DOI 10.1094/MPMI-07-12-0176-CR; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; Skogerson K, 2010, J AGR FOOD CHEM, V58, P3600, DOI 10.1021/jf903705y; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Strack D, 2006, NEW PHYTOL, V172, P22, DOI 10.1111/j.1469-8137.2006.01837.x; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Suzuki K, 2007, PLANT SCI, V173, P291, DOI 10.1016/j.plantsci.2007.06.002; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vidhyasekaran P, 1997, PHYTOPATHOLOGY, V87, P1258, DOI 10.1094/PHYTO.1997.87.12.1258; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146910; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zabela MD, 2002, MOL PLANT MICROBE IN, V15, P808, DOI 10.1094/MPMI.2002.15.8.808; Zhang ZhiMing, 2012, African Journal of Biotechnology, V11, P2827	66	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192486	10.1371/journal.pone.0192486	http://dx.doi.org/10.1371/journal.pone.0192486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408919	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800071
J	Kuo, SY; Lin, YC; Lai, YC; Liao, JT; Hsu, YH; Huang, HC; Hu, CC				Kuo, Song-Yi; Lin, Yuan-Chuen; Lai, Yi-Chin; Liao, Jia-Teh; Hsu, Yau-Heiu; Huang, Hsiou-Chen; Hu, Chung-Chi			Production of fluorescent antibody-labeling proteins in plants using a viral vector and the application in the detection of Acidovorax citrulli and Bamboo mosaic virus	PLOS ONE			English	Article							AVENAE SUBSP CITRULLI; CELL-TO-CELL; CLEAVAGE ACTIVITIES; FUSION PROTEIN; COAT PROTEIN; EXPRESSION; BINDING; CONSTRUCTION; APHTHOVIRUS; MOVEMENT	Serological methods are relatively convenient and simple for the detection of pathogens for front-line workers. On-site visualization of the test results plays a pivotal role in the process. However, an efficient, universal labeling agent for antibodies is needed for the development of efficient serological detection tools. In this study, a Bamboo mosaic virus (BaMV)-based viral vector was employed to express recombinant proteins, collectively designated GfED, consisting of Staphylococcus aureus Protein A domain ED (SpaED) fused to either the N- or C-terminal of an improved green florescent protein (GFP) with or without the coat protein (CP) of BaMV, efficiently in Chenopodium quinoa. The GfED in crude leaf extracts could specifically attach to IgG molecules of rabbits and mice, effectively labeling IgG with GFP, emitting green light at 506 nm when excited at 450 nm using simple, handheld equipment. To demonstrate the applicability of GfED in serological assays, we have developed a fluorescent dot blot assay for the rapid detection of Acidovorax citrulli (Ac), a bacterial pathogen of cucurbits, and BaMV, a viral pathogen of bamboos. By using the crude extracts of inoculated C. quinoa leaves expressing GfED as an IgG-labeling agent, the pathogens were easily and quickly detected through uncomplicated operations using simple equipment, with results observable by the naked eye. Examination using fluorescent microscopy and transmission electron microscopy revealed that the GfED subunits may assemble into virus-like particles, which were further involved in the formation of aggregates of GfED-anti-body-antigen complexes with the potential for fluorescence signal enhancement. The results suggested that plant-expressed GfED may serve as a promising alternative of IgG-labeling agent for current serological assays.	[Kuo, Song-Yi; Lin, Yuan-Chuen; Lai, Yi-Chin; Liao, Jia-Teh; Hsu, Yau-Heiu; Huang, Hsiou-Chen; Hu, Chung-Chi] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan	National Chung Hsing University	Hsu, YH; Huang, HC; Hu, CC (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan.	yhhsu@dragon.nchu.edu.tw; hchuang@dragon.nchu.edu.tw; cchu@dragon.nchu.edu.tw			Ministry of Science and Technology, Taiwan [NSC 102-2811-B-005-038]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [100AS-1.1.12-BQ-B1(Z), 101AS-10.3.1-BQ-B2(Z), 102AS-10.2.5-BQ-B2(Z)]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan	This study was supported by Post-doctoral grant NSC 102-2811-B-005-038 to YCL from Ministry of Science and Technology, Taiwan, and grants 100AS-1.1.12-BQ-B1(Z), 101AS-10.3.1-BQ-B2(Z), and 102AS-10.2.5-BQ-B2(Z) to HCH and CCH from Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan.	Aoki T, 2000, BIOSCI BIOTECH BIOCH, V64, P1547, DOI 10.1271/bbb.64.1547; Aoki T, 1996, FEBS LETT, V384, P193, DOI 10.1016/0014-5793(96)00289-X; Arai R, 1998, J FERMENT BIOENG, V86, P440, DOI 10.1016/S0922-338X(98)80148-7; Buchwalow IB, 2010, IMMUNOHISTOCHEMISTRY: BASICS AND METHODS, P1, DOI 10.1007/978-3-642-04609-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Chang KC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00870; Chen TH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00788; Chen TH, 2012, VIRUS RES, V166, P109, DOI 10.1016/j.virusres.2012.02.021; Cruz SS, 1998, PLANT CELL, V10, P495, DOI 10.1105/tpc.10.4.495; Deng WL, 2010, PLANT DIS, V94, P1065, DOI 10.1094/PDIS-94-8-1065A; Dickmeis C, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00189; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Fang Y, 2015, BIOSENSORS-BASEL, V5, P537, DOI 10.3390/bios5030537; Gecchele E, 2015, JOVE-J VIS EXP, DOI 10.3791/52459; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352; Huang Z, 2006, VACCINE, V24, P2506, DOI 10.1016/j.vaccine.2005.12.024; Hung CJ, 2014, MOL PLANT MICROBE IN, V27, P1211, DOI 10.1094/MPMI-04-14-0112-R; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; KING EO, 1954, J LAB CLIN MED, V44, P301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATIN RX, 1995, PLANT DIS, V79, P761, DOI 10.1094/PD-79-0761; Lee CC, 2011, J VIROL, V85, P12022, DOI 10.1128/JVI.05595-11; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; LIN NS, 1991, PHYTOPATHOLOGY, V81, P1551, DOI 10.1094/Phyto-81-1551; LIN NS, 1993, PLANT DIS, V77, P448, DOI 10.1094/PD-77-0448; Maniatis T., 1982, MOL CLONING; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Merlin M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/136419; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; Muthamilselvan T, 2016, PLANT BIOTECHNOL J, V14, P231, DOI 10.1111/pbi.12377; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Ogi H, 2007, BIOSENS BIOELECTRON, V22, P3238, DOI 10.1016/j.bios.2007.03.003; Prachayasittikul V, 2005, EXCLI J, V4, P91; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Savary S, 2012, FOOD SECUR, V4, P519, DOI 10.1007/s12571-012-0200-5; SCHAAD NW, 1978, INT J SYST BACTERIOL, V28, P117, DOI 10.1099/00207713-28-1-117; SHUTTLEWORTH HL, 1987, GENE, V58, P283, DOI 10.1016/0378-1119(87)90383-0; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vira S, 2010, ANAL BIOCHEM, V402, P146, DOI 10.1016/j.ab.2010.03.036; WILLEMS A, 1992, INT J SYST BACTERIOL, V42, P107, DOI 10.1099/00207713-42-1-107; Yang CD, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-62	48	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192455	10.1371/journal.pone.0192455	http://dx.doi.org/10.1371/journal.pone.0192455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408944	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800068
J	Xia, KL				Xia, Kelin			Sequence-based multiscale modeling for high-throughput chromosome conformation capture (Hi-C) data analysis	PLOS ONE			English	Article							TOPOLOGICAL DOMAINS; FUNCTIONAL-ORGANIZATION; GENOME; PRINCIPLES; IDENTIFICATION; SHAPE	In this paper, we introduce sequence-based multiscale modeling for biomolecular data analysis. We employ spectral clustering method in our modeling and reveal the difference between sequence-based global scale clustering and local scale clustering. Essentially, two types of distances, i.e., Euclidean (or spatial) distance and genomic (or sequential) distance, can be used in data clustering. Clusters from sequence-based global scale models optimize spatial distances, meaning spatially adjacent loci are more likely to be assigned into the same cluster. Sequence-based local scale models, on the other hand, result in clusters that optimize genomic distances. That is to say, in these models, sequentially adjoining loci tend to be cluster together. We propose two sequence-based multiscale models (SeqMMs) for the study of chromosome hierarchical structures, including genomic compartments and topological associated domains (TADs). We find that genomic compartments are determined only by global scale information in the Hi-C data. The removal of all the local interactions within a band region as large as 10 Mb in genomic distance has almost no significant influence on the final compartment results. Further, in TAD analysis, we find that when the sequential scale is small, a tiny variation of diagonal band region in a contact map will result in a great change in the predicted TAD boundaries. When the scale value is larger than a threshold value, the TAD boundaries become very consistent. This threshold value is highly related to TAD sizes. By the comparison of our results with those previously obtained using a spectral clustering model, we find that our method is more robust and reliable. Finally, we demonstrate that almost all TAD boundaries from both clustering methods are local minimum of a TAD summation function.	[Xia, Kelin] Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 637371, Singapore; [Xia, Kelin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637371, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xia, KL (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 637371, Singapore.; Xia, KL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637371, Singapore.	xiakelin@ntu.edu.sg	XIA, KELIN/AAF-7490-2020; XIA, KELIN/I-7880-2016	XIA, KELIN/0000-0003-4183-0943; XIA, KELIN/0000-0003-4183-0943	Nanyang Technological University Startup Grant [M4081842.110]; Singapore Ministry of Education Academic Research Fund Tier 1 [M401110000]	Nanyang Technological University Startup Grant(Nanyang Technological University); Singapore Ministry of Education Academic Research Fund Tier 1(Ministry of Education, Singapore)	This work was supported by Nanyang Technological University (http://www.ntu.edu.sg/) Startup Grant M4081842.110 and Singapore Ministry of Education (https://www.moe.gov.sg/) Academic Research Fund Tier 1 M401110000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The author would like to thank Amartya Sanyal for valuable discussions. This work was supported in part by Nanyang Technological University Startup Grant M4081842.110 and Singapore Ministry of Education Academic Research fund Tier 1 M401110000.	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Cang Z. X., 2017, INT J NUMERICAL METH; Cang ZX, 2017, BIOINFORMATICS, V33, P3549, DOI 10.1093/bioinformatics/btx460; Cang ZX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005690; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chen HM, 2015, P NATL ACAD SCI USA, V112, P8002, DOI 10.1073/pnas.1505822112; Chen J, 2016, BIOINFORMATICS, V32, P2151, DOI 10.1093/bioinformatics/btw221; Chung F., 1997, SPECTRAL GRAPH THEOR; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feng X, 2012, INT J NUMER METH BIO, V28, P1198, DOI 10.1002/cnm.2532; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hu M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002893; Imakaev MV, 2015, FEBS LETT, V589, P3031, DOI 10.1016/j.febslet.2015.09.004; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Lesne A, 2014, NAT METHODS, V11, P1141, DOI [10.1038/nmeth.3104, 10.1038/NMETH.3104]; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904; Ming D, 2002, P NATL ACAD SCI USA, V99, P8620, DOI 10.1073/pnas.082148899; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Opron K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4882258; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanyal A, 2011, CURR OPIN CELL BIOL, V23, P325, DOI 10.1016/j.ceb.2011.03.009; Schmitt AD, 2016, NAT REV MOL CELL BIO, V17, P743, DOI 10.1038/nrm.2016.104; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Segal MR, 2014, BIOSTATISTICS, V15, P442, DOI 10.1093/biostatistics/kxu003; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wei, 2016, ARXIV161201735; Xia KL, 2018, PHYS CHEM CHEM PHYS, V20, P658, DOI 10.1039/c7cp07177a; Xia K, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931733; Xia KL, 2015, J COMPUT BIOL, V22, P887, DOI 10.1089/cmb.2015.0104; Xia KL, 2015, J COMPUT CHEM, V36, P1502, DOI 10.1002/jcc.23953; Xia KL, 2014, INT J NUMER METH BIO, V30, P814, DOI 10.1002/cnm.2655; Xia K, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4830404; Xia KL, 2014, J COMPUT PHYS, V257, P912, DOI 10.1016/j.jcp.2013.09.034; Zhang B, 2015, P NATL ACAD SCI USA, V112, P6062, DOI 10.1073/pnas.1506257112; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhang ZZ, 2013, J COMPUT BIOL, V20, P831, DOI 10.1089/cmb.2013.0076; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	54	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191899	10.1371/journal.pone.0191899	http://dx.doi.org/10.1371/journal.pone.0191899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408904	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800028
J	Gong, JH; Zheng, YB; Wang, Y; Sheng, WJ; Li, Y; Liu, XJ; Si, SY; Shao, RG; Zhen, YS				Gong, Jianhua; Zheng, Yanbo; Wang, Ying; Sheng, Weijin; Li, Yi; Liu, Xiujun; Si, Shuyi; Shao, Rongguang; Zhen, Yongsu			A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway	PLOS ONE			English	Article							ATM PROTEIN-KINASE; BIOLOGICAL EVALUATION; ATAXIA-TELANGIECTASIA; CHECKPOINT CONTROL; CARCINOMA-CELLS; DERIVATIVES; CHK2; INHIBITORS; DESIGN; P53	Through cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted cytotoxicity against cancer cells. In the present study, we evaluated its antitumor efficacy and the possible mechanism. By MTT assay, IMB5043 inhibited the proliferation of various human cancer cells lines, especially hepatocarcinoma SMMC-7721 cells. IMB5043 blocked cell cycle with G2/M arrest, induced cell apoptosis, and inhibited the migration and invasion of SMMC-7721 cells. As verified by comet assay and gamma-H2AX foci formation, IMB5043 caused DNA damage and activated ATM, Chk2 and p53 through phosphorylation. As shown by Gene microarray analysis, the differentially expressed genes in SMMC-7721 cells treated with IMB5043 were highly related to cell death and apoptosis. IMB5043 suppressed the growth of hepatocarcinoma SMMC-7721 xenograft in athymic mice. By histopathological examination, no lesions were found in bone marrow and various organs of the treated mice. Our findings reveal that IMB5043 as an active compound consisting of both pyridazinone and thiophene moieties exerts antitumor efficacy through activation of ATM-Chk2 pathway. IMB5043 may serve as a promising leading compound for the development of antitumor drugs.	[Liu, Xiujun; Si, Shuyi; Shao, Rongguang; Zhen, Yongsu] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing, Peoples R China.	zhenys@imb.pumc.edu.cn	Gong, Jian-Hua/L-5284-2019		Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-010]	Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences	This work was supported by grants from Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-010].	Akhtar W, 2017, MINI REV MED CHEM, V17; Akhtar W, 2016, EUR J MED CHEM, V123, P256, DOI 10.1016/j.ejmech.2016.07.061; Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Annovazzi L, 2017, CANCERS, V9, DOI 10.3390/cancers9060057; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brooke DG, 2014, BIOORGAN MED CHEM, V22, P1029, DOI 10.1016/j.bmc.2013.12.041; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Dorsch D, 2015, BIOORG MED CHEM LETT, V25, P1597, DOI 10.1016/j.bmcl.2015.02.002; Forsch RA, 2002, BIOORGAN MED CHEM, V10, P2067, DOI 10.1016/S0968-0896(02)00018-4; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Ghorab MM, 2014, ACTA PHARMACEUT, V64, P419, DOI 10.2478/acph-2014-0035; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jaballah MY, 2017, DRUG RES, V67, P138, DOI 10.1055/s-0042-119992; Jerome KD, 2010, BIOORG MED CHEM LETT, V20, P3146, DOI 10.1016/j.bmcl.2010.03.088; Kim EY, 2016, ARCH PHARM RES, V39, P453, DOI 10.1007/s12272-015-0703-7; Lin HL, 2011, DRUG METAB DISPOS, V39, P345, DOI 10.1124/dmd.110.034074; Lu D, 2017, ACS MED CHEM LETT, V8, P830, DOI 10.1021/acsmedchemlett.7b00172; Marechal A., 2013, COLD SPRING HARB PER, V5; McGowan CH, 2002, CELL CYCLE, V1, P401, DOI 10.4161/cc.1.6.264; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Panathur N, 2016, MED CHEM RES, V25, P135, DOI 10.1007/s00044-015-1473-y; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Rakesh KS, 2015, MED CHEM, V11, P462, DOI 10.2174/1573406411666141210141918; Romagnoli R, 2013, J MED CHEM, V56, P2606, DOI 10.1021/jm400043d; Saad HA, 2011, MOLECULES, V16, P4937, DOI 10.3390/molecules16064937; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Singh J, 2017, FUTURE MED CHEM, V9, P95, DOI 10.4155/fmc-2016-0194; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Wang J, 2015, BIOORG MED CHEM LETT, V25, P2340, DOI 10.1016/j.bmcl.2015.04.013; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhou SG, 2014, EUR J MED CHEM, V83, P581, DOI 10.1016/j.ejmech.2014.06.068; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191984	10.1371/journal.pone.0191984	http://dx.doi.org/10.1371/journal.pone.0191984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394294	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400022
J	Hernan, AE; Mahoney, JM; Curry, W; Richard, G; Lucas, MM; Massey, A; Holmes, GL; Scott, RC				Hernan, Amanda E.; Mahoney, J. Matthew; Curry, Willie; Richard, Greg; Lucas, Marcella M.; Massey, Andrew; Holmes, Gregory L.; Scott, Rod C.			Environmental enrichment normalizes hippocampal timing coding in a malformed hippocampus	PLOS ONE			English	Article							NEURONAL MIGRATION DISORDERS; PLACE CELLS; METHYLAZOXYMETHANOL ACETATE; CORTICAL DYSPLASIA; TEMPORAL SEQUENCES; PHASE PRECESSION; ANIMAL-MODEL; RAT; INTERNEURONS; COMPRESSION	Neurodevelopmental insults leading to malformations of cortical development (MCD) are a common cause of psychiatric disorders, learning impairments and epilepsy. In the methylazoxymethanol (MAM) model of MCDs, animals have impairments in spatial cognition that, remarkably, are improved by post-weaning environmental enrichment (EE). To establish how EE impacts network-level mechanisms of spatial cognition, hippocampal in vivo single unit recordings were performed in freely moving animals in an open arena. We took a generalized linear modeling approach to extract fine spike timing (FST) characteristics and related these to place cell fidelity used as a surrogate of spatial cognition. We find that MAM disrupts FST and place-modulated rate coding in hippocampal CA1 and that EE improves many FST parameters towards normal. Moreover, FST parameters predict spatial coherence of neurons, suggesting that mechanisms determining altered FST are responsible for impaired cognition in MCDs. This suggests that FST parameters could represent a therapeutic target to improve cognition even in the context of a brain that develops with a structural abnormality.	[Hernan, Amanda E.; Mahoney, J. Matthew; Curry, Willie; Richard, Greg; Massey, Andrew; Holmes, Gregory L.; Scott, Rod C.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Lucas, Marcella M.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	University of Vermont; Dartmouth College; University of London; University College London	Hernan, AE; Scott, RC (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.; Scott, RC (corresponding author), UCL, Inst Child Hlth, London, England.	Amanda.Hernan@uvm.edu; Rodney.Scott@uvm.edu		Hernan, Amanda/0000-0003-4931-3481; Scott, Rod/0000-0002-8944-928X	NIH [7R01NS075249-04]; National Institutes of Health - National Institute of Neurological Disease and Stroke [7R01NS075249-04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health - National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health - National Institute of Neurological Disease and Stroke, 7R01NS075249-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant 7R01NS075249-04 awarded to RCS. The authors declare no conflicts of interest.	Amilhon B, 2015, NEURON, V86, P1277, DOI 10.1016/j.neuron.2015.05.027; Baraban SC, 1995, EPILEPSY RES, V22, P145, DOI 10.1016/0920-1211(95)00045-3; Buzsaki G., 2002, NEURON; Calcagnotto ME, 2005, J NEUROSCI, V25, P9649, DOI 10.1523/JNEUROSCI.2687-05.2005; Casanova MF, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-67; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chadwick A, 2015, ELIFE, V4, DOI 10.7554/eLife.03542; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fiore M, 2004, NEUROREPORT, V15, P1791, DOI 10.1097/01.wnr.0000135934.03635.6a; Germano IM, 1998, J NEUROSCI RES, V51, P473, DOI 10.1002/(SICI)1097-4547(19980215)51:4<473::AID-JNR7>3.0.CO;2-9; Germano IM, 1996, EPILEPSIA, V37, P902, DOI 10.1111/j.1528-1157.1996.tb00044.x; Hradetzky E, 2012, NEUROPSYCHOPHARMACOL, V37, P364, DOI 10.1038/npp.2011.219; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jenks KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084492; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; KUZNIECKY R, 1993, NEUROLOGY, V43, P681, DOI 10.1212/WNL.43.4.681; Lenck-Santini PP, 2008, J NEUROSCI, V28, P5053, DOI 10.1523/JNEUROSCI.5024-07.2008; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lucas MM, 2011, BRAIN, V134, P1684, DOI 10.1093/brain/awr087; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Penschuck S, 2006, EUR J NEUROSCI, V23, P279, DOI 10.1111/j.1460-9568.2005.04536.x; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Piontkewitz Y, 2011, BIOL PSYCHIAT, V70, P842, DOI 10.1016/j.biopsych.2011.06.007; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder MA, 2013, NEUROPSYCHOPHARMACOL, V38, P328, DOI 10.1038/npp.2012.180; Yamada S, 2007, K MEANS ADVANTAGES C	32	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191488	10.1371/journal.pone.0191488	http://dx.doi.org/10.1371/journal.pone.0191488			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394267	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400012
J	Mayaphi, SH; Martin, DJ; Olorunju, SAS; Williams, BG; Quinn, TC; Stoltz, AC				Mayaphi, Simnikiwe H.; Martin, Desmond J.; Olorunju, Steve A. S.; Williams, Brian G.; Quinn, Thomas C.; Stoltz, Anton C.			High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HETEROSEXUAL TRANSMISSION; DRUG-RESISTANCE; INFECTION; PREVALENCE; THAILAND; COHORT; UGANDA; PARTNERSHIPS	Objective To assess the prevalence of HIV risk behaviour among sexually active HIV sero-negative individuals in the Tshwane district of South Africa (SA). Methods Demographic and HIV risk behaviour data were collected on a questionnaire from participants of a cross-sectional study that screened for early HIV infection using pooled nucleic acid amplification testing (NAAT). The study enrolled individuals who tested negative on rapid HIV tests performed at five HIV counseling and testing (HCT) clinics, which included four antenatal clinics and one general HCT clinic. Results The study enrolled 9547 predominantly black participants (96.6%) with a median age of 27 years (interquartile range [IQR]: 23-31). There were 1661 non-pregnant and 7886 pregnant participants largely enrolled from the general and antenatal HCT clinics, respectively. NAAT detected HIV infection in 61 participants (0.6%; 95% confidence interval [CI]: 0.4-0.8) in the whole study. A high proportion of study participants, 62.8% and 63.0%, were unaware of their partner's HIV status; and also had high prevalence, 88.5% and 99.5%, of recent unprotected sex in the general and pregnant population, respectively. Consistent use of condoms was associated with protection against HIV infection in the general population. Trends of higher odds for HIV infection were observed with most demographic and HIV risk factors at univariate analysis, however, multivariate analysis did not show statistical significance for almost all these factors. A significantly lower risk of HIV infection was observed in circumcised men (p < 0.001). Conclusions These data show that a large segment of sexually active people in the Tshwane district of SA have high risk exposure to HIV. The detection of newly diagnosed HIV infections in all study clinics reflects a wide distribution of individuals who are capable of sustaining HIV transmission in the setting where HIV risk behaviour is highly prevalent. A questionnaire that captures HIV risk behaviour would be useful during HIV counselling and testing to ensure that there is a systematic way of identifying HIV risk factors and that counselling is optimised for each individual. HIV risk behaviour surveillance could be used to inform relevant HIV prevention interventions that could be implemented at a community or population level.	[Mayaphi, Simnikiwe H.; Martin, Desmond J.] Univ Pretoria, Dept Med Virol, City Of Tshwane, South Africa; [Mayaphi, Simnikiwe H.] NHLS TAD, City Of Tshwane, South Africa; [Martin, Desmond J.] Toga Labs, Johannesburg, South Africa; [Olorunju, Steve A. S.] MRC, Biostat Unit, City Of Tshwane, South Africa; [Williams, Brian G.] South African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Stoltz, Anton C.] Univ Pretoria, Dept Internal Med, Div Infect Dis, City Of Tshwane, South Africa	University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Pretoria	Mayaphi, SH (corresponding author), NHLS TAD, City Of Tshwane, South Africa.	sim.mayaphi@up.ac.za		Mayaphi, Simnikiwe/0000-0002-5453-4353	NHLS Research Trust fund; University of Pretoria; MRC - SIR grant; Discovery Foundation grant; Division of Intramural Research, NIAID, NIH; Toga Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361] Funding Source: NIH RePORTER	NHLS Research Trust fund; University of Pretoria; MRC - SIR grant; Discovery Foundation grant; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Toga Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NHLS Research Trust fund - SHM & DJM, University of Pretoria research assistant grant - SHM, MRC - SIR grant - SHM, Discovery Foundation grant - SHM, and The Division of Intramural Research, NIAID, NIH - TCQ. Prof Desmond J. Martin [DJM] is an employee of a commercial company, Toga Laboratories. The Toga Laboratories provided support in the form of salaries for [DJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Kagaayi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092015; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Kalichman SC, 2007, AM J DRUG ALCOHOL AB, V33, P687, DOI 10.1080/00952990701522716; Karita E, 2016, JAIDS-J ACQ IMM DEF, V73, pE51, DOI 10.1097/QAI.0000000000001138; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Mayaphi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164943; Mohlabane N, 2015, J PSYCHOL, V6, P19; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Onoya D, 2016, PUBLIC HEALTH, V136, P152, DOI 10.1016/j.puhe.2016.03.029; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Population Reference Bereau, 2016, WORLD POP DAT SHEET; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg NE, 2016, SEX TRANSM INFECT, V92, P579, DOI 10.1136/sextrans-2016-052651; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Shisana O, 2004, SAMJ S AFR MED J, V94, P537; Shisana O., 2014, AFRICAN NATL HIV P; Statistics SA, 2015, MIDY POP EST; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Strode A, 2010, SAMJ S AFR MED J, V100, P247, DOI 10.7196/SAMJ.3609; Talu A, 2010, INT J DRUG POLICY, V21, P56, DOI 10.1016/j.drugpo.2009.02.007; UNAIDS, 2016, GLOB AIDS UPD; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; Yuntadilok N, 2014, AIDS BEHAV, V18, pS42, DOI 10.1007/s10461-013-0522-0	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192357	10.1371/journal.pone.0192357	http://dx.doi.org/10.1371/journal.pone.0192357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394288	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400037
J	Chen, L; Yuan, JX; Xu, YJ; Zhang, FX; Chen, ZL				Chen, Lu; Yuan, Juxiang; Xu, Yingjun; Zhang, Fengxia; Chen, Zhenlei			Comparison of clinical manifestations and antibiotic resistances among three genospecies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex	PLOS ONE			English	Article							BACTEREMIA; NOSOCOMIALIS; INFECTIONS; OUTCOMES; PITTII; IDENTIFICATION; COLISTIN; FEATURES; CHINA; ICU	The Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex has emerged as a high priority among hospital-acquired pathogens in intensive care units (ICUs), posing a challenge to infection management practices. In this study, the clinical characteristics, antimicrobial susceptibility patterns, and patients outcome among genospecies were retrospectively compared. Samples were taken from the tracheal secretions of 143 patients in the ICU. Genospecies of the ACB complex were discriminated by analysis of the 16S-23S rRNA gene intergenic spacer (ITS) sequence. Univariate and multiple variable logistic regression analyses were performed to identify risk factors for infection and mortality. Three genospecies were isolated: A. baumannii (73, 51.0%), A. nosocomialis (29, 20.3%), and A. pittii (41, 28.7%). The results showed that the distribution of infection and colonization among the three genospecies were the same, while A. baumannii was more resistant to common antibiotics than A. nosocomialis and A. pittii. Advanced age, a long stay in the ICU, acute physiology and chronic health evaluation (APACHE) II score, the use of a mechanical ventilator, and previous antibiotic use were risk factors for patient infection. The APACHE II score was a risk factor for mortality in patients with ACB complex isolated from tracheal secretions. Poor outcome of patients with ACB complex isolated from tracheal secretion appears to be related to the APACHE II score rather than genospecies.	[Chen, Lu; Yuan, Juxiang; Xu, Yingjun] North China Univ Sci & Technol, Coll Publ Hlth, Tangshan, Hebei, Peoples R China; [Chen, Lu; Zhang, Fengxia] Second Hosp Tangshan, Dept Infect Control, Tangshan, Hebei, Peoples R China; [Chen, Zhenlei] Kailuan Gen Hosp, Infect Control, Tangshan, Hebei, Peoples R China	North China University of Science & Technology	Yuan, JX (corresponding author), North China Univ Sci & Technol, Coll Publ Hlth, Tangshan, Hebei, Peoples R China.	99647312@qq.com						Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Arroyo LA, 2005, J CLIN MICROBIOL, V43, P903, DOI 10.1128/JCM.43.2.903-905.2005; Blot S, 2003, INTENS CARE MED, V29, P471, DOI 10.1007/s00134-003-1648-8; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x; Espinal P, 2011, FUTURE MICROBIOL, V6, P495, DOI [10.2217/fmb.11.30, 10.2217/FMB.11.30]; Fitzpatrick MA, 2015, J INFECTION, V70, P144, DOI 10.1016/j.jinf.2014.09.004; Fu Y, 2012, J ANTIMICROB CHEMOTH, V67, P2114, DOI 10.1093/jac/dks192; Garnacho-Montero J, 2015, INTENS CARE MED, V41, P2057, DOI 10.1007/s00134-015-4079-4; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32066; Jiang MJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01687; Jones RN, 2007, J CLIN MICROBIOL, V45, P227, DOI 10.1128/JCM.01588-06; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Kuo LC, 2007, CLIN MICROBIOL INFEC, V13, P196, DOI 10.1111/j.1469-0691.2006.01601.x; Lee HY, 2014, CRIT CARE MED, V42, P1081, DOI 10.1097/CCM.0000000000000125; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mari-Almirall M, 2017, CLIN MICROBIOL INFEC, V23, DOI [10.1016/j.culher.2016.11.020, 10.1016/j.cmi.2016.11.020]; Na IY, 2016, J MICROBIOL BIOTECHN, V26, P171, DOI 10.4014/jmb.1507.07076; Park KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065026; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Rello J, 2003, INTENS CARE MED, V29, P350, DOI 10.1007/s00134-003-1661-y; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Wang XH, 2013, DIAGN MICR INFEC DIS, V76, P392, DOI 10.1016/j.diagmicrobio.2013.03.020; Wayne P., 2014, PERFORMANCE STANDARD, V34, P50; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Yang Q, 2016, PLOS ONE, V8; Zhang R, 2014, EUR J CLIN MICROBIOL, V33, P853, DOI 10.1007/s10096-013-2024-4	30	15	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191748	10.1371/journal.pone.0191748	http://dx.doi.org/10.1371/journal.pone.0191748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389980	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400031
J	Cheng, YT; Imanirad, P; Jutooru, I; Hedrick, E; Jin, UH; Hoffman, AR; de Araujo, JL; Morpurgo, B; Golovko, A; Safe, S				Cheng, Yating; Imanirad, Parisa; Jutooru, Indira; Hedrick, Erik; Jin, Un-Ho; Hoffman, Aline Rodrigues; de Araujo, Jeann Leal; Morpurgo, Benjamin; Golovko, Andrei; Safe, Stephen			Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer	PLOS ONE			English	Article							NONCODING RNA MALAT1; TUMOR-GROWTH; LNCRNA MALAT1; POOR-PROGNOSIS; NUCLEAR SPECKLES; REGULATORY ROLE; STEM-CELLS; KAPPA-B; GENE; EXPRESSION	Metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) is a long non-coding RNA (lncRNA) that is a negative prognostic factor for patients with pancreatic cancer and several other tumors. In this study, we show that knockdown of MALAT-1 in Panc1 and other pancreatic cancer cell lines decreases cell proliferation, survival and migration. We previously observed similar results for the lncRNAs HOTTIP and HOTAIR in Panc1 cells; however, RNAseq comparison of genes regulated by MALAT-1 shows minimal overlap with HOTTIP/HOTAIR-regulated genes. Analysis of changes in gene expression after MALAT-1 knockdown shows that this lncRNA represses several tumor suppressor-like genes including N-myc downregulated gene-1 (NDRG-1), a tumor suppressor in pancreatic cancer that is also corepressed by EZH2 (a PRC2 complex member). We also observed that Specificity proteins Sp1, Sp3 and Sp4 are overexpressed in Panc1 cells and Sp knockdown or treatment with small molecules that decrease Sp proteins expression also decrease MALAT-1 expression. We also generated Kras-overexpressing p53L/L;LSL-Kras(G12D)L/+; p48Cre+/-(p53 (L/L)/Kras(G12D)) and p53L/+;LSLKras(G12D)L/+;p48Cre+/-(p53L/+/Kras(G12D)) mice which are p53 homo-and heterozygous, respectively. These mice rapidly develop pancreatic ductal adenocarcinoma-like tumors and were crossed with MALAT-1(-/-) mice. We observed that the loss of one or two MALAT-1 alleles in these Ras overexpressing mice does not significantly affect the time to death; however, the loss of MALAT-1 in the p53(-/+) (heterozygote) mice slightly increases their lifespan.	[Cheng, Yating; Imanirad, Parisa; Jutooru, Indira; Hedrick, Erik; Jin, Un-Ho; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Hoffman, Aline Rodrigues; de Araujo, Jeann Leal] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Morpurgo, Benjamin; Golovko, Andrei] Texas A&M Univ, Texas A&M Inst Genom Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	de Araujo, Jeann Leal/S-5955-2019	de Araujo, Jeann Leal/0000-0001-8688-9864	National Institute of Environmental Health Sciences [P30-E5023512]; Texas AgriLife Research	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Texas AgriLife Research	This work was supported by the National Institute of Environmental Health Sciences [P30-E5023512] (SS) and Texas AgriLife Research (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B. D., 2015, CANC RES; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Cheng YT, 2015, ONCOTARGET, V6, P10840, DOI 10.18632/oncotarget.3450; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hedrick E, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7925; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hogan B, 1994, MANIPULATING MOUSE E; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jiao F, 2015, INT J MOL SCI, V16, P6677, DOI 10.3390/ijms16046677; Jiao F, 2014, ONCOL REP, V32, P2485, DOI 10.3892/or.2014.3518; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Kim K, 2012, ONCOGENE; Li BZ, 2014, J BIOL CHEM, V289, P29365, DOI 10.1074/jbc.M114.572693; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Li SF, 2015, J CANCER RES CLIN, V141, P1909, DOI 10.1007/s00432-015-1951-0; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Lin R, 2011, FEBS LETT, V585, P671, DOI 10.1016/j.febslet.2011.01.030; Liu JH, 2014, ASIAN PAC J CANCER P, V15, P2971, DOI 10.7314/APJCP.2014.15.7.2971; Ma KX, 2015, TUMOR BIOL, V36, P3355, DOI 10.1007/s13277-014-2969-7; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Okugawa Y, 2014, CARCINOGENESIS, V35, P2731, DOI 10.1093/carcin/bgu200; Pang EJ, 2015, TUMOR BIOL, V36, P2403, DOI 10.1007/s13277-014-2850-8; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Shen LQ, 2015, J NEURO-ONCOL, V121, P101, DOI 10.1007/s11060-014-1613-0; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao Y, 2014, CANCER RES, V74, P5103, DOI 10.1158/0008-5472.CAN-14-0427; Zheng HT, 2014, INT J CLIN EXP PATHO, V7, P3174; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	50	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192264	10.1371/journal.pone.0192264	http://dx.doi.org/10.1371/journal.pone.0192264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389953	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400084
J	Conrad, KA; Rodriguez, R; Salcedo, EC; Rauceo, JM				Conrad, Karen A.; Rodriguez, Ronald; Salcedo, Eugenia C.; Rauceo, Jason M.			The Candida albicans stress response gene Stomatin-Like Protein 3 is implicated in ROS-induced apoptotic-like death of yeast phase cells	PLOS ONE			English	Article							HUMAN FUNGAL PATHOGEN; IDENTIFICATION; VISUALIZATION; DISRUPTION; EXPRESSION; FLOTILLIN; SEQUENCE; SKO1	The ubiquitous presence of SPFH (Stomatin, Prohibitin, Flotillin, HflK/HflC) proteins in all domains of life suggests that their function would be conserved. However, SPFH functions are diverse with organism-specific attributes. SPFH proteins play critical roles in physiological processes such as mechanosensation and respiration. Here, we characterize the stomatin ORF19.7296/SLP3 in the opportunistic human pathogen Candida albicans. Consistent with the localization of stomatin proteins, a Slp3p-Yfp fusion protein formed visible puncta along the plasma membrane. We also visualized Slp3p within the vacuolar lumen. Slp3p primary sequence analyses identified four putative S-palmitoylation sites, which may facilitate membrane localization and are conserved features of stomatins. Plasma membrane insertion sequences are present in mammalian and nematode SPFH proteins, but are absent in Slp3p. Strikingly, Slp3p was present in yeast cells, but was absent in hyphal cells, thus categorizing it as a yeast-phase specific protein. Slp3p membrane fluorescence significantly increased in response to cellular stress caused by plasma membrane, cell wall, oxidative, or osmotic perturbants, implicating SLP3 as a general stress-response gene. A slp3 Delta/Delta homozygous null mutant had no detected phenotype when slp3 Delta/Delta mutants were grown in the presence of a variety of stress agents. Also, we did not observe a defect in ion accumulation, filamentation, endocytosis, vacuolar structure and function, cell wall structure, or cytoskeletal structure. However, SLP3 over-expression triggered apoptotic-like death following prolonged exposure to oxidative stress or when cells were induced to form hyphae. Our findings reveal the cellular localization of Slp3p, and for the first time associate Slp3p function with the oxidative stress response.	[Conrad, Karen A.; Rodriguez, Ronald; Salcedo, Eugenia C.; Rauceo, Jason M.] CUNY, John Jay Coll, Dept Sci, New York, NY 10021 USA; [Rodriguez, Ronald] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Salcedo, Eugenia C.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA	City University of New York (CUNY) System; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Rauceo, JM (corresponding author), CUNY, John Jay Coll, Dept Sci, New York, NY 10021 USA.	jrauceo@jjay.cuny.edu			National Institute of General Medical Sciences [SC3GM111133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM111133] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences (http://www.nigms.nih.gov/), grant number SC3GM111133 to JMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Armstrong J, 2010, TRENDS CELL BIOL, V20, P580, DOI 10.1016/j.tcb.2010.06.010; Bartolome A, 2016, APMIS, V124, P271, DOI 10.1111/apm.12505; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cabezon V, 2009, PROTEOMICS, V9, P4770, DOI 10.1002/pmic.200800988; Chaillot J, 2015, ANTIMICROB AGENTS CH, V59, P4584, DOI 10.1128/AAC.00551-15; Chen TW, 2016, CELL BIOL INT, V40, P926, DOI 10.1002/cbin.10636; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; David C., 2005, STRATHERN METHODS IN; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Dempwolff F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006116; Dunkel N, 2014, MICROBIOL-SGM, V160, P1599, DOI 10.1099/mic.0.078238-0; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Hao BH, 2013, ANTIMICROB AGENTS CH, V57, P326, DOI 10.1128/AAC.01366-12; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1065, P195, DOI 10.1016/0005-2736(91)90230-6; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Lapatsina L, 2012, EUR J CELL BIOL, V91, P240, DOI 10.1016/j.ejcb.2011.01.018; Leach MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11704; Lee JH, 2017, FASEB J, V31, P47, DOI 10.1096/fj.201600643R; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Magee PT, 2003, INFECT IMMUN, V71, P2299, DOI 10.1128/IAI.71.5.2299-2309.2003; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Marotta DH, 2013, GENOMICS, V102, P363, DOI 10.1016/j.ygeno.2013.06.002; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2008, CELL MICROBIOL, V10, P2180, DOI 10.1111/j.1462-5822.2008.01198.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Rauceo JM, 2008, MOL BIOL CELL, V19, P2741, DOI 10.1091/mbc.E08-02-0191; Reuter AT, 2013, EUKARYOT CELL, V12, P529, DOI 10.1128/EC.00324-12; Richards A, 2012, J MICROBIOL METH, V91, P155, DOI 10.1016/j.mimet.2012.08.002; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Rungaldier S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178646; Rungaldier S, 2013, BBA-BIOMEMBRANES, V1828, P956, DOI 10.1016/j.bbamem.2012.11.030; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; Takeshita N, 2012, MOL MICROBIOL, V83, P1136, DOI 10.1111/j.1365-2958.2012.07996.x; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Vasicek EM, 2014, ANTIMICROB AGENTS CH, V58, P6807, DOI 10.1128/AAC.00064-14; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Wetzel C, 2017, NAT NEUROSCI, V20, P209, DOI 10.1038/nn.4454; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yu QL, 2015, CHEM-BIOL INTERACT, V227, P1, DOI 10.1016/j.cbi.2014.12.014	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192250	10.1371/journal.pone.0192250	http://dx.doi.org/10.1371/journal.pone.0192250			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389961	gold, Green Published			2022-12-27	WOS:000423793400082
J	Dromard, CR; Bouchon-Navaro, Y; Cordonnier, S; Guene, M; Harmelin-Vivien, M; Bouchon, C				Dromard, Charlotte R.; Bouchon-Navaro, Yolande; Cordonnier, Sebastien; Guene, Mathilde; Harmelin-Vivien, Mireille; Bouchon, Claude			Different transfer pathways of an organochlorine pesticide across marine tropical food webs assessed with stable isotope analysis	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; DIPHENYL ETHERS PBDES; FRENCH-WEST-INDIES; TROPHIC TRANSFER; CHLORDECONE EXPOSURE; NITROGEN ISOTOPES; RISK-ASSESSMENT; TRACE-METALS; BIOMAGNIFICATION; BIOACCUMULATION	Chlordecone is a persistent organochlorine pesticide used in the banana fields of the French West Indies from 1972 to 1993. Three marine habitats (mangroves, seagrass beds and coral reefs) of two study sites located downstream contaminated rivers were chosen to evaluate the level of contamination of marine food webs. On each habitat, the food chain collected included suspended organic matter, primary producers (macroalgae, algal turf, seagrass), zooplankton, symbiotic organisms (corals, sea anemones), primary consumers (herbivores, suspension feeders, biofilm feeders), omnivores and detritivores (lobsters, fish), secondary consumers (carnivores 1: invertebrate feeders, planktivores) and tertiary consumers (carnivores 2: invertebrate and fish feeders, piscivores). Log-linear regressions of the concentrations of chlordecone versus nitrogen isotopic ratios (delta(15) N) were used to assess the bioaccumulation of chlordecone along trophic food webs. At each site, bioconcentration and bioamplification take part on the transfer of chlordecone in marine organisms. In mangroves (i.e. close to the source of pollution), lower trophic magnification factors (TMF) indicated that bioconcentration prevailed over bioamplification phenomenon. The opposite phenomenon appeared on coral reefs in which bioconcentration processes were less important and bioamplification pathway became dominant. Far from the source of pollution, molecules of chlordecone seemed to be transfered to organisms mostly via trophic interactions rather than water contact.	[Dromard, Charlotte R.; Bouchon-Navaro, Yolande; Cordonnier, Sebastien; Guene, Mathilde; Bouchon, Claude] Univ Antilles, UMR BOREA, CNRS MNHN UPMC UCBN IRD UA 7208 207, Lab Excellence CORAIL, Pointe a Pitre, Guadeloupe, France; [Harmelin-Vivien, Mireille] Aix Marseille Univ, CNRS IRD UM 110, Inst Mediterraneen Oceanol MIO, Marseille, France	UDICE-French Research Universities; Sorbonne Universite; Universite des Antilles; UDICE-French Research Universities; Aix-Marseille Universite	Dromard, CR (corresponding author), Univ Antilles, UMR BOREA, CNRS MNHN UPMC UCBN IRD UA 7208 207, Lab Excellence CORAIL, Pointe a Pitre, Guadeloupe, France.	charlotte.dromard@univ-antilles.fr		Dromard, Charlotte R./0000-0003-2463-5687	LABEX CORAIL; Contrat de Recherche Developpement Chlohal 2	LABEX CORAIL; Contrat de Recherche Developpement Chlohal 2	This study was funded by the LABEX CORAIL (stable isotope analyses) and by the "Contrat de Recherche Developpement Chlohal 2" coordinated by the Prefecture of Martinique Island (chlordecone analyses) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell L, 1998, CAN J FISH AQUAT SCI, V55, P1114, DOI 10.1139/cjfas-55-5-1114; Bayen S, 2005, CHEMOSPHERE, V61, P303, DOI 10.1016/j.chemosphere.2005.02.097; Bertrand J, 2013, RESULTATS CAMPAGNES; Borga K, 2001, ENVIRON POLLUT, V113, P187, DOI 10.1016/S0269-7491(00)00171-8; Bouchon C, 2003, NIVEAU CONTAMINATION; Bouchon C, 2007, CONTAMINATION PESTIC; Bouchon C, 2016, ENVIRON SCI POLLUT R, V23, P61, DOI 10.1007/s11356-015-5682-1; BROMAN D, 1992, ENVIRON TOXICOL CHEM, V11, P331; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Cabidoche YM, 2009, ENVIRON POLLUT, V157, P1697, DOI 10.1016/j.envpol.2008.12.015; Cabidoche YM., 2011, INNOV AGRON, V16, P117; Cattan P, 2006, SOIL TILL RES, V86, P38, DOI 10.1016/j.still.2005.02.002; Charlotte DR, 2016, MAR POLLUT BULL, V107, P102, DOI 10.1016/j.marpolbul.2016.04.012; Coat S, 2006, AQUAT LIVING RESOUR, V19, P181, DOI 10.1051/alr:2006016; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dietz R, 2000, SCI TOTAL ENVIRON, V245, P221, DOI 10.1016/S0048-9697(99)00447-7; Dromard C. R., 2017, ENVIRON SCI POLLUT R, P1; Dromard CR, 2016, ENVIRON SCI POLLUT R, V23, P73, DOI 10.1007/s11356-015-4732-z; EPSTEIN SS, 1978, SCI TOTAL ENVIRON, V9, P1, DOI 10.1016/0048-9697(78)90002-5; EVANS MS, 1991, ARCH ENVIRON CON TOX, V20, P87, DOI 10.1007/BF01065333; Fernandez A, 2007, MAR POLLUT BULL, V54, P1681, DOI 10.1016/j.marpolbul.2007.08.007; FISHER DJ, 1983, AQUAT TOXICOL, V4, P219, DOI 10.1016/0166-445X(83)90019-X; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; GLYNN PW, 1995, MAR POLLUT BULL, V30, P397, DOI 10.1016/0025-326X(94)00206-O; Harmelin-Vivien M, 2012, MAR POLLUT BULL, V64, P974, DOI 10.1016/j.marpolbul.2012.02.014; HAWKER DW, 1985, CHEMOSPHERE, V14, P1835, DOI 10.1016/0045-6535(85)90126-2; Haynes D, 2000, MAR POLLUT BULL, V41, P267, DOI 10.1016/S0025-326X(00)00134-X; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Hoekstra PF, 2003, ENVIRON POLLUT, V124, P509, DOI 10.1016/S0269-7491(02)00482-7; HUFF JE, 1978, J ENVIRON PATHOL TOX, V1, P377; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Joly PB, 1968, RECONSTRUCTION CHRON; Kay SH, 1984, POTENTIAL BIOMAGNIFI; Kidd KA, 2001, ENVIRON SCI TECHNOL, V35, P14, DOI 10.1021/es001119a; Kiriluk RM, 1995, CAN J FISH AQUAT SCI, V52, P2660, DOI 10.1139/f95-855; Kucklick JR, 1996, ENVIRON TOXICOL CHEM, V15, P1388, DOI [10.1897/1551-5028(1996)015&lt;1388:ODITPF&gt;2.3.CO;2, 10.1002/etc.5620150819]; LEBLANC GA, 1995, ENVIRON SCI TECHNOL, V29, P154, DOI 10.1021/es00001a020; Liang Y, 1999, WATER RES, V33, P1337, DOI 10.1016/S0043-1354(98)00353-4; LOGANATHAN BG, 1994, AMBIO, V23, P187; Luellen DR, 2006, SCI TOTAL ENVIRON, V358, P286, DOI 10.1016/j.scitotenv.2005.08.046; Ma XD, 2013, MAR POLLUT BULL, V74, P110, DOI 10.1016/j.marpolbul.2013.07.020; Mancinelli G, 2015, ESTUAR COAST SHELF S, V156, P195, DOI 10.1016/j.ecss.2014.11.030; Mizukawa K, 2009, MAR POLLUT BULL, V58, P1217, DOI 10.1016/j.marpolbul.2009.03.008; Multigner L, 2016, ENVIRON SCI POLLUT R, V23, P3, DOI 10.1007/s11356-015-4621-5; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Paez-Osuna F, 2002, MAR POLLUT BULL, V44, P1303, DOI 10.1016/S0025-326X(02)00172-8; Russell RW, 1999, ENVIRON TOXICOL CHEM, V18, P1250, DOI [10.1002/etc.5620180626, 10.1897/1551-5028(1999)018&lt;1250:ROCAEF&gt;2.3.CO;2]; Salvat B, 2016, ENVIRON SCI POLLUT R, V23, P49, DOI 10.1007/s11356-015-4395-9; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Simcock A, 2016, 1 GLOBAL INTEGRATED, P1; Strandberg B, 1998, SCI TOTAL ENVIRON, V217, P143, DOI 10.1016/S0048-9697(98)00173-9; Sun YX, 2015, MAR POLLUT BULL, V99, P150, DOI 10.1016/j.marpolbul.2015.07.041; THOMANN RV, 1984, ENVIRON SCI TECHNOL, V18, P65, DOI 10.1021/es00120a003; Vallack HW, 1998, ENVIRON TOXICOL PHAR, V6, P143, DOI 10.1016/S1382-6689(98)00036-2; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6	55	18	18	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191335	10.1371/journal.pone.0191335	http://dx.doi.org/10.1371/journal.pone.0191335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390017	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400016
J	Okhovat, MA; Ziari, K; Ranjbaran, R; Nikouyan, N				Okhovat, Mohammad Ali; Ziari, Katayoun; Ranjbaran, Reza; Nikouyan, Negin			The effect of histone deacetylase inhibitors on AHSP expression	PLOS ONE			English	Article							HEMOGLOBIN-STABILIZING PROTEIN; KRUPPEL-LIKE FACTOR; HOMOZYGOUS BETA-THALASSEMIA; GLOBIN MESSENGER-RNA; CHAIN FATTY-ACIDS; FACTOR EKLF GENE; ALPHA-HEMOGLOBIN; GAMMA-GLOBIN; ERYTHROPOIESIS; INDUCTION	Alpha-hemoglobin stabilizing protein (AHSP) is a molecular chaperone that can reduce the damage caused by excess free alpha-globin to erythroid cells in patients with impaired beta-globin chain synthesis. We assessed the effect of sodium phenylbutyrate and sodium valproate, two histone deacetylase inhibitors (HDIs) that are being studied for the treatment of hemoglobinopathies, on the expression of AHSP, BCL11A (all isoforms), gamma-globin genes (HBG1/2), and some related transcription factors including GATA1, NFE2, EKLF, KLF4, and STAT3. For this purpose, the K562 cell line was cultured for 2, 4, and 6 days in the presence and absence of sodium phenylbutyrate and sodium valproate. Relative real-time qRT-PCR analysis of mRNA levels was performed to determine the effects of the two compounds on gene expression. Expression of all target mRNAs increased significantly (p < 0.05), except for the expression of BCL11A, which was down-regulated (p < 0.05) in the cells treated with both compounds relative to the levels measured for untreated cells. The findings indicated that sodium valproate had a more considerable effect than sodium phenylbutyrate (p < 0.0005) on BCL11A repression and the up-regulation of other studied genes. gamma-Globin and AHSP gene expression continuously increased during the culture period in the treated cells, with the highest gene expression observed for 1 mM sodium valproate after 6 days. Both compounds repressed the expression of BCL11A (-XL, -L, -S) and up-regulated GATA1, NFE2, EKLF, KLF4, STAT3, AHSP, and gamma-globin genes expression. Moreover, sodium valproate showed a stronger effect on repressing BCL11A and escalating the expression of other target genes. The findings of this in vitro experiment could be considered in selecting drugs for clinical use in patients with beta-hemoglobinopathies.	[Okhovat, Mohammad Ali; Ranjbaran, Reza; Nikouyan, Negin] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran; [Ziari, Katayoun] AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran	Shiraz University of Medical Science	Okhovat, MA (corresponding author), Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran.; Ziari, K (corresponding author), AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran.	Okhovat.Clinicallab@gmail.com; Dr.Katayoun.Ziari@gmail.com	Okhovat, Mohammad Ali/B-9586-2014; Ranjbaran, Reza/AAA-5838-2020; Ranjbaran, Reza/AGM-4558-2022; ziari, Katayoun/ABG-1108-2021	Okhovat, Mohammad Ali/0000-0003-2137-1428; Ranjbaran, Reza/0000-0002-8890-0999; Nikouyan, Negin/0000-0003-3588-2448				Anderson KP, 1998, J BIOL CHEM, V273, P14347, DOI 10.1074/jbc.273.23.14347; Borgna-Pignatti C, 2007, BRIT J HAEMATOL, V138, P291, DOI 10.1111/j.1365-2141.2007.06654.x; Cao C, 2014, SCI CHINA LIFE SCI, V57, P488, DOI 10.1007/s11427-014-4652-z; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; Chenais B, 1997, LEUKEMIA, V11, P1575, DOI 10.1038/sj.leu.2400755; COLLINS AF, 1994, BLOOD, V84, P1690; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dempsey NJ, 2003, BLOOD, V102, P4214, DOI 10.1182/blood-2002-12-3766; dos Santos CO, 2008, AM J HEMATOL, V83, P103, DOI 10.1002/ajh.21041; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Galanello R, 2003, BLOOD, p1881a; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Jalali Far Mohammad Ali, 2016, Int J Hematol Oncol Stem Cell Res, V10, P37; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; LIAKOPOULOU E, 1995, BLOOD, V86, P3227; Lim WF, 2012, BLOOD CELL MOL DIS, V48, P17, DOI 10.1016/j.bcmd.2011.10.002; PERRINE SP, 1987, BIOCHEM BIOPH RES CO, V148, P694, DOI 10.1016/0006-291X(87)90932-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Ranjbaran R, 2014, ANN CLIN LAB SCI, V44, P189; Reich S, 2000, BLOOD, V96, P3357, DOI 10.1182/blood.V96.10.3357.h8003357_3357_3363; Ronzoni L, 2014, BRIT J HAEMATOL, V165, P714, DOI 10.1111/bjh.12814; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Selby R, 1997, VALPROIC ACID AUGMEN; SHER GD, 1995, NEW ENGL J MED, V332, P1606, DOI 10.1056/NEJM199506153322404; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Tallack MR, 2013, CURR OPIN HEMATOL, V20, P193, DOI 10.1097/MOH.0b013e32835f59ba; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Weinberg RS, 2005, BLOOD, V105, P1807, DOI 10.1182/blood-2004-02-0454; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; Witt O, 2002, AM J HEMATOL, V71, P45, DOI 10.1002/ajh.10161; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhao Guo-wei, 2010, Chinese Medical Sciences Journal, V25, P193, DOI 10.1016/S1001-9294(11)60001-1; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	45	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0189267	10.1371/journal.pone.0189267	http://dx.doi.org/10.1371/journal.pone.0189267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389946	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400003
J	Sinko, K; Jagsch, R; Drog, C; Mosgoeller, W; Wutzl, A; Millesi, G; Klug, C				Sinko, Klaus; Jagsch, Reinhold; Drog, Claudio; Mosgoeller, Wilhelm; Wutzl, Arno; Millesi, Gabriele; Klug, Clemens			Facial esthetics and the assignment of personality traits before and after orthognathic surgery rated on video clips	PLOS ONE			English	Article							1ST IMPRESSIONS; ATTRACTIVENESS; FACE	Typically, before and after surgical correction faces are assessed on still images by surgeons, orthodontists, the patients, and family members. We hypothesized that judgment of faces in motion and by naive raters may closer reflect the impact on patients' real life, and the treatment impact on e.g. career chances. Therefore we assessed faces from dysgnathic patients (Class II, III and Laterognathia) on video clips. Class I faces served as anchor and controls. Each patient's face was assessed twice before and after treatment in changing sequence, by 155 naive raters with similar age to the patients. The raters provided independent estimates on aesthetic trait pairs like ugly/beautiful, and personality trait pairs like dominant /flexible. Furthermore the perception of attractiveness, intelligence, health, the persons' erotic aura, faithfulness, and five additional items were rated. We estimated the significance of the perceived treatment related differences and the respective effect size by general linear models for repeated measures. The obtained results were comparable to our previous rating on still images. There was an overall trend, that faces in video clips are rated along common stereotypes to a lesser extent than photographs. We observed significant class differences and treatment related changes of most aesthetic traits (e.g. beauty, attractiveness), these were comparable to intelligence, erotic aura and to some extend healthy appearance. While some personality traits (e.g. faithfulness) did not differ between the classes and between baseline and after treatment, we found that the intervention significantly and effectively altered the perception of the personality trait self-confidence. The effect size was highest in Class III patients, smallest in Class II patients, and in between for patients with Laterognathia. All dysgnathic patients benefitted from orthognathic surgery. We conclude that motion can mitigate marked stereotypes but does not entirely offset the mostly negative perception of dysgnathic faces.	[Sinko, Klaus; Wutzl, Arno; Millesi, Gabriele; Klug, Clemens] Med Univ Vienna, Clin Craniomaxillofacial & Oral Surg, Vienna, Austria; [Jagsch, Reinhold] Univ Vienna, Dept Psychol, Clin Psychol & Hlth Psychol, Vienna, Austria; [Drog, Claudio] Med Univ Vienna, Univ Clin Dent, Vienna, Austria; [Mosgoeller, Wilhelm] Med Univ Vienna, Inst Canc Res, Vienna, Austria	Medical University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna	Sinko, K (corresponding author), Med Univ Vienna, Clin Craniomaxillofacial & Oral Surg, Vienna, Austria.	klaus.sinko@meduniwien.ac.at		Jagsch, Reinhold/0000-0002-3864-6048; Klug, Clemens/0000-0001-7307-6397				Cellerino A, 2003, J Endocrinol Invest, V26, P45; Cunningham SJ, 1996, BRIT J ORAL MAX SURG, V34, P210, DOI 10.1016/S0266-4356(96)90271-5; Dayan S, 2004, AESTHET PLAST SURG, V28, P301, DOI 10.1007/s00266-004-1017-1; DESMIT A, 1984, AM J ORTHOD DENTOFAC, V86, P67, DOI 10.1016/0002-9416(84)90278-1; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Honn M, 2008, J OROFAC ORTHOP, V69, P20, DOI 10.1007/s00056-008-0735-4; Honn Mirjam, 2005, J Orofac Orthop, V66, P187, DOI 10.1007/s00056-005-0445-0; Islam S, 2017, J PLAST RECONSTR AES, V70, P931, DOI 10.1016/j.bjps.2017.03.012; Johnston C, 2005, EUR J ORTHODONT, V27, P129, DOI 10.1093/ejo/cjh093; Johnston P, 2013, CORTEX, V49, P2462, DOI 10.1016/j.cortex.2013.01.002; Kessler H., 2011, PSYCHOSOCIAL MED, V8; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Livingston RW, 2009, PSYCHOL SCI, V20, P1229, DOI 10.1111/j.1467-9280.2009.02431.x; Michiels G, 1994, Int J Adult Orthodon Orthognath Surg, V9, P95; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Rhodes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026653; Rubenstein AJ, 2005, PSYCHOL SCI, V16, P759, DOI 10.1111/j.1467-9280.2005.01610.x; Sinko K, 2012, INT J ORAL MAX SURG, V41, P469, DOI 10.1016/j.ijom.2011.10.026; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	20	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191718	10.1371/journal.pone.0191718	http://dx.doi.org/10.1371/journal.pone.0191718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390018	Green Submitted, gold, Green Published			2022-12-27	WOS:000423793400029
J	Teuschl, Y; Trapl, M; Ratajczak, P; Matz, K; Dachenhausen, A; Brainin, M				Teuschl, Yvonne; Trapl, Michaela; Ratajczak, Paulina; Matz, Karl; Dachenhausen, Alexandra; Brainin, Michael			Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; GUGGING SWALLOWING SCREEN; RESPIRATORY-INFECTIONS; OUTCOMES; RISK; INTERVENTION; PREDICTORS; ASPIRATION; MANAGEMENT; DIAGNOSIS	Background and purpose While formal screening for dysphagia following acute stroke is strongly recommended, there is little evidence on how multi-consistency screening and dietary modifications affect the rate of stroke-associated pneumonia (SAP). This observational study reports which factors affect formal screening on a stroke-unit and how dietary recommendations relate to SAP. Method Analyses from a database including 1394 patients admitted with acute stroke at our stroke-unit in Austria between 2012 and 2014. Dietary modifications were performed following the recommendations from the Gugging Swallowing Screen (GUSS). Patients evaluated with GUSS were compared to the unscreened patients. Results Overall, 993 (71.2%) patients were screened with GUSS; of these 50 (5.0%) developed SAP. In the 401 unscreened patients, the SAP rate was similar: 22 (5.5%). Multivariable analysis showed that either mild to very mild strokes or very severe strokes were less likely to undergo formal screening. Older age, pre-existing disability, history of hypertension, atrial fibrillation, stroke severity, cardiological and neurological complications, nasogastric tubes, and intubation were significant markers for SAP. Out of 216 patients, 30 (13.9%) developed SAP in spite of receiving nil per mouth (NPO). Conclusion The routine use of GUSS is less often applied in either mild strokes or very severe strokes. While most patients with high risk of SAP were identified by GUSS and assigned to NPO, dietary modifications could not prevent SAP in 1 of 7 cases. Other causes of SAP such as silent aspiration, bacteraemia or central breathing disturbances should be considered.	[Teuschl, Yvonne; Ratajczak, Paulina; Matz, Karl; Dachenhausen, Alexandra; Brainin, Michael] Danube Univ Krems, Dept Clin Neurosci & Prevent Med, Krems, Austria; [Trapl, Michaela; Matz, Karl] Univ Hosp Tulln, Dept Neurol, Tulln, Austria; [Matz, Karl] Karl Landsteiner Univ Hlth Sci, Krems, Austria	Danube University Krems	Brainin, M (corresponding author), Danube Univ Krems, Dept Clin Neurosci & Prevent Med, Krems, Austria.	michael.brainin@donau-uni.ac.at		Matz, Karl/0000-0002-2851-9897; Trapl-Grundschober, Michaela/0000-0003-3740-9136; Teuschl, Yvonne/0000-0002-1755-7943				Al-Khaled M, 2016, CEREBROVASC DIS, V42, P81, DOI 10.1159/000445299; Aoki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154608; Arnold M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148424; Baijens LWJ, 2016, CLIN INTERV AGING, V11, P1403, DOI 10.2147/CIA.S107750; Bray BD, 2017, J NEUROL NEUROSUR PS, V88, P25, DOI 10.1136/jnnp-2016-313356; Brogan E, 2014, DYSPHAGIA, V29, P340, DOI 10.1007/s00455-013-9514-5; Carnaby G, 2006, LANCET NEUROL, V5, P31, DOI 10.1016/S1474-4422(05)70252-0; Cichero JAY, 2017, DYSPHAGIA, V32, P293, DOI 10.1007/s00455-016-9758-y; de Lima Alvarenga EH, 2017, EUR ARCH OTORHINOLAR; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Joundi RA, 2017, STROKE, V48, P900, DOI 10.1161/STROKEAHA.116.015332; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kishore AK, 2015, STROKE, V46, P1202, DOI 10.1161/STROKEAHA.114.007843; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langdon PC, 2009, NEUROEPIDEMIOLOGY, V32, P107, DOI 10.1159/000177036; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Masrur S, 2013, J STROKE CEREBROVASC, V22, pE301, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.013; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Palli C, 2017, STROKE, V48, P2583, DOI 10.1161/STROKEAHA.117.018157; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Smith CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001307; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Teuschl Y, 2013, STROKE, V44, P1070, DOI 10.1161/STROKEAHA.111.676114; Titsworth WL, 2013, STROKE, V44, P3154, DOI 10.1161/STROKEAHA.111.000204; Trapl M, 2017, EUR J NEUROL, V24, pE34, DOI 10.1111/ene.13298; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Warnecke T, 2017, EUR J NEUROL, V24, P594, DOI 10.1111/ene.13251; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110	31	21	30	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192142	10.1371/journal.pone.0192142	http://dx.doi.org/10.1371/journal.pone.0192142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389984	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400070
J	Cook, DA; Pencille, LJ; Dupras, DM; Linderbaum, JA; Pankratz, VS; Wilkinson, JM				Cook, David A.; Pencille, Laurie J.; Dupras, Denise M.; Linderbaum, Jane A.; Pankratz, V. Shane; Wilkinson, John M.			Practice variation and practice guidelines: Attitudes of generalist and specialist physicians, nurse practitioners, and physician assistants	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; DECISION-SUPPORT; ADHERENCE; CARE; CANCER; ASSOCIATION; PERCEPTIONS; STRATEGIES	Objective To understand clinicians' beliefs about practice variation and how variation might be reduced. Methods We surveyed board-certified physicians (N = 178), nurse practitioners (N = 60), and physician assistants (N = 12) at an academic medical center and two community clinics, representing family medicine, general internal medicine, and cardiology, from February-April 2016. The Internet-based questionnaire ascertained clinicians' beliefs regarding practice variation, clinical practice guidelines, and costs. Results Respondents agreed that practice variation should be reduced (mean [SD] 4.5 [1.1]; 1 = strongly disagree, 6 = strongly agree), but agreed less strongly (4.1 [1.0]) that it can realistically be reduced. They moderately agreed that variation is justified by situational differences (3.9 [1.2]). They strongly agreed (5.2 [0.8]) that clinicians should help reduce healthcare costs, but agreed less strongly (4.4 [1.1]) that reducing practice variation would reduce costs. Nearly all respondents (234/249 [94%]) currently depend on practice guidelines. Clinicians rated differences in clinician style and experience as most influencing practice variation, and inaccessibility of guidelines as least influential. Time to apply standards, and patient decision aids, were rated most likely to help standardize practice. Nurse practitioners and physicians assistants (vs physicians) and less experienced (vs senior) clinicians rated more favorably several factors that might help to standardize practice. Differences by specialty and academic vs community practice were small. Conclusions Clinicians believe that practice variation should be reduced, but are less certain that this can be achieved. Accessibility of guidelines is not a significant barrier to practice standardization, whereas more time to apply standards is viewed as potentially helpful.	[Cook, David A.; Pencille, Laurie J.; Linderbaum, Jane A.] Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA; [Cook, David A.] Mayo Clin, Coll Med, Mayo Clin Online Learning, Rochester, MN 55905 USA; [Cook, David A.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [Pencille, Laurie J.] Mayo Clin, Ctr Sci Hlth Care Delivery, Rochester, MN USA; [Dupras, Denise M.] Mayo Clin, Div Primary Care Internal Med, Rochester, MN USA; [Linderbaum, Jane A.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Pankratz, V. Shane] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Wilkinson, John M.] Mayo Clin, Dept Family Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of New Mexico; University of New Mexico's Health Sciences Center; Mayo Clinic	Cook, DA (corresponding author), Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA.; Cook, DA (corresponding author), Mayo Clin, Coll Med, Mayo Clin Online Learning, Rochester, MN 55905 USA.; Cook, DA (corresponding author), Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA.	cook.david33@mayo.edu						Adam MA, 2016, SURGERY, V159, P41, DOI 10.1016/j.surg.2015.04.056; Arts DL, 2016, INT J MED INFORM, V89, P55, DOI 10.1016/j.ijmedinf.2016.02.009; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Baxter PE, 2015, HEALTH POLICY, V119, P1096, DOI 10.1016/j.healthpol.2015.05.003; Boland GM, 2013, CANCER-AM CANCER SOC, V119, P1593, DOI 10.1002/cncr.27935; BROUWERS MC, 2014, IMPLEMENT SCI, V9; Brydges R, 2012, MED EDUC, V46, P71, DOI 10.1111/j.1365-2923.2011.04100.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carlsen B, 2011, BMJ QUAL SAF, V20, P158, DOI 10.1136/bmjqs.2009.034249; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Carpentier MY, 2013, J CANCER SURVIV, V7, P464, DOI 10.1007/s11764-013-0290-x; Clough JD, 2016, J GEN INTERN MED, V31, P1278, DOI 10.1007/s11606-016-3745-8; Clough JD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002594; Cook DA, 2016, MED EDUC, V50, P997, DOI 10.1111/medu.13074; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Farquhar CM, 2002, MED J AUSTRALIA, V177, P502, DOI 10.5694/j.1326-5377.2002.tb04920.x; Fiander M, 2015, COCHRANE DB SYST REV, DOI [10.1097/XEB.0000000000000074, 10.1002/14651858.CD004749.pub3]; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Flodgren G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010669.pub2; Forrest CB, 2013, PEDIATRICS, V131, pE1071, DOI 10.1542/peds.2012-1988; Gouvea M, 2015, BRAZ J INFECT DIS, V19, P517, DOI 10.1016/j.bjid.2015.06.004; Grant A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-72; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Kastner M, 2015, J CLIN EPIDEMIOL, V68, P498, DOI 10.1016/j.jclinepi.2014.12.013; Linder JA, 2010, INT J QUAL HEALTH C, V22, P469, DOI 10.1093/intqhc/mzq052; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; Mercuri M, 2011, J EVAL CLIN PRACT, V17, P671, DOI 10.1111/j.1365-2753.2011.01689.x; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Nuckols TK, 2008, J GEN INTERN MED, V23, P37, DOI 10.1007/s11606-007-0440-9; O'Connor Annette M, 2004, Health Aff (Millwood), VSuppl Variation, pVAR63; Oderda GM, 2014, POSTGRAD MED, V126, P257, DOI 10.3810/pgm.2014.05.2774; Patel J, 2014, INT J SURG, V12, P1317, DOI 10.1016/j.ijsu.2014.10.031; Patel N, 2015, DIGEST DIS SCI, V60, P2937, DOI 10.1007/s10620-015-3685-x; Prevedello LM, 2013, AM J MED, V126, P975, DOI 10.1016/j.amjmed.2013.04.018; Reames BN, 2014, ANN SURG, V259, P616, DOI 10.1097/SLA.0000000000000248; Reschovsky JD, 2015, J GEN INTERN MED, V30, P555, DOI 10.1007/s11606-015-3366-7; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Sivananthan SN, 2013, J AM GERIATR SOC, V61, P1277, DOI 10.1111/jgs.12368; Steinman MA, 2004, AM J MED, V117, P747, DOI 10.1016/j.amjmed.2004.03.035; TUNIS SR, 1994, ANN INTERN MED, V120, P956, DOI 10.7326/0003-4819-120-11-199406010-00008; Urkin J, 2013, ACTA PAEDIATR, V102, P1075, DOI 10.1111/apa.12364; van Diepen S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001708; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513; Wilson ME, 2013, INTENS CARE MED, V39, P1009, DOI 10.1007/s00134-013-2896-x; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Worrall G, 1997, CAN MED ASSOC J, V156, P1705; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	52	32	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191943	10.1371/journal.pone.0191943	http://dx.doi.org/10.1371/journal.pone.0191943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385203	gold, Green Published, Green Submitted			2022-12-27	WOS:000423668400065
J	Mupfumi, L; Moyo, S; Molebatsi, K; Thami, PK; Anderson, M; Mogashoa, T; Iketleng, T; Makhema, J; Marlink, R; Kasvosve, I; Essex, M; Musonda, RM; Gaseitsiwe, S				Mupfumi, Lucy; Moyo, Sikhulile; Molebatsi, Kesaobaka; Thami, Prisca K.; Anderson, Motswedi; Mogashoa, Tuelo; Iketleng, Thato; Makhema, Joseph; Marlink, Ric; Kasvosve, Ishmael; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani			Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAMS; RISK-FACTORS; EARLY MORTALITY; HIGH-INCOME; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; ADULTS; INITIATION; RATES; TERM	Background There is a high burden of tuberculosis (TB) in HIV antiretroviral programmes in Africa. However, few studies have looked at predictors of incident TB while on Truvada-based combination antiretroviral therapy (cART) regimens. Methods We estimated TB incidence among individuals enrolled into an observational cohort evaluating the efficacy and tolerability of Truvada-based cART in Gaborone, Botswana between 2008 and 2011. We used Cox proportional hazards regressions to determine predictors of incident TB. Results Of 300 participants enrolled, 45 (15%) had a diagnosis of TB at baseline. During 428 person-years (py) of follow-up, the incidence rate of TB was 3.04/100py (95% CI, 1.695.06), with 60% of the cases occurring within 3 months of ART initiation. Incident cases had low baseline CD4+ T cell counts (153cells/mm(3) [Q1, Q3: 82, 242]; p = 0.69) and hemoglobin levels (9.2g/dl [Q1, Q3: 8.5,10.1]; p<0.01). In univariate analysis, low BMI (HR = 0.73; 95% CI 0.580.91; p = 0.01) and hemoglobin levels <8 g/dl (HR = 10.84; 95%CI: 2.9940.06; p<0.01) were risk factors for TB. Time to incident TB diagnosis was significantly reduced in patients with poor immunological recovery (p = 0.04). There was no association between baseline viral load and risk of TB (HR = 1.75; 95%CI: 0.704.37). Conclusion Low hemoglobin levels prior to initiation of ART are significant predictors of incident tuberculosis. Therefore, there is potential utility of iron biomarkers to identify patients at risk of TB prior to initiation on ART. Furthermore, additional strategies are required for patients with poor immunological recovery to reduce excess risk of TB while on ART.	[Mupfumi, Lucy; Moyo, Sikhulile; Thami, Prisca K.; Anderson, Motswedi; Mogashoa, Tuelo; Iketleng, Thato; Makhema, Joseph; Marlink, Ric; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Mupfumi, Lucy; Mogashoa, Tuelo; Kasvosve, Ishmael] Univ Botswana, Sch Allied Hlth Profess, Dept Med Lab Sci, Gaborone, Botswana; [Moyo, Sikhulile; Makhema, Joseph; Marlink, Ric; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Molebatsi, Kesaobaka] Univ Botswana, Dept Stat, Gaborone, Botswana; [Thami, Prisca K.; Anderson, Motswedi] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Iketleng, Thato] Univ KwaZulu Natal, Coll Hlth Sci, Durban, South Africa; [Marlink, Ric] Rutgers State Univ, Rutgers Global Hlth Inst, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Botswana-Harvard AIDS Institute Partnership; University of Botswana; Harvard University; Harvard T.H. Chan School of Public Health; University of Botswana; University of Botswana; University of Kwazulu Natal; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mupfumi, L (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.; Mupfumi, L (corresponding author), Univ Botswana, Sch Allied Hlth Profess, Dept Med Lab Sci, Gaborone, Botswana.	lmupfumi@bhp.org.bw	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Iketleng, Thato/0000-0002-5725-295X; Mupfumi, Lucy/0000-0002-2290-2481; Kasvosve, Ishmael/0000-0002-2046-545X; Mogashoa, Tuelo/0000-0003-4156-8746; THAMI, PRISCA/0000-0002-4550-2560	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government; SANTHE; ACHAP; Government of Botswana; Bill AMP; Melinda Gates Foundation; MSD/Merck Company Foundation; Fogarty International Center, of the National Institutes of Health [D43 TWO10543]; National Institute of Mental Health, of the National Institutes of Health [D43 TWO10543]; FOGARTY INTERNATIONAL CENTER [D43TW009610, D43TW010543] Funding Source: NIH RePORTER	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; SANTHE; ACHAP; Government of Botswana; Bill AMP; Melinda Gates Foundation(CGIAR); MSD/Merck Company Foundation; Fogarty International Center, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant # 107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of MS, NEPAD Agency, Wellcome Trust or the UK government. LM, KM, PT, TM& SG received funding from SANTHE. The Bomolemo study was funded by ACHAP, a country-led, public private development partnership between the Government of Botswana, the Bill & Melinda Gates Foundation, and the MSD/Merck Company Foundation. SM was supported by the Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health under Award Number D43 TWO10543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2016, ORAL DIS, V22, P53, DOI 10.1111/odi.12390; Alemu YM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009058; Anderson M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw140; Auld AF, 2013, PLOS ONE, P8; Benova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035948; Bisson GP, 2015, CURR HIV-AIDS REP, V12, P107, DOI 10.1007/s11904-015-0256-x; Brennan AT, 2016, INT J TUBERC LUNG D, V20, P1040, DOI 10.5588/ijtld.15.0488; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chang CA, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv154; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Dhasmana DJ, 2008, DRUGS, V68, P191, DOI 10.2165/00003495-200868020-00004; Diedrich CR, 2016, J INFECT DIS, V214, P1309, DOI 10.1093/infdis/jiw313; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Gupta RK, 2015, LANCET HIV, V2, pE243, DOI 10.1016/S2352-3018(15)00063-6; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kerkhoff AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0320-9; Kufa T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1598-8; Lawn SD, 2005, CLIN INFECT DIS, V41, P1783, DOI 10.1086/498308; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AM J RESP CRIT CARE, V172, P1348, DOI 10.1164/ajrccm.172.10.1348; Lawn SD, 2005, CLIN INFECT DIS, V41, P1683, DOI 10.1086/498030; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, LANCET, V372, P287, DOI 10.1016/S0140-6736(08)61101-0; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2006, SAMJ S AFR MED J, V96, P502; Lawn SD, 2011, AIDS, V25, P1554, DOI 10.1097/QAD.0b013e328348fb61; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Mupfumi L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu038; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2013, LANCET INFECT DIS, V13, P825, DOI 10.1016/S1473-3099(13)70218-4; Ravimohan S, 2013, J INFECT DIS, V208, P1784, DOI 10.1093/infdis/jit368; Samandari T, 2015, AIDS, V29, P351, DOI 10.1097/QAD.0000000000000535; Sumner T, 2016, AIDS, V30, P1279, DOI 10.1097/QAD.0000000000001078; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Thobakgale C, 2017, JAIDS-J ACQ IMM DEF, V74, P213, DOI 10.1097/QAI.0000000000001181; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Van Tieu H, 2009, AIDS RES HUM RETROV, V25, P1083, DOI 10.1089/aid.2009.0055; Visser ME, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003650.pub4; Wood R, 2007, AM J RESP CRIT CARE, P175	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192030	10.1371/journal.pone.0192030	http://dx.doi.org/10.1371/journal.pone.0192030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385208	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400071
J	Kasradze, A; Echeverria, D; Zakhashvili, K; Bautista, C; Heyer, N; Imnadze, P; Mitrskhulava, V				Kasradze, Ana; Echeverria, Diana; Zakhashvili, Khatuna; Bautista, Christian; Heyer, Nicholas; Imnadze, Paata; Mitrskhulava, Veriko			Rates and risk factors for human cutaneous anthrax in the country of Georgia: National surveillance data, 2008-2015	PLOS ONE			English	Article							LIVESTOCK	Introduction Anthrax is endemic in the country of Georgia. The most common cutaneous anthrax form accounts for 95% of anthrax cases and often is self-resolving. Humans are infected from processing contaminated animal products, contacting sick animals, or by insect bites. Objective We aimed to describe the burden of human cutaneous anthrax and associated risk factors using the national surveillance data. Methods We extracted all human cutaneous anthrax cases from Electronic Integrated Disease Surveillance System (EIDSS) from 1 January 2008 to 31 December 2015. We conducted descriptive analyses to characterize the number of confirmed, probable and suspected cases by age groups, gender, ethnicity, year and geographic area. Results Out of 911 reported cutaneous anthrax cases, 299 (33%) were rejected. Out of remaining 612 cases, 437 (71%), 172 (28%), and 3 (<0.004%) were classified as confirmed, probable and suspected cases of cutaneous Anthrax, respectively; 467 (76.3%) were male. Georgians accounted for 56% (343/612) of cutaneous anthrax cases. Handling animal products (aOR 4.36, 95% CI 2.61-7.26) and living near pastoralist routes (aOR 2.74, 95% CI 1.57-4.76) were associated with cutaneous anthrax. Conclusions This study provides eight-year trends for cutaneous anthrax in humans in the country of Georgia. A comprehensive explanation for the observed rise and fall of the incidence rates of human cutaneous anthrax in 2008-2015 remains to be clarified but is likely associated with discontinuation of mandatory national livestock vaccination in 2008 coupled with weakened human and animal national health systems which were disrupted after the Soviet Union collapsed. Our analysis identifies living near pastoralist routes, handling animal products and travel to endemic areas within two weeks before the disease onset as risk factors for cutaneous anthrax. The evidence underscores the importance of One Health recommendations to activate anthrax awareness campaigns, supervise the destruction of known anthrax carcasses, record global position system coordinates of sites and disinfect infected soils and introduce a participatory health education tool on anthrax.	[Kasradze, Ana; Zakhashvili, Khatuna; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Echeverria, Diana; Heyer, Nicholas; Mitrskhulava, Veriko] Branch Battelle Mem Inst Georgia, Tbilisi, Georgia; [Echeverria, Diana] Univ Washington, Seattle, WA 98195 USA; [Bautista, Christian] US Walter Reed Army, Inst Res, Washington, DC USA; [Mitrskhulava, Veriko] David Tvildiani Med Univ, Tbilisi, Georgia	National Center for Disease Control & Public Health - Georgia; University of Washington; University of Washington Seattle	Kasradze, A (corresponding author), Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia.	anakasradze@gmail.com	Mirtskhulava, Veriko/AAE-9815-2020	Mirtskhulava, Veriko/0000-0002-7394-4876; Bautista, Christian/0000-0002-1228-0754; Kasradze, Ana/0000-0003-3442-2722				Doganay M, 2009, VECTOR-BORNE ZOONOT, V9, P131, DOI 10.1089/vbz.2008.0032; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kracalik I., 2014, CHANGING PATTERNS HU, V8; Kracalik I, 2014, EMERG INFECT DIS, V20, P261, DOI 10.3201/eid2002.130522; Kracalik IT., 2013, EVIDENCE LOCAL PERSI, V7; Kukhalashvili T., 2007, ANTHRAX FOCI GEORGIA; Navdarashvili A, 2016, EPIDEMIOL INFECT, V144, P76, DOI 10.1017/S0950268815001442; QIAamp&REG;, 2012, QIAAMP DSP DNA BLOOD; Quddus MA, 2008, ACCIDENT ANAL PREV, V40, P1732, DOI 10.1016/j.aap.2008.06.011; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Tutrone WD, 2002, CUTIS, V69, P27; Wahl TG, 2012, ELECT INTEGRATED DIS; WHO, 2008, ANTHRAX HUMANS ANIMA; Woods CW, 2004, AM J TROP MED HYG, V71, P48, DOI 10.4269/ajtmh.2004.71.48	14	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192031	10.1371/journal.pone.0192031	http://dx.doi.org/10.1371/journal.pone.0192031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415029	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300047
J	Wetzels, SU; Eger, M; Burmester, M; Kreienbrock, L; Abdulmawjood, A; Pinior, B; Wagner, M; Breves, G; Mann, E				Wetzels, Stefanie U.; Eger, Melanie; Burmester, Marion; Kreienbrock, Lothar; Abdulmawjood, Amir; Pinior, Beate; Wagner, Martin; Breves, Gerhard; Mann, Evelyne			The application of rumen simulation technique (RUSITEC) for studying dynamics of the bacterial community and metabolome in rumen fluid and the effects of a challenge with Clostridium perfringens	PLOS ONE			English	Article							ACIDOSIS SARA ADAPTATION; MICROBIAL-POPULATIONS; VARIABLE COMPOSITION; METHANE PRODUCTION; FERMENTATION; DIVERSITY; DIETS; SPECIFICITY; MICROFLORA; SUBSTRATE	The rumen simulation technique (RUSITEC) is a well-established semicontinuous in vitro model for investigating ruminal fermentation; however, information on the stability of the ruminal bacterial microbiota and metabolome in the RUSITEC system is rarely available. The availability of high resolution methods, such as high-throughput sequencing and metabolomics improve our knowledge about the rumen microbial ecosystem and its fermentation processes. Thus, we used Illumina MiSeq 16S rRNA amplicon sequencing and a combination of direct injection mass spectrometry with a reverse-phase LC-MS/MS to evaluate the dynamics of the bacterial community and the concentration of several metabolites in a RUSITEC experiment as a function of time and in response to a challenge with a pathogenic Clostridium perfringens (C. perfringens) strain. After four days of equilibration, samples were collected on days 5, 6, 7, 10, 12 and 15 of the steady-state and experimental period. From a total of six fermenters, three non-infected fermenters were used for investigating time-dependent alterations; three fermenters were incubated with C. perfringens and compared with the non-infected vessels at days 10, 12 and 15. Along the time-line, there was no statistically significant change of the overall bacterial community, however, some phylotypes were enriched at certain time points. A decrease in Fibrobacter and Elusimicrobia over time was followed by an increase in Firmicutes and Actinobacteria. In contrast, classical fermentation measurements such as pH, redox potential, NH3-N, short chain fatty acids and the concentrations of metabolites determined by metabolomics (biogenic amines, hexoses and amino acids) remained stable throughout the experiment. In response to C. perfringens addition the concentrations of several amino acids increased. Although the overall bacterial community was not altered here either, some minor changes such as an enrichment of Synergistetes and Bacteroidetes were detectable over time. In conclusion, both, the bacterial community composition and the metabolome in the RUSITEC system were relatively stable during the experiment.	[Wetzels, Stefanie U.; Wagner, Martin; Mann, Evelyne] Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Eger, Melanie; Burmester, Marion; Breves, Gerhard] Univ Vet Med Hannover, Inst Physiol, Hannover, Germany; [Kreienbrock, Lothar] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Abdulmawjood, Amir] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Pinior, Beate] Univ Vet Med Vienna, Inst Vet Publ Hlth, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Vienna	Mann, E (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.; Breves, G (corresponding author), Univ Vet Med Hannover, Inst Physiol, Hannover, Germany.	Gerhard.Breves@tiho-hannover.de; Evelyne.Mann@vetmeduni.ac.at	Selberherr, Evelyne/AAM-9702-2021; Breves, Gerhard/ABI-1315-2020; Abdulmawjood, Amir/AAL-5523-2020; Pinior, Beate/O-8547-2017; Selberherr, Evelyne/I-3795-2014	Selberherr, Evelyne/0000-0002-2253-5247; Pinior, Beate/0000-0001-8554-5963; 	Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Stephan Schmitz-Esser of the Department of Animal Science, University of Iowa for useful comments on the manuscript as well as Monika Dzieciol and Viktoria Neubauer of the Institute for Milk Hygiene, Milk Technology and Food Science of the University of Veterinary Medicine, Vienna for data submission and assistance in the laboratory. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	[Anonymous], 2000, ENGLISH; [Anonymous], R LANG ENV STAT COMP; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Belanche A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00905; Belanche A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00299; Belanche A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv160; Boguhn J, 2008, ARCH ANIM NUTR, V62, P454, DOI 10.1080/17450390802453443; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comtet-Marre S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00067; CZERKAWSKI JW, 1977, BRIT J NUTR, V38, P371, DOI 10.1079/BJN19770102; Duarte AC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00704; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ertl P, 2015, J DAIRY SCI, V98, P4762, DOI 10.3168/jds.2014-9063; Fasina YO, 2016, POULTRY SCI, V95, P247, DOI 10.3382/ps/pev329; Fecteau ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160353; Fohler S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0812-6; Giraldo LA, 2007, BRIT J NUTR, V98, P753, DOI 10.1017/S0007114507744446; Goossens E, 2017, VET RES, V48, DOI 10.1186/s13567-017-0413-x; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2011, FEMS MICROBIOL ECOL, V78, P275, DOI 10.1111/j.1574-6941.2011.01154.x; Hristov AN, 2001, J ANIM SCI, V79, P515; Indikova I, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01266; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Koch M, 2006, BRIT J NUTR, V96, P820, DOI 10.1017/BJN20061889; Kudva IT, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-48; Lebrun M, 2010, VET REC, V167, P13, DOI [10.1136/vr.b4859, 10.1136/vr.167.1.12]; Lengowski MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150115; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Martinez ME, 2010, J DAIRY SCI, V93, P3699, DOI 10.3168/jds.2009-2934; Martinez ME, 2010, J DAIRY SCI, V93, P3684, DOI 10.3168/jds.2009-2933; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagpal R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0561-y; Pitta DW, 2016, ANAEROBE, V38, P50, DOI 10.1016/j.anaerobe.2015.12.003; Plaizier JC, 2017, MICROB ECOL, V74, P485, DOI 10.1007/s00248-017-0940-z; PREVOT S, 1994, ZOOL SCI, V11, P871; Riede S, 2013, ARCH ANIM NUTR, V67, P368, DOI 10.1080/1745039X.2013.830518; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Strobel E, 2008, ENVIRON MICROBIOL, V10, P483, DOI 10.1111/j.1462-2920.2007.01469.x; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Wetzels SU, 2017, J DAIRY SCI, V100, P1829, DOI 10.3168/jds.2016-11620; Wong MT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00961; Zakrzewski M, 2012, J BIOTECHNOL, V158, P248, DOI 10.1016/j.jbiotec.2012.01.020; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhao S, 2014, LETT APPL MICROBIOL, V59, P79, DOI 10.1111/lam.12247; Ziemer CJ, 2000, ENVIRON MICROBIOL, V2, P632, DOI 10.1046/j.1462-2920.2000.00146.x	56	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192256	10.1371/journal.pone.0192256	http://dx.doi.org/10.1371/journal.pone.0192256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415046	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300064
J	Koparde, P; Mehta, P; Reddy, S; Ramakrishnan, U; Mukherjee, S; Robin, VV				Koparde, Pankaj; Mehta, Prachi; Reddy, Sushma; Ramakrishnan, Uma; Mukherjee, Shomita; Robin, V. V.			The critically endangered forest owlet Heteroglaux blewitti is nested within the currently recognized Athene clade: A century-old debate addressed	PLOS ONE			English	Article							BRAMA AVES STRIGIFORMES; PANDE ET-AL.; POSSIBLE HYBRID; FOSSIL OWLS; NORTHERN MAHARASHTRA; UPPER PLIOCENE; BIRDS; DIVERSIFICATION; PHYLOGENY; DISCOVERY	Range-restricted species generally have specific niche requirements and may often have unique evolutionary histories. Unfortunately, many of these species severely lack basic research, resulting in poor conservation strategies. The phylogenetic relationship of the Critically Endangered Forest Owlet Heteroglaux blewitti has been the subject of a century-old debate. The current classifications based on non-phylogenetic comparisons of morphology place the small owls of Asia into three genera, namely, Athene, Glaucidium, and Heteroglaux. Based on morphological and anatomical data, H. blewitti has been alternatively hypothesized to belong within Athene, Glaucidium, or its own monotypic genus Heteroglaux. To test these competing hypotheses, we sequenced six loci (similar to 4300 bp data) and performed phylogenetic analyses of owlets. Mitochondrial and nuclear trees were not congruent in their placement of H. blewitti. However, both mitochondrial and nuclear combined datasets showed strong statistical support with high maximum likelihood bootstrap (>/ = 90) and Bayesian posterior probability values (>/ = 0.98) for H. blewitti being nested in the currently recognized Athene group, but not sister to Indian A. brama. The divergence of H. blewitti from its sister taxa was between 4.3 and 5.7 Ma coinciding with a period of drastic climatic changes in the Indian subcontinent. This study presented the first genetic analysis of H. blewitti, a Critically Endangered species, and addressed the long debate on the relationships of the Athene-Heteroglaux-Glaucidium complex. We recommend further studies with more data and complete taxon sampling to understand the biogeography of Indian Athene species.	[Koparde, Pankaj; Mukherjee, Shomita] Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Biol, Coimbatore, Tamil Nadu, India; [Koparde, Pankaj] Manipal Acad Higher Educ, Manipal, Karnataka, India; [Koparde, Pankaj; Robin, V. V.] Indian Inst Sci Educ & Res, Tirupati, Andhra Pradesh, India; [Mehta, Prachi] Wildlife Res & Conservat Soc, Pune, Maharashtra, India; [Reddy, Sushma] Loyola Univ, Chicago, IL 60611 USA; [Ramakrishnan, Uma] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Salim Ali Center for Ornithology & Natural History (SACON); Manipal Academy of Higher Education (MAHE); Indian Institute of Science Education & Research (IISER) - Tirupati; Loyola University Chicago; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Koparde, P (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Biol, Coimbatore, Tamil Nadu, India.; Koparde, P (corresponding author), Manipal Acad Higher Educ, Manipal, Karnataka, India.; Koparde, P (corresponding author), Indian Inst Sci Educ & Res, Tirupati, Andhra Pradesh, India.	pankajkoparde@gmail.com	Robin, V.V./H-7299-2019; Koparde, Pankaj/H-8085-2015	Robin, V.V./0000-0003-3109-5498; Koparde, Pankaj/0000-0002-7418-8814; Reddy, Sushma/0000-0001-7263-0763; Ramakrishnan, Uma/0000-0002-5370-5966	Department of Biotechnology, Government of India [BT/PR4812/BCE/8/898/2012]; US National Science Foundation [DEB-1457624]; Direct For Biological Sciences [1457624] Funding Source: National Science Foundation	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/) provided a research grant (file no. BT/PR4812/BCE/8/898/2012) to SM; US National Science Foundation (https://www.nsf.gov/) (DEB-1457624) provided a grant to SR for partial museum work. In both cases, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1983, HDB BIRDS INDIA PAKI, V2nd; Baker ECS, 1934, NIDIFICATION BIRDS I, VIII; Barrowclough GF, 2005, MOL ECOL, V14, P1109, DOI 10.1111/j.1365-294X.2005.02465.x; Bawa KS, 2006, CURR SCI INDIA, V91, P1005; Bedetti C, 2013, PALAEONTOGR ABT A, V298, P31; Bell Christopher J., 2004, P232; Berger D. D., 1959, Bird-Banding, V30, P18, DOI 10.2307/4510726; BirdLife International, HET BLEW IUCN RED LI; Blanford WT, FAUNA BRIT INDIA INC, V3; Boev Zlatozar N., 2002, P29; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Bures S, 2002, HEREDITAS, V136, P254, DOI 10.1034/j.1601-5223.2002.1360313.x; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Claramunt S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501005; Clements JF, 2013, EBIRD CLEMENTS CHECK; del Hoyo J, 1999, HDB BIRDS WORLD VOLU, V5; Dickinson E. C., 2013, HOWARD MOORE COMPLET, V1; Dong F, 2010, MOL PHYLOGENET EVOL, V57, P1268, DOI 10.1016/j.ympev.2010.09.023; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Dubois A, SYNOPSIS AVIUM NOUVE; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FEDUCCIA JA, 1970, WILSON BULL, V82, P332; FORD NL, 1966, CONDOR, V68, P472, DOI 10.2307/1365319; FORD NL, 1967, AUK, V84, P115, DOI 10.2307/4083261; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Gill F, 2013, IOC WORLD BIRD LIST; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Guerra C, 2012, J ORNITHOL, V153, P347, DOI 10.1007/s10336-011-0749-3; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAMER TE, 1994, AUK, V111, P487, DOI 10.2307/4088616; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holmes IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163738; Hume, 1873, STRAY FEATHERS, V1, P468; Ishtiaq Farah, 2011, Journal of Threatened Taxa, V3, P1798; Jathar Girish, 2015, Journal of the Bombay Natural History Society, V112, P55, DOI 10.17087/jbnhs/2015/v112i2/104924; Jathar Girish, 2011, Journal of Threatened Taxa, V3, P1800; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Kahindo CM, 2017, IBIS, V159, P415, DOI 10.1111/ibi.12453; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Konig C., 1999, OWLS GUIDE OWLS WORL; Konig C., 2008, OWLS WORLD; Kurochkin EN, 2011, PALEONTOL J+, V45, P445, DOI 10.1134/S003103011104006X; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LANYON SM, 1994, EVOLUTION, V48, P679, DOI 10.1111/j.1558-5646.1994.tb01353.x; Madhusudan MD, 2006, CURR SCI INDIA, V91, P1015; Meher-Homji V.M., 1983, FEDDES REPERT, V94, P407; Mehta Prachi, 2008, BirdingASIA, V10, P77; Mlikovsky J., 1998, Buteo, V10, P5; Mlikovsky J., 2002, CENOZOIC BIRDS WOR 1; MONROE BL, 1993, WORLD CHECKLIST BIRD; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1799; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1804; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1727; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pavia M, 2015, ACTA PALAEONTOL POL, V60, P815, DOI 10.4202/app.00077.2014; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rasmussen PC, 2013, FORKTAIL, P78; Rasmussen Pamela C., 1999, Forktail, V15, P61; Reddy S, 2008, MOL PHYLOGENET EVOL, V47, P54, DOI 10.1016/j.ympev.2008.01.014; Reddy S, 2014, MOL PHYLOGENET EVOL, V77, P159, DOI 10.1016/j.ympev.2014.04.023; Ribeiro AM, 2011, EVOLUTION, V65, P3499, DOI 10.1111/j.1558-5646.2011.01397.x; Robin VV, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0882-6; Robin VV, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0861; Roje DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087428; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sibley CG, 1990, DISTRIBUTION TAXONOM; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wink M., 2014, VOGELWARTE, V52, P325; Wink M, 2009, ARDEA, V97, P581, DOI 10.5253/078.097.0425; Wolters HE, 1975, VOGELARTEN ERDE; Wood JR, 2017, ZOOL J LINN SOC-LOND, V179, P907, DOI 10.1111/zoj.12483	83	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192359	10.1371/journal.pone.0192359	http://dx.doi.org/10.1371/journal.pone.0192359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401484	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400054
J	Anderson, EM; McClelland, S; Maksimova, E; Strezoska, Z; Basila, M; Briner, AE; Barrangou, R; Smith, AV				Anderson, Emily M.; McClelland, Shawn; Maksimova, Elena; Strezoska, Zaklina; Basila, Megan; Briner, Alexandra E.; Barrangou, Rodolphe; Smith, Anja van Brabant			Lactobacillus gasseri CRISPR-Cas9 characterization In Vitro reveals a flexible mode of protospacer-adjacent motif recognition	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASE; CAS SYSTEMS; STRUCTURAL BASIS; DIVERSITY; PAM	While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized a CRISPR-Cas9 system from L. gasseri and found that it has modest activity in a cell-free lysate assay but no activity in mammalian cells even when altering promoter, position of tag sequences and NLS, and length of crRNA:tracrRNA. In the lysate assay we tested over 400 sequential crRNA target sequences and found that the Lga Cas9 PAM is NNGA/NDRA, different than NTAA predicted from the native bacterial host. In addition, we found multiple instances of consecutive crRNA target sites, indicating flexibility in either PAM sequence or distance from the crRNA target site. This work highlights the need for characterization of new CRISPR systems and highlights the non-triviality of porting them into eukaryotes as gene editing tools.	[Anderson, Emily M.; McClelland, Shawn; Maksimova, Elena; Strezoska, Zaklina; Basila, Megan; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA; [Briner, Alexandra E.; Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University	Smith, AV (corresponding author), Dharmacon, Lafayette, CO 80026 USA.	anja.smith@horizondiscovery.com	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504; Crawley, Alexandra/0000-0002-3970-9506	GE Healthcare Dharmacon, Inc.; North Carolina State University	GE Healthcare Dharmacon, Inc.; North Carolina State University	"This work was funded by GE Healthcare Dharmacon, Inc. and internal funding from North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Briner A, 2014, MOL CELL IN PRESS; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Wang T, 2016, COLD SPRING HARBOR P, V2016; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	29	1	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192181	10.1371/journal.pone.0192181	http://dx.doi.org/10.1371/journal.pone.0192181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394276	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400029
J	Mahmud, A; Aljunid, SM				Mahmud, Aidalina; Aljunid, Syed Mohamed			Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach	PLOS ONE			English	Article							HEALTH-CARE SERVICES; BREAST-CANCER; RURAL WOMEN; ACCESS; DISTANCE; POPULATION; PREDICTORS; ATTENDANCE; DIAGNOSIS; KNOWLEDGE	Access to healthcare is essential in the pursuit of universal health coverage. Components of access are availability, accessibility (spatial and non-spatial), affordability and acceptability. Measuring spatial accessibility is common approach to evaluating access to health care. This study aimed to determine the availability and spatial accessibility of subsidised mammogram screening in Peninsular Malaysia. Availability was determined from the number and distribution of facilities. Spatial accessibility was determined using the travel impedance approach to represent the revealed access as opposed to potential access measured by other spatial measurement methods. The driving distance of return trips from the respondent's residence to the facilities was determined using a mapping application. The travel expenditure was estimated by multiplying the total travel distance by a standardised travel allowance rate, plus parking fees. Respondents in this study were 344 breast cancer patients who received treatment at 4 referral hospitals between 2015 and 2016. In terms of availability, there were at least 6 major entities which provided subsidised mammogram programs. Facilities with mammogram involved with these programs were located more densely in the central and west coast region of the Peninsula. The ratio of mammogram facility to the target population of women aged 40-74 years ranged between 1: 10,000 and 1: 80,000. In terms of accessibility, of the 3.6% of the respondents had undergone mammogram screening, their mean travel distance was 53.4 km (SD = 34.5, range 8-112 km) and the mean travel expenditure was RM 38.97 (SD = 24.00, range RM7.60-78.40). Among those who did not go for mammogram screening, the estimated travel distance and expenditure had a skewed distribution with median travel distance of 22.0 km (IQR 12.0, 42.0, range 2.0-340.0) and the median travel cost of RM 17.40 (IQR 10.40, 30.00, range 3.40-240.00). Higher travel impedance was noted among those who lived in sub-urban and rural areas. In summary, availability of mammogram facilities was good in the central and west coast of the peninsula. The overall provider-to-population ratio was lower than recommended. Based on the travel impedance approach used, accessibility to subsidised mammogram screening among the respondents was good in urban areas but deprived in other areas. This study was a preliminary study with limitations. Nonetheless, the evidence suggests that actions have to be taken to improve the accessibility to opportunistic mammogram screening in Malaysia in pursuit of universal health coverage.	[Mahmud, Aidalina; Aljunid, Syed Mohamed] Univ Kebangsaan Malaysia, Int Ctr Casemix & Clin Coding, Fac Med, Kuala Lumpur, Malaysia; [Aljunid, Syed Mohamed] Kuwait Univ, Fac Publ Hlth, Hlth Sci Ctr, Dept Hlth Policy & Management, Kuwait, Kuwait	Universiti Kebangsaan Malaysia; Kuwait University	Mahmud, A (corresponding author), Univ Kebangsaan Malaysia, Int Ctr Casemix & Clin Coding, Fac Med, Kuala Lumpur, Malaysia.	aidalina75@gmail.com	Aljunid, Syed/J-6009-2014	Aljunid, Syed/0000-0002-0380-1335	Universiti kebangsaan malaysia medical centre fundamental research grant [ff-2015-308]; Medical Research Ethics Committee [NMRR-15-929-25001]; UKM Research and Ethics Committee [FF-2012-308]; Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant [ff-2015-308]	Universiti kebangsaan malaysia medical centre fundamental research grant; Medical Research Ethics Committee; UKM Research and Ethics Committee; Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant	This work was funded by the Universiti kebangsaan malaysia medical centre fundamental research grant [ff-2015-308] to SMA and AM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Director General of Health Malaysia for his permission to publish this article. This study was approved by the Medical Research Ethics Committee (NMRR-15-929-25001) and UKM Research and Ethics Committee (Research Code: FF-2012-308). This work was supported by Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant (FF-2015-308).	Abdullah NN, 2011, ASIAN PAC J CANCER P, V12, P2643; Al-Naggar RA, 2012, ASIAN PAC J CANCER P, V13, P3595, DOI 10.7314/APJCP.2012.13.8.3595; [Anonymous], GUID SUBS MAMM SCREE; [Anonymous], 2003, 3 TREAS; [Anonymous], 2011, MOHKASA441 GU NAT GU; Brustrom JE, 2001, MIL MED, V166, P347, DOI 10.1093/milmed/166.4.347; Chan P Y, 2011, Med J Malaysia, V66, P456; Dahlui M, 2011, ASIAN PAC J CANCER P, V12, P369; Dahlui M, 2013, PREV MED, V57, pS18, DOI 10.1016/j.ypmed.2012.12.010; Dahlui M, 2012, ASIAN PAC J CANCER P, V13, P3443, DOI 10.7314/APJCP.2012.13.7.3443; DeNino WF, 2010, SURG OBES RELAT DIS, V6, P597, DOI 10.1016/j.soard.2010.09.008; Department of Statistics Malaysia Official Portal, 2014, REP HOUS INC BAS AM; Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; Huang B, 2009, J RURAL HEALTH, V25, P366, DOI 10.1111/j.1748-0361.2009.00245.x; HURLEY SF, 1994, AM J PUBLIC HEALTH, V84, P1655, DOI 10.2105/AJPH.84.10.1655; Institut Kesihatan Umum, 2006, NAT HLTH MORB SURV 3; Jackson KL, 2013, DIS COLON RECTUM, V56, P367, DOI 10.1097/DCR.0b013e31827e939e; Jacoby I, 1991, J Rural Health, V7, P427; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Lauzier S, 2013, JNCI-J NATL CANCER I; Lin Swu-Jane, 2004, J Med Syst, V28, P301, DOI 10.1023/B:JOMS.0000032846.20676.94; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo Wei, 2004, J Med Syst, V28, P287, DOI 10.1023/B:JOMS.0000032845.90730.84; MANDELBLATT J, 1991, AM J PUBLIC HEALTH, V81, P646, DOI 10.2105/AJPH.81.5.646; Maxwell AJ, 2000, J MED SCREEN, V7, P114, DOI 10.1136/jms.7.2.114; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; McGrail MR, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-124; Ministry of Health Malaysia, CLIN PRACT GUID MAN; Ministry of Health Malaysia, 2011, MOHKASA4411 GU MIN H; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Norlaili AA, 2013, ASIAN PAC J CANCER P, V14, P7161, DOI 10.7314/APJCP.2013.14.12.7161; Parsa P, 2010, ASIAN PAC J CANCER P, V11, P681; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; Putthasri W, 2004, REGIONAL HLTH FORUM, V8, P84; Rahmah MA, 2013, MALAY, V519, P79; Rosmawati NHN, 2010, ASIAN PAC J CANCER P, V11, P767; Sheehan TJ, 2005, INT J HEALTH GEOGR, V9, P1; Smith RA, 2011, SALUD PUBLICA MEXICO, V53, P394; St-Jacques S, 2013, J EPIDEMIOLOGY COMMU; Subramanian P, 2013, ASIAN PAC J CANCER P, V14, P6783, DOI 10.7314/APJCP.2013.14.11.6783; Weedon-Fekjaer H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3701; Yusof A, 2014, ASIAN PAC J CANCER P, V15, P8095, DOI 10.7314/APJCP.2014.15.19.8095	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191764	10.1371/journal.pone.0191764	http://dx.doi.org/10.1371/journal.pone.0191764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389972	gold, Green Submitted, Green Published			2022-12-27	WOS:000423793400032
J	Malmborg, K; Sinare, H; Kautsky, EE; Ouedraogo, I; Gordon, LJ				Malmborg, Katja; Sinare, Hanna; Kautsky, Elin Enfors; Ouedraogo, Issa; Gordon, Line J.			Mapping regional livelihood benefits from local ecosystem services assessments in rural Sahel	PLOS ONE			English	Article							REMOTE-SENSING IMAGERY; BURKINA-FASO; WEST-AFRICA; LAND-COVER; VEGETATION; CLASSIFICATION; CONSERVATION; REFLECTANCE; LANDSCAPES; TRADEOFFS	Most current approaches to landscape scale ecosystem service assessments rely on detailed secondary data. This type of data is seldom available in regions with high levels of poverty and strong local dependence on provisioning ecosystem services for livelihoods. We develop a method to extrapolate results from a previously published village scale ecosystem services assessment to a higher administrative level, relevant for land use decision making. The method combines remote sensing (using a hybrid classification method) and interviews with community members. The resulting landscape scale maps show the spatial distribution of five different livelihood benefits (nutritional diversity, income, insurance/saving, material assets and energy, and crops for consumption) that illustrate the strong multi-functionality of the Sahelian landscapes. The maps highlight the importance of a diverse set of sub-units of the landscape in supporting Sahelian livelihoods. We see a large potential in using the resulting type of livelihood benefit maps for guiding future land use decisions in the Sahel.	[Malmborg, Katja; Sinare, Hanna; Kautsky, Elin Enfors; Gordon, Line J.] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Ouedraogo, Issa] ICRASAT West & Cent Africa Reg Off, CGIAR Program Climate Change Agr & Food Secur CCA, Bamako, Mali	Stockholm University; CGIAR	Malmborg, K (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.	katja.malmborg@su.se	Malmborg, Katja/GXG-5967-2022; BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Sinare, Hanna/0000-0001-5236-9203; Malmborg, Katja/0000-0003-1660-4514; Gordon, Line/0000-0002-3520-4340	Swedish International Development Cooperation Agency; Swedish International Development Cooperation Agency [SWE-2008-148]; Vetenskapsradet [SWE-2012-115]; Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems; Swedish Foundation For Strategic Environmental Research; Ebba och Sven Schwartz Stiftelse	Swedish International Development Cooperation Agency; Swedish International Development Cooperation Agency; Vetenskapsradet(Swedish Research Council); Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems; Swedish Foundation For Strategic Environmental Research(Swedish Foundation for Strategic Research); Ebba och Sven Schwartz Stiftelse	The research was funded from the following sources: Grant to conduct fieldwork through the Minor Field Studies programme funded by the Swedish International Development Cooperation Agency (http://www.sida.se/) received by KM; Grant Adapting to changing climate in drylands: The re-greening in Sahel as a potential success case from the Swedish International Development Cooperation Agency (SWE-2008-148) and Vetenskapsradet (SWE-2012-115, http://www.vr.se/) received by LG and EEK; Grant Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems (https://wle.cgiar.org/) received by LG and EEK; Core funding to the Stockholm Resilience Centre from the Swedish Foundation For Strategic Environmental Research (http://www.mistra.org/) given to KM, HS, EEK, LG; funding from Ebba och Sven Schwartz Stiftelse (https://schwartzstiftelse.com/) received by LG; and support by funding from the Swedish International Development Cooperation Agency for the GRAID Programme at the Stockholm Resilience Centre to HS and EEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig MHA, 2014, REMOTE SENS LETT, V5, P423, DOI 10.1080/2150704X.2014.915434; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Dawson N, 2015, ECOL ECON, V117, P62, DOI 10.1016/j.ecolecon.2015.06.018; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Douxchamps S., 2014, WATER RESOURCES RURA, V3, P1; Douxchamps S., 2015, WATER RESOUR RURAL D, V6, P92, DOI [10.1016/j.wrr.2014.10.001, DOI 10.1016/J.WRR.2014.10.001]; Douxchamps S, 2016, REG ENVIRON CHANGE, V16, P1305, DOI 10.1007/s10113-015-0838-6; Dymond CC, 2002, REMOTE SENS ENVIRON, V80, P460, DOI 10.1016/S0034-4257(01)00324-8; Economic Commission for Latin America and the Caribbean, 2014, LCG2634P EC COMM LAT; Egoh B, 2012, INDICATORS MAPPING E; ESA, 2009, GLOBCOVER; ESRI, 2013, ARCGIS DESKT REL 10; European Space Agency, 2018, COP PROGR; EVIS, 2013, ENVI VERS 5 1; Fagerholm N, 2012, ECOL INDIC, V18, P421, DOI 10.1016/j.ecolind.2011.12.004; FAO, 2013, GREAT GREEN WALL GRE; FAO, 2013, FAO STAT YB 2013; FAO - Food and Agriculture Organization of the United Nations, 2004, SAH WEATH CROP SIT R; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Hagberg S., 2006, AFR TODAY, V52, P109, DOI [10.1353/at.2006.0046., DOI 10.1353/AT.2006.0046]; Holen E., 2015, USING SOIL PROPERTIE; IFAD UNEP, 2013, ROM INT FUND AGR DEV, V17, P54; IGBF, 2014, US SPEC PERM I GEOGR; INSD, 2006, MON REG NORD; INSD, 2006, MON REG CTR NORD; INSD, 2007, DIR DEM; INSD. Redensement general de la population et de l'habitation (RGPH), 2006, THEM 2 ET STRUCT POP, P1; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; KAUFMAN YJ, 1994, IEEE T GEOSCI REMOTE, V32, P672, DOI 10.1109/36.297984; Keshtkar H. R., 2013, Desert, V17, P137; Lemoalle J, 2010, WATER INT, V35, P655, DOI 10.1080/02508060.2010.510793; MA, 2005, ECOSYSTEMS HUMAN WEL; Malinga R, 2015, ECOSYST SERV, V13, P57, DOI 10.1016/j.ecoser.2015.01.006; Malmborg K., 2015, IDENTIFYING ECOTOPES; Malmstrom CM, 2009, RESTOR ECOL, V17, P526, DOI 10.1111/j.1526-100X.2008.00411.x; Mbow C, 2013, J ARID ENVIRON, V97, P56, DOI 10.1016/j.jaridenv.2013.05.011; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; NASA LP DAAC, 2011, PROD METI NASA NASA; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Ofosu EA, 2010, PHYS CHEM EARTH, V35, P706, DOI 10.1016/j.pce.2010.07.005; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Paudyal K, 2015, ECOSYST SERV, V13, P81, DOI 10.1016/j.ecoser.2015.01.007; Peterson G, 2016, IPBES 2016 METHODOLO; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; PRUDENCIO CY, 1993, AGR ECOSYST ENVIRON, V47, P237, DOI 10.1016/0167-8809(93)90125-9; Queiroz C, 2015, AMBIO, V44, pS89, DOI 10.1007/s13280-014-0601-0; Ramirez-Gomez SOI, 2015, ECOSYST SERV, P1; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Sesnie SE, 2010, INT J REMOTE SENS, V31, P2885, DOI 10.1080/01431160903140803; Sidibe A, 2005, AGR WATER MANAGE, V71, P211, DOI 10.1016/j.agwat.2004.09.002; Sinare H, 2016, ECOSYST SERV, V21, P141, DOI 10.1016/j.ecoser.2016.08.004; Sinare H, 2015, AGR ECOSYST ENVIRON, V200, P186, DOI 10.1016/j.agee.2014.11.009; Suich H, 2015, ECOSYST SERV, V12, P137, DOI 10.1016/j.ecoser.2015.02.005; Tappan G, 2007, AGR SYST, V94, P38, DOI 10.1016/j.agsy.2005.07.011; UNDP, 2014, HUM DEV REP SUST HUM; USGS, 2014, US GEOL SURV EARTH E; Vrebos D, 2014, ECOSYST SERV, P1; Wastfelt A, 2013, INT J APPL EARTH OBS, V23, P234, DOI 10.1016/j.jag.2012.09.006; WRI, 2005, MILLENNIUM DEV GOALS; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zheng G, 2007, J ENVIRON MANAGE, V85, P616, DOI 10.1016/j.jenvman.2006.07.015; Zizka A, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-9	69	11	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192019	10.1371/journal.pone.0192019	http://dx.doi.org/10.1371/journal.pone.0192019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389965	Green Accepted, Green Published, gold			2022-12-27	WOS:000423793400051
J	van den Ham, HJ; Cooper, JD; Tomasik, J; Bahn, S; Aerts, JL; Osterhaus, ADME; Gruters, RA; Andeweg, AC				van den Ham, Henk-Jan; Cooper, Jason D.; Tomasik, Jakub; Bahn, Sabine; Aerts, Joeri L.; Osterhaus, Albert D. M. E.; Gruters, Rob A.; Andeweg, Arno C.		DC-TRN trial investigators	Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; MICROBIAL TRANSLOCATION; REPLICATION; ACTIVATION; NEF; TAT; REV; RESPONSES; THERAPY	Objectives To characterize the host response to dendritic cell-based immunotherapy and subsequent combined antiretroviral therapy (cART) interruption in HIV-1-infected individuals at the plasma protein level. Design An autologous dendritic cell (DC) therapeutic vaccine was administered to HIV-infected individuals, stable on cART. The effect of vaccination was evaluated at the plasma protein level during the period preceding cART interruption, during analytical therapy interruption and at viral reactivation. Healthy controls and post-exposure prophylactically treated healthy individuals were included as controls. Methods Plasma marker ('analyte') levels including cytokines, chemokines, growth factors, and hormones were measured in trial participants and control plasma samples using a multiplex immunoassay. Analyte levels were analysed using principle component analysis, cluster analysis and limma. Blood neutrophil counts were analysed using linear regression. Results Plasma analyte levels of HIV-infected individuals are markedly different from those of healthy controls and HIV-negative individuals receiving post-exposure prophylaxis. Viral reactivation following cART interruption also affects multiple analytes, but cART interruption itself only has only a minor effect. We find that Thyroxine-Binding Globulin (TBG) levels and late-stage neutrophil numbers correlate with the time off cART after DC vaccination. Furthermore, analysis shows that cART alters several regulators of blood glucose levels, including C-peptide, chromogranin-A and leptin. HIV reactivation is associated with the upregulation of CXCR3 ligands. Conclusions Chronic HIV infection leads to a change in multiple plasma analyte levels, as does virus reactivation after cART interruption. Furthermore, we find evidence for the involvement of TBG and neutrophils in the response to DC-vaccination in the setting of HIV-infection.	[van den Ham, Henk-Jan; Gruters, Rob A.; Andeweg, Arno C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Cooper, Jason D.; Tomasik, Jakub; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Tomasik, Jakub; Bahn, Sabine] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Aerts, Joeri L.] Vrije Univ Brussel, Dept Physiol & Immunol, Lab Mol & Cellular Therapy, Brussels, Belgium; [Osterhaus, Albert D. M. E.] Vet Univ Hannover, Res Inst Infect Dis & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Brussel; University of Veterinary Medicine Hannover, Foundation	van den Ham, HJ (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	h.j.vandenham@erasmusmc.nl	allard, sabine/B-9248-2014; van den Ham, HJ/ABF-1071-2021; Gruters, Rob/AAM-2362-2020; Aerts, Joeri/J-6957-2014	Aerts, Joeri/0000-0002-9902-3696; Tomasik, Jakub/0000-0002-2127-4487; van den Ham, Henk-Jan/0000-0001-8582-5404	VIRGO consortium - Dutch government [FES0908]; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways [286334]; Dutch Fund for Economic Structure Reinforcement; NeuroBasic PharmaPhenomics project [0908]; Stanley Medical Research Institute (SMRI); Wetenschappelijk Fonds Willy Gepts of the UZ Brussel	VIRGO consortium - Dutch government; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways; Dutch Fund for Economic Structure Reinforcement; NeuroBasic PharmaPhenomics project; Stanley Medical Research Institute (SMRI); Wetenschappelijk Fonds Willy Gepts of the UZ Brussel	This work was supported by the VIRGO consortium that is funded by the Dutch government project number FES0908. JT was also supported through grants awarded to Psynova Neurotech Ltd. by the European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (ref. 286334, PSYCH-AID project); and by the Dutch Fund for Economic Structure Reinforcement, the NeuroBasic PharmaPhenomics project (ref. 0908). SB was also supported by a grant from the Stanley Medical Research Institute (SMRI). JLA was supported by the Wetenschappelijk Fonds Willy Gepts of the UZ Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard SD, 2008, VACCINE, V26, P3735, DOI 10.1016/j.vaccine.2008.04.077; Allard SD, 2012, CLIN IMMUNOL, V142, P252, DOI 10.1016/j.clim.2011.10.010; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; de Goede AL, 2015, VACCINE, V33, P2922, DOI 10.1016/j.vaccine.2015.04.047; de Goede AL, 2013, AIDS, V27, P2679, DOI 10.1097/01.aids.0000433813.67662.92; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Graziani GM, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20497; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hoffmann CJ, 2007, CLIN INFECT DIS, V45, P488, DOI 10.1086/519978; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Lian JQ, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18892; Little R.J.A., 2002, STAT ANAL MISSING DA; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Shebl FM, 2012, AIDS RES HUM RETROV, V28, P809, DOI [10.1089/aid.2011.0144, 10.1089/AID.2011.0144]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236; van den Ham HJ, 2009, RHEUMATOLOGY, V48, P899, DOI 10.1093/rheumatology/kep125; Vrisekoop N, 2015, AIDS, V29, P2071, DOI 10.1097/QAD.0000000000000822; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192278	10.1371/journal.pone.0192278	http://dx.doi.org/10.1371/journal.pone.0192278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389978	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400085
J	Xu, Y; Yu, F; Li, XZ; Ma, L; Dong, D; Kou, Q; Sui, JX; Gan, ZB; Gong, L; Yang, M; Wang, YY; Sun, Y; Wang, JB; Wang, HF				Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Wang, Yueyun; Sun, Yue; Wang, Jinbao; Wang, Hongfa			Spatiotemporal patterns of the macrofaunal community structure in the East China Sea, off the coast of Zhejiang, China, and the impact of the Kuroshio Branch Current	PLOS ONE			English	Article							SOUTH YELLOW SEA; MACROBENTHIC COMMUNITY; WATER MASSES; COPEPOD ASSEMBLAGES; SPATIAL VARIATIONS; DIVERSITY; DYNAMICS; ESTUARY; SHELF; NORTHEAST	The Kuroshio Current intrudes in the bottom layer of the East China Sea continental shelf from the northeast of Taiwan via two bottom branches named the Nearshore Kuroshio Branch Current (NKBC, along the 60 m isobath) and the Offshore Kuroshio Branch Current (OKBC, along the 100 m isobath). However, knowledge on the macrofaunal responses to these bottom branches is limited. This study examined the variations in the benthic macrofaunal community in a section of the East China Sea under the influence of the NKBC. Seven sites corresponding to three regions (the west, middle and east region) were sampled using an Agassiz trawl net at a monthly rate from February to November 2015 (except in August). A total of 270 macrofaunal species were collected in this study. Cluster analysis and nMDS ordination revealed three communities: the inshore, Kuroshio and offshore communities, roughly corresponding to the west, middle and east of NKBC route. Significant differences in the species composition (one-way PERMANOVA) and diversity indices (oneway ANOVA) among the regions and communities were observed, while no statistically significant difference among the months was detected. The indicator species also varied among the communities, with Sternaspis scutata and Odontamblyopus rubicundus dominating the inshore community, Camatopsis rubida, Schizaster lacunosus and Craspidaster hesperus dominating the Kuroshio community, and Portunus argentatus, Champsodon snyderi and Coelorinchus multispinulosus dominating the offshore community. Some rare species (e.g., Neobythites sivicola) may indicate the passage of the NKBC better than the indicator species. A redundancy analysis was used to describe the relationship between the macrofaunal species and environmental variables in this study. Water depth and turbidity played important roles in the distribution of the macrofauna. S. scutata and O. rubicundus were associated with high turbidity and shallow depth, while Plesionika izumiae and P. argentatus were associated with low turbidity and deep depth. This study outlines the impact of the NKBC on the distribution patterns of the macrofaunal community of the East China Sea. More studies are needed to understand the detailed interactions between macrofauna and the NKBC in the future.	[Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao; Wang, Hongfa] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Yong; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Yu, Fei] Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China; [Wang, Yueyun] State Ocean Adm, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology; State Oceanic Administration	Li, XZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.; Li, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, XZ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lixzh@qdio.ac.cn	Sui, Jixing/AAB-6929-2020; Wang, Yueyun/N-1496-2019	Li, Xinzheng/0000-0001-6344-6542; Wang, Yueyun/0000-0001-5709-4149	Chinese Academy of Sciences [XDA11020303, XDA11020305]; Ocean Public Welfare Scientific Research Project; State Oceanic Administration of the PRC [201505004-1]; National Natural Science Foundation of China [41176133, 41406157]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ01]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ocean Public Welfare Scientific Research Project; State Oceanic Administration of the PRC; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology	This research is funded by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11020303, XDA11020305), the Ocean Public Welfare Scientific Research Project, the State Oceanic Administration of the PRC (No. 201505004-1), the National Natural Science Foundation of China (Nos. 41176133 and 41406157) and the Scientific and Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2008, ESTUAR COAST SHELF S, V80, P357, DOI 10.1016/j.ecss.2008.08.017; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Carvalho S, 2007, AQUACULTURE, V262, P227, DOI 10.1016/j.aquaculture.2006.11.028; Chang NN, 2012, CONT SHELF RES, V47, P42, DOI 10.1016/j.csr.2012.06.011; Chao M, 2012, J COASTAL RES, V28, P1008, DOI 10.2112/JCOASTRES-D-11-00194.1; Colloca F, 2003, ESTUAR COAST SHELF S, V56, P469, DOI 10.1016/S0272-7714(02)00196-8; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; [范士亮 Fan Shiliang], 2010, [海洋科学进展, Advances in Marine Science], V28, P489; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; GESAMP, 1994, ANTHR INFL SED DISCH; Gong GC, 2003, DEEP-SEA RES PT II, V50, P1219, DOI 10.1016/S0967-0645(03)00019-5; Gong GC, 1996, CONT SHELF RES, V16, P1561, DOI 10.1016/0278-4343(96)00005-2; [韩东燕 Han Dongyan], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P148; Hwang JS, 2007, J EXP MAR BIOL ECOL, V352, P12, DOI 10.1016/j.jembe.2007.06.034; Hwang JS, 2006, J PLANKTON RES, V28, P943, DOI 10.1093/plankt/fbl031; Hwang JS, 2005, J PLANKTON RES, V27, P205, DOI 10.1093/plankt/fbh162; Legendre P., 2012, NUMERICAL ECOLOGY; Li H, 2016, DEEP-SEA RES PT II, V124, P84, DOI 10.1016/j.dsr2.2015.06.008; Lin SQ, 2016, DEEP-SEA RES PT II, V124, P93, DOI 10.1016/j.dsr2.2015.02.017; Liu Lu-San, 2002, Shengwu Duoyangxing, V10, P351; Liu R., 1986, Studia Marina Sinica, P153; Nicholls P., 2003, ARC03267 NIWA; Oksanen J., 2016, R PACKAG; Pan GL, 2012, J ZHEJIANG OCEAN U N, V31, P482; Peng SY, 2014, CHIN J OCEANOL LIMN, V32, P576, DOI 10.1007/s00343-014-3068-8; Raivo K, 2013, PHEATMAP PRETTY HEAT; Roberts DW., 2012, LABDSV ORDINATION MU; Shao K.-T, 2017, TAIWAN FISH DATABASE; Shen Wei, 2008, Marine Fisheries, V30, P319; Shuai FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146441; Wei CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046707; Wentao Wang, 2016, Journal of Geophysical Research: Oceans, V121, P7073, DOI 10.1002/2016JC011882; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wildsmith MD, 2011, MAR POLLUT BULL, V62, P525, DOI 10.1016/j.marpolbul.2010.11.031; Xu Y, 2017, CHIN J OCEANOL LIMN, V35, P1152, DOI 10.1007/s00343-017-6085-6; Xu Y, 2016, AQUAT ECOSYST HEALTH, V19, P411, DOI 10.1080/14634988.2016.1249257; Xu Y, 2016, AQUAT ECOSYST HEALTH, V19, P92, DOI 10.1080/14634988.2016.1139429; [徐勇 Xu Yong], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P478; Yang DZ, 2013, J MARINE SYST, V123, P1, DOI 10.1016/j.jmarsys.2013.04.002; Yang DZ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007528; Yang DZ, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006777; Yang Junyi, 2007, Acta Ecologica Sinica, V27, P34; Yu Cun-Gen, 2010, Oceanologia et Limnologia Sinica, V41, P410; Yu Cun-Gen, 2009, Oceanologia et Limnologia Sinica, V40, P353; Zhang Bo, 2009, Yingyong Shengtai Xuebao, V20, P344; Zhang CX, 2015, J MARINE SYST, V141, P98, DOI 10.1016/j.jmarsys.2014.09.003; Zhang Heng, 2009, Yingyong Shengtai Xuebao, V20, P2519; Zhang J, 2007, PROG OCEANOGR, V74, P449, DOI 10.1016/j.pocean.2007.04.019; Zhang JL, 2016, J OCEANOGR, V72, P189, DOI 10.1007/s10872-015-0319-z; Zhang JL, 2012, CHIN J OCEANOL LIMN, V30, P248, DOI 10.1007/s00343-012-1076-0; Zhang Zhuang-li, 2009, Marine Fisheries, V31, P369; [赵瑞祥 Zhao Ruixiang], 2014, [海洋学报, Acta Oceanologica Sinica], V36, P20; Zuo T, 2006, J MARINE SYST, V59, P159, DOI 10.1016/j.jmarsys.2005.09.008	54	5	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192023	10.1371/journal.pone.0192023	http://dx.doi.org/10.1371/journal.pone.0192023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385207	Green Published, Green Submitted, gold			2022-12-27	WOS:000423668400070
J	Evstafieva, AG; Kovaleva, IE; Shoshinova, MS; Budanov, AV; Chumakov, PM				Evstafieva, Alexandra G.; Kovaleva, Irina E.; Shoshinova, Maria S.; Budanov, Andrei V.; Chumakov, Peter M.			Implication of KRT16, FAM129A and HKDC1 genes as ATF4 regulated components of the integrated stress response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EPIDERMAL-GROWTH-FACTOR; TRANSCRIPTION FACTOR 4; TRANSLATIONAL CONTROL; C-JUN; EXPRESSION; PHOSPHORYLATION; INDUCTION; DISEASE; CANCER	The ATF4 transcription factor is a key regulator of the adaptive integrated stress response (ISR) induced by various stresses and pathologies. Identification of novel transcription targets of ATF4 during ISR would contribute to the understanding of adaptive networks and help to identify novel therapeutic targets. We were previously searching for genes that display an inverse regulation mode by the transcription factors ATF4 and p53 in response to mitochondrial respiration chain complex III inhibition. Among the selected candidates the human genes for cytokeratine 16 (KRT16), anti-apoptotic protein Niban (FAM129A) and hexokinase HKDC1 have been found highly responsive to ATF4 overexpression. Here we explored potential roles of the induction of KRT16, FAM129A and HKDC1 genes in ISR. As verified by RT-qPCR, a dysfunction of mitochondrial respiration chain and ER stress resulted in a partially ATF4-dependent stimulation of KRT16, FAM129A and HKDC1 expression in the HCT116 colon carcinoma cell line. ISRIB, a specific inhibitor of ISR, was able to downregulate the ER stress-induced levels of KRT16, FAM129A and HKDC1 transcripts. An inhibition of ATF4 by RNAi attenuated the induction of KRT16, FAM129A and HKDC1 mRNAs in response to ER stress or to a dysfunctional mitochondrial respiration. The similar induction of the three genes was observed in another tumor-derived cervical carcinoma cell line HeLa. However, in HaCaT and HEK293T cells that display transformed phenotypes, but do not originate from patient-derived tumors, the ER stress-inducing treatments resulted in an upregulation of FAM129A and HKDC1, but not KRT16 transcripts, By a luciferase reporter approach we identified a highly active ATF4-responsive element within the upstream region of the KRT16 gene. The results suggest a conditional regulation of KRT16 gene by ATF4 that may be inhibited in normal cells, but engaged during cancer progression. Potential roles of KRT16, FAM129A and HKDC1 genes upregulation in adaptive stress responses and pathologies are discussed.	[Evstafieva, Alexandra G.; Kovaleva, Irina E.] Lomonosov Moscow State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Evstafieva, Alexandra G.; Shoshinova, Maria S.] Lomonosov Moscow State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Budanov, Andrei V.; Chumakov, Peter M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Budanov, Andrei V.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Chumakov, Peter M.] Russian Acad Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Sci Ctr Res & Dev Immune Biol Prod, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Trinity College Dublin; Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Sciences	Evstafieva, AG (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia.; Chumakov, PM (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.; Chumakov, PM (corresponding author), Russian Acad Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Sci Ctr Res & Dev Immune Biol Prod, Moscow, Russia.	evstaf@genebee.msu.ru; peterchumakov@gmail.com	Budanov, Andrei V/HGD-5487-2022	Budanov, Andrei V/0000-0002-7943-1000; Chumakov, Peter/0000-0002-8078-2908	Russian Fund for Basic Research [15-04-04945-a]; Russian Science Foundation [14-50-00060, 17-14-01420]; Russian Science Foundation [17-14-01420] Funding Source: Russian Science Foundation	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Fund for Basic Research, grant number 15-04-04945-a (A.G.E.), http://www.rfbr.ru/rffi/eng/; Russian Science Foundation grant number 14-50-00060 (P.M.C.) and 17-14-01420 (A.V.B.), www.rscf.ru/en.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bell D, 2016, CANCER-AM CANCER SOC, V122, P1513, DOI 10.1002/cncr.29959; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carvalheira G, 2015, ONCOTARGET, V6, P28357, DOI 10.18632/oncotarget.4947; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eliason MJ, 2012, J AM ACAD DERMATOL, V67, P680, DOI 10.1016/j.jaad.2011.12.009; Endo H, 2008, ENVIRON HEALTH PERSP, V116, P873, DOI 10.1289/ehp.10696; Evstafieva AG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.469; Garaeva AA, 2016, CELL CYCLE, V15, P64, DOI 10.1080/15384101.2015.1120929; Guo C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7069; Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Horiguchi M, 2013, CANCER RES, V73, P2639, DOI 10.1158/0008-5472.CAN-12-2492; Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032; Irwin DM, 2008, COMP BIOCHEM PHYS D, V3, P96, DOI 10.1016/j.cbd.2007.11.002; Ito S, 2010, HEAD NECK-J SCI SPEC, V32, P96, DOI 10.1002/hed.21153; Ji HT, 2012, EMBO REP, V13, P554, DOI 10.1038/embor.2012.53; Khutornenko AA, 2014, ACTA NATURAE, V6, P69, DOI 10.32607/20758251-2014-6-1-69-75; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kovaleva IE, 2016, GENE, V590, P177, DOI 10.1016/j.gene.2016.06.037; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li GH, 2014, BIOINFORMATICS, V30, P748, DOI 10.1093/bioinformatics/btt606; Machesney M, 1998, AM J PATHOL, V152, P1133; Matsumoto F, 2006, HUM PATHOL, V37, P1592, DOI 10.1016/j.humpath.2006.06.022; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ohno M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00022; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Sun GD, 2007, BIOCHEM BIOPH RES CO, V360, P181, DOI 10.1016/j.bbrc.2007.06.021; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Sykes EK, 2016, CANCERS, V8, DOI 10.3390/cancers8030030; van 't Wout EFA, 2014, AM J RESP CELL MOL, V50, P1005, DOI 10.1165/rcmb.2014-0019TR; Wang YN, 2006, MOL PHARMACOL, V69, P85, DOI 10.1124/mol.105.016220; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986; Zha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122322	46	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191107	10.1371/journal.pone.0191107	http://dx.doi.org/10.1371/journal.pone.0191107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420561	gold, Green Submitted, Green Published			2022-12-27	WOS:000424517900010
J	Stepanov, A; Karelina, T; Markevich, N; Demin, O; Nicholas, T				Stepanov, Alexander; Karelina, Tatiana; Markevich, Nikolai; Demin, Oleg; Nicholas, Timothy			A mathematical model of multisite phosphorylation of tau protein	PLOS ONE			English	Article							SITE-SPECIFIC PHOSPHORYLATION; ALZHEIMERS; DEPHOSPHORYLATION; SPECTROSCOPY; TRUNCATION; GSK-3-BETA; TOXICITY; PP2A	Abnormal tau metabolism followed by formation of tau deposits causes a number of neurodegenerative diseases called tauopathies including Alzheimer's disease. Hyperphosphorylation of tau protein precedes tau aggregation and is a topic of interest for the development of pharmacological interventions to prevent pathology progression at early stages. The development of a mathematical model of multisite phosphorylation of tau would be helpful for searching for the targets of pharmacological interventions and candidates for biomarkers of pathology progression. In the present study, we for the first time developed a model of multisite phosphorylation of tau protein and elucidated the relative contribution of kinases to phosphorylation of distinct sites. The model describes phosphorylation of tau or PKA-prephosphorylated tau by GSK3 beta and CDK5 and dephosphorylation by PP2A, accurately reproducing the data for short-term kinetics of tau (de)phosphorylation. Our results suggest that kinase inhibition may more specifically prevent tau hyperphosphorylation, e.g., on PHF sites, which are key biomarkers of pathological changes in Alzheimer's disease. The main features of our model are partial phosphorylation of tau residues and merging of random and sequential mechanisms of multisite phosphorylation within the framework of the probability-based approach assuming independent phosphorylation events.	[Stepanov, Alexander; Karelina, Tatiana; Markevich, Nikolai; Demin, Oleg] InSysBio, Moscow, Russia; [Nicholas, Timothy] Pfizer Global R&D, Groton, CT USA; [Markevich, Nikolai] RAS, Inst Theoret & Expt Biophys, Pushchino, Russia	Pfizer; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Stepanov, A (corresponding author), InSysBio, Moscow, Russia.	stepanov@insysbio.com	Stepanov, Alexander/V-7287-2019; markevich, nikolai i/J-9564-2014; Stepanov, Alexander/GQY-8569-2022	Stepanov, Alexander/0000-0002-9113-9440; Stepanov, Alexander/0000-0002-9113-9440				Amniai L, 2011, BIOCHEM BIOPH RES CO, V412, P743, DOI 10.1016/j.bbrc.2011.08.046; Ben Bouallegue F, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0260-z; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Chu DD, 2016, J ALZHEIMERS DIS, V49, P365, DOI 10.3233/JAD-150497; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cummings Jeffrey, 2016, Alzheimers Dement (N Y), V2, P222, DOI 10.1016/j.trci.2016.07.001; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Faeder JR, 2005, SYSTEMS BIOL, V2, P5, DOI 10.1049/sb:20045031; Flores-Rodriguez P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00033; Gizzatkulov NM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-109; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Jin NN, 2017, FEBS LETT, V591, P1053, DOI 10.1002/1873-3468.12617; Kawakami F, 2013, FEBS J, P1; Khanna MR, 2016, ALZHEIMERS DEMENT, V12, P1051, DOI 10.1016/j.jalz.2016.06.006; Kiris E, 2011, J BIOL CHEM, V286, P14257, DOI 10.1074/jbc.M111.219311; Kolobkov D, 2016, J BIOPHARM STAT, V26, P742, DOI 10.1080/10543406.2015.1052818; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Povellato G, 2014, BIOL OPEN, V3, P1, DOI 10.1242/bio.20136692; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Struyfs H, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00138; Suwanmajo T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1405; Suwanmajo T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0742; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yao XQ, 2011, BIOCHEM J, V437, P335, DOI 10.1042/BJ20110347	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192519	10.1371/journal.pone.0192519	http://dx.doi.org/10.1371/journal.pone.0192519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408874	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800078
J	Kim, C; Wright, FC; Hong, NJL; Groot, G; Helyer, L; Meiers, P; Quan, ML; Urquhart, R; Warburton, R; Gagliardi, AR				Kim, Claire; Wright, Frances C.; Hong, Nicole J. Look; Groot, Gary; Helyer, Lucy; Meiers, Pamela; Quan, May Lynn; Urquhart, Robin; Warburton, Rebecca; Gagliardi, Anna R.			Patient and provider experiences with active surveillance: A scoping review	PLOS ONE			English	Review							QUALITY-OF-LIFE; LOCALIZED PROSTATE-CANCER; CHRONIC LYMPHOCYTIC-LEUKEMIA; TREATMENT DECISION-MAKING; CARCINOMA IN-SITU; TREATMENT RECOMMENDATIONS; PERCEIVED STRESS; RENAL TUMORS; YOUNGER MEN; MANAGEMENT	Objective Active surveillance (AS) represents a fundamental shift in managing select cancer patients that initiates treatment only upon disease progression to avoid overtreatment. Given uncertain outcomes, patient engagement could support decision-making about AS. Little is known about how to optimize patient engagement for AS decision-making. This scoping review aimed to characterize research on patient and provider communication about AS, and associated determinants and outcomes. Methods MEDLINE, EMBASE, CINAHL, and The Cochrane Library were searched from 2006 to October 2016. English language studies that evaluated cancer patient or provider AS views, experiences or behavioural interventions were eligible. Screening and data extraction were done in duplicate. Summary statistics were used to describe study characteristics and findings. Results A total of 2,078 studies were identified, 1,587 were unique, and 1,243 were excluded based on titles/abstracts. Among 344 full-text articles, 73 studies were eligible: 2 ductal carcinoma in situ (DCIS), 4 chronic lymphocytic leukemia (CLL), 6 renal cell carcinoma (RCC) and 61 prostate cancer. The most influential determinant of initiating AS was physician recommendation. Others included higher socioeconomic status, smaller tumor size, comorbid disease, older age, and preference to avoid adverse treatment effects. AS patients desired more information about AS and reassurance about future treatment options, involvement in decision-making and assessment of illness uncertainty and supportive care needs during follow-up. Only three studies of prostate cancer evaluated interventions to improve AS communication or experience. Conclusions This study revealed a paucity of research on AS communication for DCIS, RCC and CLL, but generated insight on how to optimize AS discussions in the context of routine care or clinical trials from research on AS for prostate cancer. Further research is needed on AS for patients with DCIS, RCC and CLL, and to evaluate interventions aimed at patients and/or providers to improve AS communication, experience and associated outcomes.	[Kim, Claire; Gagliardi, Anna R.] Univ Hlth Network, Dept Clin Decis Making & Hlth Care, Toronto, ON, Canada; [Wright, Frances C.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Hong, Nicole J. Look] Sunnybrook Hlth Sci Ctr, Div Surg Oncol, Toronto, ON, Canada; [Groot, Gary] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Helyer, Lucy] Dalhousie Univ, Div Gen Surg, Halifax, NS, Canada; [Meiers, Pamela] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Quan, May Lynn] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Urquhart, Robin] Dalhousie Univ, Dept Surg, Halifax, NS, Canada; [Warburton, Rebecca] Univ British Columbia, Dept Surg, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Saskatchewan; Dalhousie University; University of Saskatchewan; University of Calgary; Dalhousie University; University of British Columbia	Gagliardi, AR (corresponding author), Univ Hlth Network, Dept Clin Decis Making & Hlth Care, Toronto, ON, Canada.	anna.gagliardi@uhnresearch.ca		Groot, Gary/0000-0002-8307-5125; Urquhart, Robin/0000-0001-8864-5716	Canadian Cancer Society Research Institute	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by the Canadian Cancer Society Research Institute (www.cancer.ca/research).r This research was conducted with funding from the Canadian Cancer Society Research Institute.	Acar C, 2014, J ENDOUROL, V28, P117, DOI 10.1089/end.2013.0349; Ahmad AE, 2016, UROLOGY, V98, P8, DOI 10.1016/j.urology.2016.06.005; Albrecht L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-52; Anandadas CN, 2011, BJU INT, V107, P1762, DOI 10.1111/j.1464-410X.2010.09833.x; Anderson J, 2014, BJU INT, V114, P55, DOI 10.1111/bju.12765; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Arredondo SA, 2008, J UROLOGY, V179, pS14, DOI 10.1016/j.juro.2008.03.132; Bailey DE, 2007, J CLIN NURS, V16, P734, DOI 10.1111/j.1365-2702.2005.01545.x; Barnett M, 2016, J CANCER SURVIV, V10, P814, DOI 10.1007/s11764-016-0527-6; Bayliss David, 2016, Urol Nurs, V36, P141; Bellardita L, 2013, EUR UROL, V64, P30, DOI 10.1016/j.eururo.2013.01.009; Benson JR, 2016, LANCET ONCOL, V17, pE442, DOI 10.1016/S1470-2045(16)30367-9; Berger ZD, 2014, PATIENT, V7, P427, DOI 10.1007/s40271-014-0066-z; Breau RH, 2011, J UROLOGY, V185, P407, DOI 10.1016/j.juro.2010.09.092; Bruinsma SM, 2017, NAT REV UROL, V14, P312, DOI 10.1038/nrurol.2017.26; Burnet KL, 2007, BJU INT, V100, P540, DOI 10.1111/j.1464-410X.2007.07009.x; Carlson LE, 2016, ANN NY ACAD SCI, V1373, P5, DOI 10.1111/nyas.13029; Chu WG, 2015, WORLD J UROL, V33, P1701, DOI 10.1007/s00345-015-1528-1; Chung MS, 2016, INVESTIG CLIN UROL, V57, P14, DOI 10.4111/icu.2016.57.1.14; Clarke MG, 2007, J UROLOGY, V178, P98, DOI 10.1016/j.juro.2007.03.029; Couper JW, 2009, MED J AUSTRALIA, V190, pS86; Davison BJ, 2011, BJU INT, V108, P1787, DOI 10.1111/j.1464-410X.2011.10200.x; Davison BJ, 2009, ONCOL NURS FORUM, V36, P89, DOI 10.1188/09.ONF.89-96; Davison BJ, 2012, PATIENT EDUC COUNS, V87, P369, DOI 10.1016/j.pec.2011.11.009; de Bekker-Grob EW, 2013, BRIT J CANCER, V109, P633, DOI 10.1038/bjc.2013.370; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Duijts SFA, 2014, PSYCHO-ONCOLOGY, V23, P481, DOI 10.1002/pon.3467; Elshof LE, 2015, EUR J CANCER, V51, P1497, DOI 10.1016/j.ejca.2015.05.008; Ervik B, 2010, CANCER NURS, V33, P382, DOI 10.1097/NCC.0b013e3181d1c8ea; Evans J, 2012, EUR J CANCER CARE, V21, P67, DOI 10.1111/j.1365-2354.2011.01278.x; Francis A, 2015, EUR J CANCER, V51, P2296, DOI 10.1016/j.ejca.2015.07.017; Goh AC, 2012, BJU INT, V110, pE50, DOI 10.1111/j.1464-410X.2011.10791.x; Gorin MA, 2012, PROSTATE CANCER P D, V15, P177, DOI 10.1038/pcan.2011.57; Gorin MA, 2011, UROLOGY, V77, P588, DOI 10.1016/j.urology.2010.10.039; Hegarty JM, 2008, AM J MENS HEALTH, V2, P133, DOI 10.1177/1557988307300467; Holtzer-Goor KM, 2015, QUAL LIFE RES, V24, P2895, DOI 10.1007/s11136-015-1039-y; Hurwitz LM, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.11.014; Isebaert S, 2008, UROL INT, V81, P383, DOI 10.1159/000167833; Jacobs BL, 2012, UROLOGY, V79, P1027, DOI 10.1016/j.urology.2011.12.052; Jeldres C, 2015, CANCER-AM CANCER SOC, V121, P2465, DOI 10.1002/cncr.29370; Joseph HJ, 2006, MIL MED, V171, P425, DOI 10.7205/MILMED.171.5.425; Katz G, 2007, UROLOGY, V69, P1157, DOI 10.1016/j.urology.2007.02.003; Kayser L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2068-8; Kazer MW, 2011, J CLIN NURS, V20, P581, DOI 10.1111/j.1365-2702.2010.03489.x; Kazer MW, 2011, ONCOL NURS FORUM, V38, P561, DOI 10.1188/11.ONF.561-568; Kennedy F, 2009, BREAST, V18, P89, DOI 10.1016/j.breast.2009.01.004; Kim SP, 2014, MED CARE, V52, P579, DOI 10.1097/MLR.0000000000000155; Leapman MS, 2017, J CLIN ONCOL, V35, P1898, DOI 10.1200/JCO.2016.68.0058; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Levin TT, 2007, GEN HOSP PSYCHIAT, V29, P251, DOI 10.1016/j.genhosppsych.2007.01.014; Loeb S, 2016, BJU INT; Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054; Mader EM, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0225-3; Maurice MJ, 2015, UROLOGY, V86, P892, DOI 10.1016/j.urology.2015.06.057; McCaffery K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008094; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mroz LW, 2013, HEALTH PSYCHOL, V32, P83, DOI 10.1037/a0029934; Nastoupil LJ, 2016, BRIT J HAEMATOL, V172, P724, DOI 10.1111/bjh.13895; Nickel B, 2015, BREAST, V24, P673, DOI 10.1016/j.breast.2015.08.004; O'Callaghan C, 2014, PSYCHO-ONCOLOGY, V23, P1391, DOI 10.1002/pon.3576; Okediji PT, 2017, CUREUS, V9, DOI 10.7759/cureus.1234; Oliffe JL, 2009, QUAL HEALTH RES, V19, P432, DOI 10.1177/1049732309332692; Orom H, 2014, UROL ONCOL-SEMIN ORI, V32, P396, DOI 10.1016/j.urolonc.2013.09.018; Parker PA, 2016, BJU INT, V117, P469, DOI 10.1111/bju.13099; Parker PA, 2013, EUR UROL, V63, P1122, DOI 10.1016/j.eururo.2013.01.034; Partridge A, 2008, CLIN BREAST CANCER, V8, P275, DOI 10.3816/CBC.2008.n.032; Pham KN, 2016, J UROLOGY, V196, P392, DOI 10.1016/j.juro.2016.02.2972; Punnen S, 2013, BJU INT, V112, pE67, DOI 10.1111/bju.12209; Ramsey SD, 2011, WORLD J UROL, V29, P3, DOI 10.1007/s00345-010-0602-y; Rathert C, 2013, MED CARE RES REV, V70, P351, DOI 10.1177/1077558712465774; Ravi P, 2014, UROL ONCOL-SEMIN ORI, V32, P1333, DOI 10.1016/j.urolonc.2014.05.005; Rittenmeyer Leslie, 2016, JBI Database System Rev Implement Rep, V14, P174, DOI 10.11124/jbisrir-2016-2270; Romero-Otero J, 2016, INT J UROL, V23, P211, DOI 10.1111/iju.13016; Ruane-McAteer E, 2016, PSYCHOONCOLOGY; Seiler D, 2012, UROLOGY, V80, P564, DOI 10.1016/j.urology.2012.04.053; Sidana A, 2012, PROSTATE, V72, P58, DOI 10.1002/pros.21406; Smaldone MC, 2013, UROLOGY, V81, P269, DOI 10.1016/j.urology.2012.09.035; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; Stewart Moira, 2011, Healthc Policy, V6, P27; Sun M, 2012, ANN SURG ONCOL, V19, P2380, DOI 10.1245/s10434-012-2247-0; Syed JS, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0569-6; Tan HJ, 2016, J UROLOGY, V195, P1724, DOI 10.1016/j.juro.2016.01.108; Taussky D, 2008, CAN J UROL, V15, P4415; Taylor KL, 2016, CANCER EPIDEM BIOMAR, V25, P1240, DOI 10.1158/1055-9965.EPI-15-1079; Timilshina N, 2017, WORLD J UROL, V35, P595, DOI 10.1007/s00345-016-1897-0; Tosoian JJ, 2016, NAT REV UROL, V13, P205, DOI 10.1038/nrurol.2016.45; van den Bergh RCN, 2010, J UROLOGY, V183, P1786, DOI 10.1016/j.juro.2009.12.099; van den Bergh RCN, 2010, BJU INT, V105, P322, DOI 10.1111/j.1464-410X.2009.08764.x; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; van den Broek EC, 2015, ANN HEMATOL, V94, P45, DOI 10.1007/s00277-014-2161-6; Vasarainen H, 2012, BJU INT, V109, P1614, DOI 10.1111/j.1464-410X.2011.10677.x; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; Volk RJ, 2015, J HEALTH COMMUN, V20, P1014, DOI 10.1080/10810730.2015.1018618; Volk RJ, 2014, PSYCHO-ONCOLOGY, V23, P467, DOI 10.1002/pon.3444; Volpe A, 2016, INT J SURG, V36, P518, DOI 10.1016/j.ijsu.2016.06.007; Wade J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008953; Watts S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006674; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Wilcox CB, 2014, BJU INT, V113, P64, DOI 10.1111/bju.12557; Womble PR, 2015, EUR UROL, V67, P44, DOI 10.1016/j.eururo.2014.08.024; Xu JP, 2012, J AM BOARD FAM MED, V25, P763, DOI 10.3122/jabfm.2012.06.120128; Xu JP, 2011, J NATL MED ASSOC, V103, P468, DOI 10.1016/S0027-9684(15)30359-X; Yanez B, 2015, J BEHAV MED, V38, P214, DOI 10.1007/s10865-014-9594-1	104	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192097	10.1371/journal.pone.0192097	http://dx.doi.org/10.1371/journal.pone.0192097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401514	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400034
J	Sandlund, L; Kongshaug, H; Horsberg, TE; Male, R; Nilsen, F; Dalvin, S				Sandlund, Liv; Kongshaug, Heidi; Horsberg, Tor Einar; Male, Rune; Nilsen, Frank; Dalvin, Sussie			Identification and characterisation of the ecdysone biosynthetic genes neverland, disembodied and shade in the salmon louse Lepeophtheirus salmonis (Copepoda, Caligidae)	PLOS ONE			English	Article							ECDYSTEROID BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; RECEPTOR; REPRODUCTION; EXPRESSION; REGULATOR; EVOLUTION; PATHWAYS; ENZYMES; PROTEIN	The salmon louse is a marine ectoparasitic copepod on salmonid fishes. Its lifecycle consists of eight developmental stages, each separated by a molt. In crustaceans and insects, molting and reproduction is controlled by circulating steroid hormones such as 20-hydroxyecdysone. Steroid hormones are synthesized from cholesterol through catalytic reactions involving a 7,8-dehydrogenase Neverland and several cytochrome P450 genes collectively called the Halloween genes. In this study, we have isolated and identified orthologs of never-land, disembodied and shade in the salmon louse (Lepeophtheirus salmonis) genome. Tissue-specific expression analysis show that the genes are expressed in intestine and reproductive tissue. In addition, levels of the steroid hormones ecdysone, 20-hydroxyecdysone and ponasterone A were measured during the reproductive stage of adult females and in early life stages.	[Sandlund, Liv; Kongshaug, Heidi; Male, Rune; Nilsen, Frank] Univ Bergen, Dept Biol Sci, Sea Lice Res Ctr, Bergen, Norway; [Sandlund, Liv; Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway; [Horsberg, Tor Einar] Norwegian Univ Life Sci, Sea Lice Res Ctr, Oslo, Norway	University of Bergen; Institute of Marine Research - Norway; Norwegian University of Life Sciences	Dalvin, S (corresponding author), Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway.	sussie.dalvin@hi.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710	Research Council of Norway, SFI-Sea Lice Research Centre [203513/O30]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	The research has been funded by the Research Council of Norway, SFI-Sea Lice Research Centre, Grant Number 203513/O30. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright LJ, 1991, CAN J ZOOL, V69; Asazuma H, 2009, ARCH INSECT BIOCHEM, V72, P220, DOI 10.1002/arch.20335; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Edvardsen RB, 2014, MAR GENOMICS; Eichner C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1277-y; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; GOHAR M, 1984, REPROD NUTR DEV, V24, P137, DOI 10.1051/rnd:19840205; GRIENEISEN ML, 1994, INSECT BIOCHEM MOLEC, V24, P115, DOI 10.1016/0965-1748(94)90078-7; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Hopkins PM, 2009, CRUSTACEAN ECDYSTERI, P73; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; LACHAISE F, 1993, J CRUSTACEAN BIOL, V13, P198, DOI 10.2307/1548970; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; Mykles DL, 2011, J STEROID BIOCHEM, V127, P8; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Pike AW, ADV PARASITOL, V44, P233; REES HH, 1995, EUR J ENTOMOL, V92, P9; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Ritchie G, 1996, J CRUSTACEAN BIOL, V16, P330, DOI 10.2307/1548891; Sandlund L, 2016, MOL BIOCHEM PARASIT, V208, P65, DOI 10.1016/j.molbiopara.2016.06.007; Sandlund L, 2015, INT J PARASITOL, V45, P175, DOI 10.1016/j.ijpara.2014.10.003; Schram Thomas A., 1993, P30; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; Spaziani E, 1999, AM ZOOL, V39, P496; Styrishave B, 2008, J MAR BIOL ASSOC UK, V88, P575, DOI [10.1017/S0025315408000878, 10.1017/S0025315408000879]; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	46	13	13	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191995	10.1371/journal.pone.0191995	http://dx.doi.org/10.1371/journal.pone.0191995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401467	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400029
J	Suzuki, Y; Uchida, K; Takemura, T; Sekine, M; Tamura, T; Furukawa, A; Hebisawa, A; Sakakibara, Y; Awano, N; Amano, T; Kobayashi, D; Negi, M; Kakegawa, T; Wada, Y; Ito, T; Suzuki, T; Akashi, T; Eishi, Y				Suzuki, Yoshimi; Uchida, Keisuke; Takemura, Tamiko; Sekine, Masaki; Tamura, Tomoki; Furukawa, Asuka; Hebisawa, Akira; Sakakibara, Yumi; Awano, Nobuyasu; Amano, Tomonari; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Akashi, Takumi; Eishi, Yoshinobu			Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis	PLOS ONE			English	Article							JAPANESE PATIENTS; DNA; MYCOBACTERIAL; CELLS; LOCALIZATION; PROTEIN; TH1	Background Propionibacterium acnes is thought to be a causative agent of sarcoidosis. Patients with sarcoidosis have circulating immune complexes. We attempted to detect P. acnes-derived immune complexes in sarcoid lesions. Methods We evaluated formalin-fixed and paraffin-embedded lymph node samples from 38 sarcoidosis patients and 90 non-sarcoidosis patients (27 patients with necrotizing lymphadenitis, 28 patients with reactive lymphadenitis, 16 patients with colon cancer, 19 patients with gastric cancer) by immunohistochemistry using anti-human immunoglobulins (IgG, IgA, and IgM) and complement (C1q and C3c) antibodies, and a P. acnes-specific monoclonal antibody (PAB antibody) that reacts with the membrane-bound lipoteichoic acid of P. acnes. Results Small round bodies (SRBs) bound to IgA, IgM, or IgG were detected in sinus macrophages, in 32 (84%), 32 (84%), or 11 (29%) sarcoid samples, respectively, and in 19 (21%), 26 (29%), or no (0%) control samples, respectively. Some of these insoluble immune complexes (IICs) also bound to C1q and C3c. We developed a microwave treatment followed by brief trypsin digestion (MT treatment) to detect PAB-reactive SRBs bound to immunoglobulins (IIC-forming P. acnes). MT treatment revealed abundant IIC-forming P. acnes in most (89%) of the sarcoid samples and sparse distribution in some (20%) of the control samples with lymphadenitis, but no IIC-forming P. acnes was detected in control samples without inflammation. IIC-forming P. acnes were mostly bound to both IgA and IgM. The PAB-reactive antigen and immunoglobulins were both located at the peripheral rim of the IIC-forming P. acnes. Conventional electron microscopy identified many SRBs (0.5-2.0 mu m diameter) in sinus macrophages of sarcoid lymph nodes with many IIC-forming P. acnes, some of which were in phagolysosomes with a degraded and lamellar appearance. Conclusions P. acnes-derived IICs in sinus macrophages were frequent and abundant in sarcoid lymph nodes, suggesting a potential etiologic link between sarcoidosis and this commensal bacterium.	[Suzuki, Yoshimi; Furukawa, Asuka; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Yoshimi; Furukawa, Asuka; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan; [Uchida, Keisuke; Sekine, Masaki; Tamura, Tomoki; Akashi, Takumi] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Bunkyo Ku, Tokyo, Japan; [Takemura, Tamiko] Japanese Red Cross Med Ctr, Div Pathol, Shibuya Ku, Tokyo, Japan; [Hebisawa, Akira] Tokyo Natl Hosp, Natl Hosp Org, Clin Res Ctr, Tokyo, Japan; [Hebisawa, Akira] Tokyo Natl Hosp, Natl Hosp Org, Pathol Div, Tokyo, Japan; [Sakakibara, Yumi] Tokyo Med & Dent Univ, Grad Sch, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Sakakibara, Yumi] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan; [Awano, Nobuyasu] Japanese Red Cross Med Ctr, Clin Resp Med, Shibuya Ku, Tokyo, Japan; [Amano, Tomonari] Tokyo Kita Med Ctr, Div Pathol, Kita Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Red Cross Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Red Cross Medical Center	Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan.	eishi.path@tmd.ac.jp	AWANO, Nobuyasu/GXG-4375-2022	AWANO, Nobuyasu/0000-0002-1438-4880				ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; CARR I, 1980, VIRCHOWS ARCH B, V32, P147, DOI 10.1007/BF02889023; Celada LJ, 2015, CLIN CHEST MED, V36, P561, DOI 10.1016/j.ccm.2015.08.001; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DANIELE RP, 1978, CHEST, V74, P261, DOI 10.1378/chest.74.3.261; de Brouwer B, 2015, SARCOIDOSIS VASC DIF, V32, P271; Ebe Y, 2000, SARCOIDOSIS VASC DIF, V17, P256; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Eishi Y., 1988, SARCOIDOSIS, P143; Eishi Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/935289; Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; GUPTA RC, 1977, AM REV RESPIR DIS, V116, P261; HEDFORS E, 1974, CLIN EXP IMMUNOL, V16, P493; HOMMA JY, 1978, JPN J EXP MED, V48, P251; Hunninghake G W, 1999, Sarcoidosis Vasc Diffuse Lung Dis, V16, P149; Iida T, 2013, MYCOBACT DIS OMICS I, P4; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Ishige I, 2005, SARCOIDOSIS VASC DIF, V22, P33; JAMES DG, 1975, AM J MED, V59, P388, DOI 10.1016/0002-9343(75)90397-6; Kwak JW, 1996, J IMMUNOL METHODS, V191, P49, DOI 10.1016/0022-1759(95)00287-1; Markova N, 2015, HUM VACC IMMUNOTHER, V11, P1192, DOI 10.1080/21645515.2015.1016682; MCIJOHNSON N, 1980, THORAX, V35, P286; Michailova L, 2005, INT J TUBERC LUNG D, V9, P907; Moscovic E A, 1978, Pathol Annu, V13 Pt 2, P69; NAKATA Y, 1986, ACTA MED OKAYAMA, V40, P257; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; OKABE T, 1981, AM REV RESPIR DIS, V124, P608; Schupp JC, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0070-7; Sell S, 1987, GRANULOMATOUS REACTI, P529; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; VERRIERJONES J, 1976, ANN NY ACAD SCI, V278, P212, DOI 10.1111/j.1749-6632.1976.tb47032.x; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243; Yorozu P, 2015, RESPIR INVESTIG, V53, P161, DOI 10.1016/j.resinv.2015.02.005; Zhou Y, 2015, CLIN EXP IMMUNOL, V181, P511, DOI 10.1111/cei.12650	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192408	10.1371/journal.pone.0192408	http://dx.doi.org/10.1371/journal.pone.0192408			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401490	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400060
J	Zahid, E; Shabbir, J				Zahid, Erum; Shabbir, Javid			Estimation of population mean in the presence of measurement error and non response under stratified random sampling	PLOS ONE			English	Article							RATIO; NONRESPONSE	In the present paper we propose an improved class of estimators in the presence of measurement error and non-response under stratified random sampling for estimating the finite population mean. The theoretical and numerical studies reveal that the proposed class of estimators performs better than other existing estimators.	[Zahid, Erum; Shabbir, Javid] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan	Quaid I Azam University	Zahid, E (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan.	erumzahid22@gmail.com	Shabbir, Javid/N-9598-2013	Shabbir, Javid/0000-0002-0035-7072	Higher Education Commission of Pakistan [213-63287-2SS2-187]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Erum Zahid received a fellowship from the Higher Education Commission of Pakistan grant 213-63287-2SS2-187. The funders had no role in study design, data collection and analysis, decision to publish or preparation the manuscript.	Azeem M, 2017, COMMUN STAT-THEOR M, V46, P1679, DOI 10.1080/03610926.2015.1026992; Cochran W.G., 2007, SAMPLING TECHNIQUES; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; FBS, 2011, CROPS AREA PRODUCTIO; FULLER WA, 1995, INT STAT REV, V63, P121, DOI 10.2307/1403606; HANSEN MH, 1946, J AM STAT ASSOC, V41, P517, DOI 10.2307/2280572; Haq A, 2013, COMMUN STAT-THEOR M, V42, P782, DOI 10.1080/03610926.2011.579377; Khare BB., 2010, ALIGARH J STAT, V30, P39; Koyuncu N, 2009, J STAT PLAN INFER, V139, P2552, DOI 10.1016/j.jspi.2008.11.009; Kumar S, 2016, J STAT THEORY PRACT, V10, P707, DOI 10.1080/15598608.2016.1216488; KUMAR SUNIL, 2015, Rev.Colomb.Estad., V38, P145, DOI 10.15446/rce.v38n1.48807; Rao P S R S, 1986, SURV METHODOL, V12, P217; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Shabbir J, 2013, ELECTRON J APPL STAT, V6, P1, DOI 10.1285/i20705948v6n1p1; Shabbir J, 2011, COMMUN STAT-THEOR M, V40, P199, DOI 10.1080/03610920903411259; Shalabh S., 1997, J INDIAN SOC AGR STA, V50, P150; Shukla D., 2012, RES REV J STAT, V1, P1; Singh HP, 2011, BRAZ J PROBAB STAT, V25, P205, DOI 10.1214/10-BJPS117; Singh RS, 2015, J MODERN APPL STAT M, V14, P12; Sudman S., 2011, MEASUREMENT ERRORS S	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191572	10.1371/journal.pone.0191572	http://dx.doi.org/10.1371/journal.pone.0191572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401519	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400014
J	Zahn, K; Linseisen, J; Heier, M; Peters, A; Thorand, B; Nairz, F; Meisinger, C				Zahn, Karl; Linseisen, Jakob; Heier, Margit; Peters, Annette; Thorand, Barbara; Nairz, Franziska; Meisinger, Christa			Body fat distribution and risk of incident ischemic stroke in men and women aged 50 to 74 years from the general population. The KORA Augsburg cohort study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CORONARY-HEART-DISEASE; MASS INDEX; MYOCARDIAL-INFARCTION; MILLION PARTICIPANTS; CARDIOVASCULAR RISK; OBESITY; METAANALYSIS; PREDICTORS; ADIPOSITY	Background It remains controversial whether measures of general or abdominal adiposity are better risk predictors for ischemic stroke. Furthermore, so far it is unclear whether body fat mass index (BFMI) and fat free mass index (FFMI) are risk predictors for ischemic stroke. This study examined the sex-specific relevance of body mass index (BMI), BROCA Index, waist circumference (WC), waist-height ratio (WHtR), BFMI and FFMI for the development of ischemic stroke in a Caucasian population. Material and methods The prospective population-based cohort study was based on 1917 men and 1832 women (aged 50 to 74 years) who participated in the third (1994/95) or fourth (1999/2001) MONICA/KORA Augsburg survey. Subjects were free of stroke at baseline. Standardized anthropometric and bioelectric impedance measurements were obtained at baseline. Hazard ratios (HR) were estimated from Cox proportional hazard models. Results During a median follow-up of 9.3 years 128 ischemic strokes occurred in men and 81 in women, respectively. Coded as quartiles WC and WHtR were significantly associated with incident stroke in multivariable analyses in women (comparing the 4th vs. the bottom quartile), but none of the adiposity measures was significantly associated with incident stroke in multivariable adjusted analyses in men. When anthropometric measures were used as continuous variables, these findings were confirmed. After multivariable adjustment the associations between obesity measures and incident ischemic stroke were statistically significant only for WC (HR 1.39, 95% CI 1.12-1.72) and WHtR in women (HR 1.39, 95% CI 1.12-1.73) per increase of 1 standard deviation. In both sexes the measures BFMI and FFMI were no independent predictors for incident ischemic stroke. Conclusions Abdominal obesity measures are independent predictors of incident ischemic stroke in women but not in men from the general adult population. Thus, it may be of particular importance for women to prevent central obesity in order to reduce their risk of ischemic stroke.	[Zahn, Karl; Linseisen, Jakob; Heier, Margit; Peters, Annette; Thorand, Barbara; Nairz, Franziska; Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zahn, Karl] Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Linseisen, Jakob; Meisinger, Christa] Ludwig Maximilians Univ Munchen, UNIKA T, Chair Epidemiol, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Zahn, K (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany.; Zahn, K (corresponding author), Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany.	zahnaugsburg@aol.com	Meisinger, Christine/B-5358-2014; Linseisen, Jakob/B-5353-2014; Peters, Annette/A-6117-2011; Heier, Margit/AAT-5280-2020; Thorand, Barbara/B-5349-2014	Linseisen, Jakob/0000-0002-9386-382X; Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440	Helmholtz Zentrum Munchen; German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Science (MC Health); Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Science (MC Health); Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ	The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Science (MC Health), Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ. This research was a master's thesis of Karl Zahn and was not supported by a grant.	Abete I, 2015, EUR J NUTR, V54, P365, DOI 10.1007/s00394-014-0716-x; [Anonymous], 2005, BIOELECTRICAL IMPEDA; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Dhaliwal SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094560; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106; Franco-Villoria M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008922; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Ibrahim-Verbaas CA, 2014, STROKE, V45, P403, DOI 10.1161/STROKEAHA.113.003044; Caceres DI, 2014, NUTR HOSP, V30, P1359, DOI 10.3305/nh.2014.30.6.7934; Kafri MW, 2014, EUR J CLIN NUTR, V68, P677, DOI 10.1038/ejcn.2013.266; Kizer JR, 2011, AM J EPIDEMIOL, V173, P10, DOI 10.1093/aje/kwq311; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lew J, 2017, CIRCULATION, V135, P544, DOI 10.1161/CIRCULATIONAHA.116.023005; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mastaglia SR, 2012, J CLIN DENSITOM, V15, P159, DOI 10.1016/j.jocd.2011.12.006; Meisinger C, 2016, GESUNDHEITSWESEN, V78, P84, DOI 10.1055/s-0041-110916; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; Neuhauser HK, 2015, BLOOD PRESS MONIT, V20, P39, DOI 10.1097/MBP.0000000000000081; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Team RC., 2022, LANG ENV STAT COMP; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; WELIN L, 1987, NEW ENGL J MED, V317, P521, DOI 10.1056/NEJM198708273170901; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804; Winter Y, 2008, STROKE, V39, P3145, DOI 10.1161/STROKEAHA.108.523001; Winter Y, 2016, J STROKE CEREBROVASC, V25, P1141, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.026; Yatsuya H, 2010, CIRC-CARDIOVASC QUAL, V3, P498, DOI 10.1161/CIRCOUTCOMES.109.908517; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692	40	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191630	10.1371/journal.pone.0191630	http://dx.doi.org/10.1371/journal.pone.0191630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401461	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400016
J	Hadweh, P; Chaitoglou, I; Gravato-Nobre, MJ; Ligoxygakis, P; Mosialos, G; Hatzivassiliou, E				Hadweh, Paul; Chaitoglou, Iro; Gravato-Nobre, Maria Joao; Ligoxygakis, Petros; Mosialos, George; Hatzivassiliou, Eudoxia			Functional analysis of the C-elegans cyld-1 gene reveals extensive similarity with its human homolog	PLOS ONE			English	Article							NF-KAPPA-B; CYLD USP; PATHWAY; EXPRESSION; RECEPTOR	The human cylindromatosis tumor suppressor (HsCyld) has attracted extensive attention due to its association with the development of multiple types of cancer. HsCyld encodes a deubiquitinating enzyme (HsCYLD) with a broad range of functions that include the regulation of several cell growth, differentiation and death pathways. HsCyld is an evolutionarily conserved gene. Homologs of HsCyld have been identified in simple model organisms such as Drosophila melanogaster and Caenorhabditis elegans (C. elegans) which offer extensive possibilities for functional analyses. In the present report we have investigated and compared the functional properties of HsCYLD and its C. elegans homolog (CeCYLD). As expected from the mammalian CYLD expression pattern, the CeCyld promoter is active in multiple tissues with certain gastrointestinal epithelia and neuronal cells showing the most prominent activity. CeCYLD is a functional deubiquitinating enzyme with similar specificity to HsCYLD towards K63-and M1-linked polyubiquiting chains. CeCYLD was capable of suppressing the TRAF2-mediated activation of NF-kappaB and AP1 similarly to HsCYLD. Finally, CeCYLD could suppress the induction of TNF-dependent gene expression in mammalian cells similarly to HsCYLD. Our results demonstrate extensively overlapping functions between the HsCYLD and CeCYLD, which establish the C. elegans protein as a valuable model for the elucidation of the complex activity of the human tumor suppressor protein.	[Hadweh, Paul; Chaitoglou, Iro; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, Thessaloniki, Macedonia, Greece; [Gravato-Nobre, Maria Joao; Ligoxygakis, Petros] Univ Oxford, Dept Biochem, South Parks Rd, Oxford, England; [Hatzivassiliou, Eudoxia] Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Thessaloniki, Macedonia, Greece	Aristotle University of Thessaloniki; University of Oxford; Aristotle University of Thessaloniki	Mosialos, G (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Thessaloniki, Macedonia, Greece.; Hatzivassiliou, E (corresponding author), Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Thessaloniki, Macedonia, Greece.	gmosialo@bio.auth.gr; eudoxiah@auth.gr		Mosialos, George/0000-0002-5342-4873; Hadweh, Paul/0000-0001-8418-9987	Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM); Bodossaki Foundation; IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM	Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM); Bodossaki Foundation; IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM	Funded by Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM) PH and Bodossaki Foundation to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Catherine Chourlia and Kyriaki Driva for assistance and reagents. This study was supported by an IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM to PH. The authors gratefully acknowledge the support provided by the Bodossaki Foundation for the acquisition of imaging equipment that was used in this study.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Fernandez-Majada V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12508; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gravato-Nobre MJ, 2008, DEV DYNAM, V237, P3762, DOI 10.1002/dvdy.21792; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hayashi M, 2014, BREAST CANCER RES TR, V143, P447, DOI 10.1007/s10549-013-2824-3; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Rajan N, 2015, LANCET ONCOL, V16, pE460, DOI 10.1016/S1470-2045(15)00245-4; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsichritzis T, 2007, DEVELOPMENT, V134, P2605, DOI 10.1242/dev.02859; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yang YF, 2016, J CELL SCI, V129, P2289, DOI 10.1242/jcs.183319	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191864	10.1371/journal.pone.0191864	http://dx.doi.org/10.1371/journal.pone.0191864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394249	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400019
J	Tai, ELM; Kueh, YC; Hitam, WHW; Wong, TY; Shatriah, I				Tai, Evelyn Li Min; Kueh, Yee Cheng; Hitam, Wan-Hazabbah Wan; Wong, Tien Yin; Shatriah, Ismail			Comparison of retinal vascular geometry in obese and non-obese children	PLOS ONE			English	Article							PROTEIN-KINASE-C; BODY-MASS INDEX; ENDOTHELIUM-DEPENDENT VASODILATION; METABOLIC SYNDROME; BLOOD-PRESSURE; VESSEL DIAMETER; MICROVASCULATURE; DYSFUNCTION; ASSOCIATION; INHIBITION	Purpose Childhood obesity is associated with adult cardiometabolic disease. We postulate that the underlying microvascular dysfunction begins in childhood. We thus aimed to compare retinal vascular parameters between obese and non-obese children. Methods This was a cross-sectional study involving 166 children aged 6 to 12 years old in Malaysia. Ocular examination, biometry, retinal photography, blood pressure and body mass index measurement were performed. Participants were divided into two groups; obese and nonobese. Retinal vascular parameters were measured using validated software. Results Mean age was 9.58 years. Approximately 51.2% were obese. Obese children had significantly narrower retinal arteriolar caliber (F(1,159) = 6.862, p = 0.010), lower arteriovenous ratio (F(1,159) = 17.412, p < 0.001), higher venular fractal dimension (F(1,159) = 4.313, p = 0.039) and higher venular curvature tortuosity (F(1,158) = 5.166, p = 0.024) than non-obese children, after adjustment for age, gender, blood pressure and axial length. Conclusions Obese children have abnormal retinal vascular geometry. These findings suggest that childhood obesity is characterized by early microvascular abnormalities that precede development of overt disease. Further research is warranted to determine if these parameters represent viable biomarkers for risk stratification in obesity.	[Tai, Evelyn Li Min; Hitam, Wan-Hazabbah Wan; Shatriah, Ismail] Univ Sains Malaysia, Dept Ophthalmol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Tai, Evelyn Li Min; Hitam, Wan-Hazabbah Wan; Shatriah, Ismail] Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; [Kueh, Yee Cheng] Univ Sains Malaysia, Unit Biostat Res Methodol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien Yin] DUKE NUS Med Sch, Singapore, Singapore; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne	Tai, ELM; Shatriah, I (corresponding author), Univ Sains Malaysia, Dept Ophthalmol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.; Tai, ELM; Shatriah, I (corresponding author), Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.; Kueh, YC (corresponding author), Univ Sains Malaysia, Unit Biostat Res Methodol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.	daileid@yahoo.com; yckueh@usm.my; shatriah@usm.my	Kueh, Yee Cheng/N-3991-2015; Shatriah, Ismail/D-3637-2016; Wong, Tien Yin/AAC-9724-2020; Wan Hitam, Wan Hazabbah/M-3262-2016; Tai, Evelyn/V-1522-2018	Kueh, Yee Cheng/0000-0003-2125-7297; Shatriah, Ismail/0000-0002-4753-4814; Wong, Tien Yin/0000-0002-8448-1264; Tai, Evelyn/0000-0001-8055-5396	Universiti Sains Malaysia Research Grants [304/PPSP/61313063, 304/PPSP/61313097]	Universiti Sains Malaysia Research Grants(Universiti Sains Malaysia)	This work was supported by Universiti Sains Malaysia Research Grants (http://www.research.usm.my/); 304/PPSP/61313063 awarded to ELMT, and 304/PPSP/61313097 awarded to WHWH. The funder had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Arciero J, 2013, INVEST OPHTH VIS SCI, V54, P5584, DOI 10.1167/iovs.12-11543; Auten RL, 2009, PEDIATR RES, V66, P121, DOI 10.1203/PDR.0b013e3181a9eafb; Bagi Z, 2012, BRIT J PHARMACOL, V165, P544, DOI 10.1111/j.1476-5381.2011.01606.x; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; BENGTSSON B, 1992, GRAEF ARCH CLIN EXP, V230, P24, DOI 10.1007/BF00166758; Benitez-Aguirre P, 2011, DIABETES CARE, V34, P1622, DOI 10.2337/dc10-2419; Bohlen HG, 2002, AM J PHYSIOL-HEART C, V283, pH391, DOI 10.1152/ajpheart.00019.2002; Brooks SD, 2015, AM J PHYSIOL-HEART C, V309, pH1846, DOI 10.1152/ajpheart.00691.2015; Bruyndonckx L, 2016, PEDIATR RES, V79, P831, DOI 10.1038/pr.2016.22; Cawley T, 1995, PHARMACOLOGY, V51, P381, DOI 10.1159/000139350; CHEN HC, 1994, EYE, V8, P97, DOI 10.1038/eye.1994.19; Cherney DZI, 2012, CAN J PHYSIOL PHARM, V90, P113, DOI [10.1139/Y11-106, 10.1139/y11-106]; Cheung CYL, 2012, HYPERTENSION, V60, P1094, DOI 10.1161/HYPERTENSIONAHA.111.189142; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cheung CY, 2015, DIABETOLOGIA, V58, P871, DOI 10.1007/s00125-015-3511-1; Cheung N, 2010, ANN NEUROL, V68, P107, DOI 10.1002/ana.22011; Crystal HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154858; Ferri C, 1999, HYPERTENSION, V34, P568, DOI 10.1161/01.HYP.34.4.568; Frisbee JC, 2006, ESSAYS BIOCHEM, V42, P145, DOI 10.1042/bse0420145; Gameiro F, 2017, PSICOTHEMA, V29, P61, DOI 10.7334/psicothema2016.202; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Gishti O, 2015, INT J OBESITY, V39, P1482, DOI 10.1038/ijo.2015.99; Gong WF, 2016, OBESITY, V24, P743, DOI 10.1002/oby.21398; Gopinath B, 2012, AM J CLIN NUTR, V95, P1215, DOI 10.3945/ajcn.111.031641; Gopinath B, 2011, INT J PEDIATR OBES, V6, pE353, DOI 10.3109/17477166.2010.500390; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Grauslund J, 2010, OPHTHALMOLOGY, V117, P1400, DOI 10.1016/j.ophtha.2009.10.047; Hamada M, 1997, EXP EYE RES, V65, P445, DOI 10.1006/exer.1997.0361; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; Turoni CJ, 2013, HORM RES PAEDIAT, V80, P281, DOI 10.1159/000354991; Justo ML, 2014, NUTR METAB CARDIOVAS, V24, P524, DOI 10.1016/j.numecd.2013.10.032; Kallerman PH, 2014, ACTA PAEDIATR, V103, P411, DOI 10.1111/apa.12549; Kawada T, 2016, CLIN NUTR, V35, P983, DOI 10.1016/j.clnu.2016.04.023; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kurniawan ED, 2012, INVEST OPHTH VIS SCI, V53, P470, DOI 10.1167/iovs.11-8835; KYLSTRA JA, 1986, GRAEF ARCH CLIN EXP, V224, P477, DOI 10.1007/BF02173368; Liang YJ, 2015, ENDOCRINE, V50, P87, DOI 10.1007/s12020-015-0560-7; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Menne J, 2013, DIABETES, V62, P1167, DOI 10.2337/db12-0534; Mitchell P, 2007, HYPERTENSION, V49, P1156, DOI 10.1161/HYPERTENSIONAHA.106.085910; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nagaoka T, 2006, INVEST OPHTH VIS SCI, V47, P1113, DOI 10.1167/iovs.05-0218; Naidu VV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147160; Ng E.Y.K., 2014, IMAGE ANALYSIS AND M; Oflaz H, 2003, DIABETES NUTR METAB, V16, P176; Park J, 2014, EXP EYE RES, V122, P13, DOI 10.1016/j.exer.2014.03.001; Patton N, 2007, INVEST OPHTH VIS SCI, V48, P1995, DOI 10.1167/iovs.06-1123; Pires A, 2015, J PEDIAT-BRAZIL, V91, P560, DOI 10.1016/j.jped.2015.01.011; Rasmussen ML, 2017, GRAEF ARCH CLIN EXP, V255, P293, DOI 10.1007/s00417-016-3454-3; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; SASONGKO MB, 2016, CURR EYE RES, V41, P551, DOI DOI 10.3109/02713683.2015.1034371; Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062; Skinner AC, 2016, OBESITY, V24, P1116, DOI 10.1002/oby.21497; Song HB, 2014, BIOCHEM BIOPH RES CO, V444, P63, DOI 10.1016/j.bbrc.2014.01.002; Suh HS, 2005, INT J OBESITY, V29, P217, DOI 10.1038/sj.ijo.0802642; Tai EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170014; Taylor B, 2007, INT J OBESITY, V31, P1527, DOI 10.1038/sj.ijo.0803674; Way KJ, 2001, DIABETIC MED, V18, P945, DOI 10.1046/j.0742-3071.2001.00638.x; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Xiao W, 2015, INVEST OPHTH VIS SCI, V56, P705, DOI 10.1167/iovs.14-14946; Yau JWY, 2010, DIABETOLOGIA, V53, P2042, DOI 10.1007/s00125-010-1811-z; ZAMIR M, 1979, J GEN PHYSIOL, V74, P537, DOI 10.1085/jgp.74.4.537; Zhang YX, 2017, J TROP PEDIAT	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191434	10.1371/journal.pone.0191434	http://dx.doi.org/10.1371/journal.pone.0191434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389952	gold, Green Published			2022-12-27	WOS:000423793400019
J	Verma, S; Goyal, S; Kumari, A; Singh, A; Jamal, S; Grover, A				Verma, Sharad; Goyal, Sukriti; Kumari, Anchala; Singh, Aditi; Jamal, Salma; Grover, Abhinav			Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; MOLECULAR-DYNAMICS SIMULATION; GENE AMPLIFICATION; KINASE DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; SOMATIC MUTATIONS; PROTEIN; ERBB2; TRASTUZUMAB; EFFICACY	HER-2 belongs to the human epidermal growth factor receptor (HER) family. Via different signal transduction pathways, HER-2 regulates normal cell proliferation, survival, and differentiation. Recently, it was reported that MCF10A, BT474, and MDA-MB-231 cells bearing the HER2 K753E mutation were resistant to lapatinib. Present study revealed that HER-2 mutant K753E showed some contrasting behaviour as compared to wild, L768S and V773L HER-2 in complex with lapatinib while similar to previously known lapatinib resistant L755S HER-2 mutant. Lapatinib showed stable but reverse orientation in binding site of K753E and the highest binding energy among studied HER2-lapatinib complexes but slightly lesser than L755S mutant. Results indicate that K753E has similar profile as L755S mutant for lapatinib. The interacting residues were also found different from other three studied forms as revealed by free energy decomposition and ligplot analysis.	[Verma, Sharad; Kumari, Anchala; Singh, Aditi; Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Goyal, Sukriti; Jamal, Salma] Banasthali Univ, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Kumari, Anchala; Singh, Aditi] TERI Sch Adv Studies, Dept Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; Banasthali Vidyapith; TERI University	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India.	abhinavgr@gmail.com	Kumari, Anchala/AAX-5951-2021	verma, sharad/0000-0002-9261-6878; Singh, Aditi/0000-0001-7438-2863	Department of Health Research (DHR); DST PURSE Grant from Jawaharlal Nehru University; Department of Health Research (DHR), India; Council of Scientific and Industrial Research (CSIR), India	Department of Health Research (DHR); DST PURSE Grant from Jawaharlal Nehru University; Department of Health Research (DHR), India; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded in part by DST PURSE Grant from Jawaharlal Nehru University in the form of support for the article's publication fee. SG received support from from the Department of Health Research (DHR), India, in the form of the Young Scientist Fellowship. SV received support from the Council of Scientific and Industrial Research (CSIR), India, in the form of a Senior Research Associateship (pool scientist scheme). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AG is thankful to Jawaharlal Nehru University for usage of all computational facilities. AG is grateful to University Grants Commission, India for the Faculty Recharge position. SV is thankful of Council of Scientific and Industrial Research (CSIR), India for providing senior research associateship (pool scientist scheme). SG acknowledges Young Scientist fellowship from Department of Health Research (DHR).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Gupta A, 2015, J RECEPT SIG TRANSD, V35, P626, DOI 10.3109/10799893.2015.1041645; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iqbal N, 2014, MOL BIOL INT, V2014; Kaburagi M, 2016, POLYM J, V48, P189, DOI 10.1038/pj.2015.82; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; MacFarlane RJ, 2011, EXPERT OPIN DRUG SAF, V10, P109, DOI 10.1517/14740338.2011.533168; Minami Y, 2007, ONCOGENE, V26, P5023, DOI 10.1038/sj.onc.1210292; Nagpal N, 2016, J RECEPT SIG TRANSD, P1; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Pandey B, 2016, GENE, V581, P31, DOI 10.1016/j.gene.2016.01.024; Pandey V, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0563-7; Patel K, 2015, COMPUT BIOL CHEM, V59, P37, DOI 10.1016/j.compbiolchem.2015.09.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Singh B, 2015, J PHYS CHEM B, V119, P392, DOI 10.1021/jp5079554; Sinha S, 2016, J BIOMOL STRUCT DYN, P1; Slamon D., 1987, SCIENCE, P235; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sun ZJ, 2015, J CELL MOL MED, V19, P2691, DOI 10.1111/jcmm.12662; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Tournier AL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208106; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Verma S, 2016, J BIOMOL STRUCT DYN, P1; Verma S, 2016, J MOL GRAPH MODEL, V67, P94, DOI 10.1016/j.jmgm.2016.05.007; Verma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149014; Verma S, 2012, J MOL GRAPH MODEL, V37, P27, DOI 10.1016/j.jmgm.2012.04.004; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang L, 2015, RSC ADV, V5, P66391, DOI 10.1039/c5ra12328c; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Zabransky DJ, 2015, P NATL ACAD SCI USA, V112, pE6205, DOI 10.1073/pnas.1516853112; Zuo WJ, 2016, CLIN CANCER RES, V22, P4859, DOI 10.1158/1078-0432.CCR-15-3036	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190942	10.1371/journal.pone.0190942	http://dx.doi.org/10.1371/journal.pone.0190942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389942	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400009
J	Alberti, G; Grima, R; Vella, NC				Alberti, Gianmarco; Grima, Reuben; Vella, Nicholas C.			The use of geographic information system and 1860s cadastral data to model agricultural suitability before heavy mechanization. A case study from Malta	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SOIL-MOISTURE; SPATIAL-DISTRIBUTION; SPECIES DISTRIBUTION; GIS; AUTOCORRELATION; VARIABILITY; ABANDONMENT; SETTLEMENT; FORESTS	The present study seeks to understand the determinants of land agricultural suitability in Malta before heavy mechanization. A GIS-based Logistic Regression model is built on the basis of the data from mid-1800s cadastral maps (cabreo). This is the first time that such data are being used for the purpose of building a predictive model. The maps record the agricultural quality of parcels (ranging from good to lowest), which is represented by different colours. The study treats the agricultural quality as a depended variable with two levels: optimal (corresponding to the good class) vs. non-optimal quality (mediocre, bad, low, and lowest classes). Seventeen predictors are isolated on the basis of literature review and data availability. Logistic Regression is used to isolate the predictors that can be considered determinants of the agricultural quality. Our model has an optimal discriminatory power (AUC: 0.92). The positive effect on land agricultural quality of the following predictors is considered and discussed: sine of the aspect (odds ratio 1.42), coast distance (2.46), Brown Rendzinas (2.31), Carbonate Raw (2.62) and Xerorendzinas (9.23) soils, distance to minor roads (4.88). Predictors resulting having a negative effect are: terrain elevation (0.96), slope (0.97), distance to the nearest geological fault lines (0.09), Terra Rossa soil (0.46), distance to secondary roads (0.19) and footpaths (0.41). The model isolates a host of topographic and cultural variables, the latter related to human mobility and landscape accessibility, which differentially contributed to the agricultural suitability, providing the bases for the creation of the fragmented and extremely variegated agricultural landscape that is the hallmark of the Maltese Islands. Our findings are also useful to suggest new questions that may be posed to the more meagre evidence from earlier periods.	[Alberti, Gianmarco; Vella, Nicholas C.] Univ Malta, Dept Class & Archaeol, Msida, Malta; [Grima, Reuben] Univ Malta, Dept Conservat & Built Heritage, Msida, Malta	University of Malta; University of Malta	Alberti, G (corresponding author), Univ Malta, Dept Class & Archaeol, Msida, Malta.	gianmarco.alberti@um.edu.mt	Grima, Reuben/GQI-2579-2022; Alberti, Gianmarco/N-1537-2014	Alberti, Gianmarco/0000-0003-2916-1767; Vella, Nicholas/0000-0001-7680-920X; Grima, Reuben/0000-0002-2866-3434	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant Agreement [323727]; ERC [323727]; European project [ERDF156]	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant Agreement; ERC(European Research Council (ERC)European Commission); European project	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 323727 (FRAGSUS Project, PI Prof. Caroline Malone, Queen's University Belfast, UK - http://www.qub.ac.uk/sites/FRAGSUS/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Digital Terrain Model was derived from LiDAR data made available through an agreement signed between the University of Malta and the Malta Environment and Planning Authority in 2013 (ERDF LIDAR data, 2012, ERDF156 Developing National Environmental Monitoring Infrastructure and Capacity, Malta Environment and Planning Authority).; We acknowledge with thanks the ERC Advanced Grant 323727 FRAGSUS that supported this work. We wish to express our warmest gratitude to the Academic Editor, Dr Hugo Rebelo, for the competence and patience shown during the long editorial process through which this study has gone. We also thank the anonymous reviewers for their constructive and encouraging comments, which allowed us to significantly improve the quality and structure of the final version of the article. We are grateful to Dr Charles Farrugia, National Archivist (Malta), for permitting the procurement of copies of the cabreo documentation for the research presented here, and for granting (on November 23 2017) the authorization to use the cabreo map represented in big 2. Prof. Saviour Formosa and Dr Timmy Gambin, both of the University of Malta, facilitated the donation of LiDAR data and orthophotos, together with computer facilities, as part of the European project ERDF156 Developing National Environmental Monitoring Infrastructure and Capacity, from the former Malta Environment and Planning Authority. We would also like to acknowledge the Principal Investigator of the FRAGSUS project, Prof. Caroline Malone (Queen's University, Belfast, UK) for her interest and support in seeing this research through to publication. The authors are solely responsible for any error or misunderstanding that may remain.	AbdelRahman MAE, 2016, EGYPT J REMOTE SENS, V19, P125, DOI 10.1016/j.ejrs.2016.02.001; Agresti A, 2003, CATEGORICAL DATA ANA; Ahmed GB, 2016, IOP C SER EARTH ENV, V37, DOI 10.1088/1755-1315/37/1/012044; Akbar KF, 2012, POL J ENVIRON STUD, V21, P1141; Akinci H, 2013, COMPUT ELECTRON AGR, V97, P71, DOI 10.1016/j.compag.2013.07.006; Alberti G, 2016, MODEL VALID R FUNCTI; Alberti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091510; Allison, 2001, LOGISTIC REGRESSION; Anderson E. W., 1997, GeoJournal, V41, P111, DOI 10.1023/A:1006876622382; Andresen J.B.R., 2008, P 35 INT C COMP APPL, P405; [Anonymous], [No title captured]; Arekhi S, 2011, AFR J BIOTECHNOL, V10, P16236, DOI 10.5897/AJB11.1122; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Bandyopadhyay S, 2009, INT J REMOTE SENS, V30, P879, DOI 10.1080/01431160802395235; Basic F, 2013, SOILS OF CROATIA; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Begum F, 2010, INT J SUST DEV WORLD, V17, P438, DOI 10.1080/13504509.2010.499034; Beh EJ, 2014, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118762875; Bevan A, 2013, MEDITERRANEAN ISLANDS, FRAGILE COMMUNITIES AND PERSISTENT LANDSCAPES: ANTIKYTHERA IN LONG-TERM PERSPECTIVE, P1, DOI 10.1017/CBO9781139519748; Blouet B., 1963, CHANGING LANDSCAPE M; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Bustamante J, 2004, J BIOGEOGR, V31, P295, DOI 10.1046/j.0305-0270.2003.01006.x; Butler DR, 2009, DEV EARTH S, V12, P1; Carrer F, 2013, J ANTHROPOL ARCHAEOL, V32, P54, DOI 10.1016/j.jaa.2012.10.001; Chang JH., 2009, CLIMATE AGR ECOLOGIC; Cherry J. F, 1991, MONUMENTA ARCHAEOLOG, V16; Clarke M. J., 2001, FEASTS ARCHAEOLOGICA, P144; Cokluk O, 2010, KURAM UYGUL EGIT BIL, V10, P1397; Collerton H., 2008, New Zealand Journal of Forestry, V53, P33; Cooke CR, 2009, CRIT CARE MED, V37, P1913, DOI 10.1097/CCM.0b013e3181a009b4; Costanzo D, 2013, LANDSLIDES; Dalli C, 2016, ISL STUD J, V11, P369; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; De Ketelaere D, 2010, NATURAL HERITAGE FROM EAST TO WEST: CASE STUDIES FROM 6 EU COUNTRIES, P231, DOI 10.1007/978-3-642-01577-9_29; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dorren L., 2004, BRIEFING PAPERS 2 SC, P97; Dunn DC, 2010, FISH RES, V102, P60, DOI 10.1016/j.fishres.2009.10.010; Evans J, 2014, TOOLBOX SURFACE GRAD; Eve SJ, 2014, J ARCHAEOL SCI, V43, P267, DOI 10.1016/j.jas.2013.12.019; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; Fenech K., 2007, HUMAN INDUCED CHANGE; Filonzi FA, 1775, PRATICHE MATEMATICHE; Fisher WB, 1961, MALTA BACKGROUND DEV, P83; Flinn KM, 2005, J BIOGEOGR, V32, P439, DOI 10.1111/j.1365-2699.2004.01198.x; Forbes H., 1996, HUMAN LANDSCAPES CLA, P68; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Franklin J, 1998, J VEG SCI, V9, P733, DOI 10.2307/3237291; Galdies C., 2011, CLIMATE MALTA STAT T; Giancristofaro R.A., 2003, STATISTICA, V63, P375; Ginori Lisci L., 1978, CABREI TOSCANA RACCO, P13; Grima R., 2005, MONUMENTS SEARCH LAN; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu ZY, 2007, COMPUT ENVIRON URBAN, V31, P667, DOI 10.1016/j.compenvurbsys.2006.11.001; Iwara AI, 2013, OPEN J ADV ENG TECH, V1, P42; Jenness J., 2007, SOME THOUGHTS ANAL T; Klute DS, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P335; Lang DM, 1960, SOILS MALTA GOZO; LUDEKE AK, 1990, J ENVIRON MANAGE, V31, P247, DOI 10.1016/S0301-4797(05)80038-6; Luder MT, 2011, ARCH SEX BEHAV, V40, P1027, DOI 10.1007/s10508-010-9714-0; Marriner N, 2012, PALAEOGEOGR PALAEOCL, V339, P52, DOI 10.1016/j.palaeo.2012.04.022; Matsui T, 2004, J VEG SCI, V15, P57, DOI 10.1658/1100-9233(2004)015[0057:CCODOF]2.0.CO;2; McDonald J, 2009, HDB BIOL STAT, V1407; Mehrjardi R. T., 2009, Analele Universitatii din Oradea, Fascicula Biologie, V16, P155; Menard S., 2002, APPL LOGISTIC REGRES; Michel JF, 2002, PREV VET MED, V56, P5, DOI 10.1016/S0167-5877(02)00120-4; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Montanarella, 2001, SOIL RESOURCES SO E, V34, P171; Mottershead D, 2010, GEOL SOC SPEC PUBL, V331, P219, DOI 10.1144/SP331.20; Muir SW, 2010, PHYS THER, V90, P338, DOI 10.2522/ptj.20090163; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Palmisano A., 2009, SETTLEMENTS PATTERNS; Pampel F.C., 2000, LOGISTIC REGRESSION; Park HA, 2013, J KOREAN ACAD NURS, V43, P154, DOI 10.4040/jkan.2013.43.2.154; Park Sun-Jeong, 2010, Urban Ecosystems, V13, P483, DOI 10.1007/s11252-010-0130-y; Pedely M, 2002, LIMESTONE ISLES CRYS; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Pittet I, 2010, ARCH DIS CHILD, V95, P711, DOI 10.1136/adc.2008.146571; Porcic M, 2010, CROSS-CULT RES, V44, P405, DOI 10.1177/1069397110378839; Preisler HK, 1997, FOREST SCI, V43, P71; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Qiu Y, 2001, J ARID ENVIRON, V49, P723, DOI 10.1006/jare.2001.0828; R Team Core, 2013, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; REID I, 1973, Journal of Hydrology (Amsterdam), V19, P309, DOI 10.1016/0022-1694(73)90105-4; Rizopoulos D, 2009, PACKAGE BOOTSTEPAIC; Role A., 2007, EUROPES LIVING LANDS, P405, DOI [10.1163/9789004278073_025, DOI 10.1163/9789004278073_025]; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg N.J., 1983, MICROCLIMATE BIOL EN; Sandor JonathanA., 2008, GEOLOGY GILA WILDERN, P167; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Schembri P. J., 1997, GeoJournal, V41, P115, DOI 10.1023/A:1006828706452; Sensoy H, 2013, IFOREST, V7, P110, DOI 10.3832/ifor0845-007; Serneels S, 2001, AGR ECOSYST ENVIRON, V85, P65, DOI 10.1016/S0167-8809(01)00188-8; Shan J., 2008, TOPOGRAPHIC LASER RA; Shishkov T, 2014, WOR SOIL BOOK SER, P1; Smit A, 2009, NATURAL HANDICAPS DU; Spiteri M., 2015, J BAROQUE STUDIES, V3, P129; Stewart K., 2013, STOREYS GUIDE GROWIN; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Sulebak JR, 2000, GEOGR ANN A, V82A, P89, DOI 10.1111/j.0435-3676.2000.00009.x; Tabachnik B., 2013, USING MULTIVARIATE S, V6th edn; Tromp-van Meerveld HJ, 2006, ADV WATER RESOUR, V29, P293, DOI 10.1016/j.advwatres.2005.02.016; Van Orshoven J, 2008, COMMON BIOPHYSICAL C; Van Orshoven J, 2013, UPDATED COMMON BIOPH; Vella NC, STORJA, P16; von Saucken P Caucci, 1997, CABREVATIO BONORUM P; Wang F, 2014, QUANTITATIVE METHODS; Wang LJ, 2011, INT J GEOMATE, V1, P99; Warren R, 2000, PREDICTIVE MODEL ARC, P7; Warren TL, 2005, FOREST ECOL MANAG, V214, P331, DOI 10.1016/j.foreco.2005.04.017; Western AW, 1999, WATER RESOUR RES, V35, P797, DOI 10.1029/1998WR900065; Wettinger G., 1981, AGR MALTA LATE MIDDL, P1; Yesilnacar E, 2005, ENG GEOL, V79, P251, DOI 10.1016/j.enggeo.2005.02.002; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Zhang ZX, 2010, J ARID ENVIRON, V74, P386, DOI 10.1016/j.jaridenv.2009.09.024	123	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192039	10.1371/journal.pone.0192039	http://dx.doi.org/10.1371/journal.pone.0192039			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415059	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300048
J	de Oliveira, SA; de Oliveira, CMG; Maleita, CMN; Silva, MDA; Abrantes, IMD; Wilcken, SRS				de Oliveira, Samara Azevedo; Goncalves de Oliveira, Claudio Marcelo; Nobre Maleita, Carla Maria; Silva, Maria de Fatima A.; de Oliveira Abrantes, Isabel Maria; Wilcken, Silvia Renata S.			First report of Meloidogyne graminis on golf courses turfgrass in Brazil	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; ORNAMENTAL PLANTS; SPP.; IDENTIFICATION; HETERODERIDAE; TYLENCHIDA; DIVERSITY; OLIVE; PCR	Plant-parasitic nematodes of the genus Meloidogyne, known as root-knot nematodes (RKN), have an important economic impact on golf course turfgrasses. The most prevalent RKN species associated with grasses are M. chitwoodi, M. graminicola, M. graminis, M. incognita, M. marylandi, M. microtyla, M. minor, M. naasi and M. sasseri. In 2010, slight thickening of the roots and RKN females with unusual features were observed in turfgrass roots on golf courses in Araras, Sao Paulo state, Brazil. This population (MgARA) was maintained in the lab and studied including morphological, morphometrical, biochemical and molecular markers. Morphology and morphometry were variable and not useful for identification, although perineal pattern morphology showed highly similarity with M. graminis description. Concerning to biochemical characterisation, the esterase phenotype Mg1, characterised by a very slow and fainter band, was detected in some protein homogenates. Regarding to molecular analysis, D2-D3 region of 28S rDNA gene and cytochrome oxidase subunit II region from mitochondrial DNA were amplified by PCR and sequenced. Phylogenetic analysis revealed that the Brazilian isolate, found associated with turfgrass, grouped with M. graminis isolates (98-99% bootstrap; variation of 8-11 and 0-24 bp, respectively), close to M. marylandi, supporting its identification as M. graminis. This is the first report of M. graminis on golf courses in Brazil.	[de Oliveira, Samara Azevedo; Silva, Maria de Fatima A.; Wilcken, Silvia Renata S.] Univ Estadual Paulista, Fac Ciencias Agron, Campus Botucatu,Rua Jose Barbosa Barros, Botucatu, SP, Brazil; [Goncalves de Oliveira, Claudio Marcelo] Inst Biol, Lab Nematol, Campinas, SP, Brazil; [Nobre Maleita, Carla Maria] UC, Chem Engn Dept, CIEPQPF Chem Proc Engn & Forest Prod Res Ctr, Rua Silvio Lima,Polo 2, Coimbra, Portugal; [Nobre Maleita, Carla Maria; de Oliveira Abrantes, Isabel Maria] UC, Dept Life Sci, CFE, Coimbra, Portugal	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Coimbra; Universidade de Coimbra	de Oliveira, SA (corresponding author), Univ Estadual Paulista, Fac Ciencias Agron, Campus Botucatu,Rua Jose Barbosa Barros, Botucatu, SP, Brazil.	samaranematologia@gmail.com	Wilcken, Silvia Renata S/H-3877-2012; Maleita, Carla Maria Nobre/AAA-1852-2021; Abrantes, Isabel/CAG-1426-2022	Wilcken, Silvia Renata S/0000-0002-9306-0197; Abrantes, Isabel/0000-0002-8761-2151	CNPq (National Counsel of Technological and Scientific Development) [134753/2013-5]; CFE through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); IATV through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); CIEPQPF through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) [UID/BIA/04004/2013, PEst-C/EQB/UI0102/2013, FCOMP-01-0124-FEDER-027960]; FCT - Ministerio da Educacao e Ciencia national funding [SFRH/BPD/85736/2012]; FCT - European Social Funds through Programa Operacional Capital Humano [SFRH/BPD/85736/2012]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CFE through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); IATV through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); CIEPQPF through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); FCT - Ministerio da Educacao e Ciencia national funding; FCT - European Social Funds through Programa Operacional Capital Humano	Samara A. de Oliveira thanks the CNPq (National Counsel of Technological and Scientific Development, cnpq.br) for the scholarship, process number: 134753/2013-5. This research was also supported by CFE, IATV, CIEPQPF and FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal) and by FCT (Fundacao para a Ciencia e a Tecnologia, Portugal), under contracts: UID/BIA/04004/2013, PEst-C/EQB/UI0102/2013 and FCOMP-01-0124-FEDER-027960. Carla Maleita (SFRH/BPD/85736/2012) acknowledge FCT for granted fellowships, financed by Ministerio da Educacao e Ciencia national funding and by the European Social Funds through Programa Operacional Capital Humano.	ABRANTES IMD, 1991, J NEMATOL, V23, P210; Al-Banna L, 2004, J NEMATOL, V36, P142; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; Brito JA, 2010, NEMATROPICA, V40, P87; Carneiro RMDG, 2004, NEMATOLOGY, V6, P287, DOI 10.1163/1568541041217942; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; COOLEN W. A., 1972, Ghent; Crow WT, 2014, J NEMATOL, V46, P8; Dias-Arieira Claudia R., 2007, Nematologia Brasileira, V31, P46; Entwistle K., 2003, ROOT KNOT NEMATODE I, P21; Ferraz LCCB, 1995, MANUAL FITOPATOLOGIA, V1, P168; Fleming CC, 2008, AGRIFOOD BIOSCIENCE, V55; Godoy LJG, 2005, THESIS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Jepson S.B., 1987, IDENTIFICATION ROOT; Khan MR, 2014, ROOT KNOT NEMATODES, P78; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; Mitkowski N., 2001, ROOT KNOT NEMATODES, V10; Negretti RRD, 2013, THESIS; Oliveira C. M. G., 2009, NEMATOLOGIA BRASILEI, V33, P218; Oliveira Claudio M. G., 2011, Nematologia Brasileira, V35, P36; OLIVEIRA CMG, 2012, TECNICAS DIAGNOSTICO, V1, P103; Perichi Guillermo, 2006, Fitopatologia Venezolana, V19, P17; Perry RN, 2010, ROOT-KNOT NEMATODES, P1; Pires AC, 2010, BIOTA NEOTROP, V10, P339, DOI 10.1590/S1676-06032010000200035; POWERS TO, 1993, J NEMATOL, V25, P1; SLEDGE EB, 1964, P HELM SOC WASH, V31, P83; Stanton J, 1997, FUND APPL NEMATOL, V20, P261; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR DP, 1974, NEMATOLOGICA, V20, P268, DOI 10.1163/187529274X00285; Wesemael WML, 2011, NEMATOLOGY, V13, P3, DOI 10.1163/138855410X526831; Ye WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143556; Zeng YS, 2012, J NEMATOL, V44, P337; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhuo Kan, 2011, Acta Prataculturae Sinica, V20, P253	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192397	10.1371/journal.pone.0192397	http://dx.doi.org/10.1371/journal.pone.0192397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415001	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300075
J	Bryan, MA; Giordano, D; Draves, KE; Green, R; Gale, M; Clark, EA				Bryan, Marianne A.; Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.			Splenic macrophages are required for protective innate immunity against West Nile virus	PLOS ONE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; CD8-ALPHA(+) DENDRITIC CELLS; ALPHA/BETA-INTERFERON; T-CELLS; NATURAL-KILLER; UNITED-STATES; DENGUE-VIRUS; INFECTION; ACTIVATION; ENCEPHALITIS	Although the spleen is a major site for West Nile virus (WNV) replication and spread, relatively little is known about which innate cells in the spleen replicate WNV, control viral dissemination, and/or prime innate and adaptive immune responses. Here we tested if splenic macrophages (M Phi s) were necessary for control of WNV infection. We selectively depleted splenic M Phi s, but not draining lymph node M Phi s, by injecting mice intravenously with clodronate liposomes several days prior to infecting them with WNV. Mice missing splenic M Phi s succumbed to WNV infection after an increased and accelerated spread of virus to the spleen and the brain. WNV-specific Ab and CTL responses were normal in splenic M Phi-depleted mice; however, numbers of NK cells and CD4 and CD8 T cells were significantly increased in the brains of infected mice. Splenic M Phi deficiency led to increased WNV in other splenic innate immune cells including CD11b(-) DCs, newly formed MFs and monocytes. Unlike other splenic myeloid subsets, splenic MFs express high levels of mRNAs encoding the complement protein C1q, the apoptotic cell clearance protein Mertk, the IL-18 cytokine and the Fc gamma R1 receptor. Splenic M Phi-deficient mice may be highly susceptible to WNV infection in part to a deficiency in C1q, Mertk, IL-18 or Caspase 12 expression.	[Bryan, Marianne A.; Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Clark, EA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Clark, EA (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.	eaclark@uw.edu		Green, Richard/0000-0001-8851-7204; Giordano, Daniela/0000-0001-8362-7017	NIAID [U19 AI83019, RO1 AI104002, R01 AI52203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100625, U19AI083019, R01AI052203] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by grants from NIAID including U19 AI83019 and RO1 AI104002 (MG) and R01 AI52203 (EAC).; This research was supported in part by grants from NIAID (U19 AI83019, RO1 AI104002, and R01 AI52203). M.A.B. and E.A.C. designed and coordinated the study with feedback from D. G.; M.A.B. and K.E.D. performed experiments and analyzed data; K.E.D. bred and prepared mice used for experiments; M.G. provided virus and key methods and edited the manuscript; M.A.B., D.G. and E.A.C. wrote and edited initial drafts of the manuscript. All authors contributed to the interpretation and conclusions presented in the manuscript.	Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309; Ashhurst TM, 2013, INDIAN J MED RES, V138, P632; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Beaulieu AM, 2015, ADV EXP MED BIOL, V850, P81, DOI 10.1007/978-3-319-15774-0_7; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Buiting AMJ, 1996, SCAND J IMMUNOL, V43, P398, DOI 10.1046/j.1365-3083.1996.d01-54.x; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655; Cyster JG, 2010, IMMUNOL CELL BIOL, V88, P617, DOI 10.1038/icb.2010.74; Daffis S, 2009, J INNATE IMMUN, V1, P435, DOI 10.1159/000226248; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Franca RFO, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0628-1; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Giordano D, 2011, J LEUKOCYTE BIOL, V89, P443, DOI 10.1189/jlb.0610329; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Ma DY, 2015, CURR OPIN VIROL, V12, P26, DOI 10.1016/j.coviro.2015.02.005; Ma DY, 2013, J VIROL, V87, P3361, DOI 10.1128/JVI.02368-12; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Mehlhop E, 2009, VIROLOGY, V393, P11, DOI 10.1016/j.virol.2009.08.019; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Murray KO, 2013, EMERG INFECT DIS, V19, P1836, DOI 10.3201/eid1911.130768; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3; Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298; Winkelmann ER, 2014, VIROLOGY, V450, P278, DOI 10.1016/j.virol.2013.12.021	67	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191690	10.1371/journal.pone.0191690	http://dx.doi.org/10.1371/journal.pone.0191690			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408905	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800023
J	Choong, TSY; Yeoh, CM; Phuah, ET; Siew, WL; Lee, YY; Tang, TK; Abdullah, L				Choong, Thomas Shean Yaw; Yeoh, Chiou Moi; Phuah, Eng-Tong; Siew, Wai-Lin; Lee, Yee-Ying; Tang, Teck-Kim; Abdullah, Luqman Chuah			Kinetic study of lipase-catalyzed glycerolysis of palm olein using Lipozyme TLIM in solvent-free system	PLOS ONE			English	Article							ENZYMATIC GLYCEROLYSIS; IMMOBILIZED LIPASE; PARTIAL HYDROLYSIS; MONOACYLGLYCEROL PRODUCTION; DIACYLGLYCEROL; OIL; ESTERIFICATION; TRIACYLGLYCEROL; MECHANISM; MODEL	Diacylglycerol (DAG) and monoacylglycerol (MAG) are two natural occurring minor components found in most edible fats and oils. These compounds have gained increasing market demand owing to their unique physicochemical properties. Enzymatic glycerolysis in solvent-free system might be a promising approach in producing DAG and MAG-enriched oil. Understanding on glycerolysis mechanism is therefore of great importance for process simulation and optimization. In this study, a commercial immobilized lipase (Lipozyme TL IM) was used to catalyze the glycerolysis reaction. The kinetics of enzymatic glycerolysis reaction between triacylglycerol (TAG) and glycerol (G) were modeled using rate equation with unsteady-state assumption. Ternary complex, ping-pong bi-bi and complex ping-pong bi-bi models were proposed and compared in this study. The reaction rate constants were determined using non-linear regression and sum of square errors (SSE) were minimized. Present work revealed satisfactory agreement between experimental data and the result generated by complex ping-pong bi-bi model as compared to other models. The proposed kinetic model would facilitate understanding on enzymatic glycerolysis for DAG and MAG production and design optimization of a pilot-scale reactor.	[Choong, Thomas Shean Yaw; Yeoh, Chiou Moi; Abdullah, Luqman Chuah] Univ Putra Malaysia, Fac Engn, Dept Chem & Environm Engn, Serdang, Selangor, Malaysia; [Choong, Thomas Shean Yaw] Univ Putra Malaysia, INTROP, Serdang, Selangor, Malaysia; [Phuah, Eng-Tong] Univ Tunku Abdul Rahman, Dept Agr & Food Sci, Fac Sci, Kampar, Perak, Malaysia; [Siew, Wai-Lin] Malaysian Palm Oil Board, Persiaran Inst, Kajang, Selangor, Malaysia; [Tang, Teck-Kim] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Lee, Yee-Ying] Monash Univ Malaysia, Sch Sci, Bandar Sunway, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Tunku Abdul Rahman (UTAR); Malaysian Palm Oil Board; Universiti Putra Malaysia; Monash University; Monash University Sunway	Choong, TSY (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Chem & Environm Engn, Serdang, Selangor, Malaysia.; Choong, TSY (corresponding author), Univ Putra Malaysia, INTROP, Serdang, Selangor, Malaysia.	csthomas@upm.edu.my	Phuah, Eng-Tong/AFV-5125-2022; Abdullah, Luqman Chuah/L-8915-2016; Phuah, Eng-Tong/S-9977-2017	Phuah, Eng-Tong/0000-0002-0334-2335; Abdullah, Luqman Chuah/0000-0003-4785-9296; Phuah, Eng-Tong/0000-0002-0334-2335; LEE, YEE YING/0000-0002-4586-5978				Al-Zuhair S, 2003, PROCESS BIOCHEM, V38, P1155, DOI 10.1016/S0032-9592(02)00279-0; BERGER M, 1992, J AM OIL CHEM SOC, V69, P955, DOI 10.1007/BF02541057; Cheirsilp B, 2007, BIOCHEM ENG J, V35, P71, DOI 10.1016/j.bej.2006.12.024; Cheong LZ, 2007, FOOD CHEM, V105, P1614, DOI 10.1016/j.foodchem.2007.03.070; Chew YH, 2008, BIOCHEM ENG J, V39, P516, DOI 10.1016/j.bej.2007.10.019; Coteron A, 1998, J AM OIL CHEM SOC, V75, P657, DOI 10.1007/s11746-998-0080-1; Damstrup ML, 2006, J AGR FOOD CHEM, V54, P7113, DOI 10.1021/jf061365r; Ferreira-Dias S, 2001, J MOL CATAL B-ENZYM, V11, P699, DOI 10.1016/S1381-1177(00)00079-5; Fureby AM, 1997, ENZYME MICROB TECH, V20, P198, DOI 10.1016/S0141-0229(96)00133-0; Garcia HS, 1995, FOOD RES INT, V28, P605, DOI 10.1016/0963-9969(95)00051-8; Garcia T, 1996, CHEM ENG SCI, V51, P2841, DOI 10.1016/0009-2509(96)00162-5; Garcia T, 1999, ENZYME MICROB TECH, V25, P584, DOI 10.1016/S0141-0229(99)00082-4; Garcia T, 2000, CHEM ENG SCI, V55, P1411, DOI 10.1016/S0009-2509(99)00425-X; GHAZALI HM, 1995, J AM OIL CHEM SOC, V72, P633, DOI 10.1007/BF02635647; Kaewthong W, 2005, PROCESS BIOCHEM, V40, P1525, DOI 10.1016/j.procbio.2003.12.002; Kristensen JB, 2005, J AM OIL CHEM SOC, V82, P329, DOI 10.1007/s11746-005-1074-5; Maki KC, 2002, AM J CLIN NUTR, V76, P1230, DOI 10.1093/ajcn/76.6.1230; Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792; Nakajima Y, 2004, J AM OIL CHEM SOC, V81, P907, DOI 10.1007/s11746-004-1000-x; Voll FAP, 2012, APPL BIOCHEM BIOTECH, V168, P1121, DOI 10.1007/s12010-012-9846-x; Phuah ET, 2012, J MOL CATAL B-ENZYM, V78, P91, DOI 10.1016/j.molcatb.2012.03.009; Plou FJ, 1996, ENZYME MICROB TECH, V18, P66, DOI 10.1016/0141-0229(96)00054-3; Rosu R, 1999, J AM OIL CHEM SOC, V76, P839, DOI 10.1007/s11746-999-0074-7; Rudkowska I, 2005, OBES RES, V13, P1864, DOI 10.1038/oby.2005.229; SONNTAG NOV, 1982, J AM OIL CHEM SOC, V59, pA795, DOI 10.1007/BF02634442; SWE PZ, 1995, J AM OIL CHEM SOC, V72, P343, DOI 10.1007/BF02541094; Tan TW, 2005, BIOCHEM ENG J, V25, P39, DOI 10.1016/j.bej.2005.03.009; Valerio A, 2009, J AGR FOOD CHEM, V57, P8350, DOI 10.1021/jf901771m; YAMANE T, 1994, J AM OIL CHEM SOC, V71, P339, DOI 10.1007/BF02638064; Yeoh CM, 2009, EUR J LIPID SCI TECH, V111, P599, DOI 10.1002/ejlt.200800265	30	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192375	10.1371/journal.pone.0192375	http://dx.doi.org/10.1371/journal.pone.0192375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401481	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400056
J	Salazar, JCS; Bieng, MAN; Melgarejo, LM; Di Rienzo, JA; Casanoves, F				Suarez Salazar, Juan Carlos; Ngo Bieng, Marie Ange; Marina Melgarejo, Luz; Di Rienzo, Julio A.; Casanoves, Fernando			First typology of cacao (Theobroma cacao L.) systems in Colombian Amazonia, based on tree species richness, canopy structure and light availability	PLOS ONE			English	Article							COCOA-BASED AGROFORESTRY; FOREST; CONSERVATION; DIVERSITY; BIODIVERSITY; VEGETATION; PACKAGE; REGION	Aim and background We present a typology of cacao agroforest systems in Colombian Amazonia. These systems had yet to be described in the literature, especially their potential in terms of biodiversity conservation. The systems studied are located in a post-conflict area, and a deforestation front in Colombian Amazonia. Cacao cropping systems are of key importance in Colombia: cacao plays a prime role in post conflict resolution, as cacao is a legal crop to replace illegal crops; cacao agroforests are expected to be a sustainable practice, promoting forest-friendly land use. Material and methods We worked in 50 x 2000 m(2) agroforest plots, in Colombian Amazonia. A cluster analysis was used to build a typology based on 28 variables characterised in each plot, and related to diversity, composition, spatial structure and light availability for the cacao trees. We included variables related to light availability to evaluate the amount of transmitted radiation to the cacao trees in each type, and its suitability for cacao ecophysiological development. Main results We identified 4 types of cacao agroforests based on differences concerning tree species diversity and the impact of canopy spatial structure on light availability for the cacao trees in the understorey. We found 127 tree species in the dataset, with some exclusive species in each type. We also found that 3 out of the 4 types identified displayed an erosion of tree species diversity. This reduction in shade tree species may have been linked to the desire to reduce shade, but we also found that all the types described were compatible with good ecophysiological development of the cacao trees. Main conclusions and prospects Cacao agroforest systems may actually be achieving biodiversity conservation goals in Colombian Amazonia. One challenging prospect will be to monitor and encourage the conservation of tree species diversity in cacao agroforest systems during the development of these cropping systems, as a form of forest-friendly management enhancing sustainable peace building in Colombia.	[Suarez Salazar, Juan Carlos] Univ Amazonia, Fac Ingn, Campus Porvenir Calle 17 Diagonal 17 Con Carrera, Florencia, Caqueta, Colombia; [Suarez Salazar, Juan Carlos; Marina Melgarejo, Luz] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Fisiol & Bioquim Vegetal, Bogota, Colombia; [Ngo Bieng, Marie Ange] CIRAD, UR Forets & Soc, CIRAD Campus Int Baillarguet, Montpellier 5, France; [Ngo Bieng, Marie Ange; Casanoves, Fernando] CATIE, CATIE Ctr Agron Trop Invest & Ensenanaza, Turrialba, Cartago, Costa Rica; [Di Rienzo, Julio A.] Univ Nacl Cordoba, Fac Ciencias Agr, Av Valparaiso S-N,Ciudad Univ, Cordoba, Argentina	Universidad Nacional de Colombia; CIRAD; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; National University of Cordoba	Bieng, MAN (corresponding author), CIRAD, UR Forets & Soc, CIRAD Campus Int Baillarguet, Montpellier 5, France.; Bieng, MAN (corresponding author), CATIE, CATIE Ctr Agron Trop Invest & Ensenanaza, Turrialba, Cartago, Costa Rica.	marie-ange.ngo_bieng@cirad.fr	Melgarejo, Luz/AAZ-5918-2020; suárez salazar, juan carlos/GXH-2202-2022; Casanoves, Fernando/I-3588-2016	Casanoves, Fernando/0000-0001-8765-9382; Melgarejo, Luz Marina/0000-0003-3148-1911; Suarez Salazar, Juan Carlos/0000-0001-5928-1837	COLCIENCIAS; IDB funds; Doctoral School of the University of Amazonia	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); IDB funds; Doctoral School of the University of Amazonia	This work was developed with the financial collaboration of COLCIENCIAS, with IDB funds and within the framework of the "Caracterizacion y tipificacion de plantaciones tradicionales de Theobroma cacao L to Juan Carlos Suarez Salazar. como estrategia de diseno e implementacion de arreglos agroforestales en el Bajo Caguan (Cartagena del Chaira)" Project, implemented by the University of Amazonia, with special contract of cooperation 590 for the year 2012, and with funds from the Doctoral School of the University of Amazonia, by means of the "Prodesarrollo de la Universidad de la Amazonia" Law No 1301 dated 2009 to Juan Carlos Suarez Salazar.	Almeida AAF, 2014, PHOTOSYNTHETICA, V52, P16, DOI 10.1007/s11099-013-0048-8; Asase A, 2010, AFR J ECOL, V48, P338, DOI 10.1111/j.1365-2028.2009.01112.x; Avila-Lovera E, 2016, EXP AGR, V52, P137, DOI 10.1017/S0014479714000593; Baptiste B, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0102; Bharathi S, 2017, J FORESTRY RES, V28, P357, DOI 10.1007/s11676-016-0328-9; Bieng MAN, 2013, BASIC APPL ECOL, V14, P329, DOI 10.1016/j.baae.2013.03.003; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Charbonnier F, 2013, AGR FOREST METEOROL, V181, P152, DOI 10.1016/j.agrformet.2013.07.010; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Deheuvels O, 2012, AGR ECOSYST ENVIRON, V149, P181, DOI 10.1016/j.agee.2011.03.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FEDECACAO, 2017, FED NAC CAC; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Gidoin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109405; Gidoin C, 2014, PHYTOPATHOLOGY, V104, P275, DOI 10.1094/PHYTO-07-13-0216-R; Harja D., 2008, SPATIALLY EXPLICIT I; ICCO (International Cocoa Organization), 2015, Q B COCOA STAT, VXL; Johns ND, 1999, ENVIRON MANAGE, V23, P31, DOI 10.1007/s002679900166; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Mariscal MJ, 2004, ECOSYSTEMS, V7, P454, DOI 10.1007/s10021-004-0137-4; Mbolo MMA, 2016, AGROFOREST SYST, V90, P577, DOI 10.1007/s10457-016-9945-8; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Oke DO, 2007, AGR ECOSYST ENVIRON, V122, P305, DOI 10.1016/j.agee.2007.01.022; Rangel JOC, 2011, PLANT BIOSYST, V145, P186, DOI 10.1080/11263504.2011.602727; Phillips-Mora W, 2007, PLANT PATHOL, V56, P911, DOI 10.1111/j.1365-3059.2007.01646.x; Quesada F., 2007, SHADEMOTION 3 0 SOFT; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Robledo, 2017, INFOSTAT VERSION; Rosalien EJ, 2017, ECOL ECON, V140, P136, DOI 10.1016/j.ecolecon.2017.04.019; Sambuichi RHR, 2012, BIODIVERS CONSERV, V21, P1055, DOI 10.1007/s10531-012-0240-3; Sanchez-Cuervo AM, 2013, ECOSYSTEMS, V16, P1052, DOI 10.1007/s10021-013-9667-y; Sierra D.C., 2016, CACAO COMO PRODUCTO; Somarriba E., 2013, Forests, Trees and Livelihoods, V22, P51, DOI 10.1080/14728028.2013.770316; Somarriba E, 2012, MAINSTREAMING AGRO F; Sonwa DJ, 2007, BIODIVERS CONSERV, V16, P2385, DOI 10.1007/s10531-007-9187-1; Sonwa DJ, 2017, AGROFOREST SYST, V91, P451, DOI 10.1007/s10457-016-9942-y; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Team RDC, 2016, R LANG ENV STAT COMP; Tomassone R, 1993, BIOMETRIE MODELISATI; Tondoh JE, 2015, GLOB ECOL CONSERV, V3, P575, DOI 10.1016/j.gecco.2015.02.007; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Zhang DS, 2014, FIELD CROP RES, V169, P132, DOI 10.1016/j.fcr.2014.09.001; Zuidema PA, 2005, AGR SYST, V84, P195, DOI 10.1016/j.agsy.2004.06.015	46	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191003	10.1371/journal.pone.0191003	http://dx.doi.org/10.1371/journal.pone.0191003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401499	gold, Green Published			2022-12-27	WOS:000424101400009
J	Hassani, A; Corboy, JR; Al-Salami, S; Khan, G				Hassani, Asma; Corboy, John R.; Al-Salami, Suhail; Khan, Gulfaraz			Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells	PLOS ONE			English	Article							HERPES-SIMPLEX VIRUS; MENINGEAL INFLAMMATION; EBV PERSISTENCE; INFECTED-CELLS; LATENT INFECTION; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; PATHOLOGY; DISEASE	Multiple sclerosis (MS) is a chronic neuroinflammatory condition of the central nervous system (CNS). It is a major cause of neurological disability in young adults, particularly women. What triggers the destruction of myelin sheaths covering nerve fibres is unknown. Both genetic and infectious agents have been implicated. Of the infectious agents, Epstein-Barr virus (EBV), a common herpesvirus, has the strongest epidemiological and serological evidence. However, the presence of EBV in the CNS and demonstration of the underlying mechanism(s) linking EBV to the pathogenesis of MS remain to be elucidated. We aimed at understanding the contribution of EBV infection in the pathology of MS. We examined 1055 specimens (440 DNA samples and 615 brain tissues) from 101 MS and 21 non-MS cases for the presence of EBV using PCR and EBER-in situ hybridization (EBER-ISH). EBV was detected by PCR and/or EBER-ISH in 91/101 (90%) of MS cases compared to only 5/21 (24%) of non-MS cases with other neuropathologies. None of the samples were PCR positive for other common herpesviruses (HSV-1, CMV, HHV-6). By quantitative PCR, EBV viral load in MS brain was mainly low to moderate in most cases. However, in 18/101 (18%) of MS cases, widespread but scattered presence of EBV infected cells was noted in the affected tissues by EBER-ISH. Immunohistochemical analysis of EBV gene expression in the 18 heavily infected cases, revealed that the EBV latent protein EBNA1, and to a lesser extent the early lytic protein BZLF1 were expressed. Furthermore, using double-staining we how for the first time that astrocytes and microglia, in addition to B-cells can also be infected. To the best of our knowledge, this is the most comprehensive study demonstrating that EBV is present and transcriptionally active in the brain of most cases of MS and supports a role for the virus in MS pathogenesis. Further studies are required to address the mechanism of EBV involvement in MS pathology.	[Hassani, Asma; Khan, Gulfaraz] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates; [Corboy, John R.] Univ Colorado, Rocky Mt MS Ctr, Sch Med, Dept Neurol, Aurora, CO USA; [Al-Salami, Suhail] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pathol, Tawam Hosp Campus, Al Ain, U Arab Emirates	United Arab Emirates University; University of Colorado System; University of Colorado Anschutz Medical Campus; United Arab Emirates University	Khan, G (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates.	g_khan@uaeu.ac.ae	Corboy, John/GVT-2436-2022; Khan, Gulfaraz/AAC-2859-2022	Khan, Gulfaraz/0000-0001-6836-1783; Al-Salam, Suhail/0000-0003-0109-5964; Hassani, Asma/0000-0001-7792-2140	UAE University [31R090, 31M263]	UAE University	The work in GK laboratory is supported by grants from UAE University (31R090, 31M263).	Ahmed W, 2015, J GEN VIROL, V96, P3646, DOI 10.1099/jgv.0.000313; Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; Al-Salam S, 2011, INT J PEDIATR OTORHI, V75, P1160, DOI 10.1016/j.ijporl.2011.06.012; Aloisi F, 2010, BRAIN, V133, DOI 10.1093/brain/awq223; Sousa ADA, 2016, ANN CLIN TRANSL NEUR, V3, P422, DOI 10.1002/acn3.310; Angelini DF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003220; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Bezold G, 2001, FERTIL STERIL, V76, P416, DOI 10.1016/S0015-0282(01)01920-3; Brooks JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005549; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; COATES PJ, 1991, J CLIN PATHOL, V44, P115, DOI 10.1136/jcp.44.2.115; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dobson Ruth, 2017, Neurol Neuroimmunol Neuroinflamm, V4, pe318, DOI 10.1212/NXI.0000000000000318; Dooley MM, 2016, J NEUROIMMUNOL, V299, P147, DOI 10.1016/j.jneuroim.2016.08.016; Dunham J, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.1; Fan H, 2001, Methods Mol Med, V49, P301, DOI 10.1385/1-59259-081-0:301; Fanaian NK, 2009, PEDIATR DEVEL PATHOL, V12, P195, DOI 10.2350/07-07-0316.1; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Gulley ML, 2008, J MOL DIAGN, V10, P279, DOI 10.2353/jmoldx.2008.080023; Hassani A, 2015, EXP MOL PATHOL, V99, P558, DOI 10.1016/j.yexmp.2015.09.013; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; HILTON DA, 1994, J NEUROL NEUROSUR PS, V57, P975, DOI 10.1136/jnnp.57.8.975; Hollsberg P, 2003, CLIN EXP IMMUNOL, V132, P137, DOI 10.1046/j.1365-2249.2003.02114.x; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Izawa K, 2017, J EXP MED, V214, P73, DOI 10.1084/jem.20160784; Jilek S, 2012, J IMMUNOL, V188, P4671, DOI 10.4049/jimmunol.1103100; Kalla M, 2012, EUR J CELL BIOL, V91, P65, DOI 10.1016/j.ejcb.2011.01.014; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; KESSLER HH, 1994, J CLIN MICROBIOL, V32, P1881, DOI 10.1128/JCM.32.8.1881-1886.1994; KHAN G, 1992, AM J PATHOL, V140, P757; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Khan G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0260-1; Khan G, 2011, EXP MOL PATHOL, V91, P466, DOI 10.1016/j.yexmp.2011.04.018; Khan Gulfaraz, 2009, V511, P311, DOI 10.1007/978-1-59745-447-6_13; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kooi EJ, 2009, J NEUROPATH EXP NEUR, V68, P1021, DOI 10.1097/NEN.0b013e3181b4bf8f; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Latham LB, 2016, ACTA NEUROL SCAND, V133, P17, DOI 10.1111/ane.12417; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LINDBERG C, 1991, NEUROEPIDEMIOLOGY, V10, P62, DOI 10.1159/000110248; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2013, J NEUROPATH EXP NEUR, V72, P29, DOI 10.1097/NEN.0b013e31827bfc62; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Miller E, 2012, ADV EXP MED BIOL, V724, P222, DOI 10.1007/978-1-4614-0653-2_17; Mostafa A, 2017, J MED VIROL, V89, P1309, DOI 10.1002/jmv.24774; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Opsahl ML, 2007, J NEUROL, V254, P425, DOI 10.1007/s00415-006-0316-7; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Pikor NB, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00657; Price AM, 2014, ADV VIRUS RES, V88, P279, DOI 10.1016/B978-0-12-800098-4.00006-4; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Sanders VJ, 1996, ARCH NEUROL-CHICAGO, V53, P125, DOI 10.1001/archneur.1996.00550020029012; Sanders VJ, 1996, J NEUROVIROL, V2, P249, DOI 10.3109/13550289609146888; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serafini B, 2013, BRAIN, V136, DOI 10.1093/brain/aws315; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thorley-Lawson DA, 2015, CURR TOP MICROBIOL, V390, P151, DOI 10.1007/978-3-319-22822-8_8; Torkildsen O, 2010, BRAIN PATHOL, V20, P720, DOI 10.1111/j.1750-3639.2009.00343.x; Tzartos JS, 2012, NEUROLOGY, V78, P15, DOI 10.1212/WNL.0b013e31823ed057; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Wilms T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184201	78	61	63	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192109	10.1371/journal.pone.0192109	http://dx.doi.org/10.1371/journal.pone.0192109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394264	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400026
J	Shang, HM; Zhou, HZ; Yang, JY; Li, R; Song, H; Wu, HX				Shang, Hong-Mei; Zhou, Hai-Zhu; Yang, Jun-Yan; Li, Ran; Song, Hui; Wu, Hong-Xin			In vitro and in vivo antioxidant activities of inulin	PLOS ONE			English	Article							LAYING PERFORMANCE; LIPID-METABOLISM; EGG QUALITY; POLYSACCHARIDE; MICROFLORA; FRUCTANS; SUPPLEMENTATION; CAPACITY; REDUCE	This study was designed to investigate the in vitro and in vivo antioxidant activities of inulin. The in vitro assays demonstrated that the antioxidant activities of inulin, including the DPPH radical scavenging activity, ABTS scavenging activity and ferric reducing power, were weak and significantly lower than those of Vitamin C (P < 0.05). The influence of dietary supplementation with inulin on the antioxidant status of laying hens was evaluated with in vivo antioxidant assays. The results indicated that inulin supplementation quadratically improved the egg production rate of the laying hens (P < 0.01). The antioxidant enzyme activities in the serum, including SOD, CAT, and GSH-Px, and the total antioxidant capacity increased quadratically as inulin levels increased (P < 0.001). The levels of MDA in the serum decreased quadratically as inulin levels increased (P < 0.001). These findings suggest that inulin has the potential to improve the antioxidant status of laying hens.	[Shang, Hong-Mei; Zhou, Hai-Zhu; Yang, Jun-Yan; Li, Ran] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Shang, Hong-Mei] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China; [Song, Hui] Jilin Agr Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Wu, Hong-Xin] Grassland Res Inst CAAS, Hohhot, Neimenggu, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Song, H (corresponding author), Jilin Agr Univ, Sch Life Sci, Changchun, Jilin, Peoples R China.	songhuinongda@163.com	Shang, Hongmei/HDL-7105-2022	Shang, Hongmei/0000-0002-0961-491X	National Natural Science Foundation of China [31601972]; China Postdoctoral Science Foundation [2017M621224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31601972 to HMS) and Project funded by China Postdoctoral Science Foundation (2017M621224 to HMS).; This work was supported by the National Natural Science Foundation of China (No. 31601972) and the Project funded by China Postdoctoral Science Foundation (No. 2017M621224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolinario AC, 2014, CARBOHYD POLYM, V101, P368, DOI 10.1016/j.carbpol.2013.09.081; Gargari BP, 2013, DIABETES METAB J, V37, P140, DOI 10.4093/dmj.2013.37.2.140; Giannenas I, 2010, RES VET SCI, V89, P78, DOI 10.1016/j.rvsc.2010.02.003; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; HE G, 2002, J ANIM SCI, V80, P81; Hu YX, 2014, INT J BIOL MACROMOL, V70, P44, DOI 10.1016/j.ijbiomac.2014.06.024; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Liu HN, 2014, POULTRY SCI, V93, P347, DOI 10.3382/ps.2013-03225; Liu J, 2015, INT J BIOL MACROMOL, V72, P1479, DOI 10.1016/j.ijbiomac.2014.09.066; Liu W, 2014, INT J BIOL MACROMOL, V65, P446, DOI 10.1016/j.ijbiomac.2014.01.062; Luo AX, 2011, MOLECULES, V16, P1579, DOI 10.3390/molecules16021579; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mudannayake DC, 2015, J FOOD SCI, V80, pC950, DOI 10.1111/1750-3841.12857; Mujahid A, 2007, POULTRY SCI, V86, P364, DOI 10.1093/ps/86.2.364; Munjal U, 2009, BRIT J NUTR, V102, P663, DOI 10.1017/S0007114509274770; Muriel P, 2008, J APPL TOXICOL, V28, P93, DOI 10.1002/jat.1310; Nabizadeh A, 2012, J ANIM FEED SCI, V21, P725, DOI 10.22358/jafs/66144/2012; National Reasearch Council, 1994, NUTR REQ POULTR, V9th; Pasqualetti V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098031; Petkova N., 2015, ACTA SCI NATURALIS, V1, P225, DOI DOI 10.1177/1934578X1701200207; Petrovsky N, 2015, VACCINE, V33, P5920, DOI 10.1016/j.vaccine.2015.09.030; Pool-Zobel B, 2002, BRIT J NUTR, V87, pS273, DOI 10.1079/BJN/2002548; Qi XL, 2011, ARCH ANIM NUTR, V65, P354, DOI 10.1080/1745039X.2011.617546; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roberfroid MB, 2002, BRIT J NUTR, V87, pS139, DOI 10.1079/BJN/2002529; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Shang HM, 2010, BRIT POULTRY SCI, V51, P791, DOI 10.1080/00071668.2010.531005; Shang HM, 2016, J SCI FOOD AGR, V96, P215, DOI 10.1002/jsfa.7084; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Shoaib M, 2016, CARBOHYD POLYM, V147, P444, DOI 10.1016/j.carbpol.2016.04.020; Tiengtam N, 2015, ANIM FEED SCI TECH, V207, P120, DOI 10.1016/j.anifeedsci.2015.05.008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassilev D, 2016, J RENEW MATER, V4, P24, DOI 10.7569/JRM.2015.634125; Wang J, 2011, CARBOHYD POLYM, V86, P1192, DOI 10.1016/j.carbpol.2011.06.014; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wu LC, 2006, FOOD CHEM, V95, P319, DOI 10.1016/j.foodchem.2005.01.002; Zhang Y, 2010, EUR FOOD RES TECHNOL, V231, P151, DOI 10.1007/s00217-010-1255-1; Zhao X, 2011, POULTRY SCI, V90, P1720, DOI 10.3382/ps.2010-01280; Zuo ZY, 2012, J APPL POULTRY RES, V21, P243, DOI 10.3382/japr.2011-00351	39	51	56	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192273	10.1371/journal.pone.0192273	http://dx.doi.org/10.1371/journal.pone.0192273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394273	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400031
J	Aibekova, L; Foley, B; Hortelano, G; Raees, M; Abdraimov, S; Toichuev, R; Ali, S				Aibekova, Lazzat; Foley, Brian; Hortelano, Gonzalo; Raees, Muhammad; Abdraimov, Sabit; Toichuev, Rakhmanbek; Ali, Syed			Molecular epidemiology of HIV-1 subtype A in former Soviet Union countries	PLOS ONE			English	Article							EASTERN-EUROPE; KAZAKSTAN; TYPE-1; PETERSBURG; UZBEKISTAN; OUTBREAK; VARIANT	While in other parts of the world it is on decline, incidence of HIV infection continues to rise in the former Soviet Union (FSU) countries. The present study was conducted to investigate the patterns and modes of HIV transmission in FSU countries. We performed phylogenetic analysis of publicly available 2705 HIV-1 subtype A pol sequences from thirteen FSU countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Russia, Ukraine and Uzbekistan. Our analysis showed that the clusters from FSU countries were intermixed, indicating a possible role of transmigration in HIV transmission. Injection drug use was found to be the most frequent mode of transmission, while the clusters from PWID and heterosexual transmission were intermixed, indicating bridging of HIV infection across populations. To control the expanding HIV epidemic in this region, harm reduction strategies should be focused on three modes of transmission, namely, cross-border migration, injection drug use and heterosexual.	[Aibekova, Lazzat; Hortelano, Gonzalo] Nazarbayev Univ, Sch Sci & Technol, Dept Biol Sci, Astana, Kazakhstan; [Foley, Brian] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Raees, Muhammad] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Div Pediat Cardiac Surg, Nashville, TN USA; [Abdraimov, Sabit] Ctr Dis Control & Prevent AIDS, Astana, Kazakhstan; [Toichuev, Rakhmanbek] Natl Acad Sci Kyrgyz Republ, Osh, Kyrgyzstan; [Ali, Syed] Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan	Nazarbayev University; United States Department of Energy (DOE); Los Alamos National Laboratory; Vanderbilt University; National Academy of Sciences of the Kyrgyz Republic (NAS KR); Nazarbayev University	Ali, S (corresponding author), Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan.	syed.ali@nu.edu.kz	Foley, Brian T/N-4527-2018	Foley, Brian T/0000-0002-1086-0296; Toichuev, R.M./0000-0002-5978-6058				Abidi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093415; Aldridge RW, 2016, LANCET INFECT DIS, V16, P962, DOI 10.1016/S1473-3099(16)00072-4; AVERT, 2016, HIV AIDS RUSS; Bobkov AF, 2004, AIDS RES HUM RETROV, V20, P1134, DOI 10.1089/aid.2004.20.1134; Bobkova M, 2013, AIDS REV, V15, P204; Carr JK, 2005, JAIDS-J ACQ IMM DEF, V39, P570; Choudinovskikh O, WP306; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Diez-Fuertes F, 2015, INFECT GENET EVOL, V33, P197, DOI 10.1016/j.meegid.2015.05.003; Dukhovlinova E, 2015, AIDS RES HUM RETROV, V31, P608, DOI [10.1089/AID.2014.0150, 10.1089/aid.2014.0150]; ECDPC, 2013, MON IMPL DUBL DECL P; El-Bassel N, 2011, AM J PUBLIC HEALTH, V101, P1075, DOI 10.2105/AJPH.2010.300085; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kurbanov F, 2003, AIDS RES HUM RETROV, V19, P731, DOI 10.1089/088922203769232520; Laga V, 2015, CURR HIV RES, V13, P219, DOI 10.2174/1570162X13666150407142834; Lapovok I. A., 2015, Voprosy Virusologii, V60, P29; Lie AL, 2012, EFFECTS INT EMIGRATI; PEPFAR, 2013, CENTR AS REG OP PLAN; Prague Process, 2013, OV MIGR PROF LIGHT; Registry-Migration, 2015, GBIF ORG SENCK CEDAM; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Saad MD, 2006, AIDS RES HUM RETROV, V22, P796, DOI 10.1089/aid.2006.22.796; Sharma S, 2015, J HEPATOL, V63, P515, DOI 10.1016/j.jhep.2015.04.026; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; UNAIDS, 2015, AIDS RESP PROGR REP; UNESCO, 2005, HIV AIDS CAUC REG SO; UNODC, 2003, GLOBAL ILL DRUG TREN	27	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191891	10.1371/journal.pone.0191891	http://dx.doi.org/10.1371/journal.pone.0191891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389951	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400041
J	Blamires, SJ; Nobbs, M; Martens, PJ; Tso, IM; Chuang, WT; Chang, CK; Sheu, HS				Blamires, Sean J.; Nobbs, Madeleine; Martens, Penny J.; Tso, I-Min; Chuang, Wei-Tsung; Chang, Chung-Kai; Sheu, Hwo-Shuenn			Multiscale mechanisms of nutritionally induced property variation in spider silks	PLOS ONE			English	Article							X-RAY-SCATTERING; SOLID-STATE NMR; DRAGLINE SILK; AMPULLATE SILK; THIN-FILMS; FIBERS; EVOLUTION; PROTEINS; PROLINE; GENES	Variability in spider major ampullate (MA) silk properties at different scales has proven difficult to determine and remains an obstacle to the development of synthetic fibers mimicking MA silk performance. A multitude of techniques may be used to measure multiscale aspects of silk properties. Here we fed five species of Araneoid spider solutions that either contained protein or were protein deprived and performed silk tensile tests, small and wide-angle Xray scattering (SAXS/WAXS), amino acid composition analyses, and silk gene expression analyses, to resolve persistent questions about how nutrient deprivation induces variations in MA silk mechanical properties across scales. Our analyses found that the properties of each spider's silk varied differently in response to variations in their protein intake. We found changes in the crystalline and non-crystalline nanostructures to play specific roles in inducing the property variations we found. Across treatment MaSp expression patterns differed in each of the five species. We found that in most species MaSp expression and amino acid composition variations did not conform with our predictions based on a traditional MaSp expression model. In general, changes to the silk's alanine and proline compositions influenced the alignment of the proteins within the silk's amorphous region, which influenced silk extensibility and toughness. Variations in structural alignment in the crystalline and non-crystalline regions influenced ultimate strength independent of genetic expression. Our study provides the deepest insights thus far into the mechanisms of how MA silk properties vary from gene expression to nanostructure formations to fiber mechanics. Such knowledge is imperative for promoting the production of synthetic silk fibers.	[Blamires, Sean J.; Nobbs, Madeleine] Univ New South Wales, Sch Biol Earth & Environm Sci D26, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Martens, Penny J.] Univ New South Wales, Grad Sch Biomed Engn, Samuels Bldg F25, Sydney, NSW, Australia; [Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chuang, Wei-Tsung; Chang, Chung-Kai; Sheu, Hwo-Shuenn] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	University of New South Wales Sydney; University of New South Wales Sydney; Tunghai University; National Synchrotron Radiation Research Center	Blamires, SJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci D26, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	s.blamires@unsw.edu.au	Blamires, Sean/F-4402-2016	Blamires, Sean/0000-0001-5953-3723; Martens, Penny/0000-0003-3098-1420	Australian Research Council [DE140101281]; UNSW Biological Earth and Environmental Sciences; Taiwan National Science Council [NSC-102-2311-B-029-001-MY3, NSC-102-2811-B-029-001]	Australian Research Council(Australian Research Council); UNSW Biological Earth and Environmental Sciences; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	Research was supported by an Australian Research Council (Discovery Early Career Researcher Award DE140101281) and UNSW Biological Earth and Environmental Sciences grant to S.J.B., and Taiwan National Science Council grants (NSC-102-2311-B-029-001-MY3 and NSC-102-2811-B-029-001) to I.M.T.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Alsop D, 2007, REG INTEGR COMP PHYS, V294, pR711 ; An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e; dos Santos-Pinto JRA, 2016, J PROTEOME RES, V15, P1179, DOI 10.1021/acs.jproteome.5b01056; Asakura T, 2013, PROG NUCL MAG RES SP, V69, P23, DOI 10.1016/j.pnmrs.2012.08.001; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; Balta-Calleja FJ, 1989, XRAY SCATTERING SYNT, V8; Benamu M, 2017, CHEMOSPHERE, V181, P241, DOI 10.1016/j.chemosphere.2017.04.079; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Blamires SJ, 2017, ANNU REV ENTOMOL, V62, P443, DOI 10.1146/annurev-ento-031616-035615; Blamires SJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081294; Blamires SJ, 2015, BIOMACROMOLECULES, V16, P1218, DOI 10.1021/acs.biomac.5b00006; Blamires SJ, 2013, BIOMACROMOLECULES, V14, P3484, DOI 10.1021/bm400803z; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Boutry C, 2013, J EXP BIOL, V216, P3606, DOI 10.1242/jeb.084236; Boutry C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022467; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; Breslauer DN, 2009, BIOMACROMOLECULES, V10, P49, DOI 10.1021/bm800752x; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Cetinkaya M, 2011, BIOPHYS J, V100, P1298, DOI 10.1016/j.bpj.2010.12.3712; Chaw RC, 2015, J PROTEOME RES, V14, P4223, DOI 10.1021/acs.jproteome.5b00353; Chung H, 2012, CURR OPIN BIOTECH, V23, P957, DOI 10.1016/j.copbio.2012.03.013; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y; Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397; Fallon A, 1987, APPL HPLC BIOCH; Fluidigm Corporation, 2017, REAL TIME PCR USERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Giesa T, 2016, BIOMACROMOLECULES, V17, P427, DOI 10.1021/acs.biomac.5b01246; Glisovic A, 2008, MACROMOLECULES, V41, P390, DOI 10.1021/ma070528p; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245; Guinier, 1963, XRAY DIFFRACTION CRY, DOI DOI 10.1002/bip.10163; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Holmes KC, 1966, USE XRAY DIFFRACTION; Hsia Y, 2011, METAL, CERAMIC AND POLYMERIC COMPOSITES FOR VARIOUS USES, P303; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jeffrey F, 2011, JOVE-J VIS EXP, V47, pe2382; Jeng US, 2010, J APPL CRYSTALLOGR, V43, P110, DOI 10.1107/S0021889809043271; Jenkins JE, 2013, BIOMACROMOLECULES, V14, P3472, DOI 10.1021/bm400791u; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Kim S, 2008, MACROMOLECULES, V41, P3401, DOI 10.1021/ma800584t; Koch MHJ, 2008, ANNU REP PROG CHEM C, V104, P35, DOI 10.1039/b703892p; Lane AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-846; Larracas C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091537; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Madurga R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14820; Morrison DF, 1983, APPL LINEAR STAT MET; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Podorov SG, 2006, J APPL CRYSTALLOGR, V39, P652, DOI 10.1107/S0021889806025696; QAIGEN, 2012, ONESTEP DT PCR HDB; Riekel C, 2001, NATURWISSENSCHAFTEN, V88, P67, DOI 10.1007/s001140000197; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/NCHEMBIO.1789, 10.1038/nchembio.1789]; Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V; Sampath S, 2012, SOFT MATTER, V8, P6713, DOI 10.1039/c2sm25373a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi XY, 2014, CHEM COMMUN, V50, P4856, DOI 10.1039/c4cc00971a; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081; Vollrath F, 2013, MRS BULL, V38, P73, DOI 10.1557/mrs.2012.314; Vollrath F, 2011, SOFT MATTER, V7, P9595, DOI 10.1039/c1sm05812f; WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0; WUTZ C, 1995, REV SCI INSTRUM, V66, P1303, DOI 10.1063/1.1145959; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	81	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192005	10.1371/journal.pone.0192005	http://dx.doi.org/10.1371/journal.pone.0192005			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390013	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400049
J	de Braganca, AC; Moreau, RLM; de Brito, T; Shimizu, MHM; Canale, D; de Jesus, DA; Silva, AMG; Gois, PH; Seguro, AC; Magaldi, AJ				de Braganca, Ana C.; Moreau, Regina L. M.; de Brito, Thales; Shimizu, Maria H. M.; Canale, Daniele; de Jesus, Denise A.; Silva, Ana M. G.; Gois, Pedro H.; Seguro, Antonio C.; Magaldi, Antonio J.			Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage	PLOS ONE			English	Correction													de Braganca, Ana Carolina/E-7892-2014; Shimizu, Maria/B-7887-2013; Canale, Daniele/E-8922-2014; Franca Gois, Pedro Henrique/F-3645-2014	Canale, Daniele/0000-0001-8609-683X; de Braganca, Ana Carolina/0000-0002-1398-2512; Franca Gois, Pedro Henrique/0000-0002-3520-3225				de Braganca AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179199	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192535	10.1371/journal.pone.0192535	http://dx.doi.org/10.1371/journal.pone.0192535			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390003	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400095
J	De Vriendt, P; Cornelis, E; Desmet, V; Vanbosseghem, R; Van de Velde, D				De Vriendt, Patricia; Cornelis, Elise; Desmet, Valerie; Vanbosseghem, Ruben; Van de Velde, Dominique			Quality in dementia care: A cross sectional study on the Bio-Psycho-Social competencies of health care professionals	PLOS ONE			English	Article							LONG-TERM-CARE; COMMUNITY OCCUPATIONAL-THERAPY; PERSON-CENTERED CARE; OF-LIFE; ALZHEIMERS-DISEASE; BIOPSYCHOSOCIAL MODEL; JOB STRAIN; PEOPLE; REHABILITATION; CAREGIVERS	Objective Professionals in dementia-care ought to be able to work within a Bio-Psycho-Social model. The objectives were to examine whether dementia-care is delivered in a Bio-Psycho-Social way, to explore the influencing factors and to evaluate the factorial validity of the 'Bio-Psycho- Social-Dementia-Care scale'. Design and setting 413 healthcare-professionals completed the 'Bio-Psycho-Social-Dementia-Care scale'. Differences between groups (settings, professions, years of experience) were calculated with a student's t-test and one-way ANOVA. The facture structure of the scale was evaluated using a confirmatory factor analysis. Results The factor-analysis confirmed the 5 subscale-structure (1) networking, (2) using the client's expertise, (3) assessment and reporting, (4) professional knowledge and skills and (5) using the environment. (No significant differences were found between professionals in residential care and community care for the subscales 'networking' and 'using the client's expertise'. Professionals in residential care score higher than community care for 'assessment and reporting' (p<0,05) and 'professional knowledge and skills' (p<0,01) but lower for 'using the environment' (p<0,001). The juniors score higher for 'professional knowledge' compared to seniors (p<0,01) and the seniors score better for 'professional experience' (p<0,01). The Cure and Care disciplines and the Therapy disciplines had higher values in 'assessment and reporting' compared to the Social Support disciplines (p<0,001 and p<0.001). The Therapy disciplines scored higher in 'using professional knowledge and skills' compared to the Social Support group (p 0.021) and the Cure and Care disciplines (p<0,001). The Social Support disciplines scored higher in 'using the environment' compared to the Therapy disciplines (p<0.001) and the Cure and care disciplines (p<0.001). Conclusion The Bio-Psycho-Social-Dementia-scale is a valid tool and offers opportunities not only to rate, but also to improve Bio- Psycho-Social functioning in dementia-care: increase interdisciplinary collaboration, facilitate assessment, combine the strengths of the different professions and install a heterogeneous team with regard to age and experience.	[De Vriendt, Patricia; Cornelis, Elise; Desmet, Valerie; Vanbosseghem, Ruben; Van de Velde, Dominique] Artevelde Univ Coll, Dept Occupat Therapy, Ghent, Belgium; [De Vriendt, Patricia; Cornelis, Elise; Desmet, Valerie; Vanbosseghem, Ruben; Van de Velde, Dominique] Artevelde Univ Coll, Dept Nursing, Res Grp Innovat Hlth Care, Ghent, Belgium; [De Vriendt, Patricia; Van de Velde, Dominique] Univ Ghent, Dept Rehabil Sci & Physiotherapy, Occupat Therapy Program, Fac Med & Hlth Sci, Ghent, Belgium; [De Vriendt, Patricia; Cornelis, Elise] Vrije Univ Brussel, Res Grp, Dept Gerontol & Frailty Ageing FRIA, Brussels, Belgium; [Cornelis, Elise] Univ Hosp Brussel, Brussels, Belgium	Artevelde University of Applied Sciences; Artevelde University of Applied Sciences; Ghent University; Vrije Universiteit Brussel	De Vriendt, P (corresponding author), Artevelde Univ Coll, Dept Occupat Therapy, Ghent, Belgium.; De Vriendt, P (corresponding author), Artevelde Univ Coll, Dept Nursing, Res Grp Innovat Hlth Care, Ghent, Belgium.; De Vriendt, P (corresponding author), Univ Ghent, Dept Rehabil Sci & Physiotherapy, Occupat Therapy Program, Fac Med & Hlth Sci, Ghent, Belgium.; De Vriendt, P (corresponding author), Vrije Univ Brussel, Res Grp, Dept Gerontol & Frailty Ageing FRIA, Brussels, Belgium.	Patricia.devriendt@arteveldehs.be		Van de Velde, Dominique/0000-0001-6982-1075; de vriendt, patricia/0000-0003-4861-7838	Artevelde University College Ghent	Artevelde University College Ghent	This project was funded by the Artevelde University College Ghent. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2017, INT J GERIATR PSYCH, V32, P68, DOI 10.1002/gps.4602; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Clissett P, 2013, INT J NURS STUD, V50, P1495, DOI 10.1016/j.ijnurstu.2013.03.001; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; De Vriendt P, 2015, INT PSYCHOGERIATR, V27, P1419, DOI 10.1017/S1041610215000563; den Ouden M, 2015, J AM MED DIR ASSOC, V16, P963, DOI 10.1016/j.jamda.2015.05.016; Doyle PJ, 2014, GERONTOLOGIST, V54, P952, DOI 10.1093/geront/gnt081; Edvardsson D, 2009, J NURS MANAGE, V17, P59, DOI 10.1111/j.1365-2834.2008.00891.x; Eijkelkamp A, 2017, HEALTHCARE PROFESSIO, P25; Elovainio M, 2015, EUR J PUBLIC HEALTH, V25, P103, DOI 10.1093/eurpub/cku115; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fiest KM, 2016, CAN J NEUROL SCI, V43, pS51, DOI 10.1017/cjn.2016.36; Gallagher-Thompson D, 2007, PSYCHOL AGING, V22, P37, DOI 10.1037/0882-7974.22.1.37; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Graff MJL, 2008, BMJ-BRIT MED J, V336, P134, DOI 10.1136/bmj.39408.481898.BE; Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005; Groen-van de Ven L, 2018, INT PSYCHOGERIATR, V30, P843, DOI 10.1017/S1041610216001381; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P401; Hirschman KB, 2005, GERONTOLOGIST, V45, P381, DOI 10.1093/geront/45.3.381; Imrie R, 2004, SOCIOL HEALTH ILL, V26, P287, DOI 10.1111/j.1467-9566.2004.00391.x; Isaia G, 2011, AGING CLIN EXP RES, V23, P463, DOI 10.3275/7412; Kamper SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h444; Kane M., 2013, DEMENTIA 2013 HIDDEN, P4; Lee HS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2920146; Li JX, 2014, INT J NURS STUD, V51, P1395, DOI 10.1016/j.ijnurstu.2014.04.003; Lin SY, 2015, GERONTOLOGIST, V55, P237, DOI 10.1093/geront/gnu122; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Low LF, 2013, AUSTRALAS J AGEING, V32, P91, DOI 10.1111/j.1741-6612.2012.00625.x; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Machiels M, 2017, INT J NURS STUD, V66, P37, DOI 10.1016/j.ijnurstu.2016.11.017; Mansbach WE, 2017, GERONTOLOGIST, V57, P461, DOI 10.1093/geront/gnv694; Miller LM, 2016, DEMENTIA-LONDON, V15, P1141, DOI 10.1177/1471301214555542; Miranda-Castillo C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-132; Mitoku Kazuko, 2014, Open Nurs J, V8, P17, DOI 10.2174/1874434620140512001; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Olde-Rikkert MGM, 2013, INT J NURS STUD, V50, P1180, DOI 10.1016/j.ijnurstu.2012.08.007; Ong K, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt189, 10.1186/alzrt158]; Oyebode JR, 2016, DEMENTIA; Palm R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-123; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Reamy AM, 2013, GERONTOLOGIST, V53, P293, DOI 10.1093/geront/gns078; Regier NG, 2017, GERONTOLOGIST, V57, P987, DOI 10.1093/geront/gnw133; Revolta C, 2016, INT PSYCHOGERIATR, V28, P1079, DOI 10.1017/S1041610215002379; Sanders T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-65; Smebye KL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-241; Spector A, 2016, INT PSYCHOGERIATR, V28, P1471, DOI 10.1017/S1041610216000338; Spector A, 2010, INT PSYCHOGERIATR, V22, P957, DOI 10.1017/S1041610210000840; Steeman E, 2007, AGING MENT HEALTH, V11, P119, DOI 10.1080/13607860600963364; Stewart-Archer LA, 2016, DEMENTIA-LONDON, V15, P1716, DOI 10.1177/1471301215576227; Tabachnick C., 2007, USING MULTIVARIATE S, V2007; Timmermans S, 2008, SOCIOL HEALTH ILL, V30, P659, DOI 10.1111/j.1467-9566.2008.01097.x; Timmons S, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0293-3; Van de Velde D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164018; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wade D, 2016, CLIN REHABIL, V30, P109, DOI 10.1177/0269215515601177; Wade D, 2011, CLIN REHABIL, V25, P387, DOI 10.1177/0269215511400282; Wade DT, 2004, BMJ-BRIT MED J, V329, P1398, DOI 10.1136/bmj.329.7479.1398; Wade DT, 2003, CLIN REHABIL, V17, P349, DOI 10.1191/0269215503cr619ed; Williams SJ, 2001, SOCIOL HEALTH ILL, V23, P135, DOI 10.1111/1467-9566.00245; Wong C, 2016, OTJR-OCCUP PART HEAL, V36, P34, DOI 10.1177/1539449215627278; World Health Organization, 2001, INT CLASS FUNCT DIS	64	2	2	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191440	10.1371/journal.pone.0191440	http://dx.doi.org/10.1371/journal.pone.0191440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389937	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400020
J	Mulye, M; Zapata, B; Gilk, SD				Mulye, Minal; Zapata, Brianne; Gilk, Stacey D.			Altering lipid droplet homeostasis affects Coxiella burnetii intracellular growth	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; DIFFERENTIATION-RELATED PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; SMALL-MOLECULE INHIBITORS; FOAM CELL-FORMATION; MYCOBACTERIUM-LEPRAE; Q-FEVER; CHLAMYDIA-TRACHOMATIS; SCHWANN-CELLS; HOST-CELLS	Coxiella burnetii is an obligate intracellular bacterial pathogen and a causative agent of culture-negative endocarditis. While C. burnetii initially infects alveolar macrophages, it has also been found in lipid droplet (LD)-containing foamy macrophages in the cardiac valves of endocarditis patients. In addition, transcriptional studies of C. burnetii-infected macrophages reported differential regulation of the LD coat protein-encoding gene perilipin 2 (plin-2). To further investigate the relationship between LDs and C. burnetii, we compared LD numbers using fluorescence microscopy in mock-infected and C. burnetii-infected alveolar macrophages. On average, C. burnetii-infected macrophages contained twice as many LDs as mock-infected macrophages. LD numbers increased as early as 24 hours post-infection, an effect reversed by blocking C. burnetii protein synthesis. The observed LD accumulation was dependent on the C. burnetii Type 4B Secretion System (T4BSS), a major virulence factor that manipulates host cellular processes by secreting bacterial effector proteins into the host cell cytoplasm. To determine the importance of LDs during C. burnetii infection, we manipulated LD homeostasis and assessed C. burnetii intracellular growth. Surprisingly, blocking LD formation with the pharmacological inhibitors triacsin C or T863, or knocking out acyl-CoA transferase-1 (acat-1) in alveolar macrophages, increased C. burnetii growth at least 2-fold. Conversely, preventing LD lipolysis by inhibiting adipose triglyceride lipase (ATGL) with atglistatin almost completely blocked bacterial growth, suggesting LD breakdown is essential for C. burnetii. Together these data suggest that maintenance of LD homeostasis, possibly via the C. burnetii T4BSS, is critical for bacterial growth.	[Mulye, Minal; Zapata, Brianne; Gilk, Stacey D.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zapata, Brianne] Calif State Univ Dominguez Hills, Dept Biol, Carson, CA 90747 USA; [Mulye, Minal] Marian Univ, Coll Osteopath Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; California State University System; California State University Dominguez Hills	Gilk, SD (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	sgilk@iu.edu		Gilk, Stacey/0000-0002-0835-057X	National Institutes of Health [AI21786, 5R25GM07592]; American Heart Association [16POST27250157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (AI21786; S.D.G.), American Heart Association (16POST27250157; M.M.) and National Institutes of Health (5R25GM07592; B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Santos T, 2014, J INFECT DIS, V210, P1951, DOI 10.1093/infdis/jiu299; Barisch C, 2017, BIOCHIMIE, V141, P54, DOI 10.1016/j.biochi.2017.06.001; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; BROUQUI P, 1994, AM J MED, V97, P451, DOI 10.1016/0002-9343(94)90325-5; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Charron AJ, 2002, J CELL SCI, V115, P3049; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cockrell DC, 2008, J MICROBIOL METH, V72, P321, DOI 10.1016/j.mimet.2007.12.015; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; DVORAK AM, 1983, J IMMUNOL, V131, P2965; Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; IZZO AA, 1993, CLIN EXP IMMUNOL, V94, P507, DOI 10.1111/j.1365-2249.1993.tb08226.x; Justis AV, 2016, CELLULAR MICROBIOLOG; KOSTER FT, 1985, J IMMUNOL, V135, P1067; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Long AP, 2012, TRAFFIC, V13, P705, DOI 10.1111/j.1600-0854.2012.01339.x; Mahapatra S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-244; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Martinez E, 2016, P NATL ACAD SCI USA, V113, pE3260, DOI 10.1073/pnas.1522811113; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12; Melo RCN, 2016, EXP CELL RES, V340, P193, DOI 10.1016/j.yexcr.2015.10.028; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Ogawa M, 2014, MICROBES INFECT, V16, P962, DOI 10.1016/j.micinf.2014.09.004; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Pulido-Mendez M., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P143; Rabhi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148640; Ren Q, 2003, ANN NY ACAD SCI, V990, P701, DOI 10.1111/j.1749-6632.2003.tb07447.x; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sandoz KM, 2014, ANTIMICROB AGENTS CH, V58, P3860, DOI 10.1128/AAC.02064-13; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; Soltysiak KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136699; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Toledo DAM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160433; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Vieira-de-Abreu A, 2011, AM J RESP CELL MOL, V44, P509, DOI 10.1165/rcmb.2010-0004OC; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; WELLER PF, 1991, AM J PATHOL, V138, P141; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	61	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192215	10.1371/journal.pone.0192215	http://dx.doi.org/10.1371/journal.pone.0192215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390006	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400076
J	Ramirez-Carvajal, L; Pauszek, SJ; Ahmed, Z; Farooq, U; Naeem, K; Shabman, RS; Stockwell, TB; Rodriguez, LL				Ramirez-Carvajal, Lisbeth; Pauszek, Steven J.; Ahmed, Zaheer; Farooq, Umer; Naeem, Khalid; Shabman, Reed S.; Stockwell, Timothy B.; Rodriguez, Luis L.			Genetic stability of foot-and-mouth disease virus during long-term infections in natural hosts	PLOS ONE			English	Article							BUFFALO SYNCERUS CAFFER; AFRICAN BUFFALO; PHYLOGENETIC ANALYSIS; RAPID DETECTION; SEROTYPE; CATTLE; PAKISTAN; FMDV; DATAMONKEY; SELECTION	Foot-and-mouth disease (FMD) is a severe infection caused by a picornavirus that affects livestock and wildlife. Persistence in ruminants is a well-documented feature of Foot-and-mouth disease virus (FMDV) pathogenesis and a major concern for disease control. Persistently infected animals harbor virus for extended periods, providing a unique opportunity to study within-host virus evolution. This study investigated the genetic dynamics of FMDV during persistent infections of naturally infected Asian buffalo. Using next-generation sequencing (NGS) we obtained 21 near complete FMDV genome sequences from 12 sub-clinically infected buffalo over a period of one year. Four animals yielded only one virus isolate and one yielded two isolates of different serotype suggesting a serial infection. Seven persistently infected animals yielded more than one virus of the same serotype showing a long-term intra-host viral genetic divergence at the consensus level of less than 2.5%. Quasi-species analysis showed few nucleotide variants and non-synonymous substitutions of progeny virus despite intra-host persistence of up to 152 days. Phylogenetic analyses of serotype Asia-1 VP1 sequences clustered all viruses from persistent animals with Group VII viruses circulating in Pakistan in 2011, but distinct from those circulating on 2008-2009. Furthermore, signature amino acid (aa) substitutions were found in the antigenically relevant VP1 of persistent viruses compared with viruses from 2008-2009. Intra-host purifying selective pressure was observed, with few codons in structural proteins undergoing positive selection. However, FMD persistent viruses did not show a clear pattern of antigenic selection. Our findings provide insight into the evolutionary dynamics of FMDV populations within naturally occurring subclinical and persistent infections that may have implications to vaccination strategies in the region.	[Ramirez-Carvajal, Lisbeth; Pauszek, Steven J.; Ahmed, Zaheer; Rodriguez, Luis L.] ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA; [Ramirez-Carvajal, Lisbeth; Ahmed, Zaheer] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA; [Ahmed, Zaheer] Anim Plant Hlth Inspect Serv, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY USA; [Farooq, Umer; Naeem, Khalid] Natl Agr Res Ctr, Anim Hlth Program, Islamabad, Pakistan; [Shabman, Reed S.; Stockwell, Timothy B.] J Craig Venter Inst, Rockville, MD USA; [Ramirez-Carvajal, Lisbeth] Univ Costa Rica, Serv Nacl Salud Anim, San Pedro Montes De Oca, San Jose, Costa Rica; [Ramirez-Carvajal, Lisbeth] Univ Costa Rica, Inst Hlth Res INISA, San Pedro Montes De Oca, San Jose, Costa Rica; [Stockwell, Timothy B.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; National Agricultural Research Council - Pakistan; J. Craig Venter Institute; Universidad Costa Rica; Universidad Costa Rica	Ramirez-Carvajal, L; Rodriguez, LL (corresponding author), ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA.; Ramirez-Carvajal, L (corresponding author), Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.; Ramirez-Carvajal, L (corresponding author), Univ Costa Rica, Serv Nacl Salud Anim, San Pedro Montes De Oca, San Jose, Costa Rica.; Ramirez-Carvajal, L (corresponding author), Univ Costa Rica, Inst Hlth Res INISA, San Pedro Montes De Oca, San Jose, Costa Rica.	lizramirez@gmail.com; luis.rodriguez@ars.usda.gov		Stockwell, Timothy/0000-0002-3595-4539; Ahmed, Zaheer/0000-0001-9622-7418	USDA-ARS; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-12-X-00060]; Plum Island Animal Disease Center Research Participation Program fellowship; ARS-USDA CRIS Project [1940-32000-061-00D]; US Department of State, BEP program [58-1940-7-161-F]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Plum Island Animal Disease Center Research Participation Program fellowship; ARS-USDA CRIS Project; US Department of State, BEP program	This research was funded in part by ARS-USDA CRIS Project 1940-32000-061-00D. Additional funding came from the US Department of State, BEP program, under agreement 58-1940-7-161-F to the NARC in Pakistan. Part of the work was also funded through an interagency agreement between USDA-ARS and the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-12-X-00060. ZA and LR were recipients of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). All opinions expressed in this paper are the authors' and do not necessarily reflect the policies and views of the USDA, DOE, ORAU/ORISE.; The authors thank Elias Torres-Arroyo, Lauro Velazquez, and Devendra Rai for technical assistance with data analysis. Also we thank Vinita Puri, for help with sample processing during NGS library preparation. This research was funded in part by ARS-USDA CRIS Project 1940-32000-061-00D. Additional funding came from the US Department of State, BEP program, under agreement 58-1940-7-161-F to the NARC in Pakistan. Part of the work was also funded through an interagency agreement between USDA-ARS and the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-12-X-00060. ZA and LRC were supported by the Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). All opinions expressed in this paper are the authors' and do not necessarily reflect the policies and views of the USDA, DOE, ORAU/ORISE. Sample collection was done by field NARC veterinarians in Pakistan Project following IACUC protocol: 209.04-15-R. Finally, we thank Costa Rica's National Center for High Technology for access to their supercomputer Kabre for data analysis.	Abdul-Hamid NF, 2011, VIRUS GENES, V43, P41, DOI 10.1007/s11262-011-0599-3; Abubakar Muhammad, 2012, Virologica Sinica, V27, P320, DOI 10.1007/s12250-012-3271-8; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; AFZAL H, 1965, B OFF INT EPIZOOT, V65, P101; Ahmed Z, 2017, TRANSBOUND EMERG DIS; ANSELL DM, 1994, EPIDEMIOL INFECT, V112, P213, DOI 10.1017/S0950268800057587; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Bari FD, 2014, VACCINE, V32, P5794, DOI 10.1016/j.vaccine.2014.08.033; Brito BP, 2013, TRANSBOUND EMERG DIS, V60, P516, DOI 10.1111/j.1865-1682.2012.01366.x; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cedillo-Barron L, 2003, VACCINE, V21, P4261, DOI 10.1016/S0264-410X(03)00453-5; Cooke JN, 2008, INFECT GENET EVOL, V8, P855, DOI 10.1016/j.meegid.2008.08.004; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; DAWE PS, 1994, VET REC, V134, P230, DOI 10.1136/vr.134.10.230; DAWE PS, 1994, VET REC, V134, P211, DOI 10.1136/vr.134.9.211; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; DUTTA PK, 1983, VET REC, V113, P134, DOI 10.1136/vr.113.6.134; Eschbaumer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162750; Farooq U, 2016, ASIAN BIOMED, V10, P123, DOI 10.5372/1905-7415.1002.472; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Freimanis GL, 2016, REV SCI TECH OIE, V35, P175, DOI 10.20506/rst.35.1.2426; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haydon DT, 2001, GENETICS, V157, P7; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamal SM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-116; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Jamal SM, 2011, J GEN VIROL, V92, P2849, DOI 10.1099/vir.0.035626-0; Jamal SM, 2010, ARCH VIROL, V155, P1487, DOI 10.1007/s00705-010-0732-y; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kanwal S., 2014, PAK BR J VIROL, V1, P21; Knight-Jones TJD, 2014, VACCINE, V32, P1848, DOI 10.1016/j.vaccine.2014.01.071; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Logan G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-828; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Mohapatra JK, 2008, VIRUS RES, V136, P16, DOI 10.1016/j.virusres.2008.04.010; Morelli MJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-12; Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Parthiban ABR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128815; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9_8; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; Samuel Karlin, 1986, EVOLUTIONARY PROCESS; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Stenfeldt C, 2013, VET MICROBIOL, V162, P330, DOI 10.1016/j.vetmic.2012.09.008; Subramaniam S, 2013, VET MICROBIOL, V167, P280, DOI 10.1016/j.vetmic.2013.08.023; Ullah A, 2016, TRANSBOUND EMERG DIS; Valarcher JF, 2009, EMERG INFECT DIS, V15, P1046, DOI 10.3201/eid1507.081621; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	61	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190977	10.1371/journal.pone.0190977	http://dx.doi.org/10.1371/journal.pone.0190977			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390015	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400011
J	Nicolella, DP; Torres-Ronda, L; Saylor, KJ; Schelling, X				Nicolella, Daniel P.; Torres-Ronda, Lorena; Saylor, Kase J.; Schelling, Xavi			Validity and reliability of an accelerometer-based player tracking device	PLOS ONE			English	Article							TRUNK-MOUNTED ACCELEROMETER; SPORTS; ACCELERATION	This study aimed to determine the intra-and inter-device accuracy and reliability of wearable athletic tracking devices, under controlled laboratory conditions. A total of nineteen portable accelerometers (Catapult OptimEye S5) were mounted to an aluminum bracket, bolted directly to an Unholtz Dickie 20K electrodynamic shaker table, and subjected to a series of oscillations in each of three orthogonal directions (front-back, side to side, and up-down), at four levels of peak acceleration (0.1g, 0.5g, 1.0g, and 3.0g), each repeated five times resulting in a total of 60 tests per unit, for a total of 1140 records. Data from each accelerometer was recorded at a sampling frequency of 100Hz. Peak accelerations recorded by the devices, Catapult PlayerLoad (TM), and calculated player load (using Catapult's Cartesian formula) were used for the analysis. The devices demonstrated excellent intradevice reliability and mixed interdevice reliability. Differences were found between devices for mean peak accelerations and PlayerLoad (TM) for each direction and level of acceleration. Interdevice effect sizes ranged from a mean of 0.54 (95% CI: 0.34-0.74) (small) to 1.20 (95% CI: 1.08-1.30) (large) and ICCs ranged from 0.77 (95% CI: 0.62-0.89) (very large) to 1.0 (95% CI: 0.99-1.0) (nearly perfect) depending upon the magnitude and direction of the applied motion. When compared to the player load determined using the Cartesian formula, the Catapult reported PlayerLoad (TM) was consistently lower by approximately 15%. These results emphasize the need for industry wide standards in reporting validity, reliability and the magnitude of measurement errors. It is recommended that device reliability and accuracy are periodically quantified.	[Nicolella, Daniel P.; Saylor, Kase J.] Southwest Res Inst, San Antonio, TX 78238 USA; [Torres-Ronda, Lorena; Schelling, Xavi] Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, Melbourne, Vic, Australia	Southwest Research Institute; Victoria University	Nicolella, DP (corresponding author), Southwest Res Inst, San Antonio, TX 78238 USA.	dnicolella@swri.org						Alexander JP, 2016, J STRENGTH COND RES, V30, P3007, DOI 10.1519/JSC.0000000000001396; Barrett S, 2014, INT J SPORT PHYSIOL, V9, P945, DOI 10.1123/ijspp.2013-0418; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P1, DOI 10.1123/IJSPP.2017-0219; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Chambers R, 2015, SPORTS MED, V45, P1065, DOI 10.1007/s40279-015-0332-9; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Dalen T, 2016, J STRENGTH COND RES, V30, P351, DOI 10.1519/JSC.0000000000001063; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Holme BR, 2015, WEARABLE MICROSENSOR, V2015; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jennings Denise, 2010, Int J Sports Physiol Perform, V5, P328; Johnston RJ, 2012, J STRENGTH COND RES, V26, P758, DOI 10.1519/JSC.0b013e318225f161; Kelly SJ, 2015, INT J SPORT PHYSIOL, V10, P106, DOI 10.1123/ijspp.2013-0408; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; Roe G, 2016, INT J PERF ANAL SPOR, V16, P590, DOI 10.1080/24748668.2016.11868911; Varley MC, 2017, INT J SPORT PHYSIOL, V12, P1059, DOI 10.1123/ijspp.2016-0534; Wundersitz DWT, 2015, INT J SPORTS MED, V36, P742, DOI 10.1055/s-0035-1547265; Wundersitz DWT, 2015, J BIOMECH, V48, P3975, DOI 10.1016/j.jbiomech.2015.09.015; Wundersitz DWT, 2015, EUR J SPORT SCI, V15, P382, DOI 10.1080/17461391.2014.955131	19	80	80	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191823	10.1371/journal.pone.0191823	http://dx.doi.org/10.1371/journal.pone.0191823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420555	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000424517900025
J	Uluseker, C; Simoni, G; Marchetti, L; Dauriz, M; Matone, A; Priami, C				Uluseker, Cansu; Simoni, Giulia; Marchetti, Luca; Dauriz, Marco; Matone, Alice; Priami, Corrado			A closed-loop multi-level model of glucose homeostasis	PLOS ONE			English	Article							MATHEMATICAL-MODEL; BODY-WEIGHT; INSULIN-RESISTANCE; LEPTIN SECRETION; FOOD-INTAKE; GHRELIN; SYSTEM; ENERGY; TRANSPORT; GLUCAGON	Background The pathophysiologic processes underlying the regulation of glucose homeostasis are considerably complex at both cellular and systemic level. A comprehensive and structured specification for the several layers of abstraction of glucose metabolism is often elusive, an issue currently solvable with the hierarchical description provided by multi-level models. In this study we propose a multi-level closed-loop model of whole-body glucose homeostasis, coupled with the molecular specifications of the insulin signaling cascade in adipocytes, under the experimental conditions of normal glucose regulation and type 2 diabetes. Methodology/Principal findings The ordinary differential equations of the model, describing the dynamics of glucose and key regulatory hormones and their reciprocal interactions among gut, liver, muscle and adipose tissue, were designed for being embedded in a modular, hierarchical structure. The closed-loop model structure allowed self-sustained simulations to represent an ideal in silico subject that adjusts its own metabolism to the fasting and feeding states, depending on the hormonal context and invariant to circadian fluctuations. The cellular level of the model provided a seamless dynamic description of the molecular mechanisms downstream the insulin receptor in the adipocytes by accounting for variations in the surrounding metabolic context. Conclusions/Significance The combination of a multi-level and closed-loop modeling approach provided a fair dynamic description of the core determinants of glucose homeostasis at both cellular and systemic scales. This model architecture is intrinsically open to incorporate supplementary layers of specifications describing further individual components influencing glucose metabolism.	[Uluseker, Cansu; Simoni, Giulia; Marchetti, Luca; Matone, Alice; Priami, Corrado] Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, TN, Italy; [Dauriz, Marco] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Verona, Italy; [Priami, Corrado] Univ Pisa, Dept Comp Sci, Pisa, Italy	University of Trento; University of Verona; University of Pisa	Priami, C (corresponding author), Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, TN, Italy.; Priami, C (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	priami@cosbi.eu	Dauriz, Marco/S-5843-2016	Dauriz, Marco/0000-0002-5542-5941; Uluseker, Cansu/0000-0001-9828-0458; Matone, Alice/0000-0003-4530-908X; Marchetti, Luca/0000-0001-9043-7705	Provincia Autonoma di Trento [2015-AG12-01091]	Provincia Autonoma di Trento(Autonomous Province of Trento)	This work was supported by Grant number 2015-AG12-01091 from Provincia Autonoma di Trento. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barazzoni R, 2014, DIABETES, V63, P2213, DOI 10.2337/db14-0407; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brubaker PL, 2007, ANN BIOMED ENG, V35, P1286, DOI 10.1007/s10439-007-9274-1; Castiglione F, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2854; Caumo A, 2000, J CLIN ENDOCR METAB, V85, P4396, DOI 10.1210/jc.85.11.4396; CELESTE R, 1978, B MATH BIOL, V40, P59, DOI 10.1016/S0092-8240(78)80030-5; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Dalla Man C, 2005, AM J PHYSIOL-ENDOC M, V289, pE909, DOI 10.1152/ajpendo.00299.2004; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; De Gaetano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1462, DOI 10.1152/ajpendo.90444.2008; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gallenberger M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-46; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Golden PL, 1997, J CLIN INVEST, V99, P14, DOI 10.1172/JCI119125; Gostner R, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2633461; Grasman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074997; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Gruetter R, 1998, J NEUROCHEM, V70, P397; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; International Diabetes Federation, 2006, DIABETES ATLAS; Jacquier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100073; Jequier E, 1999, PHYSIOL REV, V79, P451, DOI 10.1152/physrev.1999.79.2.451; Kang H, 2012, ISLETS, V4, P84, DOI 10.4161/isl.19505; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Levy JR, 2000, AM J PHYSIOL-ENDOC M, V278, pE892, DOI 10.1152/ajpendo.2000.278.5.E892; Lodish H., 2007, MOL CELL BIOL; Lozada S, 2010, GLUCOSE REGULATION D; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marchetti L., 2017, SIMULATION ALGORITHM; Marchetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36029; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Nussey S, 2001, ENDOCRINOLOGY INTEGR, V2, P23; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Palumbo P, 2013, MATH BIOSCI, V244, P69, DOI 10.1016/j.mbs.2013.05.006; Pattaranit R, 2008, J R SOC INTERFACE, V5, P1119, DOI 10.1098/rsif.2008.0216; Poretsky L, 2010, PRINCIPLES DIABETES, P1; PORTE D, 1981, DIABETOLOGIA, V20, P274, DOI 10.1007/BF00254493; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; Sakata Ichiro, 2010, Int J Pept, V2010, DOI 10.1155/2010/945056; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; Sulston K.W., 2006, ATLANTIC, V1, P31; Taborsky Gerald J Jr, 2010, J Diabetes Sci Technol, V4, P1338; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Toghaw P, 2013, INT J MATH COMPUT SI, V7, P439; Toghaw P, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-16; Topp B, 2000, J THEOR BIOL, V206, P605, DOI 10.1006/jtbi.2000.2150; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037	62	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0190627	10.1371/journal.pone.0190627	http://dx.doi.org/10.1371/journal.pone.0190627			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420588	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900006
J	Ando, K; Rynearson, S; Muleta, KT; Gedamu, J; Girma, B; Bosque-Perez, NA; Chen, MS; Pumphrey, MO				Ando, Kaori; Rynearson, Sheri; Muleta, Kebede T.; Gedamu, Jhonatan; Girma, Bedada; Bosque-Perez, Nilsa A.; Chen, Ming-Shun; Pumphrey, Mike O.			Genome-wide associations for multiple pest resistances in a Northwestern United States elite spring wheat panel	PLOS ONE			English	Article							STRIPE-RUST RESISTANCE; F-SP TRITICI; QUANTITATIVE TRAIT LOCI; TEMPERATURE ADULT-PLANT; HESSIAN FLY RESISTANCE; SEPTORIA-TRITICI; GENETIC ARCHITECTURE; MYCOSPHAERELLA-GRAMINICOLA; HEXAPLOID WHEAT; COMPLEX TRAITS	Northern areas of the western United States are one of the most productive wheat growing regions in the United States. Increasing productivity through breeding is hindered by several biotic stresses which slow and constrain targeted yield improvement. In order to understand genetic variation for stripe rust (Puccinia striiformis f. sp. tritici), Septoria tritici blotch (Myco-sphaerella graminicola), and Hessian fly (Mayetiola destructor) in regional germplasm, a panel of 408 elite spring wheat lines was characterized and genotyped with an Illumina 9K wheat single nucleotide polymorphism (SNP) chip to enable genome-wide association study (GWAS) analyses. Significant marker-trait associations were identified for stripe rust (38 loci), Septoria tritici blotch (8) and Hessian fly (9) resistance. Many of the QTL corresponded with previously reported gene locations or QTL, but we also discovered new resistance loci for each trait. We validated one of the stripe rust resistance loci detected by GWAS in a bi-parental mapping population, which confirmed the detection of Yr15 in the panel. This study elucidated well-defined chromosome regions for multiple pest resistances in elite Northwest germplasm. Newly identified resistance loci, along with SNPs more tightly linked to previously reported genes or QTL will help future breeding and marker assisted selection efforts.	[Ando, Kaori; Rynearson, Sheri; Muleta, Kebede T.; Pumphrey, Mike O.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Gedamu, Jhonatan] Holeta Agr Res Ctr, Ethiopian Inst Agr Res, Holeta, Ethiopia; [Girma, Bedada] Kulumsa Agr Res Ctr, Ethiopian Inst Agr Res, Assela, Ethiopia; [Bosque-Perez, Nilsa A.] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Ando, Kaori] USDA ARS, Crop Improvement & Protect Res Unit, Salinas, CA USA; [Muleta, Kebede T.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA	Washington State University; Ethiopian Institute of Agricultural Research (EIAR); Ethiopian Institute of Agricultural Research (EIAR); Idaho; University of Idaho; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; United States Department of Agriculture (USDA); Kansas State University	Pumphrey, MO (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	m.pumphrey@wsu.edu	Pumphrey, Michael/V-8830-2019; Muleta, Kebede/K-4978-2019	Muleta, Kebede/0000-0001-5403-5098; Pumphrey, Michael/0000-0001-7524-9634; Ando, Kaori/0000-0003-3658-7598	Bill & Melinda Gates Foundation; USDA, Agriculture and Food Research Initiative [2011-68002-30029, 2017-67007-25939]; Washington Wheat Commission; Idaho Wheat Commission	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); USDA, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); Washington Wheat Commission; Idaho Wheat Commission	W This project was supported in part by funds provided by the Bill & Melinda Gates Foundation, by the USDA, Agriculture and Food Research Initiative 2011-68002-30029 (Triticeae Coordinated Agricultural Project) and 2017-67007-25939, and by the Washington Wheat Commission and the Idaho Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari TB, 2003, PHYTOPATHOLOGY, V93, P1158, DOI 10.1094/PHYTO.2003.93.9.1158; AMRI A, 1990, J HERED, V81, P71, DOI 10.1093/oxfordjournals.jhered.a110929; Arraiano LS, 2007, PLANT PATHOL, V56, P73, DOI 10.1111/j.1365-3059.2006.01499.x; Arraiano LS, 2006, PLANT PATHOL, V55, P726, DOI 10.1111/j.1365-3059.2006.01444.x; Bajgain P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0628-9; Bansal UK, 2014, MOL BREEDING, V33, P51, DOI 10.1007/s11032-013-9933-x; Bernardo R, 2016, CROP SCI, V56, P1067, DOI 10.2135/cropsci2015.09.0586; Besnier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070651; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown JKM, 2015, FUNGAL GENET BIOL, V79, P33, DOI 10.1016/j.fgb.2015.04.017; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Bulli P, 2016, G3-GENES GENOM GENET, V6, P2237, DOI 10.1534/g3.116.028407; Cainong JC, 2010, CROP SCI, V50, P920, DOI 10.2135/cropsci2009.06.0310; CAMACHOCASAS MA, 1995, CROP SCI, V35, P971, DOI 10.2135/cropsci1995.0011183X003500040006x; Cambron SE, 2010, J ECON ENTOMOL, V103, P2229, DOI 10.1603/EC10219; Carter AH, 2014, CROP SCI, V54, P971, DOI 10.2135/cropsci2012.11.0636; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen J, 2009, J PLANT REGIST, V3, P264, DOI 10.3198/jpr2008.12.0690crc; Chen JL, 2012, MOL BREEDING, V29, P791, DOI 10.1007/s11032-011-9590-x; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Cheng P, 2014, THEOR APPL GENET, V127, P2267, DOI 10.1007/s00122-014-2378-8; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Cowling S.G., 2006, THESIS; Dadkhodaie NA, 2011, THEOR APPL GENET, V122, P479, DOI 10.1007/s00122-010-1462-y; Del Conte SCC, 2005, J ECON ENTOMOL, V98, P805, DOI 10.1603/0022-0493-98.3.805; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EYAL Z, 1987, EUPHYTICA, V36, P237, DOI 10.1007/BF00730670; FRIEBE B, 1990, THEOR APPL GENET, V79, P385, DOI 10.1007/BF01186083; Gao N, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0278-9; Goodwin SB, 2012, CABI PLANT PROT SER, P151, DOI 10.1079/9781845938185.0151; Guo Q, 2008, PHYTOPATHOLOGY, V98, P803, DOI 10.1094/PHYTO-98-7-0803; Hayes LE, 2016, PLANT DIS, V100, P483, DOI 10.1094/PDIS-02-15-0214-RE; Ishikawa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111337; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Li CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/830618; Li CL, 2013, THEOR APPL GENET, V126, P2065, DOI 10.1007/s00122-013-2118-5; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li XP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00833; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line R.F., 1991, USDA TECHNICAL B, V1788; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lopes MS, 2015, THEOR APPL GENET, V128, P453, DOI 10.1007/s00122-014-2444-2; Lopez CG, 2003, CROP SCI, V43, P577, DOI 10.2135/cropsci2003.0577; Lovell DJ, 1997, PLANT PATHOL, V46, P126, DOI 10.1046/j.1365-3059.1997.d01-206.x; Luo PG, 2008, GENOME, V51, P922, DOI 10.1139/G08-079; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Marais GF, 2005, EUPHYTICA, V143, P115, DOI 10.1007/s10681-005-2911-6; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Naruoka Y, 2016, CROP SCI, V56, P3055, DOI 10.2135/cropsci2016.03.0189; Peng JH, 1999, THEOR APPL GENET, V98, P862, DOI 10.1007/s001220051145; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pike K, 1993, PNW CONSERVATION TIL; Ponomarenko A., 2011, SEPTORIA TRITICI BLO; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Randhawa MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0270-0; Ratcliffe RH, 2000, J ECON ENTOMOL, V93, P1319, DOI 10.1603/0022-0493-93.4.1319; Rife TW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1404-9; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; SAARI EE, 1975, PLANT DIS REP, V59, P377; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Schotzko DJ, 2002, J AGR URBAN ENTOMOL, V19, P95; Sebesta EE, 1997, CROP SCI, V37, P635, DOI 10.2135/cropsci1997.0011183X003700020065x; Sharma RC, 2007, CROP SCI, V47, P961, DOI 10.2135/cropsci2006.03.0201; TAVELLA CM, 1978, EUPHYTICA, V27, P577, DOI 10.1007/BF00043184; Teferi TA, 2015, CROP PROT, V68, P67, DOI 10.1016/j.cropro.2014.10.020; Van Oojien J. W., 2006, JOINMAP 4 SOFTWARE C; VANBEUNINGEN LT, 1990, PLANT DIS, V74, P488, DOI 10.1094/PD-74-0488; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wan AM, 2016, PLANT DIS, V100, P966, DOI 10.1094/PDIS-10-15-1122-RE; Wang MN, 2012, J PLANT REGIST, V6, P104, DOI 10.3198/jpr2011.05.0261crg; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; Xu LS, 2013, THEOR APPL GENET, V126, P523, DOI 10.1007/s00122-012-1998-0; Zegeye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105593; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259	79	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191305	10.1371/journal.pone.0191305	http://dx.doi.org/10.1371/journal.pone.0191305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415008	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300023
J	Carranza, S; Xipell, M; Tarroso, P; Gardner, A; Arnold, EN; Robinson, MD; Simo-Riudalbas, M; Vasconcelos, R; de Pous, P; Amat, F; Smid, J; Sindaco, R; Metallinou, M; Els, J; Pleguezuelos, JM; Machado, L; Donaire, D; Martinez, G; Garcia-Porta, J; Mazuch, T; Wilms, T; Gebhart, J; Aznar, J; Gallego, J; Zwanzig, BM; Fernandez-Guiberteau, D; Papenfuss, T; Al Saadi, S; Alghafri, A; Khalifa, S; Al Farqani, H; Bilal, SB; Alazri, IS; Al Adhoobi, AS; Al Omairi, ZS; Al Shariani, M; Al Kiyumi, A; Al Sariri, T; Al Shukaili, AS; Al Akhzami, SN				Carranza, Salvador; Xipell, Meritxell; Tarroso, Pedro; Gardner, Andrew; Arnold, Edwin Nicholas; Robinson, Michael D.; Simo-Riudalbas, Marc; Vasconcelos, Raquel; de Pous, Philip; Amat, Felix; Smid, Jiri; Sindaco, Roberto; Metallinou, Margarita; Els, Johannes; Manuel Pleguezuelos, Juan; Machado, Luis; Donaire, David; Martinez, Gabriel; Garcia-Porta, Joan; Mazuch, Tomas; Wilms, Thomas; Gebhart, Juergen; Aznar, Javier; Gallego, Javier; Zwanzig, Bernd-Michael; Fernandez-Guiberteau, Daniel; Papenfuss, Theodore; Al Saadi, Saleh; Alghafri, Ali; Khalifa, Sultan; Al Farqani, Hamed; Bilal, Salim Bait; Alazri, Iman Sulaiman; Al Adhoobi, Aziza Saud; Al Omairi, Zeyana Salim; Al Shariani, Mohammed; Al Kiyumi, Ali; Al Sariri, Thuraya; Al Shukaili, Ahmed Said; Al Akhzami, Suleiman Nasser			Diversity, distribution and conservation of the terrestrial reptiles of Oman (Sauropsida, Squamata)	PLOS ONE			English	Article							SULTANATE-OF-OMAN; PRISTURUS-RUPESTRIS; NORTH-AFRICA; BIOGEOGRAPHY; GEKKONIDAE; TAXONOMY; SYSTEMATICS; LIZARDS; ARABIA; BIODIVERSITY	In the present work, we use an exceptional database including 5,359 records of 101 species of Oman's terrestrial reptiles together with spatial tools to infer the spatial patterns of species richness and endemicity, to infer the habitat preference of each species and to better define conservation priorities, with especial focus on the effectiveness of the protected areas in preserving this unique arid fauna. Our results indicate that the sampling effort is not only remarkable from a taxonomic point of view, with multiple observations for most species, but also for the spatial coverage achieved. The observations are distributed almost continuously across the two-dimensional climatic space of Oman defined by the mean annual temperature and the total annual precipitation and across the Principal Component Analysis (PCA) of the multivariate climatic space and are well represented within 17 out of the 20 climatic clusters grouping 10% of the explained climatic variance defined by PC1 and PC2. Species richness is highest in the Hajar and Dhofar Mountains, two of the most biodiverse areas of the Arabian Peninsula, and endemic species richness is greatest in the Jebel Akhdar, the highest part of the Hajar Mountains. Oman's 22 protected areas cover only 3.91% of the country, including within their limits 63.37% of terrestrial reptiles and 50% of all endemics. Our analyses show that large areas of the climatic space of Oman lie outside protected areas and that seven of the 20 climatic clusters are not protected at all. The results of the gap analysis indicate that most of the species are below the conservation target of 17% or even the less restrictive 12% of their total area within a protected area in order to be considered adequately protected. Therefore, an evaluation of the coverage of the current network of protected areas and the identification of priority protected areas for reptiles using reserve design algorithms are urgently needed. Our study also shows that more than half of the species are still pending of a definitive evaluation by the International Union for Conservation of Nature (IUCN).	[Carranza, Salvador; Xipell, Meritxell; Tarroso, Pedro; Simo-Riudalbas, Marc; Vasconcelos, Raquel; de Pous, Philip; Metallinou, Margarita; Machado, Luis; Garcia-Porta, Joan] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim de la Barceloneta, Barcelona, Spain; [Tarroso, Pedro; Vasconcelos, Raquel; Machado, Luis] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBio Lab Associado, CIBIO, Vairao, Portugal; [Gardner, Andrew] Univ Western Australia, Sch Mol Sci, Crawley, WA, Australia; [Arnold, Edwin Nicholas] Nat Hist Museum, Dept Zool, London, England; [Robinson, Michael D.] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khod Muscat, Oman; [Amat, Felix] Museu Granollers Ciencies Nat, Area Herpetol, Palaudaries, Granollers, Spain; [Smid, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic; [Sindaco, Roberto] Museo Civ Storia Nat, Carmagnola, TO, Italy; [Els, Johannes] Environm & Protected Areas Author, Breeding Ctr Endangered Arabian Wildlife, Sharjah, U Arab Emirates; [Manuel Pleguezuelos, Juan] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Machado, Luis] Univ Porto, Fac Ciencias, Dept Biol, Oporto, Portugal; [Donaire, David] Asociac Herpetol Fretum Gaditanum, Mar Egeo, Jerez De La Fra, Spain; [Wilms, Thomas] Allwetterzoo Munster, Munster, Germany; [Fernandez-Guiberteau, Daniel] Escola Nat Parets, C Galende, Parets Del Vall, Spain; [Papenfuss, Theodore] Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA; [Al Saadi, Saleh; Alghafri, Ali; Khalifa, Sultan; Al Farqani, Hamed; Bilal, Salim Bait; Alazri, Iman Sulaiman; Al Adhoobi, Aziza Saud; Al Omairi, Zeyana Salim; Al Shariani, Mohammed; Al Kiyumi, Ali; Al Sariri, Thuraya; Al Shukaili, Ahmed Said; Al Akhzami, Suleiman Nasser] Minist Environm & Climate Affairs, Muscat, Oman	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade do Porto; University of Western Australia; Natural History Museum London; Sultan Qaboos University; National Museum; University of Granada; Universidade do Porto; University of California System; University of California Berkeley	Carranza, S (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim de la Barceloneta, Barcelona, Spain.	salvador.carranza@ibe.upf-csic.es	Smid, Jiri/N-1616-2013; Machado, Luis/D-2732-2015; Tarroso, Pedro/I-3023-2012; Carranza, Salvador/A-2126-2012; Vasconcelos, Raquel/H-5524-2012; Garcia-Porta, Joan/AAA-8771-2020	Smid, Jiri/0000-0002-0309-209X; Machado, Luis/0000-0002-8637-5043; Tarroso, Pedro/0000-0002-2694-1170; Carranza, Salvador/0000-0002-5378-3008; Vasconcelos, Raquel/0000-0002-4717-9429; Al Adhoobi, Aziza S/0000-0002-7326-8011; Sindaco, Roberto/0000-0002-2590-9603; Els, Johannes/0000-0002-5614-1887; Garcia-Porta, Joan/0000-0003-4032-9495	Ministerio de Economia y Competitividad, Spain (FEDER) [CGL2012-36970, CGL2015-70390-P]; project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman [22412027]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014-SGR-1532]; FPI grant from the Ministerio de Economia y Competitividad, Spain [BES-2013-064248]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/79913/2011, SFRH/BPD/93473/2013, SFRH/BD/89820/2012]; Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia	Ministerio de Economia y Competitividad, Spain (FEDER)(Spanish Government); project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); FPI grant from the Ministerio de Economia y Competitividad, Spain; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	This work was funded by grants CGL2012-36970, CGL2015-70390-P from the Ministerio de Economia y Competitividad, Spain (cofunded by FEDER) to SC, the project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman (Ref: 22412027) to SC and grant 2014-SGR-1532 from the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya to SC. MSR is funded by a FPI grant from the Ministerio de Economia y Competitividad, Spain (BES-2013-064248); RV, PT and LM were funded by Fundacao para a Ciencia e Tecnologia (FCT) through post-doc grants (SFRH/BPD/79913/2011) to RV, (SFRH/BPD/93473/2013) to PT and PhD grant (SFRH/BD/89820/2012) to LM, financed by Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold E.N., 1986, Fauna of Saudi Arabia, V8, P385; Arnold E.N., 1982, Fauna of Saudi Arabia, V4, P468; Arnold E.N., 1986, Fauna of Saudi Arabia, V8, P352; Arnold EN, 2009, ZOOTAXA, P1; Arnold E.N., 1980, Fauna of Saudi Arabia, V2, P368; ARNOLD E N, 1972, Zoologische Mededelingen (Leiden), V47, P111; Arnold E. N., 1980, J OMAN STUDIES SPECI, P273; Arnold E.N., 1977, J OMAN STUDIES SPECI, V1, P81; Arnold E. Nicholas, 1994, Fauna of Saudi Arabia, V14, P424; Arnold EN, 1977, J OMAN STUD SPEC REP, V1, P59; Badiane A, 2014, ZOOTAXA, V3835, P33, DOI 10.11646/zootaxa.3835.1.2; Becker R, 1988, COMPUTER SCI SERIES; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brito JC, 2016, DIVERS DISTRIB, V22, P371, DOI 10.1111/ddi.12416; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Buttiker W., 1980, Journal of Oman Studies Special Report, P217; Camargo A, 2010, MOL ECOL, V19, P3250, DOI 10.1111/j.1365-294X.2010.04722.x; Cantu C, 2004, BIOL CONSERV, V115, P411, DOI 10.1016/S0006-3207(03)00158-7; Carranza S., 2003, Systematics and Biodiversity, V1, P275, DOI 10.1017/S1477200003001099; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carranza S, 2014, THE TREE OF LIFE, P530; Carranza S, 2016, PEERJ, V4, DOI 10.7717/peerj.2371; Carranza S, 2012, ZOOTAXA, P1; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Cox N., 2012, CONSERVATION STATUS; de Pous P, 2016, J ZOOL SYST EVOL RES, V54, P67, DOI 10.1111/jzs.12107; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Edgell HS., 2006, ARABINA DESERTS NATU; Eriksen J, 2013, OFFICIAL LIST BIRDS; Funk VA, 2002, SYST BIOL, V51, P235, DOI 10.1080/10635150252899743; Gallagher M.D., 1980, Journal of Oman Studies Special Report, P347; Garcia-Porta J, 2017, J BIOGEOGR, V44, P1694, DOI 10.1111/jbi.12929; GARDNER AS, 1994, J HERPETOL, V28, P141, DOI 10.2307/1564612; Gardner AS., 2013, AMPHIBIANS REPTILES; Gasperetti J., 1988, Fauna of Saudi Arabia, V9, P169; GITTLEMAN JL, 1991, NATURE, V351, P524, DOI 10.1038/351524a0; Greathead DJ, 1980, J OMAN STUDIES SPECI, V2, P233; Grieco C., 2013, MONOGRAFIE SOC HERPE, VI, DOI DOI 10.1146/annurev.ecolsys.34.012103.144032; Harrison D.L., 1980, Journal of Oman Studies Special Report, P387; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoogstraal H., 1980, Journal of Oman Studies Special Report, P265; Khuroo AA, 2007, J NAT CONSERV, V15, P256, DOI 10.1016/j.jnc.2007.07.003; Kwarteng AY, 2009, INT J CLIMATOL, V29, P605, DOI 10.1002/joc.1727; Larsen T.B., 1980, Journal of Oman Studies Special Report, P153; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mandaville J., 1977, PLANTS J OMAN STUDIE, V1, P229; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McNeely Jeffrey A., 2002, Journal for Nature Conservation (Jena), V10, P145, DOI 10.1078/1617-1381-00015; Meiri S, 2016, BIOL CONSERV, V204, P6, DOI 10.1016/j.biocon.2016.03.009; Metallinou Margarita, 2014, Biodivers Data J, pe4011, DOI 10.3897/BDJ.2.e4011; Metallinou M, 2015, MOL PHYLOGENET EVOL, V85, P208, DOI 10.1016/j.ympev.2015.02.010; Metallinou M, 2013, ZOOTAXA, V 3745, P449, DOI 10.11646/zootaxa.3745.4.3; Morrison WR, 2009, BIOL CONSERV, V142, P3201, DOI 10.1016/j.biocon.2009.07.019; Murrell P., 2005, R GRAPHICS; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; QGIS Development Team, 2019, QGIS GEOGR INF SYST; Roll U, 2017, NAT ECOL EVOL, V1, P1677, DOI 10.1038/s41559-017-0332-2; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Sale JB, 1980, J OMAN STUDIES SPECI, V2, P17; Simo-Riudalbas M, SYST BIODIVERS; Simo-Riudalbas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180397; Sindaco R, 2008, MONOGRAFIE SOC HERPE; Smid J, 2015, ZOOTAXA, V4033, P380, DOI 10.11646/zootaxa.4033.3.4; Smid J, 2015, SYST BIODIVERS, V13, P346, DOI 10.1080/14772000.2014.996264; Smid Jiri, 2010, Herpetology Notes, V3, P329; Tamar K, 2016, MOL PHYLOGENET EVOL, V97, P55, DOI 10.1016/j.ympev.2015.12.021; Uetz P., 2020, REPTILE DATABASE; Vasconcelos R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149985; Vasconcelos R, 2014, ZOOTAXA, V3835, P501, DOI 10.11646/zootaxa.3835.4.4; Vasconcelos R, 2012, BIOL CONSERV, V153, P276, DOI 10.1016/j.biocon.2012.04.020; Wallach V., 2014, SNAKES WORLD CATALOG; Waterston A.R., 1980, Journal of Oman Studies Special Report, P149; Wiens JJ, 2013, EVOLUTION, V67, P1715, DOI 10.1111/evo.12053; Wilson DE, 2005, MAMMAL SPECIES WORLD, V2, P745; Wiltshire E.P., 1980, Journal of Oman Studies Special Report, P187; Wright R. Gerald, 1996, P3; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	78	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190389	10.1371/journal.pone.0190389	http://dx.doi.org/10.1371/journal.pone.0190389			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414999	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300007
J	Dwivedi, B; Kowalski, J				Dwivedi, Bhakti; Kowalski, Jeanne			shinyGISPA: A web application for characterizing phenotype by gene sets using multiple omics data combinations	PLOS ONE			English	Article								While many methods exist for integrating multi-omics data or defining gene sets, there is no one single tool that defines gene sets based on merging of multiple omics data sets. We present shinyGISPA, an open-source application with a user-friendly web-based interface to define genes according to their similarity in several molecular changes that are driving a disease phenotype. This tool was developed to help facilitate the usability of a previously published method, Gene Integrated Set Profile Analysis (GISPA), among researchers with limited computer-programming skills. The GISPA method allows the identification of multiple gene sets that may play a role in the characterization, clinical application, or functional relevance of a disease phenotype. The tool provides an automated workflow that is highly scalable and adaptable to applications that go beyond genomic data merging analysis. It is available at http://shinygispa.winship.emory.edu/shinyGISPA/.	[Dwivedi, Bhakti; Kowalski, Jeanne] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Kowalski, Jeanne] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health	Kowalski, J (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Kowalski, J (corresponding author), Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.	jeanne.kowalski@emory.edu		Dwivedi, Bhakti/0000-0002-9029-3737; Kowalski, Jeanne/0000-0003-3458-3024	Leukemia and Lymphoma Society Translational Research Program Award; Georgia Research Alliance Scientist Award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; NIH/NCI [P30CA138292]	Leukemia and Lymphoma Society Translational Research Program Award(Leukemia and Lymphoma Society); Georgia Research Alliance Scientist Award; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Leukemia and Lymphoma Society Translational Research Program Award (Kowalski) and a Georgia Research Alliance Scientist Award (Kowalski). Research reported in this publication was supported in part by the Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University and NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chang W, 2017, WEB APPL FRAMEWORK R; Heiberger RM, 2014, J STAT SOFTW, V57; Killick R, 2014, J STAT SOFTW, V58, P1; Kowalski J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1503; Kristensen VN, 2014, NAT REV CANCER, V14, P299, DOI 10.1038/nrc3721; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAMINAU J, 2014, ISRN BIOINFORMATICS, V2014, P7, DOI DOI 10.1155/2014/345106	8	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192563	10.1371/journal.pone.0192563	http://dx.doi.org/10.1371/journal.pone.0192563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415010	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300087
J	Sriver, RL; Lempert, RJ; Wikman-Svahn, P; Keller, K				Sriver, Ryan L.; Lempert, Robert J.; Wikman-Svahn, Per; Keller, Klaus			Characterizing uncertain sea-level rise projections to support investment decisions	PLOS ONE			English	Article							CLIMATE-CHANGE UNCERTAINTIES; ICE-SHEET; EXPERT JUDGMENT; FLOOD RISK; MANAGEMENT; IMPACTS; ADAPTATION	Many institutions worldwide are considering how to include uncertainty about future changes in sea-levels and storm surges into their investment decisions regarding large capital infrastructures. Here we examine how to characterize deeply uncertain climate change projections to support such decisions using Robust Decision Making analysis. We address questions regarding how to confront the potential for future changes in low probability but large impact flooding events due to changes in sea-levels and storm surges. Such extreme events can affect investments in infrastructure but have proved difficult to consider in such decisions because of the deep uncertainty surrounding them. This study utilizes Robust Decision Making methods to address two questions applied to investment decisions at the Port of Los Angeles: (1) Under what future conditions would a Port of Los Angeles decision to harden its facilities against extreme flood scenarios at the next upgrade pass a cost-benefit test, and (2) Do sea-level rise projections and other information suggest such conditions are sufficiently likely to justify such an investment? We also compare and contrast the Robust Decision Making methods with a full probabilistic analysis. These two analysis frameworks result in similar investment recommendations for different idealized future sea-level projections, but provide different information to decision makers and envision different types of engagement with stakeholders. In particular, the full probabilistic analysis begins by aggregating the best scientific information into a single set of joint probability distributions, while the Robust Decision Making analysis identifies scenarios where a decision to invest in near-term response to extreme sea-level rise passes a cost-benefit test, and then assembles scientific information of differing levels of confidence to help decision makers judge whether or not these scenarios are sufficiently likely to justify making such investments. Results highlight the highly-localized and context dependent nature of applying Robust Decision Making methods to inform investment decisions.	[Sriver, Ryan L.] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Lempert, Robert J.] RAND Corp, Santa Monica, CA USA; [Wikman-Svahn, Per; Keller, Klaus] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Wikman-Svahn, Per] Royal Inst Technol, Dept Philosophy & Hist, Stockholm, Sweden	University of Illinois System; University of Illinois Urbana-Champaign; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University; Royal Institute of Technology	Sriver, RL (corresponding author), Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA.	rsriver@illinois.edu	Keller, Klaus/A-6742-2013		National Science Foundation [SES-0345925]; Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI); Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement [GEO-1240507]; Penn State Center for Climate Risk Management; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI); Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement; Penn State Center for Climate Risk Management; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by the National Science Foundation through (Grant SES-0345925), as well as the Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI), the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507, and the Penn State Center for Climate Risk Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Allison I, 2009, ANTARCT SCI, V21, P413, DOI 10.1017/S0954102009990137; Anthoff D, 2010, MITIG ADAPT STRAT GL, V15, P321, DOI 10.1007/s11027-010-9220-7; Applegate PJ, 2012, CRYOSPHERE, V6, P589, DOI 10.5194/tc-6-589-2012; Bakker AMR, 2017, CLIMATIC CHANGE, V140, P339, DOI 10.1007/s10584-016-1864-1; Bakker AMR, SEA LEVEL PROJECTION; Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Bromirski PD, 2003, J CLIMATE, V16, P982, DOI 10.1175/1520-0442(2003)016<0982:SVATCC>2.0.CO;2; Bromirski PD, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006759; Brown C, 2012, EOS T AGU, V93, P401, DOI DOI 10.1029/2012EO410001; Bryant BP, 2010, TECHNOL FORECAST SOC, V77, P34, DOI 10.1016/j.techfore.2009.08.002; Buchanan MK, 2016, CLIMATIC CHANGE, V137, P347, DOI 10.1007/s10584-016-1664-7; Bursztyn D, 2006, J STAT PLAN INFER, V136, P1103, DOI 10.1016/j.jspi.2004.08.007; Caldwell P.C., 2015, SEA LEVEL MEASURED T; Carter TR, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P133; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cayan DR, 2016, CREATING PROBABILIST; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Church JA, 2006, AUST METEOROL MAG, V55, P253; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Church JA, 2013, SCIENCE, V342, P1445, DOI 10.1126/science.342.6165.1445-a; Church JA, 2011, OCEANOGRAPHY, V24, P130, DOI 10.5670/oceanog.2011.33; Church JA, 2008, SUSTAIN SCI, V3, P9, DOI 10.1007/s11625-008-0042-4; CO-CAT, 2010, STATE OF CALIFORNIA; Dalal S, 2013, ENVIRON MODELL SOFTW, V48, P49, DOI 10.1016/j.envsoft.2013.05.013; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dessai S, 2007, GLOBAL ENVIRON CHANG, V17, P59, DOI 10.1016/j.gloenvcha.2006.11.005; Diaz D, 2016, AM ECON REV, V106, P607, DOI 10.1257/aer.p20161103; DOUGLAS BC, 1992, J GEOPHYS RES-OCEANS, V97, P12699, DOI 10.1029/92JC01133; Gilboa I, 2008, J ECON PERSPECT, V22, P173, DOI 10.1257/jep.22.3.173; Gilboa I, 2009, ECON PHILOS, V25, P285, DOI 10.1017/S0266267109990241; Giuliani M, 2014, WATER RESOUR RES, V50, P3355, DOI 10.1002/2013WR014700; Goes M, 2011, CLIMATIC CHANGE, V109, P719, DOI 10.1007/s10584-010-9961-z; Griggs G., 2017, RISING SEAS CALIFORN; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Grinsted A, 2013, P NATL ACAD SCI USA, V110, P5369, DOI 10.1073/pnas.1209980110; Hall JW, 2012, RISK ANAL, V32, P1657, DOI 10.1111/j.1539-6924.2012.01802.x; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Hinkel J, 2013, CLIMATIC CHANGE, V117, P783, DOI 10.1007/s10584-012-0564-8; Hogan E, 2017, WATER-SUI, V9, DOI 10.3390/w9070483; Holgate S, 2007, SCIENCE, V317, DOI 10.1126/science.1140942; HOSKING JRM, 1990, J ROY STAT SOC B MET, V52, P105; Hunter JR, 2013, OCEAN ENG, V71, P17, DOI 10.1016/j.oceaneng.2012.12.041; Hunter J, 2012, CLIMATIC CHANGE, V113, P239, DOI 10.1007/s10584-011-0332-1; Irvine PJ, 2012, NAT CLIM CHANGE, V2, P97, DOI [10.1038/nclimate1351, 10.1038/NCLIMATE1351]; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Jevrejeva S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003229; Jevrejeva S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033611; Jonkman SN, 2008, RISK ANAL, V28, P1357, DOI 10.1111/j.1539-6924.2008.01103.x; Jonkman SN, 2013, J COASTAL RES, V29, P1212, DOI 10.2112/JCOASTRES-D-12-00230.1; Kalra N., 2014, 6906 WORLD BANK, DOI DOI 10.1596/1813-9450-6906; Keller K., 2015, OXFORD HDB MACROECON; Keller K, 2008, CLIMATIC CHANGE, V91, P5, DOI 10.1007/s10584-006-9114-6; Kemp AC, 2011, P NATL ACAD SCI USA, V108, P11017, DOI 10.1073/pnas.1015619108; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Kunreuther H, 2013, NAT CLIM CHANGE, V3, P447, DOI [10.1038/NCLIMATE1740, 10.1038/nclimate1740]; Le Bars D, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6512; Le Cozannet G, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5528; Lempert R, 2004, CLIMATIC CHANGE, V65, P1, DOI 10.1023/B:CLIM.0000037561.75281.b3; Lempert R, 2012, CHARACTERIZING UNCER; Lempert R.J., 2003, SHAPING NEXT 100 YEA; Lempert RJ, 2002, P NATL ACAD SCI USA, V99, P7309, DOI 10.1073/pnas.082081699; Lempert RJ, 2005, GOVT UNCERTAIN WORLD; Lempert RJ, 2014, J BENEFIT-COST ANAL, V5, P487, DOI 10.1515/jbca-2014-9006; Levermann A, 2014, EARTH SYST DYNAM, V5, P271, DOI 10.5194/esd-5-271-2014; Little CM, 2013, NAT CLIM CHANGE, V3, P654, DOI [10.1038/NCLIMATE1845, 10.1038/nclimate1845]; Matschoss P. R., 2010, GUIDANCE NOTE LEAD A; McInerney D, 2012, CLIMATIC CHANGE, V112, P547, DOI 10.1007/s10584-011-0377-1; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Mendez FJ, 2007, J ATMOS OCEAN TECH, V24, P894, DOI 10.1175/JTECH2009.1; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Miller KG, 2013, EARTHS FUTURE, V1, P3, DOI 10.1002/2013EF000135; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; Moore JC, 2013, REV GEOPHYS, V51, P484, DOI 10.1002/rog.20015; Morgan MG, 2014, P NATL ACAD SCI USA, V111, P7176, DOI 10.1073/pnas.1319946111; Morgan MG., 1992, UNCERTAINTY GUIDE DE; Mudersbach C, 2010, J FLOOD RISK MANAG, V3, P52, DOI 10.1111/j.1753-318X.2009.01054.x; National Research Council, 2009, INF DEC CHANG CLIM; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI [10.1098/rsta.2010.0291, 10.1098/rsta.2010.029]; Oppenheimer M, 2008, CLIMATIC CHANGE, V89, P155, DOI 10.1007/s10584-008-9405-1; Oppenheimer M, 2016, SCIENCE, V354, P1375, DOI 10.1126/science.aak9460; Oppenheimer M, 2016, NAT CLIM CHANGE, V6, P445, DOI 10.1038/NCLIMATE2959; Pardaens AK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047678; Parris A, 2018, CPO1 NOAA OAR; PateCornell ME, 1996, RELIAB ENG SYST SAFE, V54, P95, DOI 10.1016/S0951-8320(96)00067-1; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pfeffer WT, 2011, OCEANOGRAPHY, V24, P94, DOI 10.5670/oceanog.2011.30; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pollard D, 2010, CLIMATIC CHANGE, V100, P173, DOI 10.1007/s10584-010-9830-9; Purvis MJ, 2008, COAST ENG, V55, P1062, DOI 10.1016/j.coastaleng.2008.04.008; Rahmstorf S., 2010, NAT CLIM CHANGE, V1, P44, DOI [10.1038/climate.2010.29, DOI 10.1038/CLIMATE.2010.29]; Rahmstorf S, 2012, CLIM DYNAM, V39, P861, DOI 10.1007/s00382-011-1226-7; Ranger N, 2010, ADAPTATION IN THE UK; Ranger N, 2013, EURO J DECIS PROCESS, V1, P233, DOI 10.1007/s40070-013-0014-5; Reeder T., 2011, DO YOU ADAPT UNCERTA; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Rosenzweig C, 2011, CLIMATIC CHANGE, V106, P93, DOI 10.1007/s10584-010-0002-8; Rosenzweig C, 2010, ANN NY ACAD SCI, V1196, P13, DOI 10.1111/j.1749-6632.2009.05306.x; Ruckert KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170052; Siddall M, 2010, J QUATERNARY SCI, V25, P19, DOI 10.1002/jqs.1270; Sriver RL, 2012, CLIMATIC CHANGE, V115, P893, DOI 10.1007/s10584-012-0610-6; Sweet W., 2017, NOAA TECHNICAL REPOR, DOI 10.7289/v5/tr-nos-coops-083; Titus JG, 1996, CLIMATIC CHANGE, V33, P151, DOI 10.1007/BF00140246; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; VANDANTZIG D, 1956, ECONOMETRICA, V24, P276, DOI 10.2307/1911632; von Storch H, 2008, OCEAN DYNAM, V58, P227, DOI 10.1007/s10236-008-0142-9; Vrijling JK, 2001, RELIAB ENG SYST SAFE, V74, P337, DOI 10.1016/S0951-8320(01)00082-5; Walker W. E., 2013, ENCY OPERATIONS RES, DOI [10.1007/978-1-4419-1153-7_1140, DOI 10.1007/978-1-4419-1153-7_1140]; Walsh KJE, 2004, J COASTAL RES, V20, P586, DOI 10.2112/1551-5036(2004)020[0586:USLRPF]2.0.CO;2; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366; Wong TE, IMPACTS ANTARCTIC FA; Wong TE, 2017, CLIMATIC CHANGE, V144, P347, DOI 10.1007/s10584-017-2039-4; Woodworth PL, 2009, INT J CLIMATOL, V29, P777, DOI 10.1002/joc.1771; Woodworth PL, 2004, J CLIMATE, V17, P1190, DOI 10.1175/1520-0442(2004)017&lt;1190:EFSCIE&gt;2.0.CO;2	118	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190641	10.1371/journal.pone.0190641	http://dx.doi.org/10.1371/journal.pone.0190641			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414978	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300009
J	Thor, P; Vermandele, F; Carignan, MH; Jacque, S; Calosi, P				Thor, Peter; Vermandele, Fanny; Carignan, Marie-Helene; Jacque, Sarah; Calosi, Piero			No maternal or direct effects of ocean acidification on egg hatching in the Arctic copepod Calanus glacialis	PLOS ONE			English	Article							CO2-INDUCED ACIDIFICATION; METABOLIC-RATES; ELEVATED CO2; FINMARCHICUS; SEA; TEMPERATURE; CARBON; PH; REPRODUCTION; MORTALITY	Widespread ocean acidification (OA) is transforming the chemistry of the global ocean and the Arctic is recognised as the region where this transformation will occur at the fastest rate. Moreover, many Arctic species are considered less capable of tolerating OA due to their lower capacity for acid-base regulation. This inability may put severe restraints on many fundamental functions, such as growth and reproductive investments, which ultimately may result in reduced fitness. However, maternal effects may alleviate severe effects on the offspring rendering them more tolerant to OA. In a highly replicated experiment we studied maternal and direct effects of OA predicted for the Arctic shelf seas on egg hatching time and success in the keystone copepod species Calanus glacialis. We incubated females at present day conditions (pH(T) 8.0) and year 2100 extreme conditions (pH(T) 7.5) during oogenesis and subsequently reciprocally transplanted laid eggs between these two conditions. Statistical tests showed no effects of maternal or direct exposure to OA at this level. We hypothesise that C. glacialis may be physiologically adapted to egg production at low pH since oogenesis can also take place at conditions of potentially low haemolymph pH of the mother during hibernation in the deep.	[Thor, Peter] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Vermandele, Fanny; Carignan, Marie-Helene; Jacque, Sarah; Calosi, Piero] Univ Quebec Rimouski, Dept Biol Chim & Geog, Rimouski, PQ, Canada	Norwegian Polar Institute; University of Quebec; Universite du Quebec a Rimouski	Thor, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	peter.thor@npolar.no	Thor, Peter/ABF-1114-2021; Thor, Peter/A-7522-2009	Thor, Peter/0000-0002-2603-2284; Thor, Peter/0000-0002-2603-2284; Vermandele, Fanny/0000-0002-0239-3835; Calosi, Piero/0000-0003-3378-2603	FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship	FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship	The study was financially supported by a grant from the FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2013, AMAP ASS 2013 ARCT O; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Bailey A, 2017, ECOLOGY EVOLUTION; Bailey A, 2017, ICES J MAR SCI, V74, P996, DOI 10.1093/icesjms/fsw066; Bernardo J, 1996, AM ZOOL, V36, P83; Bonnet D, 2004, J PLANKTON RES, V26, P937, DOI 10.1093/plankt/fbh087; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Cao L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028605; CLARKE A, 1980, BIOL J LINN SOC, V14, P77, DOI 10.1111/j.1095-8312.1980.tb00099.x; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Daase M, 2013, CAN J FISH AQUAT SCI, V70, P871, DOI 10.1139/cjfas-2012-0401; Davidson E. H., 1976, GENE ACTIVITY EARLY; De Wit P, 2016, EVOL APPL, V9, P1112, DOI 10.1111/eva.12335; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dupont S, 2013, NATURE, V498, P429, DOI 10.1038/498429a; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eiane K, 2004, MAR ECOL PROG SER, V268, P183, DOI 10.3354/meps268183; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fransson A, 2016, POLAR BIOL, V39, P1841, DOI 10.1007/s00300-016-1955-5; Fransson A, 2001, CONT SHELF RES, V21, P225, DOI 10.1016/S0278-4343(00)00088-1; Freese D, 2015, LIMNOL OCEANOGR, V60, P2121, DOI 10.1002/lno.10158; GIESKES JM, 1969, LIMNOL OCEANOGR, V14, P679, DOI 10.4319/lo.1969.14.5.0679; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lowry L., 1993, BOWHEAD WHALES; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mumm N, 1998, POLAR BIOL, V20, P189, DOI 10.1007/s003000050295; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; Nielsen TG, 2014, MAR BIOL, V161, P1299, DOI 10.1007/s00227-014-2419-5; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2010, GUIDE BEST PRACTICE, P137; Rastrick SPS, 2011, PHYSIOL BIOCHEM ZOOL, V84, P154, DOI 10.1086/658857; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Runge JA, 2016, ICES J MAR SCI, V73, P937, DOI 10.1093/icesjms/fsv258; Sell AF, 2001, LIMNOL OCEANOGR, V46, P953, DOI 10.4319/lo.2001.46.4.0953; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Strickland JD, 1972, PRACTICAL HDB SEAWAT, V167, P310; Thor P, 2008, MAR ECOL PROG SER, V359, P151, DOI 10.3354/meps07376; Thor P, 2007, MAR ECOL PROG SER, V331, P131, DOI 10.3354/meps331131; Thor P, 2018, GLOBAL CHANGE BIOL, V24, pE365, DOI 10.1111/gcb.13870; Thor P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168735; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Titelman J, 2003, MAR ECOL PROG SER, V247, P137, DOI 10.3354/meps247137; Turner LM, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2984-x; Turner LM, 2015, J EXP BIOL, V218, P2148, DOI 10.1242/jeb.117705; Vehmaa A., 2015, BIOGEOSCIENCES DISCU, V12, P18541, DOI [10.5194/bgd-12-18541-2015, DOI 10.5194/BGD-12-18541-2015]; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Weydmann A, 2016, POLAR BIOL, P1; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553	69	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192496	10.1371/journal.pone.0192496	http://dx.doi.org/10.1371/journal.pone.0192496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415083	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300081
J	Dai, YK; Li, DY; Zhang, YZ; Huang, MX; Zhou, YL; Ye, JT; Wang, Q; Hu, L				Dai, Yun-kai; Li, Dan-yan; Zhang, Yun-zhan; Huang, Meng-xin; Zhou, Yi-le; Ye, Jin-tong; Wang, Qi; Hu, Ling			Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials	PLOS ONE			English	Article							DISORDERS; PRACTITIONERS; DIAGNOSIS; QUALITY	Objective To systematically evaluate the efficacy and safety of Modified Tongxie Yaofang (M-TXYF) for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). Method Electronic databases including PubMed, Springer Link, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature (CBM), Wanfang, and Chinese Scientific Journals Database (VIP) were conducted from their inception through May 11, 2017 without language restrictions. Primary and secondary outcomes were estimated by 95% confidence intervals (CI). RevMan 5.3 and the Cochrane Collaboration's risk of bias tool were analyzed for this meta-analysis. Results Twenty-three literatures with a total of 1972 patients were included for the meta-analysis. The overall risk of bias evaluation was low. The pooled odds ratio showed that M-TXYF was significantly superior to routine pharmacotherapies (RP) in clinical therapeutic efficacy (OR 4.04, 95% CI 3.09, 5.27, P < 0.00001, therapeutic gain = 17.6%, number needed to treat (NNT) = 5.7). Moreover, compared with RP, M-TXYF showed that it can significantly reduce the scores of abdominal pain (standardized mean difference (SMD) -1.27; 95% CI -1.99, -0.56; P = 0.0005), abdominal distention (SMD -0.37; 95% CI -0.73, -0.01; P = 0.09), diarrhea (SMD -1.10; 95% CI -1.95, -0.25; P = 0.01), and frequency of defecation (SMD -1.42; 95% CI -2.19, -0.65; P = 0.0003). The differences of the adverse events between experiment and control groups had no statistical significance. Conclusion This meta-analysis indicated that M-TXYF could be a promising Chinese herbal formula in treating IBS-D. However, considering the lack of higher quality of randomized controlled trials (RCTs), highly believable evidences should be required.	[Dai, Yun-kai; Li, Dan-yan; Zhang, Yun-zhan; Huang, Meng-xin; Zhou, Yi-le; Ye, Jin-tong; Hu, Ling] Guangzhou Univ Chinese Med, Inst Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Wang, Qi] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Hu, L (corresponding author), Guangzhou Univ Chinese Med, Inst Gastroenterol, Guangzhou, Guangdong, Peoples R China.; Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China.	wqitcm@qq.com; drhuling@163.com	hu, ling/GWC-1104-2022	Wang, Qi/0000-0001-7626-676X	National Natural Science Foundation of China [81373563]; Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine [64]; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine [7, 2016KYTD07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine	This study was supported by National Natural Science Foundation of China, No. 81373563; Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No. 64; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No. 7, No. 2016KYTD07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China, No.81373563; Construction of high-level university of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.64; Innovation team to foster scientific research projects of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine (2016) No.7, No.2016KYTD07.	An L. F., 2017, J SHANXI COLL TRADIT, V18, P68; Bian ZX, 2006, J ALTERN COMPLEM MED, V12, P401, DOI 10.1089/acm.2006.12.401; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Cai G, 2006, JIANGXI J TRADITIONA, V37, P20; Chen JL, 2016, CHIN J INTEGR TRAD W, V24, P442; Chen Ming-xian, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P656; Deechakawan W, 2014, GASTROENTEROL NURS, V37, P24, DOI 10.1097/SGA.0000000000000017; Fang P, ZHEJIANG J INTEGRATE; Gao Wen-yan, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P212, DOI 10.3736/jcim20090303; [葛飞 Ge Fei], 2016, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V32, P213; Grundmann O, 2010, J GASTROEN HEPATOL, V25, P691, DOI 10.1111/j.1440-1746.2009.06120.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Li DH, 2010, CHINESE J EXPT TRADI, V16, P118; Li K, 2015, LAB MED CLIN, V12, P1707; Li SJ, 2015, J LIAONING U TRADITI, V17, P85; Liang Zhan-fan, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P819, DOI 10.3736/jcim20090904; Lopez-Alvarenga JC, 2013, REV GASTROENTEROL ME, V78, P21, DOI 10.1016/j.rgmx.2012.10.003; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Ma D. Y., 2016, SHANXI J TCM, V32, P16; Martinez-Vazquez MA, 2012, REV GASTROENTEROL ME, V77, P82, DOI 10.1016/j.rgmx.2012.04.002; Pan F, 2009, CHIN J INTEGR MED, V15, P216, DOI 10.1007/s11655-009-0216-7; Peng MZ, 2014, WORLD CHINESE MED, V9, P1595; Poynard T, 2001, ALIMENT PHARM THER, V15, P355, DOI 10.1046/j.1365-2036.2001.00937.x; Qian X, 2016, ZHEJIANG J INTEGRATE, V26, P941; Rapps N, 2008, J PSYCHOSOM RES, V64, P599, DOI 10.1016/j.jpsychores.2008.02.018; Ruepert L, 2001, COCHRANE DATABASE SY; Savovic J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-37; Simren M, 2006, CLIN GASTROENTEROL H, V4, P187, DOI 10.1016/S1542-3565(05)00981-X; Stanghellini V, 2016, GASTROENTEROLOGY, V150, P1380, DOI 10.1053/j.gastro.2016.02.011; Sung JJY, 2004, ALIMENT PHARM THER, V20, P1205, DOI 10.1111/j.1365-2036.2004.02242.x; Tao L, 2012, BEIJING J TRADITIONA, V31, P437; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Tu Y, 2013, J PRACTICAL TRADITIO, V27, P41; Wang HF, 2012, WORLD J INTEGRATED T, V7, P425; Wang JianWei, 2014, China Journal of Traditional Chinese Medicine and Pharmacy, V29, P1070; Wang Y. X., 2013, HENAN TRADITIONAL CH, V33, P67; Wen PY, 2014, FUJIAN J TRADITIONAL, V45, P30; Xiao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122397; Xu HuiJuan, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P268; Xu MH, 2011, NEI MONGOL J TRADITI, V3021, P38; Yang C, 2015, WORLD CHINESE MED, V10, P675; Zhang GS, 2010, MODERN J INTEGRATED, V19, P3612; Zhang LN, 2014, W J TRADITIONAL CHIN, V27, P120; Zhang SS, 2009, J CAPITAL MED U, V30, P436; Zhang SS, 2015, J CAPITAL MED U, V36, P645; Zhen XY., 2002, GUIDING PRINCIPLES C, P139; Zheng L, 2015, CLIN GASTROENTEROL H, V13, P1285, DOI 10.1016/j.cgh.2015.01.015; Zhu Q, 2005, CHIN J CLIN PHARM TH, V10, P957; 赵迎盼, 2015, [中华医学杂志, National Medical Journal of China], V95, P637	51	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192319	10.1371/journal.pone.0192319	http://dx.doi.org/10.1371/journal.pone.0192319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408906	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800055
J	Andrade, ACD; Mingoti, SA; Fernandes, AP; de Andrade, RG; Friche, AAD; Xavier, CC; Proietti, FA; Diez-Roux, AV; Caiaffa, WT				de Souza Andrade, Amanda Cristina; Mingoti, Sueli Aparecida; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Xavier, Cesar Coelho; Proietti, Fernando Augusto; Diez-Roux, Ana V.; Caiaffa, Waleska Teixeira			Neighborhood-based physical activity differences: Evaluation of the effect of health promotion program	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; ACTIVITY INTERVENTIONS; LATIN-AMERICA; BRAZIL; ADULTS; PARTICIPATION; RECIFE	Introduction The practice of physical activity is an important factor in the prevention of health problems. However, a small portion of the population is physically active. Recent reviews show that physical activity classes in community settings have the potential to increase population levels of physical activity and reduce health inequalities. Objective To evaluate the effect of the Academias da Cidade Program in Belo Horizonte on the practice of physical activity in leisure time (PALT) by non-users living near the program centers. Methods We conducted a home-based health survey in Belo Horizonte (2008 +/- 2009) with 1,581 adults who were non-users of the program and who lived within a 1,500-meter radius of one active program center (exposed group) and two nonoperational centers with sites reserved for their construction (unexposed group). We collected data on PALT levels (>= 150 minutes/week), which was measured with the Physical Activity International Questionnaire and analyzed with binary logistic regression using the Generalized Estimating Equations method. The propensity score was used as an adjustment variable to control the potential confusion in the measures of effect of exposure studied. Results The overall prevalence of the PALT was 26.5% in the exposed group and 22.7% in the unexposed group. The exposed group was more likely to be active in leisure time (OR = 1.05; CI 95%: 1.01 +/- 1.10). When considering the interaction between exposed group and distance, individuals in the exposed group who lived less than 500 meters from the program center were more likely to be active in leisure time (OR = 1.18, CI 95%: 1.03 +/- 1.35) compared to their counterparts. Conclusion Promoting physical activity in the community can favorably affect PALT levels among residents, especially those living closest to intervention centers. We believe the Academias da Cidade Program is a promising strategy to facilitate the access to appropriate spaces for the practice of physical activity and contribute to increase the levels physical activity within populations.	[de Souza Andrade, Amanda Cristina; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [de Souza Andrade, Amanda Cristina; Mingoti, Sueli Aparecida; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Xavier, Cesar Coelho; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira] Belo Horizonte Observ Urban Hlth, Belo Horizonte, MG, Brazil; [Mingoti, Sueli Aparecida] Univ Fed Minas Gerais, Inst Exact Sci, Belo Horizonte, MG, Brazil; [Xavier, Cesar Coelho; Proietti, Fernando Augusto] Fac Hlth & Human Ecol, Vespasiano, Brazil; [Diez-Roux, Ana V.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Drexel University	Andrade, ACD (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.; Andrade, ACD (corresponding author), Belo Horizonte Observ Urban Hlth, Belo Horizonte, MG, Brazil.	amandasouza_est@yahoo.com.br	Andrade, Roseli/GVS-7908-2022; Friche, Amelia A L/F-6114-2015; Mingoti, Sueli Aparecida/A-2967-2015	Cristina de Souza Andrade, Amanda/0000-0002-3366-4423	National Health Fund of the Ministry of Health; Fapemig; CNPq; NIH / Fogarty International Center; CAPES	National Health Fund of the Ministry of Health; Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH / Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Health Fund of the Ministry of Health, Fapemig, CNPq, NIH / Fogarty International Center. The CAPES for a research scholarship to ACSA and APE. CNPq for a research productivity scholarship to the researcher WTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Basu S, 2017, ANNU REV PUBL HEALTH, V38, P351, DOI 10.1146/annurev-publhealth-031816-044208; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brasil. Ministerio da Saude, 2011, AV AT FIS BRAS, P125; Caiaffa W. T., 2010, Urban health: global perspectives, P437; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Moraes José Rodrigo de, 2011, Rev. bras. epidemiol., V14, P589, DOI 10.1590/S1415-790X2011000400006; Dias MAS, 2010, DESAFIOS INOVACOES G, P63; Fernandes AP, 2015, CAD SAUDE PUBLICA, V31, pS195, DOI 10.1590/0102-311X00104514; Friche AAL., 2015, SAUDE URBANA BELO HO; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hino Adriano Akira Ferreira, 2010, Rev. bras. cineantropom. desempenho hum., V12, P387, DOI 10.5007/1980-0037.2010V12N5P387; Hoehner CM, 2008, AM J PREV MED, V34, P224, DOI 10.1016/j.amepre.2007.11.016; Hoehner CM, 2013, AM J PREV MED, V44, pE31, DOI 10.1016/j.amepre.2012.10.026; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; IBGE ( Instituto Brasileiro de Geografia e Estatistica), 2011, SIN CENS DEM 2010; Malta D.C., 2014, REV BRAS ATIVIDADE F, V19, P286, DOI DOI 10.12820/RBAFS.V.19N3P286; Mendonca BC, 2010, J PHYS ACT HEALTH, V7, pS223, DOI 10.1123/jpah.7.s2.s223; Pazin J, 2016, HEALTH PLACE, V39, P18, DOI 10.1016/j.healthplace.2016.02.005; Reis RS, 2014, MED SCI SPORT EXER, V46, P92, DOI 10.1249/MSS.0b013e3182a365ae; Ribeiro Manoel Carlos Sampaio de Almeida, 2016, Cad. Metrop., V18, P401, DOI 10.1590/2236-9996.2016-3605; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Silva I, 2015, REV BRAS AT FIS SAUD, V20, P286; Simoes EJ, 2017, PREV MED, V103, pS66, DOI 10.1016/j.ypmed.2016.09.032; Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978; WHO, 2006, PROM PHYS ACT ACT LI; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	31	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192115	10.1371/journal.pone.0192115	http://dx.doi.org/10.1371/journal.pone.0192115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401506	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400036
J	Inomata, T; Konno, S; Nagai, K; Suzuki, M; Nishimura, M				Inomata, Takashi; Konno, Satoshi; Nagai, Katsura; Suzuki, Masaru; Nishimura, Masaharu			Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PREVALENCE; CELLS	Pulmonary Mycobacterium avium complex (MAC) infection is increasing in prevalence worldwide even in immunocompetent individuals. Despite its variable clinical course, the clinical and immunological factors associated with radiographical severity and progression are not largely unknown. We aimed to study the association between the inflammatory cell and cytokine profiles at the local infected site, and the radiological severity and/or progression of pulmonary MAC infection. In this retrospective cohort study, 22 healthy subjects and 37 consecutive patients who were diagnosed as having pulmonary MAC infection by positive cultures of bronchoalveolar lavage (BAL) fluids were enrolled. The 37 patients were divided into 2 groups based on the predominant BAL inflammatory cell type: the lymphocyte-dominant (LD) group and neutrophil-dominant (ND) groups. The high-resolution computed tomography score in both the lavaged segment and whole lung and cytokines profiles were compared between the 2 groups. The clinical course after the BAL procedure was also compared between the 2 groups. Both the segment and whole lung scores in the ND group were significantly higher than the LD group (P < 0.001). Levels of IL-8 in the BAL fluids were significantly higher in the ND group compared to the LD group (P = 0.01). In contrast, levels of IL-22 were significantly lower in the ND group compared to the LD group (P < 0.001). The prevalence of patients who showed deterioration of the disease was significantly higher in the ND group (83.3%) than the LD group (12.5%) (P < 0.01). Neutrophil-predominant inflammatory response at the infected site is associated with the radiographical severity and progression of pulmonary MAC infection.	[Inomata, Takashi; Konno, Satoshi; Nagai, Katsura; Suzuki, Masaru; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan	Hokkaido University	Konno, S (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan.	satkonno@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012; Nishimura, Masaharu/A-4062-2012	Suzuki, Masaru/0000-0002-2124-6793; Nishimura, Masaharu/0000-0002-6456-4361				BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Donohue MJ, 2016, ANN AM THORAC SOC, V13, P2143, DOI 10.1513/AnnalsATS.201605-353OC; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fowler SJ, 2006, EUR RESPIR J, V28, P1204, DOI 10.1183/09031936.06.00149805; GREENING AP, 1985, THORAX, V40, P278, DOI 10.1136/thx.40.4.278; Grenier P, 1993, J Thorac Imaging, V8, P213, DOI 10.1097/00005382-199322000-00006; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; HOLLAND SM, 1994, NEW ENGL J MED, V330, P1348, DOI 10.1056/NEJM199405123301904; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Ide S, 2015, PLOS ONE, V28; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Justa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093279; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Mabuchi T, 2012, J DERMATOL SCI, V65, P4, DOI 10.1016/j.jdermsci.2011.11.007; Morimoto Kozo, 2014, Ann Am Thorac Soc, V11, P1, DOI 10.1513/AnnalsATS.201303-067OC; Odajima N, 2010, HUM PATHOL, V41, P935, DOI 10.1016/j.humpath.2009.12.009; Sakai S, 2014, CURR OPIN IMMUNOL, V29, P137, DOI 10.1016/j.coi.2014.06.003; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shigemura M, 2010, LUNG, V188, P151, DOI 10.1007/s00408-009-9218-7; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Stern AS, 1996, LIFE SCI, V58, P639, DOI 10.1016/0024-3205(95)02247-3; Wu J, 2014, PLOS ONE, V16; Yamazaki Y, 1999, AM J RESP CRIT CARE, V160, P1851, DOI 10.1164/ajrccm.160.6.9902019; Yamazaki Y, 1998, EUR RESPIR J, V11, P1227, DOI 10.1183/09031936.98.11061227	29	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190189	10.1371/journal.pone.0190189	http://dx.doi.org/10.1371/journal.pone.0190189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401501	Green Submitted, gold, Green Published			2022-12-27	WOS:000424101400003
J	Stewart, SA; Clive, AO; Maskell, NA; Penz, E				Stewart, Samuel Alan; Clive, Amelia O.; Maskell, Nick A.; Penz, Erika			Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; RANDOMIZED CONTROLLED-TRIAL; SENSITIVITY; PREVENTION	Background The SMART trial is a UK-based, multicentre RCT comparing prophylactic radiotherapy and symptom-based (deferred) radiotherapy in 203 patients with Malignant Pleural Mesothelioma who had undergone large bore pleural interventions. Using costs and quality of life data collected alongside the clinical trial, we will estimate the cost-effectiveness of prophylactic radiotherapy compared to deferred radiotherapy over a 1-year period. Methods Healthcare utilization and costs were captured during the trial. Utility weights produced by the EQ-5D questionnaire were used to determine quality-adjusted life-years (QALY) gained. The incremental cost-effectiveness ratio was calculated over the one-year trial period. Results Costs were similar in the immediate and deferred radiotherapy groups: 5480.40 pound (SD = 7040; pound n = 102) and 5461.40 pound (SD = 7770; pound n = 101) respectively. There was also no difference in QALY: 0.498 (95% CI: [0.45, 0.547]) in the prophylactic radiotherapy group versus 0.525 (95% CI: [0.471, 0.580]) in the deferred group. At a willingness to pay threshold of 30,000 pound/QALY there was only a 24% chance that prophylactic radiotherapy was cost-effective compared to deferred radiotherapy. Conclusions There was no significant effect of prophylactic radiotherapy on quality of life in the intervention group, nor was there any discernable decrease in healthcare costs. There is little evidence to suggest that prophylactic radiotherapy is a cost-effective intervention in this population.	[Stewart, Samuel Alan] Dalhousie Univ, Halifax, NS, Canada; [Clive, Amelia O.] North Bristol NHS Trust, Resp Res Unit, Bristol, Avon, England; [Maskell, Nick A.] Univ Bristol, Sch Clin Sci, Acad Resp Unit, Bristol, Avon, England; [Penz, Erika] Univ Saskatchewan, Saskatoon, SK, Canada	Dalhousie University; North Bristol NHS Trust; University of Bristol; University of Saskatchewan	Stewart, SA (corresponding author), Dalhousie Univ, Halifax, NS, Canada.	sam.stewart@dal.ca	Penz, Erika/AAZ-9541-2020	Penz, Erika/0000-0003-2610-8450; maskell, nick/0000-0002-1276-6500; Stewart, Samuel Alan/0000-0001-6299-7967	UK National Institute for Health Research (NIHR) under Research for Patient Benefit (RfPB) Programme [PB-PG-0610-22345]; National Institute for Health Research [PB-PG-0610-22345] Funding Source: researchfish	UK National Institute for Health Research (NIHR) under Research for Patient Benefit (RfPB) Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded in full by the UK National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (grant reference number PB-PG-0610-22345). The views expressed are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR, or the UK Department of Health.	Agarwal PP, 2006, RADIOLOGY, V241, P589, DOI 10.1148/radiol.2412051020; Bang HJ, 2012, J STAT THEORY PRACT, V6, P428, DOI 10.1080/15598608.2012.695571; Bayman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010589; BOUTIN C, 1995, CHEST, V108, P754, DOI 10.1378/chest.108.3.754; Bydder S, 2004, BRIT J CANCER, V91, P9, DOI 10.1038/sj.bjc.6601957; CARMICHAEL J, 1989, EUR J CANCER CLIN ON, V25, P527, DOI 10.1016/0277-5379(89)90266-6; Clive AO, 2016, LANCET ONCOL, V17, P1094, DOI 10.1016/S1470-2045(16)30095-X; Clive AO, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006673; Department of Health, 2007, MES FRAM ADV NHS ORG; Devlin N, 2007, EQ 5D VALUE SETS, V2; Health and Safety Executive, 2014, MES GREAT BRIT 2014; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; NHS England, 2016, GUID ENH TAR OPT 201; O'Rourke N, 2007, RADIOTHER ONCOL, V84, P18, DOI 10.1016/j.radonc.2007.05.022; Penz ED, 2014, CHEST, V146, P991, DOI 10.1378/chest.13-2481; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190257	10.1371/journal.pone.0190257	http://dx.doi.org/10.1371/journal.pone.0190257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401495	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400004
J	White, MC; Baxter, LS; Close, KL; Ravelojaona, VA; Rakotoarison, HN; Bruno, E; Herbert, A; Andean, V; Callahan, J; Andriamanjato, HH; Shrime, MG				White, Michelle C.; Baxter, Linden S.; Close, Kristin L.; Ravelojaona, Vaonandianina A.; Rakotoarison, Hasiniaina N.; Bruno, Emily; Herbert, Alison; Andean, Vanessa; Callahan, James; Andriamanjato, Hery H.; Shrime, Mark G.			Evaluation of a countrywide implementation of the world health organisation surgical safety checklist in Madagascar	PLOS ONE			English	Article							PATIENT OUTCOMES; MENTAL-HEALTH; MORTALITY; SURGERY; STRATEGIES; PROGRAM; QUALITY	Background The 2009 World Health Organisation (WHO) surgical safety checklist significantly reduces surgical mortality and morbidity (up to 47%). Yet in 2016, only 25% of East African anesthetists regularly use the checklist. Nationwide implementation of the checklist is reported in high-income countries, but in low-and middle-income countries (LMICs) reports of successful implementations are sparse, limited to single institutions and require intensive support. Since checklist use leads to the biggest improvements in outcomes in LMICs, methods of wide-scale implementation are needed. We hypothesized that, using a three-day course, successful wide-scale implementation of the checklist could be achieved, as measured by at least 50% compliance with six basic safety processes at three to four months. We also aimed to determine predictors for checklist utilization. Materials and methods Using a blended educational implementation strategy based on prior pilot studies we designed a three-day dynamic educational course to facilitate widespread implementation of the WHO checklist. The course utilized lectures, film, small group breakouts, participant feedback and simulation to teach the knowledge, skills and behavior changes needed to implement the checklist. In collaboration with the Ministry of Health and local hospital leadership, the course was delivered to 427 multi-disciplinary staff at 21 hospitals located in 19 of 22 regions of Madagascar between September 2015 and March 2016. We evaluated implementation at three to four months using questionnaires (with a 5-point Likert scale) and focus groups. Multivariate linear regression was used to test predictors of checklist utilization. Results At three to four months, 65% of respondents reported always using the checklist, with another 13% using it in part. Participant's years in practice, hospital size, or surgical volume did not predict checklist use. Checklist use was associated with counting instruments (p<0.05), but not with verifying: patient identity, difficult intubation risk, risk of blood loss, prophylactic antibiotic administration, or counting needles and sponges. Conclusion Use of a multi-disciplinary three-day course for checklist implementation resulted in 78% of participants using the checklist, at three months; and an increase in counting surgical instruments. Successful checklist implementation was not predicted by participant length of medical service, hospital size or surgical volume. If reproducible in other countries, widespread implementation in LMICs becomes a realistic possibility.	[White, Michelle C.; Baxter, Linden S.; Close, Kristin L.; Ravelojaona, Vaonandianina A.; Rakotoarison, Hasiniaina N.; Bruno, Emily; Herbert, Alison; Andean, Vanessa; Callahan, James] Mercy Ships, Dept Med Capac Bldg, Port Of Toamasina, Madagascar; [White, Michelle C.; Close, Kristin L.; Shrime, Mark G.] Mercy Ships, Africa Bur, Dept Med Capac Bldg, Cotonou, Benin; [Bruno, Emily] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN 38163 USA; [Bruno, Emily; Shrime, Mark G.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA USA; [Andean, Vanessa] Austin Hosp, Melbourne, Vic, Australia; [Andriamanjato, Hery H.] Minist Sante Publ, Antananarivo, Madagascar; [Shrime, Mark G.] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Off Global Surg & Hlth, Boston, MA 02114 USA	University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	White, MC (corresponding author), Mercy Ships, Dept Med Capac Bldg, Port Of Toamasina, Madagascar.; White, MC (corresponding author), Mercy Ships, Africa Bur, Dept Med Capac Bldg, Cotonou, Benin.	doctormcw@gmail.com		Baxter, Linden/0000-0002-3759-635X	National Institute for Academic Anaesthesia, U.K; Boston Children's Hospital, Boston, MA, U.S.A.; Medical Student Public Service Fund	National Institute for Academic Anaesthesia, U.K; Boston Children's Hospital, Boston, MA, U.S.A.; Medical Student Public Service Fund	LSB received a travel and education grant from the National Institute for Academic Anaesthesia, U.K. EB received funding for International travel by Boston Children's Hospital, Boston, MA, U.S.A.; and funding from the Mark Allen McConkey, M.D., Medical Student Public Service Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveling EL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003039; Bashford T, 2014, PATIENT SAF SURG, V8, DOI 10.1186/1754-9493-8-16; Bergs J, 2014, BRIT J SURG, V101, P150, DOI 10.1002/bjs.9381; Bergs J, 2015, BMJ QUAL SAF, V24, P776, DOI 10.1136/bmjqs-2015-004021; Bermudez L, 2010, WORLD J SURG, V34, P403, DOI 10.1007/s00268-009-0253-6; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Conley-Tyler M., 2005, EVAL J AUSTRALAS, V4, P3, DOI [DOI 10.1177/1035719X05004001-202, 10.1177/1035719X05004001-202]; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Enright A, 2016, A A CASE REP, V6, P366, DOI 10.1213/XAA.0000000000000335; Epiu I, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0228-8; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gil J, 2012, WORLD J SURG, V36, P2795, DOI 10.1007/s00268-012-1768-9; Haugen AS, 2015, ANN SURG, V261, P821, DOI 10.1097/SLA.0000000000000716; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kasatpibal N, 2012, SURG INFECT, V13, P50, DOI 10.1089/sur.2011.043; Kwok AC, 2013, ANN SURG, V257, P633, DOI 10.1097/SLA.0b013e3182777fa4; Lilaonitkul M, 2015, ANAESTHESIA, V70, P1345, DOI 10.1111/anae.13226; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Peters M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003968; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139; Russ S, 2013, ANN SURG, V258, P856, DOI 10.1097/SLA.0000000000000206; Scottish National Health Service, 2013, HEALTHC QUAL STRAT N; Stawicki SP, 2014, AM J SURG, V208, P65, DOI 10.1016/j.amjsurg.2013.09.029; van Klei WA, 2012, ANN SURG, V255, P44, DOI 10.1097/SLA.0b013e31823779ae; Walker IA, 2012, BRIT J ANAESTH, V109, P47, DOI 10.1093/bja/aes175; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; White MC, 2016, GLOBAL ANESTHESIA PE, V2, P158, DOI DOI 10.15761/GAPM.1000142; White MC, 2007, PEDIATR ANESTH, V17, P421, DOI 10.1111/j.1460-9592.2007.02211.x; White MC, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0266-0; WorldBank, WORLD BANK SUBN POP; Yuan CT, 2012, JT COMM J QUAL PATIE, V38, P254, DOI 10.1016/S1553-7250(12)38032-X; Yusa A, 2016, EVAL PROGRAM PLANN, V54, P11, DOI 10.1016/j.evalprogplan.2015.09.006	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191849	10.1371/journal.pone.0191849	http://dx.doi.org/10.1371/journal.pone.0191849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401465	gold, Green Submitted, Green Published			2022-12-27	WOS:000424101400024
J	Gong, JJ; Du, XY; Li, ZK; Li, XH; Guo, M; Lu, J; Wang, Y; Chen, ZW; Li, CL				Gong, Jingjing; Du, Xiaoyan; Li, Zhenkun; Li, Xiaohong; Guo, Meng; Lu, Jing; Wang, Ying; Chen, Zhenwen; Li, Changlong			Differential expression of genes identified by suppression subtractive hybridization in liver and adipose tissue of gerbils with diabetes	PLOS ONE			English	Article							CYSTATHIONINE-GAMMA-LYASE; BETA-CELL; HOMEOSTASIS; DYSFUNCTION; DISRUPTION; PROFILIN-1; RESISTANCE; ADIPOCYTE; MELLITUS; PROTEIN	Objectives We aimed at identifying genes related to hereditary type 2 diabetes expressed in the liver and the adipose tissue of spontaneous diabetic gerbils using suppression subtractive hybridization (SSH) screening. Methods Two gerbil littermates, one with high and the other with normal blood glucose level, from our previously bred spontaneous diabetic gerbil strain were used in this study. To identify differentially expressed genes in the liver and the adipose tissue, mRNA from these tissues was extracted and SSH libraries were constructed for screening. After sequencing and BLAST analyzing, up or down-regulated genes possibly involved in metabolism and diabetes were selected, and their expression levels in diabetic gerbils and normal controls were analyzed using quantitative RT-PCR and Western blotting. Results A total of 4 SSH libraries were prepared from the liver and the adipose tissue of gerbils. There are 95 up or down-regulated genes were identified to be involved in metabolism, oxidoreduction, RNA binding, cell proliferation, and differentiation or other function. Expression of 17 genes most possibly associated with diabetes was analyzed and seven genes (Sardh, Slc39a7, Pfn1, Arg1, Cth, Sod1 and P4hb) in the liver and one gene (Fabp4) in the adipose tissue were identified that were significantly differentially expressed between diabetic gerbils and control animals. Conclusions We identified eight genes associated with type 2 diabetes from the liver and the adipose tissue of gerbils via SSH screening. These findings provide further insights into the molecular mechanisms of diabetes and imply the value of our spontaneous diabetic gerbil strain as a diabetes model.	[Gong, Jingjing; Li, Zhenkun; Li, Xiaohong; Lu, Jing; Chen, Zhenwen; Li, Changlong] Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Du, Xiaoyan; Guo, Meng; Wang, Ying] Capital Med Univ, Dept Lab Anim, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, CL (corresponding author), Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China.	li-changlong@126.com	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022; Du, Xiaoyan/ABD-3167-2021; Li, Changlong/AAJ-4483-2020	Du, Xiaoyan/0000-0002-4030-7299; zhang long, li/0000-0001-6832-785X	National Science Foundation of China [31272393, 31572341, 31572348, 31402027]; Key Projects in the National Science & Technology Pillar Program [2015BA109601]; Beijing Natural Science Foundation [7141002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by the National Science Foundation of China Nos. 31272393 and 31572341 Xiaoyan Du, No 31572348 Changlong Li, No 31402027 Meng Guo, the website is http://www.nsfc.gov.cn/, Key Projects in the National Science & Technology Pillar Program (No. 2015BA109601) and the Beijing Natural Science Foundation (No.7141002), Zhenwen Chen, the website is http://bjnsf.bjkw.gov.cn/.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Badapanda C, 2013, BIOINFORMATION, V9, P216, DOI 10.6026/97320630009216; Beleznai T, 2011, AM J PHYSIOL-HEART C, V300, pH777, DOI 10.1152/ajpheart.00831.2010; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; BOQUIST L, 1972, DIABETOLOGIA, V8, P274, DOI 10.1007/BF01225571; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Chen SCC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04631-7; Cusi K, 2017, DIABETES OBES METAB, V19, P1630, DOI 10.1111/dom.12973; DU X, 2017, EXP ANIM; Fam BC, 2012, J ENDOCRINOL, V214, P313, DOI 10.1530/JOE-12-0032; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076029; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Karamchandani JR, 2015, HUM PATHOL, V46, P673, DOI 10.1016/j.humpath.2014.11.007; Li XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159420; Li Z, 2015, PLOS ONE, V10; Manna P, 2014, J BIOL CHEM, V289, P11767, DOI 10.1074/jbc.M113.524645; Muscogiuri G, 2013, DIABETES, V62, P4201, DOI 10.2337/db13-0314; Myers SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079316; Pae M, 2014, ADIPOCYTE, V3, P69, DOI 10.4161/adip.26965; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Prabhanjan M, 2016, DIABETES RES CLIN PR, V113, P160, DOI 10.1016/j.diabres.2015.12.015; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sun S, 2013, NEURO-ONCOLOGY, V15, P562, DOI 10.1093/neuonc/not005; Taniguchi S, 2012, MOL CELL ENDOCRINOL, V350, P31, DOI 10.1016/j.mce.2011.11.016; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yang KY, 2016, J ENDOCRINOL, V229, P343, DOI 10.1530/JOE-15-0517	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191212	10.1371/journal.pone.0191212	http://dx.doi.org/10.1371/journal.pone.0191212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394254	Green Published, gold, Green Submitted			2022-12-27	WOS:000424060400009
J	Gutierrez, S; Diago, MAP; Fernandez-Novales, J; Tardaguila, J				Gutierrez, Salvador; Diago, Maria A. P.; Fernandez-Novales, Juan; Tardaguila, Javier			Vineyard water status assessment using on-the-go thermal imaging and machine learning	PLOS ONE			English	Article							STOMATAL RESPONSE; STRESS INDEX; GRAPEVINE; IMAGERY; THERMOGRAPHY; VARIABILITY; PHYSIOLOGY; ENSEMBLE; CLOSURE; FOREST	The high impact of irrigation in crop quality and yield in grapevine makes the development of plant water status monitoring systems an essential issue in the context of sustainable viticulture. This study presents an on-the-go approach for the estimation of vineyard water status using thermal imaging and machine learning. The experiments were conducted during seven different weeks from July to September in season 2016. A thermal camera was embedded on an all-terrain vehicle moving at 5 km/h to take on-the-go thermal images of the vineyard canopy at 1.2 m of distance and 1.0 m from the ground. The two sides of the canopy were measured for the development of side-specific and global models. Stem water potential was acquired and used as reference method. Additionally, reference temperatures T-dry and T-wet were determined for the calculation of two thermal indices: the crop water stress index (CWSI) and the Jones index (I-g). Prediction models were built with and without considering the reference temperatures as input of the training algorithms. When using the reference temperatures, the best models casted determination coefficients R-2 of 0.61 and 0.58 for cross validation and prediction (RMSE values of 0.190 MPa and 0.204 MPa), respectively. Nevertheless, when the reference temperatures were not considered in the training of the models, their performance statistics responded in the same way, returning R-2 values up to 0.62 and 0.65 for cross validation and prediction (RMSE values of 0.190 MPa and 0.184 MPa), respectively. The outcomes provided by the machine learning algorithms support the use of thermal imaging for fast, reliable estimation of a vineyard water status, even suppressing the necessity of supervised acquisition of reference temperatures. The new developed on-the-go method can be very useful in the grape and wine industry for assessing and mapping vineyard water status.	[Gutierrez, Salvador; Diago, Maria A. P.; Fernandez-Novales, Juan; Tardaguila, Javier] Univ La Rioja, Inst Ciencias Vid & Vino, CSIC, Gobierno La Rioja, Ctra Burgos Km 6, Logrono 26007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Tardaguila, J (corresponding author), Univ La Rioja, Inst Ciencias Vid & Vino, CSIC, Gobierno La Rioja, Ctra Burgos Km 6, Logrono 26007, Spain.	javier.tardaguila@unirioja.es	Tardaguila, Javier/K-3512-2012; Fernández-Novales, Juan/K-7123-2015; Diago, Maria P/R-9547-2018; Novales, Juan Fernández/ABG-2333-2021; Gutiérrez, Salvador/T-7637-2019; Gutiérrez, Salvador/GLV-0302-2022	Tardaguila, Javier/0000-0002-6639-8723; Fernández-Novales, Juan/0000-0001-9973-2604; Diago, Maria P/0000-0003-4049-0879; Novales, Juan Fernández/0000-0001-9973-2604; Gutiérrez, Salvador/0000-0002-8205-9772; 	FP7 ERA-net project; CORE Organic Plus; European Commission; Formacion para el Personal Investigador grant by Universidad de La Rioja, Gobierno de La Rioja [299/2016]; Spanish Ministry of Economy, Industry and Competitiveness (MINECO); Ramon y Cajal grant [RYC-2015-18429]; FPI grant by Universidad de La Rioja, Gobierno de La Rioja [299/2016]	FP7 ERA-net project; CORE Organic Plus; European Commission(European CommissionEuropean Commission Joint Research Centre); Formacion para el Personal Investigador grant by Universidad de La Rioja, Gobierno de La Rioja; Spanish Ministry of Economy, Industry and Competitiveness (MINECO)(Spanish Government); Ramon y Cajal grant(Spanish Government); FPI grant by Universidad de La Rioja, Gobierno de La Rioja	This work is part of the RESOLVE project, for which the authors acknowledge the financial support provided by transnational funding bodies, being partners of the FP7 ERA-net project, CORE Organic Plus, and the cofund from the European Commission. Salvador Gutierrez would like to acknowledge the research founding Formacion para el Personal Investigador grant 299/2016 by Universidad de La Rioja, Gobierno de La Rioja. Dr. Maria P. Diago is funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) with a Ramon y Cajal grant RYC-2015-18429.; The authors acknowledge Carlos Poblete for his support in the design of the experimental layout and Daniel Sepulveda and Marjolaine Chatin for their help with the measurement of the stem water potential. Special thanks to Luis Angel Garcia for his support and to Bodegas Vivanco, for providing the vineyard to conduct the study. This work is part of the RESOLVE project, for which the authors acknowledge the financial support provided by transnational funding bodies, being partners of the FP7 ERA-net project, CORE Organic Plus, and the cofund from the European Commission. Salvador Gutierrez would like to acknowledge the research founding FPI grant 299/2016 by Universidad de La Rioja, Gobierno de La Rioja. Dr. Maria P. Diago is funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) with a Ramon y Cajal grant RYC-2015-18429.	Acevedo-Opazo C, 2008, PRECIS AGRIC, V9, P285, DOI 10.1007/s11119-008-9073-1; Acevedo-Opazo C, 2010, PRECIS AGRIC, V11, P358, DOI 10.1007/s11119-010-9164-7; Baluja J, 2012, IRRIGATION SCI, V30, P511, DOI 10.1007/s00271-012-0382-9; Bellvert J, 2016, AUST J GRAPE WINE R, V22, P307, DOI 10.1111/ajgw.12173; Bellvert J, 2015, IRRIGATION SCI, V33, P81, DOI 10.1007/s00271-014-0456-y; Bellvert J, 2014, PRECIS AGRIC, V15, P361, DOI 10.1007/s11119-013-9334-5; Brillante L, 2016, PRECIS AGRIC, V17, P637, DOI 10.1007/s11119-016-9441-1; Brillante L, 2016, FRONT PLANT SCI, P7; Brillante L, 2015, COMPUT ELECTRON AGR, V117, P186, DOI 10.1016/j.compag.2015.07.017; Cohen Y, 2015, PRECIS AGRIC, V16, P311, DOI 10.1007/s11119-014-9378-1; Cohen Y, 2016, PRECIS AGRIC, P1; Costa JM, 2010, USE THERMAL IMAGING; Costa JM, 2012, FUNCT PLANT BIOL, V39, P179, DOI 10.1071/FP11156; De Bei R, 2011, AUST J GRAPE WINE R, V17, P62, DOI 10.1111/j.1755-0238.2010.00117.x; Diago MP, 2017, AUST J GRAPE WINE R, V23, P409, DOI 10.1111/ajgw.12283; Fernaandez-Novales J, 2017, BIOSYSTEMS ENG; Fernandez JE, 2014, AGR WATER MANAGE, V142, P99, DOI 10.1016/j.agwat.2014.04.017; Fuentes S, 2012, IRRIGATION SCI, V30, P523, DOI 10.1007/s00271-012-0375-8; Grant OM, 2016, J HORTIC SCI BIOTECH, V91, P43, DOI 10.1080/14620316.2015.1110991; Grant OM, 2007, J EXP BOT, V58, P815, DOI 10.1093/jxb/erl153; Grant OM, 2006, PHYSIOL PLANTARUM, V127, P507, DOI 10.1111/j.1399-3054.2006.00686.x; Gutierrez S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16020236; Gutierrez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143197; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Han J, 2012, MOR KAUF D, P1; HARRISONMURRAY RS, 1991, J HORTIC SCI, V66, P141, DOI 10.1080/00221589.1991.11516136; Hinkelmann K., 2007, DESIGN ANAL EXPT INT; IDSO SB, 1981, AGR METEOROL, V24, P45, DOI 10.1016/0002-1571(81)90032-7; Intrigliolo D, 2009, 6 INT S IRR HORT CRO, V889, P99; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Jones Hamlyn G., 2003, Journal of Agricultural Meteorology, V59, P205, DOI 10.2480/agrmet.59.205; Jones HG, 1999, AGR FOREST METEOROL, V95, P139, DOI 10.1016/S0168-1923(99)00030-1; Jones HG, 2004, J EXP BOT, V55, P2427, DOI 10.1093/jxb/erh213; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Meron M, 2010, PRECIS AGRIC, V11, P148, DOI 10.1007/s11119-009-9153-x; Costa JM, 2013, J EXP BOT, V64, P3937, DOI 10.1093/jxb/ert029; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Pou A, 2014, AGR WATER MANAGE, V134, P60, DOI 10.1016/j.agwat.2013.11.010; Prieto JA, 2010, J INT SCI VIGNE VIN, V44, P9; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Santos AO, 2009, SCI AGR, V66, P287, DOI 10.1590/S0103-90162009000300001; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schultz HR, 2010, AUST J GRAPE WINE R, V16, P4, DOI 10.1111/j.1755-0238.2009.00074.x; Sepulveda-Reyes D, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100822; Soar CJ, 2006, AUST J GRAPE WINE R, V12, P2, DOI 10.1111/j.1755-0238.2006.tb00038.x; Tardaguila J, 2017, J SCI FOOD AGR, V97, P3772, DOI 10.1002/jsfa.8241; Witten IH, 2011, MOR KAUF D, P1	49	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192037	10.1371/journal.pone.0192037	http://dx.doi.org/10.1371/journal.pone.0192037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389982	Green Published, gold			2022-12-27	WOS:000423793400055
J	Legault, R; Zogg, GP; Travis, SE				Legault, Rene, II; Zogg, Gregory P.; Travis, Steven E.			Competitive interactions between native Spartina alterniflora and non-native Phragmites australis depend on nutrient loading and temperature	PLOS ONE			English	Article							COMMON REED; INVASIVE PLANTS; DIVERSITY; NITROGEN; GROWTH; EXPANSION; SALINITY; LINEAGES; WETLANDS; MARSHES	We explored the nature and impact of competitive interactions between the salt marsh foundational plant Spartina alterniflora and invasive Phragmites australis in New England under varying levels of anthropogenic influence from nutrient loading and temperature warming. Plants were grown with and without competition in mesocosms over a four-month growing season. Mesocosms were split evenly among three levels of nutrient additions and two temperatures varying by an average of similar to 3 degrees C, manipulated using small greenhouses. We measured aboveground productivity as total biomass, numbers of new stems, and mean stem height. Nutrient enrichment increased all growth parameters, while competition generally reduced aboveground biomass and the production of new stems in both species. Most importantly, smooth cordgrass suffered no negative consequences of competition when no nutrients were added and temperature was elevated. The results of this study suggest that minimizing nutrient loading into coastal marshes could be an important factor in slowing the spread of common reed into the low marsh zone of New England salt marshes as global temperatures continue to warm.	[Legault, Rene, II; Zogg, Gregory P.; Travis, Steven E.] Univ New England, Dept Biol, Biddeford, ME 04005 USA; [Legault, Rene, II] Rhode Isl Dept Environm Management, Off Water Resources, Providence, RI USA	University of New England - Maine	Travis, SE (corresponding author), Univ New England, Dept Biol, Biddeford, ME 04005 USA.	stravis@une.edu		Travis, Steven/0000-0001-9338-8953	Maine Association of Wetland Scientists; New England Estuarine Research Society	Maine Association of Wetland Scientists; New England Estuarine Research Society	This study was supported by grants from the Maine Association of Wetland Scientists and the New England Estuarine Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bernal B, 2017, GLOBAL CHANGE BIOL, V23, P2104, DOI 10.1111/gcb.13539; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Tho BT, 2016, BIOL INVASIONS, V18, P2563, DOI 10.1007/s10530-016-1158-6; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; Busso CA, 2013, INTERCIENCIA, V38, P95; Caplan JS, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu020; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; Crosby SC, 2017, ESTUAR COAST, V40, P213, DOI 10.1007/s12237-016-0142-9; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Douhovnikoff V, 2014, AM J BOT, V101, P1577, DOI 10.3732/ajb.1400177; Eller F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01833; Farnsworth EJ, 2003, WETLANDS, V23, P750, DOI 10.1672/0277-5212(2003)023[0750:CEOFWP]2.0.CO;2; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Gornish ES, 2013, AM J BOT, V100, P1422, DOI 10.3732/ajb.1300046; Hanson A, 2016, ESTUAR COAST, V39, P1376, DOI 10.1007/s12237-016-0090-4; Hazelton Eric L G, 2014, AoB Plants, V6, DOI 10.1093/aobpla/plu001; Holdredge C, 2011, BIOL INVASIONS, V13, P423, DOI 10.1007/s10530-010-9836-2; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; IPCC, 2014, CLIMATE CHANGE 2014; Johnson DS, 2016, ECOL APPL, V26, P2647, DOI 10.1002/eap.1402; Kettenring KM, 2012, BIOL INVASIONS, V14, P2489, DOI 10.1007/s10530-012-0246-5; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; McCormick MK, 2010, J ECOL, V98, P1369, DOI 10.1111/j.1365-2745.2010.01712.x; Medeiros DL, 2013, WETLANDS, V33, P421, DOI 10.1007/s13157-013-0400-6; Minchinton TE, 2003, ECOL APPL, V13, P1400, DOI 10.1890/02-5136; Moore GE, 2012, NORTHEAST NAT, V19, P611, DOI 10.1656/045.019.0406; Mozdzer TJ, 2011, MAR ECOL PROG SER, V433, P43, DOI 10.3354/meps09117; Mozdzer TJ, 2016, BIOL INVASIONS, V18, P2619, DOI 10.1007/s10530-016-1156-8; Mozdzer TJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt048; Mozdzer TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042794; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Mozdzer TJ, 2010, J ECOL, V98, P451, DOI 10.1111/j.1365-2745.2009.01625.x; Mykleby Philip M., 2015, Great Plains Research, V25, P63; Peter CR, 2010, ESTUAR COAST, V33, P1225, DOI 10.1007/s12237-010-9328-8; Price AL, 2014, WETLANDS, V34, P369, DOI 10.1007/s13157-013-0504-z; Ravit B, 2007, WETLANDS, V27, P915, DOI 10.1672/0277-5212(2007)27[915:TEODAN]2.0.CO;2; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saltonstall K, 2007, AQUAT BOT, V86, P331, DOI 10.1016/j.aquabot.2006.12.003; Sciance MB, 2016, BIOL INVASIONS, V18, P2661, DOI 10.1007/s10530-016-1136-z; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Slater MA, 2017, AQUAT BOT, V136, P220, DOI 10.1016/j.aquabot.2016.10.006; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Watson EB, 2017, ESTUAR COAST, V40, P617, DOI [10.1007/s12237-016-0166-1, 10.1007/s12237-016-0069-1]; Windham L, 2001, WETLANDS, V21, P179, DOI 10.1672/0277-5212(2001)021[0179:COBPAD]2.0.CO;2; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673	54	13	13	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192234	10.1371/journal.pone.0192234	http://dx.doi.org/10.1371/journal.pone.0192234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389960	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400079
J	Mochida, Y; Yamamoto, T; Fuchida, S; Aida, J; Kondo, K				Mochida, Yuki; Yamamoto, Tatsuo; Fuchida, Shinya; Aida, Jun; Kondo, Katsunori			Does poor oral health status increase the risk of falls?: The JAGES Project Longitudinal Study	PLOS ONE			English	Article							POSTURAL SWAY; OLDER-ADULTS; INJURIES; HOME; AGE	We sought to examine if self-reported oral health conditions regarding difficulty eating tough foods, dry mouth, choking, number of teeth and denture use are associated with incident falls. Our study was based on panel data from the Japan Gerontological Evaluation Study conducted in 2010 and 2013 using self-administered questionnaires. Data from 19,995 male and 20,858 female community-dwelling older people aged >= 65 years without a history of falls within the previous year in 2010 were analyzed. Multilevel logistic regression models were used to determine the association between poor oral health in 2010 and multiple incident falls in 2013 after adjusting for possible confounders and considering differences in municipalities. The percentage of males and females who reported falls in 2013 were 2.4% and 2.1%, respectively. After adjusting for age, educational attainment, equivalized income, depression, self-rated health, instrumental activities of daily living, body mass index, present illness related to falls, social participation, walking in min/day, alcohol drinking status, and municipality population density, dry mouth in males (odds ratio [OR] = 1.41; 95% confidence interval [CI]: 1.12-1.77) and choking in females (OR = 1.64; 95% CI: 1.27-2.11) were significantly associated with incident falls. Difficulty eating tough foods in both sexes and choking in males were marginally associated with incident falls (p<0.1). Females having 10-19 teeth without dentures (OR = 1.63; 95% CI: 1.14-2.31), <= 9 teeth with dentures (OR = 1.36; 95% CI: 1.03-1.80), and <= 9 without dentures (OR = 1.46; 95% CI: 1.02-2.08) were significantly associated with incident falls compared with those having >= 20 teeth, respectively. These findings suggest that poor oral function, having fewer teeth, and not using dentures are predictors of incident falls. Further studies are needed to determine whether improving oral health can reduce the risk of falls.	[Mochida, Yuki; Yamamoto, Tatsuo; Fuchida, Shinya] Kanagawa Dent Univ, Grad Sch Dent, Div Dent Sociol, Dept Oral Sci, Yokosuka, Kanagawa, Japan; [Aida, Jun] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Obu, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan	Kanagawa Dental College; Tohoku University; Chiba University; National Center for Geriatrics & Gerontology	Yamamoto, T (corresponding author), Kanagawa Dent Univ, Grad Sch Dent, Div Dent Sociol, Dept Oral Sci, Yokosuka, Kanagawa, Japan.	yamamoto.tatsuo@kdu.ac.jp	Aida, Jun/S-9371-2019; Kondo, Katsunori/AAI-6373-2020	Aida, Jun/0000-0002-8405-9872; Yamamoto, Tatsuo/0000-0001-5147-3711	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities; Japan Society for the Promotion of Science (JSPS) KAKENHI [22330172, 22390400, 23243070, 23590786, 23790710, 24390469, 24530698]; Health Labour Sciences Research [H22-Choju-Shitei-008, H24-Junkanki [Seishu]-Ippan-007, H24-Chikpkibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015]; Research and Development Grants for Longevity Science from the Japan Agency for Medical Research and Development (AMED); Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology [24-17, 24-23]; Japan Foundation For Aging And Health [J09KF00804];  [24683018];  [25253052];  [25870573];  [25870881];  [26285138];  [26882010];  [15H01972];  [15H05059];  [H25-Choju-Ippan-003];  [H26-Irryo-Shitei-003 [Fukkou]];  [H26-Choju-lppan-006];  [H27-Ninchisyou-Ippan-001]; Grants-in-Aid for Scientific Research [15H05059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research; Research and Development Grants for Longevity Science from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology; Japan Foundation For Aging And Health; ; ; ; ; ; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (2009-2013), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers (22330172, 22390400, 23243070, 23590786, 23790710, 24390469, 24530698, 24683018, 25253052, 25870573, 25870881, 26285138, 26882010, 15H01972, 15H05059), Health Labour Sciences Research Grants (H22-Choju-Shitei-008, H24-Junkanki [Seishu]-Ippan-007, H24-Chikpkibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Choju-Ippan-003, H26-Irryo-Shitei-003 [Fukkou], H26-Choju-lppan-006, H27-Ninchisyou-Ippan-001), Research and Development Grants for Longevity Science from the Japan Agency for Medical Research and Development (AMED), Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology (24-17, 24-23), and the Japan Foundation For Aging And Health (J09KF00804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study used data from the Japan Gerontological Evaluation Study (JAGES), which was supported by the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)Supported Program for the Strategic Research Foundation at Private Universities (2009-2013), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers (22330172, 22390400, 23243070, 23590786, 23790710, 24390469, 24530698, 24683018, 25253052, 25870573, 25870881, 26285138, 26882010, 15H01972, 15H05059), Health Labour Sciences Research Grants (H22-Choju-Shitei-008, H24-Junkanki [Seishu]-Ippan-007, H24-Chikyu-kibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Choju-Ippan-003, H26-Irryo-Shitei-003 [Fukkou], H26-Choju-Ippan-006, H27-Ninchisyou-Ippan-001), Research and Development Grants for Longevity Science from the Japan Agency for Medical Research and Development (AMED), Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology (24-17, 24-23), and the Japan Foundation For Aging And Health (J09KF00804).	Arai H, 2015, GERIATR GERONTOL INT, V15, P518, DOI 10.1111/ggi.12397; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Cabinet office Government of Japan, 2015, ANN REP AG SOC; Gangloff P, 2000, NEUROSCI LETT, V293, P203, DOI 10.1016/S0304-3940(00)01528-7; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Hayashi T, 2014, J HLTH WELFARE STAT, V61, P1; Hayashi T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/537614; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Kim JW, 2014, BIO-MED MATER ENG, V24, P2707, DOI 10.3233/BME-141088; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Koyama S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010768; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Masumoto Taeko, 2015, Nihon Koshu Eisei Zasshi, V62, P390, DOI 10.11236/jph.62.8_390; Matsuda R., 2010, HLTH INEQUALITIES JA, P37; Moreland JD, 2004, J AM GERIATR SOC, V52, P1121, DOI 10.1111/j.1532-5415.2004.52310.x; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Okubo M, 2010, J PROSTHODONT RES, V54, P42, DOI 10.1016/j.jpor.2009.09.002; Okuyama N, 2011, ARCH GERONTOL GERIAT, V52, P172, DOI 10.1016/j.archger.2010.03.011; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Prudham D, 1981, Age Ageing, V10, P141; Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001; Takata Y, 2004, ORAL DIS, V10, P44, DOI 10.1046/j.1354-523X.2003.00972.x; Tamura BK, 2013, J AM MED DIR ASSOC, V14, P649, DOI 10.1016/j.jamda.2013.02.022; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Ueno Megumi, 2006, Nihon Ronen Igakkai Zasshi, V43, P92; Villa A, 2016, ORAL DIS, V22, P365, DOI 10.1111/odi.12402; World Health Organization (WHO) Ageing and Life Course Unit, WHO GLOB REP FALLP; Xuan SY, 2012, GERODONTOLOGY, V29, pE988, DOI 10.1111/j.1741-2358.2011.00596.x; Xue QL, 2008, J GERONTOL A-BIOL, V63, P984, DOI 10.1093/gerona/63.9.984; Yamamoto T, 2012, HLTH SCI HLTH CARE, V12, P4; Yamamoto T, 2012, BMJ OPEN, V31, P2; Yamamoto T, 2017, J AM GERIATR SOC, V65, P1079, DOI 10.1111/jgs.14777; Yamashita Y, 2015, JAPANESE J HLTH PROM, V5, P9	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192251	10.1371/journal.pone.0192251	http://dx.doi.org/10.1371/journal.pone.0192251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389975	gold, Green Published, Green Submitted			2022-12-27	WOS:000423793400083
J	Sun, WP; Yao, SH; Tang, JL; Liu, S; Chen, J; Deng, DQ; Zeng, CP				Sun, Weiping; Yao, Sihong; Tang, Jielong; Liu, Shuai; Chen, Juan; Deng, Daqing; Zeng, Chunping			Integrative analysis of super enhancer SNPs for type 2 diabetes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; AORTIC STIFFNESS; DOWN-REGULATION; ADIPOSE-TISSUE; PPAR-GAMMA; ASSOCIATION; TCF7L2	Clinical studies in type 2 diabetes (T2D) primarily focused on the single nucleotide polymor-phisms (SNPs) located in protein-coding regions. Recently, the SNPs located in noncoding regions have also been recognized to play an important role in disease susceptibility. The super enhancer is a cluster of transcriptional enhancers located in noncoding regions. It plays a critical role in cell-type specific gene expression. However, the exact mechanism of the super enhancer SNPs for T2D remains unclear. In this study, we integrated genomewide association studies (GWASs) and T2D cell/tissue-specific histone modification ChIP-seq data to identify T2D-associated SNPs in super enhancer, followed by comprehensive bioinformatics analyses to further explore the functional importance of these SNPs. We identified several interesting T2D super enhancer SNPs. Interesting, most of them were clustered within the same or neighboring super enhancers. A number of SNPs are involved in chromatin interactive regulation and/or potentially influence the binding affinity of transcription factors. Gene Ontology (GO) analysis showed a significant enrichment in several well-known signaling pathways and regulatory process, e.g. WNT signaling pathway, which plays a key role in T2D metabolism. Our results highlighted the potential functional importance of T2D super enhancer SNPs, which may yield novel insights into the pathogenesis of T2D.	[Sun, Weiping; Chen, Juan; Deng, Daqing] First Peoples Hosp Xiangtan City, Dept Geriatr, Xiangtan, Peoples R China; [Yao, Sihong] Jishou Univ, Sch Med, Dept Clin Med, Jishou, Peoples R China; [Tang, Jielong; Liu, Shuai; Zeng, Chunping] Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China	Jishou University; Guangzhou Medical University	Zeng, CP (corresponding author), Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	zcp193@163.com			technological innovation project of Foshan City [2017AG100102]; medical technology research fund of Guangdong province [A2017575]	technological innovation project of Foshan City; medical technology research fund of Guangdong province	This study was partially supported or benefited by grants from technological innovation project of Foshan City (2017AG100102), and medical technology research fund of Guangdong province (A2017575).	Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardoso CRL, 2013, DIABETES CARE, V36, P3772, DOI 10.2337/dc13-0506; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Choi SS, 2016, DIABETES, V65, P829, DOI 10.2337/db15-1382; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Dworacki G, 2015, IMMUNOLOGY, V146, P456, DOI 10.1111/imm.12522; Ehnert S, 2015, EXP CELL RES, V332, P247, DOI 10.1016/j.yexcr.2014.12.011; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Golbidi S, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00136; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo LY, 2016, NUCLEIC ACIDS RES, V44, pD888, DOI 10.1093/nar/gkv1107; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Karoli Ritu, 2014, Indian J Endocrinol Metab, V18, P552, DOI 10.4103/2230-8210.137518; Kebapci N, 2007, NEUROUROL URODYNAM, V26, P814, DOI 10.1002/nau.20422; Khan IU, 2008, ANTI-CANCER AGENT ME, V8, P186; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Kumar NP, 2015, IMMUNOLOGY, V144, P677, DOI 10.1111/imm.12421; Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lekva T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136892; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mansour AS, 2013, J HYPERTENS, V31, P1584, DOI 10.1097/HJH.0b013e3283613074; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Santos FRM, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-55; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Reimann F, 2016, DIABETOLOGIA, V59, P229, DOI 10.1007/s00125-015-3825-z; Saddik Basema, 2015, Online J Public Health Inform, V7, pe214, DOI 10.5210/ojphi.v7i2.6011; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Seeley RJ, 2016, NAT MED, V22, P709, DOI 10.1038/nm.4137; Shaw-Smith C, 2014, DIABETES, V63, P2888, DOI 10.2337/db14-0061; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Siti SD, 2012, BLOOD, V120, P1281; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Wang QJ, 2015, APMIS, V123, P146, DOI 10.1111/apm.12330; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Willemsen G, 2015, TWIN RES HUM GENET, V18, P762, DOI 10.1017/thg.2015.83; Xia C, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6494795; Yang Y, 2015, GENET MOL RES, V14, P10064, DOI 10.4238/2015.August.21.13; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou JB, 2015, PEERJ, V3, DOI 10.7717/peerj.1304	71	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192105	10.1371/journal.pone.0192105	http://dx.doi.org/10.1371/journal.pone.0192105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385209	Green Submitted, Green Published, gold			2022-12-27	WOS:000423668400077
J	Chen, YZ; Lu, XY; Liu, GD				Chen, Yao-Zhong; Lu, Xiao-Ying; Liu, Gen-Di			Effects of different radio-opacifying agents on physicochemical and biological properties of a novel root-end filling material	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; CYTOTOXICITY; HYDROXYAPATITE; RADIOPACITY; CEMENT; GLASS; BIOCOMPATIBILITY; FIBROBLASTS; RESPONSES	Background/Purpose Radio-opacity is an essential attribute of ideal root-end filling materials because it is important for clinicians to observe root canal filling and to facilitate the follow-up instructions. The novel root-end filling material (NRFM) has good cytocompatibility and physicochemical properties but low intrinsic radio-opacity value. To improve its radio-opacity value, three novel radio-opaque root-end filling materials (NRRFMs) were developed by adding barium sulphate (NRFM-Ba), bismuth trioxide (NRFM-Bi) and zirconium dioxide (NRFM-Zr) to NRFM, respectively. The purpose of this study was to identify the suitable radio-opacifier for NRFM through evaluating their physicochemical and biological properties, in comparison with NRFM and glass ionomer cement (GIC). Methods NRRFMs were characterized using X-ray diffraction (XRD) and Fourier transform infrared spectrophotometry (FTIR). Physicochemical properties including setting time, compressive strength, porosity, pH variation, solubility, washout resistance, contact angle and radiopacity were investigated. Cytocompatibility of both freshly mixed and set NRRFMs was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Alkaline phosphatase (ALP) activity assay and alizarin red staining were used to investigate the osteogenic differentiation potential of NRFM-Zr. Data were analyzed using two-way ANOVA (pH variation, solubility and ALP activity) and one-way ANOVA (for the other variables). Results (1) NRRFMs were primarily composed of hydroxyapatite, calcium carboxylate salt and the corresponding radio-opacity agents (barium sulphate, bismuth trioxide or zirconium dioxide). (2) Besides similar physicochemical properties in terms of setting time, pH variation, solubility, washout resistance and contact angle to NRFM, NRFM-Bi and NRFM-Zr exhibited lower porosity and greater compressive strength after being set for 7 days and their radio-opacity were greater than the 3 mm aluminium thickness specified in ISO 6876 (2001). (3) MTT assay revealed that freshly mixed and set NRFM-Zr presented better cell viability than NRFM-Ba and NRFM-Bi at 24 hours and 48 hours (P< 0.05). (4) NRFM-Zr significantly enhanced ALP activity and calcium formation of human osteoblast-like Saos-2 cells when compared with negative group and GIC (P< 0.05). Conclusion NRFM-Zr presents desirable physicochemical and biological properties, thus zirconium dioxide may be a suitable radio-opacifier for NRFM.	[Chen, Yao-Zhong; Liu, Gen-Di] Southeast Univ, Zhongda Hosp, Med Coll, Dept Operat Dent & Endodont, Nanjing, Jiangsu, Peoples R China; [Chen, Yao-Zhong; Lu, Xiao-Ying] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Lu, XY (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	luxy@seu.edu.cn		chen, yaozhong/0000-0002-2215-7354	Natural Science Foundation of China [30270391]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100092110027]; Research Fund of Health and Family Planning Commission of Jiangsu Province [H201642]; Medical Science Development Fund of Health and Family Planning Commission of Nanjing [YKK15244]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Fund of Health and Family Planning Commission of Jiangsu Province; Medical Science Development Fund of Health and Family Planning Commission of Nanjing	This work was supported by Natural Science Foundation of China (Grant No. 30270391 to Xiaoying Lu), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20100092110027 to Xiaoying Lu), the Research Fund of Health and Family Planning Commission of Jiangsu Province (Grant No. H201642 to Yaozhong Chen) and the Medical Science Development Fund of Health and Family Planning Commission of Nanjing (Grant No. YKK15244 to Yaozhong Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2009, 109935 ISO; Antonijevic D, 2014, CLIN ORAL INVEST, V18, P1597, DOI 10.1007/s00784-013-1130-0; ARAKI K, 1993, J ENDODONT, V19, P554, DOI 10.1016/S0099-2399(06)81285-9; Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015; Bodrumlu E, 2008, AUST ENDOD J, V34, P30, DOI 10.1111/j.1747-4477.2007.00085.x; Bortoluzzi EA, 2009, ORAL SURG ORAL MED O, V108, P628, DOI 10.1016/j.tripleo.2009.04.044; Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x; Camilleri J, 2010, INT ENDOD J, V43, P21, DOI 10.1111/j.1365-2591.2009.01621.x; Camilleri J, 2010, J ENDODONT, V36, P502, DOI 10.1016/j.joen.2009.10.018; Cao ZD, 2016, CHINESE MED J-PEKING, V129, P194, DOI 10.4103/0366-6999.173489; Chen CC, 2002, J BIOMED MATER RES, V60, P452, DOI 10.1002/jbm.1291; Chen YZ, 2013, INT ENDOD J, V46, P556, DOI 10.1111/iej.12028; Cho Y, 2015, J DENT RES, V94, P491, DOI 10.1177/0022034514566432; Chong B, 2005, ENDOD TOP, V11, P114; Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018; Gjorgievska E, 2015, MICROSC MICROANAL, V21, P392, DOI 10.1017/S1431927615000057; Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032; Haglund R, 2003, ORAL SURG ORAL MED O, V95, P739, DOI 10.1067/moe.2003.231; Han B, 2009, ACTA BIOMATER, V5, P3165, DOI 10.1016/j.actbio.2009.04.024; Duarte MAH, 2009, J ENDODONT, V35, P737, DOI 10.1016/j.joen.2009.02.006; International Organization for Standardization (ISO), 2009, 1099312 ISO; International Standards Organization, 2001, 6876 ISO; Jafarnia B, 2009, ORAL SURG ORAL MED O, V107, P739, DOI 10.1016/j.tripleo.2009.01.009; Khashaba RM, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/691452; Kim Hyeongseok, 2013, International Journal of Stem Cells, V6, P67; Kiran S, 2009, BIOMATERIALS, V30, P5552, DOI 10.1016/j.biomaterials.2009.06.049; Kulan P, 2016, J ENDODONT, V42, P276, DOI 10.1016/j.joen.2015.10.015; Lubben B, 2001, LARYNGO RHINO OTOL, V80, P214; Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011; Min KS, 2007, J ENDODONT, V33, P1342, DOI 10.1016/j.joen.2007.07.012; Mohn D, 2010, INT ENDOD J, V43, P210, DOI 10.1111/j.1365-2591.2009.01660.x; Moshaverinia A, 2008, ACTA BIOMATER, V4, P432, DOI 10.1016/j.actbio.2007.07.011; Murray PE, 2000, BIOMATERIALS, V21, P1711, DOI 10.1016/S0142-9612(00)00056-9; Nagaraja BM, 2007, J COLLOID INTERF SCI, V316, P645, DOI 10.1016/j.jcis.2007.09.004; Ndong F, 2012, INT ENDOD J, V45, P557, DOI 10.1111/j.1365-2591.2012.02011.x; Pepiol A, 2011, BIOMATERIALS, V32, P6389, DOI 10.1016/j.biomaterials.2011.05.056; SCHMALZ G, 1994, J MATER SCI-MATER M, V5, P43, DOI 10.1007/BF00121153; Schwarze T, 2002, J ENDODONT, V28, P784, DOI 10.1097/00004770-200211000-00009; Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X; Shen YD, 2016, J BIOMED MATER RES B, V104, P96, DOI 10.1002/jbm.b.33363; Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9; Sun M, 2010, ACTA POLYM SIN, P1430, DOI 10.3724/SP.J.1105.2010.09444; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2; Viapiana R, 2014, INT ENDOD J, V47, P437, DOI 10.1111/iej.12167; Viapiana Raqueli, 2014, Dent Mater, V30, P1005, DOI 10.1016/j.dental.2014.05.007; Zhang W, 2010, INT ENDOD J, V43, P769, DOI 10.1111/j.1365-2591.2010.01733.x; Zhang XC, 2017, MOL MED REP, V15, P1673, DOI 10.3892/mmr.2017.6165; Zheng M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140278	48	1	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191123	10.1371/journal.pone.0191123	http://dx.doi.org/10.1371/journal.pone.0191123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420559	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900011
J	Tang, H; Xu, LX; Hu, FX				Tang, Hao; Xu, Liuxiong; Hu, Fuxiang			Hydrodynamic characteristics of knotted and knotless purse seine netting panels as determined in a flume tank	PLOS ONE			English	Article							FISH CAGES; NETS; DRAG	Nylon (PA) netting is widely used in purse seines and other fishing gears due to its high strength and good sinking performance. However, hydrodynamic properties of nylon netting of different characteristics are poorly understood. This study investigated hydrodynamic characteristics of nylon netting of different knot types and solidity ratios under different attack angles and flow velocities. It was found that the hydrodynamic coefficient of netting panels was related to Reynolds number, solidity ratio, attack angle, knot type and twine construction. The solidity ratio was found to positively correlate with drag coefficient when the netting was normal to the flow (C-D90), but not the case when the netting was parallel to the flow (C-D0). For netting panels inclined to the flow, the inclined drag coefficient had a negative relationship with the solidity ratio for attack angles between 0 degrees and 50 degrees, but a positive relationship for attack angles between 50 degrees and 90 degrees. The lift coefficient increased with the attack angle, reaching the culminating point at an attack angle of 50 degrees, before subsequent decline. We found that the drag generated by knot accounted for 15-25% of total drag, and the knotted netting with higher solidity ratio exhibited a greater C-D0, but it was not the case for the knotless netting. Compared to knotless polyethylene (PE) netting, the drag coefficients of knotless PA netting were dominant at higher Reynolds number (Re>2200).	[Tang, Hao; Xu, Liuxiong] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Tang, Hao] Tongji Univ, Sch Ocean & Earth Sci, Shanghai, Peoples R China; [Xu, Liuxiong] Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China; [Xu, Liuxiong; Hu, Fuxiang] Shanghai Educ Commiss, Summit & Highland Discipline Construct Fisherie, Shanghai, Peoples R China; [Hu, Fuxiang] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo, Japan	Shanghai Ocean University; Tongji University; National Engineering Research Center for Oceanic Fisheries; Tokyo University of Marine Science & Technology	Xu, LX (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.; Xu, LX (corresponding author), Natl Engn Res Ctr Ocean Fisheries, Shanghai, Peoples R China.; Xu, LX (corresponding author), Shanghai Educ Commiss, Summit & Highland Discipline Construct Fisherie, Shanghai, Peoples R China.	lxxu@shou.edu.cn	Tang, Hao/GXH-6097-2022	Tang, Hao/0000-0002-3393-1683	Shanghai Education Commission "Summit and Highland" Discipline Construction for Fisheries Sciences [B2-5005-13-0001-5]; "Summit and Highland" Discipline Construction for Fisheries Sciences, the Shanghai Education Commission [B2-5005-13-0001-5]	Shanghai Education Commission "Summit and Highland" Discipline Construction for Fisheries Sciences; "Summit and Highland" Discipline Construction for Fisheries Sciences, the Shanghai Education Commission	Funding for this project was provided by the Shanghai Education Commission Summit and Highland Discipline Construction for Fisheries Sciences (No. B2-5005-13-0001-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by Summit and Highland Discipline Construction for Fisheries Sciences, the Shanghai Education Commission (No. B2-5005-13-0001-5). We would like to express many thanks to Shuchuang Dong from Tokyo University of Marine Science and Technology for his assistance in experimental work. Our thanks also extend to Professor He Pingguo, University of Massachusetts for his critical comments and English edits.	AARSNES JV, 1990, ENGINEERING FOR OFFSHORE FISH FARMING, P137; Balash C, 2009, AQUACULT ENG, V41, P14, DOI 10.1016/j.aquaeng.2009.04.003; Cha BJ, 2013, AQUACULT ENG, V56, P79, DOI 10.1016/j.aquaeng.2013.05.002; Fridman AL, 1976, RYBOLOVNOE HOZYAJSTV, V6, P38; Hosseini SA, 2011, FISHERIES SCI, V77, P503, DOI 10.1007/s12562-011-0371-6; Kawakami T., 1964, MODERN FISHING GEAR, V2; Kim HY, 2007, FISH RES, V88, P109, DOI 10.1016/j.fishres.2007.08.007; Kumazawa T, 2012, NIPPON SUISAN GAKK, V78, P180, DOI 10.2331/suisan.78.180; LoLand G, 1991, CURRENT FORCES FLOW; Matsuda K., 2001, PHYS FISHING GEAR, P29; Milne P. H, 1979, FISH SHELLFISH FARMI, P185; Miyazaki Y., 1964, J TOKYO U FISH, V50, P95; Tsukrov I, 2003, OCEAN ENG, V30, P251, DOI 10.1016/S0029-8018(02)00021-5; Tsukrov I, 2011, OCEAN ENG, V38, P1979, DOI 10.1016/j.oceaneng.2011.09.019; Zhan JM, 2006, AQUACULT ENG, V35, P91, DOI 10.1016/j.aquaeng.2005.08.013; Zhou C, 2015, OCEAN ENG, V110, P89, DOI 10.1016/j.oceaneng.2015.09.043	16	13	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192206	10.1371/journal.pone.0192206	http://dx.doi.org/10.1371/journal.pone.0192206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420569	Green Published, gold, Green Submitted			2022-12-27	WOS:000424517900052
J	Azzazy, MF				Azzazy, Mohamed F.			Exploratory palynological studies at the Tell el-Daba'a-Avaris archaeological site	PLOS ONE			English	Article							NILE DELTA; POLLEN; VEGETATION; EGYPT; FLORA	A palynological study of samples collected from the Tell el-Daba'a (Avaris) archaeological site, the capital of the Hyksos located in the Northeastern Nile Delta, Egypt, was conducted. A range of samples were analyzed for pollen content: mudbricks from tomb walls dating from the Middle (cal. 2124-1778 BC) and New Kingdom ages (cal. 1550-1750 BC), kitchen remains dating from the Middle Kingdom, kitchen middens from the 19th Dynasty (cal. 1750-1058 BC), and tomb offering jars from the Late Period (cal. 1000-600 BC). Floristic composition of modern vegetation analysis at different habitats revealed four community types and nine associated types, providing an indicator of high soil salinity and moisture content. Cereal and Achillea-type pollen were common in the mudbrick samples, indicating the probable use of these plants as temper during mudbrick manufacturing in the Middle and New Kingdoms. The kitchen samples were dominated by cereals, broad bean, celery, and other weed pollen types, indicating the importance of cereals, legumes, and celery as strategic crops for food or medicines during the Middle Kingdom period. Weed pollen types were probably associated with crops, with "Cheno-am" pollen type recorded at highest abundance in the tomb filling jar, which may indicate the use of these aromatic herbs to repel insects and animals from tombs.	[Azzazy, Mohamed F.] Univ Sadat City, Surveys Nat Resources Dept, Environm Studies & Res Inst, Sadat City, Egypt	Egyptian Knowledge Bank (EKB); University of Sadat City	Azzazy, MF (corresponding author), Univ Sadat City, Surveys Nat Resources Dept, Environm Studies & Res Inst, Sadat City, Egypt.	Mohamed.azzazy@esri.usc.edu.eg	Azzazy, Mohamed/X-1010-2019; Azzazy, Mohamed/G-1545-2017	Azzazy, Mohamed/0000-0001-5009-4322; Azzazy, Mohamed/0000-0001-5009-4322				Abd El-Fattah R I, 1994, EGYPT J BOT, V34, P77; Akeret O, 2008, NOR ARCHAEOL REV, V13, P37, DOI [10.1179/174963108x279201, DOI 10.1080/00293652.1991.9965535]; Andersen S.T., 1979, DANMARKS GEOLOGISKE, P69; Andersen ST, 1979, IDENTIFICATION WILD; Andrew R, 1980, QUATERNARY RES ASS T; Ayyad S., 1988, THESIS; Ayyad S., 1993, PACT J, V42, P20; Ayyad SM, 1995, J UNION BIOL, V2, P1110; Bennett K.D., 2002, TRACKING ENV CHANGE, P5, DOI DOI 10.1007/0-306-47668-1; Bennett KD, 1994, QUATERNARY NEWSLETTE, V73, P6; BIETAK M, 1991, B AM SCH ORIENTAL RE, P27, DOI 10.2307/1357163; Bietak M., 1975, TELL EL DABAA FUNDOR; Bietak M., 1979, EGYPTOLOGY SOCIAL SC, P95; Bietak M, 2003, MINOAN PAINTINGS AVA, P166; Booth C., 2005, HYKSOS PERIOD EGYPT; Boulos L., 1983, Medicinal plants of North Africa.; Boulos L, 1995, FLORA EGYPT CHECKLIS, P283; BRYANT VM, 1993, AM ANTIQUITY, V58, P277, DOI 10.2307/281970; Campbell ID, 1999, PALAEOGEOGR PALAEOCL, V149, P245, DOI 10.1016/S0031-0182(98)00204-1; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; COUTELLIER V, 1987, MAR GEOL, V77, P257, DOI 10.1016/0025-3227(87)90116-2; Davis OK, 1997, N AM ARCHAEOL, V18, P97; Dickson C, 1988, CIRCAEA, V5, P67; Dorner J., 1993, MITTEILUNGEN ANTHR G, V123, P401; Dusan M., 2006, ASIAN AFRICAN STUDIE, V15, P55; El Beialy SY, 2001, ANTIQUITY, V75, P735, DOI 10.1017/S0003598X00089249; El-Shenbary S., 1985, THESIS; ELGHAZALI GEB, 1993, REV PALAEOBOT PALYNO, V76, P99, DOI 10.1016/0034-6667(93)90077-8; Erdtman G., 1969, HDB PALYNOLOGY MORPH; Erdtman G., 1943, INTRO POLLEN ANAL; Faegri K., 1975, Textbook of pollen analysis.; Fahmy AGED, 1997, VEG HIST ARCHAEOBOT, V6, P241; Gardiner AH, EGYPTIAN GRAMMAR; Grivetti LE, 2001, MEDITERRANEAN DIET C; Gunther K, 2015, ARCHAEOZOOLOGY AFRIC; Hanson HC, 1965, THE PLANT COMMUNITY; Hardesty DL., 2008, ENCY ARCHAEOLOGY, P1414; Kamil J, 2007, LIFE LEGACY EGYPTOLO; Klinkenberg BE, 2008, ELECT ATLAS PLANTS B; LEROY SAG, 1992, VEG HIST ARCHAEOBOT, V1, P43, DOI DOI 10.1007/BF00190700; Li YC, 2005, GRANA, V44, P160, DOI 10.1080/00173130500230608; Marriner N, 2006, SEDIMENT GEOL, V186, P13, DOI 10.1016/j.sedgeo.2005.12.001; Marriner N, 2007, EARTH-SCI REV, V80, P137, DOI 10.1016/j.earscirev.2006.10.003; Marshall DM, 2007, ETHNOPALYNOLOGICAL A; Montet P., 1956, CR HEBD ACAD SCI, V100, P112; Moore P.D., 1991, POLLEN ANAL; Ollive V, 2006, QUATERN INT, V150, P28, DOI 10.1016/j.quaint.2006.01.006; Pearsall DeborahM., 2015, PALEOETHNOBOTANY HDB, V3rd ed; RITCHIE JC, 1986, GRANA, V25, P177, DOI 10.1080/00173138609427719; Rossignol M, 1969, SEDIMENTATION PALYNO; SAAD S I, 1967, Pollen et Spores, V9, P467; Sadori L, 2006, VEG HIST ARCHAEOBOT, V15, P205, DOI 10.1007/s00334-005-0029-3; Shehata A., 1959, ANN SERVICE ANTIQUIT, P207; SINGH G, 1973, NEW PHYTOL, V72, P191, DOI 10.1111/j.1469-8137.1973.tb02025.x; Stockmarr J, 1971, TABLETS SPORES USED; Taeckholm V., 1974, STUDENTSFLORA EGYPT, V2nd ed., P261; Thanheiser U., 1992, PLANT FOOD REMAINS T, P117; Toussoun PO, 1922, MEMOIRES LINSTITUT D; Uphof J.C.T., 1959, DICT EC PLANTS; van Zinderen Bakker E. M., 1982, POLLEN SPORES, V24, P235; Zahran MA, 1970, B I DESERT EGYPTE, V18, P229; Zahran MA, 1995, 2 S AFR PAL, P57; [张元明 Zhang yuanming], 2003, [地理学报, Acta Geographica Sinica], V58, P109	63	0	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0180770	10.1371/journal.pone.0180770	http://dx.doi.org/10.1371/journal.pone.0180770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415021	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300001
J	Boscolo-Rizzo, P; Zorzi, M; Del Mistro, A; Da Mosto, MC; Tirelli, G; Buzzoni, C; Rugge, M; Polesel, J; Guzzinati, S				Boscolo-Rizzo, Paolo; Zorzi, Manuel; Del Mistro, Annarosa; Da Mosto, Maria Cristina; Tirelli, Giancarlo; Buzzoni, Carlotta; Rugge, Massimo; Polesel, Jerry; Guzzinati, Stefano		AIRTUM Working Grp	The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; ALCOHOL-DRINKING; UNITED-STATES; LARYNGEAL-CANCER; INCIDENCE TRENDS; SEXUAL-BEHAVIOR; UNKNOWN PRIMARY; ORAL-CAVITY	The current study aimed to investigate the incidence and survival patterns of HNSCCs arising from different anatomic sites, potentially related (the oropharynx) or unrelated (the oral cavity, the larynx/hypopharynx) to HPV, to provide clues on possible growing impact of HPV in the epidemiology of HNSCC in Italy. Epidemiological data were retrieved from ten long-term Cancer Registries covering a population of 7.8 million inhabitants. Trends were described by means of the estimated annual percent change (APC) stratified by age and gender, and compared between HPV-related and HPV-unrelated anatomical sites. The data regarding 28,295 HNSCCs diagnosed in Italy between 1988 and 2012 were analyzed. In males, the incidence rate (IR) of cancers arising from sites unrelated to HPV infection significantly decreased in all age groups (APC:-3.31 for larynx/hypopharynx; APC:-1.77 for oral cavity), whereas stable IR were observed for cancers arising from sites related to HPV infection. In females, IR for cancers from HPV-related sites increased significantly over the observed period; the largest increment was noted in those over 60 (APC: 2.92%) who also showed a significantly lower number of HNSCCs from the larynx/hypopharynx (APC:-0.84) and a significantly higher number of oral cavity tumors (APC = 2.15). The five-year relative survival remained largely unchanged in the patients with laryngeal/hypopharyngeal SCC and, conversely, significantly improved in the patients with SCC at HPV-related sites. The trends observed suggest a potential increasing impact of HPV infection on the epidemiology of HNSCC in Italy, but to a lesser extent and with a different pattern from that observed in other Western countries.	[Boscolo-Rizzo, Paolo; Da Mosto, Maria Cristina] Univ Padua, Reg Ctr Head & Neck Canc, Dept Neurosci, Treviso, Italy; [Zorzi, Manuel; Rugge, Massimo; Guzzinati, Stefano] Veneto Tumor Registry, Padua, Italy; [Del Mistro, Annarosa] Veneto Inst Oncol IOV IRCCS, Padua, Italy; [Tirelli, Giancarlo] Univ Trieste, Hosp Cattinara, Head & Neck Dept, Trieste, Italy; [Buzzoni, Carlotta] AIRTUM Database, Florence, Italy; [Buzzoni, Carlotta] Canc Prevent & Res Inst ISPO, Clin & Descript Epidemiol Unit, Tuscany Canc Registry, Florence, Italy; [Rugge, Massimo] Univ Padua, Dept Med, Surg Pathol Unit, Padua, Italy; [Polesel, Jerry] CRO Aviano Natl Canc Inst, Unit Canc Epidemiol, Aviano, Italy	University of Padua; Azienda Zero; IRCCS Istituto Oncologico Veneto (IOV); University of Trieste; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Padua; IRCCS Aviano (CRO)	Guzzinati, S (corresponding author), Veneto Tumor Registry, Padua, Italy.	stefano.guzzinati@regione.veneto.it	Boscolo-Rizzo, Paolo/AAI-5666-2021; Polesel, Jerry/AAA-5750-2019; tirelli, giancarlo/G-3118-2012	Boscolo-Rizzo, Paolo/0000-0002-4635-7959; Polesel, Jerry/0000-0001-9381-1520; tirelli, giancarlo/0000-0002-7871-2011; RUGGE, MASSIMO/0000-0002-0679-0563; guzzinati, stefano/0000-0002-4908-5506				Agalliu I, 2016, JAMA ONCOL; Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Boscolo-Rizzo P, 2015, CLIN EXP METASTAS, V32, P835, DOI 10.1007/s10585-015-9744-z; Bossi P, 2014, ANN ONCOL, V25, P694, DOI 10.1093/annonc/mdu004; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Castellsague X, 2017, RECENT RESULTS CANC, V206, P27, DOI 10.1007/978-3-319-43580-0_2; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiesi A, 1999, RECENT SOCIAL TRENDS; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2016, ORAL ONCOL, V62, P20, DOI 10.1016/j.oraloncology.2016.09.005; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Gallus S, 2003, CANCER EPIDEM BIOMAR, V12, P514; Gallus S, 2011, PREV MED, V52, P434, DOI 10.1016/j.ypmed.2011.03.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Hussein AA, 2017, EUR J CANCER, V82, P115, DOI 10.1016/j.ejca.2017.05.026; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; Islami F, 2010, ORAL ONCOL, V46, P802, DOI 10.1016/j.oraloncology.2010.07.015; Jehannin-Ligier K, 2017, INT J CANCER, V140, P2032, DOI 10.1002/ijc.30631; Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088; Lugo A, 2017, TUMORI J, V103, P353, DOI 10.5301/tj.5000644; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Rettig E, 2015, EXPERT REV ANTICANC, V15, P35, DOI 10.1586/14737140.2015.957189; Schroeder L, 2017, EUR J CANCER, V74, P73, DOI 10.1016/j.ejca.2016.12.020; Tramacere I, 2010, ORAL ONCOL, V46, P497, DOI 10.1016/j.oraloncology.2010.03.024; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; Underwood JM, 2015, J COMMUN HEALTH, V40, P414, DOI 10.1007/s10900-014-9951-6; van Monsjou HS, 2015, ORAL ONCOL, V51, P901, DOI 10.1016/j.oraloncology.2015.06.011; Viarisio D, 2016, CANCER RES, V76, P4216, DOI 10.1158/0008-5472.CAN-16-0370; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	44	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192621	10.1371/journal.pone.0192621	http://dx.doi.org/10.1371/journal.pone.0192621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415020	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300090
J	Lerman, S; Jung, M; Arredondo, EM; Barnhart, JM; Cai, JW; Castaneda, SF; Daviglus, ML; Espinoza, RA; Giachello, AL; Molina, KM; Perreira, K; Salgado, H; Wassertheil-Smoller, S; Kaplan, RC				Lerman, Shir; Jung, Molly; Arredondo, Elva M.; Barnhart, Janice M.; Cai, Jianwen; Castaneda, Sheila F.; Daviglus, Martha L.; Espinoza, Rebeca A.; Giachello, Aida L.; Molina, Kristine M.; Perreira, Krista; Salgado, Hugo; Wassertheil-Smoller, Sylvia; Kaplan, Robert C.			Religiosity prevalence and its association with depression and anxiety symptoms among Hispanic/Latino adults	PLOS ONE			English	Article							DISEASE RISK-FACTORS; CES-D; CARDIOVASCULAR-DISEASE; SHORT-FORM; HEALTH; MORTALITY; LATINOS; WOMEN; SPIRITUALITY; HCHS/SOL	Objectives Religion plays an important role in the lives of people in the United States. We examined the prevalence of religiosity among Hispanic/Latinos in four regions of the United States and looked at its correlation to depression and anxiety symptoms. Design The population-based Hispanic Community Health Study/Study of Latinos enrolled a cohort of Hispanic/Latino adults (N = 16,415) ages 18-74 in four US cities from June 2008 to June 2011. Participants with complete data on religiosity (i.e., religious affiliation, frequency of attending religious activities and importance of religion), depression (assessed with the CESD-10), and trait anxiety (assessed with the STAI-10) were included in the present study. Distribution of religiosity is described by sociodemographic characteristics. Associations between religiosity with depression and anxiety were examined with logistic regression models controlling for sex, age group, education, Hispanic/Latino background, clinical center, and nativity. Results The majority of the population (89.5%) reported having a religious affiliation. Weekly attendance at religious activities was reported by 41.6% of participants, while 20.6% did not attend any religious activities. Religion was very important to 63.9% and not at all important to 6.7% of the population. The CES-D scores and trait anxiety scores were not significantly related in the overall group to frequency of attending religious activity or perceived importance of religion. However, in age-stratified analyses, among older individuals (65+ years old) reporting "never" participating in religious activities compared to more than once per week was associated with an 80% higher likelihood of having high depressive symptomatology. Similarly, in the older age group, no religious affiliation or reporting that religion is "not at all important" was associated with greater anxiety symptomatology. Conclusion Religiosity varied by Hispanic/Latino background. Lack of religiosity was associated with elevated depressive or anxiety symptomology in older adults but not in young or middle-aged adults.	[Lerman, Shir] Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA USA; [Jung, Molly; Barnhart, Janice M.; Wassertheil-Smoller, Sylvia; Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Arredondo, Elva M.; Castaneda, Sheila F.; Espinoza, Rebeca A.; Salgado, Hugo] San Diego State Univ, Grad Sch Publ Hlth, Div Hlth Promot & Behav Sci, San Diego, CA 92182 USA; [Cai, Jianwen; Perreira, Krista] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Dept Med, Chicago, IL USA; [Giachello, Aida L.; Molina, Kristine M.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA	University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine; California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, RC (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA.	robert.kaplan@einstein.yu.edu	Lerman Ginzburg, Shir/GWZ-4113-2022; Castaneda, Sheila/I-4132-2014	Deloukas, Panos/0000-0001-9251-070X; Castaneda, Sheila/0000-0002-1975-0544; Lerman Ginzburg, Shir/0000-0003-1119-670X	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01-HC65236]; San Diego State University [N01-HC65237]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA172009] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI, https://www.nhlbi.nih.gov/) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities (https://www.nimhd.nih.gov/), National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/), National Institute of Dental and Craniofacial Research (https://www.nictersiih.gov/), National Institute of Diabetes and Digestive and Kidney Diseases (httpsiNiwuniddk.riih.govi), National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.govi), and the NIH Institution-Office of Dietary Supplements (https://ods.od.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria M, 2007, AM J PUBLIC HEALTH, V97, pS4; Alegria M, 2015, ICPSR20240V8 INT CON; Alegria M, 2008, AM J PSYCHIAT, V165, P359, DOI 10.1176/appi.ajp.2007.07040704; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BELL JAMES, 2014, RELIG LATIN AM WIDES; Brierley J, 2013, J MED ETHICS, V39, P573, DOI 10.1136/medethics-2011-100104; Castaneda SF, 2016, PREV MED, V87, P144, DOI 10.1016/j.ypmed.2016.02.032; Chida Y, 2009, PSYCHOTHER PSYCHOSOM, V78, P81, DOI 10.1159/000190791; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Curlin FA, 2007, NEW ENGL J MED, V356, P593, DOI 10.1056/NEJMsa065316; Funk C, 2014, FEWER HISPANICS ARE; GARCIA M, 1989, PSYCHIAT RES, V27, P137, DOI 10.1016/0165-1781(89)90129-7; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Gonzalez P, 2017, PSYCHOL ASSESSMENT, V29, P372, DOI 10.1037/pas0000330; Grzywacz JG, 2006, HISPANIC J BEHAV SCI, V28, P404, DOI 10.1177/0739986306290645; Hill PC, 2003, AM PSYCHOL, V58, P64, DOI 10.1037/0003-066X.58.1.64; Koenig HG, 2014, J PSYCHOSOM RES, V77, P135, DOI 10.1016/j.jpsychores.2014.05.002; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Li SS, 2016, JAMA INTERN MED, V176, P777, DOI 10.1001/jamainternmed.2016.1615; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Moreno O, 2013, J LAT O PSYCHOL, V1, P53, DOI 10.1037/a0031376; Ornelas IJ, 2011, SOC SCI MED, V73, P1169, DOI 10.1016/j.socscimed.2011.07.002; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Potochnick SR, 2010, J NERV MENT DIS, V198, P470, DOI 10.1097/NMD.0b013e3181e4ce24; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rutledge T, 2012, J WOMENS HEALTH, V21, P133, DOI 10.1089/jwh.2011.2787; Salaycik KJ, 2007, STROKE, V38, P16, DOI 10.1161/01.STR.0000251695.39877.ca; Schnall E, 2012, J RELIG HEALTH, V51, P20, DOI 10.1007/s10943-011-9549-6; Schnall E, 2010, PSYCHOL HEALTH, V25, P249, DOI 10.1080/08870440802311322; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Swenson CJ, 2000, AM J EPIDEMIOL, V152, P1048, DOI 10.1093/aje/152.11.1048; Wassertheil-Smoller S, 2014, ANN EPIDEMIOL, V24, P822, DOI 10.1016/j.annepidem.2014.09.003; Wassertheil-Smoller S, 2014, SEMIN REPROD MED, V32, P438, DOI 10.1055/s-0034-1384627	33	20	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0185661	10.1371/journal.pone.0185661	http://dx.doi.org/10.1371/journal.pone.0185661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415030	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300003
J	Overbosch, FW; Schinkel, J; Stolte, IG; Prins, M; Sonder, GJB				Overbosch, Femke W.; Schinkel, Janke; Stolte, Ineke G.; Prins, Maria; Sonder, Gerard J. B.			Dengue virus infection among long-term travelers from the Netherlands: A prospective study, 2008-2011	PLOS ONE			English	Article								Background Dengue is increasing rapidly in endemic regions. Data on incidence among travelers to these areas are limited. Five prospective studies have been performed thus far, mainly among short-term travelers. Objective To obtain the attack and incidence rate (AR, IR) of dengue virus (DENV) infection among long-term travelers and identify associated risk factors. Methods A prospective study was performed among long-term travelers (12-52 weeks) attending the Public Health Service in Amsterdam. Clients planning to travel to (sub) tropical countries were invited to participate. Participants kept a travel diary, recording itinerary, symptoms, and physician visits. Pre- and post-travel blood samples were serologically tested for the presence of Anti-DENV IgG antibodies. Seroconversion was considered suggestive of a primary DENV infection. Anti-DENV IgG present in both corresponding samples in combination with a post-/pre-travel ratio of >= 4:1 was suggestive of a secondary infection. Risk factors for a DENV infection were studied using poisson regression. Results In total, 600 participants were included; median age was 25 years (IQR: 23-29), 35.5% were male, and median travel duration was 20 weeks (IQR: 15-25). In 39 of 600 participants (AR: 6.5%; 95% CI 4.5-8.5%) anti-DENV IgG test results were suggestive of a recent infection, yielding an IR of 13.9 per 1,000 person-months traveling (95% CI: 9.9-19.1). No secondary infections were found. IR for Asia, Africa, and America were comparable and 13.5, 15.8, and 13.6 per 1,000 person-months respectively. Of participants with a recent DENV infection, 51% did not report dengue-like illness (DLI) or fever, but 10% were hospitalized. In multivariable analysis, travelers who seroconverted were significantly more likely to be vaccinated with >= 2 flavivirus vaccines for the current trip or to have reported DLI in >1 consecutive weeks. Conclusions Long-term travelers are at substantial risk of DENV infection. Half of those with a DENV infection reported no symptoms, but 10% were hospitalized, demonstrating the importance of advising anti-mosquito measures during travel.	[Overbosch, Femke W.; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Overbosch, Femke W.; Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands; [Schinkel, Janke] Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, Amsterdam, Netherlands; [Stolte, Ineke G.; Prins, Maria] Publ Hlth Serv GGD, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [Stolte, Ineke G.; Prins, Maria] Acad Med Ctr, Amsterdam Infect & Immun Inst AI&II, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [Sonder, Gerard J. B.] Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Amsterdam, Netherlands; [Stolte, Ineke G.] Inholland, Fac Hlth Sports & Social Work, Haarlem, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Overbosch, FW (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.; Overbosch, FW (corresponding author), Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands.	foverbosch@ggd.amsterdam.nl			Netherlands Organization for Health Research and Development (ZonMW) [12501 0001]; Public Health Service Amsterdam, the Netherlands	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Public Health Service Amsterdam, the Netherlands(Netherlands Government)	This study was conducted within the Amsterdam Academic Collaborative Center on Public Health: a collaboration between the Public Health Service of Amsterdam and the Academic Medical Center of the University of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative Center on Public Health is financially supported by the Netherlands Organization for Health Research and Development (ZonMW; grant number 12501 0001) to GJBS. The study was funded by the Public Health Service Amsterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaten GGG, 2011, EMERG INFECT DIS, V17, P821, DOI 10.3201/eid1705.101125; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Landelijk Coo E rdinatiecentrum Reizigersadvisering, 2008, NATIONAL COORDINATIO; Leder K, 2013, TRAVEL MED INFECT DI, V11, P210, DOI 10.1016/j.tmaid.2013.06.008; McBride WJH, 1998, AM J TROP MED HYG, V59, P457, DOI 10.4269/ajtmh.1998.59.457; Overbosch FW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-493; Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14; Potasman I, 1999, EMERG INFECT DIS, V5, P824, DOI 10.3201/eid0506.990615; Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1; Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; UN-United Nations, 2012, WORLD POP PROSP 2012; Wilder-Smith A, 2015, J TRAVEL MED, V22, P200, DOI 10.1111/jtm.12198; World Health Organization, 2015, DENG OV 2012; World Health Organization, 2017, DENG AND SEV DENG; World Tourism Organization, 2015, UNWTO TOUR HIGHL 201	20	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192193	10.1371/journal.pone.0192193	http://dx.doi.org/10.1371/journal.pone.0192193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415063	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300056
J	Tsuboi, T; Maeda, M; Hayashi, T				Tsuboi, Tomoe; Maeda, Morihiko; Hayashi, Toshio			Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR-DISEASE; CELLULAR SENESCENCE; CELLS; ATHEROSCLEROSIS; TELOMERASE; SUPPLEMENTATION; SUPEROXIDE; EXPRESSION; MECHANISM	L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-Cit). Our previous study revealed that chronic administration of a combination of L-Cit and L-Arg has a better therapeutic effect on high cholesterol-induced atherosclerosis in rabbits. We investigated how L-Arg and L-Cit affect endothelial function, aging and atherosclerosis. Following a 3-day stimulation of human umbilical venous endothelial cells (HUVECs) with high glucose (HG: 22 mM) and L-Arg (300 mu M), L-Cit (300 mu M) or L-Arg plus L-Cit (LALC: each 150 mu M) supplementation, endothelial senescence and function were evaluated. These amino acids were also administered to dyslipidemic type 2 diabetic (ZDFM) rats fed a high cholesterol diet. They were fed L-Arg or L-Cit or LALC for four weeks. Aortic senescence was investigated by measuring senescence-associated beta-galactosidase (SA-beta-gal), telomerase activity, DNA damage and p16(INK4a) protein expression. Only L-Cit and LALC supplementation retarded the HG-induced endothelial senescence, as evaluated by SA-beta-gal activity, a widely used marker of cellular senescence, p16(INK4a) expression, a senescence-related protein, and DNA damage. Under HG conditions, L-Cit and LCLA restored telomerase activity to levels observed under normal glucose (NG) conditions. Under HG conditions, L-Cit decreased ROS production, as measured by CM-H(2)DCFDA and the expression of p67(phox), a major component of NADPH oxidase. Under HG conditions, L-Cit and LALC increased NO production, as measured by DAF-2AM. Endothelial NO synthase (eNOS) and phosphorylated eNOS were decreased under HG conditions and L-Cit and LALC significantly increased these levels. Arginase 2 protein expression increased under the HG conditions, and L-Cit and LALC significantly attenuated this effect. In ZDFM rats, SA-beta-gal activity was detected on the aortic endothelial surface; however, L-Cit and LALC reduced these levels. L-Cit and LALC both decreased the proportion of senescent cells. Furthermore, treatment with LALC for 4 weeks increased plasma NO production. Therefore conclusively, L-citrulline supplementation rescued NO levels better than L-arginine supplementation by inhibiting ROS production and arginase 2 protein expression. Consequently, L-Cit and LCLA supplementation retaeded HG-induced endothelial senescence.	[Tsuboi, Tomoe; Maeda, Morihiko; Hayashi, Toshio] Nagoya Univ, Grad Sch Med, Sch Hlth Sci, Dept Geriatr,Higashi Ku, Nagoya, Aichi, Japan; [Tsuboi, Tomoe] Chubu Univ, Grad Sch Biosci & Biotechnol, Matsumoto Cho, Kasugai, Aichi, Japan	Nagoya University; Chubu University	Hayashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Sch Hlth Sci, Dept Geriatr,Higashi Ku, Nagoya, Aichi, Japan.	hayashi@med.nagoya-u.ac.jp	Hayashi, Toshio/I-7346-2014	Hayashi, Toshio/0000-0002-7711-2700	KYOWA HAKKO BIO CO., LTD.	KYOWA HAKKO BIO CO., LTD.	This work was supported by a grant from KYOWA HAKKO BIO CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from KYOWA HAKKO BIO CO., LTD.	Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Buys CHCM, 2000, NEW ENGL J MED, V342, P1282, DOI 10.1056/NEJM200004273421710; Dworakowski R, 2008, J AM COLL CARDIOL, V51, P1349, DOI 10.1016/j.jacc.2007.12.033; El-Kirsh AAA, 2011, CELL BIOCHEM FUNCT, V29, P414, DOI 10.1002/cbf.1766; Fukatsu A, 2007, AM J PHYSIOL-HEART C, V293, pH790, DOI 10.1152/ajpheart.01141.2006; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hardy TA, 2002, FREE RADICAL BIO MED, V32, P122, DOI 10.1016/S0891-5849(01)00781-X; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; HAYASHI T, 1991, ATHEROSCLEROSIS, V87, P23, DOI 10.1016/0021-9150(91)90229-V; Hayashi T, 2004, CARDIOVASC RES, V61, P339, DOI 10.1016/j.cardiores.2003.09.027; Hayashi T, 2014, PLOS ONE, pe88391; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P10485, DOI 10.1073/pnas.0603918103; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Ignarro Louis J, 2004, Curr Atheroscler Rep, V6, P281, DOI 10.1007/s11883-004-0059-9; Jamaluddin MS, 2014, CURR PHARM DESIGN, V20, P3563, DOI 10.2174/13816128113196660744; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123169; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Morita M, 2014, BIOCHEM BIOPH RES CO, V454, P53, DOI 10.1016/j.bbrc.2014.10.029; Ochiai M, 2012, INT J CARDIOL, V155, P257, DOI 10.1016/j.ijcard.2010.10.004; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Romero MJ, 2006, CARDIOVASC DRUG REV, V24, P275, DOI 10.1111/j.1527-3466.2006.00275.x; Scalera F, 2009, BIOCHEM BIOPH RES CO, V386, P650, DOI 10.1016/j.bbrc.2009.06.091; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yokoi N, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/103731; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634	36	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192252	10.1371/journal.pone.0192252	http://dx.doi.org/10.1371/journal.pone.0192252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415069	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300063
J	de la Fuente, C; Pinkham, C; Dabbagh, D; Beitzel, B; Garrison, A; Palacios, G; Hodge, KA; Petricoin, EF; Schmaljohn, C; Campbell, CE; Narayanan, A; Kehn-Hall, K				de la Fuente, Cynthia; Pinkham, Chelsea; Dabbagh, Deemah; Beitzel, Brett; Garrison, Aura; Palacios, Gustavo; Hodge, Kimberley Alex; Petricoin, Emanuel F.; Schmaljohn, Connie; Campbell, Catherine E.; Narayanan, Aarthi; Kehn-Hall, Kylene			Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection	PLOS ONE			English	Article							NSS PROTEIN; TRANSCRIPTION FACTOR; POTENTIAL MECHANISM; GENE-EXPRESSION; DOWN-REGULATION; GROWTH; RECEPTOR; BINDING; PHOSPHORYLATION; GLYCOPROTEIN	Rift Valley fever virus (RVFV) infects both ruminants and humans leading to a wide variance of pathologies dependent on host background and age. Utilizing a targeted reverse phase protein array (RPPA) to define changes in signaling cascades after in vitro infection of human cells with virulent and attenuated RVFV strains, we observed high phosphorylation of Smad transcription factors. This evolutionarily conserved family is phosphorylated by and transduces the activation of TGF-beta superfamily receptors. Moreover, we observed that phosphorylation of Smad proteins required active RVFV replication and loss of NSs impaired this activation, further corroborating the RPPA results. Gene promoter analysis of transcripts altered after RVFV infection identified 913 genes that contained a Smad-response element. Functional annotation of these potential Smad-regulated genes clustered in axonal guidance, hepatic fibrosis and cell signaling pathways involved in cellular adhesion/migration, calcium influx, and cytoskeletal reorganization. Furthermore, chromatin immunoprecipitation confirmed the presence of a Smad complex on the interleukin 1 receptor type 2 (IL1R2) promoter, which acts as a decoy receptor for IL-1 activation.	[de la Fuente, Cynthia; Pinkham, Chelsea; Dabbagh, Deemah; Narayanan, Aarthi; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Sch Syst Biol, Manassas, VA 22030 USA; [Beitzel, Brett; Garrison, Aura; Palacios, Gustavo; Schmaljohn, Connie] United States Army Med Res Inst Infect Dis, Frederick, MD USA; [Hodge, Kimberley Alex; Petricoin, Emanuel F.] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Manassas, VA USA; [Campbell, Catherine E.] DCE Consulting, Vienna, VA USA	George Mason University; George Mason University	Kehn-Hall, K (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Sch Syst Biol, Manassas, VA 22030 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Palacios, Gustavo/I-7773-2015; Garrison, Aura/O-4123-2019	Palacios, Gustavo/0000-0001-5062-1938; Garrison, Aura/0000-0003-3034-6400; Beitzel, Brett/0000-0002-3798-6411	Defense Threat Reduction Agency (DTRA) grant [HDTRA1-13-1-0006]; DTRA grant [HDTRA1-13-1-0006]	Defense Threat Reduction Agency (DTRA) grant; DTRA grant	This work was funded through a Defense Threat Reduction Agency (DTRA) grant HDTRA1-13-1-0006 to KK and AN. DTRA does not have any role in the design of the study and collection, analysis, and interpretation of data and nor in writing the manuscript. DCE Consulting provided bioinformatics analysis for this study as a subcontract award as part of DTRA grant HDTRA1-13-1-0006. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5; Argentou N, 2016, INFLAMM RES, V65, P355, DOI 10.1007/s00011-016-0921-6; Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372; Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Benedict A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00676; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; BROWN JL, 1981, INFECT IMMUN, V33, P848, DOI 10.1128/IAI.33.3.848-853.1981; Bruice P. Y, 2004, ORGANIC CHEM; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Copeland AM, 2015, VIROLOGY, V486, P88, DOI 10.1016/j.virol.2015.09.003; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cyr N, 2015, P NATL ACAD SCI USA, V112, P6021, DOI 10.1073/pnas.1503688112; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Gaudreault NN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00664; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-46; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hill C. S., 2016, COLD SPRING HARB PER, V8; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2012, ANTIVIR RES, V95, P293, DOI 10.1016/j.antiviral.2012.06.001; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Konig R, 2015, CURR OPIN MICROBIOL, V26, P79, DOI 10.1016/j.mib.2015.06.001; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; KUBINYI H, 1979, FARMACO-ED SCI, V34, P248; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Liu XJ, 1998, CANCER RES, V58, P4752; Lokugamage N, 2012, J VIROL, V86, P13566, DOI 10.1128/JVI.02081-12; Ly HJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0573-8; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124; Morikawa M, 2016, COLD SPRING HARB PER, V8; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Pin E, 2014, CURR PROTOC PROTEIN, V75; Pinkham C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14800-3; Pinkham C, 2016, VIROLOGY, V496, P175, DOI 10.1016/j.virol.2016.06.004; Pokharel SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00174; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rolin AI, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.81; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shafagati N, 2016, VIRULENCE, V7, P756, DOI 10.1080/21505594.2016.1185585; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Signore M, 2017, METHODS MOL BIOL, V1606, P51, DOI 10.1007/978-1-4939-6990-6_4; SMITH H, 1980, SCAND J INFECT DIS, P119; TENDIJKE P, 1990, MOL CELL BIOL, V10, P4473, DOI 10.1128/MCB.10.9.4473; Terasaki K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005047; Theodorescu D, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000294; Tiwari R, 2011, VIROLOGY, V413, P60, DOI 10.1016/j.virol.2011.02.002; Urata S, 2011, J VIROL, V85, P795, DOI 10.1128/JVI.02019-10; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang Y, 2017, ONCOL REP, V37, P3520, DOI 10.3892/or.2017.5618; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wu Q, 2017, AM J PHYSL LUNG CELL; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Xu PL, 2014, MOL CELL, V56, P723, DOI 10.1016/j.molcel.2014.11.027; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang F, 2017, GASTROENTEROLOGY, V152, P257, DOI 10.1053/j.gastro.2016.09.033	98	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191983	10.1371/journal.pone.0191983	http://dx.doi.org/10.1371/journal.pone.0191983			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408900	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800038
J	Hung, KKC; Graham, CA; Lo, RSL; Leung, YK; Leung, LY; Man, SY; Woo, WK; Cattermole, GN; Rainer, TH				Hung, Kevin K. C.; Graham, Colin A.; Lo, Ronson S. L.; Leung, Yuk Ki; Leung, Ling Yan; Man, S. Y.; Woo, W. K.; Cattermole, Giles N.; Rainer, Timothy H.			Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUG; LOW-BACK-PAIN; ACETAMINOPHEN; EFFICACY; ANKLE; RISK	Background Soft tissue injuries commonly present to the emergency department (ED), often with acute pain. They cause significant suffering and morbidity if not adequately treated. Paracetamol and ibuprofen are commonly used analgesics, but it remains unknown if either one or the combination of both is superior for pain control. Objectives To investigate the analgesic effect of paracetamol, ibuprofen and the combination of both in the treatment of soft tissue injury in an ED, and the side effect profile of these drugs. Methods Double-blind, double dummy, placebo-controlled randomised controlled trial. 782 adult patients presenting with soft tissue injury without obvious fractures attending the ED of a university hospital in the New Territories of Hong Kong were recruited. Patients were randomised using a random number table into three parallel arms of paracetamol only, ibuprofen only and a combination of paracetamol and ibuprofen in a 1: 1: 1 ratio. The primary outcome measure was pain score at rest and on activity in the first 2 hours and first 3 days. Data was analysed on an intention to treat basis. Results There was no statistically significant difference in pain score in the initial two hours between the three groups, and no clinically significant difference in pain score in the first three days. Conclusion There was no difference in analgesic effects or side effects observed using oral paracetamol, ibuprofen or a combination of both in patients with mild to moderate pain after soft tissue injuries attending the ED.	[Hung, Kevin K. C.; Graham, Colin A.; Lo, Ronson S. L.; Leung, Yuk Ki; Leung, Ling Yan; Man, S. Y.; Woo, W. K.; Cattermole, Giles N.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Graham, CA (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China.	cagraham@cuhk.edu.hk	Cattermole, Giles N/C-9041-2014; Hung, Kevin KC/H-8327-2016; Graham, Colin A/B-4535-2013; LEUNG, Ling Yan/J-9298-2015; Lo, Ronson/H-2856-2016; LEUNG, Ling Yan/T-4918-2019; Rainer, Timothy/I-2591-2013	Cattermole, Giles N/0000-0002-8910-2307; Hung, Kevin KC/0000-0001-8706-7758; Graham, Colin A/0000-0002-4381-7470; LEUNG, Ling Yan/0000-0003-2048-8747; Lo, Ronson/0000-0003-3822-4918; LEUNG, Ling Yan/0000-0003-2048-8747; Rainer, Timothy/0000-0003-3355-3237	Chinese University of Hong Kong [2041095]; Hong Kong College of Emergency Medicine Research Fund [6902289]	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong College of Emergency Medicine Research Fund	This research study was supported by a Direct Grant for Research from the Chinese University of Hong Kong (Reference Number: 2041095) and the Hong Kong College of Emergency Medicine Research Fund (Reference Number: 6902289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Benedetti C, 1990, MANAGEMENT PAIN, P1640; BLAND M, 1995, INTRO MED STAT; Bondarsky EE, 2013, AM J EMERG MED, V31, P1357, DOI 10.1016/j.ajem.2013.06.007; British Medical Association, 2004, BRIT NATL FORMULARY, V45; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Collins S, 2000, SINGLE DOSE ORAL IBU; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Derry CJ, 2009, SINGLE DOSE ORAL IBU; Ducharme J, 2000, ANN EMERG MED, V35, P592, DOI 10.1016/S0196-0644(00)70033-3; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jantos TJ, 1996, ANN EMERG MED, V28, P145, DOI 10.1016/S0196-0644(96)70054-9; Kirkwood BR, 1988, ESSENTIALS MED STAT, P167; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Moore RA, 2015, EUR J PAIN, V19, P1213, DOI 10.1002/ejp.649; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008659.pub3; Moore RA, 2014, PAIN, V155, P14, DOI 10.1016/j.pain.2013.08.013; National Guideline Centre (UK), 2016, LOW BACK PAIN SCIAT; OWEN PR, 1984, AM J OBSTET GYNECOL, V148, P96, DOI 10.1016/S0002-9378(84)80039-3; Perez-Gutthann S, 1999, PHARMACOTHERAPY, V19, P854, DOI 10.1592/phco.19.10.854.31550; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; Romsing J, 2000, ACTA ANAESTH SCAND, V44, P291, DOI 10.1034/j.1399-6576.2000.440312.x; Rubin A, 1996, AM FAM PHYSICIAN, V54, P1609; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Todd KH, 1996, ACAD EMERG MED, V3, P142, DOI 10.1111/j.1553-2712.1996.tb03402.x; Wedmore IS, 2000, EMERG MED CLIN N AM, V18, P85, DOI 10.1016/S0733-8627(05)70109-7; Woo WW, 2005, ANN EMERG MED, V46, P352, DOI 10.1016/j.annemergmed.2005.01.023	33	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192043	10.1371/journal.pone.0192043	http://dx.doi.org/10.1371/journal.pone.0192043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408866	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800043
J	Kimura-Suda, H; Takahata, M; Ito, T; Shimizu, T; Kanazawa, K; Ota, M; Iwasaki, N				Kimura-Suda, Hiromi; Takahata, Masahiko; Ito, Teppei; Shimizu, Tomohiro; Kanazawa, Kyosuke; Ota, Masahiro; Iwasaki, Norimasa			Quick and easy sample preparation without resin embedding for the bone quality assessment of fresh calcified bone using fourier transform infrared imaging	PLOS ONE			English	Article							COLLAGEN FIBER ORIENTATION; KIDNEY-DISEASE; SPECTROSCOPY; MICROSPECTROSCOPY; TISSUES; RATS; PROTEIN	Fourier transform infrared (FTIR) imaging is a powerful tool for the assessment of bone quality; however, it requires the preparation of thin bone sections. Conventional poly(methyl methacrylate) (PMMA) embedding for the preparation of sections takes more than two weeks and causes denaturation of the bone. Development of a quick and easy sample preparation technique without denaturation is needed for accurate clinical evaluation of fresh calcified bone using FTIR imaging. Frozen sectioning allows the quick and easy preparation of thin sections without denaturation, but it requires a substrate with good chemical resistance and improved heat shock resistance. Polypropylene (PP) film afforded both good chemical resistance and greater heat shock resistance, and the 4-mu m-thick PP film coated with glue was thin enough for the IR beam to pass through it, while the optical anisotropy of infrared bands overlapping with PO43- band was negligible. The bone quality of femoral thin sections prepared by the conventional PMMA embedding and sectioning procedure (RESIN-S) or the newly developed frozen sectioning procedure (FROZEN-S) was evaluated by FTIR imaging. The mineral-to-matrix ratio and crystallinity in the RESIN-S sections were higher than those in the FROZEN-S sections, whereas the carbonate-to-phosphate ratio in the RESIN-S sections was lower than that in the FROZEN-S sections. In RESIN-S, the increased mineral-to-matrix ratio could be caused by dehydration, and the increased crystallinity and decreased carbonate-to-phosphate ratio might be consequence of dissolution of bone mineral during PMMA embedding. Therefore, the combined use of PP film coated with glue and the frozen sectioning procedure without denaturation appears well suited to the assessment of the bone quality of fresh calcified bone using FTIR imaging.	[Kimura-Suda, Hiromi; Ito, Teppei; Kanazawa, Kyosuke] Chitose Inst Sci & Technol, Grad Sch Photon Sci, Chitose, Hokkaido, Japan; [Takahata, Masahiko; Shimizu, Tomohiro; Ota, Masahiro; Iwasaki, Norimasa] Hokkaido Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan	Hokkaido University	Kimura-Suda, H (corresponding author), Chitose Inst Sci & Technol, Grad Sch Photon Sci, Chitose, Hokkaido, Japan.	kimurasu@photon.chitose.ac.jp	Takahata, Masahiko/E-1929-2012; kimura-suda, Hiromi/ABA-9749-2020	Takahata, Masahiko/0000-0002-2436-2175; kimura-suda, Hiromi/0000-0002-4335-9027	KAKENHI [25462357, 24591237, 16K10916]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) C. Award Number: 25462357 Recipient: Masahiko Takahata; and a Grant-in-Aid for Scientific Research (KAKENHI) C. Award Number: 24591237, 16K10916 Recipient: Hiromi Kimura-Suda.	Acerbo AS, 2012, ANAL CHEM, V84, P3607, DOI 10.1021/ac203375d; Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z; Bairi VG, 2016, SPECTROCHIM ACTA B, V116, P21, DOI 10.1016/j.sab.2015.11.008; BOSKEY AL, 1982, CALCIFIED TISSUE INT, V34, P328, DOI 10.1007/BF02411262; BOUCEK RJ, 1979, BIOCHEM J, V177, P853, DOI 10.1042/bj1770853; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Gadeleta SJ, 2000, BONE, V27, P541, DOI 10.1016/S8756-3282(00)00362-8; Hanifi A, 2013, ANAL CHIM ACTA, V779, P41, DOI 10.1016/j.aca.2013.03.053; Ito T, 2015, MOL CRYST LIQ CRYST, V622, P114, DOI 10.1080/15421406.2015.1097011; Kimura-Suda H, 2012, MOL CRYST LIQ CRYST, V566, P75, DOI 10.1080/15421406.2012.701831; Kimura-Suda H, 2017, J ORAL BIOSCI, V59, P142, DOI 10.1016/j.job.2017.04.002; Kimura-Suda H, 2015, E-J SURF SCI NANOTEC, V13, P244, DOI 10.1380/ejssnt.2015.244; Kimura-Suda H, 2013, J ORAL BIOSCI, V55, P61, DOI 10.1016/j.job.2013.04.006; LEES S, 1981, CALCIFIED TISSUE INT, V33, P83, DOI 10.1007/BF02409417; LEES S, 1981, CALCIFIED TISSUE INT, V33, P591, DOI 10.1007/BF02409497; McElderry JDP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574525; Miller LM, 2013, BBA-BIOMEMBRANES, V1828, P2339, DOI 10.1016/j.bbamem.2013.01.014; MORRIS MD, 2009, INFRARED RAMAN SPECT, P149; Nicholson CL, 2012, ANAL CHEM, V84, P3369, DOI 10.1021/ac300123r; PLESHKO NL, 1992, J HISTOCHEM CYTOCHEM, V40, P1413, DOI 10.1177/40.9.1506677; PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221; Rehman I., 2012, FT IR RAMAN CHARACTE, P213; Rehman IU, 2012, CHEM STRUCTURAL ANAL, P189; REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Yeni YN, 2006, CALCIFIED TISSUE INT, V78, P363, DOI 10.1007/s00223-005-0301-7	28	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189650	10.1371/journal.pone.0189650	http://dx.doi.org/10.1371/journal.pone.0189650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408856	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800005
J	Mui, AM; Yang, V; Aung, MH; Fu, JM; Adekunle, AN; Prall, BC; Sidhu, CS; Park, HN; Boatright, JH; Iuvone, PM; Pardue, MT				Mui, Amanda M.; Yang, Victoria; Aung, Moe H.; Fu, Jieming; Adekunle, Adewumi N.; Prall, Brian C.; Sidhu, Curran S.; Park, Han Na; Boatright, Jeffrey H.; Iuvone, P. Michael; Pardue, Machelle T.			Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; NEUROTROPHIC FACTOR; GANGLION-CELLS; MESSENGER-RNA; RAT RETINA; A-WAVE; MICE; EXPERIENCE; SYSTEM; ELECTRORETINOGRAM	Visual experience during the critical period modulates visual development such that deprivation causes visual impairments while stimulation induces enhancements. This study aimed to determine whether visual stimulation in the form of daily optomotor response (OMR) testing during the mouse critical period (1) improves aspects of visual function, (2) involves retinal mechanisms and (3) is mediated by brain derived neurotrophic factor (BDNF) and dopamine (DA) signaling pathways. We tested spatial frequency thresholds in C57BLI6J mice daily from postnatal days 16 to 23 (P16 to P23) using OMR testing. Daily OMR-treated mice were compared to littermate controls that were placed in the OMR chamber without moving gratings. Contrast sensitivity thresholds, electroretinograms (ERGs), visual evoked potentials, and pattern ERGs were acquired at P21. To determine the role of BDNF signaling, a TrkB receptor antagonist (ANA-12) was systemically injected 2 hours prior to OMR testing in another cohort of mice. BDNF immunohistochemistry was performed on retina and brain sections. Retinal DA levels were measured using high-performance liquid chromatography. Daily OMR testing enhanced spatial frequency thresholds and contrast sensitivity compared to controls. OMR-treated mice also had improved rod-driven ERG oscillatory potential response times, greater BDNF immunoreactivity in the retinal ganglion cell layer, and increased retinal DA content compared to controls. VEPs and pattern ERGs were unchanged. Systemic delivery of ANA-12 attenuated OMR-induced visual enhancements. Daily OMR testing during the critical period leads to general visual function improvements accompanied by increased DA and BDNF in the retina, with this process being requisitely mediated by TrkB activation. These results suggest that novel combination therapies involving visual stimulation and using both behavioral and molecular approaches may benefit degenerative retinal diseases or amblyopia.	[Mui, Amanda M.; Adekunle, Adewumi N.; Prall, Brian C.; Sidhu, Curran S.; Park, Han Na; Boatright, Jeffrey H.; Iuvone, P. Michael; Pardue, Machelle T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Mui, Amanda M.; Yang, Victoria; Fu, Jieming; Adekunle, Adewumi N.; Prall, Brian C.; Park, Han Na; Boatright, Jeffrey H.; Pardue, Machelle T.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA; [Yang, Victoria; Fu, Jieming; Pardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Aung, Moe H.; Prall, Brian C.; Iuvone, P. Michael; Pardue, Machelle T.] Emory Univ, Neurosci Program, Atlanta, GA 30322 USA; [Iuvone, P. Michael] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Pardue, MT (corresponding author), Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.; Pardue, MT (corresponding author), Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA.; Pardue, MT (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.; Pardue, MT (corresponding author), Emory Univ, Neurosci Program, Atlanta, GA 30322 USA.	machelle.pardue@bme.gatech.edu	Pardue, Machelle T/N-9795-2013		Rehabilitation Research and Development Service at the Department of Veterans Affairs; Research Career Scientist Award; Research to Prevent Blindness Departmental Award; Katz Foundation;  [NEI R01 EY016435];  [R01 EY014026];  [R01 EY004864];  [P30 EY006030]; NATIONAL EYE INSTITUTE [R01EY021592, R01EY014026, R01EY004864, P30EY006360, R01EY016435] Funding Source: NIH RePORTER	Rehabilitation Research and Development Service at the Department of Veterans Affairs(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); Research to Prevent Blindness Departmental Award(Research to Prevent Blindness (RPB)); Katz Foundation; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Rehabilitation Research and Development Service at the Department of Veterans Affairs, Research Career Scientist Award to MTP; Research to Prevent Blindness Departmental Award to Emory Ophthalmology; the Katz Foundation to JHB; and NEI R01 EY016435, R01 EY014026, R01 EY004864, and P30 EY006030.	Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; BODISWOLLNER I, 1990, TRENDS NEUROSCI, V13, P296, DOI 10.1016/0166-2236(90)90113-O; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chou T-H, 2014, VISUAL NEUROSCI, P2469; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; Franklin BJ, 2007, MOUSE BRAIN STEROTAX; Fujieda H, 2008, EXP EYE RES, V86, P335, DOI 10.1016/j.exer.2007.11.005; Giovannelli A, 2008, BIOCHEM BIOPH RES CO, V365, P349, DOI 10.1016/j.bbrc.2007.10.204; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanif AM, 2015, INVEST OPHTH VIS SCI, V56, P6839, DOI 10.1167/iovs.15-16792; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kretschmer F, 2017, J NEUROPHYSIOL, V118, P300, DOI 10.1152/jn.00055.2017; Lawson EC, 2014, J NEUROSCI, V34, P2406, DOI 10.1523/JNEUROSCI.2062-13.2014; Liu BH, 2016, NATURE, V538, P383, DOI 10.1038/nature19818; Lunghi C, 2013, J VISION, V13, DOI 10.1167/13.6.1; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Neal M, 2003, INVEST OPHTH VIS SCI, V44, P791, DOI 10.1167/iovs.02-0557; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; Pardue Machelle T., 2001, Documenta Ophthalmologica, V103, P155, DOI 10.1023/A:1012202410144; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Pollock GS, 2001, J NEUROSCI, V21, P3923, DOI 10.1523/JNEUROSCI.21-11-03923.2001; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; STAFFORD CA, 1984, OPHTHAL PHYSL OPT, V4, P95, DOI 10.1016/0275-5408(84)90059-0; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Tian N, 2008, J PHYSIOL-LONDON, V586, P4347, DOI 10.1113/jphysiol.2008.159202; Tschetter WW, 2013, J NEUROSCI, V33, P5362, DOI 10.1523/JNEUROSCI.5229-12.2013; Tschetter WW, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00044; Turner PV, 2005, COMPARATIVE MED, V55, P175; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379	53	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192435	10.1371/journal.pone.0192435	http://dx.doi.org/10.1371/journal.pone.0192435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408880	Green Submitted, Green Published, gold			2022-12-27	WOS:000424302800065
J	Ooka, M; Abe, T; Cho, K; Koike, K; Takeda, S; Hirota, K				Ooka, Masato; Abe, Takuya; Cho, Kosai; Koike, Kaoru; Takeda, Shunichi; Hirota, Kouji			Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FACILITATE HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-I INHIBITORS; DNA-POLYMERASE DELTA; POLY(ADP-RIBOSE) POLYMERASE; ATAXIA-TELANGIECTASIA; TRANSLESION SYNTHESIS; EXCISION-REPAIR; CELLS; ACTIVATION	ALC1 (amplified in liver cancer 1), an SNF2 superfamily chromatin-remodeling factor also known as CHD1 L (chromodomain helicase/ATPase DNA binding protein 1-like), is implicated in base-excision repair, where PARP (Poly(ADP-ribose) polymerase) mediated Poly (ADP-ribose) signaling facilitates the recruitment of this protein to damage sites. We here demonstrate the critical role played by ALC1 in the regulation of replication-fork progression in cleaved template strands. To analyze the role played by ALC1 as well as its functional relationship with PARP1, we generated ALC1(-/-), PARP1(-/-), and ALC1(-/-)/PARP1(-/-) cells from chicken DT40 cells. We then exposed these cells to camptothecin (CPT), a topoisomerase I poison that generates single-strand breaks and causes the collapse of replication forks. The ALC1(-/-) and PARP1(-/-) cells exhibited both higher sensitivity to CPT and an increased number of chromosome aberrations, compared with wild-type cells. Moreover, phenotypes were very similar across all three mutants, indicating that the role played by ALC1 in CPT tolerance is dependent upon the PARP pathway. Remarkably, inactivation of ALC1 resulted in a failure to slow replication-fork progression after CPT exposure, indicating that ALC1 regulates replication-fork progression at DNA-damage sites. We disrupted ATPase activity by inserting the E165Q mutation into the ALC1 gene, and found that the resulting ALC1(-/E/65Q) cells displayed a CPT sensitivity indistinguishable from that of the null-mutant cells. This observation suggests that ALC1 contributes to cellular tolerance to CPT, possibly as a chromatin remodeler. This idea is supported by the fact that CPT exposure induced chromatin relaxation in the vicinity of newly synthesized DNA in wild-type but not in ALC1(-/-) cells. This implies a previously unappreciated role for ALC1 in DNA replication, in which ALC1 may regulate replication-fork slowing at CPT-induced DNA-damage sites.	[Ooka, Masato; Abe, Takuya; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, 1-1 Minami Osawa, Hachioji, Tokyo, Japan; [Cho, Kosai; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Cho, Kosai; Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Sakyo Ku, Kyoto, Japan	Tokyo Metropolitan University; Kyoto University; Kyoto University	Hirota, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.; Takeda, S; Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp; khirota@tmu.ac.jp	Ooka, Masato/HHN-0222-2022	Ooka, Masato/0000-0002-2729-2619; Takeda, Shunichi/0000-0002-7924-7991; Hirota, Kouji/0000-0003-1676-979X	JSPS KAKENHI [JP16K12598, JP16H02957, JP16H01314, JP16H06306]; JSPS Core-to-Core Program (A) Advanced Research Networks; Takeda Science Foundation; Yamada Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program (A) Advanced Research Networks; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation	This work was supported by the JSPS KAKENHI Grant Number (JP16K12598, JP16H02957 and JP16H01314 to KH, and JP16H06306 to ST), the JSPS Core-to-Core Program (A) Advanced Research Networks (to ST), the Takeda Science Foundation and Yamada Science Foundation (to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Asada R, 2015, MOL CELL BIOL, V35, P847, DOI 10.1128/MCB.00924-14; Ball LG, 2005, ACTA PHARMACOL SIN, V26, P897, DOI 10.1111/j.1745-7254.2005.00165.x; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Croset A, 2013, NUCLEIC ACIDS RES, V41, P7344, DOI 10.1093/nar/gkt522; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Gottschalk AJ, 2012, J BIOL CHEM, P287; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hanzlikova H, 2016, NUCL ACIDS RES; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2016, NUCLEIC ACIDS RES, V44, P7242, DOI 10.1093/nar/gkw439; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kobayashi S, 2015, ONCOGENE, V34, P4403, DOI 10.1038/onc.2014.371; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Mu QJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143030; Ooka M, 2016, CHEMOSPHERE, V164, P106, DOI 10.1016/j.chemosphere.2016.08.092; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Tsuda M, PLOS ONE IN PRESS; Tsuda M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188320; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192421	10.1371/journal.pone.0192421	http://dx.doi.org/10.1371/journal.pone.0192421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408941	gold, Green Submitted, Green Published			2022-12-27	WOS:000424302800063
J	Saltykova, A; Wuyts, V; Mattheus, W; Bertrand, S; Roosens, NHC; Marchal, K; De Keersmaecker, SCJ				Saltykova, Assia; Wuyts, Veronique; Mattheus, Wesley; Bertrand, Sophie; Roosens, Nancy H. C.; Marchal, Kathleen; De Keersmaecker, Sigrid C. J.			Comparison of SNP-based subtyping workflows for bacterial isolates using WGS data, applied to Salmonella enterica serotype Typhimurium and serotype 1,4,[5], 12:i:-	PLOS ONE			English	Article							ESCHERICHIA-COLI; TYPING METHODS; GENOME; SURVEILLANCE; OUTBREAKS; SCHEME; RESISTANCE; VIRULENCE; FRAMEWORK; ALIGNMENT	Whole genome sequencing represents a promising new technology for subtyping of bacterial pathogens. Besides the technological advances which have pushed the approach forward, the last years have been marked by considerable evolution of the whole genome sequencing data analysis methods. Prior to application of the technology as a routine epidemiological typing tool, however, reliable and efficient data analysis strategies need to be identified among the wide variety of the emerged methodologies. In this work, we have compared three existing SNP-based subtyping workflows using a benchmark dataset of 32 Salmonella enterica subsp. enterica serovar Typhimurium and serovar 1,4,[5], 12:i:- isolates including five isolates from a confirmed outbreak and three isolates obtained from the same patient at different time points. The analysis was carried out using the original (high-coverage) and a down-sampled (low-coverage) datasets and two different reference genomes. All three tested workflows, namely CSI Phylogeny-based workflow, CFSAN-based workflow and PHEnix-based workflow, were able to correctly group the confirmed outbreak isolates and isolates from the same patient with all combinations of reference genomes and datasets. However, the workflows differed strongly with respect to the SNP distances between isolates and sensitivity towards sequencing coverage, which could be linked to the specific data analysis strategies used therein. To demonstrate the effect of particular data analysis steps, several modifications of the existing workflows were also tested. This allowed us to propose data analysis schemes most suitable for routine SNP-based subtyping applied to S. Typhimurium and S. 1,4,[5], 12: i:-. Results presented in this study illustrate the importance of using correct data analysis strategies and to define benchmark and fine-tune parameters applied within routine data analysis pipelines to obtain optimal results.	[Saltykova, Assia; Wuyts, Veronique; Roosens, Nancy H. C.; De Keersmaecker, Sigrid C. J.] Sci Inst Publ Hlth, Platform Biotechnol & Mol Biol, Brussels, Belgium; [Saltykova, Assia; Marchal, Kathleen] Univ Ghent, IMEC, Dept Informat Technol, IDLab, Ghent, Belgium; [Mattheus, Wesley; Bertrand, Sophie] Sci Inst Publ Hlth, Bacterial Dis Div, Communicable & Infect Dis, Brussels, Belgium; [Marchal, Kathleen] Ghent Univ VIB, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Marchal, Kathleen] Univ Pretoria, Pretoria, South Africa	Ghent University; IMEC; Flanders Institute for Biotechnology (VIB); Ghent University; University of Pretoria	De Keersmaecker, SCJ (corresponding author), Sci Inst Publ Hlth, Platform Biotechnol & Mol Biol, Brussels, Belgium.; Marchal, K (corresponding author), Univ Ghent, IMEC, Dept Informat Technol, IDLab, Ghent, Belgium.; Marchal, K (corresponding author), Ghent Univ VIB, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium.; Marchal, K (corresponding author), Univ Pretoria, Pretoria, South Africa.	Kathleen.Marchal@ugent.be; Sigrid.dekeersmaecker@wiv-isp.be	De Keersmaecker, Sigrid/ABB-5332-2021; Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017	De Keersmaecker, Sigrid/0000-0003-4198-4133; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Roosens, Nancy H C J/0000-0001-9218-078X	RP/PJ WIV-ISP (NeXSplorer.iph); Federal Public Service of Health, Food Chain Safety and Environment; Belgian Ministry of Social Affairs through a fund within the Health Insurance System	RP/PJ WIV-ISP (NeXSplorer.iph); Federal Public Service of Health, Food Chain Safety and Environment; Belgian Ministry of Social Affairs through a fund within the Health Insurance System	This work was supported by RP/PJ WIV-ISP (NeXSplorer.iph), the Federal Public Service of Health, Food Chain Safety and Environment. The National Reference Centre for Salmonella and Shigella is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Andrews S., 2010, FASTQC QUALITY CONTR; Angelo K. M., 2014, MMWR-MORBID MORTAL W, V64, P144; Ashton Philip M, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.2c05a47d292f376afc5a6fcdd8a7a3b6; Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chen CC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2201-1; Cunningham SA, 2017, J CLIN MICROBIOL, V55, P1946, DOI 10.1128/JCM.00029-17; David S, 2016, J CLIN MICROBIOL, V54, P2135, DOI 10.1128/JCM.00432-16; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; den Bakker HC, 2011, APPL ENVIRON MICROB, V77, P8648, DOI 10.1128/AEM.06538-11; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; ECDC, 2016, EXP OP WHOL GEN SEQ; EFSA, 2015, EFSA J, V13; European Centre for Disease Prevention and Control, 2015, EXP OP INTR NEXT GEN; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gordon NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Inns T, 2017, EPIDEMIOL INFECT, V145, P289, DOI 10.1017/S0950268816001941; Inns T, 2014, EURO SURVEILL B EUR, V20; Jenkins C, 2015, APPL ENVIRON MICROB, V81, P3946, DOI 10.1128/AEM.04188-14; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwong JC, 2016, J CLIN MICROBIOL, V54, P333, DOI 10.1128/JCM.02344-15; Laabei M, 2014, GENOME RES, V24, P839, DOI 10.1101/gr.165415.113; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LEEKITCHAROENPHON, 2012, BMC GENOMICS S7, V13; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB, V82, P2516, DOI 10.1128/AEM.03821-15; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Leekitcharoenphon P, 2013, J INFECT DEV COUNTR, V7, P696, DOI 10.3855/jidc.3328; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Octavia S, 2015, J CLIN MICROBIOL AM, V53; Octavia S, 2015, J CLIN MICROBIOL, V53, P1063, DOI 10.1128/JCM.03235-14; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Okoro CK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003611; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; PETTENGILL JB, 2014, PEERJ, V2; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P154, DOI 10.1089/fpd.2006.3.154; Taylor AJ, 2015, J CLIN MICROBIOL, V53, P3334, DOI 10.1128/JCM.01280-15; Thomas M, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0213-x; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wilson MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146929; Wuyts V, 2015, APPL MICROBIOL BIOT, V99, P8137, DOI 10.1007/s00253-015-6831-7; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055; Wyres KL, 2014, PATHOGENS, V3, P437, DOI 10.3390/pathogens3020437; Wysoker A, 2015, PICARD TOOLS VERSION; Ying Z., 2017, GENOMEANALYSIS TK JA; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15	69	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192504	10.1371/journal.pone.0192504	http://dx.doi.org/10.1371/journal.pone.0192504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408896	gold, Green Published, Green Submitted			2022-12-27	WOS:000424302800073
J	Lv, SL; Wang, R; Wang, Q; Han, L; Tuo, XQ; Hou, HL; Liu, Y; Shi, Z; Wang, Q; Li, Y; Sun, C; Xue, X; Li, QL				Lv, Shulan; Wang, Rui; Wang, Qi; Han, Lu; Tuo, Xiaoqian; Hou, Huilian; Liu, Yu; Shi, Zan; Wang, Qing; Li, Yan; Sun, Chao; Xue, Xue; Li, Qiling			A novel solution configuration on liquid-based endometrial cytology	PLOS ONE			English	Article							TAO BRUSH; DIAGNOSIS; PATHOLOGY; CARCINOMA; LESIONS; CANCER; WOMEN	Objective Early detection and diagnosis of endometrial carcinoma and precancerous change would undoubtedly become the most alluring part for researchers. With the emergence of endometrial brush samplers, a new upsurge in endometrial cytology is in the making. But endometrial specimens obtained by the endometrial brush samplers require special preservation solution. The objective of this study is to develop a new kind of endometrial-cell preservation solution and to test the availability compared with a patented liquid-based cell preservation solution. Methods In this controlled study, we had 5 endometrial cases collected with Li Brush from the First Affiliated Hospital of Xi'an Jiaotong University (09/2016 to 12/2016). The samples of each case were collected 2 times separately and perserved in different perservation solutions. One was a kind of novel endometrial cell preservation solution and the other was a kind of patented liquid-based cell (LBC) preservation solution. The endometrial cells were smeared on slides by using the ZP-C automated slide preparation system and stained with Papanicolaou stain. A semi-quantitative scoring system was used to analyze the quality of slides. Statistical analysis was performed using the Wilcoxon signed rank test on the SPSS program (SPSS 18.0). In all LBC preparations, endometrial cells from the novel endometrial cells preservation solution had more cell quantity, less red blood cell fragments, and the background was cleaner compared with control group. Although the novel endometrial-cell preservation solution showed cellularity and absence of blood and debris expressed by no statistically significant differences (p = 0.063 and 0.102 respectively). The preservation period of the two kinds of liquids was equivalent. Conclusions The novel endometrial-cell preservation solution is superior to the liquid-base cell preservation solution for cervical cells, with clear background, diagnostic cells and low cost.	[Lv, Shulan; Wang, Qi; Han, Lu; Tuo, Xiaoqian; Shi, Zan; Wang, Qing; Li, Yan; Sun, Chao; Xue, Xue; Li, Qiling] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian, Shaanxi, Peoples R China; [Wang, Rui] Northwest Womens & Childrens Hosp, ART Ctr, Xian, Shaanxi, Peoples R China; [Hou, Huilian; Liu, Yu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pathol, Xian, Shaanxi, Peoples R China; [Li, Qiling] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Big Data & Bioinformat, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, QL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian, Shaanxi, Peoples R China.; Li, QL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Big Data & Bioinformat, Xian, Shaanxi, Peoples R China.	liqiling@mail.xjtu.edu.cn	li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022; Wang, Brian/HGA-9535-2022; Li, Yang/GWM-7879-2022	Li, Qiling/0000-0003-3763-4456	Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University [XJTU1AHCR2014-007]; Key Research and Development Project of Shaanxi Provincial Science and Technology Department [2017ZDXM-SF-068]; Natural Foundation of Shaanxi Province [2017ZDJC-11]; Shaanxi Provincial Collaborative Technology Innovation Project [2017XT-026]	Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University; Key Research and Development Project of Shaanxi Provincial Science and Technology Department; Natural Foundation of Shaanxi Province; Shaanxi Provincial Collaborative Technology Innovation Project	This work was funded partly by the Clinical Research Award of the First Affiliated Hospital of Xian Jiaotong University (XJTU1AHCR2014-007), Key Research and Development Project of Shaanxi Provincial Science and Technology Department (2017ZDXM-SF-068), Natural Foundation of Shaanxi Province (2017ZDJC-11) and Shaanxi Provincial Collaborative Technology Innovation Project (2017XT-026).	Arafa M, 2010, PATHOLOGY, V42, P613, DOI 10.3109/00313025.2010.520307; Catteau X, 2014, ISRN OBSTET GYNECOL, V2014, P536495; CLYMAN MJ, 1955, OBSTET GYNECOL, V6, P258; Du J, 2016, J CANCER RES CLIN, V142, P2515, DOI 10.1007/s00432-016-2215-3; Fadda G, 2011, ACTA CYTOL, V55, P389, DOI 10.1159/000329029; Gibb Randall K, 2011, Rev Obstet Gynecol, V4, pS2; Gupta JK, 2002, ACTA OBSTET GYN SCAN, V81, P799, DOI 10.1034/j.1600-0412.2001.810902.x; Iavazzo C, 2011, ANTICANCER RES, V31, P3469; Kalpalata Tripathy AM, 2014, J CYTOL, V32, P17; Kipp BR, 2008, CANCER CYTOPATHOL, V114, P228, DOI 10.1002/cncr.23636; LOVE WE, 1954, J CELL COMPAR PHYSL, V44, P291, DOI 10.1002/jcp.1030440211; Maksem John MD, 1997, DIAGNOSTIC CYTOPATHO, V17; Moroney JW, 2007, GYNECOL ONCOL, V105, P672, DOI 10.1016/j.ygyno.2007.01.040; Pan QJ, 2014, GYNECOL ONCOL, V133, P172, DOI 10.1016/j.ygyno.2014.03.008; Papaefthimiou M, 2005, CANCER CYTOPATHOL, V105, P56, DOI 10.1002/cncr.21025; Wen J, 2015, CHINESE MED J-PEKING, V128, P648, DOI 10.4103/0366-6999.151664; Wu HHJ, 2000, AM J CLIN PATHOL, V114, P412, DOI 10.1093/ajcp/114.3.412; YANG GCH, 1995, ACTA CYTOL, V39, P55; ZHU JIE1 IN, 2007, ONCOL REP, V18, P4	19	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190851	10.1371/journal.pone.0190851	http://dx.doi.org/10.1371/journal.pone.0190851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401497	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400006
J	Shi, JY; Jie-Ni; Zhuang, LF; Zhang, XM; Fan, LF; Lai, HC				Shi, Jun-Yu; Jie-Ni; Zhuang, Long-fei; Zhang, Xiao-Meng; Fan, Lin-Feng; Lai, Hong-Chang			Peri-implant conditions and marginal bone loss around cemented and screw-retained single implant crowns in posterior regions: A retrospective cohort study with up to 4 years follow-up	PLOS ONE			English	Article							COMPLICATION RATES; SUPPORTED RECONSTRUCTIONS; PROSTHESIS; RETENTION; SURVIVAL; METAANALYSIS; ASSOCIATION; DISEASES; OUTCOMES	The aim of the present study was to identify the peri-implant conditions (bleeding on probing (BOP), pocket probing depth (PPD), modified plaque index (mPI)) and marginal bone loss (MBL, marginal bone level change between follow-up and occlusal loading) around cemented and screw-retained posterior single crowns on tissue-level implants. The study was a retrospective cohort study with up to 4 years (mean 2.5 years) follow-up. Patients with either cemented or screw-retained crowns in posterior regions were included. Implant survival, technical complications, BOP, PPD, mPI, MBL, biologic complications (peri-implant mocositis and peri-implantitis) were evaluated. Mann-Whitney U test was used to test the difference between the screw-retained group (SG) and cemented group (CG). 176 patients (SG: 94, CG: 82) were included. The implant survival rates were 100% in SG and 98.8% in CG. Prosthetic screw loosening was found in 8 restorations (8.7%) at follow-up visit. Peri-implant mucositis rate was significantly higher in the SG group (42.1%) than that in the CG group (32.2%) (P = 0.04). Six patients (6.38%) in the screw-retained group and 5 patients (6.10%) in the cemented group were diagnosed with peri-implantitis, the difference did not reach statistical significance (P>0.05). No significant difference of PPD, mPI and MBL were found between two groups (P = 0.11, 0.13 and 0.08, respectively). High implant survival rates were achieved in both groups. Cemented single crowns on tissue-level implants showed comparable peri-implant conditions in comparison with two-piece screw-retained crowns. Well-designed prospective cohort or randomized controlled clinical trials with longer follow-up are needed to confirm the result.	[Shi, Jun-Yu; Jie-Ni; Zhang, Xiao-Meng; Lai, Hong-Chang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Dent Implantat,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Zhuang, Long-fei] Shanghai Adore Dent Care, Shanghai, Peoples R China; [Fan, Lin-Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol,Shanghai Key Lab Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lai, HC (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Dent Implantat,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Fan, LF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.	fanlinfeng0419@163.com; lhc9@hotmail.com		Shi, Jun-Yu/0000-0002-8241-2572	National Natural Science Foundation of China [81500892]; Shanghai Summit & Plateau Disciplines	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit & Plateau Disciplines	The study was funded by National Natural Science Foundation of China (81500892) and Shanghai Summit & Plateau Disciplines to Junyu Shi.	Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Lemos CAA, 2016, J PROSTHET DENT, V115, P419, DOI 10.1016/j.prosdent.2015.08.026; Boitelle P, 2014, J ORAL REHABIL, V41, P853, DOI 10.1111/joor.12205; Dalago HR, 2017, CLIN ORAL IMPLAN RES, V28, P144, DOI 10.1111/clr.12772; Gu YX, 2016, CLIN ORAL IMPLAN RES, V27, P120, DOI 10.1111/clr.12547; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Korsch M, 2015, QUINTESSENCE INT, V46, P583, DOI 10.3290/j.qi.a34077; Kotsakis G, 2015, J PERIODONTOL, P1; Kotsakis G, 2016, J PERIODONTOL, V87, P999, DOI 10.1902/jop.2016.160236; Kotsakis GA, 2016, J PERIODONTOL, V87, P212, DOI 10.1902/jop.2015.150450; Lee JH, 2016, J ADV PROSTHODONT, V8, P150, DOI 10.4047/jap.2016.8.2.150; Linkevicius T, 2013, CLIN ORAL IMPLAN RES, V24, P1179, DOI 10.1111/j.1600-0501.2012.02570.x; Linkevicius T, 2013, CLIN ORAL IMPLAN RES, V24, P71, DOI 10.1111/j.1600-0501.2012.02453.x; Millen C, 2015, INT J ORAL MAX IMPL, V30, P110, DOI 10.11607/jomi.3607; Pesce P, 2015, J PROSTHET DENT, V114, P346, DOI 10.1016/j.prosdent.2015.04.002; Pjetursson BE, 2014, INT J ORAL MAX IMPL, V29, P308, DOI 10.11607/jomi.2014suppl.g5.2; Rismanchian M, 2012, J ORAL IMPLANTOL, V38, P677, DOI 10.1563/AAID-JOI-D-11-00167; Sailer I, 2012, CLIN ORAL IMPLAN RES, V23, P163, DOI 10.1111/j.1600-0501.2012.02538.x; Sgolastra F, 2015, CLIN ORAL IMPLAN RES, V26, pe8, DOI 10.1111/clr.12319; Sherif S, 2014, J PROSTHODONT, V23, P1, DOI 10.1111/jopr.12128; Squier RS, 2001, INT J ORAL MAX IMPL, V16, P793; Weber HP, 2007, INT J ORAL MAX IMPL, V22, P140; Wittneben JG, 2014, INT J ORAL MAX IMPL, V29, P84, DOI 10.11607/jomi.2014suppl.g2.1; Zhao X, 2016, CLIN ORAL IMPLAN RES, V27, P106, DOI 10.1111/clr.12540	24	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191717	10.1371/journal.pone.0191717	http://dx.doi.org/10.1371/journal.pone.0191717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401469	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400017
J	Li, H; Bennett, MT; Jiang, XM; Zhang, KB; Yang, XH				Li, Hao; Bennett, Michael T.; Jiang, Xuemei; Zhang, Kebin; Yang, Xiaohui			Rural Household Preferences for Active Participation in "Payment for Ecosystem Service" Programs: A Case in the Miyun Reservoir Catchment, China (vol 12, e0169483, 2017)	PLOS ONE			English	Correction									[Li, Hao; Zhang, Kebin] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University	Li, H (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China.							Li H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169483	1	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192546	10.1371/journal.pone.0192546	http://dx.doi.org/10.1371/journal.pone.0192546			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394287	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400048
J	Seipone, ID; Singh, R; Patel, VB; Singh, A; Gordon, ML; Muema, DM; Dheda, K; Ndung'u, T				Seipone, Ikanyeng D.; Singh, Ravesh; Patel, Vinod B.; Singh, Avashna; Gordon, Michelle L.; Muema, Daniel M.; Dheda, Keertan; Ndung'u, Thumbi			Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CEREBRAL SPINAL-FLUID; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; ANTIRETROVIRAL THERAPY; REPLICATION; DIAGNOSIS; PLEOCYTOSIS; CYTOKINES; FAILURE	To gain a better understanding of the immunopathogenesis of tuberculous meningitis (TBM) and identify potential diagnostic biomarkers that may discriminate TBM from other HIV-1-associated meningitides, we assessed HIV-1 viral load levels, drug resistance patterns in antiretroviral therapy (ART)-experienced patients with persistent viremia and soluble immunological analytes in peripheral blood and cerebrospinal fluid (CSF) of HIV-1 infected patients with TBM versus other meningitides. One hundred and three matched blood and CSF samples collected from HIV-1 infected patients with TBM or other meningitides presenting at a hospital in Durban, South Africa, from January 2009 to December 2011 were studied. HIV-1 RNA and 28 soluble immunological potential biomarkers were quantified in blood plasma and CSF. Viremic samples were assessed for HIV-1 drug resistance mutations. There were 16 TBM, 46 probable TBM, 35 non-TBM patients, and six unclassifiable patients. TBM and non-TBM patients did not differ in median plasma viral load but TBM patients had significantly higher median CSF viral load than non-TBM participants (p = 0.0005). No major drug resistance mutations were detected in viremic samples. Interleukin (IL)-1 beta, IL-17, platelet derived growth factor (PDGF)-BB, granulocyte colony stimulating factor (G-CSF) and cathelicidin were significantly elevated in the CNS of TBM participants compared to other patients although these associations were lost after correction for false discovery. Our data suggest that TB co-infection of the CNS is associated with enhanced localized HIV-1 viral replication but none of the evaluated soluble immunological potential biomarkers could reliably distinguish TBM from other HIV-associated meningitides.	[Seipone, Ikanyeng D.; Singh, Ravesh; Singh, Avashna; Gordon, Michelle L.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Singh, Ravesh] Inkosi Albert Luthuli Cent Hosp, Dept Microbiol, Natl Hlth Lab Serv, KwaZulu Natal Acad Complex, Durban, South Africa; [Patel, Vinod B.] Univ KwaZulu Natal, Inkosi Albert Luthuli Cent Hosp, Dept Neurol, Durban, South Africa; [Patel, Vinod B.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Muema, Daniel M.; Ndung'u, Thumbi] Africa Hlth Res Inst, Durban, South Africa; [Muema, Daniel M.] Kenya Govt Med Res Ctr, Wellcome Trust Res Program, Ctr Geog Med Res Coast, Kilifi, Kenya; [Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Lung Inst, Dept Med, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Ndung'u, Thumbi] MIT, Ragon Inst MGH, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ndung'u, Thumbi] Harvard Univ, Cambridge, MA 02138 USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; Africa Health Research Institute; Kenya Medical Research Institute; University of Cape Town; University of Cape Town; University of Cape Town; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Max Planck Society	Ndung'u, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.; Ndung'u, T (corresponding author), Africa Hlth Res Inst, Durban, South Africa.; Ndung'u, T (corresponding author), MIT, Ragon Inst MGH, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Ndung'u, T (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Ndung'u, T (corresponding author), Max Planck Inst Infect Biol, Berlin, Germany.	ndungu@ukzn.ac.za		Muema, Daniel/0000-0001-7995-1682; Gordon, Michelle/0000-0001-9945-1394; Seipone, Ikanyeng Dolly/0000-0003-2853-4736; Ndung'u, Thumbi/0000-0003-2962-3992	Medical Education Partnership Initiative (MEPI) seed funding, College of Health Sciences, University of KwaZulu-Natal; Howard Hughes Medical Institute [55007427]; Wellcome Trust through Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; Victor Daitz Foundation; South African National Research Foundation; South African Medical Research Council through the South Africa HIV/AIDS Research Platform (SHARP); Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal	Medical Education Partnership Initiative (MEPI) seed funding, College of Health Sciences, University of KwaZulu-Natal; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust through Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; Victor Daitz Foundation; South African National Research Foundation(National Research Foundation - South Africa); South African Medical Research Council through the South Africa HIV/AIDS Research Platform (SHARP); Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal	This work was supported by the Medical Education Partnership Initiative (MEPI) seed funding, College of Health Sciences, University of KwaZulu-Natal; Howard Hughes Medical Institute (grant number 55007427) to TN; the Wellcome Trust through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative (grant # DEL-15-006); the Victor Daitz Foundation to TN; South African National Research Foundation to KD and TN; and the South African Medical Research Council through the South Africa HIV/AIDS Research Platform (SHARP) to TN. Open Access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We would like to acknowledge the patients and their families, and staff at the HIV Pathogenesis Programme and Inkosi Albert Luthuli Central Hospital. Open Access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal.	[Anonymous], 2013, S AFRICA DEP HLTH AN; Babu GN, 2008, NEUROSCI LETT, V436, P48, DOI 10.1016/j.neulet.2008.02.060; Bhigjee AI, 2007, INT J INFECT DIS, V11, P348, DOI 10.1016/j.ijid.2006.07.007; Boileau C, 2008, JAIDS-J ACQ IMM DEF, V48, P476, DOI 10.1097/QAI.0b013e31817dc416; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Christo PP, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-147; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; De Cock KM, JAMA, V268, P1581; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Garvey LJ, 2009, AIDS RES HUM RETROV, V25, P765, DOI 10.1089/aid.2008.0292; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Goletti D, 1996, J IMMUNOL, V157, P1271; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hightower GK, 2009, VIROLOGY, V394, P243, DOI 10.1016/j.virol.2009.08.007; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Jordan Michael R, 2013, World J AIDS, V3, P71; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Letendre SL, TOP HIV MED, V17, P46; Marais S, 2016, AIDS, V30, P395, DOI 10.1097/QAD.0000000000000904; Misra UK, 2010, NEUROSCI LETT, V483, P6, DOI 10.1016/j.neulet.2010.07.029; Morris L, 1998, J INFECT DIS, V177, P473, DOI 10.1086/517379; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Patel VB, 2011, J CLIN MICROBIOL, V49, P3971, DOI 10.1128/JCM.01128-11; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Patel VN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012497; Pillay V, 2008, ANTIVIR THER, V13, P101; Robertson K, 2010, J NEUROVIROL, V16, P189, DOI 10.3109/13550284.2010.489597; Sanchez-Portocarrero J, 1999, INFECTION, V27, P313, DOI 10.1007/s150100050035; Schnell G, 2011, PLOS PATHOG, P7; Smith DM, 2009, VIROLOGY, V385, P204, DOI 10.1016/j.virol.2008.11.010; Spudich S, 2006, J INFECT DIS, V194, P1686, DOI 10.1086/508750; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Thobakgale C, 2017, JAIDS-J ACQ IMM DEF, V74, P213, DOI 10.1097/QAI.0000000000001181; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thwaites GE, 2013, CURR OPIN NEUROL, V26, P295, DOI 10.1097/WCO.0b013e3283602814; Torok ME, 2015, BRIT MED BULL, V113, P117, DOI 10.1093/bmb/ldv003; van Lelyveld SFL, 2010, CLIN INFECT DIS, V50, P387, DOI 10.1086/649874; Visser DH, 2014, CLIN INFECT DIS, P1; Wright EJ, 2014, CURR OPIN HIV AIDS, V9, P539, DOI 10.1097/COH.0000000000000109	46	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192060	10.1371/journal.pone.0192060	http://dx.doi.org/10.1371/journal.pone.0192060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394269	gold, Green Submitted, Green Published			2022-12-27	WOS:000424060400023
J	Ather, JL; Poynter, ME				Ather, Jennifer L.; Poynter, Matthew E.			Serum amyloid A3 is required for normal weight and immunometabolic function in mice	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; REGULATORY T-CELLS; HEPATITIS-C VIRUS; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; ALLERGIC SENSITIZATION; OBESITY; POPULATION; METABOLISM; MECHANISMS	Serum amyloid A (SAA) is an apolipoprotein that is robustly upregulated in numerous inflammatory diseases and has been implicated as a candidate pro-inflammatory mediator. However, studies comparing endogenous SAAs and recombinant forms of the acute phase protein have generated conflicting data on the function of SAA in immunity. We generated SAA3 knockout mice to evaluate the contribution of SAA3 to immune-mediated disease, and found that mice lacking SAA3 develop adult-onset obesity and metabolic dysfunction along with defects in innate immune development. Mice that lack SAA3 gain more weight, exhibit increased visceral adipose deposition, and develop hepatic steatosis compared to wild-type littermates. Leukocytes from the adipose tissue of SAA3(-/-) mice express a pro-inflammatory phenotype, and bone marrow derived dendritic cells from mice lacking SAA3 secrete increased levels of IL-1 beta, IL-6, IL-23, and TNF alpha in response to LPS compared to cells from wild-type mice. Finally, BMDC lacking SAA3 demonstrate an impaired endotoxin tolerance response and inhibited responses to retinoic acid. Our findings indicate that endogenous SAA3 modulates metabolic and immune homeostasis.	[Ather, Jennifer L.; Poynter, Matthew E.] Univ Vermont, Dept Med, Vermont Lung Ctr, Div Pulm Dis & Crit Care, Burlington, VT 05405 USA	University of Vermont	Poynter, ME (corresponding author), Univ Vermont, Dept Med, Vermont Lung Ctr, Div Pulm Dis & Crit Care, Burlington, VT 05405 USA.	Matthew.Poynter@uvm.edu			National Institutes of Health [R01 HL107291, R01 HL133920]; Flight Attendant Medical Research Institute (FAMRI) [CIA 113045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107291, R01HL133920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants R01 HL107291 and R01 HL133920 from the National Institutes of Health, and a Clinical Innovator award from the Flight Attendant Medical Research Institute (FAMRI) grant CIA 113045 to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Bakdash G, 2015, MUCOSAL IMMUNOL, V8, P265, DOI 10.1038/mi.2014.64; Bevelander M, 2007, J IMMUNOL, V179, P3680, DOI 10.4049/jimmunol.179.6.3680; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Dullaart RPF, 2013, OBESITY, V21, P361, DOI 10.1002/oby.20058; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; Hawkesworth S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.24; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lee WJ, 2015, DIABETES, V64, P2836, DOI 10.2337/db14-1668; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Poynter ME, 2012, PULM PHARMACOL THER, V25, P438, DOI 10.1016/j.pupt.2012.04.005; RAMADORI G, 1985, J IMMUNOL, V135, P3645; Reigstad CS, 2010, GUT MICROBES, V1, P55, DOI 10.4161/gmic.1.1.10514; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; STEEL DM, 1993, GENOMICS, V16, P447, DOI 10.1006/geno.1993.1209; Tannock LR, 2017, J LIPID RES; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wang B, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.36; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192352	10.1371/journal.pone.0192352	http://dx.doi.org/10.1371/journal.pone.0192352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390039	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400090
J	Huskens, D; Sang, Y; Konings, J; van der Vorm, L; de Laat, B; Kelchtermans, H; Roest, M				Huskens, Dana; Sang, Yaqiu; Konings, Joke; van der Vorm, Lisa; de laat, Bas; Kelchtermans, Hilde; Roest, Mark			Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test	PLOS ONE			English	Article							GPIIB-IIIA ACTIVATION; P-SELECTIN; IN-VITRO; AGGREGATION; DISORDERS; AGGREGOMETRY; DIAGNOSIS; SEX; HYPOREACTIVITY; TEMPERATURE	Introduction Platelet function testing with flow cytometry has additional value to existing platelet function testing for diagnosing bleeding disorders, monitoring anti-platelet therapy, transfusion medicine and prediction of thrombosis. The major challenge is to use this technique as a diagnostic test. The aim of this study is to standardize preparation, optimization and validation of the test kit and to determine reference values in a population of 129 healthy individuals. Methods Platelet function tests with 3 agonists and antibodies against P-selectin, activated alpha IIb beta 3 and glycoprotein Ib (GPIb), were prepared and stored at -20 degrees C until used. Diluted whole blood was added and platelet activation was quantified by the density of activation markers, using flow cytometry. Anti-mouse Ig. particles were included to validate stability of the test and to standardize results. Reference intervals were determined. Results Blood stored at room temperature (RT) for up to 4h after blood donation and preheated/tested at 37 degrees C resulted in stable results (%CV<10%), in contrast to measuring at RT. The intra-assay % CV was <5%. Incubation of anti-mouse Ig. particles with antibodies stored for up to 12 months proved to give a stable fluorescence. The inter-individual variation measured in the 129 individuals varied between 23% and 37% for P-selectin expression and alpha IIb beta 3 activation, respectively. Conclusions The current study contributes to the translation of flow cytometry based platelet function testing from a scientific tool to a diagnostic test. Platelet function measurements, using prepared and stored platelet activation kits, are reproducible if executed at 37 degrees C. The reference ranges can be validated in clinical laboratories and ongoing studies are investigating if reduced platelet reactivity in patients with bleeding complications can be detected.	[Huskens, Dana; Sang, Yaqiu; Konings, Joke; van der Vorm, Lisa; de laat, Bas; Kelchtermans, Hilde; Roest, Mark] Maastricht Univ, Cardiovasc Res Inst Maastricht, Med Ctr, Maastricht, Netherlands; [Huskens, Dana; Sang, Yaqiu; Konings, Joke; van der Vorm, Lisa; de laat, Bas; Kelchtermans, Hilde; Roest, Mark] Synapse Res Inst, Maastricht, Netherlands; [van der Vorm, Lisa] Gelre Hosp, Dept Clin Chem & Hematol, Apeldoorn, Netherlands	Maastricht University; Gelre Hospitals	Huskens, D (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Med Ctr, Maastricht, Netherlands.; Huskens, D (corresponding author), Synapse Res Inst, Maastricht, Netherlands.	D.Huskens@thrombin.com		Kelchtermans, Hilde/0000-0002-2724-3438; van der Vorm, Lisa/0000-0003-0698-5878; Huskens, Dana/0000-0002-5999-5685	China Scholarship Council (CSC) [201606790009]	China Scholarship Council (CSC)(China Scholarship Council)	Yaqiu Sang (File no. 201606790009) has been awarded a scholarship under the State Scholarship Fund to pursue her study in the Netherlands as a PhD student by the China Scholarship Council (CSC).	Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bednarek FJ, 2009, THROMB RES, V124, P42, DOI 10.1016/j.thromres.2008.10.004; Beyan C, 2006, CLIN LAB HAEMATOL, V28, P14, DOI 10.1111/j.1365-2257.2006.00742.x; Boknas N., 2017, PLATELETS, P1, DOI 10.1080/09537104.2017.1349305.; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; CLSI and IFCC, 2008, DEF EST VER REF INT, V28, P1; Dovlatova N, 2014, J THROMB HAEMOST, V12, P660, DOI 10.1111/jth.12555; Faraday N, 1997, THROMB HAEMOSTASIS, V77, P748; Faraday N, 1998, ANESTHESIOLOGY, V88, P1579, DOI 10.1097/00000542-199806000-00022; Femia EA, 2013, J THROMB HAEMOST, V11, P2193, DOI 10.1111/jth.12432; Frelinger AL, 2015, BLOOD, V126, P873, DOI 10.1182/blood-2015-02-628461; Gresele P, 2015, J THROMB HAEMOST, V13, P314, DOI 10.1111/jth.12792; Gresele P, 2014, J THROMB HAEMOST, V12, P1562, DOI 10.1111/jth.12650; Harrison P, 2011, BRIT J HAEMATOL, V155, P30, DOI 10.1111/j.1365-2141.2011.08793.x; JOHNSON M, 1975, NATURE, V253, P355, DOI 10.1038/253355a0; Jones CI, 2016, MAMM GENOME, V27, P358, DOI 10.1007/s00335-016-9629-8; Kaiser AFC, 2012, PLATELETS, V23, P359, DOI 10.3109/09537104.2011.624211; Kappelmayer J, 2004, CLIN CHEM LAB MED, V42, P475, DOI 10.1515/CCLM.2004.082; Kicken CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172265; Krueger LA, 2002, CURR PROTOC CYTOM, V6; LAROSA CA, 1994, J VASC SURG, V19, P306, DOI 10.1016/S0741-5214(94)70106-7; Loncar Robert, 2007, Thromb J, V5, P5, DOI 10.1186/1477-9560-5-5; Maurer-Spurej E, 2001, LAB INVEST, V81, P581, DOI 10.1038/labinvest.3780267; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; Michelson A. D., 2013, PLATELETS; Michelson AD, 2000, METHODS, V21, P259, DOI 10.1006/meth.2000.1006; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; Michelson AD., 2019, PLATELETS, V4th ed.; Minamino T, 1998, CIRCULATION, V98, P1721, DOI 10.1161/01.CIR.98.17.1721; Neuger J, 1999, PSYCHIAT RES, V85, P189, DOI 10.1016/S0165-1781(99)00006-2; NIES AS, 1992, CLIN PHARMACOL THER, V52, P605, DOI 10.1038/clpt.1992.198; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Peerschke EIB, 2014, AM J CLIN PATHOL, V142, P647, DOI 10.1309/AJCPP43SEYCBJLHJ; Rajasekhar D, 1997, THROMB HAEMOSTASIS, V77, P1002; Ramstrom S, 2016, SEMIN THROMB HEMOST, V42, P268, DOI 10.1055/s-0035-1570082; Roest M, 2013, TRANSFUS MED HEMOTH, V40, P117, DOI 10.1159/000350688; Rosse W., 1995, BLOOD PRINCIPLES PRA, P367; Rubak P, 2016, PLATELETS, V27, P66, DOI 10.3109/09537104.2015.1032919; Rubak P, 2012, THROMB RES, V130, P420, DOI 10.1016/j.thromres.2012.06.017; Rudez G, 2009, J THROMB HAEMOST, V7, P1247, DOI 10.1111/j.1538-7836.2009.03488.x; SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032; Scharbert G, 2006, ANESTH ANALG, V102, P1280, DOI 10.1213/01.ane.0000199399.04496.6d; Schmitz G, 1998, THROMB HAEMOSTASIS, V79, P885; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307	45	30	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192079	10.1371/journal.pone.0192079	http://dx.doi.org/10.1371/journal.pone.0192079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389990	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400063
J	Kohl, C; Tachedjian, M; Todd, S; Monaghan, P; Boyd, V; Marsh, GA; Crameri, G; Field, H; Kurth, A; Smith, I; Wang, LF				Kohl, Claudia; Tachedjian, Mary; Todd, Shawn; Monaghan, Paul; Boyd, Victoria; Marsh, Glenn A.; Crameri, Gary; Field, Hume; Kurth, Andreas; Smith, Ina; Wang, Lin-Fa			Hervey virus: Study on co-circulation with Henipaviruses in Pteropid bats within their distribution range from Australia to Africa	PLOS ONE			English	Article							LENGTH GENOME SEQUENCE; FRUIT BATS; RESERVOIR HOSTS; TIOMAN VIRUS; HENDRA VIRUS; FLYING-FOXES; PARAMYXOVIRUSES; PIGS; REPRODUCTION; MULTIPLE	In 2011, an unusually large number of independent Hendra virus outbreaks were recorded on horse properties in Queensland and New South Wales, Australia. Urine from bat colonies adjacent to the outbreak sites were sampled and screened for Hendra and other viruses. Several novel paramyxoviruses were also isolated at different locations. Here one of the novel viruses, named Hervey virus (HerPV), is fully characterized by genome sequencing, annotation, phylogeny and in vitro host range, and its serological cross-reactivity and neutralization patterns are examined. HerPV may have ecological and spatial and temporal patterns similar to Hendra virus and could serve as a sentinel virus for the surveillance of this highly pathogenic virus. The suitability of HerPV as potential sentinel virus is further assessed by determining the serological prevalence of HerPV antibodies in fruit-eating bats from Australia, Indonesia, Papua New Guinea, Tanzania and the Gulf of Guinea, indicating the presence of similar viruses in regions beyond the Australian border.	[Kohl, Claudia; Kurth, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Seestr 10, Berlin, Germany; [Tachedjian, Mary; Todd, Shawn; Monaghan, Paul; Boyd, Victoria; Marsh, Glenn A.; Crameri, Gary; Smith, Ina; Wang, Lin-Fa] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Field, Hume] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Wang, Lin-Fa] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore	Robert Koch Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); EcoHealth Alliance; National University of Singapore	Smith, I; Wang, LF (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.; Wang, LF (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.	Ina.Smith@csiro.au; linfa.wang@duke-nus.edu.sg	wang, lin/HHM-2225-2022; Smith, Ina/H-7225-2013; wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022; Marsh, Glenn A/A-5418-2013; Tachedjian, Mary/H-4572-2013	Smith, Ina/0000-0001-5807-3737; Marsh, Glenn A/0000-0002-3469-1837; Tachedjian, Mary/0000-0002-8936-6564; Wang, Lin-Fa/0000-0003-2752-0535	CSIRO appropriation funds, a German-Australian Mobility Call Grant [RI 17.5, BMBF 01DR14007]; Australian Queensland through a National Hendra Virus Research Program Grant [NHeVRP_05]; New South Wales Governments through a National Hendra Virus Research Program Grant [NHeVRP_05]; National Research Foundation in Singapore [NRF2012NRF-CRP001-056]; Konrad Adenauer Foundation	CSIRO appropriation funds, a German-Australian Mobility Call Grant; Australian Queensland through a National Hendra Virus Research Program Grant; New South Wales Governments through a National Hendra Virus Research Program Grant; National Research Foundation in Singapore(National Research Foundation, Singapore); Konrad Adenauer Foundation	This research was partially funded by CSIRO appropriation funds, a German-Australian Mobility Call Grant (RI 17.5 and BMBF 01DR14007) to L-FW and CK; and the Australian Queensland and New South Wales Governments through a National Hendra Virus Research Program Grant (NHeVRP_05) to HF. L-FW is supported in part by a National Research Foundation grant (NRF2012NRF-CRP001-056) in Singapore. CK was supported as a visiting scientist at AAHL in 2012 by a fellowship from the Konrad Adenauer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Ursula Erikli for copy-editing and Annika Brinkmann for technical assistance. We thank Andrew Breed, Andrew Cunningham, Alison Peel, Craig Smith and James Wood for providing the bat serum samples for our previous collaborative studies. We thank the CSIRO AAHL Hendra virus response team (Michelle Baker, Kate Baker, Jennifer Barr, Amy Burroughs, Bronwyn Clayton, Johanna Dups, Reuben Klein, Huajun Zhang, Peng Zhou) and the staff of Biosecurity Queensland, Department of Agriculture and Fisheries (Craig Smith, Carol de Jong, Deb Melville and Alice Broos), for assistance in collecting urine samples during the Hendra virus outbreaks of 2011. This research was partially funded by CSIRO appropriation funds, a German-Australian Mobility Call Grant (RI 17.5 and BMBF 01DR14007) to L-FW and CK; and the Australian Queensland and New South Wales Governments through a National Hendra Virus Research Program Grant (NHeVRP_05) to HF. L-FW is supported in part by a National Research Foundation grant (NRF2012NRF-CRP001-056) in Singapore. CK was supported as a visiting scientist at AAHL in 2012 by a fellowship from the Konrad Adenauer Foundation.	Baker KS, 2012, J GEN VIROL, V93, P850, DOI 10.1099/vir.0.039339-0; Baker KS, 2014, J ANIM ECOL, V83, P415, DOI 10.1111/1365-2656.12153; Baker KS, 2013, J VIROL, V87, P1348, DOI 10.1128/JVI.01202-12; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bowden TR, 2012, J GEN VIROL, V93, P1007, DOI 10.1099/vir.0.038448-0; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021; Chua KB, 2002, ARCH VIROL, V147, P1323, DOI 10.1007/s00705-002-0815-5; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Fauquet CM, 2001, ARCH VIROL, V146, P189, DOI 10.1007/s007050170203; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klose SM, 2006, J COMP PHYSIOL A, V192, P341, DOI 10.1007/s00359-005-0067-4; Kurth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038688; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Wang LF, 2007, ARCH VIROL, V152, P1259, DOI 10.1007/s00705-007-0959-4; Weiss S, 2012, EMERG INFECT DIS, V18, P1536, DOI 10.3201/eid1809.111607; Yaiw KC, 2008, J VIROL, V82, P565, DOI 10.1128/JVI.01660-07	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191933	10.1371/journal.pone.0191933	http://dx.doi.org/10.1371/journal.pone.0191933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390028	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400043
J	Loft, ND; Skov, L; Rasmussen, MK; Gniadecki, R; Dam, TN; Brandslund, I; Hoffmann, HJ; Andersen, MR; Dessau, RB; Bergmann, AC; Andersen, NM; Abildtoft, MK; Andersen, PS; Hetland, ML; Glintborg, B; Bank, S; Vogel, U; Andersen, V				Loft, Nikolai Dyrberg; Skov, Lone; Rasmussen, Mads Kirchheiner; Gniadecki, Robert; Dam, Tomas Norman; Brandslund, Ivan; Hoffmann, Hans Jurgen; Andersen, Malene Rohr; Dessau, Ram Benny; Bergmann, Ann Christina; Andersen, Niels Moller; Abildtoft, Mikkel Kramme; Andersen, Paal Skytt; Hetland, Merete Lund; Glintborg, Bente; Bank, Steffen; Vogel, Ulla; Andersen, Vibeke			Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis	PLOS ONE			English	Article							FACTOR-ALPHA GENE; NF-KAPPA-B; SUSCEPTIBILITY LOCI; IL23R GENES; EARLY-ONSET; NSAID USE; RISK; IL12B; DISEASE; VULGARIS	Background Psoriasis (PsO) is a chronic inflammatory disease with predominantly cutaneous manifestations. Approximately one third of patients with PsO develop psoriatic arthritis (PsA), whereas the remaining proportion of patients has isolated cutaneous psoriasis (PsC). These two phenotypes share common immunology, but with different heredity that might in part be explained by genetic variables. Methods Using a candidate gene approach, we studied 53 single nucleotide polymorphisms (SNPs) in 37 genes that regulate inflammation. In total, we assessed 480 patients with PsO from DERMBIO, of whom 151 had PsC for 10 years or more (PsC10), 459 patients with PsA from DANBIO, and 795 healthy controls. Using logistic regression analysis, crude and adjusted for age and gender, we assessed associations between genetic variants and PsO, PsC10, and PsA, as well as associations between genetic variants and development of PsA in PsO. Results Eleven polymorphisms in 10 genes were nominally associated with PsO and/or PsC and/or PsA (P < 0.05). After correction for multiple testing with a false discovery rate of 5%, two SNPs remained significant: TNF (rs361525) was associated with PsO, PsC10, and PsA; and IL12B (rs6887695) was associated with PsO. Conclusion Among a cohort of Danish patients with moderate-to-severe psoriasis, two SNPs in the IL12B and TNF genes were associated with susceptibility of psoriasis. None of the SNPs were specifically associated with isolated cutaneous psoriasis or psoriatic arthritis.	[Loft, Nikolai Dyrberg; Skov, Lone] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark; [Rasmussen, Mads Kirchheiner] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark; [Gniadecki, Robert] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark; [Dam, Tomas Norman] Dermatol Clin, Nykoebing Falster, Denmark; [Brandslund, Ivan] Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis & Allergy B, Aarhus, Denmark; [Andersen, Malene Rohr] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Dessau, Ram Benny] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Bergmann, Ann Christina; Andersen, Niels Moller; Bank, Steffen; Andersen, Vibeke] Hosp Southern Jutland, Focused Res Unit Mol Diagnost & Clin Res, IRS Ctr Soenderjylland, Aabenraa, Denmark; [Abildtoft, Mikkel Kramme] Zitelab Aps, Copenhagen, Denmark; [Andersen, Paal Skytt] Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Hetland, Merete Lund; Glintborg, Bente] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, DANBIO Registry, Glostrup, Denmark; [Hetland, Merete Lund; Glintborg, Bente] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark; [Glintborg, Bente] Herlev & Gentofte Hosp, Dept Rheumatol, Hellerup, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Andersen, Vibeke] Univ Southern Denmark, OPEN Odense Patient Data Explorat Network, Odense, Denmark	University of Copenhagen; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Rigshospitalet; Rigshospitalet; National Research Centre for the Working Environment; University of Southern Denmark; University of Southern Denmark	Loft, ND (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark.	nikolai.dyrberg.loft@regionh.dk	Skov, Lone/W-3575-2018; Hetland, Merete L/AAE-5297-2019; Glintborg, Bente/W-6374-2019; Hoffman, Hans Jurgen/I-6969-2018; Vogel, Ulla B/I-5048-2012; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020; Gniadecki, Robert/A-5696-2010; Andersen, Paal Skytt/H-2087-2015	Hetland, Merete L/0000-0003-4229-6818; Glintborg, Bente/0000-0002-8931-8482; Hoffman, Hans Jurgen/0000-0002-6743-7931; Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Gniadecki, Robert/0000-0002-2310-8300; Rasmussen, Mads Kirchheiner/0000-0001-8242-9377; Andersen, Paal Skytt/0000-0001-5656-0427; Skov, Lone/0000-0002-4784-9680; Dessau, Ram/0000-0002-1497-6309; Loft, Nikolai Dyrberg/0000-0002-2950-3280; Brandslund, Ivan/0000-0002-4203-5442	Psoriasisforeningen; Robert Wehnerts og Kirsten Wehnerts Fonden; Knud og Edith Eriksens Mindefond; Gigtforeningen [A2037, A3570]; DERMBIO; Novo Nordisk Foundation [NNF150C0017622]; Novo Nordisk Foundation	Psoriasisforeningen; Robert Wehnerts og Kirsten Wehnerts Fonden; Knud og Edith Eriksens Mindefond; Gigtforeningen; DERMBIO; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work was funded by Psoriasisforeningen, Robert Wehnerts og Kirsten Wehnerts Fonden, Knud og Edith Eriksens Mindefond, Gigtforeningen (A2037, A3570), DERMBIO, and the Novo Nordisk Foundation (NNF150C0017622). The Novo Nordisk Foundation provided support in form of a scholarship for author NDL, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The rest of the Funders supported the study with funding for collection and analysis of biological material. MKA is employed by Zitelap Aps. Zitelap Aps provided support in the form of salary for author MKA and is responsible for management of the DERMBIO and DANBIO databases, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baliwag J, 2015, CYTOKINE, V73, P342, DOI 10.1016/j.cyto.2014.12.014; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowes J, 2015, ANN RHEUM DIS, V74, P1882, DOI 10.1136/annrheumdis-2014-207187; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Bowes J, 2012, ANN RHEUM DIS, V71, P313, DOI 10.1136/ard.2011.154690; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Budu-Aggrey A, 2016, ANN RHEUM DIS, V75, P1417, DOI 10.1136/annrheumdis-2016-209290; Butt C, 2006, J RHEUMATOL, V33, P1631; Cardili RN, 2016, INT J DERMATOL, V55, pE16, DOI 10.1111/ijd.12894; Chandran V, 2014, RHEUMATOLOGY, V53, P233, DOI 10.1093/rheumatology/ket296; De Simone C, 2015, J EUR ACAD DERMATOL, V29, P1786, DOI 10.1111/jdv.13024; Duffin KC, 2009, J INVEST DERMATOL, V129, P2777, DOI 10.1038/jid.2009.169; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Eder L, 2011, ANN RHEUM DIS, V70, P1594, DOI 10.1136/ard.2010.147421; Eiris N, 2014, J DERMATOL SCI, V75, P167, DOI 10.1016/j.jdermsci.2014.05.010; Eiris N, 2012, CYTOKINE, V60, P27, DOI 10.1016/j.cyto.2012.05.030; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Eskandari-Nasab E, 2013, SCAND J IMMUNOL, V78, P85, DOI 10.1111/sji.12054; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Gladman DD, 2011, ANN RHEUM DIS, V70, P2152, DOI 10.1136/ard.2011.150938; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Goldminz AM, 2013, J DERMATOL SCI, V69, P89, DOI 10.1016/j.jdermsci.2012.11.002; Haroon M, 2015, ANN RHEUM DIS, V74, P1045, DOI 10.1136/annrheumdis-2013-204858; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Ibfelt EH, 2016, CLIN EPIDEMIOL, V8, P737, DOI 10.2147/CLEP.S99490; Isssik S, 308G A 238G A POL TN; Jia Y, 2013, CLIN EXP DERMATOL, V38, P836, DOI 10.1111/ced.12136; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Lee YH, 2013, IMMUNOL INVEST, V42, P726, DOI 10.3109/08820139.2013.810241; Loft ND, 2017, PHARMACOGENOMICS J; Mossner R, 2004, ARCH DERMATOL RES, V296, P1, DOI 10.1007/s00403-004-0463-6; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2010, ARCH DERMATOL RES, V302, P139, DOI 10.1007/s00403-009-0986-y; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nedoszytko B, 2007, BRIT J DERMATOL, V157, P165, DOI 10.1111/j.1365-2133.2007.07993.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oka A, 2013, IMMUNOGENETICS, V65, P823, DOI 10.1007/s00251-013-0721-x; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Petersen RK, 2012, CANCER LETT, V315, P59, DOI 10.1016/j.canlet.2011.10.009; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rajesh D, 2017, INT J DERMATOL, V56, P307, DOI 10.1111/ijd.13482; Reich K, 2007, ARTHRITIS RHEUM, V56, P2056, DOI 10.1002/art.22590; Sakkas LI, 2017, AUTOIMMUN REV, V16, P10, DOI 10.1016/j.autrev.2016.09.015; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Sode J, 2016, PHARMACOGENOMICS J; Sode J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139781; Sode J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100361; Soto-Sanchez J, 2010, CYTOKINE, V50, P114, DOI 10.1016/j.cyto.2010.01.006; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Theander E, 2014, ANN RHEUM DIS, V73, P407, DOI 10.1136/annrheumdis-2012-201972; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2007, CARCINOGENESIS, V28, P427, DOI 10.1093/carcin/bgl170; Wang XB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000613; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415; Yang Q, 2013, BRIT J DERMATOL, V168, P1060, DOI 10.1111/bjd.12142; Zachariae H, 2003, AM J CLIN DERMATOL, V4, P441, DOI 10.2165/00128071-200304070-00001; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu KJ, 2013, RHEUMATOL INT, V33, P1785, DOI 10.1007/s00296-012-2637-4; Zhu KJ, 2012, INFLAMM RES, V61, P1149, DOI 10.1007/s00011-012-0509-8; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068827	66	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192010	10.1371/journal.pone.0192010	http://dx.doi.org/10.1371/journal.pone.0192010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389950	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400050
J	Manderstedt, E; Lind-Hallden, C; Lethagen, S; Hallden, C				Manderstedt, Eric; Lind-Hallden, Christina; Lethagen, Stefan; Hallden, Christer			Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients	PLOS ONE			English	Article							LINKAGE; ASSOCIATION; CONTRIBUTES; VARIANTS; SIGN	von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association with type 1 VWD in the Swedish population. In order to screen for CLEC4M variants, the CLEC4M gene region was re-sequenced and the polymorphic neck region was genotyped in 106 type 1 VWD patients from unrelated type 1 VWD families. Single nucleotide variants (SNV) and variable number tandem repeat (VNTR) allele and genotype frequencies were then compared with 294 individuals from the 1000Genomes project and 436 Swedish control individuals. Re-sequencing identified a total of 42 SNVs. Rare variants showed no accumulation in type 1 VWD patients and are not thought to contribute substantially to type 1 VWD. The only missense mutation (rs2277998, NP_001138379.1: p.Asp224Asn) had a higher frequency in type 1 VWD patients than in controls (4.9%). The VNTR genotypes 57 and 67 were observed at higher frequencies than expected in type 1 VWD patients (6.4% and 6.2%) and showed an increase in patients compared with controls (7.4% and 3.1%). Strong linkage disequilibrium in the CLEC4M region makes it difficult to distinguish between the effect of the missense mutation and the VNTR genotypes. In conclusion, heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population.	[Manderstedt, Eric; Lind-Hallden, Christina; Hallden, Christer] Kristianstad Univ, Biomed, Kristianstad, Sweden; [Lethagen, Stefan] Univ Copenhagen, Copenhagen, Denmark; [Lethagen, Stefan] Sobi, Stockholm, Sweden; [Lethagen, Stefan] Lund Univ, Lund, Sweden	Kristianstad University; University of Copenhagen; Swedish Orphan Biovitrum; Lund University	Manderstedt, E (corresponding author), Kristianstad Univ, Biomed, Kristianstad, Sweden.	eric.manderstedt@hkr.se		Manderstedt, Eric/0000-0002-8984-9697	Sobi	Sobi	Stefan Lethagen [SL] is employed by and receive salary from Sobi. The funder provided support in the form of salary for author [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Casari C., 2013, J THROMB HAEMOST, V11, P1538; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Desch KC, 2013, P NATL ACAD SCI USA, V110, P588, DOI 10.1073/pnas.1219885110; Flood VH, 2016, BLOOD, V127, P2481, DOI 10.1182/blood-2015-10-673681; Goodeve AC, 2010, BLOOD REV, V24, P123, DOI 10.1016/j.blre.2010.03.003; Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200; Hallden C, 2012, J THROMB HAEMOST, V10, P2503, DOI 10.1111/jth.12010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lanke E, 2005, J THROMB HAEMOST, V3, P2656, DOI 10.1111/j.1538-7836.2005.01631.x; Leckband DE, 2011, BIOCHEMISTRY-US, V50, P6125, DOI 10.1021/bi2003444; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042972; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030268; Lillicrap D, 2013, HEMATOL-AM SOC HEMAT, P254, DOI 10.1182/asheducation-2013.1.254; Liu Huanliang, 2005, Methods Mol Biol, V304, P471; Manderstedt E, TH OPEN; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rydz N, 2013, BLOOD, V121, P5228, DOI 10.1182/blood-2012-10-457507; Sanders YV, 2015, J THROMB HAEMOST, V13, P956, DOI 10.1111/jth.12927; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; van Loon JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040624; Zhi LT, 2007, NAT GENET, V39, P691, DOI [10.1038/ng0607-692, 10.1038/ng0607-691]; Zhu DY, 2010, BIOCHEM BIOPH RES CO, V393, P598, DOI 10.1016/j.bbrc.2010.02.021	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192024	10.1371/journal.pone.0192024	http://dx.doi.org/10.1371/journal.pone.0192024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389944	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400052
J	Silvino, ACR; Costa, GL; de Araujo, FCF; Ascher, DB; Pires, DEV; Fontes, CJF; Carvalho, LH; de Brito, CFA; Sousa, TN				Silvino, Ana Carolina Rios; Costa, Gabriel Luiz; Faustino de Araujo, Flavia Carolina; Ascher, David Benjamin; Valente Pires, Douglas Eduardo; Fernandes Fontes, Cor Jesus; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira; Sousa, Tais Nobrega			Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses (vol 11, e0160172, 2016)	PLOS ONE			English	Correction													Pires, Douglas/ABC-7445-2020; de Sousa, Tais Nobrega/AAG-6225-2019; Carvalho, Luzia H/AAW-3461-2021; Fontes, Cor JF/G-7331-2018	Pires, Douglas/0000-0002-3004-2119; de Sousa, Tais Nobrega/0000-0002-6874-9427; Fontes, Cor JF/0000-0003-2756-0588				Silvino ACR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160172	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192534	10.1371/journal.pone.0192534	http://dx.doi.org/10.1371/journal.pone.0192534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389962	Green Published, gold			2022-12-27	WOS:000423793400094
J	Atujuna, M; Newman, PA; Wallace, M; Eluhu, M; Rubincam, C; Brown, B; Bekker, LG				Atujuna, Millicent; Newman, Peter A.; Wallace, Melissa; Eluhu, Megan; Rubincam, Clara; Brown, Ben; Bekker, Linda-Gail			Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; RECTAL MICROBICIDES; YOUNG MEN; VACCINE; SEX; INFECTION; RISK; CHALLENGES; EFFICACY; TRIALS	Background New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships. Methods We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight indepth interviews with key informant healthcare workers. The interview guide described preexposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software. Results Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape. Conclusions Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.	[Atujuna, Millicent; Wallace, Melissa; Eluhu, Megan; Brown, Ben; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Fdn, Hlth Sci Fac, Inst Infect Dis, Cape Town, South Africa; [Newman, Peter A.; Rubincam, Clara] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada	University of Cape Town; University of Toronto	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Bekker, Linda-Gail/AAZ-8929-2020; Newman, Peter A/P-7056-2019	Newman, Peter A/0000-0003-0444-5915; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Atujuna, Millicent/0000-0003-1287-2634; Wallace, Melissa/0000-0001-7007-1910	Canadian Institutes of Health Research [THA-118570]; Canada Research Chairs Program (Canada Research Chair in Health and Social Justice)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program (Canada Research Chair in Health and Social Justice)	This study was funded by a grant from the Canadian Institutes of Health Research (THA-118570) to the CHVI Team in Social and Behavioral Research on HIV Vaccines (PI: PN). PN was supported by the Canada Research Chairs Program (Canada Research Chair in Health and Social Justice). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulai MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-40; Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Bauermeister J, 2016, AIDS EDUC PREV, V28, P1, DOI 10.1521/aeap.2016.28.1.1; Bekker LG, LANCET HIV; Cameron MP, 2013, VACCINE, V31, P3712, DOI 10.1016/j.vaccine.2013.05.089; Chakrapani V, 2007, AIDS EDUC PREV, V19, P346, DOI 10.1521/aeap.2007.19.4.346; Chakrapani V, 2017, QUAL HEALTH RES, V27, P1236, DOI 10.1177/1049732317697947; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Fassin, 2007, BODIES REMEMBER EXPE; Fassin D, 2003, BMJ-BRIT MED J, V326, P495, DOI 10.1136/bmj.326.7387.495; Gafos M, 2013, AIDS CARE, V25, P573, DOI 10.1080/09540121.2012.722604; Galea JT, 2014, AM J PUBLIC HEALTH, V104, pE113, DOI 10.2105/AJPH.2013.301731; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Harrington M., PIPELINE REPORT 2017; Harrison A, 2001, SOC TRANSITION, V31, P69, DOI DOI 10.1080/21528586.2001.10419031; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Lee SJ, 2014, VACCINE, V32, P5013, DOI 10.1016/j.vaccine.2014.07.018; Luecke EH, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20875; Mack Natasha, 2014, J Int AIDS Soc, V17, P19157, DOI 10.7448/IAS.17.3.19157; Madlala SL, 2002, SOC DYNAMICS, V28, P1; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mcgowan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125363; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Middelkoop K, 2010, AM J RESP CRIT CARE, V182, P1080, DOI 10.1164/rccm.201004-0598OC; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Navarro Vicente, 2009, Glob Health Promot, V16, P5, DOI 10.1177/1757975908100746; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2008, VACCINE, V26, P2528, DOI 10.1016/j.vaccine.2008.03.004; Newman PA, 2016, AIDS BEHAV, V20, P2588, DOI 10.1007/s10461-015-1258-9; Newman PA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18476; Newman PA, 2012, EXPERT REV VACCINES, V11, P1, DOI [10.1586/erv.11.162, 10.1586/ERV.11.162]; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; NIH National Institute of Allergy and Infectious Diseases, NIH SPONS HIV VACC T; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb; Preston-Whyte Eleanor M, 2003, Afr J AIDS Res, V2, P89, DOI 10.2989/16085906.2003.9626563; Rees H, 2015, 2015 C RETR OPP INF; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Roberts Kathleen Johnston, 2005, J Natl Med Assoc, V97, P1662; Rubincam C, 2016, EXPERT REV VACCINES, V15, P331, DOI 10.1586/14760584.2016.1118349; Sayles JN, 2010, HEALTH EDUC BEHAV, V37, P193, DOI 10.1177/1090198109335654; Seeley J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17397; Simbayi L., 2014, S AFRICAN NATL HIV P, P194; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tarantola D, 2011, VACCINE, V29, pD135, DOI 10.1016/j.vaccine.2011.07.027; UNAIDS, FAST TRACK COMB PREV; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; World Health Organization (WHO), 2016, WHO CONS GUID HIV PR, pxii; Zanoni BC, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000004	66	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0191251	10.1371/journal.pone.0191251	http://dx.doi.org/10.1371/journal.pone.0191251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420549	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900013
J	Lau, Y; Htun, TP; Kwong, HKD				Lau, Ying; Tha Pyai Htun; Kwong, Ho Keung Dennis			Sociodemographic, obstetric characteristics, antenatal morbidities, and perinatal depressive symptoms: A three-wave prospective study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; PREGNANT-WOMEN; RISK-FACTORS; MATERNAL DEPRESSION; POSTNATAL DEPRESSION; UNPLANNED PREGNANCY; ANXIETY; ASSOCIATION; PREVALENCE; PREDICTORS	Objectives This study aimed (1) to investigate the pattern of perinatal depressive symptoms, and (2) to determine the relationships between sociodemographic characteristics, obstetric factors, antenatal morbidities, postnatal conditions, and perinatal depressive symptoms using a structural equation model (SEM). Method A three-wave prospective longitudinal design was used for 361 women in their second trimester, third trimester, and at six weeks postpartum. The Edinburgh Postnatal Depression Scale (EPDS) was used to assess the depressive symptoms. Results The intensity of depressive symptoms was the highest in the second trimester among the three waves. The SEM showed that unmarried status, unplanned pregnancy, gestational diabetes, and headache were significantly associated with EPDS in the first and second waves. The EPDS in the first wave was able to predict the EPDS in the second and third waves. The SEM has satisfactorily fit with the data (chi-square/degree of freedom = 1.42, incremental fit index = 0.91, Tucker-Lewis index = 0.90, comparative fit index = 0.91, and root mean square error of approximation = 0.03). Conclusion The findings highlight the significance of monitoring depressive symptoms in the second trimester. Findings from this study could be useful in the design of effective intervention among women with unmarried status, unplanned pregnancy, gestational diabetes, and headache in order to reduce risk of perinatal depressive symptoms.	[Lau, Ying; Tha Pyai Htun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore, Singapore; [Kwong, Ho Keung Dennis] Macao Polytech Inst, Sch Hlth Sci, Macau, Peoples R China	National University of Singapore; Macao Polytechnic University	Lau, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore, Singapore.	nurly@nus.edu.sg	YING, LAU/HHS-2619-2022	LAU, Ying/0000-0002-8289-3441	Macao Polytechnic Institute [RP/ESS/01/2011]	Macao Polytechnic Institute	The study was funded by Macao Polytechnic Institute, Grant numbers:RP/ESS/01/2011 to YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrpt.	Abujilban SK, 2014, HEALTH CARE WOMEN IN, V35, P200, DOI 10.1080/07399332.2013.817411; Agrati D, 2016, HORM BEHAV, V77, P141, DOI 10.1016/j.yhbeh.2015.07.016; Lara MA, 2015, J AFFECT DISORDERS, V175, P18, DOI 10.1016/j.jad.2014.12.035; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Bayrampour H, 2015, MIDWIFERY, V31, P582, DOI 10.1016/j.midw.2015.02.009; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Betts KS, 2015, DEPRESS ANXIETY, V32, P82, DOI 10.1002/da.22272; Bjerke SEY, 2008, J MATERN-FETAL NEO M, V21, P889, DOI 10.1080/14767050802320340; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Byrn M, 2015, JOGNN-J OBST GYN NEO, V44, P246, DOI 10.1111/1552-6909.12554; Byrn Mary A, 2013, Nurs Womens Health, V17, P22, DOI 10.1111/1751-486X.12003; Byrne BM, 2010, STUCTURAL EQUATION M; Cheng CY, 2013, HEALTH CARE WOMEN IN, V34, P539, DOI 10.1080/07399332.2012.655389; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Everitt B. S., 2001, APPL MULTIVARIATE DA; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Field A., 2013, DISCOVERING STAT USI; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Frediani F, 2007, NEUROL SCI, V28, pS161, DOI 10.1007/s10072-007-0771-7; Gaillard A, 2014, PSYCHIAT RES, V215, P341, DOI 10.1016/j.psychres.2013.10.003; Gonulal D, 2014, TURKISH J PEDIATR, V56, P171; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hassanein IMA, 2014, INT J GYNECOL OBSTET, V125, P138, DOI 10.1016/j.ijgo.2013.11.006; Hein A, 2014, ARCH GYNECOL OBSTET, V289, P755, DOI 10.1007/s00404-013-3046-y; Hodgkinson EL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-330; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.21427/D7CF7R, 10.21427/D79B73]; Jeong HG, 2013, GEN HOSP PSYCHIAT, V35, P354, DOI 10.1016/j.genhosppsych.2013.02.009; Katz ER, 2012, PSYCHOL MED, V42, P943, DOI 10.1017/S0033291711002121; Kim DR, 2013, ARCH WOMEN MENT HLTH, V16, P475, DOI 10.1007/s00737-013-0371-x; Kline R.B., 2011, PRINCIPLES PRACTICE; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lau Y, 2010, INT J NURS STUD, V47, P1139, DOI 10.1016/j.ijnurstu.2010.02.005; Lau Y, 2010, ARCH WOMEN MENT HLTH, V13, P153, DOI 10.1007/s00737-009-0134-x; Lee YS, 1996, J PSYCHOLINGUIST RES, V25, P527, DOI 10.1007/BF01758181; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Madigan S, 2014, CHILD ABUSE NEGLECT, V38, P1160, DOI 10.1016/j.chiabu.2014.04.002; Martini J, 2015, J AFFECT DISORDERS, V175, P385, DOI 10.1016/j.jad.2015.01.012; Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012; McArdle J.J., 2014, LONGITUDINAL DATA AN, DOI [10.1037/14440-000, DOI 10.1037/14440-000]; Montazeri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-11; Ngai FW, 2015, J PSYCHOSOM RES, V78, P156, DOI 10.1016/j.jpsychores.2014.12.003; Nunally J. C., 1994, PSYCHOMETRIC THEORY; Orta OR, 2015, J AFFECT DISORDERS, V172, P390, DOI 10.1016/j.jad.2014.10.032; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Pinsonneault JK, 2013, ARCH WOMEN MENT HLTH, V16, P499, DOI 10.1007/s00737-013-0373-8; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; Roca A, 2013, J AFFECT DISORDERS, V150, P807, DOI 10.1016/j.jad.2013.02.040; Roomruangwong C, 2011, ASIAN BIOMED, V5, P179, DOI 10.5372/1905-7415.0502.024; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI [10.13287/j.1001-9332.202201.010, DOI 10.1002/0470010940]; Setse R, 2009, MATERN CHILD HLTH J, V13, P577, DOI 10.1007/s10995-008-0392-7; Sheskin DJ, 2011, HDB PARAMETRIC NONPA; Sundaram S, 2014, WOMEN HEALTH ISS, V24, pE381, DOI 10.1016/j.whi.2014.05.001; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vivilaki VG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-329; Wang YQ, 2009, INT J NURS STUD, V46, P813, DOI 10.1016/j.ijnurstu.2009.01.010; Weobong B, 2015, DEPRESS ANXIETY, V32, P108, DOI 10.1002/da.22218; West S. G., 1995, STRUCTURAL EQUATION, P56; Wiener S, 2015, LANG COGN NEUROSCI, V30, P1048, DOI 10.1080/23273798.2014.946934; Woody CA, 2017, J AFFECT DISORDERS, V219, P86, DOI 10.1016/j.jad.2017.05.003; Yanikkerem E, 2013, J OBSTET GYNAECOL RE, V39, P180, DOI 10.1111/j.1447-0756.2012.01958.x; Yee LM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.029; Yilmaz E, 2016, J PEDIATR ADOL GYNEC, V29, P65, DOI 10.1016/j.jpag.2015.06.010; Zeng ZL, 2014, INT J TOUR RES, V16, P105, DOI 10.1002/jtr.1902	70	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0188365	10.1371/journal.pone.0188365	http://dx.doi.org/10.1371/journal.pone.0188365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420535	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900001
J	Zhou, Y; Zhou, GF; Broughton, S; Westcott, S; Zhang, XQ; Xu, YH; Xu, L; Li, CD; Zhang, WY				Zhou, Yi; Zhou, Gaofeng; Broughton, Sue; Westcott, Sharon; Zhang, Xiaoqi; Xu, Yanhao; Xu, Le; Li, Chengdao; Zhang, Wenying			Towards the identification of a gene for prostrate tillers in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							GROWTH HABIT; RICE; GRAVITROPISM; MAIZE; LOCUS; LAZY1	Tiller angle, an important agronomic trait, contributes to crop production and plays a vital role in breeding for plant architecture. A barley line V-V-HD, which has prostrate tillers during vegetative growth and erect tillers after booting, is considered the ideal type for repressing weed growth and increasing leaf area during early growth. Genetic analysis identified that the prostrate trait in V-V-HD is controlled by a single gene. A double haploid population with 208 lines from V-V-HD x Buloke was used to map the prostrate growth gene. Ninety-six SNP markers were used for primary mapping, and subsequently, SSR and InDel markers were used for fine mapping. The gene was fine-mapped to a 3.53 Mb region on chromosome 3HL between the markers InDelz3028 and InDelz3032 with 52 candidate genes located in this region. Gene annotation analysis of the 52 genes within the target region indicated that a gene involved in zinc-ion binding (gene ID HORVU3Hr1G090910) is likely to be the candidate gene for prostrate growth in V-V-HD, and is linked to the denso/sdw gene. Association analysis showed that prostrate plants were shorter, flowered later.	[Zhou, Yi; Xu, Yanhao; Xu, Le; Zhang, Wenying] Yangtze Univ, Sch Agr, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China; [Zhou, Yi; Zhou, Gaofeng; Zhang, Xiaoqi; Xu, Yanhao; Li, Chengdao] Murdoch Univ, WA State Agr Biotechnol Ctr, Western Barley Genet Alliance, Murdoch, WA, Australia; [Broughton, Sue; Westcott, Sharon; Li, Chengdao] Govt Western Australia, Dept Primary Ind & Reg Dev, S Perth, WA, Australia	Yangtze University; Murdoch University	Zhang, WY (corresponding author), Yangtze Univ, Sch Agr, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China.; Li, CD (corresponding author), Murdoch Univ, WA State Agr Biotechnol Ctr, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Govt Western Australia, Dept Primary Ind & Reg Dev, S Perth, WA, Australia.	c.Li@murdoch.edu.au; wyzhang@yangtzeu.edu.cn	Zhang, Wenying/P-2509-2018	Zhang, Wenying/0000-0002-9926-4115; Xu, Yanhao/0000-0002-7917-8885	National Natural Science Foundation of China [31471496]; Grains Research & Development Corporation of Australia [UMU00050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grains Research & Development Corporation of Australia(Grains R&D Corp)	This work was supported by the National Natural Science Foundation of China (No. 31471496) to Wenying Zhang and Grains Research & Development Corporation of Australia (UMU00050) to Chengdao Li.	Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collar C, 2014, EUR FOOD RES TECHNOL, V238, P459, DOI 10.1007/s00217-013-2128-1; Corcoran M, 1948, PLANT PHYSIOL, V75, P105; Dabbert T, 2010, THEOR APPL GENET, V121, P705, DOI 10.1007/s00122-010-1342-5; Dabbert T, 2009, THEOR APPL GENET, V118, P1351, DOI 10.1007/s00122-009-0985-6; Didon UME, 2002, J AGRON CROP SCI, V188, P176, DOI 10.1046/j.1439-037X.2002.00566.x; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; DONALD CM, 1979, J AGR SCI, V93, P261, DOI 10.1017/S0021859600037941; Dong HJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006412; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178177; Howard TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087053; Hussien A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0032; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kuczynska A, 2014, ELECTRON J BIOTECHN, V17, P217, DOI 10.1016/j.ejbt.2014.07.005; LAURIE DA, 1993, PLANT BREEDING, V111, P198, DOI 10.1111/j.1439-0523.1993.tb00630.x; Lewis MJ, 2001, KIRK OTHMER ENCY CHE, P561; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Liu XQ, 2008, J MULTIVARIATE ANAL, V99, P1503, DOI 10.1016/j.jmva.2008.01.004; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Okagaki RJ, 2013, FUNCT INTEGR GENOMIC, V13, P33, DOI 10.1007/s10142-012-0299-7; OZMINKOWSKI RH, 1990, HORTSCIENCE, V25, P914, DOI 10.21273/HORTSCI.25.8.914; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Van Overbeek J, 1936, J HERED, V27, P93; Voorrips R, 2001, JOINMAP 3 0 SOFTWARE; Wang YH, 2008, NAT GENET, V40, P1273, DOI 10.1038/ng1108-1273; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	35	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192263	10.1371/journal.pone.0192263	http://dx.doi.org/10.1371/journal.pone.0192263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420581	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900058
J	Fink, DS; Santaella-Tenorio, J; Keyes, KM				Fink, David S.; Santaella-Tenorio, Julian; Keyes, Katherine M.			Increase in suicides the months after the death of Robin Williams in the US	PLOS ONE			English	Article							CELEBRITY SUICIDE; MEDIA; PREVENTION; AUSTRALIA; RATES	Investigating suicides following the death of Robin Williams, a beloved actor and comedian, on August 11th, 2014, we used time-series analysis to estimate the expected number of suicides during the months following Williams' death. Monthly suicide count data in the US (1999-2015) were from the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research (CDC WONDER). Expected suicides were calculated using a seasonal autoregressive integrated moving averages model to account for both the seasonal patterns and autoregression. Time-series models indicated that we would expect 16,849 suicides from August to December 2014; however, we observed 18,690 suicides in that period, suggesting an excess of 1,841 cases (9.85% increase). Although excess suicides were observed across gender and age groups, males and persons aged 30 +/- 44 had the greatest increase in excess suicide events. This study documents associations between Robin Williams' death and suicide deaths in the population thereafter.	[Fink, David S.; Santaella-Tenorio, Julian; Keyes, Katherine M.] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA	Columbia University	Fink, DS (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10027 USA.	dsf2130@columbia.edu	Fink, David S./F-1634-2014	Fink, David S./0000-0003-1531-1525; Santaella-Tenorio, Julian/0000-0003-3060-5994	National Institute of Drug Abuse (NIDA) [T32DA031099]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA031099] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (NIDA; https://www.drugabuse.gov/) grant number T32DA031099 (D.S.F.). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barthel M., EVOLVING ROLE NEWS T; Bernstein L, 2014, WASHINGTON POST; Chen YY, 2012, SOC PSYCH PSYCH EPID, V47, P215, DOI 10.1007/s00127-010-0331-y; Cheng ATA, 2007, INT J EPIDEMIOL, V36, P1229, DOI 10.1093/ije/dym196; Etzersdorfer Elmar, 2004, Arch Suicide Res, V8, P137, DOI 10.1080/13811110490270985; Gould M., 2014, LANCET PSYCHIAT, V1, P34, DOI DOI 10.1016/S2215-0366(14)70225-1; Gould MS, 2001, ANN NY ACAD SCI, V932, P200; Jobes DA, 1996, SUICIDE LIFE-THREAT, V26, P260; Koburger N, 2015, J AFFECT DISORDERS, V185, P38, DOI 10.1016/j.jad.2015.06.037; Kumar M, HT 15 P 26 ACM C HYP; Lee J, 2014, SUICIDE LIFE-THREAT, V44, P457, DOI 10.1111/sltb.12109; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Martin G, 1997, ARCH SUICIDE RES, V3, P187, DOI 10.1080/13811119708258271; Niederkrotenthaler T, 2007, AUST NZ J PSYCHIAT, V41, P419, DOI 10.1080/00048670701266680; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Perlroth N., 2014, NY TIMES; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Pirkis J, 2014, LANCET PSYCHIAT, V1, P5, DOI 10.1016/S2215-0366(14)70227-5; Pirkis JE, 2006, SOC SCI MED, V62, P2874, DOI 10.1016/j.socscimed.2005.11.033; SCHMIDTKE A, 1988, PSYCHOL MED, V18, P665, DOI 10.1017/S0033291700008345; Shumway R. H., 2013, TIME SERIES ANAL ITS; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Stack S, 2005, SUICIDE LIFE-THREAT, V35, P121, DOI 10.1521/suli.35.2.121.62877; Stack S, 2000, SOC SCI QUART, V81, P957; Stack SJ, 1987, AM SOCIOL REV, V52; Tousignant M, 2005, SOC SCI MED, V60, P1919, DOI 10.1016/j.socscimed.2004.08.054; World Health Organization, 2008, PREV SUIC RES MED PR; Yip PSF, 2006, J AFFECT DISORDERS, V93, P245, DOI 10.1016/j.jad.2006.03.015	30	78	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191405	10.1371/journal.pone.0191405	http://dx.doi.org/10.1371/journal.pone.0191405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415016	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300026
J	Li, XY; Liu, LJ; Yang, HJ; Li, Y				Li, Xiaoyu; Liu, Lijuan; Yang, Huijin; Li, Yan			Relationships between carbon fluxes and environmental factors in a drip-irrigated, film-mulched cotton field in arid region	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NET ECOSYSTEM EXCHANGE; STAND-SCALE TRANSPIRATION; VAPOR-PRESSURE DEFICIT; JARVIS-STEWART MODEL; PLASTIC FILM; EDDY COVARIANCE; DIOXIDE EXCHANGE; CO2 FLUXES; INTERANNUAL VARIATIONS	Environmental factors and human activities play important roles in carbon fixation and emissions generated from croplands. Eddy covariance measurements in a drip-irrigated, film-mulched cotton field were used to analyze the relationships between carbon fluxes and environmental factors in Wulanwusu, northern Xinjiang, an arid region of Northwest China. Our results showed that the cumulative net carbon flux (NEE) was -304.8 g Cm-2 (a strong sink) over the whole cotton growing season in 2012, which was more than that in cotton cropland without plastic film mulching and drip-irrigation. Moreover, when time is scaled up from a half-hour to a month, the correlations of gross primary production (GPP) to air temperature (T-air), net solar radiation (R-n) and soil water content (SWC) gradually become stronger due to ecosystem resistance and resilience as well as the protection of plastic film mulching. The GPP is more strongly correlated with R-n than T-air at time scales from minutes to days, while it reverses at time scales from days to weeks. This outcome is largely determined by the biochemical characteristics of photosynthesis. SWC and vapor pressure deficit (VPD) at all time scales are weakly correlated with GPP because plastic film mulching and regularly drip-irrigation allow soil to maintain sufficient water.	[Li, Xiaoyu; Liu, Lijuan; Li, Yan] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Linan, Peoples R China; [Li, Xiaoyu] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China; [Yang, Huijin] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Hubei, Peoples R China	Zhejiang A&F University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Wuhan University	Li, Y (corresponding author), Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Linan, Peoples R China.	liyan2016@zafu.edu.cn	yang, huijin/AAK-9960-2021		973 Program of China [2014CB954204]; National Natural Science Foundation of China [31470708, U1503182, 41501205, 41271202]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received financial support from the 973 Program of China (No. 2014CB954204), National Natural Science Foundation of China (No. 31470708, U1503182, 41501205 & 41271202).	An TT, 2015, SOIL BIOL BIOCHEM, V80, P53, DOI 10.1016/j.soilbio.2014.09.024; ANTONIA RA, 1993, EXP FLUIDS, V14, P203; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Bai J, 2015, J ARID LAND, V7, P272, DOI 10.1007/s40333-014-0012-x; Baker JT, 2009, AGRON J, V101, P52, DOI 10.2134/agronj2008.0007x; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Berger S, 2013, AGR ECOSYST ENVIRON, V167, P43, DOI 10.1016/j.agee.2013.01.010; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Beringer J, 2013, AGR FOREST METEOROL, V182, P239, DOI 10.1016/j.agrformet.2013.06.008; Beziat P, 2009, AGR FOREST METEOROL, V149, P1628, DOI 10.1016/j.agrformet.2009.05.004; Bristow KL, 1996, THEOR APPL CLIMATOL, V54, P85, DOI 10.1007/BF00863561; Broeckx LS, 2014, GCB BIOENERGY, V6, P473, DOI 10.1111/gcbb.12087; Burba G, 2006, 27 C AGR FOR MET; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Conaty WC, 2014, FUNCT PLANT BIOL, V41, P535, DOI 10.1071/FP13223; Cuello JP, 2015, APPL SOIL ECOL, V91, P48, DOI 10.1016/j.apsoil.2015.02.007; De Luca V, 2000, J AGR ENG RES, V77, P93, DOI 10.1006/jaer.2000.0565; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Ge ZM, 2011, AGR FOREST METEOROL, V151, P191, DOI 10.1016/j.agrformet.2010.10.003; Giasson MA, 2006, AGR FOREST METEOROL, V140, P23, DOI 10.1016/j.agrformet.2006.08.001; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Hollings S., 1985, RESILENCE ECOSYSTEMS; Jaksic V, 2006, AGR FOREST METEOROL, V139, P323, DOI 10.1016/j.agrformet.2006.07.009; Kolari P, 2004, GLOBAL CHANGE BIOL, V10, P1106, DOI 10.1111/j.1529-8817.2003.00797.x; Lei HM, 2010, GLOBAL CHANGE BIOL, V16, P2944, DOI 10.1111/j.1365-2486.2009.02136.x; Li J., 2014, THESIS; Li SX, 2013, AGR WATER MANAGE, V116, P39, DOI 10.1016/j.agwat.2012.10.004; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Li Z, 2014, J AGR SCI-CAMBRIDGE, V152, P534, DOI 10.1017/S0021859613000701; Li Z, 2005, SCI CHINA SER D, V34, P46; Li ZG, 2011, PEDOSPHERE, V21, P178, DOI 10.1016/S1002-0160(11)60116-1; Liao Y, 2004, AGR SCI CHINA, V4, P865; Ling HB, 2013, QUATERN INT, V286, P116, DOI 10.1016/j.quaint.2012.07.027; Liu CA, 2013, EUR J SOIL BIOL, V57, P9, DOI 10.1016/j.ejsobi.2013.03.007; [刘贤赵 Liu Xianzhao1], 2014, [地球科学进展, Advance in Earth Sciences], V29, P216; Liu Y, 2010, ACTA AGR SCAND B-S P, V60, P245, DOI 10.1080/09064710902878121; Miller AE, 2002, OECOLOGIA, V130, P609, DOI 10.1007/s00442-001-0838-8; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P3102, DOI 10.1111/j.1365-2486.2011.02459.x; Oelbermann M, 2004, AGR ECOSYST ENVIRON, V104, P359, DOI 10.1016/j.agee.2004.04.001; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Saigusa N, 2008, AGR FOREST METEOROL, V148, P700, DOI 10.1016/j.agrformet.2007.12.006; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Tong XJ, 2014, J HYDROL, V512, P221, DOI 10.1016/j.jhydrol.2014.02.042; Tubiello FN, 1999, AGRON J, V91, P247, DOI 10.2134/agronj1999.00021962009100020012x; Velasco E, 2005, ATMOS ENVIRON, V39, P7433, DOI 10.1016/j.atmosenv.2005.08.038; Vourlitis GL, 2000, ECOL APPL, V10, P60, DOI 10.1890/1051-0761(2000)010[0060:PMFSPM]2.0.CO;2; Wang GS, 2016, AGR WATER MANAGE, V163, P403, DOI 10.1016/j.agwat.2015.10.012; Wang Yu-Hui, 2014, Chinese Journal of Plant Ecology, V38, P795, DOI 10.3724/SP.J.1258.2014.00075; Watson R.T., 1996, CLIMATE CHANGE 1995; Watson R. T., 1990, GREENHOUSE GASES AER; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Whitley R, 2008, PLANT SOIL, V305, P35, DOI 10.1007/s11104-007-9399-x; Whitley R, 2013, HYDROL PROCESS, V27, P1133, DOI 10.1002/hyp.9280; Whitley R, 2009, J HYDROL, V373, P256, DOI 10.1016/j.jhydrol.2009.04.036; Whitley RJ, 2011, GLOBAL CHANGE BIOL, V17, P3130, DOI 10.1111/j.1365-2486.2011.02425.x; Williams M, 1998, PLANT CELL ENVIRON, V21, P953, DOI 10.1046/j.1365-3040.1998.00339.x; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wu J, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1007/S40515-014-0013-4; Wu YH, 1996, AGR FOREST METEOROL, V81, P299, DOI 10.1016/0168-1923(95)02320-8; Xue QW, 2004, ENVIRON EXP BOT, V51, P167, DOI 10.1016/j.envexpbot.2003.09.003; Yang QD, 2012, J HYDROL, V452, P102, DOI 10.1016/j.jhydrol.2012.05.041; Yoshimoto M, 2005, AGR FOREST METEOROL, V133, P226, DOI 10.1016/j.agrformet.2005.09.010; Zhang F, 2015, ARID LAND RES MANAG, V29, P432, DOI 10.1080/15324982.2015.1018456; Zhang QQ, 2012, ENVIRON EARTH SCI, V66, P683, DOI 10.1007/s12665-011-1276-5; Zhang SL, 2011, SOIL TILL RES, V112, P92, DOI 10.1016/j.still.2010.11.006; Zhou LM, 2015, SOIL TILL RES, V150, P21, DOI 10.1016/j.still.2015.01.006; Zhou LM, 2012, FIELD CROP RES, V126, P181, DOI 10.1016/j.fcr.2011.10.010; Zhou SQ, 2012, HYDROL PROCESS, V26, P1169, DOI 10.1002/hyp.8208; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	73	12	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192467	10.1371/journal.pone.0192467	http://dx.doi.org/10.1371/journal.pone.0192467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415018	Green Submitted, Green Published, gold			2022-12-27	WOS:000424325300078
J	Matoga, MM; Rosenberg, NE; Stanley, CC; LaCourse, S; Munthali, CK; Nsona, DP; Haac, B; Hoffman, I; Hosseinipour, MC				Matoga, Mitch M.; Rosenberg, Nora E.; Stanley, Christopher C.; LaCourse, Sylvia; Munthali, Charles K.; Nsona, Dominic P.; Haac, Bryce; Hoffman, Irving; Hosseinipour, Mina C.			Inpatient mortality rates during an era of increased access to HIV testing and ART: A prospective observational study in Lilongwe, Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; RURAL DISTRICT; SURGICAL WARDS; SCALE-UP; ADULTS; PREVALENCE; OUTCOMES; DISEASE; INCOME	Background In the era of increased access to HIV testing and antiretroviral treatment (ART), the impact of HIV and ART status on inpatient mortality in Malawi is unknown. Methods We prospectively followed adult inpatients at Kamuzu Central Hospital medical wards in Lilongwe, Malawi, between 2011 and 2012, to evaluate causes of mortality, and the impact of HIV and ART status on mortality. We divided the study population into five categories: HIV-negative, new HIV-positive, ART-naive patients, new ART-initiators, and ART-experienced. We used multivariate binomial regression models to compare risk of death between categories. Results Among 2911 admitted patients the mean age was 38.5 years, and 50% were women. Eighty-one percent (81%) of patients had a known HIV status at the time of discharge or death. Mortality was 19.4% and varied between 13.9% (HIV-negative patients) and 32.9% (HIV-positive patients on ART <= 1 year). In multivariable analyses adjusted for age, sex and leading causes of mortality, being new HIV-positive (RR = 1.64 95% CI: 1.16-2.32), ART-naive (RR = 2.28 95% CI: 1.66-2.32) or being a new ART-initiator (RR = 2.41 95% CI: 1.85-3.14) were associated with elevated risk of mortality compared to HIV-negative patients. ART-experienced patients had comparable mortality (RR = 1.33 95% CI: 0.94-1.88) to HIV-negative patients. Conclusion HIV related mortality remains high among medical inpatients, especially among HIV-positive patients who recently initiated ART or have not started ART yet.	[Matoga, Mitch M.; Rosenberg, Nora E.; Stanley, Christopher C.; Hosseinipour, Mina C.] Univ North Carolina Project, Lilongwe, Malawi; [Rosenberg, Nora E.; Hoffman, Irving; Hosseinipour, Mina C.] Univ N Carolina, Chapel Hill, NC USA; [LaCourse, Sylvia] Univ Washington, Seattle, WA 98195 USA; [Munthali, Charles K.] Kamuzu Cent Hosp, Lilongwe, Malawi; [Nsona, Dominic P.] Lighthouse Trust, Lilongwe, Malawi; [Haac, Bryce] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Matoga, MM (corresponding author), Univ North Carolina Project, Lilongwe, Malawi.	mmatoga@unclilongwe.org		Matoga, Mitch/0000-0002-6542-8193	National Institutes of Health through the University of North Carolina, Center for AIDS Research [NIH P30-AI50410-14]; NIH [P30-AI50410-14]; UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program [R25 TW009340]; National Institute of Mental Health [K99 MH104154-01A1]; Doris Duke; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Recovery and Reinvestment Act; Health Management Information Systems Office; UNC Center for AIDS Research CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI120793] Funding Source: NIH RePORTER	National Institutes of Health through the University of North Carolina, Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke(Doris Duke Charitable Foundation (DDCF)); Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Recovery and Reinvestment Act; Health Management Information Systems Office; UNC Center for AIDS Research CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institutes of Health through the University of North Carolina, Center for AIDS Research under award NIH P30-AI50410-14. This grant supported the study design, data collection and manuscript preparation. MM received funding from NIH P30-AI50410-14. NR was supported by the UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program (R25 TW009340) and The National Institute of Mental Health (K99 MH104154-01A1). BH received funding from Doris Duke. SL received funding from the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Recovery and Reinvestment Act. Bryce Haac is supported as a Doris Duke scholar.; We would like to thank the staff at Kamuzu Central Hospital medical department, counselors from Lighthouse Trust and the Health Management Information Systems Office for their support. We are also thankful to the UNC Center for AIDS Research CFAR for supporting this research.	Akinkuotu A, 2011, INT J STD AIDS, V22, P465, DOI 10.1258/ijsa.2011.011021; Allain TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168368; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan AT, 2016, JAIDS-J ACQ IMM DEF, V73, P1, DOI 10.1097/QAI.0000000000001112; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, HIV TREATMENT PREVEN; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Kendig Claire E, 2013, Trop Med Health, V41, P163, DOI 10.2149/tmh.2013-12; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; LaCourse SM, 2015, J ACQ IMMUN DEF SYND, V1, P31; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Malawi MDS, 2011, MAL HIV GUID, P1; Malawi National AIDS Commission, 2015, MAL AIDS RESP PROGR; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Myer L, 2013, SAMJ S AFR MED J, V103, P28, DOI [10.7196/samj.6285, 10.7196/SAMJ.6285]; Ogoina D, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/940580; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perry ME, 2016, INT J STD AIDS; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Wajanga BMK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0627-9; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization (WHO), 2015, GUID START ANT THER, P78; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191944	10.1371/journal.pone.0191944	http://dx.doi.org/10.1371/journal.pone.0191944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415015	Green Published, Green Submitted, gold			2022-12-27	WOS:000424325300046
J	van Hooft, P; Dougherty, ER; Getz, WM; Greyling, BJ; Zwaan, BJ; Bastos, ADS				van Hooft, Pim; Dougherty, Eric R.; Getz, Wayne M.; Greyling, Barend J.; Zwaan, Bas J.; Bastos, Armanda D. S.			Genetic responsiveness of African buffalo to environmental stressors: A role for epigenetics in balancing autosomal and sex chromosome interactions?	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; BOVINE TUBERCULOSIS; NATURAL-SELECTION; MODEL SELECTION; SYNCERUS-CAFFER; MALE-FERTILITY; RATIO; INHERITANCE; MAINTENANCE; PREDATION	In the African buffalo (Syncerus caffer) population of the Kruger National Park (South Africa) a primary sex-ratio distorter and a primary sex-ratio suppressor have been shown to occur on the Y chromosome. A subsequent autosomal microsatellite study indicated that two types of deleterious alleles with a negative effect on male body condition, but a positive effect on relative fitness when averaged across sexes and generations, occur genome-wide and at high frequencies in the same population. One type negatively affects body condition of both sexes, while the other acts antagonistically: it negatively affects male but positively affects female body condition. Here we show that high frequencies of male-deleterious alleles are attributable to Y-chromosomal distorter-suppressor pair activity and that these alleles are suppressed in individuals born after three dry pre-birth years, likely through epigenetic modification. Epigenetic suppression was indicated by statistical interactions between pre-birth rainfall, a proxy for parental body condition, and the phenotypic effect of homozygosity/heterozygosity status of microsatellites linked to male-deleterious alleles, while a role for the Y-chromosomal distorter-suppressor pair was indicated by between-sex genetic differences among pre-dispersal calves. We argue that suppression of male-deleterious alleles results in negative frequency-dependent selection of the Y distorter and suppressor; a prerequisite for a stable polymorphism of the Y distorter-suppressor pair. The Y distorter seems to be responsible for positive selection of male-deleterious alleles during resource-rich periods and the Y suppressor for positive selection of these alleles during resource-poor periods. Male-deleterious alleles were also associated with susceptibility to bovine tuberculosis, indicating that Kruger buffalo are sensitive to stressors such as diseases and droughts. We anticipate that future genetic studies on African buffalo will provide important new insights into gene fitness and epigenetic modification in the context of sex-ratio distortion and infectious disease dynamics.	[van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [van Hooft, Pim; Greyling, Barend J.; Bastos, Armanda D. S.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Herts, South Africa; [Dougherty, Eric R.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Greyling, Barend J.] Agr Res Council, Irene, South Africa; [Zwaan, Bas J.] Wageningen Univ, Lab Genet, Wageningen, Netherlands	Wageningen University & Research; University of Pretoria; University of California System; University of California Berkeley; University of Kwazulu Natal; Agricultural Research Council of South Africa; Wageningen University & Research	van Hooft, P (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.; van Hooft, P (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Herts, South Africa.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Zwaan, Bas/D-8721-2015	Bastos, Armanda/0000-0002-9223-4204; Zwaan, Bas/0000-0002-8221-4998; Dougherty, Eric/0000-0001-5140-1646	US NIH/NSF Ecology of Infectious Disease [GM83863]	US NIH/NSF Ecology of Infectious Disease	Laboratory analyses were supported by US NIH/NSF Ecology of Infectious Disease Grant GM83863 awarded to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barson NJ, 2015, NATURE, V528, P405, DOI 10.1038/nature16062; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beechler BR, 2015, TRANSBOUND EMERG DIS, V62, P24, DOI 10.1111/tbed.12197; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Calcagno V, 2010, J STAT SOFTW, V34, P1; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Carvalho AB, 1999, HEREDITY, V83, P221, DOI 10.1038/sj.hdy.6886100; Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748; CLARK AG, 1990, GENETICS, V125, P527; CLARK AG, 1987, GENETICS, V115, P569; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; de Garine-Wichatitsky M, 2010, EMERG INFECT DIS, V16, P884, DOI 10.3201/eid1605.090710; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; De Vos V, 1983, POPULATION CONTROL L; Dean AM, 2005, GENETICS, V169, P1147, DOI 10.1534/genetics.104.036053; Ezenwa VO, 2009, AFR J ECOL, V47, P476, DOI 10.1111/j.1365-2028.2008.00960.x; Gardner A, 2011, J EVOLUTION BIOL, V24, P1801, DOI 10.1111/j.1420-9101.2011.02310.x; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Gorsich EE, 2015, J ANIM ECOL, V84, P999, DOI 10.1111/1365-2656.12356; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Hay CT, 2008, J ANIM ECOL, V77, P850, DOI 10.1111/j.1365-2656.2008.01409.x; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jaenike J, 1999, EVOLUTION, V53, P164, DOI 10.1111/j.1558-5646.1999.tb05342.x; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; James WH, 2017, EARLY HUM DEV, V109, P50, DOI 10.1016/j.earlhumdev.2017.03.002; Kerry R, 2013, INT J GEOGR INF SCI, V27, P47, DOI 10.1080/13658816.2012.663917; Lane-deGraaf KE, 2015, CONSERV GENET, V16, P289, DOI 10.1007/s10592-014-0658-0; Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Navara KJ, 2013, INTEGR COMP BIOL, V53, P877, DOI 10.1093/icb/ict081; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Orr HA, 2001, GENETICS, V157, P875; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Smitz N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0203-2; Spencer HG, 2016, AM NAT, V187, P658, DOI 10.1086/685827; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; van Hooft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111778; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Otterdijk SD, 2016, FASEB J, V30, P2457, DOI 10.1096/fj.201500083; VANHOOFT P, 2010, BMC EVOL BIOL, V10, DOI DOI 10.1186/1471-2148-1110-1106; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vosloo W, 2009, TRANSBOUND EMERG DIS, V56, P18, DOI 10.1111/j.1865-1682.2008.01059.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191481	10.1371/journal.pone.0191481	http://dx.doi.org/10.1371/journal.pone.0191481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415077	Green Published, gold			2022-12-27	WOS:000424325300029
J	Zahr, NM				Zahr, Natalie M.			Peripheral TNF alpha elevations in abstinent alcoholics are associated with hepatitis C infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TUMOR-NECROSIS-FACTOR; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; BRAIN-SLICE CULTURES; USE DISORDERS; LIVER-FIBROSIS; CHEMOATTRACTANT PROTEIN-1; ANTIRETROVIRAL THERAPY	Substantial evidence supports the view that inflammatory processes contribute to brain alterations in HIV infection. Mechanisms recently proposed to underlie neuropathology in Alcohol Use Disorder (AUD) include elevations in peripheral cytokines that sensitize the brain to the damaging effects of alcohol. This study included 4 groups: healthy controls, individuals with AUD (abstinent from alcohol at examination), those infected with HIV, and those comorbid for HIV and AUD. The aim was to determine whether inflammatory cytokines are elevated in AUD as they are in HIV infection. Cytokines showing group differences included interferon gamma-induced protein 10 (IP-10) and tumor necrosis factor alpha (TNF alpha). Follow-up t-tests revealed that TNF alpha and IP-10 were higher in AUD than controls but only in AUD patients who were seropositive for Hepatitis C virus (HCV). Specificity of TNF alpha and IP-10 elevations to HCV infection status was provided by correlations between cytokine levels and HCV viral load and indices of liver integrity including albumin/globulin ratio, fibrosis scores, and AST/platelet count ratio. Because TNF alpha levels were mediated by HCV infection, this study provides no evidence for elevations in peripheral cytokines in "uncomplicated", abstinent alcoholics, independent of liver disease or HCV infection. Nonetheless, these results corroborate evidence for elevations in IP-10 and TNF alpha in HIV and for IP-10 levels in HIV+HCV co-infection.	[Zahr, Natalie M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zahr, Natalie M.] SRI Int, Neurosci Dept, Menlo Pk, CA 94025 USA	Stanford University; SRI International	Zahr, NM (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Zahr, NM (corresponding author), SRI Int, Neurosci Dept, Menlo Pk, CA 94025 USA.	nzahr@stanford.edu	Zahr, Natalie/W-5292-2019; Zahr, Natalie/L-7692-2016	Zahr, Natalie/0000-0002-3346-4894	National Institute of Alcohol Abuse and Alcoholism (NIAAA) [U01 AA017347, U01 AA013521, K05 AA017168, R01 AA005965, R37 AA010723]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, U01AA017347, U01AA013521] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported with grant funding from the National Institute of Alcohol Abuse and Alcoholism (NIAAA) including U01 AA017347, U01 AA013521, K05 AA017168, R01 AA005965, R37 AA010723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Agrawal RG, 2011, BRAIN BEHAV IMMUN, V25, pS165, DOI 10.1016/j.bbi.2011.03.002; Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Auguet T, 2010, ALCOHOL, V44, P211, DOI 10.1016/j.alcohol.2010.02.007; Augustynska B, 2015, ACTA BIOCHIM POL, V62, P63, DOI 10.18388/abp.2014_772; Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Bagyinszky E, 2017, J NEUROL SCI, V376, P242, DOI 10.1016/j.jns.2017.03.031; Bajo M, 2015, BRAIN BEHAV IMMUN, V45, P189, DOI 10.1016/j.bbi.2014.11.011; Bajo M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00049; Banerjee A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140498; Barve S, 2010, ALCOHOL RES HEALTH, V33, P229; Bautista AP, 1997, HEPATOLOGY, V25, P335, DOI 10.1002/hep.510250214; Baxter-Potter LN, 2017, NEUROSCIENCE, V346, P238, DOI 10.1016/j.neuroscience.2017.01.015; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beech RD, 2012, ALCOHOL CLIN EXP RES, V36, P1487, DOI 10.1111/j.1530-0277.2012.01775.x; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00129; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bonacini M, 2011, ANN HEPATOL, V10, P502, DOI 10.1016/S1665-2681(19)31519-4; Braithwaite RS, 2007, AIDS CARE, V19, P459, DOI 10.1080/09540120601095734; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Cohen RA, 2011, J NEUROIMMUNOL, V233, P204, DOI 10.1016/j.jneuroim.2010.11.006; Conigliaro J, 2006, MED CARE, V44, pS1, DOI 10.1097/01.mlr.0000223659.36369.cf; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Correia S, 2013, J NEUROIMMUNOL, V265, P117, DOI 10.1016/j.jneuroim.2013.09.005; Corrigan F, 2015, BRAIN BEHAV IMMUN, V45, P245, DOI 10.1016/j.bbi.2014.12.019; Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x; Crews FT., 2017, NEUROPHARMACOLOGY; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Cui SQ, 2015, BRAZ J MED BIOL RES, V48, P515, DOI 10.1590/1414-431X20144250; Daniluk J, 2001, ALCOHOL, V23, P29, DOI 10.1016/S0741-8329(00)00134-8; Davis RL, 2004, NEUROSCI LETT, V371, P128, DOI 10.1016/j.neulet.2004.08.051; de Timary P, 2017, NEUROPHARMACOLOGY; El Serafy MA, 2017, ARAB J GASTROENTEROL, V18, P51, DOI 10.1016/j.ajg.2017.05.005; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; First M. B., 1998, STRUCTURED CLIN INTE; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Franchi S, 2010, INT J IMMUNOPATH PH, V23, P847, DOI 10.1177/039463201002300320; Freeman K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-97; Fuller BE, 2009, CURR OPIN PSYCHIATR, V22, P401, DOI 10.1097/YCO.0b013e32832cadb9; Fuster D, 2014, AIDS, V28, P1059, DOI 10.1097/QAD.0000000000000184; Fuster D, 2013, AIDS RES HUM RETROV, V29, P1110, DOI [10.1089/aid.2012.0348, 10.1089/AID.2012.0348]; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Gaydos J, 2016, AM J PHYSIOL-LUNG C, V310, pL507, DOI 10.1152/ajplung.00242.2015; Gendelman HE, 1997, AIDS, V11, pS35; GENDELMAN HE, 1994, RES IMMUNOL, V145, P679, DOI 10.1016/S0923-2494(05)80054-9; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gonzalez-Quintela A, 2000, CYTOKINE, V12, P1437, DOI 10.1006/cyto.2000.0715; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gonzalez-Reimers E, 2012, ALCOHOL ALCOHOLISM, V47, P390, DOI 10.1093/alcalc/ags041; Gonzalez-Reimers E, 2011, ALCOHOL ALCOHOLISM, V46, P529, DOI 10.1093/alcalc/agr064; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graham CS, 2007, J INFECT DIS, V195, P847, DOI 10.1086/511990; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; HAASE AT, 1986, MICROB PATHOGENESIS, V1, P1, DOI 10.1016/0882-4010(86)90026-4; Hajarizadeh B, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0482-x; Harper KM, 2015, ALCOHOL CLIN EXP RES, V39, P2375, DOI 10.1111/acer.12898; Harris RA, 2017, J NEUROSCI, V37, P1139, DOI 10.1523/JNEUROSCI.2002-16.2016; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Heberlein A, 2014, ALCOHOL, V48, P671, DOI 10.1016/j.alcohol.2014.08.003; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hoyt LR, 2017, REDOX BIOL, V12, P883, DOI 10.1016/j.redox.2017.04.020; Irwin M, 2004, BRAIN BEHAV IMMUN, V18, P349, DOI 10.1016/j.bbi.2004.02.001; Jaatinen P, 2003, ALCOHOL, V29, P91, DOI 10.1016/S0741-8329(03)00002-8; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; June HL, 2015, NEUROPSYCHOPHARMACOL, V40, P1549, DOI 10.1038/npp.2015.4; Karlsson C, 2016, ADDICTION BIOL; Karnofsky D., 1949, CLIN EVALUATION CHEM, P191; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kebir O, 2011, EUR ADDICT RES, V17, P146, DOI 10.1159/000324849; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Knapp DJ, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030025; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; LAHDEVIRTA J, 1988, AM J MED, V85, P289, DOI 10.1016/0002-9343(88)90576-1; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Langford D, 2001, BRAIN PATHOL, V11, P306; Laso FJ, 1998, J HEPATOL, V28, P771, DOI 10.1016/S0168-8278(98)80226-2; Leclercq S, 2014, BIOL PSYCHIAT, V76, P725, DOI 10.1016/j.biopsych.2014.02.003; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; Lee CH, 2013, CLIN MOL HEPATOL, V19, P376, DOI 10.3350/cmh.2013.19.4.376; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JA, 2011, P NATL ACAD SCI USA, V108, P4465, DOI 10.1073/pnas.1019020108; Maes M, 1998, PSYCHIAT RES, V78, P151, DOI 10.1016/S0165-1781(98)00010-9; Manzardo AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040472; Marcondes MCG, 2008, ALCOHOL CLIN EXP RES, V32, P1583, DOI 10.1111/j.1530-0277.2008.00730.x; Marcos M, 2009, AM J EPIDEMIOL, V170, P948, DOI 10.1093/aje/kwp236; Marshall SA, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020016; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Matta B, 2016, CURR HIV-AIDS REP, V13, P279, DOI 10.1007/s11904-016-0329-5; Mattis S, 1998, DEMENTIA RATING SCAL; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; Miguez MJ, 2003, ADDICT BIOL, V8, P33, DOI 10.1080/1355621031000069855; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Molina PE, 2006, ALCOHOL CLIN EXP RES, V30, P2065, DOI 10.1111/j.1530-0277.2006.00252.x; Neupane SP, 2014, CNS NEUROSCI THER, V20, P898, DOI 10.1111/cns.12303; Neupane SP, 2015, ALCOHOL, V49, P471, DOI 10.1016/j.alcohol.2015.01.012; Neupane SP, 2015, ALCOHOL CLIN EXP RES, V39, P514, DOI 10.1111/acer.12651; Okvist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000930; Pascual M, 2016, ADDICTION BIOL; Pastor IJ, 2005, ALCOHOL CLIN EXP RES, V29, P1928, DOI 10.1097/01.alc.0000187595.19324.ca; Pastor L, 2017, CLIN INFECT DIS, V65, P1670, DOI 10.1093/cid/cix600; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V63, P272, DOI 10.1097/QAI.0b013e318289bced; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Peters L, 2010, CURR OPIN HIV AIDS, V5, P517, DOI 10.1097/COH.0b013e32833e3ee6; Petry NM, 1999, INT J STD AIDS, V10, P561, DOI 10.1258/0956462991914654; Ploquin MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005774; PULLIAM L, 1991, J CLIN INVEST, V87, P503, DOI 10.1172/JCI115024; Qin L, 2012, J NEUROINFLAMM, V9; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qu J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-15; Reiberger T, 2008, ANTIVIR THER, V13, P969; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; Samet JH, 2007, PANMINERVA MED, V49, P67; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Scherzer R, 2017, AIDS, V31, P71, DOI 10.1097/QAD.0000000000001278; Schneider R, 2017, NEUROCHEM RES, V42, P2135, DOI 10.1007/s11064-017-2218-8; Serretti A, 2006, NEUROSCI LETT, V406, P107, DOI 10.1016/j.neulet.2006.07.003; Sevigny JJ, 2004, NEUROLOGY, V63, P2084, DOI 10.1212/01.WNL.0000145763.68284.15; SHERON N, 1991, CLIN EXP IMMUNOL, V84, P449; Skinner H., 1982, DEV VALIDATION LIFET; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; SULTANA C, 2013, HEPAT MON, V13; Swardfager W, 2016, NEUROSCI BIOBEHAV R, V64, P148, DOI 10.1016/j.neubiorev.2016.02.017; Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/AID.2014.0004, 10.1089/aid.2014.0004]; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Thandassery RB, 2016, J CLIN GASTROENTEROL, V50, P518, DOI 10.1097/MCG.0000000000000489; Trepanier MO, 2016, MOL PSYCHIATR, V21, P1009, DOI 10.1038/mp.2016.90; Umhau JC, 2014, ALCOHOL CLIN EXP RES, V38, P1301, DOI 10.1111/acer.12367; Vaidya SA, 2014, J INFECT DIS, V210, P1042, DOI 10.1093/infdis/jiu206; Valenta JP, 2016, ALCOHOL CLIN EXP RES, V40, P187, DOI 10.1111/acer.12928; Viana MSVB, 2009, ANN HEPATOL, V8, P26, DOI 10.1016/S1665-2681(19)31807-1; VAZEUX R, 1987, AM J PATHOL, V126, P403; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Wechsler D., 2001, WECHSLER TEST ADULT; Weiss JM, 1999, J IMMUNOL, V163, P2953; Wiley CA, 2003, BRAIN PATHOL, V13, P415; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wiley CA, 2003, BRAIN PATHOLOGY ZURI, V13, P6; Wu Y, 2012, BRIT J PHARMACOL, V165, P1319, DOI 10.1111/j.1476-5381.2011.01572.x; Yamauchi M, 2001, ALCOHOL CLIN EXP RES, V25, p7S, DOI 10.1111/j.1530-0277.2001.tb02409.x; ZANGERLE R, 1994, IMMUNOL LETT, V41, P229, DOI 10.1016/0165-2478(94)90138-4; Zeremski M, 2007, JAIDS-J ACQ IMM DEF, V45, P262; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	164	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191586	10.1371/journal.pone.0191586	http://dx.doi.org/10.1371/journal.pone.0191586			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408932	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800022
J	Zhou, JL; Zhang, LJ; Xuan, P; Fan, Y; Yang, LS; Hu, CQ; Bo, QL; Wang, GX; Sheng, J; Wang, SF				Zhou, Jielin; Zhang, Liangjian; Xuan, Peng; Fan, Yong; Yang, Linsheng; Hu, Chunqiu; Bo, Qingli; Wang, Guoxiu; Sheng, Jie; Wang, Sufang			The relationship between famine exposure during early life and body mass index in adulthood: A systematic review and meta-analysis	PLOS ONE			English	Review							CHINESE FAMINE; CARDIOVASCULAR RISK; DUTCH FAMINE; OBESITY; HEALTH; MEN; OVERWEIGHT; PREGNANCY; DISEASE; QUALITY	Background Previous epidemiologic studies have reported famine exposure during early life association with overweight or obesity in adulthood, but a consistent perspective has not been established to date. Purpose To determine, by conducting a systematic review and meta-analysis, whether exposure to famine could increase body mass index (BMI) in adult or not, and assess the association between famine exposure and the risk of overweight or obesity. Methods Published articles were systematically searched (until August, 2017) from PubMed, Science-Direct, Cochrane, and China National Knowledge Infrastructure. Initially, comparing differences in BMI between exposed and non-exposed groups that weight mean difference (WMD) were used. Subsequently, the effect of famine exposure on overweight or obesity risk, which pooled relative risks (RRs), odds ratios (ORs) or hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Result Twenty studies were included in this systematic review and meta-analysis. Compared with non-exposed group, famine exposure group significantly increased the risk of overweight (OR = 1.10, 95% CI: 1.04-1.16) and obesity (OR = 1.15, 95% CI: 1.05-1.24). Sensitivity analyses revealed no significant change in the famine exposure and BMI, the risk of overweight and obesity study when any one study was excluded. Subgroup analyses showed that age, gender, exposure type, study type, continent, famine cause and paper publication date were associated with BMI, the risk of overweight and obesity. Meta-regression analyses suggested that continent, famine cause could partially explain heterogeneity for famine exposure and BMI studies. Conclusion The systematic review and meta-analysis indicates that famine exposure during early life may increase BMI, the risk of overweight and obesity, especially for female, fetal famine exposure or subject age less than 50. Furthermore, famine exposure group the risk of overweight and obesity in cross-sectional studies, Asian studies, famine cause by natural disaster or paper published from 2015 to the present studies are higher than that of non-exposed group.	[Zhou, Jielin; Zhang, Liangjian; Xuan, Peng; Fan, Yong; Yang, Linsheng; Hu, Chunqiu; Bo, Qingli; Wang, Guoxiu; Sheng, Jie; Wang, Sufang] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China	Anhui Medical University	Wang, SF (corresponding author), Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China.	wangsufangdev@126.com	xuan, peng/GZM-3516-2022		National Natural Science Foundation of China [81102125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81102125). The sponsor contributed to the study design, sample or data analysis, and interpretation of the results.	Abeelen AFMV, 2013, PLOS ONE, V8; Bejar LM, 2011, REV ESP ENFERM DIG, V103, P519, DOI 10.4321/s1130-01082011001000004; Bleker LS, 2016, J GERONTOL A-BIOL, V71; Charles MA, 2016, M S-MED SCI, V32, P15, DOI 10.1051/medsci/20163201004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fall CHD, 2013, NESTLE NUTR WORKS SE, V74, P11, DOI 10.1159/000348384; Finer S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011768; Fransen HP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156609; Han TS, 1997, INT J OBESITY, V21, P587, DOI 10.1038/sj.ijo.0800446; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Keinan-Boker L, 2015, ISR MED ASSOC J, V17, P206; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Krauss Ronald M., 1998, Circulation, V98, P1472; Li yuanbi, 2014, RELATIONSHIP EARLY F; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2017, NUTR METAB CARDIOVAS, V27, P154, DOI 10.1016/j.numecd.2016.11.125; Luo ZC, 2010, WORLD J DIABETES, V1, P89, DOI 10.4239/wjd.v1.i3.89; Miller GE, 2011, PSYCHOL BULL, V409, P1603; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; PROIETTO J, 1994, BAILLIERE CLIN ENDOC, V8, P509, DOI 10.1016/S0950-351X(05)80284-8; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Rotar O, 2015, J HYPERTENS, V33, P1772, DOI 10.1097/HJH.0000000000000640; Sanford B. A., 2014, COMPUTATIONAL BIOMEC, P101; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Shi ZM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-904; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stein AD, 2009, EPIDEMIOLOGY, V20, P909, DOI 10.1097/EDE.0b013e3181b5f227; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wang JW, 2009, ASIA PAC J CLIN NUTR, V18, P105; Wang J, 2016, J NUTR, V146, P2289, DOI 10.3945/jn.116.234575; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Wang YH, 2010, OBESITY, V18, P588, DOI 10.1038/oby.2009.296; Wang ZH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3122-x; Wang ZQ, 2015, OBES RES CLIN PRACT, V9, P1, DOI 10.1016/j.orcp.2014.01.006; Welon Z, 2002, AM J HUM BIOL, V14, P693, DOI 10.1002/ajhb.10079; Xu HW, 2016, SOC SCI MED, V148, P110, DOI 10.1016/j.socscimed.2015.11.028; yan Zhao, 2013, EARLY LIFE EXPOSURE; Yang Z, 2008, OBES REV, V9, P95, DOI 10.1111/j.1467-789X.2007.00447.x; Zhang ZN, 2017, BIODEMOGR SOC BIOL, V63, P148, DOI 10.1080/19485565.2017.1311203	46	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192212	10.1371/journal.pone.0192212	http://dx.doi.org/10.1371/journal.pone.0192212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408921	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800048
J	Benitez, AD; Martins, FDC; Mareze, M; Santos, NJR; Ferreira, FP; Martins, CM; Garcia, JL; Mitsuka-Bregano, R; Freire, RL; Biondo, AW; Navarro, IT				Benitez, Aline do Nascimento; Cardoso Martins, Felippe Danyel; Mareze, Marcelle; Rodrigues Santos, Nelson Jesse; Ferreira, Fernanda Pinto; Martins, Camila Marinelli; Garcia, Joao Luis; Mitsuka-Bregano, Regina; Freire, Roberta Lemos; Biondo, Alexander Welker; Navarro, Italmar Teodorico			Spatial and simultaneous representative seroprevalence of anti-Toxoplasma gondii antibodies in owners and their domiciled dogs in a major city of southern Brazil (vol 12, e0180906, 2017)	PLOS ONE			English	Correction													Bregano, Regina Mitsuka/AAX-3103-2020; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Garcia, Joao Luis/Y-8864-2019; Luis, João/AAE-9252-2019; BIONDO, ALEXANDER WELKER W/E-8823-2018	BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; Garcia, Joao Luis/0000-0002-5736-7511; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821				Benitez AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180906	1	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192570	10.1371/journal.pone.0192570	http://dx.doi.org/10.1371/journal.pone.0192570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401515	Green Published, Green Submitted, gold			2022-12-27	WOS:000424101400065
J	Farah, G; Siwek, D; Cummings, P				Farah, George; Siwek, Donald; Cummings, Peter			Tau accumulations in the brains of woodpeckers	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; DISEASE; NEUROPATHOLOGY; DIAGNOSIS; INJURY	Woodpeckers experience forces up to 1200-1400 g while pecking. It is assumed due to evolutionary adaptations, the woodpecker is immune to brain injury. This assumption has led to the use of the woodpecker as a model in the development of sports safety equipment such as football helmets. However, it is unknown at this time if the woodpecker brain develops neuro-trauma in relation to the high g-forces experienced during pecking. The brains of 10 ethanol preserved woodpeckers and 5 ethanol preserved red-winged black bird experimental controls were examined using Gallyas silver stain and anti-phospho-tau. The results demonstrated perivascular and white matter tract silver-positive deposits in eight out of the 10 woodpecker brains. The tau positive accumulations were seen in white matter tracts in 2 of the 3 woodpeckers examined. No staining was identified in control birds. The negative staining of controls birds contrasted with the diffuse positive staining woodpecker sections suggest the possibility that pecking may induce the accumulation of tau in the woodpecker brain. Further research is needed to better understand the relationship.	[Farah, George; Siwek, Donald; Cummings, Peter] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA	Boston University	Cummings, P (corresponding author), Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA.	pmc@bu.edu			Department of Anatomy and Neurobiology at the Boston University School of Medicine; Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant	Department of Anatomy and Neurobiology at the Boston University School of Medicine; Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant	Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant was the source of funding for this project (to George Farah). With this grant, we were able to purchase laboratory materials such as antibodies and various chemicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the two museums who believed in our project and generously donated the preserved museum specimens to our project. A large debt of gratitude to the Field Museum of Chicago, IL and its Ornithology Department for donating specimens: 379007, 379008, 379005, 379006, 379009, 291433, 291434, 291435, and 238695. Secondly, to the Harvard Museum of Natural History at Harvard University in Cambridge, MA. We would like to thank Dr. Scott Edwards and Mr. Jeremiah Trimble from the Ornithology Department at the Harvard Museum of Comparative Zoology for their enthusiasm and generous specimen donation for this project. Without both museums' help, we would not have been able to complete this project. Another thanks to the Department of Anatomy and Neurobiology at the Boston University School of Medicine for funding this project. We would also like to thank Dr. Brian Le for his editorial contribution to the production of this manuscript. Finally, Mr. Farah and Dr. Cummings would like to dedicate this manuscript to Dr. Donald Siwek who suddenly passed away during the writing of this manuscript. His wealth of knowledge and mentorship was unbounded and will be dearly missed.	[Anonymous], 2017, TRAUM BRAIN INJ RES; [Anonymous], 2017, IHC STAIN PROT PAR F; Bailes JE, 2007, J ATHL TRAINING, V42, P126; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Kingsbury MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020720; MAY PRA, 1976, LANCET, V1, P454; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta P.S., 2016, SAE TECH PAP, DOI [10.4271/2016-01-0396, DOI 10.4271/2016-01-0396]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2	15	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191526	10.1371/journal.pone.0191526	http://dx.doi.org/10.1371/journal.pone.0191526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394252	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400013
J	Monro, AK; Bystriakova, N; Fu, LF; Wen, F; Wei, YG				Monro, Alexandre K.; Bystriakova, Nadia; Fu, Longfei; Wen, Fang; Wei, Yigang			Discovery of a diverse cave flora in China	PLOS ONE			English	Article							LIMESTONE KARSTS; CONSERVATION; URTICACEAE; ECOLOGY; QUALITY	Few studies document plants in caves. Our field observations of a widespread and seemingly angiosperm-rich cave flora in SW China lead us to test the following hypotheses, 1) SW China caves contain a diverse vascular plant flora, 2) that this is a relic of a largely absent forest type lacking endemic species, and 3) that the light environment plants occupy in caves is not distinct from non-cave habitats. To do so we surveyed 61 caves and used species accumulation curves (SAC) to estimate the total diversity of this flora and used a subsample of 14 caves to characterise the light environment. We used regional floras and existing conservation assessments to evaluate the conservation value of this flora. We used observations on human disturbance within caves to evaluate anthropogenic activities. Four-hundred-and-eighteen vascular plant species were documented with SACs predicting a total diversity of 529-846. Ninety-three percent of the species documented are known karst forest species, 7% are endemic to caves and 81% of the species are angiosperms. We demonstrate that the light environment in caves is distinct to that of terrestrial habitats and that a subset of the flora likely grow in the lowest light levels documented for vascularised plants. Our results suggest that the proportion of species threatened with extinction is like that for the terrestrial habitat and that almost half of the entrance caverns sampled showed signs of human disturbance. We believe that this is the first time that such an extensive sample of cave flora has been undertaken and that such a diverse vascular plant flora has been observed in caves which we predict occurs elsewhere in SE Asia. We argue that the cave flora is an extension of the karst forest understory present prior to catastrophic deforestation in the 20thC. We suggest that within SW China caves serve as both refuges and a valuable source of germplasm for the restoration of karst forest. We also propose that caves represent a distinct habitat for plants that is most similar to that of the forest understory, but distinct with respect to the absence of trees, leaf litter, root mats, higher levels of atmospheric CO2, and lower diurnal and annual variation in temperature and humidity. We highlight tourism, agriculture and the absence of legislated protection of caves as the main current threats to this flora.	[Monro, Alexandre K.; Wen, Fang] Royal Bot Gardens, Herbarium, London, England; [Monro, Alexandre K.] IUCN Cave Invertebrate Specialist Grp, Gland, Switzerland; [Bystriakova, Nadia] Nat Hist Museum, Core Res Labs, London, England; [Fu, Longfei; Wei, Yigang] Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Inst Bot, Guangxi Key Lab Plant Conservat & Restorat Ecol K, Guilin, Guangxi, Peoples R China	Royal Botanic Gardens, Kew; Natural History Museum London	Wei, YG (corresponding author), Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Inst Bot, Guangxi Key Lab Plant Conservat & Restorat Ecol K, Guilin, Guangxi, Peoples R China.	weiyigang@aliyun.com			Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project [KFJ-1W-NO1-13]; National Natural Science Foundation of China [31160039, 31260038, 31460159, 31570307]; Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain [16-380-32, GKB15-B-11, GKB15-A-11]; Bentham Moxon Trust for the conservation of species, a Royal Society; Special Funds of the Natural History Museum, London	Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain; Bentham Moxon Trust for the conservation of species, a Royal Society; Special Funds of the Natural History Museum, London	This work was supported by 'The Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project' (KFJ-1W-NO1-13); the National Natural Science Foundation of China (No. 31160039, 31260038, 31460159 and 31570307); the Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain (16-380-32 (GKB15-A-11, GKB15-B-11)); the Bentham Moxon Trust for the conservation of species, a Royal Society travel award and Special Funds of the Natural History Museum, London.; This work was supported by 'The Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project' (KFJ-1W-NO1-13); the National Natural Science Foundation of China (No. 31160039, 31260038, 31460159 and 31570307); the Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain (16-380-32 (GKB15-A-11, GKB15-B-11)); the Bentham Moxon Trust for the conservation of species, a Royal Society travel award and Special Funds of the Natural History Museum, London.	[Anonymous], 2014, R LANG ENV STAT COMP; Auler AS, 2014, ENVIRON EARTH SCI, V1, P487, DOI DOI 10.1007/978-3-642-17435-3_; Bichuette ME, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P65; Brummitt N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0015; Cain M, 2014, ECOLOGY, P51; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; Culver David C., 1992, NSS (National Speleological Society) Bulletin, V54, P79; Culver DC, 2009, BIOL CAVES OTHER SUB, P40; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; Fang D, 1993, B BOT RES, V13, P330; Flore Dobat C., 1998, ENCY BIOSPELEOLOGICA, V2; Fu LF, 2017, NORD J BOT, V35, P251, DOI 10.1111/njb.01281; Gabriel R, 2004, AMCS B, V7, P114; Gillieson D, 2005, PHYS GEOGRAPHY SE AS, P157; Glime J.M., 2017, PHYSL ECOLOGY, V1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Holsinger JR, 1976, GEOLOGY BIOL PENNSYL, P72; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Humphreys WF, 2000, ECOSY WORLD, V30, P3; HUNTOON PW, 1992, GROUND WATER, V30, P167, DOI 10.1111/j.1745-6584.1992.tb01788.x; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Juberthie C., 2000, WORLD SUBTERRANEAN E, P17; Karanovic T, 2013, INVERTEBR SYST, V27, P540, DOI 10.1071/IS12084; Letts MG, 2005, J TROP ECOL, V21, P549, DOI 10.1017/S0266467405002488; Liu JR, 2004, STUDY TROPICAL KARST, P15; Liu LF, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/362521; LUNING K, 1979, MAR ECOL PROG SER, V1, P195, DOI 10.3354/meps001195; Mason-Williams A, 1967, INT J SPELEOL, V2, P397; Ministry of Environmental Protection of the People's Republic of China, CHIN RED LIST BIOD H; Monro AK, 2012, PHYTOKEYS, V19, P51, DOI 10.3897/phytokeys.19.3968; Moseley Max, 2010, Cave and Karst Science, V36, P53; Neill H, 2004, ENVIRON GEOL, V45, P550, DOI 10.1007/s00254-003-0910-2; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Onac BP, 2011, INT J SPELEOL, V40, P79, DOI 10.5038/1827-806X.40.2.1; PALMER AN, 1991, GEOL SOC AM BULL, V103, P1, DOI 10.1130/0016-7606(1991)103<0001:OAMOLC>2.3.CO;2; Parise M, 2009, ENVIRON GEOL, V58, P235, DOI 10.1007/s00254-008-1608-2; Pentecost A, 2001, INT J SPELEOL, V30, P27, DOI DOI 10.5038/1827-806X.30.1.3; Prous X, 2015, INT J SPELEOL, V44, P177, DOI 10.5038/1827-806X.44.2.7; Qin H.N., 2010, CHECKLIST VASCULAR P; Romero A., 2012, POLYMATH INTERDISCIP, V2, P1; Romero A, 2009, ECOL BIODIVERS CONS, P62, DOI 10.1017/CBO9780511596841.003; Scopoli JA, 1772, DISS SCI NAT, V1, P84; Serena Fabrizio, 1997, Memoires de Biospeologie, V24, P183; Sheue CR, 2007, AM J BOT, V94, P1922, DOI 10.3732/ajb.94.12.1922; Shu SS, 2013, SCIENCE, V340, P272, DOI 10.1126/science.340.6130.272-a; Shui YM, 2006, SEED PLANTS KARST RE, V1; Simoes MH, 2014, ACTA CARSOLOGICA, V43, P159; Sutherland WJ, 2012, TRENDS ECOL EVOL, V27, P12, DOI 10.1016/j.tree.2011.10.011; Tao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127821; Tuttle M.D., 1978, 1977 NATL CAVE MANAG, P108; Von Humboldt A, 1793, FLORAE FRIBERGENSIS, P108; Wang W, 2011, INT FOREST REV, V13, P416, DOI 10.1505/146554811798811290; Wei Y.-G., 2010, GESNERIACEAE S CHINA; Whitten T., 2012, INT CEMENT REV   JUN, P116; Whitten T, 2009, J APPL ECOL, V46, P520, DOI 10.1111/j.1365-2664.2009.01630.x; Williams P., 2008, WORLD HERITAGE CAVES, P5; Wonnacott TH, 1990, INTRO STAT, P103; Wu Z.Y., 1994, FLORA CHINA, V1; [曾馥平 ZENG FuPing], 2007, [生态学报, Acta Ecologica Sinica], V27, P5110, DOI 10.1016/S1872-2032(08)60016-5; Zhang LB, 2011, SYST BOT, V36, P854, DOI 10.1600/036364411X604877; Zhang YH, 2012, J GUILIN U TECHNOL, V32, P20, DOI [10.3969/j.issn.1674-9057.2012.01.003, DOI 10.19694/J.CNKI.ISSN2095-2457.2018.02.008]; Zhang ZH, 2012, J TROP FOR SCI, V24, P498; Zhou H.-G., 1996, GUIHAIA, V16; Zou T. C., 2001, GUIZHOU ENDEMIC RARE	70	39	42	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190801	10.1371/journal.pone.0190801	http://dx.doi.org/10.1371/journal.pone.0190801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415039	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300010
J	Oo, AZ; Sudo, S; Akiyama, H; Win, KT; Shibata, A; Yamamoto, A; Sano, T; Hirono, Y				Oo, Aung Zaw; Sudo, Shigeto; Akiyama, Hiroko; Win, Khin Thuzar; Shibata, Akira; Yamamoto, Akinori; Sano, Tomohito; Hirono, Yuhei			Effect of dolomite and biochar addition on N2O and CO2 emissions from acidic tea field soil	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; ORGANIC-CARBON MINERALIZATION; CHEMICAL-PROPERTIES; DENITRIFICATION; MOISTURE; DIOXIDE; TEMPERATURE; LIME; FLUX; PH	A laboratory study was conducted to study the effects of liming and different biochar amendments on N2O and CO2 emissions from acidic tea field soil. The first experiment was done with three different rates of N treatment; N 300 (300 kg N ha(-1)), N 600 (600 kg N ha(-1)) and N 900 (900 kg N ha(-1)) and four different rates of bamboo biochar amendment; 0%, 0.5%, 1% and 2% biochar. The second experiment was done with three different biochars at a rate of 2% (rice husk, sawdust, and bamboo) and a control and lime treatment (dolomite) and control at two moisture levels (50% and 90% water filled pore space (WFPS)). The results showed that dolomite and biochar amendment significantly increased soil pH. However, only biochar amendment showed a significant increase in total carbon (C), C/N (the ratio of total carbon and total nitrogen), and C/IN ratio (the ratio of total carbon and inorganic nitrogen) at the end of incubation. Reduction in soil NO3--N concentration was observed under different biochar amendments. Bamboo biochar with the rates of 0.5, 1 and 2% reduced cumulative N2O emission by 38%, 48% and 61%, respectively, compare to the control soil in experiment 1. Dolomite and biochar, either alone or combined significantly reduced cumulative N2O emission by 4.6% to 32.7% in experiment 2. Reduction in N2O production under biochar amendment was due to increases in soil pH and decreases in the magnitude of mineral-N in soil. Although, both dolomite and biochar increased cumulative CO2 emission, only biochar amendment had a significant effect. The present study suggests that application of dolomite and biochar to acidic tea field soil can mitigate N2O emissions.	[Oo, Aung Zaw; Sudo, Shigeto; Akiyama, Hiroko] Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan; [Win, Khin Thuzar] Natl Agr & Food Res Org NARO, Cent Reg Agr Res Ctr, Kannondai 2-1-18, Tsukuba, Ibaraki, Japan; [Shibata, Akira] Ritsumeikan Univ, Kyoto, Japan; [Yamamoto, Akinori] Tokyo Gakugei Univ, Koganei, Tokyo, Japan; [Sano, Tomohito; Hirono, Yuhei] Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, 2769 Kanaya Shishidoi, Shimada, Shizuoka, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Ritsumeikan University; Tokyo Gakugei University	Oo, AZ; Sudo, S (corresponding author), Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan.	aungzawoo@affrc.go.jp; ssudo@affrc.go.jp	Sano, Tomohito/ABI-2664-2020; , 0000-0002-2689-7560/ABB-2870-2020; Hiroko, Akiyama/T-8715-2017	Sano, Tomohito/0000-0002-1101-2117; , 0000-0002-2689-7560/0000-0002-2689-7560; Hiroko, Akiyama/0000-0001-8821-5185; Oo, Aung Zaw/0000-0002-0571-0613; Win, Khin Thuzar/0000-0002-4834-078X	Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)"	Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)"	This work was supported by the Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)."	Akiyama H, 2006, SOIL SCI PLANT NUTR, V52, P774, DOI 10.1111/j.1747-0765.2006.00097.x; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; Baggs EM, 2010, BIOL FERT SOILS, V46, P793, DOI 10.1007/s00374-010-0484-6; Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bolan NS, 2011, ADV AGRON, V110, P1, DOI 10.1016/B978-0-12-385531-2.00001-3; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chia CH, 2014, J ANAL APPL PYROL, V108, P26, DOI 10.1016/j.jaap.2014.05.021; Ciais P, 2013, COMP GEOM-THEOR APPL; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dong YJ, 2014, J ARID LAND, V6, P37, DOI 10.1007/s40333-013-0195-6; Downie A., 2009, BIOCHAR ENV MANAGEME, P13; Ernfors M, 2007, BIOGEOCHEMISTRY, V84, P219, DOI 10.1007/s10533-007-9123-1; Erntors M, 2007, BIOGEOCHEM, V84, P219; Feng K, 2003, NUTR CYCL AGROECOSYS, V67, P283, DOI 10.1023/B:FRES.0000003664.51048.0e; Feng Z, 2017, SCI TOTAL ENV; Fuentes JP, 2006, SOIL TILL RES, V88, P123, DOI 10.1016/j.still.2005.05.001; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Higgins S, 2013, NUTR CYCL AGROECOSYS, V95, P219, DOI 10.1007/s10705-013-9559-8; Hirono Y, 2012, SOIL SCI PLANT NUTR, V58, P384, DOI 10.1080/00380768.2012.686434; IPCC, 2014, IPCC CLIM CHANG 2014; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Kong YH, 2013, SOIL SCI PLANT NUTR, V59, P790, DOI 10.1080/00380768.2013.817938; Li X, 2002, BIOL FERT SOILS, V35, P108, DOI 10.1007/s00374-002-0447-7; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Major J, 2009, BIOCHAR ENV MANAGEME, P271; NIES (National Institute for Environmental Studies), 2012, NATIONAL GREENHOUSE; Nishimura S, 2005, SOIL SCI SOC AM J, V69, P1977, DOI 10.2136/sssaj2005.0035; Obia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138781; Page K, 2010, SOIL RES, V47, P747; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rochette P, 2006, SOIL SCI SOC AM J, V70, P744, DOI 10.2136/sssaj2005.0242; Ruan JY, 2007, ANN BOT-LONDON, V99, P301, DOI 10.1093/aob/mcl258; Saarnio S, 2013, SOIL BIOL BIOCHEM, V58, P99, DOI 10.1016/j.soilbio.2012.10.035; Shaaban M, 2017, ENVIRON SCI POLLUT R, V24, P9241, DOI 10.1007/s11356-017-8602-8; Shaaban M, 2015, ENVIRON SCI POLLUT R, V22, P19961, DOI 10.1007/s11356-015-5238-4; Shaaban M, 2014, J CHEM SOC PAKISTAN, V36, P875; Singla A, 2014, BIOL FERT SOILS, V50, P1201, DOI 10.1007/s00374-014-0950-7; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; Smith Keith, 2010, NITROUS OXIDE CLIMAT; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Taghizadeh-Toosi A, 2011, J ENVIRON QUAL, V40, P468, DOI 10.2134/jeq2010.0419; Thammasom Nipa, 2016, Agriculture and Natural Resources, V50, P192, DOI 10.1016/j.anres.2016.01.003; Tokuda S, 2004, SOIL SCI PLANT NUTR, V50, P365, DOI 10.1080/00380768.2004.10408490; Troy SM, 2013, SOIL BIOL BIOCHEM, V60, P173, DOI 10.1016/j.soilbio.2013.01.019; Valzano FP, 2001, AUST J SOIL RES, V39, P1307, DOI 10.1071/SR99086; van Zwieten L, 2010, AUST J SOIL RES, V48, P555, DOI 10.1071/SR10004; Van Zwieten L, 2009, BIOCHAR ENV MANAGEME, P227, DOI DOI 10.4324/9781849770552; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yu YX, 2016, APPL SOIL ECOL, V100, P75, DOI 10.1016/j.apsoil.2015.12.009; Zhang XH, 2007, J ENVIRON SCI, V19, P319, DOI 10.1016/S1001-0742(07)60052-7; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	60	33	35	9	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192235	10.1371/journal.pone.0192235	http://dx.doi.org/10.1371/journal.pone.0192235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394272	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400030
J	Claar, DC; Szostek, L; McDevitt-Irwin, JM; Schanze, JJ; Baum, JK				Claar, Danielle C.; Szostek, Lisa; McDevitt-Irwin, Jamie M.; Schanze, Julian J.; Baum, Julia K.			Global patterns and impacts of El Nino events on coral reefs: A meta-analysis	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; TEMPERATURE; RECOVERY; STRESS; FUTURE; OCEAN; CONSERVATION; VARIABILITY; RESILIENCE	Impacts of global climate change on coral reefs are being amplified by pulse heat stress events, including El Nino, the warm phase of the El Nino Southern Oscillation (ENSO). Despite reports of extensive coral bleaching and up to 97% coral mortality induced by El Nino events, a quantitative synthesis of the nature, intensity, and drivers of El Nino and La Nina impacts on corals is lacking. Herein, we first present a global meta-analysis of studies quantifying the effects of El Nino/La Nina-warming on corals, surveying studies from both the primary literature and International Coral Reef Symposium (ICRS) Proceedings. Overall, the strongest signal for El Nino/La Nina-associated coral bleaching was long-term mean temperature; bleaching decreased with decreasing long-term mean temperature (n = 20 studies). Additionally, coral cover losses during El Nino/La Nina were shaped by localized maximum heat stress and long-term mean temperature (n = 28 studies). Second, we present a method for quantifying coral heat stress which, for any coral reef location in the world, allows extraction of remotely-sensed degree heating weeks (DHW) for any date (since 1982), quantification of the maximum DHW, and the time lag since the maximum DHW. Using this method, we show that the 2015/16 El Nino event instigated unprecedented global coral heat stress across the world's oceans. With El Nino events expected to increase in frequency and severity this century, it is imperative that we gain a clear understanding of how these thermal stress anomalies impact different coral species and coral reef regions. We therefore finish with recommendations for future coral bleaching studies that will foster improved syntheses, as well as predictive and adaptive capacity to extreme warming events.	[Claar, Danielle C.; Szostek, Lisa; McDevitt-Irwin, Jamie M.; Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Schanze, Julian J.] Earth & Space Res, Seattle, WA USA	University of Victoria	Claar, DC (corresponding author), Univ Victoria, Dept Biol, Victoria, BC, Canada.	dclaar@uvic.ca	Claar, Danielle/AAP-9348-2020	Claar, Danielle/0000-0003-2389-111X; Baum, Julia/0000-0002-9827-1612	Vanier Canada Graduate Scholarship; NSERC Canada Graduate Scholarship; NSERC Discovery Grant	Vanier Canada Graduate Scholarship; NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the scientists, technicians, and volunteers who collected the original data for each included paper, we could not have conducted this global analysis without your hard work. We also thank Wolfgang Viechtbauer for the development and maintenance of the R metafor package, and for model construction advice. We gratefully acknowledge support from a Vanier Canada Graduate Scholarship to DCC; an NSERC Canada Graduate Scholarship to JM-I; and an NSERC Discovery Grant to JKB. These funders did not directly support this work.	Aeby GS, 2003, CORAL REEFS, V22, P256, DOI 10.1007/s00338-003-0309-2; Ahmed M, 2007, OCEAN COAST MANAGE, V50, P103, DOI 10.1016/j.ocecoaman.2006.08.010; Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Allen M., 2014, IPCC 5 ASSESSMENT SY; [Anonymous], 1988, ANNUAL REVIEW OF ECO, V19, P309; Arthur R, 2006, CORAL REEFS, V25, P427, DOI 10.1007/s00338-006-0127-4; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Boylan P., 2008, PROC 11 INT CORAL RE, V2, P854; Boyle MA, 2013, COMPUT HUM BEHAV, V29, P1023, DOI 10.1016/j.chb.2012.07.031; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Davey MK, 1998, WEATHER, V53, P295; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; Eakin C., 2016, REEF ENCOUNTER, V31, P20, DOI DOI 10.1007/S00338-019-01844-2; Eakin CM, 2001, B MAR SCI, V69, P171; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Furby KA, 2013, CORAL REEFS, V32, P505, DOI 10.1007/s00338-012-0998-5; Garde LA, 2014, J OPER OCEANOGR, V7, P21, DOI 10.1080/1755876X.2014.11020150; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1991, SCIENCE, V253, P69, DOI 10.1126/science.253.5015.69; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Glynn PW., 1984, WIDESPREAD CORAL MOR, V11, P133; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TJ, 1994, AMBIO, V23, P176; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Guzman HM, 2006, BIOLOGY, V151, P401; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Hedges LV, 2014, STAT METHODS META AN; Heron SF, 2014, J OPER OCEANOGR, V7, P3, DOI 10.1080/1755876X.2014.11020154; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Igulu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114715; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; Koricheva J, J ECOLOGY, V102, P828; Liu G, 2006, P 10 INT COR REEF S; Liu G., 2003, EOS T AM GEOPHYS UN, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001, DOI 10.1029/2003EO150001]; Liu G, 2008, P 11 INT COR REEF S, P951; Liu G., 2013, ANN GIS, V143, P1, DOI [DOI 10.1080/19475683.2011.576266, 10.1080/19475683.2011.576266]; Lix JK, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5176-8; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McDevitt-Irwin JM, 2016, MAR ECOL PROG SER, V557, P133, DOI 10.3354/meps11848; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Montgomery R. S., 1994, EOS, V75, P145, DOI DOI 10.1029/94E000837; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Climatic Data Center, 2007, GHRSST LEV 4 AVHRR O, DOI 10.5067/GHAAO-4BC01; NOAA Coral Reef Watch, 2000, UPD TWIC WEEKL NOAA; NOAA Coral Reef Watch, 2013, UPD DAIL NOAA COR RE; Norstrom AV, 2016, FRONT ECOL ENVIRON, V14, P490, DOI 10.1002/fee.1427; PHILANDER SGH, 1983, NATURE, V305, P16, DOI 10.1038/305016a0; Przeslawski R, 2015, GLOBAL CHANGE BIOL, V21, P2122, DOI 10.1111/gcb.12833; Putnam HM, 2017, CURR BIOL, V27, pR528, DOI 10.1016/j.cub.2017.04.047; R Development Core Team, 2009, R LANG ENV STAT COMP; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1554/04-602; SALVAT B, 1992, GLOBAL ENVIRON CHANG, V2, P12, DOI 10.1016/0959-3780(92)90032-3; Souter DW, 2000, OCEAN COAST MANAGE, V43, P657, DOI 10.1016/S0964-5691(00)00053-3; SPURGEON JPG, 1992, MAR POLLUT BULL, V24, P529, DOI 10.1016/0025-326X(92)90704-A; Stone L, 1999, ECOL LETT, V2, P325, DOI 10.1046/j.1461-0248.1999.00092.x; Toscano MA, 2002, 7 INT C REM SENS MAR; Toscano MA, 2002, P 9 INT COR REEF S; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; van Hooidonk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39666; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wilkinson C, 1999, NATURE RESOUR, V35, P16; Wilkinson C, 1999, AMBIO, V28, P188; Wilkinson CR, 1996, GLOB CHANGE BIOL, V2, P547, DOI 10.1111/j.1365-2486.1996.tb00066.x; Williams E. H., 1990, ATOLL RES B, V335, P67; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	94	50	50	15	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190957	10.1371/journal.pone.0190957	http://dx.doi.org/10.1371/journal.pone.0190957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401493	gold, Green Published, Green Submitted			2022-12-27	WOS:000424101400008
J	Gandolfo, LC; Speed, TP				Gandolfo, Luke C.; Speed, Terence P.			RLE plots: Visualizing unwanted variation in high dimensional data	PLOS ONE			English	Article							QUALITY ASSESSMENT; MICROARRAY DATA; VARIANCE	Unwanted variation can be highly problematic and so its detection is often crucial. Relative log expression (RLE) plots are a powerful tool for visualizing such variation in high dimensional data. We provide a detailed examination of these plots, with the aid of examples and simulation, explaining what they are and what they can reveal. RLE plots are particularly useful for assessing whether a procedure aimed at removing unwanted variation, i.e. a normalization procedure, has been successful. These plots, while originally devised for gene expression data from microarrays, can also be used to reveal unwanted variation in many other kinds of high dimensional data, where such variation can be problematic.	[Gandolfo, Luke C.; Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic, Australia; [Gandolfo, Luke C.; Speed, Terence P.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Gandolfo, LC (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic, Australia.; Gandolfo, LC (corresponding author), Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia.	gandolfo@wehi.edu.au		Gandolfo, Luke/0000-0002-3599-2455	National Health and Medical Research Council of Australia [1054618]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support from the National Health and Medical Research Council of Australia (Program Grant 1054618). See https://www.nhmrc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2005, STAT BIOL HEALTH, P33; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; MANDEL J, 1971, TECHNOMETRICS, V13, P1, DOI 10.2307/1267072; MANDEL J, 1969, J RES NBS B MATH SCI, VB 73, P309, DOI 10.6028/jres.073B.031; SCHERER A., 2009, BATCH EFFECTS NOISE; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337	9	34	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191629	10.1371/journal.pone.0191629	http://dx.doi.org/10.1371/journal.pone.0191629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401521	Green Published, gold, Green Submitted			2022-12-27	WOS:000424101400015
J	Russo-Abrahao, T; Lacerda-Abreu, MA; Gomes, T; Cosentino-Gomes, D; Carvalho-De-Araujo, AD; Rodrigues, MF; de Oliveira, ACL; Rumjanek, FD; Monteiro, RQ; Meyer-Fernandes, JAR				Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Gomes, Taina; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Rodrigues, Mariana Figueiredo; Leal de Oliveira, Ana Carolina; Rumjanek, Franklin David; Monteiro, Robson de Queiroz; Meyer-Fernandes, Jose Roberto			Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231	PLOS ONE			English	Article							ENERGY-METABOLISM; SLC34A2; MIGRATION; SLC20	Background Recent studies demonstrate that interstitial inorganic phosphate is significantly elevated in the breast cancer microenvironment as compared to normal tissue. In addition it has been shown that breast cancer cells express high levels of the NaPi-IIb carrier (SLC34A2), suggesting that this carrier may play a role in breast cancer progression. However, the biochemical behavior of inorganic phosphate (P-i) transporter in this cancer type remains elusive. Methods In this work, we characterize the kinetic parameters of Pi transport in the aggressive human breast cancer cell line, MDA-MB-231, and correlated P-i transport with cell migration and adhesion. Results We determined the influence of sodium concentration, pH, metabolic inhibitors, as well as the affinity for inorganic phosphate in P-i transport. We observed that the inorganic phosphate is dependent on sodium transport (K-0,K-5 value = 21.98 mM for NaCl). Furthermore, the transport is modulated by different pH values and increasing concentrations of P-i, following the Michaelis-Menten kinetics (K-0,K-5 = 0.08 mM P-i). PFA, monensin, furosemide and ouabain inhibited P-i transport, cell migration and adhesion. Conclusions Taken together, these results showed that the uptake of P-i in MDA-MB-231 cells is modulated by sodium and by regulatory mechanisms of intracellular sodium gradient. General Significance: Pi transport might be regarded as a potential target for therapy against tumor progression.	[Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Gomes, Taina; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Rodrigues, Mariana Figueiredo; Leal de Oliveira, Ana Carolina; Rumjanek, Franklin David; Monteiro, Robson de Queiroz; Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioqum Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil; [Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Meyer-Fernandes, Jose Roberto] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Meyer-Fernandes, JAR (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioqum Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil.; Meyer-Fernandes, JAR (corresponding author), Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil.	meyer@bioqmed.ufrj.br	Monteiro, Robson/GRX-0672-2022; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Cosentino-Gomes, Daniela/F-9374-2013; de Queiroz Monteiro, Robson/M-7097-2019	Monteiro, Robson/0000-0002-5260-2332; Cosentino-Gomes, Daniela/0000-0001-5690-5413	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401134/2014-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [e-26/201.300/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.002352/2017-24]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://cnpq.br/ - 401134/2014-8 to TR-A; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - http:// www.faperj.br/ - e-26/201.300/2014 to JRM-F; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - 23038.002352/2017-24 to JRM-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo ND, 2011, RECENT PAT ANTI-CANC, V6, P15; Andrini O, 2008, CHANNELS, V2, P346, DOI 10.4161/chan.2.5.6900; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Bobko AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012; Chen DR, 2010, ANTICANCER RES, V30, P4135; Dick CF, 2013, BBA-GEN SUBJECTS, V1830, P4265, DOI 10.1016/j.bbagen.2013.04.034; Dick CF, 2014, BBA-GEN SUBJECTS, V1840, P2123, DOI 10.1016/j.bbagen.2014.03.014; Elser JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001028; Forster I, 2011, ADV CHRONIC KIDNEY D, V18, P63, DOI 10.1053/j.ackd.2011.01.006; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Forster IC, 2012, CURR TOP MEMBR, V70, P313, DOI 10.1016/B978-0-12-394316-3.00010-7; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ito M, 2007, AM J PHYSIOL-CELL PH, V292, pC526, DOI 10.1152/ajpcell.00357.2006; Jiang ZX, 2016, TUMOR BIOL, V37, P10383, DOI 10.1007/s13277-016-4928-y; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Kwiatkowska E, 2016, J BIOENERG BIOMEMBR, V48, P23, DOI 10.1007/s10863-015-9637-5; Li YY, 2016, PROCEEDINGS OF THE 2016 IEEE 41ST CONFERENCE ON LOCAL COMPUTER NETWORKS - LCN WORKSHOPS 2016, P34, DOI [10.1109/LCNW.2016.21, 10.1109/LCN.2016.026]; Lin YM, 2015, MOL CARCINOGEN, V54, P926, DOI 10.1002/mc.22153; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117058; Mariano-Oliveira A, 2008, INT J BIOCHEM CELL B, V40, P517, DOI 10.1016/j.biocel.2007.09.002; Milani A, 2014, WORLD J CLIN ONCOL, V5, P990, DOI 10.5306/wjco.v5.i5.990; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Park JH, 2009, INT J BIOCHEM CELL B, V41, P659, DOI 10.1016/j.biocel.2008.07.010; Rodrigues MF, 2015, J CELL BIOCHEM, V116, P797, DOI 10.1002/jcb.25036; Ross CR, 2015, BIOORG MED CHEM LETT, V25, P1715, DOI 10.1016/j.bmcl.2015.02.071; Russo-Abrahao T, 2013, BBA-GEN SUBJECTS, V1830, P2683, DOI 10.1016/j.bbagen.2012.11.017; Russo-Abrahao T, 2017, J BIOENERG BIOMEMBR, V49, P183, DOI 10.1007/s10863-017-9695-y; Shyian M., 2011, Experimental Oncology, V33, P94; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Villa-Bellosta R, 2009, AM J PHYSIOL-CELL PH, V297, pC516, DOI 10.1152/ajpcell.00186.2009; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z	36	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191270	10.1371/journal.pone.0191270	http://dx.doi.org/10.1371/journal.pone.0191270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415049	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300020
J	Mugabe, VA; Ali, S; Chelene, I; Monteiro, VO; Guiliche, OL; Muianga, AF; Mula, F; Antonio, V; Chongo, I; Oludele, J; Falk, K; Paploski, IA; Reis, MG; Kitron, U; Kummerer, BM; Ribeiro, GS; Gudo, ES				Mugabe, Vanio Andre; Ali, Sadia; Chelene, Imelda; Monteiro, Vanessa Onofre; Guiliche, Onelia; Muianga, Argentina Felisbela; Mula, Flora; Antonio, Virgilio; Chongo, Inocencio; Oludele, John; Falk, Kerstin; Paploski, Igor A.; Reis, Mitermayer G.; Kitron, Uriel; Kuemmerer, Beate M.; Ribeiro, Guilherme S.; Gudo, Eduardo Samo			Evidence for chikungunya and dengue transmission in Quelimane, Mozambique: Results from an investigation of a potential outbreak of chikungunya virus	PLOS ONE			English	Article							SEROPREVALENCE	Background In January 2016, health authorities from Zambezia province, Mozambique reported the detection of some patients presenting with fever, arthralgia, and a positive result for chikungunya in an IgM-based Rapid Diagnostic Test (RDT). We initiated a study to investigate a potential chikungunya outbreak in the city of Quelimane. Methods/Principal findings From February to June 2016, we conducted a cross-sectional study enrolling febrile patients attending five outpatient health units in Quelimane. Serum from each patient was tested for CHIKV and DENV, using IgM and IgG ELISA and qRT-PCR. Patients were also tested for malaria by RDT. Entomological surveys were performed around patients' households, and we calculated the proportion of positive ovitraps and the egg density per trap. A total of 163 patients were recruited, of which 99 (60.7%) were female. The median age was 28 years. IgM and IgG anti-CHIKV antibodies were identified in 17 (10.4%) and 103 (63.2%) patients, respectively. Plaque reduction neutralization assay confirmed the presence of anti-CHIKV antibodies in a subset of 11 tested patients with positive IgG results. IgM anti-DENV antibodies were found in 1 (0.9%) of 104 tested patients. Malaria was diagnosed in 35 (21.5%) patients, 2 of whom were also IgM-positive for CHIKV. Older age and lower education level were independently associated with the prevalence of IgG anti-CHIKV antibodies. Immature forms of Aedes aegypti were collected in 16 (20.3%) of 79 surveyed households. We also found that 25.0% (16/64) of the traps were positive, with an average of 90.8 eggs per pallet. Conclusions Our investigation demonstrated that no CHIKV outbreak was ongoing in Quelimane; rather, endemic transmission of the virus has been ongoing. Aedes aegypti mosquitoes are abundant, but dengue cases occurred only sporadically. Further population-based cohort studies are needed to improve our understanding of aspects related to the dynamics of arboviral transmission in Mozambique, as well as in other parts of Sub-Saharan Africa.	[Mugabe, Vanio Andre; Paploski, Igor A.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Mugabe, Vanio Andre; Paploski, Igor A.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil; [Mugabe, Vanio Andre] Univ Pedag Quelimane, Zambezia, Mozambique; [Ali, Sadia; Chelene, Imelda; Monteiro, Vanessa Onofre; Guiliche, Onelia; Muianga, Argentina Felisbela; Mula, Flora; Antonio, Virgilio; Chongo, Inocencio; Oludele, John; Gudo, Eduardo Samo] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Falk, Kerstin] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Falk, Kerstin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA; [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Public Health Agency of Sweden; Karolinska Institutet; Universidade Federal da Bahia; Emory University; University of Bonn	Gudo, ES (corresponding author), Minist Saude, Inst Nacl Saude, Maputo, Mozambique.	esamogudojr@gmail.com	Kümmerer, Beate/HGV-0882-2022; Reis, Mitermayer/AAO-9742-2020; Paploski, Igor AD/D-7015-2014; Ribeiro, Guilherme/B-6624-2008	Reis, Mitermayer/0000-0002-3051-9060; Paploski, Igor AD/0000-0002-3689-2042; Ribeiro, Guilherme/0000-0002-6798-2059; Mugabe, Vanio/0000-0001-6676-4378; Kitron, Uriel/0000-0003-0493-2043; Ali-Pereira, Sadia/0000-0001-5275-2659	European Foundation Initiative into Neglected Tropical Disease [91 488]; U.S. Centers for Disease Control and Prevention [5NU14GH001237-03-00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	European Foundation Initiative into Neglected Tropical Disease; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ESG received funds from the European Foundation Initiative into Neglected Tropical Disease (Grant # 91 488) and by the U.S. Centers for Disease Control and Prevention through a cooperative agreement number 5NU14GH001237-03-00. The views expressed in this written publication do not necessarily reflect the official policies of the U.S. Department of Health and Human Services. VAM, IADP, UK and GSR received scholarships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly MM, 2017, BIOMED CENTRAL, P4; [Anonymous], WHO DIR GEN SUMM OUT; CDC, 2016, TRIOPL REAL TIM RI P; Dick GWA, 1952, ZIKA VIRUS, P46; Diop D, 2015, MOJ PUBLIC HLTH, V2, P43; Glasker S, 2013, VIRUS REPLICON PARTI, P1; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; Gudo ES, 2015, SEROLOGICAL EVIDENCE, P1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29; Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054; Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4; Kikuti M, 2015, SPATIAL DISTRIBUTION, P1; KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201; Kraemer MUG, 2015, GLOBAL DISTRIBUTION, P1; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003721; Lala A., 2013, ESTUDO BASE CONSELHO; Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543; Messina JP, 2007, MAPPING GLOBAL ENV S, V2016, P1; Ministerio de Economia e Financas de Mocambique, 2016, POBR BEM EST MOC QUA, P87; Muianga A, 2016, INT J INFECT DIS, V45, P174, DOI 10.1016/j.ijid.2016.02.411; Nsoesie EO, 2015, GLOBAL DISTRIBUTION, P1; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; Rezza G, 2016, DENGUE CHIKUNGUNYA L, P7724; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROBINSON MC, 1955, EPIDEMIC VIRUS DIS S, P28; Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231; Yusoff AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-211	33	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192110	10.1371/journal.pone.0192110	http://dx.doi.org/10.1371/journal.pone.0192110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415070	gold, Green Published, Green Submitted			2022-12-27	WOS:000424325300050
J	Doyle, JR; Bottomley, PA				Doyle, John R.; Bottomley, Paul A.			Relative age effect in elite soccer: More early-born players, but no better valued, and no paragon clubs or countries	PLOS ONE			English	Article							GERMAN SOCCER; SELECTION; FOOTBALL; BIRTH	The paper analyses two datasets of elite soccer players (top 1000 professionals and UEFA Under-19 Youth League). In both, we find a Relative Age Effect (RAE) for frequency, but not for value. That is, while there are more players born at the start of the competition year, their transfer values are no higher, nor are they given more game time. We use Poisson regression to derive a transparent index of the discrimination present in RAE. Also, because Poisson is valid for small frequency counts, it supports analysis at the disaggregated levels of country and club. From this, we conclude there are no paragon clubs or countries immune to RAE; that is clubs and countries do not differ systematically in the RAE they experience; also, that Poisson regression is a powerful and flexible method of analysing RAE data.	[Doyle, John R.; Bottomley, Paul A.] Cardiff Univ, Business Sch, Cardiff, S Glam, Wales	Cardiff University	Bottomley, PA (corresponding author), Cardiff Univ, Business Sch, Cardiff, S Glam, Wales.	bottomleypa@cardiff.ac.uk		Bottomley, Paul/0000-0001-8131-6768				Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Alton A, 1998, EDUC RES, V40, P105, DOI 10.1080/0013188980400111; Ashworth J, 2007, J SPORT ECON, V8, P355, DOI 10.1177/1527002506287695; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1093/qje/121.4.1437; Bryson A., 2014, 8645 IZA; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Cobley S, 2008, J SPORT SCI, V26, P1531, DOI 10.1080/02640410802298250; Crawford C, 2014, J R STAT SOC A STAT, V177, P829, DOI 10.1111/rssa.12071; Deprez D, 2012, INT J SPORTS MED, V33, P987, DOI 10.1055/s-0032-1311654; Doyle JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176206; Fumarco L, 2015, WORKING PAPERS MANAG; Fumarco L, 2017, FRONT PSYCHOL, P8; Fumarco L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182827; Furley P, 2016, FRONT PSYCHOL, P7; Gibbs BG, 2012, INT REV SOCIOL SPORT, V47, P644, DOI 10.1177/1012690211414343; Goodman R, 2003, BMJ-BRIT MED J, V327, P472, DOI 10.1136/bmj.327.7413.472; Gutierrez Diaz del Campo D, 2010, J SPORT SCI MED, V9, P190; Hancock DJ, 2013, EUR J SPORT SCI, V13, P630, DOI 10.1080/17461391.2013.775352; Helsen WF, 2012, J SPORT SCI, V30, P1665, DOI 10.1080/02640414.2012.721929; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Herm S, 2014, SPORT MANAG REV, V17, P484, DOI 10.1016/j.smr.2013.12.006; Hill B, 2016, EUR SPORT MANAG Q, V16, P292, DOI 10.1080/16184742.2015.1131730; Hjertstrand P, 2017, 1176 IFN; Irwin JR, 2003, J MARKETING RES, V40, P366, DOI 10.1509/jmkr.40.3.366.19237; Jackson J, 2011, OBSERVER; Jimenez IP, 2008, J SPORT SCI, V26, P995, DOI 10.1080/02640410801910285; Larkin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175716; Loffing F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00620; Lovell R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137238; Matsubayashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135349; McCarthy N, 2016, J SPORT SCI, V34, P1461, DOI 10.1080/02640414.2015.1119297; Ramsey F, STAT SLEUTH COURSE M, P3; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Schorer J., 2015, PSYCHOL TEST ASSESSM, V57, P126; Vaeyens Roel, 2013, SCI SOCCER DEV ELITE, P289; Van Den Tillaar R, 2012, J SPORT SCI, V30, P807, DOI 10.1080/02640414.2012.671529	36	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192209	10.1371/journal.pone.0192209	http://dx.doi.org/10.1371/journal.pone.0192209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV4BG	29420576	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000424517900053
J	Higaki, A; Mogi, M; Iwanami, J; Min, LJ; Bai, HY; Shan, BS; Kukida, M; Kan-no, H; Ikeda, S; Higaki, J; Horiuchi, M				Higaki, Akinori; Mogi, Masaki; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Kan-no, Harumi; Ikeda, Shuntaro; Higaki, Jitsuo; Horiuchi, Masatsugu			Predicting outcome of Morris water maze test in vascular dementia mouse model with deep learning	PLOS ONE			English	Article							MEMORY	The Morris water maze test (MWM) is one of the most popular and established behavioral tests to evaluate rodents' spatial learning ability. The conventional training period is around 5 days, but there is no clear evidence or guidelines about the appropriate duration. In many cases, the final outcome of the MWM seems predicable from previous data and their trend. So, we assumed that if we can predict the final result with high accuracy, the experimental period could be shortened and the burden on testers reduced. An artificial neural network (ANN) is a useful modeling method for datasets that enables us to obtain an accurate mathematical model. Therefore, we constructed an ANN system to estimate the final outcome in MWM from the previously obtained 4 days of data in both normal mice and vascular dementia model mice. Ten-week-old male C57B1/6 mice (wild type, WT) were subjected to bilateral common carotid artery stenosis (WT-BCAS) or sham-operation (WT-sham). At 6 weeks after surgery, we evaluated their cognitive function with MWM. Mean escape latency was significantly longer in WT-BCAS than in WT-sham. All data were collected and used as training data and test data for the ANN system. We defined a multiple layer perceptron (MLP) as a prediction model using an open source framework for deep learning, Chainer. After a certain number of updates, we compared the predicted values and actual measured values with test data. A significant correlation coefficient was derived form the updated ANN model in both WT-sham and WT-BCAS. Next, we analyzed the predictive capability of human testers with the same datasets. There was no significant difference in the prediction accuracy between human testers and ANN models in both WT-sham and WT-BCAS. In conclusion, deep learning method with ANN could predict the final outcome in MWM from 4 days of data with high predictive accuracy in a vascular dementia model.	[Higaki, Akinori; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Kan-no, Harumi; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Higaki, Akinori; Kukida, Masayoshi; Ikeda, Shuntaro; Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan; [Mogi, Masaki] Ehime Univ, Grad Sch Med, Dept Pharmacol, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.; Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan.	keroplant83@gmail.com	Higaki, Akinori/AAA-2551-2019	Higaki, Akinori/0000-0002-0827-874X				Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Araghinejad S, 2013, CHAINER A NEXT GENER; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Coltman R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.09.005; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deng L., 2014, SIGNAL PROCESS, V7, P3, DOI DOI 10.1561/2000000039; Deng L., 2014, DATA DRIVEN MODELING, V7, P3; Enrique AM, 2009, MATH COMPUT MODEL, V49, P207; Hosseini-Sharifabad A, 2011, DARU, V19, P166; Iwanami J, 2015, J AM SOC HYPERTENS, V9, P250, DOI 10.1016/j.jash.2015.01.010; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; STR, 2007, STR; STR, 1960, STR; Tachibana K, 2011, BRAIN RES, V1388, P69, DOI 10.1016/j.brainres.2011.02.086; Timic T, 2013, BEHAV BRAIN RES, V241, P198, DOI 10.1016/j.bbr.2012.12.014; Xiao HG, 2017, J HYPERTENS, V35, P1577, DOI 10.1097/HJH.0000000000001337; Yaslan Y, 2017, MEASUREMENT, V103, P52, DOI 10.1016/j.measurement.2017.02.007	24	14	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191708	10.1371/journal.pone.0191708	http://dx.doi.org/10.1371/journal.pone.0191708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415035	Green Published, gold, Green Submitted			2022-12-27	WOS:000424325300038
J	Ohde, T; Dadou, I				Ohde, Thomas; Dadou, Isabelle			Seasonal and annual variability of coastal sulphur plumes in the northern Benguela upwelling system	PLOS ONE			English	Article							HYDROGEN-SULFIDE ERUPTIONS; ATLANTIC-OCEAN; INTERANNUAL VARIABILITY; FRONTAL ZONE; LARGE-SCALE; SULFATE REDUCTION; NAMIBIAN SHELF; WATER; OXYGEN; ANGOLA	We investigated the seasonal and annual variability of surface sulphur plumes in the northern Benguela upwelling system off Namibia because of their significant impacts on the marine ecosystem, fishing industry, aquaculture farming and tourism due to their toxic properties. We identified the sulphur plumes in ocean colour satellite data of the medium resolution imaging spectrometer (MERIS) for the 2002-2012 time period using the differences in the spectral properties of Namibian Benguela optical water types. The sulphur events have a strong seasonal cycle with pronounced main and off-seasons forced by local and remote-driven processes. The main peak season is in late austral summer and early austral autumn at the beginning of the annual upwelling cycle caused by increasing equatorwards along-shore winds. The sulphur plume activity is high between February and April during the seasonal oxygen minimum associated with the seasonal reduction of cross-shore ventilation of the bottom waters, the seasonal southernmost position of the Angola Benguela Frontal Zone, the seasonal maximum of water mass fractions of South Atlantic and Angola Gyre Central Waters as well as the seasonal arrival of the downwelling coastal trapped waves. The off-season is in austral spring and early austral summer during increased upwelling intensity and enhanced oxygen supply. The annual variability of sulphur events is characterized by very high activities in years 2004, 2005 and 2010 interrupted by periods of lower activity in years 2002 to 2003, 2006 to 2009 and 2011 to 2012. This result can be explained by the relative contributions or adding effects of local and remote-driven forces (from the equatorial area). The probability for the occurrence of sulphur plumes is enhanced in years with a lower annual mean of upwelling intensity, decreased oxygen supply associated with decreased lateral ventilation of bottom waters, more southern position of the Angola Benguela Frontal Zone, increased mass fraction of South Atlantic Central Water and stronger downwelling coastal trapped waves. Understanding of the variability and forcing processes of the toxic sulphur events will help in the future to monitor and forecast them as well as to manage their social and economic consequences in the northern Benguela upwelling system off Namibia.	[Ohde, Thomas; Dadou, Isabelle] Univ Toulouse, UPS, IRD, CNRS,CNES,LEGOS, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales	Ohde, T (corresponding author), Univ Toulouse, UPS, IRD, CNRS,CNES,LEGOS, Toulouse, France.	Thomas.Ohde@legos.obs-mip.fr	Ohde, Thomas/J-4926-2015	Ohde, Thomas/0000-0001-8117-814X	European Union's Horizon research and innovation program under Marie Sklodowska-Curie grant [706426]; host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France; NASA/HQ; NASA	European Union's Horizon research and innovation program under Marie Sklodowska-Curie grant; host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France; NASA/HQ; NASA(National Aeronautics & Space Administration (NASA))	This study has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 706426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 706426. The authors thank the host institute OMP/LEGOS (Observatoire Midi-Pyrenees/Laboratoire d'Etudes en Geophysique et Oceanographie Spatiales) in France for their support. This investigation was mainly based on satellite data of different sources. The MERIS and MSI data were kindly provided by ESA. We acknowledge the use of MODIS data from LANCE FIRMS operated by the NASA/GSFC/Earth Science Data and Information System (ESDIS) with funding provided by NASA/HQ. Data products of the Ocean Biology Processing Group (OBPG) were used (HICO, VIIRS, MODIS). TMI, QuikScat, ASCAT and CCMP data were produced by Remote Sensing Systems (RSS) and sponsored by NASA. RSS TMI data are available at www.remss.com. We are grateful to NASA Goddard Space Flight Center for providing access to TMI TDR files. The Ssalto/Duacs altimeter SLA product was produced and distributed by the Copernicus Marine and Environment Monitoring Service (CMEMS) (http://www.marine.copernicus.eu). The CARS climatology was developed by CSIRO Marine and Atmospheric Research. The software packages IDL (https://www.harrisgeospatial.com), SeaDAS (https:// seadas.gsfc.nasa.gov), SNAP (http://step.esa.int/main/toolboxes/snap/) and ACOLITE (https://odnature.naturalsciences.be/remsem/software-and-data/acolite) were taken for the processing of satellite data. Some of the analyses used in this paper were produced with the online data systems of GIOVANNI (https://giovanni.sci.gsfc.nasa.gov) and Asia-Pacific Data Research Center (http://apdrc.soest.hawaii.edu).	Ahmed S, 2011, PROC SPIE, V8030, DOI 10.1117/12.884674; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Antoine D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004472; Atlas R, 2011, B AM METEOROL SOC, V92, P157, DOI 10.1175/2010BAMS2946.1; Bachelery ML, 2016, GEOPHYS RES LETT, V43, P8617, DOI 10.1002/2016GL070288; Bachelery ML, 2016, J GEOPHYS RES-OCEANS, V121, P284, DOI 10.1002/2015JC011168; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BAILEY G W, 1985, South African Journal of Marine Science, P197; Bourassa MA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001028; Bourg L, 2012, MERIS 3 DATA REPROCE; BOYD AJ, 1987, S AFR J MARINE SCI, V5, P107, DOI 10.2989/025776187784522577; Bremner J. M., 1978, THESIS; Bremner JM, 1983, COASTAL UPWELLING B; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Bruchert V, 2003, GEOCHIM COSMOCHIM AC, V67, P4505, DOI 10.1016/S0016-7037(03)00275-8; Bruchert V, 2009, PROG OCEANOGR, V83, P169, DOI 10.1016/j.pocean.2009.07.017; BUBNOV VA, 1972, OCEANOLOGY-USSR, V12, P193; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN P, 1987, S AFR J MARINE SCI, V5, P85, DOI 10.2989/025776187784522162; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chelton DB, 2005, MON WEATHER REV, V133, P409, DOI 10.1175/MWR-2861.1; Li CC, 2006, TERR ATMOS OCEAN SCI, V17, P447; Classen T, 1930, PALAEBIOLOGICA, V111, P13; Colberg F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027463; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Dogliotti AI, 2009, INT J REMOTE SENS, V30, P251, DOI 10.1080/01431160802311133; Ebuchi N, 2002, J ATMOS OCEAN TECH, V19, P2049, DOI 10.1175/1520-0426(2002)019<2049:EOWVOB>2.0.CO;2; Ekman VW., 1905, ARKIV MAT ASTRON FIZ, V2, P1; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; EVANS CL, 1967, Q J EXP PHYSIOL CMS, V52, P231, DOI 10.1113/expphysiol.1967.sp001909; Feng H, 2008, INT J REMOTE SENS, V29, P4479, DOI 10.1080/01431160801918599; Ferdelman TG, 1999, LIMNOL OCEANOGR, V44, P650, DOI 10.4319/lo.1999.44.3.0650; Findlay AJ, 2017, LIMNOL OCEANOGR, V62, P1853, DOI 10.1002/lno.10539; Findlay AJ, 2014, GEOCHIM COSMOCHIM AC, V142, P334, DOI 10.1016/j.gca.2014.07.032; Flohr A, 2014, BIOGEOSCIENCES, V11, P885, DOI 10.5194/bg-11-885-2014; Florenchie P, 2004, J CLIMATE, V17, P2318, DOI 10.1175/1520-0442(2004)017<2318:EOIWAC>2.0.CO;2; Florenchie P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017172; Galan A, 2014, LIMNOL OCEANOGR, V59, P1865, DOI 10.4319/lo.2014.59.6.1865; Gentemann CL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002092; Ghanea M, 2016, ADV SPACE RES, V57, P127, DOI 10.1016/j.asr.2015.10.040; GILL AE, 1974, DEEP-SEA RES, V21, P325, DOI 10.1016/0011-7471(74)90038-2; GORDON AL, 1995, DEEP-SEA RES PT I, V42, P1, DOI 10.1016/0967-0637(94)00032-N; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Gutknecht E, 2013, BIOGEOSCIENCES, V10, P3559, DOI 10.5194/bg-10-3559-2013; Hagen E, 2001, OCEANOL ACTA, V24, P557, DOI 10.1016/S0399-1784(01)01173-2; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Hamukuaya H, 1994, SURVEY JUVENILE HAKE; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Junker T, 2017, J MARINE SYST, V165, P36, DOI 10.1016/j.jmarsys.2016.09.003; Kostianoy AG, 1999, J GEOPHYS RES-OCEANS, V104, P20963, DOI 10.1029/1999JC900017; Lamont T, 2017, J MARINE SYSTEMS; Lass HU, 2005, CONT SHELF RES, V25, P1473, DOI 10.1016/j.csr.2005.04.012; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lee MA, 2010, TERR ATMOS OCEAN SCI, V21, P727, DOI 10.3319/TAO.2009.09.07.01(Oc); Louw DC, 2016, J MARINE SYST, V157, P124, DOI 10.1016/j.jmarsys.2016.01.009; Lucke RL, 2011, APPL OPTICS, V50, P1501, DOI 10.1364/AO.50.001501; Lubbecke JF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005964; MAIER S, 1984, INT J SYST BACTERIOL, V34, P414, DOI 10.1099/00207713-34-4-414; MEEUWIS JM, 1990, S AFR J MARINE SCI, V9, P261; Mendonca A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3328872; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Monteiro PMS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026234; Monteiro PMS, 2006, LAR MAR ECOSYST, V14, P71; Monteiro PMS, 2005, CONT SHELF RES, V25, P1864, DOI 10.1016/j.csr.2005.06.012; MOROSHKIN KV, 1970, OCEANOLOGY-USSR, V10, P27; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Oesch DC, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002857; Ohde T, 2007, INT J REMOTE SENS, V28, P609, DOI 10.1080/01431160600972961; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Ohde T, 2011, INT J REMOTE SENS, V32, P9327, DOI 10.1080/01431161.2011.554455; Ohde T, 2009, CENT EUR J GEOSCI, V1, P340, DOI 10.2478/v10085-009-0020-9; Polo I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004495; Poole R, 1999, DEEP-SEA RES PT I, V46, P1895, DOI 10.1016/S0967-0637(99)00025-4; Ricciardulli L, 2016, ASCAT METOP A DATA P; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rouault M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052099; Schmidt M, 2016, PROG OCEANOGR, V149, P145, DOI 10.1016/j.pocean.2016.09.004; Schouten MW, 2005, DEEP-SEA RES PT I, V52, P477, DOI 10.1016/j.dsr.2004.10.007; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Schunck H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068661; Senan R, 200129 CAOS; Shannon L.V., 1996, S ATLANTIC PRESENT C; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1986, J MAR RES, V44, P495, DOI 10.1357/002224086788403105; Shillington FA, 2006, LAR MAR ECOSYST, V14, P49; Shillington FA, 1998, SEA; Urquhart EA, 2013, REMOTE SENS ENVIRON, V135, P167, DOI 10.1016/j.rse.2013.03.034; van der Plas AK, 2007, AFR J MAR SCI, V29, P37, DOI 10.2989/AJMS.2007.29.1.3.68; Vanhellemont Q, 2014, REMOTE SENS ENVIRON, V145, P105, DOI 10.1016/j.rse.2014.01.009; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2009, PROG OCEANOGR, V83, P296, DOI 10.1016/j.pocean.2009.07.008; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wentz F. J., 2015, REMOTE SENSING SYSTE	99	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192140	10.1371/journal.pone.0192140	http://dx.doi.org/10.1371/journal.pone.0192140			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420587	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900042
J	Sardar, P; Kempken, F				Sardar, Puspendu; Kempken, Frank			Characterization of indole-3-pyruvic acid pathway-mediated biosynthesis of auxin in Neurospora crassa	PLOS ONE			English	Article							BACTERIAL BIOSYNTHESIS; EVOLUTIONARY PATTERNS; CONIDIAL GERMINATION; DATABASE RESOURCES; SALKOWSKI REAGENT; CRYSTAL-STRUCTURE; IAA BIOSYNTHESIS; NATIONAL-CENTER; YOUNG HYPHAE; IDENTIFICATION	Plants, bacteria and some fungi are known to produce indole-3-acetic acid (IAA) by employing various pathways. Among these pathways, the indole-3-pyruvic acid (IPA) pathway is the best studied in green plants and plant-associated beneficial microbes. While IAA production circuitry in plants has been studied for decades, little is known regarding the IAA biosynthesis pathway in fungal species. Here, we present the first data for IAA-producing genes and the associated biosynthesis pathway in a non-pathogenic fungus, Neurospora crassa. For this purpose, we used a computational approach to determine the genes and outlined the IAA production circuitry in N. crassa. We then validated these data with experimental evidence. Here, we describe the homologous genes that are present in the IPA pathway of IAA production in N. crassa. High-performance liquid chromatography and thin-layer chromatography unambiguously identified IAA, indole-3-lactic acid (ILA) and tryptophol (TOL) from cultures supplemented with tryptophan. Deletion of the gene (cfp) that encodes the enzyme indole-3-pyruvate decarboxylase, which converts IPA to indole-3-acetaldehyde (IAAld), results in an accumulation of higher levels of ILA in the N. crassa culture medium. A double knock-out strain (Delta cbs-3;Delta ahd-2) for the enzyme IAAld dehydrogenase, which converts IAAld to IAA, shows a many fold decrease in IAA production compared with the wild type strain. The Delta cbs-3;Delta ahd-2 strain also displays slower conidiation and produces many fewer conidiospores than the wild type strain.	[Sardar, Puspendu; Kempken, Frank] Univ Kiel, Bot Inst & Bot Garten, Abt Bot Genet & Mol Biol, Kiel, Germany	University of Kiel	Kempken, F (corresponding author), Univ Kiel, Bot Inst & Bot Garten, Abt Bot Genet & Mol Biol, Kiel, Germany.	fkempken@bot.uni-kiel.de	Sardar, Puspendu/W-6727-2019	Sardar, Puspendu/0000-0001-8011-2915; Kempken, Frank/0000-0002-7853-8009	Max-Planck-International-Research-School Evolutionary Biology	Max-Planck-International-Research-School Evolutionary Biology	The authors received no specific funding for this work. However PS received a stipend from the Max-Planck-International-Research-School Evolutionary Biology.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; Bulfer SL, 2013, PROTEIN SCI, V22, P1417, DOI 10.1002/pro.2315; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; EPSTEIN CJ, 1964, NATURE, V203, P1350, DOI 10.1038/2031350a0; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Fu SF, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1048052; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GRUEN HE, 1959, ANNU REV PLANT PHYS, V10, P405, DOI 10.1146/annurev.pp.10.060159.002201; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUNASEKA.M, 1972, MYCOLOGIA, V64, P1180, DOI 10.2307/3758087; Hilbert M, 2012, NEW PHYTOL, V196, P520, DOI 10.1111/j.1469-8137.2012.04275.x; HUTTER R, 1986, ANNU REV MICROBIOL, V40, P55, DOI 10.1146/annurev.mi.40.100186.000415; Kollath-Leiss K, 2014, EUKARYOT CELL, V13, P1051, DOI 10.1128/EC.00061-14; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; LINDEGREN CARL C., 1932, BULL TORREY BOT CLUB, V59, P85, DOI 10.2307/2480556; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Manulis S, 1998, MOL PLANT MICROBE IN, V11, P634, DOI 10.1094/MPMI.1998.11.7.634; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; NAKAMURA T, 1978, PLANT CELL PHYSIOL, V19, P705; NAKAMURA T, 1988, PLANT GROWTH REGUL, V7, P201; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Normanly J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001594; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Phi QT, 2008, J MICROBIOL BIOTECHN, V18, P1235; Pietrzak I, 1995, Przegl Lek, V52, P522; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SANDBERG G, 1984, PLANTA, V161, P398, DOI 10.1007/BF00394569; Schutz A, 2003, EUR J BIOCHEM, V270, P2312, DOI 10.1046/j.1432-1033.2003.03601.x; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Szkop M, 2013, ANTON LEEUW INT J G, V103, P683, DOI 10.1007/s10482-012-9838-4; Sztein AE, 2000, INT J PLANT SCI, V161, P849, DOI 10.1086/317566; TOMITA K, 1984, PLANT CELL PHYSIOL, V25, P355; TOMITA K, 1987, AGR BIOL CHEM TOKYO, V51, P2633; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Tudzynski B, 2002, MYCOTA, V10, P183; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zuther K, 2008, MOL MICROBIOL, V68, P152, DOI 10.1111/j.1365-2958.2008.06144.x	56	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2018	13	2							e0192293	10.1371/journal.pone.0192293	http://dx.doi.org/10.1371/journal.pone.0192293			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV4BG	29420579	Green Published, Green Submitted, gold			2022-12-27	WOS:000424517900061
J	Nascimento, MS; Carminati, JA; Morishita, KN; Neto, DPA; Pinheiro, HP; Maia, RP				Nascimento, Maristela S.; Carminati, Joyce A.; Morishita, Karen N.; Amorim Neto, Dionisio P.; Pinheiro, Hildete P.; Maia, Rafael P.			Long-term kinetics of Salmonella Typhimurium ATCC 14028 survival on peanuts and peanut confectionery products	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; WATER ACTIVITY FOODS; LISTERIA-MONOCYTOGENES; HEAT-RESISTANCE; ENTERICA; OUTBREAK; BUTTER; INACTIVATION; TEMPERATURE; TENNESSEE	Due to recent large outbreaks, peanuts have been considered a product of potential risk for Salmonella. Usually, peanut products show a low water activity (a(w)) and high fat content, which contribute to increasing the thermal resistance and survival of Salmonella. This study evaluated the long-term kinetics of Salmonella survival on different peanut products under storage at 28 degrees C for 420 days. Samples of raw in-shell peanuts (a(w) = 0.29), roasted peanuts (a(w) = 0.39), unblanched peanut kernel (a(w) = 0.54), peanut brittle (a(w) = 0.30), pacoca (a(w) = 0.40) and pe-de-moca (a(w) = 0.68) were inoculated with Salmonella Typhimurium ATCC 14028 at two inoculum levels (3 and 6 log cfu/g). The Salmonella behavior was influenced (p<0.05) by a(w), lipid, carbohydrate and protein content. In most cases for both inoculum levels, the greatest reductions were seen after the first two weeks of storage, followed by a slower decline phase. The lowest reductions were verified in pacoca and roasted peanuts, with counts of 1.01 and 0.87 log cfu/g at low inoculum level and 2.53 and 3.82 log cfu/g at high inoculum level at the end of the storage time. The highest loss of viability was observed in pe-de-moca, with absence of Salmonella in 10-g after 180 days at low inoculum level. The Weibull model provided a suitable fit to the data (R-2 >= 0.81), with delta value ranging from 0.06 to 49.75 days. Therefore, the results demonstrated that Salmonella survives longer in peanut products, beyond the shelf life (>420 days), especially in products with aw around 0.40.	[Nascimento, Maristela S.; Carminati, Joyce A.; Morishita, Karen N.; Amorim Neto, Dionisio P.] Univ Estadual Campinas, Sch Food Engn, Dept Food Technol, Campinas, SP, Brazil; [Pinheiro, Hildete P.; Maia, Rafael P.] Univ Estadual Campinas, Dept Stat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Nascimento, MS (corresponding author), Univ Estadual Campinas, Sch Food Engn, Dept Food Technol, Campinas, SP, Brazil.	mnasci@unicamp.br	Nascimento, Maristela da Silva do/J-3054-2015; Amorim Neto, Dionisio Pedro/AAA-8444-2022; Maia, Rafael Pimentel/F-6942-2012	Nascimento, Maristela da Silva do/0000-0003-1791-0361; Amorim Neto, Dionisio Pedro/0000-0001-6763-273X; Maia, Rafael Pimentel/0000-0001-5736-8269; Noda Morishita, Karen/0000-0002-1951-7996	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/13942-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Process 2013/13942-4), www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo for financial support (Process 2013/13942-4).	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P85; [Anonymous], 2007, 657912007 ISSO INT O; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuchat LR, 2013, J FOOD PROTECT, V76, P150, DOI 10.4315/0362-028X.JFP-12-211; Beuchat LR, 2010, J FOOD PROTECT, V73, P1257, DOI 10.4315/0362-028X-73.7.1257; Blessington T, 2012, J FOOD PROTECT, V75, P245, DOI 10.4315/0362-028X.JFP-11-278; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brar PK, 2015, J FOOD PROTECT, V78, P323, DOI 10.4315/0362-028X.JFP-14-327; Burnett SL, 2000, J APPL MICROBIOL, V89, P472, DOI 10.1046/j.1365-2672.2000.01138.x; Canovas D, 2001, J BACTERIOL, V183, P3365, DOI 10.1128/JB.183.11.3365-3371.2001; Carminati JD, 2016, J APPL MICROBIOL, V121, P1071, DOI 10.1111/jam.13235; Centers for Disease Control Prevention [CDC], 2014, MULT OUTBR SALM BRAE; Centre for Disease Control and Prevention (CDC), 2012, MULT OUTBR SALM BRED; CORRY JEL, 1974, J APPL BACTERIOL, V37, P31, DOI 10.1111/j.1365-2672.1974.tb00412.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Danyluk MD, 2007, J FOOD PROTECT, V70, P820, DOI 10.4315/0362-028X-70.4.820; do Nascimento MD, 2012, INT J FOOD MICROBIOL, V159, P225, DOI 10.1016/j.ijfoodmicro.2012.08.017; Farakos SMS, 2013, INT J FOOD MICROBIOL, V166, P280, DOI 10.1016/j.ijfoodmicro.2013.07.007; Farakos SMS, 2014, J FOOD PROTECT, V77, P1448, DOI 10.4315/0362-028X.JFP-14-013; He YS, 2011, APPL ENVIRON MICROB, V77, P8434, DOI 10.1128/AEM.06270-11; Horwitz W., 2006, OFFICIAL METHODS ANA, P72; Instituto Adolfo Lutz, 2005, MET FIS QUIM AN AL N; JUVEN BJ, 1984, J FOOD PROTECT, V47, P445, DOI 10.4315/0362-028X-47.6.445; Kataoka AI, 2014, J FOOD PROTECT, V77, P1252, DOI 10.4315/0362-028X.JFP-13-553; Keller SE, 2012, J FOOD PROTECT, V75, P1125, DOI 10.4315/0362-028X.JFP-11-477; Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105; Kimber MA, 2012, J FOOD PROTECT, V75, P1394, DOI 10.4315/0362-028X.JFP-12-023; Kirk MD, 2004, EPIDEMIOL INFECT, V132, P571, DOI 10.1017/S095026880400216X; Li HP, 2014, J FOOD PROTECT, V77, P67, DOI 10.4315/0362-028X.JFP-13-277; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Mattick KL, 2000, APPL ENVIRON MICROB, V66, P4921, DOI 10.1128/AEM.66.11.4921-4925.2000; MOSSEL DAA, 1965, POULTRY SCI, V44, P890, DOI 10.3382/ps.0440890; Park EJ, 2008, J FOOD SCI, V73, pM82, DOI 10.1111/j.1750-3841.2007.00638.x; Scheil W, 1998, AUST NZ J PUBL HEAL, V22, P536, DOI 10.1111/j.1467-842X.1998.tb01434.x; TAMMINGA SK, 1976, J HYG-CAMBRIDGE, V76, P41, DOI 10.1017/S0022172400054929; Uesugi AR, 2006, J FOOD PROTECT, V69, P1851, DOI 10.4315/0362-028X-69.8.1851; [No title captured]	39	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							0192457	10.1371/journal.pone.0192457	http://dx.doi.org/10.1371/journal.pone.0192457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401480	Green Submitted, Green Published, gold			2022-12-27	WOS:000424101400062
J	Chen, CH; Chang, CK; Tu, CY; Liao, WC; Wu, BR; Chou, KT; Chiou, YR; Yang, SN; Zhang, G; Huang, TC				Chen, Chia-Hung; Chang, Chih-Kun; Tu, Chih-Yen; Liao, Wei-Chih; Wu, Bing-Ru; Chou, Kuei-Ting; Chiou, Yu-Rou; Yang, Shih-Neng; Zhang, Geoffrey; Huang, Tzung-Chi			Radiomic features analysis in computed tomography images of lung nodule classification	PLOS ONE			English	Article							PULMONARY NODULES; RESPONSE EVALUATION; TEXTURAL FEATURES; TUMOR RESPONSE; CANCER; CT; MANAGEMENT; DIAGNOSIS; SIZE	Purpose Radiomics, which extract large amount of quantification image features from diagnostic medical images had been widely used for prognostication, treatment response prediction and cancer detection. The treatment options for lung nodules depend on their diagnosis, benign or malignant. Conventionally, lung nodule diagnosis is based on invasive biopsy. Recently, radiomics features, a non-invasive method based on clinical images, have shown high potential in lesion classification, treatment outcome prediction. Methods Lung nodule classification using radiomics based on Computed Tomography (CT) image data was investigated and a 4-feature signature was introduced for lung nodule classification. Retrospectively, 72 patients with 75 pulmonary nodules were collected. Radiomics feature extraction was performed on non-enhanced CT images with contours which were delineated by an experienced radiation oncologist. Result Among the 750 image features in each case, 76 features were found to have significant differences between benign and malignant lesions. A radiomics signature was composed of the best 4 features which included Laws_LSL_min, Laws_SLL_energy, Laws_SSL_skewness and Laws_EEL_uniformity. The accuracy using the signature in benign or malignant classification was 84% with the sensitivity of 92.85% and the specificity of 72.73%. Conclusion The classification signature based on radiomics features demonstrated very good accuracy and high potential in clinical application.	[Chen, Chia-Hung; Tu, Chih-Yen; Liao, Wei-Chih; Wu, Bing-Ru] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Chang, Chih-Kun] Chang Bing Show Chwan Mem Hosp, Dept Med Imaging, Changhua, Taiwan; [Chou, Kuei-Ting; Yang, Shih-Neng; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chiou, Yu-Rou; Yang, Shih-Neng; Huang, Tzung-Chi] China Med Univ Hosp, Artificial Intelligence Ctr Med Diag, Taichung, Taiwan; [Zhang, Geoffrey] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, 12902 USF Magnolia Dr, Tampa, FL USA; [Huang, Tzung-Chi] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Bing Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Asia University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.; Huang, TC (corresponding author), China Med Univ Hosp, Artificial Intelligence Ctr Med Diag, Taichung, Taiwan.; Huang, TC (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 106-2221-E-039-007]; Chang Bing Show Chwan Memorial Hospital [RD106070]; China Medical University Hospital [DMR-107-058]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Bing Show Chwan Memorial Hospital; China Medical University Hospital	This study was financially supported by Ministry of Science and Technology, Taiwan (MOST 106-2221-E-039-007; URLs: https://www.most.gov.tw/), Chang Bing Show Chwan Memorial Hospital (RD106070; URLs: https://patientsbeyondborders.com/hospital), and China Medical University Hospital (DMR-107-058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Birchard KR, 2009, CANCER-AM CANCER SOC, V115, P581, DOI 10.1002/cncr.24060; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buckler AJ, 2011, RADIOLOGY, V258, P906, DOI 10.1148/radiol.10100799; Cebulla J, 2015, BRIT J CANCER, V112, P504, DOI 10.1038/bjc.2014.628; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; El-Baz A., 2011, LUNG IMAGING COMPUTE; Fass L, 2008, MOL ONCOL, V2, P115, DOI 10.1016/j.molonc.2008.04.001; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He L, 2016, SCI REPORTS, V6; Kim H, 2015, INVEST RADIOL, V50, P571, DOI 10.1097/RLI.0000000000000152; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Kurland BF, 2012, MAGN RESON IMAGING, V30, P1301, DOI 10.1016/j.mri.2012.06.009; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Laws KI, 1980, TEXTURED IMAGE SEGME; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Liang M., 2012, 3D COOCCURRENCE MATR; McNitt-Gray MF, 1999, COMPUT MED IMAG GRAP, V23, P339, DOI 10.1016/S0895-6111(99)00033-6; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oberije C, 2014, RADIOTHER ONCOL, V112, P37, DOI 10.1016/j.radonc.2014.04.012; Oliver JA, 2015, TRANSL ONCOL, V8, P524, DOI 10.1016/j.tranon.2015.11.013; Parmar C, 2015, SCI REP, P5; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Zhao BS, 2010, CLIN CANCER RES, V16, P4647, DOI 10.1158/1078-0432.CCR-10-0125	35	87	94	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192002	10.1371/journal.pone.0192002	http://dx.doi.org/10.1371/journal.pone.0192002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401463	Green Submitted, gold, Green Published			2022-12-27	WOS:000424101400030
J	Larpin, Y; Oechslin, F; Moreillon, P; Resch, G; Entenza, JM; Mancini, S				Larpin, Yu; Oechslin, Frank; Moreillon, Philippe; Resch, Gregory; Entenza, Jose Manuel; Mancini, Stefano			In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; RESISTANT; ENDOLYSINS; ANTIMICROBIALS; MODEL; PEPTIDES; THERAPY	The recent rise of multidrug-resistant Gram-negative bacteria represents a serious threat to public health and makes the search for novel effective alternatives to antibiotics a compelling need. Bacteriophage (Phage) lysins are enzymes that hydrolyze the cell wall of bacteria and represent a promising alternative to tackle this ever-increasing problem. Despite their use is believed to be restricted to Gram-positive bacteria, recent findings have shown that they can also be used against Gram-negative bacteria. By using a phage genome-based screening approach, we identified and characterized a novel lysin, PlyE146, encoded by an Escherichia coli prophage and with a predicted molecular mass of ca. 17 kDa. PlyE146 is composed of a C-terminal cationic peptide and a N-terminal N-acetylmuramidase domain. Histidine-tagged PlyE146 was overexpressed from a plasmid in Lactococcus lactis NZ9000 and purified by NI-NTA chromatography. PlyE146 exhibited in vitro optimal bactericidal activity against E. coli K12 (3.6 log(10) CFU/mL decrease) after 2 h of incubation at 37 degrees C at a concentration of 400 mu g/mL in the absence of NaCl and at pH 6.0. Under these conditions, PlyE146 displayed antimicrobial activity towards several other E. coli, Pseudomonas aeruginosa (3 to 3.8-log(10) CFU/mL decrease) and Acinetobacter baumannii (4.9 to >5-log(10) CFU/mL decrease) strains. Therefore, PlyE146 represents a promising therapeutic agent against E. coli, P. aeruginosa and A. baumannii infections. However, further studies are required to improve the efficacy of PlyE146 under physiological conditions.	[Larpin, Yu; Oechslin, Frank; Moreillon, Philippe; Resch, Gregory; Entenza, Jose Manuel; Mancini, Stefano] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Mancini, Stefano] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	University of Lausanne; University of Zurich	Entenza, JM (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	jose.entenza@unil.ch		resch, gregory/0000-0003-2341-4591; Larpin, Yu/0000-0002-4313-5509; Oechslin, Frank/0000-0002-8473-8795	Swiss National Science Foundation [310030-125325]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant 310030-125325). There was no additional external funding received for this study.	Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14; Briers Y, 2014, ANTIMICROB AGENTS CH, V58, P3774, DOI 10.1128/AAC.02668-14; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Defraine V, 2016, ANTIMICROB AGENTS CH, V60, P3480, DOI 10.1128/AAC.00285-16; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Huang GT, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0681-2; Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485; Jun SY, 2013, INT J ANTIMICROB AG, V41, P156, DOI 10.1016/j.ijantimicag.2012.10.011; Junn HJ, 2005, PROTEIN EXPRES PURIF, V42, P78, DOI 10.1016/j.pep.2005.03.026; Lai MJ, 2013, INT J ANTIMICROB AG, V42, P141, DOI 10.1016/j.ijantimicag.2013.04.022; Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14; Ma Q, 2017, ANTON LEEUW INT J G, V110, P347, DOI 10.1007/s10482-016-0806-2; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; Oechslin F, 2013, ANTIMICROB AGENTS CH, V57, P6276, DOI 10.1128/AAC.01701-13; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Poirel L, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00006-2; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]; Spellberg B, 2008, LANCET INFECT DIS, V8, P211, DOI 10.1016/S1473-3099(08)70048-3; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Yang H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01471; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	27	52	58	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192507	10.1371/journal.pone.0192507	http://dx.doi.org/10.1371/journal.pone.0192507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408864	Green Published, gold, Green Submitted			2022-12-27	WOS:000424302800074
J	Pritchard, J; Upjohn, M; Hirson, T				Pritchard, Joy; Upjohn, Melissa; Hirson, Tamsin			Improving working equine welfare in 'hardwin' situations, where gains are difficult, expensive or marginal	PLOS ONE			English	Article							POSITIVE WELFARE; BEHAVIOR; DELPHI; HORSES; HEALTH; METHODOLOGY; COUNTRIES	Purpose Brooke is a non-government organisation with working equine welfare programmes across Africa, Asia and Latin America. In 2014, staff from ten country programmes were asked to identify 'no-win' situations (subsequently reframed as ` hard-wins') D where improving equine welfare is proving difficult, expensive and/or marginal D in order to inform strategic decisions on how to approach, manage and mitigate for such situations. Methods The Delphi-type consultation process had three phases. Round 1 posed five questions in the form of a workshop, survey and semi-structured interviews. Round 2 re-presented key themes and sense-checked initial conclusions. Round 3 reviewed the nature and prevalence of hard-win situations at an international meeting of all participants. Results Reasons given for hard-win situations included: no economic or social benefit from caring for working animals; poor resource availability; lack of empathy for working equids or their owners among wider stakeholders; deep-seated social issues, such as addiction or illegal working; areas with a high animal turnover or migratory human population; lack of community cooperation or cohesion; unsafe areas where welfare interventions cannot be adequately supported. Participants estimated the prevalence of hard-win situations as 40-70% of their work. They suggested some current ways of working that may be contributing to the problem, and opportunities to tackle hard-wins more effectively. Conclusion and animal welfare implications Respondents agreed that if equine welfare improvements are to span generations of animals, interventions cannot rely on relatively simple, technical knowledge-transfer strategies and quick-wins alone. Programmes need to be more flexible and iterative and less risk-averse in their approaches to embedding good equine welfare practices in all relevant actors. Consultation recommendations informed development of Brooke's new global strategy, a revised organisational structure and redefinition of roles and responsibilities to streamline ways to approach hard-wins in the complex environments and socio-economic contexts in which working equids are found.	[Pritchard, Joy] Animals Int Dev, Banwell, N Somerset, England; [Upjohn, Melissa] Dogs Trust, London, England; [Hirson, Tamsin] Boston Consulting Grp Inc, London, England	Boston Consulting Group (BCG)	Upjohn, M (corresponding author), Dogs Trust, London, England.	melissa.upjohn@dogstrust.org.uk						Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Burford JH, 2017, EQUINE VET EDUC, V29, pS19; Collins J, 2009, VET J, V181, P63, DOI 10.1016/j.tvjl.2009.03.012; Davis R, 2015, HEALTH PSYCHOL REV, V9, P323, DOI 10.1080/17437199.2014.941722; Dijk L. van, 2010, The 6th International Colloquium on Working Equids: learning from others. Proceedings of an International Colloquium, New Delhi, India, 29 November - 2 December 2010, P51; Easterly W., 2006, WHITE MANS BURDEN; Edgar Joanne L, 2013, Animals (Basel), V3, P584, DOI 10.3390/ani3030584; Ellerman D., 2004, Review of Social Economy, V62, P149, DOI 10.1080/00346760410001684424; EWB Engineers without Borders Canada, 2010, ADM FAIL FAIL FORW P; FAOSTAT database [internet] Food and Agriculture Organisation of the United Nations, 2014, STAT DAT PROD LIV AN; Frewer LJ, 2011, TECHNOL FORECAST SOC, V78, P1514, DOI 10.1016/j.techfore.2011.05.005; Grimshaw JM, 2001, MED CARE, V39, pII2; Ireland JL, 2012, EQUINE VET J, V44, P94, DOI 10.1111/j.2042-3306.2011.00394.x; Jones H., 330 ODI; Ko M, 2014, BMJ QUAL SAF, V23, P177, DOI 10.1136/bmjqs-2013-002591; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McInerney J., ANIMAL WELFARE EC PO; Michie S., 2011, IMPLEMENT SCI, V6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Pritchard J., 2014, Proceedings of the 7th International Colloquium on Working Equids, Royal Holloway, University of London, UK. 1st-3rd July, 2014, P2; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Ramalingam B., 2014, BEST PRACTICE BEST F; Ramalingam B, 285 ODI; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Schon D. A., 1971, STABLE STATE; Schon D.A, 2017, REFLECTIVE PRACTITIO; Taylor D, 2006 REV UND NAT I H; Valette D., 2014, KEY FINDINGS RES ETH; Van Dijk L, 2010, SHARING LOAD GUIDE I, P139; Weary DM, 2015, ANIMALS, P1; Wentholt MTA, 2012, PREV VET MED, V103, P81, DOI 10.1016/j.prevetmed.2011.09.021; Wessells MG, 2009, AM PSYCHOL, V64, P842, DOI 10.1037/0003-066X.64.8.842; Wong S, 2009, RURAL REMOTE HEALTH, V9; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009; Yesuf M, 2009, AM J AGR ECON, V91, P1022, DOI 10.1111/j.1467-8276.2009.01307.x	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191950	10.1371/journal.pone.0191950	http://dx.doi.org/10.1371/journal.pone.0191950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408887	Green Published, Green Submitted, gold			2022-12-27	WOS:000424302800034
J	Park, SH; Lee, CW; Cho, SM; Lee, H; Park, H; Lee, J; Lee, JH				Park, Sun-Ha; Lee, Chang Woo; Cho, Sung Mi; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck			Crystal structure and enzymatic properties of chalcone isomerase from the Antarctic vascular plant Deschampsia antarctica Desv.	PLOS ONE			English	Article							FLAVANONE ISOMERASE; REACTION-MECHANISM; FLAVONOIDS; BIOSYNTHESIS; PURIFICATION; REFINEMENT; FLOWERS; BINDING; STRESS; COLOR	Chalcone isomerase (CHI) is an important enzyme for flavonoid biosynthesis that catalyzes the intramolecular cyclization of chalcones into (S)-flavanones. CHIs have been classified into two types based on their substrate specificity. Type I CHIs use naringenin chalcone as a substrate and are found in most of plants besides legumes, whereas type II CHIs in leguminous plants can also utilize isoliquiritigenin. In this study, we found that the CHI from the Antarctic plant Deschampsia antarctica (DaCHI1) is of type I based on sequence homology but can use type II CHI substrates. To clarify the enzymatic mechanism of DaCHI1 at the molecular level, the crystal structures of unliganded DaCHI1 and isoliquiritigenin-bound DaCHI1 were determined at 2.7 and 2.1 angstrom resolutions, respectively. The structures revealed that isoliquiritigenin binds to the active site of DaCHI1 and induces conformational changes. Additionally, the activity assay showed that while DaCHI1 exhibits substrate preference for naringenin chalcone, it can also utilize isoliquiritigenin although the catalytic activity was relatively low. Based on these results, we propose that DaCHI1 uses various substrates to produce antioxidant flavonoids as an adaptation to oxidative stresses associated with harsh environmental conditions.	[Park, Sun-Ha; Lee, Chang Woo; Cho, Sung Mi; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea	Korea Polar Research Institute (KOPRI)	Lee, J; Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Lee, J; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	jelee@kopri.re.kr; junhyucklee@kopri.re.kr		Lee, Hyoungseok/0000-0002-5831-6345; Cho, Sung Mi/0000-0001-5414-7727	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute [PE18080]	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute	This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (PE18080) funded by the Korea Polar Research Institute to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff at the X-ray crystallography core facility of the Korea Basic Science Institute (Ochang, Korea) and BL-5C of the Pohang Accelerator Laboratory (Pohang, Korea) for assistance with data collection. This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (PE18080) funded by the Korea Polar Research Institute.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; BOLAND MJ, 1975, EUR J BIOCHEM, V50, P383, DOI 10.1111/j.1432-1033.1975.tb09814.x; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng H, 2011, PLANT CELL REP, V30, P49, DOI 10.1007/s00299-010-0943-4; DIXON RA, 1988, PHYTOCHEMISTRY, V27, P2801, DOI 10.1016/0031-9422(88)80666-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; FORKMANN G, 1980, BIOCHEM GENET, V18, P519, DOI 10.1007/BF00484399; Gall M, 2014, ANGEW CHEM INT EDIT, V53, P1439, DOI 10.1002/anie.201306952; GROTEWOLD E, 1994, MOL GEN GENET, V242, P1; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2000, NAT STRUCT BIOL, V7, P786, DOI 10.1038/79025; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Kim S, 2004, MOL GENET GENOMICS, V272, P411, DOI 10.1007/s00438-004-1076-7; Kozlowska Aleksandra, 2014, Rocz Panstw Zakl Hig, V65, P79; Lee Eung-Ryoung, 2007, Recent Pat Biotechnol, V1, P139, DOI 10.2174/187220807780809445; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; MCKHANN HI, 1994, PLANT MOL BIOL, V24, P767, DOI 10.1007/BF00029858; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MOL JNM, 1985, PHYTOCHEMISTRY, V24, P2267; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ngaki MN, 2012, NATURE, V485, P530, DOI 10.1038/nature11009; Nishihara M, 2005, FEBS LETT, V579, P6074, DOI 10.1016/j.febslet.2005.09.073; NORTH ACT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P351, DOI 10.1107/S0567739468000707; Pearson AR, 2007, BIOCHEMISTRY-US, V46, P8340, DOI 10.1021/bi700086r; Qin JC, 2011, PLANTA MED, V77, P765, DOI 10.1055/s-0030-1250566; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Shimada N, 2003, PLANT PHYSIOL, V131, P941, DOI 10.1104/pp.004820; Shoeva OY, 2014, GENE, V538, P334, DOI 10.1016/j.gene.2014.01.008; Thomsen M, 2015, ACTA CRYSTALLOGR D, V71, P907, DOI 10.1107/S1399004715001935; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zamora P, 2013, POLAR BIOL, V36, P1269, DOI 10.1007/s00300-013-1346-0; Zhang HC, 2009, PLANT CELL REP, V28, P1205, DOI 10.1007/s00299-009-0721-3; Zhang Y, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-6; Zhou B, 2007, J EXP BOT, V58, P1771, DOI 10.1093/jxb/erm036	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192415	10.1371/journal.pone.0192415	http://dx.doi.org/10.1371/journal.pone.0192415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394293	Green Submitted, Green Published, gold			2022-12-27	WOS:000424060400044
J	Huang, YP; Yang, HJ; Qi, XM; Malekian, R; Pfeiffer, O; Li, ZX				Huang, Yaping; Yang, Haijun; Qi, Xuemei; Malekian, Reza; Pfeiffer, Olivia; Li, Zhixiong			A novel selection method of seismic attributes based on gray relational degree and support vector machine	PLOS ONE			English	Article								The selection of seismic attributes is a key process in reservoir prediction because the prediction accuracy relies on the reliability and credibility of the seismic attributes. However, effective selection method for useful seismic attributes is still a challenge. This paper presents a novel selection method of seismic attributes for reservoir prediction based on the gray relational degree (GRD) and support vector machine (SVM). The proposed method has a two-hierarchical structure. In the first hierarchy, the primary selection of seismic attributes is achieved by calculating the GRD between seismic attributes and reservoir parameters, and the GRD between the seismic attributes. The principle of the primary selection is that these seismic attributes with higher GRD to the reservoir parameters will have smaller GRD between themselves as compared to those with lower GRD to the reservoir parameters. Then the SVM is employed in the second hierarchy to perform an interactive error verification using training samples for the purpose of determining the final seismic attributes. A real-world case study was conducted to evaluate the proposed GRD-SVM method. Reliable seismic attributes were selected to predict the coalbed methane (CBM) content in southern Qinshui basin, China. In the analysis, the instantaneous amplitude, instantaneous bandwidth, instantaneous frequency, and minimum negative curvature were selected, and the predicted CBM content was fundamentally consistent with the measured CBM content. This real-world case study demonstrates that the proposed method is able to effectively select seismic attributes, and improve the prediction accuracy. Thus, the proposed GRD-SVM method can be used for the selection of seismic attributes in practice.	[Huang, Yaping; Qi, Xuemei] China Univ Min & Technol, Sch Resources & Geosci, Xuzhou, Peoples R China; [Huang, Yaping] China Univ Min & Technol, Key Lab Coal Methane & Fire Control, Minist Educ, Xuzhou, Peoples R China; [Yang, Haijun] Tarim Oilfield Co, Inst China Petr, Korla, Xinjiang, Peoples R China; [Malekian, Reza] Univ Pretoria, Dept Elect Elect & Comp Engn, Pretoria, South Africa; [Pfeiffer, Olivia] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Li, Zhixiong] China Univ Min & Technol, Sch Mechatron Engn, Xuzhou, Peoples R China; [Li, Zhixiong] Univ Wollongong, Sch Mech Mat Mechatron & Biomed Engn, Wollongong, NSW, Australia	China University of Mining & Technology; China University of Mining & Technology; University of Pretoria; University of Massachusetts System; University of Massachusetts Amherst; China University of Mining & Technology; University of Wollongong	Li, ZX (corresponding author), China Univ Min & Technol, Sch Mechatron Engn, Xuzhou, Peoples R China.; Li, ZX (corresponding author), Univ Wollongong, Sch Mech Mat Mechatron & Biomed Engn, Wollongong, NSW, Australia.	zhixiong.li@ieee.org	Li, Zhixiong/G-8418-2018	Li, Zhixiong/0000-0002-7265-0008	Natural Science Foundation of China [41704104]; Chinese Postdoctoral Science Foundation [2014M551703]; Fundamental Research Funds for the Central Universities [2012QNA62]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); UOW; Institute of China Petroleum Tarim Oilfield Company	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); UOW; Institute of China Petroleum Tarim Oilfield Company	We acknowledge the financial support provided by the Natural Science Foundation of China (Grant No. 41704104), the Chinese Postdoctoral Science Foundation (Grant No. 2014M551703), the Fundamental Research Funds for the Central Universities (Grant No. 2012QNA62), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) to YH. VC fellowship of UOW to ZL. The Institute of China Petroleum Tarim Oilfield Company provided support in the form of salaries for author Haijun Yang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We acknowledge the financial support provided by the Natural Science Foundation of China (Grant No. 41704104), the Chinese Postdoctoral Science Foundation (Grant No. 2014M551703), the Fundamental Research Funds for the Central Universities (Grant No. 2012QNA62), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and VC fellowship of UOW. The Institute of China Petroleum Tarim Oilfield Company provided support in the form of salaries for author Haijun Yang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmed OA, 2010, GEOPHYSICS, V75, pP1, DOI 10.1190/1.3298443; Bahorich M, 1995, LEADING EDGE, V14, P1053, DOI [10.1190/1.1437077, DOI 10.1190/1.1437077]; Barnes AE, 2007, GEOPHYSICS, V72, pP33, DOI 10.1190/1.2716717; Chen XP, 2013, CHINESE J GEOPHYS-CH, V56, P2837, DOI 10.6038/cjg20130832; Chen XP, 2013, GEOPHYSICS, V78, pD237, DOI 10.1190/GEO2012-0352.1; Chopra S, 2005, GEOPHYSICS, V70, p3SO, DOI 10.1190/1.2098670; Chopra S, 2007, EXPLORATION, P1; Deng J, 2004, PRESS; Dorrington KP, 2004, GEOPHYSICS, V69, P212, DOI 10.1190/1.1649389; Fomel S, 2007, GEOPHYSICS, V72, pA29, DOI 10.1190/1.2437573; Fu DJ, 2006, GEOPHYSICS, V71, pB151, DOI 10.1190/1.2335636; Fu X, 2006, COALBED GAS GEOLOGY; Galvis I.S., 2017, LEADING EDGE, V36, P239, DOI [10.1190/tle36030239.1, DOI 10.1190/TLE36030239.1]; Gao J, 2006, APPL GEOPHYS, V3, P243; Gholami A, 2017, J PETROL SCI ENG, V152, P238, DOI 10.1016/j.petrol.2017.03.013; Hampson DP, 2001, GEOPHYSICS, V66, P220, DOI 10.1190/1.1444899; Iturraran-Viveros U, 2012, J APPL GEOPHYS, V76, P1, DOI 10.1016/j.jappgeo.2011.10.012; Jiang Y, 2016, MEASUREMENT SCI TECH, V27; Kalkomey C.T., 1997, LEAD EDGE, V16, P247, DOI DOI 10.1190/1.1437610; Li Z, 2018, RELIAB ENG SYST SAFE, DOI DOI 10.1016/j.jfluidstructs.2017.12.019; Li ZX, 2018, RENEW ENERG, V116, P55, DOI 10.1016/j.renene.2016.12.013; Qi XM, 2012, APPL GEOPHYS, V9, P80, DOI 10.1007/s11770-012-0317-5; TANER MT, 1979, GEOPHYSICS, V44, P1041, DOI 10.1190/1.1440994; Torrado L, 2014, GEOPHYSICS, V79, pB221, DOI 10.1190/GEO2013-0429.1; Wang ZG, 2015, GEOPHYSICS, V80, pB35, DOI 10.1190/GEO2014-0362.1; Zhang C, 2010, SEG DENVER 2010 ANNU, P1586	27	10	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192407	10.1371/journal.pone.0192407	http://dx.doi.org/10.1371/journal.pone.0192407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394297	Green Published, Green Submitted, gold			2022-12-27	WOS:000424060400043
J	Almutairy, M; Torng, E				Almutairy, Meznah; Torng, Eric			Comparing fixed sampling with minimizer sampling when using k-mer indexes to find maximal exact matches	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SPARSE SUFFIX ARRAYS; DE-BRUIJN GRAPHS; LARGE GENOMES; SEQUENCES; ALGORITHM; DATABASE; SEARCH; BLAST; GENERATION	Bioinformatics applications and pipelines increasingly use k-mer indexes to search for similar sequences. The major problem with k-mer indexes is that they require lots of memory. Sampling is often used to reduce index size and query time. Most applications use one of two major types of sampling: fixed sampling and minimizer sampling. It is well known that fixed sampling will produce a smaller index, typically by roughly a factor of two, whereas it is generally assumed that minimizer sampling will produce faster query times since query k-mers can also be sampled. However, no direct comparison of fixed and minimizer sampling has been performed to verify these assumptions. We systematically compare fixed and minimizer sampling using the human genome as our database. We use the resulting k-mer indexes for fixed sampling and minimizer sampling to find all maximal exact matches between our database, the human genome, and three separate query sets, the mouse genome, the chimp genome, and an NGS data set. We reach the following conclusions. First, using larger k-mers reduces query time for both fixed sampling and minimizer sampling at a cost of requiring more space. If we use the same k-mer size for both methods, fixed sampling requires typically half as much space whereas minimizer sampling processes queries only slightly faster. If we are allowed to use any k-mer size for each method, then we can choose a k-mer size such that fixed sampling both uses less space and processes queries faster than minimizer sampling. The reason is that although minimizer sampling is able to sample query k-mers, the number of shared k-mer occurrences that must be processed is much larger for minimizer sampling than fixed sampling. In conclusion, we argue that for any application where each shared k-mer occurrence must be processed, fixed sampling is the right sampling method.	[Almutairy, Meznah; Torng, Eric] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Almutairy, Meznah] Imam Muhammad ibn Saud Islamic Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia	Michigan State University; Imam Mohammad Ibn Saud Islamic University (IMSIU)	Almutairy, M; Torng, E (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.; Almutairy, M (corresponding author), Imam Muhammad ibn Saud Islamic Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia.	mrmutairy@imamu.edu.sa; torng@msu.edu		Almutairy, Meznah/0000-0001-7254-1867	Michigan State University; Al-Imam Muhammad ibn Saud Islamic University	Michigan State University; Al-Imam Muhammad ibn Saud Islamic University	We thank the anonymous reviewers for their very helpful comments that greatly improved the paper. This work was supported in part by Michigan State University through computational resources provided by the Institute for Cyber-Enabled Research. We also would like to acknowledge Al-Imam Muhammad ibn Saud Islamic University for support of this work.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Ahmadi A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1246; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Almutairy M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Chikhi R, 2014, LECT N BIOINFORMAT, V8394, P35, DOI 10.1007/978-3-319-05269-4_4; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Deorowicz S, 2015, BIOINFORMATICS, V31, P1569, DOI 10.1093/bioinformatics/btv022; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hormozdiari F, 2011, BIOINFORMATICS, V27, P1915, DOI 10.1093/bioinformatics/btr303; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Jain C, 2017, LECT N BIOINFORMAT, V10229, P66, DOI 10.1007/978-3-319-56970-3_5; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan Z, 2009, BIOINFORMATICS, V25, P1609, DOI 10.1093/bioinformatics/btp275; Khiste N, 2015, BIOINFORMATICS, V31, P509, DOI 10.1093/bioinformatics/btu687; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y, 2015, ARXIV PREPRINT; Li Y, 2013, PROC VLDB ENDOW, V6, P169, DOI 10.14778/2535569.2448951; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Movahedi NS, 2012, 2012 IEEE INT C BIOI, P1; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Orenstein Y, 2016, LECT N BIOINFORMAT, V9838, P257, DOI 10.1007/978-3-319-43681-4_21; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Peterlongo P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-48; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schleimer S., 2003, P 2003 ACM SIGMOD IN, P76, DOI DOI 10.1145/872757.872770; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith KC, 2016, SLIDING WINDOW MINIM; Vyverman M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0533-0; Vyverman M, 2013, BIOINFORMATICS, V29, P802, DOI 10.1093/bioinformatics/btt042; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0189960	10.1371/journal.pone.0189960	http://dx.doi.org/10.1371/journal.pone.0189960			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389989	Green Published, gold, Green Submitted			2022-12-27	WOS:000423793400004
J	Silva, DAS; Tremblay, MS; de Souza, MDM; Mooney, M; Naghavi, M; Malta, DC				Santos Silva, Diego Augusto; Tremblay, Mark Stephen; Marinho de Souza, Maria de Fatima; Mooney, Meghan; Naghavi, Mohsen; Malta, Deborah Carvalho			Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; ASSOCIATION; TIME; RISK; ADULTS	Introduction The aims of this study were to estimate all-cause and cause-specific mortality and years of life lost, investigated by disability-adjusted life-years (DALYs), due to colorectal cancer attributable to physical inactivity in Brazil and in the states; to analyze the temporal trend of these estimates over 25 years (1990-2015) compared with global estimates and according to the socioeconomic status of states of Brazil. Methods Databases from the Global Burden of Disease Study (GBD) for Brazil, Brazilian states and global information were used. It was estimated the total number and the age-standardized rates of deaths and DALYs for colorectal cancer attributable to physical inactivity in the years 1990 and 2015. We used the Socioeconomic Development Index (SDI). Results Physical inactivity was responsible for a substantial number of deaths (1990: 1,302; 2015: 119,351) and DALYs (1990: 31,121; 2015: 87,116) due to colorectal cancer in Brazil. From 1990 to 2015, the mortality and DALYs due to colorectal cancer attributable to physical inactivity increased in Brazil (0.6% and 0.6%, respectively) and decreased around the world (-0.8% and -1.1%, respectively). The Brazilian states with better socioeconomic indicators had higher rates of mortality and morbidity by colorectal cancer due to physical inactivity (p<0.01). Physical inactivity was responsible for deaths and DALYs due to colorectal cancer in Brazil. Conclusions Over 25 years, the Brazilian population showed more worrisome results than around the world. Actions to combat physical inactivity and greater cancer screening and treatment are urgent in the Brazilian states.	[Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil; [Tremblay, Mark Stephen] Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Marinho de Souza, Maria de Fatima] Minist Hlth, Dept Surveillance Noncommunicable Dis & Injuries, Brasilia, DF, Brazil; [Mooney, Meghan; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Sch Nursing, Belo Horizonte, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); University of Ottawa; Children's Hospital of Eastern Ontario; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Universidade Federal de Minas Gerais	Silva, DAS (corresponding author), Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil.	diegoaugustoss@yahoo.com.br	Marinho, Fatima/AFJ-2948-2022; Silva, Diego/GRF-5446-2022; Malta, Deborah Carvalho/L-2491-2019; Tremblay, Mark/AAF-2981-2019; Tremblay, Mark/ABI-5477-2020; Marinho, Fatima/ABC-8725-2021; Silva, Diego Augusto Santos/AAB-9249-2020; Marinho, Fatima/AAF-4556-2022	Marinho, Fatima/0000-0003-3287-9163; Malta, Deborah Carvalho/0000-0002-8214-5734; Silva, Diego Augusto Santos/0000-0002-0489-7906; Marinho, Fatima/0000-0003-3287-9163	National Council for Scientific and Technological Development from Brazil; Ministry of Health from Brazil [25000192049/2014-14]	National Council for Scientific and Technological Development from Brazil; Ministry of Health from Brazil	The author (DASS and DCM) thanks the National Council for Scientific and Technological Development from Brazil for the research grant (PQ). Bill & Melinda Gates Foundation (GBD Global) and Ministry of Health from Brazil (GBD 2015 Brazil-states; Process No. 25000192049/2014-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breen N, 2017, CANCER CAUSE CONTROL, V28, P117, DOI 10.1007/s10552-016-0842-2; Del Duca GF, 2013, CAD SAUDE PUBLICA, V29, P2119, DOI 10.1590/0102-311X00130412; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Farris MS, 2015, CANCER EPIDEM BIOMAR, V24, P1462, DOI 10.1158/1055-9965.EPI-15-0301; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2018, INT J PUBLIC HEALTH, V63, P151, DOI 10.1007/s00038-017-0999-9; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Friedenreich CM, J MOL MED IN PRESS; Guerra Maximiliano Ribeiro, 2017, Rev. bras. epidemiol., V20, P102, DOI 10.1590/1980-5497201700050009; Ishitani Lenice Harumi, 2017, Rev. bras. epidemiol., V20, P34, DOI 10.1590/1980-5497201700050004; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Malta D, 2015, REV BRASILEIRA ATIVI, V20, P141, DOI [10.1590/S1415-790X2011000500006, DOI 10.12820/rbafs.v.20n2p141]; Malta Deborah Carvalho, 2017, Rev. bras. epidemiol., V20, P217, DOI 10.1590/1980-5497201700050018; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Murray, 2002, SUMMARY MEASURES POP, P205; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Quadrilatero J, 2003, J SPORT MED PHYS FIT, V43, P121; Queiroz Bernardo Lanza, 2017, Rev. bras. epidemiol., V20, P21, DOI 10.1590/1980-5497201700050003; Schwarz E, 2012, REV SAUDE PUBL, V46, P108, DOI 10.1590/S0034-89102012005000061; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Souza Maria de Fatima Marinho de, 2017, Rev Bras Epidemiol, V20Suppl 01, P1, DOI 10.1590/1980-5497201700050001; Stopa SR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051000074, 10.1590/s1518-8787.2017051000074]; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN, DOI DOI 10.1017/CBO9781107415324.004; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2013, GLOBAL ACTION PLAN F	28	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190943	10.1371/journal.pone.0190943	http://dx.doi.org/10.1371/journal.pone.0190943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390002	Green Submitted, Green Published, gold			2022-12-27	WOS:000423793400010
J	Beaver, JM; Lai, YH; Rolle, SJ; Weng, LW; Greenberg, MM; Liu, Y				Beaver, Jill M.; Lai, Yanhao; Rolle, Shantell J.; Weng, Liwei; Greenberg, Marc M.; Liu, Yuan			An oxidized abasic lesion inhibits base excision repair leading to DNA strand breaks in a trinucleotide repeat tract	PLOS ONE			English	Article							POLYMERASE-BETA; GENETIC INSTABILITY; PHOSPHATE LYASE; HUMAN-DISEASE; EXPANSION; DAMAGE; MECHANISM; SITE; DEOXYRIBOSE; 8-OXO-7,8-DIHYDROGUANINE	Oxidative DNA damage and base excision repair (BER) play important roles in modulating trinucleotide repeat (TNR) instability that is associated with human neurodegenerative diseases and cancer. We have reported that BER of base lesions can lead to TNR instability. However, it is unknown if modifications of the sugar in an abasic lesion modulate TNR instability. In this study, we characterized the effects of the oxidized sugar, 5'-(2-phosphoryl-1,4-dioxobutane)(DOB) in CAG repeat tracts on the activities of key BER enzymes, as well as on repeat instability. We found that DOB crosslinked with DNA polymerase beta and inhibited its synthesis activity in CAG repeat tracts. Surprisingly, we found that DOB also formed cross-links with DNA ligase I and inhibited its ligation activity, thereby reducing the efficiency of BER. This subsequently resulted in the accumulation of DNA strand breaks in a CAG repeat tract. Our study provides important new insights into the adverse effects of an oxidized abasic lesion on BER and suggests a potential alternate repair pathway through which an oxidized abasic lesion may modulate TNR instability.	[Beaver, Jill M.; Liu, Yuan] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Lai, Yanhao; Rolle, Shantell J.; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Weng, Liwei; Greenberg, Marc M.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Liu, Yuan] Florida Int Univ, Sch Integrated Sci & Humanities, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; Johns Hopkins University; State University System of Florida; Florida International University	Liu, Y (corresponding author), Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Sch Integrated Sci & Humanities, Biomol Sci Inst, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019		National Institutes of Health [R01ES023569]; Florida International University RISE Fellowship; National Institute of General Medical Sciences [GM-063028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida International University RISE Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [R01ES023569 to Y. Liu], Florida International University RISE Fellowship [to J.M.B.], and National Institute of General Medical Sciences [GM-063028 to M.M.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; National Institutes of Health [R01ES023569 to Y.Liu]. Florida International University RISE Fellowship [to J.M.B.]. National Institute of General Medical Sciences [GM-063028 to M.M.G.]	Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beaver JM, 2015, NUCLEIC ACIDS RES, V43, P5948, DOI 10.1093/nar/gkv530; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chen BZ, 2004, CHEM RES TOXICOL, V17, P1406, DOI 10.1021/tx049818e; Cilli P, 2016, NUCLEIC ACIDS RES, V44, P5190, DOI 10.1093/nar/gkw170; Derevyanko AG, 2012, BIOCHEMISTRY-MOSCOW+, V77, P270, DOI 10.1134/S0006297912030054; GOLDBERG IH, 1991, ACCOUNTS CHEM RES, V24, P191, DOI 10.1021/ar00007a001; Goula AV, 2012, BIOCHEMISTRY-US, V51, P3919, DOI 10.1021/bi300410d; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Greenberg MM, 2014, CURR OPIN CHEM BIOL, V21, P48, DOI 10.1016/j.cbpa.2014.03.018; Guan LR, 2010, BIOCHEMISTRY-US, V49, P9904, DOI 10.1021/bi101533a; Guan LR, 2010, J AM CHEM SOC, V132, P5004, DOI 10.1021/ja101372c; Guan LR, 2009, J AM CHEM SOC, V131, P15225, DOI 10.1021/ja9061695; Hashimoto M, 2001, J AM CHEM SOC, V123, P3161, DOI 10.1021/ja003354z; Jacobs AC, 2011, BIOCHEMISTRY-US, V50, P136, DOI 10.1021/bi1017667; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kodama T, 2005, J ORG CHEM, V70, P9916, DOI 10.1021/jo051666k; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093464; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Pitie M, 2010, CHEM REV, V110, P1018, DOI 10.1021/cr900247m; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Tarantino ME, 2015, J BIOL CHEM, V290, P21154, DOI 10.1074/jbc.M115.666438; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Usdin K, 2015, CRIT REV BIOCHEM MOL, V50, P142, DOI 10.3109/10409238.2014.999192; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Xu M, 2014, NUCLEIC ACIDS RES, V42, P13749, DOI 10.1093/nar/gku1239; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192148	10.1371/journal.pone.0192148	http://dx.doi.org/10.1371/journal.pone.0192148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389977	Green Published, Green Submitted, gold			2022-12-27	WOS:000423793400072
